{
    "http://www.ncbi.nlm.nih.gov/pubmed/28293123": [
        "Lung cancer is the leading killer of both men and women in the US, and the 5-year survival remains poor.",
        "In early studies, treatment with pembrolizumab led to dramatic and durable responses in select patients (PD-L1+ tumors).",
        "However, the approval of checkpoint blockade immunotherapy has shifted the treatment paradigm and provides hope for improved survival.",
        "The initial approval and subsequent studies of pembrolizumab required and utilized a companion diagnostic test, Dako's IHC 22C3, to assess PD-L1 status of patients.",
        "Finally, the impact of pembrolizumab in NSCLC is growing as evidenced by the numerous, ongoing trials open for combinations with chemotherapy, chemoradiation, other immunotherapeutics, immunomodulators, tyrosine kinase inhibitors, PI3K inhibitors, MEK inhibitors, hypomethylating agents, and histone deacetylase inhibitors.",
        "In patients with \u226550% PD-L1+ tumors, pembrolizumab had a clear progression-free survival and overall survival benefit.",
        "Toxicity was mostly immune related and similar to checkpoint blockade toxicities observed in previous studies.",
        "Further studies are also evaluating pembrolizumab in small-cell lung cancer and malignant pleural mesothelioma.",
        "This remarkable efficacy lead to approval of pembrolizumab in the second-line setting as response rates were almost doubled compared to standard of care (SOC) chemotherapy.",
        "The evaluation and scoring system of this assay has been used by other companies as a reference to develop their own assays, which may complicate selection of patients.",
        "This explosion of studies truly conveys the lack of therapeutic answers for lung cancer patients and the promise of pembrolizumab.",
        "The ability of non-small-cell lung cancer (NSCLC) to evade the host immune system can be overcome by agents such as pembrolizumab (MK-3475/lambrolizumab), which is a monoclonal antibody targeting the programmed death 1 (PD-1) receptor.",
        "Most recently, data in the first-line setting from the KEYNOTE-024 study have redefined the SOC therapy for a selected subset of patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24161931": [
        "Furthermore, in vivo inhibition of miR-25 by a specific antagomir evoked spontaneous cardiac dysfunction and sensitized the murine myocardium to heart failure in a Hand2-dependent manner.",
        "Although aberrant reactivation of embryonic gene programs is intricately linked to pathological heart disease, the transcription factors driving these gene programs remain ill-defined.",
        "Conversely, conditional gene-targeted Hand2 mice demonstrated a marked resistance to pressure-overload-induced hypertrophy, fibrosis, ventricular dysfunction and induction of a fetal gene program.",
        "In line, mutant mice overexpressing Hand2 in otherwise healthy heart muscle cells developed a phenotype of pathological hypertrophy.",
        "Our results reveal that signalling cascades integrate with microRNAs to induce the expression of the bHLH transcription factor Hand2 in the postnatal mammalian myocardium with impact on embryonic gene programs in heart failure.",
        "Here we report that increased calcineurin/Nfat signalling and decreased miR-25 expression integrate to re-express the basic helix-loop-helix (bHLH) transcription factor dHAND (also known as Hand2) in the diseased human and mouse myocardium."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28081177": [
        "Whether the observed impact is based on direct actions of Mic-1/Gdf15 deficiency on the CNS or whether the behavioural effects are mediated by indirect actions on e.g. other neurotransmitter systems must be clarified in future studies.",
        "MIC-1/GDF15 is secreted into the cerebrospinal fluid and increased levels of MIC-1/GDF15 are associated with a variety of diseases including cognitive decline.",
        "Overall sex effects were evident for social behaviours, fear conditioning, and sensorimotor gating.",
        "This is the first study defining the role of Mic-1/Gdf15 in a number of behavioural domains.",
        "Mic-1 KO mice exhibited a task-dependent increase in locomotion and exploration and reduced anxiety-related behaviours across tests.",
        "Furthermore, Mic-1/Gdf15 knockout mice (Mic-1 KO) weigh more, have increased adiposity, associated with increased spontaneous food intake, and exhibit reduced basal energy expenditure and physical activity.",
        "The current study was designed to comprehensively determine the role of MIC-1/GDF15 on behavioural domains of male and female knockout mice including locomotion, exploration, anxiety, cognition, social behaviours, and sensorimotor gating.",
        "Interestingly, knockout mice formed an increased association with the conditioned stimulus in fear conditioning testing and also displayed significantly improved prepulse inhibition.",
        "Spatial working memory and social behaviours were not affected by Mic-1/Gdf15 deficiency.",
        "Macrophage inhibitory cytokine-1 (MIC-1), also known as growth differentiation factor 15 (GDF15), is a stress response cytokine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28062617": [
        "GDF-15 has favorable preanalytic characteristics and can be measured in serum and plasma by immunoassay.",
        "Cardiovascular (CV) disease is a major driver of GDF-15 production.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Growth differentiation factor 15 (GDF-15) is expressed and secreted in response to inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28025863": [
        "Inflammatory mediators and tumour-derived factors are thought to play an important role in the aetiology of CACS.",
        "The area postrema (AP) and the nucleus tractus solitarii are two important brainstem centres for the control of eating during acute sickness conditions.",
        "However, the central and peripheral mechanisms contributing to CACS are insufficiently understood.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The cancer-anorexia-cachexia syndrome (CACS) negatively affects survival and therapy success in cancer patients.",
        "Recently, the tumour-derived macrophage inhibitory cytokine-1 (MIC-1) emerged as a possible mediator of cancer anorexia because lesions of these brainstem areas attenuated the anorectic effect of exogenous MIC-1 in mice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27750354": [
        "Adults with obesity have increased serum concentrations of MIC-1/GDF15.",
        "Further work would be required to find out if MIC-1/GDF15 has any role in the early inflammatory, cardiac and metabolic changes in childhood obesity.",
        "Growth differentiation factor-15, also known as macrophage inhibitory cytokine-1 (MIC-1/GDF15) is a member of the transforming growth factor- \u03b2 super family and increases during inflammatory states.",
        "MIC-1/GDF15 was positively correlated with CRP, ALT and aortic dimension when normal-weight and obese children were analyzed together. <b>Conclusions:</b> MIC-1/GDF15 may provide a link between childhood obesity and cardio metabolic complications that will occur in time course.",
        "MIC-1/GDF15 is associated with cardio metabolic risk in adults. <b>Design:</b> Identification of obese children at higher risk for cardio metabolic complications is important.",
        "The relations of MIC-1/GDF15 to parameters of obesity in children have never been studied. <b>Methods:</b> We measured serum MIC-1/GDF15 concentration in obese children by EL\u0130SA and evaluated its relationship with anthropometric, biochemical and echocardiographic parameters. <b>Results:</b> No significant difference in serum MIC-1/GDF15 between normal-weight and obese children was observed.",
        "<b>Objective:</b> Childhood obesity which is a predictor of adulthood obesity is associated with type 2 diabetes, metabolic syndrome, dyslipidemia, coronary artery diseases and subclinical inflammation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28159780": [
        "Elevations in GDF-15 may identify a novel pathway involved in loss of kidney function among patients with CKD.",
        "Among the 224 C-PROBE and 297 SKS participants, 72 (32.1%) and 94 (32.0%) patients, respectively, reached a composite end point of 30% decline in eGFR or progression to ESRD over a median of 1.8 and 2.0 years of follow up, respectively.",
        "In matching samples of 24 patients with CKD from the C-PROBE study, circulating GDF-15 levels significantly correlated with intrarenal <i>GDF15</i> transcript levels (<i>r</i>=0.54, <i>P</i>=0.01).",
        "Circulating GDF-15 may be a marker for intrarenal <i>GDF15</i>-related signaling pathways associated with CKD and CKD progression.",
        "Among participants in the Clinical Phenotyping and Resource Biobank (C-PROBE) study and the Seattle Kidney Study (SKS), we tested whether kidney tissue expression of <i>GDF15</i> mRNA correlates with circulating levels of GDF-15 and whether elevations in circulating GDF-15 are associated with decline in kidney function.",
        "These results show that circulating GDF-15 levels strongly correlated with intrarenal expression of <i>GDF15</i> and significantly associated with increased risk of CKD progression in two independent cohorts.",
        "In multivariable models, after adjusting for potential confounders, every doubling of GDF-15 level associated with a 72% higher (95% confidence interval, 1.21 to 4.45; <i>P</i>=0.003) and 65% higher (95% confidence interval, 1.08 to 2.50; <i>P</i>=0.02) risk of progression of kidney disease in C-PROBE and SKS participants, respectively.",
        "Growth differentiation factor-15 (GDF-15) is a member of the TGF-<i>\u03b2</i> cytokine superfamily that is widely expressed and may be induced in response to tissue injury."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12399934": [
        "A follow-up over 83 generations has been carried out, by the Southern blotting technique, of a Drosophila stock which is unstable in the location of Bari 1 elements.",
        "The relevance to the mechanism(s) that contains the potentially deleterious effects of transposition is discussed.",
        "These results suggest that in Drosophila preferential insertion sites may be defined with the contribution of host factors, although alternative interpretations are also possible.",
        "The persistent intrastock polymorphism detected is largely amenable to insertion/excision equilibria at 36 genomic sites that form a gradient in occupancy.",
        "In a closely related stock, Bari 1 elements are stable and exhibit a substantially different genomic distribution."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9689229": [
        "The availability of completely sequenced genomes has created an opportunity for high throughput mutational studies.",
        "This suggests that A + T-rich sequences similar to the Tn916 insertion site would be more likely to reside in the intergenic DNA.",
        "It was determined that the intergenic DNA was over 5% more A + T-rich than that of protein coding sequences.",
        "DNA was isolated from Tn916-mutagenized cells, and the point of transposon insertion was determined by inverse PCR, DNA sequencing, and mapping to the wild-type genome sequence.",
        "Although Tn916 integrated at multiple dispersed positions throughout the chromosome, 9 of 10 insertion events occurred in noncoding, intergenic DNA.",
        "Eighty percent of the 30 highest-scoring predicted Tn916 target sites were from intergenic, nonprotein-coding regions of the genome.",
        "These data support the hypothesis that Tn916 has a marked preference for insertion into noncoding DNA for H. influenzae, suggesting that this mobile element has evolved to minimize disruption of host cell function on integration.",
        "Using the conjugative transposon Tn916, a pilot project was initiated to determine the efficiency of gene disruption in the first completely sequenced bacterium, Haemophilus influenzae Rd strain KW20.",
        "In an effort to identify other likely sites for transposon integration, a hidden Markov model of the consensus target insertion site was derived from the Tn916-H. influenzae junction fragments and searched against the entire genome.",
        "Analysis of the insertion sites at the nucleotide level demonstrated a biased pattern of insertion into regions rich in stretches of A's and T's."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15947908": [
        "We assume that RYS1 became active in rye very recently, as different plants from in vivo-growing cultivars showed that these elements were present or absent in the same genomic position in which the in vitro-activated element was found.",
        "The study of two variable amplicons of rye indicates that RYS1, a mobile element, is activated during tissue culture.",
        "We propose that RYS1 could be a foldback (FB) transposon.",
        "This high rate of modification in these particular loci, both in the in vivo and in vitro populations, could indicate that probably the mechanisms promoting genetic variability in nature are the same that induce variation in vitro, and the modifications induced by somaclonal variation could be already present in vivo populations.",
        "Preferential integration points in the rye genome exist, because the new insertions seem to be located, in all studied cases, in the same genome positions.",
        "The FB transposons have been rarely reported in plants; RYS1 is the first described in rye and also the first active plant FB transposon reported."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16717285": [
        "To accommodate sequences up to 3 Mb for these analyses, we developed an automated method, ProTIS, that can generate profiles of predicted integration events.",
        "Initially we found that a mathematical description of DNA-deformability, called V(step), could be used to distinguish preferential integration sites for Sleeping Beauty (SB) transposons into a particular 100 bp region of a plasmid [G. Liu, A. M. Geurts, K. Yae, A. R. Srinivassan, S. C. Fahrenkrug, D. A. Largaespada,J. Takeda, K. Horie, W. K. Olson and P. B. Hackett (2005) J. Mol.",
        "Biol., 346, 161-173 ].",
        "Based on these findings, we extended our examination of integration of SB transposons into whole plasmids and chromosomal DNA.",
        "We analyzed the insertion sites of several transposons and retroviruses to detect patterns of integration that might be useful for prediction of preferred integration sites.",
        "These elements can be used for functional genomics, gene transfer and human gene therapy.",
        "ProTIS analysis can be useful for functional genomic, gene transfer and human gene therapy applications using the SB system.",
        "Nonetheless, ProTIS has the utility for predicting likely SB transposon integration sites in investigator-selected regions of genomes and our general strategy may be useful for other mobile elements once a sufficiently high density of sites in a single region are obtained.",
        "However, a similar approach did not reveal any structural pattern of DNA that could be used to predict favored integration sites for other transposons as well as retroviruses and lentiviruses due to a limitation of available data sets.",
        "Mobile genetic elements with the ability to integrate genetic information into chromosomes can cause disease over short periods of time and shape genomes over eons.",
        "However, their integration-site preferences, which are critically important for these uses, are poorly understood."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21276256": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Among the Solanaceae plants, the pepper genome is three times larger than that of tomato.",
        "Although the gene repertoire and gene order of both species are well conserved, the cause of the genome-size difference is not known.",
        "To determine the causes for the expansion of pepper euchromatic regions, we compared the pepper genome to that of tomato."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26818075": [
        "No strict motif was found, but a preference for structural features in the target DNA associated with DNA flexibility (Twist, Tilt, Rise, Roll, Shift, and Slide) was observed.",
        "Genome-wide analysis shows that Ds integration sites in the presence or absence of marker selection are remarkably similar and distributed throughout the genome.",
        "DNA transposons and retroviruses are important transgenic tools for genome engineering.",
        "Our findings show that structural features influence the integration of heterologous DNA in genomes, and have implications for targeted genome engineering.",
        "Here, we compare over 1300 Ds transposon integration sites in zebrafish with Tol2 transposon and retroviral integration sites.",
        "An important consideration affecting the choice of transgenic vector is their insertion site preferences.",
        "Previous large-scale analyses of Ds transposon integration sites in plants were done on the basis of reporter gene expression or germ-line transmission, making it difficult to discern vertebrate integration preferences.",
        "Remarkably, this feature is also found in transposon and retroviral integrations in maize and mouse cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29106446": [
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      FunImageJ is a Lisp framework for scientific image processing built upon the ImageJ software ecosystem.",
        "The framework provides a natural functional-style for programming, while accounting for the performance requirements necessary in big data processing commonly encountered in biological image analysis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25501636": [
        "Our results show that cerumen contains a complex mixture of VOCs and that the amounts of these compounds vary across individuals as well as across ethnic/racial groups.",
        "Our findings also reveal that ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest that other biochemical pathways must be involved.",
        "This report describes the volatile organic compounds (VOCs) associated with human cerumen (earwax) and the effects of ethnicity/race and variation on the ATP-binding cassette, sub-family C, member 11 gene (ABCC11).",
        "Employing gas chromatography/mass spectrometry (GC/MS) we have identified the nature and relative abundance of cerumen VOCs from 32 male donors.",
        "In six of the seven compounds whose detected concentrations were found to be statistically different across groups, individuals of African descent (AfD) &gt; Caucasian descent (CaD) &gt; Asians descent (AsD).",
        "Examination of the composition and diversity of external auditory canal microbiota in a small subset of our subject population revealed that the ear microbiota may not be directly correlated with either ethnic group membership or ABCC11 genotype.",
        "A single nucleotide polymorphism (SNP) in ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian descent."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24572763": [
        "The principal odorants are volatile organic C2-to-C6 acids.",
        "In this initial report we find that both groups emit many of the same VOCs but differ significantly in the amounts produced.",
        "We report here the initial examination of volatile organic compounds (VOCs) emanating from human earwax (cerumen).",
        "The type of cerumen and underarm odor produced by East Asians differ markedly from that produced by non-Asians.",
        "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal and the secretion of axillary odor precursors.",
        "Recent studies link a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11) to the production of different types of axillary odorants and cerumen.",
        "The physical appearance of cerumen from the two groups also matches previously reported ethnic differences, viz., cerumen from East Asians appears dry and white while that from non-Asians is typically wet and yellowish-brown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25398740": [
        "Human milk is a source of bacteria to the infant gut; however, the origin of milk bacteria, as well as their impact on neonatal gut microbiota establishment, remains largely unknown.",
        "In the past years, results provided by different research groups suggest that certain bacteria from the maternal gastrointestinal tract could translocate through a mechanism involving mononuclear immune cells, migrate to the mammary glands via an endogenous cellular route (the bacterial entero-mammary pathway), and subsequently colonize the gastrointestinal tract of the breast-fed neonate.",
        "If such findings are confirmed in the future, we could exert a positive influence on infant health by modulating the maternal gut microbiota."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24793967": [
        "Most reported SFTS cases are farmers living in rural areas.",
        "The seroprevalence of SFTS virus in farmers has not been investigated.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Severe fever with thrombocytopenia syndrome (SFTS) is a newly identified viral zoonosis caused by a phlebovirus.",
        "The current knowledge of SFTS virus seroprevalence in animals, especially in wild animals, is still poor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25711611": [
        "The possibility that SFTSV transmission may occur by both the transstadial and transovarial routes was suggested by the fact that viral RNA was detected in H. longicornis at all developmental stages.",
        "This study provides evidence that implicates ticks as not only vectors but also, reservoirs of SFTSV.",
        "Eggs were obtained from 22 blood-fed female ticks through maintenance at room temperature after collection.",
        "Both adult and immature ticks were obtained, and all ticks collected from vegetation were unfed.",
        "In total, 3,145 ticks of the species Haemaphysalis longicornis (3,048; 96.9%), R. microplus (82; 2.6%), H. campanulata (9; 0.3%), and Dermacentor sinicus (5; 0.2%) were collected from animals and vegetation at Yantai in Shandong Province.",
        "Tick-derived sequences shared over 95.6% identity with human- and animal-derived isolates.",
        "Severe fever with thrombocytopenia syndrome virus (SFTSV) viral RNA was identified in H. longicornis and R. microplus, with a prevalence of 4.75 per 100 ticks (95% confidence interval [95% CI] = 3.87-5.63) for ticks collected from animals and 2.24 per 100 ticks (95% CI = 1.27-3.21) for ticks collected from vegetation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27495089": [
        "Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome caused by hyperinflammation.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Severe fever with thrombocytopenia syndrome (SFTS) is a new emerging zoonosis.",
        "Here, we report the case of SFTS-associated HLH."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26957392": [
        "Takydromus wolteri had the highest tick index (0.7; total number ticks/total number collected hosts) among lizards and skinks, while Rhabdophis tigrinus had the highest tick index (2.2) among the snakes.",
        "In total, 132 reptiles, including 49 lizards (two species), 15 skinks (one species), and 68 snakes (eight species) were collected.",
        "Ixodes nipponensis larvae and nymphs accounted for 11.1% and 88.9%, respectively, of all ticks collected from lizards and skinks, while only A. testudinarium nymphs were collected from snakes.",
        "SFTS virus was detected in both I. nipponensis and A. testudinarium collected from lizards and snakes.",
        "In total, 84 ixodid ticks belonging to two genera (Ixodes and Amblyomma) were collected from 28/132 (21.2%) lizards, skinks, and snakes.",
        "These results implicate lizards and snakes as potential hosts of SFTS virus.",
        "Ixodes nipponensis Kitaoka &amp; Saito was only collected from lizards and skinks, while Amblyomma testudinarium Koch was only collected from snakes.",
        "A survey of reptile-associated ticks and their infection status with severe fever with thrombocytopenia syndrome (SFTS) virus was conducted to determine the relative abundance and distribution among lizards, skinks, and snakes in the Republic of Korea (ROK).",
        "Nymphs of both species of ticks were collected from lizards and skinks from April to October, while I. nipponensis larvae were collected only from September to October.",
        "Ixodes nipponensis larvae and nymphs were preferentially attached to the lateral trunk (83.3%) and the foreleg axillae (16.7%) of lizards and skinks.",
        "Phylogenetic analysis of SFTS viruses of ticks collected from two lizards and one snake demonstrated close relationships with SFTS virus strains observed from humans and ticks in the ROK, China, and Japan."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29665796": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease.",
        "Haemophysalis longicornis ticks have been considered the vector of severe fever with thrombocytopenia syndrome virus (SFTSV).",
        "However, clear data on the transmission of SFTS from ticks to humans are limited."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29715199": [
        "Remarkably, only approximately 6% Cxcr4+/o hematopoietic stem cell (HSC) chimerism after transplantation in unconditioned Cxcr4+/w recipient BM supported more than 70% long-term donor myeloid chimerism in blood and corrected myeloid cell deficiency in blood.",
        "To test whether there may be an advantage of one approach over the other for WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome - a primary immunodeficiency disorder caused by gain-of-function autosomal dominant mutations in chemokine receptor CXCR4 - we performed competitive transplantation experiments using both lethally irradiated WT (Cxcr4+/+) and unconditioned WHIM (Cxcr4+/w) recipient mice.",
        "For gene therapy of gain-of-function autosomal dominant diseases, either correcting or deleting the disease allele is potentially curative.",
        "Donor Cxcr4+/o HSCs differentiated normally and did not undergo exhaustion as late as 465 days after transplantation.",
        "In both models, hematopoietic reconstitution was markedly superior using BM cells from donors hemizygous for Cxcr4 (Cxcr4+/o) compared with BM cells from Cxcr4+/+ donors.",
        "Thus, disease allele deletion resulting in Cxcr4 haploinsufficiency was superior to disease allele repair in a mouse model of gene therapy for WHIM syndrome, allowing correction of leukopenia without recipient conditioning."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29659363": [
        "We present the case of a 21 year old woman who showed leukopenia at 10 months of age and one year later multiple infections with hypogammaglobulinemia requiring intravenous immunoglobulin.",
        "At age 20, small warts in hands that progressed to forearms, knees, abdomen and face were recorded.",
        "Treatment consists in prophylactic antibiotics, immunoglobulin replacement and granulocyte or granulocyte/monocyte colony stimulating factors.",
        "A bone marrow aspiration showed increased myeloid series with predominance of immature elements.",
        "WHIM syndrome is a primary autosomal dominant immuno deficiency due to CXCR4 mutations characterized by mucocutaneous warts, hypogammaglobulinemia, recurrent bacterial infections and myelokathesis.",
        "CXCR4 gene sequencing was done detecting a heterozygous p.Arg334STOP mutation, confirming WHIM syndrome.",
        "This disease is infrequent and difficult to diagnose.",
        "On the basis of infections, low levels of IgG, IgA, IgM and lymphopenia with absent memory B cells, a diagnosis of common variable immunodeficiency was made.",
        "During follow up she developed chronic neutropenia.",
        "She started intravenous immunoglobulin replacement and prophylactic antibiotics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28768817": [
        "In addition, CXCR4-WHIM-dependent calcium flux and wound healing of human papillomavirus-immortalized cell lines in response to CXCL12 was effectively inhibited by the nanobodies.",
        "Nanobodies are therapeutic proteins based on the smallest functional fragments of heavy chain antibodies.",
        "They combine the advantages of small-molecule drugs and antibody-based therapeutics due to their relative small size, high stability, and high affinity.",
        "Treatment of WHIM patients currently consists of symptom relief, leading to unsatisfactory clinical responses.",
        "Considering the broad functions of CXCR4 in maintaining leukocyte homeostasis, patients are panleukopenic and display altered immune responses, likely as a consequence of impairment in the differentiation and trafficking of leukocytes.",
        "The CXCR4-targeting nanobodies displace CXCL12 binding and bind CXCR4-wild type and CXCR4-WHIM (R334X/S338X) mutants and with (sub-) nanomolar affinities.",
        "The disease is primarily caused by C-terminal truncation mutations of the chemokine receptor CXCR4, giving these CXCR4-WHIM mutants a gain of function in response to their ligand CXCL12.",
        "WHIM syndrome is a rare congenital immunodeficiency disease, named after its main clinical manifestations: warts, hypogammaglobulinemia, infections, and myelokathexis, which refers to abnormal accumulation of mature neutrophils in the bone marrow.",
        "The nanobodies' epitope was mapped to extracellular loop 2 of CXCR4, overlapping with the binding site of CXCL12.",
        "As an alternative and potentially more effective approach, we tested the potency and efficacy of CXCR4-specific nanobodies on inhibiting CXCR4-WHIM mutants.",
        "Monovalent, and in particular bivalent, nanobodies were more potent than AMD3100 in reducing CXCL12-mediated G protein activation.",
        "Based on these in vitro results, we conclude that CXCR4 nanobodies hold significant potential as alternative therapeutics for CXCR4-associated diseases such as WHIM syndrome.",
        "We compared the potential of monovalent and bivalent CXCR4-specific nanobodies to inhibit CXCL12-induced CXCR4-WHIM-mediated signaling with the small-molecule clinical candidate AMD3100."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28928741": [
        "The Warts, Hypogammaglobulinemia, Infections, Myelokathexis (WHIM) syndrome is an immunodeficiency caused by mutations in chemokine receptor CXCR4.",
        "These results suggest that WHIM-mutant CXCR4 may lead to spontaneous aberrant B-cell activation, via CXCL12-mediated costimulation, impairing B-cell survival and thus possibly contributing to the WHIM syndrome defects in adaptive immunity.",
        "A reduction in antigenic load during immunization in the mouse was able to circumvent the adaptive immunity defects.",
        "WHIM patient adaptive immunity defects remain largely unexplained.",
        "Intriguingly, WHIM-mutant B cells were also characterized by spontaneous activation.",
        "The WHIM CXCR4-mediated costimulation led to increased B-cell activation, possibly involving mTOR, albeit without concurrently promoting survival.",
        "We have previously shown that WHIM-mutant T cells form unstable immunological synapses, affecting T cell activation.",
        "Searching for a mechanistic explanation for these observations, we uncovered a novel costimulatory effect of CXCL12, the CXCR4 ligand, on WHIM-mutant but not wild-type B cells.",
        "Here, we show that, in WHIM patients and WHIM CXCR4 knock-in mice, B cells are more apoptosis prone."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28512628": [
        "Most patients present heterozygous autosomal dominant mutations of the gene encoding CXCR4.",
        "We speculate that abnormalities that affect CXCR4/CXCL12 pair, including GRK levels or activity, might be responsible for this WHIM-like disorder.",
        "HIV testing was negative.",
        "Myelokathexis refers to the retention of mature neutrophils in the bone marrow (BM), which accounts for degenerative changes and hypersegmentation.",
        "Consequently, aberrant CXCL12/CXCR4 signaling impairs the receptor downregulation causing hyperactivation (gain-of-function) that affects BM homing for myelopoiesis and lymphopoiesis and the release of neutrophils in the bloodstream.",
        "We report the case of a 26-year-old female with severe foot and hand cutaneous warts since childhood, recalcitrant genital condylomatas, bacterial infections, and intraepithelial cervical neoplasia.",
        "Not only CXCR4 but also GATA2, NEMO, and CD40L gene mutations were excluded.",
        "Although the BM did not reveal a classical pattern of myelokathexis, the observation of consistent signs of neutrophil dysplasia has fuelled the hypothesis of a novel WHIM variant or a novel immunodeficiency.",
        "WHIM syndrome is a condition in which affected persons have chronic peripheral neutropenia, lymphopenia, abnormal susceptibility to human papilloma virus infection, and myelokathexis.",
        "BM smears revealed, in the presence of a normal cellularity, hyperplasia of myeloid cells (MPO positive) and karyorrhexis, especially in neutrophils and eosinophils.",
        "Laboratory tests revealed severe B lymphopenia and HPV high and low risk types.",
        "Our patient presented a clinical and histological picture reminiscent of WHIM in the presence of normal peripheral neutrophil counts and wild-type CXCR4 gene.",
        "Of note, neutrophils with altered lobation of nuclei connected by long thin chromatin filaments were observed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29066537": [
        "We critically evaluate the diagnostic criteria of WHIM syndrome, particularly when WHIM syndrome should be suspected in patients with congenital neutropenia and lymphopenia despite the absence of hypogammaglobulinemia and/or warts.",
        "Some patients present with hypogammaglobulinemia and/or refractory warts of skin and genitalia.",
        "Finally, we discuss recent results of trials evaluating plerixafor, a selective antagonist of CXCR4, as a mechanism-oriented strategy for treatment of WHIM patients.",
        "The available therapeutic measures aimed at preventing the risk for infection in WHIM patients are discussed.",
        "Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a genetic disease characterized by neutropenia, lymphopenia, susceptibility to infections, and myelokathexis, which describes degenerative changes of mature neutrophils and hyperplasia of bone marrow myeloid cells.",
        "These mutations lead to an increased sensitivity of neutrophils and lymphocytes to the unique ligand CXCL12 and to an increased accumulation of mature neutrophils in the bone marrow.",
        "Despite greatly improved knowledge of the disease, therapeutic choices are insufficient to prevent some of the disease outcomes, such as development of bronchiectasis, anogenital dysplasia, or invasive cancer.",
        "The disorder, which is inherited as an autosomal dominant trait, is caused by heterozygous mutations of the chemokine receptor CXCR4.",
        "Congenital cardiac defects constitute uncommon manifestations of the disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21178277": [
        "Dysfunctions are characterized by impaired desensitization and receptor internalization, which are associated with enhanced responses to the chemokine.",
        "This rare disorder is mostly linked to inherited heterozygous autosomal dominant mutations in the gene encoding CXCR4, a G protein coupled receptor with a unique ligand, the chemokine CXCL12/SDF-1.",
        "As a result we can expect to identify markers of the WHIM syndrome, as well as other disorders with WHIM-like features that are associated with dysfunctions of the CXCL12/CXCR4 axis.",
        "The WHIM syndrome features susceptibility to human Papillomavirus infection-induced warts and carcinomas, hypogammaglobulinemia, recurrent bacterial infections, B and T-cell lymphopenia, and neutropenia associated with retention of senescent neutrophils in the bone marrow (i.e. myelokathexis).",
        "In spite of this genetic heterogeneity, leukocytes from WHIM patients share in common dysfunctions of the CXCR4-mediated signaling pathway upon exposure to CXCL12.",
        "Some individuals who have full clinical forms of the syndrome carry a wild type CXCR4 gene.",
        "Our increasing understanding of the mechanisms that account for the aberrant CXCL12/CXCR4-mediated responses is beginning to provide insight into the pathogenesis of the disorder."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/14612668": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      WHIM syndrome (the association of warts, hypogammaglobulinemia, recurrent bacterial infections, and 'myelokathexis') is a rare congenital form of neutropenia associated with an unusual immune disorder involving hypogammaglonulinemia and abnormal susceptibility to warts.",
        "In this review, we describe the clinical, laboratory and genetic features of WHIM syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30359297": [
        "We show that commonly used clustering methods produce results that substantially disagree and that do not match the biological expectations of co-expressed gene clusters.",
        "Identifying co-expressed gene clusters can provide evidence for genetic or physical interactions.",
        "Additionally, clust can simultaneously cluster multiple datasets, enabling users to leverage the large quantity of public expression data for novel comparative analysis.",
        "Clust is available at https://github.com/BaselAbujamous/clust .",
        "Thus, co-expression clustering is a routine step in large-scale analyses of gene expression data.",
        "We present clust, a method that solves these problems by extracting clusters matching the biological expectations of co-expressed genes and outperforms widely used methods."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28381231": [
        "To investigate the impact of pre- and postnatal pet exposure on infant gut microbiota following various birth scenarios, this study employed a large subsample of 746 infants from the Canadian Healthy Infant Longitudinal Development Study (CHILD) cohort, whose mothers were enrolled during pregnancy between 2009 and 2012.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Early-life exposure to household pets has the capacity to reduce risk for overweight and allergic disease, especially following caesarean delivery.",
        "Participating mothers were asked to report on household pet ownership at recruitment during the second or third trimester and 3 months postpartum.",
        "Two categories of pet exposure (i) only during pregnancy and (ii) pre- and postnatally were compared to no pet exposure under different birth scenarios.",
        "Infant gut microbiota were profiled with 16S rRNA sequencing from faecal samples collected at the mean age of 3.3 months.",
        "Since there is some evidence that pets also alter the gut microbial composition of infants, changes to the gut microbiome are putative pathways by which pet exposure can reduce these risks to health."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26620522": [
        "Therefore, in this work, we present the Protein-Protein Interaction Database for Maize (PPIM), which covers 2,762,560 interactions among 14,000 proteins.",
        "Maize (Zea mays) is one of the most important crops worldwide.",
        "The database is freely available at http://comp-sysbio.org/ppim with a user-friendly powerful interface.",
        "We believe that the PPIM resource can help biologists better understand the maize crop.",
        "To understand the biological processes underlying various traits of the crop (e.g. yield and response to stress), a detailed protein-protein interaction (PPI) network is highly demanded.",
        "The PPIM contains not only accurately predicted PPIs but also those molecular interactions collected from the literature.",
        "Unfortunately, there are very few such PPIs available in the literature."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27492077": [
        "Most of the clinical symptoms of AD appear at a very later stage, therefore, the identification of disease markers is essential which can help proper detection of AD at an earlier stage and slow down its progression.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Alzheimer&amp;amp;#039;s disease (AD) is the most prevalent neurodegenerative disease throughout the world.",
        "Studies have implicated that epigenetic biomarkers, such as DNA methylation, histone modification and non coding RNA mediated regulation serve crucial roles in several disease progression including AD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26228302": [
        "We hypothesised that NGLY1 failure to degrade certain proteins may result in their accumulation and overexpression and used a systems biology approach to identify proteins that may be affected by NGLY1 deficiency.",
        "Examination of normal tissue microarrays demonstrated that FAF1-to-NGLY1 ratio is maximal (more than 3:1) in skeletal muscle and brain tissues microarrays.",
        "To test this hypothesis, laboratory studies that will assess if FAF1 protein is overexpressed in tissues of patients with mutated NGLY1 are required.",
        "The enzyme N-glycanase 1 (NGLY1) is considered a component of the endoplasmic reticulum-associated degradation (ERAD) machinery and clinical manifestations of its dysfunction include global developmental delay, a movement disorder, peripheral neuropathy, liver disorders, microcephaly, diminished reflexes and seizures.",
        "This evidence may explain the pathologies in brain and muscle tissues of patients with mutated NGLY1.",
        "Genes that interact with the NGLY1 gene according to BioGRID database of physical and genetic interactions were analysed with STRING Protein-Protein interaction database.",
        "Although several mutations in NGLY1 have been identified, the relation between the defected protein and the above described pathologies is yet unknown.",
        "Network analysis identified FAF1 (Fas-Associated Factor 1), an apoptosis-potentiating protein, as a possible degradation substrate of NGLY1."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25622637": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To systemically explore the cellular adhesion signal transduction network of tumor necrosis factor-alpha (TNF-\u03b1)-induced hepatocellular carcinoma cells with bioinformatics tools."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17503393": [
        "The mean correlation coefficient of the gene expression profiles of our predicted interactions is significantly higher than that for random pairs in S. cerevisiae.",
        "In addition, we find several novel interactions which are consistent with the functions of the proteins.",
        "DAPID is a database of domain-annotated protein interactions inferred from three-dimensional (3D) interacting domains of protein complexes in the Protein Data Bank (PDB).",
        "It is available online at http://gemdock.life.nctu.edu.tw/dapid.",
        "Our model derives these interactions by utilizing a new concept, called the ''3D-domain interologs'' which is similar to ''interologs''.",
        "In S. cerevisiae, there is 18.6% overlap between our predicted protein-protein interactions and ones in the DIP database.",
        "The DAPID currently holds 1008 3D-interacting domain pairs and 101511 predicted 3D-domain annotated protein-protein interactions.",
        "The DAPID data model allows users to visualize 3D interacting domains, contact residues, and molecular details of any predicted protein-protein interactions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15531608": [
        "The content is based on published experimental evidence that has been processed by human expert curators.",
        "The MIPS mammalian protein-protein interaction database (MPPI) is a new resource of high-quality experimental protein interaction data in mammals.",
        "We provide the full dataset for download and a flexible and powerful web interface for users with various requirements."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10786290": [
        "Currently there is no widely accepted repository of this interaction information.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Protein-protein interactions provide vital information concerning the function of proteins, complexes and networks.",
        "Our aim is to provide a single database with the necessary architecture to fully store, query and analyse interaction data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27980099": [
        "A new dynamic interaction network viewer allows the easy navigation and filtering of all genetic and protein interaction data, as well as for bioactive compounds and their established targets.",
        "BioGRID data are directly downloadable without restriction in a variety of standardized formats and are freely distributed through partner model organism databases and meta-databases.",
        "BioGRID curates the biomedical literature for major model organism species, including humans, with a recent emphasis on central biological processes and specific human diseases.",
        "To facilitate network-based approaches to drug discovery, BioGRID now incorporates 27 501 chemical-protein interactions for human drug targets, as drawn from the DrugBank database.",
        "The Biological General Repository for Interaction Datasets (BioGRID: https://thebiogrid.org) is an open access database dedicated to the annotation and archival of protein, genetic and chemical interactions for all major model organism species and humans.",
        "As of September 2016 (build 3.4.140), the BioGRID contains 1 072 173 genetic and protein interactions, and 38 559 post-translational modifications, as manually annotated from 48 114 publications.",
        "This dataset represents interaction records for 66 model organisms and represents a 30% increase compared to the previous 2015 BioGRID update."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29623652": [
        "This article summarized the milestones in the development of baloxavir leading to this first global approval for influenza A or B virus infections.",
        "In February 2018, baloxavir received its first global approval in Japan for the treatment of influenza A or B virus infections.",
        "The drug blocks influenza virus proliferation by inhibiting the initiation of mRNA synthesis.",
        "Phase III development is underway in the USA, EU and other countries for this indication.",
        "Baloxavir marboxil (Xofluza\u2122; baloxavir) is an oral cap-dependent endonuclease inhibitor that has been developed by Roche and Shionogi."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29941893": [
        "Here, we characterize the impact on BXA susceptibility and replicative capacity of variant viruses detected in the post-treatment monitoring of the clinical studies.",
        "These mechanistic insights provide markers for future surveillance of treated populations.",
        "The viruses harboring the I38T substitution show severely impaired replicative fitness in cells, and correspondingly reduced endonuclease activity in vitro.",
        "We find that the PA I38T substitution is a major pathway for reduced susceptibility to BXA, with 30- to 50-fold and 7-fold EC<sub>50</sub> changes in A and B viruses, respectively.",
        "Co-crystal structures of wild-type and I38T influenza A and B endonucleases bound to BXA show that the mutation reduces van der Waals contacts with the inhibitor.",
        "A reduced affinity to the I38T mutant is supported by the lower stability of the BXA-bound endonuclease.",
        "Baloxavir acid (BXA), derived from the prodrug baloxavir marboxil (BXM), potently and selectively inhibits the cap-dependent endonuclease within the polymerase PA subunit of influenza A and B viruses.",
        "In clinical trials, single doses of BXM profoundly decrease viral titers as well as alleviating influenza symptoms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30184455": [
        "It has shown therapeutic activity in preclinical models of influenza A and B virus infections, including strains resistant to current antiviral agents.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30396860": [
        "The antiviral mechanism of action of baloxavir is unique; the drug blocks initiation of viral mRNA synthesis, thus preventing proliferation of the influenza virus.",
        "A single oral dose of baloxavir is usually well tolerated; it hastens alleviation of influenza symptoms and shortens the duration of viral shedding.",
        "Although further clinical investigation is required to explore this issue, baloxavir may revolutionize our understanding of influenza virus biology.",
        "Baloxavir marboxil is an orally available prodrug of baloxavir acid.",
        "Japan was the first country to approve baloxavir marboxil as a treatment for influenza.",
        "However, novel influenza variants exhibiting over 10-fold reductions in baloxavir susceptibility emerged in baloxavir-treated patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29124969": [
        "From all taxa identified, the relative abundance of the phylum Zygomycota, comprising the family Mucoraceae and genus Mucor, was negatively associated with cIMT and this association remained significant after controlling for false discovery rate.",
        "Interestingly, the relative abundance of Mucor racemosus was negatively associated both with FRS and cIMT.",
        "Obese subjects with detectable Mucor spp. had a similar cardiovascular risk profile as non-obese subjects.",
        "Variable importance in projection scores showed that M. racemosus abundance had the same impact in the model as waist-to-hip ratio, high-density lipoprotein-cholesterol, fasting triglycerides or fasting glucose, suggesting that M. racemosus relative abundance in the gut may be a relevant biomarker for cardiovascular risk.",
        "Here, we present a preliminary study of the possible contribution of gut mycobiota to sub-clinical atherosclerosis in a well-characterised group of obese and non-obese subjects in association with the Framingham Risk Score (FRS) and carotid intima-media thickness (cIMT).",
        "The mycobiotic component of the microbiota comprises an integral, yet under-researched, part of the gastrointestinal tract.",
        "Partial least square discriminant analyses modelling, evaluating the potential relevance of gut mycobiota in patients stratified by mean values of cIMT, showed that even a 1 component model had a high accuracy (0.789), with a high R2 value (0.51)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29301859": [
        "We demonstrate that PARL-mediated cleavage during mitochondrial import partitions STARD7 to the cytosol and the mitochondrial intermembrane space.",
        "Negatively charged amino acids in STARD7 serve as a sorting signal allowing mitochondrial release of mature STARD7 upon cleavage by PARL On the other hand, membrane insertion of STARD7 mediated by the TIM23 complex promotes mitochondrial localization of mature STARD7.",
        "Mitochondrial STARD7 is necessary and sufficient for the accumulation of phosphatidylcholine in the inner membrane and for the maintenance of respiration and cristae morphogenesis.",
        "Intramembrane-cleaving peptidases of the rhomboid family regulate diverse cellular processes that are critical for development and cell survival.",
        "Thus, PARL preserves mitochondrial membrane homeostasis via STARD7 processing and is emerging as a critical regulator of protein localization between mitochondria and the cytosol.",
        "The function of the rhomboid protease PARL in the mitochondrial inner membrane has been linked to mitophagy and apoptosis, but other regulatory functions are likely to exist.",
        "Here, we identify the START domain-containing protein STARD7 as an intramitochondrial lipid transfer protein for phosphatidylcholine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12417197": [
        "Here we present evidence for a new processing pathway, involving novel signal peptidase activities.",
        "The mAAA protease subunits Yta10 (Afg3) and Yta12 (Rca1) were identified both to be essential for the first processing step.",
        "In addition, the Pcp1 (Ygr101w) gene product was found to be required for the second processing step, yielding the mature Ccp1 protein.",
        "It is known, that Ccp1 is synthesised as a precursor with a N-terminal pre-sequence, that is proteolytically removed during transport of the protein.",
        "Similar processing mechanisms may exist, because the mAAA subunits and the newly identified Pcp1 protein belong to ubiquitous protein families.",
        "The yeast protein cytochrome c peroxidase (Ccp1) is nuclearly encoded and imported into the mitochondrial intermembrane space, where it is involved in degradation of reactive oxygen species.",
        "A model of coupled Ccp1 transport and N-terminal processing by the mAAA complex and Pcp1 is discussed.",
        "The newly identified Pcp1 protein belongs to the rhomboid-GlpG superfamily of putative intramembrane peptidases.",
        "Inactivation of the protease motifs in mAAA and Pcp1 blocks the respective steps of proteolysis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22921757": [
        "For hiGlpG we have shown that these oligomers exist in the lipid bilayer.",
        "More importantly co-immunoprecipitation studies demonstrate that the dimer is present in the lipid bilayer suggesting a physiological dimer.",
        "Using gel filtration and crosslinking we demonstrate that hiGlpG is dimeric and functional in DDM detergent solution.",
        "For hiGlpG and ecGlpG, rhomboids consisting of the core 6 transmembrane domains without and with soluble domains respectively, and YqgP, predicted to have 7 transmembrane domains with larger soluble domains at the termini, the predominant species was dimeric with low amounts of monomer and tetramers observed.",
        "Rhomboid peptidases (proteases) play key roles in signaling events at the membrane bilayer.",
        "Understanding the regulation of rhomboid function is crucial for insight into its mechanism of action.",
        "To examine the effect of the membrane domain alone on oligomeric state of rhomboid, hiGlpG, the simplest form from the rhomboid class of intramembrane proteases representing the canonical rhomboid core of six transmembrane domains, was studied further.",
        "We subjected Haemophilus influenzae, (hiGlpG), Escherichia coli GlpG (ecGlpG) and Bacillus subtilis (YqgP) to sedimentation equilibrium analysis in detergent-solubilized dodecylmaltoside (DDM) solution.",
        "Here we examine the oligomeric state of three different rhomboid proteases.",
        "This is the first detailed oligomeric state characterization of the rhomboid family of peptidases.",
        "Overall these results indicate that rhomboids form oligomers which are facilitated by the membrane domain."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21455272": [
        "The present review studies the structures of these two orthologs.",
        "Rhomboids are intramembrane serine peptidases conserved in all kingdoms of life.",
        "Functional and regulatory implications of these variations are discussed.",
        "These signals, when disrupted, can contribute to various diseases.",
        "It has been proposed that the substrate entry gate is composed of helix 5 and loop 5.",
        "Their general role is to cleave integral membrane proteins to release signalling molecules.",
        "In ecGlpG structures, different conformations of loop 5 and helix 5 are observed.",
        "Overall, less variation is observed in loop 4, suggesting this region acts as an anchor for the substrate gate.",
        "Open and closed conformations of ecGlpG structures are compared with each other and with hiGlpG, surveying differences in hydrophobic interactions within loop 5 and helix 5.",
        "Crystal structures of H. influenzae (hiGlpG) and E. coli GlpG (ecGlpG) rhomboids have revealed a structure with six transmembrane helices and a Ser-His catalytic dyad buried within the membrane.",
        "One emerging issue was the identification of the mobile element in the protein that allows substrate docking.",
        "Furthermore, a comparison of the ecGlpG and hiGlpG structures reveals differences in loop 4."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30190407": [
        "Fertilization is fundamental for sexual reproduction, yet its molecular mechanisms are poorly understood.",
        "Membrane-bound Bouncer mediates sperm-egg binding and is thus essential for sperm entry into the egg.",
        "Bouncer's closest homolog in tetrapods, SPACA4, is restricted to the male germline in internally fertilizing vertebrates, which suggests that our findings in fish have relevance to human biology.",
        "We found that an oocyte-expressed Ly6/uPAR protein, which we call Bouncer, is a crucial fertilization factor in zebrafish.",
        "Remarkably, Bouncer not only is required for sperm-egg interaction but is also sufficient to allow cross-species fertilization between zebrafish and medaka, two fish species that diverged more than 200 million years ago.",
        "Our study thus identifies Bouncer as a key determinant of species-specific fertilization in fish."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17194778": [
        "We also present evidence that in cases where one ohnolog has been lost from the genome of a post-WGD species, the lost copy was likely to have been the faster-evolving member of the pair prior to its loss.",
        "We investigated patterns of rate asymmetry in sequence evolution among the gene pairs (ohnologs) formed by whole-genome duplication (WGD) in yeast species.",
        "These results suggest that a significant fraction of the retained ohnologs in yeast species underwent neofunctionalization soon after duplication.",
        "By comparing three species (Saccharomyces cerevisiae, Candida glabrata, and S. castellii) that underwent WGD to a nonduplicated outgroup (Kluyveromyces lactis), and by using a synteny framework to establish orthology and paralogy relationships at each duplicated locus, we show that 56% of ohnolog pairs show significantly asymmetric protein sequence evolution.",
        "For ohnolog pairs that remain duplicated in two species there is a strong tendency for the faster-evolving copy in one species to be orthologous to the faster copy in the other species, which indicates that the evolutionary rate differences were established before speciation and hence soon after the WGD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20820472": [
        "In particular, different studies confirmed that the yeast S. cerevisiae arose from a 100-150 million-year old whole-genome duplication.",
        "Duplication mechanisms include small-scale, or \"local\", events such as unequal crossing over and retroposition, together with global events, such as chromosomal or whole genome duplication (WGD).",
        "Detection and study of duplications are usually based on sequence alignment, synteny and phylogenetic techniques, but protein domains are also useful in assessing protein homology.",
        "We test the accuracy and the reliability of this method in detecting instances of gene duplication in the yeast S. cerevisiae.",
        "We find evidence that this comes from functional migration within similar domain superfamilies, but also from the existence of small sets of WGD and non-WGD specific domain superfamilies with largely different functions.",
        "On the other hand, WGD and non-WGD paralogs tend to have different functions.",
        "Finally, the Gene Ontology similarity of paralogs tends to decrease with duplication age, while this tendency is weaker or not observable by the comparison of the domain architectures of paralogs.",
        "Overall, the gathered evidence gives a different viewpoint on the biological specificity of the WGD and at the same time points out the validity of domain architecture comparison as a tool for detecting homology.",
        "WGD and non-WGD superfamilies carry distinct functions.",
        "This suggests that the set of domains composing a protein tends to be maintained, while its function, cellular process or localization diversifies.",
        "In particular, we analyze the evolution of WGD and non-WGD paralogs from the domain viewpoint, in comparison with a more standard functional analysis of the genes.",
        "A large number of domains is shared by genes that underwent local and global duplications, indicating the existence of a common set of \"duplicable\" domains.",
        "This observation gives a novel perspective on the finding that WGD paralogs tend to be functionally different from small-scale paralogs.",
        "Gene duplication is a key mechanism in evolution for generating new functionality, and it is known to have produced a large proportion of genes.",
        "We develop a simple and computationally efficient protein domain architecture comparison method based on the domain assignments available from public databases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17494770": [
        "In addition, by comparing the pattern of gene loss among K. polysporus, S. cerevisiae, and three other yeasts that diverged after the WGD, we show that the patterns of gene loss changed over time.",
        "Initially, both members of a duplicate pair were equally likely to be lost, but loss of the same gene copy in independent lineages was increasingly favored at later time points.",
        "Almost half of their surviving single-copy genes are not orthologs but paralogs formed by WGD, as would be expected if most gene pairs were resolved independently.",
        "By sequencing the K. polysporus genome and comparing it with the S. cerevisiae genome using a likelihood model of gene loss, we show that these species diverged very soon after the WGD, when their common ancestor contained &gt;9,000 genes.",
        "The apparent low initial sequence divergence of the gene pairs leads us to propose that the yeast WGD was probably an autopolyploidization.",
        "This trend parallels an increasing restriction of reciprocal gene loss to more slowly evolving gene pairs over time and suggests that, as duplicate genes diverged, one gene copy became favored over the other.",
        "Among yeasts that underwent whole-genome duplication (WGD), Kluyveromyces polysporus represents the lineage most distant from Saccharomyces cerevisiae.",
        "The two genomes subsequently converged onto similar current sizes (5,600 protein-coding genes each) and independently retained sets of duplicated genes that are strikingly similar."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15004568": [
        "Recently, it has become possible to test this notion by searching complete genome sequence for signs of ancient duplication.",
        "Whole-genome duplication followed by massive gene loss and specialization has long been postulated as a powerful mechanism of evolutionary innovation.",
        "The two genomes are related by a 1:2 mapping, with each region of K. waltii corresponding to two regions of S. cerevisiae, as expected for whole-genome duplication.",
        "This resolves the long-standing controversy on the ancestry of the yeast genome, and makes it possible to study the fate of duplicated genes directly.",
        "Strikingly, 95% of cases of accelerated evolution involve only one member of a gene pair, providing strong support for a specific model of evolution, and allowing us to distinguish ancestral and derived functions.",
        "Here, we show that the yeast Saccharomyces cerevisiae arose from ancient whole-genome duplication, by sequencing and analysing Kluyveromyces waltii, a related yeast species that diverged before the duplication."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27803011": [
        "He had smoked 10 g of opium per week for a year and a half.",
        "This is an important case report of a UK resident describing lead toxicity secondary to the inhalation of opium.",
        "The patient underwent chelation therapy and has recovered clinically and biochemically.",
        "He had extravascular haemolytic anaemia with punctate basophilic stippling on blood film.",
        "On examination, he had diffuse abdominal tenderness and faecal loading.",
        "The patient's serum lead concentration was substantially elevated and he perhaps demonstrated Burton's line.",
        "Public health experts were notified and conducted an assessment of the risk to the patient and others; their lead exposure questionnaire was subsequently amended.",
        "A 46-year-old man of Iranian origin presented with a 4-day history of colicky abdominal pain and absolute constipation on a background of several weeks of irritability and malaise.",
        "This was cleared, but the abdominal pain, nausea and vomiting persisted."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24559541": [
        "<strong class=\"sub-title\">\n          Background and objective:\n        </strong>\n      \n      Lead poisoning is normally caused by repeated occupational inhalation of lead.",
        "However, lead may also be absorbed through the digestive route.",
        "Some alternative medical treatments, such as Ayurvedic medicine, can also contain lead and may result in poisoning."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17179719": [
        "The sign though inconstant, is still a valuable clinical clue.",
        "Lead colic, anaemia, renal tubulopathies and motor neuropathies are well recognised.",
        "This paper sketches the early history and remembers the important contribution of Henry Burton, who described the gums to be bordered by a narrow leaden-blue line, about the one-twentieth part of an inch in width, whilst the substance of the gum apparently retained its ordinary colour and condition.",
        "Lead poisoning in both its acute and chronic forms has been recognised since the second century BCE."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29096012": [
        "It measures depth from BAM or CRAM files at either each nucleotide position in a genome or for sets of genomic regions.",
        "Mosdepth uses a simple algorithm that is computationally efficient and enables it to quickly produce coverage summaries.",
        "Genomic regions may be specified as either a BED file to evaluate coverage across capture regions, or as a fixed-size window as required for copy-number calling.",
        "We demonstrate that mosdepth is faster than existing tools and provides flexibility in the types of coverage profiles produced.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      Mosdepth is a new command-line tool for rapidly calculating genome-wide sequencing coverage."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26146997": [
        "We did not identify significant differences between well-controlled HIV-positive patients and HIV-negative controls, suggesting that well-controlled HIV-positive patients essentially harbor similar oral flora compared to patients without HIV.",
        "In the immunosuppressed population, the spectrum of potential oral disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi's sarcoma, oral warts and other diseases.",
        "The analysis was complicated by uneven enrollment in the patient cohorts, with only five HIV-negative patients enrolled in the study and by the rapid improvement in the health of HIV-infected children between the time the study was conceived and completed.",
        "Patient demographics and clinical characteristics were collected from a cross-section of patients undergoing routine dental care.",
        "The goal of the study was to observe the potential diversity of the oral microbiota among individual patients, sample locations, HIV status and various dental characteristics.",
        "The generally good oral health of the HIV-negative patients limited the number of dental plaque samples that could be collected.",
        "We found that there were significant differences in the microbiome among the enrolled patients, and between sampling locations.",
        "Multiple specimens from different sampling sites in the mouth were collected for each patient.",
        "Here, we used 454 pyrosequencing of bacterial 16S rRNA genes to examine the oral microbiome of saliva, mucosal and tooth samples from HIV-positive and negative children.",
        "Alterations in the oral microbiota may be associated with disorders such as gingivitis, periodontitis, childhood caries, alveolar osteitis, oral candidiasis and endodontic infections.",
        "Additional studies are needed to better characterize the oral microbiome in children and those with poorly-controlled HIV infections.",
        "The oral microbial community (microbiota) plays a critical role in human health and disease.",
        "Nor were significant differences in the oral microbiota identified between different teeth or with different dental characteristics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22143885": [
        "Knockdown of Mp1 inhibited FGF4-induced differentiation but did not alter FGF4-driven proliferation.",
        "Knockdown of Mp1 in invasive GCT cells resulted in resistance to differentiation, thereby showing a functional role for Mp1 both in normal differentiation of ES cells and in germ cell cancer.",
        "Knockdown of Mp1 redirected FGF4 signaling from differentiation toward pluripotency and up-regulated the pluripotency-related genes Esrrb, Rex1, Tcl1, and Sox2.",
        "This uncoupling of differentiation and proliferation was also observed when oncogenic Ras isoforms were overexpressed in ES cells.",
        "Fibroblast growth factor 4 (FGF4) signaling is required for initial fate commitment of ES cells.",
        "Despite intense investigation of intrinsic and extrinsic factors that regulate pluripotency, the process of initial fate commitment of embryonic stem (ES) cells is still poorly understood.",
        "Knockdown of the scaffolding protein Mek binding protein 1 (Mp1, also known as Lamtor3 or Map2k1ip1) stimulated self-renewal of ES cells, blocked differentiation, and promoted proliferation.",
        "We also found that human germ cell tumors (GCTs) express low amounts of Mp1 in the invasive embryonic carcinoma and seminoma histologies and higher amounts of Mp1 in the noninvasive carcinoma in situ precursor and differentiated components.",
        "We used a genome-wide short hairpin RNA screen in mouse ES cells to identify genes that are essential for initiation of differentiation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23508100": [
        "Interaction of Dax1 and Esrrb was mediated through LXXLL motifs of Dax1 and the activation- and ligand-binding domains of Esrrb.",
        "Here, we identified an orphan nuclear receptor, Esrrb (estrogen-related receptor beta), as a Dax1-interacting protein.",
        "Furthermore, Esrrb enhanced the promoter activity of the Dax1 gene via direct binding to Esrrb-binding site 1 (ERRE1, where \"ERRE\" represents \"Esrrb-responsive element\") of the promoter.",
        "Self-renewal capacity and pluripotency, which are controlled by the Oct3/4-centered transcriptional regulatory network, are major characteristics of embryonic stem (ES) cells.",
        "Furthermore, we revealed that Oct3/4, Dax1, and Esrrb have a competitive inhibition capacity for each complex.",
        "Expression of Dax1 was suppressed followed by Oct3/4 repression; however, overexpression of Esrrb maintained expression of Dax1 even in the absence of Oct3/4, indicating that Dax1 is a direct downstream target of Esrrb and that Esrrb can regulate Dax1 expression in an Oct3/4-independent manner.",
        "We also found that the transcriptional activity of Esrrb was repressed by Dax1.",
        "These data, together with previous findings, suggest that Dax1 functions as a negative regulator of Esrrb and Oct3/4, and these molecules form a regulatory loop for controlling the pluripotency and self-renewal capacity of ES cells.",
        "Nuclear hormone receptor Dax1 is one of the crucial factors in the network."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23169531": [
        "For this purpose, we developed a novel motif-discovery tool termed fexcom that systematically interrogates ChIP-seq data to discover spatially constrained TF-TF composite motifs occurring over short DNA distances.",
        "In addition to the well-known and most prevalent sox-oct motif, we also discovered a novel constrained spacer motif for Esrrb and Sox2 with a gap of between 2 and 8 bps that Essrb and Sox2 cobind in a selective fashion.",
        "Through the use of knockdown experiments, we argue that the Esrrb-Sox2 complex is an arbiter of gene expression differences between ESCs and epiblast stem cells (EpiSC).",
        "A number of genes downregulated upon dual Esrrb/Sox2 knockdown (e.g., Klf4, Klf5, Jam2, Pecam1) are similarly downregulated in the ESC to EpiSC transition and contain the esrrb-sox motif.",
        "We applied this to the extensive ChIP-seq data available from mouse embryonic stem cells (ESCs).",
        "We reasoned that within this data novel motif grammars could be identified that controlled distinct biological programs.",
        "Through positive regulation of this transcriptional repressor, we argue the Esrrb-Sox2 complex promotes the ESC state through inhibition of the EpiSC transcriptional program and the same trio may also function to maintain trophoblast stem cells.",
        "The prototypical Esrrb-Sox2 target gene, containing an esrrb-sox element conserved throughout eutherian and metatherian mammals, is Nr0b1.",
        "Transcription factors (TF) often bind in heterodimeric complexes with each TF recognizing a specific neighboring cis element in the regulatory region of the genome.",
        "Comprehension of this DNA motif grammar is opaque, yet recent developments have allowed the interrogation of genome-wide TF binding sites."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24929238": [
        "Here, we have addressed function and regulation of Nanog in epiblasts of postimplantation mouse embryos by conditional knockdown (KD), chromatin immunoprecipitation (ChIP) using in vivo epiblasts, and protein interaction with the Nanog promoter in vitro.",
        "Nanog expression in epiblast is directly regulated by Nodal/Smad2 pathway in a visceral endoderm-dependent manner.",
        "Differentiation of Nanog-KD epiblasts demonstrated requirement for Nanog in stabilization of pluripotency.",
        "Notably, Nanog promoters switch from Oct4/Esrrb in ICM/ESCs to Oct4/Smad2 in epiblasts.",
        "Nanog, a core pluripotency factor, is required for stabilizing pluripotency of inner cell mass (ICM) and embryonic stem cells (ESCs), and survival of primordial germ cells in mice.",
        "Collectively, these data demonstrate that Nanog plays a key role in stabilizing Epiblast pluripotency mediated by Nodal/Smad2 signaling, which is involved in Nanog promoter switching in early developing embryos.",
        "Smad2 directly associates with Oct4 to form Nanog promoting protein complex."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28019079": [
        "Cutis Verticis Gyrata-Intellectual Disability (CVG-ID) syndrome is a rare neurocutaneous syndrome characterized by intellectual disability and scalp folds and furrows that are typically absent at birth and are first noticed after puberty.",
        "Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome. \u00a9 2016 Wiley Periodicals, Inc.",
        "First reported in 1893, the syndrome was mainly identified in subjects living in psychiatric institutions, where it was found to have a prevalence of up to 11.4%.",
        "CVG-ID is now a less reported and possibly under-recognized syndrome.",
        "Most patients were reported in the literature during the first half of the 20th century."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29863979": [
        "In the dose-escalation portion of the phase 1 study of cemiplimab, a deep and durable response was observed in a patient with metastatic cutaneous squamous-cell carcinoma.",
        "This cancer may be responsive to immune therapy, because the mutation burden of the tumor is high and the disease risk is strongly associated with immunosuppression.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      No systemic therapies have been approved for the treatment of advanced cutaneous squamous-cell carcinoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30377167": [
        "The drug is the first FDA-approved treatment for this indication.",
        "The FDA greenlighted the PD-1 inhibitor cemiplimab to treat patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for surgery or radiation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25415278": [
        "Here, we report the first comprehensive characterisation of the KP in 1) cultured human glioma cells and 2) plasma from patients with glioblastoma (GBM).",
        "KP activation (KYN/TRP) was significantly higher, whereas the concentrations of the neuroreactive KP metabolites TRP, KYNA, QUIN and PIC and the KYNA/KYN ratio were significantly lower in GBM patient plasma (n = 18) compared to controls.",
        "Our data revealed that interferon-gamma (IFN-\u03b3) stimulation significantly potentiated the expression of the KP enzymes, IDO-1 IDO-2, kynureninase (KYNU), kynurenine hydroxylase (KMO) and significantly down-regulated 2-amino-3-carboxymuconate semialdehyde decarboxylase (ACMSD) and kynurenine aminotransferase-I (KAT-I) expression in cultured human glioma cells.",
        "This significantly increased KP activity but significantly lowered the KYNA/KYN neuroprotective ratio in human cultured glioma cells.",
        "The kynurenine pathway (KP) is the principal route of L-tryptophan (TRP) catabolism leading to the production of kynurenine (KYN), the neuroprotectants, kynurenic acid (KYNA) and picolinic acid (PIC), the excitotoxin, quinolinic acid (QUIN) and the essential pyridine nucleotide, nicotinamide adenine dinucleotide (NAD(+)).",
        "These results provide further evidence for the involvement of the KP in glioma pathophysiology and highlight a potential role of KP products as novel and highly attractive therapeutic targets to evaluate for the treatment of brain tumors, aimed at restoring anti-tumor immunity and reducing the capacity for malignant cells to produce NAD(+), which is necessary for energy production and DNA repair.",
        "The enzymes indoleamine 2,3-dioxygenase-1 (IDO-1), indoleamine 2,3-dioxygenase-2 (IDO-2) and tryptophan 2,3-dioxygenase (TDO-2) initiate the first step of the KP.",
        "IDO-1 and TDO-2 induction in tumors are crucial mechanisms implicated to play pivotal roles in suppressing anti-tumor immunity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/7588946": [
        "While the PET scan showed no major abnormalities, and the baseline SPET study revealed only minor changes, the acetazolamide-enhanced SPET study revealed a marked reduction of the cortical perfusion reserve, particularly in both frontal lobes.",
        "In systemic lupus erythematosus (SLE), brain and kidney are the most frequently affected organs.",
        "It is concluded that \"preclinical\" CNS involvement, mainly caused by pathological mechanisms involving the cerebral blood vessels, can be considered to exist in this patient with SLE.",
        "Functional imaging has been proven to be more sensitive than morphological imaging (magnetic resonance imaging and computed tomography).",
        "Measurements of cerebral blood flow and metabolism by means of positron emission tomography (PET) and single-photon emission tomography (SPET) can contribute to the diagnostic assessment of the involvement of the central nervous system (CNS) in SLE.",
        "In addition to a SPET study using technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) and a PET scan with fluorine-18 deoxyglucose (18FDG), a SPET study after acetazolamide injection was performed in order to assess the cerebral perfusion reserve.",
        "In this report, we present the case of a 70-year-old female patient, suffering from SLE without symptoms of CNS involvement."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24268009": [
        "Any part of the heart can be affected, including the pericardium, myocardium, coronary arteries, valves, and the conduction system.",
        "However, with the rapid advancement of basic science and translational research approaches, it is now becoming easier to identify specific mutations associated with SLE.",
        "A better understanding of these genetic factors may eventually allow clinicians to categorize and predict the patients who are at risk for specific cardiac manifestations of SLE.",
        "Many unanswered questions remain in terms of understanding the pathogenesis of cardiac manifestations of SLE.",
        "It is not currently possible to predict the patients who are at greatest risk for the various types of cardiac involvement.",
        "In addition to pericarditis and myocarditis, a high incidence of CAD has become increasingly recognized as a cause of mortality, especially in older adult patients and those with long-standing SLE.",
        "The heart is one of the most frequently affected organs in SLE."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25186992": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with wide clinical features ranging from cutaneous manifestations to systemic disease.",
        "Skin is one of the most commonly affected organs in SLE."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28355987": [
        "Eleven (84.6%) patients complained of fever and abdominal pain, four (30.8%) had positive Murphy's sign and six (46.2%) had elevated liver enzymes.",
        "For patients with AAC in SLE, treatment with aggressive glucocorticoids could result in a good prognosis.",
        "Their medical records were systematically reviewed.",
        "Results Among the 8411 hospitalized SLE patients in PUMCH, 13 (0.15%) were identified to have SLE-AAC.",
        "Conclusion Our study suggests that AAC is a relatively uncommon and underestimated gastrointestinal involvement of SLE that is often associated with active disease.",
        "The diagnosis of AAC was based on clinical manifestations and confirmed by radiologic findings including a distended gallbladder with thickened wall, pericholecystic fluid and absence of gallstones.",
        "Eleven (84.6%) of them were female, with a mean age of 30.1 \u00b1 8.6 years.",
        "Objective We aimed to investigate the clinical features of acute acalculous cholecystitis (AAC) in patients with systemic lupus erythematosus (SLE).",
        "AAC was the initial manifestation of SLE in four (30.8%) cases.",
        "The median SLE Disease Activity Index was 8.0 (range 0-20.0) at the time of AAC.",
        "All patients received treatment of glucocorticoids and immunosuppressants but none underwent surgical intervention.",
        "During a median follow-up of 28 months (range, 2-320 months), 12 cases (92.4%) responded to treatment with no relapse and one patient (7.6%) died of septic shock.",
        "Other affected organs in SLE-AAC included kidney (11, 84.6%) and hematologic system (11, 84.6%), followed by mucocutaneous (seven, 53.8%), musculoskeletal (seven, 53.8%) and neuropsychiatric (two, 15.4%) systems.",
        "Methods SLE patients with AAC hospitalized in the Peking Union Medical College Hospital (PUMCH) from January 2001 to September 2015 were retrospectively analyzed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21767292": [
        "Recently, the involvement of various cytokines has been shown in the pathogenesis of LE.",
        "Although immune abnormalities, as well as heritable, hormonal and environmental factors, are involved in the pathology of LE, the actual pathogenesis is still unclear.",
        "In this article, we review the contributions of major cytokines such as interferon, tumor necrosis factor-\u03b1 and interleukin-18 to LE, especially SLE and CLE.",
        "Systemic lupus erythematosus (SLE) is a systemic autoimmune disease which affects multiple organs.",
        "Moreover, some trials with biological agents targeted specific cytokines are also ongoing for SLE.",
        "Cutaneous lupus erythematosus (CLE) includes skin symptoms seen in SLE and cutaneous-limited LE.",
        "Lupus erythematosus (LE) includes a broad spectrum of diseases from a cutaneous-limited type to a systemic type."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29255114": [
        "This is crucial for switching GPI-anchored proteins (GPI-APs) from protein folding to transport states.",
        "Glycosylphosphatidylinositol (GPI) anchoring of proteins is a conserved posttranslational modification in the endoplasmic reticulum (ER).",
        "Once the system is disrupted by ER stress, unprocessed GPI-APs become exposed on the cell surface.",
        "Soon after GPI is attached, an acyl chain on the GPI inositol is removed by post-GPI attachment to proteins 1 (PGAP1), a GPI-inositol deacylase.",
        "Calnexin was specifically associated with GPI-APs, dependent on <i>N</i>-glycan and GPI moieties, and assisted efficient GPI-inositol deacylation by PGAP1.",
        "We performed haploid genetic screens to identify factors regulating GPI-inositol deacylation, identifying seven genes.",
        "Under chronic ER stress caused by misfolded GPI-APs, inositol-acylated GPI-APs were exposed on the cell surface.",
        "These results indicated that <i>N</i>-glycans participate in quality control and temporal ER retention of GPI-APs, ensuring their correct folding and GPI processing before exiting from the ER.",
        "In particular, calnexin cycle impairment caused inefficient GPI-inositol deacylation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29027702": [
        "Our data reveals, for the first time (to our knowledge), the existence of genes related to GPI anchor remodelling in O. minuta cells.",
        "Microscopy and western blotting analysis showed mislocalization and/or lower retention of Gas1Ap and Gas1Bp within the membrane fraction in per1\u0394 or gup1\u0394 mutant cells, suggesting the significance of lipid remodelling for GPI-anchored proteins in O. minuta.",
        "To date, the products of the PER1, GUP1 and CWH43 genes of the yeast Saccharomyces cerevisiae have been shown to be involved in the lipid remodelling.",
        "The O. minuta per1\u0394 mutant exhibited a more fragile phenotype than the gup1\u0394 or cwh43\u0394 mutants.",
        "The lipid moieties of GPI-anchored proteins undergo remodelling processes during their maturation.",
        "Here, we focus on the putative GPI remodelling pathway in the methylotrophic yeast Ogataea minuta.",
        "Localization behaviour of Gas1Bp differed from that of Gas1Ap.",
        "We found that O. minuta possesses two copies of the GAS1 gene, which we designate GAS1A and GAS1B.",
        "In eukaryotes, the glycosylphosphatidylinositol (GPI) modification of many glycoproteins on the cell surface is highly conserved.",
        "To address the role of GPI modification in O. minuta, we assessed the effect of these mutations on the processing and localization of the O. minuta homologues of the Gas1 protein; in S. cerevisiae, Gas1p is an abundant and well-characterized GPI-anchored protein.",
        "Disruption of GUP1 or CWH43 in O. minuta caused a growth defect under non-permissive conditions.",
        "We found that the O. minuta homologues of PER1, GUP1 and CWH43 are functionally compatible with those of S. cerevisiae."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29393895": [
        "In fungi, a number of GPI-anchored proteins (GPI-APs) are involved in the remodeling of the cell wall polymers.",
        "On the other hand, the GM isolated from the <i>\u0394per1</i> mutant membranes possesses a ceramide moiety as the parental strain, showing that GPI anchor of the GM follow a distinct unknown biosynthetic pathway.",
        "To investigate the role of the GPI pathway in the biosynthesis of the GM and cell wall organization, the deletion of <i>PER1</i>-coding for a phospholipase required for the first step of the GPI lipid remodeling-was undertaken.",
        "Biochemical characterization of the GPI-anchor isolated from GPI-APs showed that the <i>PER1</i> deficient mutant produced a lipid anchor with a diacylglycerol.",
        "Glycosylphosphatidylinositols (GPIs) are lipid anchors allowing the exposure of proteins at the outer layer of the plasma membrane.",
        "GPIs follow a specific biosynthetic pathway in the endoplasmic reticulum.",
        "In addition to GPI-APs, <i>A. fumigatus</i> produces a GPI-anchored polysaccharide, the galactomannan (GM), that remains unique in the fungal kingdom.",
        "The absence of a ceramide on GPI-anchors in the <i>\u0394per1</i> mutant led to a mislocation of GPI-APs and to an alteration of the composition of the cell wall alkali-insoluble fraction.",
        "After the transfer of the protein onto the GPI-anchor, a lipid remodeling occurs to substitute the diacylglycerol moiety by a ceramide."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30094187": [
        "The 28 genes currently involved in the synthesis and remodelling of the GPI anchor add to the ever-growing class of congenital glycosylation disorders.",
        "Recent advances in next generation sequencing technology have led to the discovery of Mabry disease and CHIME syndrome genetic aetiology.",
        "Defining GPI-APs role in disease bears significant clinical implications.",
        "Glycosylphosphatidylinositol anchored proteins (GPI-APs) represent a class of soluble proteins attached to the external leaflet of the plasma membrane by a post-translation modification, the GPI anchor.",
        "Moreover, with each described mutation known phenotypes expand and new ones emerge without clear genotype-phenotype correlation.",
        "A protein database search was made for human GPI-APs with defined pathology to help building-up a physio-pathological mechanism from a clinical perspective.",
        "GPI-APs function in vitamin-B6 and folate transport, nucleotide metabolism and lipid homeostasis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29113828": [
        "Here we investigated whether 3-hydroxy butyrate dehydrogenase 2 (BDH2), a modulator of intracellular iron homeostasis, was involved in regulating DNA hypomethylation and hyper-hydroxymethylation in lupus CD4<sup>+</sup> T cells.",
        "Moreover, we showed that BDH2 was the target gene of miR-21. miR-21 promoted DNA demethylation in CD4<sup>+</sup> T cells through inhibiting BDH2 expression.",
        "The decreased BDH2 contributed to DNA hyper-hydroxymethylation and hypomethylation via increasing intracellular iron in CD4<sup>+</sup> T cells, which led to overexpression of immune related genes.",
        "Our results showed that BDH2 expression was decreased, intracellular iron was increased, global DNA hydroxymethylation level was elevated, while methylation level was reduced in lupus CD4<sup>+</sup> T cells compared with healthy controls.",
        "Our data demonstrated that the dysregulation of iron homeostasis in CD4<sup>+</sup> T cells induced by BDH2 deficiency contributes to DNA demethylation and self-reactive T cells in SLE.",
        "DNA hypomethylation plays an important role in the pathogenesis of systemic lupus erythematosus (SLE)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29425851": [
        "While the pathophysiological involvement of epigenetic changes in SLE has been accepted for some time, we only recently started to investigate and understand molecular events contributing to epigenetic dysregulation.",
        "Here, epigenetic alterations will be discussed with a focus on underling molecular events that may be target of preventative measures or future treatment strategies.",
        "Altered DNA methylation and hydroxymethylation as well as histone modifications mediate changes in chromatin accessibility and gene expression in immune cells from SLE patients.",
        "Defective epigenetic control contributes to uncontrolled expression of inflammatory mediators, including cytokines and co-receptors, resulting in systemic inflammation and tissue damage.",
        "Epigenetic events have been linked with disease expression in individuals genetically predisposed to the development of systemic lupus erythematosus (SLE), a severe systemic autoimmune/inflammatory disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28752494": [
        "Epigenetic dysregulation has been suggested as the missing link between genetic risk and the development of clinically evident disease.",
        "Though genetic predisposition is essential for disease expression, risk alleles in single genes are usually insufficient to confer disease.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Systemic lupus erythematosus is a severe autoimmune/inflammatory condition of unknown pathophysiology."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23340289": [
        "Accumulating evidence has indicated that abnormal DNA hypomethylation in T cells is an important epigenetic hallmark in SLE.",
        "As an important post-translational modification, DNA methylation mainly suppresses the expression of relevant genes.",
        "On the other hand, certain miRNAs, RFX1, defective ERK pathway signaling, Gadd45\u03b1 and DNA hydroxymethylation have been proposed as potential mechanisms leading to DNA hypomethylation in lupus.",
        "In this review, we summarize current understanding of T cell DNA methylation changes and the consequently altered gene expressions in lupus, and how they contribute to the development of SLE.",
        "Possible mechanisms underlying these aberrancies are also discussed based on the reported literature and our own findings.",
        "Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease characterized by production of autoantibodies against a series of nuclear antigens.",
        "Apart from those classic methylation-sensitive autoimmunity-related genes in lupus, such as CD11a (ITGAL), Perforin (PRF1), CD70 (TNFSF7), CD40 ligand (TNFSF5) and PP2Ac\u03b1, the genome-wide methylation pattern has also been explored recently, providing us a more and more full-scale picture of the abnormal status of DNA methylation in SLE.",
        "Although the exact cause of SLE is still unknown, the influence of environment, which is largely reflected by the epigenetic mechanisms, with DNA methylation changes in particular, are generally considered as key players in the pathogenesis of SLE."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26984631": [
        "Taken together, our study reveals a critical differential 5-hmC in the genome-wide promoter regions of SLE CD4(+) T cells and provides a novel mechanism that suggests that DNA hydroxymethylation contributes to the aberrant regulation of genes transcription in the pathogenesis of SLE.",
        "One of the major disappointments in autoimmunity has been the relative lack of informative data when genomewide associations (GWAS) have been applied to patients with systemic lupus erythematosus (SLE).",
        "Moreover, we present the differential patterns of DNA hydroxymethylation in genome-wide promoter regions in SLE CD4(+) T cells compared with healthy controls.",
        "5-Hydroxymethylcytosine (5-hmC) is a newly discovered modified form of cytosine suspected to be an important epigenetic modification in embryonic development, cell differentiation and cancer.",
        "Furthermore, we demonstrate that CTCF, as a transcription factor, can mediate DNA hydroxymethylation and contribute to overexpression of SOCS1 in CD4(+) T cells through binding to the promoter region of SOCS1.",
        "Through a combined analysis of differential DNA hydroxymethylation profile and gene expression profile in SLE CD4(+) T cells, we found 131 genes with the increased 5-hmC in promoter regions and up-regulated expression in SLE CD4(+) T cells compared with healthy controls, including selected immune-related genes, i.e. SOCS1, NR2F6 and IL15RA, which were also confirmed by ChIP-qPCR.",
        "Here, we show an increased 5-hmC level in genomic DNA in CD4(+) T cells of patients with SLE compared with healthy controls, accompanied by the up-regulated expression of the Ten-eleven translocation TET2 and TET3, which can enzymatically convert 5-methylcytosine (5-mC) to 5-hmC.",
        "Indeed, there is increasing evidence that SLE is characterized by widespread epigenetic changes.",
        "We identified 2748 genes with increased 5-hmC levels in promoter regions in SLE CD4(+) T cells, which were enriched in critical pathways, including neurotrophin signaling, WNT signaling, MAPK signaling, calcium signaling and the mTOR signaling pathway.",
        "DNA methylation dynamics have already been implicated in the pathogenesis of SLE, while little is known about hydroxymethylation in this process."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20174964": [
        "The possibility of translational regulation of this enzyme was addressed.",
        "Mutation of the 5' proximal AUG resulted in increased translational efficiency of the adjacent coding sequence, whereas no significant effect was observed after mutation of the second AUG.",
        "Poly(A)polymerase-alpha (PAPOLA) has been the most extensively investigated mammalian polyadenylating enzyme, mainly in regard to its multifaceted post-translational regulation.",
        "These observations imply that translational regulation is among the conserved mechanisms regulating PAPOLA expression.",
        "The transcription start site was mapped and two uORFs, highly conserved among several species, were identified in the 211-bp long, GC-rich, 5' UTR of the PAPOLA mRNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21300291": [
        "Structural and biochemical studies of Escherichia coli PAP (EcPAP) revealed that the shape and size of the nucleobase-interacting pocket of EcPAP are maintained by an intra-molecular hydrogen-network, making it suitable for the accommodation of only ATP, using a single amino acid, Arg(197).",
        "PolyA polymerase (PAP) adds a polyA tail onto the 3'-end of RNAs without a nucleic acid template, using adenosine-5'-triphosphate (ATP) as a substrate.",
        "The mechanism for the substrate selection by eubacterial PAP remains obscure.",
        "A comparison of the EcPAP structure with those of other template-independent RNA polymerases suggests that structural changes of domain(s) outside the conserved catalytic core domain altered the substrate specificities of the template-independent RNA polymerases.",
        "EcPAP has a flexible basic C-terminal region that contributes to optimal RNA translocation for processive adenosine 5'-monophosphate (AMP) incorporations onto the 3'-end of RNAs.",
        "The pocket structure is sustained by interactions between the catalytic domain and the RNA-binding domain."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15909992": [
        "The reaction (A(n) + ATP &lt;--&gt; A(n+1) + PP(i)) is adequately described by a rapid equilibrium random mechanism.",
        "Consistent with these data, an induced fit mechanism for nucleotide specificity is proposed whereby PAP couples a uniform binding mechanism, which selects for ATP, with a ground-state destabilization mechanism, which serves to accelerate the velocity for the correct substrate.",
        "Several thermodynamic parameters for the reaction were determined or calculated, including the overall equilibrium constant (K(eq) = 84) and the apparent equilibrium constant of the internal step (K(int) = 4) which involves the rate-determining interconversion of central complexes.",
        "Comparison of the sulfur elemental effect on Vmax/Km revealed differences in the mechanism by which either nucleotide is incorporated.",
        "A comprehensive steady-state kinetic analysis of PAP was conducted which included initial velocity studies of the forward and reverse reactions, inhibition studies, and the use of alternative substrates.",
        "A large (100-fold) difference in Vmax accounts for nucleotide specificity (ATP vs CTP), despite an only 3-fold difference in Km.",
        "Comparison of the sulfur elemental effect on Vmax for ATP and CTP suggests that the chemical step is rate-determining for both reactions.",
        "Polyadenylate polymerase (PAP) catalyzes the synthesis of 3'-polyadenylate tails onto mRNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24489730": [
        "Downregulated genes included oncogenes and those that play roles in cell invasion, cell growth, and cell division.",
        "HIC-1 is a gene that is hypermethylated in cancer, and commonly downregulated in human breast cancer.",
        "5-CdR partially reversed HIC-1 expression, and modulated cell growth and apoptosis. dsHIC1-2998, an saRNA, showed activating efficacy in breast cancer cells.",
        "A group of differentially expressed genes were characterized by cDNA microarray.",
        "HIC-1 immunohistochemistry resulted in mean staining scores in cancer tissue and normal ductal epithelia of 3.54 and 8.2, respectively (p&lt;0.01).",
        "Our findings may provide valuable resources not only for gene functional studies, but also for potential clinical applications to develop novel drug targets.",
        "We also analyzed its biological function by restoring HIC-1 expression using 5-aza-2' deoxycytidine (5-CdR) and small-activating RNAs for the reversal of HIC-1 tumor suppressive effects on MCF-7 and MDA-MB-231 cell lines.",
        "We assessed HIC-1 expression on a tissue microarray containing 80 cases of breast cancer.",
        "An Agilent Q44h global expressing microarray was probed after restoring the expression of HIC-1.",
        "However, the precise mechanisms and molecular pathways regulated by HIC-1 remain unclear.",
        "Upon saRNA treatment, genes upregulated included those involved in immune activation, cell cycle interference, the induction of apoptosis, anti-metastasis, and cell differentiation.",
        "Data demonstrated that HIC-1 expression was reduced significantly in breast cancer tissues."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22872227": [
        "Subsequent growth of bladder tumors is confirmed and monitored by in vivo bladder ultrasound and bioluminescent imaging.",
        "The mouse model is established by urethral catheterization under inhaled general anesthetic.",
        "The tumors are then treated intravesically with saRNA formulated in lipid nanoparticles (LNPs).",
        "Chemical burn is then introduced to the bladder mucosa using intravesical silver nitrate solution to disrupt the bladder glycosaminoglycan layer and allows cells to attach.",
        "We present a novel method for treating bladder cancer with intravesically delivered small activating RNA (saRNA) in an orthotopic xenograft mouse bladder tumor model.",
        "Tumor growth is monitored with ultrasound and bioluminescence.",
        "Following several washes with sterile water, human bladder cancer KU-7-luc2-GFP cells are instilled through the catheter into the bladder to dwell for 2 hours.",
        "All steps of this procedure are demonstrated in the accompanying video."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28639200": [
        "The prognosis for hepatocellular carcinoma (HCC) remains poor and has not improved in over two decades.",
        "By using an saRNA to activate C/EBP\u03b1, we can exploit the cell's own transcription machinery to enhance gene expression without relying on exogenous vectors that have been the backbone of gene therapy. saRNAs do not integrate into the host genome and can be modified to avoid immune stimulation.",
        "In preclinical models of liver disease, treatment with C/EBP\u03b1 saRNA has shown reduction in tumor volume and improvement in serum markers of essential liver function such as albumin, bilirubin, aspartate aminotransferase (AST), and alanine transaminase (ALT).",
        "For the remaining, the outlook remains bleak.",
        "The transcription factor CCAAT/enhancer-binding protein alpha (C/EBP\u03b1), a critical regulator of hepatocyte function, is suppressed in many advanced liver diseases.",
        "A better approach to target \"undruggable\" molecular pathways that reverse HCC is therefore urgently needed.",
        "This saRNA that activates C/EBP\u03b1 for advanced HCC is the first saRNA therapy to have entered a human clinical trial.",
        "The hope is that this new tool will help break the dismal 20-year trend and provide a more positive prognosis for patients with severe liver disease.",
        "Small activating RNAs (saRNAs) may provide a novel strategy to activate expression of genes that become dysregulated in chronic disease.",
        "Although sorafenib is the standard-of-care treatment for these patients, only a small number respond.",
        "Most patients with advanced HCC who are not eligible for surgery have limited treatment options due to poor liver function or large, unresectable tumors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30191596": [
        "As a potent and selective drug, brigatinib exhibits high efficacy against wild-type and mutant anaplastic lymphoma kinase (ALK) proteins to treat non-small cell lung cancer.",
        "These ALK mutations have significant influences on the flexibility of P-loop region and DFG sequences, but do not impair the hydrogen bonds between brigatinib and the residue Met1199 of hinge region.",
        "In this work, the mechanisms of brigatinib binding to wild type and four mutant ALKs were investigated to gain insight into the dynamic energetic and structural information with respect to the design of novel inhibitors.",
        "Together, the detailed explanation of mechanisms of those mutations with brigatinib further provide several guidelines for the development of more effective ALK inhibitors.",
        "Comparison between ALK-brigatinib and ALK-crizotinib suggests that the scaffold of brigatinib is well anchored to the residue Met1199 of hinge region by two hydrogen bonds, and the residue Lys1150 has the strong electrostatic interaction with the dimethylphosphine oxide moiety in brigatinib.",
        "And mutations (L1196M, G1269A, F1174L, and R1275Q) induce diverse conformational changes of brigatinib and the obvious energy variation of residues Glu1167, Arg1209, Asp1270, and Asp1203."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30394941": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      We describe recent developments in the rapidly evolving field of anaplastic lymphoma kinase-targeting agents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29174221": [
        "Pulmonary AEs during therapy with ceritinib, alectinib, and lorlatinib occurred in 1.1%, 2.6%, and 1.8% of the patients, respectively.",
        "Radiological patterns of pneumonia were reported in 25 patients, whereas imaging evocative of interstitial lung disease in 37.",
        "Its early recognition and treatment are crucial for the best outcome of this subgroup of patients, whose overall prognosis is being improved by the availability of several targeted agents.",
        "Crizotinib was responsible for pulmonary adverse events (AEs) in 1.8% of exposed patients (49 of 2706).",
        "With the limit of a lower number of treated patients (n = 359), brigatinib resulted as the most frequently involved in lung toxicity (7%; n = 25).",
        "Studies were identified using MEDLINE and additional sources (European Society for Medical Oncology, American Society of Clinical Oncology, and World Conference on Lung Cancer abstracts) in agreement with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Cochrane guidelines.",
        "Sixty-five percent of cases accounted for Grade 3 or 4 events, with a mortality rate of 9%.",
        "Lung toxicity is a rare albeit potentially severe side effect in NSCLC patients receiving ALK-TKIs, apparently more frequent with brigatinib.",
        "Moving from our experience regarding a patient who developed lung toxicity while receiving 2 different anaplastic lymphoma kinase (ALK)-TKIs, we performed a systematic review to assess the epidemiologic magnitude and the clinical significance of such toxicity in NSCLC patients treated with ALK-TKIs.",
        "Lung toxicity was reported in 105 of 4943 NSCLC patients (2.1%).",
        "Lung toxicity is a potential fatal effect involving non-small-cell lung cancer (NSCLC) patients exposed to tyrosine kinase inhibitors (TKIs).",
        "Overall, 26 of 105 patients (25%) permanently discontinued treatment because of lung toxicity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29187012": [
        "The identification of these genetic driver alterations created new potential for highly active therapeutic interventions.",
        "Next-generation ALK inhibitors, more potent and brain-penetrable than crizotinib, may be effective in re-inducing remissions when cancers are still addicted to ALK.",
        "Anaplastic lymphoma kinase (ALK) and ROS1 rearrangements define important molecular subgroups of advanced non-small cell lung cancer (NSCLC).",
        "Regarding ROS1 rearrangement, to date crizotinib is the only ALK-tyrosine kinase inhibitor receiving indication as treatment of ROS1 positive advanced NSCLC.",
        "Ceritinib and alectinib are approved for metastatic ALK positive NSCLC patients, while brigatinib received granted accelerated approval by the United States Food and Drug Administration.",
        "Further research will clarify the best management of ALK-positive NSCLC, above all who progress on first-line crizotinib.",
        "After initial response to crizotinib, tumors inevitably relapse.",
        "Expert commentary: Although novel ALK-inhibitors are under clinical investigation compared to crizotinib as front-line treatment for ALK-positive NSCLC, nowadays the current standard first-line therapy for these patients is crizotinib.",
        "Areas covered: Crizotinib, the first-in-class ALK/ROS1/MET inhibitor, was initially approved as second-line treatment of ALK-positive advanced NSCLC but after this, it was firmly established as the standard first-line therapy for advanced ALK-positive NSCLC.",
        "After discovery of ALK rearrangements in NSCLC, it was recognized that these confer sensitivity to ALK inhibition."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29256901": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      The review will highlight recent advances in development of ALK-TKIs and management of patients with ALK-positive nonsmall cell lung cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27144831": [
        "This report describes the design and synthesis of a series of 2,4-diarylaminopyrimidine-based potent and selective ALK inhibitors culminating in identification of the investigational clinical candidate brigatinib.",
        "A unique structural feature of brigatinib is a phosphine oxide, an overlooked but novel hydrogen-bond acceptor that drives potency and selectivity in addition to favorable ADME properties.",
        "Brigatinib represents the most clinically advanced phosphine oxide-containing drug candidate to date and is currently being evaluated in a global phase 2 registration trial.",
        "Brigatinib displayed low nanomolar IC50s against native ALK and all tested clinically relevant ALK mutants in both enzyme-based biochemical and cell-based viability assays and demonstrated efficacy in multiple ALK+ xenografts in mice, including Karpas-299 (anaplastic large-cell lymphomas [ALCL]) and H3122 (NSCLC).",
        "In the treatment of echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase positive (ALK+) non-small-cell lung cancer (NSCLC), secondary mutations within the ALK kinase domain have emerged as a major resistance mechanism to both first- and second-generation ALK inhibitors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27789693": [
        "Data from different functional categories are integrated in a scoring system that quantitatively measures the functionality of SNPs to help select important variants from a large pool.",
        "Here we present 3DSNP, an integrated database for annotating human noncoding variants by exploring their roles in the distal interactions between genes and regulatory elements.",
        "3DSNP integrates 3D chromatin interactions, local chromatin signatures in different cell types and linkage disequilibrium (LD) information from the 1000 Genomes Project.",
        "The 3DSNP database is available at http://biotech.bmi.ac.cn/3dsnp/.",
        "Recent high-throughput chromosome conformation capture studies have outlined the principles of these elements interacting and regulating the expression of distal target genes through three-dimensional (3D) chromatin looping.",
        "The vast noncoding portion of the human genome harbors a rich array of functional elements and disease-causing regulatory variants.",
        "3DSNP provides informative visualization tools to display the integrated local and 3D chromatin signatures and the genetic associations among variants.",
        "3DSNP is a valuable resource for the annotation of human noncoding genome sequence and investigating the impact of noncoding variants on clinical phenotypes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25431273": [
        "The United Nations Millennium Development Goal of reversing the global spread of tuberculosis by 2015 has been offset by the rampant re-emergence of drug-resistant tuberculosis, in particular fluoroquinolone-resistant multidrug-resistant and extensively drug-resistant tuberculosis.",
        "After decades of quiescence in the development of antituberculosis medications, bedaquiline and delamanid have been conditionally approved for the treatment of drug-resistant tuberculosis, while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase II clinical trials.",
        "This review largely discusses six novel drugs that have been evaluated in phase II and III clinical trials, with focus on the clinical evidence for efficacy and safety, potential drug interactions, and prospect for using multiple novel drugs in new regimens.",
        "Before novel drugs can find their place in the battle against drug-resistant tuberculosis, linezolid has been compassionately used with success in the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28726036": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      The present study was aimed to determine whether trefoil factor family (TFF) peptides which were generally considered to be resistant to proteolysis could be digested by gingipains, a major proteinases produced by Porphyromonas gingivalis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29984580": [
        "The transpeptidation products were often more abundant than the corresponding hydrolysis products.",
        "The transpeptidation of host proteins in vivo may potentially lead to the breakdown of immunological tolerance, culminating in autoimmune reactions.",
        "Mass spectrometric analysis of the substrates digested with gingipains in the presence of GlyGly showed that transpeptidation outcompeted hydrolysis, whereas the trypsin-digested controls exhibited predominantly hydrolysis activity.",
        "In the absence of GlyGly, hemoglobin peptides produced during digestion were utilized as acceptors leading to the detection of up to 116 different transpeptidation products in a single reaction.",
        "P. gingivalis cells were able to digest hemoglobin faster when acceptor peptides derived from human serum albumin were included in the reaction, suggesting that gingipain-catalyzed transpeptidation may be relevant for substrates encountered in vivo.",
        "Purified gingipains and P. gingivalis whole cells were used to digest selected substrates including human hemoglobin in the presence or absence of peptide acceptors.",
        "The reaction kinetics suggested that GlyGly may function as an acceptor molecule for gingipain-catalyzed transpeptidation.",
        "Porphyromonas gingivalis is a keystone periodontal pathogen that has been associated with autoimmune disorders.",
        "The cell surface proteases Lys-gingipain (Kgp) and Arg-gingipains (RgpA and RgpB) are major virulence factors, and their proteolytic activity is enhanced by small peptides such as glycylglycine (GlyGly).",
        "The transpeptidation levels increased with increasing concentration of GlyGly.",
        "All hemoglobin cleavage sites were found to be suitable for GlyGly transpeptidation, and this transpeptidation enhanced hemoglobin digestion.",
        "Purified gingipains and whole cells exhibited extensive transpeptidation activities on human hemoglobin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28107612": [
        "Porphyromonas gingivalis expresses several proteinaceous hemin-binding sites, which are important in the binding/transport of heme/hemin from the host.",
        "In this study we investigated the role of LPS in the deposition of \u03bc-oxo-bisheme on the cell-surface.",
        "Porphyromonas gingivalis is a Gram-negative black pigmenting anaerobe that is unable to synthesize heme [Fe(II)-protoporphyrin IX] or hemin [Fe(III)-protoporphyrin IX-Cl], which are important growth/virulence factors, and must therefore derive them from the host.",
        "The gingipains are required for the production of the black pigment, \u03bc-oxo-bisheme {[Fe(III)PPIX]<sub>2</sub> O}, which is derived from hemoglobin and deposited on the bacterial cell-surface leading to the characteristic black colonies when grown on blood agar.",
        "However, only those mutants lacking A-LPS showed reduced hemin-binding when cells in suspension were incubated with hemin.",
        "We conclude that A-LPS in the outer-membrane of P. gingivalis serves as a scaffold/anchor for the retention of \u03bc-oxo-bisheme on the cell surface and pigmentation is dependent on the presence of A-LPS.",
        "Using native, de-O-phosphorylated and de-lipidated LPS from P. gingivalis W50 and porR strains, we demonstrated that hemin-binding to O-polysaccharide (PS) and to the lipid A moiety of LPS was reduced compared with hemin-binding to A-PS.",
        "It also synthesizes several virulence factors, namely cysteine-proteases Arg- and Lys-gingipains and two lipopolysaccharides (LPS), O-LPS and A-LPS.",
        "A P. gingivalis mutant defective in the biosynthesis of Arg-gingipains, namely rgpA/rgpB, produces brown colonies on blood agar and mutants defective in Lys-gingipain (kgp) and LPS biosynthesis namely porR, waaL, wzy, and pg0129 (\u03b1-1, 3-mannosyltransferase) produce non-pigmented colonies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27280980": [
        "Various molecules, such as derivatives of fluoroquinolones (e.g. gatifloxacin, moxifloxacin and DC-159a), rifamycins (rifapentine), oxazolidinones (linezolid, sutezolid/PNU-100480), diarylquinolines (TMC207/bedaquiline), antifungal azoles, pyrrole (LL3858), nitroimidazopyran (PA824), nitroimidazole (OPC67683, TBA-354), diamine (SQ109) and benzothiazinone (BTZ043) are being developed in an attempt to combat the disease.",
        "In spite of consistent efforts being made, the disease has not been curtailed yet.",
        "The current situation clearly manifests the need to discover and develop new potent molecules/approaches that could help to tackle drug resistance.",
        "It also talks about the possible role of nanosciences in combating TB.",
        "Starting from the first drug against TB, the review discusses the entire history and the course of development of the drugs which are available today in the market as well as those which are under various phases of clinical and pre-clinical trials along with their mechanism of action.",
        "This review presents a general introduction to the current status of the disease, the biology of the pathogen as well as the state of drug development against tuberculosis (TB) with emphasis on the major problems and bottlenecks associated with the same.",
        "Tuberculosis is very much rampant in our society and accounts for a large number of deaths annually.",
        "The emergence of MDR and XDR strains in the society along with an increase in the number of HIV cases and that of latent TB, have further aggravated the problem making the disease very much persistent."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28483959": [
        "The MIC<sub>90</sub> of gepotidacin for 50 <i>S. aureus</i> (including methicillin-resistant <i>S. aureus</i> [MRSA]) and 50 <i>S. pneumoniae</i> (including penicillin-nonsusceptible) isolates was 0.5 \u03bcg/ml, and for <i>E. coli</i> (<i>n</i> = 25 isolates), it was 4 \u03bcg/ml.",
        "The most common interaction when testing gepotidacin was indifference (fractional inhibitory concentration index of &gt;0.5 to \u22644; 82.7% for Gram-positive isolates and 82.6% for Gram-negative isolates).",
        "Checkerboard analysis of gepotidacin combined with other antimicrobials demonstrated no occurrences of antagonism with agents from multiple antimicrobial classes.",
        "The postantibiotic effect (PAE) of gepotidacin was short when it was tested against <i>S. aureus</i> (\u22640.6 h against MRSA and MSSA), and the PAE-sub-MIC effect (SME) was extended (&gt;8 h; three isolates at 0.5\u00d7 MIC).",
        "Gepotidacin was bactericidal against <i>S. aureus</i>, <i>S. pneumoniae</i>, and <i>E. coli</i>, with MBC/MIC ratios of \u22644 against 98, 98, and 88% of the isolates tested, respectively.",
        "Gepotidacin is a first-in-class, novel triazaacenaphthylene antibiotic that inhibits bacterial DNA replication and has <i>in vitro</i> activity against susceptible and drug-resistant pathogens.",
        "These <i>in vitro</i> data indicate that gepotidacin is a bactericidal agent that exhibits a modest PAE and an extended PAE-SME against Gram-positive and -negative bacteria and merits further study for potential use in treating infections caused by these pathogens.",
        "The PAE of levofloxacin was modest (0.0 to 2.4 h), and the PAE-SME observed varied from 1.2 to &gt;9 h at 0.5\u00d7 MIC.",
        "Reference <i>in vitro</i> methods were used to investigate the MICs and minimum bactericidal concentrations (MBCs) of gepotidacin and comparator agents for <i>Staphylococcus aureus</i>, <i>Streptococcus pneumoniae</i>, and <i>Escherichia coli</i> Gepotidacin <i>in vitro</i> activity was also evaluated by using time-kill kinetics and broth microdilution checkerboard methods for synergy testing and for postantibiotic and subinhibitory effects.",
        "Time-kill curves indicated that the bactericidal activity of gepotidacin was observed at 4\u00d7 or 10\u00d7 MIC at 24 h for all of the isolates. <i>S. aureus</i> regrowth was observed in the presence of gepotidacin, and the resulting gepotidacin MICs were 2- to 128-fold higher than the baseline gepotidacin MICs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30503518": [
        "Although it is essential for fucose salvage, this pathway is thought to make only a minor contribution to the total amount of GDP-fucose.",
        "FUK encodes fucokinase, the only enzyme capable of converting L-fucose to fucose-1-phosphate, which will ultimately be used for synthesizing GDP-fucose, the donor substrate for all fucosyltransferases.",
        "There was also a decrease in the incorporation of [5,6-<sup>3</sup>H]-fucose into fucosylated glycoproteins.",
        "Lys994 has previously been shown to be an important site for ubiquitin conjugation.",
        "The first individual was compound heterozygous for c.667T&gt;C (p.Ser223Pro) and c.2047C&gt;T (p.Arg683Cys), and the second individual was homozygous for c.2980A&gt;C (p.Lys994Gln).",
        "Here we describe two unrelated individuals who have pathogenic variants in FUK and who presented with severe developmental delays, encephalopathy, intractable seizures, and hypotonia.",
        "Skin fibroblasts from the first individual confirmed the variants as loss of function and showed significant decreases in total GDP-[<sup>3</sup>H] fucose and [<sup>3</sup>H] fucose-1-phosphate.",
        "Here, we show that loss-of-function variants in FUK cause a congenital glycosylation disorder characterized by a defective fucose-salvage pathway.",
        "A second pathway, the major de novo pathway, involves conversion of GDP-mannose to GDP-fucose."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12056818": [
        "These results reveal that the discovered cDNA encodes the fucokinase protein and they confirm that a functional kinase domain is located in the C-terminal part of the enzyme.",
        "L-Fucose kinase (fucokinase) takes part in the salvage pathway for reutilization of fucose from the degradation of oligosaccharides.",
        "Fucokinase full-length protein and a deletion mutant lacking the first 363 amino acids of the N-terminus were expressed in Escherichia coli BL21 cells.",
        "Human fucokinase polypeptide chain consists of 990 amino acids with a predicted molecular mass of 107 kDa.",
        "The amino acid sequence of human fucokinase was derived from a cDNA encoding a protein of hitherto unidentified function.",
        "Both proteins displayed fucokinase activity.",
        "The C-terminal part of its amino acid sequence showed sequence motifs typical for sugar kinases.",
        "Fucose is a major component of complex carbohydrates."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27940404": [
        "Contrary to long-held dogma, human milk is not sterile.",
        "Instead, it provides infants a rich source of diverse bacteria, particularly microbes belonging to the Staphylococcus, Streptococcus, and Pseudomonas genera.",
        "The origins of the bacteria in milk are thought to include the maternal gastrointestinal tract (via an entero-mammary pathway) and through bacterial exposure of the breast during nursing.",
        "Currently, almost nothing is known about whether variation in microbe consumption by the infant via human milk and that of the mammary gland, itself, impacts short-term and/or long-term infant and maternal health although several studies suggest this is likely.",
        "We urge the clinical and public health communities to be patient, however, in order to allow human milk and lactation researchers to first understand what constitutes 'normal' in terms of the milk microbiome (as well as factors that impact microbial community structure) prior to jumping the gun to investigate if and how this important source of microbes impacts maternal and infant health.",
        "Very little is known about factors that influence variation in the milk microbiome among women and populations, although time postpartum, delivery mode, and maternal factors such as diet and antibiotic use might be important."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28843918": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      We evaluated the safety/tolerability of longer-term open-label treatment with cariprazine in patients who had responded to cariprazine for acute bipolar mania."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29017067": [
        "Post hoc analyses of pooled data from 3 pivotal trials of cariprazine in manic/mixed episodes associated with bipolar I disorder were conducted to investigate the effect of cariprazine on various criteria of response and remission.",
        "Cariprazine is FDA approved for the acute treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adults.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Rates of response and remission are measures that endorse the clinical significance of treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28478771": [
        "This 53-week study evaluated the long-term safety and tolerability of cariprazine in patients with schizophrenia.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Cariprazine, a dopamine D3/D2 partial agonist atypical antipsychotic with preferential binding to D3 receptors, is approved for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder.",
        "The efficacy and safety of cariprazine was established in three randomized, double-blind, placebo-controlled, 6-week trials in patients with acute exacerbation of schizophrenia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30372510": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Cariprazine was approved for treating schizophrenia and bipolar disorder, and currently is being evaluated for treating depression in clinical trials in the United States.",
        "We systematically reviewed the literature on the efficacy and safety of cariprazine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29303456": [
        "This case is unusual in its late age of symptom onset, the primacy of lateral (\"no-no\") involuntary head rotations, and the associated tectal tumor.",
        "A comprehensive and up-to-date review of the literature of BHDS and video documentation of the phenomenon are presented.",
        "The second case is a 7.5-year-old girl with BHDS associated with a suprasellar cyst.",
        "She was successfully treated with an endoscopic fenestration but preexisting endocrinopathy persisted, and the patient was diagnosed with autism spectrum disorder at age 12 years.",
        "Treatment is surgical.",
        "Bobble-head doll syndrome (BHDS) is a rare pediatric movement disorder presenting with involuntary 2- to 3-Hz head movements.",
        "The first is a 14-year-old boy with BHDS associated with aqueductal obstruction and triventricular hydrocephalus secondary to a tectal tumor.",
        "He was successfully treated by endoscopic third ventriculostomy, and all symptoms resolved immediately in the recovery room.",
        "The authors present 2 cases of BHDS.",
        "Common signs and symptoms also found on presentation include macrocephaly, ataxia, developmental delay, optic disc pallor or atrophy, hyperreflexia, tremor, obesity, endocrinopathy, visual disturbance or impairment, headache, and vomiting, among others.",
        "This second case is more typical of BHDS.",
        "The syndrome is associated with suprasellar cysts, third ventricular cysts, or aqueductal obstruction, along with a few other less common conditions.",
        "The cause of involuntary head motions is not understood."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29593205": [
        "During 4 years of follow-up observation without medication, neuropsychiatric symptoms did not relapse.",
        "Brain magnetic resonance imaging showed a large suprasellar arachnoid cyst extending into the third ventricle, with obstructive hydrocephalus, characteristic of bobble-head doll syndrome.",
        "Endoscopic fenestration of the suprasellar arachnoid cyst was performed.",
        "A 22-year-old man was admitted with gradually aggravating stereotypic head movement with hypomania.",
        "Stereotypic head movement stopped immediately after surgery and hypomanic symptoms gradually improved within a month.",
        "We report our experience of surgically treating stereotypy and hypomania in a case of bobble-head doll syndrome and discuss the possible neuropsychiatric mechanisms of this rare disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25506155": [
        "Clinically, it is characterized by a to and fro or side to side movement of the head at the frequency of 2 to 3 Hz.",
        "MRI Scan showed a large contrast-enhanced lesion in the region of the third ventricle along with gross hydrocephalus.",
        "Bobble-head doll syndrome is a rare condition and therefore this case is presented and the literature reviewed.",
        "Ventriculo-peritoneal shunt was inserted and the movements of the head disappeared completely.",
        "An eleven year old child presented in the outpatient department with continuous to and fro movement of the head and declining vision for the last one month.",
        "It is mostly associated with cystic lesions around the third ventricle, choroid plexus papilloma, aqueductal stenosis and other rare disorders.",
        "Bobble-head Doll Syndrome is a rare and unique movement disorder found in children."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24075844": [
        "Side-to-side (no-no) head bobbing is less frequently described.",
        "Bobble-head doll syndrome is usually associated with dilation of the third ventricle, but is rarely associated with posterior fossa disease.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Bobble-head doll syndrome is a rare and surgically treatable movement disorder characterized by up-and-down (yes-yes) head bobbing occurring at a rate of 2-3 Hz."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22886034": [
        "After surgery, BHDS persisted longer the more the subsequent treatment was delayed.",
        "The etiology of this syndrome remains unknown and no standard treatment has yet been established.",
        "Bobble-head doll syndrome (BHDS) is a complex syndrome with the dominant symptom of repetitive anteroposterior head movement.",
        "We hereby report four cases treated at our department.",
        "Based on our own experience, we state that the method of choice should be the neuroendoscopy and this must be performed promptly after diagnosis is made.",
        "All the patients presented a psychomotor retardation due to an obstructive hydrocephalus.",
        "Only 57 patients are quoted in the literature.",
        "Cyst decompression was achieved in all four cases and clinical recovery was evident in three of the four patients observed.",
        "In this article, we provide a concise overview of the theories of pathogenesis, presentation, and management of this syndrome.",
        "All the patients were treated using neuroendoscopic techniques: two with ventriculocystostomy, and two with ventriculocystocisternostomy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25878736": [
        "The bobble-head doll movement is a rare movement disorder characterized by antero-posterior bobbling of the head and neck on the trunk every 2-3 seconds.",
        "We present three cases with bobble-head doll syndrome associated with a large suprasellar arachnoid cyst and obstructive hydrocephalus, which were treated with endoscopic cystoventriculocisternostomy and marsupialization of the cyst.",
        "Suprasellar arachnoid cysts can have varied presentations with signs and symptoms of obstructive hydrocephalus, visual impairment, endocrinal dysfunction, gait ataxia and rarely bobble-head doll movement."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21348815": [
        "In the neonate and infant, among other benefits, lactation confers protection from future both type 1 and type 2 diabetes.",
        "The present review outlines the role of breastfeeding in diabetes.",
        "Moreover, it appears to reduce the risk of premenopausal breast cancer and ovarian cancer.",
        "Whether lactation protects women with gestational diabetes mellitus and their offspring from future T2DM remains to be answered.",
        "In conclusion, breastfeeding could be considered a modifiable risk factor for the development of diabetes and even a potential protective lifestyle measure from future cardio-metabolic and malignant diseases.",
        "Therefore, insulin currently remains the optimal antidiabetic treatment during lactation.",
        "Therefore, health care professionals should encourage both women with and without diabetes to breastfeed their children.",
        "Importantly, for diabetic mothers, antidiabetic treatment itself may affect breastfeeding.",
        "There is not enough data to allow the use of oral hypoglycaemic agents.",
        "In the mother, breastfeeding has been suggested to reduce the incidence of type 2 diabetes mellitus, the metabolic syndrome and cardiovascular disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29016169": [
        "Several studies provide support for the view that the enteric microbiome influences behavior through the microbiota-gut-brain axis.",
        "(PsycINFO Database Record",
        "At the intersection between neuroscience, microbiology, and psychiatry, the enteric microbiome has potential to become a novel paradigm for studying the psychobiological underpinnings of mental illness.",
        "Moreover, recent findings are suggestive of the possibility that dysregulation of the enteric microbiota (i.e., dysbiosis) and associated bacterial translocation across the intestinal epithelium may be involved in the pathophysiology of stress-related psychiatric disorders, particularly depression.",
        "Finally, and drawing on these independent lines of research, an integrative conceptual model is proposed in which stress-induced enteric dysbiosis and intestinal permeability confer risk for negative mental health outcomes through immunoregulatory, endocrinal, and neural pathways.",
        "The current article reviews preliminary evidence linking the enteric microbiota and its metabolites to psychiatric illness, along with separate lines of empirical inquiry on the potential involvement of psychosocial stressors, proinflammatory cytokines and neuroinflammation, the hypothalamic-pituitary-adrenal axis, and vagal nerve activation, respectively, in this relationship."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19625390": [
        "We show that the retention of genes in duplicate in the model, corresponds nicely with those retained in duplicate after the ancestral WGD in S. cerevisiae.",
        "Also, we observe that transporter and glycolytic genes have a higher probability to be retained in duplicate after WGD and subsequent gene loss, both in the model as in S. cerevisiae, which leads to an increase in glycolytic flux after WGD.",
        "Thus, our model confirms the hypothesis that WGD has been important in the adaptation of yeast to the new, glucose-rich environment that arose after the appearance of angiosperms.",
        "Using the metabolic network of Saccharomyces cerevisiae as an example, we primarily study the outcome of WGD on yeast as it currently is.",
        "This is indeed the case for adaptation to high glucose levels.",
        "Moreover, the model shows that WGD is almost always detrimental on the short term in environments to which the lineage is preadapted, but can have immediate fitness benefits in \"new\" environments.",
        "Whole genome duplications (WGDs) have been hypothesized to be responsible for major transitions in evolution.",
        "However, similar results were obtained using a recontructed hypothetical metabolic network of the pre-WGD ancestor.",
        "Here we develop a genome scale evolutionary model to study the dynamics of gene loss and metabolic adaptation after WGD.",
        "This explains why WGD, while pivotal in the evolution of many lineages and an apparent \"easy\" genetic operator, occurs relatively rarely.",
        "However, the effects of WGD and subsequent gene loss on cellular behavior and metabolism are still poorly understood.",
        "Furthermore, the model shows that WGD leads to better adaptation than small-scale duplications, in environments for which duplication of a whole pathway instead of single reactions is needed to increase fitness."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17916239": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Genes in populations are in constant flux, being gained through duplication and occasionally retained or, more frequently, lost from the genome.",
        "In this study we compare pairs of identifiable gene duplicates generated by small-scale (predominantly single-gene) duplications with those created by a large-scale gene duplication event (whole-genome duplication) in the yeast Saccharomyces cerevisiae."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20525287": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Gene duplication, a major evolutionary path to genomic innovation, can occur at the scale of an entire genome.",
        "One such \"whole-genome duplication\" (WGD) event among the Ascomycota fungi gave rise to genes with distinct biological properties compared to small-scale duplications."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21079672": [
        "These observations validated previous theoretic predictions about instability of genetic redundancy.",
        "Our study revealed the general principles for the long-term retention of genetic redundancy.",
        "However, counter-intuitively, several recent studies reported little functional redundancy between these buffering duplicates.",
        "The loss of backup capacity generally follows a neutral mode, with the buffering strength decreasing in proportion to divergence time, and the vast majority of the paralogs have already lost their backup capacity.",
        "The large yeast genetic interactions released recently allowed us to address these issues on a genome-wide scale.",
        "However, departing from the general neutral mode, intriguingly, our analysis revealed the presence of natural selection in stabilizing functional overlap between SSD pairs.",
        "Even though mutual buffering was observed to be prevalent among duplicated genes, we showed that the observed backup capacity is largely an evolutionarily transient state.",
        "We established that functional redundancy between duplicates is a pre-requisite and thus is highly predictive of their backup capacity.",
        "It is anticipated that, to achieve mutual buffering, the duplicated paralogs must at least share some functional overlap.",
        "We herein characterized the synthetic genetic interactions for \u223c500 pairs of yeast duplicated genes originated from either whole-genome duplication (WGD) or small-scale duplication (SSD) events.",
        "These selected pairs, both WGD and SSD, tend to have decelerated functional evolution, have higher propensities of co-clustering into the same protein complexes, and share common interacting partners.",
        "However, theoretical predictions suggest such backup by redundancy is evolutionarily unstable, and the extent of genetic robustness contributed from redundancy remains controversial.",
        "This observation was particularly pronounced with the use of a newly introduced metric in scoring functional overlap between paralogs on the basis of gene ontology annotations.",
        "The frequent dispensability of duplicated genes in budding yeast is heralded as a hallmark of genetic robustness contributed by genetic redundancy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27799339": [
        "The mechanism of duplication matters, with whole-genome duplicates being more transcriptionally altered than small-scale duplicates.",
        "Gene and genome duplication are the major sources of biological innovations in plants and animals.",
        "These patterns are strongly correlated with the functional dependencies and sequence divergence profiles of gene copies.",
        "The predominant transcriptional pattern follows the classic theory of evolution by gene duplication; with one gene copy remaining unaltered under stress, while its sister copy presents large transcriptional plasticity and a prominent role in adaptation.",
        "However, here we show that increased phenotypic plasticity after duplication plays a more major role than thought before in the origin of adaptations.",
        "Analysis of the transcriptomes of yeast shows that gene duplication increases the transcriptional response to environmental changes, with duplicated genes exhibiting signatures of adaptive transcriptional patterns in response to stress.",
        "Functional and transcriptional divergence between the copies after gene duplication has been considered the main driver of innovations .",
        "We show that, unlike singletons, duplicates respond more specifically to stress, supporting the role of natural selection in the transcriptional plasticity of duplicates.",
        "We perform an exhaustive analysis of the transcriptional alterations of duplicated genes in the unicellular eukaryote Saccharomyces cerevisiae when challenged with five different environmental stresses.",
        "Our results reveal the underlying transcriptional complexity of duplicated genes and its role in the origin of adaptations.",
        "Moreover, we find additional transcriptional profiles that are suggestive of neo- and subfunctionalization of duplicate gene copies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23300483": [
        "Researchers have long been enthralled with the idea that gene duplication can generate novel functions, crediting this process with great evolutionary importance.",
        "We propose a novel model that uncovers the complexity of evolution after gene duplication.",
        "This conclusion is supported by: (a) SSD-duplicates establish more genetic interactions than singletons and WGD-duplicates; (b) SSD-duplicates copies share more interaction-partners than WGD-duplicates copies; (c) WGD-duplicates interaction partners are more functionally related than SSD-duplicates partners; (d) SSD-duplicates gene copies are more functionally divergent from one another, while keeping more overlapping functions, and diverge in their sub-cellular locations more than WGD-duplicates copies; and (e) SSD-duplicates complement their functions to a greater extent than WGD-duplicates.",
        "Empirical data shows that whole-genome duplications (WGDs) are more likely to be retained than small-scale duplications (SSDs), though their relative contribution to the functional fate of duplicates remains unexplored.",
        "Using the map of genetic interactions and the re-sequencing of 27 Saccharomyces cerevisiae genomes evolving for 2,200 generations we show that SSD-duplicates lead to neo-functionalization while WGD-duplicates partition ancestral functions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22977178": [
        "Non-long terminal repeat (non-LTR) retrotransposons are highly abundant elements that are present in chromosomes throughout the eukaryotic domain of life.",
        "The long interspersed nuclear element (LINE-1) (L1) clade of non-LTR retrotransposons has been particularly successful in mammals, accounting for 30-40% of human genome sequence.",
        "These episomal products are a previously unseen alternative fate of LINE retrotransposition, and may represent an unexpected source for de novo retrotransposition.",
        "The current model of LINE retrotransposition, target-primed reverse transcription, culminates in a chromosomally integrated end product.",
        "Using a budding yeast model of non-LTR retrotransposition, we show that in addition to producing these 'classical', chromosomally integrated products, a fungal L1 clade member (Zorro3) can generate abundant, RNA-derived episomal products.",
        "Genetic evidence suggests that these products are likely to be formed via a variation of target-primed reverse transcription."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26681518": [
        "Analyses of sequence junctions reveal no signs of NHEJ or autointegration events.",
        "Ty eccDNA can arise from the circularization of extrachromosomal linear DNA during the transpositional life cycle of retrotransposons, or from circularization of genomic Ty DNA.",
        "This opens the possibility that retrotransposable elements could move around in the genome without an RNA intermediate directly through DNA circularization.",
        "Extrachromosomal circular DNA (eccDNA) derived from chromosomal Ty retrotransposons in yeast can be generated in multiple ways.",
        "By performing an in-depth investigation of sequence reads stemming from Ty eccDNAs obtained from populations of Saccharomyces cerevisiae S288c, we find that eccDNAs predominantly correspond to full-length Ty1 elements.",
        "Circularization may happen through nonhomologous end-joining (NHEJ) of long terminal repeats (LTRs) flanking Ty elements, by Ty autointegration, or by LTR-LTR recombination.",
        "We detect recombination junctions that are consistent with yeast Ty eccDNAs being generated through recombination events within the genome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28090380": [
        "Circular DNAs are extra-chromosomal fragments that become circularized by genomic recombination events.",
        "In yeast, this can result in gene copy number variations when circles contain genes and origins of replication.",
        "Here, I speculate on the potential and implications of circular DNAs generated through recombination between human transposable elements.",
        "We have recently shown that yeast LTR elements generate circular DNAs through recombination events between their flanking long terminal repeats (LTRs).",
        "Similarly, circular DNAs can be generated by recombination between LTRs residing at different genomic loci, in which case the circular DNA will contain the intervening sequence."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26979517": [
        "Circularization of genomic DNA is observed across eukaryotic species, in a range of different cell types, and from all parts of the genome.",
        "In yeast, the predominant type of transposable element is a so-called LTR (long terminal repeats) retrotransposable element that moves through a copy-and-paste mechanism.",
        "Transposable elements are mobile genetic elements scattered across eukaryotic genomes.",
        "As circular DNA structures may recombine with the genome and re-integrate into a novel genomic locus, transposable elements could move through circularization.",
        "Different classes of transposable elements move either through a copy-and-paste or a cut-and-paste.",
        "The generation of circular DNAs is a relatively unrecognized type of genomic structural variation, but recent findings point to a possible role of circular DNAs in the movement of transposable elements.",
        "A recent study on circular DNAs in yeast found that transposable element sequence residing in circular structures mostly corresponded to full-length transposable elements.",
        "Although further experimental evidence is needed to establish the extent to which movement of transposable elements through DNA circularization takes place, such movement is likely to have a functional impact on the genomic context.",
        "The observed circularization of this element means it potentially could move through a cut-and-paste mechanism as well."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30127433": [
        "Here we show that cohesin is required for the core transcriptional response of primary macrophages to microbial signals, and for inducible enhancer activity that underpins inflammatory gene expression.",
        "Consistent with a role for inflammatory signals in promoting myeloid differentiation of hematopoietic stem and progenitor cells (HPSCs), cohesin mutations in HSPCs led to reduced inflammatory gene expression and increased resistance to differentiation-inducing inflammatory stimuli.",
        "Nevertheless, even the complete removal of cohesin has surprisingly little impact on steady-state gene transcription and enhancer activity.",
        "These findings uncover an unexpected dependence of inducible gene expression on cohesin, link cohesin with myeloid differentiation, and may help explain the prevalence of cohesin mutations in human acute myeloid leukemia.",
        "Cohesin is important for 3D genome organization."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28988646": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Patients with advanced sarcomas have a poor prognosis and few treatment options that improve overall survival.",
        "Chemotherapy and targeted therapies offer short-lived disease control.",
        "We assessed pembrolizumab, an anti-PD-1 antibody, for safety and activity in patients with advanced soft-tissue sarcoma or bone sarcoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28165476": [
        "We demonstrate recovery of gene and protein expression, restoration of sensory cell function, rescue of complex auditory function and recovery of hearing and balance behavior to near wild-type levels.",
        "As restoration of complex auditory and balance function is likely to require gene delivery systems that target auditory and vestibular sensory cells with high efficiency, we delivered wild-type Ush1c into the inner ear of Ush1c c.216G&gt;A mice using a synthetic adeno-associated viral vector, Anc80L65, shown to transduce 80-90% of sensory hair cells.",
        "The data represent unprecedented recovery of inner ear function and suggest that biological therapies to treat deafness may be suitable for translation to humans with genetic inner ear disorders.",
        "Because there are currently no biological treatments for hearing loss, we sought to advance gene therapy approaches to treat genetic deafness.",
        "We focused on Usher syndrome, a devastating genetic disorder that causes blindness, balance disorders and profound deafness, and studied a knock-in mouse model, Ush1c c.216G&gt;A, for Usher syndrome type IC (USH1C)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30359302": [
        "Here, we introduce the computational framework PINES (Phenotype-Informed Noncoding Element Scoring), which predicts the functional impact of noncoding variants by integrating epigenetic annotations in a phenotype-dependent manner.",
        "PINES enables analyses to be customized towards genomic annotations from cell types of the highest relevance given the phenotype of interest.",
        "Functional characterization of the noncoding genome is essential for biological understanding of gene regulation and disease.",
        "We illustrate that PINES identifies functional noncoding variation more accurately than methods that do not use phenotype-weighted knowledge, while at the same time being flexible and easy to use via a dedicated web portal."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25886781": [
        "The ALS Milano-Torino staging (ALS-MITOS) system was proposed as a novel tool to measure the progression of ALS and overcome these limitations.",
        "The intrinsic limitations of the ALS Functional Rating Scale-Revised (ALSFRS-R), including non-linearity, multidimensionality and floor-effect, have emerged and its usefulness argued.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      The choice of adequate proxy for long-term survival, the ultimate outcome in randomised clinical trials (RCT) assessing disease-modifying treatments for amyotrophic lateral sclerosis (ALS), is a key issue.",
        "This study was performed to validate the ALS-MITOS as a 6-month proxy of survival in 200 ALS patients followed up to 18 months."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25595151": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess the efficacy of recombinant human erythropoietin (rhEPO) in amyotrophic lateral sclerosis (ALS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16802291": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To determine whether chronic treatment with celecoxib, a cyclooxygenase-2 inhibitor that has been shown to be beneficial in preclinical testing, is safe and effective in amyotrophic lateral sclerosis (ALS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23040961": [
        "Conjunctivitis, capillary hemangioma, conjunctival telangiectasia, trauma, retrograde epistaxis and nasal and paranasal neoplasms may play a role in its etiology.",
        "Hemolacria is a very rare entity which literally means \"bloody tears\".",
        "In our case report, a 11-year-old female patient who presented with the complaint of bilateral epistaxis accompanied by bloody tears that had been present for 2 years and whose endoscopic examination revealed hyperemia and increased vascularity in the nasal cavity mucosa was discussed together with a review of the literature."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23689678": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Hemolacria is a rare phenomenon of bloody tears caused by various ocular and systemic conditions, as well as psychological, pharmacologic, and idiopathic etiologies.",
        "It is predominantly unilateral and self-limiting, but because of limited literature, its prevalence and predilection toward a specific gender, race, or age is not known.",
        "Hemolacria is typically a benign process; however, serious systemic associations can exist."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21617906": [
        "Hematidrosis (bloody sweat) and hemolacria (bloody tears) are very rare phenomena.",
        "The authors herein report hematidrosis and hemolacria occurring together in a 10-year-old girl.",
        "The role of propranolol in its treatment is highlighted."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20224466": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      The purpose of this study was to report recurrent hemolacria, or \"bloody tears,\" as a sign of scleral buckle (SB) infection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27879619": [
        "While a variety of established complications are associated with this technique, most are directly understood and treated.",
        "Surgical repair of orbital fractures with implants is a widely used treatment modality.",
        "The authors present a unique case of bloody epiphora, accompanied by orbital hemorrhage arising several years after orbital floor fracture repair, due to erosion of the nasolacrimal drainage system by a displaced implant combined with anticoagulation.",
        "The collection and evaluation of all protected patient health information was compliant with the regulations and conditions set forth in the Health Insurance Portability and Availability Act of 1996.",
        "Bloody epiphora is a finding with potentially ominous causes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29358049": [
        "Non-coding \"ultraconserved\" regions containing hundreds of consecutive bases of perfect sequence conservation across mammalian genomes can function as distant-acting enhancers.",
        "Here, we show that ultraconserved enhancers are required for normal development.",
        "Focusing on some of the longest ultraconserved sites genome wide, located near the essential neuronal transcription factor Arx, we used genome editing to create an expanded series of knockout mice lacking individual or combinations of ultraconserved enhancers.",
        "Mice with single or pairwise deletions of ultraconserved enhancers were viable and fertile but in nearly all cases showed neurological or growth abnormalities, including substantial alterations of neuron populations and structural brain defects.",
        "However, initial deletion studies in mice revealed that loss of such extraordinarily constrained sequences had no immediate impact on viability.",
        "Our results demonstrate the functional importance of ultraconserved enhancers and indicate that remarkably strong sequence conservation likely results from fitness deficits that appear subtle in a laboratory setting."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29495404": [
        "We recently have established a successful xenograft model of human glioblastoma cells by enriching hyaluronic acid-dependent spheroid-forming populations termed U251MG-P1 cells from U251MG cells.",
        "Evaluating the sensitivity to anti-cancer agents, we found U251MG-P1 cells were sensitive to doxorubicin with IC<sub>50</sub> at 200 nM.",
        "Since U251MG-P1 cells have been confirmed to express CD44 along with principal stemness marker genes, <i>OCT3/4</i>, <i>SOX2</i>, <i>KLF4</i> and <i>Nanog</i>, this CD44 expressing population appeared to majorly consist of undifferentiated cells.",
        "The liposome modified with M-CTX-Fc was designed with a diameter of approximately 100-150 nm and showed high encapsulation efficiency, adequate loading capacity of anticancer drug, enhanced antitumor effects demonstrating increasing uptake into the cells in vitro; M-CTX-Fc-L-Dox shows great promise in its ability to suppress tumor growth in vivo and it could serve as a template for targeted delivery of other therapeutics.",
        "Although doxorubicin has serious side-effects, establishment of an efficient therapy targeting undifferentiated glioblastoma cell population is necessary.",
        "Combining these results together, we designed M-CTX-Fc conjugated liposomes encapsulating doxorubicin and used U251MG-P1 cells as the target model in this study.",
        "We previously designed a chlorotoxin peptide fused to human IgG Fc region without hinge sequence (M-CTX-Fc), which exhibited a stronger growth inhibitory effect on the glioblastoma cell line A172 than an original chlorotoxin peptide."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30486274": [
        "Chlorotoxin (CTX) is a 36-amino-acid disulfide-containing peptide derived from the venom of the scorpion <i>Leiurus quinquestriatus</i>.",
        "It interacts with voltage gated chloride channels, Annexin-2, and matrix metalloproteinase-2 (MMP-2).",
        "With its ability to penetrate the blood-brain-barrier (BBB) and its tyrosine residue allows covalent conjugation with functional moieties, CTX is an attractive platform to explore development of diagnostic and therapeutic agents for gliomas.",
        "CTX-based bioconjugates have been widely subjected to phase I/II clinical trials and have shown substantial promise.",
        "In this review, we outline CTX structure and its molecular targets, summarize molecular variations of CTX developed for glioma imaging, and discuss future trends and perspectives for CTX conjugates as a theranostic agent.",
        "CTX alters physiology in numerous ways.",
        "Many studies have demonstrated that CTX preferentially binds to neuroectodermal tumors, such as glioblastoma, without cross-reactivity to normal brain cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28415833": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Chloride channels have already been over-expressed in the different types of cancer.",
        "In this study, we characterized a putative chlorotoxin from a cDNA library of the venom glands obtained from the Iranian scorpion Odontobuthus doriae.",
        "Chlorotoxins, as the blocking agent of these channels, have been indicated to be an effective drug against tumors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28459137": [
        "Chlorotoxin (CTX), a disulfide-rich peptide from the scorpion Leiurus quinquestriatus, has several promising biopharmaceutical properties, including preferential affinity for certain cancer cells, high serum stability, and cell penetration.",
        "Here, we focus on its ability to internalize into cells-a trait associated with a privileged subclass of peptides called cell-penetrating peptides-and whether it can be improved through conservative substitutions.",
        "CTX_M1 (ie, [K15R/K23R]CTX) and CTX_M2 (ie, [K15R/K23R/Y29W]CTX) mutants showed at least a twofold improvement in uptake compared to CTX.",
        "Importantly, the mutants have high stability, remaining intact in serum for over 24 h; thus, retaining the characteristic stability of their parent peptide.",
        "Mutants of CTX were made using solid-phase peptide synthesis and internalization into human cervical carcinoma (HeLa) cells was monitored by fluorescence and confocal microscopy.",
        "These properties underpin its potential for use as a drug design scaffold, especially for the treatment of cancer; indeed, several analogs of CTX have reached clinical trials.",
        "We further showed that these mutants internalize into HeLa cells largely via an energy-dependent mechanism.",
        "Overall, we have shown that simple conservative substitutions can enhance the cellular uptake of CTX, suggesting that such type of mutations might be useful for improving uptake of other peptide toxins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29104121": [
        "<strong class=\"sub-title\">\n          Background &amp; aims:\n        </strong>\n      \n      Vesatolimod (GS-9620) is an oral agonist of toll-like receptor 7, an activator of innate and adaptive immune responses.",
        "Herein the safety and efficacy of vesatolimod is assessed after once-weekly treatment in patients with chronic hepatitis B (CHB) infection suppressed on oral antiviral treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29447106": [
        "This unusual biogenesis restricts the use of Sec in recombinant proteins, limiting our ability to study the properties of selenoproteins.",
        "Sec is synthesized on its cognate tRNA (tRNA<sup>Sec</sup>) by the concerted action of several enzymes.",
        "Incorporation of Sec into protein requires recoding of the stop codon UGA aided by a specific mRNA structure, the SECIS element.",
        "Selenocysteine (Sec), a rare genetically encoded amino acid with unusual chemical properties, is of great interest for protein engineering.",
        "Here we focus on strategies for in vivo Sec insertion at any position(s) within a recombinant protein in a SECIS-independent manner: (i) engineering of tRNA<sup>Sec</sup> for use by EF-Tu without the SECIS requirement, and (ii) design of a SECIS-independent SelB route.",
        "While all other aminoacyl-tRNAs are delivered to the ribosome by the elongation factor Tu (EF-Tu), Sec-tRNA<sup>Sec</sup> requires a dedicated factor, SelB.",
        "Several methods are currently available for the synthesis selenoproteins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29323455": [
        "Selenocysteine (SeC) is a naturally available Se-containing amino acid that displays splendid anticancer activities against several human tumors.",
        "Osteosarcoma represents the most common primary malignant bone tumor in children and adolescents, which shows severe resistance toward standard chemotherapy because of high invasive capacity and growing incidence.",
        "However, little information about SeC-induced growth inhibition against human osteosarcoma is available.",
        "SeC treatment also resulted in mitochondrial dysfunction through affecting Bcl-2 family expression.",
        "ROS inhibition effectively blocked SeC-induced cytotoxicity and p53 phosphorylation.",
        "Importantly, MG-63 human osteosarcoma xenograft growth in nude mice was significantly suppressed in vivo through triggering apoptosis and p53 phosphorylation.",
        "The results revealed that SeC significantly inhibited MG-63 human osteosarcoma cells growth in vitro through induction of S-phase arrest and apoptosis, as reflected by the decrease of cyclin A and CDK-2, PARP cleavage, and caspases activation.",
        "Herein, the anticancer efficiency and underlying mechanism of SeC against human osteosarcoma were evaluated in vitro and in vivo.",
        "Moreover, SeC triggered p53 phosphorylation by inducing reactive oxygen species (ROS) overproduction.",
        "These results indicated that SeC had the potential to inhibit human osteosarcoma cells growth in vitro and in vivo through triggering mitochondrial dysfunction and ROS-mediated p53 phosphorylation, which validated the potential application of Se-containing compounds in treatment of human osteosarcoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29972742": [
        "There is no known effective treatment for smallpox; therefore, tecovirimat is being developed as an oral smallpox therapy.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Smallpox was declared eradicated in 1980, but variola virus (VARV), which causes smallpox, still exists.",
        "Because clinical trials in a context of natural disease are not possible, an alternative developmental path to evaluate efficacy and safety was needed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29982575": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Tecovirimat (ST-246) is being developed as an antiviral therapeutic for smallpox for use in the event of an accidental or intentional release.",
        "The last reported case of smallpox was 1978 but the potential for use of variola virus for biowarfare has renewed interest in smallpox antiviral therapeutics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30120738": [
        "Tecovirimat was approved under the US FDA's Animal Rule, in which marketing approval is based on its efficacy in relevant animal models.",
        "Tecovirimat (TPOXX<sup>\u00ae</sup>) is an orthopoxvirus-specific antiviral drug developed by SIGA Technologies in conjunction with the US Department of Health and Human Services' Biomedical Advances Research and Development Authority.",
        "In July 2018, oral tecovirimat was approved in the USA for the treatment of human smallpox disease caused by variola virus in adults and paediatric patients weighing \u2265 13 kg.",
        "This article summarises the milestones in the development of tecovirimat leading to this first approval for the treatment of human smallpox disease in adults and paediatric patients weighing \u2265 13 kg.",
        "It acts by inhibiting the activity of the orthopoxvirus VP37 envelope wrapping protein, thereby preventing the formation of egress-competent enveloped virions, which are essential for dissemination of the virus in the host.",
        "An intravenous formulation of tecovirimat is undergoing phase I development for the treatment of smallpox infection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29773767": [
        "Current recommendations recognize the importance of oral antivirals and call for having at least two smallpox antivirals with different mechanisms of action available in the event of a smallpox outbreak.",
        "Given the devastating potential of smallpox as a bioweapon, preparation of a multi-pronged defense that accounts for the most obvious bioengineering possibilities is strategically imperative.",
        "Advances in synthetic biology heighten concerns that a bioterror attack with variola would utilize engineered resistance to antivirals and potentially vaccines.",
        "Multiple antivirals are recommended due in large part to the propensity of viruses to become resistant to antiviral therapy, especially monotherapy.",
        "Smallpox (variola) virus is considered a Category A bioterrorism agent due to its ability to spread rapidly and the high morbidity and mortality rates associated with infection.",
        "Brincidofovir, an oral antiviral in late stage development, has proven effective against orthopoxviruses in vitro and in vivo, has a different mechanism of action from tecovirimat (the only oral smallpox antiviral currently in the US Strategic National Stockpile), and has a resistance profile that reduces concerns in the scenario of a bioterror attack using genetically engineered smallpox."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25896687": [
        "In contrast, postexposure treatment with tecovirimat alone or in combination with ACAM2000 provided full protection.",
        "The therapeutic efficacies of smallpox vaccine ACAM2000 and antiviral tecovirimat given alone or in combination starting on day 3 postinfection were compared in a cynomolgus macaque model of lethal monkeypox virus infection.",
        "Additionally, tecovirimat treatment delayed until day 4, 5, or 6 postinfection was 83% (days 4 and 5) or 50% (day 6) effective.",
        "Postexposure administration of ACAM2000 alone did not provide any protection against severe monkeypox disease or mortality."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24100494": [
        "Agents Chemother., 51:689-695, 2007; E. Sbrana, R. Jordan, D. E. Hruby, R. I. Mateo, S. Y. Xiao, et al., Am.",
        "Med.",
        "Furthermore, in clinical trials thus far, the drug appears to be safe, with a good pharmacokinetic profile.",
        "Following challenge, 50% of placebo-treated controls succumbed to infection, while all tecovirimat-treated animals survived regardless of whether treatment was started at 2 or 4 days postinfection.",
        "79:13139-13149, 2005; D. C. Quenelle, R. M. Buller, S. Parker, K. A. Keith, D. E. Hruby, et al., Antimicrob.",
        "Naturally occurring smallpox has been eradicated but remains a considerable threat as a biowarfare/bioterrorist weapon (F. Fleck, Bull.",
        "World Health Organ.",
        "Tecovirimat has been shown to be efficacious in preventing lethal orthopoxviral disease in numerous animal models (G. Yang, D. C. Pevear, M. H. Davies, M. S. Collett, T. Bailey, et al., J. Virol.",
        "J. Trop.",
        "Currently, SIGA Technologies is developing the small-molecule oral drug, tecovirimat (previously known as ST-246), as a postexposure therapeutic treatment of orthopoxvirus disease, including smallpox.",
        "Tecovirimat appears to be an effective smallpox therapeutic in nonhuman primates, suggesting that it is reasonably likely to provide therapeutic benefit in smallpox-infected humans.",
        "In addition, tecovirimat treatment resulted in dramatic reductions in dermal lesion counts, oropharyngeal virus shedding, and viral DNA circulating in the blood.",
        "While effective, the smallpox vaccine is currently not recommended for routine use in the general public due to safety concerns (http://www.bt.cdc.gov/agent/smallpox/vaccination).",
        "81:917-918, 2003).",
        "76:768-773, 2007).",
        "In this study, the efficacy of tecovirimat was evaluated in both a prelesional and postlesional setting in nonhuman primates challenged intravenously with 1 \u00d7 10(8) PFU of Variola virus (VARV; the causative agent of smallpox), a model for smallpox disease in humans.",
        "Although clinical disease was evident in tecovirimat-treated animals, it was generally very mild and appeared to resolve earlier than in placebo-treated controls that survived infection.",
        "Safe and effective countermeasures, particularly those effective after exposure to smallpox, are needed.",
        "Hyg."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25827645": [
        "Patients were evaluated with the Hamilton Depression Rating Scale (HDRS) at baseline and weeks 2, 4 and 6.",
        "In conclusion, simvastatin seems to be a safe and effective adjuvant therapy for patients suffering from major depressive disorder.",
        "Statins have been shown to decrease depressive symptoms in certain groups of patients, an effect that is mostly attributed to their anti-inflammatory and neurotransmitter modulatory potentials.",
        "Simvastatin-treated patients experienced significantly more reductions in HDRS scores compared to the placebo group by the end of the trial (p=0.02).",
        "However, more confirmatory studies are warranted.",
        "Probable clinical and laboratory adverse events were also monitored and compared between the two groups.",
        "In this double-blind placebo-controlled clinical trial, 48 patients were randomly allocated to receive simvastatin or placebo as an adjunct to fluoxetine for six weeks.",
        "Early improvement and response rates were significantly greater in the simvastatin group than the placebo group (p=0.02 and p=0.01, respectively) but remission rate was not significantly different between the two groups (p=0.36).",
        "No serious adverse event was reported during this trial.",
        "We aimed to investigate the antidepressant effects of simvastatin as an adjuvant therapy in patients with moderate to severe depression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30281647": [
        "In this work, we tested the hypothesis that repeated exposure of wild type C57BL/6 mice to orally administered Pg results in neuroinflammation, neurodegeneration, microgliosis, astrogliosis and formation of intra- and extracellular amyloid plaque and neurofibrillary tangles (NFTs) which are pathognomonic signs of AD.",
        "However, neuropathology resulting from Pg oral application is not known.",
        "Further, studies using animal model of periodontitis and human post-mortem brain tissues from subjects with AD strongly suggest that a gram-negative periodontal pathogen, Porphyromonas gingivalis (Pg) and/or its product gingipain is/are translocated to the brain.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The results from cross sectional and longitudinal studies show that periodontitis is closely associated with cognitive impairment (CI) and Alzhemer's Disease (AD)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28800332": [
        "This study revealed that the hippocampal microvascular structure of P. gingivalis-infected ApoE-/- mice possesses elevated oxidative stress levels, resulting in the associated tight junction proteins being susceptible to increased oxidative/proteolytic degradation, leading to a loss of functional integrity.",
        "This study examined oxidative stress, in the form of increased protein carbonylation and oxidative protein damage, in the tumor necrosis factor-\u03b1 (TNF-\u03b1) transgenic mouse that models inflammatory TNF-\u03b1 excess during bacterial infection; and in the apolipoprotein knockout (ApoE-/-) mouse brains, following Porphyromonas gingivalis gingival monoinfection.",
        "Immunoblot analysis confirmed the presence of variable carbonyl content and oxidative protein damage in all lysates, with TNF-\u03b1 transgenic blots exhibiting increased protein carbonyl content, with consistently prominent bands at 25 kDa (p = 0.0001), 43 kDa, and 68 kDa, over wild-type mice.",
        "Compared to sham-infected ApoE-/- mouse blots, P. gingivalis-infected brain tissue blots demonstrated the greatest detectable protein carbonyl content overall, with numerous prominent bands at 25 kDa (p = 0.001) and 43 kDa (p = 0.0001) and an exclusive band to this group between 30-43 kDa* (p = 0.0001).",
        "The polymicrobial dysbiotic subgingival biofilm microbes associated with periodontal disease appear to contribute to developing pathologies in distal body sites, including the brain.",
        "Following 2,4-dinitrophenylhydrazine derivatization, carbonyl groups were detected in frontal lobe brain tissue lysates by immunoblotting and immunohistochemical analysis of fixed tissue sections from the frontotemporal lobe and the hippocampus.",
        "In addition, marked immunostaining was detected exclusively in the microvasculature in P. gingivalis-infected hippocampal tissue sections, compared to sham-infected, wild-type, and TNF-\u03b1 transgenic mice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29627873": [
        "Although several disease-modifying treatment (DMT) options exist for relapsing forms of this disease, DMT options are few for progressive MS (PPMS and SPMS).",
        "Although most MS patients have a relapsing-remitting course (RRMS) at disease onset, a substantial proportion later develop chronic progression, termed secondary progressive MS (SPMS).",
        "Approximately 10% of MS patients experience chronic progression from disease onset, termed primary progressive multiple sclerosis (PPMS).",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Multiple sclerosis (MS) is an immune-mediated disorder that affects the central nervous system (CNS), often first affecting people in early adulthood.",
        "Herein, we strive to define progressive MS, review major clinical trials aimed at progressive MS, and delineate potential strategies in the management of progressive MS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30157388": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      There are limited treatments for progressive multiple sclerosis.",
        "Ibudilast inhibits several cyclic nucleotide phosphodiesterases, macrophage migration inhibitory factor, and toll-like receptor 4 and can cross the blood-brain barrier, with potential salutary effects in progressive multiple sclerosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30255442": [
        "The treatment of both PPMS and SPMS, collectively referred to as progressive MS, has proven quite challenging due to the multifactorial and poorly understood pathophysiology of multiple sclerosis in general, specifically that of progressive disease.",
        "However, some patients initially present with primary progressive disease (PPMS) that is characterized by a gradual accumulation of neurological symptoms and subsequent disability accumulation.",
        "Specifically, the current evidence regarding treatment of progressive MS with ocrelizumab, simvastatin, ibudilast, alpha-lipoic acid, high-dose biotin, siponimod, and cell-based therapies are discussed.",
        "Despite the fact that majority of patients with multiple sclerosis (MS) have relapsing-remitting disease, many transition to secondary progressive disease (SPMS) over time.",
        "The purpose of this article is to discuss important clinical and pathophysiologic differences between relapsing and progressive forms of MS, review previous notable trials of drugs in progressive MS, examine current literature regarding recent and promising progressive MS treatments, and discuss future considerations for progressive MS therapeutics and management.",
        "This transition is thought to be related to neurodegenerative processes increasingly predominating over inflammatory processes as the driving forces of disability."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29779852": [
        "Based on our knowledge of pathophysiology, three therapeutic strategies are proposed: anti-inflammatory (ocrelizumab, siponimod\u2026); remyelinating (opicinumab); and neuroprotective (high-dose biotin, ibudilast, simvastatin\u2026).",
        "Nevertheless, despite recent promising positive clinical trials, new methodological approaches for therapeutic protocols with adaptable outcomes to assess progression are still needed.",
        "Management of progressive multiple sclerosis (MS) is one of the main challenges of the new century."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28258674": [
        "Ibudilast (IBD) is a non\u2011selective (3, 4, 10, 11) phosphodiesterase (PDE) inhibitor, used mainly as a bronchodilator for the treatment of bronchial asthma.",
        "The results from preclinical and clinical studies indicate that IBD has a broader range of action through suppression of pro\u2011inflammatory cytokines (IL\u20116, IL\u20111\u03b2, TNF\u2011\u03b1), toll\u2011like receptor 4 blockade (TLR\u20114), inhibition of a macrophage migration inhibitory factor (MIF), up\u2011regulation the anti\u2011inflammatory cytokine (IL\u201110), and promotion of neurotrophic factors (GDNF, NGF, NT\u20114).",
        "Current article provides an overview of the pharmacology of IBD with a focus on preclinical and clinical data supporting its potential neuroprotective benefits for neurological conditions, including multiple sclerosis, neuropathic pain, medication overuse headache, stroke, opioid, alcohol and methamphetamine abuse.",
        "PDE play a central role in cellular function (e.g. differentiation, synaptic plasticity and inflammatory response) by metabolizing cyclic nucleotides.",
        "Recent data indicate that the efficacy of IBD appears to be independent from PDE inhibition activity and rather linked to glial activity attenuation.",
        "Additional advantages of IBD, such as crossing the blood-brain barrier, good tolerance and activity by oral administration, makes it a promising therapeutic candidate for treating neuroinflammatory conditions, where the currently available treatment remains unsatisfying due to poor tolerability and/or sub\u2011optimal efficacy.",
        "IBD has no direct receptor affinity with exemption of some undefined effect on adenosine receptors that makes the drug devoid of its receptors\u2011mediated adverse effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27521810": [
        "Optimal biomarkers for phase II PMS trials is unknown.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Primary and secondary progressive multiple sclerosis (MS), collectively called progressive multiple sclerosis (PMS), is characterized by gradual progression of disability.",
        "The current anti-inflammatory treatments for MS have little or no efficacy in PMS in the absence of obvious active inflammation.",
        "The goals of SPRINT-MS study are to evaluate the safety and efficacy of ibudilast in PMS and to directly compare several imaging metrics for utility in PMS trials.",
        "Ibudilast is an inhibitor of macrophage migration inhibitor factor and phosphodiesterases-4 and -10 and exhibits possible neuroprotective properties."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27501293": [
        "It has been found to have anti-inflammatory and neuroprotective properties in animal studies and in-vitro studies; it is currently being studied in progressive MS.",
        "Clinically, this is manifest as relapsing and remitting neurological symptoms and progressive accumulation of disability.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS) characterized by inflammatory demyelination and progressive axonal loss.",
        "Ibudilast is a nonselective phosphodiesterase inhibitor which works by blocking the cleavage of cyclic adenosine monophosphate (cAMP)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26586303": [
        "2.",
        "Unchanged GSK2140944 was the predominant circulating component (&gt;60% DRM), with the main circulating metabolite M4 formed by oxidation of the triazaacenaphthylene moiety representing 10.8% (considered major) and 8.6% drug-related material by the oral and i.v. route, respectively.",
        "Urinary elimination (59%) was major by the i.v. route, whereas fecal elimination (53%) pre-dominated via the oral route.",
        "Six male subjects received [(14)C] GSK2140944 orally (2000 mg) and as a single 2-hour i.v. infusion (1000 mg).",
        "Approximately 50% of the oral dose was absorbed and eliminated mainly as unchanged GSK2140944 in urine (\u223c20% of dose).",
        "The metabolism and disposition in healthy human subjects was investigated.",
        "This study demonstrates the use of AMS to overcome radioprofiling challenges presented by low specific activity resulted from high doses administration.",
        "1.",
        "3.",
        "Elimination via metabolism (\u223c13% of dose) was relatively minor.",
        "GSK2140944 is a novel bacterial topoisomerase inhibitor in development for the treatment of bacterial infections.",
        "The facile oxidation of GSK2140944 to metabolite M4 was believed to be a result of activation by adjacent electron withdrawing groups.",
        "Accelerator mass spectrometry (AMS) was used for the analysis of plasma and bile samples due to the low level of radioactivity in samples (low specific activity of the doses)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30286773": [
        "Our browser provides multiple methods linking distal cis-regulatory elements with their potential target genes.",
        "Here, we introduce the 3D Genome Browser, http://3dgenome.org , which allows users to conveniently explore both their own and over 300 publicly available chromatin interaction data of different types.",
        "We design a new binary data format for Hi-C data that reduces the file size by at least a magnitude and allows users to visualize chromatin interactions over millions of base pairs within seconds.",
        "Users can seamlessly integrate thousands of other omics data to gain a comprehensive view of both regulatory landscape and 3D genome structure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25990738": [
        "We also illustrate the usefulness of our 3D genome Web browser to explore human genome structures.",
        "We introduce simultaneously a database system to store and query 3D genomic data (3DBG), and a 3D genome browser to visualize and explore 3D genome structures (3DGB).",
        "Nonetheless, the storage technology and visualization tools need to evolve to offer to the scientific community fast and convenient access to these data.",
        "The 3D genome browser is available at http://3dgb.cs.mcgill.ca/.",
        "Recent releases of genome three-dimensional (3D) structures have the potential to transform our understanding of genomes.",
        "We benchmark 3DBG against state-of-the-art systems and demonstrate that it is faster than previous solutions, and importantly gracefully scales with the size of data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28842640": [
        "This study underlines the potential role of an inter-omics approach in understanding the metabolic pathways involved in IBD.",
        "The composition of gut microbiota may change in IBD affected individuals, but whether dysbiosis is the cause or the consequence of inflammatory processes in the intestinal tissue is still unclear.",
        "At genus level Escherichia, Faecalibacterium, Streptococcus, Sutterella and Veillonella were increased, whereas Bacteroides, Flavobacterium, and Oscillospira decreased.",
        "The combined evaluation of metabolites and fecal microbiome can be useful to discriminate between healthy subjects and patients with IBD.",
        "The metabolites content and the microbiological profiles were significantly different between IBD and healthy subjects.",
        "In the IBD group, Firmicutes, Proteobacteria, Verrucomicrobia, and Fusobacteria were significantly increased, whereas Bacteroidetes and Cyanobacteria were decreased.",
        "Here, the composition of the microbiota and the metabolites in stool of 183 subjects (82 UC, 50 CD, and 51 healthy controls) were determined.",
        "Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract of uncertain origin, which includes ulcerative colitis (UC) and Crohn's disease (CD).",
        "Various metabolites including biogenic amines, amino acids, lipids, were significantly increased in IBD, while others, such as two B group vitamins, were decreased in IBD compared to healthy subjects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26574491": [
        "<strong class=\"sub-title\">\n          Background and aims:\n        </strong>\n      \n      Gut microbiota is involved in many physiological functions and its imbalance is associated with several diseases, particularly with inflammatory bowel diseases.",
        "Mucosa-associated microbiota could have a key role in induction of host immunity and in inflammatory process.",
        "Although the role of fungi has been suggested in inflammatory disease pathogenesis, the fungal microbiota has not yet been deeply explored.",
        "Here we analysed the bacterial and fungal composition of the mucosa-associated microbiota of Crohn's disease patients and healthy subjects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26764594": [
        "Chronic inflammatory disorders are thought to arise due to an interplay between predisposing host genetics and environmental factors.",
        "These events drive permanent alterations in anti-commensal immunity, microbiota composition, and chronic inflammation, which persist long after Yersinia clearence.",
        "Examining that model further, we uncovered an altered cellular immune response that promotes the recruitment of neutrophils which in turn increases metabolism of the respiratory electron acceptor tetrathionate by Yersinia.",
        "For example, the onset of inflammatory bowel disease is associated with enteric proteobacterial infection, yet the mechanistic basis for this association is unclear.",
        "We have shown previously that genetic defiency in TLR1 promotes acute enteric infection by the proteobacteria Yersinia enterocolitica.",
        "Deletion of the bacterial genes involved in tetrathionate respiration or treatment using targeted probiotics could prevent microbiota alterations and inflammation.",
        "Thus, acute infection can drive long term immune and microbiota alterations leading to chronic inflammatory disease in genetically predisposed individuals."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26749064": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To compare colonic microbial composition in systemic sclerosis (SSc) patients and healthy controls and to determine whether certain microbial genera are associated with gastrointestinal (GI) tract symptoms in patients with SSc."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24668769": [
        "<strong class=\"sub-title\">\n          Scope:\n        </strong>\n      \n      Ulcerative colitis (UC) is a chronic inflammatory disease of the colon. \u03b1-Mangostin (\u03b1-MG), the most abundant xanthone in mangosteen fruit, exerts anti-inflammatory and antibacterial activities in vitro.",
        "We evaluated the impact of dietary \u03b1-MG on murine experimental colitis and on the gut microbiota of healthy mice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25018784": [
        "The foremost aim of this study is to consider and compare the gut microbiota composition in patients suffering from different stages of UC.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The healthy human intestine is represented by the presence of bacterial communities predominantly belonging to obligate anaerobes; however disparity and dysanaerobiosis in intestinal microflora may lead to the progression of ulcerative colitis (UC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29328005": [
        "The patient was treated with various regimens of antiepileptic medications for 16 months, but the seizures remained medically intractable.",
        "Magnetic resonance imaging and video-electroencephalography monitoring revealed a primarily intraventricular hypothalamic hamartoma and gelastic seizures occurring 20-30 times daily.",
        "There were no perioperative complications, and 2 years postprocedure, the patient remains seizure free with marked behavioral and cognitive improvements.",
        "At 3 years of age, he underwent stereotactic laser ablation with an aim of disconnection of the lesion.",
        "The procedure was performed with the NeuroBlate SideFire probe.",
        "The authors describe the case of a 22-month-old boy who presented with gelastic seizures and developmental delay.",
        "To the authors' knowledge, this is the first reported use of this technology for this procedure and serves as proof of concept."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27838155": [
        "The authors perform a systematic analysis of two commercially available MRgLITT systems used in neurosurgery: the Visualase\u00ae thermal therapy and NeuroBlate\u00ae Systems.",
        "Data extraction was performed in a blinded fashion.",
        "Laser neurosurgery has evolved over recent decades.",
        "A total of 223 patients were identified with the majority having undergone treatment with Visualase (n=154, 69%).",
        "Twenty-two articles were included in the quantitative synthesis.",
        "Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) is a novel minimally invasive modality that uses heat from laser probes to destroy tissue.",
        "Epilepsy was the most common indication for Visualase therapy (n=8 studies, 47%).",
        "Head-to-head comparison of these systems was difficult given the variance in indications (and therefore patient population) and disparate literature.",
        "Brain mass was the most common indication for NeuroBlate therapy (n=3 studies, 60%).",
        "There were no significant differences, except in age, wherein the NeuroBlate group was nearly twice as old as the Visualase group (p&lt;0.001).",
        "Clinical indications are currently being defined and will continue to emerge as laser technologies become more sophisticated.",
        "Frame, total complications, and length-of-stay (LOS) were non-significant when adjusted for age and number of patients.",
        "Advances in probe design, cooling mechanisms, and real-time MR thermography have increased laser utilization in neurosurgery."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28188403": [
        "We report the published clinical experiences with SLT in epilepsy surgery (altogether approximately 200 cases) with respect to complications, brain structural alterations, seizure outcome, neuropsychological findings and treatment costs.",
        "We describe the history and rationale of laser neurosurgery as well as the two available SLT systems (Visualase\u00ae and NeuroBlate\u00ae; CE marks pending).",
        "Both systems are coupled with magnetic resonance imaging (MRI) and MR thermometry, thereby increasing patient safety.",
        "In common with other stereotactic procedures, stereotactic laser thermocoagulation (SLT) promises gentle destruction of pathological tissue, which might become especially relevant for epilepsy surgery in the future.",
        "Compared to standard resection, no large craniotomy is necessary, cortical damage during access to deep-seated lesions can be avoided and interventions close to eloquent brain areas become possible.",
        "Due to the inadequate quality of studies, the neuropsychological superiority of SLT has not yet been unambiguously demonstrated.",
        "The rate of seizure-free patients seems to be slightly lower than for resection surgery."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28348940": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      We describe the feasibility of using minimally invasive robotic laser interstitial thermotherapy (LITT) for achieving an anterior two-thirds as well as a complete corpus callosotomy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28411414": [
        "Damage to cortical areas when accessing deep lesions can be minimized or completely avoided, and treating epileptogenic foci near eloquent or even vital brain areas becomes possible.",
        "Overall, the seizure outcome appears to be slightly worse than for resective surgery.",
        "Also, the cost-benefit ratio requires further critical evaluation.",
        "Due to insufficient research methods (e.g. non-established measures, lack of a control condition), the expected neuropsychological superiority over resective surgery has not been unambiguously demonstrated thus far.",
        "Besides other innovative stereotactic procedures (radiofrequency thermocoagulation, focused ultrasound, gamma knife) laser interstitial thermotherapy (LiTT) provides minimally invasive destruction of pathological soft tissues which could be especially relevant for epilepsy surgeries involving adult and pediatric patients.",
        "We also discuss the published clinical experience with LiTT in the field of epilepsy surgery (approximately 200 cases) with regard to complications, LiTT-induced, long-term brain structural alterations, seizure outcome, preliminary neuropsychological findings and first estimates of treatment costs.",
        "Clinical, multi-center and adequately controlled outcome studies of high quality should also accompany the imminent introduction of LiTT into the field of epilepsy surgery and therewith permit critical scientific evaluation and rational, individual, clinical decisions.",
        "Here, we briefly describe the history and rationale of laser neurosurgery as well as the technical key features of the two currently available systems for magnetic resonance-guided LiTT (Visualase<sup>\u00ae</sup>, NeuroBlate<sup>\u00ae</sup>; CE marks pending for both).",
        "Unlike standard resections, no craniotomy is required; just a tiny borehole trepanation is sufficient."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24810945": [
        "The extent of thermal damage was determined using thermal damage threshold (TDT) lines: yellow TDT line (43 \u00b0C for 2 min) and blue TDT line (43\u00b0C for 10 min).",
        "Volumetric analysis was performed to determine the extent-of-coverage of tumor volume by TDT lines.",
        "The median overall survival (OS) for the cohort was not reached; however, the 1-year estimate of OS was 68 \u00b1 9%.",
        "We report our multicenter results of laser interstitial thermal therapy (LITT) in DTA-HGGs.",
        "Median progression-free survival (PFS) was 5.1 months.",
        "Controlled thermal damage to the tumor may have the same impact in DTA-HGGs.",
        "LITT can be used effectively for treatment of DTA-HGGs.",
        "Patient outcomes were evaluated statistically.",
        "We retrospectively reviewed 34 consecutive DTA-HGG patients (24 glioblastoma, 10 anaplastic) who underwent LITT at Cleveland Clinic, Washington University, and Wake Forest University (May 2011-December 2012) using the NeuroBlate(\u00ae) System.",
        "More complete coverage of tumor by TDT lines improves PFS which can be translated as the extent of resection concept for surgery.",
        "Thirteen cases who met the following two criteria-(1) &lt;0.05 cm(3) tumor volume not covered by the yellow TDT line and (2) &lt;1.5 cm(3) additional tumor volume not covered by the blue TDT line-had better PFS than the other 21 cases (9.7 vs. 4.6 months; P = 0.02).",
        "After 7.2 months of follow-up, 71% of cases demonstrated progression and 34% died.",
        "Surgical extent-of-resection has been shown to have an impact on high-grade glioma (HGG) outcomes; however, complete resection is rarely achievable in difficult-to-access (DTA) tumors.",
        "LITT was delivered as upfront in 19 and delivered as salvage in 16 cases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24471476": [
        "However complete, curative, resection is not achievable in many tumors leading to the need for adjuvant chemotherapy and radiation therapy.",
        "LITT can be considered as an alternative type of surgery for difficult to access brain tumors and also for tumors in patients who are deemed high risk for more traditional surgery.",
        "Laser interstitial thermal therapy (LITT) is a minimally invasive cytoreductive treatment.",
        "A low voltage laser is used to induce hyperthermia and to kill tumor cells.",
        "Cytoreductive surgery is used as the first line treatment for most brain tumors.",
        "Treatment of brain tumors remains challenging.",
        "The extent of thermal damage is controlled through use of real-time MR-thermography guidance.",
        "Initial results have shown the feasibility of LITT for a variety of brain pathologies.",
        "Randomized trials are currently planned to continue assessing the efficacy of LITT and long-term follow-up data are awaited."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23560574": [
        "The NeuroBlate System incorporates several technological advances to overcome these drawbacks.",
        "<strong class=\"sub-title\">\n          Object:\n        </strong>\n      \n      Laser interstitial thermal therapy has been used as an ablative treatment for glioma; however, its development was limited due to technical issues.",
        "The authors report a Phase I, thermal dose-escalation trial assessing the safety and efficacy of NeuroBlate in recurrent glioblastoma multiforme (rGBM)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27569544": [
        "Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases.",
        "Overall, Genomiser is able to identify causal regulatory variants as the top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",
        "The interpretation of non-coding variants still constitutes a major challenge in the application of whole-genome sequencing in Mendelian disease, especially for single-nucleotide and other small non-coding variants.",
        "Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to discover variants associated to specific Mendelian disorders."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29456181": [
        "Despite their involvement in human cancer, the physiological role of T-UCEs is still unknown.",
        "Altogether, our findings provide unprecedented evidence that T-UCEs regulate physiological cellular functions and point to an essential role of T-UCstem1 in preserving ESC identity.",
        "Here, we identify a lncRNA containing the uc.170+, named T-UCstem1, and provide in vitro and in vivo evidence that it plays essential roles in embryonic stem cells (ESCs) by modulating cytoplasmic miRNA levels and preserving transcriptional dynamics.",
        "Most of them are transcribed and represent a new family of long non-coding RNAs (lncRNAs), the transcribed UCEs (T-UCEs).",
        "Specifically, while T-UCstem1::miR-9 cytoplasmic interplay regulates ESC proliferation by reducing miR-9 levels, nuclear T-UCstem1 maintains ESC self-renewal and transcriptional identity by stabilizing polycomb repressive complex 2 on bivalent domains.",
        "Ultraconserved elements (UCEs) show the peculiar feature to retain extended perfect sequence identity among human, mouse, and rat genomes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30379987": [
        "We also show the correlation for raw read counts reported by TPMCalculator, HTSeq and featureCounts.",
        "The program describes the genomic features through a model generated from the gene transfer format file used during alignments reporting of the TPM values and the raw read counts for each feature.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      The quantification of RNA sequencing (RNA-seq) abundance using a normalization method that calculates transcripts per million (TPM) is a key step to compare multiple samples from different experiments.",
        "TPMCalculator is a one-step software to process RNA-seq alignments in BAM format and reports TPM values, raw read counts and feature lengths for genes, transcripts, exons and introns.",
        "In this paper, we show the correlation for 1256 samples from the TCGA-BRCA project between TPM and FPKM reported by TPMCalculator and RSeQC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30461311": [
        "<b><i>Background:</i></b> Escobar syndrome, a nonlethal variant of multiple pterygium syndromes (MPS), is a rare autosomal recessive disorder characterized by pterygia and multiple joint contractures along with other anomalies.",
        "Variants in cholinergic receptor nicotinic gamma subunit (<i>CHRNG</i>) have been previously reported in patients with Escobar syndrome. <b><i>Objective:</i></b> We studied a consanguineous Pakistani family affected with Escobar syndrome to identify the underlying genetic defect through short tandem repeat (STR) genotyping and direct DNA sequencing. <b><i>Results:</i></b> Genotyping with microsatellite markers (D2S427, D2S2344, and D2S206) revealed linkage of the disease phenotype in the family to the <i>CHRNG</i> locus.",
        "The unaffected parents and siblings in the family were heterozygous carriers of this disease-causing variant. <b><i>Conclusion:</i></b> We report the identification of a nonsense <i>CHRNG</i> variant in a consanguineous Pakistani family affected with Escobar syndrome.",
        "Using Sanger sequencing, we identified a homozygous nonsense <i>CHRNG</i> variant c.136C&gt;T (p.R46*), predicted to produce a truncated protein that leads to acetylcholine receptor deficiency, causing MPS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27902173": [
        "It is generally characterized by multiple pterygia that are found in the cervical, antecubital and popliteal regions.",
        "In this report, we present the treatment management of a 14-year-old case with late stage Escobar syndrome who was admitted due to multiple pterygia and bilateral knee contractures.",
        "The treatment of the case was done in three stages: soft tissue procedures, femoral recurvatum osteotomy and triple arthrodesis, respectively.",
        "In addition to all these, the patient did intensive physical therapy for one year.",
        "As a result of the operations and physical therapy, adequate muscle strength was obtained.",
        "Escobar (multiple pterygium) syndrome is progressive and a very rare syndrome.",
        "The treatment of this case was conducted in collaboration with the department of orthopedics and the department of physical therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25411939": [
        "We report orthopaedic manifestation and the treatment outcome of two siblings with Escobar syndrome caused by homozygous mutations of the CHRNG gene.",
        "Escobar syndrome is a nonlethal subtype of multiple pterygium syndromes, characterized by webbing across the joints, congenital joint contracture, facial dysmorphism and a variety of other congenital anomalies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25219146": [
        "The Escobar variant of multiple pterygium syndrome (MPS) is a rare, autosomal recessive disorder which may lead to many serious or even lethal fetal abnormalities.",
        "Parental and maternal genetic examinations were performed and allowed for early prenatal diagnostics in the next pregnancy resulting in the birth of a healthy newborn.",
        "Other symptoms of the disease were found during the second trimester of pregnancy using ultrasonography examination.",
        "MPS is characterized by pterygia, arthrogryposis (joint contractures), and intrauterine growth restriction (IUGR).",
        "In the case described below, increased fetal nuchal translucency was the first abnormality diagnosed already in the first trimester of pregnancy.",
        "Also, genetic amniocentesis revealed no genetic disorders and the Escobar syndrome was diagnosed post mortem."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24472885": [
        "The clinical presentation of nonlethal Escobar, as well as diagnosis and treatment strategies, is provided with caregiving strategies.",
        "The etiologies from maternal causes were excluded prior to birth.",
        "The diagnosis was confirmed by a positive CHRNG gene sequence analysis after discharge.",
        "It is usually diagnosed in utero on fetal ultrasound and then confirmed in the neonatal period.",
        "Subsequent workup after birth led to a highly suspected diagnosis of nonlethal Escobar by the geneticist.",
        "The infant demonstrated contractures and bilateral hip subluxation but was feeding well and was discharged home with outpatient follow-up.",
        "Treatment after discharge has been extensive secondary to difficulties associated with this disease.",
        "It is a form of arthrogryposis multiplex congenita characterized by excessive webbing (pterygia), congenital contractures (arthrogryposis), and scoliosis.",
        "Nonlethal Escobar is a rare disorder that is a variant of multiple pterygium syndromes.",
        "A case of nonlethal neonatal Escobar is reported in a 35-week-and-6-day old infant who presented in utero with decreased fetal movement, oligohydramnios, and arthrogryposis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25365855": [
        "We describe an 8-days-old male newborn from consanguineous parents with ES who also presented heterotaxia syndrome and esophageal atresia, anomalies that not have been previously reported as associated to ES.",
        "Escobar syndrome (ES) or multiple pterygia syndrome (MIM#265000) is an infrequent condition characterized by facial dysmorphism, multiple webbing (pterygia), congenital contractures (arthrogryposis) and other internal anomalies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25196531": [
        "After a 3-month follow-up, she reported having normal menstrual bleeding intervals each month without any complications.",
        "Patients with Escobar syndrome may suffer from abdominal pain due to imperforate hymen.",
        "Careful evaluation of these patients must include a complete gynaecological assessment and, if indicated, surgical treatment must be performed without delay.",
        "We present a 15-year-old patient with Escobar syndrome who complained of persistent blunt abdominal pain for 1 year.",
        "Escobar syndrome is characterized with multiple pterygia or webs of the skin and multiple congenital anomalies.",
        "The patient's postoperative course was uneventful and her complaints resolved completely.",
        "Preoperative evaluation confirmed the diagnosis of imperforate hymen, and the patient underwent hymenectomy under intravenous sedation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26401871": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      RNA activation (RNAa) is a mechanism of gene activation triggered by promoter-targeted small double stranded RNAs (dsRNAs), also known as small activating RNAs (saRNAs).",
        "Myogenic regulatory factor MyoD is regarded as the master activator of myogenic differentiation cascade by binding to enhancer of muscle specific genes.",
        "It is thus expected that by promoting differentiation of adipose-derived stem cells (ADSCs) into myoblasts by activating MyoD gene through RNAa may offer benefits to SUI.",
        "Stress urinary incontinence (SUI) is a condition primarily resulted from urethral sphincter deficiency."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29266015": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Hypomethylating agents (HMAs) are the standard of care for patients with myelodysplastic syndromes (MDS).",
        "The purpose of this review is to provide an overview of the different therapies under development for MDS after HMA therapy.",
        "Although these agents induce responses in up to 40% of patients, most patients ultimately experience loss of response."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29670690": [
        "Preliminary data from phase 1 clinical trials enrolling patients with cancers harboring an IDH1 mutation indicate that AG-120 has an acceptable safety profile and clinical activity.",
        "IDH1 mutations have been described in an array of hematologic malignancies and solid tumors.",
        "Somatic point mutations at a key arginine residue (R132) within the active site of the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) confer a novel gain of function in cancer cells, resulting in the production of d-2-hydroxyglutarate (2-HG), an oncometabolite.",
        "Elevated 2-HG levels are implicated in epigenetic alterations and impaired cellular differentiation.",
        "Here, we report the discovery of AG-120 (ivosidenib), an inhibitor of the IDH1 mutant enzyme that exhibits profound 2-HG lowering in tumor models and the ability to effect differentiation of primary patient AML samples ex vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29934313": [
        "The drug spurred complete remission or complete remission with partial hematologic recovery in 30.4% of patients.",
        "The most common side effects of at least grade 3 were prolonged QT interval and IDH differentiation syndrome.",
        "A phase I study suggests that ivosidenib can induce remission in patients with relapsed or refractory acute myeloid leukemia characterized by <i>IDH1</i> mutations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29860938": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Mutations in the gene encoding isocitrate dehydrogenase 1 ( IDH1) occur in 6 to 10% of patients with acute myeloid leukemia (AML).",
        "Ivosidenib (AG-120) is an oral, targeted, small-molecule inhibitor of mutant IDH1."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29950729": [
        "Here we describe two patients with IDH2-mutant AML who had a clinical response to enasidenib followed by clinical resistance, disease progression, and a recurrent increase in circulating levels of 2HG.",
        "Somatic mutations in the isocitrate dehydrogenase 2 gene (IDH2) contribute to the pathogenesis of acute myeloid leukaemia (AML) through the production of the oncometabolite 2-hydroxyglutarate (2HG)<sup>1-8</sup>.",
        "The expression of either of these mutant disease alleles alone did not induce the production of 2HG; however, the expression of the Q316E or I319M mutation together with the R140Q mutation in trans allowed 2HG production that was resistant to inhibition by enasidenib.",
        "The in trans mutations occurred at glutamine 316 (Q316E) and isoleucine 319 (I319M), which are at the interface where enasidenib binds to the IDH2 dimer.",
        "Our observations uncover a mechanism of acquired resistance to a targeted therapy and underscore the importance of 2HG production in the pathogenesis of IDH-mutant malignancies.",
        "We show that therapeutic resistance is associated with the emergence of second-site IDH2 mutations in trans, such that the resistance mutations occurred in the IDH2 allele without the neomorphic R140Q mutation.",
        "Biochemical studies predicted that resistance to allosteric IDH inhibitors could also occur via IDH dimer-interface mutations in cis, which was confirmed in a patient with acquired resistance to the IDH1 inhibitor ivosidenib (AG-120).",
        "Enasidenib (AG-221) is an allosteric inhibitor that binds to the IDH2 dimer interface and blocks the production of 2HG by IDH2 mutants<sup>9,10</sup>.",
        "In a phase I/II clinical trial, enasidenib inhibited the production of 2HG and induced clinical responses in relapsed or refractory IDH2-mutant AML<sup>11</sup>."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30093505": [
        "The approval was based on results of a phase I trial in which 32.8% of patients treated with the drug had a complete remission or a complete remission with a partial hematologic recovery.",
        "The FDA approved ivosidenib for patients with <i>IDH1</i>-mutant relapsed/refractory acute myeloid leukemia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25559105": [
        "The method is a fast and sensitive alternative to DNase-seq for assaying chromatin accessibility genome-wide, or to MNase-seq for assaying nucleosome positions in accessible regions of the genome.",
        "This method probes DNA accessibility with hyperactive Tn5 transposase, which inserts sequencing adapters into accessible regions of chromatin.",
        "This unit describes Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq), a method for mapping chromatin accessibility genome-wide.",
        "Sequencing reads can then be used to infer regions of increased accessibility, as well as to map regions of transcription-factor binding and nucleosome position."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29155775": [
        "This information serves as an unbiased approach for discovering the network of relevant transcription factors and mechanisms of chromatin structure that govern gene expression programs.",
        "These regions represent regulatory DNA elements (e.g., promoters, enhancers, locus control regions, insulators) to which transcription factors bind.",
        "Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) is a method used for the identification of open (accessible) regions of chromatin.",
        "Moreover, to save time and money, we introduced quality control measures to assess the ATAC-seq library prior to sequencing.",
        "These guidelines will also be useful for laboratories which are not proficient with next-generation sequencing methods.",
        "Importantly, the principles presented in this protocol allow its adaptation to other human immune and non-immune primary cells and cell lines.",
        "This comprehensive protocol begins with cell harvest, then describes the molecular procedure of chromatin tagmentation, sample preparation for next-generation sequencing, and also includes methods and considerations for the computational analyses used to interpret the results.",
        "Mapping the accessible chromatin landscape is a powerful approach for uncovering active regulatory elements across the genome.",
        "We present a detailed ATAC-seq protocol optimized for human primary immune cells i.e. CD4+ lymphocytes (T helper 1 (Th1) and Th2 cells).",
        "ATAC-seq is a robust and sensitive alternative to DNase I hypersensitivity analysis coupled with next-generation sequencing (DNase-seq) and formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) for genome-wide analysis of chromatin accessibility and to the sequencing of micrococcal nuclease-sensitive sites (MNase-seq) to determine nucleosome positioning."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25679813": [
        "Genomic enhancers regulate spatio-temporal gene expression by recruiting specific combinations of transcription factors (TFs).",
        "Additionally we tested if the predicted Stat92E responsive regulatory regions are genuine, using ectopic induction of JAK/STAT signaling in developing eye discs, and observed that similar chromatin changes indeed occurred.",
        "When TFs are bound to active regulatory regions, they displace canonical nucleosomes, making these regions biochemically detectable as nucleosome-depleted regions or accessible/open chromatin.",
        "In conclusion, we show that FAIRE-seq and ATAC-seq based open chromatin profiling, combined with motif discovery, is a straightforward approach to identify functional genomic regulatory regions, master regulators, and gene regulatory networks controlling complex in vivo processes.",
        "We validated the importance of Stat92E in the development of the tumors by introducing a loss of function Stat92E mutant, which was sufficient to rescue the tumor phenotype.",
        "Using both techniques, we screened for regulatory regions that become ectopically active during Ras-dependent oncogenesis, and identified 3778 regions that become (over-)activated during tumor development.",
        "Here we ask whether open chromatin profiling can be used to identify the entire repertoire of active promoters and enhancers underlying tissue-specific gene expression during normal development and oncogenesis in vivo.",
        "Next, we applied motif discovery to search for candidate transcription factors that could bind these regions and identified AP-1 and Stat92E as key regulators.",
        "Finally, we determine that these are functionally significant regulatory changes, as nearby target genes are up- or down-regulated.",
        "To this end, we first compare two different approaches to detect open chromatin in vivo using the Drosophila eye primordium as a model system: FAIRE-seq, based on physical separation of open versus closed chromatin; and ATAC-seq, based on preferential integration of a transposon into open chromatin.",
        "We find that both methods reproducibly capture the tissue-specific chromatin activity of regulatory regions, including promoters, enhancers, and insulators."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30375457": [
        "However, on average, ~35% of open chromatin regions (OCRs) from ATAC-seq samples map to enhancers.",
        "Finally, PEAS inferred individual-specific enhancers from 19 islet ATAC-seq samples and revealed variability in enhancer activity across individuals, including those driven by genetic differences.",
        "Assay for Transposase Accessible Chromatin (ATAC-seq) technology can interrogate chromatin accessibility from small cell numbers and facilitate studying enhancers in pathologies.",
        "PEAS recapitulated ChromHMM-defined enhancers in CD14+ monocytes, CD4+ T cells, GM12878, peripheral blood mononuclear cells, and pancreatic islets.",
        "PEAS models trained on these 5 cell types effectively predicted enhancers in four cell types that are not used in model training (EndoC-\u03b2H1, na\u00efve CD8+ T, MCF7, and K562 cells).",
        "Enhancers are cis-acting sequences that regulate transcription rates of their target genes in a cell-specific manner and harbor disease-associated sequence variants in cognate cell types.",
        "PEAS is an easy-to-use tool developed to study enhancers in pathologies by taking advantage of the increasing number of clinical epigenomes.",
        "Many complex diseases are associated with enhancer malfunction, necessitating the discovery and study of enhancers from clinical samples.",
        "We developed a neural network-based model, Predicting Enhancers from ATAC-Seq data (PEAS), to effectively infer enhancers from clinical ATAC-seq samples by extracting ATAC-seq data features and integrating these with sequence-related features (e.g., GC ratio)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30421411": [
        "A laboratory protocol is presented for these methods as well as examples of typical results and visualizations.",
        "Combining ATAC-Seq with RNA Sequencing (RNA-Seq) is a rapid approach for studying the relationship between genome structure and changes in global patterns of gene expression from a single experiment.",
        "Assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-Seq) is a powerful technique for identifying nucleosome-free regions of the genome.",
        "This chapter describes sequencing-based methods for profiling dynamic changes in DNA accessibility and gene expression in Saccharomyces cerevisiae."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29605854": [
        "Recently a new technique coupled with high-throughput sequencing named Assay for Transposase Accessible Chromatin (ATAC-seq) emerged as an efficient method to chart open chromatin genome wide.",
        "Such mechanisms rely largely on noncoding regulatory sequences that allow the establishment and maintenance of cell identity and tissue-specific cellular functions.The study of chromatin structure and nucleosome positioning allowed revealing transcription factor accessible genomic sites with regulatory potential, facilitating the comprehension of tissue-specific cis-regulatory networks.",
        "The application of such technique to different cell types allowed unmasking tissue-specific regulatory elements and characterizing cis-regulatory networks.",
        "The regulatory mechanisms that ensure an accurate control of gene transcription are central to cellular function, development and disease.",
        "Herein we describe the implementation of the ATAC-seq method to human pancreatic islets, a tissue playing a central role in the control of glucose metabolism."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29052193": [
        "In this chapter, we describe an approach to map accessible chromatin features in plants using the Assay for Transposase-Accessible Chromatin, combined with high-throughput sequencing (ATAC-seq), which was originally developed for cultured animal cells.",
        "The application of ATAC-seq to plant tissue has been challenging due to the difficulty of isolating nuclei sufficiently free of interfering organellar DNA.",
        "We provide detailed instructions for transposase treatment of nuclei isolated using either approach, as well as subsequent preparation of ATAC-seq libraries.",
        "The procedures described here are optimized for Arabidopsis thaliana but can also be applied to other plant species.",
        "Identifying and characterizing highly accessible chromatin regions assists in determining the location of genomic regulatory elements and understanding transcriptional regulation.",
        "Sequencing-ready ATAC-seq libraries can be prepared from plant tissue in as little as one day.",
        "Here we present two different approaches to purify plant nuclei for ATAC-seq: the INTACT method (Isolation of Nuclei TAgged in specific Cell Types) to isolate nuclei from individual cell types of the plant, and tissue lysis followed by sucrose sedimentation to isolate sufficiently pure total nuclei.",
        "This technique utilizes a hyperactive Tn5 transposase to cause DNA cleavage and simultaneous insertion of sequencing adapters into open chromatin regions of the input nuclei."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28846090": [
        "We present Omni-ATAC, an improved ATAC-seq protocol for chromatin accessibility profiling that works across multiple applications with substantial improvement of signal-to-background ratio and information content.",
        "The Omni-ATAC protocol enables the interrogation of personal regulomes in tissue context and translational studies.",
        "The Omni-ATAC protocol generates chromatin accessibility profiles from archival frozen tissue samples and 50-\u03bcm sections, revealing the activities of disease-associated DNA elements in distinct human brain structures."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28550296": [
        "Both treatments resulted in considerable reduction of mitochondrial reads (1.7 and 3-fold, respectively).",
        "As the regions of open chromatin of interest are usually located in the nuclear genome, mitochondrial reads are typically discarded from the analysis.",
        "The highest number of peaks and highest quality data was obtained by preparing samples with the original ATAC-seq protocol (using detergent) and treating them with CRISPR.",
        "This strategy reduced the amount of sequencing required to call a high number of peaks, which could lead to cost reduction when performing ATAC-seq on large numbers of samples and in cell types that contain a large amount of mitochondria.",
        "We tested two approaches to decrease wasted sequencing in ATAC-seq libraries generated from lymphoblastoid cell lines: targeted cleavage of mitochondrial DNA fragments using CRISPR technology and removal of detergent from the cell lysis buffer.",
        "ATAC-seq is a high-throughput sequencing technique that identifies open chromatin.",
        "Depending on the cell type, ATAC-seq samples may contain ~20-80% of mitochondrial sequencing reads.",
        "We analyzed the effects of these treatments on the number of usable (unique, non-mitochondrial) reads and the number and quality of peaks called, including peaks identified in enhancers and transcription start sites.",
        "The removal of detergent, however, resulted in increased background and fewer peaks."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27250555": [
        "Here we describe vcfanno, which flexibly extracts and summarizes attributes from multiple annotation files and integrates the annotations within the INFO column of the original VCF file.",
        "Vcfanno is available at https://github.com/brentp/vcfanno under the MIT license.",
        "The integration of genome annotations is critical to the identification of genetic variants that are relevant to studies of disease or other traits.",
        "However, comprehensive variant annotation with diverse file formats is difficult with existing methods.",
        "By leveraging a parallel \"chromosome sweeping\" algorithm, we demonstrate substantial performance gains by annotating ~85,000 variants per second with 50 attributes from 17 commonly used genome annotation resources."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30173918": [
        "We identify a subset of boundaries with markedly higher CpG island density compared to the rest of the genome. daSTRs specifically localize to ultra-high-density CpG island boundaries, suggesting they might be hotspots for epigenetic misregulation or topological disruption linked to STR expansion.",
        "Our data uncover higher-order chromatin architecture as a new dimension in understanding repeat expansion disorders.",
        "A fundamental unresolved question is why some STRs are susceptible to pathologic expansion, whereas thousands of repeat tracts across the human genome are relatively stable.",
        "Fragile X syndrome patients exhibit severe boundary disruption in a manner that correlates with local loss of CTCF occupancy and the degree of FMR1 silencing.",
        "More than 25 inherited human disorders are caused by the unstable expansion of repetitive DNA sequences termed short tandem repeats (STRs).",
        "Here, we discover that nearly all disease-associated STRs (daSTRs) are located at boundaries demarcating 3D chromatin domains."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29996107": [
        "Examining both human and mouse genomes, we interrogate the relationship of UCEs to three features of chromosome organization derived from Hi-C studies.",
        "Finally, as the relationships between UCEs and human Hi-C features are conserved in mouse, our findings suggest that UCEs contribute to interspecies conservation of genome organization and, thus, genome stability.",
        "Regarding loop anchors, UCEs are neither overrepresented nor underrepresented, but those present in loop anchors are enriched for splice sites.",
        "This study explores the relationship between three-dimensional genome organization and ultraconserved elements (UCEs), an enigmatic set of DNA elements that are perfectly conserved between the reference genomes of distantly related species.",
        "We find that UCEs are enriched within contact domains and, further, that the subset of UCEs within domains shared across diverse cell types are linked to kidney-related and neuronal processes.",
        "In boundaries, UCEs are generally depleted, with those that do overlap boundaries being overrepresented in exonic UCEs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26181593": [
        "Hence, identifying ohnologs is central to better understand the evolution of vertebrates and their susceptibility to genetic diseases.",
        "Paralogs retained from WGD, also coined 'ohnologs' after Susumu Ohno, have been shown to be typically associated with development, signaling and gene regulation.",
        "Whole genome duplications (WGD) have now been firmly established in all major eukaryotic kingdoms.",
        "These approaches are thus limited by lineage specific rearrangements in individual genomes.",
        "Such a synteny comparison across multiple genomes is shown to enhance the statistical power of ohnolog identification in vertebrates compared to earlier approaches, by overcoming lineage specific genome rearrangements.",
        "In the light of the importance of WGD on the genetic makeup of vertebrates, our analysis provides a useful resource for researchers interested in gaining further insights on vertebrate evolution and genetic diseases.",
        "Ohnologs, which amount to about 20 to 35% of genes in the human genome, have also been shown to be prone to dominant deleterious mutations and frequently implicated in cancer and genetic diseases.",
        "In particular, all vertebrates descend from two rounds of WGDs, that occurred in their jawless ancestor some 500 MY ago.",
        "Early computational analyses to identify vertebrate ohnologs relied on content-based synteny comparisons between the human genome and a single invertebrate outgroup genome or within the human genome itself.",
        "We report, in this study, the identification of vertebrate ohnologs based on the quantitative assessment and integration of synteny conservation between six amniote vertebrates and six invertebrate outgroups.",
        "Ohnolog gene families can be browsed and downloaded for three statistical confidence levels or recompiled for specific, user-defined, significance criteria at http://ohnologs.curie.fr/."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27297469": [
        "We analyzed the colocalization frequency of ohnologs based on chromatin interaction datasets of seven human cell lines and found that ohnolog pairs exhibit higher spatial proximity in 3D nuclear organization than other paralog pairs and than randomly chosen ohnologs in the genome.",
        "Dosage sensitive genes frequently occur in the same metabolic pathway and in physically interacting proteins.",
        "This phenomenon is further supported by the stronger similarity of gene co-expression and of gene ontology terms of colocalized ohnologs.",
        "Ohnologs -paralogous gene pairs generated by whole genome duplication- are enriched for dosage sensitive genes, that is, genes that have a phenotype due to copy number changes.",
        "In addition, for a large fraction of ohnologs, the spatial colocalization is conserved in mouse cells, suggestive of functional constraint on their 3D positioning in the nucleus.",
        "Accumulating evidence reveals that functionally related genes tend to co-localize in the three-dimensional (3D) arrangement of chromosomes.",
        "We query whether the spatial distribution of ohnologs has implications for their dosage balance.",
        "We also found that colocalized ohnologs are more resistant to copy number variations and more likely to be disease-associated genes, which indicates a stronger dosage balance in ohnologs with high spatial proximity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17068775": [
        "Some zebrafish genes appear to lack an ortholog in the human genome and researchers often call them \"novel\" genes.",
        "How does the evolution of ohnologs differ from the evolution of gene duplicates arising from other mechanisms, such as tandem duplication or retrotransposition?",
        "What roles do differences in ohnolog content play in the origin of developmental mechanisms that differ among lineages?",
        "Ohnologs are paralogs stemming from such genome duplication events, and some zebrafish genes said to be \"novel\" are more appropriately interpreted as \"ohnologs gone missing\", cases in which ohnologs are preserved differentially in different evolutionary lineages.",
        "Here we consider ohnologs present in the zebrafish genome but absent from the human genome.",
        "The origin of many so-called \"novel\" genes becomes apparent when considered in the context of genome duplication events that occurred during evolution of the phylum Chordata, including two rounds at about the origin of the subphylum Vertebrata (R1 and R2) and one round before the teleost radiation (R3).",
        "To what extent do different major vertebrate lineages or different teleost lineages differ in ohnolog content?",
        "This review explores these questions.",
        "Reasonable hypotheses are that lineage-specific loss of ohnologs can play a role in establishing lineage divergence and in the origin of developmental innovations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23917329": [
        "We propose that investigating copy number variation of genes in regions that are typically copy number variation deserts is an efficient means to find disease-related copy number variations.",
        "However, it is unclear what genomic factors affect the deleterious effects of copy number variations and the biological significance of the biased genomic distribution of copy number variations remains poorly understood.",
        "Our results suggest that the genomic location of ohnologs is a determining factor in the retention of copy number variations and that the dosage-balanced ohnologs are likely to cause the deleterious effects of copy number variations in these regions.",
        "Most copy number variations are neutral, but some are deleterious and associated with various human diseases.",
        "Here we show that non-ohnologs neighbouring ohnologs are unlikely to have copy number variations, resulting in ohnolog-rich regions in vertebrate genomes being copy number variation deserts.",
        "Copy number variations are distributed non-randomly in vertebrate genomes, and it was recently reported that ohnologs, which are duplicated genes derived from whole genome duplication, are refractory to copy number variations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30346488": [
        "Therefore, we developed TissueEnrich, a tool that calculates tissue-specific gene enrichment in an input gene set.",
        "We demonstrated that TissueEnrich can assign tissue identities to single cell clusters and differentiated embryonic stem cells.",
        "While tools have been developed to identify biological processes that are enriched in the genes sets, there remains a need for tools that identify enrichment of tissue-specific genes.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      RNA-Seq data analysis results in lists of genes that may have a similar function, based on differential gene expression analysis or co-expression network analysis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28924672": [
        "OligoSTORM and OligoDNA-PAINT meld the Oligopaint technology for fluorescent in situ hybridization (FISH) with, respectively, Stochastic Optical Reconstruction Microscopy (STORM) and DNA-based Point Accumulation for Imaging in Nanoscale Topography (DNA-PAINT) to enable in situ single-molecule super-resolution imaging of nucleic acids.",
        "Both strategies enable \u226420 nm resolution and are appropriate for imaging nanoscale features of the genomes of a wide range of species, including human, mouse, and fruit fly (Drosophila)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8159911": [
        "While the knowledge concerning the role of the immune system in many internal disorders has grown rapidly in recent years, there are few methods to assess immune system activation in clinical practice.",
        "As expected, we found an increase in urine neopterin in patients with malignant tumors, autoimmune disorders like systemic lupus erythematosus or inflammatory bowel disease, and infections.",
        "Measurement of urine neopterin, product of a metabolic pathway controlled by interferon-gamma, has been found useful in many clinical conditions.",
        "In addition, significant correlations between urine neopterin and zinc and neopterin and copper excretion were found suggesting a physiological role of neopterin as urine antioxidant.",
        "The present study concerns neopterin excretion in 157 patients with different internal disorders.",
        "Elevated neopterin levels were also observed in acute pancreatitis and in acute myocardial infarction."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20305046": [
        "Experimental and animal studies suggested that estrogens play an important role in the development of systemic lupus erythematosus (SLE) through a variety of mechanisms involved in the regulation of the immune system.",
        "Polymorphisms analysed included: ESR1 PvuII, XbaI, and GT repeat; ESR2 RsaI, AluI, and CA repeat; and CYP19A1 RsaI, SfaN1, and TTTA repeat.",
        "Carrying the PPXX genotype conferred the highest risk (PPXX vs. ppxx, OR: 4.6, 95% CI: 1.3-15.9).",
        "We performed a genetic study of SLE among 46 medical record-confirmed female SLE cases and 102 female controls participating in an Internet-based case-control study of SLE.",
        "We found significant association of the ESR1 PvuII (PP vs. pp, odds ratio (OR): 3.1, 95% confidence interval (CI): 1.1-9.3) and XbaI (XX vs. xx, adjusted OR: 3.4, 95% CI: 1.1-10.5) with SLE.",
        "Our results support a role of estrogen in pathogenesis of SLE and suggested that genetic variants in the estrogen receptor genes might influence susceptibility.",
        "We also found an association of SLE with the ESR2 CA repeat (SS vs. LL, OR: 2.8, 95% CI: 1.0-8.0).",
        "The objective of this study was to investigate the association between genetic variations in estrogen metabolic pathway genes, including estrogen receptor alpha (ESR1), estrogen receptor beta (ESR2), and aromatase (CYP19A1), and risk of SLE."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24494566": [
        "According to the OPLS load diagram, 12 differential metabolites, including traumatic acid, PAF, 12 (S)-HEPE, 15(S)-HETrE and Hepoxilin B3 were identified by using accurate mass combined with MS/MS data After treatment with Jieduquyuziyin prescription, the relative contents of PAF, 12 (S)-HETE were close to the level of the control group.",
        "According to the analysis on metabolic pathway, SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism pathway, while Jieduquyuziyin prescription has a effect in regulating disorder of unsaturated fatty acid metabolism pathway.",
        "To establish a metabonomic method based on high performance liquid chromatography-quadrupole-time of flight mass spectrometry (HPLC-Q-TOF/MS), in order to study the changes in serum metabolites of systemic lupus erythematosus (SLE) mice after treatment of Jieduquyuziyin prescription, the pathogenesis of SLE and mechanism of drug action.",
        "The orthogonal partial least squares (OPLS) was applied for the pattern recognition of experimental data, finding a significant difference in the control group, the SLE model group, the Jieduquyuziyin prescription-treated group and the prednisone acetate-treated group."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24040398": [
        "FLI1 dose-dependently activated the Neu1 promoter in mouse and human T cell lines.",
        "Together, our results suggest reducing FLI1 in lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism.",
        "We demonstrate that adoptive transfer of MRL/lpr Fli1(+/+) or Fli1(+/-) T cells and B cells into Rag1-deficient mice results in significantly decreased serum immunoglobulin levels in animals receiving Fli1(+/-) lupus T cells compared to animals receiving Fli1(+/+) lupus T cells regardless of the genotype of co-transferred lupus B cells.",
        "Systemic Lupus erythematosus (SLE) is an autoimmune disease caused, in part, by abnormalities in cells of the immune system including B and T cells.",
        "Reducing the expression of FLI1 or targeting the glycosphingolipid metabolic pathway in lupus may serve as a therapeutic approach to treating lupus.",
        "Moreover, the Fli1(+/-) T cells expressed significantly less neuraminidase 1 (Neu1) message and decreased NEU activity during early disease and significantly decreased levels of glycosphingolipids during late disease compared to Fli1(+/+) T cells.",
        "In this study we analyze the effects of reducing FLI1 in the MRL/lpr lupus prone model on T cell function.",
        "Genetically reducing globally the expression of the ETS transcription factor FLI1 by 50% in two lupus mouse models significantly improves disease measures and survival through an unknown mechanism.",
        "Ex vivo analyses of MRL/lpr T cells demonstrated that Fli1(+/-) T cells produce significantly less IL-4 during early and late disease and exhibited significantly decreased TCR-specific activation during early disease compared to Fli1(+/+) T cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24772967": [
        "SHEsis web-based platform analysis showed mild to moderate linkage disequilibrium between the CYP1A1 ml, m2 and m4 variants (D': 0.19-0.37).",
        "To conclude, hyperinducibility of CYP1A1 due to ml and m4 variants and defective phase-II detoxification due to COMT H108L and GSTT1 null variants increase the susceptibility to SLE.",
        "Cytochrome P 450 1A1 (CYP1A1) m4 (OR: 4.93, 95% CI: 1.31-18.49), catecholamine-o-methyl transferase (COMT) H108L (OR: 1.39, 95% CI: 1.03-1.88) and glutathione-S-transferase (GST) T1 null (OR: 1.83, 95% CI: 1.11- 3.01) variants showed association with SLE risk.",
        "In view of documented evidence that catechol estrogen-DNA adducts serve as epitopes for binding of anti-nuclear antibodies, genetic polymorphisms of the xenobiotic metabolic pathway involved in estrogen metabolism might contribute towards pathophysiology of systemic lupus erythematosus (SLE).",
        "Among the different haplotypes of CYP1A1, CAC-haplotype harboring CYP1A1 ml variant showed association with SLE risk (OR: 1.46, 95% CI: 1.11-1.92).",
        "To test this hypothesis, a case-control study was conducted.",
        "Multifactor dimensionality reduction analysis (MDR) showed potential gene-gene interactions between the phase II variants i.e. COMT H108L x GSTT1 null x GSTM1 null (p &lt; 0.0001) and also between the phase II and I variants i.e. COMT H108L x GSTTI null x CYP1A1 ml x CYP1A1 m2 in inflating the risk of SLE by 3.33-folds (95% CI: 2.30-4.82) and 4.00-folds (95% CI: 2.77-5.78), respectively."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24333266": [
        "SLE cases exhibited elevated plasma homocysteine levels compared to healthy controls (24.93 \u00b1 1.3 vs. 11.67 \u00b1 0.48 \u03bcmol/l), while plasma folate levels showed no association (7.10 \u00b1 2.49 vs. 7.64 \u00b1 2.09 ng/ml).",
        "To conclude, one-carbon genetic variants influence epigenetic of MHC2TA and RFC1, thus contributing to phenotypic heterogeneity of SLE.",
        "PCR-RFLP/AFLP, bisulfite-sequencing and real-time PCR approaches were used for genetic, epigenetic and expression analysis respectively.",
        "SLE cases with hypocomplementemia showed hypermethylation of RFC1, hypomethylation/up regulation of MHC2TA and down regulation of HLA-DR.",
        "Plasma folate and thymidylate synthase (TYMS) 5'-UTR 28 bp tandem repeat showed an inverse association with methylation of RFC1 and MHC2TA.",
        "The expression of RFC1 (0.37 \u00b1 0.09 vs. 0.60 \u00b1 0.17) and HLA-DR (0.68 \u00b1 0.17 vs. 0.98 \u00b1 0.02) was down regulated in the SLE cases.",
        "The hypermethylation of RFC1 as observed in the current study may contribute for its down regulation.",
        "The current study was conducted to elucidate the effect of genetic variations in one-carbon metabolism on the epigenetic regulation of major histocompatibility complex II transactivator (MHC2TA), reduced folate carrier 1 (RFC1/SLC19A1) and human leukocyte antigen (HLA)-DR in systemic lupus erythematosus (SLE).",
        "The up regulation of RFC1 and HLA-DR was observed in anti-dsDNA antibody positive SLE cases.",
        "The RFC1 80G&gt;A polymorphism showed 1.32-fold risk (95% CI: 1.02-1.72) for SLE, while glutamate carboxypeptidase II (GCPII) 1561C&gt;T showed reduced risk (OR: 0.47, 95% CI: 0.24-0.90).",
        "The hypermethylation of MHC2TA and down regulation of RFC1, MHC2TA and HLA-DR were observed in anti-cardiolipin antibody positive SLE cases.",
        "The hypomethylation/upregulation of RFC1 and MHC2TA was observed in anti-RNP antibody positive cases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25648260": [
        "Gene-gene interactions within one-carbon metabolic pathway were observed in CAD (GCPII 1561 C&gt;T, SHMT 1420 C&gt;T and MTHFR 677 C&gt;T) and PD (cSHMT 1420 C&gt;T, MTRR 66 A&gt;G and RFC1 80 G&gt;A).",
        "Putatively functional polymorphisms of one-carbon and xenobiotic metabolic pathways influence susceptibility for wide spectrum of diseases.",
        "Gene-gene interactions within one-carbon metabolic pathway were observed in diseases with male preponderance.",
        "The current study was aimed to explore gene-gene interactions among these two metabolic pathways in four diseases i.e. breast cancer, systemic lupus erythematosus (SLE), coronary artery disease (CAD) and Parkinson's disease (PD).",
        "Multifactor dimensionality reduction analysis was carried out on four case-control datasets.",
        "Cross-talk was observed between one-carbon and xenobiotic pathways in breast cancer (RFC 80 G&gt;A, COMT H108L and TYMS 5'-UTR 28 bp tandem repeat) and SLE (CYP1A1 m1, MTRR 66 A&gt;G and GSTT1).",
        "These interaction models showed good predictability of risk for PD (The area under the receiver operating characteristic curve (C) = 0.83) and SLE (C = 0.73); and moderate predictability of risk for breast cancer (C = 0.64) and CAD (C = 0.63).",
        "Cross-talk between one-carbon and xenobiotic pathways was observed in diseases with female preponderance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20477100": [
        "High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristic and cardiovascular risk factors.",
        "66(2), 208-214 (2007).",
        "The paper under evaluation examined the hypothesis that patients with lupus have a higher prevalence of the metabolic syndrome and that there is an association of the metabolic syndrome with other cardiovascular risk factors and inflammation.",
        "Rheum.",
        "Ann.",
        "In this regard, inflammation is not only associated with systemic lupus patients but is also present in patients with metabolic syndrome and insulin resistance.",
        "This additional clinical complication can be attributed to traditional risk factors for atherosclerosis, use of corticosteroids and might also be the result of inflammatory mechanisms, all of which are aggravated in lupus patients.",
        "Dis.",
        "Evaluation of: Chung CP, Avalos I, Oeser A et al.",
        "Systemic lupus erythematosus is associated with higher rates of cardiovascular morbidity and mortality, related to accelerated atherosclerosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29850774": [
        "Statistical analysis of Mendelian violations can provide truth set-independent benchmarking information, and enable benchmarking less-studied variants and diverse populations.",
        "An alternative way of performing benchmarking is based on Mendelian constraints between related individuals.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Classical methods of comparing the accuracies of variant calling pipelines are based on truth sets of variants whose genotypes are previously determined with high confidence."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30046703": [
        "After the acute episode is resolved, patients face a significant risk of relapse and long-term complications associated with significant morbidity and even mortality.",
        "Thrombotic thrombocytopenic purpura (TTP) is characterized by microangiopathic hemolytic anemia and a consumptive thrombocytopenia, as a result of severe deficiency of ADAMTS13.",
        "The standard of care of the acute episode is treatment with plasma exchange and immunosuppression.",
        "In addition, identifying biomarkers to allow us to better predict the risk for relapse and the development of these long-term complications in patients with TTP are a few of the challenges that require our attention moving forward.",
        "Novel treatments have been under development and will be discussed in this review.",
        "Caplacizumab, a nanobody that blocks the interaction between VWF and platelets, has shown promising results in decreasing the time to recover from the acute events that will hopefully translate into long-term clinical benefit for patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30298461": [
        "Ablynx, a Sanofi Company, has developed the anti-von Willebrand factor Nanobody<sup>\u00ae</sup> caplacizumab (Cablivi\u2122) for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP).",
        "This article summarizes the milestones in the development of caplacizumab leading to this first approval.",
        "Based on positive results in phase II and III trials in patients with aTTP, caplacizumab was recently approved in the EU for the treatment of adults experiencing an episode of aTTP, in conjunction with plasma exchange and immunosuppression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28110841": [
        "In this context, the introduction of rituximab has probably been the second major breakthrough in TTP management.",
        "In more severe patients, salvage strategies may include twice daily TPE, pulses of cyclophosphamide, vincristine, as well as splenectomy in the more desperate cases.",
        "Promising agents under evaluation include N-acetylcysteine, bortezomib, recombinant ADAMTS13 and caplacizumab, an inhibitor of the glycoprotein-Ib/IX-von Willebrand factor axis.",
        "However, relapses occur in up to 40% of patients and refractory disease with fatal outcomes still occurs.",
        "In the coming years, the TTP therapeutic landscape should be enriched by original strategies stemming from clinical experience and new agents that are currently being evaluated in large, ideally international, clinical trials.",
        "Rituximab is now routinely recommended during the acute phase, typically in patients with a suboptimal response to treatment, or even as frontline therapy, with high response rates.",
        "In this life-threatening disease, relapses can be efficiently prevented in patients with a severe acquired ADAMTS13 deficiency and otherwise in remission with the use of rituximab.",
        "Daily therapeutic plasma exchange (TPE) transformed the historically fatal prognosis of acquired, anti-ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura (TTP), leading to the current overall survival rates of &gt;80%."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28139813": [
        "The thrombotic-thrombocytopenic purpura (TTP) is an acute, life-threatening disease, characterised by enhanced platelet aggregation, disturbed microcirculation and organ dysfunction.",
        "With the currently available treatment (plasma exchange, infusions, corticosteroids) mortality ist still as high as 10-15 %.",
        "Recent, pathophysiology-based developments may improve the outcome.",
        "The most promising candidates for future treatment of TTP are: rituximab for termination of the autoimmune process, caplacizumab for prevention of platelet-VWF-interaction, and recombinant ADAMTS13 for replacement of the inhibited or missing enzyme."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28645643": [
        "In the coming years, the TTP therapeutic landscape should be enriched by original strategies stemming from clinical experience and new agents that are currently being evaluated in large, international, clinical trials.",
        "In this life-threatening and debilitating disease, relapses can be efficiently prevented in patients with a severe acquired ADAMTS13 deficiency and otherwise in remission with the use of rituximab.",
        "Promising agents under evaluation include caplacizumab (an inhibitor of the glycoprotein-Ib/IX-Von-Willebrand factor axis), N-acetylcysteine, recombinant ADAMTS13, and anti-plasmocyte compounds.",
        "However, relapses occur in up to 40% of patients and refractory disease with fatal outcomes still occurs, typically within the first days of management.",
        "Daily therapeutic plasma exchange (TPE) transformed the historically fatal prognosis of acquired, anti-ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura (TTP), leading to the current overall survival rates of &gt;80%.",
        "In more severe patients, salvage strategies typically include twice daily TPE, pulses of cyclophosphamide, as well as splenectomy in the more desperate cases.",
        "In this context, the introduction of rituximab has been the second major breakthrough in TTP management.",
        "Rituximab is now routinely recommended during the acute phase, typically in patients with a suboptimal response to treatment, and increasingly as frontline therapy, with high response rates in the following weeks."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28445600": [
        "Fewer caplacizumab-treated patients had a major TE event, an exacerbation, or died versus placebo.",
        "Essentials Acquired thrombotic thrombocytopenic purpura (aTTP) is linked with significant morbidity/mortality.",
        "Caplacizumab has the potential to reduce the acute morbidity and mortality associated with aTTP.",
        "Caplacizumab's effect on major thromboembolic (TE) events, exacerbations and death was studied."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29209322": [
        "It is now anticipated that the first V<sub>H</sub>H-based antibody drug, Caplacizumab, a bivalent anti-vWF antibody for treating rare blood clotting disorders, may be approved and commercialized in 2018 or shortly thereafter.",
        "Tremendous effort has been expended over the past two and a half decades to understand many aspects of camelid heavy chain antibodies, from their biology, evolution, and immunogenetics to their potential applications in various fields of research and medicine.",
        "In this article, I present a historical perspective on the development of camelid single-domain antibodies (sdAbs or V<sub>H</sub>Hs, also widely known as nanobodies) since their discovery and discuss the advantages and disadvantages of these unique molecules in various areas of research, industry, and medicine.",
        "This elusive first approval, along with the expiry of key patents, may substantially alter the scientific and biomedical landscape surrounding camelid sdAbs and pave the way for their emergence as mainstream biotherapeutics.",
        "While entrepreneurial spirit has certainly catalyzed the exploration of nanobodies as marketable products, IP restrictions may be partially responsible for the relatively long time span between the discovery of these biomolecules and their entry into the pharmaceutical market.",
        "Commercialization of camelid sdAbs exploded in 2001 with a flurry of patents issued to the Vrije Universiteit Brussel (VUB) and later taken on by the Vlaams Interuniversitair Instituut voor Biotechnologie (VIB) and, after 2002, the VIB-founded spin-off company, Ablynx."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26863353": [
        "This microvascular thrombosis causes multiorgan ischemia with potentially life-threatening complications.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Acquired thrombotic thrombocytopenic purpura (TTP) is caused by aggregation of platelets on ultralarge von Willebrand factor multimers.",
        "Daily plasma exchange and immunosuppressive therapies induce remission, but mortality and morbidity due to microthrombosis remain high."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25548914": [
        "Most were SDE in a single tissue.",
        "Surprisingly, nearly half of the probesets that were (SDE) in multiple tissues were oppositely sex biased in different tissues, and most SDE probesets were also expressed without sex bias in other tissues.",
        "14.5% of expressed probesets were SDE in at least one tissue, with higher expression nearly twice as prevalent in males compared to females.",
        "The occurrence of SDE probesets was not strongly correlated between tissues.",
        "The estrogen receptor was implicated in differential gene expression in the duodenum.",
        "Within individual tissues, however, relational networks of SDE genes were identified.",
        "Two genes were widely SDE: Xist (female-only) and Eif2s3y (male-only).",
        "Sexually dimorphic gene expression may provide insights into mechanisms underlying phenotypic sex differences.",
        "Online data are provided as a resource for further analyses (GEO reference GSE63362).",
        "In the liver, networks relating to differential metabolism between the sexes were seen.",
        "The sexually dimorphic expression of genes across 26 somatic rat tissues was using Affymetrix RAE-230 genechips.",
        "The frequency of SDE probesets varied widely between tissues, and was highest in the duodenum (6.2%), whilst less than 0.05% in over half of the surveyed tissues.",
        "To conclude, sexually dimorphic gene expression is common, but highly tissue-dependent.",
        "We considered probesets to be sexually dimorphically expressed (SDE) if they were measurably expressed above background in at least one sex, there was at least a two-fold difference in expression (dimorphism) between the sexes, and the differences were statistically significant after correcting for false discovery."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23122604": [
        "We hypothesized that sex-related differences in IGF-1 expression in equine embryos during the phase of maternal recognition of pregnancy might exist and thus contribute to preferential survival of embryos from either of both sexes under specific environmental conditions.",
        "An adjustment of sex ratio of offspring to the conditions present at conception is seen in many mammals including horses.",
        "The sex of the embryo was determined by detection of X-inactivation specific transcript (Xist) RNA and equine sex determining region of the Y chromosome DNA.",
        "Results demonstrate an increased expression of IGF-1 in female equine embryos.",
        "Sex-related influences on expression of the IGF system are probably related to a gradual X chromosome inactivation.",
        "In several species, growth factors including insulin like growth factor (IGF)-1 have been shown to promote embryonic development by decreasing apoptosis and increasing cell proliferation.",
        "Insulin like growth factor-1 mRNA expression of in vivo-produced equine embryos on different days of pregnancy (Day 8, N = 6; Day 10, N = 8; Day 12, N = 14) was analyzed.",
        "From 28 embryos tested, 15 (54%) showed positive Xist expression and were thus classified as female.",
        "Insulin like growth factor-1 mRNA expression was influenced by sex (P = 0.01) but not by day of pregnancy (relative expression of IGF-1 in relation to \u03b2-actin, Day 8: male 5.1 \u00b1 2.1, female 11.4; Day 10: male 5.2 \u00b1 1.6, female 17.4 \u00b1 6.7; Day 12: male 2.6 \u00b1 0.3, female 11.6 \u00b1 2.4).",
        "This depends on preferential survival of male embryos under conditions of high energy intake.",
        "Embryos positive for Xist expression were classified as female, and Xist negative and equine sex determining region of the Y chromosome positive embryos were classified as male.",
        "Insulin like growth factor-1 mRNA expression was evaluated by reverse transcription quantitative polymerase chain reaction."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22925639": [
        "The results demonstrate that expression of Xist is restricted to female equine embryos.",
        "Female and male primary equine dermal cell cultures were used as positive and negative controls, respectively.",
        "From 29 embryos tested by quantitative RT-PCR, 16 showed positive Xist expression (55%).",
        "We also demonstrated by strand-specific RT-PCR that in the horse, as in humans, the counter transcript Tsix seems to be truncated not reaching Exon 1.",
        "Until now, sex determination in equine embryos has been performed by detection of Y-chromosome-specific sequences only.",
        "In the present study, expression of a Barr-body-specific marker, the X-inactivated-specific transcript (Xist) gene, whose gene product consists of RNA which coats and thereby inactivates one of the X chromosomes, was investigated in equine embryos produced in vivo.",
        "Preattachment embryos at different times after ovulation (Day 8: n = 9; Day 10: n = 12; Day 12: n = 15) were analyzed for Xist RNA expression using quantitative and qualitative reverse transcription-polymerase chain reaction (RT-PCR).",
        "All of the Xist-negative equine embryos tested by quantitative PCR were positive for eSRY.",
        "From 36 embryos assessed by qualitative RT-PCR, 18 showed positive Xist expression (50%).",
        "In contrast to many other species, neither Xist nor Tsix was expressed in equine male testicular tissue.",
        "Xist can thus be considered an X-inactivation-specific marker which can be used in concert with Y-specific markers for sex determination.",
        "Embryos tested negative for Xist were evaluated for expression of the male-specific eSRY gene by qualitative PCR at the DNA level."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21241365": [
        "Their transcripts would constitute a significant difference, as male metabolism is not adapted to a 'female-like' gene dosage.",
        "We evaluated the expression of selected X-linked genes in our 41, XX(Y)* male mice to determine whether these genes escape inactivation and whether tissue-specific differences occur.",
        "<strong class=\"sub-title\">\n          Aim:\n        </strong>\n      \n      We hypothesized that patients with Klinefelter's syndrome (KS) not only undergo X inactivation, but also that genes escape from inactivation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17373633": [
        "Our findings show that estrogen affects the expression of some adipocyte genes in a site-specific manner.",
        "To test whether estrogen regulates genes expressed in the adipose tissue in a site-specific manner, we studied the effect of exogenous estradiol on the gene expression in visceral and subcutaneous adipose tissues of male ob/ob mice.",
        "Sex hormones are likely to be involved in sex differences in adipose tissue distribution.",
        "When estradiol was subcutaneously administrated to male mice, the expression of monocyte-chemoattractant protein-1 (MCP-1) and androgen receptor (AR) genes was regulated in a site-specific manner.",
        "We screened genes expressed in a site- and sex-specific manner, and genes that were affected by exogenous estradiol by DNA chip analysis.",
        "DEAD-box Y RNA helicase (DBY) and eukaryotic initiation factor 2 gamma Y (eIF2gamma Y) were expressed only in male adipose tissue.",
        "They were verified by real-time PCR.",
        "The difference in the amount of estrogen receptor did not account for the site-specific effect of estrogen.",
        "X-chromosome inactive specific transcript (Xist) was expressed only in female adipose tissue.",
        "Myosin heavy chain 2B (Myh4) and phosphoglycerate mutase muscle-specific subunit (Pgam) were expressed specifically in the subcutaneous adipose tissue, and uroplakin IIIb (UP3) was expressed specifically in the visceral adipose tissue."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10026129": [
        "Reverse transcription-polymerase chain reaction (RT-PCR) revealed the presence of Xist transcripts in all adult female somatic tissues evaluated.",
        "These results suggest that Xist expression precedes the onset of late replication in the bovine embryo, in a pattern compatible with a possible role of bovine Xist in the initiation of X chromosome inactivation.",
        "No evidence for Xist transcription was observed after a single round of RT-PCR from pools of in vitro-derived embryos at the 2- to 4-cell stage.",
        "In the present study, we analyzed the patterns of Xist transcription and the onset of X chromosome inactivation in bovine preattachment embryos.",
        "Xist transcripts, however, were subsequently detected from the 2-cell stage onward after nested RT-PCR.",
        "Preferential [3H]thymidine labeling indicative of late replication of one of the X chromosomes was noted in female embryos of different developmental ages as follows: 2 of 7 (28.5%) early blastocysts, 6 of 13 (46.1%) blastocysts, 8 of 11 (72.1%) expanded blastocysts, and 14 of 17 (77.7%) hatched blastocysts.",
        "In contrast, among the male tissues examined, Xist expression was detected only in testis.",
        "Xist transcripts were detected as a faint amplicon at the 8-cell stage initially, and consistently thereafter in all stages examined up to and including the expanded blastocyst stage.",
        "Expression of the X inactive-specific transcript (Xist) is thought to be essential for the initiation of X chromosome inactivation and dosage compensation during female embryo development."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/1345168": [
        "Mammalian X-chromosome inactivation is thought to be controlled by the X inactivation centre (XIC, X-controlling element -Xce-in mice).",
        "Our results indicate that while the X chromosome in males is active in somatic cells, it undergoes inactivation during spermatogenesis.",
        "A human gene, XIST and its mouse counterpart, Xist, which map to the XIC/Xce, are expressed exclusively from inactive X chromosomes, suggesting their involvement in the process of X-inactivation.",
        "We now report the presence of Xist/XIST transcripts in newborn and adult mouse testes, and in human testicular tissue with normal spermatogenesis, but not in the testes of patients who lack germ cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28780180": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Parkinson's disease (PD) is characterized by bradykinesia, rigidity, postural instability and tremor.",
        "Several pathologic processes can produce this syndrome, but neurodegeneration accompanied by neuronal inclusions composed of \u03b1-synuclein (Lewy bodies) is considered the typical pathologic correlate of PD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28784297": [
        "Heiko Braak found that alpha-synuclein accumulates initially in the olfactory system and lower brainstem and then travels in an anatomic pattern to involve other regions of the brain and thereby cause progressive symptoms.",
        "At the same time that the alpha-synuclein era was developing, clinical advances took place by recognizing PD as hosting a wide variety of nonmotor features with eventual cognitive impairment in many.",
        "Therapeutics has also evolved.",
        "The revolutionary therapeutic breakthrough was the introduction of high dosage levodopa therapy by George Cotzias in 1967.",
        "Alpha-synuclein was somehow converted to a rogue protein.",
        "Following 40 years of the dopa/dopamine era, we have entered the era of alpha-synuclein, the protein present in Lewy bodies.",
        "The Lewy body was described in 1912, and the substantia nigra was found to be depigmented with neuronal loss and gliosis in 1919.",
        "It took almost 100 years before a meaningful advance occurred in any basic science understanding of Parkinson disease (PD) following James Parkinson's description in 1817.",
        "Arvid Carlsson and Oleh Hornykiewicz were the major pioneers.",
        "Although the most effective therapy for the motor features remains levodopa, surgical approaches and drugs for nonmotor problems continue to expand our ability to treat people with PD.",
        "The link between dopamine and PD began in 1957, 140 years after Parkinson's Essay.",
        "Where this originates and how it is propagated are under intense investigation.",
        "We can expect therapeutic advances in neuroprotection as the basic science discoveries uncovered in the alpha-synuclein era are translated into effective treatments."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26667592": [
        "Using human brain tissue from control, PD and DLB and light and confocal immunohistochemistry with antibodies to superoxide dismutase 2 as a marker for mitochondria, \u03b1-synuclein for Lewy bodies and \u03b2III Tubulin for microtubules we have examined the relationship between Lewy bodies and mitochondrial loss.",
        "In PD, multiple Lewy bodies were often observed with \u03b1-synuclein interacting with DNA to cause marked nuclear degradation.",
        "Neuronal loss in specific brain regions and neurons with intracellular inclusions termed Lewy bodies are the pathologic hallmark in both Parkinson's disease (PD) and dementia with Lewy bodies (DLB).",
        "We have shown microtubule regression and mitochondrial and nuclear degradation in neurons with developing Lewy bodies.",
        "In PD, \u03b1-synuclein aggregations are associated with intact mitochondria but interacts with and causes nuclear degradation which may be the major cause of cell death.",
        "This work suggests that Lewy bodies are cytotoxic.",
        "In DLB, we suggest that microtubule regression and mitochondrial loss results in decreased cellular energy and axonal transport that leads to cell death.",
        "Lewy bodies comprise of aggregated intracellular vesicles and proteins and \u03b1-synuclein is reported to be a major protein component.",
        "In DLB, the mitochondria are drawn into the Lewy body and the mitochondrial integrity is lost."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27986376": [
        "Towards this end, the present study examined the effects of intracranial rotenone treatment on TH and \u03b1-synuclein immunohistochemistry in addition to forelimb motor function.",
        "Clarification of this issue is important because an intracranial rotenone mouse model of Parkinson's disease has not been established.",
        "Mice were unilaterally infused with either vehicle or rotenone (2\u03bcg/site) in both the medial forebrain bundle and the substantia nigra.",
        "Moreover, a significant bilateral increase in \u03b1-synuclein immunofluorescence was found in the substantia nigra of lesioned mice, as compared to control animals.",
        "Recently, intracranial infusion of rotenone was found to increase the protein levels of the Lewy body constituents, \u03b1-synuclein and small ubiquitin-related modifier-1(SUMO-1), in the lesioned hemisphere of the mouse brain.",
        "The pesticide rotenone has been shown to cause systemic inhibition of mitochondrial complex I activity, with consequent degeneration of dopamine neurons along the nigrostriatal pathway, as observed in Parkinson's disease (PD).",
        "The forelimb asymmetry (cylinder) test indicated a significant decrease in use of the contralateral forelimb in lesioned animals as compared to the sham group.",
        "These findings indicate that this intracranial rotenone mouse model will be useful for studies of neurodegenerative disorders such as PD.",
        "Densitometric analysis revealed a significant depletion of TH immunofluorescence within the ipsilateral striatum and substantia nigra of lesioned animals.",
        "These findings are supportive of a mouse model of PD, but information about the dopamine-synthesizing enzyme, tyrosine hydroxylase (TH), an essential marker of dopaminergic status, was not reported."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22020330": [
        "We show that RAS(v12) expression induces SASP-like changes in untransformed human mesothelial cells, and that p53 ablation increases the effect of RAS(v12) expression.",
        "Here we show that pemetrexed-treated mesothelioma cells undergo accelerated senescence.",
        "We show by fluorescence-activated cell sorting of purified ALDH(bright) and ALDH(low) cells, that both cell-autonomous and cell-non-autonomous mechanisms converge to maintain the SASP-induced, EMT-like cell subpopulations.",
        "In fact, small hairpin RNA-mediated ablation of STAT3 deeply attenuates the induction of EMT genes and the increase of ALDH(bright) cells induced by SASP-cytokines.",
        "Chemoresistant ALDH(bright) cells exist within primary MPM specimens and enrichment for ALDH(bright) cells correlates with an earlier tumor onset into NOD/SCID mice.",
        "This strongly affects the chemoresistance of MPM cells in vitro and leads to anticancer effects in vivo.",
        "Conditioned media from senescent MPM (malignant pleural mesothelioma) cells trigger the emergence of EMT (epithelial-to-mesenchymal)-like, clonogenic and chemoresistant cell subpopulations, expressing high levels of ALDH (aldehyde dehydrogenase) activity (ALDH(bright) cells).",
        "We identify STAT3 activation as a crucial event downstream to SASP signaling.",
        "This is characterized by the secretion of proinflammatory and mitogenic cytokines, reminiscent of an SASP (senescence-associated secretory phenotype)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23296657": [
        "These techniques should facilitate the discovery of novel functions and regulators of the SASP.",
        "Numerous activities of senescent cells depend on the aptitude of these cells to secrete myriads of bioactive molecules, a behavior termed the senescence-associated secretory phenotype (SASP).",
        "As an example, we discuss the assessment of the major SASP factor interleukin-6 in senescent human fibroblasts.",
        "The biological functions and the regulation of the SASP are beginning to emerge, and current SASP assessment techniques include the analysis of SASP factors at the mRNA level, the direct measurement of factors inside or outside the cell (i.e., secreted), and the detection of SASP-provoked cellular responses.",
        "Here, we focus on a simple approach to collect SASP-conditioned media in order to directly measure secreted SASP factors using sandwich enzyme-linked immunosorbent assay.",
        "Cellular senescence suppresses cancer by eliminating potentially oncogenic cells, participates in tissue repair, contributes to cancer therapy, and promotes organismal aging.",
        "Supplemental notes are provided to easily adapt this procedure to other SASP factors, change cell types, or scale the techniques for different volumes or high-throughput measurements.",
        "The SASP supports cell-autonomous functions like the senescence-associated growth arrest, and mediates paracrine interactions between senescent cells and their surrounding microenvironment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27731420": [
        "To determine the consequences of whole chromosome instability (W-CIN) we down-regulated the spindle assembly checkpoint component BUB1 and the mitotic cohesin SMC1A, and used four-color-interphase-FISH coupled with BrdU incorporation and analyses of senescence features to reveal the fate of W-CIN cells.",
        "Cultures enriched with not-diploid cells acquired a senescence-associated secretory phenotype (SASP) characterized by IL1B, CXCL8, CCL2, TNF, CCL27 and other pro-inflammatory factors including a novel SASP component CLEC11A.",
        "These findings suggest that W-CIN triggers premature senescence, presumably to prevent the propagation of cells with an abnormal DNA content.",
        "Age-related accumulation of ploidy changes is associated with decreased expression of genes controlling chromosome segregation and cohesin functions.",
        "SAFs of W-CIN cells were remarkably similar to those induced by replicative senescence but occurred in only 13 days versus 4 months.",
        "Cells deviating from diploidy have the ability to communicate with their microenvironment by secretion of an array of signaling factors.",
        "Our results suggest that aneuploid cells that accumulate during aging in some mammalian tissues potentially contribute to age-related pathologies and inflammation through SASP secretion.",
        "W-CIN induced DNA double strand breaks and elevated oxidative stress, but caused low apoptosis.",
        "We observed significant correlations between levels of not-diploid cells and senescence-associated features (SAFs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28741506": [
        "Some tumor cells also undergo senescence in response to chemotherapy.",
        "Senescent cells secrete cytokines and other factors of the senescence-associated secretory phenotype (SASP) that contribute to tumor suppression by enforcing arrest and recruiting immune cells that remove these damaged or oncogene-expressing cells from organisms.",
        "Here, we discuss the studies that have demonstrated a complex and often conflicting role for the SASP in tumorigenesis and treatment response.",
        "Cellular senescence is a permanent growth arrest in cells with damage or stress that could lead to transformation.",
        "Likewise, the SASP in treated cancers can either contribute to durable responses or drive relapse.",
        "However, some cells can develop a SASP comprising factors that are immunosuppressive and protumorigenic by paracrine mechanisms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26943583": [
        "Emerging evidence suggest that preventing SASP development could help to slow the rate of aging and the progression of age-related diseases, including cancer.",
        "Aim of this study was to evaluate whether and how adalimumab, a monoclonal antibody directed against tumor necrosis factor-\u03b1 (TNF-\u03b1), a major SASP component, can prevent the SASP.",
        "Endothelial cell senescence is characterized by acquisition of senescence-associated secretory phenotype (SASP), able to promote inflammaging and cancer progression.",
        "Interestingly, conditioned medium from senescent HUVECs treated with adalimumab was less consistent than medium from untreated cells in inducing migration- and mammosphere- promoting effects on MCF-7 cells.Our findings suggest that adalimumab can induce epigenetic modifications in cells undergoing senescence, thus contributing to the attenuation of SASP tumor-promoting effects.",
        "A three-pronged approach has been adopted to assess the if adalimumab is able to: i) modulate a panel of classic and novel senescence- and SASP-associated markers (interleukin [IL]-6, senescence associated-\u03b2-galactosidase, p16/Ink4a, plasminogen activator inhibitor 1, endothelial nitric oxide synthase, miR-146a-5p/Irak1 and miR-126-3p/Spred1) in human umbilical vein endothelial cells (HUVECs); ii) reduce the paracrine effects of senescent HUVECs' secretome on MCF-7 breast cancer cells, through wound healing and mammosphere assay; and iii) exert significant decrease of miR-146a-5p and increase of miR-126-3p in circulating angiogenic cells (CACs) from psoriasis patients receiving adalimumab in monotherapy.TNF-\u03b1 blockade associated with adalimumab induced significant reduction in released IL-6 and significant increase in eNOS and miR-126-3p expression levels in long-term HUVEC cultures.A significant reduction in miR-146a-5p expression levels both in long-term HUVEC cultures and in CACs isolated from psoriasis patients was also evident."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28217839": [
        "We have shown that the mitochondria are essential for development of senescence and many of the associated phenotypes, including the often detrimental senescence-associated secretory phenotype (SASP).",
        "While these interventions show promise, their potential pitfalls are discussed herein.",
        "Here, we disentangle many ways in which the mitochondria may influence senescence and development of the SASP and focus on possible pathways that could be exploited for future generation of anti-senescence therapies with a clear aim; to specifically eliminate the problematic features of senescent cells, while maintaining their beneficial characteristics.",
        "Anti-senescence therapies, such as drugs that specifically kill senescent cells, to stave off ageing are currently under investigation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27812871": [
        "Not only is this an invaluable tool for conducting large-scale RNAi or compound screenings, but also allows rapid validation of candidates of interest.",
        "This approach can be also used to screen for siRNA able to perturb the expression of SASP components during OIS.",
        "The diverse arrays of proteins secreted by senescent cells have been described to influence aging and to have both pro-tumorigenic and anti-tumorigenic influences on the surrounding microenvironment.",
        "The use of high-throughput technology allows us to obtain visual and quantitative data on a large number of samples quickly and easily.",
        "Further characterization of these proteins, known as the senescence-associated secretory phenotype (SASP), and their regulators is required to understand and further manipulate such activities.",
        "Here, we describe how we use the Widefield High-Content Analysis Systems to characterize the phenotypes of cells following modulation by potential regulators of Oncogene-Induced Senescence (OIS) by measuring numerous markers of senescence, including the SASP."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11997343": [
        "The remaining explanation is that most of the annotated genes in the recently duplicated category are pseudogenes, a proportion corresponding to 20% of all of the annotated C. elegans genes.",
        "Lessons learned in identifying pseudogenes in C. elegans could be of value in the annotation of the genomes of other species where, although there may be fewer pseudogenes, they may be harder to detect.",
        "Further support for this surprisingly high figure was sought by comparing sequences for families of recently duplicated C. elegans genes.",
        "We attempted to determine the expression patterns for a random sample of the annotated genes using reporter gene fusions.",
        "Analysis of the data suggests that this is not due to conditional or low-level expression.",
        "A low success rate was obtained for evolutionarily recently duplicated genes.",
        "Although only a preliminary analysis, clear evidence for a gene having been recently inactivated by genetic drift was found for many genes in the recently duplicated category.",
        "Only a minority of the genes, identified in the Caenorhabditis elegans genome sequence data by computer analysis, have been characterized experimentally.",
        "At least 4% of the annotated C. elegans genes can be recognized as pseudogenes simply from closer inspection of the sequence data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24463456": [
        "Its Caenorhabditis elegans (C. elegans) ortholog, AHR-1, facilitates neuronal development, growth and movement.",
        "Under-expressed genes included soluble guanylate cyclase (gcy) family genes, some of which were previously demonstrated to be regulated by AHR-1.",
        "Conserved xenobiotic response elements were identified in the 5' flanking regions of some but not all of the gcy, nlp-20, and fbxa genes.",
        "These results extend previous studies demonstrating control of gcy family gene expression by AHR-1, and furthermore suggest a role of AHR-1 in regulation of a neuropeptide gene as well as pseudogenes.",
        "We investigated the effect of AHR mutation on the transcriptional profile of L4 stage C. elegans using RNA-seq and quantitative real time PCR in order to understand better AHR-1 function at the genomic level.",
        "Illumina HiSeq 2000 sequencing yielded 51.1, 61.2 and 54.0 million reads from wild-type controls, ahr-1(ia03) and ahr-1(ju145) mutants, respectively, providing detection of over 18,000 transcripts in each sample.",
        "A neuropeptide-like protein gene, nlp-20, and a F-box domain protein gene fbxa-192 and its pseudogenes fbxa-191 and fbxa-193 were also under-expressed.",
        "Fourteen transcripts were over-expressed and 125 under-expressed in both ahr-1 mutants when compared to wild-type.",
        "The aryl hydrocarbon receptor (AHR) functions in higher organisms in development, metabolism and toxic responses."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26870725": [
        "The present review describes established assays commonly used to assess aquaporin function in cells and tissues, as well as the experimental biophysical strategies required to reveal functional regulation and identify modulators, the first step for aquaporin drug discovery.",
        "Appropriate methods for functional analysis comprising suitable cell models and techniques to accurately evaluate water and solute membrane permeability are essential to validate aquaporin function and assess short-term regulation.",
        "Water is the major component of cells and tissues throughout all forms of life.",
        "Fluxes of water and solutes through cell membranes and epithelia are essential for osmoregulation and energy homeostasis.",
        "Detecting aquaporin function is critical for assessing regulation and screening for new activity modulators that can prompt the development of efficient medicines.",
        "Aquaporins have important biological roles and have been implicated in several pathophysiological conditions suggesting a great translational potential in aquaporin-based diagnostics and therapeutics.",
        "Aquaporins are membrane channels expressed in almost every organism and involved in the bidirectional transfer of water and small solutes across cell membranes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29208350": [
        "Mesenchymal stem cells (MSCs) have the potential to differentiate into endothelial lineage cells, which makes them attractive candidates for therapeutic angiogenesis.",
        "The aim of this study was to investigate efficient differentiation of MSCs into ECs by inducing medium in vitro.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Endothelial cells (ECs) play an important role in neovascularisation, but are too limited in number for adequate therapeutic applications."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29243545": [
        "The largest proportion of CD4+CD25+ regulatory T cells was observed in the low-grade ureteral cancer group and almost none were observed in ureteral papillomas.",
        "The largest proportion of CD8+ cytotoxic T-lymphocytes was observed in the ureteral polyps.",
        "The largest proportion of CD16+CD68+ macrophages was observed in the high-grade ureteral cancer group, which was significantly higher than that observed in the ureteral papillomas.",
        "Objective To evaluate the role of macrophage infiltration in the differentiation process of ureteral polyps and cancers.",
        "The samples were immunohistochemically stained for cluster of differentiation (CD)4, CD8, CD16, CD25, CD56 and CD68 using immunofluorescence in order to identify different T-lymphocyte populations and macrophages.",
        "The largest proportion of CD56+ natural killer cells was detected in the ureteral polyps, with very low levels observed in the other three groups.",
        "Conclusions This study revealed that CD16+CD68+ macrophages appear to participate in ureteral neoplastic transformation.",
        "Results A total of 70 specimens were included in the analysis: 21 specimens of ureteral cancer, 17 specimens of ureteral papilloma, and 32 specimens of ureteral polyps.",
        "Methods This retrospective immunohistochemical study analysed archival samples of pathologically-confirmed specimens of low- and high-grade ureteral cancer, ureteral papilloma and ureteral polyps."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11381193": [
        "Overall, accurate classification of acute leukemias was possible from a simple peripheral blood sample in 62 of 66 cases (93.9%).",
        "The aim of this work was to determine the immunophenotyping profile of patients with leukemia, by means of a flow cytometric method: 66 blood samples coming from leukemic persons in the Sahel region were studied by flow cytometry, using about thirty monoclonal antibodies all marked with a fluorochrome, in one or two colour systems to assess their distribution according to type (lymphoid B or T / myeloid) and age, and to search for possible co-expressions of markers of different lineages.",
        "In agreement with studies from other countries, the majority of AML cases occurred among adults.",
        "The marked preponderance of childhood B-ALL in our series is, at least partly, attributable to the age distribution of the Tunisian population.",
        "The precision of immunological characterization of leukemias was improved by a certain number of technical innovations, particularly hybridoma production and standardization, resulting in monoclonal antibodies and definition of recognised cellular antigens (designated by CD: Cluster of Differentiation).",
        "A high proportion of AML cases in our series co-expressed markers of other lineages."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30406902": [
        "Longer-term, dolutegravir plus rilpivirine demonstrated durable maintenance of virological suppression and remained generally well tolerated for up to 100 weeks.",
        "Switching to once-daily dolutegravir plus rilpivirine was generally well tolerated and associated with more favourable renal and bone parameters than remaining on the current ART regimen.",
        "The fixed-dose STR combines the integrase strand transfer inhibitor dolutegravir with the non-nucleoside reverse transcriptase inhibitor rilpivirine.",
        "Thus, dolutegravir/rilpivirine provides a convenient alternative treatment option for some adults with HIV-1 infection and no history of virological failure who are already virologically suppressed on (and wish to switch from) their current ART regimen.",
        "Switching to a two-drug regimen of dolutegravir plus rilpivirine was also associated with high rates of virological suppression in real-world observational studies.",
        "Dolutegravir/rilpivirine (Juluca<sup>\u00ae</sup>) is the first two-drug single-tablet regimen (STR) to be approved for the treatment of HIV-1 infection in adults.",
        "In two phase III non-inferiority trials (SWORD-1 and SWORD-2) in treatment-experienced patients already virologically suppressed on their current antiretroviral (ART) regimen, switching to once-daily dolutegravir plus rilpivirine maintained virological suppression over 48 weeks."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29788413": [
        "It also provides lexicon-based concept tagging as well as the state-of-the-art pre-trained taggers such as TaggerOne, GNormPlus and tmVar. ezTag is freely available at http://eztag.bioqrator.org.",
        "To support annotating a wide variety of biological concepts with or without pre-existing training data, we developed ezTag, a web-based annotation tool that allows curators to perform annotation and provide training data with humans in the loop. ezTag supports both abstracts in PubMed and full-text articles in PubMed Central.",
        "Due to the limited training data available, however, current annotation systems primarily focus only on common concept types such as genes or diseases.",
        "Recently, advanced text-mining techniques have been shown to speed up manual data curation by providing human annotators with automated pre-annotations generated by rules or machine learning models."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28935156": [
        "Therefore, IL-17 receptor signaling in monocytes may potentiate the effects of IL-17A released by other immune cells and may aggravate neuroinflammation in ASD.",
        "Millions of children are affected by different neurodevelopmental disorders, out of which autism spectrum disorder (ASD) poses a major hurdle to normal life style due to associated behavioral abnormalities.",
        "With this background, we performed this study in peripheral monocytes of ASD patients and age-matched typically developing children.",
        "These data connect increased IL-17A/IL-17RA signaling in ASD patients with enhanced oxidative inflammation in monocytes.",
        "Our study shows that ASD individuals have increased IL-17RA expression in monocytes which is associated with increased nuclear factor kappa-light-chain-enhancer of activated B cells (NF\u03baB) pathway and inducible nitric oxide synthase (iNOS)/nitrotyrosine expression as compared to typically developing children.",
        "Our study further suggests that blockade of IL-17A/IL-17 receptor signaling may be beneficial in the children with ASD.",
        "Moreover, in vitro activation of IL-17 receptor by IL-17A in monocytes isolated from ASD individuals leads to enhanced iNOS expression via NF\u03baB pathway.",
        "IL-17A may enhance neuroinflammation via its IL-17A receptor, i.e. IL-17RA expressed in immune cells (such as monocytes) of autistic children.",
        "However, whether IL-17A/IL-17RA signaling contributes to oxidative inflammation in monocytes of autistic children has not been explored previously.",
        "Several studies have shown an increased expression/release of Th17 related cytokine, IL-17A in ASD.",
        "Increased oxidative stress has been implicated in a number of neuropsychiatric disorders including ASD.",
        "IL-17RA antibody treatment in vitro reversed IL-17A-induced increase in NF\u03baB and iNOS/nitrotyrosine expression in monocytes isolated from ASD subjects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28930285": [
        "IL-17A, markedly produced by T<sub>H</sub>17 cells even after the peak of inflammation, was found to participate in the negative regulation of LV formation.",
        "During inflammation lymphatic vessels (LVs) are enlarged and their density is increased to facilitate the migration of activated immune cells and antigens.",
        "Here we show that interleukin (IL)-17A, secreted from T helper type 17 (T<sub>H</sub>17) cells, is a negative regulator of lymphangiogenesis during the resolution phase of T<sub>H</sub>17-mediated immune responses.",
        "To investigate the role of IL-17A in vivo, we utilized a cholera toxin-mediated inflammation model and identified inflammation and resolution phases based on the numbers of recruited immune cells.",
        "Moreover, blockade of IL-17A resulted in not only increased density of LVs in tissues but also their enhanced function.",
        "However, after antigen clearance, the expanded LVs shrink to maintain homeostasis.",
        "Moreover, IL-17A suppresses the expression of major lymphatic markers in lymphatic endothelial cells and decreases in vitro LV formation.",
        "Taken together, these findings improve the current understanding of the relationship between LVs and inflammatory cytokines in pathologic conditions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28941323": [
        "IL-22 and IL-17A derive from both independent and overlapping lineages, defined as T helper (Th)22 and IL-22<sup>+</sup> Th17 cells.",
        "Donor Th22 and IL-22<sup>+</sup> Th17 cells share a similar IL-6-dependent developmental pathway, and while Th22 cells arise independently of the IL-22<sup>+</sup> Th17 lineage, IL-17 signaling to donor Th22 directly promotes their development in allo-SCT.",
        "Prevention and treatment of GVHD remain inadequate and commonly lead to end-organ dysfunction and opportunistic infection.",
        "Together, these data demonstrate a key role for donor-derived IL-22 in patients with chronic skin GVHD and confirm parallel but symbiotic developmental pathways of Th22 and Th17 differentiation.",
        "Graft-versus-host disease (GVHD) is the major cause of nonrelapse morbidity and mortality after allogeneic stem cell transplantation (allo-SCT).",
        "The role of interleukin (IL)-17 and IL-22 in GVHD remains uncertain, due to an apparent lack of lineage fidelity and variable and contextually determined protective and pathogenic effects.",
        "In the clinic, high levels of both IL-17A and IL-22 expression are present in the skin of patients with GVHD after allo-SCT.",
        "Importantly, while both IL-22 and IL-17 mediate skin GVHD, Th17-induced chronic GVHD can be attenuated by IL-22 inhibition in preclinical systems.",
        "We demonstrate that donor T cell-derived IL-22 significantly exacerbates cutaneous chronic GVHD and that IL-22 is produced by highly inflammatory donor CD4<sup>+</sup> T cells posttransplantation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30489337": [
        "The novel immunotherapy based on immune checkpoint inhibitors (ICIs) presents as the therapeutic 'Holly Grail' in lung cancer treatment.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Despite aggressive treatment based on definitive chemoradiotherapy, 5-year overall survival in unresectable stage III nonsmall cell lung cancer remains poor (15-20%)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28960263": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Monoclonal antibodies against programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) are effective therapies in patients with non-small cell lung cancer (NSCLC).",
        "Herein, the authors performed a systematic review investigating differences in the toxicities of PD-1 and PD-L1 inhibitors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29140105": [
        "Durvalumab (MEDI4736) is a selective, high-affinity, human IgG1 monoclonal antibody that blocks PD-L1, which binds to PD-1 and CD80, but not to PD-L2.",
        "In contrast, early data reveal lower response rates in EGFR and ALK-positive patients.",
        "Impressive activity has been recently reported after chemoradiation in locally advanced patients; promising activity was observed with other ICI combinations, and potentially with other drugs including platinum-based chemotherapy.",
        "Durvalumab is under evaluation in early, locally advanced and advanced disease as monotherapy and combined with ICIs, targeted therapies, chemotherapy and radiotherapy.",
        "Immune checkpoint inhibitors (ICIs) are a key component of treating advanced cancer patients, principally antibodies against CTLA-4 and PD-1 or PD-L1.",
        "Single-agent durvalumab showed clinical efficacy and a manageable safety profile in advanced non-small-cell lung cancer, particularly the \u226525% PD-L1+ population."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29069302": [
        "The main problem with checkpoint blockers is that only a fraction of patients respond to the therapy.",
        "Insufficient immune activation is considered as one of the main reason for low response rates and combination of checkpoint blockers has been proposed to increase the response rates.",
        "This review aims to help in design of optimal checkpoint blocker combinations by discussing the mechanistic details and outlining the subtle differences between major checkpoints targeted for cancer immunotherapy.",
        "The combination of checkpoint blockers was successful in melanoma but had significant adverse events.",
        "Six drugs including one CTLA-4 blocker (ipilimumab), two PD-1 blockers (nivolumab and pembrolizumab) and three PD-L1 blockers (atezolizumab, avelumab and durvalumab) are approved for the treatment of different types of cancers including both solid tumors such as melanoma, lung cancer, head and neck cancer, bladder cancer and Merkel cell cancer as well as hematological tumors such as classic Hodgkin's lymphoma.",
        "Among several checkpoint receptors of immune cells, cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), programmed cell death protein-1 (PD-1), T-cell immunoglobulin and ITIM domain (TIGIT), T-cell immunoglobulin-3 (TIM-3) and lymphocyte activation gene 3 (LAG-3) are the most commonly targeted checkpoints for cancer immunotherapy.",
        "A combination that is selected based on the mechanistic differences between checkpoints and the differences in expression of checkpoints and their ligands in the tumor microenvironment could have a synergistic effect in a given cancer subtype and also have a manageable safety profile.",
        "Checkpoint receptor blockers, known to act by blocking the pathways that inhibit immune cell activation and stimulate immune responses against tumor cells, have been immensely successful in the treatment of cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29303787": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      The therapeutic armamentarium for advanced non-small-cell lung cancer has evolved considerably over the past years.",
        "These immunotherapies are associated with a distinct toxicity profile based on autoimmune organ toxicity which is a new challenge for supportive care during treatment with these drugs.",
        "Immune checkpoint inhibitors targeting programmed cell death-1 such as pembrolizumab and nivolumab or programmed cell death ligand 1 such as atezolizumab, durvalumab and avelumab have shown favorable efficacy results in this patient population in the first-line and second-line setting."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29358503": [
        "Here, we discuss the clinical and translational implications of integrating PD-1/PD-L1 inhibitors in the management of patients with unresectable stage III NSCLC. <i>Clin Cancer Res; 24(6); 1271-6. \u00a92018 AACR</i>.",
        "In addition, preclinical and early clinical evidence suggests that chemotherapy and radiation may work synergistically with anti-PD-1/PD-L1 therapy to promote antitumor immunity, which has led to the initiation of clinical trials testing these drugs in patients with stage III NSCLC.",
        "Although cCRT is potentially curative, 5-year overall survival has hovered around 20%, despite extensive efforts to improve outcomes with increasing doses of conformal radiation and intensification of systemic therapy with either induction or consolidation chemotherapy.",
        "A preliminary report of a randomized phase III trial, the PACIFIC trial, demonstrated an impressive increase in median progression-free survival with consolidative durvalumab, a PD-L1 inhibitor, compared with observation after cCRT.",
        "Concurrent chemoradiation (cCRT) with platinum-based chemotherapy is standard-of-care therapy for patients with stage III unresectable non-small cell lung cancer (NSCLC).",
        "PD-1/PD-L1 immune checkpoint inhibitors have demonstrated unprecedented efficacy in patients with stage IV NSCLC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28705024": [
        "Ongoing clinical trials were also reviewed.",
        "The PACIFIC trial assessing durvalumab after standard chemoradiotherapy for locally advanced NSCLC has already met its primary endpoint and the potential of durvalumab will be reinforced if phase III randomized studies of first-line (MYSTIC trial) and second or subsequent (ARCTIC trial) lines of therapy demonstrate superiority over the current standard of care.",
        "The authors believe that durvalumab will likely play an important role in future treatment strategies for NSCLC.",
        "Other notable PD-L1 inhibitors under development include avelumab and durvalumab.",
        "ICI, such as the PD-1 inhibitors nivolumab and pembrolizumab and the PD-L1 inhibitor atezolizumab, have already been marketed for the treatment of pretreated patients with advanced NSCLC.",
        "Immune checkpoint inhibitors (ICI) are now a therapeutic option for advanced non-small cell lung cancer (NSCLC) patients.",
        "Areas covered: This article reviews literature on durvalumab development, from the preclinical data to the results of phase III clinical trials, whether published or presented at international scientific conferences.",
        "Expert opinion: Early phase trials of durvalumab monotherapy (and in combination) have demonstrated activity in advanced NSCLC patients and it has demonstrated a good safety profile."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19008962": [
        "Interaction with a complex formed by uPA and its inhibitor PAI-1 induces cell surface down regulation and recycling of the receptor via the clathrin-coated pathway, a process dependent on the association to LRP-1.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The urokinase receptor (uPAR/CD87) is highly expressed in malignant tumours. uPAR, as a GPI anchored protein, is preferentially located at the cell surface, where it interacts with its ligands urokinase (uPA) and the extracellular matrix protein vitronectin, thus promoting plasmin generation, cell-matrix interactions and intracellular signalling events."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11359936": [
        "These results demonstrate that GPI-anchored uPAR is endocytosed by piggybacking on LRP and that direct binding of occupied uPAR to LRP is essential for internalization of occupied uPAR, regeneration of unoccupied uPAR, plasmin generation, and invasion and migration through extracellular matrix.",
        "We found that in the absence of uPA:PAI-1, uPAR is randomly distributed along the plasma membrane, whereas uPA:PAI-1 promotes formation of uPAR-LRP complexes and initiates redistribution of occupied uPAR to clathrin-coated pits. uPAR-LRP complexes are endocytosed via clathrin-coated vesicles and traffic together to early endosomes (EE) because they can be coimmunoprecipitated from immunoisolated EE, and internalization is blocked by depletion of intracellular K(+).",
        "Here we investigated whether direct interaction between uPAR, a glycosyl-phosphatidylinositol-anchored protein, and LRP, a transmembrane receptor, is required for clearance of uPA:PAI-1, regeneration of unoccupied uPAR, activation of plasminogen, and the ability of HT1080 cells to invade extracellular matrix.",
        "Moreover, uPA-dependent plasmin generation and the ability of HT1080 cells to migrate through Matrigel-coated invasion chambers are also inhibited in the presence of D3.",
        "Direct binding of domain 3 (D3) of uPAR to LRP is required for clearance of uPA-PAI-1-occupied uPAR because internalization is blocked by incubation with recombinant D3.",
        "Low-density lipoprotein receptor-related protein (LRP) mediates internalization of urokinase:plasminogen activator inhibitor complexes (uPA:PAI-1) and the urokinase receptor (uPAR)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28284174": [
        "This relationship is studied at age five and age eight (school age), and disaggregated across socioeconomic factors of gender, urban/rural setting and indigenous/nonindigenous status.",
        "However, after correcting for possible bias due to unobservable heterogeneity, there is little evidence of this relationship.",
        "On the other end of the weight distribution, indigenous children who are severely thin or thin have significantly lower cognitive scores, a relationship that holds after correcting for possible bias and appears to strengthen between ages of five and eight.",
        "The one exception is for a weakly significant relationship between obese female children and higher cognition, a relationship which tends to weaken between the ages of five and eight.",
        "This paper contributes to a very small set of literature on child cognition and obesity, points to the importance of controlling for unobserved heterogeneity in estimation, and is the first of its kind to study this relationship in a developing country.",
        "Child weight status is measured by a full distribution of child weight, from severely thin to obese, using data from a z-score for body mass index and cognition is measured by the Spanish version of the Picture Peabody Vocabulary Test (PPVT).",
        "This paper exploits three rounds of panel data provided by the Peruvian dataset of the Young Lives study to investigate the relationship between child cognition and obesity status among the poor.",
        "The initial results suggests that obese children have higher cognitive scores and that this result is driven by those who are female, non-indigenous and live in an urban region."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28837952": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Obesity has been implicated in the pathophysiology of major depressive disorder (MDD), which prompted us to examine the possible association of obesity with cognitive function and brain structure in patients with MDD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26107577": [
        "Annu Rev Psychol 2009;60:173-96]-a conceptual model designed to relate brain structure and function to one's level of cognitive ability.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      This review focuses on the relationship between obesity and aging and how these interact to affect cognitive function.",
        "The topics covered are guided by the Scaffolding Theory of Aging and Cognition (STAC [Park and Reuter-Lorenz."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15591798": [
        "General obesity (BMI &gt; or = 25) and poor cognition were strongly associated in the presence of abdominal obesity.",
        "Cognitive function was ascertained using the Korean Mini-Mental State Examination (K-MMSE), and obesity using anthropometric measures including waist circumference and body mass index (BMI).",
        "This study aimed to investigate associations between obesity and poor cognitive performance using data from a community study of 467 individuals aged &gt; or = 65 years in South Korea.",
        "Poor cognitive performance was present in 37% of the sample.",
        "Interaction terms with abdominal obesity for BMI increase were significant (p = 0.007).",
        "Obesity was associated with poor cognition, and obesity indexes must be carefully considered to reveal this relationship.",
        "Poor cognition was negatively associated with overweight (BMI 23-25) with normal waist circumference."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24119725": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Previous studies investigating the relationship between obesity and cognition as well as gender differences in these relationships reported equivocal results.",
        "Here, we examined age, years of education, schizophrenia, and gender differences which might affect the relationship between obesity and cognition."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26928024": [
        "Individuals with mood disorders (bipolar disorder (BD) or major depressive disorder (MDD)) display an increased prevalence of both obesity and risk factors for cardiovascular diseases.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Obesity is a common medical illness that is increasingly recognised as conferring risk of decline in cognitive performance, independent of other comorbid medical conditions.",
        "The independent contribution of obesity to cognitive decline in this population has not been explored.",
        "This study examines the impact of obesity on cognition by comparing neuropsychological performance in obese individuals, with or without a mood disorder before and after undergoing bariatric surgery.",
        "Moreover, BD and MDD are associated with impairment in cognitive functioning across multiple domains."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23922324": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Overweight and obesity are risk factors for cardiovascular disease.",
        "There is also an association between body mass index (BMI) and cognitive ability.",
        "Since low birth weight is associated with adult metabolic disease, particularly in obese subjects, the question emerges whether obesity has an additional negative effect on cognitive function in subjects with low birth weight."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25496905": [
        "Importantly, withdrawal of the palatable diet led to a stress-like response.",
        "Obesity-related inflammatory changes have been found in the human brain.",
        "Furthermore, access to this palatable diet attenuated the physiological effects of acute stress (restraint), indicating that it could act as a comfort food.",
        "Changes in food composition and availability have contributed to the dramatic increase in obesity over the past 30-40 years in developed and, increasingly, in developing countries.",
        "Excess sugar alone had similar effects, and both diets were linked to increased inflammatory markers in the hippocampus, a critical region involved in memory.",
        "These data have implications for minimizing harm caused by unhealthy eating.",
        "Ongoing work examines interventions to prevent or reverse diet-induced cognitive impairments.",
        "Some human studies have demonstrated increased preference for high fat and high sugar foods in people reporting greater stress exposure.",
        "We have examined neurochemical changes in the brain in rodent models during the development of obesity, including the impact of obesity on cognition, reward neurocircuitry and stress responsiveness.",
        "Impairments in cognitive function have been associated with obesity in both people and rodents.",
        "The brain plays a critical role in regulating energy balance.",
        "However, as little as 1 week of exposure to a high fat, high sugar diet selectively impaired place but not object recognition memory in the rat.",
        "In more chronic studies, the diet also attenuated anxiety-like behavior in rats exposed to stress (maternal separation) early in life, but these rats may suffer greater metabolic harm than rats exposed to the early life stressor but not provided with the palatable diet.",
        "Using supermarket foods high in fat and sugar, we showed that such a diet leads to changes in neurotransmitters involved in the hedonic appraisal of foods, indicative of an addiction-like capacity of foods high in fat and/or sugar."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26638123": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To test the hypothesis that obesity is associated with impaired cognitive outcomes in the pre-school years."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28514983": [
        "The review concludes that there is consistent evidence in the animal literature and emerging evidence from human studies that supports this VCM.",
        "It is also noted, however, that to date studies lack the nutritional specificity needed to be able to translate these basic research findings into clear nutritional effects, and concludes that there is an urgent need for additional research to clarify the precise nature of the apparent effects of consuming HFS diets on cognition.",
        "These findings lead into the vicious cycle model (VCM), which suggests that these cognitive changes have knock-on negative effects for future appetite control, and evidence that altered hippocampal function is also associated with impaired appetite control is explored.",
        "There is parallel evidence that people who are overweight or obese tend to perform worse on a variety of cognitive tasks.",
        "There is increasing evidence for important roles of key cognitive processes, including attention, memory and learning, in the short-term decision making about eating.",
        "In this review, the evidence for these two ideas is summarised and then the idea that overconsumption of Western-style high-fat (HF)-high-sugar diets may underlie the association between obesity and poorer cognitive performance is explored.",
        "In particular, evidence in animals and human subjects that repeated consumption of HF or HF and sugar (HFS) diets leads to specific impairments in the functioning of the hippocampus, which underpin the consequent changes in cognition is summarised."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22258511": [
        "In particular, the neuropsychological sequelae of obesity carry wide ranging functional implications.",
        "Obesity is a significant contemporary health concern that carries wide-ranging implications for society, as well as for individual health and well-being.",
        "The review culminates in a preliminary model of obesity-related cognitive dysfunction and suggestions for future research, including the potential reversibility of these changes with weight-loss.",
        "The present review integrates the recent literature regarding patterns of obesity-related cognitive dysfunction and brain alterations and also indicates potential mechanisms for these neuropathological changes.",
        "While research in this area is growing, our knowledge of obesity-related cognitive dysfunction and brain alterations has not yet been synthesized."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26163814": [
        "These articles indicate that the age of onset of Type 1 diabetes may be relevant to future cognitive function and that disease duration of Type 2 diabetes and sociocultural factors are related to cognitive decline during the aging process.",
        "The collection of articles highlights the importance of using a life span perspective to understand the influence of both Type 1 and Type 2 diabetes on brain metabolism, function, and structure.",
        "Diabetes and obesity, two major public health concerns, are associated with increased risk for problems in multiple organ systems, including the central nervous system.",
        "The hypothalamus and other neural circuits, notably the dopaminergic system that underlies feeding and reward-related aspects of food intake, are among the key factors involved in obesity.",
        "Moreover, these studies show that distressing environmental circumstances can adversely influence neurocognitive dysfunction associated with obesity and diabetes.",
        "This special issue concludes with a conceptual framework for linking obesity and diabetes with accelerated cognitive decline as related to the aging process.",
        "The adverse effects of diabetes and obesity on cognitive functioning are increasingly well recognized.",
        "This special issue of Psychosomatic Medicine features the latest research linking diabetes, obesity, and brain structure, function, and metabolism and follows a special meeting on this topic organized by the American Psychosomatic Society in October 2013.",
        "Research on the associations between obesity and cognitive function is described using the positive effects of weight reduction following bariatric surgery or behavioral methods.",
        "Evidence for the increased prevalence of diabetes and obesity is reviewed as it relates to cognitive decline."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29675744": [
        "TaiMed Biologics is developing ibalizumab (Trogarzo\u2122, ibalizumab-uiyk)-a humanised IgG4 monoclonal antibody-as a treatment for HIV-1 infection.",
        "This article summarizes the milestones in the development of ibalizumab leading to this first approval in HIV-1 treatment.",
        "Ibalizumab blocks HIV entry into CD4 cells while preserving normal immunological function and is the first CD4-directed post-attachment HIV-1 inhibitor and the first humanised monoclonal antibody for the treatment of HIV/AIDS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29689540": [
        "Investigational nonnucleoside analogue reverse transcriptase inhibitors (NNRTIs) include doravirine, which is active in vitro against NNRTI-resistant HIV and was potent and well-tolerated when used in combination with a dual-nucleoside analogue RTI (nRTI) backbone in treatment-naive individuals.New integrase strand transfer inhibitors (InSTIs) include recently approved bictegravir, which is active against InSTI-resistant viral strains in vitro and was potent and well-tolerated in combination regimens in treatment-naive individuals, and investigational cabotegravir, which is being studied with monthly parenteral dosing for HIV maintenance treatment and with bimonthly dosing for HIV preexposure prophylaxis (PrEP).",
        "This article summarizes presentations by Roy M. Gulick, MD, MPH, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in Los Angeles, California, in April 2017, and at the 2017 Ryan White HIV/AIDS Program Clinical Conference, held in San Antonio, Texas, in August 2017.",
        "Investigational HIV entry inhibitors include the new CD4 attachment inhibitor fostemsavir, which targets HIV envelope glycoprotein 120, and recently approved ibalizumab, which binds the CD4 receptor.",
        "Over the past 30 years, antiretroviral drug regimens for treating HIV infection have become more effective, safer, and more convenient.",
        "Investigational antiretroviral drugs include the nucleoside analogue reverse transcriptase translocation inhibitor (NRTTI) MK-8591, a long-acting compound that could be dosed once weekly.",
        "Despite 31 currently approved drugs, the pipeline of investigational HIV drugs remains full."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29746266": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Antiretroviral options for patients infected with multiclass resistant HIV-1 warrant the development of new agents with unique mechanisms of action and modes of delivery.",
        "Here we review one such agent, ibalizumab, a parenteral CD4 postattachment inhibitor that has demonstrated efficacy as part of combination antiretroviral therapy in the treatment of HIV-1."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29989910": [
        "Trogarzo (ibalizumab-uiyk) is a CD4-directed post-attachment HIV-1 inhibitor, indicated for use with other antiretroviral inhibitors in adults with multidrug resistant HIV-1 infection who aren't responding to their antiretroviral regimen.",
        "But FDA approval was based on a study of only 40 people-and it had no control group.",
        "It is considered an advance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30110589": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Ibalizumab, a humanized IgG4 monoclonal antibody, blocks the entry of human immunodeficiency virus type 1 (HIV-1) by noncompetitive binding to CD4."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30378502": [
        "Recently, two new drugs among the new generation of entry inhibitors showed promises for both their characteristics and mechanism of action.",
        "In order to ensure sustained HIV-RNA suppression in these patients and to improve current antiretroviral treatment regimens in the fight against multi-drug resistant strains, new drugs are needed.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Heavily treated HIV-1 infected patients may have limited therapeutic alternatives."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28429756": [
        "Numerous crystal structures of HIV gp120 have been reported, alone or with receptor CD4 and cognate antibodies; however, no sole gp120/CD4 complex without stabilization by an antibody is available.",
        "A mutagenesis study on critical residues revealed that the stability of this interface is important for the efficiency of Env-mediated membrane fusion.",
        "Interestingly, in addition to the canonical binding surface, a second interacting interface was identified.",
        "Therefore, we identified the possibility of the involvement of a second gp120-CD4 interaction interface during viral entry, and also provided a reasonable explanation for the broad activity of neutralizing antibody ibalizumab.",
        "Here, we report a crystal structure of the gp120/CD4 complex without the aid of an antibody from HIV-1 CRF07_BC, a strain circulating in China.",
        "Furthermore, we found that a broad neutralizing antibody, ibalizumab, which targets CD4 in the absence of gp120, occupies the same binding surface as the second interface identified here on gp120."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28480599": [
        "We examined whether laboratory accuracy improves with longer EQA participation and whether IQA remediation is effective.",
        "Selected laboratories are required to have oversight, performance monitoring, and remediation undertaken by Immunology Quality Assessment (IQA) staff under the DAIDS contract.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The United Kingdom National External Quality Assessment Service (UK NEQAS) for Leucocyte Immunophenotyping Immune Monitoring Programme, provides external quality assessment (EQA) to non-U.S. laboratories affiliated with the NIH NIAID Division of AIDS (DAIDS) clinical trials networks."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28605137": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To elucidate the diversity of systemic lupus erythematosus (SLE) based on immunophenotyping."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27749361": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      This review gives an overview of the systems-immunology single-cell proteomic and transcriptomic approaches that can be applied to study primary immunodeficiency.",
        "It also introduces recent advances in multiparameter tissue imaging, which allows extensive immune phenotyping in disease-affected tissue."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9660728": [
        "Clinical applications of flow cytometry currently utilized in the laboratory include cell surface antigen determinations or immunophenotyping of hematologic cells, DNA analysis of hematopoietic malignancies and solid tumors, and measurement of CD4 (T helper/inducer cell) absolute counts and T helper/T suppressor (CD4/CD8) ratios in the evaluation of immune deficiency.",
        "Flow cytometry often offers a more rapid, sensitive, accurate, and quantitative means of analyzing a particular cell population in a heterogeneous cell suspension as compared to more traditional microscopic methods.",
        "Flow cytometry is an innovative technology that measures certain cell parameters as the cells flow in a fluid stream and in single file past an analytical laser light source.",
        "This article is intended to provide a general understanding of the technological basis of how a flow cytometer functions as well as an overview of both current and future flow cytometric clinical laboratory applications."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28133951": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      The workup of lymphoproliferative disorders (LPDs) involves the combined use of flow cytometry (FC) and immunohistochemistry (IHC).",
        "We aimed to establish a cost-effective diagnostic algorithm based on initial FC categorization to reduce repetitive immunophenotyping.",
        "This often results in duplicate immunophenotypic testing and adds costs that may not be eligible for reimbursement based on the Medicare National Correct Coding Initiative."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29357074": [
        "Subcutaneous emicizumab-kxwh is awaiting approval in several countries worldwide, including in the EU and Japan, and is undergoing phase 3 development in haemophilia A without FVIII inhibitors.",
        "Emicizumab-kxwh (Hemlibra<sup>\u00ae</sup>) is a bispecific humanized monoclonal antibody that restores the function of missing activated FVIII by bridging activated FIX and FX to facilitate effective haemostasis in patients with haemophilia A. Subcutaneous emicizumab-kxwh is approved in the USA for use as routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and paediatric patients with haemophilia A (congenital FVIII deficiency) with FVIII inhibitors.",
        "This article summarizes the milestones in the development of emicizumab-kxwh leading to its first global approval for use as prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with haemophilia A."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29214439": [
        "In phase I-I/II studies, emicizumab reduced the bleeding frequency in patients with severe hemophilia A, regardless of the presence of factor VIII inhibitors, at once-weekly subcutaneous doses of 0.3, 1, and 3 mg/kg.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Emicizumab (ACE910) is a bispecific antibody mimicking the cofactor function of activated coagulation factor VIII."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29645406": [
        "Activity of Emi in the co-presence of factor VIII or bypassing agents was quantified.",
        "Essentials The activated partial prothrombin time (aPTT) cannot predict the activity of emicizumab (Emi).",
        "This assay is useful for assessing coagulation potential in Emi-treated hemophilia A.",
        "Adjusted clot waveform analyses using a prothrombin time (PT)/aPTT initiator were developed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29769259": [
        "Hemophilia and von Willebrand disease are the most common congenital bleeding disorders.",
        "Treatment of these disorders has focused on replacement of the missing coagulation factor to prevent or treat bleeding.",
        "New technologies and insights into hemostasis have driven the development of many promising new therapies for hemophilia and von Willebrand disease.",
        "Emerging bypass agents including zymogen-like factor IXa and Xa molecules are in development and a bispecific antibody, emicizumab, demonstrated efficacy in a phase 3 trial in people with hemophilia A and inhibitors.",
        "The first recombinant von Willebrand factor (VWF) product has been approved and has unique VWF multimer content and does not contain factor VIII.",
        "Tissue factor pathway inhibitor, the protein C/S system, and antithrombin are targets of novel compounds in development to alter the hemostatic balance and new approaches using modified factor VIII molecules are being tested for prevention and eradication of inhibitor antibodies in hemophilia A.",
        "These new approaches may offer better routes of administration, improved dosing regimens, and better efficacy for prevention and treatment of bleeding in congenital bleeding disorders."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29734520": [
        "A mixture of two anti-Emi monoclonal antibodies (mAb) effectively neutralized the Emi activity.",
        "The inclusion of anti-Emi mAbs in routine FVIII assays would be useful for Emi-treated patients.",
        "Anti-Emi mAbs completely eliminated the influence of Emi on FVIII activity and inhibitor titer.",
        "Essentials Emicizumab (Emi) affects the APTT-based assays of factor (F)VIII activity and inhibitor titer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29888855": [
        "Combined bypassing agent and bispecific antibody increased thrombin generation up to 17-fold.",
        "Thrombotic effects should be considered when combining emicizumab with plasma bypassing agent.",
        "Essentials Patients with hemophilia A and inhibitors receiving emicizumab experience breakthrough bleeding.",
        "Safety concerns may exist when combining emicizumab with bypassing agents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28862760": [
        "Aberrant c-Met activity has been implicated in the development of hepatocellular carcinoma (HCC), suggesting that c-Met inhibition may have therapeutic potential.",
        "Preliminary results suggest that selective c-Met inhibitors have antitumor activity in HCC, with acceptable safety and tolerability in patients with Child-Pugh A liver function.",
        "(Hepatology 2018;67:1132-1149).",
        "In contrast, selective c-Met inhibitors (tepotinib, capmatinib) can be dosed at a level predicted to achieve complete inhibition of tumor c-Met activity.",
        "Ongoing trials have been designed to assess the efficacy and safety of selective c-Met inhibition compared with standard therapy in patients with HCC that were selected based on tumor c-Met status.",
        "Thus, c-Met inhibition continues to be an active area of research in HCC, with well-designed trials in progress to investigate the benefit of selective c-Met inhibitors.",
        "This lack of observed efficacy is likely due to several factors, including trial design, lack of patient selection according to tumor c-Met status, and the prevalent off-target activity of these agents, which may indicate that c-Met inhibition is incomplete.",
        "However, clinical trials of nonselective kinase inhibitors with c-Met activity (tivantinib, cabozantinib, foretinib, and golvatinib) in patients with HCC have failed so far to demonstrate significant efficacy.",
        "Moreover, results from early trials can be used to optimize the design of clinical trials of these agents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29253194": [
        "Chemotherapy is one of the most important treatment modalities for advanced hepatocellular carcinoma (HCC).",
        "At present, various novel combination regimens including these agents are currently under development.",
        "Hepatic arterial infusion chemotherapy (HAIC) is frequently adopted for the treatment of locally advanced HCC in Japan, based on reports of high response rates and favorable long-term outcomes.",
        "More recently, promising outcomes have also been reported with new agents, such as nivolumab and cabozantinib.",
        "In 2016, a clear survival benefit of regorafenib over placebo was demonstrated in HCC patients showing disease progression after sorafenib treatment.",
        "Following the introduction of sorafenib for the treatment of HCC, Phase III trials of numerous other agents as first-line or second-line chemotherapy have been conducted to determine if any of these agents might offer superior survival benefit to sorafenib.",
        "On the basis of the results of two pivotal Phase III placebo-controlled studies, sorafenib is currently acknowledged worldwide as the standard therapeutic agent for advanced HCC.",
        "A year later, in 2017, lenvatinib has been shown to be non-inferior to sorafenib, in terms of the overall survival, in chemo-na\u00efve patients with advanced HCC.",
        "In the future, demonstration of the survival advantage of HAIC and the recognition of HAIC as one of the standard treatments for patients with advanced HCC are expected.",
        "Although some randomized controlled trials of HAIC plus sorafenib vs. sorafenib alone as first-line therapy have been conducted in patients with advanced HCC, no firm evidence of the superiority of one over the other has been established yet."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29505843": [
        "Treating HCC and designing clinical trials are particularly challenging because co-existing liver disease, present in most patients, limits aggressive therapeutic options.",
        "Positive results in recent phase III clinical trials have confirmed the high value of anti-angiogenic therapies for HCC in both first (sorafenib and lenvatinib) and second line (regorafenib and cabozantinib) treatment modalities.",
        "Hepatocellular carcinomas (HCCs) are characterised by considerable phenotypic and molecular heterogeneity.",
        "However, failure of several large randomised controlled clinical trials over the last 10 years underlines the necessity for innovative treatment strategies and implementation of translational findings to overcome the unmet clinical need.",
        "Furthermore, the promising results from novel immunotherapies are likely to complement the landscape of active compounds for HCC and will require a completely different approach to patients, as well as the development of prognostic/predictive biomarkers.",
        "Given our increasing understanding of the most abundant molecular alterations in HCC, effective enrichment of patients based on clinical and molecular biomarkers, as well as adaptive clinical trials, are now feasible and should be implemented.",
        "Herein, we aim to review important aspects of precision medicine approaches in HCC that might contribute to improving the molecular subclassification of patients in a clinical trial setting and pave the way for novel therapeutic strategies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29913090": [
        "In recent years, immune checkpoint inhibitors have shown promising clinical activity and safety in patients with advanced HCC.",
        "However, few agents have shown efficacy.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Many clinical trials have been conducted with chemotherapies in patients with advanced hepatocellular carcinoma (HCC).",
        "It is thought that the efficacy of some agents might have resulted from the heterogeneity of tumors, insufficient dosages due to liver cirrhosis, and post-therapy effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29972759": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Cabozantinib inhibits tyrosine kinases, including vascular endothelial growth factor receptors 1, 2, and 3, MET, and AXL, which are implicated in the progression of hepatocellular carcinoma and the development of resistance to sorafenib, the standard initial treatment for advanced disease.",
        "This randomized, double-blind, phase 3 trial evaluated cabozantinib as compared with placebo in previously treated patients with advanced hepatocellular carcinoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29807383": [
        "<strong class=\"sub-title\">\n          Status quo:\n        </strong>\n      \n      Hepatocellular carcinoma guidelines are currently under revision.",
        "A new edition is expected in 2018.",
        "Surgical resection or liver transplantation are curative treatment options for early stage HCC.",
        "Patients with chronic liver diseases or cirrhosis require HCC screening by ultrasound every 6 months."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29783126": [
        "A key recommendation in the management of patients receiving sorafenib is to promote close communication between the patient and the physician so that adverse events (AEs) are detected early and severe AEs can be prevented.",
        "More recently, regorafenib and nivolumab have received approval in the second-line setting after sorafenib, with further positive phase 3 studies emerging in the first line (lenvatinib non-inferior to sorafenib) and second line versus placebo (cabozantinib and ramucirumab).",
        "The hepatocellular carcinoma (HCC) treatment landscape changed a decade ago, with sorafenib demonstrating survival benefit in the first-line setting and becoming the first systemic therapy to be approved for HCC.",
        "Sorafenib-related AEs have been identified as clinical biomarkers for sorafenib efficacy.",
        "Healthcare professionals have become more efficient in managing AEs, identifying patients who are likely to benefit from treatment, and assessing response to treatment, resulting in a trend towards increased overall survival in the sorafenib arms of clinical studies.",
        "The rapidly changing treatment landscape due to the emergence of new treatment options (sorafenib and lenvatinib equally effective in first line; regorafenib, cabozantinib, and ramucirumab showing OS benefit in second line with nivolumab approved by the FDA based on response rate) underscores the importance of re-assessing the role of the first approved systemic agent in HCC, sorafenib."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29283440": [
        "Cabozantinib is an oral small-molecule multitargeted tyrosine kinase inhibitor (TKI) that may confer an advantage over other TKIs that target a single receptor.",
        "Common adverse events are reviewed, and management strategies for select adverse events are discussed.",
        "Rationale for use, clinical trial data, and current recommendations for cabozantinib in renal cell cancer, thyroid cancer, prostate cancer, hepatocellular cancer, and lung cancer are detailed in this article.",
        "It was approved by the U.S. Food and Drug Administration for the treatment of both advanced renal cell carcinoma and progressive metastatic medullary thyroid cancer, and it is being investigated for a wide array of other malignancies.",
        "Implications for contemporary practitioners are also provided because use of this novel agent is likely to increase as more studies are completed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30039640": [
        "Since then many drugs failed in the first- and second-line setting and it took almost another decade until further tyrosine kinase inhibitors succeeded in phase III trials.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The approval of the tyrosine kinase inhibitor sorafenib in 2007 marked a milestone in the treatment of hepatocellular carcinoma, as sorafenib was the first systemic therapy to show a survival benefit in patients with advanced hepatocellular carcinoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30317696": [
        "Careful evaluation of the clinical trials for approved systemic treatments of HCC is crucial when considering the best options for those with HCC recurrence after LT.",
        "Physicians and patients alike will greatly benefit from this expanded arsenal of treatments once all these new drugs for the treatment of HCC finally become available.",
        "We have also summarized from a critical and clinical point of view the issues involved in the management of patients who are candidates for systemic treatment in this era of multiple drugs for the same indication.",
        "In addition, nivolumab as a second-line agent was approved by the US Food and Drug Administration in 2017 based on improved radiological response data.",
        "Although several first-line or second-line treatments have been shown to be effective for HCC, each of these trials was composed of its own specific populations, and those with HCC recurrence after LT were excluded.",
        "Unfortunately, in our review of the available data, we found a conspicuous lack of approved systemic treatments for HCC in the distinct setting of after liver transplantation (LT).",
        "The principal advancements in the treatment of hepatocellular carcinoma (HCC) are the use of new systemic treatments, such as lenvatinib in first-line treatment and regorafenib, cabozantinib, and ramucirumab in second-line treatment, because of their benefits in terms of overall survival."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30308081": [
        "Intermediate stage HCC, or Barcelona Clinic Liver Cancer stage B, is regarded as a heterogeneous category with a wide spectrum of tumors and patients, and several subclassifications of the stage have been proposed to show different prognoses; there are also different recommended therapies in each subgroup.",
        "Transcatheter arterial therapies for hepatocellular carcinoma (HCC) have developed during the last decade.",
        "Because of differences of available medical resources and techniques in treatment procedures between countries, the most ideal and useful subgrouping remains inconclusive at present.",
        "Other molecular-targeted and immune-oncological medicines are expected to follow in the near future.",
        "Recent prospective and retrospective studies supported the usefulness of platinum agents as a chemotherapeutic at the time of varied TACE therapy.",
        "Authors have subclassified patients based on combinations of tumor size, tumor number, and liver function, with or without performance status.",
        "Some studies have suggested an advantage of early introduction of molecular-targeted therapy for TACE-resistant HCC in the intermediate stage.",
        "Although balloon-occluded TACE is an effective therapy for localized HCC and drug-eluting microspheres seemed to show a higher response rate in certain HCCs, the definite advantages of those procedures still remain uncertain.",
        "A fine powder formulation of cisplatin and the new platinum agent miriplatin became standard medicines in addition to anthracyclines in transcatheter arterial chemoembolization (TACE) in Japan.",
        "Recently, a few systemic chemotherapies proved to be effective for advanced stage HCC in phase III studies: lenvatinib as the first line of therapy, and regorafenib, cabozantinib, and ramucirumab as second-line therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28703624": [
        "Cabozantinib is approved for progressive metastatic medullary thyroid cancer and previously treated renal cell carcinoma, and is in development for multiple solid tumors.",
        "Cabozantinib is oral, small-molecule tyrosine kinase inhibitor that primarily targets MET, VEGFR2, AXL and RET, with additional effect on KIT and FLT3.",
        "It has been granted orphan drug status in the USA for this indication.",
        "This is an area of interest to improve outcomes and quality of life.",
        "Despite clinical studies with different mechanisms of action, no new systemic therapies were approved for hepatocellular carcinoma (HCC) between sorafenib in 2007 and regorafenib in 2017.",
        "Given positive results from a Phase II study, cabozantinib is under evaluation in a Phase III randomized controlled trial for patients with advanced HCC previously treated with sorafenib.",
        "This review summarizes the development of cabozantinib in HCC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28934466": [
        "Here, we report that Esco2 localizes to the chromosomes during oocyte meiotic maturation.",
        "Furthermore, depletion of Esco2 causes a severely impaired spindle assembly and chromosome alignment, accompanied by the remarkably elevated incidence of defective kinetochore-microtubule attachments which consequently lead to the generation of aneuploid eggs.",
        "However, its exact roles during oocyte meiosis have not clearly defined.",
        "Mutations in Esco2 cause Roberts syndrome, a developmental disease characterized by severe prenatal retardation as well as limb and facial abnormalities.",
        "Thus, our data assign a novel meiotic function to Esco2 beyond its role in the cohesion establishment during mouse oocyte meiosis.",
        "Depletion of Esco2 by morpholino microinjection leads to the precocious polar body extrusion, the escape of metaphase I arrest induced by nocodazole treatment and the loss of BubR1 from kinetochores, indicative of inactivated SAC.",
        "Notably, we find that the involvement of Esco2 in SAC and kinetochore functions is mediated by its binding to histone H4 and acetylation of H4K16 both in vivo and in vitro.",
        "Sister chromatid cohesion, mediated by cohesin complex and established by the acetyltransferases Esco1 and Esco2, is essential for faithful chromosome segregation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28422453": [
        "These include Roberts syndrome (RBS), Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome (WABS).",
        "Defects in mitotic failure and apoptosis i.e. trans DNA tethering events are believed to be the underlying cause of RBS, whereas the underlying cause of CdLS is largely modeled as occurring through defects in transcriptional processes i.e. cis DNA tethering events.",
        "We propose that transcriptional deregulation is the predominant mechanism through which cohesinopathies arise.",
        "We highlight numerous studies that illustrate the utility of zebrafish to provide novel insights into the phenotypes, genes affected and the possible mechanisms underlying cohesinopathies.",
        "Though these syndromes share a similar suite of phenotypes and arise due to mutations in a common cohesion pathway, the underlying mechanisms are currently believed to be distinct.",
        "Developmental Dynamics 246:881-888, 2017. \u00a9 2017 Wiley Periodicals, Inc.",
        "Here, we review recent findings described primarily in zebrafish, paired with additional studies in other model systems, including human patient cells, which challenge the notion that cohesinopathies represent separate syndromes.",
        "Genetic mapping studies reveal that mutations in cohesion pathways are responsible for multispectrum developmental abnormalities termed cohesinopathies.",
        "The cohesinopathies are characterized by overlapping phenotypes ranging from craniofacial deformities, limb defects, and mental retardation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26710928": [
        "In conclusion, we report a novel ESCO2 mutation and expand the clinical spectrum of Roberts syndrome.",
        "Further, sequencing of the ESCO2 gene identified a novel mutation c.244_245dupCT (p.T83Pfs*20) in one family besides two previously reported mutations c.760_761insA (p.T254Nfs*27) and c.764_765delTT (p.F255Cfs*25).",
        "A literature review and case comparison was performed.",
        "Serial fetal ultrasound examinations and measurements of long bones diagnosed two affected fetuses in two of the studied families.",
        "The severity of the mesomelic shortening of the limbs and craniofacial anomalies showed variability among patients.",
        "All patients presented with growth retardation, mesomelic shortening of the limbs more in the upper than in the lower limbs and microcephaly.",
        "Roberts syndrome and SC phocomelia syndrome are rare autosomal recessive genetic disorders representing the extremes of the spectrum of severity of the same condition, caused by mutations in ESCO2 gene.",
        "Interestingly, patient 1 had abnormal skin hypopigmentation.",
        "We report three new patients with Roberts syndrome from three unrelated consanguineous Egyptian families.",
        "Patients were subjected to clinical, cytogenetic and radiologic examinations.",
        "All mutations were in homozygous state, in exon 3.",
        "Cytogenetic analysis showed the characteristic premature separation of centromeres and puffing of heterochromatic regions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26729373": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Roberts syndrome (RBS) is a human developmental disorder caused by mutations in the cohesin acetyltransferase ESCO2.",
        "We previously reported that mTORC1 signaling was depressed and overall translation was reduced in RBS cells and zebrafish models for RBS.",
        "Treatment of RBS cells and zebrafish RBS models with L-leucine partially rescued mTOR function and protein synthesis, correlating with increased cell division and improved development."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29084713": [
        "RBS arises due to autosomal recessive mutations in cohesin auxiliary factor <i>ESCO2</i>, the gene that encodes an N-acetyltransferase which targets the SMC3 subunit of the cohesin complex.",
        "CdLS arises due to autosomal dominant mutations or haploinsufficiencies in cohesin subunits (<i>SMC1A</i>, <i>SMC3</i> and <i>RAD21</i>) or cohesin auxiliary factors (<i>NIPBL</i> and <i>HDAC8</i>) that result in transcriptional dysregulation of developmental programs.",
        "A popular model states that RBS arises due to mitotic failure and loss of progenitor stem cells through apoptosis.",
        "Here, we show that morpholino-mediated knockdown of <i>smc3</i> reduces <i>cx43</i> expression and perturbs zebrafish bone and tissue regeneration similar to those previously reported for <i>esco2</i> knockdown.",
        "Previously, we used the clinically relevant <i>CX43</i> to demonstrate a transcriptional role for Esco2. <i>CX43</i> is a gap junction gene conserved among all vertebrates that is required for direct cell-cell communication between adjacent cells such that <i>cx43</i> mutations result in oculodentodigital dysplasia.",
        "In support of this model, chromatin immunoprecipitation assays reveal that Smc3 binds to a discrete region of the <i>cx43</i> promoter, suggesting that Esco2 exerts transcriptional regulation of <i>cx43</i> through modification of Smc3 bound to the <i>cx43</i> promoter.",
        "Previous findings in the zebrafish regenerating fin, however, suggest that Esco2<i>-</i>knockdown results in transcription dysregulation, independent of apoptosis, similar to that observed in CdLS patients.",
        "Also similar to Esco2-dependent phenotypes, Smc3-dependent bone and tissue regeneration defects are rescued by transgenic Cx43 overexpression, suggesting that Smc3 and Esco2 cooperatively act to regulate cx43 transcription.",
        "These birth defects are collectively termed cohesinopathies as both arise from mutations in cohesion genes.",
        "Robert syndrome (RBS) and Cornelia de Lange syndrome (CdLS) are human developmental disorders characterized by craniofacial deformities, limb malformation and mental retardation.",
        "The mechanism that underlies RBS, however, remains unknown.",
        "These findings have the potential to unify RBS and CdLS as transcription-based mechanisms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29059320": [
        "Large-scale sequencing studies discovered substantial genetic variants occurring in enhancers which regulate genes via long range chromatin interactions.",
        "DiseaseEnhancer provides a promising avenue for researchers to facilitate the understanding of enhancer deregulation in disease pathogenesis, and identify new biomarkers for disease diagnosis and therapy.",
        "As of July 2017, DiseaseEnhancer includes 847 disease-associated enhancers in 143 human diseases.",
        "Importantly, such variants could affect enhancer regulation by changing transcription factor bindings or enhancer hijacking, and in turn, make an essential contribution to disease progression.",
        "Database features include basic enhancer information (i.e. genomic location and target genes); disease types; associated variants on the enhancer and their mediated phenotypes (i.e. gain/loss of enhancer and the alterations of transcription factor bindings).",
        "To facilitate better usage of published data and exploring enhancer deregulation in various human diseases, we created DiseaseEnhancer (http://biocc.hrbmu.edu.cn/DiseaseEnhancer/), a manually curated database for disease-associated enhancers.",
        "We also include a feature on our website to export any query results into a file and download the full database."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29247018": [
        "Three months after the therapy, 32% of the patients showed complete responses and 6% showed partial responses.",
        "After 6 months, those rates were 30% and 7%.",
        "The phase II JULIET trial suggests that the CD19-targeting CAR T-cell therapy tisagenlecleucel produces durable responses in patients with relapsed and refractory diffuse large B-cell lymphoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29385370": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      In a single-center phase 1-2a study, the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel produced high rates of complete remission and was associated with serious but mainly reversible toxic effects in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29914976": [
        "Chimeric antigen receptor T cells demonstrate efficacy in B-cell malignancies, leading to US Food and Drug Administration approval of axicabtagene ciloleucel (October 2017) and tisagenlecleucel (May 2018) for large B-cell lymphomas after 2 prior lines of therapy.",
        "This article reviews data of current diffuse large B-cell lymphoma management, focusing on axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel.",
        "Durable remissions are seen in 30% to 40% of study-treated patients, but toxicities of cytokine release syndrome and neurotoxicity require administration in specialized centers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30501490": [
        "The chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel targets and eliminates CD19-expressing B cells and showed efficacy against B-cell lymphomas in a single-center, phase 2a study.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Patients with diffuse large B-cell lymphoma that is refractory to primary and second-line therapies or that has relapsed after stem-cell transplantation have a poor prognosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29451276": [
        "On August 30, 2017, the U.S. Food and Drug Administration (FDA) approved Novartis' tisagenlecleucel (CTL-019, Kymriah), which is a synthetic bioimmune product of anti-CD19 chimeric antigen receptor (CAR) T cells, for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL).",
        "Results from clinical trials indicate that anti-CD19 CAR T-cell therapies could successfully induce high response rates in B-ALL patients.",
        "Conventional standard therapies for B-ALL have high failure rates, thus developing new therapies is crucial for patients with B-ALL.",
        "However, related toxicities, such as cytokine release syndrome and CAR T-cell-related encephalopathy syndrome, may be severe or even fatal, and the management of such toxicities is therefore vital.",
        "This was a milestone in tumor immunology on account of the significant antitumor effect of tisagenlecleucel for the treatment of relapsed/refractory B-ALL patients.",
        "This review will focus on the clinical application of anti-CD19 CAR T-cell therapy in B-ALL treatment, including design features of CAR constructs, therapeutic use of tisagenlecleucel, CAR T-cell therapy clinical trials and related toxicity, and prospects for cancer immunotherapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30213399": [
        "Relapsed or refractory aggressive B-cell lymphoma has an extremely poor prognosis and efforts to develop novel therapies for these patients have failed for almost four decades until the advent of chimeric antigen receptor (CAR) T-cell therapy.",
        "Within the last one year, two anti-CD19 CAR T-cell therapy products, axicabtagene ciloleucel and tisagenlecleucel, were approved by the United States Food and Drug Administration for the treatment of relapsed or refractory large B-cell lymphoma after at least two lines of systemic therapy based on multicenter single-arm phase two clinical trials.",
        "Here, we will discuss the different components of the CAR construct and their mechanisms of action, the role of conditioning chemotherapy, the efficacy and toxicity observed with anti-CD19 CAR T-cell therapies in aggressive B-cell lymphomas, and emerging strategies to further improve the safety and efficacy of these highly promising approaches."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30309857": [
        "On August 30, 2017, the FDA approved tisagenlecleucel for treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory in second or later relapse.",
        "A study of safety with 15 years of follow-up is required as a condition of the approval.See related commentary by Geyer, p. 1133.",
        "Tisagenlecleucel (Kymriah; Novartis Pharmaceuticals) is a CD19-directed genetically modified autologous T-cell immunotherapy.",
        "Cytokine release syndrome (79%) and neurologic events (65%) were serious toxicities reported in the trial.",
        "With implementation of a Risk Evaluation and Mitigation Strategy, the benefit-risk profile was considered acceptable for this patient population with such resistant ALL.",
        "With a median follow-up of 4.8 months, the median duration of response was not reached.",
        "Treatment consisted of fludarabine and cyclophosphamide followed 2 to 14 days later by a single dose of tisagenlecleucel.",
        "Approval was based on the complete remission (CR) rate, durability of CR, and minimal residual disease (MRD) &lt;0.01% in a cohort of 63 children and young adults with relapsed or refractory ALL treated on a single-arm trial (CCTL019B2202).",
        "The CR rate was 63% (95% confidence interval, 50%-75%), and all CRs had MRD &lt;0.01%."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30111196": [
        "Advances in immunotherapy, with the introduction of chimeric antigen receptor T-cell therapies and the development of tisagenlecleucel, have changed the landscape.",
        "Survival from time of relapse is typically measured in weeks to months, and standard chemotherapy and currently approved targeted therapy achieve remission in less than a third of affected patients.",
        "Areas covered: This review will describe the pharmacology of tisagenlecleucel and summarize the clinical evidence for its use in the treatment of multiple-relapsed or refractory B-cell ALL (B-ALL).",
        "Also discussed are other immunotherapies for B-ALL as well as the most commonly-encountered toxicities and corresponding management strategies.",
        "In responding patients, remissions have been reported on the order of years, and thus, tisagenlecleucel may herald a dramatic shift in the treatment paradigm of this largely fatal disease.",
        "Expert commentary: Early phase trials indicate that tisagenlecleucel significantly improves survival for patients with B-ALL that is refractory or in second or later relapse.",
        "Cure rates for pediatric and young adult patients with refractory or recurrently relapsed acute lymphoblastic leukemia (ALL) are dismal.",
        "To date, the only definitive curative therapy has been allogeneic hematopoietic stem cell transplant (HSCT)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30190371": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Tisagenlecleucel is an anti-CD19 chimeric antigen receptor (CAR19) T-cell therapy approved for the treatment of children and young adults with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28846097": [
        "The mechanisms through which GDF15 reduces body weight remain poorly understood, because the cognate receptor for GDF15 is unknown.",
        "Our data identify GFRAL as a new regulator of body weight and as the bona fide receptor mediating the metabolic effects of GDF15, enabling a more comprehensive assessment of GDF15 as a potential pharmacotherapy for the treatment of obesity.",
        "In addition, diet-induced obesity and insulin resistance are exacerbated in GFRAL-deficient mice, suggesting a homeostatic role for this receptor in metabolism.",
        "Finally, we demonstrate that GDF15-induced cell signaling requires the interaction of GFRAL with the coreceptor RET.",
        "Growth differentiation factor 15 (GDF15), a distant member of the transforming growth factor (TGF)-\u03b2 family, is a secreted protein that circulates as a 25-kDa dimer.",
        "In humans, elevated GDF15 correlates with weight loss, and the administration of GDF15 to mice with obesity reduces body weight, at least in part, by decreasing food intake.",
        "Here we show that recombinant GDF15 induces weight loss in mice fed a high-fat diet and in nonhuman primates with spontaneous obesity.",
        "Gfral is expressed in neurons of the area postrema and nucleus of the solitary tract in mice and humans, and genetic deletion of the receptor abrogates the ability of GDF15 to decrease food intake and body weight in mice.",
        "Furthermore, we find that GDF15 binds with high affinity to GDNF family receptor \u03b1-like (GFRAL), a distant relative of receptors for a distinct class of the TGF-\u03b2 superfamily ligands."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28846099": [
        "Lastly, given that GDF15 did not increase energy expenditure in treated mice with obesity, the anti-obesity actions of the cytokine are likely driven primarily by a reduction in food intake.",
        "However, the cognate receptor of GDF15 is unknown.",
        "We further found that GFRAL expression was limited to hindbrain neurons and not present in peripheral tissues, which suggests that GDF15-GFRAL-mediated regulation of food intake is by a central mechanism.",
        "We also found that GDF15-mediated reductions in food intake and body weight of mice with obesity were abolished in GFRAL-knockout mice.",
        "Here we show that GDF15 binds specifically to GDNF family receptor \u03b1-like (GFRAL) with high affinity, and that GFRAL requires association with the coreceptor RET to elicit intracellular signaling in response to GDF15 stimulation.",
        "Growth differentiation factor 15 (GDF15; also known as MIC-1) is a divergent member of the TGF-\u03b2 superfamily and is associated with body-weight regulation in humans and rodents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28846098": [
        "Blocking the interaction between GDF15 and GFRAL with a monoclonal antibody prevented the metabolic effects of GDF15 in rats.",
        "Gfral<sup>-/-</sup> mice were refractory to the effects of recombinant human GDF15 on body-weight, food-intake and glucose parameters.",
        "4,5,6).",
        "GFRAL binds to GDF15 in vitro and is required for the metabolic actions of GDF15 with respect to body weight and food intake in vivo in mice.",
        "A connection between GDF15 and body-weight regulation was initially suggested on the basis of an observation that increasing GDF15 levels in serum correlated with weight loss in individuals with advanced prostate cancer.",
        "In animal models, overexpression of GDF15 leads to a lean phenotype, hypophagia and other improvements in metabolic parameters, suggesting that recombinant GDF15 protein could potentially be used in the treatment of obesity and type 2 diabetes.",
        "Growth/differentiation factor 15 (GDF15), also known as MIC-1, is a distant member of the transforming growth factor-\u03b2 (TGF-\u03b2) superfamily and has been implicated in various biological functions, including cancer cachexia, renal and heart failure, atherosclerosis and metabolism.",
        "However, the signaling and mechanism of action of GDF15 are poorly understood owing to the absence of a clearly identified cognate receptor.",
        "Together, our data demonstrate that GFRAL is a receptor for GDF15 that mediates the metabolic effects of GDF15.",
        "Here we report that GDNF-family receptor \u03b1-like (GFRAL), an orphan member of the GFR-\u03b1 family, is a high-affinity receptor for GDF15.",
        "Gfral mRNA is highly expressed in the area postrema of mouse, rat and monkey, in accordance with previous reports implicating this region of the brain in the metabolic actions of GDF15 (refs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28953886": [
        "It then triggers the activation of neurons localized within the parabrachial nucleus and central amygdala, which constitute part of the 'emergency circuit' that shapes feeding responses to stressful conditions.",
        "GDF15 levels increase in response to tissue stress and injury, and elevated levels are associated with body weight loss in numerous chronic human diseases.",
        "GDF15 activates GFRAL-expressing neurons localized exclusively in the area postrema and nucleus tractus solitarius of the mouse brainstem.",
        "GDF15 regulates food intake, energy expenditure and body weight in response to metabolic and toxin-induced stresses; we show that Gfral knockout mice are hyperphagic under stressed conditions and are resistant to chemotherapy-induced anorexia and body weight loss.",
        "Recent studies have identified brain areas outside the hypothalamus that are activated under these 'non-homeostatic' conditions, but the molecular nature of the peripheral signals and brain-localized receptors that activate these circuits remains elusive.",
        "By isolating GFRAL as the receptor for GDF15-induced anorexia and weight loss, we identify a mechanistic basis for the non-homeostatic regulation of neural circuitry by a peripheral signal associated with tissue damage and stress.",
        "Here we identify glial cell-derived neurotrophic factor (GDNF) receptor alpha-like (GFRAL) as a brainstem-restricted receptor for growth and differentiation factor 15 (GDF15).",
        "In stressed or disease conditions, however, animals use alternative neuronal pathways to adapt to the metabolic challenges of altered energy demand.",
        "These findings provide opportunities to develop therapeutic agents for the treatment of disorders with altered energy demand.",
        "Under homeostatic conditions, animals use well-defined hypothalamic neural circuits to help maintain stable body weight, by integrating metabolic and hormonal signals from the periphery to balance food consumption and energy expenditure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29129392": [
        "Four laboratories have recently identified GFRAL, an orphan receptor of the glial-derived neurotrophic factor (GDNF) receptor \u03b1 family, as the receptor for MIC-1/GDF15, signaling though the coreceptor Ret.",
        "Macrophage inhibitory cytokine-1/growth differentiation factor 15 (MIC-1/GDF15) is a divergent transforming growth factor (TGF\u03b2) superfamily cytokine implicated in biological and disease processes including metabolism, cancer, and chronic inflammation, but whose receptor has remained elusive.",
        "These data identify a new systemic to central nervous system (CNS) circuit that regulates metabolism in response to stress and which could be targeted to treat both severe obesity and anorexia/cachexia syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29028963": [
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      In an effort to better understand the molecular drivers of synaptic and neurophysiologic dysfunction in Alzheimer's disease (AD), we analyzed neuronal gene expression data from human AD brain tissue to identify master regulators of synaptic gene expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26202100": [
        "We found 3124 DEGs, many of which were highly correlated with Braak stage and cerebral atrophy.",
        "Upstream regulator analysis predicted the TLR4 ligands, STAT3 and NFKBIA, for activated pathways and RICTOR for mitochondrial genes.",
        "Previous studies have evaluated gene expression in Alzheimer's disease (AD) brains to identify mechanistic processes, but have been limited by the size of the datasets studied.",
        "Here we have implemented a novel meta-analysis approach to identify differentially expressed genes (DEGs) in published datasets comprising 450 late onset AD (LOAD) brains and 212 controls.",
        "NOROS was also up-regulated, and mitochondrial dysfunction down-regulated, in healthy ageing subjects.",
        "We suggest that NEUROD6, ZCCHC17, PPEF1 and MANBAL are potentially implicated in LOAD, with predicted links to calcium signalling and protein mannosylation.",
        "Protein-protein interaction network analysis emphasised the role of NFKB; identified a key interaction of CLU with complement; and linked TYROBP, TREM2 and DOK3 to modulation of LPS signalling through TLR4 and to phosphatidylinositol metabolism.",
        "Our study demonstrates a highly injurious combination of TLR4-mediated NFKB signalling, NOROS inflammatory pathway activation, and mitochondrial dysfunction in LOAD.",
        "Pathway Analysis revealed the most perturbed pathways to be (a) nitric oxide and reactive oxygen species in macrophages (NOROS), (b) NFkB and (c) mitochondrial dysfunction."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29172462": [
        "This modification can occur as mono- or poly-ADP-ribosylation.",
        "Posttranslational modifications (PTMs) regulate protein functions and interactions.",
        "Furthermore, the different domains that interpret either mono- or poly-ADP-ribosylation and the implications for cellular processes are described.",
        "ADP-ribosylation is a PTM, in which ADP-ribosyltransferases use nicotinamide adenine dinucleotide (NAD<sup>+</sup>) to modify target proteins with ADP-ribose.",
        "Here we discuss the properties of the different enzymes associated with ADP-ribosylation and the consequences of this PTM on substrates.",
        "ADP-Ribosylation is reversed by hydrolases that cleave the glycosidic bonds either between ADP-ribose units or between the protein proximal ADP-ribose and a given amino acid side chain.",
        "The latter involves the synthesis of long ADP-ribose chains that have specific properties due to the nature of the polymer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29327913": [
        "Despite this very exciting progress in the clinic, the basic signaling mechanism that connects PARP1 to a diverse array of biological processes is still poorly understood.",
        "Indeed, three PARP1 inhibitors (Olaparib, Rucaparib, and Niraparib) have recently been approved by the Food and Drug Administration for the treatment of ovarian cancer.",
        "It is catalyzed by a class of enzymes known as poly-ADP-ribose polymerases (PARPs).",
        "Once activated, PARP1 is responsible for the synthesis of a large number of PARylated proteins and initiation of the DNA damage response mechanisms.",
        "This is, in large part, due to the inherent technical difficulty associated with the analysis of protein PARylation, which is a low-abundance, labile, and heterogeneous PTM.",
        "In this Perspective, we discuss these breakthroughs, including their technical development, and applications that provide a global view of the many biological processes regulated by this important protein modification.",
        "Poly-ADP-ribosylation (PARylation) is a protein posttranslational modification (PTM) that is critically involved in many biological processes that are linked to cell stress responses.",
        "The study of PARylation has been greatly facilitated by the recent advances in mass spectrometry-based proteomic technologies tailored to the analysis of this modification.",
        "Moreover, in 2017, both Olaparib and Niraparib have also been approved for the treatment of fallopian tube cancer and primary peritoneal cancer.",
        "This observation provided the rationale for developing PARP1 inhibitors for the treatment of human malignancies.",
        "In particular, PARP1 is a nuclear protein that is activated upon sensing nicked DNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29554239": [
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      ADP-ribosylation is a post-translational modification (PTM) implicated in several crucial cellular processes, ranging from regulation of DNA repair and chromatin structure to cell metabolism and stress responses.",
        "Identification of ADP-ribosylation sites is required to discern the molecular mechanisms regulated by this modification.",
        "To date, a complete understanding of ADP-ribosylation targets and their modification sites in different tissues and disease states is still lacking.",
        "This motivated us to develop a computational tool for the prediction of ADP-ribosylated sites."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28013485": [
        "We retrospectively analyzed 93 consecutive single-pregnancy patients who underwent cesarean section with combined spinal-epidural anesthesia.",
        "The patients were divided into two groups, depending on the use of 6% HES 130/0.4: group A (461 \u00b1 167 ml of saline-based HES was administered; 43 patients) and group B (HES not administered; 50 patients).",
        "However, the use of saline-based HES may lead to hyperchloremia.",
        "No differences were observed in the Apgar score or other umbilical cord laboratory data at delivery (Na<sup>+</sup>, K<sup>+</sup>, pH, base excess).",
        "This study aimed to clarify the effects of saline-based HES on umbilical cord chloride level at delivery.",
        "Hydroxyethyl starch (HES) is widely used to prevent and treat spinal anesthesia-induced hypotension during cesarean section.",
        "In conclusion, we suggest that although the use of up to 500 ml of saline-based HES during cesarean section influences umbilical cord blood electrolytes, the effect is not of a clinically significant magnitude.",
        "The major outcome was umbilical cord chloride level at delivery.",
        "The umbilical cord chloride level at delivery was statistically significantly higher in group A than in group B, but clinically similar (108 \u00b1 2 vs. 107 \u00b1 2 mmol/l, P = 0.02).",
        "The volume infused from operating room admission until delivery was not significantly different between groups."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19466346": [
        "However, opioids are not devoid of side effects.",
        "The aim of this study was to compare the side effects of subarachnoid sufentanil associated with bupivacaine to those caused by epidural sufentanil associated with ropivacaine in the doses used in the Anesthesiology Department in pregnant women undergoing labor analgesia.",
        "<strong class=\"sub-title\">\n          Background and objectives:\n        </strong>\n      \n      The association of an opioid with a local anesthetic improves the quality of labor analgesia and reduces the risk of systemic toxicity of the local anesthetic."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16612292": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Injury results in the massive release of norepinephrine (NE) into the peripheral circulation.",
        "Recent investigations have demonstrated functional adrenoreceptors on the cellular mediators of cutaneous wound healing and NE-induced phenotypic alterations in immune cells have been demonstrated in vitro.",
        "The purpose of this study was to compare cutaneous wound healing in norepinephrine-intact and norepinephrine-depleted mice.",
        "Despite this, there is little description of how NE might alter the phases of wound healing in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18687123": [
        "Mice with genetic deletions of scavenger receptors, such as SR-A and MARCO, are susceptible to infection or inflammation from inhaled pathogens or dusts.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Scavenger receptors are important components of the innate immune system in the lung, allowing alveolar macrophages to bind and phagocytose numerous unopsonized targets.",
        "However, the signaling pathways required for scavenger receptor-mediated phagocytosis of unopsonized particles have not been characterized."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8262564": [
        "Comparison of plate types demonstrated that opaque white 96-well luminostrips produced a 100 fold greater fluorescent output, and were more sensitive than black fluoroplates.",
        "The technique allows rapid analysis of large numbers of samples, and requires only a small sample volume.",
        "The number of beads phagocytized was determined from a standard curve of bead number versus fluorescent output.",
        "The phagocytic activity of resident and thioglycollate-elicited peritoneal macrophages was compared using this technique.",
        "For the phagocytic assay, fluorescein conjugated polystyrene beads were incubated with macrophage monolayers in white luminostrips.",
        "A highly sensitive quantitative fluorometric assay for phagocytosis, previously measured using fluorescence spectrophotometry or flow cytometry, has been adapted for use with a 96-well fluorescence plate reader.",
        "After incubation, cells were washed, lysed and phagocytosis quantified by determining the fluorescent intensity using a fluorescence plate reader.",
        "Intraplate variability was also significantly lower using white luminostrips."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29502249": [
        "With short-term Se repletion, selenoenzyme activities resulted in three Se response curve patterns: (1) liver and kidney Gpx1, Gpx4, and Txnrd activities were sigmoidal or hyperbolic with breakpoints (0.08-0.19 \u03bcg Se/g) that were double those observed in studies starting with Se-adequate mice; (2) red blood cell Gpx1 activity was not significantly changed; and (3) plasma Gpx3 activity only increased substantially with 0.3 \u03bcg Se/g.",
        "Se deficiency decreased the activities of plasma Gpx3, liver Gpx1, liver Txnrd, and liver Gpx4 to 3, 0.3, 11, and 50% of WT Se-adequate levels, respectively, but the Gpx1 genotype had no effect on growth or changes in activity or expression of selenoproteins other than Gpx1.",
        "Plasma Gpx3 is secreted from kidney.",
        "In this short-term study, kidney Gpx3 mRNA reached plateau levels at 0.1 \u03bcg Se/g, and other kidney selenoenzyme activities reached plateau levels at \u2264 0.2 \u03bcg Se/g, so sufficient Se should have been present in kidney.",
        "This repletion study shows that loss of capacity to incorporate Se into Gpx1 in Gpx1 KO mice does not dramatically alter expression of other Se biomarkers, nor the short-term flux of Se from intestine to liver to kidney.",
        "Se repletion increased selenoprotein transcripts to Se-adequate levels after 7 days; Se response curves and apparent Se requirements for selenoprotein transcripts were similar to those observed in studies starting with Se-adequate mice.",
        "To investigate the impact of deletion of Gpx1 on Se metabolism, Se flux, and apparent Se requirements, KO, Gpx1 heterozygous (Het), and Gpx1 wild-type (WT) mice were fed Se-deficient diet for 17 weeks, then repleted with graded levels of Se (0-0.3 \u03bcg Se/g as Na<sub>2</sub>SeO<sub>3</sub>) for 7 days, and selenoprotein activities and transcripts were determined in blood, liver, and kidney.",
        "Thus, the delayed increase in plasma Gpx3 activity suggests that newly synthesized and secreted kidney Gpx3 is preferentially retained in kidney or rapidly cleared by binding to basement membranes in kidney or in other tissues.",
        "Glutathione peroxidase (Gpx1) is the major selenoprotein in most tissues in animals.",
        "Knockout (KO) of Gpx1 decreases Gpx1 activity to near zero and substantially reduces liver selenium (Se) levels, but has no overt effects in otherwise healthy mice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25922076": [
        "Recently, the cytosolic form of Gpx4 was identified as an upstream regulator of a novel form of non-apoptotic cell death, called ferroptosis, whereas the mitochondrial isoform of Gpx4 was previously shown to be crucial for male fertility.",
        "These findings are reminiscent of sperm isolated from selenium-deprived rodents or from mice specifically lacking mitochondrial Gpx4.",
        "Subfertility was manifested in a reduced number of litters from heterozygous breeding and an impairment of spermatozoa to fertilize oocytes in vitro.",
        "Here, we generated and analyzed mice with a targeted mutation of the active site selenocysteine of Gpx4 (Gpx4_U46S).",
        "Due to a strongly facilitated incorporation of Ser in the polypeptide chain as compared with selenocysteine at the UGA codon, expression of the catalytically inactive Gpx4_U46S was found to be strongly increased.",
        "Morphologically, sperm isolated from heterozygous Gpx4_U46S mice revealed many structural abnormalities particularly in the spermatozoa midpiece due to improper oxidation and polymerization of sperm capsular proteins and malformation of the mitochondrial capsule surrounding and stabilizing sperm mitochondria.",
        "The selenoenzyme Gpx4 is essential for early embryogenesis and cell viability for its unique function to prevent phospholipid oxidation.",
        "Mice homozygous for Gpx4_U46S died at the same embryonic stage (E7.5) as Gpx4(-/-) embryos as expected.",
        "Because the stability of the mitochondrial capsule of mature spermatozoa depends on the moonlighting function of Gpx4 both as an enzyme oxidizing capsular protein thiols and as a structural protein, tightly controlled expression of functional Gpx4 emerges as a key for full male fertility.",
        "Surprisingly, male mice heterozygous for Gpx4_U46S presented subfertility."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24795696": [
        "This chapter sets out the major pathways of testis generation, the metabolism of ROS, and highlights the transcriptional regulation by steroid receptors of antioxidant stress enzymes and their functional implications.",
        "Spermatogenesis is a complex process of male germ cells proliferation and maturation from diploid spermatogonia, through meiosis, to mature haploid spermatozoa.",
        "It also deals with of the advantages of the system biology for an antioxidant under steroid control, the major selenoprotein expressed by germ cells in the testis, the phospholipid hydroperoxide glutathione peroxidase (PHGPx/GPx4) having multiple functions and representing the pivotal link between selenium, sperm quality, and species preservation.",
        "The gonadal tissue, with abundance of highly unsaturated fatty acids, high rates of cell division, and variety of testis enzymes results very vulnerable to the overexpression of reactive oxygen species (ROS).",
        "In order to address this risk, testis has developed a sophisticated array of antioxidant systems comprising both enzymes and free radical scavengers.",
        "The process involves dynamic interactions between the developing germ cells and their supporting Sertoli cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28968643": [
        "Recent advances in bisulfite sequencing allow detection of single nucleotide variations (SNVs) achieving high sensitivity, but accurately identifying heterozygous SNVs from partially C-to-T converted sequences remains challenging.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      DNA methylation is important for gene silencing and imprinting in both plants and animals."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27824633": [
        "At study endpoint, 42.1% of patients were 'much or very much improved' on inositol compared with 35.3% on placebo.",
        "Patients were assessed using the Massachusetts General Hospital Hair Pulling Scale, the NIMH Trichotillomania Severity Scale, Clinical Global Impression Scale, and measures of depression, anxiety, and psychosocial functioning.",
        "Data on the pharmacological treatment of trichotillomania are limited, with no clear first-line agent.",
        "Trichotillomania is characterized by repetitive pulling that causes noticeable hair loss.",
        "A total of 38 individuals (35 women; mean age: 28.9\u00b111.4) with trichotillomania entered a 10-week, double-blind, placebo-controlled trial to evaluate the safety and efficacy of inositol (dosing ranging from 6 to 18 g/day).",
        "Patients assigned to inositol failed to show significantly greater reductions on primary or secondary outcomes measures compared with placebo (all P&gt;0.05).",
        "This is the first study assessing the efficacy of inositol in the treatment of trichotillomania, but found no differences in symptom reductions between inositol and placebo.",
        "Future studies should examine whether inositol may be beneficial in controlling pulling behavior in a subgroup of individuals with trichotillomania.",
        "Outcomes were examined using a linear mixed-effects model.",
        "The aim of the current study was to determine the efficacy and tolerability of inositol in adults with trichotillomania."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28183072": [
        "Results for acupuncture were as follows: The mechanism of action of acupuncture increases serotonergic activity and releases endorphins in the hypothalamus and limbic region, which could be beneficial in patients with trichotillomania and excoriation disorder.",
        "In the current research team's experience, mainly yoga and aerobic exercise have been shown useful in combination with psychotherapy and pharmacotherapy.",
        "As exercise has qualities that allow individuals to improve their mood and reduce their anxiety, it is likely that it also can help reduce behaviors like hair pulling or scratching, and it should be considered to be an adjunctive therapy.",
        "\u2022 Results for yoga were as follows: This technique may influence the structure and functioning of the areas of emotional processing involved in the pathophysiology of excoriation disorder and other body-focused repetitive behaviors, such as trichotillomania.",
        "Results for aerobic exercise were as follows: People suffering from excoriation disorder and other-body focused repetitive behaviors generally have a worsening of their behaviors in times of negative mood and anxiety.",
        "Treatments include pharmacotherapy, psychotherapy, and alternative therapies.",
        "Results",
        "Results for biofeedback were as follows: Several case reports have suggested the value of biofeedback in reducing tics, which bear some psychophysiological similarities to body-focused repetitive behaviors, such as trichotillomania and excoriation disorder.",
        "\u2022 The review indicates that yoga, aerobic exercise, acupuncture, biofeedback, hypnosis, and inositol and N-acetylcysteine all show promise in the treatment of excoriation disorder and other body-focused repetitive behaviors, such as trichotillomania.",
        "Setting",
        "Design",
        "\u2022 This review article intended to review the current literature on the alternative therapies to provide a brief update on their benefits for the treatment of excoriation disorder for use in conjunction with psychotherapy and pharmacotherapy in the management of a challenging group of patients.",
        "Obtaining solid evidence about the long-term beneficial effects of these alternative therapies for the treatment of excoriation disorder requires more investigation.",
        "Conclusions",
        "Although still limited, the current research team's use of yoga as a treatment has given useful results.",
        "\u2022 This review was conducted at the National University of Asunci\u00f3n (San Lorenzo, Paraguay).",
        "Results for hypnosis were as follows: When used as a channel for other types of interventions, such as psychotherapy, hypnosis can help counteract the stress that triggers the picking behaviors in some patients.",
        "\u2022 This review (focusing on literature published in the last 15 y, selected from a search of PubMed) critically considers the evidence for the use of alternative therapies in the treatment of excoriation disorder.",
        "Results for inositol and N-acetylcysteine were as follows: Although more research is needed, these are promising drugs that may be helpful in reducing the picking behavior.",
        "Alternative therapies for excoriation disorder and other body-focused repetitive behaviors include yoga, aerobic exercise, acupuncture, biofeedback, hypnosis, and inositol and N-acetylcysteine, among others.",
        "\u2022 Excoriation (skin picking) disorder is characterized by the need or urge to pick, scratch, pinch, touch, rub, scrub, squeeze, bite, or dig the skin, and it can be a perplexing condition for the inexperienced physician.",
        "Context",
        "Objective"
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20369022": [
        "We conclude that integrating cellular phenotype associations with organismal complex traits will facilitate the biological interpretation of the genetic effects on these traits.",
        "Following the observation of a significant abundance of regulatory signals among currently published GWAS loci, we apply our method with the goal to prioritize relevant genes for each of the respective complex traits.",
        "Furthermore, we present an extension of the method in trans, where interrogating the whole genome for downstream effects of the disease variant can be informative regarding its unknown primary biological effect.",
        "Expression quantitative trait loci (eQTLs) have been implicated in disease associations through overlaps between eQTLs and GWAS signals.",
        "In the present study, we propose an empirical methodology, which we call Regulatory Trait Concordance (RTC) that accounts for local LD structure and integrates eQTLs and GWAS results in order to reveal the subset of association signals that are due to cis eQTLs.",
        "The recent success of genome-wide association studies (GWAS) is now followed by the challenge to determine how the reported susceptibility variants mediate complex traits and diseases.",
        "We simulate genomic regions of various LD patterns with both a single or two causal variants and show that our score outperforms SNP correlation metrics, be they statistical (r(2)) or historical (D').",
        "We detect several potential disease-causing regulatory effects, with a strong enrichment for immunity-related conditions, consistent with the nature of the cell line tested (LCLs).",
        "However, the abundance of eQTLs and the strong correlation structure (LD) in the genome make it likely that some of these overlaps are coincidental and not driven by the same functional variants."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29059182": [
        "Genome-wide association studies have identified hundreds of risk loci for autoimmune disease, yet only a minority (~25%) share genetic effects with changes to gene expression (eQTLs) in immune cells.",
        "We performed integrative cis-eQTL analysis using association statistics from twenty autoimmune diseases (560 independent loci) and RNA-Seq data from 373 individuals of the Geuvadis cohort profiled at gene-, isoform-, exon-, junction-, and intron-level resolution in lymphoblastoid cell lines.",
        "After stringently testing for a shared causal variant using both the Joint Likelihood Mapping and Regulatory Trait Concordance frameworks, we found that gene-level quantification significantly underestimated the number of causal cis-eQTLs.",
        "RNA-Seq based quantification at whole-gene resolution, where abundance is estimated by culminating expression of all transcripts or exons of the same gene, is likely to account for this observed lack of colocalisation as subtle isoform switches and expression variation in independent exons can be concealed.",
        "Our findings are provided as a web resource.",
        "More than a fifth of autoimmune loci shared an underlying causal variant in a single cell type by combining all five quantification types; a marked increase over current estimates of steady-state causal cis-eQTLs.",
        "Many of the known and novel genes were concealed at gene-level (e.g. IKZF2, TYK2, LYST).",
        "Exon-level analysis detected disease-associated cis-eQTLs that subtly altered transcription globally across the target gene.",
        "Only 5.0-5.3% of loci were found to share a causal cis-eQTL at gene-level compared to 12.9-18.4% at exon-level and 9.6-10.5% at junction-level.",
        "We applied a linear mixed-effects model to distinguish cis-eQTLs modulating all expression elements of a gene from those where the signal is only evident in a subset of elements.",
        "We dissected in detail the genetic associations of systemic lupus erythematosus and functionally annotated the candidate genes.",
        "Causal cis-eQTLs detected at different quantification types localised to discrete epigenetic annotations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29058715": [
        "Our approach not only implicates the gene likely mediating individual GWAS signals, but also highlights tissues where the genetic causality for an individual trait is likely manifested.",
        "Here we describe a new approach to estimate the tissues behind the genetic causality of a variety of GWAS traits, using the cis-eQTLs in 44 tissues from the Genotype-Tissue Expression (GTEx) Consortium.",
        "One direct and powerful way to assess the genetic causality behind GWAS is through analysis of expression quantitative trait loci (eQTLs).",
        "By normalizing the GWAS-eQTL probabilities by the tissue-sharing estimates for eQTLs, we generate relative tissue-causality profiles for GWAS traits.",
        "We have adapted the regulatory trait concordance (RTC) score to measure the probability of eQTLs being active in multiple tissues and to calculate the probability that a GWAS-associated variant and an eQTL tag the same functional effect.",
        "How to interpret the biological causes underlying the predisposing markers identified through genome-wide association studies (GWAS) remains an open question."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28859904": [
        "Here, we analyzed the mechanism by which BPA alters progesterone biosynthesis in immature rat granulosa cells.",
        "BPA decreased mRNA expression of ATP binding cassette transporter-A1 (Abca1) and increased level of sterol regulatory element binding protein 1.",
        "BPA increased expression of steroidogenic acute regulatory protein (StAR), cholesterol side-chain cleavage enzyme and 3\u03b2-hydroxysteroid dehydrogenase in granulosa cells; however, BPA prevented the basal and the FSH-induced progesterone production.",
        "BPA caused sequestration of cholesterol to the perinuclear area, as evident by the Filipin staining.",
        "Exposure to BPA leads to alterations in steroidogenesis of ovarian granulosa cells.",
        "Bisphenol A (BPA) is an endocrine disruptor used in a variety of consumer products.",
        "These results indicate that exposure to BPA disrupts cholesterol homeostasis leading to decreased progesterone production in immature rat granulosa cells.",
        "Addition of exogenous cell-permeable cholesterol restored the effect of BPA on Abca1 and Star mRNA expression and partially reversed BPA's effect on progesterone production."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29197565": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Niemann-Pick type C (NP-C), one of 50 inherited lysosomal storage disorders, is caused by NPC protein impairment that leads to unesterified cholesterol accumulation in late endosomal/lysosomal compartments.",
        "The clinical manifestations of NP-C include hepatosplenomegaly, neurological and psychiatric symptoms.",
        "Lately, two metabolites that are markedly increased in NP-C patients are arising as biomarkers for this disease screening: 7-ketocholesterol and cholestane-3\u03b2,5\u03b1,6\u03b2-triol, both oxidized cholesterol products.",
        "Current diagnosis for NP-C is based on observation of the accumulated cholesterol in fibroblasts of affected individuals, using an invasive and time expensive test, called Filipin staining."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30093524": [
        "The inhibitory action of the compounds on TRP channel activation develops by lipid raft disruption, and the presence and the position of the carboxamido group is essential.",
        "Therefore, our aim was to investigate whether this compound exerts its effect through lipid raft disruption and the steroid backbone (C3) or whether altered position of the carboxamido group (C2) influences the inhibitory action by measuring Ca<sup>2+</sup> transients on isolated neurons and calcium-uptake on receptor-expressing CHO cells.",
        "Membrane cholesterol content was measured by filipin staining and membrane polarization by fluorescence spectroscopy.",
        "Both the percentage of responsive cells and the magnitude of the intracellular Ca<sup>2+</sup> enhancement evoked by the TRPV1 agonist capsaicin were significantly inhibited after C1 and C2 incubation, but not after C3 administration.",
        "C1 was able to reduce other TRP channel activation as well.",
        "The compounds induced cholesterol depletion in CHO cells, but only C1 induced changes in membrane polarization.",
        "Transient Receptor Potential (TRP) cation channels, like the TRP Vanilloid 1 (TRPV1) and TRP Ankyrin 1 (TRPA1), are expressed on primary sensory neurons.",
        "We have provided evidence previously that lipid raft disruption influenced the TRP channel activation, and a carboxamido-steroid compound (C1) inhibited TRPV1 activation.",
        "These thermosensor channels play a role in pain processing."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29845234": [
        "The present study measured the effects of quercetin on the expression of ATP\u2011binding cassette transporter 1 (ABCAl), ATP\u2011binding cassette sub\u2011family G member 1 (ABCG1), liver X receptor\u2011\u03b1 (LXR\u2011\u03b1), proprotein convertase subtilisin/kexin type 9 (PCSK9), p53, p21 and p16 induced by oxidized low density lipoprotein (ox\u2011LDL).",
        "Quercetin is a flavonoid that has anti\u2011inflammatory, anti\u2011oxidant and lipid metabolic effects.",
        "It has also been reported to reduce the risk of cardiovascular disease.",
        "RAW264.7 macrophages were exposed to ox\u2011LDL with or without 20 \u00b5mol/l quercetin and cell proliferation and senescence were quantified using \u03b2\u2011gal staining.",
        "Quercetin increased RAW264.7 cell viability and reduced lipid accumulation, senescence, lipid droplets, intracellular cholesterol and TC.",
        "Superoxide dismutase (SOD), malondialdehyde (MDA) and lipid droplets were measured in the cytoplasm using oil red staining, while intracellular and total cholesterol (TC) were measured using filipin staining and a TC kit.",
        "It was concluded that quercetin inhibits ox\u2011LDL\u2011induced lipid droplets in RAW264.7 cells by upregulation of ABCAl, ABCG1, LXR\u2011\u03b1 and downregulation of PCSK9, p53, p21 and p16.",
        "Immunofluorescent studies and western blot analysis were performed to quantify the expression of ABCAl, ABCG1, LXR\u2011\u03b1, PCSK9, p53, p21 and p16."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30258093": [
        "This study presents the design and synthesis of fluorescent probes for cholesterol recognition and demonstrates their selectivity by a variety of methods.",
        "FP-5 displayed a stronger signal, with faster kinetics, than the commercial TF-Chol probe.",
        "Reliable tools for cholesterol detection are in demand.",
        "The construction of dedicated library of 14 probes was based on heterocyclic (pyridine)-sterol derivatives with various attached fluorophores.",
        "The monitoring of intracellular cholesterol homeostasis and trafficking is of great importance because their imbalance leads to many pathologies.",
        "Hence, FP-5 has high potential as a new probe for monitoring cholesterol trafficking and its disorders.",
        "In addition, cells with pharmacologically disrupted cholesterol transport, or with a genetic mutation of cholesterol transporting protein NPC1, exhibited strong and fast FP-5 signal in the endo/lysosomal compartment, co-localizing with filipin staining of cholesterol.",
        "The most promising probe, a P1-BODIPY conjugate FP-5, was analysed in detail and showed an intensive labelling of cellular membranes followed by intracellular redistribution into various cholesterol rich organelles and vesicles."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28416184": [
        "Aberrant WNT signaling drives colorectal cancer (CRC).",
        "In the cytoplasm, TIAM1 localizes to the destruction complex and promotes TAZ degradation by enhancing its interaction with \u03b2TrCP.",
        "Importantly, high nuclear TIAM1 in clinical specimens associates with increased CRC patient survival.",
        "We demonstrate that TIAM1 shuttles between the cytoplasm and nucleus antagonizing TAZ/YAP by distinct mechanisms in the two compartments.",
        "Nuclear TIAM1 suppresses TAZ/YAP interaction with TEADs, inhibiting expression of TAZ/YAP target genes implicated in epithelial-mesenchymal transition, cell migration, and invasion, and consequently suppresses CRC cell migration and invasion.",
        "Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating YAP/TAZ activity.",
        "Here, we identify TIAM1 as a critical antagonist of CRC progression through inhibiting TAZ and YAP, effectors of WNT signaling."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17132223": [
        "In this study, we tested the hypothesis that Tiam1 is a determinant of proliferation and metastasis in colorectal cancer, and we examined the effect of the inhibition of Tiam1 expression on proliferation and metastasis.",
        "Using an orthotopic xenograft model in nude mice, we confirmed that Tiam1 silencing could reduce tumor growth by subcutaneous injection and could suppress lung and liver metastases of colorectal cancer cells.",
        "We succeeded in establishing the Tiam1 knockdown colorectal cancer cell line using human immunodeficiency virus lentivirus-mediated RNA interference (RNAi) and found that the silencing of Tiam1 resulted in the effective inhibition of in vitro cell growth and of the invasive ability of colorectal cancer cells.",
        "Our results suggest that Tiam1 truly plays a causal role in the metastasis of colorectal cancer and that RNAi-mediated silencing of Tiam1 may provide an opportunity to develop a new treatment strategy for colorectal cancer.",
        "T lymphoma invasion and metastasis 1 (Tiam1) is a metastasis-related gene of T lymphoma that is also involved in the metastasis of a variety of other cancers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29509874": [
        "Despite their importance and extensive studies, no database/resource on carbonylated proteins/sites exists.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Oxidative stress and protein damage have been associated with over 200 human ailments including cancer, stroke, neuro-degenerative diseases and aging.",
        "As such information is very useful to research in biology/medicine, we have manually curated a data-resource (CarbonylDB) of experimentally-confirmed carbonylated proteins/sites.",
        "Protein carbonylation, a chemically diverse oxidative post-translational modification, is widely considered as the biomarker for oxidative stress and protein damage."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10671368": [
        "Simultaneous observation of fluorescently-labeled NLS-bearing proteins, lamin B receptor (LBR)-GFP, and Hoechst33342-stained chromosomes revealed that nuclear membranes reassembled around chromosomes by 5 minutes after the onset of anaphase (early telophase) whereas nuclear import function was recovered later, at 8 minutes.",
        "Taken together, these results showed that emerin, LBR, and several NPC components (RanBP2, Nup153, p62), but not Tpr, reconstitute around chromosomes very early in telophase prior to the recovery of nuclear import activity.",
        "GFP-tagged emerin also accumulated on chromosomes 5 minutes after the onset of anaphase.",
        "We determined the times when the nuclear membrane, nuclear pore complex (NPC) components, and nuclear import function were recovered during telophase in living HeLa cells.",
        "Interestingly, emerin and LBR initially accumulated at distinct, separate locations, but then became uniform 8 minutes after the onset of anaphase, concurrent with the recovery of nuclear import function.",
        "We further determined the timing of NPC assembly by immunofluorescence staining of cells fixed at precise times after the onset of anaphase."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15659641": [
        "Our results establish a unique relationship between two analogous nucleoporins Nup124p and Nup153 wherein the function of a common domain in retrotransposition is conserved.",
        "We demonstrate that in vitro-translated Nup124p and Nup153 coimmunoprecipitate Tf1-Gag or HIV-1 Vpr.",
        "Failure to import Tf1-Gag into the nucleus in a nup124 null mutant resulted in complete loss of Tf1 transposition.",
        "Though full-length Nup153 was unable to complement the Tf1 transposition defect in a nup124 null mutant, we provide evidence that both nucleoporins share a unique N-terminal domain, Nup124p(AA264-454) and Nup153(AA448-634) that is absolutely essential for Tf1 transposition.",
        "We report that the fission yeast nucleoporin Nup124p is required for the nuclear import of both, retrotransposon Tf1-Gag as well as the retroviral HIV-1 Vpr.",
        "Epigenetic overexpression of this domain in a wild-type (nup124(+)) background blocked Tf1 activity implying that sequences from Nup124p and the human Nup153 challenged the same pathway affecting Tf1 transposition.",
        "On the basis of protein domain similarity, the human nucleoporin Nup153 was identified as a putative homolog of Nup124p.",
        "Similarly, nuclear import of HIV-1 Vpr was impaired in nup124 null mutant strains and cells became resistant to Vpr's cell-killing activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16133350": [
        "The scope of Nup153 function also extends beyond the canonical view of the pore as a trafficking gateway.",
        "During the transition into mitosis, Nup153 directs proteins involved in membrane remodeling to the nuclear envelope.",
        "As cells exit mitosis, Nup153 is recruited to the chromosomal surface, where nuclear pores are formed anew in a complicated process still under much experimental scrutiny.",
        "In addition to being important to pore architecture, Nup153 is a key participant in both import and export.",
        "The vertebrate pore protein Nup153 plays pivotal roles in nuclear pore function.",
        "Overall, the versatile nature of Nup153 underscores an emerging view of the nuclear pore at the nexus of many key cellular processes.",
        "In addition, Nup153 is targeted for protease cleavage during apoptosis and in response to certain viral infections, providing molecular insight into pore reconfiguration during cell response."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22075984": [
        "Our data define the structure-function relationships within this emerging 53BP1-NUP153/importin-\u03b2 pathway and implicate this mechanism in the maintenance of genome integrity.",
        "Here, we provide the complete results of this screen as an information resource, and validate and functionally characterize one of the identified 'hits': a nuclear pore component NUP153 as a novel factor specifically required for 53BP1 nuclear import.",
        "Finally, we show that the C-terminal part of NUP153 is required for effective 53BP1 nuclear import, and that 53BP1 is imported to the nucleus through the NUP153-importin-\u03b2 interplay.",
        "53BP1 is a mediator of DNA damage response (DDR) and a tumor suppressor whose accumulation on damaged chromatin promotes DNA repair and enhances DDR signaling.",
        "Using foci formation of 53BP1 as a readout in two human cell lines, we performed an siRNA-based functional high-content microscopy screen for modulators of cellular response to ionizing radiation (IR).",
        "Using a range of cell and molecular biology approaches including live-cell imaging, we show that knockdown of NUP153 prevents 53BP1, but not several other DDR factors, from entering the nuclei in the newly forming daughter cells.",
        "This translates into decreased IR-induced 53BP1 focus formation, delayed DNA repair and impaired cell survival after IR.",
        "In addition, NUP153 depletion exacerbates DNA damage caused by replication stress."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25485891": [
        "NPCs have a roughly tripartite structural organization with the so-called nuclear basket emanating from the NPC scaffold into the nucleoplasm.",
        "We show that the assembly and integrity of the nuclear basket is not affected by Nup153 depletion, whereas its integrity is perturbed in cells expressing high concentrations of the zinc-finger domain of Nup153.",
        "The nuclear basket is composed of the 3 nucleoporins Nup153, Nup50, and Tpr, but their specific role for the structural organization of this NPC substructure is, however, not well established.",
        "Nuclear pore complexes (NPCs) span the 2 membranes of the nuclear envelope (NE) and facilitate nucleocytoplasmic exchange of macromolecules.",
        "In this study, we have used thin-section transmission electron microscopy to determine the structural consequences of altering the expression of Nup153 in human cells.",
        "Our data indicate a central function of Nup153 in the organization of the nucleus, not only at the periphery, but throughout the entire nuclear interior.",
        "Moreover, even mild over-expression of Nup153 is coinciding with massive changes in nuclear organization and it is the excess of the zinc-finger domain of Nup153 that is sufficient to induce these rearrangements."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28513807": [
        "<strong class=\"sub-title\">\n          Aims:\n        </strong>\n      \n      Beyond the control of nuclear-cytoplasmic trafficking nucleoporins regulate gene expression and are involved in cardiac diseases.",
        "Here we aimed to determine the contribution of Nup153 to the epigenetic alterations occurring in cardiomyopathy of dystrophin-deficient mdx mice (C57BL/10ScSn-Dmd mdx /J).",
        "Notably, a number of cardiovascular disorders have been linked to alterations in epigenetic mechanisms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28751496": [
        "DNA double-strand breaks are typically repaired through either the high-fidelity process of homologous recombination (HR), in which BRCA1 plays a key role, or the more error-prone process of non-homologous end joining (NHEJ), which relies on 53BP1.",
        "The nucleoporin Nup153 has been implicated in the DNA damage response, attributed to a role in promoting nuclear import of 53BP1.",
        "The requirement for Nup153 and Nup50 in promoting 53BP1 recruitment to damage foci induced by either etoposide or olaparib is abrogated in cells deficient for BRCA1 or its partner BARD1, but not in cells deficient for BRCA2.",
        "Together, our results further highlight the antagonistic relationship between 53BP1 and BRCA1, and place Nup153 and Nup50 in a molecular pathway that regulates 53BP1 function by counteracting BRCA1-mediated events.",
        "The balance between NHEJ and HR depends, in part, on whether 53BP1 predominates in binding to damage sites, where it protects the DNA ends from resection.",
        "Here, we define a distinct requirement for Nup153 in 53BP1 intranuclear targeting to damage foci and report that Nup153 likely facilitates the role of another nucleoporin, Nup50, in 53BP1 targeting."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8794857": [
        "Targeting information for Nup153 resides in the NH2-terminal domain since this region of the molecule can direct an ordinarily cytoplasmic protein, pyruvate kinase, to the nuclear face of the nuclear pore complex.",
        "The RNA trafficking defect was, however, dependent upon the Nup153 COOH-terminal domain which contains most of the XFXFG repeats.",
        "While overexpression of certain Nup153 constructs was found to result in the formation of unusual intranuclear membrane arrays, this structural phenotype could not be correlated with the effects on poly (A)+ RNA distribution.",
        "It is proposed that this region of Nup153, lying within the distal ring of the nuclear basket, represents a docking site for mRNA molecules exiting the nucleus.",
        "This protein exhibits a tripartite structure consisting of a zinc finger domain flanked by large (60-70 kD) NH2- and COOH-terminal domains.",
        "Overexpression of Nup153 results in the dramatic accumulation of nuclear poly (A)+ RNA, suggesting an inhibition of RNA export from the nucleus.",
        "This is not due to a general decline in nucleocytoplasmic transport or to occlusion or loss of nuclear pore complexes since nuclear protein import is unaffected.",
        "When full-length human Nup153 is expressed in BHK cells, it accumulates appropriately at the nucleoplasmic face of the nuclear envelope.",
        "Nup153 is a large (153 kD) O-linked glyco-protein which is a component of the basket structure located on the nucleoplasmic face of nuclear pore complexes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29235894": [
        "The development or worsening of cytopenias in patients receiving ruxolitinib uncovered an unmet need that has been addressed by alternative approaches.",
        "Herein, we provide an overview of pacritinib, from early preclinical studies to the latest and ongoing PAC203 trial, as an emerging therapy for MF.",
        "The treatment landscape for myelofibrosis (MF) has reached the molecular era by targeting different pathways that are implied in this myeloproliferative neoplasm.",
        "Pacritinib, a dual JAK2 and FLT3 inhibitor which also inhibits IRAK1, has demonstrated the ability to favorably impact MF-associated splenomegaly and symptom burden, while having limited myelosuppression with manageable gastrointestinal toxicity.",
        "A few years ago, the first-in-class JAK1/JAK2 inhibitor ruxolitinib, demonstrated reductions in both constitutional symptoms and splenomegaly, leading to the US FDA approval."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29650801": [
        "Decrease of hemoglobin/platelet levels and increased infection rates are the most common side effects of RUX, and nonmelanoma skin tumors need to be monitored while on treatment.",
        "Myeloproliferative neoplasms (MPNs) include essential thrombocythemia, polycythemia vera (PV), and primary myelofibrosis (MF).",
        "In conclusion, the introduction of JAKis raises the bar of treatment goals in MF and PV.",
        "The primary end points in MF trials were spleen volume response (SVR) and symptom response, whereas in PV trials they were hematocrit control with or without spleen response.",
        "Symptom relief was evident in both conditions.",
        "In advanced MF, RUX achieved a long lasting SVR of &gt;35% in \u223c60% of patients, establishing a new benchmark for MF treatment.",
        "RUX efficacy in early MF is also remarkable and toxicity is mild.",
        "In PV, RUX achieved hematocrit control in \u223c60% of cases and SVR in 40%.",
        "Among JAK2 inhibitors (JAKis), ruxolitinib (RUX) has been approved for the treatment of intermediate and high-risk MF and for PV inadequately controlled by or intolerant of hydroxyurea.",
        "Phenotype-driver mutations of <i>JAK2</i>, <i>CALR</i>, and <i>MPL</i> genes are present in MPNs and can be variably combined with additional mutations.",
        "Other JAKis, such as fedratinib and pacritinib, proved to be useful in MF.",
        "Driver mutations entail a constitutive activation of the JAK2/STAT pathway, the key signaling cascade in MPNs.",
        "In the long-term, however, many MF patients lose their SVR.",
        "Indeed, the definition of RUX failure and the design of new trials in this setting are unmet needs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29522138": [
        "<strong class=\"sub-title\">\n          Importance:\n        </strong>\n      \n      Myelofibrosis is a hematologic malignancy characterized by splenomegaly and debilitating symptoms.",
        "Thrombocytopenia is a poor prognostic feature and limits use of Janus kinase 1 (JAK1)/Janus kinase 2 (JAK2) inhibitor ruxolitinib."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29562644": [
        "Alteration of CXCL12/CXCR4 pathway could also lead to splenic EMH by migrated clonal hematopoietic cells from BM to the spleen.",
        "EMH is associated with abnormal trafficking patterns of clonal hematopoietic cells due to the dysregulated bone marrow (BM) microenvironment leading to progressive splenomegaly.",
        "Myelofibrosis (MF) is a clinical manifestation of chronic BCR-ABL1-negative chronic myeloproliferative neoplasms.",
        "Especially, significant spleen reduction responses of the drugs were demonstrated in several randomized clinical studies, although those could not eradicate allele burdens of MF.",
        "Splenomegaly is one of the major clinical manifestations of MF and is directly linked to splenic extramedullary hematopoiesis (EMH).",
        "Several gene mutations were found to be associated with significant splenomegaly in MF.",
        "In addition, MF patients with \u22651 mutations in AZXL1, EZH1 or IDH1/2 had significantly low spleen reduction response in ruxolitinib treatment.",
        "In recent data, <i>JAK2</i><i>V617F</i> homozygous mutation was associated with a larger spleen size.",
        "In other data, <i>CALR</i> mutations in MF were signigicantly associated with longer larger splenomegaly-free survivals than others.",
        "Developments of JAK inhibitors, such as ruxolitinib, pacritinib, momelotinib, and febratinib enabled the effective management in MF patients.",
        "Several recent data have emphasized the role of several cytokines for splenic EMH.",
        "Moreover, low Gata1 expression was found to be significantly associated with the EMH."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29616317": [
        "Despite a median platelet count of 49 \u00d7 10<sup>9</sup>/L at restart of PAC, no significant change in hematologic profile was observed.",
        "This study reports the detailed outcomes of 19 of these PAC retreatment patients with a median follow-up of 8 months.",
        "Thirty-three patients benefitting from PAC on clinical trial prior to the hold were allowed to resume therapy on an individual, compassionate-use basis.",
        "Pacritinib (PAC), a multi-kinase inhibitor with specificity for JAK2, FLT3, and IRAK1 but sparing JAK1, has demonstrated clinical activity in MF with minimal myelosuppression.",
        "The median time to discontinuation of PAC therapy on compassionate use for all 33 patients was 12.2 (95% CI 8.3-NR) months.",
        "PAC retreatment was associated with modest improvement in splenomegaly without progressive myelosuppression and supports the continued development of this agent for the treatment of MF second line to ruxolitinib or in the setting of treatment-limiting thrombocytopenia.",
        "Myelofibrosis (MF) is a chronic yet progressive myeloid neoplasm in which only a minority of patients undergo curative therapy, hematopoietic stem cell transplantation.",
        "Ruxolitinib, a JAK1/2 inhibitor, is the lone therapy approved for MF, offering a clear symptom and spleen benefit at the expense of treatment-related cytopenias.",
        "Grade 3/4 adverse events of epistaxis (n = 1), asymptomatic QT prolongation (n = 1), and bradycardia (n = 1) occurred in three patients within the first 3 months of retreatment.",
        "One death due to catheter-associated sepsis occurred.",
        "Due to an FDA-mandated full clinical hold, the randomized phase 3 PERSIST trials were abruptly stopped and PAC was immediately discontinued for all patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28336242": [
        "We aimed to assess the efficacy and safety of pacritinib versus best available therapy in patients with myelofibrosis irrespective of baseline cytopenias.",
        "Pacritinib, which inhibits both JAK2 and FLT3, induced spleen responses with limited myelosuppression in phase 1/2 trials.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Available therapies for myelofibrosis can exacerbate cytopenias and are not indicated for patients with severe thrombocytopenia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30001163": [
        "The results of an ongoing dose-finding, phase II study are eagerly awaited in order to move this promising myelofibrosis therapy forward.",
        "Expert commentary: Pacritinib has demonstrated promising results in patients with myelofibrosis and thrombocytopenia.",
        "Safety concerns pertaining to cardiovascular events and bleeding that arose in an early analysis of PERSIST-2 were likely related to the advanced disease state enrolled rather than clear attribution to pacritinib.",
        "Treatment with ruxolitinib, a selective JAK1/2 inhibitor, has significantly improved the lives of patients with myelofibrosis.",
        "The circumstances surrounding the full clinical hold temporarily placed on pacritinib will also be explored.",
        "Pacritinib is a novel JAK2/FLT3 inhibitor associated with less treatment-related myelosuppression that has the potential to fill these unmet treatment needs.",
        "Unfortunately, this treatment is frequently limited by cytopenias, precluding a high-risk group characterized by baseline thrombocytopenia.",
        "Additionally, there are no approved treatments for patients who have progressed while receiving ruxolitinib.",
        "Areas covered: This review will describe the preclinical rationale for JAK2/FLT3 inhibition, review the pharmacology of pacritinib, and detail available clinical data for pacritinib treatment of myelofibrosis.",
        "Improvements in splenomegaly and symptom burden were observed with the 200 mg twice-daily dose in PERSIST-2, including those with platelet counts &lt;50,000 mm."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26367195": [
        "The first-in-class JAK1/JAK2 inhibitor ruxolitinib inhibits JAK/STAT signaling, inducing durable reductions in splenomegaly and constitutional symptoms in patients with myelofibrosis.",
        "This article examines the role of JAK2 and FLT3 signaling in myelofibrosis and provides an overview of the clinical development of pacritinib as a new therapy for myelofibrosis.",
        "However, the association of ruxolitinib therapy with myelosuppression indicates the continued need for optimal treatment choices in myelofibrosis.",
        "Pacritinib, a dual JAK2 and FLT3 inhibitor, improves disease-related symptoms and signs with manageable gastrointestinal toxicity in patients with myelofibrosis with splenomegaly and high-risk features, without causing overt myelosuppression, and therefore may provide an important treatment option for a range of patients with myelofibrosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25762180": [
        "Grade 1 or 2 diarrhea (69%) and nausea (49%) were the most common treatment-emergent adverse events.",
        "Pacritinib (SB1518) is a Janus kinase 2 (JAK2), JAK2(V617F), and Fms-like tyrosine kinase 3 inhibitor that does not inhibit JAK1.",
        "Median MF symptom improvement was \u226550% for all symptoms except fatigue.",
        "It demonstrated a favorable safety profile with promising efficacy in phase 1 studies in patients with primary and secondary myelofibrosis (MF).",
        "At entry, 40% had hemoglobin &lt;10 g/dL and 43% had platelets &lt;100 000\u00d7 10(9)/L. Up to week 24, 8 of 26 evaluable patients (31%) achieved a \u226535% decrease in spleen volume determined by magnetic resonance imaging and 14 of 33 (42%) attained a \u226550% reduction in spleen size by physical examination.",
        "Thirty-five patients were enrolled.",
        "Pacritinib is an active agent in patients with MF, offering a potential treatment option for patients with preexisting anemia and thrombocytopenia.",
        "Patients with any degree of cytopenia were eligible.",
        "The study drug was discontinued in 9 patients (26%) due to adverse events (4 severe).",
        "This multicenter phase 2 study further characterized the safety and efficacy of pacritinib in the treatment of patients with MF.",
        "Eligible patients had clinical splenomegaly poorly controlled with standard therapies or were newly diagnosed with intermediate- or high-risk Lille score.",
        "This trial was registered at www.clinicaltrials.gov as <a href=\"http://clinicaltrials.gov/show/NCT00745550\" title=\"See in ClinicalTrials.gov\">#NCT00745550</a>."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26389774": [
        "Several other JAKIs are undergoing evaluation in the clinical trial setting and Pacritinib , a novel JAK2 and FLT3 inhibitor, is at an advanced stage of investigation with recent completion of a Phase III trial and another ongoing.",
        "Ruxolitinib, a JAK1 and 2 inhibitor, is the only currently approved agent.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Myelofibrosis (MF) is a clonal haematological disease associated with recurrent somatic gene mutations (JAK2V617F, MPL, CALR) and constitutive activation of the Janus kinase (JAK)/Signal Transducer and Activator of Transcription pathway.",
        "MF is often characterised by debilitating symptoms and JAK inhibitors (JAKIs) have revolutionised available therapeutic options."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24855821": [
        "But there are shortcomings: Many recombinant proteins are quickly degraded by proteolytic enzymes or are rapidly cleared by kidney filtration resulting in a short circulating half-life.",
        "Additionally they are prone to be recognized by the immune system resulting in the generation of neutralizing and non-neutralizing antibodies.",
        "PEGylation, a process by which polyethylene glycol chains are attached to protein and peptide drugs, can overcome these and other shortcomings.",
        "Protein and peptide drugs hold great promise as therapeutic agents.",
        "By increasing the molecular mass of proteins and peptides and shielding them from proteolytic enzymes, PEGylation primarily improves pharmacokinetics and helps to prevent adverse drug reactions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30515690": [
        "The change of patterns from no methylation or hemi-methylation of internal and external cytosines into full-methylation of internal and external cytosines accounted for a large proportion in enhanced methylation aspects.",
        "The full-methylation into no methylation or hemi- or full-methylation of internal and external cytosines occupied most of demethylation.",
        "The results showed that the DNA methylated profile of I. sinensis was affected by Pb and Cd stress.",
        "Then the degrees and the patterns of DNA methylation in the leaves were measured on the 14th day using Methylation Sensitive Amplified Polymorphism (MSAP) technique.",
        "To investigate the molecular response of ancient plants to heavy metal stress and to explore the feature of DNA methylation in endangered plants after exposure to heavy metals, the Isoetes sinensis, an endangered plant, was stressed with three different concentrations of two heavy metals lead (Pb) and cadmium (Cd), respectively.",
        "There was no significant difference in the amount of DNA methylation among control check (CK), Pb stress group, and Cd stress group (CK 46.96%, Pb 48.23%, and Cd 48.1%).",
        "However, full-methylation level of Pb stress group (28.34%) and Cd stress group (20.25%) was lower than control (33.91%), in contrast, hemi-methylation level Pb stress group (19.89%) and Cd stress group (27.85%) were higher than control (13.04%).",
        "The proportion of DNA methylation (including hypermethylation) by both Pb and Cd stresses is nearly equal (39.04% and 39.71%), but the proportion of DNA demethylation by Cd is higher than that by Pb (46.86% than 33.92%)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29053963": [
        "However, its physiological responses for heavy metal remain to be elucidated.",
        "Consistently, a dramatic change in DNA methylation patterns was detected in excess Cu-exposed H. verticillata.",
        "Here, through employing proteomics approach, we found that excess Cu significantly induced the expressions of four DNA methylation related proteins in H. verticillata, which were the homologues of two domains rearranged methyltransferases (DRM), a methyltransferases chromomethylase (CMT) and a histone H3 lysine-9 specific SUVH6-like (SUVH6).",
        "Taken together, our findings demonstrate that two different ways to influence DNA methylation in excess Cu-treated H. verticillata.",
        "Further analysis suggested this changed DNA methylation may be owing to the ROS-induced DNA damage.",
        "Because of the accumulation of heavy metals, Hydrilla verticillata (L.f.)",
        "Royle, a rooted submerged perennial aquatic herb, is being developed as a potential tool to clean the aquatic ecosystem polluted by heavy metals.",
        "Surprisingly, administration of the NADPH oxidase inhibitors, diphenylene iodonium (DPI) and imidazole (IMZ) that block production of reactive oxygen species (ROS) could trigger the remethylation of genomic sites that were demethylated by excess Cu, indicating that Cu-induced ROS might be another way to affect DNA methylation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27354700": [
        "Lossless compression methods are now close to their theoretical limits and hence there is a need for lossy methods that further reduce the complexity of these data without impacting downstream analyses.",
        "Most of the entropy of short read data lies not in the sequence of read bases themselves but in their Quality Scores-the confidence measurement that each base has been sequenced correctly.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      The exponential reduction in cost of genome sequencing has resulted in a rapid growth of genomic data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28011643": [
        "Bacterial pathogens recruit circulating proteins to their own surfaces, co-opting the host protein functions as a mechanism of virulence.",
        "Particular attention has focused on the binding of plasminogen (Plg) to bacterial surfaces, as it has been shown that this interaction contributes to bacterial adhesion to host cells, invasion of host tissues, and evasion of the immune system.",
        "We identified three SpGAPDH lysine residues that were instrumental in defining the kinetic and thermodynamic parameters of the interaction.",
        "Although Plg typically binds to these receptors via several lysine-binding domains, the specific interactions that occur have not been documented in all cases.",
        "Altogether, the integration of the data presented in this work allows us to propose a structural model for the molecular interaction of the SpGAPDH-Plg complex.",
        "Several bacterial proteins are known to serve as receptors for Plg including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a cytoplasmic enzyme that appears on the cell surface in this moonlighting role.",
        "To shed light on this question, we have described a combination of peptide-spot array screening, competition and SPR assays, high-resolution crystallography, and mutational analyses to characterize the interaction between SpGAPDH and Plg.",
        "However, identification of the relevant residues could help define strategies for mitigating the virulence of important human pathogens, such as <i>Streptococcus pneumoniae</i> (Sp)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25666684": [
        "In addition, we show that rDiGAPDH and rDiGAL enhance the expression of the urokinase-type plasminogen activator (uPA) on canine endothelial cells in culture and that both proteins are expressed on the surface of D. immitis in close contact with the blood of the host.",
        "Moreover, several isoforms of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and galectin (GAL) were identified in both antigenic extracts as plasminogen-binding proteins.",
        "This interaction needs the involvement of lysine residues, many of which are located externally in both proteins as have been shown by the molecular modeling of their secondary structures.",
        "These data suggest that D. immitis could use the associated surface GAPDH and GAL as physiological plasminogen receptors to shift the fibrinolytic balance towards the generation of plasmin, which might constitute a survival mechanism to avoid the clot formation in its intravascular habitat.",
        "Previous studies have shown that D. immitis can use their excretory/secretory (ES) and surface antigens to enhance fibrinolysis, which could limit the formation of clots in its surrounding environment.",
        "Cardiopulmonary dirofilariosis is a cosmopolitan disease caused by Dirofilaria immitis, a filaroid parasite whose adult worms live for years in the vascular system of its host.",
        "This study includes the cloning, sequencing and expression of the recombinant forms of the GAPDH and GAL of D. immitis (rDiGAPDH and rDiGAL) and the analysis of their capacity as plasminogen-binding proteins.",
        "The results indicate that rDiGAPDH and rDiGAL are able to bind plasminogen and stimulate plasmin generation by tissue plasminogen activator (tPA).",
        "The aim of this work is to study the interaction of the GAPDH and GAL of D. immitis with the fibrinolytic system of the host."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17449317": [
        "Of these forms, the more basic is secreted.",
        "To date a role for extracellular GAPDH in the pathogenesis of Gram-negative bacteria has not been described.",
        "Western blotting and immunoelectron microscopy showed that GAPDH is located on the bacterial surface and released to the culture medium of EHEC and EPEC strains.",
        "Non-pathogenic E. coli strains do not secrete GAPDH.",
        "These observations indicate that exported GAPDH may act as a virulence factor which could contribute to EHEC and EPEC pathogenesis.",
        "This is the first description of an extracellular localization for this enzyme, with a function other than its glycolytic role in Gram-negative pathogens.",
        "Recombinant E. coli GAPDH was purified and polyclonal antibodies were obtained.",
        "Two-dimensional electrophoresis analysis showed that in E. coli GAPDH is present at least in two major forms with different isoelectric points.",
        "Purified GAPDH was found to bind human plasminogen and fibrinogen in Far-Western blot and ELISA-based assays.",
        "In addition, GAPDH remained associated with colonic Caco-2 epithelial cells after adhesion of EHEC or EPEC.",
        "The aim of this study was to analyze the extracellular localization of GAPDH in enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains and to examine its interaction with host components that could be related to the infection mechanism.",
        "Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) is an anchorless, multifunctional protein displayed on the surface of several fungi and Gram-positive pathogens, which contributes to their adhesion and virulence.",
        "GAPDH export in these Gram-negative pathogens depends on the external medium, is not mediated by vesicles and leads to an extracellular active enzyme."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15039372": [
        "In this study we demonstrate specific plasmin- and plasminogen-binding activity for the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which is located in the cytoplasm as well as on the surface of pneumococci.",
        "The recruitment of plasminogen endows the bacterial cell surface of Streptococcus pneumoniae with proteolytic activity.",
        "GAPDH exhibits a high affinity for plasmin and a significantly lower affinity for plasminogen."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29961568": [
        "Functional studies using fibroblast cells from two affected individuals with the c.1516C&gt;T mutation showed a truncated WASF1 and a defect in actin remodeling.",
        "Next-generation sequencing has been invaluable in the elucidation of the genetic etiology of many subtypes of intellectual disability in recent years.",
        "Here, using exome sequencing and whole-genome sequencing, we identified three de novo truncating mutations in WAS protein family member 1 (WASF1) in five unrelated individuals with moderate to profound intellectual disability with autistic features and seizures.",
        "WASF1, also known as WAVE1, is part of the WAVE complex and acts as a mediator between Rac-GTPase and actin to induce actin polymerization.",
        "All three variants are predicted to partially or fully disrupt the C-terminal actin-binding WCA domain.",
        "The three mutations connected by Matchmaker Exchange were c.1516C&gt;T (p.Arg506Ter), which occurs in three unrelated individuals, c.1558C&gt;T (p.Gln520Ter), and c.1482delinsGCCAGG (p.Ile494MetfsTer23).",
        "This study provides evidence that de novo heterozygous mutations in WASF1 cause a rare form of intellectual disability."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29167924": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      CPX-351 is a novel liposomal formulation of cytarabine and daunorubicin which has recently been FDA approved for treatment of acute myeloid leukemia (AML).",
        "The current study investigated the pharmacokinetics (PK) of this liposomal formulation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29791854": [
        "However, loss of Nup133 specifically perturbs the formation of the nuclear basket as manifested by the absence of Tpr in about half of the NPCs combined with altered dynamics of Nup153.",
        "Using single-pore detection and average NE-fluorescence intensity, we find that Nup133 is dispensable for interphase and postmitotic NPC scaffold assembly in pluripotent mESCs.",
        "Our findings thus revisit the role of the Y-complex in pore biogenesis and provide insights into the interplay between NPC scaffold architecture, nuclear basket assembly, and the generation of heterogeneity among NPCs.",
        "Nup133 belongs to the Y-complex, a key component of the nuclear pore complex (NPC) scaffold.",
        "We further demonstrate that its central domain mediates Nup133's role in assembling Tpr and Nup153 into a properly configured nuclear basket.",
        "Studies on a null mutation in mice previously revealed that Nup133 is essential for embryonic development but not for mouse embryonic stem cell (mESC) proliferation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25942622": [
        "In vivo, high levels of the Nup1/Nup60 amphipathic helices cause deformation of the yeast nuclear membrane, whereas adjacent helical regions contribute to anchoring the basket to the NPC core.",
        "Here we show that the NPC basket proteins Nup1 and Nup60 directly induce membrane curvature by amphipathic helix insertion into the lipid bilayer.",
        "How NPCs interact with lipids, promoting membrane bending and NPC integrity, is poorly understood.",
        "The cylindrical NPC core forms a protein coat lining a highly curved membrane opening and has a basket-like structure appended to the nucleoplasmic side.",
        "Basket amphipathic helices are functionally linked to distinct transmembrane nucleoporins of the NPC core, suggesting a key contribution to the membrane remodeling events that underlie NPC assembly.",
        "In a cell-free system, both Nup1 and Nup60 transform spherical liposomes into highly curved membrane structures.",
        "Nuclear pore complexes (NPCs) are selective transport channels embedded in the nuclear envelope."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23591820": [
        "The THO/TREX complex couples transcription to mRNA export and recruits the mRNA export receptor NXF1 for the transport of messenger ribonucleoprotein particles (mRNP) to the NPC.",
        "Moreover, the association of TREX-2 with the NPC requires the basket nucleoporins NUP153 and TPR, but is independent of transcription.",
        "Differential profiles of mRNA nuclear accumulation reveal that TREX-2 functions similarly to basket nucleoporins, but differently from NXF1.",
        "In eukaryotes, mRNA export involves many evolutionarily conserved factors that carry the nascent transcript to the nuclear pore complex (NPC).",
        "Here, we characterize the dynamics of human TREX-2 and show that it stably associates with the NPC basket.",
        "The transcription and export complex 2 (TREX-2) was suggested to interact with NXF1 and to shuttle between transcription sites and the NPC.",
        "Thus, our results show that TREX-2 is an NPC-associated complex in mammalian cells and suggest that it is involved in putative NPC basket-related functions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17724121": [
        "Loss of Esc1 (or Nup60) alters SUMO conjugate accumulation and enhances ulp1 mutant defects.",
        "In esc1Delta cells, Ulp1 and nuclear basket components Nup60 and Mlp1 no longer distribute broadly around the nuclear periphery, but co-localize in a small number of dense-staining perinuclear foci.",
        "The nuclear pore complex (NPC) is both the major conduit for nucleocytoplasmic trafficking and a platform for organizing macromolecules at the nuclear envelope.",
        "We report that yeast Esc1, a non-NPC nuclear envelope protein, is required both for proper assembly of the nuclear basket, a structure extending into the nucleus from the NPC, and for normal NPC localization of the Ulp1 SUMO protease.",
        "Similar to previous findings with Mlp1, both Esc1 and Ulp1 help retain unspliced pre-mRNAs in the nucleus.",
        "Therefore, these proteins are essential for proper nuclear basket function, which includes mRNA surveillance and regulation of SUMO protein dynamics.",
        "The results raise the possibility that NPC-localized protein desumoylation may be a key regulatory event preventing inappropriate pre-mRNA export."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11598013": [
        "Nuclear reconstitution is used to investigate the role of Nup153 in nucleo- cytoplasmic transport and NPC architecture.",
        "NPCs assembled in the absence of Nup153 lacked several nuclear basket components, were unevenly distributed in the NE and, unlike wild-type NPCs, were mobile within the NE.",
        "The nuclear pore complex (NPC) is a large proteinaceous structure through which bidirectional transport of macromolecules across the nuclear envelope (NE) takes place.",
        "Nup153 is a peripheral NPC component that has been implicated in protein and RNP transport and in the interaction of NPCs with the nuclear lamina.",
        "Our results therefore reveal functions for Nup153 in NPC assembly, in anchoring NPCs within the NE and in mediating specific nuclear import events.",
        "Here, Nup153 is localized by immunogold electron microscopy to a position on the nuclear ring of the NPC.",
        "This was due to a reduction in import complex translocation rather than to defective receptor recycling.",
        "Importin alpha/beta-mediated protein import into the nucleus was strongly reduced in the absence of Nup153, while transportin-mediated import was unaffected."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10921874": [
        "Our results indicate that both the recruitment and maintenance of Nup153 at the pore are dependent upon the integrity of the lamina.",
        "In vitro translated Nup153 and lamin B(3) co-immunoprecipitate, and lamin B(3) interacts specifically with the C-terminal domain of Nup153.",
        "In cell-free extracts of Xenopus eggs that support the assembly of replication-competent nuclei, we found that lamin B(3) specifically associates with four polypeptides (termed SLAPs, soluble lamin associated proteins).",
        "When lamina assembly is prevented using the dominant-negative mutant XlaminB delta 2+, Nup153 does not appear at the nuclear envelope, while other F/GXFG-containing nucleoporins and Nup93 are recruited normally.",
        "Here, one SLAP is identified as the nuclear pore complex protein Nup153, one member of the F/GXFG motif-containing nucleoporins.",
        "However, Nup153 recruitment at the nuclear envelope is lost.",
        "Incorporation of Nup153 occurs at the same time as lamina assembly.",
        "During nuclear envelope assembly, other F/GXFG-containing nucleoporins are incorporated into the nuclear envelope preceding lamina assembly.",
        "When the lamina of pre-assembled nuclei is disrupted using the same dominant-negative mutant, the distribution of other nucleoporins is unaffected."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11839768": [
        "Whereas nuclear import mediated by a basic amino acid signal was unaffected, nuclear export mediated by a leucine-rich signal was retarded significantly.",
        "Since neither the precise localization of Tpr nor its functions are well defined, we generated antibodies to three regions of Tpr to clarify these issues.",
        "Injection of anti-Tpr antibodies into mitotic cells resulted in depletion of Tpr from the nuclear envelope without loss of other pore complex basket proteins.",
        "Tpr is a coiled-coil protein found near the nucleoplasmic side of the pore complex.",
        "Nuclear injection of anti-Tpr antibodies in interphase cells similarly yielded inhibition of protein export but not import.",
        "Antibody localization together with imaging of GFP-Tpr in living cells revealed that Tpr is in discrete foci inside the nucleus similar to several other nucleoporins but is not present in intranuclear filamentous networks (Zimowska et al., 1997) or in long filaments extending from the pore complex (Cordes et al., 1997) as proposed.",
        "Using light and EM immunolocalization, we determined that mammalian Tpr is concentrated within the nuclear basket of the pore complex in a distribution similar to Nup153 and Nup98.",
        "These results indicate that Tpr is a nucleoporin of the nuclear basket with a role in nuclear protein export."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9348540": [
        "From these experiments, we conclude that the vertebrate and yeast pore have significant homology in their functionally important cores and that, with the identification of Nup93 and the 205-kDa protein, we have extended the knowledge of the nearest-neighbor interactions of this core in both yeast and vertebrates.",
        "Yeast and vertebrate nuclear pores display significant morphological similarity by electron microscopy, but sequence similarity between the respective proteins has been more difficult to observe.",
        "Immunoprecipitation from both mammalian and Xenopus cell extracts indicates that a small fraction of Nup93 physically interacts with the nucleoporin p62, just as yeast Nic96p interacts with the yeast p62 homologue.",
        "The putative human nucleoporin of 205 kDa has related sequence homologues in Caenorhabditis elegans and Saccharomyces cerevisiae.",
        "The Nup93-complex-depleted nuclei are clearly defective for correct nuclear pore assembly.",
        "Polyclonal antiserum to human Nup93 detects corresponding proteins in human, rat, and Xenopus cells.",
        "Immunofluorescence and immunoelectron microscopy localize vertebrate Nup93 at the nuclear basket and at or near the nuclear entry to the gated channel of the pore.",
        "Mass spectrometric sequencing of the human 205-kDa protein reveals that this protein is encoded by an open reading frame, KIAAO225, present in the human database.",
        "The analyze the role of the Nup93 complex in the pore, nuclei were assembled that lack the Nup93 complex after immunodepletion of a Xenopus nuclear reconstitution extract.",
        "Herein we have identified a vertebrate nucleoporin, Nup93, in both human and Xenopus that has proved to be an evolutionarily related homologue of the yeast nucleoporin Nic96p.",
        "However, a large fraction of vertebrate Nup93 is extracted from pores and is also present in Xenopus egg extracts in complex with a newly discovered 205-kDa protein."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25602437": [
        "We find that the R391H cardiac arrhythmia/sudden death mutation of Nup155 prevents both its subcomplex assembly and nuclear rim targeting of the LacO array.",
        "Furthermore, Nup133 and Nup153 efficiently targeted the LacO array to the nuclear periphery.",
        "Assembly of a nuclear pore complex requires the organization of many soluble sub-complexes into a final massive structure embedded in the nuclear envelope.",
        "The LacI-Nup fusion proteins, which bound to the array, were examined for their ability to recruit endogenous nucleoporins to the intranuclear LacO site.",
        "By use of a LacI/LacO reporter system, we were able to assess nucleoporin (Nup) interactions, show that they occur with a high level of specificity, and identify nucleoporins sufficient for initiation of the complex process of NPC assembly in vivo.",
        "Eleven nucleoporins from different sub-complexes were fused to LacI-CFP and transfected separately into a human cell line containing a stably integrated LacO DNA array.",
        "Strikingly, Nup133 and Nup107 of the Nup107/160 subcomplex and Nup153 and Nup50 of the nuclear pore basket recruited a near full complement of nucleoporins to the LacO array.",
        "In addition, we show that this system can be applied to functional studies of individual nucleoporin domains as well as to specific nucleoporin disease mutations.",
        "Nuclear pore complexes (NPCs) form the gateway to the nucleus, mediating virtually all nucleocytoplasmic trafficking.",
        "Our data support a hierarchical, seeded assembly pathway and identify Nup133 and Nup153 as effective \"seeds\" for NPC assembly.",
        "Many could recruit nucleoporins of the same sub-complex and a number could also recruit other sub-complexes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10806081": [
        "In an effort to map this nucleoporin more precisely within the nuclear basket we have developed an experimental approach for localizing Nup153 expressed and incorporated in vivo into Xenopus oocyte NPCs.",
        "This new approach for localizing nucleoporins within the structure of the NPC overcomes limitations of previous techniques and allows for greater specificity and resolution than have been possible with previous methods.",
        "This approach involves the microinjection into the cytoplasm of Xenopus oocytes of in vitro synthesized mRNA from a vector encoding an epitope-tagged cDNA.",
        "Nup153 is a molecular constituent of the nuclear basket of the nuclear pore complex (NPC) that plays a critical role in nuclear export of RNAs and proteins.",
        "Here we present results obtained by Western blots, fluorescence microscopy, and immuno-electron microscopy, which clearly document that the heterologous protein is properly expressed, targeted, and incorporated into preexisting Xenopus NPCs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11535617": [
        "Yeast lacking Nup60p exhibit minor defects in nuclear export of Kap60p, nuclear import of Kap95p-Kap60p-dependent cargoes, and diffusion of small proteins across the NPC.",
        "Gsp1p-GTP enhances by 10-fold the affinity between Nup60p and Nup2p, and restores binding of Nup2p-Kap60p complexes to Nup60p.",
        "Purified Nup60p and Nup2p bind each other directly, but the stability of the complex is compromised when Kap60p binds Nup2p.",
        "Here, we show that these necleoporins can be isolated from yeast extracts by affinity chromatography on karyopherin Kap95p-coated beads.",
        "We find that Nup60p binds to Nup2p and serves as a docking site for Kap95p-Kap60p heterodimers and Kap123p.",
        "Nup60p also binds Gsp1p-GTP and its guanine nucleotide exchange factor Prp20p, and functions as a Gsp1p guanine nucleotide dissociation inhibitor by reducing the activity of Prp20p.",
        "To characterize Nup60p further, Nup60p-coated beads were used to capture its interacting proteins from extracts.",
        "The results suggest a dynamic interaction, controlled by the nucleoplasmic concentration of Gsp1p-GTP, between Nup60p and Nup2p at the NPC.",
        "Yeast lacking Nup60p also fail to anchor Nup2p at the NPC, resulting in the mislocalization of Nup2p to the nucleoplasm and cytoplasm.",
        "The nucleoporins Nup60p, Nup2p, and Nup1p form part of the nuclear basket structure of the Saccharomyces cerevisiae nuclear pore complex (NPC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15229283": [
        "The NPC core consists of globular subunits sandwiched between two coaxial ring-like structures of which the ring facing the nuclear interior is capped by a fibrous structure called the nuclear basket.",
        "By postembedding immunoelectron microscopy, we have mapped the positions of several human NPC proteins relative to the NPC core and its associated basket, including Nup93, Nup96, Nup98, Nup107, Nup153, Nup205, and the coiled coil-dominated 267-kDa protein Tpr.",
        "We propose a model in which Tpr constitutes the central architectural element that forms the scaffold of the nuclear basket.",
        "The vertebrate nuclear pore complex (NPC) is a macromolecular assembly of protein subcomplexes forming a structure of eightfold radial symmetry.",
        "The position of Tpr in turn is shown to coincide with that of the nuclear basket, with different Tpr protein domains corresponding to distinct basket segments.",
        "Nup93 and Nup205 are other NPC core elements that are important for long-term maintenance of NPCs but initially dispensable for the anchoring of Nup153 and Tpr.",
        "We show that Nup96 and Nup107 are core elements of the NPC proper that are essential for NPC assembly and docking of Nup153 and Tpr to the NPC.",
        "Immunogold-labeling for Nup98 also results in preferential labeling of NPC core regions, whereas Nup153 is shown to bind via its amino-terminal domain to the nuclear coaxial ring linking the NPC core structures and Tpr.",
        "To further assess their contributions to NPC and basket architecture, the genes encoding Nup93, Nup96, Nup107, and Nup205 were posttranscriptionally silenced by RNA interference (RNAi) in HeLa cells, complementing recent RNAi experiments on Nup153 and Tpr."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11567018": [
        "Perturbation of Nup153 function was demonstrated previously to block the export of several classes of RNA cargo.",
        "Traffic between the nucleus and cytoplasm takes place through a macromolecular structure termed the nuclear pore complex.",
        "Moreover, these studies also showed that Nup153 can stably associate with RNA in vitro.",
        "After cloning this region of Xenopus Nup153, we performed a cross-species analysis.",
        "One such protein, the nucleoporin Nup153, is localized to the nuclear basket of the pore complex and has been shown to be a central component of the nuclear transport machinery.",
        "In this study, we have mapped a domain within Nup153, encompassing amino acids 250-400 in human Nup153, that is responsible for RNA association.",
        "Despite variation in sequence conservation between Drosophila, Xenopus, and human, this domain of Nup153 displayed robust RNA binding activity in each case, indicating that this property is a hallmark feature of Nup153 and pointing toward a subset of amino acid residues that are key to conferring this ability.",
        "We have further determined that a recombinant fragment of Nup153 can bind directly to RNA and that this fragment can interact with endogenous RNA targets.",
        "To understand how the vital process of nucleocytoplasmic transport occurs, the contribution of individual pore proteins must be elucidated.",
        "Our findings identify a functionally conserved domain in Nup153 and suggest a role for RNA binding in Nup153 function at the nuclear pore."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25845599": [
        "Ulp1, whose maintenance at nuclear pores depends on the Nup84 complex, impacts on THO-dependent gene expression, whereas the nuclear basket-associated Mlp1/Pml39 proteins prevent pre-mRNA export at a later stage, contributing to mRNA quality control.",
        "Our study thus highlights the multiplicity of mechanisms by which nuclear pores contribute to gene expression, and further provides the first evidence that intronic sequences can alleviate early mRNP biogenesis defects.",
        "However, the molecular mechanisms of this nuclear pore-dependent mRNA quality control, including the sumoylated targets of Ulp1, have remained unidentified.",
        "Several nuclear pore-associated factors, including the SUMO-protease Ulp1, have been proposed to prevent the export of intron-containing messenger ribonucleoparticles (mRNPs) in yeast.",
        "Indeed, we show that the presence of introns within THO target genes attenuates the effect of THO inactivation on their transcription.",
        "Here, we demonstrate that the apparent 'pre-mRNA leakage' phenotype arising upon ULP1 inactivation is shared by sumoylation mutants of the THO complex, an early mRNP biogenesis factor.",
        "Epistasis analyses further clarify that different nuclear pore components influence intron-containing gene expression at distinct stages.",
        "Importantly, we establish that alteration of THO complex activity differentially impairs the expression of intronless and intron-containing reporter genes, rather than triggering bona fide 'pre-mRNA leakage'."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22475052": [
        "Four patients at doses of 4.5 mg/kg and 6.0 mg/kg experienced grade 3 or 4 asymptomatic elevated amylase and lipase levels.",
        "The maximally tolerated dose (MTD) of lucatumumab was 3.0 mg/kg.",
        "Saturation of CD40 receptor on CLL cells was uniform at all doses post-treatment but also persisted at trough time points in the 3.0 mg/kg or greater cohorts.",
        "Lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity (ADCC).",
        "Future efforts with lucatumumab in CLL should focus on combination-based therapy.",
        "Of the 26 patients enrolled, 17 patients had stable disease (mean duration of 76 days, range 29-504 days) and one patient had a nodular partial response for 230 days.",
        "In summary, lucatumumab had acceptable tolerability, pharmacokinetics that supported chronic dosing and pharmacodynamic target antagonism at doses of 3.0 mg/kg, but demonstrated minimal single-agent activity.",
        "Twenty-six patients with relapsed CLL were enrolled on five different dose cohorts administered weekly for 4 weeks.",
        "We evaluated lucatumumab in a phase I clinical trial in chronic lymphocytic leukemia (CLL).",
        "At the MTD, the median half-life of lucatumumab was 50 h following the first infusion, and 124 h following the fourth infusion."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29090408": [
        "Heat shock proteins are involved in cellular repair and protective mechanisms that counter characteristic features of neurodegenerative diseases such as protein misfolding and aggregation.",
        "More pronounced effects on neuronal viability were apparent at 44 \u00b0C heat shock compared to 43 \u00b0C. siRNA knockdown suggests that HSPA6 and HSPA1A contribute to protection of differentiated human neuronal cells from cellular stress.",
        "The effect of knockdown of HSPA6 and HSPA1A expression was examined in relation to the ability of differentiated human SH-SY5Y neuronal cells to tolerate thermal stress.",
        "The HSPA (Hsp70) multigene family includes the widely studied HSPA1A (Hsp70-1) and the little studied HSPA6 (Hsp70B') which is present in the human genome and not in mouse and rat.",
        "Low dose co-application of celastrol and arimoclomol, which induces Hsps, enhanced the ability of differentiated neurons to survive heat shock.",
        "Small interfering RNA (siRNA) knockdown of HSPA6 and HSPA1A resulted in loss of the protective effect of co-application of celastrol/arimoclomol."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29367439": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To examine the safety and tolerability as well as the preliminary efficacy of arimoclomol, a heat shock protein co-inducer that promotes nascent protein folding, in patients with rapidly progressive <i>SOD1</i> amyotrophic lateral sclerosis (ALS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30497978": [
        "Importantly, arimoclomol efficiently crosses the blood-brain-barrier presenting an opportunity to target the neurological manifestations of GD, which remains without a disease-modifying therapy.",
        "The investigational drug arimoclomol, which is in phase II/III clinical trials, is a well-characterized HSP amplifier and has been extensively clinically tested.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Gaucher Disease is caused by mutations of the GBA gene which encodes the lysosomal enzyme acid beta-glucosidase (GCase).",
        "GBA mutations commonly affect GCase function by perturbing its protein homeostasis rather than its catalytic activity.",
        "Heat shock proteins are well known cytoprotective molecules with functions in protein homeostasis and lysosomal function and their manipulation has been suggested as a potential therapeutic strategy for GD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29159344": [
        "A new efficient chiral synthesis of enantiopure arimoclomol (2) is reported from (R)-(-)-glycidyl nosylate (11) with complete retention of chiral integrity.",
        "These studies will be helpful towards a better understanding of the PK-PD relationship of 2 in disease models.",
        "Pharmacokinetic data was generated in vivo in mouse and showed a low brain : plasma ratio.",
        "Off-target pharmacology of arimoclomol (2) was evaluated against a representative set of drug targets and showed modest binding to a few kinases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27605553": [
        "HSP70 penetrated effectively into murine tissues including the CNS and inhibited glycosphingolipid accumulation in murine models of Fabry disease (Gla(-/-)), Sandhoff disease (Hexb(-/-)), and Niemann-Pick disease type C (Npc1(-/-)) and attenuated a wide spectrum of disease-associated neurological symptoms in Hexb(-/-) and Npc1(-/-) mice.",
        "HSP70 treatment reversed lysosomal pathology in primary fibroblasts from 14 patients with eight different LSDs.",
        "The existing treatment options are limited and have no or only modest efficacy against neurological manifestations of disease.",
        "Oral administration of arimoclomol, a small-molecule coinducer of HSPs that is currently in clinical trials for Niemann-Pick disease type C (NPC), recapitulated the effects of recombinant human HSP70, suggesting that heat shock protein-based therapies merit clinical evaluation for treating LSDs.",
        "We demonstrate that recombinant human heat shock protein 70 (HSP70) improves the binding of several sphingolipid-degrading enzymes to their essential cofactor bis(monoacyl)glycerophosphate in vitro.",
        "Lysosomal storage diseases (LSDs) often manifest with severe systemic and central nervous system (CNS) symptoms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27009270": [
        "Previous therapeutic trials have targeted the inflammatory features of sIBM but all have failed.",
        "Sporadic inclusion body myositis (sIBM) is the commonest severe myopathy in patients more than 50 years of age.",
        "We therefore evaluated arimoclomol in an investigator-led, randomized, double-blind, placebo-controlled, proof-of-concept trial in sIBM patients and showed that arimoclomol was safe and well tolerated.",
        "Using rat myoblast cultures, we found that up-regulation of the heat shock response with arimoclomol reduced key pathological markers of sIBM in vitro.",
        "Furthermore, in mutant valosin-containing protein (VCP) mice, which develop an inclusion body myopathy, treatment with arimoclomol ameliorated disease pathology and improved muscle function.",
        "Because protein dyshomeostasis may also play a role in sIBM, we tested the effects of targeting this feature of the disease.",
        "Although arimoclomol improved some IBM-like pathology in the mutant VCP mouse, we did not see statistically significant evidence of efficacy in the proof-of-concept patient trial."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18673445": [
        "Although the pathogenesis of ALS remains unclear, there is evidence for the involvement of proteasome dysfunction and heat shock proteins in the disease.",
        "Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by motoneuron degeneration, resulting in muscle paralysis and death, typically within 1-5 years of diagnosis.",
        "In order to establish whether post-symptomatic treatment with arimoclomol is effective, in this study we carried out a systematic assessment of different treatment regimes in SOD(G93A) mice.",
        "However, this previous study only examined the effects arimoclomol when treatment was initiated in pre- or early symptomatic stages of the disease.",
        "Clearly, to be of benefit to the majority of ALS patients, any therapy must be effective after symptom onset.",
        "We have previously shown that treatment with a co-inducer of the heat shock response called arimoclomol is effective in the SOD(G93A) mouse model of ALS, delaying disease progression and extending the lifespan of SOD(G93A) mice (Kieran et al. 2004).",
        "Treatment from 75 days also significantly increased the lifespan of SOD(G93A) mice, although treatment from 90 days has no significant effect on lifespan.",
        "The mechanism of action of arimoclomol involves potentiation of the heat shock response, and treatment with arimoclomol increased Hsp70 expression.",
        "Treatment with arimoclomol from early (75 days) or late (90 days) symptomatic stages significantly improved muscle function.",
        "Interestingly, this up-regulation in Hsp70 was accompanied by a decrease in the number of ubiquitin-positive aggregates in the spinal cord of treated SOD(G93A) mice, suggesting that arimoclomol directly effects protein aggregation and degradation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23978556": [
        "Arimoclomol has been found to be neuroprotective in a number of neurodegenerative disease models, including Amyotrophic Lateral Sclerosis (ALS), and in mutant Superoxide Dismutase 1 (SOD1) mice that model ALS, Arimoclomol rescues motor neurons, improves neuromuscular function and extends lifespan.",
        "Enhanced heat shock protein expression not only affects protein aggregation directly, but can also lead to more effective clearance of protein aggregates via the unfolded protein response, the proteasome-ubiquitin system or by autophagy.",
        "For example, protein aggregation is a characteristic pathological feature of neurodegenerative diseases including ALS.",
        "Arimoclomol is a hydroxylamine derivative, a group of compounds which have unique properties as co-inducers of heat shock protein expression, but only under conditions of cellular stress.",
        "Cells and pathways affected by ALS pathology and which may be targeted by a heat shock protein-based therapy are also discussed in this review.",
        "Therefore, by targeting multiple pathological mechanisms, compounds such as Arimoclomol may be particularly effective in the development of a disease-modifying therapy for ALS and other neurodegenerative disorders.",
        "ALS is a complex, multifactorial disease affecting a number of cell types and intracellular pathways.",
        "The therapeutic potential of Arimoclomol is currently under investigation in a Phase II clinical trial for ALS patients with SOD1 mutations.",
        "In this review we summarize the evidence for the neuroprotective effects of enhanced heat shock protein expression by Arimoclomol and other inducers of the Heat Shock Response.",
        "However, compounds such as Arimoclomol have effects beyond targeting protein mis-handling and can also affect additional pathological mechanisms such as oxidative stress."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18551622": [
        "The objectives of the present study were to assess the safety, tolerability, and pharmacokinetics of arimoclomol in ALS.",
        "Serum pharmacokinetic profiles support dosing of three times per day.",
        "Arimoclomol was shown to be safe, and it crosses the blood-brain barrier.",
        "Arimoclomol CSF levels increased with dose.",
        "Arimoclomol resulted in dose-linear pharmacologic exposures and the half-life did not change with continued treatment.",
        "Arimoclomol is an investigational drug for amyotrophic lateral sclerosis (ALS) that amplifies heat shock protein gene expression during cell stress.",
        "Eighty-four participants with ALS received arimoclomol at one of three oral doses (25, 50, or 100 mg three times daily) or placebo.",
        "Participants who completed 12 weeks of treatment could enroll in a 6-month open-label study.",
        "The primary outcome measure was safety and tolerability.",
        "A subset of 44 participants provided serum and cerebrospinal fluid (CSF) samples for pharmacokinetic analysis.",
        "An efficacy study in ALS is planned.",
        "Arimoclomol at doses up to 300 mg/day was well tolerated and safe."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27273088": [
        "Arimoclomol is a co-activator that prolongs the binding of activated HSF1 to heat shock elements (HSEs) in the promoter regions of inducible Hsp genes.",
        "The co-application strategy of celastrol and arimoclomol targets multiple neurodegenerative disease-associated pathologies including protein misfolding and protein aggregation, inflammatory and oxidative stress, and synaptic dysfunction.",
        "Upregulation of heat shock proteins (Hsps) mitigates against the accumulation of misfolded, aggregation-prone proteins and synaptic dysfunction, which is recognized as an early event in neurodegenerative diseases.",
        "Few effective therapies exist for the treatment of neurodegenerative diseases that have been characterized as protein misfolding disorders.",
        "The dosages employed did not affect cell viability or neuronal process morphology.",
        "Elevated Hsp levels peaked at 10 to 12 h for HSPA6, HSPA1A, DNAJB1, and HO-1 and at 24 h for HSPB1.",
        "The induced Hsps included the little studied HSPA6 (Hsp70B'), a potentially neuroprotective protein that is present in the human genome but not in rat and mouse and hence is missing in current animal models of neurodegenerative disease.",
        "Enhanced induction of a set of Hsps in differentiated human SH-SY5Y neuronal cells was observed following co-application of celastrol and arimoclomol, compared to their individual application.",
        "Celastrol activates heat shock transcription factor 1 (HSF1), the master regulator of Hsp gene transcription, and also exhibits potent anti-inflammatory and anti-oxidant activities.",
        "Enhanced induction of HSPA1A (Hsp70-1), DNAJB1 (Hsp40), HO-1 (Hsp32), and HSPB1 (Hsp27) was also observed.",
        "Co-application of celastrol and arimoclomol induced higher Hsp levels compared to heat shock paired with arimoclomol."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19938902": [
        "We review the rationale for testing arimoclomol in sporadic and familial ALS in the context of available safety and pharmacokinetic data.",
        "The pharmacological profile of arimoclomol and the available preclinical data make it a promising therapeutic possibility in ALS.",
        "A 3-month Phase IIa study in people with ALS demonstrated safety at dosages up to 300 mg/day and another study is currently recruiting participants with familial ALS caused by mutations in the superoxide dismutase gene.",
        "Several single- and multiple-dose safety studies have been completed in healthy control subjects.",
        "Arimoclomol, an amplifier of heat shock protein expression involved in cellular stress response, has emerged as a potential therapeutic candidate in amyotrophic lateral sclerosis (ALS) in recent years.",
        "The current review attempts to bring together our existing understanding of the actions of arimoclomol with the disease profile of ALS.",
        "Treatment with arimoclomol was reported to improve survival and muscle function in a mouse model of motor neuron disease.",
        "Published and unpublished literature relative to the drug in the past two decades is discussed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23393146": [
        "Spinal and bulbar muscular atrophy, also known as Kennedy's disease, is an adult-onset hereditary neurodegenerative disorder caused by an expansion of the polyglutamine repeat in the first exon in the androgen receptor gene.",
        "We therefore evaluated the therapeutic potential of arimoclomol in mice with spinal and bulbar muscular atrophy.",
        "Although the precise disease pathophysiology is largely unknown, it appears to be related to abnormal accumulation of the pathogenic androgen receptor protein within the nucleus, leading to disruption of cellular processes.",
        "Using a mouse model of spinal and bulbar muscular atrophy that exhibits many of the characteristic features of the human disease, in vivo physiological assessment of muscle function revealed that mice with the pathogenic expansion of the androgen receptor develop a motor deficit characterized by a reduction in muscle force, abnormal muscle contractile characteristics, loss of functional motor units and motor neuron degeneration.",
        "Arimoclomol significantly improved hindlimb muscle force and contractile characteristics, rescued motor units and, importantly, improved motor neuron survival and upregulated the expression of the vascular endothelial growth factor which possess neurotrophic activity.",
        "Arimoclomol was administered orally, in drinking water, from symptom onset and the effects established at 18 months of age, a late stage of disease.",
        "These results provide evidence that upregulation of the heat shock response by treatment with arimoclomol may have therapeutic potential in the treatment of spinal and bulbar muscular atrophy and may also be a possible approach for the treatment of other neurodegenerative diseases.",
        "We have previously shown that treatment with arimoclomol, a co-inducer of the heat shock stress response, delays disease progression in the mutant superoxide dismutase 1 mouse model of amyotrophic lateral sclerosis, a fatal motor neuron disease.",
        "Pathologically, the disease is defined by selective loss of spinal and bulbar motor neurons causing bulbar, facial and limb weakness."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29844364": [
        "The mechanisms regulating the actin cap are currently poorly understood.",
        "Here, we demonstrate that STEF/TIAM2, a Rac1 selective guanine nucleotide exchange factor, localises at the nuclear envelope, co-localising with the key perinuclear proteins Nesprin-2G and Non-muscle myosin IIB (NMMIIB), where it regulates perinuclear Rac1 activity.",
        "The perinuclear actin cap is an important cytoskeletal structure that regulates nuclear morphology and re-orientation during front-rear polarisation.",
        "We show that STEF depletion reduces apical perinuclear actin cables (a phenotype rescued by targeting active Rac1 to the nuclear envelope), increases nuclear height and impairs nuclear re-orientation.",
        "STEF down-regulation also reduces perinuclear pMLC and decreases myosin-generated tension at the nuclear envelope, suggesting that STEF-mediated Rac1 activity regulates NMMIIB activity to promote stabilisation of the perinuclear actin cap.",
        "Finally, STEF depletion decreases nuclear stiffness and reduces expression of TAZ-regulated genes, indicating an alteration in mechanosensing pathways as a consequence of disruption of the actin cap."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21460187": [
        "During a 30-min incubation with dbcAMP, Rac1 activity gradually increased throughout the cells and remained at its maximal level.",
        "PKA phosphorylates STEF at three residues (Thr-749, Ser-782, Ser-1562); Thr-749 phosphorylation was critical for dbcAMP-induced Rac1 activation and neurite extension.",
        "After a 5-h incubation with dbcAMP, Rac1 and Cdc42 were activated at the protruding tips of neurites without PIP(3) accumulation. dbcAMP-induced Rac1 activation was principally mediated by protein kinase A (PKA) and Sif- and Tiam1-like exchange factor (STEF)/Tiam2.",
        "During dbcAMP-induced neurite outgrowth, PKA activation at the plasma membrane became localized to neurite tips; this localization may contribute to local Rac1 activation at the same neurite tips.",
        "We examined spatiotemporal changes in Rac1 and Cdc42 activity and phosphatidylinositol 3,4,5-triphosphate (PIP(3)) concentration in dibutyryl cAMP (dbcAMP)-treated PC12D cells using F\u00f6rster resonance energy transfer-based biosensors.",
        "Considering the critical role of Rac1 in neuronal morphogenesis, the PKA-STEF-Rac1 pathway may play a crucial role in cytoskeletal regulation during neurite/axon outgrowth and guidance, which depend on cAMP signals.",
        "STEF depletion drastically reduced dbcAMP-induced neurite outgrowth.",
        "The second messenger cAMP plays a pivotal role in neurite/axon growth and guidance, but its downstream pathways leading to the regulation of Rho GTPases, centrally implicated in neuronal morphogenesis, remain elusive.",
        "There was no change in PIP(3) concentration."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29072354": [
        "Upon cAMP treatment, p190B was recruited to the plasma membrane.",
        "During outgrowth, a trafficking system supplies membrane at growth cones.",
        "Plasmalemmal TC10 activity decreased abruptly after cAMP addition in neuronal cells.",
        "TC10 is a Rho family GTPase that is essential for specific types of vesicular trafficking.",
        "TC10 was locally inactivated at extending neurite tips in cAMP-treated PC12 cells.",
        "The cAMP-induced TC10 inactivation was mediated by PKA.",
        "Cyclic AMP plays a pivotal role in neurite growth.",
        "Here, we investigated a mechanical linkage between cAMP and TC10 in neuritogenesis.",
        "Together, the PKA-STEF-Rac1-p190B pathway leading to inactivation of TC10 and RhoA at the plasma membrane plays an important role in cAMP-induced neurite outgrowth.",
        "TC10 depletion led to a decrease in cAMP-induced neurite outgrowth.",
        "Constitutively active TC10 could not rescue this growth reduction, supporting our model for a role of GTP hydrolysis of TC10 in neuritogenesis by accelerating vesicle fusion.",
        "However, the cAMP-induced signaling leading to the regulation of membrane trafficking remains unknown.",
        "STEF depletion and Rac1-N17 expression reduced cAMP-induced TC10 inactivation.",
        "Considering cAMP-induced RhoA inactivation, we found that p190B, but not p190A, mediated inactivation of TC10 and RhoA.",
        "Recent studies have shown a role of TC10 in neurite growth in NGF-treated PC12 cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29310585": [
        "We investigated the outbreak to identify potential exposures that facilitated measles transmission, assess vaccine effectiveness (VE) and vaccination coverage (VC), and recommend prevention and control measures.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      In April 2015, Kamwenge District, western Uganda reported a measles outbreak."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26613224": [
        "This report presents two pediatric cases clinically resembling measles that were diagnosed as HHV-6 based on a virogene detection test.",
        "However, Japan is currently experiencing sporadic measles outbreaks, which complicate the establishment of diagnosis.",
        "Measles is a highly contagious viral infection associated with clinical symptoms such as fever, cough, conjunctivitis, coryza, eruption and increased serum immunoglobulin M (IgM) antibodies.",
        "This underscores the importance of performing pathogen testing to confirm a diagnosis when measles is suspected.",
        "A clinical diagnosis is easily established when the chain of infection can be followed.",
        "Furthermore, other exanthematous infections such as rubella, human parvovirus B19, human herpesvirus 6 (HHV-6) and HHV-7 present with clinical symptoms and IgM antibody levels similar to those in measles.",
        "Therefore, real-time polymerase chain reaction virogene testing has been part of Japan's standard diagnostic protocol for measles since 2010."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15230469": [
        "The sequence data showed that the MV isolate of concern is of the D5 genotype.",
        "After isolating the virus in B95a cells, a fragment of the nucleoprotein (N) gene was amplified by reverse transcription-polymerase chain reaction (RT-PCR) and subjected to direct nucleotide sequencing.",
        "This patient had typical clinical measles infection symptoms: fever, rash, cough and coryza.",
        "This study reports on molecular analysis of a Measles virus (MV) isolate from a patient who was infected in Japan but showed symptoms after arriving to Brazil."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28169856": [
        "The purpose of this review is to analyze the recent literature and improve our understanding of certain key clinical aspects.",
        "After more than 3 decades of research, the underlying pathophysiologic mechanisms remain incompletely understood and important questions remain regarding the evaluation and management of these patients.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Subarachnoid hemorrhage from a ruptured aneurysm (aSAH) is a complex disorder with the potential to have devastating effects on the brain as well as other organ systems."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28661267": [
        "We applied a random-effects model to calculate the data.",
        "Conclusions Simvastatin showed no benefits in decreasing the incidence of vasospasm, DCI, or all-cause mortality after aneurysmal SAH.",
        "Sensitivity analysis showed that the STASH trial, which had a large population, did not influence the consolidated results of all three outcomes.",
        "We found no statistically significant effects on vasospasm detected by transcranial cerebral Doppler (relative risk [RR], 0.91; 95% confidence interval [CI], 0.55-1.49), delayed cerebral ischemia (DCI) (RR, 0.85; 95% CI, 0.63-1.14), or all-cause mortality (RR, 1.02; 95% CI, 0.67-1.54).",
        "Subgroup analysis showed that these consolidated results were stable at different doses, different times to start of treatment, and different courses of treatment in all included RCTs.",
        "Results Five RCTs involving 951 patients met the eligibility criteria.",
        "Methods MEDLINE, EMBASE, and the Cochrane Library were searched for all randomized controlled trials (RCTs) investigating the therapeutic effect of simvastatin on aneurysmal SAH.",
        "Objective The present study was performed to explore the therapeutic potential of simvastatin in subarachnoid hemorrhage (SAH) in the context of the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) trial.",
        "We conclude that patients with SAH should not be treated routinely with simvastatin during the acute stage."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28966073": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Simvastatin might be beneficial to the patients with aneurysmal subarachnoid hemorrhage.",
        "We conducted a systematic review and meta-analysis to explore the efficacy of simvastatin for aneurysmal subarachnoid hemorrhage.",
        "However, the results remained controversial."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27160932": [
        "Many strategies remain to be tested in larger randomized controlled trials.",
        "Cilostazol, eicosapentaenoic acid, erythropoietin, heparin, and methylprednisolone yield promising results in smaller, non-randomized or retrospective studies and warrant further investigation.",
        "Human clinical trials assessing treatment strategies, published in the last 5 yr, were included based on full-text analysis.",
        "Many novel therapies for preventing and treating DCI after aneurysmal subarachnoid haemorrhage have been assessed, with variable results.",
        "We identified 49 studies meeting our inclusion criteria.",
        "A systematic literature search of three databases (PubMed, ISI Web of Science, and Embase) was performed.",
        "Clazosentan, magnesium, and simvastatin have been tested in large high-quality trials but failed to show a beneficial effect.",
        "Methods to improve subarachnoid blood clearance have been established, but their effect on outcome remains unclear.",
        ": The leading cause of morbidity and mortality after surviving the rupture of an intracranial aneurysm is delayed cerebral ischaemia (DCI).",
        "Study data were extracted using tables depicting study type, sample size, and outcome variables.",
        "Current evidence does not support prophylactic use of clazosentan, magnesium, or simvastatin.",
        "Limitations of the study designs often preclude definite statements.",
        "Haemodynamic management of DCI is evolving towards euvolaemic hypertension.",
        "We present an update of recent literature on the current status of prevention and treatment strategies for DCI after aneurysmal subarachnoid haemorrhage.",
        "Endovascular rescue therapies, such as percutaneous transluminal balloon angioplasty and intra-arterial spasmolysis, are able to resolve angiographic vasospasm, but their effect on outcome needs to be proved.",
        "Topical application of nicardipine via implants after clipping has been shown to reduce clinical and angiographic vasospasm."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26285662": [
        "We therefore explored whether acute simvastatin treatment would improve cognitive outcomes.",
        "Recently, acute simvastatin treatment was not shown to be beneficial in neurological outcome using modified Rankin Scale.",
        "Cognitive function is another important dimension of outcome assessment and yet had not been investigated in statin studies for aneurysmal subarachnoid hemorrhage.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Experimental evidence has indicated the benefit of simvastatin in the treatment of subarachnoid hemorrhage (SAH)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26587185": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      The goal of this study was to assess the effect of high-dose simvastatin on cerebral vasospasm and its clinical outcome after aneurysmal subarachnoid hemorrhage (SAH) in Korean patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25516195": [
        "We hypothesized that a high dose of 80 mg of simvastatin daily for 3 weeks would reduce the incidence of delayed ischemic deficits after subarachnoid hemorrhage compared with a lower dose (40 mg of simvastatin daily) and lead to improved clinical outcomes.",
        "Two randomized placebo-controlled pilot trials that used the highest clinically approved dose of simvastatin (80 mg daily) gave positive results despite the fact that a lower dose of simvastatin (40 mg daily) did not improve clinical outcomes.",
        "<strong class=\"sub-title\">\n          Background and purpose:\n        </strong>\n      \n      Experimental evidence has indicated the benefits of simvastatin for the treatment of subarachnoid hemorrhage."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29044468": [
        "In well over half of the individuals with rare disease who undergo clinical or research next-generation sequencing, the responsible gene cannot be determined.",
        "MME was created to establish a federated network connecting databases of genomic and phenotypic data using a common application programming interface (API).",
        "To date, seven databases can exchange data using the API (GeneMatcher, PhenomeCentral, DECIPHER, MyGene2, matchbox, Australian Genomics Health Alliance Patient Archive, and Monarch Initiative; the latter included for model organism matching).",
        "Some reasons for this relatively low yield include unappreciated phenotypic heterogeneity; locus heterogeneity; somatic and germline mosaicism; variants of uncertain functional significance; technically inaccessible areas of the genome; incorrect mode of inheritance investigated; and inadequate communication between clinicians and basic scientists with knowledge of particular genes, proteins, or biological systems.",
        "To facilitate such communication and improve the search for patients or model organisms with similar phenotypes and variants in specific candidate genes, we have developed the Matchmaker Exchange (MME).",
        "This article guides usage of the MME for rare disease gene discovery. \u00a9 2017 by John Wiley &amp; Sons, Inc."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23363814": [
        "We hypothesized that patients with recurrent glioblastoma would exhibit differential antitumor benefit based on tumor PTEN/EGFRvIII status when treated with the antiangiogenic agent pazopanib and the ErbB inhibitor lapatinib.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Increased mitogenic signaling and angiogenesis, frequently facilitated by somatic activation of EGF receptor (EGFR; ErbB1) and/or loss of PTEN, and VEGF overexpression, respectively, drive malignant glioma growth."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20200024": [
        "The primary endpoint was efficacy as measured by 6-month progression-free survival (PFS6).",
        "The median PFS was 12 weeks (95% confidence interval [CI]: 8-14 weeks) and only 1 patient had a PFS time &gt; or =6 months (PFS6 = 3%).",
        "Thirty patients (86%) had died and median survival was 35 weeks (95% CI: 24-47 weeks).",
        "Patients with &lt; or =2 relapses and no prior anti-VEGF/VEGFR therapy were treated with pazopanib 800 mg daily on 4-week cycles without planned interruptions.",
        "Single-agent pazopanib did not prolong PFS in this patient population but showed in situ biological activity as demonstrated by radiographic responses.",
        "ClinicalTrials.gov identifier: <a href=\"http://clinicaltrials.gov/show/NCT00459381\" title=\"See in ClinicalTrials.gov\">NCT00459381</a>.",
        "Two patients had a partial radiographic response by standard bidimensional measurements, whereas 9 patients (6 at the 8-week point and 3 only within the first month of treatment) had decreased contrast enhancement, vasogenic edema, and mass effect but &lt;50% reduction in tumor.",
        "Thirty-five GBM patients with a median age of 53 years and median Karnofsky performance scale of 90 were accrued.",
        "Pazopanib was reasonably well tolerated with a spectrum of toxicities similar to other anti-VEGF/VEGFR agents.",
        "Brain magnetic resonance imaging and clinical reassessment were made every 8 weeks.",
        "The objective of this phase II single-arm study was to evaluate the efficacy and safety of pazopanib, a multi-targeted tyrosine kinase inhibitor, against vascular endothelial growth factor receptor (VEGFR)-1, -2, and -3, platelet-derived growth factor receptor-alpha and -beta, and c-Kit, in recurrent glioblastoma.",
        "Grade 3/4 toxicities included leukopenia (n = 1), lymphopenia (n = 2), thrombocytopenia (n = 1), ALT elevation (n = 3), AST elevation (n = 1), CNS hemorrhage (n = 1), fatigue (n = 1), and thrombotic/embolic events (n = 3); 8 patients required dose reduction."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28965519": [
        "The OAR are a reliable tool to exclude fractures in children over 5 years of age when applied by physicians.",
        "Our objective was to determine the accuracy of the OAR when applied by non-physician providers (NPP).",
        "Limited data support its use by other health care workers in children.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      The Ottawa Ankle Rules (OAR) are a clinical decision tool used to minimize unnecessary radiographs in ankle and foot injuries."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29891469": [
        "In this study, we sought to develop and evaluate the use of a mobile app version of The Ottawa Rules.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The Ottawa Ankle Rules, Ottawa Knee Rule, and Canadian C-Spine Rule-together known as The Ottawa Rules-are a set of internationally validated clinical decision rules developed to decrease unnecessary diagnostic imaging in the emergency department."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30183240": [
        "The Ottawa Ankle Rule shows the areas of tenderness to be evaluated in ankle trauma patients to determine the need for imaging."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28363615": [
        "This is in contrast to a previous prospective study which showed that this rule yielded only 87% sensitivity.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      A recent multicenter prospective Canadian study presented prospective evidence supporting the Low Risk Ankle Rules (LRAR) as a means of reducing the number of ankle radiographs ordered for children presenting with an ankle injury while maintaining nearly 100% sensitivity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28764972": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Ankle decision rules are developed to expedite patient care and reduce the number of radiographs of the ankle and foot.",
        "Currently, only three systematic reviews have been conducted on the accuracy of the Ottawa Ankle and Foot Rules (OAFR) in adults and children.",
        "However, no systematic review has been performed to determine the most accurate ankle decision rule."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26262468": [
        "The original and modified Ottawa Ankle Rules (OARs) were developed as clinical decision rules for use in emergency departments.",
        "However, the OARs have not been evaluated as an acute clinical evaluation tool."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25933807": [
        "The primary aim of this study was to compare the diagnostic accuracy and reproducibility of both rules.",
        "However, still 50% of patients with ankle injuries undergo unnecessary radiography.",
        "Furthermore, the ability of triage nurses to accurately interpret the BAR was assessed.",
        "Compared to the OAR, the Bernese ankle rule (BAR) has an acclaimed 84% reduction in radiography without loss of sensitivity.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      The Ottawa ankle rules (OAR) brought about a reduction of radiographs on the Emergency Department (ED)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24971221": [
        "Although only a few patients with foot and ankle sprain present fractures and the fracture patterns are almost always simple, lack of fracture diagnosis can lead to poor functional outcomes.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Foot and ankle injuries are frequent in emergency departments."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11782648": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      The Ottawa ankle rule (OAR) is a clinical decision rule used in emergency departments to identify which patients with acute ankle/midfoot injury require radiography.",
        "The purpose of this study was to implement the OAR, with a modification to improve the specificity for identifying malleolar fractures (the \"Buffalo rule\"), in a sports medicine center and measure impact on physician practice and cost savings."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29344893": [
        "Methods to enumerate immune subsets such as immunohistochemistry or flow cytometry suffer from limitations in phenotypic markers and can be challenging to practically implement and standardize.",
        "An alternative approach is to acquire aggregative high dimensional data from cellular mixtures and to subsequently infer the cellular components computationally.",
        "Tumor infiltrating leukocytes (TILs) are an integral component of the tumor microenvironment and have been found to correlate with prognosis and response to therapy.",
        "Combining support vector regression with prior knowledge of expression profiles from purified leukocyte subsets, CIBERSORT can accurately estimate the immune composition of a tumor biopsy.",
        "In this chapter, we provide a primer on the CIBERSORT method and illustrate its use for characterizing TILs in tumor samples profiled by microarray or RNA-Seq.",
        "We recently described CIBERSORT, a versatile computational method for quantifying cell fractions from bulk tissue gene expression profiles (GEPs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25822800": [
        "CIBERSORT should enable large-scale analysis of RNA mixtures for cellular biomarkers and therapeutic targets (http://cibersort.stanford.edu/).",
        "When applied to enumeration of hematopoietic subsets in RNA mixtures from fresh, frozen and fixed tissues, including solid tumors, CIBERSORT outperformed other methods with respect to noise, unknown mixture content and closely related cell types.",
        "We introduce CIBERSORT, a method for characterizing cell composition of complex tissues from their gene expression profiles."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26193342": [
        "Molecular profiles of tumors and tumor-associated cells hold great promise as biomarkers of clinical outcomes.",
        "For example, tumor-associated neutrophil and plasma cell signatures emerged as significant but opposite predictors of survival for diverse solid tumors, including breast and lung adenocarcinomas.",
        "However, existing data sets are fragmented and difficult to analyze systematically.",
        "By using this resource, we identified a forkhead box MI (FOXM1) regulatory network as a major predictor of adverse outcomes, and we found that expression of favorably prognostic genes, including KLRB1 (encoding CD161), largely reflect tumor-associated leukocytes.",
        "This resource and associated analytical tools (http://precog.stanford.edu) may help delineate prognostic genes and leukocyte subsets within and across cancers, shed light on the impact of tumor heterogeneity on cancer outcomes, and facilitate the discovery of biomarkers and therapeutic targets.",
        "Here we present a pan-cancer resource and meta-analysis of expression signatures from \u223c18,000 human tumors with overall survival outcomes across 39 malignancies.",
        "By applying CIBERSORT, a computational approach for inferring leukocyte representation in bulk tumor transcriptomes, we identified complex associations between 22 distinct leukocyte subsets and cancer survival."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27959923": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Immune infiltration of breast tumours is associated with clinical outcome.",
        "However, past work has not accounted for the diversity of functionally distinct cell types that make up the immune response.",
        "The aim of this study was to determine whether differences in the cellular composition of the immune infiltrate in breast tumours influence survival and treatment response, and whether these effects differ by molecular subtype."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27233495": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      APOBEC3B is a cytosine deaminase implicated in immune response to viral infection, cancer predisposition and carcinogenesis.",
        "Germline APOBEC3B deletion is more common in East Asian women and confers a modest risk to breast cancer in both East Asian and Caucasian women.",
        "Analysis of tumour samples from women of European descent has shown that germline APOBEC3B deletion is associated with an increased propensity to develop somatic mutations and with an enrichment for immune response-related gene sets.",
        "However, this has not been examined in Asian tumour samples, where population differences in genetic and dietary factors may have an impact on the immune system."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30117315": [
        "However, previous work has not accounted for the diversity of functionally distinct cell types that make up the immune response.",
        "Immune infiltration of colorectal cancer (CRC) is closely associated with clinical outcome.",
        "Of the cell subpopulations investigated, tumors lacking M1 macrophages or with an increased number of M2 macrophages, eosinophils, and neutrophils were associated with the poor prognosis.",
        "Collectively, our data suggest that subtle differences in the cellular composition of the immune infiltrate in CRC appear to exist, and these differences are likely to be important determinants of both prognosis and response to treatment.",
        "The fraction of 22 immune cells subpopulations was evaluated to determine the associations between each cell type and survival and response to chemotherapy.",
        "Unsupervised clustering analysis using immune cell proportions revealed five subgroups of tumors, largely defined by the balance between macrophages M1, M2, and NK resting cells, with distinct survival patterns, and associated with well-established molecular subtype.",
        "As a result, profiles of immune infiltration vary significantly between paired cancer and paracancerous tissue and the variation could characterize the individual differences.",
        "In this study, based on a deconvolution algorithm (known as CIBERSORT) and clinical annotated expression profiles, we comprehensively analyzed the tumor-infiltrating immune cells present in CRC for the first time."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28826097": [
        "Collectively, our data suggest that tumor-infiltrating immune cells in lung cancer are likely to be important determinants of both prognosis and response to immunotherapies.",
        "However, immunohistochemistry-based analysis of tumor infiltrates can be misleading as the representative marker of an immune subpopulation might be expressed in other cell types.",
        "Moreover, Kaplan-Meier analysis of the prognostic value of immune checkpoint molecules revealed that expression of ICOS was positively correlated the clinical outcome of patients with LUAD.",
        "As a result, tumors lacking memory B cells or with increased number of M0 macrophages were associated with the poor prognosis in LUAD at early clinical stage.",
        "A total of 22 types of both adaptive and innate tumor-infiltrating immune cells were evaluated in LUAD (n=492) and LUSC (n=488).",
        "Tumor-infiltrating immune cells are closely associated with clinical outcome.",
        "In this study, based on a metagene approach (known as CIBERSORT) and an online databse, The Cancer Immunome Atlas (https://tcia.at/), we comprehensively analyzed the tumor-infiltrating immune cells present in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC).",
        "In LUSC, T follicular helper cells were associated with favorable outcome, while increased number of neutrophils predicted a poor outcome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28193155": [
        "While a number of reference-based deconvolution algorithms have emerged, their potential remains underexplored and a comparative evaluation of these algorithms beyond tissues such as blood is still lacking.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Intra-sample cellular heterogeneity presents numerous challenges to the identification of biomarkers in large Epigenome-Wide Association Studies (EWAS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29770915": [
        "We hypothesized that since cytotoxic T cells release cytolytic proteins such as perforin (PRF1) and pro-apoptotic granzymes (GZMA) to attack cancer cells, a cytolytic activity score (CYT) would be a useful tool to assess anticancer immunity.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Elevated tumor-infiltrating lymphocytes (TILs) within the tumor microenvironment is a known positive prognostic factor in colorectal cancer (CRC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27737921": [
        "New insights into the role of tumor-infiltrating immune cells suggest that their composition, as well as their functionality, might serve as a biomarker to enable optimal patient selection for current systemic therapies and upcoming treatment options such as immunotherapy.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting in considerable undertreatment or overtreatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29670256": [
        "Activated mast cells, monocytes and plasma cells were decreased in HCC, while resting mast cells, total and na\u00efve B cells, CD4<sup>+</sup> memory resting and CD8<sup>+</sup> T cells were increased when compared to healthy livers.",
        "The recently developed CIBERSORT method allows immune cell profiling by deconvolution of gene expression microarray data.",
        "Mast cells were evaluated by immunohistochemistry in ten HCC patients.",
        "Strong total immune cell infiltration into HCC correlated with total B cells, memory B cells, T follicular helper cells and M1 macrophages, whereas weak infiltration was linked to resting NK cells, neutrophils and resting mast cells.",
        "By applying CIBERSORT, we assessed the relative proportions of immune cells in 41 healthy human livers, 305 HCC samples and 82 HCC adjacent tissues.",
        "Previously described S1, S2 and S3 molecular HCC subclasses demonstrated increased M1-polarized macrophages in the S3 subclass with good prognosis.",
        "Tumor-infiltrating immune cells are highly relevant for prognosis and identification of immunotherapy targets in hepatocellular carcinoma (HCC).",
        "Immunohistochemical analysis of patient samples confirmed the reduced frequency of mast cells in human HCC tumor tissue as compared to tumor adjacent tissue.",
        "The obtained immune cell profiles provided enumeration and activation status of 22 immune cell subtypes.",
        "Our data demonstrate that deconvolution of gene expression data by CIBERSORT provides valuable information about immune cell composition of HCC patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30374348": [
        "Considering the fact that immune responses are heterogenous and that the clinical outcome could be influenced by the interplay of various immune cell types, it is imperative to evaluate multiple intra-tumoral immune cell types in the same set of patients. <b>Objective:</b> To evaluate the individual and combined effects of diverse intra-tumoral immune cell types on recurrence after complete surgical resection in early stage lung adenocarcinoma. <b>Methods:</b> We obtained NCBI GEO datasets for lung adenocarcinoma, the most prevalent histological subtype of NSCLC and re-analyzed the gene expression data of 292 patients with early stage cancer (IA/IB).",
        "Furthermore, stratification of the patients on the basis of a score estimated from the levels of four cell types enabled the identification of patients with significantly increased probability of recurrence (~50%) after surgery. <b>Significance:</b> Our analysis suggests that concomitant levels of macrophages and plasma cells, in addition to the T regs and non-TregCD4+ T cells in tumors can identify patients with early stage lung cancer at greater risk of recurrence.",
        "CIBERSORT was used to resolve 22 immune cell types from the tumor transcriptomes.",
        "Importantly, the intra-tumoral immune phenotype comprising these four cell types varied among patients and differentially associated with recurrence depending on net levels of positive and negative prognostic factors.",
        "Conversely, increased proportion of non-Treg CD4+ T cells and plasma cells were associated with a lower probability of recurrence.",
        "Survival analysis was carried out to assess the effect of immune cell types and genes associated with recurrence. <b>Results:</b> Out of the 22 cell types, a high proportion of Tregs and monocyte-macrophages in the tumors were associated with significantly increased probability of recurrence.",
        "<b>Background:</b> Studies in the past have identified selected immune cells that associate with different clinical outcomes in non-small cell lung cancer (NSCLC).",
        "Despite a high level of intra-tumoral plasma cells, a concomitant high level of monocyte-macrophages reduced the freedom from recurrence from ~80 to ~50% at 80 months (<i>p</i> &lt; 0.05).",
        "The higher expression of <i>CCL20</i> (which can direct the migration of cells of B cell lineage), <i>XCL1</i> (associated with prototypical Th1 responses) and the immunoglobulin chains <i>IGHV4.34</i> and <i>IGLV6.57</i> were associated with a significantly lower probability of recurrence."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30261315": [
        "The association was also found in opposite direction for monocytes.",
        "Taken together, our result suggests a beneficial effect of RM T cells and a detrimental effect of monocytes for IPF.",
        "We used Cibersort to deconvolute immune cell components based on PBMCs or whole blood IPF genomics datasets.",
        "We found that a higher proportion of resting memory (RM) T cells was associated with a better survival and a higher DLco (diffusing capacity for carbon monoxide) in IPF patients.",
        "Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive decline of lung function.",
        "Here, we tested the importance of differential proportions of blood immune cells to IPF clinical outcomes.",
        "Future genomics studies of IPF should be more focused on these two types of cells.",
        "Additionally, in IPF patients as compared to healthy controls, proportions of monocytes were observed to be higher, yet RM T cells were observed to be lower."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28405516": [
        "Across all cancers, the abundance of \u03b1\u03b2 TILs and TCRV\u03b39V\u03b42<sup>+</sup> \u03b3\u03b4 TILs did not correlate. \u03b1\u03b2 TIL abundance paralleled the mutational load of tumors and positively correlated with inflammation, infiltration of monocytes, macrophages and dendritic cells (DC), antigen processing and presentation, and cytolytic activity, in line with an association with a favorable outcome.",
        "In contrast, the abundance of TCRV\u03b39V\u03b42<sup>+</sup> \u03b3\u03b4 TILs did not correlate with these hallmarks and was variably associated with outcome, suggesting that distinct contexts underlie TCRV\u03b39V\u03b42<sup>+</sup> \u03b3\u03b4 TIL and \u03b1\u03b2 TIL mobilizations in cancer.",
        "We report their prominence in B cell-acute lymphoblastic leukemia (B-ALL), acute promyelocytic leukemia (M3-AML) and chronic myeloid leukemia (CML) as well as in inflammatory breast, prostate, esophagus, pancreas and lung carcinoma.",
        "Here, by implementing machine learning from microarray data, we first improved the computational identification of blood-derived TCRV\u03b39V\u03b42<sup>+</sup> \u03b3\u03b4 lymphocytes and then applied this strategy to assess their abundance as tumor infiltrating lymphocytes (\u03b3\u03b4 TIL) in \u223c10,000 cancer biopsies from 50 types of hematological and solid malignancies.",
        "They are currently investigated in several clinical trials of cancer immunotherapy but so far, their tumor infiltration has not been systematically explored across human cancers.",
        "Novel algorithms allowing the deconvolution of bulk tumor transcriptomes to find the relative proportions of infiltrating leucocytes, such as CIBERSORT, should be appropriate for this aim but in practice they fail to accurately recognize \u03b3\u03b4 T lymphocytes.",
        "Most human blood \u03b3\u03b4 cells are cytolytic TCRV\u03b39V\u03b42<sup>+</sup> lymphocytes with antitumor activity.",
        "We observed considerable inter-individual variation of TCRV\u03b39V\u03b42<sup>+</sup>\u03b3\u03b4 TIL abundance both within each type and across the spectrum of cancers tested."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30479695": [
        "Reasons for this failure include the lack of validation of novel molecular targets, which are often characterized in animal models and directly transposed to human trials.",
        "In human GB, NRP1 expression is highly correlated with markers of monocytes/macrophages, as well as genes that contribute to the pro-tumorigenic phenotype of these cells.",
        "Here we build on our previous findings, which describe how the multi-functional co-receptor Neuropilin-1 (NRP1) signals through glioma associated microglia/macrophages (GAMS) to promote murine glioma, and investigate NRP1 expression in human glioma.",
        "Over the course of the last decade, there has been a failure to develop new treatments for GB.",
        "We find that NRP1 expression is correlated with poor prognosis, glioma grade, and associates with the mesenchymal GB subtype.",
        "Additionally, CIBERSORT <i>in silico</i> deconvolution was used to determine fractions of immune cell sub-populations within the gene expression datasets.",
        "High grade gliomas, including glioblastoma (GB), are devastating malignancies with very poor prognosis.",
        "Clinical and gene expression data were obtained via The Cancer Genome Atlas (TCGA), and analyzed using R statistical software."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29796177": [
        "Gene expression of CSF-1 and CSF-1R was strongly associated with myeloid cell infiltration, while we found no or only weak correlations between IL-34, PTPRZ1, syndecan-1 and myeloid cells. <i>In vitro</i> experiments showed that tyrosine phosphorylation of CSF-1R, ERK, and FAK and cell migration are differentially regulated by IL-34 and CSF-1 in breast cancer cell lines.",
        "Furthermore, IL-34 is not associated with myeloid cell infiltration and directly regulates breast cancer cell migration and signaling.",
        "Collectively, our data suggest that correlation of IL-34 gene expression with survival is dependent on the molecular breast cancer subtype.",
        "IL-34 plays a role in innate immunity, inflammation, and cancer.",
        "However, the role of IL-34 in breast cancer is still ill-defined.",
        "Interleukin-34 (IL-34) is a ligand for the CSF-1R and has also two additional receptors, PTPRZ1 and syndecan-1.",
        "Expression of IL-34 was associated with a favorable prognosis in luminal and HER2 but not basal breast cancer patients.",
        "We analyzed IL-34 mRNA expression in breast cancer cell lines and breast cancer patients and applied established computational approaches (CIBERSORT, ESTIMATE, TIMER, TCIA), to analyze gene expression data from The Cancer Genome Atlas (TCGA)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29562236": [
        "The role of de novo mutations in regulatory elements affecting genes associated with developmental disorders, or other genes, has been essentially unexplored.",
        "We previously estimated that 42% of patients with severe developmental disorders carry pathogenic de novo mutations in coding sequences.",
        "Our findings represent a robust estimate of the contribution of de novo mutations in regulatory elements to this genetically heterogeneous set of disorders, and emphasize the importance of combining functional and evolutionary evidence to identify regulatory causes of genetic disorders.",
        "We identified de novo mutations in three classes of putative regulatory elements in almost 8,000 patients with developmental disorders.",
        "We identified a significant twofold enrichment of recurrently mutated elements.",
        "We estimate that, genome-wide, 1-3% of patients without a diagnostic coding variant carry pathogenic de novo mutations in fetal brain-active regulatory elements and that only 0.15% of all possible mutations within highly conserved fetal brain-active elements cause neurodevelopmental disorders with a dominant mechanism.",
        "Here we show that de novo mutations in highly evolutionarily conserved fetal brain-active elements are significantly and specifically enriched in neurodevelopmental disorders."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28620891": [
        "In this study, we characterize the pharmacokinetics (PKs) of olaratumab in a cancer patient population.",
        "In a randomized phase II study, olaratumab plus doxorubicin met its predefined primary endpoint for progression-free survival and achieved a highly significant improvement in overall survival versus doxorubicin alone in patients with advanced or metastatic soft tissue sarcoma (STS).",
        "<strong class=\"sub-title\">\n          Background and objectives:\n        </strong>\n      \n      Olaratumab is a recombinant human monoclonal antibody that binds to platelet-derived growth factor receptor-\u03b1 (PDGFR\u03b1)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29191969": [
        "<b>Purpose:</b> Platelet-derived growth factor receptor \u03b1 (PDGFR\u03b1) is implicated in several adult and pediatric malignancies, where activated signaling in tumor cells and/or cells within the microenvironment drive tumorigenesis and disease progression.",
        "In this study, we investigated olaratumab in preclinical models of pediatric bone and soft tissue tumors.<b>Experimental Design:</b> PDGFR\u03b1 expression was evaluated by qPCR and Western blot analysis.",
        "Olaratumab was investigated in <i>in vitro</i> cell proliferation and invasion assays using pediatric osteosarcoma and rhabdoid tumor cell lines. <i>In vivo</i> activity of olaratumab was assessed in preclinical mouse models of pediatric osteosarcoma and malignant rhabdoid tumor.<b>Results:</b><i>In vitro</i> olaratumab treatment of osteosarcoma and rhabdoid tumor cell lines reduced proliferation and inhibited invasion driven by individual platelet-derived growth factors (PDGFs) or serum.",
        "Furthermore, olaratumab delayed primary tumor growth in mouse models of pediatric osteosarcoma and malignant rhabdoid tumor, and this activity was enhanced by combination with either doxorubicin or cisplatin.<b>Conclusions:</b> Overall, these data indicate that olaratumab, alone and in combination with standard of care, blocks the growth of some preclinical PDGFR\u03b1-expressing pediatric bone and soft tissue tumor models. <i>Clin Cancer Res; 24(4); 847-57. \u00a92017 AACR</i>.",
        "Olaratumab (LY3012207/IMC-3G3) is a human mAb that exclusively binds to PDGFR\u03b1 and recently received accelerated FDA approval and conditional EMA approval for treatment of advanced adult sarcoma patients in combination with doxorubicin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29413687": [
        "Recent randomised phase II trial data have indicated that the addition of olaratumab, a novel monoclonal antibody against platelet-derived growth factor receptor alpha (PDGFR\u03b1), to doxorubicin confers an unprecedented improvement in overall survival to patients with anthracycline-na\u00efve advanced soft tissue sarcoma.",
        "Proposed mechanisms of olaratumab activity include engagement of anti-tumour immune responses and alterations of the tumour stroma, but these require further evaluation.",
        "Ongoing and future preclinical and translational studies, coupled with the anticipated results of a phase III trial that has completed enrolment, should provide greater insight into the efficacy and mode of action of olaratumab in soft tissue sarcomas.",
        "However, this result was disproportionate with progression-free survival and response rate, and consequently there are unanswered questions regarding the precise mechanism of action of olaratumab.",
        "Meanwhile, the drug-specific contribution of cytotoxic agents to olaratumab-containing combinations has yet to be characterised.",
        "While preclinical data show that olaratumab specifically inhibits PDGFR\u03b1-mediated oncogenic signalling with attendant anti-tumour effects, a lack of correlation between pharmacodynamics markers of PDGFR\u03b1 inhibition and clinical benefit from olaratumab suggest other mechanisms beyond modulation of downstream PDGFR\u03b1 molecular pathways."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29497315": [
        "The antitumor activity of olaratumab has been tested in vitro and in vivo, and inhibition of tumor growth has been observed in cancer cell lines, including glioblastoma and leiomyosarcoma cells.",
        "The purpose of this review was to evaluate the rationale of olaratumab in the treatment of advanced STSs and its emerging role in clinical practice.",
        "In November 2016, the European Medicines Agency (EMA) granted conditional approval for olaratumab in the same indication under its Accelerated Assessment Program.",
        "Moreover, final analysis of overall survival (OS) showed a median OS of 26.5 months with olaratumab plus doxorubicin vs 14.7 months with doxorubicin, with a gain of 11.8 months (HR 0.46, 95% CI 0.30-0.71, <i>p</i>=0.0003).",
        "The median progression-free survival (PFS), which was the primary end point of the study, was improved for patients treated with olaratumab plus doxorubicin compared to those treated with doxorubicin monotherapy (6.6 vs 4.1 months, respectively; HR 0.672, 95% CI 0.442-1.021, <i>p</i>=0.0615).",
        "The study is ongoing, but enrollment is closed.",
        "It represents the first-in-class antibody to be approved by regulatory authorities for the treatment of advanced soft-tissue sarcomas (STSs) in combination with doxorubicin, based on the results of the Phase Ib/II trial by Tap et al.",
        "In October 2016, olaratumab was admitted in the Accelerated Approval Program by the US Food and Drug Administration (FDA) for use in combination with doxorubicin for the treatment of adult patients with STSs.",
        "A double-blind, placebo-controlled, randomized Phase III study (ANNOUNCE trial, <a href=\"http://clinicaltrials.gov/show/NCT02451943\" title=\"See in ClinicalTrials.gov\">NCT02451943</a>) is being performed in order to confirm the survival advantage of olaratumab and to provide definitive drug confirmation by regulators.",
        "Lartruvo<sup>\u00ae</sup> (olaratumab) is a fully human immunoglobulin G subclass 1 (IgG1) monoclonal antibody that inhibits platelet-derived growth factor receptor alpha (PDGFR\u03b1)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27995580": [
        "In addition, the EMA granted conditional approval for olaratumab in this indication in November 2016 following a review under the EMA's Accelerated Assessment Program.",
        "Olaratumab (Lartruvo\u2122) is a fully human IgG1 monoclonal antibody targeted against the human platelet-derived growth factor (PDGF) receptor \u03b1 (PDGFR\u03b1).",
        "It was developed by Eli Lilly and Co. (previously ImClone Systems) after PDGFR\u03b1 was identified as a potential therapeutic target in a variety of cancers.",
        "Olaratumab acts by selectively binding PDGFR\u03b1, thereby blocking PDGF ligand binding and inhibiting PDGFR\u03b1 activation and downstream signalling.",
        "Olaratumab has also been investigated in phase II trials in several other cancers.",
        "This article summarizes the milestones in the development of olaratumab leading to this first approval, for use in combination with doxorubicin for the treatment of soft tissue sarcoma in adults.",
        "An international, confirmatory phase III trial in patients with soft tissue sarcoma is ongoing (ANNOUNCE; <a href=\"http://clinicaltrials.gov/show/NCT02451943\" title=\"See in ClinicalTrials.gov\">NCT02451943</a>).",
        "In October 2016, olaratumab received its first global approval, in the USA, for use in combination with doxorubicin for the treatment of adult patients with soft tissue sarcoma.",
        "The approval was granted by the US FDA under its Accelerated Approval Program based on the results of the JGDG phase II trial (<a href=\"http://clinicaltrials.gov/show/NCT01185964\" title=\"See in ClinicalTrials.gov\">NCT01185964</a>)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27291997": [
        "Olaratumab is a human antiplatelet-derived growth factor receptor \u03b1 monoclonal antibody that has antitumour activity in human sarcoma xenografts.",
        "We aimed to assess the efficacy of olaratumab plus doxorubicin in patients with advanced or metastatic soft-tissue sarcoma.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Treatment with doxorubicin is a present standard of care for patients with metastatic soft-tissue sarcoma and median overall survival for those treated is 12-16 months, but few, if any, novel treatments or chemotherapy combinations have been able to improve these poor outcomes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30406840": [
        "Olaratumab plus doxorubicin improved survivalversus doxorubicin in an open-label, randomised phase 2 soft tissue sarcoma (STS) trial.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Olaratumab is a recombinant human IgG1 monoclonal antibody against PGDFR\u03b1.",
        "We characterised the olaratumab exposure-response relationship for progression-free survival (PFS), overall survival (OS), and safety."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28917265": [
        "Here, we reviewed the biology of the PDGF/PDGFR axis, particularly focusing on its role in cancer, and then we discussed on the effects of PDGFR-\u03b1 inhibition in the therapy of advanced soft tissue sarcomas.",
        "Advanced soft tissue sarcomas are aggressive cancers with limited therapeutic options.",
        "Recently, inhibition of platelet-derived growth factor receptor (PDGFR)-\u03b1 by the monoclonal antibody olaratumab showed promising clinical activity.",
        "If confirmed, this would be one of the first examples of targeted therapy effective in advanced soft tissue sarcomas therapy independently of the histologic subtype."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28838379": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      In non-small cell lung cancer (NSCLC), platelet-derived growth factor receptor (PDGFR) mediates angiogenesis, tissue invasion, and tumor interstitial pressure.",
        "Olaratumab (IMC-3G3) is a fully human anti-PDGFR\u03b1 monoclonal antibody.",
        "This Phase II study assessed safety and efficacy of olaratumab+paclitaxel/carboplatin (P/C) versus P/C alone for previously untreated advanced NSCLC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28447475": [
        "An open-label phase Ib and randomized phase II trial in patients with advanced soft tissue sarcoma demonstrated that the addition of olaratumab to doxorubicin prolonged progression-free survival by 2.5 months and overall survival by 11.8 months when compared to doxorubicin alone.",
        "Its antagonistic behavior inhibits the receptor's tyrosine kinase activity, thereby, turning off the downstream signaling cascades responsible for soft tissue sarcoma tumorigenesis.",
        "Expert commentary: The combination of olaratumab plus doxorubicin has provided a new front-line therapeutic option for soft tissue sarcoma patients.",
        "Areas covered: This drug profile takes a comprehensive look at the clinical studies leading to FDA approval of olaratumab as well as its safety and efficacy as a front-line treatment option for sarcoma patients.",
        "The literature search was primarily conducted using PubMed.",
        "Olaratumab is a humanized IgG1 monoclonal antibody that blocks the platelet-derived growth factor receptor alpha (PDGFR\u03b1).",
        "A phase III confirmatory trial (ClinicalTrials.gov Identifier <a href=\"http://clinicaltrials.gov/show/NCT02451943\" title=\"See in ClinicalTrials.gov\">NCT02451943</a>) will be completed in 2020.",
        "Of importance, this clinically meaningful increase in overall survival did not come at the expense of a significantly greater number of toxicities.",
        "In October 2016, olaratumab received Food and Drug Administration (FDA) approval for its use in combination with doxorubicin for treatment of advanced soft tissue sarcoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24816152": [
        "Based on the pharmacokinetic concentration profile of olaratumab, the trough concentrations following single and multiple doses at 15 mg/kg on days 1 and 8 every 3 weeks (cohort 3) and multiple doses at 20 mg/kg every 2 weeks (cohort 2) were above the 155 \u03bcg/mL target.",
        "Olaratumab (IMC-3G3) is a fully human IgG1 monoclonal antibody that selectively binds the external domain of human platelet-derived growth factor receptor-\u03b1 with high affinity and blocks ligand binding.",
        "Seven patients (43.8%) had a best response of stable disease.",
        "Three to six patients were enrolled into each of three cohorts: Patients received i.v. olaratumab: 10 mg/kg on days 1 and 8 every 3 weeks (cohort 1); 20 mg/kg every 2 weeks (cohort 2); and 15 mg/kg on days 1 and 8 every 3 weeks (cohort 3).",
        "Thus, these two doses could represent an acceptable schedule for future trials in Japanese patients.",
        "Sixteen patients were treated across three cohorts.",
        "Olaratumab had an acceptable safety profile and was well tolerated.",
        "Doses were escalated from cohort 1 through cohort 3.",
        "One patient (cohort 2) had two olaratumab-related Grade 3 TEAEs (increased aspartate aminotransferase and tumor hemorrhage); otherwise, olaratumab-related TEAEs were Grade 1/2.",
        "The most common olaratumab-related treatment-emergent adverse events (TEAEs) were proteinuria (25.0%) and elevated aspartate transaminase (12.5%).",
        "There were no dose-limiting toxicities, so the maximum tolerated dose was not reached.",
        "This was a single-center, dose-escalation, phase I trial of olaratumab in Japanese patients with advanced/refractory solid malignancies.",
        "The primary objective was to establish the safety and pharmacokinetic profile of olaratumab."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28691538": [
        "Unfortunately, the first-line doxorubicin-based treatment has not been improved since the 1970s.",
        "However, it must be qualified, as the study includes several uncertainties.",
        "This trial showed a great improvement in overall survival (OS), with an increase in survival from 14.7 months to 26.5 months for patients in the experimental arm and showed acceptable toxicity.",
        "These uncertainties should be addressed by the ongoing Phase 3 JGDJ confirmatory trial, for which the final efficacy analysis is expected by 2019.",
        "Areas covered: The authors review the role of olaratumab in the treatment of STS by focusing on the recent, randomized Phase II JDGD trial that challenged patients with unresectable or metastatic STS with doxorubicin in the presence or absence of olaratumab.",
        "Platelet-derived growth factor (PDGF) receptor alpha (PDGFR-\u03b1) and its ligands are co-expressed in many types of cancer, including sarcomas.",
        "Expert opinion: Results seem promising.",
        "Olaratumab is a fully human IgG1-type anti-PDGFR-\u03b1 monoclonal antibody with a high affinity and a low 50% inhibitory concentration (IC50).",
        "They are involved in stimulating growth and regulating stromal-derived fibroblasts and angiogenesis.",
        "PDGFR-\u03b1 and its ligand may play an important role in tumorigenesis and be a potential target in the treatment of sarcomas.",
        "Soft tissue sarcomas (STS) are rare malignant tumors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24452395": [
        "This phase I study assessed the safety, maximum tolerated dose (MTD), recommended phase II dose (RP2D), pharmacokinetics, and preliminary antitumor activity of olaratumab in patients with advanced solid tumors.",
        "Olaratumab (IMC-3G3) is a fully human monoclonal antibody that selectively binds human PDGFR\u03b1 and blocks ligand binding.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      The platelet-derived growth factor receptor (PDGFR) has an important role in tumorigenesis and tumor progression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29263653": [
        "The prognosis of metastatic STS is poor with a life expectancy of 12-18 months.",
        "This approval was based upon an improvement in overall survival of patients receiving the combination of doxorubicin and olaratumab compared to those receiving doxo-rubicin alone.",
        "Based on early-phase clinical trials, olaratumab appears to be a promising agent for the treatment of STS.",
        "Soft-tissue sarcoma (STS) is a heterogeneous group of tumors that arise from mesenchymal tissue.",
        "The mainstay of treatment is chemotherapy with an anthracycline.",
        "This drug recently received the US Food and Drug Administration's accelerated approval for the treatment of advanced STS when combined with doxorubicin.",
        "Olaratumab is a fully human IgG1 monoclonal antibody that binds to platelet-derived growth factor receptor \u03b1 (PDGFR-\u03b1) preventing binding of its ligands and receptor activation.",
        "The addition of other chemotherapeutic agents to an anthracycline has been studied with limited success in improving outcomes for STS patients.",
        "In this review, we have analyzed the available literature on the development of olaratumab, its clinical utility, and its place in therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30353601": [
        "Subsequent exposure-response analysis suggested that higher olaratumab exposures earlier might improve outcomes in patients at risk of early disease progression.",
        "Patients in Cohorts 2 and 3 received doxorubicin 75 mg/m<sup>2</sup> on Day 1.",
        "One patient in Cohort 2 experienced a dose-limiting toxicity of Grade 3 febrile neutropenia.",
        "Olaratumab serum concentrations in Cohort 3 reached a steady-state exceeding the target level in Cycle 1.",
        "Patients in Cohort 3 received a 20 mg/kg loading dose of olaratumab in Cycle 1.",
        "This phase 1 study (3 treatment cohorts; minimum 6 patients each) investigated the safety, pharmacokinetics and antitumor activity of olaratumab plus doxorubicin in Japanese patients with STS.",
        "Olaratumab plus doxorubicin had an acceptable safety profile in patients with STS.",
        "Patients received olaratumab 15 mg/kg on Days 1 and 8 during each 21-day cycle until disease progression.",
        "Doxorubicin was administered for up to 6 cycles.",
        "Partial response was confirmed in 4 patients (2 each in Cohorts 2 and 3).",
        "Most treatment-emergent adverse events were of mild and moderate severity, and were known doxorubicin toxicities.",
        "Patients in Cohort 1 received doxorubicin 25 mg/m<sup>2</sup> on Days 1, 2 and 3.",
        "Olaratumab, a monoclonal antibody targeting human platelet-derived growth factor receptor \u03b1, plus doxorubicin significantly improved overall survival in patients with advanced soft-tissue sarcoma (STS) in a prior phase 1b/2 randomized trial.",
        "A loading dose of olaratumab 20 mg/kg was effective for achieving minimum serum concentrations above the target trough level in Cycle 1."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30513001": [
        "However, several new drugs and indications have become available in recent years.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Soft-tissue sarcomas (STS) are a heterogeneous group of diseases that are characterized by a historic lack of active treatment options."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28778132": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To review and summarize data on olaratumab, which was approved by the US Food and Drug Administration (FDA) in October 2016, in combination with doxorubicin, for the treatment of advanced soft tissue sarcoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28187274": [
        "Olaratumab blocks ligand binding and thereby inhibits activation of PDGFRA kinase activity.",
        "Pre-clinically, this antibody inhibited PDGFRA-dependent tumor growth.",
        "Lartruvo (olaratumab) is a monoclonal antibody against the extracellular domain of PDGFRA.",
        "In a randomized Phase II study, adding olaratumab to doxorubicin chemotherapy significantly improved overall survival, leading to FDA approval."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28734947": [
        "We show colocalization of PDGFR\u03b1 in murine carbon tetrachloride, bile duct ligation, and 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine models of chronic liver injury, and investigate the role of PDGFR\u03b1 on proliferation, profibrotic gene expression, and migration in primary human HSCs (HHSteCs) using the PDGFR\u03b1-specific inhibitory monoclonal antibody olaratumab.",
        "Platelet-derived growth factor receptor \u03b1 (PDGFR\u03b1), a tyrosine kinase receptor, is up-regulated in hepatic stellate cells (HSCs) during chronic liver injury.",
        "Using phospho-specific antibodies, we show that olaratumab attenuates PDGFR\u03b1 activation in response to PDGF-BB, and reduced phosphorylation of extracellular signal-regulated kinase 1 and 2, Elk-1, p38, Akt, focal adhesion kinase, mechanistic target of rapamycin, C10 regulator of kinase II, and C10 regulator of kinase-like, suggesting that PDGFR\u03b1 contributes to mitogenesis and actin reorganization through diverse downstream effectors.",
        "Although lacking any effects on HHSteC transdifferentiation assessed by gene expression of ACTA2, TGFB1, COL1A1, SYP1, and FN1, olaratumab specifically reduced HHSteC proliferation (AlamarBlue assay) and cell migration (transwell migration assays).",
        "Our findings support a distinct contribution of PDGFR\u03b1 signaling to HSC proliferation and migration and provide evidence that inhibition of PDGFR\u03b1 signaling could alter the pathogenesis of hepatic fibrosis.",
        "HSCs mediate hepatic fibrosis through their activation from a quiescent state partially in response to profibrotic growth factors.",
        "HSC activation entails enhanced expression of profibrotic genes, increase in proliferation, and increase in motility, which facilitates migration within the hepatic lobule."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28745071": [
        "The results of this trial led to approval of olaratumab in combination with doxorubicin in adult anthracycline-naive unresectable soft tissue sarcoma.",
        "A Phase Ib/randomized Phase II trial of doxorubicin with or without the monoclonal antibody to PDGFR-\u03b1, olaratumab, demonstrated a significant difference in median overall survival in favor of the olaratumab arm.",
        "In the first line setting, a number of randomized trials have shown no difference in overall survival between combination anthracycline schedules and single agent doxorubicin.",
        "In this review, we describe some of the preclinical and early clinical data of olaratumab in sarcomas, the Phase Ib/II trial and ongoing trials with olaratumab in sarcomas.",
        "The outcome for patients with unresectable/metastatic soft tissue sarcoma remains poor with few treatment options."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29119300": [
        "Fourteen of eighteen children randomized to placebo received open label IVIG 6 weeks after the blinded infusion, so follow-up results reported below largely reflect outcomes in a population of children who received at least one dose of IVIG.",
        "During the interim period (6-57 months after entering the clinical trial), 24 (72%) had experienced at least one exacerbation of PANDAS symptoms, with a median of one exacerbation per child (range 1-12; interquartile range 0-3).",
        "The outcomes of this cohort are better than those previously reported for childhood-onset OCD, which may support conceptualization of PANDAS as a subacute illness similar to Sydenham chorea.",
        "A variety of treatment modalities, including antibiotics, IVIG, psychiatric medications, cognitive behavioral therapy, and others, were used to treat these exacerbations, and were often used in combination.",
        "This study prospectively followed 33 children with PANDAS for up to 4.8 years (mean 3.3 \u00b1 0.7 years) after enrollment in a 24-week randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin (IVIG) (N = 35).",
        "Telephone interviews with the parents of participants found that at the time of phone follow-up, 29 (88%) were not experiencing clinically significant obsessive-compulsive symptoms.",
        "However, some children developed a chronic course of illness, highlighting the need for research that identifies specific symptoms or biomarkers that can be used to predict the longitudinal course of symptoms in PANDAS.",
        "Little is known about the natural history of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29722936": [
        "This review examines the best-quality evidence supporting the practice-based use of antibiotics in these psychiatric conditions.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Antibiotics have been used extensively by clinicians to treat patients with PANDAS or PANS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome, respectively)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30325890": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) hypothesis suggests an association between group A beta-hemolytic streptococcus (GABHS) infections and subsequent onset or exacerbation of neuropsychiatric symptoms, such as obsessive-compulsive disorder or tic disorders."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24019622": [
        "In this regard, we focused on to investigate a possible relation between the TNF-\u03b1 gene promoter region-308 G/A and - 850 C/T polymorphisms and PANDAS.",
        "Tumor necrosis factor (TNF), encoded by TNF-\u03b1 gene has an important role in the apoptotic mechanisms of autoimmune diseases.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) is a newly defined disease in neuropsychiatry and occurs with an autoimmune mechanism after Group A Beta Hemolytic Streptococcus (GABHS) infection.",
        "Recently, TNF-\u03b1 polymorphisms and autoimmune/psychiatric disorders have been reported to be related."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25151976": [
        "In all subjects we evaluated serum concentrations of free-T3, free-T4, thyrotropin, and the following auto-antibodies: anti-thyroperoxidase, anti-thyroglobulin, anti-thyrotropin receptor, anti-gliadin, anti-endomysium, anti-tissue transglutaminase, anti-nuclear, anti-smooth muscle, anti-extractable nuclear antigens, anti-phospholipid, plus lupus-like anticoagulant.",
        "However, PANDAS patients with autoimmune diseases or positivity for any organ- and nonorgan-specific antibodies showed significantly higher anti-streptolysin O and anti-DNAse B titers, as well as a history of more frequent throat infections than controls (p&lt;0.0001).",
        "Children and adolescents with PANDAS should not be actually screened for thyroid function, celiac disease and/or autoimmune diseases.",
        "The aim of our study was to evaluate the prevalence of autoimmune phenomena, including thyroid function abnormalities, specific celiac disease antibodies, and positivity of organ- or nonorgan-specific autoantibodies in a large cohort of Caucasian children and adolescents with PANDAS.",
        "Evaluating the overall disease duration, we did not observe any significant difference between patients with (3.4\u00b12.15 years) and without (3.4\u00b12.89 years) autoimmune abnormalities.",
        "Poor data are available about the clear definition of PANDAS's autoimmune origin.",
        "Abnormalities of thyroid function and thyroid autoimmune diseases, as well as the association with celiac disease or organ- and nonorgan-specific autoimmunity seem not more frequent in children and adolescents with PANDAS than in healthy controls.",
        "The results were compared with those obtained from 197 age- and sex-matched healthy controls (130 males, 67 females; mean age 6.8\u00b12.9 years, range 2.3-14.8 years).",
        "Seventy-seven consecutive patients (59 males, 18 females; mean age 6.3\u00b12.5 years, range 2.0-14.5 years) strictly fulfilling the clinical criteria for PANDAS diagnosis were recruited.",
        "A potential relationship between autoimmunity and PANDAS should be assessed further in larger studies.",
        "The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are basically characterized by obsessive-compulsive symptoms and/or tics triggered by group-A beta-hemolytic Streptococcus infections.",
        "The frequencies of subclinical (3.8% vs 3.6%) and overt hypothyroidism (1.2% vs 0%), autoimmune thyroiditis (2.46% vs 1.14%), celiac disease (1.2% vs 0.05%), and positivity of organ- and nonorgan-specific autoantibodies (5.1% vs 4.8%) were not statistically significant between patients with PANDAS and controls."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18817720": [
        "This child has had no further symptoms after tonsillectomy.",
        "In this disease, there is a relationship between group A beta haemolytic streptococcal tonsil infections and the exacerbation of neuropsychiatric disorders.",
        "The understanding about PANDAS syndrome and tonsillectomy is reviewed.",
        "A case report of a 9-year-old child with PANDAS syndrome is presented.",
        "PANDAS Syndrome (Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus) is a rare disease described in 1998."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16970875": [
        "PANDAS constitutes a subset of children with tics, Tourette syndrome, and obsessive-compulsive disorder.",
        "The recognition that some pediatric neurobehavioral syndromes have infectious and/or immunologic triggers points to important new avenues of disease treatment.",
        "In this review, we summarize this complex and rapidly evolving area of clinical research.",
        "In addition to strictly defined PANDAS, we and others have recognized several PANDAS variants, including adult-onset variant, a dystonic variant, a myoclonic variant, and a \"chronic\" PANDAS variant.",
        "Streptococcal infection in children is usually benign and self-limited.",
        "PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) is a well-defined syndrome in which tics (motor and/or vocal) and/or obsessive-compulsive disorder consistently exacerbate in temporal correlation to a group A beta-hemolytic streptococcal infection.",
        "Sydenham chorea is the best defined and best recognized.",
        "The nosology and classification of these entities are rapidly evolving.",
        "In a small percentage of children, prominent neurologic and/or psychiatric sequelae can occur."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20864184": [
        "Thus, we hypothesized that a sample of children with OCD and/or tics would have an increased maternal risk for an autoimmune response relative to population norms.",
        "We also expected maternal prevalence of various autoimmune diseases to be higher among those participants that met the putative criteria for PANDAS.",
        "Of recent interest, a subtype of obsessive-compulsive disorder (OCD) and tic disorders known collectively as Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus (PANDAS) is believed to be secondary to central nervous system (CNS) autoimmunity that occurs in relation to group A streptococcal infection.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      A commonality across a number of pediatric neuropsychiatric disorders is a higher than typical rate of familial - and especially maternal - autoimmune disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19913659": [
        "Although a number of immunological biomarkers have been proposed as markers of the PANDAS variant, at present, none of these has been conclusively proved useful to diagnose and monitor disease course in children with a suspicion of PANDAS.",
        "In addition, preliminary results suggest that the PANDAS spectrum might be enlarged to include attention deficit/hyperactivity disorder.",
        "Moreover, longitudinal retrospective studies suggest that a recent exposure to GABHS might be a risk factor for the onset of tics and obsessive-compulsive symptoms.",
        "Given the relevance of this topic for general pediatric health, additional research efforts to solve all the pending issues and the hottest points of debate are warranted.",
        "Diagnosis and treatment of the PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections) variant of Gilles de la Tourette syndrome (GTS) and childhood-onset obsessive-compulsive disorder (OCD) are still controversial issues.",
        "Most cross-sectional studies confirm a significant association between GTS and the development of an immune response against group A beta-hemolytic streptococcus (GABHS).",
        "Finally, despite their empirical use in community settings, we still lack conclusive, evidence-based data regarding the usefulness of antibiotic and immunomodulatory treatments in children with PANDAS.",
        "However, further evidence from longitudinal prospective research is needed to verify whether a temporal association between GABHS infections and symptom exacerbations is a useful and reliable criterion for the diagnosis of PANDAS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29112476": [
        "Despite the well-known action of 25-hydroxyvitamin D [25(OH)D] on different conditions driven by systemic inflammation, there are no data about the 25(OH)D status in patients with PANDAS.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are immune-mediated diseases characterized by obsessive-compulsive symptoms and/or tics triggered by group A Streptococcus infections."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28498087": [
        "After almost 20 years, PANDAS has not been accepted as distinct disorder and new criteria for paediatric acute-onset neuropsychiatric syndrome (PANS) have been replaced it, highlighting the fact that several agents rather than only Streptococcus might be involved.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      'Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections' (PANDAS) identified a unique subgroup of patients with abrupt onset of obsessive compulsive disorder (OCD) symptoms clinically related to Streptococcus infection and accompanied by neuropsychological and motor symptoms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15703218": [
        "By fusing FcgammaR to pH-sensitive fluorescent proteins, we observed that the cytoplasmic domain of the receptors enters an acidic compartment, indicative of inward budding and formation of multivesicular structures.",
        "Preventing the generation of multivesicular structures did not impair the acquisition of late endosomal and lysosomal markers, indicating that phagosomal fusion and fission are controlled separately.",
        "The topology of the receptor was confirmed by flow cytometry of purified phagosomes.",
        "FcgammaR, which show a continuous distribution throughout the membrane of nascent phagosomes were found at later times to cluster into punctate, vesicular structures, before disappearing.",
        "Remarkably, proteasomal function is also involved in the vesiculation process.",
        "In situ photoactivation of receptors tagged with a light-sensitive fluorescent protein revealed that some of these vesicles detach, whereas others remain associated with the phagosome.",
        "Phagosomal proteins are ubiquitylated, and ubiquitylation was found to be required for formation of acidic multivesicular structures.",
        "Despite the insertion of vast amounts of additional membrane, the phagosomal surface area remains approximately constant, implying active ongoing fission.",
        "To investigate the mechanisms underlying phagosomal fission we monitored the fate of Fcgamma receptors (FcgammaR), which are known to be cleared from the phagosome during maturation.",
        "Phagosomes undergo multiple rounds of fusion with compartments of the endocytic pathway during the course of maturation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29376029": [
        "Protein ubiquitination is critical for regulation of numerous eukaryotic cellular processes such as protein homeostasis, cell cycle progression, immune response, DNA repair, and vesicular trafficking.",
        "Furthermore, membranes of the bacterial phagosome are enriched with ubiquitinated proteins in a way that requires its Dot/Icm type IV secretion system, suggesting the involvement of effectors in the manipulation of the host ubiquitination machinery.",
        "Here we summarize recent advances in our understanding of mechanisms exploited by <i>L. pneumophila</i> effector proteins to hijack the host ubiquitination pathway.",
        "Given the importance of ubiquitination in the regulation of host immunity, it is not surprising that many infectious agents have evolved strategies to interfere with the ubiquitination network with sophisticated mechanisms such as functional mimicry.",
        "Ubiquitination often leads to the alteration of protein stability, subcellular localization, or interaction with other proteins.",
        "The optimal intracellular replication of <i>L. pneumophila</i> requires the host ubiquitin-proteasome system.",
        "The facultative intracellular pathogen <i>Legionella pneumophila</i> is the causative agent of Legionnaires' disease. <i>L. pneumophila</i> is phagocytosed by macrophages and is able to replicate within a niche called Legionella-containing vacuole (LCV).",
        "The biogenesis of LCV is dependent upon the Dot/Icm type IV secretion system which delivers more than 330 effector proteins into host cytosol."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24303998": [
        "The disease is vaccine preventable and eradication of the virus is considered feasible, in principle.",
        "Declining disease prevalence, combined with public anxiety over the vaccination's safety, has led to increased vaccine refusal, especially in Europe.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      The measles virus is a major human pathogen responsible for approximately 150,000 deaths annually.",
        "This has led to the resurgence of measles in some areas.",
        "However, a herd immunity exceeding 95% is required to prevent sporadic viral outbreaks in a population."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29773326": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Tremelimumab, an anti-CTLA4 monoclonal antibody, initially showed good activity when used alone in patients with mesothelioma, but did not improve the overall survival of patients who failed on first-line or second-line chemotherapy compared with placebo in the DETERMINE study.",
        "We aimed to investigate the efficacy and safety of first-line or second-line tremelimumab combined with durvalumab, an anti-PD-L1 monoclonal antibody, in patients with malignant mesothelioma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28231719": [
        "Biological and clinical considerations rule out the use of tremelimumab as single agent for MM and, more generally, the use of immune checkpoint inhibitors for MM is still largely questionable and not supported by evidences.",
        "Criticism and perspective of this treatment are also discussed.",
        "One approach to immunotherapy is immune checkpoint inhibitors, such as blockage of CTLA-4 and PD-1/PD-L1.",
        "Immunotherapy is an emerging therapeutic strategy with a promising clinical outcome in some solid tumors, particularly metastatic melanoma.",
        "This special report aims to describe the state of clinical trials of tremelimumab in patients with unresectable malignant mesothelioma (MM) in particular with regard to the clinical efficacy, safety and tolerability."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28729154": [
        "In the DETERMINE study, we investigated the effects of the cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody tremelimumab in patients with previously treated advanced malignant mesothelioma.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      New therapeutic strategies for malignant mesothelioma are urgently needed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29770715": [
        "There is a focus on the diagnosis and treatment of these side effects including differentiation syndrome.",
        "However, given the fact that enasidenib is a highly specific inhibitor of an early stable mutation, it is questionable whether a strategy of targeting a single mutation or pathway in relapsed AML will allow for better than the 20% complete remission (CR) rate observed with this therapy.",
        "The proper role for single mutation targeting in AML needs to be carefully considered.",
        "A majority of the effort has been concentrated on targeting gene mutations or pathway activations with precision therapeutics.",
        "Enasidenib targets cells with mutant copies of isocitrate dehydrogenase-2 (IDH2), inhibiting the oncometabolite 2-hydroxyglutarte (2-HG) formed by the mutant IDH2.",
        "Expert commentary: We are experiencing a revolution in the understanding of the mechanism of AML.",
        "Enasidenib is beneficial in a patient population that previously had limited treatment options.",
        "Areas covered: We review the studies leading to enasidenib's approval, as well as common side effects and safety issues experienced during the clinical trials.",
        "In August 2017, the United States Federal Drug Administration (FDA) approved enasidenib (Idhifa, Celgene/Agios) for adults with relapsed and refractory acute myelogenous leukemia (AML) with an IDH2 mutation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27895032": [
        "Activation of receptor shedding by mechanical cues, hypoxia, radiation, and phosphosignaling offers insight into mechanisms of drug resistance.",
        "Receptor substrates of sheddases include the cytokine receptors TNFR1 and IL6R; the Notch receptors; type-I and -III TGF\u03b2 receptors; receptor tyrosine kinases (RTK) such as HER2, HER4, and VEGFR2; and, in particular, MET and TAM-family RTKs AXL and Mer (MerTK).",
        "It is increasingly clear that the proteolytic shedding of transmembrane receptors impacts pathophysiology and drug response.",
        "This particularly holds for kinase inhibitors targeting BRAF (such as vemurafenib and dabrafenib) and MEK (such as trametinib and cobimetinib), along with direct sheddase inhibitors.",
        "Clin Cancer Res; 23(3); 623-9. \u00a92016 AACR.",
        "Translatable strategies to exploit receptor shedding include combination kinase inhibitor regimens, recombinant decoy receptors based on endogenous counterparts, and, potentially, immunotherapy.",
        "Proteases known as sheddases cleave the extracellular domains of their substrates from the cell surface.",
        "The A Disintegrin and Metalloproteinases ADAM10 and ADAM17 are among the most prominent sheddases, being widely expressed in many tissues, frequently overexpressed in cancer, and promiscuously cleaving diverse substrates.",
        "Receptor proteolysis can be detected in patient fluids and is especially relevant in melanoma, glioblastoma, lung cancer, and triple-negative breast cancer where RTK substrates, MAPK signaling, and ADAMs are frequently dysregulated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28034848": [
        "This newly discovered post-translational processing of AXL may provide an explanation for the diverse functions of AXL, especially in the context of drug resistance in cancer cells.-Lu, Y., Wan, J., Yang, Z., Lei, X., Niu, Q., Jiang, L., Passtoors, W.",
        "In the present study, we demonstrate that AXL, but not TYRO3 or MERTK, is efficiently and sequentially cleaved by \u03b1- and \u03b3-secretases in various types of cancer cell lines.",
        "Of interest, we found that the \u03b3-secretase-uncleavable AXL mutant caused an elevated chemoresistance in non-small-cell lung cancer cells.",
        "Altogether, our findings suggest that AXL can undergo sequential processing mediated by various proteases kept in a homeostatic balance.",
        "Deregulation of the TAM (TYRO3, AXL, and MERTK) family of receptor tyrosine kinases (RTKs) has recently been demonstrated to predominately promote survival and chemoresistance of cancer cells.",
        "Proteolytic processing of AXL redirected signaling toward a secretase-mediated pathway, away from the classic, well-known, ligand-dependent canonical RTK signaling pathway.",
        "C., Wu, F. Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells.",
        "The AXL intracellular domain cleavage product, but not full-length AXL, was further shown to translocate into the nucleus <i>via</i> a nuclear localization sequence that harbored a basic HRRKK motif.",
        "Intramembrane proteolysis mediated by presenilin/\u03b3-secretase is known to regulate the homeostasis of some RTKs.",
        "M., Zang, A., Fraering, P."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28904208": [
        "For most RTKs, however, it is unknown whether they can exploit this new signaling mechanism.",
        "The screen covering 45 of the 55 human RTKs identified 12 new as well as all nine previously published gamma-secretase substrates.",
        "Taken together, these data indicate that gamma-secretase-mediated cleavage provides an additional signaling mechanism for numerous human RTKs.",
        "We biochemically validated the screen by demonstrating that the release of a soluble intracellular fragment from endogenous AXL was dependent on the sheddase disintegrin and metalloprotease 10 (ADAM10) and the gamma-secretase component presenilin-1.",
        "Here we used a system-wide screen to address the frequency of susceptibility to gamma-secretase cleavage among human RTKs.",
        "Receptor tyrosine kinases (RTKs) have been demonstrated to signal via regulated intramembrane proteolysis, in which ectodomain shedding and subsequent intramembrane cleavage by gamma-secretase leads to release of a soluble intracellular receptor fragment with functional activity.",
        "Functional analysis of the cleavable RTKs indicated that proliferation promoted by overexpression of the TAM family members AXL or TYRO3 depends on gamma-secretase cleavage."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28734578": [
        "The preeminent example of this repurposing is ATP, which functions as a building block for nucleic acids, an energy source for enzymatic reactions, a phosphate donor to regulate intracellular signaling, and a neurotransmitter to control the activity of neurons.",
        "A series of recent studies now consolidates the view that phosphatidylserine (PtdSer), a common phospholipid constituent of membrane bilayers, is similarly repurposed for use as a signal between cells and that the ligands and receptors of the Tyro3/Axl/Mer (TAM) family of receptor tyrosine kinases (RTKs) are prominent transducers of this signal.",
        "Nature repeatedly repurposes, in that molecules that serve as metabolites, energy depots, or polymer subunits are at the same time used to deliver signals within and between cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18620092": [
        "In this chapter, we first provide a comprehensive review of the structure, regulation, biologic functions, and downstream signaling pathways of these receptors.",
        "In addition, we discuss recent evidence which suggests a role for TAM receptors in oncogenic mechanisms as family members are overexpressed in a spectrum of human cancers and have prognostic significance in some.",
        "Genetic or experimental alteration of TAM receptor function can contribute to a number of disease states, including coagulopathy, autoimmune disease, retinitis pigmentosa, and cancer.",
        "Further research will be necessary to evaluate the full clinical implications of TAM family expression and activation in cancer.",
        "Possible strategies for targeted inhibition of the TAM family in the treatment of human cancer are described.",
        "This small family of RTKs regulates an intriguing mix of processes, including cell proliferation/survival, cell adhesion and migration, blood clot stabilization, and regulation of inflammatory cytokine release.",
        "Tyro-3, Axl, and Mer constitute the TAM family of receptor tyrosine kinases (RTKs) characterized by a conserved sequence within the kinase domain and adhesion molecule-like extracellular domains."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25568918": [
        "Rather than functioning as oncogenic drivers, their induction in tumour cells predominately promotes survival, chemoresistance and motility.",
        "The unique mode of maximal activation of this RTK family requires an extracellular lipid\u2013protein complex.",
        "For example, the protein ligand, growth arrest-specific protein 6 (GAS6), binds to phosphatidylserine (PtdSer) that is externalized on apoptotic cell membranes, which activates MERTK on macrophages.",
        "Thus, TAM kinase inhibition could stimulate antitumour immunity, reduce tumour cell survival, enhance chemosensitivity and diminish metastatic potential.",
        "The TYRO3, AXL (also known as UFO) and MERTK (TAM) family of receptor tyrosine kinases (RTKs) are aberrantly expressed in multiple haematological and epithelial malignancies.",
        "This triggers engulfment of apoptotic material and subsequent anti-inflammatory macrophage polarization.",
        "In tumours, autocrine and paracrine ligands and apoptotic cells are abundant, which provide a survival signal to the tumour cell and favour an anti-inflammatory, immunosuppressive microenvironment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18374195": [
        "Gas6 employs a unique mechanism of action, interacting through its vitamin K-dependent Gla module with phosphatidylserine-containing membranes and through its carboxy-terminal LG domains with the TAM membrane receptors.",
        "Since then, the role of Gas6, protein S, and the TAM receptors has been found to be important in inflammation, hemostasis, and cancer, making this system an interesting target in biomedicine.",
        "Gas6 (growth arrest-specific gene 6) is the last addition to the family of plasma vitamin K-dependent proteins.",
        "Gas6 was cloned and characterized in 1993 and found to be similar to the plasma anticoagulant protein S. Soon after it was recognized as a growth factor-like molecule, as it interacted with receptor tyrosine kinases (RTKs) of the TAM family; Tyro3, Axl, and MerTK.",
        "The fact that these proteins are affected by anti-vitamin K therapy is discussed in detail."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22749189": [
        "Our goal was to design a type II inhibitor specific for this family, i.e. able to interact with the allosteric pocket and with the hinge region of the kinase.",
        "Analysis of the affinity of 6g for active and inactive forms of Abl1, an RTK protein that does not belong to the TAM subfamily, together with the binding modes of 6g predicted by docking studies, indicates that 6g displays some selectivity for the TAM family and may act as a type II inhibitor.",
        "The TAM subfamily of Receptor Tyrosine Kinases (RTKs) contains three human proteins of therapeutical interest, Axl, Mer, and Tyro3.",
        "We report the synthesis of several series of purine analogues of BMS-777607.",
        "The most potent inhibitor 6g exhibits Kds of 39, 42, 65 and 200 nM against Axl, Mer, Met and Tyro3 respectively.",
        "The structural diversity of the designed inhibitors was expected to modify the interactions formed in the binding site and consequently to modulate their selectivity profiles."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27780404": [
        "However, the functional contribution of each TAM family member to the progression of hepatic inflammation remains elusive.",
        "In this study, we explore the role of individual TAM family proteins during autophagy induction and evaluate their contribution to hepatic inflammation.",
        "In agreement with these observations, axl<sup>-/-</sup> mice show more severe symptoms than do wild-type (Axl<sup>+/+</sup>) mice following acute hepatic injury induced by administration of lipopolysaccharide (LPS) or carbon tetrachloride (CCl<sub>4</sub>).",
        "Based on our results, autophosphorylation of 2 tyrosine residues (Tyr815 and Tyr860) in the cytoplasmic domain of AXL in mice is required for autophagy induction and AXL-mediated autophagy induction is dependent on MAPK (mitogen-activated protein kinase)14 activity.",
        "Macrophages are one of the key mediators which regulate the progress of hepatic inflammation.",
        "Furthermore, induction of AXL-mediated autophagy prevents CASP1 (caspase 1)-dependent IL1B (interleukin 1, \u03b2) and IL18 (interleukin 18) maturation by inhibiting NLRP3 (NLR family, pyrin domain containing 3) inflammasome activation.",
        "Among the TAM family of RTKs, AXL (AXL receptor tyrosine kinase) only induces autophagy in macrophages after interaction with its ligand, GAS6 (growth arrest specific 6).",
        "Increasing evidence shows that the TAM (TYRO3, AXL and MERTK) family of RTKs (receptor tyrosine kinases), which is expressed in macrophages, alleviates inflammatory responses through a negative feedback loop.",
        "Hence, GAS6-AXL signaling-mediated autophagy induction in murine macrophages ameliorates hepatic inflammatory responses by inhibiting NLRP3 inflammasome activation.",
        "Severe hepatic inflammation is a common cause of acute or chronic liver disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24184575": [
        "The TAM family of RTKs, consisting of Tyro3, Axl, and MerTK, is prominently expressed during the development and function of the central nervous system (CNS).",
        "Aberrant expression and dysregulated activation of TAM family members has been demonstrated in a variety of CNS-related disorders and diseases, including the most common but least treatable brain cancer in children and adults: glioblastoma multiforme.",
        "Receptor tyrosine kinases (RTKs) are cell surface proteins that tightly regulate a variety of downstream intra-cellular processes; ligand-receptor interactions result in cascades of signaling events leading to growth, proliferation, differentiation and migration.",
        "There are 58 described RTKs, which are further categorized into 20 different RTK families.",
        "When dysregulated or overexpressed, these RTKs are implicated in disordered growth, development, and oncogenesis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28450637": [
        "By contrast, when endogenous Pcdh diversity is overridden by the expression of a single-tricluster gene repertoire (\u03b1 and \u03b2 and \u03b3), OSN axons fail to converge to form glomeruli, likely owing to contact-mediated repulsion between axons expressing identical combinations of Pcdh isoforms.",
        "Although deletion of individual <i>Pcdh</i> clusters had subtle phenotypic consequences, the loss of all three clusters (tricluster deletion) led to a severe axonal arborization defect and loss of self-avoidance.",
        "The vertebrate clustered protocadherin (Pcdh) cell surface proteins are encoded by three closely linked gene clusters (<i>Pcdh</i>\u03b1, <i>Pcdh</i>\u03b2, and <i>Pcdh</i>\u03b3).",
        "Here, we show that all three gene clusters functionally cooperate to provide individual mouse olfactory sensory neurons (OSNs) with the cell surface diversity required for their assembly into distinct glomeruli in the olfactory bulb."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29378418": [
        "Multiple novel therapeutic agents against acute myeloid leukemia (AML) have been evaluated in the past several decades without meaningful clinical improvement in outcomes, especially for AML patients age \u226560, where the overall incidence of AML is highest.",
        "This review summarizes the clinical development of CPX-351 as induction therapy.",
        "Therapeutic options mainly consist of hypomethylating agents, ongoing clinical trials and, less commonly, intensive cytotoxic chemotherapy.",
        "CPX-351, a novel liposomal formulation which encapsulates cytarabine and daunorubicin in 5:1 molar ratio, has shown promising efficacy, leading to recent US FDA approval for front-line therapy for patients with therapy-related AML and AML with myelodysplasia-related changes based on a large multicenter Phase III clinical trial."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28929384": [
        "Results of the recent studies indicate that endogenous synthesis of glycine, proline, and Hyp is inadequate for maximal growth, collagen production, or feed efficiency in pigs, chickens, and fish.",
        "Although glycine, proline and Hyp, and gelatin can be used as feed additives in animal diets, these ingredients except for glycine are relatively expensive, which precludes their inclusion in practical rations.",
        "Glycine, proline, and hydroxyproline (Hyp) contribute to 57% of total amino acids (AAs) in collagen, which accounts for one-third of proteins in animals.",
        "Mammals, birds, and fish can synthesize: (1) glycine from threonine, serine, choline, and Hyp; (2) proline from arginine; and (3) Hyp from proline residues in collagen, in a cell- and tissue-specific manner.",
        "Alternatively, hydrolyzed feather meal (HFM), which contains 9% glycine, 5% Hyp, and 12% proline, holds great promise as a low cost but abundant dietary source of glycine, Hyp, and proline for ruminants and nonruminants.",
        "Finally, HFM may be used as a feed additive to prevent or ameliorate connective tissue disorders in domestic and aquatic animals.",
        "Because HFM is deficient in most AAs, future research efforts should be directed at improving the bioavailability of its AAs and the balance of AAs in HFM-supplemented diets.",
        "As the most abundant protein in the body, collagen is essential to maintain the normal structure and strength of connective tissue, such as bones, skin, cartilage, and blood vessels.",
        "In addition, livestock (e.g., pigs, cattle, and sheep) produces proline from glutamine and glutamate in the small intestine, but this pathway is absent from birds and possibly most fish species."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29146366": [
        "However, for gelatin, problems associated with false-positive and false-negative results, inconsistencies and low reactivity of commercially available kits have been observed with regard to ELISA and PCR methods.",
        "Therefore we developed a selective bottom-up LC-MS methodology for quantitative gelatin species determination with a lower limit of quantification of 0.05%.",
        "Collagen is the most abundant protein family in mammals.",
        "The validated method can be used to determine the purity of gelatin batches with regard to bovine and porcine constituents.",
        "The present article describes the validation of this method, which was performed according to Good Laboratory Practice, and the theoretical justification for bovine and porcine target selection.",
        "The gelatin industry would benefit from a sensitive and reliable species detection method to unambiguously demonstrate species authenticity of their products.",
        "PCR and ELISA could in principle be used for this purpose.",
        "Commercial edible gelatins are often produced from bovine and porcine skin and bone and consist mainly of partially hydrolyzed collagen type 1."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29144022": [
        "Nowadays, the biomolecule can be obtained by extraction from natural sources such as plants and animals or by recombinant protein production systems including yeast, bacteria, mammalian cells, insects or plants, or artificial fibrils that mimic collagen characteristics like the artificial polymer commercially named as KOD.",
        "2016. http://www.revista60ymas.es/InterPresent1/groups/revistas/documents/binario/ses330informe.pdf.].",
        "Nevertheless, there has been little effort on identifying which collagen types are the most suitable for cosmetic purposes, for which the present review will try to enlighten in a general scope this unattended matter.",
        "As a solution, the cosmetic industry incorporated collagen as an ingredient of different treatments to enhance the user youth and well-being, and some common presentations are creams, nutritional supplement for bone and cartilage regeneration, vascular and cardiac reconstruction, skin replacement, and augmentation of soft skin among others [J App Pharm Sci.",
        "Due to its abundance, strength and its directly proportional relation with skin aging, collagen has gained great interest in the cosmetic industry.",
        "2015;5:123-127].",
        "Published 2017.].",
        "This molecule is one of the most abundant in many of the living organisms due to its connective role in biological structures.",
        "It has been established that the collagen fibers are damaged with the pass of time, losing thickness and strength which has been strongly related with skin aging phenomena [Col\u00e1geno para todo.",
        "Because of its increased use, its market size is valued over USD 6.63 billion by 2025 [Collagen Market By Source (Bovine, Porcine, Poultry, Marine), Product (Gelatin, Hydrolyzed Collagen), Application (Food &amp; Beverages, Healthcare, Cosmetics), By Region, And Segment Forecasts, 2014 - 2025.",
        "Grand View Research. http://www.grandviewresearch.com/industry-analysis/collagen-market.",
        "60 y m\u00e1s.",
        "Collagen is a fibrillar protein that conforms the conjunctive and connective tissues in the human body, essentially skin, joints, and bones."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28842125": [
        "Cardiovascular disease (CVD) is the leading cause of death throughout the world.",
        "In this review, we discuss the role of miR-214 in various cardiac disease conditions, including ischaemic heart diseases, cardiac hypertrophy, pulmonary arterial hypertension (PAH), angiogenesis following vascular injury and heart failure.",
        "However, it is considered as a promising marker in the prognosis, diagnosis and treatment of cardiovascular diseases.",
        "MicroRNAs (miRNAs) are critical endogenous small noncoding RNAs that negatively modulate gene expression by regulating its translation. miRNAs are implicated in most physiological processes of the heart and in the pathological progression of cardiovascular diseases. miR-214 is a deregulated miRNA in many pathological conditions, and it contributes to the pathogenesis of multiple human disorders, including cancer and cardiovascular diseases. miR-214 has dual functions in different cardiac pathological circumstances.",
        "The increase in new patients every year leads to a demand for the identification of valid and novel prognostic and diagnostic biomarkers for the prevention and treatment of cardiovascular diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23242657": [
        "Likewise, serum levels of c-miRNAs such as miR-423-5p have been evaluated as potential biomarkers in the diagnosis and prognosis of heart failure.",
        "MicroRNAs (miRNAs) are a class of non-coding small RNAs representing one of the most exciting areas of modern medical science. miRNAs modulate a large and complex regulatory network of gene expression of the majority of the protein-coding genes.",
        "On the other hand, the manipulation of miRNAs levels using techniques such as 'miR mimics' and 'antagomiRs' is becoming evident the enormous potential of miRNAs as promising therapeutic strategies in heart failure.",
        "Currently, evidences suggest that miRNAs play a crucial role in the pathogenesis of heart failure.",
        "Recent data indicate that these miRNAs as well as miR-206 change their expression quickly in response to physical activity.",
        "Some miRNAs as miR-1, miR-133 and miR-208a are highly expressed in the heart and strongly associated with the development of cardiac hypertrophy.",
        "The differential regulation of miRNAs in response to exercise suggests a potential value of circulating miRNAs (c-miRNAs) as biomarkers of physiological mediators of the cardiovascular adaptation induced by exercise."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22735911": [
        "Some miRNAs highly expressed in the heart, such as miR-1, miR-133 and miR-208, are strongly associated with the development of cardiac hypertrophy, while the exact role of miR-21 in the cardiovascular system remains controversial.",
        "Lines of evidence have recently suggested that miRNAs play a key role in the pathogenesis of heart failure.",
        "Serum levels of circulating miRNAs such as miR-423-5p are being evaluated as potential biomarkers in the diagnosis and prognosis of heart failure.",
        "MicroRNAs (miRNAs) are a group of newly discovered small RNAs, non-coding, which represent one of the most exciting areas of modern medical science as they modulate a huge and complex regulatory network of gene expression.",
        "On the other hand, the manipulation of levels of miRNAs using techniques such as mimicking the miRNAs (miRmimics) and antagonistic miRNAs (antagomiRs) is making increasingly evident the enormous potential of miRNAs as promising therapeutic strategies in heart failure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18288197": [
        "The results reveal a mechanism for the integration of nuclear phosphoinositide signals and a method for regulating gene expression.",
        "Star-PAP and PIPKIalpha function together in a complex to control the expression of select mRNAs, including the transcript encoding the key cytoprotective enzyme haem oxygenase-1 (refs 8, 9) and other oxidative stress response genes by regulating the 3'-end formation of their mRNAs.",
        "In addition to functions in the cytosol, phosphoinositides are present in the nucleus, where they modulate several functions; however, the mechanism by which they directly regulate nuclear functions remains unknown.",
        "Phosphoinositides are a family of lipid signalling molecules that regulate many cellular functions in eukaryotes.",
        "Therefore, to determine roles for nuclear PtdIns4,5P2 we set out to identify proteins that interacted with the nuclear PIPK, PIPKIalpha.",
        "Here we show that PIPKIalpha co-localizes at nuclear speckles and interacts with a newly identified non-canonical poly(A) polymerase, which we have termed Star-PAP (nuclear speckle targeted PIPKIalpha regulated-poly(A) polymerase) and that the activity of Star-PAP can be specifically regulated by PtdIns4,5P2.",
        "Phosphatidylinositol-4,5-bisphosphate (PtdIns4,5P2), the central component in the phosphoinositide signalling circuitry, is generated primarily by type I phosphatidylinositol 4-phosphate 5-kinases (PIPKIalpha, PIPKIbeta and PIPKIgamma).",
        "Taken together, the data demonstrate a model by which phosphoinositide signalling works in tandem with complement pathways to regulate the activity of Star-PAP and the subsequent biosynthesis of its target mRNA.",
        "PIPKIs regulate cellular functions through interactions with protein partners, often PtdIns4,5P2 effectors, that target PIPKIs to discrete subcellular compartments, resulting in the spatial and temporal generation of PtdIns4,5P2 required for the regulation of specific signalling pathways."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26138484": [
        "Star-PAP activity is stimulated by lipid messenger phosphatidyl inositol 4,5 bisphoshate (PI4,5P2) and is regulated by the associated Type I phosphatidylinositol-4-phosphate 5-kinase that synthesizes PI4,5P2 as well as protein kinases.",
        "We identified a phosphorylated residue (serine 6, S6) on Star-PAP in the zinc finger region, the domain required for PIPKI\u03b1 interaction.",
        "S6 phosphorylation together with coactivator PIPKI\u03b1 controlled select subset of Star-PAP target messages by regulating Star-PAP-mRNA association.",
        "Our results establish a novel role for phosphorylation in determining Star-PAP target mRNA specificity and regulation of 3'-end processing.",
        "These associated kinases act as coactivators of Star-PAP that regulates its activity and specificity toward mRNAs, yet the mechanism of control of these interactions are not defined.",
        "Unlike the CKI\u03b1 mediated phosphorylation at the catalytic domain, Star-PAP S6 phosphorylation is insensitive to oxidative stress suggesting a signal mediated regulation of CKI\u03b1 activity.",
        "We show that S6 is phosphorylated by CKI\u03b1 within the nucleus which is required for Star-PAP nuclear retention and interaction with PIPKI\u03b1.",
        "Star-PAP is a nuclear non-canonical poly(A) polymerase (PAP) that shows specificity toward mRNA targets."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24768001": [
        "Primordial dwarfism (PD) is characterized by global growth failure, both during embryogenesis and postnatally.",
        "Paradoxically, LARP7 deficiency was previously assumed to be associated with increased cell growth and proliferation via activation of positive transcription elongation factor b (P-TEFb).",
        "We further discover that Larp7 knockdown does not affect pluripotency but instead primes embryonic stem cells (ESCs) for differentiation via downregulation of Lin28, a positive regulator of organismal growth.",
        "Here, we show that Larp7 deficiency likely does not significantly increase P-TEFb activity.",
        "Loss-of-function germline mutations in La ribonucleoprotein domain family, member 7 (LAPR7) have recently been linked to PD.",
        "Mechanistically, we show that Larp7 interacts with a poly(A) polymerase Star-PAP to maintain Lin28 mRNA stability.",
        "We propose that proper regulation of Lin28 and PTEFb is essential for embryonic cells to achieve a sufficient number of cell divisions prior to differentiation and ultimately to maintain proper organismal size."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21102410": [
        "Star-PAP is a poly (A) polymerase (PAP) that is putatively required for 3'-end cleavage and polyadenylation of a select set of pre-messenger RNAs (mRNAs), including heme oxygenase (HO-1) mRNA.",
        "To investigate the underlying mechanism, the cleavage and polyadenylation of pre-mRNA was reconstituted with nuclear lysates. siRNA knockdown of Star-PAP abolished cleavage of HO-1, and this phenotype could be rescued by recombinant Star-PAP but not PAP\u03b1.",
        "This mechanism is distinct from canonical PAP\u03b1, which is recruited to the cleavage complex by interacting with CPSF 160.",
        "The data support a model where Star-PAP binds to the RNA, recruits the CPSF complex to the 3'-end of pre-mRNA and then defines cleavage by CPSF 73 and subsequent polyadenylation of its target mRNAs.",
        "In vitro and in vivo Star-PAP was required for the stable association of CPSF complex to pre-mRNA and then CPSF 73 specifically cleaved the mRNA at the 3'-cleavage site.",
        "Star-PAP directly associated with cleavage and polyadenylation specificity factor (CPSF) 160 and 73 subunits and also the targeted pre-mRNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29140814": [
        "Patients affected by this chronic disorder suffer with a pan-field visual disturbance described as tiny flickering dots, which resemble the static noise of an untuned television.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      We provide an overview of the neurological condition known as visual snow syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29193050": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Using a \"double-pulse\" adaptation paradigm, in which two stimuli are presented in quick succession, this study examines the neural mechanisms underlying potentiation of the visual evoked potential (VEP) in visual snow syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29934719": [
        "We also discuss the theories on the pathophysiological mechanisms of visual snow, as well as the current approach to treatment.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      In this article, we review illustrative case descriptions of both primary and secondary visual snow from our clinic.",
        "We discuss recently proposed criteria for visual snow syndrome and offer a slight modification of these criteria."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30095537": [
        "This entity often is considered psychogenic in nature, to the detriment of the patient's best interests, but the high frequency of similar visual symptoms argues for an organic deficit.",
        "Recently, it was characterized as the defining feature of a VS syndrome (VSS), which includes palinopsia, photophobia, photopsias, entoptic phenomena, nyctalopia, and tinnitus.",
        "The purpose of this review is to clarify VSS as a true entity and elaborate the nature of individual symptoms and their relationship to each other.",
        "Sixty percent of patients with VSS also experience migraine, with or without aura.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Visual snow (VS) is a constant visual disturbance described as flickering dots occupying the entire visual field."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30383334": [
        "Dunnett post hoc analysis was significant for all comparisons between VS and controls.",
        "Patients with visual snow syndrome (VS) suffer from a debilitating continuous visual disturbance of unknown mechanism.",
        "Visual evoked potentials from patients with VS demonstrated increased N145 latency (in milliseconds, VS: 152.7 \u00b1 7.9 vs M: 145.3 \u00b1 9.8 vs C: 145.5 \u00b1 9.4; F = 3.28; p = 0.046) and reduced N75-P100 amplitudes (in microvolts, VS: 7.4 \u00b1 3.5 vs M: 12.5 \u00b1 4.7 vs C: 10.8 \u00b1 3.4; F = 3.16; p = 0.051).",
        "These findings are in agreement with the idea that the primary disturbance in VS is a dysfunction of the visual association cortex.",
        "The present study tested the hypothesis of dysfunctional visual processing using visual evoked potentials.",
        "Eighteen patients were compared to age-matched migraineurs (M) and healthy controls (C) using 2-way analysis of variance with group (VS, M, C) and gender as factors.",
        "Ann Neurol 2018;84:946-949."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27508888": [
        "The following additional visual symptoms were identified: illusionary palinopsia (n = 6), disturbance of night vision (n = 5), positive light phenomena (n = 7).",
        "The diagnosis of a visual snow syndrome requires the appearance of typical additional visual symptoms and the exclusion of ophthalmological or neurological causes, or pharmacological influences. <b>Patients and Methods</b> Three male and four female subjects between 13 and 36 years of age referred with visual snow were investigated and asked about their symptoms.",
        "A complete ophthalmological investigation, including binocular fundoscopy, was performed in all patients.",
        "Visual function parameters are not impaired.",
        "The intake of hallucinogenic drugs or centrally active pharmaceuticals was denied by all patients.",
        "Apart from eye diseases, a persistent migraine aura as well as neurological diseases or the intake of hallucinogenic drugs must be excluded as possible causes of visual snow and palinopsia.",
        "Furthermore, best corrected visual acuity, perimetry, binocular functions, colour vision (D15-test), full-field ERG, pattern-reversal VEP and SD-OCT images of macula and optic nerve (RNFL) were analysed. <b>Results</b> Visual acuity of at least 1.0 and normal findings for all further investigations were observed in all patients.",
        "The findings of available or initiated neurological investigations were normal. <b>Conclusions</b> The visual snow syndrome has to be regarded as a diagnosis of exclusion.",
        "A history of migraine with aura was reported in five patients.",
        "<b>Background</b> The symptom \"visual snow\" describes the continuous perception of tiny flickering dots within the whole visual field of both eyes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28723606": [
        "While most of these symptoms appear to be visual in nature, approximately 63% of patients studied also report continuous bilateral tinnitus.",
        "Visual snow is a symptom described as the continuous perception of tiny flickering dots in the entire field of vision, similar to static of an analog television.",
        "Visual snow syndrome is a cluster of symptoms found highly prevalent in patients that present with visual snow.",
        "The high correlation of visual-snow-syndrome patients presenting with tinnitus suggests that they may share a common underlying pathophysiology."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24699650": [
        "Notably, the ice-binding site of FfIBP is composed of a T-A/G-X-T/N motif, which is similar to the ice-binding residues of hyperactive antifreeze proteins.",
        "Although FfIBP closely resembles Leucosporidium (recently re-classified as Glaciozyma) IBP (LeIBP) in its amino-acid sequence, the thermal hysteresis (TH) activity of FfIBP appears to be tenfold higher than that of LeIBP.",
        "The refined structure of FfIBP shows an intramolecular disulfide bond, and analytical ultracentrifugation and analytical size-exclusion chromatography show that it behaves as a monomer in solution.",
        "Sequence alignments and structural comparisons of IBPs allowed two groups of IBPs to be defined, depending on sequence differences between the \u03b12 and \u03b14 loop regions and the presence of the disulfide bond.",
        "In conclusion, this study provides a molecular basis for understanding the antifreeze mechanism of FfIBP and provides new insights into the reasons for the higher TH activity of FfIBP compared with LeIBP.",
        "The X-ray crystal structure of FfIBP was determined to 2.1 \u00c5 resolution to gain insight into its ice-binding mechanism.",
        "Ice-binding proteins (IBPs) inhibit ice growth through direct interaction with ice crystals to permit the survival of polar organisms in extremely cold environments.",
        "A comparison of the FfIBP and LeIBP structures reveals that FfIBP has different ice-binding residues as well as a greater surface area in the ice-binding site.",
        "Thus, it is proposed that the difference in TH activity between FfIBP and LeIBP may arise from the amino-acid composition of the ice-binding site, which correlates with differences in affinity and surface complementarity to the ice crystal.",
        "FfIBP is an ice-binding protein encoded by the Antarctic bacterium Flavobacterium frigoris PS1."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23203635": [
        "More importantly, the rLeIBP secreted into culture media was stable and active for 6 days of fermentation.",
        "The thermal hysteresis (TH) activity of rLeIBP was about 0.42 \u00b0C, which is almost the same to those reported previously.",
        "In a laboratory-scale fermentation (7 L), the optimal induction temperature and pH were determined to be 25 \u00b0C and 6.0, respectively.",
        "The availability of large quantities of rLeIBP may accelerate further application studies.",
        "In the pilot-scale fermentation (700 L) under the same conditions, the yield of rLeIBP was 300 mg/l.",
        "Ice-binding proteins (IBPs) can bind to the ice crystal and inhibit its growth.",
        "Further, employing glycerol fed-batch phase prior to methanol induction phase enhanced the production of recombinant LelBP (rLeIBP) by \u223c100 mg/l.",
        "The total amount of secreted proteins at these conditions (25 \u00b0C, pH 6.0, and glycerol fed-batch phase) was \u223c443 mg/l, 60 % of which was rLeIBP, yielding \u223c272 mg/l.",
        "(LeIBP) was constructed and subjected to high-level expression in methylotrophic Pichia pastoris system.",
        "Because this property of IBPs can increase the freeze-thaw survival of cells, IBPs have attracted the attention from industries for their potential use in biotechnological applications.",
        "However, their use was largely hampered by the lack of the large-scale recombinant production system.",
        "To our best knowledge, this result reports the highest production yield of the recombinant IBP.",
        "In this study, the codon-optimized IBP from Leucosporidium sp."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22303017": [
        "Structural analysis of the LeIBPs revealed a dimeric right-handed \u03b2-helix fold, which is composed of three parts: a large coiled structural domain, a long helix region (residues 96-115 form a long \u03b1-helix that packs along one face of the \u03b2-helix), and a C-terminal hydrophobic loop region ((243)PFVPAPEVV(251)).",
        "Arctic yeast Leucosporidium sp. produces a glycosylated ice-binding protein (LeIBP) with a molecular mass of \u223c25 kDa, which can lower the freezing point below the melting point once it binds to ice.",
        "Here, we report the crystal structures of non-glycosylated LeIBP and glycosylated LeIBP at 1.57- and 2.43-\u00c5 resolution, respectively.",
        "We also determined that the aligned Thr/Ser/Ala residues are critical for ice binding within the B face of LeIBP using site-directed mutagenesis.",
        "LeIBP is a member of a large class of ice-binding proteins, the structures of which are unknown.",
        "Although LeIBP has a common \u03b2-helical fold similar to that of canonical hyperactive antifreeze proteins, the ice-binding site is more complex and does not have a simple ice-binding motif.",
        "Unexpectedly, the C-terminal hydrophobic loop region has an extended conformation pointing away from the body of the coiled structural domain and forms intertwined dimer interactions.",
        "In addition, structural analysis of glycosylated LeIBP with sugar moieties attached to Asn(185) provides a basis for interpreting previous biochemical analyses as well as the increased stability and secretion of glycosylated LeIBP.",
        "In conclusion, we could identify the ice-binding site of LeIBP and discuss differences in the ice-binding modes compared with other known antifreeze proteins and ice-binding proteins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30296411": [
        "Owing to their unique characteristics, IBPs have been studied for applications in food, pharmaceuticals, and medicine, as well as from a general scientific point of view.",
        "In this study, we have used differential scanning calorimetry (DSC) and Raman spectroscopy as tools to understand the ice binding activity of the Arctic-yeast-originating extracellular ice binding glycoprotein (LeIBP) isolated from Leucosporidium sp.",
        "From the DSC results, an increase in the specific heat capacity was confirmed for 1 mg/mL LeIBP, which suggested that additional heat flow was required for the change in temperature.",
        "AY30.",
        "Ice binding proteins (IBPs) have been attracting significant interest on account of their characteristic of inhibiting ice growth and recrystallization.",
        "In addition, the temperature corresponding to the phase change of the solution was measured, and Raman spectroscopy was carried out on the frozen and molten phases, respectively.",
        "Furthermore, principal component analysis (PCA) of the Raman spectra yielded the contrast factor between the freezing and melting states.",
        "From the results of Raman analysis, we confirmed that the helical vibrations related to the ice binding sites on LeIBP were dramatically suppressed when the LeIBP solution was frozen.",
        "Both DSC and Raman spectroscopy are widely used to study the ice binding activity and the structural changes associated with molecular vibrations in cryobiology."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29769354": [
        "A similar analysis was performed with two additional A*29:02-positive, ERAP1-concordant, cell lines expressing or not ERAP2.",
        "Virtually all patients of the rare inflammatory eye disease birdshot chorioretinopathy (BSCR) carry the HLA-A*29:02 allele.",
        "The paradoxical effects on peptide length suggest that unproductive binding to ERAP2 might protect some peptides from ERAP1 over-trimming.",
        "BSCR is also associated with endoplasmic reticulum aminopeptidase 2 (ERAP2), an enzyme involved in processing HLA class I ligands, thus implicating the A*29:02 peptidome in this disease.",
        "An ERAP2-negative cell line was transduced with lentiviral constructs containing GFP-ERAP2 or GFP alone, and the A*29:02 peptidomes from both transduced cells were compared.",
        "To investigate the relationship between both risk factors we employed label-free quantitative mass spectrometry to characterize the effects of ERAP2 on the A*29:02-bound peptidome.",
        "The alterations in the A*29:02 peptidome suggest that the association of ERAP2 with BSCR is through its effects on peptide processing.",
        "These differ from those on the ankylosing spondylitis-associated HLA-B*27.",
        "Thus, ERAP2 alters the peptidome of distinct HLA molecules as a function of their specific binding preferences, influencing different pathological outcomes in an allele-dependent way.",
        "The influence on N-terminal residues can be explained by a direct effect of ERAP2 on trimming, without ruling out and improved processing in concert with ERAP1.",
        "In both comparisons the presence of ERAP2 affected the following features of the A*29:02 peptidome: 1) Length, with increased amounts of peptides &gt;9-mers, and 2) N-terminal residues, with less ERAP2-susceptible and more hydrophobic ones."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24957906": [
        "We have conducted a genome-wide association study in 96 Dutch and 27 Spanish cases, and 398 unrelated Dutch and 380 Spanish controls.",
        "Intriguingly, &gt;95% of cases carry the HLA-A29 allele, which defines the strongest documented HLA association for a human disease.",
        "This study further defined an extremely strong MHC risk component in BSCR, and detected evidence for a novel disease mechanism that affects peptide processing in the endoplasmic reticulum.",
        "Birdshot chorioretinopathy (BSCR) is a rare form of autoimmune uveitis that can lead to severe visual impairment.",
        "We also identified two novel susceptibility loci at 5q15 near ERAP2 (rs7705093; OR = 2.3, 95% CI 1.7-3.1, for the T allele, P = 8.6 \u00d7 10(-8)) and at 14q32.31 in the TECPR2 gene (rs150571175; OR = 6.1, 95% CI 3.2-11.7, for the A allele, P = 3.2 \u00d7 10(-8)).",
        "Functional analyses revealed that the risk allele of the polymorphism near ERAP2 is strongly associated with high mRNA and protein expression of ERAP2 in B cells.",
        "The association near ERAP2 was confirmed in an independent British case-control samples (combined meta-analysis P = 1.7 \u00d7 10(-9)).",
        "Fine-mapping the primary MHC association through high-resolution imputation at classical HLA loci, identified HLA-A*29:02 as the principal MHC association (odds ratio (OR) = 157.5, 95% CI 91.6-272.6, P = 6.6 \u00d7 10(-74))."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30102239": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Use of wearable ECG devices for arrhythmia screening is limited due to poor signal quality, small number of leads and short records, leading to incorrect recognition of pathological events.",
        "This paper introduces a novel approach to classification (normal/'N', atrial fibrillation/'A', other/'O', and noisy/'P') of short single-lead ECGs recorded by wearable devices."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26540314": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Biliary tract cancer (BTC) is a rare and lethal disease with few therapeutic options.",
        "Preclinical data suggest that the epidermal growth factor receptor (EGFR) pathway could be involved in its progression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29413685": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Combination chemotherapy has shown benefit in the treatment of biliary cancer and further improvements might be achieved by the addition of a biological agent.",
        "We report here the effect of chemotherapy with the monoclonal EGFR antibody panitumumab as therapy for KRAS wild-type biliary cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29893894": [
        "Although the efficacy of immune checkpoint inhibitors, such as anti-PD-1, anti-PD-L1 and anti-CTLA4 antibodies, remains unknown at present, basic data and results of ongoing clinical trials are anticipated.",
        "Biliary tract cancer, carcinoma of the extrahepatic bile ducts, carcinoma of the gall bladder, ampullary carcinoma and intrahepatic cholangiocarcinoma are often identified at an advanced stage and have poor prognoses.",
        "A phase III trial of gemcitabine plus cisplatin vs. gemcitabine plus cisplatin plus S-1 (MITSUBA) was conducted, and the report on the results of the final analysis is being awaited.",
        "Although effective chemotherapy regimens are needed, their development remains unsatisfactory.",
        "A standard second-line chemotherapeutic regimen has not yet been established.",
        "Despite many clinical trials being conducted with molecular targeted agents including erlotinib, cetuximab, panitumumab, bevacizumab, sorafenib, cediranib, trametinib and vandetanib, no agent has shown to be effective for advanced biliary tract cancer.",
        "From the results of a phase III clinical trial (ABC-02 trial), gemcitabine plus cisplatin is the standard first-line chemotherapeutic regimen for advanced biliary tract cancer.",
        "A phase III trial of gemcitabine plus cisplatin vs. gemcitabine plus S-1 therapy (FUGA-BT) demonstrated the non-inferiority of gemcitabine plus S-1 to gemcitabine plus cisplatin.",
        "Fluoropyrimidines are frequently used in clinical practice.",
        "FGFR2 fusion gene, mutations of IDH1/2, BRAF, BRCA1/2, ATM, PIK3CA and overexpression of c-MET and HER2/neu are reported relatively frequently and are interesting targets.",
        "Next-generation sequencing shows great promise by allowing rapid mutational analysis of multiple genes in human cancers, and attractive driver genetic alterations have been reported in biliary tract cancer.",
        "Therefore, future development in precision medicine utilizing next-generation sequencing is expected."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23819169": [
        "Adding panitumumab to standard protocols does not prolong survival but provokes additional adverse effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27822311": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Deletions in the long arm of chromosome 1 have been described in patients with a phenotype consisting primarily of obesity, intellectual disability and autism-spectrum disorder.",
        "The minimal region of overlap comprises two genes: <i>DPYD</i> and <i>MIR137</i>."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22003227": [
        "Recent studies identified miRNAs as important regulators of learning and memory in model organisms.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      MicroRNAs (miRNAs) are non-coding gene transcripts involved in post-transcriptional regulation of genes.",
        "So far, no mutations in specific miRNA genes have been associated with impaired cognitive functions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26132585": [
        "Intrinsic errors reported within this assay demonstrate the challenge of identifying and understanding the breast cancer groups.",
        "The PAM50 method, based on the expression levels of 50 genes, uses a single sample predictor model to assign subtype labels to samples.",
        "In this study, we aim to: a) identify novel biomarkers for subtype individuation by exploring the competence of a newly proposed method named CM1 score, and b) apply an ensemble learning, as opposed to the use of a single classifier, for sample subtype assignment.",
        "The overarching objective is to improve class prediction.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The prediction of breast cancer intrinsic subtypes has been introduced as a valuable strategy to determine patient diagnosis and prognosis, and therapy response."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28620450": [
        "In addition, a random forest (RF) classifier using a gene signature ( <i>ABCB1, ABCB11, ABCC1, ABCC10, BAD, BBC3, BCL2, BCL2L1, BMF, CYP2C8, CYP3A4, MAP2, MAP4, MAPT, NR1I2,SLCO1B3, TUBB1, TUBB4A, </i>and <i>TUBB4B</i>) predicted &gt;3-year survival with 85.5% accuracy in 420 HT patients.",
        "A support vector machine (SVM) model of paclitaxel response containing genes <i>ABCB1, ABCB11, ABCC1, ABCC10, BAD, BBC3, BCL2, BCL2L1, BMF, CYP2C8, CYP3A4, MAP2, MAP4, MAPT, NR1I2, SLCO1B3, TUBB1, TUBB4A,</i> and <i>TUBB4B</i> was 78.6% accurate in predicting survival of 84 patients treated with both HT and CT (median survival \u2265 4.4 yr).",
        "The performance of other machine learning approaches was also evaluated at different survival thresholds.",
        "Paclitaxel gene signatures exhibited the best performance, however the other agents also predicted survival with acceptable accuracies.",
        "A similar RF gene signature showed 82.7% accuracy in 504 patients treated with CT and/or HT.",
        "This machine learning method, which distinguishes sensitivity vs. resistance in breast cancer cell lines and validates predictions in patients; was also used to derive gene signatures of other HT (tamoxifen) and CT agents (methotrexate, epirubicin, doxorubicin, and 5-fluorouracil) used in METABRIC.",
        "Minimum redundancy maximum relevance feature selection of a paclitaxel-based SVM classifier based on expression of genes <i>BCL2L1, BBC3, FGF2, FN1, </i>and <i>TWIST1</i><i> </i>was 81.1% accurate in 53 CT patients.",
        "Genomic aberrations and gene expression-defined subtypes in the large METABRIC patient cohort have been used to stratify and predict survival.",
        "These results suggest that tumor gene expression signatures refined by machine learning techniques can be useful for predicting survival after drug therapies.",
        "The present study used normalized gene expression signatures of paclitaxel drug response to predict outcome for different survival times in METABRIC patients receiving hormone (HT) and, in some cases, chemotherapy (CT) agents.",
        "Accuracy was lower (73.4%) in 304 untreated patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26770261": [
        "Towards the development of robust strategies, we designed an iterative approach to consistently discriminate intrinsic subtypes and improve class prediction in the METABRIC dataset.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Multi-gene lists and single sample predictor models have been currently used to reduce the multidimensional complexity of breast cancers, and to identify intrinsic subtypes.",
        "The perceived inability of some models to deal with the challenges of processing high-dimensional data, however, limits the accurate characterisation of these subtypes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29532008": [
        "Central histopathology (<i>N</i> = 1643) review was undertaken to explore the relationship between these ten molecular subtypes and traditional clinicopathological features.",
        "The integration of genomic and transcriptomic profiles of 2000 breast tumours from the METABRIC [Molecular Taxonomy of Breast Cancer International Consortium] cohort revealed ten subtypes, termed integrative clusters (IntClust/s), characterised by distinct genomic drivers.",
        "Whilst the ten IntClust subtypes of breast cancer show characteristic patterns of association with traditional clinicopathological variables, no IntClust can be adequately identified by these variables alone.",
        "Hence, the addition of genomic stratification has the potential to enhance the biological relevance of the current clinical evaluation and facilitate genome-guided therapeutic strategies.",
        "Lymph node status and Nottingham Prognostic Index [NPI] categories were also significantly associated with IntClust subtype.",
        "IntClust subtypes were significantly associated with histological type, tumour grade, receptor status, and lymphocytic infiltration (<i>p</i> &lt; 0.0001).",
        "IntClust 3 was enriched for tubular and lobular carcinomas, the latter largely accounting for the association with <i>CDH1</i> mutations in this cluster.",
        "Mucinous carcinomas were not present in IntClusts 5 or 10, but did not show an association with any of the remaining IntClusts.",
        "IntClust 5 was dominated by HER2 positivity (127/151), including both hormone receptor-positive (60/72) and hormone receptor-negative tumours (67/77).",
        "In contrast, medullary-like cancers were associated with IntClust 10 (15/26).",
        "Hormone receptor-positive tumours were scattered across all IntClusts.",
        "Triple-negative tumours comprised the majority of IntClust 10 (132/159) and around a quarter of IntClust 4 (52/217)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19948017": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      In molecular profiling studies of cancer patients, experimental and clinical data are combined in order to understand the clinical heterogeneity of the disease: clinical information for each subject needs to be linked to tumour samples, macromolecules extracted, and experimental results.",
        "This may involve the integration of clinical data sets from several different sources: these data sets may employ different data definitions and some may be incomplete."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22912679": [
        "METABRIC is a large breast cancer study that may have been the first in which eQTL-based detection of mismatches was used during the study, rather than after the event, to aid quality assurance.",
        "In particular we identify the complications of using tumour samples, of considering cellularity and RNA quality, of distinct subgroups existing in the study population (including family structures), and of choosing eQTLs to use.",
        "We had adopted a similar approach, termed 'BADGER', in the METABRIC project.",
        "It has recently been proposed that expression quantitative trait loci (eQTLs) and their associated effects could be used to identify sample mix-ups and this approach has been applied to a number of large population genomics studies to illustrate the prevalence of the problem.",
        "We report here on the particular issues associated with large cancer studies performed using historical samples, which complicate the interpretation of such approaches.",
        "We also present some results regarding the design of experiments given consideration of these matters.",
        "The eQTL-based approach to identifying sample tracking errors is seen to be of value to these studies, but requiring care in its implementation.",
        "Sample tracking errors have been and always will be a part of the practical implementation of large experiments."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29727689": [
        "Furthermore, we performed in vitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.",
        "Our findings revealed potential target genes for associations of genetic susceptibility risk loci and provided underlying mechanisms for a better understanding of the pathogenesis of breast cancer.",
        "Genome-wide association studies (GWASs) have identified more than 150 common genetic loci for breast cancer risk.",
        "We identified a total of 101 genes for 51 lead variants after combing the results of a meta-analysis of METABRIC and TCGA, and the results from GTEx at a Benjamini-Hochberg (BH)-adjusted p &lt; 0.05.",
        "We conducted a cis-expression quantitative trait loci (cis-eQTL) analysis using normal or tumor breast transcriptome data from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), The Cancer Genome Atlas (TCGA), and the Genotype-Tissue Expression (GTEx) project.",
        "Using luciferase reporter assays in both estrogen-receptor positive (ER<sup>+</sup>) and negative (ER<sup>-</sup>) cell lines, we showed that alternative alleles of potential functional single-nucleotide polymorphisms (SNPs), rs11552449 (DCLRE1B), rs7257932 (SSBP4), rs3747479 (MRPS30), rs2236007 (PAX9), and rs73134739 (ATG10), could significantly change promoter activities of their target genes compared to reference alleles.",
        "However, the target genes and underlying mechanisms remain largely unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30181556": [
        "Independent validation of prognostic interactions was achieved using data from the METABRIC study.",
        "In conclusion, uncommon recurrent somatic mutations should be further explored to create a more complete explanation of the highly variable outcomes that typifies ER+ breast cancer.",
        "DDR1 mutations were strongly associated with poor prognosis in UBC-TAM despite stringent false discovery correction (q = 0.0003).",
        "For MA12, poor outcome associated with PIK3R1 mutation was also reproducible.",
        "Here we report targeted sequencing of 83 genes using DNA from primary breast cancer samples from 625 postmenopausal (UBC-TAM series) and 328 premenopausal (MA12 trial) hormone receptor-positive (HR+) patients to determine interactions between somatic mutation and prognosis.",
        "In UBC-TAM, NF1 frame-shift nonsense (FS/NS) mutations were also a poor outcome driver that was validated in METABRIC.",
        "Previously established associations between MAP3K1 and PIK3CA mutations with luminal A status/favorable prognosis and TP53 mutations with Luminal B/non-luminal tumors/poor prognosis were observed, validating the methodological approach."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27312051": [
        "However, the best molecular marker or test to use has not yet been identified.",
        "We did this study to identify factors that drive proliferation and its associated features in breast cancer and assess their association with clinical outcomes and response to chemotherapy.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Proliferation markers and profiles have been recommended for guiding the choice of systemic treatments for breast cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28472085": [
        "Activation of the immune system is associated with tumor response and may help identify TNBC with favorable outcome.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Most patients with early stage triple negative breast cancer (TNBC) receive adjuvant chemotherapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30097312": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Early stage estrogen receptor (ER)-positive breast cancer may be treated with chemotherapy in addition to hormone therapy.",
        "Currently available molecular signatures assess the risk of recurrence and the benefit of chemotherapy; however, these tests may have large intermediate risk groups, limiting their usefulness."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26813959": [
        "We experimentally follow mechanistic hypotheses resulting from the computational study and establish that active serotonin production is a major metabolic feature of the poor prognosis group.",
        "Classification of the personalized landscapes derived from 997 tumour samples within the Metabric discovery dataset reveals a novel poor prognosis cluster, reproducible in the 995-sample validation dataset.",
        "We create personalized metabolic landscapes for each tumour by exploring sets of active reactions that satisfy constraints derived from human biochemistry and maximize congruency with the Metabric transcriptome data.",
        "A major roadblock in the effective treatment of cancers is their heterogeneity, whereby multiple molecular landscapes are classified as a single disease.",
        "These data support the reconsideration of concomitant serotonin-specific uptake inhibitors treatment during breast cancer chemotherapy.",
        "To explore the contribution of cellular metabolism to cancer heterogeneity, we analyse the Metabric dataset, a landmark genomic and transcriptomic study of 2,000 individual breast tumours, in the context of the human genome-scale metabolic network."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27634906": [
        "Finally, we analyzed whether RBsig would discriminate palbociclib-sensitive and -resistant breast cancer cells in a large RNA sequencing-based dataset.",
        "Further validation in patients receiving palbociclib is warranted.",
        "We hypothesize that complex alterations of the Retinoblastoma (Rb) pathway might be implicated in resistance to CDK4/6 inhibitors and aim to investigate whether signatures of Rb loss-of-function would identify breast cancer cell lines resistant to palbociclib.",
        "The RBsig was prognostic in the METABRIC dataset (discovery: HR = 1.93 [1.5-2.4] p = 1.4e-08; validation: HR = 2.01 [1.6-2.5] p = 1.3e-09).",
        "The RBsig was able to identify palbociclib resistant and sensitive breast cancer cells (ROC AUC = 0,7778).",
        "We established a gene expression signature of Rb loss-of-function (RBsig) by identifying genes correlated with E2F1 and E2F2 expression in breast cancers within The Cancer Genome Atlas.",
        "Signatures of RB loss might be helpful in personalizing treatment of patients with HR+/HER2neg breast cancer.",
        "To better personalize patients treatment it is critical to identify subgroups that would mostly benefit from it.",
        "We assessed the RBsig prognostic role in the METABRIC and in a comprehensive breast cancer meta-dataset.",
        "Palbociclib is a CDK4/6 inhibitor that received FDA approval for treatment of hormone receptor positive (HR+) HER2 negative (HER2neg) advanced breast cancer.",
        "The RBsig was associated with RB1 genetic status in all tumors (p &lt;7e-32) and in luminal or basal subtypes (p &lt; 7e-11 and p &lt; 0.002, respectively).",
        "Untreated and endocrine treated patients with estrogen receptor positive breast cancer expressing high RBsig had significantly worse recurrence free survival compared to those with low RBsig (HR = 2.37 [1.8 - 3.2] p = 1.87e-08 and HR = 2.62 [1.9- 3.5] p = 8.6e-11, respectively)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26671300": [
        "Despite the strong associations, TP53 mutation independently predicted shorter relapse-free survival (hazard ratio [HR] = 1.63, P = 0.007) in the NTUH cohort and shorter breast cancer-specific survival (HR = 2.35, P = &lt;0.001) in the METABRIC cohort.",
        "We found that TP53 mutation was significantly associated with high-risk IHC4 group and with luminal B, HER2-enriched, and basal-like subtypes.",
        "TP53 mutational analysis added significant prognostic information in addition to the IHC4 score (\u2206 LR-\u03c7(2) = 8.61, P = 0.002) in the NTUH cohort and the PAM50 subtypes (\u2206 LR-\u03c7(2) = 18.9, P = &lt;0.001) in the METABRIC cohort.",
        "IHC4 and PAM50 assays have been shown to provide additional prognostic information for patients with early breast cancer.",
        "We conclude that incorporating TP53 mutation analysis can enhance the prognostic accuracy of the IHC4 and PAM50 assays.",
        "We evaluated whether incorporating TP53 mutation analysis can further enhance their prognostic accuracy.",
        "We examined TP53 mutation and the IHC4 score in tumors of 605 patients diagnosed with stage I-III breast cancer at National Taiwan University Hospital (the NTUH cohort).",
        "We obtained information regarding TP53 mutation and PAM50 subtypes in 699 tumors from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26354892": [
        "Independent association signals and potential functional variants in this locus have not been explored.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      A recent association study identified a common variant (rs9790517) at 4q24 to be associated with breast cancer risk."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23106814": [
        "A recent METABRIC study explored the effects of cis-acting and trans-acting factors of gene expression regulation in breast cancer.",
        "Large research consortia such as the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), The Cancer Genome Atlas and International Cancer Genomics Consortium are systematically interrogating large sets of tumor samples through integrated analysis of genome-wide DNA copy number and promoter methylation, transcriptome-wide RNA expression, protein expression and exome-wide sequencing.",
        "By making their data sets publicly available, these large consortia are inviting new types of analysis that have the potential to drive breast cancer research into previously unexplored avenues."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24555495": [
        "We present and discuss recent and ongoing clinical trials in this field, including clinical studies which combine anti-CD40 treatment with other cancer-treatments, such as Rituximab and Tremelimumab.",
        "The promising results from these early clinical trials have encouraged clinical drug development in order to investigate the effect of CD40 mAbs in combination with other cancer immunotherapies, in particular interleukin (IL)-2.",
        "An in-depth analysis of this immunotherapy is provided elsewhere.",
        "Here, Dacetuzumab and Lucatumumab are in the most advanced stage and are being tested as treatment for malignancies such as chronic lymphatic leukemia (CLL), Multiple Myeloma (MM), and non-Hodgkin's lymphoma (NHL).",
        "The costimulatory molecule CD40 is a member of the tumor necrosis factor (TNF) receptor superfamily and is expressed on various antigen presenting cells (APCs) as well as some tumor cells.",
        "Treatment with anti-CD40 monoclonal antibodies has been exploited in several cancer immunotherapy studies in mice and led to the development of anti-CD40 antibodies for clinical use.",
        "In the present review, we provide an update of the most recent clinical trials with anti-CD40 antibodies.",
        "The binding to the natural ligand CD40L, which is expressed on T helper cells, leads to APC activation and thus enhancement of immune responses."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21896491": [
        "By combining these data with global gene expression profiling of virus-infected cells, we found that most of the sites bound by NF-\u03baB in the human genome do not correlate with changes in gene expression of the nearby genes and they do not appear to function in the context of synthetic promoters.",
        "The transcription factor NF-\u03baB is a critical regulator of immune responses.",
        "Remarkably, we identified a novel abundant NF-\u03baB-binding site residing in specialized Alu-repetitive elements having the potential for long range transcription regulation, thus suggesting that in addition to its known role, NF-\u03baB has a primate-specific function and a role in human evolution.",
        "These results demonstrate that repetitive elements interspersed in the human genome function as common target sites for transcription factors and may play an important role in expanding the repertoire of binding sites to engage new genes into regulatory networks.",
        "To determine how NF-\u03baB builds transcriptional control networks, we need to obtain a topographic map of the factor bound to the genome and correlate it with global gene expression.",
        "We discovered that most of the NF-\u03baB-bound genomic sites deviate from the consensus and are located away from conventional promoter regions.",
        "We used a ChIP cloning technique and identified novel NF-\u03baB target genes in response to virus infection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23771139": [
        "Using nuclear factor-\u03baB (NF-\u03baB) ChIP-Seq data, we present a framework for iterative learning of regulatory networks.",
        "A de novo motif enrichment analysis uncovers secondary TFBSs (AP1, SP1) at characteristic distances from NF-\u03baB/RelA TFBSs.",
        "For every possible transcription factor-binding site (TFBS)-putatively regulated gene pair, the relative distance and orientation are calculated to learn which TFBSs are most likely to regulate a given gene.",
        "Weighted TFBS contributions to putative gene regulation are integrated to derive an NF-\u03baB gene network.",
        "Comparison with experimental ENCODE ChIP-Seq data indicates that experimental TFBSs highly correlate with predicted sites.",
        "Our probabilistic method yields more accurate NF-\u03baB/RelA-regulated networks than a traditional, distance-based approach, confirmed by both analysis of gene expression and increased informativity of Genome Ontology annotations.",
        "We observe that RelA-SP1-enriched promoters have distinct expression profiles from that of RelA-AP1 and are enriched in introns, CpG islands and DNase accessible sites.",
        "Our analysis provides new insights into how co-occurring TFBSs and local chromatin context orchestrate activation of NF-\u03baB/RelA sub-pathways differing in biological function and temporal expression patterns.",
        "Sixteen novel NF-\u03baB/RelA-regulated genes and TFBSs were experimentally validated, including TANK, a negative feedback gene whose expression is NF-\u03baB/RelA dependent and requires a functional interaction with the AP1 TFBSs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28494534": [
        "This study evaluated the therapeutic role of ferroptosis in classic chemotherapy drugs, including the underlying mechanism.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Ferroptosis is a new mode of regulated cell death, which is completely distinct from other cell death modes based on morphological, biochemical, and genetic criteria."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28515173": [
        "HO-1<sup>-/-</sup> cells showed increased dose-dependent erastin- or RSL3-induced cell death in comparison to HO-1<sup>+/+</sup> PTCs.",
        "However, the role of HO-1 in regulating ferroptosis is unclear.",
        "Ferroptosis is an iron-dependent form of regulated nonapoptotic cell death, which contributes to damage in models of acute kidney injury (AKI).",
        "Treatment of HO-1<sup>+/+</sup> PTCs with erastin resulted in a time- and dose-dependent increase in HO-1 gene expression and protein levels compared with vehicle-treated controls.",
        "Iron supplementation with ferric ammonium citrate in erastin-treated cells decreased cell viability further in HO-1<sup>-/-</sup> PTCs compared with HO-1<sup>+/+</sup> cells.",
        "The purpose of this study was to elucidate the role of HO-1 in regulating ferroptotic cell death in renal proximal tubule cells (PTCs).",
        "Cotreatment with ferrostatin-1 (ferroptosis inhibitor), deferoxamine (iron chelator), or N-acetyl-l-cysteine (glutathione replenisher) significantly increased cell viability and attenuated erastin-induced ferroptosis in both HO-1<sup>+/+</sup> and HO-1<sup>-/-</sup> PTCs.",
        "Heme oxygenase-1 (HO-1) is a cytoprotective enzyme induced in response to cellular stress, and is protective against AKI because of its antiapoptotic and anti-inflammatory properties.",
        "These results demonstrate an important antiferroptotic role of HO-1 in renal epithelial cells.",
        "Cells were assessed for changes in morphology and metabolic activity as an indicator of cell viability.",
        "Immortalized PTCs obtained from HO-1<sup>+/+</sup> and HO-1<sup>-/-</sup> mice were treated with erastin or RSL3, ferroptosis inducers, in the presence or absence of antioxidants, an iron source, or an iron chelator."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29175614": [
        "The relevance of ferroptosis to disease and therapy is also discussed.",
        "Distinctive from other death mechanisms, ferroptosis requires cellular iron and lipid peroxides, and is dictated by specific cellular metabolic processes.",
        "This paper reviews the recent advances and outstanding questions of the field by focusing on the role of cellular metabolism in ferroptosis.",
        "Ferroptosis is a newly defined iron-dependent, non-apoptotic mode of cell death with necrotic morphology.",
        "Importantly, ferroptosis has been implicated in a plethora of human diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29127238": [
        "However, ferroptosis in the heart is not well characterized.",
        "Understanding the effects of mTOR in preventing iron-mediated cell death will provide a new therapy for patients with myocardial infarction.",
        "Live/dead cell viability assays revealed that Fe(III)-citrate, erastin, and RSL3 induced cell death.",
        "2',7'-Dichlorodihydrofluorescein diacetate measurement of reactive oxygen species (ROS) production showed that erastin-induced ROS production was significantly lower in mTOR transgenic versus control CMs.",
        "However, ferroptosis in the heart is not well understood.",
        "NEW &amp; NOTEWORTHY Ferroptosis has recently been reported as a new form of iron-dependent nonapoptotic cell death.",
        "CMs were treated with ferric iron [Fe(III)]-citrate, erastin, a class 1 ferroptosis inducer, or Ras-selective lethal 3 (RSL3), a class 2 ferroptosis inducer.",
        "To define the role of cardiac mTOR on cell survival in iron-mediated cell death, we examined cardiomyocyte (CM) cell viability under excess iron and ferroptosis conditions.",
        "Adult mouse CMs were isolated from cardiac-specific mTOR transgenic mice, cardiac-specific mTOR knockout mice, or control mice.",
        "Cotreatment with ferrostatin-1, a ferroptosis inhibitor, inhibited cell death in all conditions. mTOR overexpression suppressed Fe(III)-citrate, erastin, and RSL3-induced cell death, whereas mTOR deletion exaggerated cell death in these conditions.",
        "Clinical studies have suggested that myocardial iron is a risk factor for left ventricular remodeling in patients after myocardial infarction.",
        "Mechanistic target of rapamycin (mTOR) protects the heart against pathological stimuli such as ischemia.",
        "These findings suggest that ferroptosis is a significant type of cell death in CMs and that mTOR plays an important role in protecting CMs against excess iron and ferroptosis, at least in part, by regulating ROS production.",
        "Ferroptosis has recently been reported as a mechanism of iron-dependent nonapoptotic cell death.",
        "Using cultured adult mouse cardiomyocytes, we demonstrated that the mechanistic target of rapamycin plays an important role in protecting cardiomyocytes against excess iron and ferroptosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29274359": [
        "Ferroptosis is a form of oxidative cell death and has become a chemotherapeutic target for cancer treatment.",
        "Studies with specific inhibitors and shRNA interventions suggested that the hierarchy of induction is Nrf2-SLC7A11-HO-1.",
        "Overexperession of SLC7A11 attenuated BAY-inhibited cell viability.",
        "The ferroptotic process induced by hHO-1 overexpression further indicated that HO-1 is a key mediator of BAY-induced ferroptosis that operates through cellular redox regulation and iron accumulation.",
        "BAY 11-7085 (BAY), which is a well-known I\u03baB\u03b1 inhibitor, suppressed viability in cancer cells via induction of ferroptotic death in an NF-\u03baB-independent manner.",
        "BAY causes compartmentalization of HO-1 into the nucleus and mitochondrion, and followed mitochondrial dysfunctions, leading to lysosome targeting for mitophagy.",
        "Reactive oxygen species scavenging, relief of lipid peroxidation, replenishment of glutathione and thiol-containing agents, as well as iron chelation, rescued BAY-induced cell death.",
        "In this study, we first discovered that BAY induced ferroptosis via Nrf2-SLC7A11-HO-1 pathway and HO-1 is a key mediator by responding to the cellular redox status.",
        "SLC7A11 inhibition by erastin, sulfasalazine, or shRNA interference sensitizes BAY-induced cell death.",
        "BAY upregulated a variety of Nrf2 target genes related to redox regulation, particularly heme oxygenase-1 (HO-1)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28549006": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To compare the outcome of per oral endoscopic myotomy (POEM) and laparoscopic Heller myotomy (LHM) for the treatment of esophageal achalasia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30341655": [
        "Hence, we sought to compare the objective esophageal pH study findings in achalasia patients after POEM and LHM.",
        "However, peri-esophageal anti-reflux barriers are preserved in POEM, which might prevent GERD.",
        "<strong class=\"sub-title\">\n          Background and aims:\n        </strong>\n      \n      Peroral endoscopic myotomy (POEM) may be associated with higher rates of gastroesophageal reflux disease (GERD) than laparoscopic Heller's myotomy with fundoplication (LHM), since POEM is not combined with a fundoplication."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28145968": [
        "This study compared the outcomes of POEM with that of the standard laparoscopic Heller myotomy (LHM) for achalasia.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Peroral endoscopic myotomy (POEM) is an emerging endoscopic treatment for achalasia and the long-term efficacy of POEM remains to be evaluated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27638274": [
        "18 patients were treated with LHM and 13 patients with RAHM.",
        "We conclude that RAHM is a safe and effective procedure.",
        "The operative time is no longer than in LHM, but it is necessary to evaluate the technique in randomized clinical trials to determine its advantages in terms of intraoperative complications.",
        "There was no difference in mean operative time (76 \u00b1 13 vs. 79 \u00b1 20 min; P = 0.73).",
        "Thirty-one patients with diagnosis of achalasia confirmed by esophagogram and manometry were included.",
        "Intraoperative complications were less frequent in the robotic-assisted procedures (5.5% vs. 0%); however, this was a non-significant difference.",
        "Dysphagia and weight loss were the main complaints in both groups.",
        "The aim of this study was to compare robotic-assisted laparoscopic Heller myotomy (RAHM) with laparoscopic Heller myotomy (LHM) in terms of efficacy and safety.",
        "94.5-100% of patients had relief of their symptoms.",
        "Minimally invasive surgery has become the gold standard for the treatment of achalasia.",
        "The incorporation of robotic technology can improve many limitations of laparoscopic surgery, through, for example, the availability of three-dimensional vision, increasing the degrees of movement, avoiding the fulcrum effect and optimizing ergonomics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28472017": [
        "The objective of this systematic review and meta-analysis was to compare the safety and efficacy of LHM and POEM.",
        "However, peroral endoscopic myotomy (POEM) is providing good short-term results.",
        "<strong class=\"sub-title\">\n          Aims and objectives:\n        </strong>\n      \n      Laparoscopic Heller myotomy (LHM) is the preferred surgical method for treating achalasia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26108140": [
        "<strong class=\"sub-title\">\n          Background and aim:\n        </strong>\n      \n      This retrospective cohort study compared clinical outcomes and quality of life after peroral endoscopic myotomy (POEM) against laparoscopic Heller myotomy (LHM) for treatment of achalasia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27901639": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Achalasia is a rare disorder in children who are commonly treated by laparoscopic Heller's myotomy (LHM).",
        "The aim of the study is to appraise the results of LHM based on a systematic literature review.",
        "However, there are no large studies evaluating the results of LHM in the pediatric population, and the need of a concomitant fundoplication remains unclear."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29218664": [
        "In this cost-utility analysis of POEM and LHM, we hypothesized that POEM would be cost-effective relative to LHM.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Per oral endoscopic myotomy (POEM) has recently emerged as a viable option relative to the classic approach of laparoscopic Heller myotomy (LHM) for the treatment of esophageal achalasia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26171430": [
        "<strong class=\"sub-title\">\n          Background and study aims:\n        </strong>\n      \n      Type III achalasia is characterized by rapidly propagating pressurization attributable to spastic contractions.",
        "Our aims were to compare the efficacy and safety of POEM with LHM for type III achalasia patients.",
        "Although laparoscopic Heller myotomy (LHM) is the current gold standard management for type III achalasia, peroral endoscopic myotomy (POEM) is conceivably superior because it allows for a longer myotomy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27338580": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Per-oral endoscopic myotomy (POEM) is a less invasive therapy for achalasia with a shorter hospitalization but with similar short- and long-term outcomes as a laparoscopic Heller myotomy (LHM).",
        "Previous literature comparing POEM to LHM has focused primarily on postoperative outcome parameters such as complications, dysphagia scores and gastro-esophageal reflux severity.",
        "This study specifically compares postoperative pain following POEM to pain following LHM, the current gold-standard operation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25783358": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Esophageal achalasia (EA) is a rare esophageal motility disorder in children.",
        "Peroral endoscopic myotomy (POEM) is becoming an alternative to LHM.",
        "The aim of this study is to evaluate the effectiveness, safety, and outcomes of POEM vs LHM in treatment of children with EA.",
        "Laparoscopic Heller myotomy (LHM) represents the treatment of choice in young patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29410262": [
        "This retrospective study aimed to compare patient-reported outcomes between LHM and POEM in a consecutive series of achalasia patients with more than 1 year of follow-up.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Although laparoscopic Heller myotomy (LHM) has been the standard of care for achalasia, per oral endoscopic myotomy (POEM) has gained popularity as a viable alternative."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30360730": [
        "USFDA on August 1, 2017, approved a drug named Enasidenib formerly known as AG-221 which is being marketed under the name Idhifa to treat R/R AML with IDH2 mutation.",
        "The overproduction of immature myeloblasts (white blood cells) is the characteristic feature of AML, thus flooding the bone marrow and reducing its capacity to produce normal blood cells.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Acute myeloid leukemia is the collective name for different types of leukemias of myeloid origin affecting blood and bone marrow.",
        "The present review depicts the broad profile of enasidenib including various aspects of chemistry, preclinical, clinical studies, pharmacokinetics, mode of action and toxicity studies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22861192": [
        "Severe adverse events were anaemia, chills, hypercalcaemia and pyrexia (7% each).",
        "In this open-label, multicentre, phase 1 study a fully human anti-CD40 antagonist monoclonal antibody, lucatumumab, was evaluated in patients with relapsed/refractory multiple myeloma (MM).",
        "Secondary objectives included safety, pharmacokinetics, pharmacodynamics and antimyeloma activity.",
        "The MTD was 4\u00b75 mg/kg.",
        "Twenty-eight patients, enrolled using a standard '3 + 3' dose escalation, received one or two (n = 3) cycles of lucatumumab 1\u00b70, 3\u00b70, 4\u00b75 or 6\u00b70 mg/kg once weekly for 4 weeks.",
        "The primary objective was to determine the maximum tolerated dose (MTD) based on dose-limiting toxicities (DLTs).",
        "DLTs included grade 4 thrombocytopenia, grade 3 increased alanine aminotransferase and grade 4 increased lipase (n = 1 each).",
        "Common lucatumumab-related adverse events were reversible, mild-to-moderate infusion reactions.",
        "These findings indicate that single-agent lucatumumab was well tolerated up to 4\u00b75 mg/kg with modest clinical activity in relapsed/refractory MM, warranting further study as a combination therapy.",
        "At doses \u22653\u00b70 mg/kg, sustained receptor occupancy (\u226587%), observed throughout weekly infusions up to 5 weeks after the last infusion, correlated with an estimated half-life of 4-19 d. Twelve patients (43%) had stable disease, and one patient (4%) maintained a partial response for \u22658 months."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29699523": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Risk scales are used widely in the management of patients presenting to hospital following self-harm.",
        "However, there is evidence that their diagnostic accuracy in predicting repeat self-harm is limited.",
        "Their predictive accuracy in population settings, and in identifying those at highest risk of suicide is not known."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29665120": [
        "Psychiatric outpatients (n = 153) with a lifetime history of suicide ideation/attempt and their treating clinicians (n = 67) were evaluated at intake.",
        "Our findings validate the importance of clinical judgment in assessing suicide risk.",
        "Clinician judgment of risk significantly predicted suicidal thoughts and behaviors at follow-up.",
        "Both the standard suicide risk instrument and clinician emotional responses contributed independently to the clinician assessment of risk, which, in turn, mediated their relationships with suicidal thoughts and behaviors.",
        "We examine the interrelations among clinicians' judgment of patients' suicide risk, clinicians' emotional responses, and standard risk factors in the short-term prediction of suicidal thoughts and behaviors.",
        "Clinicians completed a standard suicide risk instrument (modified SAD PERSONS scale), a 10-point Likert scale assessment of judgment of patient suicide risk (Clinician Prediction Scale), and a measure of their emotional responses to the patient (Therapist Response Questionnaire-Suicide Form).",
        "The Columbia Suicide Severity Rating Scale and the Beck Scale for Suicide Ideation were administered at a one-month follow-up assessment (n = 114, 74.5%).",
        "Clinical judgment appears to be informed both by concrete risk factors and clinicians' emotional responses to suicidal patients, highlighting emotional awareness as a promising area for research and training."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28302702": [
        "Scale <i>a priori</i> cut-offs were evaluated using diagnostic accuracy statistics.",
        "In line with national guidelines, risk scales should not be used to determine patient management or predict self-harm.",
        "<b>Background</b>Scales are widely used in psychiatric assessments following self-harm.",
        "The area under the curve (AUC) was used to determine optimal cut-offs and compare global accuracy.<b>Results</b>In total, 483 episodes of self-harm were included in the study.",
        "The AUC ranged from 0.55 (95% CI 0.50-0.61) for the SAD PERSONS scale to 0.74 (95% CI 0.69-0.79) for the clinician global scale.",
        "The remaining scales performed significantly worse than clinician and patient estimates of risk (<i>P</i>&lt;0.001).<b>Conclusions</b>Risk scales following self-harm have limited clinical utility and may waste valuable resources.",
        "Positive predictive values were modest.",
        "The episode-based 6-month repetition rate was 30% (<i>n</i> = 145).",
        "Most scales performed no better than clinician or patient ratings of risk.",
        "Some performed considerably worse.",
        "Positive predictive values ranged from 13% (95% CI 2-47) for the Modified SAD PERSONS Scale to 47% (95% CI 41-53) for the clinician assessment of risk.",
        "Robust evidence for their diagnostic use is lacking.<b>Aims</b>To evaluate the performance of risk scales (Manchester Self-Harm Rule, ReACT Self-Harm Rule, SAD PERSONS scale, Modified SAD PERSONS scale, Barratt Impulsiveness Scale); and patient and clinician estimates of risk in identifying patients who repeat self-harm within 6 months.<b>Method</b>A multisite prospective cohort study was conducted of adults aged 18 years and over referred to liaison psychiatry services following self-harm.",
        "Sensitivity ranged from 1% (95% CI 0-5) for the SAD PERSONS scale, to 97% (95% CI 93-99) for the Manchester Self-Harm Rule."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28471534": [
        "The SAD PERSONS suicide risk assessment scale is widely implemented in clinical settings despite limited supporting evidence.",
        "This article aims to determine the ability of the SAD PERSONS scale (SPS) to predict future suicide in the emergency department.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Suicide is a major public health issue, and a priority requirement is accurately identifying high-risk individuals."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28723978": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Instruments have been developed to facilitate suicide risk assessment.",
        "We aimed to evaluate the evidence for these instruments including assessment of risk of bias and diagnostic accuracy for suicide and suicide attempt."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22795212": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      The SAD PERSONS scale is a widely used risk assessment tool for suicidal behavior despite a paucity of supporting data.",
        "The objective of this study was to examine the ability of the scale in predicting suicide attempts."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24533537": [
        "A brief rating scale to assess repetition risk of self-harm is important for high-risk identification and early interventions in suicide prevention.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Past and repeated self-harm are long-term risks to completed suicide.",
        "The study aimed to examine the validity of the Chinese SAD PERSONS Scale (CSPS) and to evaluate its feasibility in clinical settings."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24884399": [
        "The study objective was to systematically review the SPS performance in clinical situations.",
        "Relevant descriptive, quality, and outcome data were reviewed.",
        "Well-designed studies that address the observed limitations are required.",
        "The SAD PERSONS scale (SPS) is widely used for suicide risk assessment in clinical and educational settings.",
        "Available literature is of limited quality and quantity.",
        "Insufficient evidence exists to support SPS use in assessment or prediction of suicidal behavior.",
        "In the search, 149 studies were identified and 9 met inclusion criteria.",
        "Only 3 studies examined SPS performance in predicting suicide outcomes; none showed the scale accurately predicted suicidal behavior.",
        "A systematic search of electronic databases was conducted.",
        "Included studies were highly variable across outcome measures, populations, and assessment methods."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21546092": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Prior studies on the association between sleep disturbances and suicidal behavior did not explore whether or not short sleep is a marker of suicide intent, lethality or risk."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26346049": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      The goal of this study was to evaluate the relationship between various suicide screening tools and clinical impression with subsequent patient psychiatric admission and near-term adverse emergency department (ED) events."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29047032": [
        "CNNs have been successfully used in both skin lesion segmentation and classification.",
        "Ostensibly, segmenting a target skin lesion will remove inessential information, non-lesion skin, and artifacts to aid in classification.",
        "For reasons heretofore unclear, previous works have found image segmentation to be, conflictingly, both detrimental and beneficial to skin lesion classification.",
        "We investigate the effect of expanding the segmentation border to include pixels surrounding the target lesion.",
        "Our results indicate that segmentation border enlargement produces, to a certain degree, better results across all metrics of interest when using a convolutional based classifier built using the transfer learning paradigm.",
        "Consequently, preprocessing methods which produce borders larger than the actual lesion can potentially improve classifier performance, more than both perfect segmentation, using dermatologist created ground truth masks, and no segmentation altogether.",
        "Melanoma is a fatal form of skin cancer when left undiagnosed.",
        "Computer-aided diagnosis systems powered by convolutional neural networks (CNNs) can improve diagnostic accuracy and save lives."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29266819": [
        "Moreover, the experimental outcome is supported by hypothesis testing and boxplot representation for classification losses.",
        "Cancer bears a poisoning threat to human society.",
        "Melanoma, the skin cancer, originates from skin layers and penetrates deep into subcutaneous layers.",
        "The lesion information is numerated as a feature set comprising geometry, photometry, border series, and texture measures.",
        "General imaging conditions are adversely affected by nonuniform illumination, which further affects the extraction of relevant information.",
        "The redundancy in feature set is reduced using information theory methods, and a classification boundary is modeled to distinguish benign and malignant samples using support vector machine, random forest, neural network, and fast discriminative mixed-membership-based naive Bayesian classifiers.",
        "There exists an extensive research in melanoma diagnosis using dermatoscopic images captured through a dermatoscope.",
        "To mitigate it, we process an image to define a smooth illumination surface using the multistage illumination compensation approach, and the infected region is extracted using the proposed multimode segmentation method.",
        "While designing a diagnostic model for general handheld imaging systems is an emerging trend, this article proposes a computer-aided decision support system for macro images captured by a general-purpose camera.",
        "The simulation results prove the significance of the proposed model that shows an improved performance as compared with competing arts."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29428356": [
        "With the Asan dataset, the area under the curve for the diagnosis of basal cell carcinoma, squamous cell carcinoma, intraepithelial carcinoma, and melanoma was 0.96 \u00b1 0.01, 0.83 \u00b1 0.01, 0.82 \u00b1 0.02, and 0.96 \u00b1 0.00, respectively.",
        "With the Edinburgh dataset, the area under the curve for the corresponding diseases was 0.90 \u00b1 0.01, 0.91 \u00b1 0.01, 0.83 \u00b1 0.01, and 0.88 \u00b1 0.01, respectively.",
        "To improve the performance of convolutional neural network, additional images with a broader range of ages and ethnicities should be collected.",
        "With the Hallym dataset, the sensitivity for basal cell carcinoma diagnosis was 87.1% \u00b1 6.0%.",
        "The tested algorithm performance with 480 Asan and Edinburgh images was comparable to that of 16 dermatologists.",
        "The convolutional neural network (Microsoft ResNet-152 model; Microsoft Research Asia, Beijing, China) was fine-tuned with images from the training portion of the Asan dataset, MED-NODE dataset, and atlas site images (19,398 images in total).",
        "The trained model was validated with the testing portion of the Asan, Hallym and Edinburgh datasets.",
        "We tested the use of a deep learning algorithm to classify the clinical images of 12 skin diseases-basal cell carcinoma, squamous cell carcinoma, intraepithelial carcinoma, actinic keratosis, seborrheic keratosis, malignant melanoma, melanocytic nevus, lentigo, pyogenic granuloma, hemangioma, dermatofibroma, and wart."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29439500": [
        "A straight-forward CNN is proposed for the dermoscopic feature extraction task.",
        "However, the accurate recognition of melanoma is extremely challenging due to the following reasons: low contrast between lesions and skin, visual similarity between melanoma and non-melanoma lesions, etc.",
        "A deep learning framework consisting of two fully convolutional residual networks (FCRN) is proposed to simultaneously produce the segmentation result and the coarse classification result.",
        "Early detection of melanoma in dermoscopy images significantly increases the survival rate.",
        "Experimental results show the promising accuracies of our frameworks, i.e., 0.753 for task 1, 0.848 for task 2 and 0.912 for task 3 were achieved.",
        "The proposed deep learning frameworks were evaluated on the ISIC 2017 dataset.",
        "A lesion index calculation unit (LICU) is developed to refine the coarse classification results by calculating the distance heat-map.",
        "Hence, reliable automatic detection of skin tumors is very useful to increase the accuracy and efficiency of pathologists.",
        "Skin lesions are a severe disease globally.",
        "In this paper, we proposed two deep learning methods to address three main tasks emerging in the area of skin lesion image processing, i.e., lesion segmentation (task 1), lesion dermoscopic feature extraction (task 2) and lesion classification (task 3)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28969863": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Computer vision may aid in melanoma detection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29846502": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Deep learning convolutional neural networks (CNN) may facilitate melanoma detection, but data comparing a CNN's diagnostic performance to larger groups of dermatologists are lacking."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28026754": [
        "This study corroborates that very deep CNNs with effective training mechanisms can be employed to solve complicated medical image analysis tasks, even with limited training data.",
        "Finally, we seamlessly integrate the proposed FCRN (for segmentation) and other very deep residual networks (for classification) to form a two-stage framework.",
        "The proposed framework is extensively evaluated on ISBI 2016 Skin Lesion Analysis Towards Melanoma Detection Challenge dataset.",
        "Then, we construct a fully convolutional residual network (FCRN) for accurate skin lesion segmentation, and further enhance its capability by incorporating a multi-scale contextual information integration scheme.",
        "Experimental results demonstrate the significant performance gains of the proposed framework, ranking the first in classification and the second in segmentation among 25 teams and 28 teams, respectively.",
        "First, we apply the residual learning to cope with the degradation and overfitting problems when a network goes deeper.",
        "This framework enables the classification network to extract more representative and specific features based on segmented results instead of the whole dermoscopy images, further alleviating the insufficiency of training data.",
        "Automated melanoma recognition in dermoscopy images is a very challenging task due to the low contrast of skin lesions, the huge intraclass variation of melanomas, the high degree of visual similarity between melanoma and non-melanoma lesions, and the existence of many artifacts in the image.",
        "This technique can ensure that our networks benefit from the performance gains achieved by increasing network depth.",
        "Compared with existing methods employing either low-level hand-crafted features or CNNs with shallower architectures, our substantially deeper networks (more than 50 layers) can acquire richer and more discriminative features for more accurate recognition.",
        "To take full advantage of very deep networks, we propose a set of schemes to ensure effective training and learning under limited training data.",
        "In order to meet these challenges, we propose a novel method for melanoma recognition by leveraging very deep convolutional neural networks (CNNs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27377536": [
        "Neutrophils are hypothesized to contribute to the pathogenesis of EAE by producing cytokines and promoting breakdown of the blood brain barrier.",
        "This review summarizes evidence supporting a functional role for neutrophils in EAE and MS, highlighting the differential regulation of neutrophil recruitment in the brain and spinal cord.",
        "Neutrophils may also influence the manifestation of EAE by facilitating parenchymal brain inflammation.",
        "The contribution of neutrophils to CNS autoimmune disease has been underappreciated, but several studies in experimental autoimmune encephalomyelitis (EAE), an animal model of MS, indicate that neutrophils have an important role in inflammation.",
        "Multiple sclerosis (MS) is believed to be initiated when myelin-specific T cells infiltrate the central nervous system (CNS), triggering subsequent recruitment of inflammatory leukocytes to the CNS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27996890": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      It has been shown that calcitriol and all-trans retinoic acid (ATRA) have modulatory effects on the immune system.",
        "The present study investigates the synergistic effects of combination treatment of calcitriol and ATRA in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27758698": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      This overview is aimed at reevaluating fundamental approaches of current MS therapies with focus being placed on their targeted underlying immune, molecular and cellular mechanisms.",
        "Currently used therapies are discussed in regard to their mechanisms of action, clinical accomplishments and unwanted side effects and complications.",
        "Special emphasis is given to the current first generation Disease Modifying Therapies (DMT) and their actions at immune mechanisms of disease.",
        "Effects of DMT on CD4+Th1 cells and their associated cytokines and signaling pathways are discussed in more detail."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30385269": [
        "However, in vitro experiments disclosed that ASI could regulate the differentiation of Th17 and Treg cells but not Th1 cells.",
        "It significantly reduced the demyelination and inflammatory infiltration of CNS in EAE mice by suppressing the percentage of Th1 and Th17 cells, which was closely associated with the inhibition of JAK/STAT and NF-\u03baB signaling pathways.",
        "In the present study, ASI was found to ameliorate the progression and hamper the recurrence of EAE effectively in the treatment regimens.",
        "ASI also increased the percentage of Treg cells in spleen and CNS, which was accompanied by elevated Foxp3.",
        "In addition, it induced the apoptosis of MOG-stimulated CD4<sup>+</sup> T cells probably through modulating STAT3/Bcl-2/Bax signaling pathways.",
        "Astragaloside IV (ASI, CAS: 84687-43-4) is one of the saponins isolated from Astragalus membranceus, a traditional Chinese medicine with immunomodulatory effect.",
        "So far, whether ASI has curative effect on experimental autoimmune encephalomyelitis (EAE), an animal model of MS, and how it affects the subsets of CD4<sup>+</sup> T cells, as well as the underlying mechanism have not been clearly elucidated.",
        "CD4<sup>+</sup> T cells, especially T-helper (Th) cells (Th1, Th2 and Th17) and regulatory T cells (Treg) play pivotal role in the pathogenesis of multiple sclerosis (MS), a demyelinating autoimmune disease occurring in central nervous system (CNS).",
        "Together, our findings suggested that ASI can modulate the differentiation of autoreactive CD4<sup>+</sup> T cells and is a potential prodrug or drug for the treatment of MS and other similar autoimmune diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29416314": [
        "This review explores the efficacy of cysteamine hydrochloride eye drops in the treatment of corneal cystine crystal accumulation and its safety profile.",
        "Cystinosis is a rare, autosomal recessive disorder leading to defective transport of cystine out of lysosomes.",
        "Subsequent cystine crystal accumulation can occur in various tissues, including the ocular surface."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29421779": [
        "Cystinosis is a rare autosomal recessive disorder resulting from defective lysosomal transport of cystine due to mutations in the cystinosin lysosomal cystine transporter (CTNS) gene.",
        "Bartter-like presentation may lead to delay in diagnosis and initiation of specific treatment for cystinosis.",
        "We report a case of a 6-year-old girl initially presenting with the features of Bartter syndrome that was diagnosed 2 years later with nephropathic cystinosis and a novel CTNS mutation.",
        "The clinical phenotype of nephropathic cystinosis is characterized by renal tubular Fanconi syndrome and development of end-stage renal disease during the first decade.",
        "Although metabolic acidosis is the classically prominent finding of the disease, a few cases may present with hypokalemic metabolic alkalosis mimicking Bartter syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29467429": [
        "We also screened a vacuolar protein sorting deletion library, and subsequently created multiple vps deletion mutants for kinetic studies.",
        "Studies on cystinosin have been limited by the absence of a robust genetic screen.",
        "Mutations in the human cystinosin gene (CTNS) cause cystinosis, a recessive autosomal disorder.",
        "Kinetic analysis yielded insights into the role of the residues (including one of the patient mutations, G197R).",
        "The results indicate that the screen could be effectively used for interrogating and understanding the CTNS protein.",
        "This enabled validation by kinetic studies, including first studies on the WT CTNS protein (that contained the GYQDL motif).",
        "The double deletion, vps1\u0394vps17\u0394, greatly enhanced uptake.",
        "Using this screen we isolated several gain of function mutants, G131S/D, G309S/D, A137V, G197R, S270T, L274F and S312N showing enhanced growth on low concentrations of cystine.",
        "In the present study we have developed a dual strategy for evaluating cystinosin function that is amenable to rapid genetic analysis.",
        "Cystinosin, a lysosomal transporter is involved in the efflux of cystine from the lysosome to the cytosol.",
        "We show that human cystinosin expressed in this yeast confers growth on cystine when the protein is mistargeted to the plasma membrane by the deletion of the C-terminal targeting signal, GYQDL."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29399045": [
        "Progress in symptomatic treatments has been more important.",
        "In terms of disease-modifying treatment options, several drugs such as dexpramipexole, pioglitazone, lithium, and many others have been tested in large multicenter trials, albeit with disappointing results.",
        "Evidence regarding secondary symptoms like spasticity, muscle cramps or sialorrhea remains generally scarce, but some new insights will also be discussed.",
        "In this review, we summarize the most important recent developments in the treatment of amyotrophic lateral sclerosis (ALS).",
        "Growing evidence suggests that multidisciplinary care in specialized clinics improves survival.",
        "Nutrition and ventilation are now an important focus of ALS therapy.",
        "Therefore, riluzole remains the only directly disease-modifying drug.",
        "On the other hand, there is still no consensus regarding best nutritional management, but big multicenter trials addressing this issue are currently ongoing.",
        "In addition, we discuss antisense oligonucleotides (ASOs) as a new and potentially causal treatment option.",
        "Several studies have firmly established that noninvasive ventilation improves patients' quality of life and prolongs survival."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29400298": [
        "In patients with mild cognitive impairment, lithium would be associated with clinical improvement and a lower level of cerebrospinal phosphorylated tau protein.",
        "In spinocerebellar ataxia, introduction of lithium may be of benefits in terms of improvement of cerebellar symptoms.",
        "The neuroprotective effects of lithium in this indication tend to be well known and are mediated by its action on two enzymes: glycogen synthase kinase-3 and inositol monophosphatase-1.",
        "Despite several positive case reports and short studies, further controlled researches have failed to substantiate any positive effects of lithium exposure in amyotrophic lateral sclerosis.",
        "Preclinical and clinical studies seek to evaluate the neuroprotective effect of lithium in neurodegenerative disorders.",
        "The aims of this literature review is to gather clinical studies that investigated the efficacy of lithium in neurodegenerative diseases, using a systematic method based on PubMed data.",
        "Large randomized controlled trials are required to asses the effect of early exposure lithium in these indications, based on reliable biological markers of disease.",
        "Lithium exposure showed a potential neuroprotective effect in studies on psychiatric populations with a lower prevalence of Alzheimer's disease in exposed patients.",
        "Lithium is used as a first line treatment in bipolar disorder.",
        "Results were found concerning Alzheimer's disease and related dementias, Huntington's disease, amyotrophic lateral sclerosis and spino-cerebellar ataxia.",
        "Lithium would allow at least a partial improvement in symptoms, including suicidal thoughts, in Huntington's disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28978660": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess whether genetic subgroups in recent amyotrophic lateral sclerosis (ALS) trials responded to treatment with lithium carbonate, but that the treatment effect was lost in a large cohort of nonresponders."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26892289": [
        "A critical question is whether these pharmacodynamic properties of lithium translate into neurodegenerative diseases modifying effects in human subjects.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Preclinical studies have shown that lithium modifies pathological cascades implicated in certain neurodegenerative disorders, such as Alzheimer's disease (AD), Huntigton`s disease (HD), multiple system atrophy (MSA) and amyotrophic lateral sclerosis (ALS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23453347": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Lithium has neuroprotective effects in cell and animal models of amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of lithium on survival.",
        "We aimed to assess whether lithium improves survival in patients with ALS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18367867": [
        "In particular, the effects induced by lithium can be summarized as follows: (i) the removal of altered mitochondria and protein aggregates; (ii) the biogenesis of well-structured mitochondria; (iii) the suppression of glial proliferation; (iv) the differentiation of newly formed neurons in the spinal cord towards a specific phenotype.",
        "In detailing the protective effects of lithium we found for the first time that this drug stimulates the biogenesis of mitochondria in the central nervous system and, uniquely in the spinal cord, it induces neuronogenesis and neuronal differentiation.",
        "In this addendum we focus on defective autophagy as a \"leit motif\" in ALS and the old and novel features of lithium which bridge autophagy activation to concomitant effects that may be useful for the treatment of a variety of neurodegenerative disorders.",
        "This clinical study was published in addition with basic (in vitro) and pre-clinical (in vivo) data demonstrating a defect of autophagy as a final common pathway in the genesis of ALS.",
        "In a pilot clinical study that we recently published we found that lithium administration slows the progression of Amyotrophic Lateral Sclerosis (ALS) in human patients.",
        "In fact, lithium was used as an autophagy inducer.",
        "In particular, the biogenesis of mitochondria and the increase of calbindin D 28K-positive neurons, which are likely to support powerful neuroprotection towards autophagy failure, mitochondriopathy and neuronal loss in the spinal cord."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20702794": [
        "We performed a multicenter trial with lithium carbonate to assess its tolerability, safety, and efficacy in patients with ALS, comparing 2 different target blood levels (0.4-0.8 mEq/L, therapeutic group [TG], vs 0.2-0.4 mEq/L, subtherapeutic group [STG]).",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      A neuroprotective effect of lithium in amyotrophic lateral sclerosis (ALS) has been recently reported."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18250315": [
        "In a parallel study on a genetic ALS animal model, the G93A mouse, we found a marked neuroprotection by lithium, which delayed disease onset and duration and augmented the life span.",
        "After lithium administration in G93A mice, the number of these neurons was higher even when compared with saline-treated WT.",
        "ALS is a devastating neurodegenerative disorder with no effective treatment.",
        "Again, lithium reduced the slow necrosis characterized by mitochondrial vacuolization and increased the number of neurons counted in lamina VII that were severely affected in saline-treated G93A mice.",
        "In the present study, we found that daily doses of lithium, leading to plasma levels ranging from 0.4 to 0.8 mEq/liter, delay disease progression in human patients affected by ALS.",
        "All these mechanisms may contribute to the effects of lithium, and these results offer a promising perspective for the treatment of human patients affected by ALS.",
        "None of the patients treated with lithium died during the 15 months of the follow-up, and disease progression was markedly attenuated when compared with age-, disease duration-, and sex-matched control patients treated with riluzole for the same amount of time.",
        "These effects were concomitant with activation of autophagy and an increase in the number of the mitochondria in motor neurons and suppressed reactive astrogliosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23582371": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Lithium was proposed in 2008 as an effective candidate in the treatment of ALS after a report claimed that it was able to delay functional deterioration by 40% and that none of the 16 patients treated with a combination of lithium plus riluzole had died during a 15-month follow-up period.",
        "This report sparked numerous phase ii clinical trials.",
        "The excellent results of this pilot study engendered considerable optimism among patients, their families, patients' associations, and the scientific community.",
        "Many patients who were not included in these studies used all resources at their disposal to access the drug as treatment under a compassionate use programme."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30247945": [
        "Among others, Epidermal Growth Factor Receptor or EGFR (HER1) mutations or amplifications are the most prevalent alterations in GB.",
        "Standard treatment of newly diagnosed glioblastoma (GB) is surgery with radiotherapy and temozolomide, but tumors will recur with a median overall survival of only 15 months.",
        "In fact, around 40% of GB cases show amplification of EGFR gene, and half of these patients carry the EGFRvIII mutation, a deletion that generates a continuous activation of the tyrosine kinase domain of the receptor.",
        "Therefore, it is necessary to improve the knowledge about the mechanisms of failure or resistance to EGFR inhibitors in GB.",
        "Expert opinion: Despite the poor global results of Dacomitinib in recurrent GB shown in a phase II trial, some patients had a significant benefit.",
        "Areas covered: We review the current knowledge about Dacomitinib, an oral, irreversible, second-generation, pan-HER tyrosine kinase inhibitor, in the treatment of glioblastoma.",
        "Dacomitinib has noteworthy antiglioma activity in preclinical models and has been tested in one phase II trial in patients with recurrent GB with EGFR amplification.",
        "It seems imperative to explore new possibilities of treatment based on targetable alterations known to be present in GB."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28575464": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      We conducted a multicenter, 2-stage, open-label, phase II trial to assess the efficacy and safety of dacomitinib in adult patients with recurrent glioblastoma (GB) and epidermal growth factor receptor gene (EGFR) amplification with or without variant III (EGFRvIII) deletion."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29500635": [
        "To investigate this, NK cells from healthy donors were isolated and NK cell ADCC capacity in response to MM cells was assessed in flow cytometry-based cytotoxicity and degranulation (CD107a) assays in the presence of TME factors.",
        "However, NK cell function has been shown to be potentially diminished by factors common in the tumor microenvironment (TME).",
        "Hypoxia, lactate, prostaglandin E2 (PGE2) or combinations were selected to mimic the TME.",
        "Nevertheless, KIR-ligand mismatched NK cells were slightly better effector cells than KIR-ligand matched NK cells.",
        "Co-staining for inhibitory KIRs and NKG2A demonstrated that daratumumab enhanced degranulation of all NK cell subsets.",
        "The addition of daratumumab (anti-CD38 antibody) augmented NK-cell cytotoxicity against target cells expressing high CD38, but not against CD38 low or negative target cells also in the presence of TME.",
        "This can serve as a platform to improve the clinical efficacy of NK cells.",
        "Hypoxia, lactate and PGE2 reduced cytotoxicity of NK cells against myeloma target cells.",
        "In summary, our study shows that combination therapy using strategies to maximize activating NK cell signaling by triggering ADCC in combination with an approach to minimize inhibitory signaling through a selection of KIR-ligand mismatched donors, can help to overcome the NK-suppressive TME.",
        "Natural killer (NK) cell-based immunotherapy is a promising novel approach to treat cancer.",
        "In this study, we assessed the synergistic potential of antibody-dependent cell-mediated cytotoxicity (ADCC) and killer immunoglobin-like receptor (KIR)-ligand mismatched NK cells to potentiate NK cell antitumor reactivity in multiple myeloma (MM)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26238440": [
        "Here, we conducted a phase I clinical trial to assess the safety, pharmacokinetics, and radiation dosimetry of (99m)Tc-EF injection following pre-administration of folic acid in healthy Japanese male adults.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Technetium etarfolatide ((99m)Tc-EF) is a radioactive diagnostic imaging agent that was developed to assess the expression of folate receptors in tumors.",
        "Administering folic acid prior to the administration of (99m)Tc-EF has been shown to improve SPECT images."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25457975": [
        "The combination of vintafolide plus etarfolatide has been evaluated in three Phase 2 studies for the treatment of various solid tumors, including ovarian, endometrial, peritoneal, and platinum-resistant ovarian cancer, as well as lung cancer.",
        "In contrast, the noninvasive single-photon emission computed tomography-based companion imaging agent, (99m)Tc-etarfolatide ((99m)Tc-EC20), is in development for use as a companion diagnostic with the FR\u03b1-targeted folate conjugate, vintafolide (EC145), to identify patients whose tumors express FR\u03b1.",
        "(99m)Tc-etarfolatide is taken up by FR-positive tumors and allows for noninvasive, whole-body monitoring of FR\u03b1 expression status throughout treatment.",
        "Conventional cancer treatment modalities have several limitations including lack of sufficient efficacy, serious untoward toxicity, as well as innate and acquired drug resistance.",
        "With the development of FR\u03b1-targeted therapies comes a concomitant prerequisite for reliable methods for the quantification of FR\u03b1 tissue expression.",
        "In contrast, targeted imaging agents can identify patients with receptors overexpressed on the surface of cancer cells, thus allowing appropriate selection of patients for personalized treatment with a desirable targeted therapeutic.",
        "Patients with FR-positive tumors, as identified by etarfolatide uptake, have had better clinical outcomes than patients with FR-negative tumors, indicating the potential of etarfolatide as a companion biomarker for predicting vintafolide response.",
        "Currently available diagnostic tools frequently require invasive surgical biopsy.",
        "Vintafolide is a folic acid conjugate of Vinca alkaloid (desacetylvinblastine hydrazide) that targets FR\u03b1-expressing tumors, thereby disrupting microtubule polymerization.",
        "The folate receptor (FR) has been identified as a new molecularly targeted entity, which is highly overexpressed on the surface of a spectrum of solid tumor cells, including ovarian, kidney, lung, brain, endometrial, colorectal, pancreatic, gastric, prostate, testicular, bladder, head and neck, breast, and non-small cell lung cancer.",
        "Furthermore, the recent availability of the crystal structures of FR\u03b1 and FR\u03b2 in complex with folates and antifolates forms a realistic basis for the rational design and implementation of novel FR-targeted drugs for the treatment of cancer and inflammatory disorders.",
        "Folic acid conjugation is a novel approach for targeting FR-expressing tissues for personalized treatment.",
        "Therefore, attaching a radioactive probe to folic acid to target diseased tissue has become a novel and powerful imaging technique.",
        "Targeted therapies combined with a reliable companion diagnostic test represent a novel approach toward efficient personalized medicine for malignant and nonmalignant disorders."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27084348": [
        "The goal of this study was to investigate macrophage-related inflammation in osteoarthritis (OA).",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Through binding to folate receptor-\u03b2 (FR-\u03b2), the new (99m)Tc-EC20 (Etarfolatide) imaging technique detects activated but not resting macrophages in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24667717": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      This report examines (99m)Tc-etarfolatide imaging to identify the presence of folate receptor (FR) on tumors of women with recurrent/refractory ovarian or endometrial cancer and correlates expression with response to FR-targeted therapy (vintafolide)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24742319": [
        "We review the development of vintafolide (EC145), a folic acid-desacetylvinblastine conjugate, the predictive utility of a FR-targeted imaging agent, technetium-(99)m-etarfolatide (EC20), the challenges in proving survival advantage, and other approaches to exploiting FR as a target in ovarian cancer.",
        "Predicting the next breakthrough is a high risk and highly expensive venture.",
        "One of the most promising prospects is folate-receptor (FR)-targeted therapy, given the high expression in FR ovarian cancer.",
        "However, no new drug has been FDA approved for ovarian cancer since 2006, and the approval of an antiangiogenic agent for ovarian cancer in the US has stalled.",
        "Seminal advances in the treatment of cancer have been achieved because of drug development in ovarian cancer; notably the developments of platinums and taxanes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24127448": [
        "The utility of an FR-targeted imaging agent, (99m)Tc-etarfolatide (EC20), in selecting patients likely to benefit from vintafolide was also examined.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Vintafolide (EC145) is a folic acid-desacetylvinblastine conjugate that binds to the folate receptor (FR), which is expressed on the majority of epithelial ovarian cancers.",
        "This randomized phase II trial evaluated vintafolide combined with pegylated liposomal doxorubicin (PLD) compared with PLD alone."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29454747": [
        "In contrast, fibrinolysis, intrahepatic congestion and hemorrhage, and mortality driven by PAI-1 deficiency were reduced in APAP-treated tPA<sup>-/-</sup>/PAI-1<sup>-/-</sup> double-knockout mice.",
        "Of interest, tPA deficiency alone did not affect APAP-induced liver damage.",
        "Compared with APAP-challenged (300 mg/kg) wild-type mice, hepatic deposition of cross-linked fibrin was reduced, with intrahepatic congestion and hemorrhage increased in PAI-1-deficient mice 24 hours after APAP overdose.",
        "We tested the hypothesis that PAI-1 limits liver-related morbidity after APAP challenge by reducing tPA-dependent fibrinolysis.",
        "Administration of recombinant wild-type human PAI-1 reduced intrahepatic hemorrhage 24 hours after APAP challenge in PAI-1<sup>-/-</sup> mice, whereas a mutant PAI-1 lacking antiprotease function had no effect.",
        "Plasminogen activator inhibitor-1 (PAI-1) is an important physiological inhibitor of tissue-type plasminogen activator (tPA) and plays a critical role in fibrinolysis.",
        "Prior studies have shown that PAI-1 prevents intrahepatic hemorrhage and mortality after APAP challenge, but the downstream mechanisms are not clear.",
        "The results identify PAI-1 as a critical regulator of intrahepatic fibrinolysis in experimental liver injury.",
        "Acetaminophen (APAP)-induced liver injury in mice is associated with activation of the coagulation cascade and deposition of fibrin in liver.",
        "PAI-1 expression is increased in both experimental APAP-induced liver injury and patients with acute liver failure.",
        "Moreover, the results suggest that the balance between PAI-1 and tPA activity is an important determinant of liver pathology after APAP overdose."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29228113": [
        "Thrombospondin-1 (THBS1) affects corpus luteum (CL) regression.",
        "These data support the contention that FGF2 and TGFB1 modulate THBS1 via miR-221.",
        "Several miRNAs predicted to target THBS1 mRNA (miR-1, miR-18a, miR-144, miR-194, and miR-221) were experimentally tested.",
        "We found that this miRNA is highly expressed in luteal cells and in mid-cycle CL.",
        "Here we sought to identify specific microRNAs (miRNAs) targeting THBS1 and investigate their possible involvement in FGF2 and TGFB1-mediated THBS1 expression.",
        "Of these, miR-221 was shown to efficiently target THBS1 expression and function in LECs.",
        "Highly induced during luteolysis, it acts as a natural anti-angiogenic, proapoptotic compound.",
        "Conversely, TGFB1 that stimulates THBS1, significantly reduces miR-221.",
        "In contrast, TGFB1 reverses the inhibitory effect of miR-221 mimic on THBS1, and enhances the upregulation of THBS1 induced by miR-221 inhibitor.",
        "These in vitro data propose that dynamic regulation of miR-221 throughout the cycle, affecting THBS1 and SERPINE1, can modulate vascular function in the CL.",
        "Plasminogen activator inhibitor-1 (PAI-1), the gene product of SERPINE1, inhibited cell adhesion, suggesting that PAI-1, like THBS1, has anti-angiogenic properties.",
        "Furthermore, FGF2 enhances the suppression of THBS1 caused by miR-221 mimic, and prevents the increase in THBS1 induced by miR-221 inhibitor.",
        "THBS1 expression is regulated in bovine luteal endothelial cells (LECs) by fibroblast growth factor-2 (FGF2) and transforming growth factor-beta1 (TGFB1) acting in an opposite manner.",
        "Consistent with the inhibition of THBS1 function, miR-221 also reduced Serpin Family E Member 1 [SERPINE1] in LECs and promoted angiogenic characteristics of LECs.",
        "Importantly, FGF2, which negatively regulates THBS1, elevates miR-221."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29967603": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Plasminogen activator inhibitor-1 (PAI-1), a crucial regulator of fibrinolysis, is increased in sepsis, but its values in predicting disease severity or mortality outcomes have been controversial.",
        "Therefore, we conducted a systematic review and meta-analysis of its predictive values in sepsis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28403786": [
        "However, also targeted therapies and biological molecules can induce reversible and irreversible cardiac dysfunction.",
        "During the last years several cases of fatal heart failure have been documented in melanoma patients treated with checkpoint inhibitors.",
        "Over the last years, cancer immunotherapies haverevolutionized the clinical management of a wide spectrum of solid and hematopoietic malignancies previously endowed with poor prognosis.",
        "Cardiac dysfunction after treatment with anthracyclines has historically been a major problem.",
        "Inhibitors of CTLA-4 and PD-1/PD-L1 pathway can unleash anti-tumor immunity and mediate cancer regressions.",
        "The recent experience with cardiovascular toxic effects associated with checkpoint inhibitors introduces important concepts biologically and clinically relevant for future oncology trials and clinical practice.",
        "Although survival of patients with different types of cancer has improved, cardiotoxicity induced by anti-neoplastic drugs remains a critical issue.",
        "Moreover, PD-1 and PD-L1 can be expressed in rodent and human cardiomyocytes.",
        "Ipilimumab (anti-CTLA-4) is the godfather of checkpoint inhibitors, whereas several blocking monoclonal antibodies targeting PD-1 (nivolumab and pembrolizumab) and PD-L1 (atezolizumab, durvalumab, avelumab, and BMS-946559) have been developed.",
        "Immune checkpoint inhibitors are at the forefront of immunotherapy: the two most prominent are the targeting of cytotoxic-T-lymphocyte-associated antigen 4 (CTLA- 4) and of programmed cell death 1 (PD-1) and its ligand PD-L1.",
        "However, early animal studies have demonstrated that after CTLA-4 inhibition and PD-1 deletion autoimmune myocarditis can occur.",
        "Although CTLA-4 inhibitors and PD-1 and PD-L1 blocking agents are frequently associated with a wide spectrum of immune-related adverse events, cardiac toxicity has been underestimated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28831813": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To summarize and evaluate immunotherapy agents targeting programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) recently approved for the treatment of metastatic urothelial carcinomas (UC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28717238": [
        "A comprehensive comparison of PD-L1 interactions with anti-PD-L1 antibodies provides a better understanding of the mechanism of PD-L1 blockade as well as new insights into the rational design of improved anti-PD-L1 therapeutics.",
        "In 2016 and 2017, monoclonal antibodies targeting PD-L1, including atezolizumab, durvalumab, and avelumab, were approved by the FDA for the treatment of multiple advanced cancers.",
        "Here, we report the crystal structures of PD-L1 in complex with atezolizumab and durvalumab to elucidate the precise epitopes involved and the structural basis for PD-1/PD-L1 blockade by these antibodies.",
        "However, it is still unknown how atezolizumab and durvalumab specifically recognize PD-L1, although this is important for investigating novel binding sites on PD-L1 targeted by other therapeutic antibodies for the design and improvement of anti-PD-L1 agents.",
        "Recently, the crystal structures of PD-L1 in complex with BMS-936559 and avelumab have been determined, revealing details of the antigen-antibody interactions.",
        "And many other anti-PD-L1 antibodies are under clinical trials."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28471727": [
        "Patients and Methods This phase I study tested durvalumab doublets in parallel 3 + 3 dose escalations.",
        "Phase II studies with biomarker evaluation are ongoing.",
        "We hypothesize the programmed death-ligand 1 (PD-L1) inhibitor, durvalumab, olaparib, or cediranib combinations are tolerable and active in recurrent women's cancers.",
        "The primary end point was the recommended phase II dose (RP2D).",
        "Two partial responses (\u226515 months and \u2265 11 months) and eight stable diseases \u2265 4 months (median, 8 months [4 to 14.5 months]) were seen in patients who received durvalumab plus olaparib, yielding an 83% disease control rate.",
        "Conclusion To our knowledge, this is the first reported anti-PD-L1 plus olaparib or cediranib combination therapy.",
        "The RP2D was durvalumab 1,500 mg every 4 weeks with olaparib 300 mg twice a day, or cediranib 20 mg, 5 days on/2 days off.",
        "Six partial responses (\u2265 5 to \u2265 8 months) and three stable diseases \u2265 4 months (4 to \u2265 8 months) were seen in 12 evaluable patients who received durvalumab plus cediranib, for a 50% response rate and a 75% disease control rate.",
        "Exposure to durvalumab increased cediranib area under the curve and maximum plasma concentration on the daily, but not intermittent, schedules.",
        "Results Between June 2015 and May 2016, 26 women were enrolled.",
        "No dose-limiting toxicity was recorded with durvalumab plus olaparib.",
        "The RP2Ds of durvalumab plus olaparib and durvalumab plus intermittent cediranib are tolerable and active.",
        "Response to therapy was independent of PD-L1 expression.",
        "Purpose Data suggest that DNA damage by poly (ADP-ribose) polymerase inhibition and/or reduced vascular endothelial growth factor signaling by vascular endothelial growth factor receptor inhibition may complement antitumor activity of immune checkpoint blockade.",
        "Durvalumab was administered at 10 mg/kg every 2 weeks or 1,500 mg every 4 weeks with either olaparib tablets twice daily or cediranib on two schedules.",
        "Response rate and pharmacokinetic analysis were secondary end points.",
        "Durvalumab plus intermittent cediranib grade 3 and 4 AEs were hypertension (one of six) and fatigue (one of six).",
        "The cediranib intermittent schedule (n = 6) was examined because of recurrent grade 2 and non-dose-limiting toxicity grade 3 and 4 adverse events (AEs) on the daily schedule (n = 8).",
        "Treatment-emergent AEs included hypertension (two of eight), diarrhea (two of eight), pulmonary embolism (two of eight), pulmonary hypertension (one of eight), and lymphopenia (one of eight)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26858122": [
        "We aimed to assess durvalumab plus tremelimumab in patients with advanced squamous or non-squamous non-small cell lung cancer (NSCLC).",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      PD-L1 and CTLA-4 immune checkpoints inhibit antitumour T-cell activity.",
        "Combination treatment with the anti-PD-L1 antibody durvalumab and the anti-CTLA-4 antibody tremelimumab might provide greater antitumour activity than either drug alone."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29958099": [
        "However, preliminary data have shown lower efficacy in EGFR mutant and ALK-positive patients.",
        "However, treatment-related toxicity associated with the combinations is an important aspect of the benefit-risk evaluation in the decision-making process.",
        "Areas covered: In advanced NSCLC patients, durvalumab has demonstrated activity and acceptable tolerability, particularly with \u226525% PD-L1 tumor expression in the EGFR and ALK wild-type population.",
        "In non-small cell lung cancer (NSCLC), immunotherapy is one of today's most important and ground-breaking systemic treatments, mainly represented by antibodies against cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death protein 1 or ligand 1 (PD-1/PD-L1).",
        "The results from the recent PACIFIC study in locally advanced patients have placed durvalumab as standard of care in consolidation after chemoradiation, leading to Food and Drug Administration (FDA) approval.",
        "Durvalumab (MEDI4736) is a high-affinity human IgG1 monoclonal antibody that binds to PD-1 and CD80, blocking PD-L1, but not PD-L2.",
        "Expert commentary: Early data suggest promising activity for durvalumab with the CTLA-4 inhibitor tremelimumab, regardless of PD-L1 expression, and potentially in combination with other drugs such as platinum-doublet chemotherapy.",
        "Results of ongoing phase III trials will provide illuminating data to confirm the place of durvalumab in the management of NSCLC patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29416316": [
        "One of the latest inhibitors is durvalumab, which is a high-affinity human immunoglobulin G1 kappa monoclonal antibody and blocks the interaction of PD-L1 with PD-1 and CD80.",
        "Our expanding knowledge of immunotherapy for solid tumors has led to an explosion of clinical trials aimed at urothelial carcinoma.",
        "Currently, there are a number of ongoing trials in advanced urothelial carcinoma both using durvalumab monotherapy and in combination with other targeted therapies.",
        "The primary strategy is centered on unleashing the immune system by releasing the inhibitory signals propagated by programmed cell death-1 (PD-1) and its ligand programmed cell death ligand-1 (PD-L1).",
        "The Food and Drug Administration has already approved a number of checkpoint inhibitors such as anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) monoclonal antibodies including ipilimumab; anti-PD-1 monoclonal antibodies including nivolumab and pembrolizumab; anti-PD-L1 antibodies including atezolizumab, avelumab, and durvalumab.",
        "In addition, durvalumab is being investigated in the non-muscle-invasive urothelial carcinoma, which is centered around intravenous formulations.",
        "Many antibody constructs have been developed to block these interactions and are used in clinical trials.",
        "These exciting developments have added a significant number of therapies in a previously limited treatment landscape."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30514390": [
        "This trial evaluated durvalumab and olaparib in patients with mCRPC with and without somatic or germline DDR mutations.",
        "Durvalumab is a human IgG1-K monoclonal antibody that targets programmed death ligand 1 and is approved by the U.S. Food and Drug Administration for locally advanced or metastatic urothelial cancer and locally advanced, unresectable stage 3 non-small cell lung cancer.",
        "Olaparib, a poly (ADP-ribose) polymerase inhibitor, has demonstrated an improvement in median progression-free survival (PFS) in select patients with metastatic castration-resistant prostate cancer (mCRPC).",
        "Data from other trials suggest there may be improved activity in men with DNA damage repair (DDR) mutations treated with checkpoint inhibitors.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Checkpoint inhibitors have not been effective for prostate cancer as single agents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27265743": [
        "Recruitment started in January 2015 and is ongoing.",
        "Anti-programmed cell death-1 and anti-programmed cell death ligand-1 (PD-L1) monotherapies have shown promising clinical activity in advanced, refractory non-small-cell lung cancer (NSCLC), but antitumor activity appears to be greater in patients with PD-L1(+) tumors compared with patients harboring PD-L1(-) tumors.",
        "The exploratory endpoints will assess potential biomarkers of treatment response.",
        "Secondary endpoints include the proportion of patients alive at 12 months, objective response rate, duration of response, progression-free survival at 6 and 12 months, safety and tolerability, pharmacokinetics, immunogenicity, and quality of life.",
        "ARCTIC (<a href=\"http://clinicaltrials.gov/show/NCT02352948\" title=\"See in ClinicalTrials.gov\">NCT02352948</a>) is a global, phase III, randomized, open-label multicenter study in patients with advanced NSCLC assessing the safety and clinical activity of durvalumab versus standard of care (SoC; erlotinib, gemcitabine, or vinorelbine) in patients with PD-L1(+) tumors (\u226525% of tumor cells with membrane staining using VENTANA PD-L1 [SP263] CDx Assay) (Sub-study A) and the combination of durvalumab + tremelimumab or either agent as monotherapy versus SoC in patients with PD-L1(-) tumors (Sub-study B).",
        "Co-primary endpoints are progression-free survival and overall survival.",
        "Eligible patients are those with locally advanced or metastatic NSCLC (Stage IIIB/IV), without epidermal growth factor receptor tyrosine kinase activating mutations or anaplastic lymphoma kinase rearrangements, who have received at least 2 prior systemic regimens, including 1 platinum-based chemotherapy regimen.",
        "Combining the anti-PD-L1 antibody durvalumab and the anti-cytotoxic T-lymphocyte antigen 4 antibody tremelimumab offers the potential for antitumor activity in patients with advanced NSCLC, regardless of PD-L1 tumor status."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29517083": [
        "This article summarizes the milestones in the development of durvalumab leading to its approval for urothelial carcinoma.",
        "Recent publications illustrate that in specific stages, immunotherapy is more effective than chemotherapy with a better toxicity profile (1).",
        "Multiple systemic immunotherapies have been approved or are currently being investigated for the management of urothelial malignancies (1).",
        "Immunotherapy has revolutionized cancer care in the modern era of oncology.",
        "Research in immunotherapy has led to important advances in the treatment of melanoma, non-small cell lung cancer and other malignancies using checkpoint inhibition.",
        "Currently, the only FDA-approved indication for the anti-PD-L1 monoclonal antibody durvalumab (MEDI-4736) is locally advanced or metastatic urothelial carcinoma that has progressed during or following platinum-based chemotherapy within 12 months of treatment.",
        "Five antibodies targeting the programmed cell death protein 1--programmed cell death 1 ligand 1 (PD-1--PD-L1) pathway have been approved by the U.S. Food and Drug Administration (FDA) for the management of various malignancies: pembrolizumab, nivolumab, atezolizumab, durvalumab and avelumab."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28643244": [
        "The US FDA has granted durvalumab accelerated approval for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.",
        "The drug is also being evaluated in phase I or II clinical trials in a wide range of solid tumours and haematological malignancies.",
        "This article summarizes the milestones in the development of durvalumab leading to this first approval for urothelial carcinoma.",
        "Intravenous durvalumab (Imfinzi\u2122; AstraZeneca) is a fully human monoclonal antibody that blocks programmed cell death ligand-1 binding to its receptors (PD-1 and CD80), resulting in enhanced T-cell responses against cancer cells.",
        "Durvalumab \u00b1 tremelimumab is under phase III clinical trials in urothelial carcinoma, non-small cell lung cancer, small cell lung cancer and head and neck squamous cell carcinoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30013326": [
        "Here, we report a meta-analysis investigating the safety and efficacy of durvalumab (MEDI4736), an inhibitor of PD-L1, in various solid tumors.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      The prominent immune checkpoint molecule, programmed cell death ligand-1 (PD-L1), is the object of increasing attention."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29554207": [
        "In the analysis of BS-seq data, this can present an important performance bottleneck that can be mitigated by appropriate algorithmic and software-engineering improvements.",
        "One strategy is to modify the read-alignment algorithms by integrating the logic related to BS-seq alignment, with the goal of making the software implementation amenable to optimizations that lead to higher speed and greater sensitivity than might otherwise be attainable.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      The alignment of bisulfite-treated DNA sequences (BS-seq reads) to a large genome involves a significant computational burden beyond that required to align non-bisulfite-treated reads."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29172076": [
        "In two small subsets of AML models, chemoresidual disease following DA chemotherapy displayed hallmark markers of leukemic LICs (CLL1 and CD34).",
        "In vivo, the two chemoresistant subpopulations (CLL1+/CD117- and CD34+/CD38+) showed higher ability to self-renewal than their counterpart subpopulations, respectively.",
        "Here we tested whether the survival benefits seen with the combination arise from the enhanced reduction of chemoresidual disease and leukemic initiating cells (LICs).",
        "Although GO shows a narrow therapeutic window in early clinical studies, recent reports detailing a modified dosing regimen of GO can be safely combined with induction chemotherapy, and the combination provides significant survival benefits in AML patients.",
        "Gemtuzumab ozogamicin (GO) is an anti-CD33 antibody-drug conjugate for the treatment of acute myeloid leukemia (AML).",
        "The combination of GO and DA chemotherapy eliminated nearly all AML burden and extended overall survival.",
        "Herein, we use cell line and patient-derived xenograft (PDX) AML models to evaluate the combination of GO with daunorubicin and cytarabine (DA) induction chemotherapy on AML blast growth and animal survival.",
        "We demonstrate that the GO and DA induction chemotherapy combination more effectively eliminates LICs in AML PDX models than either single agent alone.",
        "CD33 was coexpressed in these functional LIC subpopulations.",
        "DA chemotherapy and GO as separate treatments reduced AML burden but left significant chemoresidual disease in multiple AML models.",
        "These data suggest that the survival benefit seen by the combination of GO and induction chemotherapy, nonclinically and clinically, may be attributed to the enhanced reduction of LICs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22080549": [
        "An empirical 'ontology' is discovered from the aggregate of experimental knowledge around user-defined areas of biological inquiry.",
        "The freely available GeneWeaver (http://www.GeneWeaver.org) powered by the Ontological Discovery Environment is a curated repository of genomic experimental results with an accompanying tool set for dynamic integration of these data sets, enabling users to interactively address questions about sets of biological functions and their relations to sets of genes.",
        "This leaves bench biologists with the complex and unscalable task of integrating data by identifying and gathering relevant studies, reanalyzing primary data, unifying gene identifiers and applying ad hoc computational analysis to the integrated set.",
        "High-throughput genome technologies have produced a wealth of data on the association of genes and gene products to biological functions.",
        "Investigators have discovered value in combining their experimental results with published genome-wide association studies, quantitative trait locus, microarray, RNA-sequencing and mutant phenotyping studies to identify gene-function associations across diverse experiments, species, conditions, behaviors or biological processes.",
        "These experimental results are typically derived from disparate data repositories, publication supplements or reconstructions from primary data stores.",
        "Thus, large numbers of independently published genomic results can be organized into new conceptual frameworks driven by the underlying, inferred biological relationships rather than a pre-existing semantic framework."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26092690": [
        "A persistent challenge lies in the interpretation of consensus and discord from functional genomics experimentation.",
        "These results illustrate an alternative to strict emphasis on replicability, whereby researchers classify experimental results to identify the conditions that lead to their similarity.",
        "The data, largely consisting of gene sets and putative biological networks, are mapped onto one another through gene identifiers and homology across species.",
        "Harmonizing and analyzing this data will enable investigators to discover relations of many genes to many diseases, and from many phenotypes and experimental paradigms to many diseases through their genomic substrates.",
        "GeneWeaver enables researchers to store, share, analyze, and compare results of their own genome-wide functional genomics experiments in an environment containing rich companion data obtained from major curated repositories, including the Mouse Genome Database and other model organism databases, along with derived data from highly specialized resources, publications, and user submissions.",
        "The GeneWeaver.org system provides a platform for cross-species integration and interrogation of heterogeneous curated and experimentally derived functional genomics data.",
        "A versatile suite of interactive tools enables investigators to perform a variety of set analysis operations to find consilience among these often noisy experimental results.",
        "Fast algorithms enable real-time analysis of large queries.",
        "Specific applications include prioritizing candidate genes for quantitative trait loci, identifying biologically valid mouse models and phenotypic assays for human disease, finding the common biological substrates of related diseases, classifying experiments and the biological concepts they represent from empirical data, and applying patterns of genomic evidence to implicate novel genes in disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26656951": [
        "The GeneWeaver data and analytics website (www.geneweaver.org) is a publically available resource for storing, curating and analyzing sets of genes from heterogeneous data sources.",
        "The system enables discovery of relationships among genes, variants, traits, drugs, environments, anatomical structures and diseases implicitly found through gene set intersections.",
        "Since the previous review in the 2012 Nucleic Acids Research Database issue, GeneWeaver's underlying analytics platform has been enhanced, its number and variety of publically available gene set data sources has been increased, and its advanced search mechanisms have been expanded.",
        "In addition, its interface has been redesigned to take advantage of flexible web services, programmatic data access, and a refined data model for handling gene network data in addition to its original emphasis on gene set data.",
        "By enumerating the common and distinct biological molecules associated with all subsets of curated or user submitted groups of gene sets and gene networks, GeneWeaver empowers users with the ability to construct data driven descriptions of shared and unique biological processes, diseases and traits within and across species."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26834590": [
        "Although this gene has not been previously implicated in alcohol-related behaviors, its function in various neural mechanisms makes a role in alcohol-related phenomena plausible.",
        "We identified highly connected genes and compared these to genes currently annotated to alcohol-related behaviors and processes.",
        "Experimental validation using a Pafah1b1 conditional knock-out mouse confirmed that this gene is associated with an increased preference for alcohol and an altered thermoregulatory response to alcohol.",
        "A wealth of such data exists, but it is often found in disparate, non-computable forms.",
        "Our interactive web-based software system, Gene Weaver (http://www.geneweaver.org), couples curated results from genomic studies to graph-theoretical tools for combinatorial analysis.",
        "Using this system we identified a gene underlying multiple alcohol-related phenotypes in four species.",
        "To address this problem we have developed a platform for integrated analysis of high-throughput or genome-wide functional genomics studies.",
        "The most highly connected gene not annotated to alcohol was Pafah1b1.",
        "Identifying the biological substrates of complex neurobehavioral traits such as alcohol dependency pose a tremendous challenge given the diverse model systems and phenotypic assessments used.",
        "A search of over 60,000 gene sets in GeneWeaver's database revealed alcohol-related experimental results including genes identified in mouse genetic mapping studies, alcohol selected Drosophila lines, Rattus differential expression, and human alcoholic brains.",
        "By making diverse cross-species functional genomics data readily computable, we were able to identify and confirm a novel alcohol-related gene that may have implications for alcohol use disorders and other effects of alcohol."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27933523": [
        "Coupling a large multispecies repository curated and empirical functional genomics data to fast computational tools allows for the rapid integrative analysis of heterogeneous data for interpreting and extrapolating systems genetics results.",
        "The abundance of existing functional genomics studies permits an integrative approach to interpreting and resolving the results of diverse systems genetics studies.",
        "GeneWeaver is an online database and suite of tools at www.geneweaver.org that allows for fast aggregation and analysis of gene set-centric data.",
        "Data are analyzed using statistical tools and advanced graph algorithms to discover new relations, prioritize candidate genes, and generate function hypotheses.",
        "Here we use GeneWeaver to find genes common to multiple gene sets, prioritize candidate genes from a quantitative trait locus, and characterize a set of differentially expressed genes.",
        "GeneWeaver contains curated experimental data together with resource-level data such as GO annotations, MP annotations, and KEGG pathways, along with persistent stores of user entered data sets.",
        "These can be entered directly into GeneWeaver or transferred from widely used resources such as GeneNetwork.org.",
        "However, a major challenge lies in assembling and harmonizing heterogeneous data sets across species for facile comparison to the positional candidate genes and coexpression networks that come from systems genetic studies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25374613": [
        "In order to adapt this model for examining related molecular components and biological networks, such as pathway or gene network data, we have developed a means to leverage the bipartite data structure to extract and analyze shared edges.",
        "In addition, we illustrate how results from maximal bipartite discovery can be decomposed into hierarchical relationships, allowing shared pathway components to be mapped through various parent-child relationships to help visualization and discovery of emergent kernel driven relationships.",
        "Interrogating common relationships among biological networks and conventional GeneWeaver gene lists will increase functional specificity and reliability of the shared biological components.",
        "The GeneWeaver bipartite data model provides an efficient means to evaluate shared molecular components from sets derived across diverse species, disease states and biological processes.",
        "This approach enables self-organization of biological processes through shared biological networks.",
        "Using the Pathway Commons database we demonstrate the ability to rapidly identify shared connected components among a diverse set of pathways."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24731198": [
        "Efficiency is achieved through an innovative exploitation of bipartite graph structure, and through computational reductions that rapidly eliminate non-maximal candidates from the search space.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Integrating and analyzing heterogeneous genome-scale data is a huge algorithmic challenge for modern systems biology.",
        "Most previously-known techniques are generally ill-suited to this foundational task, because they are relatively inefficient and without effective scaling.",
        "In this paper, a powerful new algorithm is described that produces all maximal bicliques in a bipartite graph.",
        "Unlike most previous approaches, the new method neither places undue restrictions on its input nor inflates the problem size.",
        "An iterative selection of vertices for consideration based on non-decreasing common neighborhood sizes boosts efficiency and leads to more balanced recursion trees.",
        "Bipartite graphs can be useful for representing relationships across pairs of disparate data types, with the interpretation of these relationships accomplished through an enumeration of maximal bicliques."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24233775": [
        "Functional genomics experiments and analyses give rise to large sets of results, each typically quantifying the relation of molecular entities including genes, gene products, polymorphisms, and other genomic features with biological characteristics or processes.",
        "Therefore, integration requires biologists to implement computational algorithms and harmonization of gene identifiers both within and across species.",
        "Account management features allow data and results to be shared among user-defined groups.",
        "The GeneWeaver web-based software system brings together a large data archive from diverse functional genomics data with a suite of combinatorial tools in an interactive environment.",
        "Users can retrieve curated gene set data, upload, store, and share their own experimental results and perform integrative analyses including novel algorithmic approaches for set-set integration of genes and functions.",
        "However, these gene-centered data are often deposited in diverse and non-interoperable stores.",
        "There is tremendous utility and value in using these data in an integrative fashion to find convergent evidence for the role of genes in various processes, to identify functionally similar molecular entities, or to compare processes based on their genomic correlates."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24923803": [
        "We have demonstrated genetic and alcohol-induced regulation of Ap3m2 expression.",
        "By exploiting recent advances in mouse genotyping, sequence, epigenetics, and phylogeny resources, we confirmed that Ap3m2 resides in an appropriately segregating genomic region.",
        "Data from multiple such publications and public data resources have been incorporated in the GeneWeaver database with &gt;60,000 gene sets including 285 alcohol withdrawal and preference-related gene sets.",
        "Extensive genetic and genomic studies of the relationship between alcohol drinking preference and withdrawal severity have been performed using animal models.",
        "Combinatorial integration of functional genomics experimental results revealed a single QTL positional candidate gene in one of the loci common to both preference and withdrawal.",
        "We have identified one of these to be an H3K4me3 site that exhibits strain differences in methylation.",
        "Genetic validation involves confirming the existence of segregating polymorphisms that could account for the phenotypic effect.",
        "Among these are evidence for positional candidates regulating these behaviors in overlapping quantitative trait loci (QTL) mapped in distinct mouse populations.",
        "Thus, by making cross-species functional genomics readily computable we identified a common QTL candidate for two related bio-behavioral processes via functional evidence and demonstrate sufficiency of the genetic locus as a source of variation underlying two traits.",
        "Although sequence analysis revealed no polymorphisms in the Ap3m2-coding region that could account for all phenotypic differences, there are several upstream SNPs that could.",
        "Functional validation studies in Ap3m2 knockout mice confirmed these relationships."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23195309": [
        "The fragmentation of public resources, interoperability, and available representations present challenges due to the array of identifiers used to represent each genome feature.",
        "Once data are organized into a coherent collection, they can be integrated using a variety of methods to analyze convergent evidence for the roles of genes in behaviors.",
        "These techniques will be increasingly necessary to understand global patterns emerging from experiments in behavioral genomics.",
        "GeneWeaver.org is a web-based software system that employs many of these techniques and has been used in the study of complex behavior and addiction.",
        "There is an increasing recognition of the value in integrating behavioral genomics data across species."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29028909": [
        "Here, we present a systematic study of ultraconserved genomic regions in the budding yeast based on the publicly available genome sequences, in order to reveal their relationship with the adaptability or fitness advantages of the budding yeast.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      In the evolution of species, a kind of special sequences, termed ultraconserved sequences (UCSs), have been inherited without any change, which strongly suggests those sequences should be crucial for the species to survive or adapt to the environment.",
        "However, the UCSs are still regarded as mysterious genetic sequences so far."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29742797": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      In this study we compared the electrodiagnostic (EDX) yield of limb muscles in revealing lower motor neuron (LMN) dysfunction by electromyography (EMG) in early-stage amyotrophic lateral sclerosis (ALS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28249004": [
        "Our study sought to compare the roles of AC and rEEC in the diagnosis of ALS.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      The accurate and early diagnosis of amyotrophic lateral sclerosis (ALS) is important for extending the life expectancy of patients.",
        "However, previous studies that have assessed the diagnostic sensitivities of the Awaji criteria (AC) and the revised El Escorial criteria (rEEC) in patients with ALS have been inconsistent, most of them were consensual regarding the advantage of Awaji over conventional criteria."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28631957": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess the added prognostic value of the aggregated clinical and electrodiagnostic data, which define a given diagnostic category according to the Awaji or revised El Escorial criteria at time of diagnosis in patients with amyotrophic lateral sclerosis (ALS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28444090": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To investigate the frequency of anxiety and depression and their association with clinical features of amyotrophic lateral sclerosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28457490": [
        "In clinical practice, it is necessary to distinguish fasciculations potentials of motor neuron disease from benign fasciculations.",
        "While most studies favor a distal axonal origin site of fasciculations, some of the fasciculations could be of cortical origin.",
        "It is not specific to motor neuron diseases, and can occur in healthy subjects, as well as in various pathologies of the peripheral nervous system, including nerve hyperexcitability syndromes.",
        "The consequences of hyperexcitability are also discussed, whether it is rather protective or deleterious in the disease course.",
        "Hyperexcitability plays an important and debated role in the pathophysiology of motor neuron diseases, especially in amyotrophic lateral sclerosis (ALS).",
        "In most studies of fasciculation potentials in ALS, the presence of complex fasciculation potentials appears to be relevant for the diagnosis and the prognosis of the disease.",
        "Neuronal and/or axonal hyperactivity and hyperexcitability is an important feature of motor neuron diseases.",
        "It results clinically in cramps and fasciculations.",
        "Fasciculations are depicted both clinically and using electromyogram, and more recently the interest of ultrasound has been highlighted.",
        "The contribution of these modifications to ALS diagnosis has been the subject of several studies.",
        "The mechanisms causing hyperexcitability are not yet clearly identified.",
        "The importance of fasciculation potentials in the diagnosis of ALS led to changes in electrophysiological criteria at Awaji consensus conference."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22892641": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To estimate the potential diagnostic added value of the Awaji criteria for diagnosis of a myotrophiclateral sclerosis (ALS), which have been compared with the previously accepted gold standard the revised El Escorial criteria in several studies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23261262": [
        "The delay can be explained by the variability of the clinical presentation and by the absence of diagnostic markers.",
        "Amyotrophic lateral sclerosis is the most common motor neuron disorder in adults.",
        "The need to diagnose and treat ALS quickly could be facilitated by the inclusion of complementary investigations that detect UMN signs.",
        "Although the diagnosis appears obvious in theory, clinical practice shows the contrary as diagnosis is delayed in many patients; the average time between symptom onset and diagnosis can reach 12 months.",
        "In all other instances the accuracy appears to be improved by the Awaji criteria.",
        "The only weakness of the new classification involves patients with UMN signs in one region and LMN in two regions; these patients were previously classified as laboratory-supported probable ALS and currently as possible ALS, a lower level of diagnostic certainty.",
        "In 2006, the Awaji criteria for the diagnosis of ALS were proposed, adding two major points to the diagnostic criteria: electromyography is considered equivalent to clinical examination for the identification of LMN signs and fasciculation potentials resume their prominent place in the diagnosis.",
        "Comparisons of the accuracy of the revisited El Escorial and Awaji criteria support improved diagnostic sensitivity without any effect on specificity with the new classification.",
        "Nevertheless, there is a body of evidence suggesting the need for a revision of these new criteria, giving more weight to clinical and complementary findings of UMN involvement.",
        "In order to standardize diagnosis for enrollment in clinical research, diagnostic criteria for ALS were created and revisited during the last 20 years."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27440148": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess the sensitivity and specificity of the Awaji and revised El Escorial diagnostic criteria (rEEC) in amyotrophic lateral sclerosis (ALS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20536375": [
        "We assessed whether the Awaji recommendations improve the sensitivity of the early diagnosis of ALS.",
        "In a retrospective study we reviewed clinical and neurophysiological data for 213 patients who visited our motor neuron disease outpatient clinic between October 2006 and December 2008.",
        "Using the El Escorial criteria, 51 patients were diagnosed with definite or probable ALS, 14 with probable laboratory-supported ALS, and 28 with possible ALS.",
        "An alternative diagnosis was present in 120 patients.",
        "However, this diagnostic improvement appears eliminated if patients with probable laboratory-supported ALS - due to UMN signs in one region - should be categorized as possible ALS.",
        "The Awaji Commission recently proposed a modification of the electrodiagnostic criteria for ALS.",
        "Applying the Awaji recommendations, 66 patients were diagnosed with either definite or probable ALS, and 27 with possible ALS.",
        "Of the 14 patients diagnosed with probable laboratory-supported ALS, eight switched to probable ALS and six to possible ALS using the Awaji recommendations; none of the patients with an ALS mimic was diagnosed with ALS according to the Awaji recommendations.",
        "In conclusion, the new criteria for ALS do not result in a loss of specificity and can potentially improve the sensitivity by 16%."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25597926": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Recently, some authors have claimed that the Awaji criteria (AC) are not always more sensitive than the revised El Escorial criteria (rEEC) in amyotrophic lateral sclerosis (ALS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27212114": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To determine the utility of the Awaji criteria in diagnosing amyotrophic lateral sclerosis (ALS) and to propose a novel modification so as to enhance sensitivity based on results of individual patient data (IPD)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21215419": [
        "However, serial electrophysiological analysis is lacking to ascertain the original intention.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Recently, new electrophysiological ALS criteria incorporating fasciculation potentials (FPs) as evidence for lower motor neuron signs (Awaji Criteria (AC)) was proposed to provide earlier detection of early-stage ALS than revised El Escorial electrophysiological criteria (REEC).",
        "The objective for this study was to elucidate whether electrophysiological criteria set for AC detects ALS earlier than REEC's counterpart in patients with ALS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24575803": [
        "Although the new approach to FPs markedly increases the number of involved muscles, it only slightly raises the number of involved regions.",
        "Results showed that implementation of the Awaji criteria increased the level of ALS diagnosis sensitivity in 5.9% of cases - 1.5% due to the new role of FPs potentials and 4.4% because of equalization of clinical and EMG findings.",
        "Medical and electrophysiological records of 135 consecutive patients with ALS and 25 patients with progressive muscular atrophy (PMA) who underwent electrophysiological examination of at least three anatomical regions were analysed retrospectively.",
        "They also increase the electrophysiological significance of fasciculation potentials (FPs).",
        "The aim of our study was to analyse whether the new parameters improve diagnostic sensitivity in ALS patients primarily diagnosed with the El Escorial criteria.",
        "The Awaji criteria, recently introduced to increase diagnosis sensitivity in amyotrophic lateral sclerosis (ALS), equate the diagnostic significance of neurogenic electrophysiological changes to clinical signs of lower motor neuron dysfunction.",
        "In 4% of patients the ALS diagnosis was, however, changed from laboratory-supported probable ALS to possible ALS.",
        "In conclusion, our study confirms that Awaji modifications are able to improve the diagnostic certainty in a few ALS cases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25843898": [
        "We assessed the sensitivity and specificity of a threshold tracking transcranial magnetic stimulation (TMS) technique, which might allow early detection of upper motor neuron dysfunction, for the diagnosis of the disorder.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Diagnosis of amyotrophic lateral sclerosis (ALS) remains problematic, with substantial diagnostic delays."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21940619": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      To study the utility of muscle ultrasound (US) for detection of fasciculations and its contribution to diagnosis in amyotrophic lateral sclerosis (ALS).",
        "Fasciculations are characteristic features of ALS, and US can detect them easily and reliably.",
        "New diagnostic criteria for ALS, the Awaji algorithm, reintroduced fasciculations as evidence of acute denervation equivalent to that of fibrillations and positive sharp waves."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24698287": [
        "Given that cortical hyperexcitability appears to be an early feature in ALS, the present study assessed the diagnostic utility of a threshold tracking transcranial magnetic stimulation technique as an aid to the research-based Awaji criteria in establishing an earlier diagnosis of ALS.",
        "<strong class=\"sub-title\">\n          Background and purpose:\n        </strong>\n      \n      The diagnosis of amyotrophic lateral sclerosis (ALS) relies on identification of a combination of upper and lower motor neuron signs.",
        "In order to improve the diagnostic sensitivity for ALS, Awaji criteria were developed, in part to better incorporate neurophysiological measures, although assessment of upper motor neuron dysfunction remained clinically based."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20928911": [
        "Our retrospective analysis of patients referred over a 6-month period to the electromyography (EMG) laboratory for suspected motor neuron disease (MND) showed a higher agreement of the Awaji modifications than the Airlie House criteria with the clinical diagnosis of ALS.",
        "Amyotrophic lateral sclerosis (ALS) remains a clinical diagnosis without validated biomarkers.",
        "To increase diagnostic sensitivity, an expert group modified the Airlie House diagnostic criteria and formulated new recommendations at a meeting on Awaji Island."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27999985": [
        "Here, we compared the inversion of the saccule to utricle area ratio (SURI) with the semi-quantitative method of grading conventionally used to diagnose MD.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Endolymphatic hydrops (EH) can be studied in patients by MRI.",
        "With the semi-quantitative grading system, previous imaging studies showed discrepancies in the occurrence and grading of EH in patients with Meniere's disease (MD)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27942898": [
        "Vestibular endolymphatic hydrops in M\u00e9ni\u00e8re's disease patients caused otolith organ dysfunction, mainly in the saccule.",
        "M\u00e9ni\u00e8re's disease is associated with hydrops of the inner ear endolymphatic space, and histopathologically, the cochlea and vestibule are usually involved.",
        "The number of M\u00e9ni\u00e8re's disease patients with abnormal ocular vestibular evoked myogenic potentials was low (19%), and they also had abnormal utricular induced linear vestibulo-ocular reflexes.",
        "We evaluated 21 patients diagnosed with unilateral definitive M\u00e9ni\u00e8re's disease using gadolinium magnetic resonance imaging to detect endolymphatic hydrops in the cochlea and vestibule.",
        "Magnetic resonance imaging revealed vestibular hydrops in 14 of 20 patients (70%).",
        "We used gadolinium-enhanced magnetic resonance imaging and measured cervical and ocular vestibular evoked myogenic potentials and the gain in the utricular induced linear vestibulo-ocular reflex to test the hypothesis that vestibular hydrops in M\u00e9ni\u00e8re's disease patients is associated with otolith organ dysfunction.",
        "Cervical and ocular vestibular evoked myogenic potentials and the gain in utricular induced linear vestibulo-ocular reflex during eccentric rotation were measured to assess otolith organ function.",
        "Among the 14 patients, ten (71%) had abnormal cervical and three (21%) had abnormal ocular vestibular evoked myogenic potentials.",
        "Four patients (4/21, 19%) had abnormal linear vestibulo-ocular reflexes, three of whom also had abnormal ocular vestibular evoked myogenic potentials.",
        "For eccentric rotation, patients were rotated while displaced from the axis of rotation, while linear acceleration stimulated the utricle and induced the vestibulo-ocular reflex.",
        "Overall, 16 of 17 patients had normal linear vestibulo-ocular reflexes and normal ocular vestibular evoked myogenic potentials."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27564645": [
        "It is assumed that the probability of immediate progression to bilateral MD from unilateral MD is very low in patients without EH on the non-affected side.",
        "Symptoms of MD may appear after formation of EH.",
        "<strong class=\"sub-title\">\n          Conclusion:\n        </strong>\n      \n      All definite Meniere's disease (MD) had endolymphatic hydrops (EH) at least in the cochlea or the vestibule."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30503567": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To employ magnetic resonance imaging (MRI) to measure the volume of the inner ear endolymphatic space (ELS) in patients with acute low-tone sensorineural hearing loss (ALHL), sudden deafness (SD), cochlear Meniere's disease (cMD), and unilateral MD (uMD) compared with control subjects (CS) with chronic rhinosinusitis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29476018": [
        "Hemorrhage, prolonged thrombocytopenia, and veno-occlusive disease were serious toxicities that were more common in patients treated with gemtuzumab ozogamicin + daunorubicin and cytarabine.",
        "Gemtuzumab ozogamicin is a CD33-targeted antibody-drug conjugate joined to calicheamicin.",
        "On September 1, 2017, the FDA granted approval for gemtuzumab ozogamicin (Mylotarg; Pfizer Inc.) in combination with daunorubicin and cytarabine and as a monotherapy for the treatment of adult patients with newly diagnosed CD33-positive acute myeloid leukemia (AML).",
        "Adverse events were similar on both arms.",
        "Approval of gemtuzumab ozogamicin monotherapy was based on a randomized trial of 237 patients with newly diagnosed AML treated without curative intent.",
        "Median overall survival (OS) was 4.9 months with gemtuzumab ozogamicin versus 3.6 months on best supportive care [HR = 0.69 (95% CI, 0.53-0.90)].",
        "Approval of gemtuzumab ozogamicin combination treatment was based on a randomized trial of 271 patients with newly diagnosed AML treated with daunorubicin and cytarabine with or without 3 mg/m<sup>2</sup> fractionated gemtuzumab ozogamicin, which resulted in an event-free survival (EFS) of 13.6 months for gemtuzumab ozogamicin + daunorubicin and cytarabine and 8.8 months for daunorubicin and cytarabine alone [HR = 0.68 (95% confidence interval (CI), 0.51-0.91)].",
        "Postapproval, several studies are required including evaluation of fractionated gemtuzumab ozogamicin pharmacokinetics, safety of combination gemtuzumab ozogamicin in the pediatric population, immunogenicity, and the effects of gemtuzumab ozogamicin on platelet function. <i>Clin Cancer Res; 24(14); 3242-6. \u00a92018 AACR</i>."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28302434": [
        "Amish communities have persistently lower immunization rates.",
        "A recent outbreak of pertussis in an Amish community in Ohio resulted in the death of a 6-week-old Amish baby.",
        "Despite this acknowledged success, childhood immunization rates continue to be much lower in select populations.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Review included childhood immunizations among the 10 great public health achievements in the United States in the 20th century.",
        "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio, resulting in 368 cases reported."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26103154": [
        "Measles can spread very rapidly in an underimmunized subpopulation like the North American Amish, with the potential for national spread within a year or so in the absence of outbreak response.",
        "Until global eradication, measles importations will continue to pose a threat to clusters of underimmunized individuals in the United States.",
        "Aggressive outbreak response efforts in Ohio probably prevented widespread transmission of measles within the entire North American Amish.",
        "Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio pushing the annual cases to the highest national number reported in the last 20 years.",
        "We explored the impact of the 2014 outbreak response compared to no or partial response.",
        "We adapted an individual-based model developed to explore potential poliovirus transmission in the North American Amish to characterize a 1988 measles outbreak in the Pennsylvania Amish and the 2014 outbreak in the Ohio Amish.",
        "Vaccination efforts significantly reduced the transmission of measles and the expected number of cases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27705270": [
        "We describe the epidemiologic features of an outbreak of measles that originated from two unvaccinated Amish men in whom measles was incubating at the time of their return to the United States from the Philippines and explore the effect of public health responses on limiting the spread of measles.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Although measles was eliminated in the United States in 2000, importations of the virus continue to cause outbreaks."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28003334": [
        "One exemplar gene is HUWE1, which has been found to be mutated in numerous studies.",
        "To determine the importance of HUWE1, we chose to examine its function in colorectal cancer, where it is mutated in up to 15 per cent of tumours.",
        "Genetic deletion of Huwe1 rapidly accelerated tumourigenic in mice carrying loss of the intestinal tumour suppressor gene Apc, with a dramatic increase in tumour initiation.",
        "However, due to the large size of this gene and a lack of functional analysis of identified mutations, their significance to carcinogenesis is unclear.",
        "Modelling of identified mutations showed that they inactivate the E3 ubiquitin ligase activity of HUWE1.",
        "Mechanistically, this phenotype was driven by increased MYC and rapid DNA damage accumulation leading to loss of the second copy of Apc The increased levels of DNA damage sensitised Huwe1-deficient tumours to DNA-damaging agents and to deletion of the anti-apoptotic protein MCL1.",
        "Taken together, these data identify HUWE1 as a bona fide tumour suppressor gene in the intestinal epithelium and suggest a potential vulnerability of HUWE1-mutated tumours to DNA-damaging agents and inhibitors of anti-apoptotic proteins.",
        "Cancer genome sequencing projects have identified hundreds of genetic alterations, often at low frequencies, raising questions as to their functional relevance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27522479": [
        "The inflammatory diseases that are most strongly associated with major histocompatibility Complex class I (MHC-I) alleles are also influenced by endoplasmic reticulum aminopeptidase (ERAP) 1 and/or 2, often in epistasis with the susceptibility MHC-I allele.",
        "Processing of specific antigens, peptide-dependent changes in global properties of the MHC-I molecules, such as folding and stability, or both may be pathogenic.",
        "A pattern emerges of analogous effects on peptide length, sequence and affinity of disparate peptidomes, suggesting that similar peptide-mediated mechanisms underlie the pathogenesis and the joint contribution of ERAP1/ERAP2 and MHC-I to distinct inflammatory diseases.",
        "This review will focus on the four major MHC-I-associated inflammatory disorders: ankylosing spondylitis, birdshot chorioretinopathy, Beh\u00e7et's disease and psoriasis.",
        "The genetics of ERAP1/ERAP2 association and the alterations induced by polymorphism of these enzymes on the risk MHC-I allotypes will be examined."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25892735": [
        "These changes resulted in increased affinity and hydrophobicity of A*29:02 ligands in an active ERAP1 context.",
        "The complexity of these alterations is such that not only peptide presentation but also other potentially pathogenic features could be affected.",
        "Since both enzymes are involved in the processing of MHC-I ligands, it seems reasonable that common peptide-mediated mechanisms may underlie the pathogenesis of these diseases.",
        "It belongs to a group of MHC-I-associated inflammatory disorders, also including ankylosing spondylitis, psoriasis, and Beh\u00e7et's disease, for which endoplasmic reticulum aminopeptidases (ERAP) 1 and/or 2 have been identified as genetic risk factors.",
        "In this study, comparative immunopeptidomics was used to characterize &gt;5000 A*29:02 ligands and quantify the effects of ERAP1 polymorphism and expression on the A*29:02 peptidome in human cells.",
        "The peptides predominant in an active ERAP1 context showed a higher frequency of nonamers and bulkier amino acid side chains at multiple positions, compared with the peptides predominant in a less active ERAP1 background.",
        "Thus, ERAP1 polymorphism has a large influence, shaping the A*29:02 peptidome through length-dependent and length-independent effects.",
        "Birdshot chorioretinopathy is a rare ocular inflammation whose genetic association with HLA-A*29:02 is the highest between a disease and a major histocompatibility complex (MHC) molecule.",
        "The results reveal the nature of the functional interaction between A*29:02 and ERAP1 and suggest that this enzyme may affect the susceptibility to birdshot chorioretinopathy by altering the A*29:02 peptidome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29088312": [
        "Here we show the full domain architecture of human TMEM132 family proteins solved using in-depth sequence and structural analysis.",
        "The extra-cellular portions of TMEM132 proteins contain five conserved domains including three tandem immunoglobulin domains, and a cohesin domain homologue, the first such domain found in animals.",
        "We reveal them to be five previously unappreciated cell adhesion molecules whose domain architecture has an early holozoan origin prior to the emergence of choanoflagellates and metazoa.",
        "These findings strongly predict a cellular adhesion function for TMEM132 family, connecting the extracellular medium with the intracellular actin cytoskeleton.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      The molecular functions of TMEM132 genes remain poorly understood and under-investigated despite their mutations associated with non-syndromic hearing loss, panic disorder and cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27161642": [
        "Gepotidacin, a novel triazaacenaphthylene antibacterial agent, is the first in a new class of type IIA topoisomerase inhibitors with activity against many biothreat and conventional pathogens, including Neisseria gonorrhoeae To assist ongoing clinical studies of gepotidacin to treat gonorrhea, a multilaboratory quality assurance investigation determined the reference organism (N. gonorrhoeae ATCC 49226) quality control MIC range to be 0.25 to 1 \u03bcg/ml (88.8% of gepotidacin MIC results at the 0.5 \u03bcg/ml mode)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29453241": [
        "The PI3K\u03b1 inhibitor alpelisib achieved a 58.2% disease control rate in <i>PIK3CA</i>-altered solid tumors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29284706": [
        "All these changes were ablated by alpelisib treatment.<b>Conclusions:</b> C2 domain deletions in <i>PIK3CA</i> generate PI3K dependence and should be considered biomarkers of sensitivity to PI3K inhibitors. <i>Clin Cancer Res; 24(6); 1426-35. \u00a92017 AACR</i>.",
        "The MCF10A cells expressing <i>PIK3CA</i> C2 deletions exhibited growth factor-independent growth, an invasive phenotype, and higher phosphorylation of AKT, ERK, and S6 compared with parental MCF10A cells.",
        "Although <i>PIK3CA</i> deletions are relatively rare, a significant portion of deletions cluster within amino acids 446-460 of the C2 domain, suggesting these residues are critical for p110\u03b1 function.<b>Experimental Design:</b> A computational structural model of <i>PIK3CA</i><sup>delP447-L455</sup> in complex with the p85 regulatory subunit and MCF10A cells expressing <i>PIK3CA</i><sup>delP447-L455</sup> and <i>PIK3CA</i><sup>H450_P458del</sup> were used to understand the phenotype of C2 domain deletions.<b>Results:</b> Computational modeling revealed specific favorable inter-residue contacts that would be lost as a result of the deletion, predicting a significant decrease in binding energy.",
        "<b>Purpose:</b> We describe herein a novel P447_L455 deletion in the C2 domain of <i>PIK3CA</i> in a patient with an ER<sup>+</sup> breast cancer with an excellent response to the PI3K\u03b1 inhibitor alpelisib.",
        "Coimmunoprecipitation experiments showed reduced binding of the C2 deletion mutants with p85 compared with wild-type p110\u03b1."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29401002": [
        "Alpelisib was rapidly absorbed; half-life was 7.6 hours at 400 mg once daily with minimal accumulation.",
        "Purpose We report the first-in-human phase Ia study to our knowledge ( ClinicalTrials.gov identifier: <a href=\"http://clinicaltrials.gov/show/NCT01219699\" title=\"See in ClinicalTrials.gov\">NCT01219699</a>) identifying the maximum tolerated dose and assessing safety and preliminary efficacy of single-agent alpelisib (BYL719), an oral phosphatidylinositol 3-kinase \u03b1 (PI3K\u03b1)-selective inhibitor.",
        "Patients and Methods In the dose-escalation phase, patients with PIK3CA-altered advanced solid tumors received once-daily or twice-daily oral alpelisib on a continuous schedule.",
        "In the dose-expansion phase, patients with PIK3CA-altered solid tumors and PIK3CA-wild-type, estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer received alpelisib 400 mg once daily.",
        "In patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer, median progression-free survival was 5.5 months.",
        "Objective tumor responses were observed at doses \u2265 270 mg once daily; overall response rate was 6.0% (n = 8; one patient with endometrial cancer had a complete response, and seven patients with cervical, breast, endometrial, colon, and rectal cancers had partial responses).",
        "Frequently mutated genes (\u2265 10% tumors) included TP53 (51.3%), APC (23.7%), KRAS (22.4%), ARID1A (13.2%), and FBXW7 (10.5%).",
        "Stable disease was achieved in 70 (52.2%) patients and was maintained &gt; 24 weeks in 13 (9.7%) patients; disease control rate (complete and partial responses and stable disease) was 58.2%.",
        "Conclusion Alpelisib demonstrated a tolerable safety profile and encouraging preliminary activity in patients with PIK3CA-altered solid tumors, supporting the rationale for selective PI3K\u03b1 inhibition in combination with other agents for the treatment of PIK3CA-mutant tumors.",
        "Nine patients (13.2%) in the dose-escalation phase had dose-limiting toxicities of hyperglycemia (n = 6), nausea (n = 2), and both hyperglycemia and hypophosphatemia (n = 1).",
        "Frequent all-grade, treatment-related adverse events included hyperglycemia (51.5%), nausea (50.0%), decreased appetite (41.8%), diarrhea (40.3%), and vomiting (31.3%).",
        "Results One hundred thirty-four patients received treatment.",
        "Alpelisib maximum tolerated doses were established as 400 mg once daily and 150 mg twice daily."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29563327": [
        "Although inhibition of phosphoinositide 3-kinase (PI3K) is an emerging strategy in cancer therapy, we and others have reported that this action can also contribute to drug-induced QT prolongation and arrhythmias by increasing cardiac late sodium current (I<sub>NaL</sub>).",
        "The inclusion of water-soluble PIP3, a downstream effector of the PI3K signaling pathway, in the pipette solution reversed these arrhythmogenic effects.",
        "By contrast, inhibition of PI3K-<i>\u03b2</i>, -<i>\u03b3</i>, and -<i>\u03b4</i> isoforms did not alter I<sub>NaL</sub> or APs.",
        "These results highlight a mechanism underlying potential cardiotoxicity of PI3K-<i>\u03b1</i> inhibitors.",
        "Previous studies in mice implicate the PI3K-<i>\u03b1</i> isoform in arrhythmia susceptibility.",
        "Chronic exposure (10-100 nM; 5-48 hours) to PI3K-<i>\u03b1</i>-specific subunit inhibitors BYL710 (alpelisib) and A66 and a pan-PI3K inhibitor (BKM120) increased I<sub>NaL</sub> in <i>SCN5A</i>-transfected CHO cells and mouse cardiomyocytes.",
        "The specific inhibitors (10-100 nM for 5 hours) markedly prolonged APs and generated triggered activity in mouse cardiomyocytes (9/12) but not in controls (0/6), and BKM120 caused similar effects (3/6).",
        "We conclude that inhibition of cardiac PI3K-<i>\u03b1</i> is arrhythmogenic by increasing I<sub>NaL</sub> and this effect is not seen with inhibition of other PI3K isoforms.",
        "Here, we have determined the effects of new anticancer drugs targeting specific PI3K isoforms on I<sub>NaL</sub> and action potentials (APs) in mouse cardiomyocytes and Chinese hamster ovary cells (CHO)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29789630": [
        "In summary, ribociclib is active in NPC models and the effect on growth inhibition was augmented when combined with alpelisib.",
        "(IC<sub>50</sub> concentrations: HK1 = 1.42 \u00b1 0.23 \u00b5M; HK1-LMP1 = 2.18 \u00b1 0.70 \u00b5M and C666-1 = 8.26 \u00b1 0.92 \u00b5M).",
        "This study evaluated the preclinical activities of ribociclib in NPC cell lines and patient derived xenograft (PDX) models.",
        "Treatment with ribociclib for 48 hours consistently showed a dose-dependent reduction in phosphorylated and total RB expression and G<sub>1</sub> cycle arrest was only observed.",
        "Over 95% cell growth inhibition was observed at 96 hours after ribociclib treatment.",
        "Ribociclib is a specific cyclin dependent kinase (Cdk) 4/6 inhibitor that induces G<sub>1</sub> arrest by blocking the formation of cyclin D1-Cdk4/6 complex and inhibiting retinoblastoma (RB) phosphorylation.",
        "Combining ribociclib with the alpha-specific PI3K inhibitor alpelisib showed a synergistic effect in two NPC PDX models in nude mice.",
        "Cyclin D1 is overexpressed in over 90% of nasopharyngeal carcinoma (NPC) and CCND1 gene activation plays a critical role in NPC pathogenesis.",
        "HK1 and C666-1 cells were chosen for analysis of ribociclib on kinase signaling, apoptosis and cell cycle.",
        "This study supports the clinical evaluation of ribociclib in NPC.",
        "The co-treatment induced a significant reduction in tumor volume in both xeno-666 and xeno-2117 compared with ribociclib treatment alone and control (p &lt; 0.01)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29850984": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Activation of the phosphoinositide 3-kinase (PI3K) pathway is an important resistance mechanism to anti-HER2 therapies.",
        "This study aimed to assess the safety and activity of alpelisib (a PI3K\u03b1 isoform-specific inhibitor) with T-DM1 in trastuzumab- and taxane-resistant HER2-positive MBC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27126994": [
        "This phase Ib study evaluated alpelisib plus letrozole's safety, tolerability, and preliminary activity in patients with metastatic ER<sup>+</sup> breast cancer refractory to endocrine therapy.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Alpelisib, a selective oral inhibitor of the class I PI3K catalytic subunit p110\u03b1, has shown synergistic antitumor activity with endocrine therapy against ER<sup>+</sup>/PIK3CA-mutated breast cancer cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28852212": [
        "We explored whether PI3K inhibitors, buparlisib and alpelisib, enhance the efficacy of tamoxifen against ER-positive BC cells.",
        "Tamoxifen is the standard first-line hormonal therapy for premenopausal women with estrogen receptor (ER)-positive metastatic breast cancer (BC).",
        "One of the crucial mechanisms underlying hormonal therapy resistance is the collateral activation of the phosphatidylinositol-3 kinase (PI3K)/AKT pathway.",
        "In the MCF-7 cells transfected with a constitutive active (myristoylated) AKT1 construct or mutant ER, the synergistic effect between alpelisib and tamoxifen was markedly attenuated, indicating that synergism depends on AKT inhibition or normally functioning ER.",
        "Combining alpelisib or buparlisib with tamoxifen also attenuated MCF-7 tumor growth in Balb/c nude mice.",
        "Our data suggest that additional PI3K blockade might be effective in enhancing the therapeutic effect of tamoxifen in ER-positive BC and support the rationale combination in clinical trials.",
        "We have observed a synergism between alpelisib or buparlisib and tamoxifen in the treatment for ER-positive BC cell lines harboring different PI3K alterations.",
        "Immunoblotting analysis showed alpelisib, buparlisib, or either drug in combination with tamoxifen downregulated the PI3K downstream targets in the MCF-7 and ZR75-1 cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26793003": [
        "PI3K inhibitors, including the pan-PI3K inhibitor buparlisib (BKM120) and the PI3K\u03b1-selective inhibitor alpelisib (BYL719), currently in clinical development by Novartis Oncology, may therefore be effective as anticancer agents.",
        "An overview of Novartis-sponsored and Novartis-supported trials that are utilizing these approaches in a range of cancer types, including breast cancer, head and neck squamous cell carcinoma, non-small cell lung carcinoma, lymphoma, and glioblastoma multiforme, is also described.",
        "However, a number of unanswered questions regarding PI3K inhibition in cancer remain, including: what is the best approach for different tumor types, and which biomarkers will accurately identify the patient populations most likely to benefit from specific PI3K inhibitors?",
        "This review summarizes the strategies being employed by Novartis Oncology to help maximize the benefits of clinical studies with buparlisib and alpelisib, including stratification according to PI3K pathway activation status, selective enrollment/target enrichment (where patients with PI3K pathway-activated tumors are specifically recruited), nonselective enrollment with mandatory tissue collection, and enrollment of patients who have progressed on previous targeted agents, such as mTOR inhibitors or endocrine therapy.",
        "The PI3K-AKT-mTOR pathway is frequently activated in cancer.",
        "Early clinical studies with PI3K inhibitors have demonstrated preliminary antitumor activity and acceptable safety profiles."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28363909": [
        "The MTD was not reached for either group and the phase II doses were selected as 200 mg encorafenib (both groups) and 300 mg alpelisib.",
        "Dose-limiting toxicities were reported in 3 patients receiving dual treatment and 2 patients receiving triple treatment.",
        "Patients with refractory <i>BRAF</i><sup>V600</sup>-mutant metastatic CRC (mCRC) were treated with a selective RAF kinase inhibitor (encorafenib) plus a monoclonal antibody targeting EGFR (cetuximab), with (<i>n</i> = 28) or without (<i>n</i> = 26) a PI3K\u03b1 inhibitor (alpelisib).",
        "The primary objective was to determine the maximum tolerated dose (MTD) or a recommended phase II dose.",
        "Combinations of cetuximab and encorafenib showed promising clinical activity and tolerability in patients with <i>BRAF</i>-mutant mCRC; confirmed overall response rates of 19% and 18% were observed and median progression-free survival was 3.7 and 4.2 months for the dual- and triple-therapy groups, respectively.<b>Significance:</b> Herein, we demonstrate that dual- (encorafenib plus cetuximab) and triple- (encorafenib plus cetuximab and alpelisib) combination treatments are tolerable and provide promising clinical activity in the difficult-to-treat patient population with <i>BRAF</i>-mutant mCRC. <i>Cancer Discov; 7(6); 610-9. \u00a92017 AACR.</i><i>See related commentary by Sundar et al., p. 558</i><i>This article is highlighted in the In This Issue feature, p. 539</i>.",
        "Preclinical evidence suggests that concomitant BRAF and EGFR inhibition leads to sustained suppression of MAPK signaling and suppressed tumor growth in <i>BRAF</i><sup>V600E</sup> colorectal cancer models."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30167089": [
        "For the dose-finding phase, the primary objective was determination of maximum tolerated and/or recommended Phase II dose of alpelisib plus paclitaxel, and the secondary objectives included the assessment of safety for this combination.",
        "We assessed the safety and activity of alpelisib, an oral, selective PI3K p110\u03b1 inhibitor, plus paclitaxel in patients with advanced solid tumors.",
        "Phosphatidylinositol 3-kinase (PI3K) pathway activation is associated with resistance to paclitaxel in solid tumors.",
        "This Phase Ib, multicenter, open-label, dose-finding study, with a planned dose-expansion phase of alpelisib once daily (QD) plus fixed-dose paclitaxel, recruited patients with advanced solid tumors.",
        "The MTD of alpelisib when administered with paclitaxel was 150 mg QD.",
        "Alpelisib plus paclitaxel has a challenging safety profile in patients with advanced solid tumors.",
        "This study was closed following the completion of the dose-finding phase.",
        "From March 2014 to August 2016, 19 patients with advanced solid tumors were treated with alpelisib QD (300 mg, n=6; 250 mg, n=4; 150 mg, n=9) plus paclitaxel (80 mg/m<sup>2</sup>, per standard of care).",
        "The planned dose-expansion phase was not initiated.",
        "Most frequent all-grade AEs were diarrhea (73.7%; Grade 3/4 10.5%) and hyperglycemia (57.9%; Grade 3/4 31.6%).",
        "During dose finding, five of 12 (41.7%) evaluable patients for MTD determination experienced dose-limiting toxicities: alpelisib 300 mg, Grade 2 hyperglycemia (n=1); alpelisib 250 mg, Grade 2 hyperglycemia (n=1), Grade 4 hyperglycemia and Grade 3 acute kidney injury (n=1); and alpelisib 150 mg, Grade 2 hyperglycemia (n=1) and Grade 4 leukopenia (n=1)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28984872": [
        "The three p53 family members, p53, p63 and p73, are structurally similar and share many biochemical activities.",
        "Here, we review interactions between the p53 and Hippo pathways within a subset of physiological contexts, focusing on normal stem cells and development, as well as regulation of apoptosis, senescence and metabolism in transformed cells.",
        "Similar to the p53 family, the Hippo signaling pathway impacts a multitude of cellular processes, spanning from cell cycle and metabolism to development and tumor suppression.",
        "This generates multiple layers of interaction, ranging from interdependent and collaborative signaling to apparent antagonistic activity.",
        "The core Hippo module consists of the tumor-suppressive MST-LATS kinases and oncogenic transcriptional co-effectors YAP and TAZ.",
        "This strengthens the need to better understand the nuances that control the molecular function of each component and the cross-talk between the different components.",
        "A wealth of accumulated data suggests a complex and delicate regulatory network connecting the p53 and Hippo pathways, in a highly context-specific manner.",
        "Yet, along with their common fundamental role in protecting genomic fidelity, each has acquired distinct functions related to diverse cell autonomous and non-autonomous processes.",
        "Furthermore, genetic and epigenetic alterations can disrupt this homeostatic network, paving the way to genomic instability and cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28937686": [
        "Second, p53 is able to translocate to the mitochondria, where it interacts with BCL-2 family members to induce membrane permeabilization and cytochrome c release. p53 transcriptional activity is regulated by a set of post-translational modifications that have been well documented.",
        "The S392A mutant displayed normal transcriptional activity following genotoxic stress, but markedly impaired ability to localize to mitochondria.",
        "In this study, we focused on the role of serine 392 phosphorylation in the control of p53-dependent apoptosis.",
        "The decreased mitochondrial localization of the S392A mutant correlated with a lower ability to induce apoptosis.",
        "We used CRISPR/Cas9 genome editing to substitute serine 392 by a non-phosphorylatable alanine in HCT-116 colon carcinoma cells.",
        "Our observations support the premise that serine 392 phosphorylation of p53 influences its mitochondrial translocation and transcription-independent apoptotic function.",
        "However, how these modifications impact the direct mitochondrial pathway of death remain poorly understood.",
        "Confirmatory observations were made following enforced expression of the S392A p53 mutant or a phospho-mimetic S392E mutant in H1299 lung carcinoma cells.",
        "First, p53 acts as a transcription factor inducing and repressing pro-apoptotic and anti-apoptotic targets genes, respectively.",
        "The tumor suppressor p53 is a key regulator of apoptosis induced by various cellular stresses. p53 can induce apoptosis by two mechanisms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28749203": [
        "Stable knockdown of NOXA completely abrogates PARP cleavage and reduces sub-G1 content, implicating NOXA as the key mediator of cell death induction by CB002.",
        "Cells exposed to CB002 show increased expression of endogenous p53 target genes NOXA, DR5, and p21 and cell death which occurs by 16 hours, as measured by cleaved caspases or PARP.",
        "Direct functional restoration of p53 as a transcription factor has been difficult to achieve in the clinic.",
        "In summary, CB002, a p53 pathway-restoring compound that targets mutant p53 for degradation and induces tumor cell death through NOXA, may be further developed as a cancer therapeutic.",
        "P53 tumor suppressor gene mutations occur in the majority of human cancers and contribute to tumor development, progression and therapy resistance.",
        "We identified CB002, as a candidate that restores p53 function in mutant p53-expressing colorectal cancer cells and without toxicity to normal human fibroblasts.",
        "We performed a functional screen using a bioluminescence-based transcriptional read-out to identify small molecules that restore the p53 pathway in mutant p53-bearing cancer cells.",
        "Moreover, CB002 decreases the stability of mutant p53 in RXF393 cancer cells and an exogenously expressed R175H p53 mutant in HCT116 p53-null cells.",
        "R175H p53 expression was rescued by addition of proteasome inhibitor MG132 to CB002, suggesting a role for ubiquitin-mediated degradation of the mutant protein."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29242642": [
        "The high frequency of TP53 mutation in tumours has prompted efforts to restore normal function of mutant p53 and thereby trigger tumour cell death and tumour elimination.",
        "This Review discusses recent progress in pharmacological reactivation of mutant p53 and highlights problems and promises with these strategies.",
        "Small molecules that can reactivate missense-mutant p53 protein have been identified by different strategies, and two compounds are being tested in clinical trials.",
        "The tumour suppressor gene TP53 is the most frequently mutated gene in cancer.",
        "Novel approaches for targeting TP53 nonsense mutations are also underway.",
        "Wild-type p53 can suppress tumour development by multiple pathways.",
        "However, mutation of TP53 and the resultant inactivation of p53 allow evasion of tumour cell death and rapid tumour progression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25808831": [
        "An otic suspension of finafloxacin (Xtoro\u2122), developed by Alcon (a division of Novartis), was recently approved in the USA for the treatment of acute otitis externa, and a Common Technical Document for this indication was also filed in Canada.",
        "It is being developed by MerLion Pharmaceuticals to treat serious bacterial infections associated with an acidic environment, including urinary tract infections and Helicobacter pylori infections.",
        "This article summarizes the milestones in the development of finafloxacin leading to this first approval for otitis externa.",
        "Oral and/or intravenous formulations are in phase I and II evaluation in uncomplicated urinary tract infections (Germany and Singapore), complicated urinary tract infections and pyelonephritis (Germany and Poland) and H. pylori infection (Germany).",
        "Finafloxacin is a fluoroquinolone antimicrobial agent that exhibits optimum efficacy in slightly acidic environments."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26523632": [
        "By steric hindrance, it can also inhibit interactions between the protein drug and proteases as well as the host immune system, thereby inhibiting inactivation of the PEGylated protein and also attenuating its immunogenicity.",
        "Unfortunately, the effect of steric hindrance also applies to protein drug-target interaction, leading to a (partial) loss of efficacy.",
        "Moreover, it can modify the pharmacokinetic profile of the PEGylated protein by delaying renal excretion, leading to a longer half-life (t1/2) of the drug.",
        "It has the potential to significantly delay aggregation of the protein by steric shielding, a frequently encountered issue in the development of protein drugs.",
        "Attachment of a chain of poly(ethylene glycol) (PEG) to a therapeutic protein, a process widely known as PEGylation, can lead to several beneficial effects.",
        "In order to avoid this undesirable effect, several efforts have been made to link PEG to a protein in a noncovalent way, providing the protein with several of the beneficial effects of PEGylation while also taking advantage of its native affinity to its target."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28782513": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      To compare the effect of elevated intraocular pressure (IOP) on retinal capillary filling in elderly vs adult rats using optical coherence tomography angiography (OCTA)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28677229": [
        "<strong class=\"sub-title\">\n          Importance:\n        </strong>\n      \n      Optical coherence tomography is used routinely in management of diabetic eye disease but has not been evaluated in Australian outreach settings for screening programmes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29111842": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      To evaluate the ability of new Swept source (SS) optical coherence tomography (OCT) technology to detect changes in retinal and choroidal thickness in patients with Parkinson's disease (PD)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29396390": [
        "MATERIAL AND METHODS The 3D-OCT examination of 25 cases of VKH was performed on the macular area, and the image characteristics were analyzed.",
        "According to OCT B-scan images, 49 (98%) eyes had ERD, 49 (98%) eyes had nerve retinal edema, 36 (72%) eyes had endometrium-like structure (including cysts), 5 (10%) eyes had RPE folds, 35 (70%) eyes had changes in the internal septum, 49 (98%) eyes had RPE monolayer structure outside the ERD region.",
        "The ILM contour graph showed abnormal uplift, and RPE surface wavy ups and downs in VKH most likely to occur.",
        "RESULTS Our study included a total of 50 eyes from 25 cases of VKH patients, 10 males and 15 females, aged 17 to 64 years, mean (39.44\u00b111.60) years old.",
        "In ILM contour figure, 50 eyes (100%) showed exceptional uplift, 5 (10%) eyes had small focal uplift for PED on the RPE surface, and 48 (96%) eyes had wavy ups and downs.",
        "BACKGROUND This study analyzed the macular 3D-OCT images of Vogt-Koyanagi-Harada disease (VKH) in uveitis, explored the characteristics of 3D-OCT images of the macular region of VKH, and assessed which characteristics contribute most to VKH diagnosis.",
        "CONCLUSIONS In OCT B-scan imaging, the ERT, retinal edema of the retina, and the RPE monolayer structure outside the range are most likely to occur in VKH.",
        "In ILM-RPE thickness, 49 (98%) eyes had retinal irregular thickening and 31 (62%) eyes had radial stripe changes.",
        "The ILM-RPE thickness chart in 3D reconstruction showed irregular thickening of the retina."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20542136": [
        "In addition, innovative methods for image display, such as C-mode sectioning, provide a unique viewing perspective and may improve interpretation of OCT images of pathologic structures.",
        "Recent technological improvements have made the acquisition of 3D-OCT datasets feasible.",
        "Three dimensional (3D) ophthalmic imaging using optical coherence tomography (OCT) has revolutionized assessment of the eye, the retina in particular.",
        "This review describes the current status of 3D-OCT scanning and interpretation, and discusses the need for standardization of clinical protocols as well as the potential benefits of 3D-OCT scanning that could come when software methods for fully exploiting these rich datasets are available clinically.",
        "Fundamental software improvements include methods for correcting subject eye motion, segmenting structures or volumes of interest, extracting relevant data post hoc and signal averaging to improve delineation of retinal layers.",
        "The implications of new image analysis approaches include improved reproducibility of measurements garnered from 3D-OCT, which may then help improve disease discrimination and progression detection.",
        "While all of these methods are being developed, most remain in an immature state.",
        "However, while volumetric data can improve disease diagnosis and follow-up, novel image analysis techniques are now necessary in order to process the dense 3D-OCT dataset.",
        "In addition, 3D-OCT offers the potential for preoperative surgical planning and intraoperative surgical guidance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25606299": [
        "Glaucoma is an ocular disease characterized by distinctive changes in the optic nerve head (ONH) and visual field.",
        "In this context, important advances in technology for non-invasive imaging of the eye have been made providing quantitative tools to measure structural changes in ONH topography, an essential element for glaucoma detection and monitoring.",
        "3D spectral domain optical coherence tomography (SD-OCT), an optical imaging technique, has been commonly used to discriminate glaucomatous from healthy subjects.",
        "To accommodate the presence of false positive detection, the estimated change detection map is then used to classify a 3D SDOCT image into the \"non-progressing\" and \"progressing\" glaucoma classes, based on a fuzzy logic classifier.",
        "In contrast to previous works that the retinal nerve fiber layer (RNFL) thickness measurement provided by commercially available spectral-domain optical coherence tomograph, we consider the whole 3D volume for change detection.",
        "Therefore, early disease detection is important so that treatment can be initiated and blindness prevented.",
        "In this paper, we present a new framework for detection of glaucoma progression using 3D SD-OCT images.",
        "We compared the diagnostic performance of the proposed framework to existing methods of progression detection.",
        "Glaucoma can strike without symptoms and causes blindness if it remains without treatment.",
        "To integrate a priori knowledge and in particular the spatial voxel dependency in the change detection map, we propose the use of the Markov Random Field to handle a such dependency."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25570836": [
        "Important advances in technology for non-invasive imaging of the eye have been made providing quantitative tools to measure structural changes in ONH topography, a crucial step in diagnosing and monitoring glaucoma.",
        "To estimate the optic disc size and rim area, we propose the use of a new regression method based on the artificial neural network principal component analysis (ANN-PCA), which allows us to model irregularity in the BMO estimation due to scan shifts and/or poor image quality.",
        "In this paper, we present a new approach for locating the Bruch's membrane opening BMO and then estimating the optic disc size and rim area of 3D Spectralis SD-OCT images.",
        "3D spectral domain optical coherence tomography (SD-OCT), an optical imaging technique, has been commonly used to discriminate glaucomatous from healthy subjects.",
        "Glaucoma is a chronic neurodegenerative disease characterized by loss of retinal ganglion cells, resulting in distinctive changes in the optic nerve head (ONH) and retinal nerve fiber layer (RNFL).",
        "To deal with the overlapping of the Bruch's membrane BM layer and the border tissue of Elschnig due to the poor image resolution, we propose the use of image deconvolution approach to separate these layers.",
        "The diagnostic accuracy of rim area, and rim to disc area ratio is compared to the diagnostic accuracy of global RNFL thickness measurements provided by two commercially available SD-OCT devices using receiver operating characteristic curve analyses."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28304075": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Steroids have been widely used to treat inner-ear diseases such as sudden sensorineural hearing loss, tinnitus, and Meniere's disease.",
        "The purpose of the present study was to explore differences in intracochlear steroid distribution by the administration method employed (systemic vs. IT injection).",
        "They can be given via either systemic or intratympanic (IT) injection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28760332": [
        "These cases are thought to account for 10%-20% of all cases of Meniere's disease.",
        "Meniere's disease is an inner ear disease, characterized by recurrent rotatory vertigo, sensorineural hearing loss and tinnitus.",
        "There are some with frequent vertigo attacks, progressive hearing loss and persistent annoying tinnitus even through the continuous standard medical treatments.",
        "In this review article, we would like to demonstrate the evidences for surgical treatments according to the previous papers, and consider the next therapeutic strategies including surgical options according to the international guidelines."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29283101": [
        "The aims of this study were to develop a disease-specific quality of life survey for patients with MD and to analyze the relationships between the audiovestibular findings and the survey.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      M\u00e9ni\u00e8re's Disease (MD) is a chronic, non-life threatening inner ear disease, with attacks of disabling vertigo, progressive hearing loss, and tinnitus as the major symptoms.",
        "All three symptoms, separately or in combination, cause great distress and have a considerable impact on the quality of life of the patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21319945": [
        "The position of the utriculo-endolymphatic valve (UEV) and blockage of the ductus reuniens in the temporal bones were not found to be directly indicative of Meniere's disease.",
        "<strong class=\"sub-title\">\n          Conclusion:\n        </strong>\n      \n      Blockage of the endolymphatic duct is a significant finding in Meniere's disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12486835": [
        "The course of the disease may be progressive or nonprogressive and, in addition to the typical presentation of Meniere's disease, two variations of the disorder have been identified: cochlear Meniere's disease, and vestibular Meniere's disease.",
        "The pathologic correlate of Meniere's disease is endolymphatic hydrops and the etiopathogenesis involves a deficiency in the absorption of endolymph.",
        "Meniere's disease is a disease of the inner ear characterized by a triad of symptoms: vestibular symptoms, auditory symptoms, and pressure.",
        "Its medical treatment is largely empiric.",
        "Bilaterality must be considered when deciding the best surgical option for a patient with Meniere's disease.",
        "The pathophysiology of the symptoms is still disputed: membranous ruptures, pressure and mechanical displacement of the end organs, or obstruction followed by an abrupt clearance of the endolymphatic duct.",
        "The diagnosis of Meniere's disease is by exclusion, and a careful history is the most important guide to a correct diagnosis.",
        "It can be further broken into two subsets: Meniere's syndrome, with a known and well-established cause, and Meniere's disease, in which the cause seems to be idiopathic.",
        "It is likely that there are racial (genetic) as well as environmental factors that influence differences in incidence among countries and among various sections of countries.",
        "Surgery may be either conservative or destructive.",
        "The disease is much more common in adults, with an average age of onset in the fourth decade, the symptoms beginning usually between ages 20 and 60 years.",
        "Surgery can be considered when, even after medical therapy, the disease progresses and the symptoms become intractable.",
        "Meniere's disease is (grossly) equally common in each sex, and right and left ears are affected with fairly equal frequency.",
        "It is the authors' opinion that endolymphatic sac surgery is an extension of conservative treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28929412": [
        "It has also been approved by the US FDA for the treatment of adult patients with chronic HCV genotype 1-6 infection without cirrhosis and with compensated cirrhosis, and for the treatment of adult patients with HCV genotype 1 infection who previously have been treated with a regimen containing either an HCV NS5A inhibitor or an NS3/4A PI, but not both.",
        "This article summarizes the milestones in the development of glecaprevir/pibrentasvir leading to its first global approval in the EU and subsequent approval in the USA for chronic HCV infection.",
        "Oral glecaprevir/pibrentasvir 300 mg/120 mg (three 100 mg/40 mg tablets) taken once daily has been approved by the EMA for the treatment of all major genotypes (genotypes 1-6) of chronic HCV infection in adults.",
        "A fixed-dose combination tablet of the hepatitis C virus (HCV) NS3/4A protease inhibitor (PI) glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/pibrentasvir; MAVIRET\u2122 (EU); MAVYRET\u2122 (USA)] has been developed by AbbVie."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29089721": [
        "Aminolevulinic acid hydrochloride (Gleolan) for the visualization of malignant tissue during surgery; delafloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir/pibrentasvir (Mavyret) for chronic HCV infection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29374165": [
        "Our results on four targets ranging in size from 15.5 to 27.3 kDa illustrate that the structures of proteins can be determined accurately and in an unsupervised manner in a matter of days.",
        "The 4D-CHAINS assignments are then used to guide automated assignment of long-range NOEs and structure refinement in autoNOE-Rosetta.",
        "The 4D-CHAINS algorithm analyzes two 4D spectra recorded using a single, fully protonated protein sample in an iterative ansatz where common NOEs between different spin systems supplement conventional through-bond connectivities to establish assignments of sidechain and backbone resonances at high levels of completeness and with a minimum error rate.",
        "Automated methods for NMR structure determination of proteins are continuously becoming more robust.",
        "However, current methods addressing larger, more complex targets rely on analyzing 6-10 complementary spectra, suggesting the need for alternative approaches.",
        "Here, we describe 4D-CHAINS/autoNOE-Rosetta, a complete pipeline for NOE-driven structure determination of medium- to larger-sized proteins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29174804": [
        "As an intermediate model, tumor organoids are also used to study the fundamental issues of tumorigenesis and metastasis.",
        "Organoids are a three-dimensional in vitro culture platform constructed from self-organizing stem cells.",
        "Thus far, our comprehension is greatly based on cell lines, organoids, and patient-derived tumor xenografts (PDTXs).",
        "They can almost accurately recapitulate tumor heterogeneity and microenvironment \"in a dish,\" which surpass established cell lines and are not as expensive and time-consuming as PDTXs.",
        "They are specifically applied for drug testing and stored as \"living biobanks.\"",
        "In this review, we highlight the translational applications of organoid technologies in tumor research and precision medicine, discuss the advantages and limitations compared with other mentioned methods, and provide our outlook on its future.",
        "Cancer harbors variable heterogeneity and plasticity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30324441": [
        "In addition, we provide details of how to process retinal organoids for single organoid gene expression analysis, immunohistochemistry, and electron microscopy.",
        "Further, retinal organoids also provide an unlimited cell source for cell replacement therapies.",
        "Here, we describe our protocol for efficiently differentiating large, stratified retinal organoids from mouse embryonic stem cells: unbiased manual dissection of the developing retinal organoid at an early stage into three evenly sized neuroepithelial portions (trisection step) doubles the yield of high-quality organoids.",
        "We also describe some useful applications of the protocol, e.g., generation of rod- or cone-enriched retinal organoids, AAV transfection, and cell birth dating.",
        "The introduction of stem cell-based technologies for the derivation of three-dimensional retinal tissues, the so-called retinal organoids, offers many new possibilities for vision research: Organoids facilitate studies on retinal development and in vitro retinal disease modeling, as well as being valuable for drug testing."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30510992": [
        "<strong class=\"sub-title\">\n          Background &amp; aims:\n        </strong>\n      \n      Oropharyngeal and esophageal squamous cell carcinomas, especially the latter, are a lethal disease, featuring intratumoral cancer cell heterogeneity and therapy resistance.",
        "We investigated the feasibility and the utility of patient-derived 3D organoids of esophageal and oropharyngeal squamous cell carcinomas.",
        "To facilitate cancer therapy in personalized medicine, three-dimensional (3D) organoids may be useful for functional characterization of cancer cells <i>ex vivo</i>."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29202274": [
        "HFD feeding substantially increased body weight, which was alleviated by RB supplementation towards the end of the feeding trial.",
        "Dietary RB restored the baseline blood glucose level, ameliorating glucose intolerance and insulin resistance, which were aggravated by HFD.",
        "Wild-type male mice (six weeks old) were randomized into 4 groups receiving a control or typical western HFD supplemented with or without 5% freeze-dried RB for 12 weeks, when mice were sacrificed for tissue collection.",
        "Red raspberry (RB) contains high amounts of dietary fibers and polyphenolic compounds, which are known for their anti-oxidative and anti-inflammatory effects.",
        "The liver is the key site for energy metabolism and a key peripheral tissue responsive to insulin.",
        "The NLR family pyrin domain containing 3 (NLRP3) inflammasome plays a critical role in insulin resistance and the pathogenesis of type 2 diabetes.",
        "RB supplementation reduced hepatic lipid accumulation in HFD mice.",
        "Thus, dietary RB intake is a promising strategy for ameliorating diet-induced metabolic abnormalities.",
        "This study evaluated the preventive effects of RB supplementation on the NLRP3 inflammasome activation and associated metabolic abnormalities induced by high fat diet (HFD).",
        "These results suggest that RB consumption improves insulin resistance and metabolic dysfunction in diet-induced obesity, which is concomitant with suppression of NLRP3 inflammasome elicited by HFD.",
        "Additionally, HFD reduced O<sub>2</sub> expenditure and CO<sub>2</sub> production, which were ameliorated by RB consumption.",
        "In agreement, RB consumption suppressed hepatic NLRP3 inflammasome activation and reduced interleukin (IL)-1\u03b2 and IL-18 production in HFD mice, accompanied with normalized mitochondriogenesis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27102896": [
        "The one of the main purposes of research was to evaluate the comparative data of the MSC transplantation with (5-azacytidine) and without commitment and to assess the post transplantation effects.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Current experimental research has proven the efficacy of transplantation bone marrow-derived mesenchymal stem cells (MSC) in the treatment of myocardial infarction (MI)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19886822": [
        "This similarity is irrespective of promoter CpG content.",
        "To what extent epigenetic information on promoters of lineage-specification genes in human progenitors influences transcriptional activation and differentiation potential remains unclear.",
        "Thus, only part of the restriction in differentiation capacity of tissue-specific stem cells is programmed by promoter DNA methylation: hypermethylation seems to constitute a barrier to differentiation, however, no or weak methylation has no predictive value for differentiation potential.",
        "We produced bisulfite sequencing maps of DNA methylation in adipogenic, myogenic, and endothelial promoters in relation to gene expression and differentiation capacity, and unravel a similarity in DNA methylation profiles between MSCs isolated from human adipose tissue, bone marrow (BM), and muscle.",
        "Moreover, in vitro MSC differentiation does not affect lineage-specific promoter methylation states, arguing that these methylation patterns in differentiated cells are already established at the progenitor stage.",
        "Further, we find a correlation between lineage-specific promoter hypermethylation and lack of differentiation capacity toward that lineage, but no relationship between weak promoter methylation and capacity of transcriptional activation or differentiation.",
        "Mesenchymal stem cells (MSCs) can differentiate into multiple mesodermal cell types in vitro; however, their differentiation capacity is influenced by their tissue of origin.",
        "Methylation patterns of MSCs are distinct from those of hematopoietic progenitor cells (HPCs), pluripotent human embryonic stem cells (hESCs), and multipotent hESC-derived mesenchymal cells (MCs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28944989": [
        "In this MiniReview, we describe the pharmacokinetics and pharmacodynamics, efficacy and side effects of the combined angiotensin receptor antagonist and neprilysin inhibitor LCZ696.",
        "LCZ696 was superior to enalapril in reducing mortality, hospitalizations and HF symptoms.",
        "A novel antihypertensive drug, LCZ696 (Entresto\u00ae), has recently been introduced, which combines the action of an antagonist of the renin-angiotensin-aldosterone system (RAAS), effectively decreasing the blood pressure, with an inhibition of neprilysin, which is responsible for metabolizing natriuretic peptides exerting antihypertensive and antifibrotic effects.",
        "Adverse effects were reduced with a slower up-titrating regimen of 6 weeks.",
        "In the earlier stages of the treatment of patients with heart failure, LCZ696 was superior in lowering the blood pressure compared to olmesartan, while the effect on blood pressure at long-term treatment was comparable for the two drugs.",
        "However, it needs to be explored whether LCZ696 is safe in pregnant women, what are the effects of long-term LCZ696 treatment on survival and whether the antifibrotic effects can be of major benefit in, for example HF with preserved ejection fraction.",
        "The numbers of adverse effects were comparable.",
        "The current results are promising and suggest that LCZ696 will be a new candidate for first-line treatment of HF.",
        "We summarize the effect of LCZ696 treatment of patients suffering from hypertension and heart failure (HF) and further highlight the role of this new drug as a treatment option in the future."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29469206": [
        "However, the best way to manage SDB in CHF remains a matter of debate.",
        "Sacubitril and valsartan are good candidates for correcting SDB of CHF patients because their known mechanisms of action are likely to counteract the pathophysiology of SDB in CHF.",
        "<strong class=\"sub-title\">\n          Aims:\n        </strong>\n      \n      Sleep-disordered breathing (SDB) is a highly prevalent co-morbidity in patients with chronic heart failure (CHF) and can play a detrimental role in the pathophysiology course of CHF.",
        "Sacubitril-valsartan has been included in the 2016 European Society of Cardiology guidelines as an alternative to angiotensin-converting enzyme inhibitors to further reduce the risk of progression of CHF, CHF hospitalization, and death in ambulatory patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29352367": [
        "Co-crystal prediction, screening, and synthesis have been reported in literature; however, co-crystal production at a larger scale needs further investigations.",
        "This positive change in regulatory perspective coupled with successful commercialization of valsartan-sacubitril co-crystal (Entresto, Novartis) has now brought co-crystals into focus, in both industries as well as academia.",
        "Quality control aspects and regulatory viewpoint crucial for commercial success are elaborated in the future perspective.",
        "This is largely because co-crystals can modify the physicochemical properties of drugs without any covalent modification in the drug molecules.",
        "The US Food and Drug Administration (FDA) now considers drug products that are designed to contain a new co-crystal, analogous to new polymorph of the active pharmaceutical ingredient (API).",
        "In addition, the scale-up issues of continuous and batch co-crystallization and other suitable techniques for pharmaceutical scale up are detailed.",
        "With this aim, the article describes various continuous methods for co-crystal production, along with in-line monitoring during co-crystal production, emphasizing on process analytical technology (PAT).",
        "The last decade has witnessed extensive growth in the field of co-crystallization for mitigating the solubility and dissolution-related issues of poorly soluble drugs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29398176": [
        "This case supports a potent vasodilatory effect of sacubitril/valsartan, and if confirmed by other studies, might warrant consideration for withholding treatment while awaiting HT, particularly in patients with risk factors for vasoplegia.",
        "He was treated with intravenous methylene blue and high-dose vasopressors, but developed acute kidney injury requiring dialysis and a prolonged stay in the intensive care unit.",
        "Vasoplegia occurs in up to 16% of patients who undergo heart transplantation (HT) and is associated with significant morbidity and mortality.",
        "We present a case of a 61-year-old man with ischemic cardiomyopathy receiving sacubitril/valsartan (Entresto; Novartis, Cambridge, MA) who developed profound hypotension after HT."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29532764": [
        "Recently, the Food and Drug Administration (FDA) approved a drug with brand name Entresto (Sacubitril/Valsartan or LCZ696), an angiotensin receptor neprilysin inhibitor for the use in Heart Failure with Reduced Ejection Fraction (HFrEF) patients instead of ACEI's and ARBs.",
        "Many drugs are approved and used in practice for management of this condition; including beta blockers, diuretics, aldosterone antagonists, Angiotensin Converting Enzyme Inhibitors (ACEI's), and Angiotensin Receptor Blockers (ARBs).",
        "The drug works through angiotensin receptor blockage via valsartan as well as neprilysin inhibition with sacubitril.",
        "This article reviews the stages that led to the development of this drug, the failure of its preceding agents, the lessons we have learnt, and the current trials of Entresto for new indications.",
        "Heart Failure (HF) is one of the main healthcare burdens in the United States and in the world.",
        "This represented a new milestone in managing heart failure patients and provided yet another therapy in our armamentarium."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30084228": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The effects of sacubitril/valsartan (S/V) on the renin-angiotensin-aldosterone system (RAAS) in dogs with cardiomegaly secondary to myxomatous mitral valve disease (MMVD) are currently unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28824789": [
        "It is therefore essential that SV treated patients are followed up over an extended period of time to detect any adverse cognitive changes.",
        "This dual action of angiotensin receptors blocker and neprilysin inhibitor (NPi) has improved HF prognosis and it is an evolution in the management of HF.",
        "NPi interferes with the breakdown and clearing of beta-amyloid peptides, the plaques seen in AD, raising concern for AD in SV patients.",
        "Both therapeutic strategies decreases morbidity and mortality but also carry considerable adverse effects.",
        "On the other hand, hypertension and cardiovascular diseases are established risk factors for AD which can be decreased by SV therapy.",
        "This review of the literature highlights the new generation of HF drug, sacubitril-valsartan (SV), trade name Entresto (researched as LCZ696, Novartis) which simultaneously blocks RAAS and NP.",
        "Although the initial follow-up of patients treated with SV has yielded promising results, there are concerns regarding potential side effects especially an increase in the risk of Alzheimer's disease (AD) and young onset of AD.",
        "The main stay pharmacotherapy for heart failure (HF) is targeted towards rennin-angiotensin-aldosterone (RAAS) and neprilysin pathways (NP)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27284124": [
        "\u25bc Sacubitril valsartan (Entresto-Novartis) is a new oral drug licensed for the treatment of symptomatic chronic heart failure in adults with reduced ejection fraction.(1) It is described as an angiotensin receptor neprilysin inhibitor and contains the neprilysin inhibitor, sacubitril and the angiotensin II receptor antagonist, valsartan.(1-3) Here, we review the evidence for sacubitril valsartan and consider its place in the management of heart failure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26417173": [
        "Sacubitril/valsartan (Entresto) for chronic heart failure; brexpiprazole (Rexulti) for major depressive disorder and schizophrenia; and lumacaftor/ivacaftor (Orkambi) for cystic fibrosis involving specific CFTR mutations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30276760": [
        "The corrected paragraph is shown below.",
        "The original version of this article unfortunately contained a mistake.",
        "There was a typo in the second sentence of the paragraph under the section Was the Dose of Drugs Fair?; \"320 mg twice a day\" should read \"160mg twice a day\"."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29554211": [
        "Thus, it is imperative to develop novel, highly accurate in silico sequence-based protein solubility predictors.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Protein solubility plays a vital role in pharmaceutical research and production yield.",
        "For a given protein, the extent of its solubility can represent the quality of its function, and is ultimately defined by its sequence.",
        "In this work we propose, DeepSol, a novel Deep Learning-based protein solubility predictor.",
        "The backbone of our framework is a convolutional neural network that exploits k-mer structure and additional sequence and structural features extracted from the protein sequence."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30286415": [
        "Meanwhile, the current application of generic treatment approaches to patients with vastly differing biological and clinical profiles is far from optimal.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      The heterogeneity of symptoms and complex etiology of depression pose a significant challenge to the personalization of treatment.",
        "While current research is difficult to directly apply to the clinic, machine learning models built using knowledge gleaned from current research may become useful clinical tools.",
        "These machine learning models will allow us to learn associations between patient features and treatment response which have predictive value at the individual patient level; this learning can be optimized by selecting high-quality input features for the model.",
        "Here, we conduct a meta-review to identify predictors of response to antidepressant therapy in order to select robust input features for machine learning models of treatment response."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28702811": [
        "Major depressive disorder (MDD), a debilitating mental illness, could cause functional disabilities and could become a social problem.",
        "The results indicated that the classification rates were better than chance.",
        "The findings could be generalized to develop a robust CAD-based tool that may help for clinical purposes.",
        "More specifically, the study resulted into SVM classification accuracy = 98%, sensitivity = 99.9%, specificity = 95% and f-measure = 0.97; LR classification accuracy = 91.7%, sensitivity = 86.66%, specificity = 96.6% and f-measure = 0.90; NB classification accuracy = 93.6%, sensitivity = 100%, specificity = 87.9% and f-measure = 0.95.",
        "It was hypothesized that EEG-based SL features could discriminate MDD patients and healthy controls with an acceptable accuracy better than measures such as interhemispheric coherence and mutual information.",
        "In conclusion, SL could be a promising method for diagnosing depression.",
        "An accurate and early diagnosis for depression could become challenging.",
        "This paper proposed a machine learning framework involving EEG-derived synchronization likelihood (SL) features as input data for automatic diagnosis of MDD.",
        "In this work, classification models such as support vector machine (SVM), logistic regression (LR) and Na\u00efve Bayesian (NB) were employed to model relationship between the EEG features and the study groups (MDD patient and healthy controls) and ultimately achieved discrimination of study participants."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29879133": [
        "For TRD defined using QIDS-C16 remission criteria, multiple machine learning models were internally cross-validated in the STAR*D training dataset and externally validated in both the STAR*D testing dataset and RIS-INT-93 independent dataset with an area under the receiver operating characteristic curve (AUC) of 0.70-0.78 and 0.72-0.77, respectively.",
        "Identification of risk factors of treatment resistance may be useful to guide treatment selection, avoid inefficient trial-and-error, and improve major depressive disorder (MDD) care.",
        "We extended the work in predictive modeling of treatment resistant depression (TRD) via partition of the data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort into a training and a testing dataset.",
        "Among all the features explored in STAR*D and RIS-INT-93 datasets, the most important feature was early or initial treatment response or symptom severity at week 2.",
        "Model developed using top 30 features identified using feature selection technique (k-means clustering followed by \u03c72 test) achieved an AUC of 0.77 in the STAR*D testing dataset.",
        "We used features from enrollment and level 1 treatment (up to week 2 response only) of STAR*D to explore the feature space comprehensively and applied machine learning methods to model TRD outcome at level 2.",
        "We also included data from a small yet completely independent cohort RIS-INT-93 as an external test dataset.",
        "In addition, the model developed using overlapping features between STAR*D and RIS-INT-93, achieved an AUC of &gt; 0.70 in both the STAR*D testing and RIS-INT-93 datasets.",
        "The upper bound for the AUC achievable with the full set of features could be as high as 0.78 in the STAR*D testing dataset.",
        "These results indicate that prediction of TRD prior to undergoing a second round of antidepressant treatment could be feasible even in the absence of biomarker data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26728563": [
        "A total of 34.6-38.1% of respondents with subsequent high persistence chronicity and 40.8-55.8% with the severity indicators were in the top 20% of the baseline ML-predicted risk distribution, while only 0.9% of respondents with subsequent hospitalizations and 1.5% with suicide attempts were in the lowest 20% of the ML-predicted risk distribution.",
        "Area under the receiver operating characteristic curve based on ML (0.63 for high chronicity and 0.71-0.76 for the other prospective outcomes) was consistently higher than for the logistic models (0.62-0.70) despite the latter models including more predictors.",
        "These results confirm that clinically useful MDD risk-stratification models can be generated from baseline patient self-reports and that ML methods improve on conventional methods in developing such models.",
        "We report results of model validation in an independent prospective national household sample of 1056 respondents with lifetime MDD at baseline.",
        "ML model prediction accuracy was also compared with that of conventional logistic regression models.",
        "Heterogeneity of major depressive disorder (MDD) illness course complicates clinical decision-making.",
        "The WMH ML models were applied to these baseline data to generate predicted outcome scores that were compared with observed scores assessed 10-12 years after baseline.",
        "Although efforts to use symptom profiles or biomarkers to develop clinically useful prognostic subtypes have had limited success, a recent report showed that machine-learning (ML) models developed from self-reports about incident episode characteristics and comorbidities among respondents with lifetime MDD in the World Health Organization World Mental Health (WMH) Surveys predicted MDD persistence, chronicity and severity with good accuracy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22544901": [
        "While feature selection was important for maximizing high predictive accuracy with machine learning, feature characterization contributed only a modest improvement to relevance vector machine-based prediction (~5%).",
        "These results indicate that machine learning techniques have the potential to inform clinical practice and research, as they can make accurate predictions about brain scan data from individual subjects.",
        "Recently, machine learning techniques such as relevance vector machines and support vector machines have been applied to predictive classification of individual scans with variable success.",
        "Quantitative abnormalities of brain structure in patients with major depressive disorder have been reported at a group level for decades.",
        "A total of 62 patients with major depressive disorder and matched controls were recruited from referred secondary care clinical populations in Aberdeen and Edinburgh, UK.",
        "Furthermore, machine learning weighting factors may reflect an objective biomarker of major depressive disorder illness severity, based on abnormalities of brain structure.",
        "However, these structural differences appear subtle in comparison with conventional radiologically defined abnormalities, with considerable inter-subject variability.",
        "The generalization ability and predictive accuracy of the classifiers was tested using data left out of the training process.",
        "Notably, while the only information provided for training the classifiers was T(1)-weighted scans plus a categorical label (major depressive disorder versus controls), both relevance vector machine and support vector machine 'weighting factors' (used for making predictions) correlated strongly with subjective ratings of illness severity.",
        "Consequently, it has not been possible to readily identify scans from patients with major depressive disorder at an individual level.",
        "High prediction accuracy was achieved (~90%).",
        "Here we describe a novel hybrid method, which combines machine learning with feature selection and characterization, with the latter aimed at maximizing the accuracy of machine learning prediction.",
        "The method was tested using a multi-centre dataset of T(1)-weighted 'structural' scans."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25066141": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Although variation in the long-term course of major depressive disorder (MDD) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods.",
        "However, it is not known whether these distinctions can be refined by added information about co-morbid conditions.",
        "The current report presents results on this question."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27551669": [
        "As symptom severity may influence brain activity, we investigated whether the severity of MDD affected the accuracies of machine learned MDD-vs-Control diagnostic classifiers.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Growing evidence documents the potential of machine learning for developing brain based diagnostic methods for major depressive disorder (MDD)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26821982": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      We aimed to integrate neural data and an advanced machine learning technique to predict individual major depressive disorder (MDD) patient severity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28455694": [
        "In CAP participants, there was a strong correlation (r = 0.734, p &lt; 0.001) between root canal LPS and the HDRS score.",
        "Dental health and \"leaky teeth\" may be intimately linked to the etiology and course of depression, while significantly impacting quality of life.",
        "Root canal LPS levels were positively associated with CAP, clinical depression, severity of depression (as measured with the Hamilton Depression Rating Scale (HDRS) and the Beck Depression Inventory) and O&amp;NS biomarkers, especially NOx and TRAP.",
        "CAP-related depression was accompanied by increased levels of NOx, LOOH, AOPP, and TRAP.",
        "Evidence indicates that major depression is accompanied by increased translocation of gut commensal Gram-negative bacteria (leaky gut) and consequent activation of oxidative and nitrosative (O&amp;NS) pathways.",
        "Measurements included advanced oxidation protein products (AOPP), nitric oxide metabolites (NOx), lipid peroxides (LOOH), -sulfhydryl (SH) groups, total radical trapping antioxidant parameter (TRAP), and paraoxonase (PON)1 activity in participants with CAP, with and without depression, as well as healthy controls (no depression, no CAP).",
        "It is concluded that increased root canal LPS accompanying CAP may cause depression and a lowered quality of life, which may be partly explained by activated O&amp;NS pathways, especially NOx thereby enhancing hypernitrosylation and thus neuroprogressive processes.",
        "There were significant and positive associations between CAP or root canal endotoxin with the vegetative and physio-somatic symptoms of the HDRS as well as a significant inverse association between root canal endotoxin and quality of life with strong effects on psychological, environmental, and social domains.",
        "This present study examined the associations among chronic apical periodontitis (CAP), root canal endotoxin levels (lipopolysaccharides, LPS), O&amp;NS pathways, depressive symptoms, and quality of life."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29432299": [
        "Ten patients (age: 18-56 years, five women) who had MDD and a score over 20 on the Hamilton's Depression Scale and 10 healthy controls (age: 24-65 years, five women) group matched for sex, age, and BMI were enrolled.",
        "Abundances of 16 bacterial families were significantly different between the MDD and healthy controls (P&lt;0.05).",
        "Here, a comparative metaproteomics analysis on the basis of an isobaric tag for relative and absolute quantification coupled with tandem mass spectrometry was carried out to explore the signature of gut microbiota in patients with MDD.",
        "However, few studies focusing on detection of the signatures of bacteria in feces of MDD patients using proteomics approach have been carried out.",
        "Furthermore, Cluster of Orthologous Groups analysis and Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that disordered metabolic pathways of bacterial proteins were mainly involved in glucose metabolism and amino acid metabolism.",
        "Major depressive disorder (MDD) is a highly prevalent and debilitating mental illness, which is associated with disorder of gut microbiota.",
        "Our findings provide a novel insight into the potential connection between gut microbiota and depression.",
        "As a result, 279 significantly differentiated bacterial proteins (P&lt;0.05) were detected and used for further bioinformatic analysis.",
        "According to phylogenetic analysis, statistically significant differences were observed for four phyla: Bacteroidetes, Proteobacteria, Firmicutes, Actinobacteria (P&lt;0.05, for each).",
        "In conclusion, fecal microbiota signatures were altered significantly in MDD patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29487059": [
        "In 1996, the relatively frequent occurrence of fms-like tyrosine kinase 3 (<i>FLT3</i>) activating mutations in acute myeloid leukemia (AML) was first recognized.",
        "Despite promising preclinical data, early clinical trials in multiple diseases showed only modest efficacy.",
        "This was the first study to show significant improvements in overall survival and event-free survival with the addition of a targeted therapy to standard chemotherapy in this population.",
        "Around the same time, durable responses were also observed in other trials of midostaurin in patients with advanced SM.",
        "Several years later, midostaurin was discovered to be a potent inhibitor of the FLT3 tyrosine kinase and to have activity against mutant forms of KIT proto-oncogene receptor tyrosine kinase, which drive advanced systemic mastocytosis (SM).",
        "Collectively, these clinical data led to the approval of midostaurin by the US Food and Drug Administration and the European Medicines Agency for both newly diagnosed <i>FLT3</i>-mutated AML and advanced SM.",
        "Midostaurin was a prototype kinase inhibitor, originally developed as a protein kinase C inhibitor and subsequently as an angiogenesis inhibitor, based on its inhibition of vascular endothelial growth factor receptor.",
        "Through a series of collaborations between industry and academia, midostaurin in combination with standard chemotherapy was evaluated in the Cancer and Leukemia Group B 10603/RATIFY study, a large, phase 3, randomized, placebo-controlled trial in patients with newly diagnosed <i>FLT3</i>-mutated AML."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30069632": [
        "Several clinical trials are active or are planned to further investigate the role of midostaurin in myeloid malignancies and mastocytosis.",
        "Midostaurin (PKC412, Rydapt<sup>\u00ae</sup>) is an oral multiple tyrosine kinase inhibitor.",
        "Midostaurin was approved by the Food and Drug Administration (FDA) and the European Medical Agency (EMA) for acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN) or mast cell leukemia (MCL).",
        "Main targets are the kinase domain receptor, vascular endothelial-, platelet derived-, and fibroblast growth factor receptor, stem cell factor receptor c-KIT, as well as mutated and wild-type FLT3 kinases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30214018": [
        "Here, we describe a previously unknown role of GRG5 in early developmental stages by analyzing its function in stem cell fate decisions.",
        "Moreover, GRG5 promotes the neuronal reprogramming of fibroblasts and maintains the self-renewal of Neural Stem Cells (NSCs) by sustaining the activity of Notch/Hes and Stat3 signaling pathways.",
        "In summary, our results demonstrate that GRG5 has pleiotropic roles in stem cell biology functioning as a stemness factor and a neural fate specifier.",
        "When ESCs exit pluripotency, GRG5 promotes neuroectodermal specification via Wnt and BMP signaling suppression.",
        "The malignant characteristics of teratomas generated by ESCs that overexpress GRG5 reveal its pro-oncogenic potential.",
        "By both loss and gain of function approaches we demonstrate that ablation of GRG5 deregulates the Embryonic Stem Cell (ESC) pluripotent state whereas its overexpression leads to enhanced self-renewal and acquisition of cancer cell-like properties.",
        "Groucho related gene 5 (GRG5) is a multifunctional protein that has been implicated in late embryonic and postnatal mouse development.",
        "Furthermore, transcriptomic analysis and cell differentiation approaches underline GRG5 as a multifaceted signaling regulator that represses mesendodermal-related genes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29146575": [
        "Thus studies were conducted to examine the effects of lumacaftor alone and lumacaftor in combination with ivacaftor (i.e., ORKAMBI) on the ability of human CF ( del508Phe/ del508Phe) monocyte-derived macrophages (MDMs) to phagocytose and kill Pseudomonas aeruginosa.",
        "Lumacaftor alone restored the ability of CF MDMs to phagocytose and kill P. aeruginosa to levels observed in MDMs obtained from non-CF (WT-CFTR) donors.",
        "This effect contrasts with the partial (~15%) correction of del508Phe Cl<sup>-</sup> secretion of airway epithelial cells by lumacaftor.",
        "Cystic fibrosis (CF), the most common lethal genetic disease in Caucasians, is characterized by chronic bacterial lung infection and excessive inflammation, which lead to progressive loss of lung function and premature death.",
        "Although ivacaftor (VX-770) alone and ivacaftor in combination with lumacaftor (VX-809) improve lung function in CF patients with the Gly551Asp and del508Phe mutations, respectively, the effects of these drugs on the function of human CF macrophages are unknown.",
        "Ivacaftor (5 \u00b5M) alone and ivacaftor in combination with lumacaftor reduced secretion of several proinflammatory cytokines.",
        "Lumacaftor had no effect on P. aeruginosa-stimulated cytokine secretion by CF MDMs.",
        "Ivacaftor reduced the ability of lumacaftor to stimulate phagocytosis and killing of P. aeruginosa.",
        "The clinical efficacy of ORKAMBI may be related in part to the ability of lumacaftor to stimulate phagocytosis and killing of P. aeruginosa by macrophages."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29351449": [
        "The CFTR protein, a chloride channel, is normally expressed on epithelial cells lining the lung, gut, and exocrine glands.",
        "Efforts to discover new modulators that could deliver a wider and greater clinical benefit are still ongoing.",
        "Research has focused on identifying small molecules, or modulators, that can restore CFTR function.",
        "In recent years, two modulators, ivacaftor (Kalydeco) and lumacaftor/ivacaftor (Orkambi), have been approved by the U.S. Food and Drug Administration to treat CF patients with certain CFTR mutations.",
        "However, traditional randomized controlled trials (RCTs) require large numbers of patients and become impracticable to test the modulators' efficacy in CF patients with CFTR mutations at frequencies much lower than 1%, suggesting the need for personalized medicine in these CF patients.",
        "The development of these modulators has served as proof-of-concept that targeting CFTR by modulators is a viable therapeutic option.",
        "To date, more than 2,000 CFTR mutations have been identified, which produce a wide range of phenotypes.",
        "Mutations in CFTR have led to pleiotropic effects in CF patients and have resulted in early morbidity and mortality.",
        "CF is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene.",
        "Cystic fibrosis (CF) is the most common life-shortening genetic disease affecting ~1 in 3,500 of the Caucasian population."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29903751": [
        "In summary, our findings show that there is a potential for nonspecific effects of VX-770 on the lipid bilayer and suggest that this effect may account for its destabilizing effect on VX-809- rescued F508del-CFTR.",
        "However, clinical studies revealed that the effect of ORKAMBI on lung function is modest and it was proposed that this modest effect relates to a negative impact of VX-770 on the stability of F508del-CFTR.",
        "Deletion of phenylalanine at position 508 (F508del) in cystic fibrosis transmembrane conductance regulator (CFTR) is the most common cystic fibrosis (CF)-causing mutation.",
        "In the current studies, we showed that this negative effect of VX-770 at 10 <i>\u03bc</i>M correlated with its inhibitory effect on VX-809-mediated correction of the interface between the second membrane spanning domain and the first nucleotide binding domain bearing F508del.",
        "Polarized total internal reflection fluorescence microscopy on a supported lipid bilayer model shows that VX-770, and not its less lipophilic derivative, increased the fluidity of and reorganized the membrane.",
        "Recently, ORKAMBI, a combination therapy that includes a corrector of the processing defect of F508del-CFTR (lumacaftor or VX-809) and a potentiator of channel activity (ivacaftor or VX-770), was approved for CF patients homozygous for this mutation.",
        "We determined that the relative destabilizing effect of a panel of VX-770 derivatives on F508del-CFTR correlated with their predicted lipophilicity.",
        "Interestingly, we found that VX-770 exerted a similar negative effect on the stability of other membrane localized solute carriers (SLC26A3, SLC26A9, and SLC6A14), suggesting that this negative effect is not specific for F508del-CFTR."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27804127": [
        "The recent US Food and Drug Administration (FDA) approval of lumacaftor combined with ivacaftor (Orkambi) targets patients with the F508del-CFTR.",
        "Cystic fibrosis (CF) is a life-limiting disease caused by defective or deficient cystic fibrosis transmembrane conductance regulator (CFTR) activity.",
        "This review covers the contemporary clinical and scientific knowledge-base for lumacaftor/ivacaftor and highlights the emerging issues from recent conflicting literature reports.",
        "The question remains: Is this breakthrough combination therapy the \"magic-bullet\" cure for the vast majority of patients with CF?"
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28769592": [
        "Traditionally, CF has been treated symptomatically with pancreatic enzymes, bronchodilators, hypertonic saline, and pulmozyme.",
        "We highlight this case to bring awareness and educate patients and clinicians of the side-effect profile of Orkambi therapy with an intent to avoid unnecessary hospitalizations, inpatient antibiotics, and other costly medical services.",
        "There are between 900 and 1000 new cases diagnosed every year.",
        "Orkambi and mucolytics decrease the viscosity of mucous secretions, leading to an accumulation of hypoviscous fluid in the alveoli, resulting in dyspnea.",
        "Cystic fibrosis (CF) is a disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator protein in the epithelial membrane, and affects at least 30,000 people in the USA.",
        "In July 2015, the US Food and Drug Administration approved Orkambi (lumacaftor/ivacaftor), a combination drug that works on reversing the effects of the defective cystic fibrosis transmembrane conductance regulator protein.",
        "This presentation can be mistaken for an infective exacerbation.",
        "We present a case in which a young female with CF recently started on Orkambi therapy presented to her primary care physician with dyspnea and increased respiratory secretions and was admitted to the hospital for 2 weeks of intravenous and inhaled antibiotic therapy for a presumed CF exacerbation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28891346": [
        "Traditionally treatment has only included supportive care.",
        "Nonetheless, pharmacoeconomic data are necessary to justify its high cost before is use becomes standard of care.",
        "Currently, LUM/IVA is the only oral agent in its class available and represents a milestone the development of therapies for the management of CF.",
        "Therefore, there is a need for safe and effective novel therapies targeting the underlying molecular defects seen with CF.",
        "Approximately 73% of patients are homozygous for the F508del cystic fibrosis transmembrane conductance regulator [CFTR] mutation.",
        "Areas covered: In 2016, the Food and Drug Administration and the European Commission approved LUM/IVA (Orkambi), a CFTR modulator that includes both a CFTR corrector and potentiator, for CF patients homozygous for the F508del CFTR mutation.",
        "Cystic Fibrosis (CF) is an autosomal recessive disease affecting up to 90,000 people worldwide.",
        "Expert commentary: LUM/IVA showed modest, but significant improvements from baseline in percent predicted FEV<sub>1</sub> (ppFEV<sub>1</sub>) as well as a reduction in pulmonary exacerbations by 35% It was shown to be safe for short- and long-term use.",
        "This article reviews the pharmacologic features, clinical efficacy, and safety of LUM/IVA and summarize the available pre-clinical and clinical data of LUM/IVA use."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28667089": [
        "Importantly, this \"amplifier\" effect was recapitulated in patient-derived nasal cultures-providing the first evidence for its efficacy in augmenting Orkambi<sup>\u00ae</sup> in tissues harboring a rare CF-causing mutation.",
        "Here, we demonstrate that patients bearing the rare mutation: c.3700 A&gt;G, causing protein misprocessing and altered channel function-similar to \u0394F508-CFTR, are unlikely to yield a robust Orkambi<sup>\u00ae</sup> response.",
        "The combination therapy of lumacaftor and ivacaftor (Orkambi<sup>\u00ae</sup>) is approved for patients bearing the major cystic fibrosis (CF) mutation: <i>\u0394F508</i> It has been predicted that Orkambi<sup>\u00ae</sup> could treat patients with rarer mutations of similar \"theratype\"; however, a standardized approach confirming efficacy in these cohorts has not been reported.",
        "We propose that this multi-disciplinary approach, including creation of CRISPR/Cas9-edited cells to profile modulators together with validation using primary tissue, will facilitate therapy development for patients with rare CF mutations.",
        "A CRISPR/Cas9-edited bronchial epithelial cell line bearing this mutation enabled studies showing that an \"amplifier\" compound, effective in increasing the levels of immature CFTR protein, augmented the Orkambi<sup>\u00ae</sup> response.",
        "While <i>in silico</i> and biochemical studies confirmed that this mutation could be corrected and potentiated by lumacaftor and ivacaftor, respectively, this combination led to a minor <i>in vitro</i> response in patient-derived tissue."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27792891": [
        "However, we observed a relatively high plasma concentration of LUMA (4.42\u03bcg/mL).",
        "Currently, no therapeutic drug monitoring assays exist for these very expensive, albeit, important drugs.",
        "The M6 concentrations (0.15\u03bcg/mL) were comparable to those of the KALYDECO patient.",
        "The assay was successfully utilized to quantify the concentration of LUMA, IVA, M1 and M6 in the plasma and sputum of CF patients undergoing therapy with KALYDECO (IVA 150mg/q12h) or ORKAMBI (200mg/q12h LUMA-125mg/q12h IVA).",
        "Surprisingly, the ORKAMBI patient displayed very low plasma concentrations of IVA (0.06\u03bcg/mL) and M1 (0.07\u03bcg/mL).",
        "M1 and M6 plasma concentrations were 0.50\u03bcg/mL and 0.16\u03bcg/mL, respectively.",
        "The introduction of the assay into the clinical setting will facilitate pharmacokinetics/pharmacodynamic analysis and assist clinicians to develop more cost effective and efficacious dosage regimens for these breakthrough CF drugs.",
        "With a mobile phase consisting of acetonitrile/water:0.1% formic acid (60:40v/v) at a flow rate of 1mL/min, a linear correlation was observed over a concentration range from 0.01 to 10\u03bcg/mL in human plasma (IVA R<sup>2</sup>&gt;0.999, IVA M1 R<sup>2</sup>&gt;0.9961, IVA M6 R<sup>2</sup>&gt;0.9898, LUMA R<sup>2</sup>&gt;0.9954).",
        "In this study, for the first time HPLC and LC-MS methods were developed and validated for rapid detection and quantification of IVA and its major metabolites hydroxymethyl-IVA M1 (active) and IVA-carboxylate M6 (inactive); and LUMA in the plasma and sputum of CF patients.",
        "The KALYDECO patient exhibited an IVA plasma concentration of 0.97\u03bcg/mL at 2.5h post dosage.",
        "This reliable and novel method offers a simple and sensitive approach for therapeutic drug monitoring of KALYDECO and ORKAMBI in plasma and sputum.",
        "ORKAMBI (ivacaftor-lumacaftor [LUMA]) and KALYDECO (ivacaftor; IVA) are two new breakthrough cystic fibrosis (CF) drugs that directly modulate the activity and trafficking of the defective CFTR underlying the CF disease state."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28611092": [
        "Together, these data continue to validate deuterium substitution as a viable approach for creating novel therapeutic agents with properties potentially differentiated from existing drugs.",
        "However, CTP-656 exhibited markedly enhanced stability when tested in vitro.",
        "In this study, we explored the pharmacological and metabolic effects of precision deuteration chemistry on ivacaftor by synthesizing two novel deuterated ivacaftor analogs, CTP-656 (<i>d</i><sub>9</sub>-ivacaftor) and <i>d</i><sub>18</sub>-ivacaftor.",
        "Ivacaftor is administered twice daily and is extensively converted in humans to major metabolites M1 and M6; therefore, the corresponding deuterated metabolites were also prepared.",
        "The deuterium isotope effects for CTP-656 metabolism (<sup>D</sup>V = 3.8, <sup>D</sup>V/K = 2.2) were notably large for a cytochrome P450-mediated oxidation.",
        "The pharmacokinetic (PK) profile of CTP-656 and <i>d</i><sub>18</sub>-ivacaftor were assessed in six healthy volunteers in a single-dose crossover study, which provided the basis for advancing CTP-656 in development.",
        "The overall PK profile, including the 15.9-hour half-life for CTP-656, suggests that CTP-656 may be dosed once daily, thereby enhancing patient adherence.",
        "Both CTP-656 and <i>d</i><sub>18</sub>-ivacaftor showed in vitro pharmacologic potency similar to that in ivacaftor, and the deuterated M1 and M6 metabolites showed pharmacology equivalent to that in the corresponding metabolites of ivacaftor, which is consistent with the findings of previous studies of deuterated compounds.",
        "Ivacaftor is currently used for the treatment of cystic fibrosis as both monotherapy (Kalydeco; Vertex Pharmaceuticals, Boston, MA) and combination therapy with lumacaftor (Orkambi; Vertex Pharmaceuticals).",
        "Each therapy targets specific patient populations: Kalydeco treats patients carrying one of nine gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein, whereas Orkambi treats patients homozygous for the F508del CFTR mutation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27990075": [
        "Lisinopril oral solution (Qbrelis) for the treatment of hypertension, heart failure, and acute myocardial infarction; etanercept-szzs (Erelzi) for multiple autoimmune disorders; and lumacaftor/ivacaftor (Orkambi) for cystic fibrosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22513995": [
        "These features minimize aspects of experimental error and hold promise for dealing with challenging experimental conditions such as archival formalin-fixed paraffin-embedded samples.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      The NanoString nCounter Platform is a new and promising technology for measuring nucleic acid abundances.",
        "It has several advantages over PCR-based techniques, including avoidance of amplification, direct sequence interrogation and digital detection for absolute quantification.",
        "However, systematic inter-sample technical artifacts caused by variability in sample preservation, bio-molecular extraction and platform fluctuations must be removed to ensure robust data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29112706": [
        "To demonstrate its utility, we apply it to a new dataset of 96 genes profiled on 41 prostate tumour and 24 matched normal samples.",
        "Although it can estimate copy number variation, relatively few tools support analysis of these data.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      The NanoString System is a well-established technology for measuring RNA and DNA abundance.",
        "To address this gap, we created NanoStringNormCNV, an R package for pre-processing and copy number variant calling from NanoString data.",
        "This package implements algorithms for pre-processing, quality-control, normalization and copy number variation detection.",
        "A series of reporting and data visualization methods support exploratory analyses."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29321310": [
        "Ad5.PGT121 and AAV1.PGT121 produced functional antibody <i>in vivo</i> Ad5.PGT121 produced PGT121 rapidly within 6 h, whereas AAV1.PGT121 produced detectable PGT121 in serum by 72 h.",
        "We investigated adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV-1-specific bNAb PGT121.",
        "In HIV-1-infected BLT humanized mice, Ad5.PGT121 resulted in a greater reduction of viral loads than did AAV1.PGT121.",
        "Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected humanized mice.",
        "Ad5.PGT121 also led to more-sustained virologic control than purified PGT121 IgG.",
        "Serum PGT121 levels were rapidly reduced by the generation of anti-PGT121 antibodies in immunocompetent mice but were durably maintained in immunocompromised mice.",
        "We investigated adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-1-infected bone marrow-liver-thymus (BLT) humanized mice.",
        "However, administration of purified bNAbs poses challenges in resource-poor settings, where the HIV-1 disease burden is greatest. <i>In vivo</i> vector-based production of bNAbs represents an alternative strategy.",
        "Broadly neutralizing antibodies (bNAbs) are being explored for HIV-1 prevention and cure strategies.",
        "Further evaluation of vector delivery of HIV-1 bNAbs is warranted, although approaches to prevent the generation of antiantibody responses may also be required.<b>IMPORTANCE</b> Broadly neutralizing antibodies (bNAbs) are being explored for HIV-1 prevention and cure strategies, but delivery of purified antibodies may prove challenging."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30139768": [
        "We found that anlotinib inhibits the cell viability of papillary thyroid cancer and ATC cell lines, likely due to abnormal spindle assembly, G2/M arrest, and activation of TP53 upon anlotinib treatment.",
        "There is no effective treatment for patients with poorly differentiated papillary thyroid cancer or anaplastic thyroid cancer (ATC).",
        "Moreover, anlotinib suppresses the migration of thyroid cancer cells in vitro and the growth of xenograft thyroid tumors in mice.",
        "In this study, we aimed to better understand the effect and efficacy of anlotinib against thyroid carcinoma cells in vitro and in vivo.",
        "Our data demonstrate that anlotinib has significant anticancer activity in thyroid cancer, and potentially offers an effective therapeutic strategy for patients of advanced thyroid cancer type.",
        "Anlotinib, a multi-kinase inhibitor, has already shown antitumor effects in various types of carcinoma in a phase I clinical trial."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28953502": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      AL3818 (anlotinib) is a receptor tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFR1, VEGFR2/KDR, and VEGFR3), stem cell factor receptor (C-kit), platelet-derived growth factor (PDGF\u03b2), and fibroblast growth factor receptors (FGFR1, FGFR2, and FGFR3).",
        "This study evaluates the efficacy of AL3818 studying tumor regression in an orthotopic murine endometrial cancer model."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29446853": [
        "Anlotinib occupied the ATP-binding pocket of VEGFR2 tyrosine kinase and showed high selectivity and inhibitory potency (IC<sub>50</sub> &lt;1 nmol/L) for VEGFR2 relative to other tyrosine kinases.",
        "Abrogating tumor angiogenesis by inhibiting vascular endothelial growth factor receptor-2 (VEGFR2) has been established as a therapeutic strategy for treating cancer.",
        "In the present study, we detailed the pharmacological properties of anlotinib, a highly potent and selective VEGFR2 inhibitor, in preclinical models.",
        "Anlotinib significantly inhibited HUVEC migration and tube formation; it also inhibited microvessel growth from explants of rat aorta in vitro and decreased vascular density in tumor tissue in vivo.",
        "Concordant with this activity, anlotinib inhibited VEGF-induced signaling and cell proliferation in HUVEC with picomolar IC<sub>50</sub> values.",
        "Compared with the well-known tyrosine kinase inhibitor sunitinib, once-daily oral dose of anlotinib showed broader and stronger in vivo antitumor efficacy and, in some models, caused tumor regression in nude mice.",
        "However, because of their low selectivity, most small molecule inhibitors of VEGFR2 tyrosine kinase show unexpected adverse effects and limited anticancer efficacy.",
        "However, micromolar concentrations of anlotinib were required to inhibit tumor cell proliferation directly in vitro.",
        "Collectively, these results indicate that anlotinib is a well-tolerated, orally active VEGFR2 inhibitor that targets angiogenesis in tumor growth, and support ongoing clinical evaluation of anlotinib for a variety of malignancies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29454091": [
        "Importantly, according to our study, the anti-angiogenic effect of anlotinib is superior to sunitinib, sorafenib and nintedanib, which are three main anti-angiogenesis drugs in clinic.",
        "Wound healing assay, chamber directional migration assay and tube formation assay indicated that anlotinib inhibited VEGF/PDGF-BB/FGF-2-induced cell migration and formation of capillary-like tubes in endothelial cells.",
        "VEGF, PDGF-BB and FGF-2 are three major pro-angiogenic factors and applied to promote angiogenesis.",
        "Furthermore, anlotinib suppressed blood vessels sprout and microvessel density in rat aortic ring assay and chicken chorioallantoic membrane (CAM) assay.",
        "In this research, we demonstrated that anlotinib, a potent multi-tyrosine kinases inhibitor (TKI), showed a significant inhibitory effect on VEGF/PDGF-BB/FGF-2-induced angiogenesis in vitro and in vivo.",
        "Mechanistically, anlotinib inhibits the activation of VEGFR2, PDGFR\u03b2 and FGFR1 as well their common downstream ERK signaling.",
        "Tumor cells recruit vascular endothelial cells and circulating endothelial progenitor cells to form new vessels to support their own growth and metastasis.",
        "Therefore, anlotinib is a potential agent to inhibit angiogenesis and be applied to tumor therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29438373": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Anlotinib (AL3818) is a novel multitarget tyrosine kinase inhibitor, inhibiting tumour angiogenesis and proliferative signalling.",
        "The objective of this study was to assess the safety and efficacy of third-line anlotinib for patients with refractory advanced non-small-cell lung cancer (RA-NSCLC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29764596": [
        "Anlotinib is a novel TKI targeting the vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR) and c-Kit.",
        "The clinical treatment effect is also not satisfactory.",
        "ALTER0303 trail, phase III study has demonstrated that Anlotinib significantly prolonged overall survival (OS) and progression-free survival (PFS) in advanced NSCLC patients as 3rd line treatment.Here we report a case of advanced lung adenocarcinoma harboring KRAS mutation treated with Anlotinib. .",
        "In recent years, the number of advanced non-small cell lung cancer (NSCLC) patients has gradually increased, and the treatment methods have also been significantly increased.",
        "However, there are no standard treatment plans at home and abroad for third-line and above patients who are refractory to targeted therapy epidermal growth factor receptor (EGFR)/anaplastic lymphoma kinase (ALK) or chemotherapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30231931": [
        "Compared to the effect of placebo, it improved both progression-free survival (PFS) and overall survival (OS) in a phase III trial in patients with advanced non-small-cell lung cancer (NSCLC), despite progression of the cancer after two lines of prior treatments.",
        "Anlotinib is a new, orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptors (PDGFR), and c-kit.",
        "Anlotinib also showed promising efficacy in patients with advanced medullary thyroid carcinoma and metastatic renal cell carcinoma (mRCC).",
        "The tolerability profile of anlotinib is similar to that of other tyrosine kinase inhibitors that target VEGFR and other tyrosine kinase-mediated pathways; however, anlotinib has a significantly lower incidence of grade 3 or higher side effects compared to that of sunitinib.",
        "Moreover, a randomized phase IIB trial demonstrated that anlotinib significantly prolonged the median PFS in patients with advanced soft tissue sarcoma (STS).",
        "We review the rationale, clinical evidence, and future perspectives of anlotinib for the treatment of multiple cancers.",
        "Recently, the China Food and Drug Administration (CFDA) approved single agent anlotinib as a third-line treatment for patients with advanced NSCLC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30098152": [
        "A phase 2 trial showed anlotinib to improve progression-free survival with a potential benefit of overall survival, leading to the phase 3 trial to confirm the drug's efficacy in advanced non-small cell lung cancer (NSCLC).",
        "<strong class=\"sub-title\">\n          Importance:\n        </strong>\n      \n      Anlotinib is a novel multitarget tyrosine kinase inhibitor for tumor angiogenesis and proliferative signaling."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30032842": [
        "This study assessed quality of life (QoL) in these patients.",
        "In the phase III ALTER-0303 trial (Clinical Trial Registry ID: <a href=\"http://clinicaltrials.gov/show/NCT 02388919\" title=\"See in ClinicalTrials.gov\">NCT 02388919</a>), anlotinib significantly improved overall survival versus placebo in advanced non-small-cell lung cancer (NSCLC) patients who had received at least two previous chemotherapy and epidermal growth factor receptor/anaplastic lymphoma kinase targeted therapy regimens.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Anlotinib is a novel multi-target tyrosine Kinase inhibitor that inhibits VEGFR2/3, FGFR1-4, PDGFD \u03b1/\u03b2, c-Kit and Ret."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27716285": [
        "We aimed to evaluate the safety, pharmacokinetics, and antitumor activity of anlotinib in patients with advanced refractory solid tumors.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Anlotinib is a novel multi-target tyrosine kinase inhibitor that is designed to primarily inhibit VEGFR2/3, FGFR1-4, PDGFR \u03b1/\u03b2, c-Kit, and Ret."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30146257": [
        "Here, we have shown the antitumor effects of anlotinib on HCC.",
        "Data indicated that anlotinib application significantly inhibited HCC cell viability, proliferation, colony formation, and prompted apoptosis in vitro.",
        "Mechanically, we demonstrated that anlotinib treatment downregulated the anti-apoptotic protein Bcl-2 and Survivin, but upregulated pro-apoptotic molecule Bax, which accounts for its therapeutic effect on HCC.",
        "Pathway analysis has shown decreased phosphorylation levels of Erk and Akt.",
        "Although anlotinib, a multi-targeted receptor tyrosine kinase inhibitor has been reported have antitumor effects in many preclinical and clinical trials, little is known about its effect on hepatocellular carcinoma (HCC).",
        "Together, this study suggests that anlotinib may have a direct antitumor progression effect on HCC by inhibiting Bcl-2 and Survivin expression, promoting Bax expression via inactivating Erk and Akt pathways and could be a promising agent treating HCC.",
        "Furthermore, animal experiments also illustrated that anlotinib alleviated HCC progression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29943374": [
        "Anlotinib is approved in China for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have undergone progression or recurrence after \u2265 2 lines of systemic chemotherapy.",
        "Anlotinib is an oral small molecule inhibitor of multiple receptor tyrosine kinases, with a broad spectrum of inhibitory effects on tumour angiogenesis and growth.",
        "This article summarizes the milestones in the development of anlotinib leading to this first approval for NSCLC.",
        "Jiangsu Chia-Tai Tianqing Pharmaceutical and Advenchen Laboratories are co-developing anlotinib (Focus V<sup>\u00ae</sup>) for the treatment of advanced cancer.",
        "Anlotinib is also undergoing phase II and/or III clinical development for various sarcomas and carcinomas in China, USA and Italy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29620050": [
        "Anlotinib exhibited large apparent volumes of distribution in rats (27.6\u00b13.1 L/kg) and dogs (6.6\u00b12.5 L/kg) and was highly bound in rat (97%), dog (96%), and human plasma (93%).",
        "Anlotinib, having good membrane permeability, was rapidly absorbed with oral bioavailability of 28%-58% in rats and 41%-77% in dogs.",
        "Cytochrome P450-mediated metabolism was probably the major elimination pathway.",
        "Anlotinib is a new oral tyrosine kinase inhibitor; this study was designed to characterize its pharmacokinetics and disposition.",
        "Samples were analyzed by liquid chromatography/mass spectrometry.",
        "Based on early reported human pharmacokinetics, drug interaction indices were 0.16 for CYP3A4 and 0.02 for CYP2C9, suggesting that anlotinib had a low propensity to precipitate drug interactions on these enzymes.",
        "Human CYP3A had the greatest metabolic capability with other human P450s playing minor roles.",
        "In human plasma, anlotinib was predominantly bound to albumin and lipoproteins, rather than to \u03b1<sub>1</sub>-acid glycoprotein or \u03b3-globulins.",
        "Anlotinib exhibits many pharmacokinetic characteristics similar to other tyrosine kinase inhibitors, except for terminal half-life, interactions with drug metabolizing enzymes and transporters, and plasma protein binding.",
        "Terminal half-life of anlotinib in dogs (22.8\u00b111.0 h) was longer than that in rats (5.1\u00b11.6 h).",
        "Concentrations of anlotinib in various tissue homogenates of rat and in those of tumor-bearing mouse were significantly higher than the associated plasma concentrations.",
        "This difference appeared to be mainly associated with an interspecies difference in total plasma clearance (rats, 5.35\u00b11.31 L\u00b7h<sup>-1</sup>\u00b7kg<sup>-1</sup>; dogs, 0.40\u00b10.06 L\u00b7h<sup>-1</sup>/kg<sup>-1</sup>).",
        "Anlotinib exhibited limited in vitro potency to inhibit many human P450s, UDP-glucuronosyltransferases, and transporters, except for CYP3A4 and CYP2C9 (in vitro half maximum inhibitory concentrations, &lt;1 \u03bcmol/L).",
        "Anlotinib was evaluated in rats, tumor-bearing mice, and dogs and also assessed in vitro to characterize its pharmacokinetics and disposition and drug interaction potential."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29028893": [
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Whole genome sequencing is becoming a diagnostics of choice for the identification of rare inherited and de novo copy number variants in families with various pediatric and late-onset genetic diseases.",
        "However, joint variant calling in pedigrees is hampered by the complexity of consensus breakpoint alignment across samples within an arbitrary pedigree structure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30201700": [
        "Virulent strain 2336 mutants lacking the entire <i>ibpA</i> gene or both DR1 and DR2 were not toxic to the monocytes but still survived within the monocytes for at least 72 h.",
        "Therefore, <i>H. somni</i> may be considered a permissive intracellular pathogen.",
        "<i>Histophilus somni</i> is capable of intracellular survival within professional phagocytic cells, but the mechanism of survival is not understood.",
        "The Fic motif within the direct repeat (DR1)/DR2 domains of the IbpA fibrillary network protein of <i>H. somni</i> is cytotoxic to epithelial and phagocytic cells, which may interfere with the bactericidal activity of these cells.",
        "These results indicated that virulent isolates of <i>H. somni</i> were capable of surviving within phagocytic cells through interference in phagosome-lysosome maturation.",
        "Monitoring of intracellular trafficking of <i>H. somni</i> with monoclonal antibodies to phagosomal markers indicated that the early phagosomal marker early endosome antigen 1 colocalized with all isolates tested, but only strains that could survive intracellularly did not colocalize with the late lysosomal marker lysosome-associated membrane protein 2 and prevented the acidification of phagosomes.",
        "An <i>H. somni</i> mutant lacking IbpA, but not the DR1/DR2 region within <i>ibpA</i>, was more susceptible to killing by antiserum than the parent, indicating that the entire protein was associated with serum resistance. <i>H. somni</i> strains expressing IbpA replicated in bovine monocytes for at least 72 h and were toxic for these cells.",
        "To determine the contribution of IbpA and Fic to resistance to host defenses, <i>H. somni</i> strains and mutants that lacked all or a region of <i>ibpA</i> (including the DR1/DR2 regions) were tested for survival in bovine monocytic cells and for serum susceptibility."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26928472": [
        "Moreover, increased co-localization was observed between pathogenic L. donovani and late phagosomal markers viz.",
        "Rab7, Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9, and V-ATPase which indicate phagosome maturation.",
        "Finally, it was confirmed that p38 MAPK is the key player in acidification and maturation of phagosome in attenuated Leishmania strain pre-exposed macrophages.",
        "In our study, these activated macrophages are found to induce phagosome maturation when infected with pathogenic Leishmania donovani.",
        "Promastigote form of Leishmania, an intracellular pathogen, delays phagosome maturation and resides inside macrophages.",
        "It was also observed that inhibition of V-type ATPase caused significant hindrance in attenuated Leishmania induced phagosome maturation.",
        "Increased co-localization of carboxyfluorescein succinimidyl ester labeled pathogenic L. donovani with Lysosome was found.",
        "To our knowledge, this study for the first time reported an approach to induce phagosome maturation in L. donovani infected macrophages which could potentiate short-term prophylactic response in future.",
        "But till date limited study has been done to manipulate the phagosomal machinery of macrophages to restrict Leishmania growth.",
        "Attenuated Leishmania strain exposed RAW 264.7 cells showed a respiratory burst and enhanced production of pro-inflammatory mediators.",
        "The augmentation of pro-inflammatory activity is mostly attributed to p38 MAPK and p44/42 MAPK."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29675446": [
        "Thereafter, automated quantification of degree of co-localization between mycobacteria and host vacuolar markers like TfR and LAMP1 is done by processing the binary images of bacteria using mathematical tools.",
        "The basic method can be applied to studying trafficking of other bacteria or particles like beads, although the kinetics of infection and phagosome maturation will depend upon the phagocytic cargo.",
        "The mathematical analysis tools are available in many standard imaging analysis programs.",
        "Here, a protocol is outlined for infection of macrophages with mycobacterial species like pathogenic Mtb, vaccine strain <i>Mycobacterium bovis-</i> bacillus Calmatte- Gu\u00e9rin (BCG) and rapidly dividing non-pathogenic <i>Mycobacterium smegmatis</i> (Msmeg), followed by indirect-immunofluorescence microscopy to visualize host vacuolar markers.",
        "This results in quantification of the mean fluorescence intensity (MFI) of these host markers directly around the bacteria/bacterial clusters with increased sensitivity relative to when done manually.",
        "However, any adaption for similar analysis should be confirmed by the individual user with their imaging and analysis platform.",
        "By manipulating host or pathogen, this assay can be used to evaluate host or bacterial determinants of intracellular trafficking.",
        "Phagolysosomal trafficking is an important innate defense pathway that clears microbes by delivering them to lysosomes, the degradative compartment of the cell. <i>Mycobacterium tuberculosis</i> (Mtb), the causative agent of tuberculosis, subverts this host defense mechanism by arresting maturation of the phagosome.",
        "The ability of Mtb to arrest its delivery to the lysosome can be demonstrated by the prolonged co-localization of bacteria containing phagosomes/vacuole with early phagosomal markers [such as, Ras-related proteins in the brain 5 (Rab5) and Transferrin receptor (TfR)], and a failure to acquire late phagosomal and lysosomal markers (such as Rab7 and LAMP1) (Deretic and Fratti, 1999, Mehra <i>et al.</i>, 2013)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20829607": [
        "The Rab7 defect was not due to excessive cholesterol accumulation and was confined to the infected vacuoles.",
        "Using murine macrophages, we investigated the stage at which maturation is arrested and analyzed the underlying mechanism.",
        "Vacuoles containing B. cenocepacia strain J2315, an isolate of the transmissible ET12 clone, recruited Rab5 and synthesized phosphatidylinositol-3-phosphate, indicating progression to the early phagosomal stage.",
        "Despite the fact that the B. cenocepacia-containing vacuoles rarely fused with lysosomes, they could nevertheless acquire the late phagosomal markers CD63 and Rab7.",
        "The bacteria preclude fusion of the phagosome with lysosomes by a process that is poorly understood.",
        "Fluorescence recovery after photobleaching and use of a probe that detects Rab7-guanosine triphosphate indicated that activation of Rab7 was impaired by B. cenocepacia, accounting at least in part for the inability of the vacuole to merge with lysosomes.",
        "Strains of the Burkholderia cepacia complex can survive within macrophages by arresting the maturation of phagocytic vacuoles.",
        "Jointly, these experiments indicate that B. cenocepacia express virulence factors capable of interfering with Rab7 function and thereby with membrane traffic."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18485117": [
        "Using the facultative intracellular bacterium Listeria monocytogenes, we show that maturation of phagosomes into phagolysosomes is severely impaired in macrophages genetically deficient for ASMase.",
        "Unlike in wild-type macrophages, phagosomes containing L. monocytogenes in ASMase(-/-) macrophages remained positive for the late phagosomal markers mannose-6-phosphate receptor (M6PR) and Rab7 for at least 2 h and, correspondingly, showed delayed acquisition of lysosomal markers like lysosome associated membrane protein 1 (Lamp1).",
        "The results of this study suggest that ASMase is required for the proper fusion of late phagosomes with lysosomes, which is crucial for efficient transfer of lysosomal antibacterial hydrolases into phagosomes.",
        "Moreover, phagosomes containing L. monocytogenes from ASMase(-/-) cells acquired significantly less listeriocidal proteases cathepsin D, B and L.",
        "The transfer of lysosomal fluid phase markers into phagosomes containing L. monocytogenes was severely impaired in ASMase(-/-) macrophages and decreased with increasing size of the cargo.",
        "The acid sphingomyelinase (ASMase) localizes to the lumen of endosomes, phagosomes and lysosomes as well as to the outer leaflet of the plasma membrane and hydrolyses sphingomyelin to ceramide and phosphorylcholine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27458220": [
        "Delafloxacin was the most potent agent tested.",
        "Delafloxacin susceptibility was not affected by \u03b2-lactamase status against H. influenzae and M. catarrhalis.",
        "MIC50 and MIC90 values against all S. pneumoniae isolates were 0.008 and 0.015 \u03bcg/ml.",
        "In this study, 200 Streptococcus pneumoniae (plus 30 levofloxacin-resistant isolates), 200 Haemophilus influenzae, and 100 Moraxella catarrhalis isolates selected primarily from the United States (2014) were tested against delafloxacin and comparator agents.",
        "Delafloxacin, an investigational anionic fluoroquinolone, is active against a broad range of Gram-positive and Gram-negative bacteria."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27216072": [
        "The Hill equation for maximum effect (Emax) was used to model the dose-response data.",
        "Delafloxacin demonstrated in vitro and in vivo potency against a diverse group of pathogens, including those with phenotypic drug resistance to other classes.",
        "In control mice the organism burden increased 2.1 \u00b1 0.44 log10 CFU/lung over the study period.",
        "MICs were determined using CLSI methods.",
        "For in vivo studies, 4-fold-increasing doses of delafloxacin (range, 0.03 to 160 mg/kg) were administered every 6 h (q6h) to infected mice.",
        "A neutropenic murine lung infection model was utilized for all treatment studies, and drug dosing was by the subcutaneous route.",
        "Single-dose PK parameter ranges include the following: for maximum concentration of drug in serum (Cmax), 2 to 70.7 mg/liter; AUC from 0 h to infinity (AUC0-\u221e), 2.8 to 152 mg \u00b7 h/liter; half-life (t1/2), 0.7 to 1 h.",
        "There was a relatively steep dose-response relationship observed with escalating doses of delafloxacin.",
        "MICs ranged from 0.004 to 1 mg/liter.",
        "At the start of therapy mice had 6.3 \u00b1 0.09 log10 CFU/lung.",
        "Treatment outcome was measured by determining organism burden in the lung (CFU counts) at the end of each experiment (24 h).",
        "AUC/MIC targets for the 1-log kill endpoint were 2- to 5-fold higher.",
        "Single-dose plasma pharmacokinetics was determined in the mouse model after administration of 2.5, 10, 40, and 160 mg/kg.",
        "Delafloxacin is a broad-spectrum anionic fluoroquinolone under development for the treatment of bacterial pneumonia.",
        "The magnitude of the PK/PD index, the area under the concentration-time curve over 24 h in the steady state divided by the MIC (AUC/MIC), associated with net stasis and 1-log kill endpoints was determined in the lung model for all isolates.",
        "Maximal organism reductions ranged from 2 log10 to more than 4 log10 The median free-drug AUC/MIC magnitude associated with net stasis for each species group was 1.45, 0.56, and 40.3 for S. aureus, S. pneumoniae, and K. pneumoniae, respectively.",
        "These results have potential relevance for clinical dose selection and evaluation of susceptibility breakpoints for delafloxacin for the treatment of lower respiratory tract infections involving these pathogens.",
        "The goal of the study was to determine the pharmacokinetic/pharmacodynamic (PK/PD) targets in the murine lung infection model for Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae Four isolates of each species were utilized for in vivo studies: for S. aureus, one methicillin-susceptible and three methicillin-resistant isolates; S. pneumoniae, two penicillin-susceptible and two penicillin-resistant isolates; K. pneumoniae, one wild-type and three extended-spectrum beta-lactamase-producing isolates."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29847465": [
        "The number of oligodendrocyte progenitors, which expressed platelet-derived growth factor receptor-\u03b1, did not change in the 2-week-old mouse brain.",
        "These results indicate that microglial activation plays an important role in the myelination process, without influencing the number of oligodendrocyte progenitors, in the development of Hexb mice.",
        "SD causes progressive neurodegeneration and changes in white matter in human infants.",
        "The data indicated not only the upregulation of immune system-related genes but also the downregulation of myelin-related genes in the 4-week-old Hexb mouse cerebral cortices.",
        "Sandhoff disease (SD) is a genetic disorder caused by a mutation of the \u03b2-subunit gene \u03b2-hexosaminidase B (HexB) in humans, which results in the massive accumulation of the ganglioside GM2 and related glycosphingolipids in the nervous system.",
        "To test the correlation between inflammation and dysmyelination, we generated double-knockout mice of Hexb and the Fc receptor \u03b3 gene (Fcr\u03b3), which is a regulator of autoimmune responses.",
        "To study how the symptoms of SD develop, we explored the difference in gene expression between 4-week-old Hexb and Hexb mouse cerebral cortices by microarray analysis.",
        "Dysmyelination recovered in these double-knockout mice.",
        "Previously, we reported that the activation state of microglia caused astrogliosis in the early stage of Hexb mouse development.",
        "An animal model of SD has been established, Hexb-deficient (Hexb) mice, which shows abnormalities resembling the severe phenotype found in human infants."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29358305": [
        "The Sandhoff disease organoids, but not the <i>HEXB</i>-corrected organoids, accumulated GM2 ganglioside and exhibited increased size and cellular proliferation compared with the <i>HEXB</i>-corrected organoids.",
        "Whole-transcriptome analysis demonstrated that development was impaired in the Sandhoff disease organoids, suggesting that alterations in neuronal differentiation may occur during early development in the GM2 gangliosidoses.",
        "Recently, cerebral organoids derived from induced pluripotent stem (iPS) cells have illuminated early developmental events altered by disease processes.",
        "Sandhoff disease, one of the GM2 gangliosidoses, is a lysosomal storage disorder characterized by the absence of \u03b2-hexosaminidase A and B activity and the concomitant lysosomal accumulation of its substrate, GM2 ganglioside.",
        "How the lysosomal accumulation of ganglioside might affect the early development of the nervous system is not understood.",
        "To develop an early neurodevelopmental model of Sandhoff disease, we first generated iPS cells from the fibroblasts of an infantile Sandhoff disease patient, then corrected one of the mutant <i>HEXB</i> alleles in those iPS cells using CRISPR/Cas9 genome-editing technology, thereby creating isogenic controls.",
        "Next, we used the parental Sandhoff disease iPS cells and isogenic <i>HEXB</i>-corrected iPS cell clones to generate cerebral organoids that modeled the first trimester of neurodevelopment.",
        "It features catastrophic neurodegeneration and death in early childhood."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29900534": [
        "Resident microglia, which are phenotypically distinct from infiltrating macrophages, are the only myeloid population present in significant numbers within the brain parenchyma in these authentic mouse models, even during the late symptomatic stages of disease when there is substantial neuroinflammation.",
        "Niemann-Pick type C disease is primarily caused by the loss of activity of the lysosomal membrane protein, NPC1, leading to storage of cholesterol and sphingosine.",
        "All three disorders display significant neuropathology, accompanied by neuroinflammation.",
        "The complete Open Science Disclosure form for this article can be found at the end of the article.",
        "OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript.",
        "This article is part of the Special Issue \"Lysosomal Storage Disorders\".",
        "Gaucher disease is caused by the loss of activity of glucocerebrosidase, leading to accumulation of glucosylceramide.",
        "Sandhoff disease results from the defective activity of \u03b2-hexosaminidase, leading to accumulation of ganglioside GM2.",
        "It is commonly assumed that neuroinflammation is the result of infiltration of monocyte-derived macrophages into the brain; for instance, cells resembling lipid-engorged macrophages ('Gaucher cells') have been observed in the brain of Gaucher disease patients.",
        "More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.",
        "We now review the evidence that inflammatory macrophages are recruited into the brain in these diseases and then go on to provide some experimental data that, at least in the three mouse models tested, monocyte-derived macrophages do not appear to infiltrate the brain.",
        "Gaucher disease exhibits a number of subtypes, with types 2 and 3 showing significant neuropathology.",
        "Approximately 70 lysosomal storage diseases are currently known, resulting from mutations in genes encoding lysosomal enzymes and membrane proteins.",
        "Defects in lysosomal enzymes that hydrolyze sphingolipids have been relatively well studied."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30236619": [
        "In addition, N-acetylgalactosamine 4-sulphate, key component of glycosaminoglycans (GAG) was significantly elevated, which was also confirmed by biochemical assays.",
        "Collectively, these results indicated major shifts of energy utilization and profound metabolic impairments, contributing to the pathogenesis mechanisms of SD.",
        "To identify potential biomarkers and unveil the pathogenic mechanisms, metabolomics analysis with reverse phase liquid chromatography (RPLC) was conducted.",
        "SD leads to progressive neurodegeneration and early death.",
        "Global metabolomics profiling may provide an innovative tool for better understanding the disease mechanisms, and identifying potential diagnostic biomarkers for SD.",
        "A total of 177, 112 and 119 metabolites were found to be significantly dysregulated in mouse liver, mouse brain and human hippocampus samples, respectively (p &lt; .05, ID score &gt; 0.5).",
        "Principal component analysis (PCA) analysis of the metabolites showed clear separation of metabolomics profiles between normal and diseased individuals.",
        "Among these metabolites, dipeptides, amino acids and derivatives were elevated, indicating a robust protein catabolism.",
        "However, there is a lack of established SD biomarkers, while the pathogenesis etiology remains to be elucidated.",
        "Through pathway enrichment analysis, we also found alterations in metabolites associated with neurotransmission, lipid metabolism, oxidative stress and inflammation.",
        "Sandhoff disease (SD) results from mutations in the HEXB gene, subsequent deficiency of N-acetyl-\u03b2-hexosaminidase (Hex) and accumulation of GM2 gangliosides."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29346510": [
        "Analysts can then quickly iterate through variants, apply filters and make decisions based on the generated images and variant metadata.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      With the rapid development in next-generation sequencing, cost and time requirements for genomic sequencing are decreasing, enabling applications in many areas such as cancer research.",
        "Often employed manual inspection of such calls is thus becoming a time-consuming procedure.",
        "VIPER was successfully employed in analyses with manual inspection of more than 10 000 calls.",
        "Many tools have been developed to analyze genomic variation ranging from single nucleotide variants to whole chromosomal aberrations.",
        "We developed the Variant InsPector and Expert Rating tool (VIPER) to speed up this process by integrating the Integrative Genomics Viewer into a web application.",
        "As sequencing throughput increases, the number of variants called by such tools also grows."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29092934": [
        "Visual inspection can greatly increase the confidence in calls, reduce the risk of false positives, and help characterize complex events.",
        "The Integrative Genomics Viewer (IGV) was one of the first tools to provide NGS data visualization, and it currently provides a rich set of tools for inspection, validation, and interpretation of NGS datasets, as well as other types of genomic data.",
        "IGV is freely available at https://www.igv.org <i>Cancer Res; 77(21); e31-34. \u00a92017 AACR</i>.",
        "Here, we present a short overview of IGV's variant review features for both single-nucleotide variants and structural variants, with examples from both cancer and germline datasets.",
        "Manual review of aligned reads for confirmation and interpretation of variant calls is an important step in many variant calling pipelines for next-generation sequencing (NGS) data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29414279": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Human T-lymphotropic virus type 1 (HTLV-1) causes the debilitating neuroinflammatory disease HTLV-1-associated myelopathy-tropical spastic paraparesis (HAM-TSP) as well as adult T-cell leukemia-lymphoma (ATLL).",
        "We evaluated mogamulizumab, a humanized anti-CCR4 monoclonal antibody that targets infected cells, in patients with HAM-TSP.",
        "In patients with HAM-TSP, HTLV-1 infects mainly CCR4+ T cells and induces functional changes, ultimately causing chronic spinal cord inflammation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29666026": [
        "Chemotherapy doublets combined with the fully humanized monoclonal antibody, bevacizumab, now constitute first-line therapy for women struggling with recurrent/metastatic cervical carcinoma.",
        "Incorporation of bevacizumab resulted in significant improvements in progression-free survival and response.",
        "All fistulas occurred in women who had received prior pelvic radiotherapy, and none resulted in emergency surgery, sepsis, or death.",
        "Moving forward, immunotherapy has now entered the clinical trial arena to address the high unmet clinical need for effective and tolerable second line therapies in this patient population.",
        "Targeting the programmed cell death 1/programmed death ligand 1 (PD-1/PD-L1) pathway using checkpoint inhibitors to break immunologic tolerance is promising.",
        "GOG 240 identified vaginal fistula as a new adverse event associated with bevacizumab use.",
        "Final protocol-specified analysis demonstrated continued separation of the survival curves favoring VEGF inhibition: 16.8 vs 13.3 months; HR 0.77; 95% CI, 0.62-9.95; p = .007.",
        "Regulatory approval for this indication was based on the phase III randomized trial, GOG 240, which demonstrated a statistically significant and clinically meaningful improvement in overall survival when bevacizumab was added to chemotherapy: 17.0 vs 13.3 months; HR 0.71; 98% CI, 0.54-0.95; p = .004.",
        "Vascular endothelial growth factor (VEGF) has emerged as a therapeutic target in several malignancies, including cervical cancer.",
        "Important considerations in attempts to inhibit the inhibitors include pseudoprogression and post-progression survival, abscopal effects, and immune-related adverse events, including endocrinopathies.",
        "The immunologic landscape involving human papillomavirus-positive head and neck carcinoma and cutaneous squamous cell carcinoma can be informative when considering feasibility of checkpoint blockade in advanced cervical cancer.",
        "Phase II studies using anti-PD-1 molecules, nivolumab and pembrolizumab are ongoing, and GOG 3016, the first phase III randomized trial of a checkpoint inhibitor (cemiplimab) in cervical cancer, recently activated.",
        "Post-progression survival was not significantly different between the arms in GOG 240.",
        "These benefits were not accompanied by deterioration in quality of life."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30456447": [
        "The drug is being investigated as a treatment for various cancers and in September 2018 received approval in the USA for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation.",
        "This article summarizes the milestones in the development of cemiplimab leading to this first global approval for the treatment of advanced cutaneous squamous cell carcinoma.",
        "Cemiplimab (LIBTAYO<sup>\u00ae</sup>; cemiplimab-rwlc), a human programmed death receptor-1 (PD-1) monoclonal antibody that binds to PD-1 and blocks its interaction with programmed death ligands 1 (PD-L1) and 2 (PD-L2), is being developed by Regeneron Pharmaceuticals and Sanofi Genzyme."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30423090": [
        "Thus, there exists a need to systematically investigate their roles in genomes.",
        "Their functions are still largely unknown.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Conserved non-coding elements (CNEs) represent an enigmatic class of genomic elements which, despite being extremely conserved across evolution, do not encode for proteins.",
        "Towards this direction, identifying sets of CNEs in a wide range of organisms is an important first step.",
        "Currently, there are no tools published in the literature for systematically identifying CNEs in genomes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25209454": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Bathing suit ichthyosis (BSI) is an uncommon phenotype classified as a minor variant of autosomal recessive congenital ichthyosis (ARCI)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16968736": [
        "Bathing suit ichthyosis (BSI) is a striking and unique clinical form of autosomal recessive congenital ichthyosis characterized by pronounced scaling on the bathing suit areas but sparing of the extremities and the central face.",
        "Altogether, we identified 13 mutations in TGM1-among them seven novel missense mutations and one novel nonsense mutation.",
        "The distribution of TGase-1 substrates in the epidermis of affected skin corresponded to the situation in TGase-1 deficiency.",
        "Here we report on a series of 10 BSI patients.",
        "In situ TGase testing in skin of BSI patients demonstrated a marked decrease of enzyme activity when the temperature was increased from 25 to 37 degrees C. We conclude that BSI is caused by TGase-1 deficiency and suggest that it is a temperature-sensitive phenotype.",
        "Our genetic, ultrastructural and biochemical investigations show that BSI is caused by transglutaminase-1 (TGase-1) deficiency.",
        "Interestingly, the expression of TGase-3 and cathepsin D was reduced.",
        "Digital thermography validated a striking correlation between warmer body areas and presence of scaling in patients suggesting a decisive influence of the skin temperature.",
        "Structural modeling for the Tyr276Asn mutation reveals that the residue is buried in the hydrophobic interior of the enzyme and that the hydroxyl side chain of Tyr276 is exposed to solvent in a cavity of the enzyme.",
        "Cryosections of healthy skin areas demonstrated an almost normal TGase activity, in contrast to the affected BSI skin, which only showed a cytoplasmic and clearly reduced TGase-1 activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20522418": [
        "It is characterized by dark-grey or brownish scaling restricted to the 'bathing suit' areas, whereas the extremities and central face are almost completely spared.",
        "We report a 2-year-old African girl with BSI with ultrastructural and biochemical demonstration of TGase-1 deficiency over the affected skin.",
        "Bathing suit ichthyosis (BSI) is a rare variant of autosomal recessive lamellar ichthyosis due to transglutaminase-1 (TGase-1) gene mutations leading to a temperature sensitive phenotype.",
        "TGase-1 gene analysis disclosed the homozygous p.R315L mutation, which may lead to a temperature sensitive dysfunction of the enzyme."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28403434": [
        "Bathing suit ichthyosis is caused by recessive, temperature-sensitive mutations in the transglutaminase-1 gene (TGM1).",
        "Fewer than 40 cases have been reported in the literature.",
        "<strong class=\"sub-title\">\n          Importance:\n        </strong>\n      \n      Bathing suit ichthyosis (BSI) is a rare congenital disorder of keratinization characterized by restriction of scale to sites of relatively higher temperature such as the trunk, with cooler areas remaining unaffected.",
        "Clear genotype-phenotype correlations have been difficult to establish because several of the same TGM1 mutations have been reported in BSI and other forms of congenital ichthyosis.",
        "We identify novel and recurrent mutations in 16 participants with BSI."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22801880": [
        "Bathing suit ichthyosis is characterized by scaling of the skin in a bathing suit pattern, mainly limited to the trunk, whereas SICI is characterized by complete disappearance of the skin lesions.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Bathing suit ichthyosis (BSI) and self-improving collodion ichthyosis (SICI) are 2 minor variants of generalized autosomal recessive congenital ichthyosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30305743": [
        "The UK Biobank project is a prospective cohort study with deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69 at recruitment.",
        "A rich variety of phenotypic and health-related information is available on each participant, including biological measurements, lifestyle indicators, biomarkers in blood and urine, and imaging of the body and brain.",
        "The open resource is unique in its size and scope.",
        "Classical allelic variation at 11 human leukocyte antigen genes was imputed, resulting in the recovery of signals with known associations between human leukocyte antigen alleles and many diseases.",
        "Genome-wide genotype data have been collected on all participants, providing many opportunities for the discovery of new genetic associations and the genetic bases of complex traits.",
        "Here we describe the centralized analysis of the genetic data, including genotype quality, properties of population structure and relatedness of the genetic data, and efficient phasing and genotype imputation that increases the number of testable variants to around 96 million.",
        "Follow-up information is provided by linking health and medical records."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27773354": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The UK Biobank is a unique resource for biomedical research, with extensive phenotypic and genetic data on half a million adults from the general population.",
        "We aimed to examine the effect of neurodevelopmental copy number variants (CNVs) on the cognitive performance of participants."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29976469": [
        "Robot-assisted cystectomy has been proposed to provide similar oncological outcomes with lower morbidity.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Radical cystectomy is the surgical standard for invasive bladder cancer.",
        "We aimed to compare progression-free survival in patients with bladder cancer treated with open cystectomy and robot-assisted cystectomy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30140466": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To investigate whether a totally intracorporeally radical cystectomy (RC) can be considered the new 'gold standard' in bladder cancer, as open RC (ORC) is the current 'gold standard' for surgical treatment of muscle-invasive and high-grade non-muscle-invasive bladder cancer.",
        "However, robot-assisted radical cystectomy (RARC) is becoming the preferred surgical approach in many centres as it seems to maintain the oncological control of open surgery whilst offering improved perioperative benefits."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25626182": [
        "RAZOR is a multi-institutional, randomized, non-inferior, phase III trial that will enrol at least 320 patients with T1-T4, N0-N1, M0 bladder cancer with \u2248160 patients in both the RARC and ORC arms at 15 participating institutions.",
        "To date, 306 patients have been randomized and accrual to the RAZOR trial is expected to conclude in 2014.",
        "The purpose of the RAZOR (randomized open vs robotic cystectomy) study is to compare open radical cystectomy (ORC) vs robot-assisted RC (RARC), pelvic lymph node dissection (PLND) and urinary diversion for oncological outcomes, complications and health-related quality of life (HRQL) measures with a primary endpoint of 2-year progression-free survival (PFS).",
        "RAZOR is a multi-institutional, non-inferiority trial evaluating cancer outcomes, surgical complications and HRQL measures of ORC vs RARC with a primary endpoint of 2-year PFS.",
        "Data will be collected prospectively at each institution for cancer outcomes, complications of surgery and HRQL measures, and then submitted to trial data management services Cancer Research and Biostatistics (CRAB) for final analyses.",
        "Full data from the RAZOR trial are not expected until 2016-2017.",
        "The RAZOR trial is a landmark study in urological oncology, randomizing T1-T4, N0-N1, M0 patients with bladder cancer to ORC vs RARC, PLND and urinary diversion.",
        "In this study, we report the RAZOR trial experimental design, objectives, data safety, and monitoring, and accrual update."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30137632": [
        "Finally, using this comprehensive approach, we identify 3455 regions with recurrent CNVs that were missing from existing catalogs.",
        "To address this, we use PopSV, a CNV caller that relies on multiple samples to control for technical variation.",
        "Applying PopSV to 640 human genomes, we find that low-mappability regions are approximately 5 times more likely to harbor germline CNVs, in stark contrast to the nearly uniform distribution observed for somatic CNVs in 95 cancer genomes.",
        "In particular, we identify 347 genes with a novel exonic CNV in low-mappability regions, including 29 genes previously associated with disease.",
        "Although whole-genome sequencing (WGS) can help identify CNVs, most analytical methods suffer from limited sensitivity and specificity, especially in regions of low mappability.",
        "We demonstrate that our calls are stable across different types of repeat-rich regions and validate the accuracy of our predictions using orthogonal approaches.",
        "In addition to known enrichments in segmental duplication and near centromeres and telomeres, we also report that CNVs are enriched in specific types of satellite and in some of the most recent families of transposable elements.",
        "Copy number variants (CNVs) are known to affect a large portion of the human genome and have been implicated in many diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30226837": [
        "By explicitly identifying the reasons for gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases, we describe gene-specific strategies for the identification of important but hitherto ignored genes that can open novel directions for future investigation.",
        "Biomedical research has been previously reported to primarily focus on a minority of all known genes.",
        "Here, we demonstrate that these differences in attention can be explained, to a large extent, exclusively from a small set of identifiable chemical, physical, and biological properties of genes.",
        "Together with knowledge about homologous genes from model organisms, these features allow us to accurately predict the number of publications on individual human genes, the year of their first report, the levels of funding awarded by the National Institutes of Health (NIH), and the development of drugs against disease-associated genes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28765121": [
        "We review novel biologic agents targeting the T-helper 17 axis, including therapies directed towards interleukin (IL)-17 (secukinumab, ixekizumab, bimekizumab), IL-17R (brodalumab), IL-12/23p40 (ustekinumab, briakinumab) and IL-23p19 (guselkumab, tildrakizumab, brazikumab, risankizumab, mirikizumab).",
        "The past three decades have witnessed remarkable advances in our ability to target specific elements of the immune and inflammatory response, fuelled by advances in both biotechnology and disease knowledge.",
        "We summarise the development and recent application of Janus kinase (JAK) inhibitors in the treatment of IMIDs, including first-generation pan-JAK inhibitors (tofacitinib, baricitinib, ruxolitinib, peficitinib) and second-generation selective JAK inhibitors (decernotinib, filgotinib, upadacitinib).",
        "As well as providing superior treatments for immune-mediated inflammatory diseases (IMIDs), such therapies also offer unrivalled opportunities to study the underlying immunopathological basis of these conditions.In this review, we explore recent approaches to the treatment of IMIDs and the insights to pathobiology that they provide.",
        "Finally, we explore recent biotechnological advances such as the development of bispecific antibodies (ABT-122, COVA322), and their application to the treatment of IMIDs.",
        "Emerging strategies to interfere with cellular adhesion processes involved in lymphocyte recruitment are discussed, including both integrin blockade (natalizumab, vedolizumab, etrolizumab) and sphingosine-1-phosphate receptor inhibition (fingolimod, ozanimod).",
        "New biologics targeting B-cells (including ocrelizumab, veltuzumab, tabalumab and atacicept) and the development of novel strategies for regulatory T-cell modulation (including low-dose IL-2 therapy and Tregitopes) are also discussed.",
        "We also present an overview of biologics active against type I and II interferons, including sifalumumab, rontalizumab, anifrolumab and fontolizumab."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28762476": [
        "Exposure-response analyses to evaluate the QT prolongation potential for upadacitinib from phase I trials and the utility of the effect of food on QTcF to demonstrate ECG assay sensitivity are presented.",
        "Exposure-response analyses of QT data from early-stage clinical studies represent a valuable tool to assess the QT prolongation potential for drugs in development in lieu of standalone thorough QT (TQT) studies.",
        "These analyses supported requesting a waiver for the regulatory requirement for a dedicated thorough QT study for upadacitinib.",
        "Upadacitinib is a Janus kinase 1 inhibitor currently being evaluated in phase III rheumatoid arthritis trials.",
        "The analyses demonstrated no effect of upadacitinib on QT interval and confirmed the sensitivity of the ECG assay to detect the small QT shortening effect caused by food.",
        "However, demonstrating adequate electrocardiogram assay sensitivity can be challenging in the absence of a positive pharmacological control.",
        "Lack of bias from manual ECG adjudication was also demonstrated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29076110": [
        "<strong class=\"sub-title\">\n          Background and objectives:\n        </strong>\n      \n      Upadacitinib is a janus kinase (JAK) 1 inhibitor being developed for the treatment of rheumatoid arthritis (RA) and other inflammatory diseases.",
        "This work characterized upadacitinib population pharmacokinetics in healthy subjects and RA patients and the effects of covariates on upadacitinib exposure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29672874": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      There is a great unmet clinical need for efficacious, tolerable, economical and orally administrated drugs for the treatment of inflammatory bowel disease (IBD).",
        "New therapeutic avenues have become possible including the development of medications that target specific genetic pathways found to be relevant in other immune mediated diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29688617": [
        "A high-fat breakfast increased upadacitinib ER C<sub>max</sub> and AUC<sub>0-inf</sub> by only 20% and 17%, respectively, relative to fasting conditions.",
        "In the present study, upadacitinib pharmacokinetics were characterized after the administration of single and multiple once-daily doses of the ER formulation in healthy subjects relative to single and multiple twice-daily doses of the IR formulation.",
        "Doses of 15 and 30 mg once daily using the ER formulation provided equivalent AUC<sub>0-24</sub> , comparable C<sub>max</sub> and C<sub>min</sub> , and a fluctuation index over a 24-hour period at steady state similar to 6 and 12 mg twice daily, respectively, using the IR formulation.",
        "These results supported the use of upadacitinib 15- and 30-mg doses of the ER formulation in the phase 3 trials in RA.",
        "The median time to peak plasma concentrations was 2 to 4 hours for the ER formulation, and steady state was achieved by day 4 of once-daily dosing.",
        "The upadacitinib extended-release (ER) formulation was developed to enable once-daily dosing.",
        "Upadacitinib was administered in the phase 2 RA trials primarily as twice-daily regimens of an immediate-release (IR) formulation.",
        "Single 15- and 30-mg ER doses provided equivalent AUC<sub>0-inf</sub> compared with single 12- and 24-mg IR doses, respectively.",
        "Increase in upadacitinib exposure was dose-proportional over the evaluated 15- to 30-mg ER dose range.",
        "Upadacitinib is a Janus kinase 1 inhibitor under development for the treatment of several inflammatory disorders including rheumatoid arthritis (RA)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30394138": [
        "The comparison with abatacept is still ongoing. <b>Expert commentary</b>: Upadacitinib has displayed a rapid and favorable efficacy profile in RA but despite being a selective JAK1 inhibitor appears to have a similar safety profile to less-selective Jakinibs.",
        "The doses of upadacitinib extended-release 15 and 30 mg daily selected in phase III RA studies have shown a near-maximum efficacy in phase II studies.",
        "Longer term safety data are awaited.",
        "Upadacitinib was superior to adalimumab using ACR70, reduction of pain-VAS and improvement of HAQ-DI.",
        "Upadacitinib selectively inhibits Janus Kinase 1 (JAK1) which could potentially reduce JAK2 and JAK3-related side effects. <b>Areas covered</b>: In this paper, we review a newly developed oral selective JAK inhibitor, upadacitinib for the treatment of RA.",
        "Upadacitinib inhibited radiographic progression and displayed rapid and sustained clinical and functional efficacy in RA when in combination with methotrexate (MTX), upadacitinib was superior to placebo in MTX-Inadequate Responders (IRs) and biologic disease modifying antirheumatic drugs-IRs while as monotherapy, it was superior to MTX in MTX-IRs and MTX-na\u00efve patients.",
        "<b>Introduction</b>: Tofacitinib and baricitinib have recently been approved as second-line treatments for Rheumatoid arthritis (RA) though their maximum expected efficacy may be limited by dose-related toxicities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29908670": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Phase 2 studies with upadacitinib, a selective Janus kinase 1 (JAK1) inhibitor, have shown safety and efficacy in the treatment of patients with active rheumatoid arthritis.",
        "We did this study to further assess the safety and efficacy of upadacitinib in patients with an inadequate response to biologic disease-modifying anti-rheumatic drugs (bDMARDs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29908669": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Upadacitinib is a selective inhibitor of Janus kinase 1 and was efficacious in phase 2 studies in patients with moderate-to-severe rheumatoid arthritis.",
        "We aimed to assess the efficacy of upadacitinib in patients with inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30500075": [
        "This phase I, single-center, open-label, 2-period crossover study evaluated the effect of multiple doses of 30 mg once daily extended-release upadacitinib on the pharmacokinetics of a single oral dose of ethinylestradiol/levonorgestrel (0.03/0.15 mg; administered alone in period 1 and on day 12 of a 14-day regimen of upadacitinib in period 2) in 22 healthy female subjects.",
        "This study was designed to evaluate the effect of multiple doses of upadacitinib on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female subjects.",
        "The harmonic mean terminal half-life for ethinylestradiol (7.7 vs 7.0 hours) and levonorgestrel (37.1 vs 33.1 hours) was similar in the presence and absence of upadacitinib.",
        "Upadacitinib is a novel selective oral Janus kinase 1 (JAK) inhibitor being developed for treatment of several inflammatory diseases.",
        "The ratios (90% confidence intervals) for maximum plasma concentration and area under the plasma drug concentration-time curve from time zero to infinity following administration of ethinylestradiol/levonorgestrel with upadacitinib compared with administration of ethinylestradiol/ levonorgestrel alone were 0.96 (0.89-1.02) and 1.1 (1.04-1.19), respectively, for ethinylestradiol, and 0.96 (0.87-1.06) and 0.96 (0.85-1.07), respectively, for levonorgestrel.",
        "Ethinylestradiol and levonorgestrel were bioequivalent in the presence and absence of upadacitinib.",
        "Oral contraceptives are anticipated to be a common concomitant medication in the target patient populations.",
        "Therefore, upadacitinib can be administered concomitantly with oral contraceptives containing ethinylestradiol or levonorgestrel."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28503781": [
        "This work evaluated effects of high-fat meal, cytochrome P450 (CYP) 3A inhibition, CYP induction, and organic anion transporting polypeptide (OATP) 1B inhibition on upadacitinib pharmacokinetics.",
        "<strong class=\"sub-title\">\n          Aims:\n        </strong>\n      \n      Upadacitinib (ABT-494) is a selective Janus kinase 1 inhibitor being developed for treatment of auto-immune inflammatory disorders."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27597741": [
        "Using CNV-RF, we identified 12 of 13 deletions in samples with known CNVs, two cases with duplications, and identified novel deletions in 22 additional cases.",
        "The analytical variability in next-generation sequencing (NGS) and artifacts in coverage data because of issues with mappability along with lack of robust bioinformatics tools for CNV detection have limited the utility of targeted NGS data to identify CNVs.",
        "We describe the development and implementation of a bioinformatics algorithm, copy number variation-random forest (CNV-RF), that incorporates a machine learning component to identify CNVs from targeted NGS data.",
        "Furthermore, no CNVs were identified among 60 genes in 14 cases with normal copy number and no CNVs were identified in another 104 patients with clinical suspicion of CNVs.",
        "CNV-RF also detected heterozygous deletions and duplications with a specificity of 50% across 4813 genes.",
        "Simultaneous detection of small copy number variations (CNVs) (&lt;0.5 kb) and single-nucleotide variants in clinically significant genes is of great interest for clinical laboratories.",
        "All positive deletions and duplications were confirmed using a quantitative PCR method.",
        "The ability of CNV-RF to detect clinically relevant CNVs with a high degree of sensitivity along with confirmation using a low-cost quantitative PCR method provides a framework for providing comprehensive NGS-based CNV/single-nucleotide variant detection in a clinical molecular diagnostics laboratory."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24223514": [
        "On the heels of several trials demonstrating the efficacy of pre-exposure prophylaxis (PrEP) and the recent approval by the FDA of the supplemental indication for Truvada as PrEP, researchers, advocates, and community providers are calling for the investigation of implementation strategies that combine behavioral interventions with biomedical prevention.",
        "This paper describes the modification and integration of an evidence-based group-level intervention into a small PrEP pilot trial with young men who have sex with men (YMSM).",
        "The behavioral intervention as well as ongoing risk reduction counseling sessions were found to be highly acceptable among a sample of racially diverse YMSM."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22874836": [
        "In January 2011, following publication of evidence of safety and efficacy of daily oral tenofovir disoproxil fumarate 300 mg (TDF)/emtricitabine 200 mg (FTC) (Truvada, Gilead Sciences) as antiretroviral preexposure prophylaxis (PrEP) to reduce the risk for HIV acquisition among MSM in the iPrEx trial, CDC issued interim guidance to make available information and important initial cautions on the use of PrEP in this population.",
        "In the United States, an estimated 48,100 new human immunodeficiency virus (HIV) infections occurred in 2009.",
        "This interim guidance includes consideration of the new information and addresses pregnancy and safety issues for heterosexually active adults at very high risk for sexual HIV acquisition that were not discussed in the previous interim guidance for the use of PrEP in MSM.",
        "Of these, 27% were in heterosexual men and women who did not inject drugs, and 64% were in men who have sex with men (MSM), including 3% in MSM who inject drugs.",
        "Those recommendations remain valid for MSM, including MSM who also have sex with women.",
        "Since January 2011, data from studies of PrEP among heterosexual men and women have become available, and on July 16, 2012, the Food and Drug Administration (FDA) approved a label indication for reduction of risk for sexual acquisition of HIV infection among adults, including both heterosexuals and MSM."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26270298": [
        "It is essential for science to trump stereotypes and sex-negative messaging in guiding decision-making affecting PrEP access and uptake.",
        "In this commentary, we review literature on sexual behavior change accompanying PrEP use, discuss risk compensation concerns and the \"Truvada whore\" stereotype as PrEP barriers, question the appropriateness of restricting PrEP access because of risk compensation, and consider sexual pleasure as a benefit of PrEP, an acceptable motive for seeking PrEP, and a core element of health.",
        "However, concern about sexual risk behavior increasing with PrEP use (risk compensation) and corresponding stereotypes of promiscuity may undermine PrEP's preventive potential.",
        "Antiretroviral preexposure prophylaxis (PrEP; emtricitabine and tenofovir disoproxil fumarate [Truvada]) prevents HIV without penalizing sexual pleasure, and may even enhance pleasure (e.g., by reducing HIV-related anxiety)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23226529": [
        "We previously showed that a coitally-dependent Truvada regimen protected macaques against rectal SHIV transmission.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Daily pre-exposure prophylaxis (PrEP) with Truvada (a combination of emtricitabine (FTC) and tenofovir (TFV) disoproxil fumarate (TDF)) is a novel HIV prevention strategy recently found to prevent HIV transmission in men who have sex with men and heterosexual couples.",
        "Here we examined FTC and tenofovir TFV exposure in vaginal tissues after oral dosing and assessed if peri-coital Truvada also protects macaques against vaginal SHIV infection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19731560": [
        "Chronic hepatitis B affects 5-10% of HIV patients in Western countries.",
        "While pegIFN-alpha monotherapy for 1 year may be considered for HIV-HBV coinfected individuals with good spontaneous HIV control (elevated CD4 cell count, low plasma HIV-RNA), and certain HBV features (genotype A, HBeAg+, low serum HBV-DNA and elevated ALT), it is clear that very few coinfected patients fulfill these criteria.",
        "At this time, most experts agree that early introduction of anti-HBV active HAART is the best strategy for the treatment of chronic hepatitis B in HIV patients, and Truvada must be part of the triple regimen.",
        "Lamivudine should no longer be used as a single anti-HBV agent in HIV-HBV co-infected patients, given its limited antiviral potency and high risk of selection of resistance, which further results in wide cross-resistance to all other nucleoside analogues.",
        "Given its potential anti-HIV activity, both entecavir and telbivudine must only be prescribed with antiretroviral agents.",
        "Its co-formulation with emtricitabine (Truvada) is particularly convenient for treating both HIV and HBV in co-infected individuals.",
        "Another worrisome aspect of the selection of lamivudine-resistant HBV is the potential for selection of vaccine escape mutants.",
        "Recent reports of transmission of lamivudine-resistant HBV in HIV patients are of especial concern, and large surveillance studies suggest that it may occur in up to 10% of new HBV infections in Western countries.",
        "In HBeAg-negative HIV patients, adefovir may be an option but the relatively low antiviral potency of this drug discourages its wide use.",
        "Lack of information about potential pharmacodynamic interactions between entecavir and abacavir (both are guanosine analogues) or between telbivudine and zidovudine or stavudine (all are thymidine analogues) further discourages their concomitant use.",
        "Currently, tenofovir must be viewed as the drug of choice in HIV-HBV co-infected patients in whom antiretroviral therapy is advised."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29902179": [
        "To improve PrEP, many next-generation regimen, including long-acting formulations, are currently investigated.",
        "Combining the population pharmacokinetics of DTG with the stochastic framework, we predicted that plasma concentrations of 145.18 and 722.23nM prevent 50- and 90% sexual transmissions respectively.",
        "Truvada (emtricitabine-tenofovir) is currently the only medication approved for PrEP.",
        "However, pre-clinical testing may not guide candidate selection, since it often fails to translate into clinical efficacy.",
        "To prioritize- and help design PrEP regimen, tools are urgently needed that integrate pharmacological-, viral- and host factors determining prophylactic efficacy.",
        "We then predicted the reduction in HIV infection when DTG was used in PrEP, PrEP 'on demand' and post-exposure prophylaxis (PEP) before/after virus exposure.",
        "While the simulation framework can easily be adapted to other PrEP candidates, our simulations indicated that oral 50mg DTG is non-inferior to Truvada.",
        "PrEP 'on demand' prevented 79-84% infections and PEP &gt;80% when initiated within 6 hours after virus exposure and continued for as long as possible.",
        "Moreover, the predicted 90% preventive concentrations can guide release kinetics of currently developed DTG nano-formulations.",
        "To achieve the 90-90-90 goals set by UNAIDS, the number of new HIV infections needs to decrease to approximately 500,000 by 2020.",
        "Once daily PrEP with 50mg oral DTG prevented 99-100% infections, and 85% of infections when 50% of dosing events were missed.",
        "One of the 'five pillars' to achieve this goal is pre-exposure prophylaxis (PrEP).",
        "Despite its advantages, Truvada is costly and requires individuals to adhere to the once-daily regimen.",
        "Integrating the aforementioned factors, we developed an efficient and exact stochastic simulation approach to predict prophylactic efficacy, as an example for dolutegravir (DTG).",
        "On the other hand, quantifying prophylactic efficacy in the clinic is ethically problematic and requires to conduct long (years) and large (N&gt;1000 individuals) trials, precluding systematic evaluation of candidates and deployment strategies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28276922": [
        "This paper expands the representations and meanings of this new technology in a different light through the voices of gay men living with HIV in Paris.",
        "The main argument of this article is that PrEP as an additional HIV prevention tool blurs the lines between science, technologies and human sexuality.",
        "This paper explores what PrEP represents for HIV-positive gay men living in Paris, based upon data collected through interviews and ethnographic research.",
        "The pre-exposure prophylaxis (PrEP) drug Truvada is a new HIV prevention technology that is predominantly promoted as relevant to HIV-negative gay men.",
        "While HIV-positive gay men do not directly consume Truvada through PrEP, they nonetheless hold opinions and understandings of this drug, specifically as it relates to their own sexuality."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26411737": [
        "Women found to be unprotected against hepatitis B were enrolled and offered three doses of hepatitis B vaccine.",
        "Women with chronic infections were not enrolled in the trial.",
        "We present the case of a participant enrolled in the FEM-PrEP clinical trial with baseline evidence of immunity against hepatitis B virus who subsequently developed acute hepatitis B.",
        "Reinfection and reactivation of previously resolved hepatitis B virus infections have been documented in immunosuppressed individuals but not in healthy individuals.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      The FEM-PrEP trial was a pre-exposure prophylaxis clinical trial to test the safety and efficacy of Truvada (tenofovir disoproxil fumarate and emtricitabine) in the prevention of human immunodeficiency virus infection.",
        "Because Truvada can suppress hepatitis B virus replication, and withdrawal of Truvada can cause hepatic flares in patients with chronic hepatitis B, pre-enrollment screening included serological screening for hepatitis B virus markers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27093238": [
        "Participants' reasons for an extended break from PrEP were related to partnership dynamics (e.g., perceived low risk of a stable partner) and phases of life (e.g., trying to conceive).",
        "Life events (e.g., holidays and travel) could prompt shorter breaks in PrEP use.",
        "Oral pre-exposure prophylaxis (PrEP) using the antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (Truvada) has been shown to dramatically reduce the risk of HIV acquisition for women at higher risk of infection if taken daily.",
        "Participants charted their sexual contacts over the previous six months, indicated whether they would have taken PrEP if available and discussed whether and why they would have suspended PrEP use.",
        "These circumstances may or may not correspond to actual contexts of lower risk, highlighting the importance of tailored PrEP risk-reduction counselling.",
        "Nearly all participants said they would have used PrEP in the previous six months; half indicated they would have suspended PrEP use at some point.",
        "Understanding when and why women would intentionally stop using an efficacious oral PrEP drug within the context of their 'normal' daily lives is essential for delivering effective PrEP risk-reduction counselling.",
        "As part of a larger study, we conducted 60 qualitative interviews with women at higher risk of HIV in Bondo, Kenya, and Pretoria, South Africa."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22581627": [
        "Twenty years after its original discovery, tenofovir has acquired a crucial position in the fight against human immunodeficiency virus (HIV).",
        "First, tenofovir disoproxil fumarate (TDF) is not only efficacious against, and has been licensed for the treatment of HIV (AIDS), but also HBV (hepatitis B).",
        "Second, for the treatment of HIV infections, TDF can be used in combination with other anti-HIV drugs, such as emtricitabine (combination termed Truvada(\u00ae)) and Truvada can be further combined with efavirenz, rilpivirine, elvitegravir, atazanavir, or darunavir, as a single once-daily oral pill.",
        "Third, Truvada can be used prophylactically to prevent transmission of HIV infection.",
        "And fourth, to prevent sexual HIV transmission, tenofovir could also be used topically (i.e., as a vaginal gel)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21632769": [
        "Five macaques received a dose of Truvada 3 days before exposing them rectally to the simian/human immunodeficiency virus mutant SHIV162p3(M184V), followed by a second dose 2 h after exposure.",
        "Five untreated animals were used as controls.",
        "Despite the high (&gt;100-fold) level of FTC resistance conferred by M184V, all five treated animals were protected from infection, while the five untreated macaques were infected (P = 0.0008).",
        "Increased susceptibility to tenofovir due to M184V and other factors, including residual antiviral activity by FTC and/or reduced virus fitness due to M184V, may all have contributed to the observed protection.",
        "Virus exposures were done weekly for up to 14 weeks.",
        "Daily preexposure prophylaxis (PrEP) with Truvada (emtricitabine [FTC] and tenofovir disoproxil fumarate [TDF]) is a novel HIV prevention strategy recently found to reduce HIV incidence among men who have sex with men.",
        "We used a macaque model of HIV transmission to investigate if Truvada maintains prophylactic efficacy against an FTC-resistant isolate containing the M184V mutation.",
        "Our results show that Truvada maintains high prophylactic efficacy against an FTC-resistant isolate."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29068302": [
        "It is the only drug approved to prevent HIV infections, and Truvada is the key pharmaceutical component of pre-exposure prophylaxis, which is aimed at preventing, rather than treating, HIV infection and transmission.",
        "Truvada is getting a new lease on life as a preventive agent."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29719497": [
        "Consistent with this, we show that mice lacking exon 3 of <i>Adar3</i> (which encodes two double stranded RNA binding domains) have increased levels of anxiety and deficits in hippocampus-dependent short- and long-term memory formation.",
        "The newest member of the A-I editing family of ADAR proteins, the vertebrate-specific ADAR3, is highly expressed in the brain, but its functional significance is unknown. <i>In vitro</i> studies have suggested that ADAR3 acts as a negative regulator of A-I RNA editing but the scope and underlying mechanisms are also unknown.",
        "The amount of regulatory RNA encoded in the genome and the extent of RNA editing by the post-transcriptional deamination of adenosine to inosine (A-I) have increased with developmental complexity and may be an important factor in the cognitive evolution of animals.",
        "RNA sequencing revealed a dysregulation of genes involved in synaptic function in the hippocampi of <i>Adar3</i>-deficient mice.",
        "These results indicate that ADAR3 contributes to cognitive processes in mammals.",
        "We also show that ADAR3 transiently translocates from the cytoplasm to the nucleus upon KCl-mediated activation in SH-SY5Y cells.",
        "Meta-analysis of published data indicates that mouse Adar3 expression is highest in the hippocampus, thalamus, amygdala, and olfactory region."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29170142": [
        "Compared to soluble cGAMP, the Ace-DEX cGAMP MPs enhanced type-I interferon responses nearly 1000-fold in vitro and 50-fold in vivo, caused up to a 10<sup>4</sup>-fold boost in antibody titers, increased Th1-associated responses, and expanded germinal center B cells and memory T cells.",
        "In this study we evaluated the adjuvant activity of the potent STING agonist, CDN 3'3'-cGAMP (cGAMP), encapsulated in acid-sensitive acetalated dextran (Ace-DEX) polymeric microparticles (MPs) which passively target antigen-presenting cells for intracellular release.",
        "Stimulator of interferon genes (STING, also known as MITA, MPYS, or ERIS) is an exciting adjuvant target due to its role in cyclic dinucleotide (CDN)-driven anti-viral immunity; however, a major hindrance is STING's cytosolic localization which requires intracellular delivery of its agonists.",
        "This formulation was superior to all particle delivery systems evaluated and maintained its bioactivity following a sterilizing dose of gamma irradiation.",
        "Furthermore, the encapsulated cGAMP elicited no observable toxicity in animals and achieved protective immunity against a lethal influenza challenge seven months post-immunization when using CDN adjuvant doses up to 100-fold lower than previous reports.",
        "Delivery of STING agonists via particle platforms has proven a more successful strategy, but the opportunity for improved formulations and bioactivity remains.",
        "For these reasons, Ace-DEX MP-encapsulated cGAMP represents a potent vaccine adjuvant of humoral and cellular immunity.",
        "Most FDA-approved adjuvants for infectious agents boost humoral but not cellular immunity, and have poorly-understood mechanisms.",
        "As a result, STING agonists administered in a soluble form have elicited suboptimal immune responses."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29505322": [
        "Our data show that systemic DMXAA treatment rapidly induced the expression of Ifnb1, Il6, and Tnfa in the SGs, and these cytokines were also elevated in circulation.",
        "Primary SG cells were used to study the expression and activation of STING.",
        "Thus, apart from viral infections, conditions that cause cellular perturbations and accumulation of host DNA within the cytosol should also be considered as possible triggers for SS.",
        "Sj\u00f6gren syndrome (SS), a chronic autoimmune disorder causing dry mouth, adversely affects the overall oral health in patients.",
        "In primary SG cells, DMXAA activated STING and induced IFN-\u03b2 production.",
        "Sera were analyzed for cytokines and autoantibodies.",
        "Upon activation, cytosolic DNA sensors can interact with the stimulator of interferon genes (STING) protein, and activation of STING causes increased expression of type I IFNs.",
        "The role of STING activation in SS is not known.",
        "Recognition of nucleic acids by cytosolic nucleic acid sensors is a major trigger for the induction of type I IFNs.",
        "In contrast, increased Ifng gene expression was dominantly detected in the SGs.",
        "The DMXAA-treated mice developed autoantibodies, sialoadenitis, and glandular hypofunction.",
        "Our study demonstrates that activation of the STING pathway holds the potential to initiate SS.",
        "In this study, to investigate whether the cytosolic DNA sensing pathway influences SS development, female C57BL/6 mice were injected with a STING agonist, dimethylxanthenone-4-acetic acid (DMXAA).",
        "Salivary glands (SGs) were studied for gene expression and inflammatory cell infiltration.",
        "STING expression in SGs was mainly observed in ductal and interstitial cells.",
        "The type I innate lymphoid cells present within the SGs were the major source of IFN-\u03b3, and their numbers increased significantly within 3 d of treatment.",
        "SG function was evaluated by measuring pilocarpine-induced salivation.",
        "Activation of innate immune responses and excessive production of type I interferons (IFNs) play a critical role in the pathogenesis of this disorder."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29472271": [
        "The majority of these studies have focused on the effect of CDNs on immune cells but have not conclusively interrogated the role of stromal cells in the acute rejection of the CDN-injected tumor.",
        "However, the specific immune mechanisms underlying these responses remain incompletely defined.",
        "Here, we revealed a mechanism of STING agonist-mediated tumor response that relied on both stromal and immune cells to achieve tumor regression and clearance.",
        "The cGAS-STING cytosolic DNA sensing pathway may play an integral role in the initiation of antitumor immune responses.",
        "These results provide evidence for crosstalk between stromal and hematopoietic cells during CDN-mediated tumor collapse after i.t. administration.",
        "Studies evaluating the immunogenicity of various cyclic dinucleotide (CDN) STING agonists administered by intratumoral (i.t.) injection showed potent induction of inflammation, tumor necrosis, and, in some cases, durable tumor-specific adaptive immunity.",
        "Using knockout and bone marrow chimeric mice, we showed that although bone marrow-derived TNF\u03b1 was necessary for CDN-induced necrosis, STING signaling in radioresistant stromal cells was also essential for CDN-mediated tumor rejection.",
        "These mechanistic insights may prove critical in the clinical development of STING agonists. <i>Cancer Immunol Res; 6(4); 422-33. \u00a92018 AACR</i>."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30079976": [
        "Biochemical and cell-based assays indicate that \u03b1-mangostin binds to and activates human STING, leading to activation of the downstream interferon regulatory factor (IRF) pathway and production of type I interferons.",
        "Furthermore, our studies show that \u03b1-mangostin has the potential to repolarize human monocyte-derived M2 macrophages to the M1 phenotype.",
        "The xanthone derivate 5',6'-dimethylxanthenone-4-acetic acid (DMXAA, also known as ASA404 or vadimezan) is a potent agonist of murine STING (stimulator of interferon genes), but cannot activate human STING.",
        "Herein we report that \u03b1-mangostin, which bears the xanthone skeleton, is an agonist of human STING, but activates murine STING to a lesser extent.",
        "The agonist effect of \u03b1-mangostin in the STING pathway might account for its antitumor and antiviral activities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29468108": [
        "Early studies of nivolumab in association with anti-angiogenic therapy have generated enthusiasm and multiple combination trials are ongoing.",
        "Targeted agents form the backbone of most therapeutic strategies in advanced renal cell carcinoma (aRCC) but ultimately resistance develops and toxicity often leads to discontinuation of treatment, limiting the clinical benefits of these treatments.",
        "Nivolumab, a fully human IgG4 anti-PD-1 antibody, selectively blocks the interaction between PD-1 and its ligands PD-L1 and PD-L2 and provides a novel therapy option for patients with aRCC.",
        "In 2015, the pivotal phase III study CheckMate 025 led to the Food and Drug Administration approval of nivolumab in patients with aRCC who had received prior anti-angiogenic therapy, and in 2017, the phase III study CheckMate 214 showed that combined immunotherapy with nivolumab plus ipilimumab resulted in greater objective response rate and prolonged progression-free survival when compared with sunitinib in intermediate- and poor-risk patients with previously untreated aRCC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29562145": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Nivolumab plus ipilimumab produced objective responses in patients with advanced renal-cell carcinoma in a pilot study.",
        "This phase 3 trial compared nivolumab plus ipilimumab with sunitinib for previously untreated clear-cell advanced renal-cell carcinoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29587324": [
        "The german kidney tumor guideline strongly recommends Nivolumab and Cabozantinib as 2nd line treatments after prior VEGF targeted therapy.",
        "Systemic treatment of metastatic renal cell carcinoma (mRCC) has substantially changed during the last 2 years due to approval of the immune-checkpoint inhibitor Nivolumab (Opdivo<sup>\u00ae</sup>) and new multikinase inhibitors (Cabozantinib, Lenvatinib, Tivozanib).",
        "Nivolumab in combination with Ipilimumab will become a standard 1st line option for patients with intermediate and high risk profile according to IMDC.",
        "Further phase-3 trials with \"new\" VEGFR-TKIs (Axitinib, Cabozantinib, Lenvatinib) and PD-1/PD-L1 inhibitor combinations are ongoing.In conclusion, the PD-1 immune checkpoint inhibitor Nivolumab will remain a standard treatment for patients with metastatic renal cell carcinoma after prior VEGF targeted therapy.",
        "Currently, numerous combinations with PD-1/PD-L1 inhibitors are compared to Sunitinib as first line treatment of mRCC.",
        "However, a considerable increase of immune related adverse events is associated with the immune combination therapy.",
        "CheckMate 025, the prospective randomized trial which led to approval of Nivolumab demonstrated improved overall survival (26 month vs. 19.7 month; hazard ratio 0.73; p = 0.0006) and response rate (26 % vs. 5 %) as well as a favorable toxicity profile compared with Everolimus.",
        "Another randomized trial demonstrates improved progression-free survival for the combination of the PD-L1 inhibitor Atezolizumab and the VEGF antibody Bevacizumab in patients with PD-L1 positive tumors; this was found in all IMDC risk groups.",
        "Furthermore, CheckMate 214 shows better side effect profile and quality of life in patients receiving Nivolumab and Ipilimumab compared with Sunitinib.",
        "Out of these CheckMate 214, a randomized phase-3 trial is the first to demonstrate a significant higher objective response rate (42 % vs. 27 %, p &lt; 0.0001) and overall survival (Sunitinib 26.0 month, median for Nivo + Ipi has been not yet reached (28.2 - NR); Hazard ratio 0.63) for the combination of Nivolumab and the CTLA-4 antibody Ipilimumab in IMDC intermediate and high risk patients.",
        "Further data are required regarding PD-1/PD-L1 inhibitors in combination with Bevacizumab and VEGFR-TKIs, respectively, including overall survival and side effect profile."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29728867": [
        "In this review, we discuss the systemic Immunotherapy with checkpoint inhibitors that have been approved or are currently being investigated in RCC, clinical experience with these agents, and its future development.",
        "378(14):1277-1290, 2018).",
        "In the United States, the estimated number of new cases of renal cell carcinoma (RCC) is approximately 65,000 case with about 15,000 deaths in the year of 2018 (Siegel et al. in CA Cancer J Clin 68(1):7, 2018).",
        "Results from clinical trials are encouraging in both front-line and second-line settings, in a phase III trial (CheckMate 025) nivolumab compared to everolimus improved overall survival in previously treated metastatic RCC who had progressed on prior treatment with targeting agents (Motzer et al. in N Engl J Med 373:1803, 2015).",
        "Historically, complete tumor regression in metastatic RCC is achievable in a minority of patients through traditional immunotherapies such as high-dose interleukin-2 (IL-2) (Fyfe et al. in J Clin Oncol 13(3):688, 1995) and interferon-alfa (IFNa) (Negrier et al. in N Engl J Med 338(18):1272, 1998); however due to the significant rate of toxicities and low efficacy; accordingly the targeted therapy with tyrosine kinase inhibitors (TKIs) and vascular endothelial growth factor-antibodies (VEGF) became the standard and prevalent treatment approach for advanced RCC both in front and subsequent lines of therapy (Escudier et al. in Ann Oncol.",
        "CheckMate 214, a phase III trial, demonstrated superior overall survival and objective response with combined checkpoint inhibitors compared to sunitinib in Treatment-Na\u00efve Advanced RCC among intermediate- and poor-risk group (Motzer et al. in N Engl J Med.",
        "A new avenue of immunotherapy utilizing novel strategy to block immune checkpoints has emerged in a new era for RCC treatment (Ascierto et al. in J Transl Med 12:291, 2014).",
        "RCC as an immunogenic malignancy is supported by many theories and facts which include tumor richness of lymphocytes infiltrate, the occurrence of spontaneous tumor regression, and the proved effect of traditional immunotherapy (Finke et al. in J Immunother 11(1):1-11, 1992), all these factors support the potential therapeutic effect of the novel immunotherapeutic agents in RCC.",
        "25(Suppl 3):iii49-iii56, 2014)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30187355": [
        "First-in-class, the PD-1 inhibitor nivolumab improved overall survival in advanced renal cell carcinoma following prior anti-angiogenic therapy, an important shift in the management of clear-cell renal cell carcinoma.",
        "Immune modulatory treatment regimens, led by immune checkpoint inhibitors, have transformed the treatment of clear-cell renal cell carcinoma.",
        "Further Phase 3 trials are awaited with tyrosine kinase and immune checkpoint inhibitor combinations.",
        "Further improvements of long-term outcomes will be driven by combinations in the first-line setting, including PD-1/PD-L1 associated with antiangiogenic therapies, or PD1/PD-L1 inhibitors with other immune checkpoint inhibitors such as anti-CTLA-4, anti-LAG-3 or TIM-3 targeted therapies.",
        "First, the CheckMate 214 trial demonstrated an objective response rate and overall survival benefit for the combination of nivolumab plus ipilimumab in the intermediate- and poor-risk patients.",
        "The continuing improvement of antitumor immunity comprehension and the emergence of new immune modulatory treatments will deeply change the management of renal cell carcinoma for the years to come.",
        "Clinical trials of immune checkpoint inhibitors are also actively investigated in the localized adjuvant or neoadjuvant setting.",
        "Second, the IMMotion 151 study demonstrated a progression-free survival benefit for the atezolizumab plus bevacizumab combination by investigator assessment.",
        "Nevertheless, the search for biomarkers along with new clinical trial designs will be crucial to better select the patients that may derive the greatest benefit from these advances.",
        "The first two randomized Phase 3 trials assessing these combinations have now challenged sunitinib in first-line setting."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30332546": [
        "The combination demonstrated a higher 18-month overall survival rate of 75% versus 60%, and a higher objective response rate of 42% versus 27%, for the combination in favor over sunitinib monotherapy.",
        "These results herald the rapidly changing role of immune checkpoint inhibitor therapy as first-line treatment for metastatic RCC.",
        "Motzer et al. have recently published in the New England Journal of Medicine the findings of CheckMate 214 trial, using nivolumab and ipilimumab, a cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitor, versus sunitinib in previously untreated advanced RCC.",
        "Nivolumab is a programmed death 1 (PD-1) inhibitor currently approved as second-line treatment for advanced renal cell carcinomas (RCC) after failure of standard antiangiogenic treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29223605": [
        "For this reason the European Association of Urology RCC guidelines have been updated.",
        "The trial showed superior survival for a combination of ipilimumab and nivolumab (IN), compared with the previous standard of care, in intermediate- and poor-risk patients with metastatic clear cell renal cell carcinoma.",
        "Therefore, sunitinib or pazopanib remains the favoured agent for this subgroup of patients.",
        "LBA5, ESMO 2017, 2017).",
        "The randomised phase III clinical trial Checkmate-214 showed a survival superiority for the combination of ipilimumab and nivolumab when compared with the previous standard of care in first-line metastatic/advanced clear cell renal cell carcinoma (RCC) (Escudier B, Tannir NM, McDermott DF, et al.",
        "Furthermore, at present, the data from the trial are immature in favourable-risk patients.",
        "CheckMate 214: efficacy and safety of nivolumab plus ipilimumab vs sunitinib for treatment-na\u00efve advanced or metastatic renal cell carcinoma, including IMDC risk and PD-L1 expression subgroups.",
        "When IN is not safe or feasible, alternative agents such as sunitinib, pazopanib, and cabozantinib should be considered.",
        "These results change the frontline standard of care for this disease and have implications for the selection of subsequent therapies.",
        "PATIENT SUMMARY: The European Association of Urology guidelines will be updated based on the results of the phase III Checkmate-214 clinical trial."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29446767": [
        "Here we tested the hypothesis that, although the genetic cause is not known, the tissue distribution of the clinical manifestations in CLAPO seems to follow a pattern of somatic mosaicism.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      CLAPO syndrome is a rare vascular disorder characterized by capillary malformation of the lower lip, lymphatic malformation predominant on the face and neck, asymmetry, and partial/generalized overgrowth."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30367574": [
        "This comprehensive and open access knowledge base is required to disseminate novel insights about cancer.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The high growth of Next Generation Sequencing data currently demands new knowledge extraction methods.",
        "State of the art rule-based classifiers are designed to extract a single classification model, possibly composed of few relevant genes.",
        "Conversely, we aim to create a large knowledge base composed of many rule-based models, and thus determine which genes could be potentially involved in the analyzed tumor.",
        "In particular, the RNA sequencing gene expression experimental technique stands out for case-control studies on cancer, which can be addressed with supervised machine learning techniques able to extract human interpretable models composed of genes, and their relation to the investigated disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30404778": [
        "The biggest limitation of CAGE is that even the most recently improved version (nAnT-iCAGE) still requires large amounts of total cellular RNA (5 \u00b5g), preventing its application to scarce biological samples such as those from early embryonic development or rare cell types.",
        "We demonstrate the ability of SLIC-CAGE to generate data for genome-wide promoterome with 1000-fold less material than required by existing CAGE methods, by generating a complex, high-quality library from mouse embryonic day 11.5 primordial germ cells.",
        "In combination with high-throughput sequencing, CAGE has revolutionized our understanding of the rules of transcription initiation, led to discovery of new core promoter sequence features, and discovered transcription initiation at enhancers genome-wide.",
        "Cap analysis of gene expression (CAGE) is a methodology for genome-wide quantitative mapping of mRNA 5' ends to precisely capture transcription start sites at a single nucleotide resolution.",
        "Here, we present SLIC-CAGE, a Super-Low Input Carrier-CAGE approach to capture 5' ends of RNA polymerase II transcripts from as little as 5-10 ng of total RNA.",
        "This dramatic increase in sensitivity is achieved by specially designed, selectively degradable carrier RNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28657199": [
        "However, there are concerns about the authenticity of medicines purchased online.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      The National Health Service in England (NHS England) does not provide pre-exposure prophylaxis (PrEP) against HIV, forcing people to purchase generic versions on the internet.",
        "We established an innovative service offering plasma tenofovir (TFV) and emcitrabine (FTC) therapeutic drug monitoring for people buying generic PrEP online, to ensure that drug concentrations in vivo were consistent with those of propriety brands and previously published data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29278542": [
        "This review summarizes the recent literature on kidney and bone health in individuals treated with TDF and the newer prodrug tenofovir alafenamide (TAF).",
        "Although TDF is well tolerated, the potential for kidney and bone toxicity has important implications for public health given the large number of individuals exposed to TDF worldwide.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      The antiviral agent tenofovir is highly effective for the treatment of HIV and hepatitis B virus infections, and the older prodrug tenofovir disoproxil fumarate (TDF) is also a component of daily preexposure prophylaxis (PrEP) to reduce the risk of HIV infection in high-risk populations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23972284": [
        "Alternatives to a daily oral PrEP regimen are being explored.",
        "In this review, we focus on the challenges and opportunities of a daily oral PrEP regimen to curb the rising incidence of HIV infection in high-risk groups, and particularly in men who have sex with men.",
        "A number of issues would need to be addressed before PrEP could be implemented, including assessing the real effectiveness and cost-effectiveness of daily PrEP, the sustainability of daily adherence, the risk of selecting resistance, the long-term safety, and the risk of change in sexual behavior that might offset the benefit of PrEP.",
        "Following US Food and Drugs Administration approval in July 2012 of daily oral tenofovir and emtricitabine for pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals in the USA, there has been much controversy about the implementation of this PrEP regimen in other countries throughout the world, and in Europe in particular."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27900502": [
        "Of 3068 citations screened, 76 peer-reviewed articles and 28 conference abstracts were included.",
        "Data abstraction used standardised forms to categorise by population groups and relevant themes.",
        "Concerns about safety, side effects, cost and effectiveness were the most frequently cited barriers to use.",
        "Healthcare providers would consider prescribing PrEP, but need more information before doing so.",
        "To prepare these guidelines, we conducted a systematic review of values and preferences among populations that might benefit from PrEP, women, heterosexual men, young women and adolescent girls, female sex workers, serodiscordant couples, transgender people and people who inject drugs, and among healthcare providers who may prescribe PrEP.",
        "Most studies (N = 78) evaluated hypothetical use of PrEP, while 26 studies included individuals who actually took PrEP or placebo.",
        "Findings from a rapidly expanding evidence base suggest that the majority of populations most likely to benefit from PrEP feel positively towards it.",
        "These same populations would benefit from overcoming current implementation challenges with the shortest possible delay.",
        "Daily oral pre-exposure prophylaxis (PrEP) is the use of antiretroviral drugs by HIV-negative people to prevent HIV infection.",
        "WHO released new guidelines in 2015 recommending PrEP for all populations at substantial risk of HIV infection.",
        "There was little indication of risk compensation.",
        "Geographic coverage was global.",
        "Awareness of PrEP was low, but once participants were presented with information about PrEP, the majority said they would consider using it.",
        "A comprehensive search strategy reviewed three electronic databases of articles and HIV-related conference abstracts (January 1990-April 2015)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25987851": [
        "The scale-up of PrEP is underway, but several implementation questions remain unanswered.",
        "Evidence is beginning to emerge from these open-label studies and will be critical for guiding PrEP scale-up.",
        "Demonstration projects and open-label extensions of placebo-controlled trials are ongoing and hope to contribute to our understanding of PrEP use and delivery outside the randomized controlled trial setting.",
        "The use of daily tenofovir/emtricitabine as oral PrEP was found to be effective in multiple placebo-controlled clinical trials and approved by the United States Food and Drug Administration.",
        "Despite significant efforts, the rate of new HIV infections worldwide remains unacceptably high, highlighting the need for new HIV prevention strategies.",
        "In addition, the Centers for Disease Control and Prevention in the United States and the World Health Organization have both released guidelines recommending the offer of oral PrEP to high-risk populations.",
        "Maximizing the public health impact of PrEP will require rollout to be combined with interventions to promote uptake, support adherence, and prevent increases in risk behavior.",
        "HIV pre-exposure prophylaxis (PrEP) is a new approach that involves the ongoing use of antiretroviral medications by HIV-negative individuals to reduce the risk of HIV infection.",
        "Outside of such studies, PrEP uptake has been slow and several client- and provider-related barriers are limiting uptake.",
        "Additional PrEP strategies are currently under investigation in placebo-controlled clinical trials and may be available in the future."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23570850": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The potential impact of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) with overlapping and nonoverlapping antiretrovirals (ARVs) on human immunodeficiency virus (HIV) transmission and drug resistance is unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27177804": [
        "We examined correlates of the willingness to use PrEP among community-recruited older PWID in Washington, DC.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Use of pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) has been shown to be effective in preventing HIV transmission."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21799568": [
        "Two antiretroviral nucleoside analog HIV-1 reverse transcriptase inhibitor drugs are currently under trial as PrEP drugs, namely tenofovirdisoproxilfumarate (TDF) alone and TDF in combination with emricitabine (FTC), to be taken as daily single dose oral drugs.",
        "This led to publication of interim guidance by CDC to use of PrEP by health providers for MSM.",
        "There are various issues/concerns with PrEP such as ADRs and resistance to TDF/FTC, adherence to drugs, acceptability, sexual disinhibition, use of PrEP as first line of defense for HIV without other prevention strategies, and cost.",
        "Pre-exposure prophylaxis (PrEP) is an experimental approach to HIV prevention and consists of antiretroviral drugs to be taken before potential HIV exposure in order to reduce the risk of HIV infection and continued during periods of risk.",
        "Few other trials are Bangkok Tenofovir Study, Partners PrEP Study, FEM-PrEP study, and VOICE (MTN-003) study.",
        "The PrEP has a potential to address unmet need in public health if delivered as a part of comprehensive toolkit of prevention services, including risk-reduction, correct and consistent use of condoms, and diagnosis and treatment of sexually transmitted infections.",
        "An effective PrEP could provide an additional safety net to sexually active persons at risk, when combined with other prevention strategies.",
        "There are 11 ongoing trials of ARV-based prevention in different at risk populations across the world.",
        "Future trials are being formulated for intermittent PrEP (iPrEP) where drugs are taken before and after sex, \"stand-in dose\" iPrEP, vaginal or rectal PrEP, etc.",
        "The iPrex trial showed that daily use of oral TDF/FTC by MSM resulted in 44% reduction in the incidence of HIV.",
        "Women represent nearly 60% of adults infected with HIV and PrEP can be a female-controlled prevention method for women who are unable to negotiate condom use."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28370177": [
        "The index of suspicion for possible PrEP 'interference' should be highest in the context of concomitant low-level positive or 'greyzone' reactivity on HIV NAT and serological tests, which is an unusual pattern in acutely HIV-infected blood donors.",
        "Another possibility is detectable HIV RNA with negative HIV serology (i.e. a potential 'NAT yield' case) but without subsequent HIV seroconversion (or disappearance of HIV RNA).",
        "The current rarity of PrEP breakthrough infection indicates that any potential safety risk is likely very small.",
        "HIV pre-exposure prophylaxis (PrEP) is the use of one or more antiretroviral medications (in combination) to prevent HIV infection.",
        "If such a person was tested in the course of donating blood, the results may therefore be difficult to interpret.",
        "Failure to seroconvert and seroreversion (loss of previously detectable HIV antibodies) have also both been observed with 2nd, 3rd and 4th generation screening immunoassays, as well as Western blot assays.",
        "Excluding antiretroviral therapy or PrEP use by the donor in such circumstances would be important.",
        "If someone who is using PrEP unknowingly becomes HIV infected (termed 'PrEP breakthrough infection'), there may be suppressed viral replication resulting in a virus level undetectable by the most sensitive HIV NAT.",
        "The most commonly used PrEP medication (Truvada<sup>\u00ae</sup> , Gilead Sciences, Inc.) acts by inhibiting HIV-1 reverse transcriptase.",
        "However, considering the increasing use of PrEP we feel it is prudent for those interpreting HIV donor screening test results to consider the potential for PrEP interference."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26746652": [
        "The World Health Organization recently recommended Truvada(\u00ae) (Gilead Sciences, Inc.) or tenofovir disoproxil fumarate (TDF) for high-risk individuals, with limited data for single-agent TDF PrEP in men who have sex with men (MSM).",
        "We report two cases of TDF PrEP failure in MSM who had received long-term TDF for hepatitis B infection and had therapeutic levels of drug immediately after HIV acquisition.",
        "Rapid antiretroviral intensification at diagnosis of acute HIV infection failed to limit immune dysfunction or prevent the establishment of a viral reservoir.",
        "The use of antiretrovirals as pre-exposure prophylaxis (PrEP) is highly efficacious in HIV prevention."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29381780": [
        "Chronic hypophosphatemia causes impaired mineralization of the bone matrix and results in rickets and osteomalacia.",
        "FGF23 excess induces hypophosphatemia via impaired phosphate reabsorption in the renal proximal tubules and decreased phosphate absorption in the intestines.",
        "Phosphate plays essential roles in many biological processes, and the serum phosphate level is tightly controlled.",
        "Several measures to inhibit FGF23 activity have been considered as possible new treatments for FGF23-related hypophosphatemic diseases.",
        "In particular, a humanized monoclonal antibody for FGF23 (burosumab) is a promising treatment in patients with XLH and TIO.",
        "However, this therapy has certain efficacy- and safety-associated limitations.",
        "Another clinically relevant form of FGF23-related hypophosphatemic disease is tumor-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.",
        "Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that regulates phosphate metabolism.",
        "This review will focus on the phosphate metabolism and the pathogenesis and treatment of FGF23-related hypophosphatemic diseases.",
        "A combination of active vitamin D and phosphate salts is the current medical therapy used to treat patients with XLH and inoperative TIO.",
        "There are several types of genetic and acquired FGF23-related hypophosphatemic diseases.",
        "Among these diseases, X-linked hypophosphatemia (XLH), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (PHEX) gene, is the most prevalent form of genetic FGF23-related hypophosphatemic rickets."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29679282": [
        "Burosumab (Crysvita<sup>\u00ae</sup>; Kyowa Hakko Kirin Co., Ltd. and Ultragenyx Pharmaceutical Inc.) is a fully human monoclonal antibody directed at fibroblast growth factor 23 (FGF23).",
        "Multinational phase III trials of burosumab are currently underway in adult and paediatric patients with XLH.",
        "Excessive FGF23 production has been implicated in various hypophosphataemic diseases.",
        "Inhibition of FGF23 by burosumab results in increased renal phosphate reabsorption and increased serum levels of phosphorus and active vitamin D.",
        "In April 2018, the US FDA approved burosumab for the treatment of XLH in adults and children one year of age and older.",
        "Burosumab is also being evaluated in the phase II setting in adults with tumour-induced osteomalacia and epidermal nevus syndrome in the USA, as well as in Japan and Korea.",
        "This article summarizes the milestones in the development of burosumab leading to its first global approval in the EU for XLH in paediatric patients.",
        "In February 2018, the EMA granted subcutaneous burosumab conditional marketing authorization for the treatment of X-linked hypophosphataemia (XLH) with radiographic evidence of bone disease in children one year of age and older and adolescents with growing skeletons."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29791829": [
        "We investigated burosumab, a monoclonal antibody that targets FGF-23, in patients with X-linked hypophosphatemia.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      X-linked hypophosphatemia is characterized by increased secretion of fibroblast growth factor 23 (FGF-23), which leads to hypophosphatemia and consequently rickets, osteomalacia, and skeletal deformities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29896030": [
        "Burosumab-twza (Crysvita) for a rare inherited form of rickets; ibalizumab-uiyk (Trogarzo) for human immunodeficiency virus type 1 infection; and tildrakizumab-asmn (Ilumya) for adults with moderate-to-severe plaque psoriasis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29947083": [
        "Biochemical markers of bone formation and resorption increased significantly from baseline with burosumab treatment compared with placebo.",
        "There were no treatment-related serious adverse events or meaningful changes from baseline in serum or urine calcium, intact parathyroid hormone, or nephrocalcinosis.",
        "In X-linked hypophosphatemia (XLH), inherited loss-of-function mutations in the PHEX gene cause excess circulating levels of fibroblast growth factor 23 (FGF23), leading to lifelong renal phosphate wasting and hypophosphatemia.",
        "Participants with hypophosphatemia and pain were assigned 1:1 to burosumab 1 mg/kg (n = 68) or placebo (n = 66) subcutaneously every 4 weeks (Q4W) and were comparable at baseline.",
        "Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.",
        "These data support the conclusion that burosumab is a novel therapeutic addressing an important medical need in adults with XLH.\u00a9 2018 The Authors.",
        "Across midpoints of dosing intervals, 94.1% of burosumab-treated participants attained mean serum phosphate concentration above the lower limit of normal compared with 7.6% of those receiving placebo (p &lt; 0.001).",
        "The safety profile of burosumab was similar to placebo.",
        "Adults with XLH present with chronic musculoskeletal pain and stiffness, short stature, lower limb deformities, fractures, and pseudofractures due to osteomalacia, accelerated osteoarthritis, dental abscesses, and enthesopathy.",
        "Burosumab significantly reduced the Western Ontario and the McMaster Universities Osteoarthritis Index (WOMAC) stiffness subscale compared with placebo (least squares [LS] mean \u00b1 standard error [SE] difference, -8.1 \u00b1 3.24; p = 0.012).",
        "At week 24, 43.1% (burosumab) and 7.7% (placebo) of baseline active fractures were fully healed; the odds of healed fracture in the burosumab group was 16.8-fold greater than that in the placebo group (p &lt; 0.001).",
        "This report summarizes results from a double-blind, placebo-controlled, phase 3 trial of burosumab in symptomatic adults with XLH.",
        "Reductions in WOMAC physical function subscale (-4.9 \u00b1 2.48; p = 0.048) and Brief Pain Inventory worst pain (-0.5 \u00b1 0.28; p = 0.092) did not achieve statistical significance after Hochberg multiplicity adjustment.",
        "Burosumab, a fully human monoclonal antibody, binds and inhibits FGF23 to correct hypophosphatemia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30207609": [
        "A novel therapy for XLH directly targeting fibroblast growth factor-23 via a humanized monoclonal antibody (burosumab-twza/CRYSVITA, henceforth referred to just as burosumab) has emerged as an effective, and recently approved, pharmacological treatment for both children and adults.",
        "This review will provide an overview of the clinical manifestations of XLH, the molecular pathophysiology, and summarize its current treatment.",
        "Although the exact molecular mechanisms by which PHEX mutations cause disturbed phosphate handling in XLH remain unknown, focus for novel therapies has more recently been based upon the finding that the bone-produced phosphaturic hormone fibroblast growth factor-23 is elevated in XLH patient plasma.",
        "Previous treatment strategies for XLH were based upon phosphate repletion plus active vitamin D analogues, which are difficult to manage, fail to address the primary pathogenesis of the disease, and can have deleterious side effects.",
        "The most common heritable disorder of renal phosphate wasting, X-linked hypophosphataemia (XLH), was discovered to be caused by inactivating mutations in the phosphate regulating gene with homology to endopeptidases on the X-chromosome (PHEX) gene in 1995."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30459508": [
        "It directly addresses the excessive FGF23 activity in patients with XLH by binding to FGF23, and inhibiting its signaling.",
        "Burosumab is well tolerated by children and adults with XLH, with most treatment-emergent adverse events being of mild to moderate severity.",
        "In clinical trials, subcutaneous burosumab increased serum phosphorus levels in pediatric and adult patients with XLH, as well as significantly improving the severity of rickets in children, and improving pain, stiffness, physical functioning, and fracture/pseudofracture healing in adults.",
        "This leads to increased gastrointestinal phosphate absorption and renal phosphate reabsorption, thereby improving serum phosphate levels, and, ultimately, bone mineralization and the risk of bone disease.",
        "Burosumab (Crysvita<sup>\u00ae</sup>), a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypophosphatemia (XLH), a condition associated with excessive FGF23 production."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30269120": [
        "Fibroblast growth factor 23(FGF23)is a phosphaturic hormone, and its excess causes several kinds of congenital and acquired hypophosphatemic diseases.",
        "X-linked hypophosphatemic rickets(XLHR)is the most prevalent form of hereditary FGF23-related hypophosphatemia.",
        "Therefore, an anti-FGF23 neutralizing antibody that blocks FGF23 activity has been produced.",
        "A combination of oral active vitamin D3 and phosphate salt is the current standard therapy for patients with FGF23-related hypophosphatemic rickets and osteomalacia.",
        "Moreover, Burosumab is being tested as a potential treatment for patients with tumor-induced osteomalacia(TIO), which is the most prevalent form of acquired FGF23-related hypophosphatemia.",
        "The safety and efficacy of a human anti-FGF23 antibody, KRN23 or burosumab, has been confirmed in adults and children with XLHR.",
        "However, these medications may cause long-term complications, such as secondary hyperparathyroidism and chronic kidney disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29545670": [
        "A report enclosed in this letter gives a brief review of current knowledge on burosumab therapy.",
        "Burosumab (KRN23) is a fully human monoclonal IgG1 antibody that binds excess fibroblast growth factor 23 (FGF23) and has been successfully tested in clinical trials in children with X-linked hypophosphatemic rickets."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29477724": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The genetic cause of primary immunodeficiency disease (PID) carries prognostic information."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30063981": [
        "The prototypic clinical phenotype of NFKB1-deficient patients includes common CVID features, such as hypogammaglobulinaemia and sinopulmonary infections, plus other highly variable individual manifestations.",
        "The patient's 6-year-old daughter, a carrier of the NFKB1 mutation, is clinically asymptomatic, but has started to show cellular and molecular changes.",
        "This case of NFKB1 deficiency appears to be a combination of immunodeficiency and a hyperinflammatory state.",
        "Monoallelic loss-of-function mutations in NFKB1 were recently recognized as the most common monogenic cause of common variable immunodeficiency (CVID).",
        "The current situation of the patient's daughter provides a glimpse of the preclinical phase of the condition.",
        "Interestingly, we also found a rare variant in NOD2 previously associated with Crohn's disease (p.His352Arg).",
        "The most noteworthy findings included marked skewing towards a Th1 phenotype in peripheral blood T cells and excessive production of proinflammatory cytokines (IL-1\u03b2, TNF\u03b1).",
        "Our patient had hypogammaglobulinaemia with a small number of B cells, most of which were na\u00efve.",
        "Using an NGS customized panel of 323 genes related to primary immunodeficiencies, we identified a novel monoallelic loss-of-function mutation in NFKB1 leading to a truncated protein (c.1149delT/p.Gly384Glu \u2217 48).",
        "Here, we describe a patient with a profound CVID phenotype and severe gastrointestinal manifestations, including chronic and recurrent diarrhoea."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29290671": [
        "Latanoprostene bunod ophthalmic solution (Vyzulta) for the reduction of intraocular pressure; letermovir (Prevymis) for prophylaxis of cytomegalovirus infection and disease after stem cell transplant; benralizumab (Fasenra) for the add-on maintenance treatment of severe asthma of an eosinophilic phenotype."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29288370": [
        "This article summarizes the milestones in the development of letermovir leading to its first global approval in Canada as well as the USA for the prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic HSCT.",
        "In addition, letermovir has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use, and is under review in several countries, including Japan.",
        "Letermovir (Prevymis\u2122) is an orally or intravenously administered cytomegalovirus (CMV) DNA terminase complex inhibitor being developed by Merck &amp; Co., Inc., under a global license from AiCuris Anti-infective Cures GmbH.",
        "Letermovir has been approved in Canada and the USA for the prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic haematopoietic stem cell transplant (HSCT)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29361041": [
        "New antivirals targeting other replication steps and inducing fewer adverse effects are therefore needed.",
        "This review focuses on the highly conserved mechanism of HCMV DNA-packaging and the potential of the terminase complex to serve as an antiviral target.",
        "We describe the intrinsic mechanism of DNA-packaging, highlighting the structure-function relationship of HCMV terminase complex components.",
        "Identified in herpesviruses and bacteriophages, and with no counterpart in mammalian cells, these terminase proteins are ideal targets for highly specific antivirals.",
        "Human cytomegalovirus (HCMV) is responsible for life-threatening infections in immunocompromised individuals and can cause serious congenital malformations.",
        "During HCMV replication, DNA maturation and packaging are performed by the terminase complex, which cleaves DNA to package the genome into the capsid.",
        "Available antivirals target the viral polymerase but are subject to cross-resistance and toxicity.",
        "Letermovir has no significant activity against other herpesvirus or non-human CMV.",
        "A new terminase inhibitor, letermovir, recently proved effective against HCMV in phase III clinical trials, but the mechanism of action is unclear."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28967706": [
        "Following washout, letermovir 80 mg was dosed twice daily for 7 and 11 days in the CsA and TAC trials, respectively, with a second dose of immunosuppressant coadministered with letermovir at steady state.",
        "Letermovir increased CsA and TAC C<sub>max</sub> by 37% and 70%, respectively, and exposure by 70% and 78%, respectively, compared with immunosuppressant alone; t<sub>\u00bd</sub> was also increased from 10.7 to 17.9 hours for CsA.",
        "In patients receiving transplants, antivirals are coadministered with cyclosporine A (CsA) or tacrolimus (TAC) immunosuppressants.",
        "CsA (50/200 mg) increased letermovir C<sub>max,ss</sub> (109%/167%) and AUC<sub>ss,\u03c4</sub> (126%/237%) and decreased t<sub>\u00bd</sub> (4.33 to 3.68/3.04 hours) versus letermovir alone.",
        "In 2 phase 1 clinical trials either CsA 50 mg or TAC 5 mg was administered to healthy males.",
        "Letermovir is being developed for human cytomegalovirus infection treatment and prophylaxis.",
        "CsA altered letermovir pharmacokinetics, whereas TAC did not.",
        "Concomitant letermovir increased TAC and CsA exposure.",
        "In addition, letermovir 40 mg twice daily was administered for 14 days, and either CsA 50 or 200 mg administered on days 7 and 14.",
        "Therefore, we investigated the potential for letermovir-immunosuppressant interactions.",
        "All treatments were well tolerated.",
        "Pharmacokinetics and tolerability were assessed.",
        "TAC did not significantly affect letermovir pharmacokinetics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29578577": [
        "Voriconazole+letermovir/VRC area under the curve and peak concentration geometric mean ratios were 0.56 (0.51, 0.62) and 0.61 (0.53, 0.71), respectively.",
        "In both trials, blood samples were collected for the assessment of the pharmacokinetic profiles of the antifungals, and safety was assessed.",
        "Letermovir did not affect POS pharmacokinetics to a clinically meaningful extent but decreased VRC exposure.",
        "Days 9 to 12 repeated days 1 to 4 coadministered with letermovir 480 mg once daily.",
        "These results suggest that letermovir may be a perpetrator of CYP2C9/19-mediated drug-drug interactions.",
        "Letermovir is a human cytomegalovirus terminase inhibitor for cytomegalovirus infection prophylaxis in hematopoietic stem cell transplant recipients.",
        "In trial 1, single-dose POS 300 mg was administered alone, followed by a 7-day washout; then letermovir 480 mg once daily was given for 14 days with POS 300 mg coadministered on day 14.",
        "In trial 2, on day 1 VRC 400 mg was given every 12 hours; on days 2 and 3, VRC 200 mg was given every 12 hours, and on day 4 VRC 200 mg.",
        "Two trials were conducted in healthy female subjects 18 to 55 years of age.",
        "The geometric mean ratios (90%CIs) for POS+letermovir/POS area under the curve and peak concentration were 0.98 (0.83, 1.17) and 1.11 (0.95, 1.29), respectively.",
        "Posaconazole (POS), a substrate of glucuronosyltransferase and P-glycoprotein, and voriconazole (VRC), a substrate of CYP2C9/19, are commonly administered to transplant recipients.",
        "Because coadministration of these azoles with letermovir is expected, the effect of letermovir on exposure to these antifungals was investigated.",
        "On days 5 to 8, letermovir 480 mg was given once daily.",
        "All treatments were generally well tolerated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29746444": [
        "In contrast, antiviral prophylaxis is not commonly used due to myelosuppressive effects of valganciclovir.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Cytomegalovirus (CMV) infection is a common opportunistic infection after allogeneic haematopoietic stem cell transplantation (HSCT).",
        "CMV surveillance-preemptive therapy is the current preferred approach for preventing CMV disease after HSCT.",
        "In this article, the role of the newly approved antiviral compound, letermovir, is reviewed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29914965": [
        "The evolution of resistance mutations sooner in UL56 than in UL54 or UL97 is consistent with prior <i>in vitro</i> observations, and UL56 codon 25 is a genetic locus for letermovir resistance distinct from loci previously described.",
        "In eight experiments, UL56 terminase gene mutations were detected beginning at 10 passages and included novel amino acid substitutions V236A, L328V, and A365S in a region previously associated with letermovir resistance.",
        "In further studies of emerging drug resistance, a baseline laboratory CMV strain was serially propagated in cell culture under a combination of letermovir and ganciclovir.",
        "Outside this region, the UL56 substitution C25F was detected at moderate drug concentrations in two experiments as either the first detected mutation or an addition to a preexisting V231L substitution.",
        "UL56 substitutions V236A, L328V, and A365S were shown to confer borderline or low-grade letermovir resistance, while C25F conferred a 5.4-fold increase in letermovir resistance (50% effective concentration [EC<sub>50</sub>]) by itself and a 46-fold increase in combination with V231L.",
        "Letermovir is a human cytomegalovirus (CMV) terminase inhibitor recently approved as prophylaxis in stem cell transplant recipients.",
        "In all cases, mutation at UL56 codon 325 conferring absolute letermovir resistance eventually developed at a median of 20 passages.",
        "No UL97 kinase or UL54 DNA polymerase mutations relevant to ganciclovir resistance were detected until many passages after the first detection of the UL56 mutations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28675594": [
        "Subjects received single, escalating doses (120, 240, 480, 720, and 960 mg; 6 letermovir, 2 placebo per cohort) or multiple, once-daily doses (240 mg; 8 letermovir, 4 placebo) of HP\u03b2CD-formulated letermovir and the associated pharmacokinetic profiles and adverse events were investigated.",
        "Single-dose and multiple-dose regimens were generally well tolerated.",
        "Letermovir is a novel antiviral in clinical development for prophylaxis against human cytomegalovirus in immunocompromised transplant recipients.",
        "Single-dose escalation resulted in a slightly more-than-dose-proportional increase in the area under the letermovir plasma concentration-time curve (AUC), whereas increase in the maximal observed letermovir plasma concentration (C<sub>max</sub> ) was dose proportional.",
        "This two-part, single-center, randomized, double-blind, placebo-controlled trial evaluated the safety and pharmacokinetics of a hydroxypropyl \u03b2-cyclodextrin (HP\u03b2CD)-based intravenous formulation of letermovir in healthy women.",
        "The terminal half-life was 28.3 h, supporting once-daily dosing (EudraCT Number: 2012-001603-20).",
        "After once-daily dosing, accumulation ratios in AUC and C<sub>max</sub> were 1.22 and 1.03, respectively."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30004790": [
        "Areas covered: In this review, we will evaluate this novel agent with a focus on letermovir mechanism of action, pharmacokinetics and metabolism, clinical efficacy, and safety and toxicities.",
        "Although available anti-CMV therapies may be effective for the prevention of CMV, they are plagued by unacceptable toxicities that prohibit their use in the post-transplant period.",
        "The positive results from the recently published Phase III study of letermovir for prevention of CMV infection in CMV-seropositive allo-HCT recipients led to its approval as a prophylactic agent for CMV in multiple countries.",
        "Expert commentary: With the introduction of letermovir, prevention of CMV infection in allo-HCT recipients may shift considerably, from a predominantly preemptive strategy to one that utilizes this novel therapy for prophylaxis.",
        "Recently studied CMV-active agents, such as maribavir and brincidofovir, failed to reduce the incidence of CMV infection in HCT recipients.",
        "Allogeneic hematopoietic cell transplants (allo-HCT) recipients are at the high-risk of reactivation of cytomegalovirus (CMV), and reactivation is associated with significant morbidity and mortality.",
        "Letermovir represents the first agent in the non-nucleoside 3,4 dihydro-quinazoline class of CMV viral terminase complex inhibitors, with activity solely against CMV."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29998227": [
        "Letermovir is a new antiviral agent with activity against human cytomegalovirus (CMV).",
        "Letermovir is available both orally and intravenously in 480-mg and 240-mg dosage forms, and is approved for use in the prophylaxis of CMV infection and disease in CMV-seropositive recipients of allogeneic hematopoietic stem cell transplant (HSCT) over the age of 18.",
        "Letermovir has shown promising clinical efficacy and is generally well tolerated, thus providing a favorable new option in the prophylaxis of CMV infection and disease.",
        "Additionally, letermovir is active against DNA polymerase inhibitor-resistant viral strains.",
        "Letermovir is metabolized primarily by hepatic OATP1B1/3 and is not recommended for patients with severe hepatic impairment (Child-Pugh class C).",
        "Letermovir works as an inhibitor of the CMV DNA terminase complex which further inhibits viral DNA processing and packaging.",
        "Cross-resistance with other useful antiviral agents in the treatment of CMV has not been observed.",
        "Renal dosage adjustments are not warranted until a creatinine clearance (CrCl) of less than 10 mL/min; however, serum creatinine should be monitored when administered to patients with a CrCl of less than 50 mL/min.",
        "The recommended dose is 480 mg p.o./i.v. once daily initiated between day 0 through day 28 post-allogeneic HSCT and continued through day 100 post-transplantation; the dose should be reduced to 240 mg daily if coadministered with cyclosporine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28827050": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Achalasia is a primary esophageal motility disorder characterized by aperistalsis of the esophagus and failed relaxation of the lower esophageal sphincter that presents rarely in childhood.",
        "The peroral endoscopic myotomy (POEM) procedure is an emerging treatment for achalasia in adults that has recently been introduced into pediatric surgical practice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28568312": [
        "The study aims to determine the prevalence of autoimmune and chronic inflammatory diseases in patients with achalasia and compare the results with those from patients with gastroesophageal reflux disease (GERD).",
        "The disease state manifests local and systemic inflammation, and it appears that an autoimmune component and specific autoantibodies participate in the pathogenesis.",
        "<strong class=\"sub-title\">\n          Background and aim:\n        </strong>\n      \n      Idiopathic achalasia is a rare esophageal motor disorder."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28919276": [
        "Endoscopic pneumodilatation and laparoscopic Heller myotomy have comparable short-term success rates, around 90%.",
        "High-resolution esophageal manometry is the key investigation.",
        "Peroral endoscopic myotomy is a promising treatment modality, however with frequent post-procedural gastroesophageal reflux.",
        "The pathophysiology of achalasia is largely unknown, and involves the destruction of ganglion cell in the esophageal myenteric plexus.",
        "The main complication after pneumodilatation is esophageal perforation, occurring in about 1% of cases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24259423": [
        "Since genetic factors predisposing to achalasia have been poorly documented, we assessed whether single nucleotide polymorphisms (SNPs) in genes mediating immune response and neuronal function contribute to achalasia susceptibility.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Idiopathic achalasia is a rare motor disorder of the oesophagus characterised by neuronal loss at the lower oesophageal sphincter.",
        "Achalasia is generally accepted as a multifactorial disorder with various genetic and environmental factors being risk-associated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8286427": [
        "The etiology of achalasia is poorly understood.",
        "Achalasia occurs across the lifespan, but is uncommon in children.",
        "The emphasis is on primary achalasia.",
        "This article describes the symptoms of achalasia, its diagnosis, and treatment.",
        "Achalasia is a motility disorder of the esophagus characterized by total loss of esophageal peristalsis and by defective lower esophageal sphincter function.",
        "The importance of patient education for effective management of this chronic illness is discussed.",
        "Most patients have progressive dysphagia for both liquids and solids.",
        "Case studies illustrate common findings in patients with achalasia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18223498": [
        "Variations in the manometric findings occur in achalasia suggesting that all manometric features should not be required to diagnose achalasia.",
        "Combined multichannel intraluminal impedance and esophageal manometry (MII-EM) allows both a functional and a manometric evaluation of esophageal motility and identifies chronic fluid retention.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Achalasia is defined manometrically by an aperistaltic esophagus."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28867969": [
        "There is significant latency prior to diagnosis, which can have nutritional implications.",
        "Although achalasia cannot be permanently cured, palliation of symptoms is possible in over 90% of patients with the treatment modalities currently available (pneumatic dilation, Heller myotomy, or peroral endoscopic myotomy).",
        "Patients often present with dysphagia to solids and liquids, regurgitation, and varying degrees of weight loss.",
        "Achalasia is one of the most studied esophageal motility disorders.",
        "The diagnosis is suspected based on clinical history and confirmed by esophageal high-resolution manometry testing.",
        "This article reviews the clinical presentation, diagnosis, and management options in patients with achalasia, as well as potential insights into histopathologic differences and nutritional implications of the subtypes of achalasia.",
        "However, the pathophysiology and reasons that patients develop achalasia are still unclear.",
        "Recent data presented in abstract form suggest that patients with type II achalasia may be most likely, and patients with type III achalasia may be least likely, to report weight loss compared to patients with type I achalasia.",
        "Esophagogastroduodenoscopy is necessary to rule out potential malignancy that can mimic achalasia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10381906": [
        "To further define immunogenetics in the pathogenesis of idiopathic achalasia, we performed tissue typing in patients with achalasia to determine their specific HLA phenotypes.",
        "<strong class=\"sub-title\">\n          Background &amp; aims:\n        </strong>\n      \n      Idiopathic achalasia is a motility disorder of the esophagus characterized by incomplete relaxation of the lower esophageal sphincter and a loss of normal peristaltic activity in the body of the esophagus.",
        "Although the underlying cause of idiopathic achalasia is unknown, the diffuse neuronal effects found suggest a possible viral or neurodegenerative mechanism.",
        "The loss of inhibitory neurons in the distal esophagus, as well as abnormalities in the vagus nerve, dorsal motor nucleus of the vagus nerve, and autonomic nervous system, have been described in achalasia.",
        "By use of serological methods, a significant association between the HLA-DQ1 phenotype and idiopathic achalasia has been found, suggesting a possible immunogenetic mechanism."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12141811": [
        "The aim of this study was to determine the cost-effectiveness of these three strategies in the treatment of achalasia in adults.",
        "Achalasia is a disorder characterized by abnormal motility of the esophageal body and the lower esophageal sphincter, resulting in dysphagia, regurgitation, and chest pain.",
        "Treatment options for achalasia include Botulinum toxin injection, pneumatic balloon dilation, and surgical esophagomyotomy.",
        "We constructed a Markov cost-effectiveness model comparing Botox injection, pneumatic balloon dilation, and laparoscopic esophagomyotomy as initial treatments of achalasia.",
        "Costs and probabilities were derived from the published literature.",
        "The utility for symptomatic achalasia was derived from a sample of patients with achalasia.",
        "Further studies should examine the long-term relapse rates following treatment with Botox and more precisely determine the quality of life of symptomatic achalasia.",
        "Although laparoscopic esophagomyotomy was more effective than the other treatment options, it was not cost-effective because of its high initial cost.",
        "Sensitivity analyses were performed.",
        "Over a five-year time horizon, pneumatic dilation was the most cost-effective treatment strategy for achalasia, with an incremental cost-effectiveness ratio of $1348 per quality-adjusted life-year compared to Botox.",
        "In conclusion, pneumatic dilation is the most cost-effective treatment option for adults with achalasia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28717439": [
        "Achalasia is a chronic incurable esophageal motility disorder characterized by impaired lower esophageal sphincter (LES) relaxation and loss of esophageal peristalsis.",
        "The most effective treatment options for achalasia include pneumatic dilation, Heller myotomy and peroral endoscopic myotomy (POEM), with the latter increasingly emerging as the treatment of choice for many patients.",
        "Although rare, it is currently the most common primary esophageal motility disorder, with an annual incidence of around 1.6 per 100,000 persons and prevalence of around 10.8/100,000 persons.",
        "Management of achalasia mainly involves improving the esophageal outflow in order to provide symptomatic relief to patients.",
        "This review focusses on evidence for current and emerging treatment options for achalasia with a particular emphasis on POEM.",
        "As the underlying etiology of achalasia remains unclear, there is currently no curative treatment for achalasia.",
        "Symptoms of achalasia include dysphagia to both solids and liquids, regurgitation, aspiration, chest pain and weight loss."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25994244": [
        "Patients with BSCL present with a distinct phenotype since subcutaneous fat is largely lacking and musculature has become more prominent.",
        "During childhood, diabetes and acanthosis nigricans evolve and female patients may develop hirsutism.",
        "Achalasia is a rare esophageal motility disorder, characterized by its distinct motility pattern with absent or incomplete lower esophageal sphincter (LES) relaxations.",
        "The exact cause of achalasia is yet unknown.",
        "Berardinelli-Seip congenital lipodystrophy (BSCL) is an uncommon autosomal recessive disorder.",
        "Here, we describe a patient with achalasia in the context of BSCL, which might be linked by a shared pathophysiologic background, as evaluated in this case report.",
        "Different genes encoding this entity have been described."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19253525": [
        "Because of uncertain etiology, treatment is only palliative and is directed at decreasing lower esophageal sphincter pressure, improving esophageal emptying and relieving the symptoms of achalasia.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Achalasia is an infrequent primary motility disorder of the esophagus.",
        "We undertook a systematic literature review of the management strategies currently available for achalasia.",
        "Current treatment options include pharmacological, endoscopic and surgical."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29771371": [
        "Instead, many scientists perform their phylogenetic analyses using contig sequences which result from the de novo assembly of sequencing reads into contigs containing only canonical nucleobases, and this may reduce both statistical power and phylogenetic accuracy.",
        "Advances in high-throughput sequencing techniques now allow relatively easy and affordable sequencing of large portions of the genome, even for nonmodel organisms.",
        "Here, we develop an easy-to-use pipeline to recover allele sequences from sequence capture data, and we use simulated and empirical data to demonstrate the utility of integrating these allele sequences to analyses performed under the multispecies coalescent model.",
        "The advantage of this approach is that it recovers a consistent set of loci, each with high sequencing depth, which leads to more confidence in the assembly of target sequences.",
        "Our empirical analyses of ultraconserved element locus data collected from the South American hummingbird genus Topaza demonstrate that phased allele sequences carry sufficient phylogenetic information to infer the genetic structure, lineage divergence, and biogeographic history of a genus that diversified during the last 3 myr.",
        "Many phylogenetic studies reduce costs by focusing their sequencing efforts on a selected set of targeted loci, commonly enriched using sequence capture.",
        "High sequencing depth can also be used to identify phylogenetically informative allelic variation within sequenced individuals, but allele sequences are infrequently assembled in phylogenetic studies.",
        "Our simulations provide evidence that analyzing allele sequences leads to more accurate estimates of tree topology and divergence times than the more common approach of using contig sequences.",
        "The phylogenetic results support the recognition of two species and suggest a high rate of gene flow across large distances of rainforest habitats but rare admixture across the Amazon River."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28247977": [
        "Future studies with standardized methodology and outcomes containing more patients are needed.",
        "Other treatments included vitamins, benzydamine hydrochloride, bupivacaine, Catuama, olive oil, trazodone, urea, and Hypericum perforatum.",
        "Capsaicin is limited by its side effects.",
        "Gabapentin was seen in one study to work alone and synergistically with ALA.",
        "Of these other treatments, Catuama and bupivacaine were the only ones with significant positive results in symptom improvement.",
        "It is characterized by oral mucosal burning and may be associated with dysgeusia, paresthesia, dysesthesia, and xerostomia.",
        "Gabapentin may also boost the effect of ALA.",
        "Catuama showed potential for benefit.",
        "ALA, topical clonazepam, gabapentin, and psychotherapy may provide modest relief of pain in BMS.",
        "Eight studies examined alpha-lipoic acid (ALA), three clonazepam, three psychotherapy, and two capsaicin, which all showed modest evidence of potentially decreasing pain/burning.",
        "Literature searches were conducted through PubMed, Web of Science, and Cochrane Library databases, which identified 22 randomized controlled trials.",
        "The goal of this systematic review was to assess the efficacy of the various treatments for BMS.",
        "The etiology of the disease process is unknown, but is thought to be neuropathic in origin.",
        "Burning mouth syndrome (BMS) is a chronic oral pain syndrome that primarily affects peri- and postmenopausal women."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29257770": [
        "Although lacking clinical signs of neuropathy, more accurate diagnostic methods have shown neuropathic involvement at various levels of the neuraxis in BMS: peripheral small fiber damage (thermal quantitative sensory testing, electrogustatometry, epithelial nerve fiber density), trigeminal system lesions in the periphery or the brainstem (brainstem reflex recordings, trigeminal neurography, evoked potentials), or signs of decreased inhibition within the central nervous system (deficient brainstem reflex habituation, positive signs in quantitative sensory testing, neurotransmitter-positron emission tomography findings indicative of deficient striatal dopamine function).",
        "Primary burning mouth syndrome (BMS) is defined as an \"intraoral burning or dysaesthetic sensation, recurring daily\u2026 more than 3 months, without clinically evident causative lesions\" (IHS 2013).",
        "Burning mouth syndrome is most prevalent in postmenopausal women, having led to a hypothesis that BMS is triggered as a consequence of nervous system damage caused by neurotoxic factors affecting especially vulnerable small fibers and basal ganglia in a setting of decrease in neuroprotective gonadal hormones and increase in stress hormone levels, typical for menopause.",
        "In addition to pain, taste alterations are frequent (dysgeusia, xerostomia).",
        "The central type does not respond to local treatments and associates often with psychiatric comorbidity (depression or anxiety), whereas the peripheral type responds to peripheral lidocaine blocks and topical clonazepam.",
        "Abnormalities in electrogustatometry indicate the involvement of the small A\u03b4 taste afferents, in addition to somatosensory small fibers.",
        "According to these findings, the clinical entity of BMS can be divided into 2 main subtypes compatible with either peripheral or central neuropathic pain, which may overlap in individual patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29284330": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Burning mouth syndrome (BMS) is a chronic orofacial pain disorder that is defined by a burning sensation in the oral mucosa.",
        "The aim of this study was to investigate the underlying factors, clinical characteristics and self-reported oral and general health factors associated with BMS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11871678": [
        "Affected patients often present with multiple oral complaints, including burning, dryness and taste alterations.",
        "Burning mouth syndrome is characterized by a burning sensation in the tongue or other oral sites, usually in the absence of clinical and laboratory findings.",
        "However, these conditions have not been consistently linked with the syndrome, and their treatment has had little impact on burning mouth symptoms.",
        "Recent studies have pointed to dysfunction of several cranial nerves associated with taste sensation as a possible cause of burning mouth syndrome.",
        "Burning mouth complaints are reported more often in women, especially after menopause.",
        "Conditions that have been reported in association with burning mouth syndrome include chronic anxiety or depression, various nutritional deficiencies, type 2 diabetes (formerly known as non-insulin-dependent diabetes) and changes in salivary function.",
        "Typically, patients awaken without pain but note increasing symptoms through the day and into the evening.",
        "Topical capsaicin has been used in some patients.",
        "Given in low dosages, benzodiazepines, tricyclic antidepressants or anticonvulsants may be effective in patients with burning mouth syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10431669": [
        "Burning mouth syndrome is characterized by a burning, painful sensation of the oral mucosa that most commonly involves the anterior tongue.",
        "Burning mouth syndrome is a complicated, poorly understood, predominantly oral condition that affects more than 1 million people in the United States.",
        "Many precipitating factors to burning mouth syndrome have been proposed, and treatment addressing these factors has had limited success.",
        "Women are particularly affected by the condition; they are diagnosed with symptoms seven times more frequently than males.",
        "This paper reviews burning mouth syndrome, associated causative factors, and treatment strategies for the physician.",
        "Patients with burning mouth syndrome are more likely to be evaluated by physicians, and therefore it is advantageous for the physician to be familiar with this oral condition."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12794658": [
        "In the scientific literature a variety of terms are used to describe similar symptoms, such as glossodynia, glossopyrosis, stomatodynia and oral dysestesia.",
        "We present a 63-year-old male patient with major depression, characterised by prominent somatic symptoms localised especially around the mouth, whose complaints started just after a prostate operation.",
        "Anxiety disorder, hypochondriasis, conversion disorder and especially depression may be considered amongst the psychological factors responsible for this situation.",
        "Burning mouth syndrome is a common disorder, usually affecting elderly females, characterised by intractable pain and burning in the oral cavity, evident especially in the tongue, together with a normal mouth mucosa.",
        "Most patients suffer from the syndrome for a long time, ranging from months up to years.",
        "The onset was reported to be gradual for most of the subjects, although many patients relate the onset of symptoms to previous dental procedures or to a previous medical illness.",
        "After excluding organic factors, depression should be considered in old patients with predominant mouth complaints.",
        "The psychological findings in burning mouth syndrome patients may be either the consequence of the chronic pain condition or its cause.",
        "The symptoms consisting of burning in the mouth, pain, dry mouth (xerostomia), an unpleasant and strange feeling of taste and itching, are all consistent with burning mouth syndrome.",
        "Burning mouth syndrome has a multifactorial etiology.",
        "It is well known that those patients had a relatively high percentage of psychiatric or psychological treatment in the past and/or present."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18624934": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Burning mouth syndrome is a disorder usually associated with an unexplained, prolonged sensation of burning inside the oral cavity.",
        "The aim of this study was to investigate the relationship between serum cytokine and T regulatory cell levels in patients with burning mouth syndrome with regard to depression and anxiety.",
        "Although the etiology is unknown, neural and psychologic factors and cytokines may be implicated in the pathogenesis of burning mouth syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17849966": [
        "Primary burning mouth syndrome, on the other hand, is relatively uncommon.",
        "Burning in the mouth in and of itself is not all that uncommon.",
        "It may result from a variety of local or generalized oral mucosal disorders, or may be secondary to referred phenomena from other locations.",
        "Thoughts on management of secondary and particularly primary burning mouth syndrome are discussed.",
        "Burning mouth syndrome is an idiopathic pain disorder, which appears to be neuropathic in origin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15773524": [
        "Burning mouth syndrome (BMS) is a predominantly oral condition characterized by the occurrence of a chronic burning that commonly involves the anterior tongue, painful sensation, dryness and taste alterations.",
        "Tongue burning is though to be also one of a non-oesophageal symptom of gastro-oesophageal reflux disease.",
        "The syndrome is reported more often in women, usually without any oral mucosal signs and laboratory abnormalities.",
        "Its etiopathogenesis remains poorly understood, and there is no consensus on diagnostic criteria and treatment strategies.",
        "As reported below, although this symptom may well be diagnostically misleading, careful diagnosis based on clinical signs may distinguish patients with BMS from those with reflux disease, and successful management of burning mouth is often enables."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8982420": [
        "The same tests were carried out in 12 healthy age- and sex-matched subjects.",
        "Contact allergy in burning mouth syndrome seems not to play a primary role; nevertheless, it is advisable to perform patch tests in selected patients to identify a possible aetiological agent.",
        "Causal factors may be psychogenic, systemic or local.",
        "The aim of the study was to determine the significance of contact allergy in the pathogenesis of burning mouth syndrome.",
        "The burning mouth syndrome is characterized by an unpleasant sensation of burning in the oral cavity, without clinical signs.",
        "The number of patients affected by burning mouth syndrome with a positive reaction to patchtesting was 6 out of 15, while the number of allergic patients in the control group was 3 out of 12.",
        "Epicutaneous patch tests were performed with the Italian standard series (GIRDCA - Gruppo Italiano di Ricerca Dermatiti da Contatto ed Ambientali), preservative and dental series.",
        "Fifteen patients with burning mouth syndrome were studied through anamnesis and laboratory analysis.",
        "No association could be found between positive reaction at patchtesting and exposure to allergens."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19302167": [
        "Some studies have suggested that burning mouth syndrome could be caused by the metals used in dental prostheses, as well as by acrylate monomers, additives and flavouring agents, although others have not found any aetiologic role for hypersensitivity to dental materials.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Burning mouth syndrome is a burning sensation or stinging disorder affecting the oral mucosa in the absence of any clinical signs or mucosal lesions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20561063": [
        "A patient developed symptoms of burning mouth syndrome after initiating topiramate treatment for headache prevention.",
        "The symptoms resolved when the medication was discontinued, and the association was replicated upon re-challenge of the drug.",
        "Burning mouth syndrome is a chronic pain condition characterized by burning, painful sensations within the oral cavity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26535101": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Burning mouth syndrome (BMS) is common conditions that affects menopause women, patients suffer from sever burning sensation.",
        "Present study was undertaken to evaluate the efficacy of low-level laser (LLL) in improving the symptoms of burning mouth syndrome.",
        "Up to now there is no definitive treatment for this disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20415926": [
        "Burning mouth syndrome (BMS) is characterized by burning pain in the tongue or other oral mucous membrane often associated with symptoms such as subjective dryness of the mouth, paraesthesia and altered taste for which no medical or dental cause can be found.",
        "The purpose of this article was to provide the practitioner with an understanding of the local, systemic and psychosocial factors which may be responsible for oral burning associated with secondary BMS, therefore providing a foundation for diagnosing primary BMS.",
        "A pragmatic approach in clarifying this issue is to divide patients into either primary (essential/idiopathic) BMS, whereby other disease is not evident or secondary BMS, where oral burning is explained by a clinical abnormality.",
        "The difficulty in diagnosing BMS lies in excluding known causes of oral burning."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23201368": [
        "This article focuses on descriptions, etiologic theories, and management of primary burning mouth syndrome, a condition for which underlying causative agents have been ruled out.",
        "When a burning sensation in the mouth is caused by local or systemic factors, it is called secondary burning mouth syndrome and when these factors are treated the pain will resolve.",
        "Pain in the tongue or oral tissues described as \"burning\" has been referred to by many terms including burning mouth syndrome.",
        "When burning mouth syndrome occurs in the absence of identified risk indicators, the term primary burning mouth syndrome is utilized."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24096230": [
        "This condition is probably of multifactorial origin; however the exact underlying etiology remains uncertain.",
        "It is observed principally in middle-aged patients and postmenopausal women and may be accompanied by xerostomia and altered taste.",
        "Burning mouth syndrome is characterized by an intense burning or stinging sensation, preferably on the tongue or in other areas of mouth.",
        "This disorder is one of the most common, encountered in the clinical practice.",
        "This article discusses several aspects of BMS, updates current knowledge about the etiopathogenesis and describes the clinical features as well as the diagnosis and management of BMS patients.",
        "Burning mouth syndrome (BMS) is a chronic oral pain or burning sensation affecting the oral mucosa, often unaccompanied by mucosal lesions or other evident clinical signs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27209717": [
        "This article will explore the many causes and treatment of patients who present with a chief complaint of \"my mouth burns,\" including symptomatic treatment for those with burning mouth syndrome.",
        "Burning mouth syndrome is a diagnosis of exclusion, which is used only after nutritional deficiencies, mucosal disease, fungal infections, hormonal disturbances and contact stomatitis have been ruled out.",
        "Burning mouth syndrome is distressing to both the patient and practitioner unable to determine the cause of the patient's symptoms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18625105": [
        "Burning mouth syndrome (BMS) is a chronic disease characterized by burning of the oral mucosa associated with a sensation of dry mouth and/or taste alterations.",
        "The efficacy of some medications in the treatment of BMS suggests that the dopaminergic system may be involved.",
        "The pathophysiology of the disease is still unknown, and evidence is conflicting; although some studies suggest a central origin, others point to a peripheral neuropathic origin.",
        "BMS occurs more frequently among postmenopausal women."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17439072": [
        "This article examines BMS, its related factors, and treatment options.",
        "This condition has a multifactorial etiology.",
        "Multiple approaches to treatment have been described.",
        "Burning mouth syndrome (BMS) is characterized by burning sensations of the oral cavity in the absence of abnormalities of the oral mucosa.",
        "BMS predominantly affects middle-aged women."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27207008": [
        "Burning mouth syndrome generally presents as a triad: Mouth pain, alteration in taste, and altered salivation, in the absence of visible mucosal lesions in the mouth.",
        "Burning mouth syndrome (BMS) is characterized by pain in the mouth with or with no inflammatory signs and no specific lesions.",
        "The differential diagnosis requires the exclusion of oral mucosal lesions or blood test alterations that can produce burning mouth sensation.",
        "Management is always based on the etiological agents involved.",
        "If burning persists after local or systemic conditions are treated, then treatment is aimed at controlling neuropathic symptoms.",
        "As a result, a multidisciplinary approach is required to bring the condition under better control.",
        "The aim of this review was to discuss several aspects of BMS, update current knowledge, and provide guidelines for patient management.",
        "The syndrome generally manifests spontaneously, and the discomfort is typically of a continuous nature but increases in intensity during evening and at night.",
        "The etiopathogenesis seems to be complex and in a large number of patients probably involves interactions among local, systemic, and/or psychogenic factors.",
        "Treatment of BMS is still unsatisfactory, and there is no definitive cure.",
        "Synonyms found in literature include glossodynia, oral dysesthesia, glossopyrosis, glossalgia, stomatopyrosis, and stomatodynia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26863819": [
        "We analyzed the etiopathogenesis of Burning Mouth Syndrome and of the burning oral sensation and currently, we could not find a consensus on the diagnosis and classification of BMS.",
        "Over the last 40 years, many researchers have addressed this disease clinically or experimentally.",
        "Thus, the etiology and pathogenesis of BMS remain unclear.",
        "Further studies are required to better understand the pathogenesis of BMS, and a \"Gold Standard\" classification is required because not every burning sensation in the mouth is BMS.",
        "The aims and purposes of this systematic review of the international literature are to discuss and clarify some considerations on Burning Mouth Syndrome (BMS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26962284": [
        "The purpose of this study was to provide the practitioner with an understanding of the local, systemic, and psychosocial factors which may be responsible for oral burning associated with BMS, and review of treatment modalities, therefore providing a foundation for diagnosis and treatment of BMS.",
        "Although the cause of BMS is not known, a complex association of biological and psychological factors has been identified, suggesting the existence of a multifactorial etiology.",
        "As the symptom of oral burning is seen in various pathological conditions, it is essential for a clinician to be aware of how to differentiate between symptom of oral burning and BMS.",
        "Burning mouth syndrome (BMS) is multifactorial in origin which is typically characterized by burning and painful sensation in an oral cavity demonstrating clinically normal mucosa.",
        "An interdisciplinary and systematic approach is required for better patient management."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23589947": [
        "It is important to distinguish between true BMS and symptomatic burning sensation which occurs when the burning sensation is secondary to a local or systemic pathologic condition.",
        "The etiology is unknown and presents a challenge for both researchers and clinicians.",
        "According to the International Association for the Study of Pain, burning mouth Syndrome (BMS) is defined as a burning pain in the tongue or other oral mucous membrane in the absence of clinical signs or laboratory findings.",
        "A diagnosis is usually reached by exclusion of other diseases.",
        "The prognosis is poor and the burning sensation can last for many years causing a dramatic impact on the patient's quality of life.",
        "The management of BMS is still not satisfactory.",
        "Currently, there are no defined diagnostic criteria for BMS.",
        "This may lead to misdiagnoses, presenting an obstacle to successful treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23772971": [
        "When local, systemic or psychological factors are present, treatment or elimination of these factors usually results in a significant clinical improvement of BMS symptoms.",
        "The secondary BMS is caused by local, systemic, and/or psychological factors; thus, its diagnosis depends on identification of the exact causative factor.",
        "It occurs more commonly in middle-aged and elderly women and often affects the tongue tip and lateral borders, lips, and hard and soft palate.",
        "In addition to a burning sensation, the patients with BMS may also complain unremitting oral mucosal pain, dysgeusia, and xerostomia.",
        "The primary BMS is essential or idiopathic, in which the organic local/systemic causes cannot be identified and a neuropathological cause is likely.",
        "The diagnosis of primary BMS depends mainly on exclusion of etiological factors.",
        "BMS can be classified into two clinical forms: primary and secondary BMS.",
        "Previous randomized controlled clinical trials found that drug therapy with capsaicin, alpha-lipoic acid, clonazepam, and antidepressants may provide relief of oral burning or pain symptom.",
        "In addition, psychotherapy and behavioral feedback may also help eliminate the BMS symptoms.",
        "Vitamin, zinc, or hormone replacement therapy has been found to be effective for reducing the oral burning or pain symptom in some BMS patients with deficiency of the corresponding factor.",
        "Burning mouth syndrome (BMS) is characterized by the presence of burning sensation of the oral mucosa in the absence of clinically apparent mucosal alterations.",
        "If patients still have the symptoms after the removal of potential causes, drug therapy should be instituted."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17559486": [
        "Treatment should be tailored to each patient and it is recommended to practice the treatment in a multidisciplinary facility.",
        "In more than a third of patients, multiple, concurrent causes of BMS may be identified.",
        "Professional delay in diagnosing, referring, and appropriately managing of BMS patients occurs frequently.",
        "It is important to note that the diagnosis of BMS should be established only after all other possible causes have been ruled out.",
        "The estimated prevalence of BMS reported in recent studies ranges between 0.7 and 4.6% of the general population.",
        "The authors have tried to emphasize new pharmacological approaches to manage this challenging disorder.",
        "The etiology of this disorder is poorly understood even though new evidence for a possible neuropathic pathogenesis of idiopathic BMS is emerging.",
        "This article discusses our current understanding of the etiology and pathogenesis of BMS.",
        "Burning mouth syndrome may present as an idiopathic condition (primary BMS type) distinct from the symptom of oral burning that can potentially arise from various local or systemic abnormalities (secondary BMS type), including nutritional deficiencies, hormonal changes associated with menopause, local oral infections, denture-related lesions, xerostomia, hypersensitivity reactions, medications, and systemic diseases including diabetes mellitus.",
        "About 1.3 million American adults, mostly women in the postmenopausal period, are afflicted with BMS.",
        "BMS is typically characterized by a continuous, spontaneous, and often intense burning sensation as if the mouth or tongue were scalded or on fire.",
        "\"Burning mouth syndrome\" (BMS) refers to a chronic orofacial pain disorder usually unaccompanied by mucosal lesions or other clinical signs of organic disease.",
        "Burning mouth syndrome is a relatively common condition."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28361205": [
        "<strong class=\"sub-title\">\n          Background and aim:\n        </strong>\n      \n      Extremely poor prognosis in hepatocellular carcinoma (HCC) patients with progressing disease was denoted by vascular invasion.",
        "This study aimed to predict CK18 as a predictive marker for macrovascular malignant invasion.",
        "Cytokeratin 18 (CK18) has been shown to be overexpressed in hepatocellular carcinoma so it is a valuable tumor marker; however, its role in vascular invasion is still unclear."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28796412": [
        "We evaluated the HLs of AFP and DCP in a cohort of such patients.",
        "<strong class=\"sub-title\">\n          Aim:\n        </strong>\n      \n      The prognostic significance of the half-lives (HLs) of \u03b1-fetoprotein (AFP) and des-\u03b3-carboxy prothrombin (DCP) in patients undergoing hepatectomy for hepatocellular carcinoma (HCC) is unclear."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28582340": [
        "Ovarian Sertoli-Leydig cell tumors (SLCTs) are uncommon neoplasms that are occasionally associated with an elevated level of serum alpha fetoprotein (AFP), a marker of germ cell neoplasms, particularly yolk sac tumor (YST).",
        "The intestinal-type mucinous glands were immunoreactive for SALL4 (4 cases), AFP (4 cases), glypican 3 (1 case), CDX2 (6 cases), and villin (7 cases), markers that are commonly expressed in YSTs, although the latter 2 markers would be expected to be positive in intestinal-type glands.",
        "We report 7 cases of ovarian SLCT (3 moderately differentiated, 2 poorly differentiated, 2 retiform) with heterologous intestinal-type glands, 6 of which were associated with elevated serum AFP.",
        "Cases of ovarian SLCT with elevated serum AFP should be sampled extensively to look for foci of intestinal-type glands, the likely source of the AFP elevation in some of these neoplasms.",
        "We show that heterologous intestinal-type glands in ovarian SLCTs often have an endodermal sinus-like (YST-like) immunophenotype and stress that these should not be misinterpreted as microscopic foci of endodermal-type YST."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28482112": [
        "Advanced hepatocellular carcinoma (HCC) has limited treatment options and poor survival, therefore early detection is critical to improving the survival of patients with HCC.",
        "Current guidelines for high-risk patients include ultrasound screenings every six months, but ultrasounds are operator dependent and not sensitive for early HCC.",
        "The data from the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial is a valuable source of data to study biomarker screening for HCC.",
        "Serum \u03b1-Fetoprotein (AFP) is a widely used diagnostic biomarker, but it has limited sensitivity and is not elevated in all HCC cases so, we incorporate a second blood-based biomarker, des'\u03b3 carboxy-prothrombin (DCP), that has shown potential as a screening marker for HCC.",
        "We assume the trajectories of AFP and DCP follow a joint hierarchical mixture model with random changepoints that allows for distinct changepoint times and subsequent trajectories of each biomarker.",
        "The screening algorithm was compared to alternatives in simulations studies under a range of possible scenarios and in the HALT-C Trial using cross-validation.",
        "Markov chain Monte Carlo methods are used to calculate posterior distributions, which are used in risk calculations among future patients and determine whether a patient has a positive screen.",
        "The changepoint indicators are jointly modeled with a Markov Random Field distribution to help detect borderline changepoints."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29154784": [
        "<strong class=\"sub-title\">\n          Aims:\n        </strong>\n      \n      We tested whether transforming growth factor \u03b21 (TGF-\u03b21) signaling plays an important role in hepatic stellate cell differentiation fate and investigated the role of Jagged1/Notch in this process."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28932898": [
        "Yeast prions, including the best studied ones ([PSI <sup>+</sup>] and [URE3]), propagate via intimate interactions with molecular chaperones.",
        "Endogenous yeast amyloids that control heritable traits and are frequently used as models for human amyloid diseases are termed yeast prions.",
        "Different yeast prions exhibit differential responses to changes in levels, functionality or localization of the components of chaperone machinery.",
        "Differences in sensitivity of prion fragmentation to Sis1 and in relative inputs of fragmentation and malpartition in prion propagation result in opposite effects of Sis1 relocalization on [PSI <sup>+</sup>] and [URE3].",
        "Contrary to frequent statements in literature, overproduction of the Hsp104 chaperone antagonizes both [PSI <sup>+</sup>] and [URE3] prions, while overproduction of the Hsp70-Ssa1 chaperone antagonizes [URE3] prion only in some, but not in all strains.",
        "Here, we provide additional data confirming differential effects of chaperones (and specifically, Hsp40s) on yeast prions and summarize current knowledge of the mechanisms underlying chaperone specificities.",
        "We suggest that the response of prions to changes in Sis1 localization represents a combination of the effects of Sis1 shortage on fragmentation of prion aggregates and on malpartition of prion aggregates during a cell division.",
        "Recently, we demonstrated that the relocalization of a fraction of the Hsp40 chaperone Sis1 from the cytosol to the nucleus by the chaperone-sorting factor Cur1 exhibits opposite effects on [PSI <sup>+</sup>] and [URE3] prions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29330303": [
        "The yeast-based prion nucleation assay, developed in our work, can be employed for mutational dissection of amyloidogenic proteins.",
        "In contrast, both a fusion of the Sup35 prion domain to a multimeric non-amyloidogenic protein and the expression of a mammalian amyloidogenic protein that is not fused to the Sup35 prion domain failed to promote prion nucleation, further indicating that physical linkage of a mammalian amyloidogenic protein to the prion domain of a yeast protein is required for the nucleation of a yeast prion.",
        "Initial nucleation of a yeast prion by transiently overproduced prion-forming protein or its (typically, QN-rich) prion domain is efficient only in the presence of another aggregated (in most cases, QN-rich) protein.",
        "Sequence alterations antagonizing or enhancing amyloidogenicity of human amyloid-\u03b2 (associated with Alzheimer's disease) and mouse prion protein (associated with prion diseases), respectively, antagonized or enhanced nucleation of a yeast prion by these proteins.",
        "Biochemical and cytological approaches confirmed the nucleation of protein aggregates in the yeast cell.",
        "Fibrous cross-\u03b2 aggregates (amyloids) and their transmissible forms (prions) cause diseases in mammals (including humans) and control heritable traits in yeast.",
        "We anticipate that it will aid in the identification of chemicals that influence initial amyloid nucleation and in searching for new amyloidogenic proteins in a variety of proteomes.",
        "Here, we demonstrate that a fusion of the prion domain of yeast protein Sup35 to some non-QN-rich mammalian proteins, associated with amyloid diseases, promotes nucleation of Sup35 prions in the absence of pre-existing aggregates."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29698650": [
        "These characteristics allow a logical basis for distinction between functional amyloids/prions and prion diseases.",
        "Saccharomyces cerevisiae is an occasional host to an array of prions, most based on self-propagating, self-templating amyloid filaments of a normally soluble protein.",
        "These infectious yeast amyloidoses are outstanding models for the many common human amyloid-based diseases that are increasingly found to have some infectious characteristics.",
        "[URE3] is a prion of Ure2p, a regulator of nitrogen catabolism, while [PSI+] is a prion of Sup35p, a subunit of the translation termination factor Sup35p.",
        "In contrast to the functional prions, [Het-s] of Podospora anserina and [BETA] of yeast, the amyloid-based yeast prions are rare in wild strains, arise sporadically, have an array of prion variants for a single prion protein sequence, have a folded in-register parallel \u03b2-sheet amyloid architecture, are detrimental to their hosts, arouse a stress response in the host, and are subject to curing by various host anti-prion systems."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26915272": [
        "The folded in-register parallel \u03b2 sheet architecture of the yeast prion amyloids naturally suggests a mechanism by which prion variant information can be faithfully transmitted for many generations.",
        "The Btn2/Cur1 system normally cures most variants of the [URE3] prion that arise.",
        "Even the most mild forms of these prions are rare in the wild, indicating that they too are detrimental to yeast.",
        "Yeast prions (infectious proteins) were discovered by their outr\u00e9 genetic properties and have become important models for an array of human prion and amyloid diseases.",
        "Although most variants of the [PSI+] and [URE3] prions are toxic or lethal, some are mild in their effects.",
        "A single prion protein can become any of many distinct amyloid forms (called prion variants or strains), each of which is self-propagating, but with different biological properties (eg, lethal vs mild).",
        "The yeast prions rely on cellular chaperones for their propagation, but can be cured by various chaperone imbalances.",
        "The beneficial [Het-s] prion of Podospora anserina poses an important contrast in its structure, biology, and evolution to the yeast prions characterized thus far."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28148884": [
        "Here, we describe their detection and characterization using genetic, cell biological, biochemical, and physical methods.",
        "Yeast prions are models for both rare mammalian prion diseases and for several very common amyloidoses such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease.",
        "Infectious proteins (prions) are usually self-templating filamentous protein polymers (amyloids).",
        "Like the lethal mammalian prions and amyloid diseases, yeast prions may be lethal, or only mildly detrimental, and show an array of phenotypes depending on the protein involved and the prion variant.",
        "Yeast prions are genes composed of protein and, like the multiple alleles of DNA-based genes, can have an array of \"variants,\" each a distinct self-propagating amyloid conformation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23379365": [
        "The in-register parallel \u03b2 sheet structure found for several infectious yeast prion amyloids naturally suggests an explanation for this conformational templating.",
        "We also review studies of the roles of chaperones, aggregate-collecting proteins, and other cellular components using yeast that have led the way in improving the understanding of similar processes that must be operating in many human amyloidoses.",
        "Most yeast prions are amyloid forms of normally soluble proteins, and a single protein sequence can have any of several self-propagating forms (called prion strains or variants), analogous to the different possible alleles of a DNA gene.",
        "The prions (infectious proteins) of Saccharomyces cerevisiae are proteins acting as genes, by templating their conformation from one molecule to another in analogy to DNA templating its sequence.",
        "Yeast prions are important models for human amyloid diseases in general, particularly because new evidence is showing infectious aspects of several human amyloidoses not previously classified as prions.",
        "A central issue in prion biology is the structural basis of this conformational templating process.",
        "While most prions are plainly diseases, the [Het-s] prion of Podospora anserina may be a functional amyloid, with important structural implications."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23077577": [
        "Previously we have developed a solid-support electron paramagnetic resonance (EPR) approach to address this problem and have identified a structured state for the Alzheimer's amyloid-\u03b2 monomer.",
        "Residual structures, if any, in the disordered region may play an important role in the aggregation process.",
        "Studies of Ure2p prion domain are complicated by its high aggregation propensity, which results in a mixture of monomer and aggregates in solution.",
        "These results suggest that Ure2p prion domain adopts a completely disordered structure in the native buffer.",
        "A completely disordered Ure2p prion domain implies that the amyloid formation of Ure2p, and likely other Q/N-rich yeast prion proteins, is primarily driven by inter-molecular interactions.",
        "Amyloid fibril formation is associated with a range of neurodegenerative diseases in humans, including Alzheimer's, Parkinson's, and prion diseases.",
        "The Ure2p prion domain is largely disordered.",
        "Here we use solid-support EPR to study the structure of Ure2p prion domain.",
        "In yeast, amyloid underlies several non-Mendelian phenotypes referred to as yeast prions.",
        "EPR spectra of Ure2p prion domain with spin labels at every fifth residue from position 10 to position 75 show similar residue mobility profile for denaturing and native buffers after accounting for the effect of solution viscosity.",
        "Ure2 protein is the basis of yeast prion [URE3].",
        "Mechanism of amyloid formation is critical for a complete understanding of the yeast prion phenomenon and human amyloid-related diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17514901": [
        "However, in contrast to mammalian prions, which cause incurable neurodegenerative diseases, prions of lower eukaryotes are related to some non-chromosomally inherited phenotypic traits.",
        "Here we summarize the results of studies of prions of the yeast Saccharomyces cerevisiae and of the use of yeast model for investigation of some human amyloidoses, such as prion diseases, Alzheimer's, Parkinson's, and Huntington's diseases.",
        "More than 20 human diseases are related to protein misfolding which causes formation of amyloids, fibrillar aggregates of normally soluble proteins.",
        "Of them only prion diseases are transmissible.",
        "Amyloids of the prion type are described in lower eukaryotes.",
        "Such diseases are called amyloid diseases or amyloidoses."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25631286": [
        "Formation of amyloids (linear ordered \u03b2-sheet-rich protein aggregates with \u03b2-strands perpendicular to the long axis of the filament) underlies most yeast and fungal prions, and a single prion protein can have any of several distinct self-propagating amyloid forms with different biological properties (prion variants).",
        "Here we review the mechanism of faithful templating of protein conformation, the biological roles of these prions, and their interactions with cellular chaperones, the Btn2 and Cur1 aggregate-handling systems, and other cellular factors governing prion generation and propagation.",
        "A prion is an infectious protein horizontally transmitting a disease or trait without a required nucleic acid.",
        "Yeast and fungal prions are nonchromosomal genes composed of protein, generally an altered form of a protein that catalyzes the same alteration of the protein.",
        "Yeast prions are thus transmitted both vertically (as genes composed of protein) and horizontally (as infectious proteins, or prions).",
        "Yeast prions increasingly are serving as models for the understanding and treatment of many mammalian amyloidoses.",
        "Human amyloidoses include the PrP-based prion conditions and many other, more common amyloid-based diseases, several of which show prion-like features.",
        "Patients with different clinical pictures of the same amyloidosis may be the equivalent of yeasts with different prion variants."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23045389": [
        "Yeast prions, based on self-seeded highly ordered fibrous aggregates (amyloids), serve as a model for human amyloid diseases.",
        "Sgt2 is conserved from yeast to humans, has previously been implicated in the guided entry of tail-anchored proteins (GET) trafficking pathway, and is known to interact with Hsps, cytosolic Get proteins, and tail-anchored proteins.",
        "Deletion of SGT2 also restores trafficking of a tail-anchored protein in cells with a disrupted GET pathway.",
        "We demonstrate that Sgt2 increases the ability of excess Ssa to counteract [PSI(+)] curing by excess Hsp104.",
        "One region of Sgt2 interacts both with the prion domain of Sup35 and with tail-anchored proteins.",
        "Here we show that the actions of Hsp104 and Ssa on [PSI(+)] are modulated by the small glutamine-rich tetratricopeptide cochaperone Sgt2.",
        "Our data implicate Sgt2 as an amyloid \"sensor\" and a regulator of chaperone targeting to different types of aggregation-prone proteins.",
        "Sgt2 levels are increased in response to the presence of a prion when major Hsps are not induced.",
        "This effect is reversed by an excess of the chaperone Hsp70-Ssa.",
        "The yeast prion [PSI(+)] can be eliminated by an excess of the chaperone Hsp104.",
        "Propagation of yeast prions depends on the balance between chaperones of the Hsp100 and Hsp70 families."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22052352": [
        "Here we focus on how alterations in abundance or function of protein chaperones and co-chaperones affect propagation of yeast prions.",
        "In spite of a considerable amount of information, a clear understanding of the molecular mechanisms underlying these effects remains wanting.",
        "The yeast system has provided considerable insight into the biology of amyloid and prions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29688121": [
        "Serum rotavirus IgA responses are an imperfect non-mechanistic correlate of protection, and the lack of an accurate serological marker is a challenge to the development of new rotavirus vaccines.",
        "Heterotypic antibodies against multiple NSP2 genotypes were detected following RV3-BB vaccination.",
        "Serological responses to rotavirus NSP2 occur following wild-type infection; however, it is unknown if serological responses to NSP2 occur following administration of rotavirus vaccines.",
        "Despite significant serum IgA response against total RV3-BB, we were unable to demonstrate a significant serological response to NSP2 in participants receiving RV3-BB when compared to placebo.",
        "Serum IgA and IgG antibody responses to total RV3-BB and NSP2 protein (RV3-BB) were assessed using ELISA.",
        "Healthy, full-term babies (n = 96) were previously recruited as part of a phase IIa safety and immunogenicity trial in Dunedin, New Zealand between January 2012 and April 2014.",
        "Participants received three doses of oral RV3-BB vaccine with the first dose given at 0-5 days after birth (neonatal schedule), or the first dose given at about 8 weeks after birth (infant schedule), or to receive placebo (placebo schedule).",
        "Our data demonstrates that while serological responses to NSP2 were detectable in a subset of participants, it is a less useful marker when compared to total rotavirus serum IgA response.",
        "The phase IIa immunogenicity trial of RV3-BB provided an opportunity to investigate the serological responses to NSP2 following vaccination."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30145099": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth.",
        "The aim of the current study was to characterise the rotavirus strains causing gastroenteritis during the Indonesian Phase IIb efficacy trial."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28059609": [
        "At the time of the study rotavirus vaccines had not been introduced in New Zealand and the burden of rotavirus disease was evident.",
        "This study aimed to investigate the effect of rotavirus specific maternal antibodies on the serum IgA response or stool excretion of vaccine virus after any dose of an oral rotavirus vaccine, RV3-BB, in parallel to a Phase IIa clinical trial conducted at Dunedin Hospital, New Zealand.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Maternal antibodies, acquired passively via placenta and/or breast milk, may contribute to the reduced efficacy of oral rotavirus vaccines observed in children in developing countries."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28481726": [
        "Shedding was defined as detection of rotavirus by VP6 reverse transcription polymerase chain reaction (RT-PCR) in stool on days 3-7 after administration of RV3-BB.",
        "In participants who shed RV3-BB, rotavirus was detectable in stool on day 1 following RV3-BB administration and remained positive until day 4-5 after administration.",
        "Vaccine take (serum immune response or stool shedding of vaccine virus after any dose) was detected after 3 doses of RV3-BB vaccine in &gt;90% of participants when the first dose was administered in the neonatal and infant schedules.",
        "Shedding of rotavirus was highest following vaccination at 8 weeks of age in both neonatal and infant schedules (19/30 and 17/27, respectively).",
        "The aim of the current study was to characterize RV3-BB shedding and virus replication following administration of RV3-BB in a neonatal and infant vaccination schedule.",
        "The distinct pattern of RV3-BB stool viral load demonstrated using a NSP3 quantitative qRT-PCR in participants who shed RV3-BB, suggests that detection of RV3-BB at day 3-7 was the result of replication rather than passage through the gastrointestinal tract.",
        "The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth.",
        "Healthy, full-term (\u2265 36 weeks gestation) babies, who were 0-5 d old were randomly assigned (1:1:1) to receive 3 doses of oral RV3-BB vaccine with the first dose given at 0-5 d after birth (neonatal schedule), or the first dose given at about 8 weeks after birth (infant schedule), or to receive placebo (placebo schedule).",
        "Rotavirus was detected in stool on days 3-7, after at least one dose of RV3-BB, in 70% (21/30) of neonate, 78% (21/27) of infant and 3% (1/32) placebo participants.",
        "A phase IIa safety and immunogenicity trial was undertaken in Dunedin, New Zealand between January 2012 and April 2014."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23597719": [
        "RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      RV3 is a human neonatal rotavirus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26318715": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Despite the success of rotavirus vaccines, suboptimal vaccine efficacy in regions with a high burden of disease continues to present a challenge to worldwide implementation.",
        "A birth dose strategy with a vaccine developed from an asymptomatic neonatal rotavirus strain has the potential to address this challenge and provide protection from severe rotavirus disease from birth."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29059087": [
        "This review discusses some of the controversies and opportunities for improved disease control in severe asthma.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Despite currently available treatments, many asthma patients remain inadequately controlled, but identifying distinct patient populations (phenotypes/endotypes) may optimize their management."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29036019": [
        "Interleukin (IL)-4 and IL-13 play a key role in type 2 (T2) asthma.",
        "This article reviews the signaling pathway of IL-4 and IL-13 and highlights its targeted therapy in severe asthma.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Severe asthma is a heterogeneous disease that can be classified into phenotypes and endotypes based upon clinical or biological characteristics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29355679": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Dupilumab, an anti-IL-4 receptor \u03b1 mAb, inhibits IL-4/IL-13 signaling, key drivers of type 2/T<sub>H</sub>2 immune diseases (eg, atopic/allergic disease).",
        "In a pivotal, phase 2b study (<a href=\"http://clinicaltrials.gov/show/NCT01854047\" title=\"See in ClinicalTrials.gov\">NCT01854047</a>), dupilumab reduced severe exacerbations, improved lung function and quality of life, and was generally well tolerated in patients with uncontrolled persistent asthma despite using medium-to-high-dose inhaled corticosteroids plus long-acting \u03b22-agonists."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28971769": [
        "Asthma is an inflammatory disease which affects millions of people worldwide.",
        "Interleukins involved in inflammatory processes are often presented as candidate targets for new drugs.",
        "From content analysis of literature of new therapeutic targets, there are various targets and drugs reported to be promising for the treatment of asthma.",
        "Therefore, through this research, we can see advances in the search for new targets and promising drugs to treat asthma.",
        "The action of such therapeutics would not only affect interleukins, but also their receptors.",
        "Small molecules (e.g. ligustrazine and SP600125) and large molecule antibodies (e.g. lebrikizumab, benralizumab, dupilumab) are being considered as novel agents for the pharmacotherapy of asthma.",
        "Therefore, it is necessary to search for new sources of therapies for the treatment of these patients in order to improve their quality of life.",
        "It is expected that these new drug candidates will eventually be approved and marketed so that asthma patients can use them to enhance their quality of life."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29782217": [
        "We assessed its efficacy and safety in patients with uncontrolled asthma.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Dupilumab is a fully human anti-interleukin-4 receptor \u03b1 monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28085503": [
        "Expert opinion: Patients with severe asthma who are not sufficiently controlled with standard-of-care represent the target asthma population for dupilumab.",
        "The lack of preclinical data and published results of the completed four phase I studies precludes a complete assessment of the pharmacological profile of dupilumab.",
        "Areas covered: Pathophysiological role of IL-4 and IL-13 in asthma; mechanism of action of dupilumab; pharmacology of IL-4 receptor; phase I and phase II studies with dupilumab; regulatory affairs.",
        "Head-to-head studies to compare dupilumab versus other biologics with different mechanism of action are required.",
        "Dupilumab (REGN668/SAR231893), produced by a collaboration between Regeneron and Sanofi, is a monoclonal antibody currently in phase III for moderate-to-severe asthma.",
        "Dupilumab seems to be generally well tolerated, but large studies are required to establish its long-term safety and tolerability.",
        "Dupilumab is directed against the \u03b1-subunit of the interleukin (IL)-4 receptor and blocks the IL-4 and IL-13 signal transduction.",
        "Pediatric studies with dupilumab are currently lacking and should be undertaken to assess efficacy and safety of this drug in children with severe asthma.",
        "If confirmed, efficacy of dupilumab in both eosinophilic and non-eosinophilic severe asthma phenotype might represent an advantage over approved biologics for asthma, including omalizumab, mepolizumab, and reslizumab."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26428945": [
        "Dupilumab inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling and was previously found to be effective in asthma.",
        "Considering that both AD and asthma are Th2 cell-mediated inflammatory processes, it is reasonable to suspect that dupilumab would be beneficial in AD.`",
        "Dupilumab is a novel monoclonal antibody that was recently studied in adult patients with moderate-to-severe AD.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Current treatment options for moderate-to-severe atopic dermatitis (AD) are limited and have potentially dangerous side effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28979129": [
        "Regardless of effective treatments being widely available and the existence of treatment guidelines, a large population of severe asthma cases remain uncontrolled.",
        "It is noteworthy that in approximately 50% of these patients, there is strong evidence of the pathogenic role of T helper type-2 (Th2) cytokines, such as interleukin (IL)-4 and IL-13, orchestrating the eosinophilic and allergic inflammatory processes.",
        "Among the recently developed antiasthma biologic drugs, the mAb dupilumab is very promising given its ability to inhibit the biological effects of both IL-4 and IL-13.",
        "In this review, we focused on IL-4 and IL-13, as these interleukins are considered to play a key role in the pathophysiology of asthma, and on dupilumab, an anti-IL-4 receptor human mAb, as a forthcoming treatment for uncontrolled severe asthma in the near future.",
        "Severe asthma constitutes illness in a relatively small proportion of all patients with asthma, but it is a major public health problem - with considerable effect on morbidity, mortality, as well as a high burden on health care resources.",
        "The recognition of distinct inflammatory phenotypes within this population has driven the development of targeted biological therapies - particularly, selective targeted monoclonal antibodies (mAbs).",
        "Achieving and maintaining asthma control in this group of patients is, therefore, of utmost importance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28990423": [
        "Dupilumab is a fully human IgG4 monoclonal antibody directed against the \u03b1 subunit of the interleukin (IL)-4 receptor (IL-4R\u03b1).",
        "Since the activation of IL-4R\u03b1 is utilized by both IL-4 and IL-13 to mediate their pathophysiological effects, dupilumab behaves as a dual antagonist of these two sister cytokines, which blocks IL-4/IL-13-dependent signal transduction.",
        "They also review: the mechanism of action of dupilumab, the phase I, II and III studies evaluating the pharmacokinetics as well as the safety, tolerability and clinical efficacy of dupilumab in asthma therapy.",
        "Expert opinion: Supported by a strategic mechanism of action, as well as by convincing preliminary clinical results, dupilumab currently appears to be a very promising biological drug for the treatment of severe uncontrolled asthma.",
        "Areas covered: Herein, the authors review the cellular and molecular pathways activated by IL-4 and IL-13, which are relevant to asthma pathobiology.",
        "It also may have benefits to comorbidities of asthma including atopic dermatitis, chronic sinusitis and nasal polyposis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30167841": [
        "No head-to-head trial has directly compared the efficacy of these drugs.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Several new biologics have been studied in patients with eosinophilic asthma with varying degrees of response on clinical outcomes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27334730": [
        "The efficacy of the investigational monoclonal antibody mepolizumab which targets IL-5 has been well documented in late onset non-atopic asthma with persistent eosinophilic airway inflammation.",
        "Also, discovery of asthma subtypes suggests new treatments.",
        "It is safe, effective, and well tolerated.",
        "Anti-IL-4 and IL-13 agents (dupilumab, lebrikizumab, and tralokinumab) which block different Th-2 inflammatory pathways and agents targeting the Th-17 inflammatory pathway in severe refractory asthma are under development.",
        "Most patients respond to current standard of care, i.e., bronchodilators, inhaled glucocorticosteroids and other anti-inflammatory drugs, but in some adequate asthma control cannot be achieved with standard treatments.",
        "However, studies on larger groups of patients are needed to confirm their safety and efficacy.",
        "At present, omalizumab is the only biological agent approved for the treatment of early-onset, severe IgE-dependent asthma.",
        "In clinical trials, these drugs reduce disease activity and improve lung function, asthma symptoms, and quality of life.",
        "Half of patients with severe asthma have T-helper type 2 (Th-2) inflammation and they are expected to benefit from monoclonal antibody-based treatments.",
        "These difficult-to-treat patients would be the target population for new biological therapies.",
        "Asthma is a heterogeneous inflammatory disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28547386": [
        "This article summarizes the milestones in the development of dupilumab leading to this first approval for the treatment of moderate-to-severe atopic dermatitis in adults.",
        "Dupilumab inhibits the signalling of the type 2 cytokines IL-4 and IL-13 and was co-developed by Regeneron Pharmaceuticals and Sanofi as a potential therapeutic agent for the treatment of atopic or allergic diseases.",
        "In addition, dupilumab is currently under phase III development across the world for the treatment of asthma and nasal polyposis as well as for atopic dermatitis in paediatric patients.",
        "In March 2017 dupilumab received its first global approval, in the USA, for use in the treatment of adult patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.",
        "Dupilumab (Dupixent<sup>\u00ae</sup>) is a fully human monoclonal antibody directed against the interleukin (IL)-4 receptor \u03b1 (IL-4R\u03b1) subunit.",
        "Dupilumab is in preregistration for this indication in the EU.",
        "The agent has also entered phase II development in the USA for the treatment of eosinophilic oesophagitis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28478972": [
        "We aimed to evaluate the long-term efficacy and safety of dupilumab with medium-potency topical corticosteroids versus placebo with topical corticosteroids in adults with moderate-to-severe atopic dermatitis.",
        "Previous 16-week monotherapy studies showed that dupilumab substantially improved signs and symptoms of moderate-to-severe atopic dermatitis with acceptable safety, validating the crucial role of interleukin 4 and interleukin 13 in atopic dermatitis pathogenesis.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Dupilumab (an anti-interleukin-4-receptor-\u03b1 monoclonal antibody) blocks signalling of interleukin 4 and interleukin 13, type 2/Th2 cytokines implicated in numerous allergic diseases ranging from asthma to atopic dermatitis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25214796": [
        "Simultaneously with the steady progress towards a better knowledge of the pathobiology of asthma, the potential usefulness of anticytokine therapies is emerging as one of the key concepts in the newly developing treatments of this widespread airway disease.",
        "Among the recently developed antiasthma biologic drugs, the monoclonal antibody dupilumab is very promising because of its ability to inhibit the biological effects of both IL-4 and IL-13.",
        "A recent trial showed that in patients with difficult-to-control asthma, dupilumab can markedly decrease asthma exacerbations and improve respiratory symptoms and lung function; these effects were paralleled by significant reductions in T-helper 2-associated inflammatory biomarkers.",
        "However, further larger and longer trials are required to extend and validate these preliminary results, and also to carefully study the safety and tolerability profile of dupilumab.",
        "In particular, given the key role played by interleukin (IL)-4 and IL-13 in the pathophysiology of the most typical aspects of asthma, such as chronic airway inflammation, tissue remodeling, and bronchial hyperresponsiveness, these pleiotropic cytokines are now considered as suitable therapeutic targets.",
        "Indeed, dupilumab prevents IL-4/13 interactions with the \u03b1-subunit of the IL-4 receptor complex."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29939132": [
        "Moderate and severe forms of allergic diseases such as atopic dermatitis and asthma are a challenge for clinicians.",
        "The results of phase III clinical studies of dupilumab in patients with persistent, uncontrolled asthma have been highly promising.",
        "Dupilumab inhibits the biological effects of the cytokines IL-4 and IL-13, which are key drivers in the TH2 response.",
        "In this context, the emerging biological drugs constitute a truly innovative therapeutic approach.",
        "The safety and tolerability profile of dupilumab has proven to be very favorable in long-term clinical trials.",
        "In this review, we focus on the mechanism of action of dupilumab, its development, and its impact on daily clinical practice in allergic diseases.",
        "A leading example is dupilumab, a monoclonal antibody targeting the \u03b1 chain of the interleukin (IL)-4 receptor.",
        "In these conditions, which severely affect the quality of life of the patient and frequently have associated allergic comorbidities, the therapeutic options are often very limited.",
        "Treatment with systemic corticosteroids and immunosuppressants has adverse effects in the long term, and a significant proportion of patients remain refractory to therapy.",
        "The efficacy and safety profile of dupilumab in the treatment of allergic diseases has been tested for more than 10 years in a variety of large clinical trials in atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, and eosinophilic esophagitis.",
        "In 2017, the United States Food and Drug Administration and the European Medicines Agency approved the use of dupilumab for the treatment of adult patients with moderateto-severe atopic dermatitis whose disease is not adequately controlled with prescribed topical treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29782224": [
        "Its effectiveness in reducing oral glucocorticoid use in patients with severe asthma while maintaining asthma control is unknown.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Dupilumab is a fully human anti-interleukin-4 receptor \u03b1 monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23688323": [
        "We evaluated the efficacy and safety of dupilumab (SAR231893/REGN668), a fully human monoclonal antibody to the alpha subunit of the interleukin-4 receptor, in patients with persistent, moderate-to-severe asthma and elevated eosinophil levels.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Moderate-to-severe asthma remains poorly treated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30244834": [
        "Although essential for epigenetic inheritance, the transfer of parental histone (H3-H4)<sub>2</sub> tetramers that contain epigenetic modifications to replicating DNA strands is poorly understood.",
        "Here, we show that the Mcm2-Ctf4-Pol\u03b1 axis facilitates the transfer of parental (H3-H4)<sub>2</sub> tetramers to lagging-strand DNA at replication forks.",
        "Similar effects are observed in Ctf4 and Pol\u03b1 primase mutants that disrupt the connection of the CMG helicase to Pol\u03b1 that resides on lagging-strand template.",
        "Mutating the conserved histone-binding domain of the Mcm2 subunit of the CMG (Cdc45-MCM-GINS) DNA helicase, which translocates along the leading-strand template, results in a marked enrichment of parental (H3-H4)<sub>2</sub> on leading strand, due to the impairment of the transfer of parental (H3-H4)<sub>2</sub> to lagging strands.",
        "Our results support a model whereby parental (H3-H4)<sub>2</sub> complexes displaced from nucleosomes by DNA unwinding at replication forks are transferred by the CMG-Ctf4-Pol\u03b1 complex to lagging-strand DNA for nucleosome assembly at the original location."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29753094": [
        "This child was compound heterozygote [NM_001080477.3(TENM3):c.4046C &gt; G; p.(Ala1349Gly) and NM_001080477.3(TENM3): c.7687C &gt; T; p.(Arg2563Trp)] for the missense likely pathogenic sequence variations in TENM3 gene.",
        "Coloboma of iris is associated with many of the cases.",
        "Here, we report a propositus with eye anomalies and intellectual disability associated with TENM3 pathogenic variations identified by exome sequencing and confirms intellectual disability as a phenotype associated with TENM3 variations.",
        "This report supports the association of TENM3 variations with colobomatous microphthalmia and expands the phenotypic spectrum associated with pathogenic variations in this gene.",
        "To our knowledge only three patients till now have been reported to have TENM3 pathogenic variations in association with microphthalmia, two siblings without developmental delay and third with developmental delay.",
        "Microphthalmia, anophthalmia are the malformations of the eye, referring to a congenital absence, and a reduced size of the eyeball."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20704474": [
        "Anophthalmia is the congenital absence of ocular tissue from the orbit.",
        "One of our two patients showed complex congenital heart disease with heterotaxia, polysplenia, and normal lung lobation.",
        "Many syndromes and malformations (e.g., anophthalmia-esophageal-genital syndrome, Matthew-Wood syndrome, CHARGE syndrome, oculo-facial-cardio-dental-syndome, heterotaxy, and Fraser syndrome) have been associated with anophthalmia.",
        "These findings may reflect a new dimension of anophthalmia, heterotaxia, and congenital heart disease associations.",
        "In this article, we discuss two cases of patients with anophthalmia and congenital heart defects, and we compare these findings with other syndromes with which anophthalmia has been associated.",
        "However, its relation with congenital heart disease has not been fully elucidated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25071894": [
        "Anophthalmia is a condition of the absence of an eye and the presence of a small eye within the orbit.",
        "Cryptophthalmos, cyclopia, synophthalmia and congenital cystic eye should be considered in differential diagnoses.",
        "Imaging modalities are crucial scanning methods.",
        "It is associated with many known syndromes.",
        "Clinical findings, as well as imaging modalities and genetic analysis, are important in making the diagnosis.",
        "We report two clinical anophthalmic siblings, emphasizing the importance of neuroradiological and orbital imaging findings in distinguishing true congenital anophthalmia from clinical anophthalmia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30262714": [
        "It can be isolated (nonsyndromic) or be observed as a sign of other diseases (syndromic).",
        "Given that children with anophthalmia already have reduced sight, it seems worthwhile to make a point of careful vigilance on hearing for all such patients.",
        "A Chinese infant was born with bilateral anophthalmia and palpebral fissure closures.",
        "The results remind us that clinical anophthalmia may be accompanied by sensorineural hearing loss and may be associated with <i>SOX2</i> mutation, and it will contribute to improving diagnosis and patient care.",
        "Thismutation was not detected in the unaffected parents and 150 unaffected control individuals.Mutation in <i>SOX2</i> is associated with bilateral clinical anophthalmia and probablywith other anomalies in the Chinese infant.",
        "Congenital anophthalmia is a rare eye anomaly which lacks a recognizable eye in the orbit.",
        "A c.70_89del (p. Asn24ArgfsX65; rs398123693) mutation in <i>SOX2</i> was identified in the Chinese infant with bilateral clinical anophthalmia and sensorineural hearing loss.",
        "Until nowhearing loss has not been reported in individuals with <i>SOX2</i> mutation.",
        "Ocular and systemic examinations were performed, and genomic DNA was prepared from peripheral leukocytes.",
        "The coding exons and the adjacent intrinsic sequence of <i>SOX2</i> were analysed by Sanger sequencing."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26250054": [
        "SOX2 genotyping in this patient revealed an apparently de novo c.70del20 deletion, a commonly reported SOX2 mutation.",
        "Although dental anomalies are uncommonly reported in the SOX2 anophthalmia syndrome, we suggest that a dental examination should be performed in patients with SOX2 mutations.",
        "In this work, a patient with the SOX2 anophthalmia syndrome and exhibiting a novel dental anomaly is described.",
        "SOX2 anophthalmia syndrome is an uncommon autosomal dominant syndrome caused by mutations in the SOX2 gene and clinically characterized by severe eye malformations (anophthalmia/microphthalmia) and extraocular anomalies mainly involving brain, esophagus, and genitalia.",
        "A review of the phenotypic variation observed in patients carrying the recurrent SOX2 c.70del20 mutation is presented."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30515001": [
        "It usually occurs in association with other systemic malformations.",
        "Though rare, it occurs worldwide.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Anophthalmia is congenital absence of the eyes; it may be unilateral or bilateral."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27785411": [
        "Clinical anophthalmia is a rare inherited disease of the eye and phenotype refers to the absence of ocular tissue in the orbit of eye.",
        "This family with isolated clinical anophthalmia, was mapped to the <i>SOX2</i> gene that is located at chromosome 3q26.3-q27.",
        "Anophthalmia may be isolated or associated with a broader syndrome and may have genetic or environmental causes.",
        "However, genetic cause has been defined in only a small proportion of cases, therefore, a consanguineous Pakistani family of the Pashtoon ethnic group, with isolated clinical anophthalmia was investigated using linkage mapping.",
        "A family pedigree was created to trace the possible mode of inheritance of the disease.",
        "Blood samples were collected from affected as well as normal members of this family, and screened for disease-associated mutations.",
        "This family was analyzed for linkage to all the known loci of clinical anophthalmia, using microsatellite short tandem repeat (STR) markers.",
        "Patients may have unilateral or bilateral anophthalmia, and generally have short palpebral fissures and small orbits.",
        "Direct sequencing was performed to find out disease-associated mutations in the candidate gene.",
        "It showed that another gene responsible for development of the eye might be present at chromosome 3q26.3-q27 and needs to be identified and screened for the disease-associated mutation in this family.",
        "However, on exonic and regulatory regions mutation screening of the <i>SOX2</i> gene, the disease-associated mutation was not identified."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17522144": [
        "Heterozygous mutations in SOX2, a SOX1B-HMG box transcription factor, have been found in up to 10% of individuals with severe microphthalmia or anophthalmia and such mutations could also be associated with a range of non-ocular abnormalities.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Developmental eye anomalies, which include anophthalmia (absent eye) or microphthalmia (small eye) are an important cause of severe visual impairment in infants and young children."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28590501": [
        "Both mutations were absent in all of the searched databases, including 10,000 in-house Chinese exome sequences, and these mutations were confirmed as having been transmitted from the parents.",
        "In silico analysis predicted these changes to be damaging, and in vitro expression analysis revealed that the mutated alleles were associated with decreased protein production and impaired tetrameric protein formation.",
        "This study firstly reported that compound heterozygous mutations of the ALDH1A3 gene can result in anophthalmia in humans, thus highlighting those heterozygous mutations in ALDH1A3 should be considered for molecular screening in anophthalmia, particularly in cases from families without consanguineous relationships.",
        "Here, we investigated a newborn with bilateral anophthalmia in a Chinese family.",
        "Anophthalmia is a rare eye development anomaly resulting in absent ocular globes or tissue in the orbit since birth.",
        "Exome sequencing revealed that compound heterozygous mutations c.287G &gt; A (p.(Arg96His)) and c.709G &gt; A (p.(Gly237Arg)) of the ALDH1A3 gene were present in the affected newborn.",
        "Comparative amino acid sequence analysis across distantly related species revealed that the residues at positions 96 and 234 were evolutionarily highly conserved."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29463814": [
        "Proper LEM-3 midbody localization and function is regulated by AIR-2/Aurora B kinase.",
        "Strikingly, LEM-3 acts cooperatively with the BRC-1/BRCA1 homologous recombination factor to promote genome integrity.",
        "LEM-3 localization depends on factors needed for midbody assembly, and LEM-3 accumulation is increased and prolonged when chromatin bridges are trapped at the cleavage plane.",
        "Faithful chromosome segregation and genome maintenance requires the removal of all DNA bridges that physically link chromosomes before cells divide.",
        "These findings provide a molecular basis for the suspected role of the LEM-3 orthologue Ankle1 in human breast cancer.",
        "LEM-3 acts at the midbody, the structure where abscission occurs at the end of cytokinesis.",
        "Using C. elegans embryos we show that the LEM-3/Ankle1 nuclease defines a previously undescribed genome integrity mechanism by processing DNA bridges right before cells divide.",
        "LEM-3 locally processes chromatin bridges that arise from incomplete DNA replication, unresolved recombination intermediates, or the perturbance of chromosome structure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29879106": [
        "Homologous recombination is essential for crossover (CO) formation and accurate chromosome segregation during meiosis.",
        "Supported by the localization of LEM-3 between dividing meiotic nuclei, this data suggest that LEM-3 is able to process erroneous recombination intermediates that persist into the second meiotic division.",
        "Both pathways require the scaffold protein SLX-4.",
        "It is of considerable importance to work out how recombination intermediates are processed, leading to CO and non-crossover (NCO) outcome.",
        "The combined loss of LEM-3 and MUS-81 leads to altered processing of recombination intermediates, a delayed disassembly of foci associated with CO designated sites, and the formation of univalents linked by SPO-11 dependent chromatin bridges (dissociated bivalents).",
        "In addition, neither CO frequency nor distribution is altered in lem-3 single mutants or in combination with mus-81 or slx-4 mutations.",
        "We previously reported that in C. elegans meiotic joint molecule resolution is mediated by two redundant pathways, conferred by the SLX-1 and MUS-81 nucleases, and by the HIM-6 Bloom helicase in conjunction with the XPF-1 endonuclease, respectively.",
        "Finally, we found persistent chromatin bridges during meiotic divisions in lem-3; slx-4 double mutants.",
        "However, in the absence of all these enzymes, residual processing of meiotic recombination intermediates still occurs and CO formation is reduced but not abolished.",
        "Genetic analysis in budding yeast and Caenorhabditis elegans indicates that the processing of meiotic recombination intermediates involves a combination of nucleases and DNA repair enzymes.",
        "However, LEM-3 foci do not colocalize with ZHP-3, a marker that congresses into CO designated sites.",
        "Here we show that the LEM-3 nuclease, mutation of which by itself does not have an overt meiotic phenotype, genetically interacts with slx-1 and mus-81 mutants, the respective double mutants displaying 100% embryonic lethality."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22383942": [
        "The mitotic defects observed in irradiated lem-3 mutant embryos are similar to those found in baf-1 (barrier-to-autointegration factor) mutants.",
        "The baf-1 gene codes for an essential and highly conserved protein known to interact with the other two C. elegans LEM domain proteins, LEM-2 and EMR-1.",
        "We confirm that LEM-3 has DNase activity in vitro. lem-3(lf) mutants are hypersensitive to various types of DNA damage, including ionizing radiation, UV-C light and crosslinking agents.",
        "Our data suggest that BAF-1, together with the LEM domain proteins, plays an important role following DNA damage - possibly by promoting the reorganization of damaged chromatin.",
        "LEM-3 contains a LEM domain and a GIY nuclease domain.",
        "In order to identify new DNA damage response genes, we isolated in a forward genetic screen 14 new mutations conferring hypersensitivity to ionizing radiation.",
        "We show that baf-1, lem-2, and emr-1 mutants are also hypersensitive to DNA damage and that loss of lem-3 sensitizes baf-1 mutants even in the absence of DNA damage.",
        "The small nematode Caenorhabditis elegans displays a spectrum of DNA damage responses similar to humans.",
        "Embryos from irradiated lem-3 hermaphrodites displayed severe defects during cell division, including chromosome mis-segregation and anaphase bridges.",
        "We present here our characterization of lem-3, one of the genes identified in this screen."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29166661": [
        "We use both concatenated and species tree analyses to examine the relationships and taxonomy of this group.",
        "Weevils (Curculionoidea) comprise one of the most diverse groups of organisms on earth.",
        "For species tree analyses we present a novel partitioning strategy to better model the molecular evolutionary process in UCEs.",
        "Here, we employ ultraconserved elements (UCEs) designed for beetles and a novel partitioning strategy of loci to help resolve phylogenetic relationships within the radiation of Australasian smurf-weevils (Eupholini).",
        "There is hardly a vascular plant or plant part without its own species of weevil feeding on it and weevil species diversity is greater than the number of fishes, birds, reptiles, amphibians and mammals combined.",
        "We found that the current taxonomy is problematic, largely grouping species on the basis of similar color patterns.",
        "Despite being emblematic of the New Guinea fauna, no previous phylogenetic studies have been conducted on the Eupholini.",
        "Finally, our results show that most loci required multiple partitions for nucleotide rate substitution, suggesting that single partitions may not be the optimal partitioning strategy to accommodate rate heterogeneity for UCE loci.",
        "In addition to a comprehensive collection of fresh specimens, we supplement our taxon sampling with museum specimens, and this study is the first target enrichment phylogenomic dataset incorporating beetle specimens from museum collections."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20178376": [
        "Here we investigated the activation mechanism of botulinum neurotoxin type E upon nicking and subsequent reduction of disulfide bond.",
        "Botulinum neurotoxins (BoNTs) are a group of large proteins that are responsible for the clinical syndrome of botulism.",
        "The seven immunologically distinct serotypes of BoNTs (A-G), each produced by various strains of Clostridium botulinum, act on the neuromuscular junction by blocking the release of the neurotransmitter acetylcholine, thereby resulting in flaccid muscle paralysis.",
        "It was observed that nicking of BoNT/E significantly enhances its endopeptidase activity and that at the physiological temperature of 37 degrees C the reduced form of nicked BoNT/E adopts a dynamically flexible conformation resulting from the exposure of hydrophobic segments and facilitating optimal cleavage of its substrate SNAP-25.",
        "Such reduction-induced increase in the flexibility of the polypeptide folding provides a rationale for the mechanism of BoNT/E endopeptidase against its intracellular substrate, SNAP-25, and complements current understanding of the mechanistics of interaction between the substrate and BoNT endopeptidase.",
        "Nicking of the single chain BoNT/E to the dichain form is associated with 100-fold increase in toxicity.",
        "BoNTs are synthesized as single inactive polypeptide chains that are cleaved by endogenous or exogenous proteases to generate the active dichain form of the toxin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9339823": [
        "This review tries to outline in brief the characteristics of Botulinum toxins, their mechanism of action and the various indications for clinical use as a therapeutic agent.",
        "As a consequence, action potentials in the motor nerve can no longer be transmitted to the muscle.",
        "Since then Botulinum toxin has developed rapidly from a frightful poison to a safe therapeutic agent with a remarkable beneficial impact on the quality of life of many thousands of patients worldwide.",
        "Around 1980 local injections of minute amounts (in the order of 0.5 ng) of Botulinum toxin type A were first successfully used in a neurological disorder named blepharospasm which is characterized by an involuntary squinting of the eyes.",
        "For more than a century they are known to be the cause of botulism, a nowadays rare intoxication with spoiled food that leads to generalized flaccid weakness of striated muscle including pharyngeal and respiratory musculature.",
        "Botulinum toxins, exotoxins of Clostridium botulinum, are the most toxic naturally occurring substances known to man.",
        "This lack in transmission, clinically appearing as weakness, may disable or actually critically endanger affected patients.",
        "However, in certain neurological diseases characterized by an abnormal increase in muscle tone or activity, for example dystonia or spasticity, a reduction in signal transmission may actually be beneficial.",
        "The toxins act primarily at peripheral cholinergic motor nerve endings by blocking the release of the neurotransmitter acetylcholine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/1311751": [
        "The H chain is believed to be associated with the highly specific and avid binding of toxin to the motor nerve end plates and also with the process of internalisation of the toxin.",
        "The toxic activity appears to be associated with the L chain which blockades the calcium-mediated release of acetylcholine, probably by interfering at the molecular level with the mechanisms whereby neurotransmitter-containing vesicles merge with the plasmalemma.",
        "A controlled manufacturing process has been developed for the therapeutic toxin which is specially formulated to give a freeze-dried product having good stability.",
        "The type A toxin is now used therapeutically to treat a variety of conditions involving involuntary muscle spasm.",
        "The toxins act primarily at peripheral cholinergic synapses by blocking the evoked release of the neurotransmitter acetylcholine.",
        "In their most active forms the toxins exist as dichain molecules in which a heavy (H) chain is linked by disulphide bonding to a light (L) chain.",
        "The therapeutic toxin is a neurotoxin-haemagglutinin complex isolated from cultures of C. botulinum.",
        "There are seven distinct serotypes of toxin.",
        "The neurotoxins produced by Clostridium botulinum are the most potent acute toxins known and are the causative agents of the neuroparalytic disease botulism.",
        "All are polypeptides of Mr about 150 kDa that have similar structure and pharmacological action."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28569348": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Botulism is a rare potentially fatal and treatable disorder caused by a bacteria-produced toxin that affects the presynaptic synaptic membrane resulting in a characteristic neuromuscular dysfunction.",
        "It is caused by either the ingestion of the toxin or the bacteria, inhalation, or wound infection.",
        "We present our observations with a descriptive case series of wound botulism secondary to black tar heroin (BTH) injection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/14747968": [
        "Infant botulism represents a distinct entity of botulism.",
        "Unrecognized mild forms or beginning muscle weakness can be a co-factor for other risk factors of sudden infant death (SIDS).",
        "Ingestion of the ubiquitously present spores of Clostridium botulinum leads to germination of the organism and neurotoxin production in the infant intestine.",
        "In studies analyzing infants who died from SIDS, botulism bacteria or toxin were found in up to 20 % of cases.",
        "Symptoms typically develop gradually in contrast to classical food botulism in which an acute onset of symptoms shortly after the ingestion of preformed toxin in a food is characteristic.",
        "Depending on the amount of toxin produced, infant botulism exhibits a broad clinical spectrum ranging from oligosymptomatic forms to a fulminant course with acute respiratory failure within hours leading to sudden death.",
        "However, positive results in these tests provide only indirect evidence for the clinical relevance of the neurotoxin since asymptomatic carriers have been found.",
        "Infant botulism therefore represents an important differential diagnosis of unexplained and inconclusive muscular hypotonia in the first year of life.",
        "Microbiologically, the diagnosis is established by identification of Clostridium botulinum organism and toxin in stool specimen.",
        "The toxin irreversibly blocks the release of acetylcholin from the motoric end plate which results in muscle weakness and paralysis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28830841": [
        "These cutting-edge advances have revolutionized pediatric neuro-oncology and have revealed novel oncogenic vulnerabilities that are being therapeutically leveraged.",
        "Promising treatments - including pathway-targeting small molecules as well as epigenetic therapy - are being evaluated in clinical trials, and recent genomic discoveries in rare glioma subgroups have led to the identification of additional new potentially-actionable alterations.",
        "Consequently, parallel research efforts have been focused on identifying the underlying genetic and biological basis of pediatric HGG in order to more clearly define prognostic subgroups for treatment stratification as well as identify new treatment targets.",
        "The management of pediatric HGG continues to be challenging, with poor outcome in many cases despite aggressive treatments.",
        "This review summarizes the current state of knowledge about the molecular characterization of pediatric HGG in correlation to the revised World Health Organization (WHO) classification, as well as provides an overview of some targeted treatment approaches in the modern clinical management of high-grade gliomas.",
        "High-grade gliomas (HGG) are the most common malignant brain tumors in the pediatric population and account for a large subset of all pediatric central nervous system neoplasms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29241176": [
        "In low-grade gliomas, surgery remains the initial option and should be directed at gross total resection in favorable locations, such as the cerebral hemispheres and the cerebellum.",
        "In non-brainstem HGG, the goal is safe maximal tumor removal, while it generally does not play any role in diffuse intrinsic pontine gliomas.",
        "The histology and location are significant prognostic factors, which influence the decision for surgical intervention, as well as the extent of possible tumor removal.",
        "This is a highly heterogeneous group, varying from the benign WHO histopathological grades I and II to malignant WHO grades III and IV.",
        "Management of high-grade gliomas (HGG), which are less common in children compared to adults, continue to pose a significant challenge.",
        "Treatment must, thus, be individualized in the majority of cases of HGG.",
        "Surgery for gliomas in children continues to be aided by technological advancements facilitating tumor resection and improving patient safety and outcomes.",
        "Gliomas are the most common type of brain cancer in the pediatric patients, constituting about 50% of all childhood intracranial tumors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29170066": [
        "Here we review the pivotal role of epigenetic alterations in the etiology and biology of gliomas.",
        "We summarize the complex interactions between \"driver\" mutations, DNA methylation, histone post-translational modifications, and overall chromatin organization, and how they inform current efforts of testing epigenetic compounds and combinations in preclinical and clinical studies.",
        "Furthermore, in adult glioblastoma patients epigenetic silencing of the DNA repair gene MGMT by promoter methylation is predictive for benefit from alkylating agent therapy.",
        "Over the last decade mutations in epigenetic regulator genes have been identified as key drivers of subtypes of gliomas with distinct clinical features.",
        "Gliomas are the most common malignant primary brain tumors, of which glioblastoma is the most malignant form (WHO grade IV), and notorious for treatment resistance.",
        "These epigenetic alterations are used as biomarkers and play a central role for classification of gliomas (WHO 2016) and treatment decisions.",
        "Most characteristic are mutations in IDH1 or IDH2 in lower grade gliomas, and histone 3 mutations in pediatric high grade gliomas that are also associated with characteristic DNA methylation patterns."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29568396": [
        "Integrated DNA methylation analysis was performed on 20 PAs and 4 normal brain samples by Illumina Infinium HumanMethylation27 BeadChips.",
        "These results suggest that PA may be related to the specific brain site where the tumor arises from region-specific cells of origin.",
        "Furthermore, we evaluated the expression levels of selected differentially methylated genes and identified two biomarkers, one, <i>IRX2</i>, related to the tumor localization and the other, <i>TOX2</i>, as tumoral biomarker.",
        "Chromosomal alterations are mostly located at chromosome 7q34 comprising the <i>BRAF</i> oncogene with consequent activation of the mitogen-activated protein kinase pathway.",
        "The aim of this study was to investigate whether distinctive methylation patterns may define biologically relevant groups of PAs.",
        "Although genetic and epigenetic alterations characterizing PA from different localizations have been reported, the role of epigenetic alterations in PA development is still not clear.",
        "We identified distinct methylation profiles characterizing PAs from different locations (infratentorial vs supratentorial) and tumors with onset before and after 3 years of age.",
        "Pilocytic astrocytoma (PA) is the most common glioma in pediatric patients and occurs in different locations.",
        "We identified and validated <i>in silico</i> the methylation alterations of some CpG islands."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29548059": [
        "Although the exact cells of origin for most pediatric gliomas remain to be identified, our current understanding is that specific cell populations during CNS development are susceptible to particular oncogenic events during certain time windows and thus give rise to pediatric gliomas with distinct histological, molecular, and clinical features.",
        "This review outlines diagnostic features and molecular alterations in pediatric low- and high-grade gliomas and how the latter might be exploited with future targeted therapeutic strategies.",
        "The genetic and epigenetic characterization of pediatric gliomas across ages and histologies has facilitated the delineation of biologically relevant subgroups and have revealed potentially targetable alterations in some of them.",
        "Gliomas are the most common primary central nervous system (CNS) neoplasms in children and adolescents and are thought to arise from their glial progenitors or stem cells.",
        "These may be roughly segregated into low-grade gliomas (WHO grades I or II; including most mixed glial-neuronal tumors) and high-grade gliomas (WHO grades III or IV) according to their clinical course when untreated, even though this is not yet entirely clear for some of the recently emerging groups."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29569086": [
        "Pilocytic astrocytomas (PAs) are benign glial tumors and one of the most common childhood posterior fossa tumors.",
        "Bleeding in low-grade tumors might be related to structural abnormalities and specific angio-architecture of tumor vessels, such as degenerative mural hyalinization, \"glomeruloid\" endothelial proliferation, presence of encased micro-aneurysms, and glioma-induced neoangiogenesis.",
        "At a later time, the identification of posterior fossa hemorrhage etiology is crucial to select the appropriate treatment and address the surgical strategy, optimizing the postoperative results.",
        "The acute hemorrhagic presentation of cerebellar PA in childhood although extremely uncommon is of critical clinical importance and necessitates promptly treatment.",
        "According to our analysis, the mortality was not related to symptom onset, tumor location, hemorrhage distribution, presence of acute hydrocephalous, and timing of surgery, while the GCS at hospital admission resulted to be the only statistically significant prognostic factor affecting survival outcome.",
        "Cerebellar hemorrhages in pediatric population are rare and mainly due to head injuries, rupture of vascular malformations, infections, or hematological diseases.",
        "We have investigated the still controversial and unclear pathophysiology underlying intratumoral hemorrhage in PAs.",
        "We described a case of hemorrhagic cerebellar PA in a 9-year-old child and reviewed the English-language literature that reported spontaneous hemorrhagic histologically proven cerebellar PA in pediatric patients (0-18 years).",
        "The abrupt onset of signs and symptoms of acute hydrocephalous and consequent raised intracranial pressure are life-threatening conditions, which need emergent medical and neurosurgical treatments.",
        "Spontaneous intratumoral hemorrhage in PAs occurs occasionally, in about 8-20% of cases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29204019": [
        "The limitations at that time, including paucity of diagnostic facilities and personnel, have improved.",
        "The previous reports from Africa suggested low frequency and different pattern of distribution of brain tumors from what obtains in other continents.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      There is controversy about the global distribution of intracranial tumors (ICTs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28748479": [
        "Recent evidence indicates involvement of the STING pathway in the induction of antitumor immune response.",
        "Understanding the function of STING pathway in cancer cells might provide important insights into the development of effective therapeutic strategies.",
        "It has been shown that activation of the STING-dependent pathway in cancer cells can result in tumor infiltration with immune cells and modulation of the anticancer immune response.",
        "This review focuses on the role of STING pathway in cancer cells, the largely unknown topic that has recently emerged to be important in the context of STING-mediated antitumor responses.",
        "Stimulator of interferon genes (STING) is an adaptor protein that plays an important role in the activation of type I interferons in response to cytosolic nucleic acid ligands.",
        "However, little is known about the consequences of activated STING-mediated signaling in cancer cells on the efficacy of the antitumor treatment.",
        "Therefore, STING agonists are now being extensively developed as a new class of cancer therapeutics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29346345": [
        "Although STING has important functions in the host defense against pathogens and in autoimmune diseases, its physiological relevance in intestinal homeostasis is largely unknown.",
        "In this study, we show that STING<sup>-/-</sup> mice presented defective protective mechanisms of intestinal mucosa, including decreased number of goblet cells, diminished mucus production, and lower levels of secretory IgA, when compared with wild-type (WT) mice.",
        "Absence of STING lead to decrease in induced intraepithelial lymphocytes (IEL) and to increase in group 1 innate lymphoid cell (ILC1) as well as ILC3 frequencies and decrease in ILC2 in the colon.",
        "Microbiota composition was altered in STING<sup>-/-</sup> mice toward a more inflammatory profile, evidencing a reduction in the Allobacolum and Bifidobacterium groups along with increase in Disulfovibrio bacteria.",
        "STING (stimulator of interferon genes) is a cytosolic sensor for cyclic dinucleotides and also an adaptor molecule for intracellular DNA receptors.",
        "Development and function of Foxp3+ and LAP+ regulatory T cells were also compromised in STING<sup>-/-</sup> mice.",
        "Moreover, these mice were highly susceptible to dextran sodium sulfate-induced colitis, T-cell-induced colitis, and enteric Salmonella typhimurium infection when compared with WT animals.",
        "Fecal content and microbiota DNA could activate STING, indicating a role of this molecule in gut.",
        "Therefore, our results identify an important role of STING in maintaining gut homeostasis and also a protective effect in controlling gut inflammation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29367762": [
        "The innate immune pathways involved in these events are known to be regulated by cellular molecules such as stimulator of interferon genes (STING), which controls type I interferon and pro-inflammatory cytokine production in response to the presence of microbial DNA or cytosolic DNA that has escaped from the nucleus.",
        "Here, we report through examination of databases that STING signaling may be commonly suppressed in a greater variety of tumors due to loss-of-function mutation or epigenetic silencing of the STING/cGAS promoter regions.",
        "STING signaling has been shown to be defective in a variety of cancers, such as colon cancer and melanoma, actions that may enable damaged cells to escape the immunosurveillance system.",
        "In comparison, RNA activated innate immune pathways controlled by RIG-I/MDA5 were significantly less affected.",
        "The production of cytokines in response to DNA-damage events may be an important host defense response to help prevent the escape of pre-cancerous cells.",
        "Examination of reported missense STING variants confirmed that many exhibited a loss-of-function phenotype and could not activate cytokine production following exposure to cytosolic DNA or DNA-damage events.",
        "Our data imply that the STING signaling pathway may be recurrently suppressed by a number of mechanisms in a considerable variety of malignant disease and be a requirement for cellular transformation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23589652": [
        "The algorithm was tested using five positive controls including both iso- and heterodisomic segmental UPDs and 30 trios from the HapMap project as negative controls.",
        "UPDtool is a computational tool for detection and classification of uniparental disomy (UPD) in trio SNP-microarray experiments.",
        "Because of its simple input format, UPDtool may also be used with other high-throughput technologies (e.g., next-generation sequencing).",
        "UPDs are rare events of chromosomal malsegregation and describe the condition of two homologous chromosomes or homologous chromosomal segments that were inherited from one parent.",
        "In addition, the chromosomal breakage points could be determined more precisely than by microsatellite analysis.",
        "We developed UPDtool to detect and classify UPDs from SNP microarray data of parent-child trios.",
        "Though high-throughput molecular screening techniques are widely used, detection of UPDs and especially the subclassification remains complex.",
        "UPDtool is platform independent, light weight and flexible.",
        "With UPDtool, we were able to correctly identify all occurrences of non-mosaic UPD within our positive controls, whereas no occurrence of UPD was found within our negative controls.",
        "The occurrence of UPD can be of major clinical relevance.",
        "Our results were compared with both the gold standard, microsatellite analysis and SNPtrio, another program available for UPD detection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17564968": [
        "Here, we describe a simple but highly sensitive method for genomewide detection of allelic composition, based on the Affymetrix single-nucleotide-polymorphism genotyping microarray platform, without dependence on the availability of constitutive DNA.",
        "By sensing subtle distortions in allele-specific signals caused by allelic imbalance with the use of anonymous controls, sensitive detection of LOH is enabled with accurate determination of allele-specific copy numbers, even in the presence of up to 70%-80% normal cell contamination.",
        "The performance of the new algorithm, called \"AsCNAR\" (allele-specific copy-number analysis using anonymous references), was demonstrated by detecting the copy-number neutral LOH, or uniparental disomy (UPD), in a large number of acute leukemia samples.",
        "We next applied this technique to detection of UPD involving the 9p arm in myeloproliferative disorders (MPDs), which is tightly associated with a homozygous JAK2 mutation.",
        "In conclusion, AsCNAR should substantially improve our ability to dissect the complexity of cancer genomes and should contribute to our understanding of the genetic basis of human cancers.",
        "Loss of heterozygosity (LOH), either with or without accompanying copy-number loss, is a cardinal feature of cancer genomes that is tightly linked to cancer development.",
        "However, detection of LOH is frequently hampered by the presence of normal cell components within tumor specimens and the limitation in availability of constitutive DNA.",
        "It revealed an unexpectedly high frequency of 9p UPD that otherwise would have been undetected and also disclosed the existence of multiple subpopulations having disti<a href=\"http://clinicaltrials.gov/show/nct 9\" title=\"See in ClinicalTrials.gov\">nct 9</a>p UPD within the same MPD specimen."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28636139": [
        "One of the commonly used approaches to treat metastatic prostate cancer was via first-generation nonsteroidal anti-androgens (NSAAs), namely flutamide, nilutamide, bicalutamide and topilutamide.",
        "Prostate cancer is the most common cancer and one of the leading causes of cancer deaths in men.",
        "Most prostate cancer patients who are initially responsive develop the most aggressive form of disease called castration-resistant prostate cancer.",
        "Second-generation NSAA receptor antagonists (enzalutamide, apalutamide and darolutamide) are emerging as additional new options to treat castration-resistant prostate cancer.",
        "Based on the review, it was concluded that the published methodologies using either HPLC or LC-MS/MS are well suited for the quantification of NSAA inhibitors in various biological fluids to delineate pharmacokinetic data.",
        "The objective of this work was to review the literature on the bioanalytical methods for the quantification of first- and second-generation NSAA inhibitors in clinical (human plasma) and preclinical (mouse plasma, rat plasma, urine and tissue homogenates etc.) studies along with relevant case studies for some chosen drugs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29420164": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Apalutamide, a competitive inhibitor of the androgen receptor, is under development for the treatment of prostate cancer.",
        "We evaluated the efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer who were at high risk for the development of metastasis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29381490": [
        "ARN had a stronger antiproliferative effect than bicalutamide, which was prominent in the 22Rv1 hormone-responsive cell line, and completely repressed cell proliferation at a concentration of 100 \u03bcmol/l.",
        "We compared the activity of ARN versus bicalutamide on prostate cancer cell lines.",
        "The 22Rv1 cell line responded to testosterone by increasing the nuclear entry of AR, AR-V7, and phosphorylated AR and by increasing the levels of prostate-specific antigen and TMPRSS2.",
        "This effect was strongly abrogated by ARN and to a clearly lower extent by bicalutamide at 10 \u03bcmol/l, both in normoxia and in hypoxia.",
        "No effect of testosterone or of antiandrogens on autophagy flux, hypoxia-related proteins, or metabolism enzyme levels was noted.",
        "The PC3 and DU145 cell lines showed poor expression of the proteins and were not responsive to testosterone.",
        "This reflects a more robust, dose-dependent, repressive effect on cell proliferation.",
        "Apalutamide (ARN-509) is an antiandrogen that binds selectively to androgen receptors (AR) and does not show antagonist-to-agonist switch like bicalutamide.",
        "The effects on autophagic flux (LC3A, p62, TFEB, LAMP2a, cathepsin D) and cell metabolism-related enzymes (hypoxia-inducible factor 1\u03b1/2\u03b1, BNIP3, carbonic anhydrase 9, LDHA, PDH, PDH-kinase) were also studied.",
        "The 22Rv1, PC3, and DU145 cell lines were used to study the effect of ARN and bicalutamide on the expression cytoplasmic/nuclear kinetics of AR, AR-V7 variant, phosphorylated AR, as well as the levels of the AR downstream proteins prostate-specific antigen and TMPRSS2, under exposure to testosterone and/or hypoxia.",
        "On the basis of in-vitro studies, evidence has been reported that ARN is more potent than bicalutamide in blocking the AR pathway in normoxia and in hypoxia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29606109": [
        "Novel androgen receptor pathway inhibitors are nowadays available for treatment of metastatic PCa and these compounds are promising for early stage disease.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Recent retrospective data suggest that neoadjuvant androgen deprivation therapy can improve the prognosis of high-risk prostate cancer (PCa) patients.",
        "Apalutamide is a pure androgen antagonist with a very high affinity with the androgen receptor.",
        "The combination of apalutamide with degarelix, an LHRH antagonist, could increase the efficacy compared to degarelix alone."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29695920": [
        "Similar to enzalutamide, apalutamide inhibits the binding of androgen to androgen receptor (AR), nuclear translocation of the androgen-AR complex, and binding of AR transcription complex to DNA-binding sites and transcription elements.",
        "US Food and Drug Administration approval in M0 CRPC was granted following positive results from the phase III SPARTAN study, where apalutamide demonstrated significant improvements in metastasis-free survival and time to symptomatic progression as compared to placebo.",
        "More recently, efforts have been directed at trying to effect change at earlier phases of the disease.",
        "Apalutamide (ARN-509), a second-generation androgen receptor antagonist, recently received approval in the nonmetastatic (M0) CRPC space.",
        "Advances in therapies have led to the approval of six therapeutic agents since 2004, each demonstrating overall survival benefit in randomized studies, and these have significantly improved the outlook for men facing metastatic castration-resistant prostate cancer (CRPC).",
        "Phase I and II trial experience demonstrates the safety and tolerability of apalutamide, as well as its efficacy in effecting prostate-specific antigen response and radiographic-free survival in CRPC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29626324": [
        "Apalutamide (Erleada<sup>TM</sup>) is a next-generation oral androgen receptor (AR) inhibitor that is being developed by Janssen for the treatment of prostate cancer (PC).",
        "In February 2018, apalutamide received its first global approval in the USA for the treatment of non-metastatic castration-resistant PC (nmCRPC).",
        "Apalutamide is undergoing phase III investigation in chemotherapy-naive patients with metastatic CRPC (in combination with abiraterone acetate plus prednisone), patients with high-risk localized or locally advanced PC receiving primary radiation therapy, and in patients with metastatic hormone-sensitive PC and biochemically-relapsed PC.",
        "It binds directly to the ligand-binding domain of the AR and blocks the effects of androgens.",
        "This article summarizes the milestones in the development of apalutamide leading to this first approval in nmCRPC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29734647": [
        "This has already led to novel classifications of prostate tumors based on gene expression profiles and mutation status, and should greatly help in the choice of novel targeted therapies best tailored to the needs of patients.",
        "Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent years.",
        "Ongoing clinical trials for different subgroups of prostate cancer patients include the evaluation of the second-generation AR antagonists enzalutamide, apalutamide and darolutamide, of inhibitors of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) pathway, of inhibitors of DNA damage response, of targeted alpha therapy and of prostate-specific membrane antigen (PSMA) targeting approaches.",
        "Also, ADT together with docetaxel treatment showed significant benefit in mHSPC.",
        "The identification of improved, personalized treatments will be much supported by the major progress recently made in the molecular characterization of early- and late-stage prostate cancer using &amp;ldquo;omics&amp;rdquo; technologies.",
        "The latest approvals include abiraterone acetate, enzalutamide and apalutamide which target androgen receptor (AR) signaling, radium-223 dichloride for reduction of bone metastases, sipuleucel-T immunotherapy and taxane-based chemotherapy.",
        "Adding abiraterone acetate to androgen deprivation therapy (ADT) in order to achieve complete androgen blockade has proven highly beneficial for treatment of locally advanced prostate cancer and metastatic hormone-sensitive prostate cancer (mHSPC).",
        "Advanced clinical studies with immune checkpoint inhibitors have shown limited benefits in prostate cancer and more trials are needed to demonstrate efficacy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29856649": [
        "Areas covered: The authors review Phase I, II, and III studies for apalutamide, in a large spectrum of PCa (from low-risk to metastatic CRPC [mCRPC]) patients as sole treatment or in the setting of combined therapy.",
        "Several studies with numerous androgen receptor (AR)-directed agents have emerged since the approval of abiraterone acetate and enzalutamide.",
        "Prostate cancer (PCa) is the most common cancer in elderly males.",
        "These data may offer potential advantages over the second-generation antiandrogens.",
        "Expert opinion: Apalutamide is an oral, investigational, AR antagonist that targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets.",
        "Also, results were promising in a recent phase III study in patients with non-mCRPC who were at high risk for the development of metastasis.",
        "One of these agents is apalutamide, which seems to be a promising AR antagonist for the treatment of CRPC.",
        "It has shown favorable safety profile and therapeutic index in Phase I studies, good tolerance and efficacy in patients with high-risk CRPC in Phase II studies.",
        "Androgen deprivation therapy (ADT) is still the cornerstone of initial treatment; however, the vast majority of patients develop castration-resistant prostate cancer (CRPC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27160947": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Apalutamide is a potent androgen receptor (AR) antagonist that targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30426794": [
        "High-risk nonmetastatic castration-resistant prostate cancer is a lethal disease that previously lacked clear treatment options.",
        "Apalutamide, an androgen receptor inhibitor, has substantial clinical response in nonmetastatic castration-resistant prostate cancer.",
        "Future research is needed to elucidate mechanisms of resistance to treatment with androgen signaling inhibitors.",
        "Apalutamide + androgen deprivation therapy is well tolerated and improves metastasis-free survival, progression-free survival and time to symptomatic progression, and is associated with a favorable trend of improved overall survival.",
        "Progression to bone metastases is associated with significant morbidity and high cost."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29466156": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Fusions involving one of three tropomyosin receptor kinases (TRK) occur in diverse cancers in children and adults.",
        "We evaluated the efficacy and safety of larotrectinib, a highly selective TRK inhibitor, in adults and children who had tumors with these fusions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29606586": [
        "Larotrectinib, a highly selective small-molecule inhibitor of the TRK kinases, had shown activity in preclinical models and in adults with tumours harbouring TRK fusions.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Gene fusions involving NTRK1, NTRK2, or NTRK3 (TRK fusions) are found in a broad range of paediatric and adult malignancies.",
        "This study aimed to assess the safety of larotrectinib in paediatric patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29764494": [
        "Pembrolizumab (Keytruda), Merck's anti-programmed cell death-1 (PD-1) monoclonal antibody (mAb), received accelerated approval in May 2017 by the US Food and Drug Administration for the treatment of adult and pediatric patients with unresectable or metastatic solid tumors that have been identified as having microsatellite instability-high (MSI-H) or deficient DNA mismatch repair (dMMR).",
        "Adjustments in our approaches to developing new anti-cancer drugs and to adopting these new cancer treatments in clinical practice need to occur in order to prepare ourselves for the new era of precision medicine.",
        "These regulatory approvals marked an important milestone that a cancer treatment may be approved based on a common biomarker rather than the anatomic location in the body where the tumor originated, and therefore established a precedent for tumor type-agnostic therapy.",
        "With increasing accessibility to genetic analysis tools such as next-generation sequencing, tumor type-agnostic therapy has become a reality, both during clinical development and in clinical practice.",
        "Shortly after, nivolumab (Opdivo), Bristol-Myers Squibb's anti-PD-1 mAb, gained an accelerated approval in August 2017 for adult and pediatric patients with MSI-H or dMMR metastatic colorectal cancer that has progressed after standard chemotherapy.",
        "Both the anti-PD-1 mAbs and the TRK-targeting therapies share some basic features: (a) biomarker-based, well-defined rare patient population; (b) exceptionally high clinical efficacy, e.g., near 40% overall response rate (ORR) for pembrolizumab across 15 tumor types with MSI-H/dMMR and 75% ORR for larotrectinib across more than 12 tumor types with NTRK-fusion proteins; (c) durable responses lasting at least 6 months with complete responses observed; and (d) parallel development in adult and pediatric populations.",
        "Precision medicine just witnessed two breakthroughs in oncology in 2017.",
        "In the 2017 American Society for Clinical Oncology annual meeting, larotrectinib (LOXO-101), Loxooncology's oral, potent, and selective inhibitor of tropomyosin receptor kinases (TRK), demonstrated unprecedented efficacy on unresectable or metastatic solid tumors with neurotrophic tropomyosin receptor kinase (NTRK)-fusion proteins in adult and pediatric patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29568395": [
        "Merestinib is an oral multi-kinase inhibitor targeting a limited number of oncokinases including MET, AXL, RON and MKNK1/2.",
        "In KM-12 cells harboring <i>TPM3-NTRK1</i> fusion, merestinib exhibits potent p-NTRK1 inhibition <i>in vitro</i> by western blot and elicits an anti-proliferative response in two- and three-dimensional growth.",
        "Here, we report that merestinib inhibits neurotrophic receptor tyrosine kinases NTRK1/2/3 which are oncogenic drivers in tumors bearing NTRK fusion resulting from chromosomal rearrangements.",
        "These preclinical data support the clinical evaluation of merestinib, a type II NTRK kinase inhibitor (<a href=\"http://clinicaltrials.gov/show/NCT02920996\" title=\"See in ClinicalTrials.gov\">NCT02920996</a>), both in treatment na\u00efve patients and in patients progressed on type I NTRK kinase inhibitors with acquired secondary G667C mutation in NTRK fusion bearing tumors.",
        "Merestinib blocks tumor growth of both wild-type and mutant G667C <i>TPM3-NTRK1</i> expressing NIH-3T3 cell-derived tumors.",
        "Merestinib is shown to be a type II NTRK1 kinase inhibitor as determined by x-ray crystallography.",
        "To recapitulate resistance observed from type I NTRK kinase inhibitors entrectinib and larotrectinib, we generated NIH-3T3 cells exogenously expressing <i>TPM3-NTRK1</i> wild-type, or acquired mutations G595R and G667C <i>in vitro</i> and <i>in vivo</i>.",
        "Merestinib treatment demonstrated profound tumor growth inhibition in <i>in vivo</i> cancer models harboring either a <i>TPM3-NTRK1</i> or an <i>ETV6-NTRK3</i> gene fusion."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30350734": [
        "The evolving role of molecular profiling of advanced cancers is discussed.",
        "These fusions drive constitutive expression and ligand-independent activation of the TRK kinase and are oncogenic.",
        "Larotrectinib is likely to be the first FDA-approved histology-agnostic molecularly targeted therapy.",
        "Larotrectinib is the first highly potent and selective small molecule ATP competitive inhibitor of all three TRK kinases to enter clinical development. <b>Areas covered</b>: This review covers the current preclinical and clinical evidence for TRK inhibitors for TRK fusion cancers, focusing on larotrectinib. <b>Expert commentary</b>: Larotrectinib has demonstrated a remarkable 75% centrally confirmed objective response rate in patients with TRK fusion cancers in phase 1 and phase 2 clinical trials with generally mild side effects.",
        "<b>Introduction</b>: TRK fusions occur across a wide range of cancers in children and adults.",
        "Responses appear independent of the patient's age, underlying histology, and specific fusion partner and are durable in many patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30204247": [
        "In the current study, the authors describe the clinical course of children with locally advanced TRK fusion sarcoma who were treated preoperatively with larotrectinib and underwent subsequent surgical resection.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The highly selective oral tropomyosin receptor kinase (TRK) inhibitor larotrectinib has demonstrated significant activity in adult and pediatric TRK fusion cancers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30069765": [
        "This concept has already been established with oncogenic gene fusions like BCR-ABL in chronic myelogenous leukemia (CML) or anaplastic lymphoma kinase (ALK) in lung cancer, including special tyrosine kinase inhibitors (TKIs) which are able to block the activation of the depending downstream proliferation pathways and, consequently, tumor growth.",
        "During the last decade, the NTRK1, 2, and 3 genes, encoding the TRKA, B, and C proteins, have attracted increasing attention as another significant and targetable gene fusion in a variety of cancers.",
        "One of the most challenging issues in oncology research and treatment is identifying oncogenic drivers within an individual patient's tumor which can be directly targeted by a clinically available therapeutic drug.",
        "Several TRK inhibitors have been developed, and one of them, Larotrectinib (formerly known as LOXO-101), represents an orally available, selective inhibitor of the TRK receptor family that has already shown substantial clinical benefit in both pediatric and adult patients harboring an NTRK gene fusion over the last few years.",
        "In this context, gene fusions as one important example of genetic aberrations leading to carcinogenesis follow the widely accepted concept that cell growth and proliferation are driven by the accomplished fusion (usually involving former proto-oncogenes) and may therefore be successfully inhibited by substances directed against the fusion."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28578312": [
        "Although responses to TRK inhibition can be dramatic and durable, duration of response may eventually be limited by acquired resistance.",
        "Larotrectinib, a selective TRK tyrosine kinase inhibitor (TKI), has demonstrated histology-agnostic efficacy in patients with TRK fusion-positive cancers.",
        "As clinical proof of concept, the first 2 patients with TRK fusion-positive cancers who developed acquired resistance mutations on larotrectinib were treated with LOXO-195 on a first-in-human basis, utilizing rapid dose titration guided by pharmacokinetic assessments.",
        "Activity against these acquired mutations was confirmed in enzyme and cell-based assays and <i>in vivo</i> tumor models.",
        "This approach led to rapid tumor responses and extended the overall duration of disease control achieved with TRK inhibition in both patients.<b>Significance:</b> LOXO-195 abrogated resistance in TRK fusion-positive cancers that acquired kinase domain mutations, a shared liability with all existing TRK TKIs.",
        "LOXO-195 is a selective TRK TKI designed to overcome acquired resistance mediated by recurrent kinase domain (solvent front and xDFG) mutations identified in multiple patients who have developed resistance to TRK TKIs.",
        "This establishes a role for sequential treatment by demonstrating continued TRK dependence and validates a paradigm for the accelerated development of next-generation inhibitors against validated oncogenic targets. <i>Cancer Discov; 7(9); 963-72. \u00a92017 AACR.</i><i>See related commentary by Parikh and Corcoran, p. 934</i><i>This article is highlighted in the In This Issue feature, p. 920</i>."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28123903": [
        "Also known as the inland robust scorpion, it is widely distributed throughout arid zones of the continent and is emerging as a model organism in biomedical research due to the chemical nature of its venom.",
        "Here we provide the first insight into the molecular variation and evolutionary history of the endemic Australian scorpion <i>Urodacus yaschenkoi</i>.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Australian scorpions have received far less attention from researchers than their overseas counterparts."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29358597": [
        "Furthermore, no mitogenomic features were diagnostic to either subspecies.",
        "Apis mellifera capensis Eschscholtz and A.m. scutellata Lepeletier are subspecies of western honey bees that are indigenous to the Republic of South Africa (RSA).",
        "We used 25 individuals that were either assigned to one of the subspecies or designated hybrids using morphometric analyses.",
        "Phylogenetic analyses of mitogenome sequences by maximum likelihood (ML) and Bayesian inference identified a monophyletic RSA clade, subdivided into two clades.",
        "Both subspecies have invasive potential and are organisms of concern for areas outside their native range, though they are important bees to beekeepers, agriculture, and the environment where they are native.",
        "A haplotype network was consistent with the phylogenetic trees.",
        "The number of variable codons across protein-coding genes (PCGs) differed among loci, with CO3 exhibiting the most variation and ATP6 the least.",
        "However, members of both subspecies occurred in both clades, indicating that A.m. capensis and A.m. scutellata are neither reciprocally monophyletic nor do they exhibit paraphyly with one subspecies nested within the other subspecies.",
        "All bees analyzed from the RSA expressed a substantial level of haplotype diversity (most samples had unique haplotypes) but limited nucleotide diversity.",
        "The aim of the present study was to examine genetic differentiation among these subspecies and estimate their phylogenetic relationships using complete mitochondrial genomes sequences."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30100329": [
        "Bortezomib-based chemotherapy, daratumumab monotherapy, and autologous hematopoietic stem cell transplantation can result in reversal of most manifestations.",
        "TEMPI syndrome is often misdiagnosed as other causes of erythrocytosis, resulting in a delayed diagnosis and further clinical deterioration.",
        "Nevertheless, the diagnosis of TEMPI syndrome remains a substantial challenge owing to its rarity and the complexity of clinical presentations.",
        "The early diagnosis of TEMPI syndrome is essential because therapies targeting the underlying plasma cells can lead to a dramatic response.",
        "Nevertheless, clonal plasma cells and monoclonal protein appear to be major contributors.",
        "The etiology and pathophysiology of this condition remains elusive.",
        "The aim of the present review was to present the clinical and biologic features of TEMPI syndrome, highlighting the differential diagnosis and outlining the present understanding of its pathophysiology and treatment.",
        "TEMPI (telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting) syndrome is a newly described clinical entity that is generally considered a plasma cell dyscrasia with multiple system involvement."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27501129": [
        "In some rare instances, immunoglobulins have a specific biological activity.",
        "The skin findings in cryoglobulinemia (CG) result from vascular immunoglobulin deposition, either as immune complexes within the vessel walls in mixed CG or within the lumina of small vessels in monoclonal CG.",
        "Some dermatologic entities are strongly associated with the presence of a monoclonal gammopathy.",
        "Abnormal cytokine secretion is the hallmark of some entities.",
        "Skin findings include papules and plaques, follicular spicules, purpura, haemorrhagic bullae, macroglossia and nail changes.",
        "Mixed CG manifests as palpable purpura of leukocytoclastic vasculitis, and monoclonal CG as stellar and/or retiform purpura that can evolve into extensive skin necrosis.",
        "This is, for example, the case when they bind lipoproteins that precipitate and induce hypocomplementemic xanthomas.",
        "High vascular endothelial growth factor levels correlate with some of the skin manifestations of the Polyneuropathy organomegaly endocrinopathy monoclonal component skin changes syndrome, such as hypertrichosis or the adenopathy and extensive skin patch overlying plasmacytoma syndrome.",
        "Xanthoderma related to antiflavin activity of the monoclonal component or acquired angioedema related to anti-C1INH activity is other example.",
        "They should be referred to as monoclonal gammopathy of cutaneous significance (MGCS).",
        "A short review of the main entities that fit into the spectrum of MGCS is provided.",
        "In other MGCS, such as scleromyxedema, Clarkson syndrome, TEMPI syndrome, cutis laxa and the neutrophilic dermatoses, the link between the monoclocal component and the entity is clearly established, but not understood so far.",
        "All the clinical manifestations of the Schnitzler syndrome are IL-1 mediated.",
        "Amyloidosis, macroglobulinoderma and follicular hyperkeratotic spicules result from extravascular immunoglobulin or immunoglobulin-related protein deposition."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25216227": [
        "In all cases, erythropoietin levels were extremely elevated at &gt;5000 IU/l, the paraprotein was IgG kappa, JAK2 V617F was negative and vascular endothelial growth factor levels were normal.",
        "Seven bone marrow aspirates and biopsies from three patients, including two post-treatment marrows, were examined.",
        "To date, 11 patients have been identified.",
        "Prominent plasma cell vacuolization and reactive-appearing lymphoid aggregates were noted in one case.",
        "Findings of myeloproliferative neoplasms, including megakaryocyte clusters and fibrosis, were not identified.",
        "This is the first morphologic review of TEMPI syndrome bone marrow samples, in order to define pathologic features that may aid in the recognition of the syndrome and to identify post-therapy changes.",
        "Patients were 36, 49, and 49 years old at time of diagnosis.",
        "It is best classified as a type of plasma cell dyscrasia with paraneoplastic manifestations, similar to POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin abnormalities).",
        "Peculiar clinical and laboratorial findings of TEMPI, including elevated erythropoietin and normal vascular endothelial growth factor level, allow the diagnosis and distinction from POEMS syndrome.",
        "In one case, the increase in clonal plasma cells reached levels of smoldering myeloma (18%), but remaining marrows showed few monoclonal plasma cells (&lt;5%).",
        "Significant decrease in erythropoietin level following treatment suggests a role of erythropoietin in monitoring therapeutic response.",
        "The bone marrow findings, although nonspecific, differ significantly from polycythemia vera.",
        "All pre-treatment biopsies showed erythroid hyperplasia, with mild nonspecific megakaryocytic, and erythroid cytologic atypia in one marrow.",
        "In conclusion, TEMPI syndrome should be considered when erythrocytosis and plasma cell dyscrasia coexist.",
        "TEMPI syndrome (telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting) is a recently described syndrome that, owing to erythrocytosis, may be confused with polycythemia vera."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25143825": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting.",
        "The underlying pathophysiology is unknown, though it has been postulated that the monoclonal gammopathy may play a causal role."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25911963": [
        "Patients with TEMPI syndrome have responded to therapies used to treat plasma cell dyscrasias and may benefit from autologous HPC transplantation.",
        "TEMPI syndrome is a recently described condition defined by teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting.",
        "Previous studies highlighted the challenges of HPC-A collection from patients with abnormal red blood cells (RBCs).",
        "We report HPC-A collection from a patient with TEMPI syndrome that was complicated by severe iron deficiency.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Collection of hematopoietic progenitor cells by apheresis (HPC-A) requires separation of cells by density."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28065641": [
        "Deep hand infections are located deep to the tendon sheaths and include synovial space infections, such as infectious tenosynovitis, deep fascial space infections, septic arthritis, necrotising fasciitis, and osteomyelitis.",
        "The various infectious processes can be categorised as superficial or deep infections based on their respective locations relative to the tendons.",
        "Multidetector computed tomography (MDCT), with its muliplanar reformation (MPR) and three-dimensional (3D) capabilities, is a powerful tool in the emergency setting for the evaluation of acute hand and wrist pathology.",
        "Hand and wrist infections can present with a spectrum of manifestations ranging from cellulitis to deep-space collections.",
        "Superficial hand infections are located superficial to the tendons and are comprised of cellulitis, lymphangitis, paronychia, pulp-space infections, herpetic whitlow, and include volar as well as dorsal subcutaneous abscesses.",
        "Although early and superficial infections of the hand may respond to non-surgical management, most hand infections are surgical emergencies.",
        "The clinical and imaging features of hand and wrist infections as evident on MDCT will be reviewed with emphasis on contiguous and closed synovial and deep fascial spaces.",
        "Knowledge of hand and wrist compartmental anatomy is essential for the accurate diagnosis and management of hand infections.",
        "Knowledge of hand compartmental anatomy enables accurate characterisation of the infectious process and localise the extent of disease in the acute setting."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28376707": [
        "Commonly, it is caused by HSV-2 in adults with positive history for genital infection.",
        "<strong class=\"sub-title\">\n          Context:\n        </strong>\n      \n      Herpetic whitlow is caused by herpes virus (type1 or 2) during primary infection or as result of autoinoculation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26001830": [
        "However, in rare cases, it may also be caused by the herpes simplex virus.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Whitlow is an infection of a finger or around the fingernails, generally caused by bacterium.",
        "Delayed recognition and/or treatment puts patients at risk of complications ranging from superinfection to herpetic encephalitis.",
        "As herpetic whitlow is not seen often, it may go under-recognised or be mistaken for a different kind of infection of the finger."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25436164": [
        "Herpetic whitlow is an acute viral infection of the hand caused by either herpes simplex virus (HSV) 1 or 2.",
        "Her symptoms improved transiently following emergent surgical open flexor sheath exploration and washout however, she required two further washouts; at eleven and thirteen months to improve symptoms.",
        "Treatment with acyclovir at thirteen months after presentation led to a complete resolution of her symptoms with no further recurrences to date.",
        "Viral cultures were obtained from the third washout as HSV infection was disclosed from further history taking.",
        "Multiple painful pustules with tracking cellulitis were partially treated by oral antibiotics.",
        "A recurrence with positive Kanavel's signs suggested flexor tenosynovitis at seven months.",
        "We emphasise the importance of careful past medical history taking as well as considering herpetic whitlow as a differential diagnosis despite the presence of strongly positive Kanavel's signs.",
        "This rare case highlights the similarity in presentation between flexor sheath infection and herpetic whitlow which can lead to diagnostic confusion and mismanagement.",
        "These were positive for HSV2.",
        "The differential diagnosis includes flexor tenosynovitis.",
        "We present a case of recurrent infection of the middle finger in an immunocompetent 19-year-old girl.",
        "Its characteristic findings are significant pain and erythema with overlying nonpurulent vesicles."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11921024": [
        "This is an illustrative case of an immunocompromised host status altering appearance and course of cutaneous disease such that the history and physical exam alone may not help in diagnosing atypical presentations of herpetic infections.",
        "Herpetic whitlow, a herpes simplex virus infection involving the digits, most commonly presents as a vesicular eruption involving a single digit.",
        "We describe a case of herpetic whitlow in a patient finishing 6 cycles of chemotherapy for refractory chronic lymphocytic leukemia that presented with a bilateral, multi-digit, crusted eruption of the hands.",
        "Diagnosis of herpetic whitlow can usually be made with the history of exposure, the characteristic vesicular eruption, and a positive Tzank smear and/or viral culture.",
        "This case underscores the necessity for clinico-histopathologic correlation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/2933494": [
        "Herpetic whitlow is a herpes simplex virus infection of the finger.",
        "The diagnosis of herpetic whitlow may be confirmed by Tzanck test, acute and convalescent herpes simplex antibody titers, viral culture, and fluorescent antibody tests.",
        "The infection is self-limited, and surgical intervention generally should be avoided.",
        "It is characterized by pain, erythema, and nonpurulent vesicle or bullae formation.",
        "It may be due to a primary or recurrent infection.",
        "It may be caused by either herpes simplex type 1 or 2.",
        "Techniques for prevention and control of the infection include appropriate isolation of patients with herpes infections, avoidance of patient care by health care personnel with active infections, and the use of gloves when handling secretions.",
        "It is a common infection in health care professionals who have frequent contact with the secretions of patients' mouths and respiratory tracts."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17674583": [
        "In children, most cases can be attributed to autoinoculation of HSV-1, while in adolescents and adults, herpetic whitlow tends to be caused by autoinoculation of HSV-2.",
        "Herpetic whitlow has been known mainly for infecting healthcare workers in contact with infected secretions or mucous membranes, but the implementation of universal precautions has resulted in a decrease in the incidence of occupation-related cases.",
        "Herpetic whitlow may have a prodrome of burning, pruritus, and/or tingling of the affected finger or the entire limb, followed by erythema, pain, and vesicle formation.",
        "Herpetic whitlow is a painful cutaneous infection that most commonly affects the distal phalanx of the fingers and occasionally the toes.",
        "It is caused by herpes simplex virus (HSV) types 1 or 2.",
        "Herpetic whitlow occurs mainly in adults aged 20 to 30 years and children."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11585074": [
        "We report a 4-year-old girl with multiple herpetic whitlows secondary to herpetic stomatitis and present a review of the medical literature based on a systematic MEDLINE search of published paediatric patients (English, French and German language).",
        "Occasionally, person-to-person transmission occurs from family members with herpes labialis.",
        "Recurrences were reported in 23%.",
        "Herpetic whitlow is a herpes simplex virus type 1 or 2 infection of the fingers characterised by erythema and painful, non-purulent vesicles.",
        "Of 42 identified patients, 72% were younger than 2 years, most had endogenous or exogenous inoculation of herpes simplex virus type 1 and 65% were initially misdiagnosed as having \"bacterial felon\".",
        "In children it typically occurs after auto-inoculation from herpes stomatitis, herpes labialis or genitalis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8362051": [
        "This paper describes a case of transmission of herpetic whitlow to the index finger of a dental student from a patient with herpes simplex virus.",
        "The recognition of intraoral viral infections in patients is important because these viruses have serious implications for health care providers.",
        "Asymptomatic permanent herpes virus carriers must also be treated with appropriate precautions.",
        "Rubber gloves must be worn when patients with primary or secondary herpetic lesions are treated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29436379": [
        "During the past few years, as more evidence has become available, a consortium of international experts determined that the 2008 guidelines from the CF Foundation needed to be reviewed and updated.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Cystic fibrosis (CF) is a complex autosomal recessive disease that continues to present unique diagnostic challenges.",
        "Because CF was first described in 1938, there has been a substantial growth of genetic and phenotypic information about the disorder."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29580829": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Sweat chloride testing for diagnosis of cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
        "Here, in a proof-of-concept study, we compare the performance of the sensor to current clinical practice in CF patients and healthy subjects.",
        "We have developed a wearable sensor with an integrated salt bridge for real-time measurement of sweat chloride concentration."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28129813": [
        "To limit irreversible organ pathology, a timely diagnosis of CF and institution of CF therapies can greatly benefit these patients.",
        "This is because newborn screening started relatively recently, it is not performed everywhere, and even for individuals who were screened, there is the possibility of a false negative.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Although the majority of cases of cystic fibrosis (CF) are now diagnosed through newborn screening, there is still a need to standardize the diagnostic criteria for those diagnosed outside of the neonatal period."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28194692": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation identification is being used with increased frequency to aid in the diagnosis of cystic fibrosis (CF) in those suspected with CF.",
        "CFTR mutational analysis results were also compared with sweat chloride results.",
        "Aim of this study was to identify diagnostic outcomes when CFTR mutational analysis was used in CF diagnosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28852705": [
        "The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF) in support of universal newborn screening programs.",
        "Amino acids, organic acids, amino acid derivatives, dipeptides, purine derivatives, and unknown exogenous compounds were identified in sweat when using high resolution tandem mass spectrometry, including metabolites associated with affected yet asymptomatic CF infants, such as asparagine and glutamine.",
        "Unexpectedly, a metabolite of pilocarpine, used to stimulate sweat secretion, pilocarpic acid, and a plasticizer metabolite from environmental exposure, mono(2-ethylhexyl)phthalic acid, were secreted in the sweat of CF infants at significantly lower concentrations relative to unaffected CF screen-positive controls.",
        "However, it provides ambiguous results for intermediate sweat chloride cases while not reflecting disease progression when classifying the complex CF disease spectrum given the pleiotropic effects of gene modifiers and environment.",
        "These results indicated a deficiency in human paraoxonase, an enzyme unrelated to mutations to the cystic fibrosis transmembrane conductance regulator (CFTR) and impaired chloride transport, which is a nonspecific arylesterase/lactonase known to mediate inflammation, bacterial biofilm formation, and recurrent lung infections in affected CF children later in life.",
        "This work sheds new light into the underlying mechanisms of CF pathophysiology as required for new advances in precision medicine of orphan diseases that benefit from early detection and intervention, including new molecular targets for therapeutic intervention.",
        "Pilocarpine-stimulated sweat specimens were collected independently from two CF clinics, including 50 unaffected infants (e.g., carriers) and 18 confirmed CF cases.",
        "Herein we report the first characterization of the sweat metabolome from screen-positive CF infants and identify metabolites associated with disease status that complement sweat chloride testing.",
        "Nontargeted metabolite profiling was performed using multisegment injection-capillary electrophoresis-mass spectrometry as a high throughput platform for analysis of polar/ionic metabolites in volume-restricted sweat samples."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29124052": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, <i>CFTR</i> (cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28208841": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Cystic Fibrosis (CF) is an autosomal recessive disorder and the incidence of this disease is undermined in Northern India.",
        "The distinguishable salty character of the sweat belonging to individuals suffering from CF makes sweat chloride estimation essential for diagnosis of CF disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15274098": [
        "However, the sweat chloride concentration did not correlate with the severity index, either in the population as a whole, or in the population of patients with alleles associated with pancreatic sufficiency, who are thought to have some residual CFTR function.",
        "This suggestion arises from the assumption that greater residual CFTR function should lead to a lower sweat chloride concentration, as well as protection against severe lung disease.",
        "We calculated a severity index for pulmonary disease, using an approach which takes into account all available pulmonary function data as well as the patient's current age and survival status.",
        "This logic gives rise to the hypothesis that the lower the sweat chloride concentration, the less severe the lung disease.",
        "These data suggest that, by itself, sweat chloride concentration does not necessarily predict a milder pulmonary course in patients with cystic fibrosis.",
        "In order to test this hypothesis, we studied 230 patients homozygous for the DeltaF508 allele, and 34 patients with at least one allele associated with pancreatic sufficiency, born since January 1, 1955, who have pulmonary function data and sweat chloride concentrations recorded in our CF center database, and no culture positive for B. cepacia.",
        "In cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant CFTR.",
        "Patients with alleles associated with pancreatic sufficiency had significantly better survival (P = 0.0083), lower sweat chloride concentration (81.4 +/- 23.8 vs. 103.2 +/- 14.2 mEq/l, P &lt; 0.0001), slower rate of decline of FEV(1) % predicted (-0.75 +/- 0.34 vs. -2.34 +/- 0.17% predicted per year), and a better severity index than patients homozygous for the DeltaF508 allele (median 73rd percentile vs. median 55th percentile, P = 0.0004)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25530017": [
        "Our objectives were to: 1) describe variables that determine sweat rate; 2) determine the analytic and diagnostic capacity of sweat chloride analysis across the range of observed sweat rates; and 3) determine the biologic variability of sweat chloride concentration.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis (CF)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28193033": [
        "From these results, we show a sweat chloride sensor can be designed to provide accurate measurements over extended times.",
        "We performed parametric studies to show how the salt bridge geometry determines equilibration between the reference and test solutions.",
        "Sweat chloride is of interest as a biomarker for cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise.",
        "Potentiometric sensors provide a relatively simple technology for on-body sweat chloride measurement, however, equilibration between reference and test solutions has limited the time over which accurate measurements can be made.",
        "The components of sweat provide an array of potential biomarkers for health and disease.",
        "We then performed on-body tests on healthy subjects while exercising to establish the feasibility of using this technology as a wearable device.",
        "Developing wearable sensors for biomarkers in sweat is a major technological challenge.",
        "Here, we report on a wearable potentiometric chloride sweat sensor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24485874": [
        "Sweat conductivity is widely used although still considered a screening test.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Sweat chloride test is the gold standard test for cystic fibrosis (CF) diagnosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18728376": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Cystic fibrosis is a chronic progressive autosomal recessive disorder caused by the CFTR gene mutations.",
        "It is quite common in Caucasians, but very rare in Asians.",
        "In this study, sweat chloride levels in Korean population were measured and analyzed by using standardized pilocarpine iontophoresis sweat chloride test.",
        "Sweat chloride test is known to be a screening test for the cystic fibrosis due to the fact that electrolyte levels in sweat are elevated in patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29338740": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Recurrent airway infections are common in patients with Down's syndrome (DS).",
        "Hence, ruling out Cystic Fibrosis (CF) in these patients is often required.",
        "This study analyses sweat secretion rate and chloride concentration in sweat samples of patients with DS in comparison to healthy controls.",
        "However, these reports are based on measurements of sweat osmolality or sodium concentrations, not chloride concentrations.",
        "In the past, the value of sweat testing - the gold standard to diagnose CF - has been questioned in DS as false positive results have been reported."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23056867": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis (CF).",
        "This study was performed to compare sweat chloride values obtained by quantitative pilocarpine iontophoresis (classic test) with sweat crystallization detected by direct observation of a drop of perspiration under light microscopy in patients with and without CF."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23605131": [
        "Patients with CF have raised concentrations of chloride and sodium in their sweat; however, it is the concentration of chloride in sweat which provides the greatest diagnostic sensitivity for CF.",
        "Due to the large number of mutations that can result in classical or atypical CF phenotype, the sweat test, which quantifies the amount of chloride and sodium in sweat, is vital in supporting the diagnosis of CF.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Cystic fibrosis (CF) is an autosomal recessive condition that has an incidence of 1:2500 live births in Northern Europe."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20349506": [
        "The authors have carried out chemical biological research using these bioactive substances as molecular probes in order to clarify the mechanisms of nyctinastic movement.",
        "This phenomenon is controlled by two endogenous bioactive substances that exhibit opposing activities: Leaf-Opening Factor (LOF), which opens the leaves, and Leaf-Closing Factor (LCF), which closes them.",
        "Leguminous plants open their leaves during the daytime and close them at night as if sleeping, a type of movement that follows circadian rhythms, and is known as nyctinastic movement.",
        "Here, we report on the detection and identification of the target proteins of these compounds using original methodology."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17304541": [
        "The use of fluorescence-labeled and photoaffinity-labeled factors revealed that the factors bind to specific cells, the motor cells, present in the pulvini, and that the membrane fraction of the motor cells contained two proteins of 210 and 180 kDa, which can bind to the factors.",
        "The relative contents of the closing and opening factors changed correlating with the nyctinastic leaf movement.",
        "Each of the nyctinastic plants of five different genera so far examined contained a pair of factors, one of which induced leaf closure and another induced leaf opening.",
        "The chemical aspects of the circadian leaf movement known as \"nyctinasty\" are discussed in this paper."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/14527150": [
        "Binding experiments using probe 1 showed that Albizza plants have receptors for a leaf-opening substance in their motor cells.",
        "Now, we have developed novel fluorescent probes (1) based on the structure of cis-p-coumaroylagmatine (3), which was isolated as a leaf-opening substance of Albizzia juribrissin Durazz.",
        "By using probes 1 we then found that genus-specific receptors are involved in nyctinasty.",
        "Periodic leaf-movement of legumes is called nyctinasty and has been known since the age of Alexander the Great.",
        "We found that nyctinasty is controlled by a periodic change of the internal concentration of leaf-opening and leaf-closing substances in the plant body."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29998471": [
        "Such predators could also detect sounds made by prey better without baffling layers of foliage overhead to damp and disperse the signal.",
        "In terrestrial environments, it is hypothesised that the vertical orientation of the blades of nyctinastic plants at night would be especially beneficial to flying nocturnal predators (e.g. bats and owls) and parasitoids whose modus operandi is death from above.",
        "The movements of prey beneath a plant with vertically oriented foliage would be visually more obvious to gleaning or swooping predators under nocturnal or crepuscular conditions.",
        "During the day, the blades of nyctinastic plant leaves (or leaflets) assume a more or less horizontal position that optimises their ability to capture sunlight for photosynthesis.",
        "Predators and parasitoids generally use some combination of visual, auditory or olfactory cues to detect prey.",
        "Moreover, any volatiles released by the prey would diffuse more directly to the awaiting olfactory apparatus of the predators or parasitoids.",
        "Foliar nyctinasty also may not solely be a behavioural adaptation against folivores; by discouraging foraging by granivores, the inclusive fitness of nyctinastic plants may be increased.",
        "It is suggested that the reduction in physical clutter that follows from nocturnal leaf closure may increase the foraging success of many types of animals that prey upon or parasitise herbivores.",
        "As an added advantage, foliar nyctinasty, by decreasing the temperature between plants through its effects on re-radiation, may slow certain types of ectothermic herbivores making them more vulnerable to predation.",
        "After discussing these previous hypotheses, a novel tritrophic hypothesis is introduced that proposes that foliar nyctinasty constitutes an indirect plant defence against nocturnal herbivores.",
        "Among the ideas put forth to explain the raison d'\u00eatre of foliar nyctinasty are that it: (i) improves the temperature relations of plants; (ii) helps remove surface water from foliage; (iii) prevents the disruption of photoperiodism by moonlight; and (iv) directly discourages insect herbivory.",
        "In addition to facilitating the demise of herbivores by carnivores and parasitoids, foliar nyctinasty, much like the enhanced illumination of the full moon, may mitigate feeding by nocturnal herbivores by altering their foraging behaviour.",
        "Foliar nyctinasty is a plant behaviour characterised by a pronounced daily oscillation in leaf orientation.",
        "Foliar nyctinasty could also provide a competitive advantage by encouraging herbivores, seeking more cover, to forage on or around non-nyctinastic species.",
        "At night, the positions that the leaf blades assume, regardless of whether they arise by rising, falling or twisting, are essentially vertical."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29983317": [
        "We show that cell-specific circadian expression of SsSLAH1 plays a key role in nyctinastic leaf opening.",
        "We confirm the importance of SLAH1 in leaf movement using SLAH1-impaired Glycine max.",
        "Identification of this \"master player\" advances our molecular understanding of nyctinasty.",
        "Nyctinastic movement is triggered by the alternate swelling and shrinking of motor cells at the base of the leaf.",
        "This, in turn, is facilitated by changing osmotic pressures brought about by ion flow through anion and potassium ion channels.",
        "In addition, SsSLAH1 co-expressed with SsSLAH3 in flexor (abaxial) motor cells promoted leaf opening.",
        "The circadian leaf opening and closing (nyctinasty) of Fabaceae has attracted scientists' attention since the era of Charles Darwin.",
        "However, key regulatory ion channels and molecular mechanisms remain largely unknown.",
        "Here, we identify three key ion channels in mimosoid tree Samanea saman: the slow-type anion channels, SsSLAH1 and SsSLAH3, and the Shaker-type potassium channel, SPORK2."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18306452": [
        "Hepatic fatty acid synthase activity was positively correlated with plasma fatty acid concentration (r = 0.513, p &lt; 0.05) that was lower in the Du-zhong group.",
        "The hepatic cholesterol concentration was lower in the Du-zhong group than in the control group.",
        "Hamsters fed with Du-zhong leaf extract for 10 weeks showed a smaller size of epididymal adipocytes compared to the control group.",
        "The supplementation of the Du-zhong leaf extract significantly lowered the plasma levels of triglyceride, total cholesterol, LDL-cholesterol, non HDL-cholesterol, and free fatty acid, whereas it elevated the HDL-cholesterol/total cholesterol ratio and apolipoprotein A-I levels.",
        "The hepatic fatty acid synthase and HMG-CoA reductase activities were significantly lowered by a Du-zhong leaf extract supplement in high fat-fed hamsters.",
        "The plasma total cholesterol concentration was positively correlated with hepatic HMG-CoA reductase activity (r = 0.547, p &lt; 0.05) and hepatic cholesterol concentration (r = 0.769, p &lt; 0.001).",
        "This study examined the effect of a Du-zhong (Eucommia ulmoides Oliver) leaf extract (0.175 g/100 g diet) that was supplemented with a high-fat diet (10% coconut oil, 0.2% cholesterol, wt/wt) on hyperlipidemic hamsters.",
        "These results demonstrate that the Du-zhong leaf extract exhibits antihyperlipidemic properties by suppressing hepatic fatty acid and cholesterol biosynthesis with the simultaneous reduction of plasma and hepatic lipids in high fat-fed hamsters."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24349058": [
        "Together, these results suggest that EUE and its active components enhance lysosomal activity, resulting in decreased ER stress and hepatic dyslipidemia.",
        "Here, we examined the potential regulatory effects of Eucommia ulmoides Oliver extracts (EUE) on hepatic dyslipidemia and its related mechanisms by in vitro and in vivo studies.",
        "EUE and its two active constituents, aucubin and geniposide, inhibited palmitate-induced endoplasmic reticulum (ER) stress, reducing hepatic lipid accumulation through secretion of apolipoprotein B and associated triglycerides and cholesterol in human HepG2 hepatocytes.",
        "To determine how EUE diminishes the ER stress response, lysosomal and proteasomal protein degradation activities were analyzed.",
        "In addition, EUE was determined to regulate hepatic dyslipidemia by enhancing lysosomal activity and to regulate ER stress in rats fed a high-fat diet.",
        "Eucommia ulmoides Oliver is a natural product widely used as a dietary supplement and medicinal plant.",
        "Although proteasomal activity was not affected, lysosomal enzyme activities including V-ATPase were significantly increased by EUE as well as aucubin and geniposide in HepG2 cells.",
        "Treatment with the V-ATPase inhibitor, bafilomycin, reversed the inhibition of ER stress, secretion of apolipoprotein B, and hepatic lipid accumulation induced by EUE or its component, aucubin or geniposide."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28100919": [
        "Eucommia ulmoides Oliver leaf extract (ELE) has been shown to have anti-hypertensive and anti-obesity effects in rats that are fed a high-fat diet (HFD).",
        "The HFD treatment caused mild obesity and hypertension in the normotensive rats, while rats receiving both ELE and the HFD had significantly lower body weights, less visceral and perirenal fat, lower blood pressure and thinner aortic media than the control rats receiving the HFD only.",
        "Long-term administration of ELE might inhibit the development of arteriosclerosis.",
        "To explore the effects of chronic administration of ELE on body weight, blood pressure and aortic media thickness, 7-week-old male Wistar-Kyoto (WKY) rats were orally administered a normal diet, a 30% HFD, or a 5% ELE plus HFD ad libitum for 10 weeks.",
        "Anti-hypertensive and anti-obesity effects may be caused by the geniposidic acid (GEA) and/or asperuloside present in ELE.",
        "These findings suggest that chronic ELE administration prevents aortic media hypertrophy in early-stage obesity with hypertension.",
        "Although plasma leptin levels were elevated in all HFD rats, adiponectin levels increased only in the ELE-treated rats.",
        "The plasma adiponectin/leptin ratio also improved in ELE-treated rats."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20691136": [
        "We used a metabolic syndrome-like rat model, produced by feeding a 35% high-fat diet (HFD), to examine potential anti-obesity and anti-metabolic syndrome effects and mechanisms of chronic administration of Eucommia leaf as an extract or green leaf powder.",
        "Both forms of Eucommia leaves minimised increases in body weight and visceral fat in a dose-dependent fashion.",
        "Concomitantly, an increase in plasma adiponectin levels and suppression of plasma resistin and TNF-\u03b1 levels were confirmed.",
        "Real-time PCR studies showed that both forms of Eucommia leaf enhanced metabolic function across several organs, including diminishing ATP production (white adipose tissue), accelerating \u03b2-oxidation (liver) and increasing the use of ketone bodies/glucose (skeletal muscle), all of which may exert anti-obesity effects under HFD conditions.",
        "Eighty rats were studied for 3 months in ten groups.",
        "The anti-obesity and anti-metabolic syndrome activity in this rat model may be maintained through secretion and regulation of adipocytokines that depend on the accumulation of visceral fat to improve insulin resistance or hyperlipaemia.",
        "Eucommia bark (Eucommia ulmoides Oliver) has been used as an herbal medicine, and more recently, the plant's leaves have been widely used to prepare tea which may have anti-obesity properties.",
        "Increases in plasma levels of TAG and NEFA, and insulin resistance secondary to HFD were lessened by both forms of Eucommia leaf.",
        "These findings suggest that chronic administration of either form of Eucommia leaves stimulates the metabolic function in rats across several organs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23564842": [
        "It has also been used for assisting the creation of disease-related mutation databases.",
        "Most of existing approaches are rule-based and focus on limited types of sequence variations, such as protein point mutations.",
        "Thus, extending their extraction scope requires significant manual efforts in examining new instances and developing corresponding rules.",
        "As such, new automatic approaches are greatly needed for extracting different kinds of mutations with high accuracy.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Text-mining mutation information from the literature becomes a critical part of the bioinformatics approach for the analysis and interpretation of sequence variations in complex diseases in the post-genomic era."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28968638": [
        "Previous studies have attempted to harvest and unlock such information with text-mining techniques but are of limited use because their mutation extraction results are not standardized or integrated with curated data.",
        "However, a wealth of knowledge about the variant biological function/disease impact is buried in unstructured literature data.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Despite significant efforts in expert curation, clinical relevance about most of the 154 million dbSNP reference variants (RS) remains unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30247488": [
        "Here we show that a deep convolutional neural network can call genetic variation in aligned next-generation sequencing read data by learning statistical relationships between images of read pileups around putative variant and true genotype calls.",
        "The approach, called DeepVariant, outperforms existing state-of-the-art tools.",
        "We further show that DeepVariant can learn to call variants in a variety of sequencing technologies and experimental designs, including deep whole genomes from 10X Genomics and Ion Ampliseq exomes, highlighting the benefits of using more automated and generalizable techniques for variant calling.",
        "Despite rapid advances in sequencing technologies, accurately calling genetic variants present in an individual genome from billions of short, errorful sequence reads remains challenging.",
        "The learned model generalizes across genome builds and mammalian species, allowing nonhuman sequencing projects to benefit from the wealth of human ground-truth data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23874564": [
        "Recently, we found that Stamp2 has a critical role in the integration of inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic cues.",
        "These results suggest that Stamp1 and Stamp2 play critical roles in adipogenesis, but through different mechanisms.",
        "Upon Stamp1 knockdown, mitotic clonal expansion was also inhibited.",
        "Suppression of Stamp1 or Stamp2 expression both led to inhibition of 3T3-L1 differentiation in concert with diminished expression of the key regulators of adipogenesis - CCAAT/enhancer binding protein alpha (C/ebp\u03b1) and peroxisome proliferator-activated receptor gamma (Ppar\u03b3).",
        "In this study, we show that all Stamp family members are differentially regulated during adipogenesis: whereas Stamp1 expression is significantly decreased upon differentiation, Stamp2 expression is increased.",
        "In contrast, Stamp2 knockdown did not affect mitotic clonal expansion, but resulted in a marked decrease in superoxide production that is known to affect adipogenesis.",
        "In contrast, Stamp3 expression is modestly changed in adipocytes compared to preadipocytes, and has a biphasic expression pattern during the course of differentiation.",
        "Six transmembrane protein of prostate (Stamp) proteins play an important role in prostate cancer cell growth."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17482547": [
        "Lack of STAMP2 in adipocytes results in aberrant inflammatory responses to both nutrients and acute inflammatory stimuli.",
        "Metabolic and inflammatory pathways crosstalk at many levels, and, while required for homeostasis, interaction between these pathways can also lead to metabolic dysregulation under conditions of chronic stress.",
        "Similarly, in whole animals, visceral adipose tissue of STAMP2(-/-) mice exhibits overt inflammation, and these mice develop spontaneous metabolic disease on a regular diet, manifesting insulin resistance, glucose intolerance, mild hyperglycemia, dyslipidemia, and fatty liver disease.",
        "Thus, we hypothesized that mechanisms might exist to prevent overt inflammatory responses during physiological fluctuations in nutrients or under nutrient-rich conditions, and we identified the six-transmembrane protein STAMP2 as a critical modulator of this integrated response system of inflammation and metabolism in adipocytes.",
        "We conclude that STAMP2 participates in integrating inflammatory and metabolic responses and thus plays a key role in systemic metabolic homeostasis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18381574": [
        "<strong class=\"sub-title\">\n          Context:\n        </strong>\n      \n      Six transmembrane protein of prostate 2 (STAMP2) is a counterregulator of adipose inflammation and insulin resistance in mice.",
        "Our hypothesis was that STAMP2 could be involved in human obesity and insulin resistance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29190878": [
        "These results suggest that STAMP2 is crucial for normal ASC conversion into adipocytes and their metabolic function, as well as their ability to facilitate PCa growth <i>in vivo</i>.",
        "Six Transmembrane Protein of Prostate 2 (STAMP2) has been implicated in both prostate cancer (PCa) and metabolic disease.",
        "Using human adipose-derived stem cells (ASCs), we report that STAMP2 expression is dramatically upregulated during adipogenesis. shRNA-mediated STAMP2 knockdown in ASCs significantly suppresses adipogenesis and interferes with optimal expression of adipogenic genes and adipocyte metabolic function.",
        "STAMP2 has unique anti-inflammatory and pro-metabolic properties in mouse adipose tissue, but there is limited information on its role in human metabolic tissues.",
        "Furthermore, ASC-derived adipocyte-mediated stimulation of prostate tumor growth in nude mice is significantly reduced upon STAMP2 knockdown in ASC adipocytes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22704678": [
        "The six-transmembrane protein Stamp2 plays an important role in metabolically triggered inflammation and insulin action.",
        "Our data reveal a role of Stamp2 in controlling intermediary metabolites to regulate inflammatory responses in macrophages and in progression of atherosclerosis.",
        "Furthermore, bone marrow transplantation experiments demonstrated that Stamp2 in myeloid cells is sufficient to protect against atherosclerosis.",
        "We report that Stamp2 is expressed in human and mouse macrophages, is regulated upon differentiation or activation, acts as an anti-inflammatory protein, and regulates foam cell formation.",
        "Stamp2 is detected in mouse and human atherosclerotic plaques, and its deficiency promotes atherosclerosis in mice.",
        "Chemical and genetic suppression of NADPH production in Stamp2(-/-) macrophages reverts the heightened inflammatory response.",
        "Absence of Stamp2 results in significant increases in cellular NADPH levels, and both NADPH homeostasis and the exaggerated inflammatory response of Stamp2(-/-) macrophages are rescued by exogenous wild-type but not by a reductase-deficient Stamp2 molecule."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21849520": [
        "<strong class=\"sub-title\">\n          Context:\n        </strong>\n      \n      Six-transmembrane protein of prostate 2 (STAMP2) is a counter-regulator of inflammation and insulin resistance according to findings in mice.",
        "However, there have been contradictory reports in humans."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19289123": [
        "Moreover, both TIARP/STAMP2 mRNA synthesis and protein expression were induced by IL-1beta in fully differentiated human mesenchymal stem cell-derived adipocytes (hMSC-Ad).",
        "Furthermore, IL-1beta, TNFalpha, and IL-6 showed synergistic stimulatory effects on TIARP/STAMP2 gene expression.",
        "TIARP/STAMP2 mRNA synthesis was significantly stimulated by IL-1beta in a dose- and time-dependent fashion in 3T3-L1 adipocytes.",
        "Signaling studies suggested that janus kinase 2, nuclear factor kappaB, and p44/42 mitogen-activated protein kinase are involved in IL-1beta-induced TIARP/STAMP2 mRNA expression.",
        "Taken together, TIARP/STAMP2 is highly upregulated in 3T3-L1 cells and hMSC-Ad by IL-1beta and might, therefore, modulate proinflammatory and insulin resistance-inducing effects of IL-1beta.",
        "The impact of interleukin (IL)-1beta on tumor necrosis factor alpha-induced adipose-related protein (TIARP)/six-transmembrane protein of prostate 2 (STAMP2) was determined in adipocytes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30359639": [
        "We show here that at pro-cognitive and anti-hyperalgesic/anti-allodynic doses, S 38093-2 preferentially occupies the mouse sigma-1 receptor in vivo, only engaging the histamine H<sub>3</sub> receptor at doses associated with wakefulness promotion and neurotransmitter (histamine, ACh) release.",
        "S 38093-2 had the lowest histamine H<sub>3</sub> receptor affinity (pK<sub>B</sub> values 5.7-6.2), seemingly at odds with previously reported, potent in vivo activity in models of cognition.",
        "Whilst all of the compounds tested displayed robust histamine H<sub>3</sub> receptor inverse agonism and did not differentiate between the main H<sub>3</sub> receptor splice variants, they displayed a wide range of affinities and kinetic properties, and included rapidly dissociating (pitolisant, S 38093-2, ABT-239) and slowly dissociating (GSK189254, JNJ-5207852, PF-3654746) agents.",
        "Furthermore, pitolisant, ABT-239 and PF-3654746 also displayed appreciable sigma-1 receptor affinity, suggesting that this property differentiates clinically evaluated histamine H<sub>3</sub> receptor antagonists and may play a role in their efficacy.",
        "As such, it has been considered as a relevant target in disorders as varied as Alzheimer's disease, schizophrenia, neuropathic pain and attention deficit hyperactivity disorder.",
        "A range of competitive antagonists/inverse agonists have progressed into clinical development, with pitolisant approved for the treatment of narcolepsy.",
        "The histamine H<sub>3</sub> receptor is a G protein-coupled receptor (GPCR) drug target that is highly expressed in the CNS, where it acts as both an auto- and hetero-receptor to regulate neurotransmission.",
        "Given the breadth of compounds developed and potential therapeutic indications, we assessed the comparative pharmacology of six investigational histamine H<sub>3</sub> agents, including pitolisant, using native tissue and recombinant cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29802412": [
        "Glucose tolerance test was performed at the beginning of week 15.",
        "To induce obesity, male CD-1 mice were fed a high-fat diet consisting of 40% fat blend for 14 weeks, water and 30% sucrose solution available ad libitum.",
        "Therefore, we studied the influence of pitolisant on body weight, water and sucrose intake as well as metabolic disturbances in the high-fat and high-sugar diet-induced obesity model in mice.",
        "The pharmacological profile of pitolisant, a histamine H<sub>3</sub> receptor antagonist/inverse agonist, indicates that this compound might reduce body weight and metabolic disturbances.",
        "Insulin tolerance was tested the day after.",
        "The plasma triglyceride levels in pitolisant-treated mice were significantly lower compared with those in control obese group.",
        "Mice fed with high-fat diet and sucrose solution showed more weight gain throughout the 12-week period of inducing obesity.",
        "In conclusion, pitolisant has a favorable influence of body weight and improves glucose tolerance and the lipid profile in obese mice.",
        "At the end of study, plasma levels of triglycerides and cholesterol were determined.",
        "Animals fed with high-fat diet and treated with pitolisant (for the next 14 days) showed significantly less weight gain than mice from the control group consuming a high-fat feed.",
        "Metformin at dose of 100 mg/kg bw (ip) was used as reference drug.",
        "Pitolisant at dose of 10 mg/kg bw (ip) was administrated during 14 days, starting from the beginning of week 13.",
        "In the group treated with pitolisant, glucose levels were significantly lower than glucose levels of control obese mice after glucose load."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30503715": [
        "Enhanced catecholamine availability and regulation of locus coeruleus (LC) norepinephrine (NE) neuron activity is likely central to the therapeutic activity of most of these compounds.",
        "Clinical trials have demonstrated efficacy for the following classes of drugs as narcolepsy treatments: alerting medications (amphetamine, methylphenidate, modafinil/armodafinil, solriamfetol [JZP-110]), antidepressants (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors), sodium oxybate, and the H<sub>3</sub>-receptor inverse agonist/antagonist pitolisant.",
        "Agents that increase catecholamines and/or LC activity may mitigate EDS and cataplexy by elevating NE regulation of GABAergic inputs from the amygdala.",
        "Although only a few drugs have received regulatory approval for narcolepsy to date, treatment involves diverse medications that affect multiple biochemical targets and neural circuits.",
        "LC NE neurons are integral to sleep/wake regulation and muscle tone; reduced excitatory input to the LC due to compromise of Hcrt/orexin neurons (likely due to autoimmune factors) results in LC NE dysregulation and contributes to narcolepsy/cataplexy symptoms.",
        "Excessive daytime sleepiness (EDS) and cataplexy are common symptoms of narcolepsy, a sleep disorder associated with the loss of hypocretin/orexin (Hcrt) neurons.",
        "Consequently, novel medications and treatment strategies aimed at preserving and/or modulating Hcrt/orexin-LC circuit integrity are warranted in narcolepsy/cataplexy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27787717": [
        "Indeed, H<sub>1</sub> agonists and H<sub>3</sub> inverse agonists elicit essentially the same effects, at least in rodents; these effects are opposite in direction to those elicited by brain-penetrating H<sub>1</sub> receptor antagonists in humans.",
        "In March 2016, the European Commission granted a marketing authorisation for pitolisant (Wakix<sup>R</sup>) (as the first representative of the H<sub>3</sub> inverse agonists) for the treatment of narcolepsy.",
        "Although the benefit for H<sub>3</sub> inverse agonists for the symptomatic treatment of dementias is inconclusive, several members of this group have shown a marked potential for the treatment of disorders associated with excessive daytime sleepiness.",
        "The G<sub>i/o</sub> protein-coupled histamine H<sub>3</sub> receptor is distributed throughout the central nervous system including areas like cerebral cortex, hippocampus and striatum with the density being highest in the posterior hypothalamus, i.e. the area in which the histaminergic cell bodies are located.",
        "In detail, H<sub>3</sub> receptors are involved in the inhibition of histamine release (presynaptic autoreceptor), impulse flow along the histaminergic neurones (somadendritic autoreceptor) and histamine synthesis.",
        "Moreover, they occur as inhibitory presynaptic heteroreceptors on serotoninergic, noradrenergic, dopaminergic, glutamatergic, GABAergic and perhaps cholinergic neurones.",
        "This review shows for four functions of the brain that the H<sub>3</sub> receptor represents a brake against the wake-promoting, anticonvulsant and anorectic effect of histamine (via postsynaptic H<sub>1</sub> receptors) and its procognitive activity (via postsynaptic H<sub>1</sub> and H<sub>2</sub> receptors).",
        "In contrast to the other histamine receptor subtypes (H<sub>1</sub>, H<sub>2</sub> and H<sub>4</sub>), the H<sub>3</sub> receptor is located presynaptically and shows a constitutive activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29075190": [
        "Therefore, the effects of histamine H3 receptor (H3R) antagonist E159 (2.5-10 mg/kg, i.p.) in adult male rats on dizocilpine (DIZ)-induced memory deficits were studied in passive avoidance paradigm (PAP) and in novel object recognition (NOR) using pitolisant (PIT) and donepezil (DOZ) as standard drugs.",
        "The involvement of histamine H3 receptors (H3Rs) in memory is well known, and the potential of H3R antagonists in therapeutic management of neuropsychiatric diseases, e.g., Alzheimer disease (AD) is well established.",
        "These results provide evidence for the potential of drugs targeting H3Rs for the treatment of neuropsychiatric disorders, e.g., AD.",
        "However, E159 at a dose of 2.5 mg/kg failed to exhibit procognitive effect on DIZ-induced long-term memory (LTM) in NOR.",
        "Moreover, the observed memory-enhancing effects of E159 (2.5 mg/kg, i.p.) were strongly abrogated when animals were administered with a combination of SCO and ZOL.",
        "Upon acute systemic pretreatment of E159 at three different doses, namely 2.5, 5, and 10 mg/kg, i.p., 2.5 and 5 but not 10 mg/kg of E159 counteracted the DIZ (0.1 mg)-induced memory deficits, and this E159 (2.5 mg)-elicited memory-improving effects in DIZ-induced amnesic model were moderately abrogated after acute systemic administration of scopolamine (SCO), H2R antagonist zolantidine (ZOL), but not with H1R antagonist pyrilamine to the animals.",
        "Furthermore, the results observed revealed that E159 (2.5 mg/kg) did not alter anxiety levels and locomotor activity of animals naive to elevated-plus maze (EPM), demonstrating that improved performances with E159 (2.5 mg/kg) in PAP or NOR are unrelated to changes in emotional responding or in spontaneous locomotor activity.",
        "Furthermore, the E159 (2.5 mg)-provided significant memory-improving effect of in DIZ-induced short-term memory (STM) impairment in NOR was comparable to the DOZ-provided memory-enhancing effect, and was abolished when animals were injected with the CNS-penetrant histamine H3R agonist <i>R</i>-(\u03b1)-methylhistamine (RAMH)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28449891": [
        "The assessment report and product information are available on the European Medicines Agency website (http://www.ema.europa.eu).",
        "The main evidence of efficacy of pitolisant was based on two Phase III clinical trials.",
        "The daily cataplexy rate in Harmony I improved against placebo with a rate ratio (rR) of 0.38 whilst in the Harmony CTP the ratio of improvement on weekly cataplexy rate against placebo was 0.512.",
        "This article summarizes the scientific review leading to approval of pitolisant in the EU.",
        "On 31 March 2016, the European Commission issued a decision for a marketing authorisation valid throughout the European Union (EU) for pitolisant (Wakix) for the treatment of narcolepsy with or without cataplexy in adults.",
        "Pitolisant is an antagonist/inverse agonist of the human histamine H3 receptor.",
        "The most commonly reported adverse reactions were headache, insomnia and nausea.",
        "The dose should be selected using an up-titration scheme depending on individual patient response and tolerance and should not exceed 36 mg/day.",
        "The improvement on excessive daytime sleepiness was shown against placebo in the Harmony I study (-3.33 points; 95% confidence interval (CI) [-5.83; -0.83]; p = 0.024) and in Harmony CTP (-3.41 points; 95% CI [-4.95; -1.87]; p &lt; 0.0001)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28490912": [
        "This review focuses on the outcomes of four clinical trials of pitolisant to treat narcolepsy.",
        "A comprehensive search of online databases (eg, Medline, PubMed, EMBASE, the Cochrane Library Database, Ovid MEDLINE, Europe PubMed Central, EBSCOhost CINAHL, ProQuest Research Library, Google Scholar, and ClinicalTrials.gov) was performed.",
        "In 60-70% of individuals with narcolepsy, it is also characterized by cataplexy or a sudden loss of muscle tone that is triggered by positive or negative emotions.",
        "Pitolisant has been studied in animal models of narcolepsy and used in clinical trials as a treatment for narcolepsy.",
        "Narcolepsy decreases the quality of life of the afflicted individuals.",
        "Currently used drugs treat EDS alone (modafinil/armodafinil, methylphenidate, and amphetamine), cataplexy alone (\"off-label\" use of antidepressants), or both EDS and cataplexy (sodium oxybate).",
        "The small molecule drug, pitolisant, acts as an inverse agonist/antagonist at the H<sub>3</sub> receptor, thus increasing histaminergic tone in the wake promoting system of the brain.",
        "These four trials show that pitolisant is an effective drug to treat EDS and cataplexy in narcolepsy.",
        "Narcolepsy is a neurological disease that affects 1 in 2,000 individuals and is characterized by excessive daytime sleepiness (EDS).",
        "A greater diversity of drug options is needed to treat narcolepsy.",
        "These drugs have abuse, tolerability, and adherence issues.",
        "Nonrandomized and randomized studies were included."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27438291": [
        "Pitolisant has orphan drug designation in the EU and the USA.",
        "Oral pitolisant is approved in the EU for the treatment of narcolepsy with or without cataplexy in adults.",
        "In the pivotal HARMONY I trial, pitolisant significantly decreased excessive daytime sleepiness versus placebo in adults with narcolepsy with or without cataplexy (primary endpoint).",
        "Pitolisant has received a Temporary Authorization of Use in France for this indication in case of treatment failure, intolerance or contraindication to currently available treatment.",
        "This article summarizes the milestones in the development of pitolisant leading to this first approval for narcolepsy.",
        "Pitolisant (Wakix\u2122) is an inverse agonist of the histamine H3 receptor that is being developed by Bioproject.",
        "Pitolisant also significantly decreased cataplexy rate versus placebo in these patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22356925": [
        "Drugs such as pitolisant, which block histamine H3 autoreceptors, constitute a newly identified class of stimulants because they increase brain histamine and enhance wakefulness in animal and human adult narcolepsy.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Narcolepsy is a rare disabling sleep disorder characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27568835": [
        "When injected alone at doses that did not affect locomotion, Pitolisant (2.5-10mg/kg, i.p.) had no rewarding properties in the place conditioning technique.",
        "The present study tested the effects of Pitolisant on locomotion, on cocaine-induced hyperactivity and on the development of conditioned place preference induced by cocaine (2 and 8mg/kg, i.p.) in male C57BL/6J mice.",
        "In contrast, Pitolisant is a non-imidazole H3 receptor inverse agonist that has already been tested in clinical trials but it remains to be determined whether this compound also potentiates the behavioral effects of cocaine.",
        "Pitolisant was injected 30min before each cocaine-pairing session.",
        "Taken together, our study indicates that Pitolisant has no addictive properties alone.",
        "Our results show that doses of Pitolisant higher than 10mg/kg depressed locomotion.",
        "Locomotion recorded on the first cocaine-pairing session was used to test the effects of Pitolisant on the locomotor effects of cocaine.",
        "Moreover, this compound does not significantly affect the stimulant and rewarding effects of cocaine.",
        "However, these potentiating effects of thioperamide do not necessarily result from H3 receptor blockade since thioperamide is an imidazole-based compound capable of enhancing plasma cocaine concentrations by blocking cytochrome P450 activity.",
        "Previous studies have demonstrated that the histamine H3 receptor inverse agonist thioperamide potentiates the stimulant and rewarding effects of cocaine.",
        "Additionally, Pitolisant did not significantly alter cocaine-induced hyperactivity and cocaine-induced conditioned place preference.",
        "These results add further evidence to support the hypothesis that a pharmacokinetic interaction is involved in the ability of thioperamide to potentiate cocaine's psychomotor effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27223666": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Pitolisant (BF2.649) is a nonimidazole histamine 3 receptor antagonist.",
        "In previous animal studies, it has been shown that pitolisant might be helpful in chronic seizure treatment of both partial and generalized epilepsies.",
        "It is the first reported study of the clinical effects of pitolisant in human epilepsy.",
        "The present study is a multicenter, national, pragmatic, noncomparative, open-label, exploratory phase II trial."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24107292": [
        "We assessed the safety and efficacy of pitolisant (previously called BF2.649), a selective histamine H3 receptor inverse agonist that activates these neurons, in patients with narcolepsy.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Narcolepsy is characterised by excessive daytime sleepiness (EDS) and cataplexy.",
        "Histamine neurons are crucial to maintain wakefulness."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23327739": [
        "We also tested whether Pitolisant reverses memory deficits induced by the non-competitive N-methyl-d-aspartate (NMDA) antagonist dizocilpine (MK-801).",
        "The present study investigated whether Pitolisant (0.625-20mg/kg, i.p.) improves consolidation and reconsolidation processes in the fear conditioning task in female C57BL/6J mice.",
        "Numerous studies have demonstrated that brain histamine plays a crucial role in learning and memory and histamine H3 receptor inverse agonists (H3R inverse agonists) have been proposed to treat cognitive disorders.",
        "The present results are the first demonstration that Pitolisant is effective in improving consolidation processes in the fear condition task and add further evidence to its potential for treating cognitive disorders.",
        "However, Pitolisant was able to reverse the deficit in reconsolidation induced by 0.12 mg/kg dizocilpine.",
        "In addition, none of the doses of Pitolisant we have tested after reactivation (reexposure to the context in which training took place 48 h earlier) affected reconsolidation, whereas dizocilpine disrupted it.",
        "Our results indicate that post-training systemic injections of Pitolisant facilitated consolidation of contextual fear memory and reversed amnesia induced by an i.p. injection of 0.12 mg/kg dizocilpine.",
        "Pitolisant (BF2.649, 1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride) was the first H3R inverse agonist that has been tested in human trials and is well tolerated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22820944": [
        "<strong class=\"sub-title\">\n          Objective and design:\n        </strong>\n      \n      Pitolisant (BF2.649) is a selective inverse agonist for the histamine H(3) receptor and was developed for the treatment of excessive daytime sleepiness in Parkinson disease, narcolepsy, and schizophrenia.",
        "MATERIALS AND TREATMENTS: Behavioral effects of pitolisant and the structural different H(3) receptor inverse agonists ciproxifan and ST-889 were tested in zymosan-induced inflammation and the spared nerve injury model for neuropathic pain.",
        "Since H(3)-ligands can decrease inflammatory pain, we tested Pitolisant in inflammatory and neuropathic pain models."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23472741": [
        "Its drug abuse potential was investigated using in vivo models in rodents and monkeys and compared with those of Modafinil, a psychostimulant currently used in the same indications.",
        "<strong class=\"sub-title\">\n          Background and purpose:\n        </strong>\n      \n      Pitolisant, a histamine H\u2083 receptor inverse agonist/antagonist is currently under Phase III clinical trials for treatment of excessive daytime sleepiness namely in narcoleptic patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28129985": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Histaminergic neurons are crucial to maintain wakefulness, but their role in cataplexy is unknown.",
        "We assessed the safety and efficacy of pitolisant, a histamine H3 receptor inverse agonist, for treatment of cataplexy in patients with narcolepsy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28200120": [
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      The extraction of sequence variants from the literature remains an important task.",
        "Existing methods primarily target standard (ST) mutation mentions (e.g. 'E6V'), leaving relevant mentions natural language (NL) largely untapped (e.g. 'glutamic acid was substituted by valine at residue 6')."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29145097": [
        "Baseline chromatographic resolution of defactinib and the I.S. was achieved on an Atlantis dC<sub>18</sub> column using an isocratic mobile phase comprising 0.2% formic acid in water and acetonitrile (25:75, v/v) delivered at a flow rate of 0.5mL/min.",
        "Defactinib and the I.S. eluted at \u223c1.59 and 0.99min, respectively.",
        "Defactinib was found to be stable under various stability conditions.",
        "This novel method has been applied to a pharmacokinetic study in mice.",
        "A linear response function was established in the concentration range of 0.13-106 ng/mL.",
        "Method validation was performed as per regulatory guidelines and the results met the acceptance criteria.",
        "The intra- and inter-day accuracy and precision were in the range of 5.57-13.3 and 8.63-12.1%, respectively.",
        "A sensitive, specific, selective and rapid LC-ESI-MS/MS method has been developed and validated for the quantification of defactinib in mice plasma using <sup>13</sup>C<sub>3,</sub><sup>15</sup>N-tofacitinib as an internal standard (I.S.).",
        "Sample preparation was accomplished through a liquid-liquid extraction process.",
        "The total chromatographic run time was 2.50min."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29314097": [
        "Focal Adhesion Kinase (FAK) activation is a mediator of docetaxel resistance in prostate cancer cells.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Docetaxel, the standard chemotherapy for metastatic castration-resistant prostate cancer (CRPC) also enhances the survival of patients with metastatic castration-sensitive prostate cancer (CSPC) when combined with androgen-deprivation therapy.",
        "The aim of this study was to investigate the effect of the second generation FAK inhibitor VS-6063 on docetaxel efficacy in pre-clinical CRPC and CSPC models."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30444612": [
        "Focal adhesion kinase (Fak) is a key player in tumor invasion and metastasis, acting simultaneously as a kinase and a scaffold for several signaling proteins.",
        "These results underline the potential that PROTACs offer in expanding the druggable space and controlling protein functions that are not easily addressed by traditional small-molecule therapeutics.",
        "In recent years, small-molecule-induced protein degradation has emerged as an orthogonal therapeutic strategy that has the potential to expand the druggable target space.",
        "While previous efforts to modulate Fak activity were limited to kinase inhibitors with low success in clinical studies, protein degradation offers a possibility to simultaneously block Fak's kinase signaling and scaffolding capabilities.",
        "Here, we report the development of a selective and potent Fak degrader, PROTAC-3, which outperforms a clinical candidate, defactinib, with respect to Fak activation as well as Fak-mediated cell migration and invasion.",
        "Enzymatic inhibition has proven to be a successful modality for the development of many small-molecule drugs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28881794": [
        "The molecular mechanisms underlying these findings were unraveled using a specific RTK array that showed a reduction in phosphorylation of key kinases such as JNK, GSK-3 \u03b1/\u03b2, and AMPK-\u03b12, due to the concomitant decrease in AKT and FAK activation.",
        "In conclusion, the combination of buparlisib and defactinib was effective against cells with reduced PTEN and warrants further studies as a novel therapeutic strategy for stage IV SCC patients with loss of PTEN expression.",
        "Prompted by our observation of a correlation between PTEN loss and FAK phosphorylation in a cohort of patients with stage IV SCC, we evaluated the relevance of PTEN loss in cancer progression as well as the efficacy of a new combined treatment with the pan PI3K inhibitor buparlisip and the FAK inhibitor defactinib.",
        "Squamous cell lung carcinoma (SCC) accounts for 30% of patients with NSCLC and to date, no molecular targeted agents are approved for this type of tumor.",
        "An increase in AKT and FAK phosphorylation, associated with increased proliferation and invasiveness, paralleled by the acquisition of mesenchymal markers, and overexpression of the oncomir miR-21 were observed in SKMES-1-derived cell clones with a stable reduction of PTEN.",
        "However, recent studies have revealed several oncogenic mutations in SCC patients, including an alteration of the PI3K/AKT pathway, i.e. PI3K point mutations and amplification, AKT mutations and loss or reduced PTEN expression.",
        "Notably, the combined treatment induced a synergistic inhibition of cell proliferation, and a significant reduction in cell migration and invasion only in cells with reduced PTEN."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27025608": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      VS-6063 (also known as defactinib or PF-04554878) is a second-generation inhibitor of focal adhesion kinase and proline-rich tyrosine kinase-2.",
        "This phase 1 study evaluated the safety and tolerability, pharmacokinetics, and clinical activity of VS-6063 in Japanese subjects with advanced solid tumor malignancies in a first-in-Asian study setting."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26334219": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      VS-6063 (also known as defactinib or PF-04554878) is a second-generation inhibitor of focal adhesion kinase (FAK) and proline-rich tyrosine kinase-2 (Pyk2).",
        "This phase I dose-escalation study was conducted in patients with advanced solid malignancies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26530902": [
        "We performed secretome analysis of the conditioned medium from tumor-induced bone to identify proteins (termed \"osteocrines\") found within this resistance niche.",
        "Studies using an osteogenic patient-derived xenograft, MDA-PCa-118b, revealed that tumor cells resistant to cabozantinib, a Met and VEGFR-2 inhibitor, reside in a \"resistance niche\" adjacent to prostate cancer-induced bone.",
        "Resistance to currently available targeted therapies significantly hampers the survival of patients with prostate cancer with bone metastasis.",
        "Here we demonstrate an important resistance mechanism initiated from tumor-induced bone.",
        "Finally, we show that upon treatment cessation, the combination of PF-562271 and cabozantinib delayed tumor recurrence in contrast to cabozantinib treatment alone.",
        "Moreover, treatment of MDA-PCa-118b tumors with PF-562271 led to decreased tumor growth, irrespective of initial tumor size.",
        "Our studies suggest that identifying paracrine de novo resistance mechanisms may significantly contribute to the generation of a broader set of potent therapeutic tools that act combinatorially to inhibit metastatic prostate cancer.",
        "In accordance with previous reports demonstrating that activation of integrin signaling pathways confers therapeutic resistance, 27 of the 90 osteocrines identified were integrin ligands.",
        "Accordingly, treatment of C4-2B4 cells with integrin ligands resulted in increased pFAK-Y397 expression and cell survival, whereas targeting integrins with FAK inhibitors PF-562271 or defactinib inhibited FAK phosphorylation and reduced the survival of PC3-mm2 cells.",
        "We found that following cabozantinib treatment, only tumor cells positioned adjacent to the newly formed woven bone remained viable and expressed high levels of pFAK-Y397 and pTalin-S425, mediators of integrin signaling."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29344652": [
        "Furthermore, chrysophanol enhanced the effect of paclitaxel on breast cancer cell apoptosis.",
        "The expression of cell cycle\u2011associated cyclin D1 and cyclin E were downregulated while p27 expression was upregulated following chrysophanol treatment at the mRNA, and protein levels.",
        "The Annexin V/propidium iodide staining assay results revealed that apoptosis levels increased following chrysophanol treatment.",
        "Inhbition of nuclear factor (NF)\u2011\u03baB by ammonium pyrrolidine dithiocarbamate diminished the effect of chrysophanol on apoptosis and associated proteins.",
        "In conclusion, the results of the current study demonstrated that chrysophanol effectively suppresses breast cancer cell proliferation and facilitates chemosentivity through modulation of the NF-\u03baB signaling pathway.",
        "Chrysophanol upregulated caspase 3 and poly (ADP\u2011ribose) polymerase cleavage in both cell lines.",
        "The aim of the present study was to clarify the role of chrysophanol on breast cancer cell lines MCF\u20117 and MDA\u2011MB\u2011231, and to identify the signal transduction pathways regulated by chrysophanol.",
        "MTT assay and flow cytometric analysis demonstrated that chrysophanol inhibited cell proliferation, and cell cycle progression in a dose\u2011dependent manner.",
        "In addition, chrysophanol downregulated apoptosis regulator Bcl\u20112 protein, and transcription factor p65 and I\u03baB phosphorylation.",
        "Chrysophanol is an anthraquinone compound, which exhibits anticancer effects on certain types of cancer cells.",
        "However, the effects of chrysophanol on human breast cancer remain to be elucidated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29367091": [
        "Our data revealed that LPS induced the up-regulation of TNF-\u03b1, IL-1\u03b2, iNOS and NF-\u03baB p65, the down-regulation of PPAR-\u03b3 were substantially suppressed by chrysophanol in RAW264.7 cells.",
        "The mRNA and protein expression of tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and inducible nitric oxide synthase (iNOS), nuclear factor kappa B (NF-\u03baB) and PPAR-\u03b3 were measured by qRT-PCR and western blotting, the production of TNF-\u03b1, IL-1\u03b2 was evaluated by ELISA.",
        "The aim of this study was to explore the effect and mechanism of chrysophanol on lipopolysaccharide (LPS)-induced anti-inflammatory effect of RAW264.7 cells and its involved potential mechanism.",
        "Sepsis is a life-threatening disease.",
        "And NF-\u03baB p65 promoter activity was analyzed by the Dual-Luciferase reporter assay system as well.",
        "Furthermore, our data also figured out that these effects of chrysophanol were largely abrogated by PPAR-\u03b3 inhibitor GW9662.",
        "However, the underlying molecular mechanisms are not well understood.",
        "Inflammation is a major concomitant symptom of sepsis Chrysophanol, an anthraquinone derivative isolated from the rhizomes of rheumpalmatum, has been reported to have a protective effect against lipopolysaccharide(LPS)-induced inflammation.",
        "Taken together, our results indicated that LPS-induced inflammation was potently compromised by chrysophanol very likely through the PPAR-\u03b3-dependent inactivation of NF-\u03baB in RAW264.7 cells.",
        "Then, the phosphorylation of NF-\u03baB p65 was also detected by western blotting.",
        "Meanwhile, PPAR-\u03b3 inhibitor GW9662 was performed to knockdown PPAR-\u03b3 expression in cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29497904": [
        "The data also indicated that the death rate of neurons and the number of astrocytes in hippocampus CA3 region was significantly improved in diabetic mice.",
        "Learning and memory function was tested by Morris water maze after the CHR injection.",
        "Therefore, application with CHR contributes to the learning and memory deficits induced by diabetes disease via inhibitory expressions of inflammatory in hippocampus region.",
        "Patients with diabetes mellitus are easy to experience diabetic encephalopathy (DE) and other cognition dysfunction, whereas the neural alterations in developing this disease are unknown yet.",
        "The morphology of neuronal cells in hippocampus CA3 region was stained by HE-staining.",
        "Chrysophanol (CHR) is one of traditional Chinese medicine which was reported to show protective effects in cognition dysfunction and inflammatory in previously studies.",
        "Application with CHR right after developing diabetes disease rescues partial blood sugar increasing, learning and memory deficits.",
        "CHR was administrated 3 days after STZ treated mice which was confirmed with diabetes for consecutive 6 days.",
        "Moreover, the underlying mechanisms of CHR's protective effect are likely associated with anti-inflammation by downregulating the expression of pro-inflammation cytokines (IL-1\u03b2, IL-4, IL-6, TNF-\u03b1) in hippocampus and inhibiting the over-activation of astrocytes in hippocampus CA3 region.",
        "In this current study, whether CHR protects learning and memory dysfunctions induced by diabetes disease or not and underlying mechanisms were studied.",
        "ELISA and Western blot assay were used to determine the levels of pro-inflammation cytokines (IL-1\u03b2, IL-4, IL-6, TNF-\u03b1) in hippocampus.",
        "DE model was induced by streptozotocin (STZ, i.p.) in ICR mice.",
        "Here, we demonstrated that mice harboring diabetes mellitus induced by STZ exhibit high blood glucose, learning and memory deficits detected by Morris water maze behavior tests."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30129050": [
        "In conclusion, chrysophanol exhibits an anticancer effect via mitochondrial calcium overload and MAPK activation, suggesting its potential as a novel anticancer agent for human epithelial ovarian cancer.",
        "Chrysophanol is a phytochemical typically extracted from rhubarb.",
        "However, the apoptotic effects of chrysophanol in ovarian cancer remain unknown.",
        "In the current study, we examined the antitumorigenic activity of chrysophanol in human epithelial ovarian cancer cells, such as ES2 and OVCAR3.",
        "Chrysophanol decreased cell viability and increased cell death in a dose-dependent manner.",
        "Although there were no significant changes in calcium ions in the of ES2 and OVCAR3 cells, the concentration of calcium in the mitochondria increased dose dependent through disruption of the mitochondrial membrane potential in both ES2 and OVCAR3 cells compared with nontreated control cells.",
        "In addition, ovarian cancer cell invasiveness was suppressed, which implied that chrysophanol plays a role in preventing ovarian cancer metastasis.",
        "Moreover, chrysophanol activated the MAPK signaling pathways in the ovarian cancer cells.",
        "In addition, chrysophanol markedly increased the intracellular reactive oxygen species production in ES2 cells, but only increased it slightly in OVCAR3 cells.",
        "Consistent with increased reactive oxygen species production, extensive lipid peroxidation was detected in chrysophanol-treated ES2 cells compared with that in untreated cells, whereas lipid peroxidation was unchanged in OVCAR3 cells in response to chrysophanol.",
        "Similar to other extracts from rhubarb, chrysophanol possesses anticancer activity against diverse cancerous cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29609691": [
        "Moreover, chrysophanol effectively relieved HFD-induced inflammation, as demonstrated by the reduction of interleukin (IL)-6 and IL-1\u03b2 and the elevation of IL-10.",
        "Taken together our study has demonstrated that chrysophanol could improve the HFD-induced obesity and provided a molecular basis for chrysophanol potential applications in the treatment of juvenile obesity and other metabolic diseases.",
        "In addition, chrysophanol markedly reduced lipid accumulation in HFD rats-derived primary hepatocytes.",
        "In HFD rats, chrysophanol treatment decreased body weight, blood glucose and the blood level of triglyceride (TG), and enhanced the level of high-density lipoprotein-cholesterol (HDL-C).",
        "Chrysophanol is a member of the anthraquinone family abundant in rhubarb, a widely used herb for obesity treatment in Traditional Chinese Medicine.",
        "Furthermore, chrysophanol markedly increased the levels of lipolytic genes and decreased the expressions of lipogenic genes in HFD rats, which was probably benefited from the activation of AMP-activated protein kinase (AMPK)/ Sirtuin 1 (SIRT1).",
        "Though several studies have indicated numerous features of chrysophanol, no study has yet reported the effect of chrysophanol on juvenile obesity.",
        "In this study, we tried to identify the anti-obesity effects of chrysophanol by using high-fat diet (HFD)-induced rats as in vivo models."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27171670": [
        "Western blot analysis revealed that ERK1/2, P90RSK, AKT, and P70S6K were increased significantly in JEG-3 cells by chrysophanol.",
        "Collectively, these results indicate that chrysophanol is a potential effective chometherapeutic agent for treatment of choriocarcinoma therapy, and minimizing side effects of conventional treatment regimens.",
        "Chrysophanol is an anthraquinone compound, mainly isolated from rhubarb, with anti-cancer effects on some types of cancer cells.",
        "However, effects of chrysophanol on human choriocarcinoma cells are not known.",
        "In addition, the phosphorylation of AKT and ERK1/2 was suppressed by LY294002 and U0126 in JEG-3 cells treated with chrysophanol, whereas, the AKT protein was activated by pre-treatment of JEG-3 cells with U0126.",
        "Furthermore, we compared therapeutic effects of chrysophanol with cisplatin and paclitaxel which are conventional salvage regimens for choriocarcinoma.",
        "Our results verified that chrysophanol has synergistic effects with traditional therapy to increase apoptosis of JEG-3 cells.",
        "J. Cell.",
        "Physiol.",
        "Next, we investigated chrysophanol-mediated effects on proliferation of JEG-3 cells using pharmacological inhibitors of PI3K/AKT (LY294002) and ERK1/2 (U0126).",
        "232: 331-339, 2017. \u00a9 2016 Wiley Periodicals, Inc.",
        "Therefore, the objective of this study was to determine effects of chrysophanol on choriocarcinoma cells (JAR and JEG-3) and identify signal transduction cascades activated by chrysophanol.",
        "Chrysophanol also increased oxidative stress in JEG-3 cells by inducing ROS generation followed by mitochondrial dysfunction including depolarization of mitochondrial inner membrane potential.",
        "Results of present study, showed that chrysophanol decreased cell viability and induced apoptosis of JEG-3, but not JAR cells, in a dose-dependent manner.",
        "Inhibition of AKT and ERK1/2 prevented chrysophanol-induced stimulation of proliferation of JEG-3 cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29698620": [
        "Metabolites M5 and M6 were also observed in bile of rats after exposure to chrysophanol, M1-M3 and one NAC conjugate (M9) were detected in urine of rats administrated chrysophanol, and urinary metabolite M9 originated from the degradation of biliary GSH conjugation M6.",
        "In the present metabolism study, three oxidative metabolites (M1-M3, aloe-emodine, 7-hydroxychrysophanol, and 2-hydroxychrysophanol) and five GSH conjugates (M4-M8) were detected in rat and human liver microsomal incubations of chrysophanol supplemented with GSH, and the formation of the metabolites was NADPH dependent except M4 and M5.",
        "These findings helped us to understand the mechanisms of chrysophanol-induced cytotoxicity.",
        "M4 and M5 were directly derived from parent compound chrysophanol, M6 arose from M2, and M7 and M8 resulted from the oxidation of M4 and M5.",
        "Previous studies demonstrated that exposure to chrysophanol induced cytotoxicity, but the mechanisms of the toxic effects remain unknown.",
        "Recombinant P450 enzyme incubation and microsome inhibition studies demonstrated that P450 1A2 was the primary enzyme responsible for the metabolic activation of chrysophanol and that P450 2B6 and P450 3A4 also participated in the generation of the oxidative metabolites.",
        "Chrysophanol, a major anthraquinone component occurring in many traditional Chinese herbs, is accepted as important active component with various pharmacological actions such as antibacterial and anticancer activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30291343": [
        "With ongoing discussions on the utility of disclosing or searching for such variants, it is of crucial importance to obtain unbiased insight in the prevalence of these incidental or secondary findings, in order to better weigh potential risks and benefits.",
        "Our results contribute to the debate on genetic risk factor screening in healthy individuals and the discussion whether the potential benefits of this knowledge and related preventive options, outweigh the risk of the emotional impact of the test result and possible stigmatization.",
        "Our study shows that 1 in 38 healthy individuals (2.7%) has a (likely) pathogenic variant in one of 59 medically actionable dominant disease genes for which the American College of Medical Genetics and Genomics (ACMG) recommends disclosure.",
        "Here, we analyzed WES data of 1640 anonymized healthy Dutch individuals to establish the frequency of medically actionable disease alleles in an outbred population of European descent.",
        "Whereas these frequencies of secondary findings are in line with what has been reported in the East-Asian population, the pathogenic variants are differently distributed across the 59 ACMG genes.",
        "Previous studies have reported a broad range of secondary findings ranging from 1 to 9%, merely attributable to differences in study design, cohorts tested, sequence technology used and genes analyzed.",
        "Additionally, we identified 36 individuals (2.2%) to be a carrier of a recessive pathogenic disease allele.",
        "Clinical genomic sequencing can identify pathogenic variants unrelated to the initial clinical question, but of medical relevance to the patients and their families."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27100513": [
        "Mucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome, is a lysosomal storage disease in which heparan sulfate is accumulated in lysosomes, as well as outside of cells, as the primary storage material.",
        "Heparan sulfate and its derivatives are the most commonly used biomarkers for diagnosis and prediction procedures.",
        "The primary storage is responsible for some disease symptoms, but other arise as a result of secondary storage, including glycosphingolipids, and subsequent processes, like oxidative stress and neuroinflammation.",
        "Currently, there is no therapy for Sanfilippo syndrome, however, clinical trials are ongoing for enzyme replacement therapy, gene therapy and substrate reduction therapy (particularly gene expression-targeted isoflavone therapy).",
        "Central nervous system is predominantly affected in all subtypes of MPS III.",
        "This disease is a complex of four conditions caused by dysfunctions of one of genes coding for lysosomal enzymes involved in degradation of heparan sulfate: SGSH (coding for heparan N-sulfatase) - causing MPS IIIA, NAGLU (coding for alpha-N-acetylglucosaminidase) - causing MPS IIIB, HGSNAT (coding for acetyl CoA alpha-glucosaminide acetyltransferase) - causing MPS IIIC), and GNS (coding for N-acetylglucosamine-6-sulfatase) - causing MPS IIID."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21910976": [
        "MPS III results from a deficiency in one of the four enzymes involved in the heparan sulfate degradation, with sulfamidase (SGSH), \u03b1-N-acetylglucosaminidase (NAGLU), acetyl-coenzyme A: \u03b1-glucosaminide N-acetyltransferase (HGSNAT), and N-acetylglucosamine-6-sulfatase (GNS) being deficient respectively in MPS IIIA, MPS IIIB, MPS IIIC and MPS IIID.",
        "These approaches allowed the identification of 11 mutations, 8 of them were novel including a mutation involving the start codon (p.Met1?), one small duplication (p.Leu11AlafsX22), one small deletion (p.Val361SerfsX52) and a large deletion of exon 1 to exon 5 in the SGSH gene, one missense mutation (p.Pro604Leu) and one nonsense mutation (p.Tyr558X) in the NAGLU gene and, finally, one missense mutation (p.Trp627Cys) and one nonsense mutation (p.Trp403X) in the HGSNAT gene.",
        "Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III) is a progressive disorder in which patients are characterized by severe central nervous system degeneration together with mild somatic disease.",
        "QMPSF (Quantitative Multiplex PCR of Short fluorescent Fragments) analysis was developed for the detection of genomic deletions and duplications in the SGSH gene.",
        "Mutation screening using PCR reaction/sequencing analysis on genomic DNA fragments was performed in seven Tunisian index cases with MPS IIIA, three with MPS IIIB and two with MPS IIIC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29369293": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Internationally adopted variant interpretation guidelines from the American College of Medical Genetics and Genomics (ACMG) are generic and require disease-specific refinement.",
        "Here we developed CardioClassifier ( http://www.cardioclassifier.org ), a semiautomated decision-support tool for inherited cardiac conditions (ICCs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29484123": [
        "Univariate and multivariate Cox regression analysis demonstrated that over-expression of uc.189 predicted poor prognosis in CSCC and EAC.",
        "In recent decades, emerging evidence demonstrates that ultraconserved elements (UCEs) encoding noncoding RNAs serve as regulators of gene expression.",
        "Tissue microarrays were constructed with 243 samples including 116 cervical squamous cell carcinomas (CSCCs), 98 endometrial adenocarcinomas (EACs), 29 ovarian cystoadenocarcinomas(OCAs), and corresponding normal tissues.",
        "This study was to identify the prognostic value of uc.189 expression in gynecological cancers.",
        "In EAC its expression was increased in 74.5% (73/98), decreased in 3.1% (3/98), and unchanged in 22.4% (22/98).",
        "In CSCC, uc.189 expression was increased in 78.5% of cases (91/116), decreased in 4.3% (5/116), and unchanged in 17.2% (20/116).",
        "Until now, the role of uc.189 in human cancers remains undefined and the clinical significance of uc.189 in gynecological cancers remains unknown.",
        "Expression of uc.189 was increased in 23, and unchanged/decreased in 6, of 29 cases of ovarian cystoadenocarcinomas.",
        "Thus, these findings suggested uc.189 might be an evaluating prognosis marker of gynecological tumors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28941722": [
        "Until now, the role of the UCE uc.189 in human cancers remains undefined and the clinical significance of uc.189 in esophageal cancers remains unknown.",
        "The expression of uc.189 was significantly higher in human ESCC compared with the adjacent noncancerous tissues (122/152, 80.3%, p&lt;0.01), and the high level of uc.189 expression was significantly correlated with invasion of the tumor (p=0.009), advanced clinical stage (p=0.000), lymph node metastasis (p=0.000), and poor prognosis.",
        "This study was to identify the prognostic value of uc.189 expression in esophageal squamous cell carcinomas (ESCC).",
        "Uc.189 might be considered as a novel molecule involved in ESCC progression, which provides a potential prognostic biomarker and therapeutic target.",
        "Ultraconserved elements (UCEs) encoding noncoding RNAs serve as important regulators in cancer biology.",
        "Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression level of uc.189 in matched cancerous tissues and adjacent noncancerous tissues from 152 patients with ESCC.",
        "High expression of uc.189 might reflect poor prognosis of ESCC and indicate a potential diagnostic target in ESCC patients.",
        "The correlation of uc.189 with clinicopathological features and prognosis were also analyzed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28749667": [
        "One major target has been the \u03b2-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search for BACE-1 inhibitors.",
        "We discuss these compounds as innovative tools for better understanding the complexity of AD and for identifying efficacious drug candidates to treat this devastating disease.",
        "It also suggests new possibilities for discovering BACE-1-targeted compounds with more complex mechanisms of actions and improved efficacy.",
        "Herein, we review the major advances in BACE-1 drug discovery, from single-target small molecule inhibitors to multitarget compounds.",
        "The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer's disease (AD), leading to many small-molecule and biological drug candidates.",
        "The lack of efficacy of verubecestat in mild-to-moderate AD raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in AD treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29461065": [
        "An enantioselective arylation reaction catalyzed by palladium complexed with substituted phosphinooxazoline (PHOX) ligands is described.",
        "This reaction was applied to the preparation of verubecestat, which is currently undergoing clinical evaluation for the treatment of Alzheimer's disease.",
        "Aza-quaternary stereocenters are readily accessible through the arylation reaction between cyclic iminosulfates and a wide variety of arylboronic acids, including electron-poor and ortho-substituted arylboronic acids."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29397980": [
        "EE determination of verubecestat is easily performed on NicoShell, another macrocyclic glycopeptide chiral selector bonded to 2.7 \u03bcm superficially porous particles.",
        "Evaluation of recently developed chiral columns revealed a single chiral selector (Teicoplanin) bonded to 2.7 \u03bcm core-shell particles using H<sub>3</sub>PO<sub>4</sub> in H<sub>2</sub>O/ACN and triethylammonium acetate: methanol based eluents at different isocratic compositions allowed good enatioseparation of all verubecestat intermediates.",
        "The analytical technical package of validated methods relies on enantioselective SFC and RPLC separations using multiple 3 and 5 \u03bcm coated polysaccharide-based chiral stationary phases (CSPs) and mobile phases combinations.",
        "Synthetic route development involves diastereoselective transformations with a need for enantiomeric excess (ee) determination of each intermediate and final active pharmaceutical ingredient (API).",
        "Verubecestat is an inhibitor of \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE1) being evaluated in clinical trials for the treatment of Alzheimer's disease.",
        "This approach enables fast and reliable enantiopurity analysis of the entire verubecestat synthetic route using only two chiral columns and mobile phases on a conventional HPLC system, simplifying technical package preparation, method validation and transfer to manufacturing facilities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29719179": [
        "A\u03b2 is produced from the sequential cleavage of amyloid precursor protein by \u03b2-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) followed by \u03b3-secretase.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Alzheimer's disease is characterized by the deposition of amyloid-beta (A\u03b2) plaques in the brain.",
        "Verubecestat is an oral BACE-1 inhibitor that reduces the A\u03b2 level in the cerebrospinal fluid of patients with Alzheimer's disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30009514": [
        "Additionally, monoclonal antibodies are being designed to redirect the inhibitory signals that limit NK cell functionality.",
        "Further understanding of the biology of NK cells will inform strategies to exploit NK cells for therapeutic purposes.",
        "Therefore, major efforts are being made to hone in on NK cell antitumour properties in immunotherapy.",
        "Previously, NK cells were thought to be short-lived, but we now know that NK cells can be long-lived and remember past exposures in response to CMV.",
        "To expand NK cells in vivo and enhance tumour targeting, IL-15 is being tested in combination with a glycogen synthase kinase (GSK) 3 inhibitor (CHIR99021), an inhibitor that has been shown to expand mature, highly functional NK cells capable of killing multiple tumour targets.",
        "To address this concern, bispecific or trispecific engagers that target NK cells to the tumour and an ADAM17 inhibitor that prevents CD16 shedding after NK cell activation are being tested.",
        "One major limitation to NK cell therapy is lack of specificity.",
        "Natural killer (NK) cells recognize targets that have been changed via malignant transformation or infection.",
        "NK cells use a plethora of activating and inhibitory receptors to recognize these changes and attack targets, but tumour cells often evade NK cells.",
        "In the clinical setting, haploidentical NK cells can be adoptively transferred to help treat cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29978334": [
        "Several clinically successful tumor-targeting mAbs induce NK cell effector functions.",
        "MEDI3622 effectively blocked ADAM17 function in NK cells and caused a marked increase in their production of IFN\u03b3.",
        "Taken together, our data show that MEDI3622 enhances the release of IFN\u03b3 by NK cells engaging antibody-bound tumor cells by blocking the shedding of CD16A.",
        "In addition, NK92 cells, a human NK cell line that lacks endogenous Fc\u03b3Rs, expressing a recombinant non-cleavable version of CD16A released significantly higher levels of IFN\u03b3 than NK92 cells expressing equivalent levels of wildtype CD16A.",
        "Unlike other NK cell activating receptors, the cell surface density of CD16A can be rapidly downregulated in a cis manner by the metalloproteinase ADAM17 following NK cell stimulation in various manners.",
        "Human NK cells exclusively recognize tumor-bound IgG by the FcR CD16A (Fc\u03b3RIIIA).",
        "We examined the effects of MEDI3622, a human mAb and potent ADAM17 inhibitor, on NK cell activation by antibody-bound tumor cells.",
        "CD16A downregulation takes place in cancer patients and this may affect the efficacy of tumor-targeting mAbs.",
        "These findings support ADAM17 as a dynamic inhibitory checkpoint of the potent activating receptor CD16A, which can be targeted by MEDI3622 to potentially increase the efficacy of anti-tumor therapeutic antibodies.",
        "The augmented release of IFN\u03b3 by NK cells was reversed by a function-blocking CD16A mAb.",
        "This was observed for NK cells exposed to different tumor cell lines and therapeutic antibodies, and over a range of effector/target ratios."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25816339": [
        "Substitution of the serine at position 197 in the middle of the cleavage region for a proline (S197P) effectively blocked CD16a and CD16b cleavage in cell-based assays.",
        "Our findings provide further characterization of CD16 cleavage by ADAM17 and they demonstrate that a non-cleavable version of CD16a can be expressed in engineered NK cells.",
        "We also show that CD16a/S197P was resistant to cleavage when expressed in the human NK cell line NK92 and primary NK cells derived from genetically-engineered human induced pluripotent stem cells.",
        "CD16a and CD16b are IgG Fc receptors expressed by human natural killer (NK) cells and neutrophils, respectively.",
        "CD16a is a potent activating receptor and despite blocking CD16a shedding, the S197P mutation did not disrupt IgG binding by the receptor or its activation of NK92 cells by antibody-treated tumor cells.",
        "Both CD16 isoforms undergo a rapid down-regulation in expression by ADAM17-mediated proteolytic cleavage upon cell activation by various stimuli.",
        "We examined soluble CD16 released from activated NK cells and neutrophils by mass spectrometric analysis, and identified three separate cleavage sites in close proximity at P1/P1' positions alanine195/valine196, valine196/serine197, and threonine198/isoleucine199, revealing a membrane proximal cleavage region in CD16."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24941379": [
        "Persistence and in vivo expansion of NK cells depends on lymphodepleting chemotherapy to make space and induce release of endogenous IL-15.",
        "Natural killer (NK) cells recognize targets stressed by malignant transformation or infection and can be long-lived.",
        "These are exciting times; more than 35 years after NK cells were initially described, we are exploiting their capacity for clinical therapy.",
        "In the clinic, haploidentical NK cells can be adoptively transferred to treat cancer.",
        "Other limitations to NK-cell therapy include poor in vivo survival and lack of specificity.",
        "They become educated by interacting with major histocompatibility antigen (MHC) class I molecules to gain function to kill targets and produce cytokines.",
        "In vivo expansion is also enhanced by cytokine administration but IL-2 has the down side of stimulating CD25hi regulatory T cells (Tregs).",
        "Bispecific or trispecific killer engagers that target CD16 on NK cells to enhance recognition of tumor antigens, and desintegrin and metalloproteinase 17 (ADAM17) inhibition that prevents CD16 shedding after NK-cell activation should promote enhanced killing of cancer with specificity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17510296": [
        "TNF-alpha and its receptors TNFRI and TNFRII are cleaved from the surface of leukocytes by a proteolytic process referred to as ectodomain shedding.",
        "This is the first simultaneous analysis of TNF-alpha, TNFRI, and TNFRII shedding by neutrophils and macrophages and the first direct evidence that ADAM17 is a primary and nonredundant sheddase.",
        "We report ablated, soluble TNF-alpha, TNFRI, and TNFRII production by neutrophils and macrophages stimulated with various microbial antigens and greatly reduced TNF-alpha levels in vivo following inflammation induction.",
        "As Adam17 gene-targeting in mice is lethal, we assessed the protease's relative contribution to TNF-alpha, TNFRI, and TNFRII shedding using radiation chimeric mice with leukocytes lacking functional ADAM17.",
        "The role of a disintegrin and metalloproteinase 17 (ADAM17) in this process by the major professional phagocytes neutrophils and macrophages, the primary producers of TNF-alpha during inflammation induction, is based entirely on indirect evidence, and other sheddases have been implicated as well."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21480393": [
        "Proliferation of glioma cells were tested by thiazolyl blue tetrazolium bromide (MTT) assay, bromodeoxyuridine incorporation assay, growth curve, and sulforhodamine B assay.",
        "The expression and activity of ADAM17 increase under some pathological conditions such as stroke and cancer.",
        "In the present study, we sought to elucidate whether ADAM17 contributes to glioma progression.",
        "A disintegrin and metalloproteinase-17 (ADAM17) is involved in proteolytic ectodomain shedding of several membrane-bound growth factors and cytokines.",
        "A Matrigel tube formation assay was performed to test capillary tube formation ability.",
        "ADAM17 promotes neural progenitor cell migration and contributes to neurogenesis after stroke and breast cancer growth and invasion.",
        "To this end, we examined the role of ADAM17 in the proliferation, invasion, and tube formation of U87 human glioma cells in vitro and tumor growth in vivo.",
        "For study of mechanism, the ADAM17 inhibitor TAPI-2 and the PI3K-AKT inhibitor LY294002 were used to counteract high-ADAM17 expression and the activated PI3K-AKT pathway, respectively.",
        "Our data show that ADAM17 promotes the U87 malignant phenotype by increased proliferation, invasion, angiogenesis, and in vivo tumor growth.",
        "This study suggests ADAM17 contributes to glioma progression through activation of the EGFR-PI3K-AKT signal pathway.",
        "TGF-\u03b1, VEGF secretion, and VEGF expression was increased by ADAM17 and counteracted by ADAM17 siRNA, TAPI-2, and LY294002 in U87 cells.",
        "ADAM17 activated, whereas ADAM17 siRNA, TAPI-2, and LY294002 deactivated the EGFR-PI3K-AKT signal pathway, which correlated with U87 cell malignant phenotype changes.",
        "Stable transfection of the U87 cell line with either a plasmid for over-expression of human ADAM17, or a siRNA to ADAM17 was employed in this study to establish high- or low-ADAM17 expression in glioma cells, respectively.",
        "Tumor growth in nude mice was significantly inhibited by ADAM17 inhibitor and A17-shRNA in vivo transfection.",
        "Matrigel invasion assays were used to assess the ability of U87 cells to penetrate the extracellular matrix (ECM).",
        "EGFR-PI3K-Akt pathway activation in U87 cells under different ADAM17 expression levels were tested by Western blot."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19395875": [
        "Matrigel invasion assays were used to assess the ability of MDA-MB-231 cells to penetrate the Extra Cellular Matrix.",
        "A disintegrin and metalloproteinase-17 (ADAM17) is involved in proteolytic ectodomain shedding of several membrane-bound growth factors and cytokines.",
        "A Matrigel tube formation assay was performed to test capillary tube formation ability.",
        "TGFalpha, VEGF secretion and VEGF expression was increasing by ADAM17 and counteracted by ADAM17 siRNA, TAPI-2 and LY294002 in MDA-MB-231 cells.",
        "The expression and activity of ADAM17 increase under some pathological conditions such as stroke and glioma.",
        "For study of mechanism, the ADAM17 inhibitor TAPI-2 and the PI3K-AKT inhibitor LY294002 were used to counteract high ADAM17 expression or the activated PI3K-AKT pathway.",
        "Proliferation of MDA-MB-231 breast cancer cells were tested by MTT, Bromodeoxyuridine incorporation assay, growth curve and sulforhodamine B assay.",
        "Stable transfection of the MDA-MB-231 cell line with either a plasmid for overexpression of human ADAM17, or a siRNA to ADAM17 was employed in this study to establish high or low ADAM17 expression in breast cancer cells, respectively.",
        "In the present study, we sought to elucidate whether ADAM17 contributes to breast cancer progression and its mechanisms.",
        "ADAM17 activated, whereas ADAM17 siRNA, TAPI-2 and LY294002 deactivated the EGFR-PI3K-AKT signal pathway, which correlated with MDA-MB-231 cell malignant phenotype changes.",
        "ADAM17 promotes neural progenitor cell migration and contributes to stroke-induced neurogenesis after stroke and brain tumor growth and invasion.",
        "EGFR-PI3K-Akt pathway activation in MDA-MB-231 cells under different ADAM17 expression levels were tested by western blot and ELISA.",
        "To this end, we examined the role of ADAM17 in the proliferation, invasion and tube formation of MDA-MB-231 breast cancer cells in vitro.",
        "This study suggests ADAM17 contributes to breast cancer progression through activation of the EGFR-PI3K-AKT signal pathway.",
        "Our data show that ADAM17 promotes the MDA-MB-231 malignant phenotype by increased proliferation, invasion and angiogenesis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23625205": [
        "ADAM17 is overexpressed in a variety of human tumors, which is associated with tumor development and progression.",
        "A disintegrin and metalloproteinase-17 (ADAM17) is a member of the metalloproteinase superfamily and involved in the cleavage of ectodomain of many transmembrane proteins.",
        "Pretreatment with EGFR inhibitor AG1478 or phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 rescued ADAM17-mediated cisplatin resistance of HCC cells.",
        "ADAM17 silencing attenuated hypoxia-induced cisplatin resistance and enhanced the accumulation of cleaved caspase-3 and PARP.",
        "Annexin V/PI double staining was performed to analyze the effects of ADAM17 on hypoxia-mediated cisplatin resistance.",
        "Forced expression of ADAM17 enhanced the phosphorylation of epidermal growth factor receptor (EGFR) and Akt without affecting the expression of total EGFR and Akt.",
        "In the present study, we sought to investigate the expression and function of ADAM17 in hypoxia-treated hepatocellular carcinoma (HCC) cells.",
        "Western blot analysis showed that overexpression of hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1), a transcription factor, upregulated the expression of ADAM17 and HIF-1\u03b1 silencing downregulated the expression of ADAM17 in hypoxia-treated HCC cells, indicating the regulation of ADAM17 by HIF-1\u03b1.",
        "Overexpression of ADAM17 reduced cisplatin-induced apoptosis in HCC cells, accompanies by less cleavage of caspase-3 and poly (ADP-ribose) polymerase (PARP).",
        "ADAM17 expression was upregulated by hypoxia treatment in HCC cells at both mRNA and protein levels.",
        "Taken together, our results indicated that ADAM17 is upregulated by hypoxia and contributes to hypoxia-induced cisplatin resistance via EGFR/PI3K/Akt pathway.",
        "Western blot analysis was used to measure the expression of ADAM17 in HCC cell lines (Hep3B and HepG2 cells)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20871631": [
        "ADAM17 (a disintegrin and metalloproteinase 17, also referred to as TNF\u03b1 converting enzyme or TACE) is a cell-surface metalloproteinase that regulates signaling via the epidermal growth factor receptor (EGFR) and has important roles in diseases such as cancer and rheumatoid arthritis.",
        "Moreover, we demonstrate that constitutive shedding of TGF\u03b1 can be reduced by inhibition of Src in several cell lines, including COS7, MCF7 (the human breast cancer cell line), PAE (a pig aortic endothelial cell line) and HaCaT (the human keratinocyte cell line) cells.",
        "Enhanced autocrine signaling could further activate tumor cells expressing oncogenic mutants of Src, whereas paracrine signaling could stimulate EGFR and ERK signaling in surrounding non-transformed cells such as stromal cells, thereby contributing to crosstalk between tumor cells and stromal cells.",
        "These findings demonstrate that ADAM17 is the principal TGF\u03b1 sheddase that is activated by Src in a manner that does not require the cytoplasmic domain of ADAM17.",
        "These results raise the possibility that activation of ADAM17 by oncogenic forms of Src can aid in promoting tumorigenesis by enhancing signaling via the EGFR and ERK in an autocrine and paracrine manner.",
        "We provide evidence that a constitutively active transforming form of Src, the E378G mutant, as well as v-Src enhance ADAM17-mediated shedding of the EGFR ligand TGF\u03b1.",
        "ADAM17 can be activated by stimulation of several tyrosine kinase receptors, raising questions about whether oncogenic tyrosine kinases could also enhance EGFR signaling and activation of extracellular signal-regulated kinase (ERK) via stimulation of ADAM17.",
        "Src(E378G)-stimulated shedding of TGF\u03b1 is abolished in Adam17(-/-) cells, but can be rescued by wild-type (wt) ADAM17 and a mutant ADAM17 lacking its cytoplasmic domain.",
        "Finally, we show that stimulation of ADAM17 by Src(E378G) leads to enhanced paracrine signaling via release of EGFR ligands into the culture supernatant.",
        "The main goal of this study was to evaluate the role of Src in activating ADAM17."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27077118": [
        "Epithelial regeneration is a key process for the recovery from ulcerative colitis (UC).",
        "Mice with systemic deletion of Adam17 developed severe dextran sulfate sodium-induced colitis when compared to mice with myeloid cell Adam17 deletion or control littermates.",
        "Here we demonstrate that a disintegrin and metalloproteinase-17 (ADAM17), a main sheddase for tumor necrosis factor (TNF)-\u03b1, is essential for defensive epithelial properties against UC by promoting epithelial cell growth and goblet cell differentiation in mouse and human.",
        "These findings suggest that maintaining ADAM17-EGFR epithelial signaling is necessary for the recovery from UC and would be beneficial to therapeutic strategies targeting ADAM17-mediated TNF-\u03b1 shedding.",
        "In UC patients, epithelial ADAM17 expression positively correlated with both cell proliferation and goblet cell number.",
        "ADAM17 was predominantly expressed by regenerating epithelia in control mice, and its loss or inhibition attenuated epidermal growth factor receptor (EGFR) activation, epithelial proliferation, mucus production and barrier functions.",
        "Conversely, ectopic EGFR stimulation promoted epithelial regeneration thereby partially rescuing the severe colitis caused by ADAM17 deficiency."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29554155": [
        "After a variety of diagnoses were considered at outside institutions, including Bell palsy, we diagnosed the patient with MRS based on clinical presentation of the classic triad.",
        "Further research is needed regarding the role of TNF-\u03b1 inhibitors in managing this rare condition.",
        "We observed a patient with MRS of 4 years' duration that was unsuccessfully treated with multiple therapies.",
        "Melkersson-Rosenthal syndrome (MRS) is a rare syndrome of facial nerve palsy, facial edema, and lingua plicata that can be difficult to treat.",
        "Treatment with adalimumab, a tumor necrosis factor \u03b1 (TNF-\u03b1) antibody, showed improvement and relapse-free progress."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29766816": [
        "<strong class=\"sub-title\">\n          Background and objective:\n        </strong>\n      \n      Melkersson Rosenthal syndrome (MRS) is a rare disorder of unknown etiology and comprises the triad: orofacial edema, recurrent facial paralysis and lingua plicata.",
        "In the current literature confusing heterogeneity exists, mixing together the historically grown terms cheilitis granulomatosa or granulomatous cheilitis, Melkersson Rosenthal syndrome and the umbrella term Orofacial Granulomatosis (OFG)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30217753": [
        "Melkersson Rosenthal syndromes (MRS) is a rare autosomal dominantly inherited neurocutaneous syndrome characterised by a triad of facial (seventh cranial) nerve palsy, recurrent orofacial swelling and fissuring of the tongue.",
        "We did not detect any putative pathogenic variants.",
        "Our data indicates that there is both clinical and genetic heterogeneity in this condition and that the causative gene remains to be identified for the majority of cases.",
        "We undertook Sanger sequencing of this gene in 14 affected unrelated individuals affected by MRS.",
        "A recent report implicated a heterozygous missense variant in SLC27A1 (FATP1) as the cause of this condition in members of an affected Chinese family."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28955585": [
        "The diagnosis and treatment procedures were presented with special emphasis to the clinical features of this rare condition.",
        "This case report describes a 39 years old male patient with recurrent swelling of the upper lip.",
        "It is rarely possible to observe all aspects of the classical triad at the same time, since these symptoms may appear in different times of life cycle.",
        "Although etiology of MRS is unclear, various factors such as infections, genetic predisposition, immune deficiency, food intolerance and stress have been held responsible.",
        "Clinical examinations showed classical triad of MRS.",
        "The most common symptom is orofacial edema.",
        "Melkersson-Rosenthal Syndrome (MRS) is a rare disorder consisting of a triad of persistent or recurrent orofacial edema, relapsing facial paralysis and fissured tongue.",
        "MRS is diagnosed based on clinical features."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29065902": [
        "When it presents in a triad encompassing facial nerve palsy, lip swelling, and fissured or furrowed tongue it is called Melkersson-Rosenthal syndrome while monosymptomatic or oligosymptomatic forms are referred to as granulomatous cheilitis.",
        "It is an uncommon clinicopathologic entity which is distinct from classic Crohn's disease.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Orofacial granulomatosis is a relatively recent term coined by Wiesenfield et al. in 1985 to define granulomatous lesions of oral mucosa without intestinal involvement.",
        "The NOD2 variant which is commonly associated with Crohn's has not been shown to have any association with orofacial granulomatosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27081272": [
        "No symptoms or signs of other systemic disease (Crohn's disease or sarcoidosis) were observed after 2 years of follow-up.",
        "Genetic screening for CARD15/NOD2 in this patient showed negative, which further confirmed the diagnosis of MRS.",
        "Lymphatic obstruction is responsible for localized edema in MRS.",
        "Our case emphasizes the specific clinical feature of MRS with genitalia involved, which was genetically different from Crohn's disease and could be an independent entity.",
        "Biopsy examinations of both the child's lower lip and penis showed noncaseating granuloma and intralymphatic granuloma infiltration.",
        "We presented the first case of complete MRS with genital swelling in a child.",
        "Melkersson-Rosenthal syndrome (MRS) is an uncommon granulomatous disease characterized by the triad of relapsing facial paralysis, orofacial swelling, and fissured tongue.",
        "Eleven other cases of suspected complete or incomplete MRS with genitalia involved were reviewed.",
        "Genital swelling in MRS is rarely reported."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27165478": [
        "The patient remained steroid-refractory, and subsequent attacks remitted with partial recovery.",
        "The authors describe oligosymptomatic Melkersson Rosenthal Syndrome in a young girl presenting sequentially with recurrent, metachronous facial nerve palsy and hemifacial swelling in early childhood followed by fissuring in the tongue in late-childhood.",
        "Histopathological examination from the affected labial area showed non-granulomatous inflammation.",
        "The clinical course is usually progressive, and etiology is unknown.",
        "Melkersson Rosenthal Syndrome is a rare neuro-mucocutaneous disorder characterized by the classic triad of facial swelling, recurrent facial nerve palsy and fissured tongue.",
        "Bilateral facial nerve conduction and blink reflex studies showed asymmetrical affection of both facial nerves with mixed features of axonal and demyelinating involvement.",
        "The combination of facial edema and facial palsy in a child should alert the physicians to the diagnosis of Melkersson Rosenthal Syndrome.",
        "A diagnostic mucosal biopsy, evaluation for systemic and oro-facial granulomatous disorders, and short course of corticosteroid treatment are recommended."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10332378": [
        "More often this syndrome presents in its oligosymptomatic forms.",
        "Melkersson-Rosenthal syndrome is classically described as a triad of orofacial swelling, facial palsy, and fissured tongue.",
        "Presented is the case of a mentally challenged man who was eventually diagnosed with Melkersson-Rosenthal syndrome only after being misdiagnosed and incorrectly treated for an odontogenic infection for more than a decade.",
        "Melkersson-Rosenthal syndrome may not be as rare as suspected but rather a syndrome that often goes undiagnosed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22836908": [
        "Melkersson-Rosenthal syndrome (MRS) is a rare neuromucocutaneous syndrome marked by the triad of recurrent nonpitting orofacial edema, fissured dorsal tongue (lingua plicata), and lower motoneuron facial paralysis.",
        "Lingua plicata occurred in 34 cases (47 %, 95 % confidence interval 35.3-59.3 %).",
        "Unilateral or partial facial nerve palsy occurred in 14 cases (19.4, 95 % confidence interval 11.4-30.8 %).",
        "There were no patients who had low C1q or C4 levels among those who were tested.",
        "Overall, the full triad canonical of Melkersson-Rosenthal syndrome was observed in nine patients (seven female, median age at symptomatic presentation 35 years (range 10-74 years), 13 %, (95 % confidence interval 6.2-22.9 %) with a median time from first symptoms to diagnosis of 4 years (range 1-35).",
        "Large case series including treatment are limited.",
        "The Melkersson-Rosenthal syndrome may present over the course of most of the lifespan and may require several years of observation to be diagnosed.",
        "The medication treatments attempted in the nine patients with the full triad of symptoms included non-steroidal anti-inflammatory drugs, oral and intra-lesional steroids, metronidazole, dapsone, acyclovir, methotrexate, and thalidomide with no consistent treatment responses.",
        "Neurologists who observe a combination of facial edema and facial palsy in a patient should consider the diagnosis of MRS and proceed to a diagnostic skin biopsy and a trial of steroid treatment for their patient.",
        "Comorbidities among those with facial edema included periodontal disease (n = 10, 14 %), history of allergic disease (n = 10, 14 %), Crohn's Disease (n = 6, 8 %), migraine headaches (n = 5, 7 %), and systemic lupus erythematosus (n = 2, 3 %).",
        "A retrospective records review was performed for the diagnoses Melkersson-Rosenthal syndrome, granulomatous cheilitis, and orofacial granulomatosis, confirmed by noncaseating granulomas on biopsy, at the Mayo Clinic in Rochester, Minnesota (1979-2009).",
        "There were 72 patients [51 women (71 %), mean age at presentation 39 years (range 8-79)] identified with facial edema with noncaseating granulomas on skin biopsy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12783021": [
        "The physician and surgeon who see patients with head and neck pathology should be familiar with Melkersson-Rosenthal syndrome, and with the possibility of its presentation in the orbit and periocular region.",
        "A triad of facial palsy, facial edema, and furrowed tongue characterizes Melkersson-Rosenthal syndrome, a rare, noncaseating granulomatous disease of unknown cause.",
        "Biopsies should be performed routinely in all patients who present with eyelid edema of unknown etiology.",
        "Because of its rarity, the syndrome is usually ignored and misdiagnosed; however, the syndrome should not only be considered in the classic perioral presentation but also in the rare periocular form, which may be confused with orbital tumors and orbital pseudotumors.",
        "Although most reported cases of Melkersson-Rosenthal syndrome involve swelling of the perioral area, the authors present a case of Melkersson-Rosenthal syndrome involving the periocular area."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10938204": [
        "Melkersson-Rosenthal syndrome is a rare disorder consisting of the triad of persistent or recurrent orofacial edema, relapsing facial paralysis and fissured tongue.",
        "It is far more uncommon to find the complete triad since it generally presents in oligosymptomatic forms.",
        "We present three cases of the Melkersson-Rosenthal syndrome with the classic triad of symptoms and discuss the etiology and the clinical and electromyography findings of this syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17103360": [
        "Melkersson-Rosenthal syndrome is characterised by a triad of recurrent orofacial swelling, relapsing facial paralysis, and fissured tongue.",
        "The therapeutic approach for an acute bout of Melkersson-Rosenthal syndrome consists mainly of steroid administration.",
        "We present a rare case of bilateral crocodile tears syndrome (CTS) in the course of Melkersson-Rosenthal syndrome.",
        "The classic triad is infrequent and oligosymptomatic variants are seen more frequently.",
        "The case deserves attention due to the rarity of the observed symptoms and signs.",
        "Botulin toxin injection into the lacrimal gland is the most modern therapeutic option.",
        "In the case presented CTS developed in a 50-year-old man after 5 incidents of facial palsy due to Melkersson-Rosenthal syndrome.",
        "It results from aberrant reinnervation of the lacrimal gland by salivary parasympathetic fibres.",
        "CTS management is composed of anticholinergic drugs and surgical procedures.",
        "CTS is a rare complication of facial nerve paralysis characterised by inappropriate lacrimation on the side of the palsy in response to salivary stimuli."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26698837": [
        "The case is probably the first description available in the literature of the Melkersson-Rosenthal as an early manifestation of mixed connective tissue disease.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      We aim to illustrate the potential viability of MCTD as an underlying aetiology of Melkersson-Rosenthal syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8725591": [
        "Exacerbations and recurrences are common.",
        "The histologic findings of noncaseating, sarcoidal granulomas support the diagnosis.",
        "Thus, the Melkersson-Rosenthal syndrome is a disease with elements of orofacial granulomatosis.",
        "The spectrum of this entity includes patients with oral Crohn's disease, patients with oral lesions who will develop typical bowel symptoms of Crohn's disease in the ensuing months to years, patients with tooth-associated infections, patients with sarcoidosis, and patients with food or contact allergies.",
        "The facial palsy is indistinguishable from Bell's palsy.",
        "The orofacial swelling is characterized by fissured, reddish-brown, swollen, nonpruritic lips or firm edema of the face.",
        "Cheilitis granulomatosa of Miescher is an example of a monosymptomatic variant of the Melkersson-Rosenthal syndrome.",
        "Orofacial granulomatosis is a clinicopathologic entity describing oral lesions with noncaseating granulomas.",
        "The value of the clinicopathologic construct of orofacial granulomatosis is to provoke the careful search for provocative causes for the reactive symptom complex of the Melkersson-Rosenthal syndrome.",
        "These granulomas are not invariably present, and their absence does not exclude the diagnosis of the Melkersson-Rosenthal syndrome.",
        "The fissured tongue is seen in one third to one half of patients and, although the least common manifestation, its presence assists in diagnosis.",
        "This is particularly true because monosymptomatic and oligosymptomatic variants are seen more commonly.",
        "The classic triad is not seen frequently in its complete form; therefore, diagnosis is difficult.",
        "The Melkersson-Rosenthal syndrome is a rare disorder of unknown etiology characterized by a triad of recurrent orofacial swelling, relapsing facial paralysis, and fissured tongue."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/1561252": [
        "A triad of facial palsy, orofacial edema, and furrowed tongue constitutes an uncommon condition known as Melkersson-Rosenthal syndrome (MRS).",
        "Systemic steroid therapy resulted in remission in two of three patients.",
        "Two patients had facial palsy, 12 had orofacial edema, and 1 patient had a furrowed tongue.",
        "Three illustrative cases are presented.",
        "We report on 14 patients with Melkersson-Rosenthal syndrome.",
        "Nine patients were treated medically.",
        "Intralesional steroid therapy had a 75 percent recurrence rate.",
        "The etiology, clinical presentation, and histologic features are discussed.",
        "Surgical excision and reconstruction were carried out in five patients with chronic lip or eyelid edema.",
        "This provided relief in all cases.",
        "An algorithm is provided that guides the surgeon with regard to both the medical and surgical treatment of the patient with Melkersson-Rosenthal syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15942506": [
        "In the case of unexplained nonpitting eyelid edema, biopsy should be performed.",
        "A 42-year-old woman with Melkersson-Rosenthal syndrome presented with painless, nonpitting, bilateral asymmetric upper eyelid edema.",
        "Melkersson-Rosenthal syndrome is an uncommon disorder characterized by a triad of facial nerve palsy, orofacial edema, and fissured tongue.",
        "The left eyelid was a bit larger than the right eyelid.",
        "CT and MRI demonstrated periorbital soft tissue thickening compatible with the microscopic findings of infiltration of lymphocytes, edema, and cystic dilatation of lymphatic vessels.",
        "Isolated bilateral eyelids swelling may be observed in Melkersson-Rosenthal syndrome.",
        "After treatment by systemic doxycycline and corticosteroid, she showed some improvement of the eyelid edema."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12150220": [
        "Herein, we report a case of MRS associated with Ehlers-Danlos syndrome due to rare presentation.",
        "Melkersson-Rosenthal syndrome (MRS) is characterized by the triad of recurrent facial palsy, lingua plicata, and facial edema.",
        "To the best of our knowledge only one case of MRS associated with Ehlers-Danlos syndrome has been reported in the literature until now."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24827666": [
        "We describe the case of a 29-year-old patient suffering from an oligosymptomatic form of the disease with orofacial oedema, cobblestone pattern on the buccal mucosa and swelling of the tongue, accompanied by intermittent fatigue, influenza-like symptoms, intermittent tinnitus and acute hearing loss.",
        "An increase of several autoimmune-associated antibodies was also detected.",
        "Under adalimumab, total remission of all symptoms was achieved, indicating that tumour necrosis factor-\u03b1 blockers are a promising therapeutic option for patients with Melkersson-Rosenthal syndrome.",
        "Melkersson-Rosenthal syndrome (MRS) is a rare granulomatous inflammatory disease characterised by the triad of orofacial oedema, facial nerve palsy and furrowed tongue.",
        "Treatment with prednisolone, azathioprine or methotrexate failed to adequately control all symptoms in the long term.",
        "In the absence of a specific and well-established therapy for MRS, treatment with adalimumab was administered."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/6743105": [
        "When the incomplete or oligosymptomatic forms are considered, the MRS may be more common than previously thought.",
        "Within a well-documented family aggregate of MRS, an index case simultaneously demonstrated all the elements of the triad, as well as gingival changes similar to those of cheilitis granulomatosa.",
        "The Melkersson-Rosenthal syndrome (MRS) is a rare condition characterized by the triad of familial relapsing peripheral facial palsy, facial edema, and lingua plicata."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15281985": [
        "Melkersson-Rosenthal syndrome is an uncommon disorder of uncertain aetiology characterized by orofacial oedema, facial nerve palsy and lingua plicata.",
        "The pathology, clinical features and management of this disorder are discussed.",
        "The triad is seldom seen in its complete form, and oligo-symptomatic or mono-symptomatic forms are more common.",
        "An unusual case of Melkersson-Rosenthal syndrome involving the left upper eyelid is presented."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/2160251": [
        "Melkersson-Rosenthal syndrome is a rare condition, classically associated with a triad of facial and/or lip edema, fissured tongue, and relapsing facial palsy.",
        "This article offers a review of the literature and presents two cases of Melkersson-Rosenthal syndrome associated with elevated serum levels of angiotensin converting enzyme in two patients of Thai descent."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15865255": [
        "The Melkersson-Rosenthal syndrome consists of triad of symptoms: recurrent oedema of lips, recurrent facial nerve paralysis and lingua plicata.",
        "Treatment is usually symptomatic and required cooperation of different specialists as: dermatologists, neurologists, dentists, laryngologists, surgeons.",
        "A rare case of Melkersson-Rosenthal syndrome in 49-year-old man was observed in the Clinic of Dermatology Silesian Medical Academy in Katowice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29255900": [
        "<strong class=\"sub-title\">\n          Importance:\n        </strong>\n      \n      Galcanezumab (LY2951742), a monoclonal antibody against calcitonin gene-related peptide (CGRP), is one of a novel class of new medicines for migraine prevention."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29432219": [
        "We provide an update on published Phase 2 and Phase 3 trials, safety/tolerability data, pharmacokinetics and mechanism of action of these biologicals.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Monoclonal antibodies (mAbs) targeting the calcitonin-gene-related peptide (CGRP) pathway have been developed for episodic and chronic migraine prevention, either through binding the CGRP ligand (eptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (erenumab)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29310444": [
        "Conclusion The results from this 3-month Phase 2b study support the initiation of larger Phase 3 trials of longer duration.",
        "Incidence of treatment-emergent anti-drug antibodies in galcanezumab dose groups (4.6% of patients during treatment period) did not appear to have any meaningful effects on safety, the pharmacokinetics of galcanezumab, or its ability to bind to the target ligand.",
        "Methods Patients aged 18-65 years with episodic migraine were evaluated in this multicenter, double-blind, randomized study.",
        "Injection-site pain was the most common injection-site reaction (galcanezumab 11.4%; placebo 2.9%, p = 0.004).",
        "Treatment-emergent injection-site reactions were reported significantly more frequently ( p = 0.013) with galcanezumab (13.9%) than with placebo (5.8%).",
        "Upper respiratory tract infection (galcanezumab 10.0%; placebo 8.8%) and nasopharyngitis (galcanezumab 7.0%; placebo 2.2%) also occurred more frequently with galcanezumab treatment.",
        "Results Treatment-emergent adverse events (TEAEs) were primarily rated as mild to moderate.",
        "After randomization, 410 patients were administered 5, 50, 120 or 300 mg of galcanezumab or placebo subcutaneously once every 4 weeks for 12 weeks, followed by a post-treatment off-drug period lasting 12 weeks.",
        "Background Safety findings from a Phase 2b study of galcanezumab, a humanized monoclonal antibody against calcitonin gene-related peptide, for prevention of migraine (<a href=\"http://clinicaltrials.gov/show/NCT02163993\" title=\"See in ClinicalTrials.gov\">NCT02163993</a>) are reported here.",
        "Adverse events leading to discontinuation with galcanezumab treatment were abdominal pain, visual impairment, and upper limb fracture, each reported by one patient.",
        "Serious adverse events reported in galcanezumab dose groups were appendicitis, Crohn's disease, suicidal ideation, and congenital ankyloglossia in an infant of a paternal pregnancy; each of these were reported by one patient.",
        "Potential hypersensitivity events were reported at similar frequencies in galcanezumab (3.3%) and placebo (5.1%) groups."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29697153": [
        "Of these, the calcitonin gene-related peptide receptor, which binds calcitonin gene-related peptide with high affinity, has attracted growing interest as a viable target for antimigraine therapies.",
        "To date, these monoclonal antibodies have shown promising efficacy in clinical trials, with no major safety concerns.",
        "Research has revealed a wide distribution of expression sites for calcitonin gene-related peptide in the central and peripheral nervous system.",
        "An incentive to pursue such research is the continuing unmet medical need of patients.",
        "The neuropeptide calcitonin gene-related peptide is well established as a key player in the pathogenesis of migraine.",
        "Clinical studies show calcitonin gene-related peptide levels correlate with migraine attacks, and decreases in this neuropeptide can indicate antimigraine therapy effectiveness.",
        "Triptans have offered some clinical benefit, but many patients do not respond and these drugs have important safety considerations.",
        "If ongoing long-term studies show that their efficacy can be maintained, this may herald a new era for effective antimigraine therapies.",
        "Currently, there is considerable excitement regarding monoclonal antibodies against calcitonin gene-related peptide (eptinezumab, galcanezumab, fremanezumab) and the calcitonin gene-related peptide receptor (erenumab).",
        "Initial calcitonin gene-related peptide-focused research led to development of the \"gepant\" small-molecule calcitonin gene-related peptide receptor blockers.",
        "Positive efficacy reports concerning the gepants have been tempered by safety findings which led to the discontinuation of some of these agents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29691490": [
        "Several of these drugs are expected to receive approval for use in migraine headache in 2018 and 2019.",
        "Treatment of migraine is on the cusp of a new era with the development of drugs that target the trigeminal sensory neuropeptide calcitonin gene-related peptide (CGRP) or its receptor.",
        "We describe the biology of CGRP signalling, summarize key clinical evidence for the role of CGRP in migraine headache, including the efficacy of CGRP-targeted treatment, and synthesize what is known about the role of CGRP in the trigeminovascular system.",
        "CGRP receptor antagonists such as ubrogepant are effective for acute relief of migraine headache, whereas monoclonal antibodies against CGRP (eptinezumab, fremanezumab and galcanezumab) or the CGRP receptor (erenumab) effectively prevent migraine attacks.",
        "Finally, we consider how the latest findings provide new insight into the central role of the trigeminal ganglion in the pathophysiology of migraine.",
        "CGRP-related therapies offer considerable improvements over existing drugs as they are the first to be designed specifically to act on the trigeminal pain system, they are more specific and they seem to have few or no adverse effects.",
        "As these drugs come into clinical use, we provide an overview of knowledge that has led to successful development of these drugs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29616494": [
        "The mean decrease in migraine days per month was between 3.4 and 6.3 days/month after 8 to 12 weeks of treatment, and the placebo subtracted benefit ranged from 1 to 2.18 days.",
        "Their site of action in migraine prevention is most likely peripheral due to large molecule size, which prevents the penetration through the blood-brain barrier and thereby shows that peripheral components play a pivotal role in the pathophysiology of a CNS disease.",
        "Calcitonin gene-related peptide (CGRP) is 37-amino-acid neuropeptide, crucially involved in migraine pathophysiology.",
        "As reviewed in this article, all 4 antibodies have been proven effective, tolerable, and safe as migraine prophylactic treatments in phase II clinical trials.",
        "Notably, up to 32% of subjects experienced total migraine freedom after drug administration.",
        "Anti-CGRP peptide and anti-CGRP receptor antibodies are the first effective treatments, which were specifically developed for the prevention of migraine.",
        "Further long-term and large-scale trials are currently under way to verify the safety and efficacy profile of mAbs.",
        "Substance class-specific adverse events and treatment-related serious adverse event did not occur.",
        "In particular, the potential risk of vascular adverse events and the role of anti-drug antibodies deserve special attention.",
        "Four monoclonal antibodies (mAbs) targeting the CGRP pathway are currently under evaluation for the prevention of episodic and chronic migraine: eptinezumab (ALD403), fremanezumab (TEV-48125), galcanezumab (LY2951742), and erenumab (AMG334)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29848108": [
        "Conclusions Galcanezumab 120 or 240 mg given once monthly was efficacious, safe, and well tolerated.",
        "Both doses were superior to placebo for all key secondary endpoints.",
        "The group differences (95% CIs) versus placebo were 2.0 (-2.6, -1.5) and 1.9 (-2.4, -1.4), respectively.",
        "Key secondary endpoints were \u226550%, \u2265 75%, and 100% response rates; monthly migraine headache days with acute migraine medication use; Patient Global Impression of Severity rating; the Role Function-Restrictive score of the Migraine-Specific Quality of Life Questionnaire.",
        "Introduction Galcanezumab is a humanized monoclonal antibody binding calcitonin gene-related peptide, used for migraine prevention.",
        "Study identification EVOLVE-2; <a href=\"http://clinicaltrials.gov/show/NCT02614196\" title=\"See in ClinicalTrials.gov\">NCT02614196</a>; https://clinicaltrials.gov/ct2/show/NCT02614196 .",
        "Injection site pain was the most common treatment-emergent adverse event, reported at similar rates in all treatment groups.",
        "Trial Registration <a href=\"http://clinicaltrials.gov/show/NCT02614196\" title=\"See in ClinicalTrials.gov\">NCT02614196</a>.",
        "Methods A global, double-blind, 6-month study of patients with episodic migraine was undertaken with 915 intent-to-treat patients randomized to monthly galcanezumab 120 mg (n = 231) or 240 mg (n = 223) or placebo (n = 461) subcutaneous injections.",
        "Both galcanezumab doses had significantly more injection site reactions and injection site pruritus, and the 240 mg group had significantly more injection site erythema versus placebo.",
        "Primary endpoint was overall mean change from baseline in monthly migraine headache days.",
        "Results Mean monthly migraine headache days were reduced by 4.3 and 4.2 days by galcanezumab 120 and 240 mg, respectively, and 2.3 days by placebo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29089894": [
        "Target engagement was evaluated by measuring inhibition of capsaicin-induced increase in dermal blood flow (DBF). <b>Findings:</b> Sixty-three subjects were randomized and included in the safety analyses.",
        "The humanized monoclonal antibody galcanezumab (LY2951742) binds to CGRP and may be effective in migraine prophylaxis. <b>Objectives:</b> The primary objective was to evaluate the safety and tolerability of single and multiple doses of galcanezumab in humans.",
        "Galcanezumab induced a robust, dose-dependent, and durable inhibition of capsaicin-induced increase in DBF, supporting the continued clinical development of galcanezumab for prophylaxis in migraine patients.",
        "One cohort of nine subjects received multiple (4) 150 mg doses of galcanezumab or placebo every other week.",
        "<b>Background:</b> Calcitonin gene-related peptide (CGRP) is pivotal in the pathophysiology of migraine headaches and represents a promising target for migraine treatment.",
        "Secondary objectives included assessing the pharmacokinetics and evaluating target engagement. <b>Methods:</b> A double-blind, randomized, placebo-controlled study (<a href=\"http://clinicaltrials.gov/show/NCT 01337596\" title=\"See in ClinicalTrials.gov\">NCT 01337596</a>) with single escalating and multiple subcutaneous (SC) doses of galcanezumab was performed in healthy male volunteers.",
        "Single doses of 1, 5, 25, 75, 200, and 600 mg of galcanezumab (<i>n</i> = 7/dose) or placebo (<i>n</i> = 2/dose) were injected SC in six consecutive cohorts of nine subjects each.",
        "There was no dose-dependent difference in type or frequency of treatment-emergent adverse events, and no clinically meaningful difference when compared with placebo.",
        "Pharmacokinetics were linear.",
        "Galcanezumab was well tolerated in single doses (1-600 mg SC) and consecutive doses (150 mg SC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30182284": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      This meta-analysis was performed to evaluate the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide (CGRP) for episodic migraine prevention."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30446596": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To evaluate the efficacy and safety of galcanezumab, a humanized monoclonal antibody that selectively binds to calcitonin gene-related peptide, in the preventive treatment of chronic migraine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30341990": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To characterize adult patients with episodic migraine who achieved 100% response to galcanezumab treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30413151": [
        "This study evaluated the safety and tolerability, as well as the effectiveness of galcanezumab for up to 12 months of treatment in patients with migraine.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Galcanezumab, a humanized monoclonal antibody that selectively binds to the calcitonin gene-related peptide, has demonstrated in previous Phase 2 and Phase 3 clinical studies (\u22646-month of treatment) a reduction in the number of migraine headache days and improved patients' functioning."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30378008": [
        "A potent vasodilator, CGRP is implicated in nociceptive transmission and migraine pathogenesis.",
        "In September 2018, the US FDA approved galcanezumab as a once-monthly subcutaneous injection for the preventive treatment of migraine in adults.",
        "Galcanezumab-gnlm (Emgality\u2122; Eli Lilly and Company), hereafter galcanezumab, is a humanized monoclonal antibody against the calcitonin gene-related peptide (CGRP) ligand.",
        "This article summarizes the milestones in the development of galcanezumab leading to its first approval for the preventive treatment of migraine in adults.",
        "In the same month, the EMA issued a positive opinion for galcanezumab for the prophylaxis of migraine in adults who have at least 4 migraine days per month.",
        "Galcanezumab is also undergoing phase III evaluation for the preventive treatment of cluster headache in North America and Europe."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30478036": [
        "Elucidating the molecular mechanism for this unusual mode of inheritance will provide new insights into how mtDNA is passed on from parent to offspring and may even lead to the development of new avenues for the therapeutic treatment for pathogenic mtDNA transmission.",
        "A comprehensive exploration of mtDNA segregation in these families shows biparental mtDNA transmission with an autosomal dominantlike inheritance mode.",
        "Heteroplasmy of mtDNA was independently examined by high-depth whole mtDNA sequencing analysis in our research laboratory and in two Clinical Laboratory Improvement Amendments and College of American Pathologists-accredited laboratories using multiple approaches.",
        "Here, we identified three unrelated multigeneration families with a high level of mtDNA heteroplasmy (ranging from 24 to 76%) in a total of 17 individuals.",
        "Although there has been considerable debate about whether paternal mitochondrial DNA (mtDNA) transmission may coexist with maternal transmission of mtDNA, it is generally believed that mitochondria and mtDNA are exclusively maternally inherited in humans.",
        "Our results suggest that, although the central dogma of maternal inheritance of mtDNA remains valid, there are some exceptional cases where paternal mtDNA could be passed to the offspring."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10760494": [
        "The present experiment examined the effects of diazepam, a positive modulator at the GABA(A) receptor, on survival and cognitive performance in traumatically brain-injured animals.",
        "Increasing inhibitory function through stimulation of gamma-aminobutyric acid (GABA(A)) receptors may attenuate excitotoxic effects and improve outcome.",
        "Rats treated with diazepam did not differ in mortality from injured rats treated with vehicle.",
        "These results suggest that enhancing inhibitory function during the acute post-injury period produces beneficial effects on both survival and outcome following experimental TBI.",
        "In experiment 1, 15 min prior to central fluid percussion brain injury, rats (n=8 per group) were injected (i.p.) with saline or diazepam (5 mg/kg or 10 mg/kg).",
        "Additional rats (n=8) were surgically prepared but not injured (sham-injury).",
        "In experiment 3, the post-injury administration of bicuculline (1.5 mg/kg, n=8), a GABA(A) antagonist, increased Morris water maze goal latencies compared to injured animals treated with saline (n=8).",
        "Also, diazepam-treated (5 mg/kg) rats had significantly shorter latencies to reach the goal platform in the Morris water maze test performed 11-15 days post-injury.",
        "Rats pre-treated with the 5 mg/kg dose of diazepam had significantly lower mortality (0%) than injured, saline-treated rats (53%).",
        "Glutamate-mediated excitotoxicity has been shown to contribute to cellular dysfunction following traumatic brain injury (TBI).",
        "In experiment 2, at 15 min post-injury, rats were given either saline (n=5) or 5 mg/kg diazepam (n=6).",
        "However, rats treated with diazepam at 15 min post-injury had significantly shorter latencies to reach the goal platform in the Morris water maze than injured, vehicle-treated rats."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28915787": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      RNA-Seq is currently used routinely, and it provides accurate information on gene transcription.",
        "Several strategies have been previously used (drop duplicated genes, distribute uniformly the reads, or estimate expression), but all of them provide biased results.",
        "However, the method cannot accurately estimate duplicated genes expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29444201": [
        "Methods have been developed that use weighted allocation of read counts but these methods treat the different types of multi-reads equivalently.",
        "RNA sequencing (RNA-seq) can provide quantitative estimates of ASE for genes with transcribed polymorphisms.",
        "Multi-mapping reads aligning equally well to multiple genomic locations, isoforms or alleles can comprise the majority (&gt;85%) of reads.",
        "When short-read sequences are aligned to a diploid transcriptome, read-mapping ambiguities confound our ability to directly count reads.",
        "We propose a hierarchical approach to allocation of read counts that first resolves ambiguities among genes, then among isoforms, and lastly between alleles.",
        "We have implemented our model in EMASE software (Expectation-Maximization for Allele Specific Expression) to estimate total gene expression, isoform usage and ASE based on this hierarchical allocation.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Allele-specific expression (ASE) refers to the differential abundance of the allelic copies of a transcript.",
        "Discarding them can result in biases and substantial loss of information."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27222271": [
        "Plasma and urine samples were collected to investigate CEP-26401 pharmacokinetics.",
        "CEP-26401 is a novel orally active, brain-penetrant, high-affinity histamine H3 receptor (H3R) antagonist, with potential therapeutic utility in cognition enhancement.",
        "CEP-26401 had a dose-dependent negative effect on sleep, with some positive effects on certain CANTAB cognitive parameters seen at lower concentrations.",
        "Further clinical studies are required to establish the potential of low-dose CEP-26401 in cognition enhancement.",
        "The derived three compartment population pharmacokinetic model, with first-order absorption and elimination, accurately described the available pharmacokinetic data.",
        "Steady-state plasma concentrations were achieved within six days of dosing.",
        "CEP-26401 exhibits dose- and time-independent pharmacokinetics, and renal excretion is a major elimination pathway.",
        "Pharmacodynamic endpoints included a subset of tasks from the Cambridge Neuropsychological Test Automated Battery (CANTAB) and nocturnal polysomnography.",
        "CEP-26401 was generally well tolerated up to 0.5 mg/day with most common treatment related adverse events being headache and insomnia.",
        "Population pharmacokinetic-pharmacodynamic modeling was conducted on one CANTAB and one polysomnography parameter of interest.",
        "CEP-26401 was slowly absorbed (median tmax range 3-6 hours) and the mean terminal elimination half-life ranged from 24-60 hours.",
        "Two randomized, double-blind, placebo-controlled dose escalation studies with single (0.02 to 5 mg) or multiple administration (0.02 to 0.5 mg once daily) of CEP-26401 were conducted in healthy subjects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22001260": [
        "CEP-26401 displayed potent antagonist and inverse agonist activities in [\u00b3\u2075S]guanosine 5'-O-(\u03b3-thio)triphosphate binding assays.",
        "In DBA/2NCrl mice, CEP-26401 at 10 and 30 mg/kg i.p. increased prepulse inhibition (PPI), whereas the antipsychotic risperidone was effective at 0.3 and 1 mg/kg i.p. Coadministration of CEP-26401 and risperidone at subefficacious doses (3 and 0.1 mg/kg i.p., respectively) increased PPI.",
        "These results demonstrate potent behavioral effects of CEP-26401 in rodent models and suggest that this novel H\u2083R antagonist may have therapeutic utility in the treatment of cognitive and attentional disorders.",
        "CEP-26401 [irdabisant; 6-{4-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-2H-pyridazin-3-one HCl] is a novel, potent histamine H\u2083 receptor (H\u2083R) antagonist/inverse agonist with drug-like properties.",
        "CEP-26401 may also have therapeutic utility in treating schizophrenia or as adjunctive therapy to approved antipsychotics.",
        "CEP-26401 improved performance in the rat social recognition model of short-term memory at doses of 0.01 to 0.1 mg/kg p.o. and was wake-promoting at 3 to 30 mg/kg p.o.",
        "High affinity of CEP-26401 for H\u2083R was demonstrated in radioligand binding displacement assays in rat brain membranes (K(i) = 2.7 \u00b1 0.3 nM) and recombinant rat and human H\u2083R-expressing systems (K(i) = 7.2 \u00b1 0.4 and 2.0 \u00b1 1.0 nM, respectively).",
        "After oral dosing of CEP-26401, occupancy of H\u2083R was estimated by the inhibition of ex vivo binding in rat cortical slices (OCC\u2085\u2080 = 0.1 \u00b1 0.003 mg/kg), and antagonism of the H\u2083R agonist R-\u03b1-methylhistamine- induced drinking response in the rat dipsogenia model was demonstrated in a similar dose range (ED\u2085\u2080 = 0.06 mg/kg)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18469850": [
        "The purpose of this review is to acquaint the reader with the current understanding of H3 receptor localization and function as a modulator of neurotransmitter release and its effects on cognitive processes, as well as to provide an update on selected H3 antagonists in various states of preclinical and clinical advancement.",
        "However, although a number of clinical studies examining the efficacy of H3 receptor antagonists for a variety of cognitive disorders are currently underway, no clinical proof of concept for an H3 receptor antagonist has been reported to date.",
        "The histamine H3 receptor, first described in 1983 as a histamine autoreceptor and later shown to also function as a heteroreceptor that regulates the release of other neurotransmitters, has been the focus of research by numerous laboratories as it represents an attractive drug target for a number of indications including cognition.",
        "The cognitive-enhancing effects of H3 antagonists across multiple cognitive domains in a wide number of preclinical cognition models also bolster confidence in this therapeutic approach for the treatment of attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia.",
        "Blockade of centrally localized H3 receptors by selective H3 receptor antagonists has been shown to enhance the release of neurotransmitters such as histamine, ACh, dopamine and norepinephrine, among others, which play important roles in cognitive processes.",
        "The discovery of effective H3 antagonists as therapeutic agents for the novel treatment of cognitive disorders will only be accomplished through continued research efforts that further our insights into the functions of the H3 receptor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28178876": [
        "For these simulations, using the heuristic Bayesian allocation strategy more than quadrupled the statistical power to [Formula: see text].",
        "Fecal microbiota transplantation's success as a therapy for C. difficile has inspired interest in performing clinical trials that experiment with fecal microbiota transplantation as a therapy for other conditions like inflammatory bowel disease, obesity, diabetes, and Parkinson's disease.",
        "Results from clinical trials that use fecal microbiota transplantation to treat inflammatory bowel disease suggest that, for at least one condition beyond C. difficile, most fecal microbiota transplantation donors produce stool that is not efficacious.",
        "We use the results of similar simulations to make recommendations about the number of patients, the number of donors, and the choice of clinical endpoint that clinical trials should use to optimize their ability to detect if fecal microbiota transplantation is effective for treating a condition.",
        "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile, a common hospital-acquired infection.",
        "The optimal strategies for identifying and using efficacious donors have not been investigated.",
        "This heuristic computes the probability that a donor is efficacious by updating prior expectations about the efficacy of fecal microbiota transplantation, the placebo rate, and the fraction of donors that produce efficacious stool.",
        "We therefore examined the optimal Bayesian response-adaptive strategy for allocating patients to donors and formulated a computationally tractable myopic heuristic.",
        "In simulations designed to mimic a recent fecal microbiota transplantation clinical trial, for which traditional power calculations predict [Formula: see text] statistical power, we found that accounting for differences in donor stool efficacy reduced the predicted statistical power to [Formula: see text]."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29020255": [
        "We report cure of a septic patient with proctitis by fecal microbiota transplant via rectal swabs (mini-FMT).",
        "This novel procedure offers a management option for recurrent CDI following total abdominal colectomy.",
        "Rarely, in fulminant Clostridium difficile infection (CDI), the rectal stump is persistently infected following total abdominal colectomy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29104169": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      We aimed to assess the asymptomatic Clostridium difficile carriage rates following fecal microbiota transplantation (FMT)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23333862": [
        "Post FMT samples from patients showed an increase in the abundance of Firmicutes and Bacteroidetes, representing 75-80% of the total sequence reads.",
        "Proteobacteria and Actinobacteria were less abundant (&lt; 5%) than that found in patients prior to FMT.",
        "Members of the phylum Firmicutes were represented by Ruminococcaceae, Lachnospiraceae, Verrucomicrobiaceae and unclassified Clostridiales and members of the Firmicutes.",
        "Our results demonstrate that frozen fecal microbiota from a healthy donor can be used to effectively treat recurrent CDI resulting in restoration of the structure of gut microbiota and clearing of Clostridum difficile.",
        "Similar bacterial taxa were found in post-transplantation samples obtained from the recipients and donor samples, but the relative abundance varied considerably between patients and time points.",
        "Here we report that high-throughput 16S rRNA gene sequencing showed stable engraftment of gut microbiota following FMT using frozen fecal bacteria from a healthy donor.",
        "Fecal microbiota transplantation (FMT) is becoming a more widely used technology for treatment of recurrent Clostridum difficile infection (CDI).",
        "While previous treatments used fresh fecal slurries as a source of microbiota for FMT, we recently reported the successful use of standardized, partially purified and frozen fecal microbiota to treat CDI.",
        "Post FMT samples from two patients were very similar to donor samples, with the Bacteroidetes phylum represented by a great abundance of members of the families Bacteroidaceae, Rikenellaceae and Porphyromonadaceae, and were largely comprised of Bacteroides, Alistipes and Parabacteroides genera.",
        "One patient subsequently received antibiotics for an unrelated infection, resulting in an increase in the number of intestinal Proteobacteria, primarily Enterobacteriaceae."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26616138": [
        "D-lactic acidosis can occur in patients with short bowel syndrome (SBS) when excessive malabsorbed carbohydrate (CHO) enters the colon and is metabolized by colonic bacteria to D-lactate.",
        "D-lactate can be absorbed systemically, and increased serum levels are associated with central nervous system toxicity manifested by confusion, ataxia, and slurred speech.",
        "Here we present the case of a child with SBS and recurrent, debilitating D-lactic acidosis, which was successfully treated with fecal transplantation.",
        "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
        "The exact mechanism of action is unknown, but it is surmised that the alteration of the intestinal microbiome, as well as the reintroduction of potential beneficial microbes, helps mediate disease.",
        "Current therapy, usually directed toward suppressing intestinal bacterial overgrowth and limiting ingested CHO, is not always successful."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29450831": [
        "There is no standard method to produce material for FMT, and there are a multitude of factors that can vary between institutions that offer this therapy.",
        "Despite these significant methodological variations, clinical outcomes in terms of cure rate appear to be remarkably similar for both FMT providers.",
        "More of these studies should be undertaken to clarify the superiority or otherwise of these variables.",
        "These methods are described in detail in this review highlighting differing practice.",
        "As FMT is increasingly being proposed for a number of conditions other than CDI, harmonization of methods and techniques may be more critical to the success of FMT, and thus it will be important to standardize these as far as practically possible.",
        "This review describes the methods and protocols that two English NHS hospitals independently adopted over the same time period to provide FMT for patients with recurrent CDI.",
        "Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile infection (CDI).",
        "Only a few studies have directly compared clinical efficacy in groups of patients who have been treated with FMT prepared differently (e.g., fresh vs. frozen) or administered by different route (e.g., by nasojejunal tube, colonoscopy or by oral administration of encapsulated product).",
        "Although the exact mechanisms of FMT have yet to be fully elucidated, replacement or restoration of a 'normal' microbiota (or at least a microbiota resembling those who have never had CDI) appears to have a positive effect on the gut dysbiosis that is thought to exist in these patients.",
        "The lack of clarity about the exact mechanism of action and the 'active ingredient' of FMT (e.g., individual or communities of bacteria, bacteriophage, or bioactive molecules such as bile acids) has hindered the ability to produce a standardized and well-characterized FMT product.",
        "There are several fundamental differences in the methods used, including selection and testing of donors, procedures for preparation and storage of material, and route of administration.",
        "Although both hospitals have treated only modest numbers of patients, these findings suggest that many of the described differences may not be critical factors in influencing the success of the procedure.",
        "Furthermore, despite being aesthetically unappealing, this 'ultimate probiotic' is a particularly attractive solution to a difficult problem that avoids repeated courses of antibiotics.",
        "There have been many well-conducted randomized controlled trials and thousands of patients reported in case series that describe success rates of approximately 90% following one or more FMT."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29076071": [
        "Therefore, it is necessary to evaluate alternative treatment methods, such as bacteriotherapy, as well as the mechanism through which beneficial bacteria inhibit the growth of C. difficile.",
        "The inhibitory effect on C. difficile growth increased with increasing bile acid concentration in the presence of Bacteroides ovatus SNUG 40239.",
        "However, FMT has important limitations including uncontrolled exposure to pathogens and standardization issues.",
        "The findings of this study are important due to the discovery of a new bacterial strain that in the presence of available bile acids inhibits growth of C. difficile.",
        "Here, we report bile acid-mediated inhibition of C. difficile by Bacteroides strains which can produce bile salt hydrolase (BSH).",
        "Furthermore, this inhibitory effect on C. difficile growth was significantly attenuated when bile acid availability was reduced by cholestyramine, a bile acid sequestrant.",
        "Bacteroides strains are not commonly used to treat CDI; however, as they comprise a large proportion of the intestinal microbiota, they can contribute to bile acid-mediated inhibition of C. difficile.",
        "Dysbiosis of the gut microbiota due to consumption of antibiotics is a major contributor to CDI.",
        "Recently, fecal microbiota transplantation (FMT) has been applied to treat CDI.",
        "These results will facilitate development of novel bacteriotherapy strategies to control CDI.",
        "Clostridium difficile infection (CDI) is one of the most common nosocomial infections."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27999162": [
        "The typical shift to post-FMT, donor-like assemblages, featuring high relative abundances of genera within the Bacteroidetes and Firmicutes phyla, was not observed in the autologous FMT subjects.",
        "The SourceTracker program, which employs a Bayesian algorithm to determine source contributions to sink communities, showed that patients initially treated by heterologous FMT had significantly higher percentages of engraftment (i.e., similarity to donor communities, mean value of 74%) compared to those who suffered recurrence following autologous FMT (1%) (P \u2264 0.013).",
        "Bacterial communities from subjects treated for recurrent Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool samples, were characterized by Illumina next-generation sequencing.",
        "The findings of this study suggest that complete donor engraftment may be not necessary if functionally critical taxa are present in subjects following antibiotic therapy.",
        "Subjects cured by autologous FMT typically had greater abundances of the Clostridium XIVa clade and Holdemania bacteria prior to treatment, and the relative abundances of these groups increased significantly after FMT compared to heterologous FMT and pre-FMT samples.",
        "As previously reported, the success of heterologous FMT (90%) was superior to that of autologous FMT (43%) (P = 0.019), and post-FMT intestinal bacterial communities differed significantly between treatment arms (P &lt; 0.001).",
        "Autologous FMT patient bacterial communities were significantly different in composition than those for heterologous FMT patients and donors (P &lt; 0.001)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24939885": [
        "It is hypothesized that FMT aids in recovery of a microbiota capable of colonization resistance to C. difficile.",
        "The fecal microbiota of recipients following transplantation was more diverse and more similar to the donor profile than the microbiota prior to transplantation.",
        "These results suggest that functional changes accompany microbial structural changes following this therapy.",
        "In particular, amino acid transport systems were overrepresented in samples collected prior to transplantation.",
        "Increased relative abundance of Bacteroidetes and decreased abundance of Proteobacteria were observed following FMT.",
        "Further identification of the specific community members and functions that promote colonization resistance may aid in the development of improved treatment methods for C. difficile infection.",
        "Here we investigated changes in the fecal microbiota structure following FMT in patients with recurrent C. difficile infection, and imputed a hypothetical functional profile based on the 16S rRNA profile using a predictive metagenomic tool.",
        "However, it is not fully understood how this occurs.",
        "Clostridium difficile infection is one of the most common health care-associated infections, and up to 40% of patients suffer from recurrence of disease following standard antibiotic therapy.",
        "Recently, fecal microbiota transplantation (FMT) has been successfully used to treat recurrent C. difficile infection.",
        "Additionally, we observed differences in the imputed metagenomic profile."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26204547": [
        "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile infection, with near 90% of success.",
        "We report a 57 years old woman who developed an antibiotic associated diarrhea with a positive polymerase chain reaction test for Clostridium Difficile toxin.",
        "She was successfully treated with Vancomycin trice but diarrhea recurred.",
        "Therefore a fecal microbiota transplant was performed using solid stools from a relative, diluted in saline and instilled in the distal ileon, with a good clinical response, without recurrence of diarrhea, during a 6-month follow-up."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27194400": [
        "Treatment options for multidrug-resistant (MDR) bacterial infections are limited and often less effective.",
        "FMT is a completely novel way to eradicate drug-resistant bacteria from the intestinal reservoir and should be further investigated to address the global problem of difficult-to-treat, MDR bacterial infections.",
        "Five trials are currently underway to further investigate the use of FMT for MDR bacterial decolonization.",
        "Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization.",
        "Non-pharmacologic approaches to preventing or treating MDR infections are currently restricted to improved antimicrobial stewardship and infection control practices.",
        "The procedure has been shown to work even in immunocompromised patients and those experiencing medical crises without any adverse events.",
        "A total of eight case reports have been published showing FMT resulted in intestinal decolonization of extended spectrum \u03b2-lactamase (ESBL)-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant Enterococci, or methicillin-resistant Staphylococcus aureus."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28195180": [
        "In addition, FMT is being investigated for a variety of indications where restoration or restructuring of the gut microbial community is hypothesized to be beneficial.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone.",
        "We sought to develop a stable, freeze-dried encapsulated preparation of standardized fecal microbiota that can be used for FMT with ease and convenience in clinical practice and research."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27648772": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection (CDI).",
        "The objective of this systematic review was to evaluate the effectiveness of FMT in the treatment of CDI."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28125667": [
        "We found that oxygen exposure degraded fecal bacterial communities, whereas freeze-thaw cycles and lag time between donor defecation and transplant preparation had much smaller effects.",
        "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
        "Our results indicate that some current practices for preparing microbiota transplant material adversely affect living fecal microbial content and highlight PMA-seq as a valuable tool to inform best practices and evaluate the suitability of clinical fecal material.",
        "Notably, the abundance of Faecalibacterium prausnitzii-an anti-inflammatory commensal bacterium whose absence is linked to inflammatory bowel disease-decreased with oxygen exposure.",
        "But variability in fecal bacterial communities-believed to be the therapeutic agent-can complicate or undermine treatment efficacy.",
        "To understand the effects of transplant preparation methods on living fecal microbial communities, we applied a DNA-sequencing method (PMA-seq) that uses propidium monoazide (PMA) to differentiate between living and dead fecal microbes, and we created an analysis pipeline to identify individual bacteria that change in abundance between samples."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23844515": [
        "As antibacterials currently used for primary C. difficile infections favor recurrences, new methods able to neutralize the bacterium without affecting the gut microbiota are badly needed.",
        "Another aspect of bad/good parasites are the use of helminth or helminth ova for treating autoimmune diseases, especially those affecting the gut.",
        "Complementary treatment with probiotic agents to reconstitute the physiologicaL intestinal flora does not yield any consistent benefit.",
        "In recent years, fecal transplantation has been used in the English-speaking countries with cure rates of about 87%.",
        "These are needed to identify the right patient, efficacy and safety profile of FMT before this approach can be widely advocated.",
        "Clostridium difficile is the etiologic agent of nosocomial and community-acquired diarrhea associated with exposure to antibiotics that disrupt the normal colonic flora.",
        "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25548572": [
        "Fecal and mucosal microbiota was analyzed before the second FMT and during 14 months after FMT by using a high-throughput phylogenetic microarray.",
        "We followed up the relief of symptoms and long-term, over-a-year microbiota stabilization in a 46-year-old man, who underwent FMT for antibiotic-induced, non-CDI colitis nine months after being treated for CDI by FMT.",
        "FMT resolved the symptoms and restored normal GI-function.",
        "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI) diseases.",
        "The presented case suggests a possible role of microbiota in restoring and maintaining normal GI-functionality and improves our knowledge on the etiology of antibiotic-induced, noninfectious colitis.",
        "Notably, the increased bacteria included Bifidobacterium spp. and various representatives of Clostridium clusters IV and XIVa, such as Clostridium leptum, Oscillospira guillermondii, Sporobacter termitidis, Anaerotruncus colihominis, Ruminococcus callidus, R. bromii, Lachnospira pectinoschiza, and C. colinum, which are presumed to be anti-inflammatory.",
        "Microbiota analysis revealed increased bacterial diversity in the rectal mucosa and a stable fecal microbiota up to three months after FMT.",
        "A number of mucosa-associated bacteria increased after FMT and some of these bacteria remained increased in feces up to 14 months."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24440934": [
        "<strong class=\"sub-title\">\n          Goal:\n        </strong>\n      \n      By systematic review, we assessed the impact of fecal microbiota transplantation (FMT) for the treatment of Clostridium difficile (CD)-associated diarrhea."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28506071": [
        "After a twelve month follow-up, the patient remains asymptomatic without Clostridium difficile infection relapses or inflammatory bowel disease flare-ups.",
        "Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure.",
        "Fecal microbiota transplantation of an unrelated healthy donor was performed by the lower route.",
        "The use of fecal microbiota transplantation in recurrent Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear.",
        "A 61-year-old man with ulcerative pancolitis was diagnosed with a third recurrence of Clostridium difficile infection, previously treated with metronidazole, vancomycin and fidaxomicin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26901316": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess the cost-effectiveness of six treatment strategies for patients diagnosed with recurrent Clostridium difficile infection (CDI) in Canada: 1. oral metronidazole; 2. oral vancomycin; 3.oral fidaxomicin; 4. fecal transplantation by enema; 5. fecal transplantation by nasogastric tube; and 6. fecal transplantation by colonoscopy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29185820": [
        "Although the most common delusional misidentification is Capgras syndrome, in which the sufferer believes a familiar person has been replaced by an identical imposter, other forms have been also described.",
        "Syndromes of delusional misidentification consist of disordered familiarity and have been reported in diverse diagnoses, including Parkinson's disease.",
        "The pathogenesis of delusions of misidentification appears to require dysfunction of or connection to a left cerebral cortical area involved in recognition of familiarity, and also right frontal cortex serving belief evaluation.",
        "Two cases of Parkinson's disease with an unusual delusional misidentification, intermetamorphosis, are presented, along with their improvement with pimavanserin, a novel atypical antipsychotic medication."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29105858": [
        "<strong class=\"sub-title\">\n          Rationale:\n        </strong>\n      \n      Pimavanserin, a selective serotonin 2A receptor inverse agonist, is a promising candidate for treating Parkinson's disease psychosis.",
        "Our previous study revealed that there might be the presence of extensive metabolites of pimavanserin in rats.",
        "However, the metabolic fate of pimavanserin in vivo remains unknown.",
        "Thus, it is essential to develop an efficient method to investigate the metabolic profile of pimavanserin in rats.",
        "Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) to date has the highest mass measurement accuracy and resolution of any mass spectrometry platform."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29098976": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Our aim was to describe the efficacy and tolerability of pimavanserin, a highly selective serotonin 5-HT2A receptor inverse agonist/antagonist indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP), using the metrics of number needed to treat (NNT) and number needed to harm (NNH)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29047301": [
        "Functionally, it acts as a potent inverse agonist at 5-HT<sub>2A</sub> receptors, with selectivity over 5-HT<sub>2C</sub> receptors and no appreciable activity at other neurotransmitter receptors.",
        "It analyzes the pharmacological, behavioral and molecular mechanisms of pimavanserin and their contribution to the therapeutic advantages of the drug as reported in published preclinical and clinical studies, press releases and product labels.",
        "The drug also displayed relatively benign safety and tolerability profiles.",
        "The drug exhibits long plasma half-life (57 hours), which support its once/day administration.",
        "Pimavanserin's mechanism of action might contribute to its unique psychopharmacological properties in the improved treatment of PDP, and perhaps psychosis in other diseases including schizophrenia and dementia-related psychosis.",
        "Expert opinion: Pimavanserin exhibits a unique pharmacological profile with nanomolar affinity at serotonin 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors.",
        "Pimavanserin is the first FDA-approved atypical antipsychotic drug indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP).",
        "Areas covered: This review focuses on the preclinical discovery of pimavanserin.",
        "Behavioral studies found that pimavanserin reversed impaired behaviors in animal models predictive of antipsychotic activity, and with no impairment of motor functions.",
        "A pivotal phase III clinical trial demonstrated significant improvement in PDP symptoms in patients receiving pimavanserin compared to placebo-treated patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29955528": [
        "The antipsychotic effects of this new agent are believed to occur via selective inverse agonist activity at serotonin 5-HT<sub>2a</sub> receptors.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Pimavanserin (Nuplazid\u2122) is an atypical antipsychotic currently indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27609312": [
        "Psychosis is highly prevalent in PD patients and is associated with poor prognosis.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Parkinson\u00b4s disease (PD) is a synucleinopathy that affects millions of people worldwide and leads to progressive disability.",
        "Pimavanserin is the first Food and Drug Administration approved medicine for the treatment of hallucinations and delusions associated with PDP.",
        "Until April 2016, there were no licensed drugs available in the United States of America (USA) for the treatment of PD psychosis (PDP)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28622212": [
        "Charts from the movement disorders clinic were reviewed for all patients who received this drug as treatment for psychosis associated with primary parkinsonism due to \u03b1-synucleinopathies.",
        "Ten patients improved and continue on the drug, whereas 5 stopped because of lack of benefit.",
        "Pimavanserin, a 5-HT2A inverse agonist, was commercially released in the United States in April 2016 for the treatment of Parkinson disease psychosis.",
        "There were no adverse events reported.",
        "No \"naturalistic\" treatment results have yet been published.",
        "Data of 10 patients with idiopathic Parkinson disease, including 1 with a long history of schizophrenia, 4 with dementia with Lewy bodies, and 1 with multiple-system atrophy, were reviewed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27830568": [
        "Cholinesterase inhibitors can ameliorate psychosis symptoms.",
        "Parkinson disease psychosis (PDP) is a common phenomenon in Parkinson disease (PD) patients treated with dopaminergic drugs, and is associated with high morbidity and mortality.",
        "All atypical antipsychotics are associated with increased mortality in this patient population.",
        "The serotonin 5-HT<sub>2A</sub> receptor inverse agonist pimavanserin was recently approved by the US FDA for the treatment of PDP and may prove to be a more targeted therapy without the downsides of atypical antipsychotics.",
        "Of these, clozapine is effective but is associated with a poor side-effect profile and the necessity for frequent blood draws.",
        "When general medical or psychiatric conditions have been ruled out, and decreasing dopaminergic agents is not effective in treating psychosis, therapies include atypical antipsychotics, primarily clozapine and quetiapine.",
        "Clinicians prefer quetiapine for its theoretically better safety profile, although there is no evidence for efficacy in treating psychosis.",
        "It also correlates with depression and dementia, and can contribute to considerable caregiver stress and burnout.",
        "While symptoms can be relieved by decreasing doses or number of anti-PD medications, this may lead to an unacceptable worsening of motor function."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28385039": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To summarize and evaluate the existing literature regarding medications to treat Parkinson's disease (PD) psychosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29185542": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      In April 2016, the Food and Drug Administration (FDA) approved a first-in-class atypical antipsychotic medication called pimavanserin for the treatment of Parkinson disease psychosis (PDP).",
        "We aim to inform readers about its indications, effectiveness, and safety profile."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29497575": [
        "Animal studies were excluded.",
        "<i>Objective</i>: Pimavanserin is the first United States Food and Drug Administration (FDA)-approved treatment for Parkinson's disease psychosis (PDP).",
        "However, two Phase III trials, including one that was terminated early, failed to show significant SAPS improvement.",
        "Randomized, controlled trials (RCTs) were prioritized. <i>Results:</i> Four RCTs were identified.",
        "English-language studies of pimavanserin for PDP were evaluated.",
        "In each, pimavanserin was well-tolerated with few adverse effects and no worsening of motor symptoms.",
        "Reference review and search of FDA.gov and clinicaltrials.gov yielded additional studies.",
        "A third Phase III trial with an improved research design utilized a nine-item subset of the SAPS, the SAPS-PD, as the primary outcome and demonstrated that pimavanserin 40mg was effective in improving PDP compared to placebo (<i>p</i>=0.0014, effect size=0.50).",
        "With limited treatment options for PDP, pimavanserin represents an important therapeutic innovation.",
        "Secondary outcomes were also significantly improved: Clinical Global Impression of Severity (CGI-S) (<i>p</i>=0.0007, effect size=0.52) and Clinical Global Impression of Improvement (CGI-I) (<i>p</i>=0.0011, effect size=0.51), caregiver burden (<i>p</i>=0.0016, effect size=0.50), nighttime sleep (<i>p</i>=0.0446, effect size=0.31), and daytime wakefulness (<i>p</i>=0.012, effect size=0.39). <i>Conclusion</i>: Evidence suggests pimavanserin attenuates PDP symptoms with few adverse effects and little risk of worsening motor function.",
        "This article reviews the safety, efficacy, and pharmacology data for pimavanserin and its role in therapy. <i>Method of Research:</i> Initial literature sources were identified via MEDLINE search (1946-September 2016) of pimavanserin and ACP-103 (original molecular designation).",
        "A Phase II trial displayed a nonsignificant trend toward Scale for Assessment of Positive Symptoms (SAPS) improvement (<i>p</i>=0.09), with significant benefits in secondary efficacy markers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28493654": [
        "We also describe a new labeling feature that presents additional efficacy data to clinicians.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.",
        "We describe the regulatory and clinical issues important to the FDA's approval of this New Drug Application, with special focus on the risk-benefit balance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29452684": [
        "No safe or effective pharmacological treatment is approved for psychosis in patients with Alzheimer's disease.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Pimavanserin is a selective 5-HT<sub>2A</sub> receptor inverse agonist and antagonist approved in the USA for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.",
        "Therefore, we aimed to evaluate the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24183563": [
        "We aimed to assess safety and efficacy of pimavanserin, a selective serotonin 5-HT2A inverse agonist, in this population.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Parkinson's disease psychosis, which includes hallucinations and delusions, is frequent and debilitating in people with Parkinson's disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26744739": [
        "Data from phase II and phase III clinical trials suggest that pimavanserin is a safe and effective treatment option for PDP.",
        "Currently there are no FDA-approved medications in the United States for the treatment of PDP, although on September 2, 2014, the United States Food and Drug Administration granted breakthrough therapy status to pimavanserin, highlighting the unmet need for therapeutics in this class.",
        "Additional studies are ongoing for the treatment of Alzheimer's psychosis, schizophrenia and insomnia.",
        "Such promising outcomes warrant a review of the available literature regarding pimavanserin and its use in the treatment of PDP symptoms.",
        "Most antipsychotic medications worsen motor dysfunction due to dopamine antagonism, and all carry a black box warning for an increased risk of mortality in elderly patients with dementia-related psychosis.",
        "Trial results indicate a significant reduction in hallucinations and delusions in patients with PDP without worsening motor symptoms.",
        "Pimavanserin (ACP-103) is a selective inverse agonist of the 5-hydroxytryptamine 2A (5-HT2A) receptor intended to treat patients with Parkinson's disease psychosis (PDP)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28880354": [
        "Another important point is that no-one has yet conducted a trial comparing clozapine and pimavanserin.&lt;br/&gt; CONCLUSION: Given that the current second drug of choice, namely quetiapine, has not been found to be effective for PDP, we are of the opinion that - if pimavanserin is registered in the Netherlands - pimavanserin could be used when the current drug of choice, clozapine, is not completely effective or is poorly tolerated.",
        "This means that results cannot be generalised.",
        "However, clozapine can have adverse effects, including agranulocytosis.",
        "Pimavanserin is an effective treatment for PDP, and, like clozapine, it has very few negative effects on motor skills.",
        "For patients who have cognitive impairments in addition to psychosis, we advise testing the patient's reaction to a cholinesterase inhibitor before starting the patient on a course of antipsychotics.",
        "Clozapine is an effective drug for treating psychosis in Parkinson's disease (PDP) and is registered as such in the Netherlands.",
        "However, all of the RCTs were funded by the manufacturer of pimavanserin and the trials were conducted in a very selective patient population.",
        "In earlier trials clozapine was shown to have a greater and faster antipsychotic effect.",
        "Many clinicians and psychiatrists have a great deal of experience with this drug.",
        "The new drug pimavanserin was recently registered in the United States for the treatment of PDP.&lt;br/&gt; AIM: To review the literature on pimavanserin and discuss the position it currently occupies in the Netherlands as a potential treatment for PDP.&lt;br/&gt; METHOD: Systematic search of the literature.&lt;br/&gt; RESULTS: We found reports on four randomised controlled trials (RCTs), one review and six articles about the pharmacokinetics and pharmacodynamics of pimavanserin.",
        "Long-term results are not yet available."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19907417": [
        "Pimavanserin showed significantly greater improvement in psychosis in patients with PDP at a dose which did not impair motor function, or cause sedation or hypotension Thus, pimavanserin may represent a novel treatment for PDP.",
        "Pimavanserin did not differentiate from placebo with regard to motor impairment, sedation, hypotension, or other side effects.",
        "Furthermore, these results support the hypothesis that attenuation of psychosis secondary to DA receptor stimulation in PDP may be achieved through selective 5-HT(2A) receptor antagonism.",
        "Clozapine and quetiapine, two atypical antipsychotic drugs, at doses markedly lower than those effective in schizophrenia, which, nevertheless, still cause sedation, hypotension, and other side effects, are widely used to treat psychotic symptoms in patients with PD psychosis (PDP), although quetiapine has never been shown to be effective in a placebo-controlled study.",
        "We postulated that pimavanserin (ACP-103), a highly selective 5-HT(2A) inverse agonist, would attenuate psychosis in patients with PDP, but avoid motoric worsening and non-motoric side effects.",
        "In this double-blind, randomized multicenter 28-day study, the tolerability and efficacy of pimavanserin was compared with placebo in 60 patients with L-DOPA or dopamine (DA) agonist-induced PDP.",
        "The demonstrated efficacy of clozapine in PDP has been attributed to serotonin (5-HT(2A)) receptor blockade.",
        "Psychotic symptoms occur in up to 40% of patients with Parkinson's disease (PD).",
        "The principal measures of efficacy of antipsychotic response to pimavanserin, the SAPS total domain score, only showed a trend.",
        "Antipsychotic efficacy was evaluated using multiple measures from the Scale for the Assessment of Positive Symptoms (SAPS) and a UPDRS Part I psychosis-relevant item.",
        "However, the pimavanserin-treated patients showed significantly greater improvement in some but not all measures of psychosis, including SAPS global measures of hallucinations and delusions, persecutory delusions, and the UPDRS measure of delusions and hallucinations.",
        "Motor function was evaluated using the Unified Parkinson's Disease Rating Scale (UPDRS) Parts II and III."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30298184": [
        "Pimavanserin, a selective 5-HT2A inverse agonist/antagonist, was approved in the U.S. for treating hallucinations and delusions associated with Parkinson's disease psychosis (PDP).",
        "In a Phase 2 study with pimavanserin in Alzheimer's disease psychosis, pimavanserin significantly (p=0.045) improved psychosis at Week 6 vs. placebo on the NPI-NH Psychosis Score (PS).",
        "The results of these studies in cognitively impaired patients with PDP provided the scientific foundation for an ongoing study of pimavanserin for treating patients with dementia-related psychosis associated with the most common neurodegenerative disorders.",
        "In a subgroup analysis of patients with cognitive impairment (MMSE score \u226521 but \u226424), the observed improvement on the SAPS-PD with pimavanserin (N=50) was also significant (p=0.002) and larger than in the overall study population without an adverse effect on cognition.",
        "The study uses a relapse-prevention design with the endpoint of time-to-relapse of psychosis to evaluate the long-term efficacy and safety of pimavanserin as a potential treatment for hallucinations and delusions of dementia-related psychosis.",
        "Patients in the pimavanserin group experienced a significant (p=0.001) improvement in Scale for the Assessment of Positive Symptoms - Parkinson's disease (SAPS-PD) scores vs. placebo.",
        "Currently, no pharmacologic treatment is approved for dementia-related psychosis.",
        "Psychosis is common across dementia types with a prevalence of 20% to 70%.",
        "Atypical antipsychotics are frequently used to treat these disorders, despite significant safety concerns.",
        "In a prespecified subgroup of patients with a baseline NPI-NH PS \u226512, a substantively larger treatment effect (p=0.011) was observed vs. participants with NPI-NH PS &lt;12."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28375643": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To review the pharmacology, pharmacokinetics, efficacy, safety, and place in therapy of pimavanserin for the treatment of hallucinations and delusions of Parkinson's disease psychosis (PDP)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26908168": [
        "Current treatment methods include the reduction of anti-Parkinson's medications, a strategy that may worsen the motor problems the medications are prescribed to alleviate, and the introduction of selected antipsychotic medications that carry with them the potential for troubling side effects and serious consequences.",
        "PDP consists of hallucinations that are mainly visual and delusions that are often of a paranoid nature.",
        "These symptoms can be the most troubling and disruptive of all the manifestations of Parkinson's disease.",
        "Parkinson's disease psychosis (PDP) is a common and often very disturbing component of Parkinson's disease (PD).",
        "If this is granted, we believe the evidence of Pimavanserin efficacy, safety and tolerability will position this medication as the first choice for treatment of Parkinson's disease psychosis.",
        "Pimavanserin has been developed and studied in clinical trials to specifically address Parkinson's disease psychosis and has been submitted to the U.S. Food and Drug Administration for its approval for this purpose."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28817967": [
        "In addition, this review will focus on the rationales behind the development of pimavanserin, mechanism of action, pharmacokinetics, pharmacodynamics, and the clinical trials evaluating the efficacy and safety of pimavanserin.",
        "Pimavanserin is the first FDA approved drug for the treatment of hallucinations and delusions associated with PDP.",
        "Last, the review will address the drug's package insert warning.",
        "Expert commentary: Pimavanserin, a 5HT2A receptor inverse agonist, is the first FDA approved drug for the treatment of PDP which has been shown to reduce psychosis in PD through its unique mechanism of action.",
        "It also correlates with depression and dementia, and can contribute to caregiver stress and burnout.",
        "Pimavanserin, does not worsen PD motor symptoms and has an acceptable safety profile.",
        "The development of pimavanserin as an antipsychotic opened a new therapeutic avenue in the treatment of PDP as well as targeting psychosis in other disorders such as Alzheimer's disease.",
        "Parkinson's disease psychosis (PDP) may develop in up to 60% of Parkinson's patients and is associated with increased morbidity and mortality.",
        "This review will discuss the pathophysiology and current management of PDP.",
        "Areas covered: For this review, a MEDLINE literature search (via PubMed) and information provided by ACADIA Pharmaceuticals were used."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27262680": [
        "This article summarizes the milestones in the development of pimavanserin leading to this first approval for the treatment of hallucinations and delusions in patients with Parkinson's disease psychosis.",
        "Pimavanserin (Nuplazid\u2122) is a selective and potent serotonin 2A (5-HT2A) receptor inverse agonist and antagonist developed by ACADIA Pharmaceuticals that has been approved in the US as a treatment for patients with hallucinations and delusions associated with Parkinson's disease psychosis.",
        "Up to 60 % of patients with Parkinson's disease may develop Parkinson's disease psychosis, which is associated with increased morbidity and mortality and has few treatment options."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28748399": [
        "This article summarizes the milestones in the development of delafloxacin leading to this first global approval for the treatment of acute bacterial skin and skin structure infections.",
        "The drug is being investigated or considered as a treatment for various bacterial infections and in June 2017 received approval in the USA for the treatment of acute bacterial skin and skin structure infections.",
        "Delafloxacin (Baxdela\u2122) is a fluoroquinolone antibacterial with activity against both gram-positive and gram-negative pathogens being developed by Melinta Therapeutics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28736918": [
        "Monoclonal antibodies (mAbs) targeting calcitonin gene-related peptide (CGRP) signaling are being explored as prophylactic treatments for migraine.",
        "Erenumab was generally well tolerated, with an acceptable safety profile, supporting further clinical development of erenumab for migraine prevention.",
        "We report the data from two phase I studies assessing the safety, pharmacokinetics (PK), and pharmacodynamics of single and multiple administrations of erenumab in healthy subjects and patients with migraine.",
        "Single doses of erenumab resulted in &gt;75% inhibition of capsaicin-induced dermal blood flow, with no apparent dose-dependency for erenumab \u226521 mg.",
        "The results indicate that the PK profile of erenumab is nonlinear from 1 mg to 70 mg and the linear portion of the clearance from 70 mg to 210 mg is consistent with other human immunoglobulin G2 antibodies.",
        "Erenumab (AMG 334) is the first potent, selective, and competitive human mAb antagonist of the CGRP receptor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30409109": [
        "We wanted to explore a possible association between individual efficacy of anti-CGRP treatment and susceptibility to migraine induction by CGRP.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Migraine prevention with erenumab and migraine induction by calcitonin gene-related peptide (CGRP) both carry notable individual variance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30086681": [
        "Erenumab also significantly reduced the proportion of patients with severe and very severe migraine-related disability and increased the proportion of patients with clinically meaningful improvements in migraine-related impact and health-related quality of life.",
        "Conclusion Erenumab reduced migraine disability and impact and improved patients' health-related quality of life, reinforcing its role as a promising new therapy for migraine prevention.",
        "Erenumab versus placebo resulted in significantly greater improvements in all patient-reported outcomes; changes from baseline were numerically higher with 140 mg erenumab.",
        "Results A total of 955 patients were randomized to receive erenumab 70 mg (n = 317), erenumab 140 mg (n = 319), or placebo (n = 319).",
        "Methods Patients enrolled in a phase 3, 6-month, double-blind, placebo-controlled study of once-monthly erenumab 70 and 140 mg for migraine prevention (STRIVE) used an eDiary during the baseline and double-blind treatment phases to complete validated, specific questionnaires, including the modified (monthly) Migraine Disability Assessment Questionnaire; Headache Impact Test; and Migraine-Specific Quality of Life Questionnaire-role function-restrictive (MSQ-RFR), -role function-preventive (MSQ-RFP), and -emotional function (MSQ-EF).",
        "Between-group differences from placebo over months 4-6 for the 70- and 140-mg dose groups were, respectively, -2.1 and -2.8 for modified (monthly) Migraine Disability Assessment Questionnaire, -2.1 and -2.3 for Headache Impact Test, 5.1 and 6.5 for MSQ-RFR, 4.2 and 5.4 for MSQ-RFP, and 5.2 and 6.7 for MSQ-EF ( p &lt; 0.001 for all).",
        "Background We evaluated the effect of erenumab, a fully human monoclonal antibody that inhibits the canonical calcitonin gene-related peptide receptor, on migraine-related disability, impact, and health-related quality of life among patients with episodic migraine.",
        "Improvements occurred rapidly and were maintained over 6 months of treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30360965": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      A substantial proportion of patients with migraine does not respond to, or cannot tolerate, oral preventive treatments.",
        "We assessed its efficacy and tolerability in patients with episodic migraine in whom previous treatment with two-to-four migraine preventives had been unsuccessful.",
        "Erenumab is a novel CGRP-receptor antibody with preventive efficacy in migraine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30242830": [
        "The first anti-CGRP treatment, an intravenous CGRP-receptor antagonist or gepant, olcegepant, was described as effective in terminating migraines in humans in 2004.",
        "Eptinezumab will likely be submitted to the FDA for prevention of migraine later in 2018.",
        "Background - CGRP was proposed as a target for primary headache therapies.",
        "Objective - To briefly describe the history of and available data on anti-calcitonin gene-related peptide (CGRP) therapies for headache.",
        "The trajectory from bench research to the approval of the first anti-CGRP receptor monoclonal antibody for clinical use in migraine prevention, erenumab, is discussed, as well as potential clinical uses of the anti-CGRP treatments.",
        "Results - The US Food and Drug Administration (FDA) approved erenumab, an anti-CGRP receptor monoclonal antibody, for prevention of migraine May 17, 2018.",
        "Conclusions - The development of anti-CGRP therapies opens a new era in the acute and preventive treatment of primary headache disorders.",
        "Translational research involved moving from delineating the relationships between CGRP and primary headaches and the clinical development of anti-CGRP treatments.",
        "At the time of this writing (May 2018), 2 other anti-CGRP monoclonal antibodies have been submitted to the FDA for the indication of prevention of migraine, galcanezumab and fremanezumab.",
        "All accessible randomized controlled trials, abstracts, platform presentations, and press releases on the monoclonal antibody trials are summarized.",
        "Galcanezumab has reportedly shown effectiveness in preventing episodic cluster headache as well, although has not yet been submitted to the FDA for this indication.",
        "Two gepants, ubrogepant and rimegepant, have completed positive pivotal trials for acute treatment of migraine, but have not yet been submitted to the FDA for this indication.",
        "Methods - The author briefly reviews some of the pathophysiology and translational research that led to the development of the gepants initially and then subsequently to the anti-CGRP and anti-CGRP receptor monoclonal antibodies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29471679": [
        "Trial registration ClinicalTrials.gov, <a href=\"http://clinicaltrials.gov/show/NCT02483585\" title=\"See in ClinicalTrials.gov\">NCT02483585</a>.",
        "Erenumab, a human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, is being evaluated for migraine prevention.",
        "Safety and adverse event profiles of erenumab were similar to placebo.",
        "All endpoints assessed change from baseline at month 3.",
        "Methods In this randomized, double-blind, placebo-controlled, phase 3 study, 577 adults with episodic migraine were randomized to placebo or 70 mg erenumab; 570 patients were included in efficacy analyses.",
        "Secondary endpoints were \u226550% reduction in monthly migraine days, change in acute migraine-specific medication treatment days, and \u22655-point reduction in Physical Impairment and Impact on Everyday Activities domain scores measured by the Migraine Physical Function Impact Diary.",
        "Primary endpoint was change in monthly migraine days.",
        "A \u2265 50% reduction in monthly migraine days was achieved by 39.7% (erenumab) and 29.5% (placebo) of patients (OR:1.59 (95% CI: 1.12, 2.27) ( p = 0.010).",
        "Migraine-specific medication treatment days were reduced by -1.2 (erenumab) and -0.6 (placebo) days, a treatment difference of -0.6 (-1.0, -0.2) ( p = 0.002).",
        "The \u22655-point reduction rates in Migraine Physical Function Impact Diary - Physical Impairment were 33.0% and 27.1% (OR:1.33 (0.92, 1.90) ( p = 0.13) and in Migraine Physical Function Impact Diary - Everyday Activities were 40.4% and 35.8% (OR:1.22 (0.87, 1.71) ( p = 0.26).",
        "Most frequent adverse events were upper respiratory tract infection, injection site pain, and nasopharyngitis.",
        "Background Calcitonin gene-related peptide plays an important role in migraine pathophysiology.",
        "(Funded by Amgen).",
        "Conclusions As a preventive treatment of episodic migraine, erenumab at a dosage of 70 mg monthly significantly reduced migraine frequency and acute migraine-specific medication use.",
        "Results Patients receiving erenumab experienced -2.9 days change in monthly migraine days, compared with -1.8 days for placebo, least-squares mean (95% CI) treatment difference of -1.0 (-1.6, -0.5) ( p &lt; 0.001)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29171821": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      We tested erenumab, a fully human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, for the prevention of episodic migraine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30074549": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      This article reviews the preventive therapy of migraine, including indications, strategies for use, and available treatments."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29968151": [
        "Based on these positive results erenumab was recently approved in the US for the preventive treatment of migraine in adults and has received a positive opinion in the EU for the prophylaxis of migraines in adults who have at least 4 migraine days per month.",
        "CGRP is a vasodilatory neuropeptide implicated in the pathophysiology of migraine and treatment with erenumab was associated with significant reductions in migraine frequency in phase II and III clinical trials.",
        "This article summarizes the milestones in the development of erenumab leading to this first approval.",
        "Amgen and Novartis are developing erenumab (AIMOVIG\u2122, erenumab-aooe)-a fully human monoclonal antibody calcitonin gene-related peptide (CGRP) receptor antagonist-for the prevention of migraine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28835404": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess long-term safety and efficacy of anti-calcitonin gene-related peptide receptor erenumab in patients with episodic migraine (EM)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30371827": [
        "Combined Annotation-Dependent Depletion (CADD) is a widely used measure of variant deleteriousness that can effectively prioritize causal variants in genetic analyses, particularly highly penetrant contributors to severe Mendelian disorders.",
        "CADD scores, software and documentation are available at https://cadd.gs.washington.edu.",
        "CADD is an integrative annotation built from more than 60 genomic features, and can score human single nucleotide variants and short insertion and deletions anywhere in the reference assembly.",
        "Here we review the latest updates to CADD, including the most recent version, 1.4, which supports the human genome build GRCh38.",
        "We also present updates to our website that include simplified variant lookup, extended documentation, an Application Program Interface and improved mechanisms for integrating CADD scores into other tools or applications.",
        "CADD uses a machine learning model trained on a binary distinction between simulated de novo variants and variants that have arisen and become fixed in human populations since the split between humans and chimpanzees; the former are free of selective pressure and may thus include both neutral and deleterious alleles, while the latter are overwhelmingly neutral (or, at most, weakly deleterious) by virtue of having survived millions of years of purifying selection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27148939": [
        "The recently developed combined annotation-dependent depletion (CADD) method generates predictive scores for single-nucleotide variants (SNVs) in all areas of the genome, including noncoding regions.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Several in silico tools have been shown to have reasonable research sensitivity and specificity for classifying sequence variants in coding regions.",
        "We sought for non-coding variants to determine the clinical validity of common CADD scores."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29340599": [
        "Several deleteriousness scores have been proposed for the non-coding part of the genome, but no large-scale comparison has been realized to date to assess their performance.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Detailed knowledge of coding sequences has led to different candidate models for pathogenic variant prioritization."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25871441": [
        "We demonstrate CADD is valuable in prioritizing variants in clinically relevant genes for further assessment by expert classification teams.",
        "In silico tools to predict pathogenicity are crucial to assess such variants and we have evaluated a new tool, Combined Annotation Dependent Depletion (CADD), and its classification of gene variants in Lynch syndrome by using a set of 2,210 DNA mismatch repair gene variants.",
        "Of 751 variants that could not be clinically classified by InSiGHT, CADD indicated that 47 variants were worth further study to confirm their putative pathogenicity.",
        "These had already been classified by experts from InSiGHT's Variant Interpretation Committee.",
        "Next-generation sequencing in clinical diagnostics is providing valuable genomic variant data, which can be used to support healthcare decisions.",
        "Overall, we found CADD scores do predict pathogenicity (Spearman's \u03c1 = 0.595, P &lt; 0.001).",
        "However, we discovered 31 major discrepancies between the InSiGHT classification and the CADD scores; these were explained in favor of the expert classification using population allele frequencies, cosegregation analyses, disease association studies, or a second-tier test."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28954263": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Prolactinomas are pituitary tumors with a very low prevalence in childhood and adolescence compared to adulthood.",
        "Resistance to these drugs is rare.",
        "This condition is preferentially treated with dopamine agonists."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29074127": [
        "These differences have been associated with earlier diagnosis in woman, as well as with serum estradiol levels.",
        "Prolactinomas are the most frequent functioning pituitary adenomas, and sex differences in tumor size, behavior and incidence have been described.",
        "The aim of this review is to summarize the literature supporting the important role of TGF\u03b21 as a local modulator of pituitary lactotroph function and to provide recent evidence for TGF\u03b21 involvement in the sex differences found in prolactinoma development in animal models.",
        "Experimental models of prolactinomas in rodents also show a higher incidence in females, and recent findings suggest that gender differences in the transforming growth factor beta 1 (TGF\u03b21) system might be involved in the sex-specific development of prolactinomas in these models."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29177641": [
        "Most women present with irregular menses and/or infertility.",
        "This review discusses the current literature and clinical understanding of prolactinomas throughout the entirety of the female life cycle.",
        "Breastfeeding is safe postpartum, provided there was no significant growth during pregnancy.",
        "Prolactinomas may be associated with decreased quality of life scores in women, and play a role in bone health and cardiovascular risk factors.",
        "Some women will experience normalization of prolactin levels postpartum.",
        "Menopause may also decrease prolactin levels and even those with macroprolactinomas may consider discontinuing their DA agonist with close follow-up.",
        "Dopamine (DA) agonists, used in their treatment, are safe during pregnancy, but in most cases are discontinued at conception with close monitoring for signs or symptoms of tumor growth.",
        "They typically occur in women in the 3rd-6th decade of life and rarely in the pediatric population or after menopause.",
        "Prolactinomas are the most common secretory pituitary adenoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10686432": [
        "It occurs more frequently in women than in men.",
        "Evidently, the SD rat is also a good animal for prolactinoma investigations.",
        "The use of melatonin as a preventive or therapeutic drug for prolactinomas should be further investigated.",
        "In E(2)-treated rats, a point mutation with a base substitution from cytidine (C) to adenine (A) was found at the -36-bp site of the proximal promoter of the prolactin gene in eutopic pituitary prolactinomas, but no change was observed in the same sequence of the prolactin gene in ectopic prolactinoma.",
        "The association of a base substitution with the hyperexpression of the prolactin gene in eutopic prolactinomas suggests that different mechanisms may mediate the formation of eutopic and ectopic prolactin-secreting tumors.",
        "These observations favor the hypothesis that prolactinoma growth is the result of pathological changes in the adenohypophysis and/or hypothalamus.",
        "In summary, improved knowledge on tumorigenesis of prolactinomas, especially in the rat model, was noted.",
        "However, pituitary radiotherapy may enable the long-term removal of prolactin-secreting tumor cells.",
        "In E(2)-induced rat prolactinomas, prolactin mRNA contents and the expression of some proto-oncogenes, e.g. c-myc and c-ras, TGFalpha and TGFbeta1 mRNA were significantly changed.",
        "Following E(2) implantation, prolactinomas developed in the eutopic adenohypophysis in situ and/or ectopic pituitary grafted under the renal capsule in SD rats.",
        "These models have expedited our progress in the recent years.",
        "These E(2)-induced rat prolactinoma models would facilitate future investigations, and expected results shall be fruitful and exciting for the development of future drug designs for the prevention and/or treatment of prolactin-secreting pituitary tumors.",
        "Recent evidence suggests that prolactinoma is a heterogeneous disorder with complicated and multifactorial etiology and pathogenesis.",
        "Dysregulation of prolactin synthesis and secretion may be the result of prolactin gene modulation.",
        "Melatonin decreases the expression of the prolactin gene in vitro suggesting that this pineal hormone may be a potential anticarcinogen in vivo.",
        "Many researchers consider the F(344) rat to be the most sensitive strain of rats to estrogen (E(2))-induced prolactinoma formation.",
        "Dopaminergic agonists are effective in the shrinkage of prolactin-secreting pituitary tumor and are preferred in some patients.",
        "In the latter case, abnormal release of hypothalamic dopamine, GABA, or brain-gut peptides (such as cholecystokinin, vasoactive intestinal polypeptide, galanin, angiotensin, opioid peptide, gastrin, gastrin-releasing peptide, pancreatic polypeptide, and adrenocorticotropic hormone) results in some of the pathological changes that may lead to hyperprolactinemia and/or prolactinoma development.",
        "It has also been shown that MT(2) (Mel(1b)) melatonin receptors are expressed in anterior pituitary cells.",
        "In addition, in rats abnormal expression of the prolactin gene was correlated with hypomethylated status of CpG sites in exons 1, 2 and 4 of the prolactin gene, as well as the increase in hypersensitive sites to DNase 1 in the encoding region of the prolactin gene.",
        "Nonetheless, E(2) treatment for 60 days also induces the formation of pituitary prolactin-secreting adenoma in male Sprague-Dawley (SD) rats.",
        "Prolactinoma is the most common type of primary pituitary tumors.",
        "The above findings are consistent with results in human prolactinoma development.",
        "To facilitate investigations on tumorigenesis of prolactinoma, animal models for prolactinomas have been developed.",
        "Apparently, a thorough understanding of prolactinoma tumorigenesis would be important."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28067908": [
        "We also identified likely causal missense variants in a gene implicated in primary immune deficiency, PLCG2, and a negative regulator of inflammation, SLAMF8.",
        "Genetic association studies have identified 215 risk loci for inflammatory bowel disease, thereby uncovering fundamental aspects of its molecular biology.",
        "We performed a genome-wide association study of 25,305 individuals and conducted a meta-analysis with published summary statistics, yielding a total sample size of 59,957 subjects.",
        "We identified 25 new susceptibility loci, 3 of which contain integrin genes that encode proteins in pathways that have been identified as important therapeutic targets in inflammatory bowel disease.",
        "In all four cases, the expression-increasing allele also increases disease risk.",
        "Our results demonstrate that new associations at common variants continue to identify genes relevant to therapeutic target identification and prioritization.",
        "The associated variants are correlated with expression changes in response to immune stimulus at two of these genes (ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM1)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30380071": [
        "DSMNC, which serves as a timely and valuable collection of somatic mutations in individual normal cells, has made it possible to analyze the burdens and signatures of somatic mutations in various types of heterogeneous normal cells.",
        "Luckily, the recent development of single-cell genomics biotechnologies enables the screening and collection of the somatic mutations, especial single nucleotide variations (SNVs), occurring in normal cells.",
        "Therefore, DSMNC will significantly improve our understanding of the characteristics of somatic mutations in normal cells.",
        "In the current version, the database collected \u223c0.8 million SNVs accumulated in \u223c600 single normal cells (579 human cells and 39 mouse cells).",
        "The database interface supports the user-friendly capability of browsing and searching the SNVs and their annotation information.",
        "The somatic mutations, recording the unique genetic cell-lineage 'history' of each proliferating normal cell, are important but remain to be investigated because of their ultra-low frequency hidden in the genetic background of heterogeneous cells.",
        "Numerous non-inherited somatic mutations, distinct from those of germ-line origin, occur in somatic cells during DNA replication per cell-division.",
        "Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29177842": [
        "The ERG preferred to use the RECOURSE trial data only given the suboptimal methodology used by the company to pool the evidence.",
        "The ERG highlighted that none of the participants in the phase II trial and approximately half of the RECOURSE participants (394 of 800) were from Europe, which might limit the applicability of the study findings to the NHS.",
        "Since the AC concluded that the most plausible ICER was \u00a349,392 per QALY gained, and that T/T meets end-of-life criteria, T/T was recommended as a cost effective use of NHS resources.",
        "In the CS, pooled evidence of two trials (a phase II trial and RECOURSE) showed that T/T resulted in a significant increase in overall survival [OS; hazard ratio (HR) 0.67, 95% CI 0.58-0.78] and progression-free survival (PFS; HR 0.46, 95% CI 0.40-0.53).",
        "Kleijnen Systematic Reviews Ltd (KSR), in collaboration with Maastricht University Medical Center, was commissioned as the Evidence Review Group (ERG).",
        "However, since there were no fundamental arguments to prevent the two trials from being pooled, the ERG also presented its base-case analysis based on the pooled effectiveness estimates.",
        "Moreover, the ERG's critical assessment of the company's economic evaluation highlighted a number of concerns that resulted in 11 adjustments to the company's base-case analysis.",
        "The ERG adjustments that had the largest impact were using the RECOURSE trial data only (instead of the pooled evidence), fixing errors and violations and using the utilities from the CORRECT trial (identified in the literature review) only.",
        "This paper presents a summary of the company's submission (CS), the ERG report and the development of the NICE guidance for the use of this drug in England and Wales by the appraisal committee (AC).",
        "The ERG produced a critical review of the clinical and cost effectiveness of T/T based upon the CS.",
        "The National Institute for Health and Care Excellence (NICE) invited Servier, the company manufacturing trifluridine and tipiracil (T/T; trade name: Lonsurf<sup>\u00ae</sup>), to submit evidence for the clinical and cost effectiveness of T/T compared with best supportive care (BSC) for metastatic colorectal cancer (third-line or later).",
        "The company base-case resulted in an incremental cost effectiveness ratio (ICER) of \u00a344,032 per QALY gained while the ERG base-case resulted in ICERs of \u00a352,695 and \u00a349,392 per QALY gained based on the RECOURSE trial only and pooled evidence, respectively.",
        "The AC considered the survival benefit of T/T clinically meaningful although relatively small."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30350179": [
        "Here, we report the safety and tolerability profile of FTD/TPI from an expanded-access program (EAP) in the US patients with mCRC whose disease has progressed on the standard therapies.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Trifluridine/tipiracil (FTD/TPI; TAS-102, Lonsurf\u00ae), a novel form of chemotherapy for metastatic colorectal cancer (mCRC), has shown clinical benefit in the global, phase III RECOURSE trial, regardless of patient age."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30445951": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Trifluridine/tipiracil (TAS-102, Lonsurf\u00ae), a novel oral anti-tumor agent combining an anti-neoplastic thymidine-based nucleoside analogue (trifluridine, FTD) with a thymidine phosphorylase inhibitor (tipiracil hydrochloride, TPI) presents a new treatment option for metastatic colorectal cancer (mCRC) patients refractory or intolerant to standard therapies.",
        "FTD/TPI was approved in the European Union (EU) in April 2016 and launched on the German market in August 15, 2016."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28315543": [
        "These AEs may affect patient adherence, particularly with completely oral regimens, such as trifluridine/tipiracil (TAS-102, Lonsurf\u00ae), an antimetabolite agent for patients with mCRC refractory or intolerant to standard therapies. .",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Treatment-related adverse events (AEs) are common in patients with metastatic colorectal cancer (mCRC) receiving chemotherapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27568360": [
        "Trifluridine/tipiracil has recently been approved for the treatment of adult patients with metastatic colorectal cancer (mCRC) who are refractory to or are not considered candidates for, current standard chemotherapy and biological therapy in the EU and USA and in unresectable advanced or recurrent CRC in Japan.",
        "In conclusion, trifluridine/tipiracil is a useful additional treatment option for the management of mCRC in patients who are refractory to, or are not considered candidates for, currently available therapies.",
        "Trifluridine/tipiracil (Lonsurf(\u00ae)) is a novel, orally active, antimetabolite agent comprised of trifluridine, a thymidine-based nucleoside analogue, and tipiracil, a potent thymidine phosphorylase inhibitor.",
        "Trifluridine is incorporated into DNA via phosphorylation, ultimately inhibiting cell proliferation.",
        "Trifluridine/tipiracil was associated with an acceptable tolerability profile, with adverse events generally being managed with dose reductions, temporary interruptions in treatment or administration of granulocyte-colony stimulating factor.",
        "The most common grade 3-4 adverse events (\u226510 %) were anaemia, neutropenia, thrombocytopenia and leukopenia.",
        "The approved regimen of oral twice-daily trifluridine/tipiracil (35 mg/m(2) twice daily on days 1-5 and 8-12 of each 28-day cycle) significantly improved overall survival and progression-free survival and was associated with a significantly higher disease control rate than placebo when added to best supportive care in the multinational, pivotal phase III trial (RECOURSE) and a phase II Japanese trial.",
        "Tipiracil increases systemic exposure of trifluridine when coadministered."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27431756": [
        "The optimal combination of TAS-102 with other agents, as well as the mechanism of resistance to this regimen should be defined in the near future.",
        "The clinical development of TAS-102 began approximately a decade ago and included 2 pivotal randomized studies, which are discussed in this review.",
        "This drug extended the median overall survival by approximately 2 months compared with placebo in a randomized phase III trial composed of Asian and non-Asian patients with refractory (or intolerant) metastatic colorectal cancer.",
        "TAS-102 (Lonsurf) is an oral fluoropyrimidine that is formed by the combination of 2 active drugs: trifluridine (a nucleoside analog) and tipiracil hydrochloride (a thymidine phosphorylase inhibitor).",
        "Within the past several years, no chemotherapy has been sufficient to increase the overall survival of patients with chemorefractory colorectal cancer.",
        "This drug has just been approved in Japan, and as soon as possible, it will be marketed in Western countries as well; it will therefore become the standard of care for this patient population."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26609205": [
        "Evolocumab (Repatha) for patients with hypercholesterolemia whose condition has not been controlled by statins and other therapies; trifluridine/tipiracil (Lonsurf) for metastatic colorectal cancer; and blood coagulation factor VIII (Nuwiq) for adults and children with hemophilia A."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26197742": [
        "Among the 4 evaluable patients, none achieved a complete or partial response.",
        "Lonsurf\u00ae is considered to be a third-line (or later) treatment.",
        "All of the adverse reactions experienced by our patients were resolved after supportive therapy.",
        "One patient (25.0%) had stable disease according to the Response Evaluation Criteria in Solid Tumors (RECIST) Guidelines outlined in the General Rules of the Study of Colorectal Cancer (The 8th Edition).",
        "However, the manufacturer has requested healthcare professionals to help develop safety measures for the appropriate and safe use of the tablets.",
        "Pharmacists have made 126 proposals to physicians regarding the use of Lonsurf\u00ae, 121 (96.0%) of which have been adopted.",
        "In this study, we evaluated the efficacy and safety of the tablets in 16 patients who received the tablets at our hospital.",
        "Among the 16 cases studied, Lonsurf\u00ae was used as a third-, fourth-, and fifth-line treatment in 9, 6, and 1 cases, respectively.",
        "The benefits of these tablets in terms of a new therapeutic option have been demonstrated.",
        "Despite a high incidence of Grade 3 or worse neutropenia (7 of the 16 patients [43.8%]), none of the patients were hospitalized due to neutropenia or other treatment-related adverse events.",
        "Therefore, Grade 3 or worse toxicities were a potential concern.",
        "In May 2014, tablets containing both trifluridine and tipiracil hydrochloride (Lonsurf\u00ae tablets) were launched in Japan ahead of other countries, for the treatment of advanced/relapsed unresectable colorectal cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28871467": [
        "Furthermore, we found that Hcy-induced expression of p-ERK1/2 and p-p38MAPK was dependent on AT-1R.",
        "EGCG can inhibit AT-1R and affect ERK1/2 and p38MAPK signaling pathways, resulting in the decrease of VSMC proliferation induced by Hcy.",
        "Compared with Hcy (500 \u00b5M)-treated cells, EGCG (20 \u00b5M)-treated cells showed decreased proliferation as well as expression of AT-1R, p-ERK1/2, and p-p38MAPK.",
        "The Western blot assay was used to determine the expression levels of angiotensin II type 1 receptor (AT-1R), ERK1/2, and p38 MAPK.",
        "Hcy increased the expression of AT-1R, whereas EGCG decreased the protein expression of AT-1R.",
        "The present study aimed to investigate the role of EGCG in Hcy-induced proliferation of vascular smooth muscle cells (VSMCs) and its underlying mechanism.",
        "Epigallocatechin gallate (EGCG), a bioactive ingredient of green tea, plays a protective role in the cardiovascular system.",
        "Compared with the control group, the HASMCs treated with Hcy at different doses (100, 200, 500, and 1000 \u00b5M) showed significantly increased proliferation.",
        "In addition, HASMC proliferation was suppressed by the addition of an AT-1R blocker (olmesartan), an ERK1/2 inhibitor (PD98059), and a p38MAPK inhibitor (SB202190).",
        "We also explored the roles of rennin-angiotensin system (RAS), extracellular signal-regulated kinases (ERK1/2), and p38 mitogen-activated protein kinase (p38 MAPK) in this process.",
        "Homocysteine (Hcy) is a major risk factor for chronic kidney disease and cardiovascular disease.",
        "Human aortic smooth muscle cells (HASMCs) were treated with different drugs for different periods.",
        "The proliferation rate of HASMCs was detected using the CCK-8 and BrdU labeling assays."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29419571": [
        "Histology and histomorphometry study of aged animals treated with EGCG showed marked increases in the diameter and volume of cardiomyocytes with concomitant reduction of numerical density when compared with aged animals.",
        "TUNEL staining and fibrosis showed a marked increase in apoptotic cell death (P &lt; 0.001) and collagen deposition (P &lt; 0.001) in aged animals treated with EGCG when compared with aged animals.",
        "Reduced reactive oxygen species (P &lt; 0.001) production with association of increased antioxidant defense system (P &lt; 0.001) in aged hearts supplemented with EGCG when compared with aged animals.",
        "The objective of the present study is to evaluate the effect of epigallocatechin gallate (EGCG) on aging-mediated cardiac hypertrophy, fibrosis, and apoptosis.",
        "Increased (P &lt; 0.001) heart volume, weight with concomitant increase of left ventricular wall thickness, and reduced ventricular cavity were observed in aged rats supplemented with EGCG compared with aged animals.",
        "At the end of 30 days, EGCG administration to the aged animals showed significant (P &lt; 0.001) reduction of low-density lipoprotein, very low-density lipoprotein, triglyceride, total cholesterol with concomitant increase of high-density lipoprotein (P &lt; 0.001) when compared with aged rats.",
        "Hence, the present study suggests that EGCG can be useful to fight against aging-induced cardiac hypertrophy, fibrosis, and apoptosis.",
        "Taken together, it is evident that EGCG may potentially inhibit aging-induced cardiac hypertrophy, fibrosis, and apoptosis, thereby preserving cardiac function.",
        "Aged animals treated with EGCG showed a marked increase in protein expression of TGF\u03b2, TNF\u03b1, and nuclear factor kappa B (NF-\u03baB) and significant (P &lt; 0.001) alteration in the gene expression of TGF\u03b2, TNF\u03b1, NF-\u03baB, \u03b1-SMA, and Nrf2 when compared with aged animals.",
        "Group I: young (3 months), group II: aged (24-26 months), group III: aged + EGCG (200 mg/kg for 30 days), and group IV: young + EGCG.",
        "The proposed mechanism would be inhibition of reactive oxygen species-dependent activation of TGF\u03b21, TNF\u03b1, and NF-\u03baB signaling pathway.",
        "The Wistar albino rats were divided into 4 groups (n = 18)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27659729": [
        "Chronic inhibition of ROS in the PVN restores the balance of neurotransmitters and cytokines in the PVN, thereby attenuating hypertensive response and sympathetic activity.",
        "Epigallocatechin-3-O-gallate (EGCG), one of the active compounds in green tea, has anti-oxidant, anti-inflammatory and vascular protective properties.",
        "SHR showed higher mean arterial pressure, plasma proinflammatory cytokines and circulating norepinephrine (NE) levels compared with WKY rats.",
        "This study was designed to determine whether chronic infusion of EGCG into the hypothalamic paraventricular nucleus (PVN) attenuates ROS and sympathetic activity and delays the progression of hypertension by up-regulating anti-inflammatory cytokines, reducing pro-inflammatory cytokines (PICs) and decreasing nuclear factor-kappa B (NF-\u03baB) activity, as well as restoring the neurotransmitters balance in the PVN of spontaneously hypertensive rats (SHR).",
        "Reactive oxygen species (ROS) in the brain are involved in the pathogenesis of hypertension.",
        "Adult normotensive Wistar-Kyoto (WKY) rats and SHR received bilateral PVN infusion of EGCG (20\u03bcg/h) or vehicle via osmotic minipumps for 4 weeks.",
        "SHR also had higher PVN levels of the subunit of NAD(P)H oxidase (gp91<sup>phox</sup>), ROS, tyrosine hydroxylase, and PICs; increased NF-\u03baB activity; and lower PVN levels of interleukin-10 (IL-10) and 67kDa isoform of glutamate decarboxylase (GAD67) than WKY rats.",
        "PVN infusion of EGCG attenuated all these changes in SHR.",
        "These findings suggest that SHR have an imbalance between excitatory and inhibitory neurotransmitters, as well as an imbalance between pro- and anti-inflammatory cytokines in the PVN."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29772459": [
        "Approximately 30-50% of advanced HER2-positive breast cancer patients will develop central nervous system (CNS) metastases, with an annual risk of around 10%, and a half of them will die from brain progression.",
        "In this article we review the role of currently available or investigational HER2 tyrosine kinase inhibitors: lapatinib, neratinib, afatinib and tucatinib in the treatment of brain metastases in HER2-positive breast cancer patients.",
        "Brain metastases in HER2-positive breast cancer patients usually constitute the first site of recurrence.",
        "Favorable physico-chemical properties of these compounds allow them for a more efficient penetration through the blood-brain barrier, and hold the promise for more effective prevention and treatment of brain metastases.",
        "An increased risk of brain metastases is also seen in patients with early HER2-positive breast cancer administered curative therapy.",
        "The small-molecule tyrosine kinase inhibitors of epidermal growth factor receptors family have established activity in HER2-positive breast cancer in both advanced disease and neoadjuvant setting.",
        "The administration of anti-HER2 monoclonal antibodies, trastuzumab and pertuzumab, considerably delays the onset of symptomatic brain disease: however, the limited penetration of these compounds into the CNS hinders their efficacy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29804905": [
        "We aimed to determine the recommended phase 2 dose, safety, pharmacokinetics, and preliminary activity of tucatinib in combination with capecitabine or trastuzumab in patients with HER2-positive breast cancer with or without brain metastases.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Tucatinib is a potent and selective oral HER2 tyrosine kinase inhibitor, with the potential to provide a well tolerated new treatment option for patients whose disease has progressed on currently available therapies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28923217": [
        "The utility of human epidermal growth factor 2 (HER2)-directed therapies-lapatinib, ado-trastuzumab emtansine (T-DM1), neratinib and tucatinib-is also being studied in this setting.",
        "However, in selected circumstances, first-line systemic treatment may be more appropriate in order to avoid neurocognitive toxicities, and potential options should be evaluated in window of opportunity trials.",
        "The advent of HER2-directed therapy resulted in greatly improved survival outcomes, but unfortunately at the price of an increased cumulative incidence of BCBM.",
        "Other strategies that may aid development of more effective clinical trials and expedite the development of promising agents include the use of different clinical endpoints and different imaging tools.",
        "Approximately 50% of patients with advanced human epidermal growth factor 2 (HER2)-positive breast cancer and triple-negative breast cancer (TNBC) ultimately develop breast cancer brain metastases (BCBM), which are associated with significant morbidity and mortality.",
        "We address the need for improved imaging techniques and innovation in clinical trial design.",
        "We review challenges in the management of BCBM, and potential treatment strategies, including novel agents such as poly-adenosine diphosphate (ADP) ribose polymerase (PARP) inhibitors (olaparib, veliparib), cyclin-dependent kinase 4/6 (CDK4/6) inhibitors (palbociclib, abemaciclib), and taxane derivatives (eg, ANG1005 and TPI-287).",
        "For example, the current practice is to initially administer whole-brain radiotherapy (WBRT) as treatment for patients with multiple BCBM."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29955792": [
        "Tucatinib is an oral, potent, human epidermal growth factor receptor 2 (HER2)-specific tyrosine kinase inhibitor (TKI) being developed as a novel treatment for ERBB2/HER2-positive breast cancer.",
        "<strong class=\"sub-title\">\n          Importance:\n        </strong>\n      \n      Treatment options for patients with disease progression after treatment with trastuzumab, pertuzumab, and ado-trastuzumab emtansine (T-DM1) are limited."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29458783": [
        "The questions regarding their treatment at progression remains unanswered at the moment.",
        "<strong class=\"sub-title\">\n          Importance:\n        </strong>\n      \n      The identification of anaplastic lymphoma kinase (ALK) rearrangements in 2-5% of non-small cell lung cancer (NSCLC) patients led to the rapid clinical development of its oral tyrosine kinase inhibitor (TKI).",
        "Crizotinib was the first ALK inhibitor approved and utilised in the treatment of ALK+ NSCLC patients in the second line setting first and subsequently in the first line one.",
        "Since then many other ALK inhibitors have been developed (ceritinib, alectinib, brigatinib, lorlatinib,etc) and the treatment paradigm of these patients has considerably drifted."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29400604": [
        "However, the clinical benefits of ALK inhibitors are almost universally limited by the emergence of drug resistance.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Anaplastic lymphoma kinase (ALK) is a validated molecular target in non-small-cell lung cancer (NSCLC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29376144": [
        "However, responses to ALK TKIs are generally short-lived.",
        "Serial molecular analysis is an informative strategy for identifying genetic mediators of resistance.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      <i>ALK</i> rearrangements predict for sensitivity to ALK tyrosine kinase inhibitors (TKIs).",
        "Although multiple studies support the clinical benefits of repeat tissue sampling, the clinical utility of longitudinal circulating tumor DNA analysis has not been established in ALK-positive lung cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29373100": [
        "Among patients treated with the third-generation ALK TKI lorlatinib, variant 3 was associated with a significantly longer progression-free survival than variant 1 (hazard ratio, 0.31; 95% CI, 0.12 to 0.79; P = .011).",
        "Emerging data suggest that the ALK fusion variant may affect clinical outcome, but the molecular basis for this association is unknown.",
        "A Foundation Medicine data set of 577 patients with ALK-positive NSCLC was also examined.",
        "In particular, ALK G1202R was more common in variant 3 than in variant 1 (32% v 0%; P &lt; .001).",
        "Results The most frequent ALK variants were EML4-ALK variant 1 in 55 patients (43%) and variant 3 in 51 patients (40%).",
        "Patients and Methods We identified 129 patients with ALK-positive NSCLC with known ALK variants.",
        "Purpose Advanced anaplastic lymphoma kinase ( ALK) fusion-positive non-small-cell lung cancers (NSCLCs) are effectively treated with ALK tyrosine kinase inhibitors (TKIs).",
        "ALK resistance mutations and clinical outcomes on ALK TKIs were retrospectively evaluated according to ALK variant.",
        "ALK resistance mutations were significantly more common in variant 3 than in variant 1 (57% v 30%; P = .023).",
        "Analysis of the Foundation Medicine database revealed similar associations of variant 3 with ALK resistance mutation and with G1202R ( P = .010 and .015, respectively).",
        "We analyzed 77 tumor biopsy specimens from patients with variants 1 and 3 who had progressed on an ALK TKI.",
        "ALK variant thus represents a potentially important factor in the selection of next-generation ALK inhibitors.",
        "However, clinical outcomes in these patients vary, and the benefit of TKIs is limited as a result of acquired resistance.",
        "Conclusion Specific ALK variants may be associated with the development of ALK resistance mutations, particularly G1202R, and provide a molecular link between variant and clinical outcome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29067878": [
        "A major goal in cancer therapeutics is to measure the concentrations of this drug in the brain metastases of patients with lung cancer, and penetration of the blood-brain barrier is important for optimal therapeutic outcomes.",
        "The Massachusetts General Hospital Radiochemistry Program, in collaboration with Pfizer, has developed unique <sup>11</sup>C and <sup>18</sup>F-labeling strategies to synthesize isotopologs of lorlatinib (PF-06463922) which is undergoing phase III clinical trial investigations for treatment of non-small-cell lung cancers with specific molecular alterations.",
        "Our future work with radiolabeled lorlatinib will include advanced PET evaluations in rodent tumor models and normal NHPs with the goal of clinical translation.",
        "Our recent publication in Nature Communications employed radiolabeled lorlatinib and positron emission tomography (PET) studies in preclinical models including nonhuman primates (NHPs) that demonstrated high brain permeability of this compound."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29744867": [
        "Moreover, oral availability of lorlatinib is markedly restricted by CYP3A4 activity.",
        "These insights may be used in optimizing the therapeutic application of lorlatinib.",
        "In Cyp3a<sup>-/-</sup> mice, the plasma exposure of lorlatinib was increased 1.3-fold, but was then twofold reduced upon transgenic overexpression of human CYP3A4 in liver and intestine, whereas relative tissue distribution of lorlatinib remained unaltered.",
        "Oral coadministration of the ABCB1/ABCG2 inhibitor elacridar increased the brain accumulation of lorlatinib in wild-type mice fourfold, that is, to the same level as in Abcb1a/1b;Abcg2<sup>-/-</sup> mice, without altering plasma exposure.",
        "Our data indicate that lorlatinib brain accumulation is substantially limited by P-glycoprotein/ABCB1 in the blood-brain barrier, but this can be effectively reversed by elacridar coadministration.",
        "Following oral lorlatinib administration (at 10 mg/kg), brain accumulation of lorlatinib, while relatively high in wild-type mice, was still fourfold increased in Abcb1a/1b<sup>-/-</sup> and Abcb1a/1b;Abcg2<sup>-/-</sup> mice, but not in single Abcg2<sup>-/-</sup> mice.",
        "We investigated the roles of the multidrug efflux transporters ABCB1 and ABCG2, and the multispecific drug-metabolizing enzyme CYP3A in plasma pharmacokinetics and tissue distribution of lorlatinib using genetically modified mouse strains.",
        "Similar results were obtained for lorlatinib testis accumulation.",
        "With therapy-resistant brain metastases a major concern in NSCLC, lorlatinib was designed to have high membrane and blood-brain barrier permeability.",
        "In vitro, human ABCB1 and mouse Abcg2 modestly transported lorlatinib.",
        "Lorlatinib (PF-06463922) is a promising oral anaplastic lymphoma kinase (ALK) and ROS1 inhibitor currently in Phase III clinical trials for treatment of non-small-cell lung cancer (NSCLC) containing an ALK rearrangement.",
        "Lorlatinib plasma levels were not altered."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30322862": [
        "ALCL cells acquired compound ALK mutations G1202R/G1269A and C1156F/L1198F <i>in vitro</i> at high drug concentrations.",
        "RNA sequencing of resistant cells showed significant alteration of PI3K/AKT and RAS/MAPK pathways.",
        "ALCL xenografts selected <i>in vivo</i> showed recurrent N1178H (5/10 mice) and G1269A (4/10 mice) mutations.",
        "Interestingly, intracellular localization of NPM/ALKN<sup>1178H</sup> skewed toward the cytoplasm in human cells, possibly mimicking overexpression.",
        "However, resistance remains a major challenge.",
        "In neuroblastoma, whole-exome sequencing and proteomic profiling of lorlatinib-resistant cells revealed a truncating NF1 mutation and hyperactivation of EGFR and ErbB4.",
        "NSCLC cells exposed <i>in vitro</i> to lorlatinib acquired hyperactivation of EGFR, which was blocked by erlotinib to restore sensitivity to lorlatinib.",
        "In this study, we utilize lorlatinib-resistant anaplastic large cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroblastoma cell lines <i>in vitro</i> and <i>in vivo</i> to investigate the acquisition of resistance and its underlying mechanisms.",
        "Functional validation by small-molecule inhibitors confirmed the involvement of these pathways in resistance to lorlatinib.",
        "These data provide an extensive characterization of resistance mechanisms that may arise in different ALK-positive cancers following lorlatinib treatment.",
        ": Targeted therapy changed the standard of care in ALK-dependent tumors.",
        "Lorlatinib is a third-generation ALK inhibitor that inhibits most ALK mutants resistant to current ALK inhibitors.",
        "SIGNIFICANCE: High-throughput genomic, transcriptomic, and proteomic profiling reveals various mechanisms by which multiple tumor types acquire resistance to the third-generation ALK inhibitor lorlatinib."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28594000": [
        "Carbon-11-labelled lorlatinib is routinely prepared with good radiochemical yields and shows reasonable tumour uptake in rodents.",
        "Lorlatinib (PF-06463922) is a next-generation small-molecule inhibitor of the orphan receptor tyrosine kinase c-ros oncogene 1 (ROS1), which has a kinase domain that is physiologically related to anaplastic lymphoma kinase (ALK), and is undergoing Phase I/II clinical trial investigations for non-small cell lung cancers.",
        "Here we prepare both <sup>11</sup>C- and <sup>18</sup>F-isotopologues of lorlatinib to determine the biodistribution and whole-body dosimetry assessments by positron emission tomography (PET).",
        "Non-traditional radiolabelling strategies are employed to enable an automated multistep <sup>11</sup>C-labelling process and an iodonium ylide-based radiofluorination.",
        "An early goal is to measure the concentrations of this drug in brain tumour lesions of lung cancer patients, as penetration of the blood-brain barrier is important for optimal therapeutic outcomes.",
        "PET imaging in non-human primates confirms that this radiotracer has high brain permeability."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30413378": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Lorlatinib is a potent, brain-penetrant, third-generation inhibitor of ALK and ROS1 tyrosine kinases with broad coverage of ALK mutations.",
        "We aimed to analyse the overall and intracranial antitumour activity of lorlatinib in patients with ALK-positive, advanced non-small-cell lung cancer.",
        "In a phase 1 study, activity was seen in patients with ALK-positive non-small-cell lung cancer, most of whom had CNS metastases and progression after ALK-directed therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30174447": [
        "Targeting ALK using tyrosine kinase inhibitors (TKI) has dramatically improved the prognosis of patients with <i>ALK</i>-rearranged NSCLC.",
        "In a Phase I/II trial, the safety and efficacy of lorlatinib were demonstrated in patients with advanced <i>ALK</i>-positive NSCLC, most of whom had central nervous system metastases and had previous ALK-TKI treatment.",
        "Furthermore, clinical trials for lorlatinib are summarized, and future perspectives in the management of patients with <i>ALK</i>-rearranged NSCLC are discussed.",
        "Another major concern regarding ALK-TKI is metastasis to the central nervous system, commonly observed in patients relapsing after ALK-TKI therapy.",
        "One mechanism of acquiring resistance is a second mutation on the <i>ALK</i> gene, and the representative mutation is L1996M in the gatekeeper residue.",
        "In this review, we discuss the structure, pharmacodynamics, and pharmacokinetics of lorlatinib and compare its characteristics with those of other ALK inhibitors.",
        "The next-generation ALK inhibitor lorlatinib (PF-06463922) has therefore been developed to inhibit resistant <i>ALK</i> mutations, including <i>ALK</i> G1202R, and to penetrate the blood-brain barrier.",
        "In particular, the solvent-front <i>ALK</i> G1202R mutation is the common cause of resistance against first- and second-generation ALK-TKIs.",
        "The identification of anaplastic lymphoma kinase (<i>ALK</i>), an oncogenetic driver mutation, in lung cancer has paved the way for a new era in the treatment of non-small cell lung cancer (NSCLC).",
        "However, most patients relapse on ALK-TKI therapy within a few years because of acquired resistance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28294067": [
        "The relationship between infections and Alzheimer's Disease (AD) etiology, especially lateonset AD (LOAD) has been continuously debated over the past three decades.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Inflammation is a part of the first line of defense of the body against invasive pathogens, and plays a crucial role in tissue regeneration and repair.",
        "A proper inflammatory response ensures the suitable resolution of inflammation and elimination of harmful stimuli, but when the inflammatory reactions are inappropriate it can lead to damage of the surrounding normal cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29249963": [
        "A working hypothesis links extrinsic inflammation as a secondary cause of AD.",
        "For example, probiotics enriched in <i>Lactobacillus</i> genus of bacteria, when ingested, exert some anti-inflammatory influence through common host/bacterial neurochemicals, both locally, and through sensory signaling back to the brain.",
        "An individual's diet also defines the consortium of microbial communities that take up residency in the oral and gastrointestinal (GI) tract microbiomes.",
        "However, the explanation of how periodontitis can lead to dementia remains unclear.",
        "Brushing and chewing on teeth supported by already injured soft tissues leads to bacteremias.",
        "Longitudinal monitoring of patients suggests a causal link between chronic periodontitis and the development of Alzheimer's disease (AD).",
        "This observation opens up an opportunity to explore the mechanisms, which may underlie the previously detected relationship between diet, oral/GI microbial communities, to anxiety, cognition and sleep patterns.",
        "Insufficient levels of essential micronutrients can lead to microbial dysbiosis through the growth of periodontal pathogens such as demonstrated for <i>P. gingivalis</i> under low hemin bioavailability.",
        "Early life dietary behaviors may cause an imbalance in the host/microbial endocrinology through a dietary intake incompatible with a healthy GI tract microbiome later in life.",
        "Their imbalance can lead to behavioral changes.",
        "This review suggests healthy diet based interventions that together with improved life style/behavioral changes may reduce and/or delay the incidence of AD.",
        "This imbalance in host/microbial endocrinology may have a lasting impact on mental health.",
        "As a result, a persistent systemic inflammatory response develops to periodontal pathogens.",
        "The pathogens, and the host's inflammatory response, subsequently lead to the initiation and progression of multiple metabolic and inflammatory co-morbidities, including AD.",
        "This hypothesis suggests a compromised oral hygiene leads to a dysbiotic oral microbiome whereby <i>Porphyromonas gingivalis</i>, a keystone periodontal pathogen, with its companion species, orchestrates immune subversion in the host."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25454820": [
        "We found that loss at 6q24.2-26 was significantly associated with the cluster of longer survival independently from other confounding factors (HR = 0.06, 95%CI = 0.01-0.43, Padj = 0.005).",
        "The prognostic value of this deletion was validated in two independent series, one consisting of 36 HGSOCs analyzed by fluorescent in situ hybridization (P = 0.04) and another comprised of 411 HGSOCs from the Cancer Genome Atlas study (TCGA) (HR = 0.67, 95%CI = 0.48-0.93, Padj = 0.019).",
        "Altogether our findings indicate that the 6q24.2-26 deletion is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life.",
        "Thus, identification of novel prognostic and predictive biomarkers is urgently needed.",
        "Copy number-based unsupervised clustering stratified HGSOCs into two clusters of different immunohistopathological features and survival outcome (HR = 0.15, 95%CI = 0.03-0.81; Padj = 0.03).",
        "Finally, by integrating copy number, RNAseq and survival data of 296 HGSOCs from TCGA we propose a few candidate genes that can potentially explain the association.",
        "We have used 42 paraffin-embedded HGSOCs, to evaluate the utility of DNA copy number alterations, as potential predictors of clinical outcome.",
        "Standard treatments for advanced high-grade serous ovarian carcinomas (HGSOCs) show significant side-effects and provide only short-term survival benefits due to disease recurrence.",
        "In addition, we confirmed the association of low expression of the genes from the region with longer survival in 799 HGSOCs (HR = 0.74, 95%CI = 0.61-0.90, log-rank P = 0.002) and 675 high-FIGO stage HGSOCs (HR = 0.76, 95%CI = 0.61-0.96, log-rank P = 0.02) available from the online tool KM-plotter."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26463438": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26405107": [
        "Cholera toxin (CT), which is secreted by V. cholerae, can enter host cells by binding to GM1, a monosialoganglioside widely distributed on the plasma membrane surface of various animal epithelial cells.",
        "To test the potential of employing the peptide mimics for intervening with the bacterial infection, those peptides were examined for their binding capacity, functional inhibitory activity and in vitro effects using a human intestinal epithelial cell line, Caco-2 cells.",
        "Our results thus provide convincing evidence that GM1-replica peptides could serve as novel agents to block CTB binding on epithelial cells and prevent the ensuing physiological effects of CT.",
        "The present study was undertaken to generate peptides that are conformationally similar to the carbohydrate epitope of GM1 for use in the treatment of cholera and related bacterial infection.",
        "One of the peptides, P3 (IPQVWRDWFKLP), was most effective in inhibiting cellular uptake of CTB and suppressing CT-stimulated cyclic adenosine monophosphate production in the cells.",
        "For this purpose, we used cholera toxin B (CTB) subunit to select CTB-binding peptides that structurally mimic GM1 from a dodecamer phage-display library.",
        "Six GM1-replica peptides were selected by biopanning based on CTB recognition.",
        "Five of the six peptides showed inhibitory activity for GM1 binding to CTB.",
        "Cholera is an acute diarrheal disease caused by infection in the gastrointestinal tract by the gram-negative bacterium, Vibrio cholerae, and is a serious public health threat worldwide.",
        "There has not been any effective treatment for this infectious disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26478842": [
        "Simultaneous binding can occur on more than one of the monosialotetrahexosylganglioside (GM1) units present on the cell surface.",
        "Thus, blocking the initial attachment of the toxin to the cell surface using inhibitors with GM1 subunits has the potential to stop the disease.",
        "In this study, we synthesized a pentavalent version and compared the binding and potency of penta- and tetravalent cholera toxin inhibitors, based on the same scaffold, for the first time.",
        "Thus, systems which can adopt more geometries, such as those described here, can be equally potent, and this may possibly be due to their ability to form higher-order structures or simply due to more statistical options for binding.",
        "Previously we showed that tetravalent GM1 molecules were sub-nanomolar inhibitors of CTB5.",
        "Such simultaneous binding arising from the toxins multivalency is believed to enhance its affinity.",
        "The pentavalent geometry did not yield major benefits over the tetravalent species, but it was still a strong inhibitor, and no major steric clashes occurred when binding the toxin.",
        "The five B-subunits (CTB5) of the Vibrio cholerae (cholera) toxin can bind to the intestinal cell surface so the entire AB5 toxin can enter the cell."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27914621": [
        "Current models of lipid rafts propose that lipid domains exist as nanoscale compositional fluctuations and these fluctuations can potentially be stabilized into larger domains, consequently better compartmentalizing cellular functions.",
        "Here, we test the role of glycolipid crosslinking as a raft targeting and ordering mechanism using the well-studied raft marker cholera toxin B pentamer (CTxB) that binds up to five GM1 glycosphingolipids to enter host cells.",
        "These results support the long-held hypothesis that CTxB stabilizes raft domains via a lipid crosslinking mechanism and establish a role for crosslinking in the partitioning of CTxB to ordered domains.",
        "However, the mechanisms governing stabilized raft assembly and function remain unclear.",
        "We show that when applied to cell-derived giant plasma membrane vesicles, a variant of CTxB containing only a single functional GM1 binding site exhibits significantly reduced partitioning to the ordered phase compared to wild-type CTxB with five binding sites.",
        "Moreover, monovalent CTxB does not stabilize membrane domains, unlike wild-type CTxB."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29883879": [
        "Plasma samples were pre-treated with 1 M aqueous ammonia after which they were brought onto supported liquid extraction (SLE) columns.",
        "Samples were measured by LC-MS/MS in the positive electron ion spray mode.",
        "The method was linear over 0.1-100 ng/mL and 1-1000 ng/mL in plasma and urine, respectively, with accuracies and precisions within \u00b115% (20% for LLOQ) and below 15% (20% for LLOQ), respectively.",
        "The method was developed to support a mass balance study in which patients received a dose of 5 mg lurbinectedin.",
        "Urine was first diluted in plasma and lurbinectedin was extracted from this matrix by liquid-liquid extraction using TBME.",
        "This article describes the development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay to quantify lurbinectedin in human plasma and urine.",
        "Lurbinectedin was eluted from the columns using tert-butyl methyl ether (TBME).",
        "Lurbinectedin is a novel highly selective inhibitor of RNA polymerase II triggering caspase-dependent apoptosis of cancerous cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30153704": [
        "While no sustained remissions were observed, single-agent lurbinectedin was transiently leukemia suppressive for some patients.",
        "Forty-two patients with relapsed/refractory AML/MDS received lurbinectedin administered as a 1-hour intravenous infusion in a 3 + 3 study design.",
        "Lurbinectedin is a next-generation minor groove binder with preclinical activity against myeloid leukemia cells.",
        "Overall, 33 of 42 patients (79%) had reduction in blasts in peripheral blood or bone marrow.",
        "Most (n = 30, 71%) were discontinued due to progressive disease.",
        "The most common laboratory abnormalities observed were an increase in creatinine (93%) and anemia, neutropenia, and thrombocytopenia (100%).",
        "Overall, lurbinectedin was safe and tolerated using the schedules and dose levels tested.",
        "Two dosing schedules were used: 3.5, 5, 7, or 6 mg on days 1 and 8 or 2, 3, 1, or 1.5 mg for 3 consecutive days on days 1 to 3.",
        "Trabectedin is an FDA-approved DNA minor groove binder that has activity against translocation-associated sarcomas.",
        "Three patients experienced dose-limiting toxicities of rhabdomyolysis (grade 4), hyperbilirubinemia (grade 3), and oral herpes (grade 3) with the day 1 and 8 schedule.",
        "Four patients with a chromosome 11q21-23 abnormality had significantly greater bone marrow blast reduction than those without such abnormality, with decrease of 31 \u00b1 14% (n = 4) vs 8 \u00b1 8% (n = 16), respectively (P = .04).",
        "Early deaths occurred from disease-related causes that were not attributable to lurbinectedin.",
        "Otherwise, adverse events mainly consisted of gastrointestinal manifestations (n = 11), febrile neutropenia/infections (n = 4), pulmonary toxicity (n = 2), and renal failure (n = 2).",
        "A dose-finding phase 1 clinical trial was performed in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) with further assessment of safety and tolerability.",
        "One patient achieved a partial response and 2 patients a morphologic leukemia-free state."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30090974": [
        "<strong class=\"sub-title\">\n          Background and objectives:\n        </strong>\n      \n      Lurbinectedin is an inhibitor of RNA polymerase II currently under clinical development for intravenous administration as a single agent and in combination with other anti-tumor agents for the treatment of several tumor types.",
        "The objective of this work was to develop a population-pharmacokinetic model in this patient setting and to elucidate the main predictors to guide the late stages of development."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30240327": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      This multicenter phase II trial evaluated lurbinectedin (PM01183), a selective inhibitor of active transcription of protein-coding genes, in patients with metastatic breast cancer.",
        "A unicenter translational substudy assessed potential mechanisms of lurbinectedin resistance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30362375": [
        "Early-phase clinical trials indicate promising activity of lurbinectedin in small-cell lung cancer.",
        "The primary end point is overall survival and key secondary end points include progression-free survival, best tumor response and duration of response, each assessed by independent review committee.",
        "Lurbinectedin is an inhibitor of active transcription of protein-coding genes, causing DNA-break accumulation, apoptosis and modulation of the tumor microenvironment.",
        "Here, we describe the rationale and design of ATLANTIS (<a href=\"http://clinicaltrials.gov/show/NCT02566993\" title=\"See in ClinicalTrials.gov\">NCT02566993</a>), an open-label, randomized, multicenter Phase III study to compare the efficacy of lurbinectedin and doxorubicin combination with standard-of-care chemotherapy, investigator's choice of cyclophosphamide/doxorubicin/vincristine or topotecan, in patients with small-cell lung cancer that has progressed following one line of platinum-based chemotherapy.",
        "Patients are randomized in a 1:1 ratio."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28683469": [
        "Lurbinectedin is structurally related to trabectedin and it inhibits active transcription and the DNA repair machinery in tumour cells.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Lurbinectedin is a novel anticancer agent currently undergoing late-stage (Phase II /III) clinical evaluation in platinum-resistant ovarian, BRCA1/2-mutated breast and small-cell lung cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27630271": [
        "Mol Cancer Ther; 15(10); 2399-412. \u00a92016 AACR.",
        "The finding that inhibition of Pol II phosphorylation prevents its degradation and the formation of DNA breaks after drug treatment underscores the connection between transcription elongation and DNA repair.",
        "This drug, currently undergoing clinical evaluation in ovarian, breast, and small cell lung cancer patients, inhibits the transcription process through (i) its binding to CG-rich sequences, mainly located around promoters of protein-coding genes; (ii) the irreversible stalling of elongating RNA polymerase II (Pol II) on the DNA template and its specific degradation by the ubiquitin/proteasome machinery; and (iii) the generation of DNA breaks and subsequent apoptosis.",
        "Our results not only help to better understand the high specificity of this drug in cancer therapy but also improve our understanding of an important transcription regulation mechanism.",
        "We have defined the mechanism of action of lurbinectedin, a marine-derived drug exhibiting a potent antitumor activity across several cancer cell lines and tumor xenografts."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29298770": [
        "In the large international phase III MAVORIC trial, patients with previously treated cutaneous T-cell lymphoma who received the anti-CCR4 monoclonal antibody mogamulizumab experienced significantly longer progression-free survival and higher response rates, as well as better quality of life, than those who received vorinostat, a standard therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29233821": [
        "In vitro, duvelisib potently killed 3 of 4 TCL lines with constitutive phospho-AKT (pAKT) vs 0 of 7 lines lacking pAKT (<i>P</i> = .024) and exceeded cell killing by the PI3K-\u03b4-specific inhibitor idelalisib.",
        "The overall response rates in patients with PTCL and CTCL were 50.0% and 31.6%, respectively (<i>P</i> = .32).",
        "Responders and nonresponders had markedly different changes in serum cytokine profiles induced by duvelisib.",
        "Duvelisib (IPI-145) is an oral inhibitor of phosphatidylinositol 3-kinase (PI3K)-\u03b4/\u03b3 isoforms currently in clinical development.",
        "Activity was seen across a wide spectrum of subtypes.",
        "The most frequently observed grade 3 and 4 adverse events were transaminase increases (40% alanine aminotransferase, 17% aspartate aminotransferase), maculopapular rash (17%), and neutropenia (17%).",
        "Administration of duvelisib to mice engrafted with a PTCL patient-derived xenograft resulted in a shift among tumor-associated macrophages from the immunosuppressive M2-like phenotype to the inflammatory M1-like phenotype.",
        "There were 3 complete responses, all among patients with PTCL.",
        "This trial was registered at www.clinicaltrials.gov as <a href=\"http://clinicaltrials.gov/show/NCT01476657\" title=\"See in ClinicalTrials.gov\">#NCT01476657</a>.",
        "In summary, duvelisib demonstrated promising clinical activity and an acceptable safety profile in relapsed/refractory TCL, as well as preclinical evidence of both tumor cell-autonomous and immune-mediated effects.",
        "We investigated these dual effects in a TCL cohort from a phase 1, open-label study of duvelisib in patients with relapsed or refractory PTCL (n = 16) and CTCL (n = 19), along with in vitro and in vivo models of TCL.",
        "PI3K-\u03b4/\u03b3 inhibition may directly inhibit malignant T-cell growth, making duvelisib a promising candidate for patients with peripheral (PTCL) or cutaneous (CTCL) T-cell lymphoma.",
        "Inhibition of either isoform may also contribute to clinical responses by modulating nonmalignant immune cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29191916": [
        "These data support further investigation of duvelisib in phase 2 and 3 studies.",
        "Severe (grade \u22653) adverse events occurred in 84% of patients: neutropenia (32%), alanine transaminase increase (20%), aspartate transaminase increase (15%), anemia and thrombocytopenia (each 14%), diarrhea (11%), and pneumonia (10%).",
        "Median time to response was \u223c1.8 months.",
        "Clinical responses were seen across a range of doses and disease subtypes: iNHL overall response rate, 58% (n = 31) with 6 complete responses (CRs); relapsed/refractory CLL, 56% (n = 55) with 1 CR; peripheral TCL, 50% (n = 16) with 3 CR; and cutaneous TCL, 32% (n = 19).",
        "Single-dose duvelisib was rapidly absorbed (time to maximum concentration, 1-2 hours), with a half-life of 5.2 to 10.9 hours.",
        "In the expansion phase (n = 179), patients with indolent non-Hodgkin lymphoma (iNHL), chronic lymphocytic leukemia (CLL), or T-cell lymphoma (TCL) were treated with 25 or 75 mg duvelisib twice daily continuously.",
        "Duvelisib is an oral dual inhibitor of phosphoinositide 3-kinase-\u03b4 (PI3K-\u03b4) and PI3K-\u03b3 in late-stage clinical development for hematologic malignancy treatment.",
        "In the dose escalation phase (n = 31), duvelisib 8 to 100 mg twice daily was administered, with MTD determined as 75 mg twice daily.",
        "This trial was registered at clinicaltrials.gov as <a href=\"http://clinicaltrials.gov/show/NCT01476657\" title=\"See in ClinicalTrials.gov\">#NCT01476657</a>.",
        "This phase 1 study evaluated maximum tolerated dose (MTD), pharmacokinetics, pharmacodynamics (PD), efficacy, and safety of duvelisib in 210 patients with advanced hematologic malignancies.",
        "PD results showed inhibition of phospho-AKT (S473) in CLL tumor cells following a single dose and near-complete inhibition of CLL proliferation (Ki-67) by cycle 2."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29479062": [
        "Microscopic tracking of cell migration within chemokine gradients revealed that PI3K\u03b3 functions in gradient sensing and impacts cell morphology and F-actin polarization.",
        "Expression of the PI3K\u03b3 subunits increased in CLL cells in response to CD40L/IL-4, whereas BCR cross-linking had no effect.",
        "We observed that pharmaceutical PI3K\u03b3 inhibition with CZC24832 significantly impaired CLL cell migration, while dual PI3K\u03b4/\u03b3 inhibitor duvelisib had a greater impact than single isoform-selective inhibitors.",
        "Knockdown of PI3K\u03b3 reduced migration of CLL cells and cell lines.",
        "Overexpression of PI3K\u03b3 subunits enhanced cell migration in response to SDF1\u03b1/CXCL12, with the strongest effect observed within ZAP70 + CLL samples.",
        "These findings provide the first evidence that PI3K\u03b3 has unique functions in malignant B cells.",
        "PI3K\u03b3 inhibition also reduced CLL adhesion to stromal cells to a similar extent as idelalisib.",
        "The PI 3-kinases (PI3K) are essential mediators of chemokine receptor signaling necessary for migration of chronic lymphocytic leukemia (CLL) cells and their interaction with tissue-resident stromal cells.",
        "While the PI3K\u03b4-specific inhibitor idelalisib shows efficacy in treatment of CLL and other B cell malignancies, the function of PI3K\u03b3 has not been extensively studied in B cells.",
        "Here, we assess whether PI3K\u03b3 has non-redundant functions in CLL migration and adhesion to stromal cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29522278": [
        "Additionally, duvelisib treatment inhibited cellular growth in the tested cell lines.",
        "Duvelisib treatment induced both apoptosis and cell cycle arrest in EBV-positive and -negative B cell lines, but not in T cell lines.",
        "Epstein-Barr virus (EBV) is a ubiquitous oncogenic virus that is associated with B cell lymphomas, including Burkitt lymphoma and Hodgkin lymphoma.",
        "An oral dual inhibitor of PI3K\u03b3 and PI3K\u03b4, duvelisib, is in clinical trials for the treatment of lymphoid malignancies.",
        "Furthermore, duvelisib treatment reduced the expression of EBV lytic genes (BZLF1 and gp350/220) in EBV-positive B cell lines, suggesting that duvelisib suppresses the lytic cycle of EBV induced by B cell receptor signaling.",
        "However, duvelisib did not induce a remarkable change in the expression of EBV latent genes.",
        "However, the additional influence of duvelisib on the tumor microenvironment was not assessed.",
        "We found that the PI3K/Akt signaling pathway was activated in most of the B and T cell lymphoma cell lines tested.",
        "Previous studies have shown that the phosphatidylinositol 3-kinase (PI3K)/Akt pathway is activated in EBV-associated lymphomas and can be a novel therapeutic target.",
        "These results may indicate that there is therapeutic potential for duvelisib administration in the treatment of EBV-associated B cell lymphomas and other B cell malignancies.",
        "Overall, B cell lines were more susceptible to duvelisib than T and NK cell lines in vitro regardless of EBV infection.",
        "In this study, we evaluated how duvelisib affects the activity of the PI3K/Akt signaling pathway and if it has antitumor effects in EBV-associated lymphoma cell lines."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30033575": [
        "Severe (Grade \u2265 3) adverse events included elevated liver enzymes (38.7%), diarrhea (25.8%), and neutropenia (29.0%).",
        "Duvelisib (IPI-145) is an oral dual inhibitor of phosphoinositide-3-kinase (PI3K)-\u03b4 and -\u03b3 in clinical development for the treatment of hematologic malignancies, including indolent non-Hodgkin lymphoma (iNHL).",
        "Three patients, all in the 75 mg BID cohort, experienced fatal AEs: E. coli sepsis, acute respiratory failure, and fungal pneumonia.",
        "Duvelisib demonstrated favorable clinical activity and an acceptable safety profile in these high-risk, heavily pretreated, relapsed/refractory iNHL patients, with 25 mg BID selected for further clinical development.",
        "Two dose-limiting toxicities (DLTs), Grade 3 transaminase elevations and Grade 3 rash, occurred at 100 mg BID, and the MTD was determined to be 75 mg BID.",
        "Across all doses, 58.1% of iNHL patients had a response (19.4% complete, 35.5% partial, and 3.2% minor); median time to response was 1.84 months and duration of response was 16.9 months.",
        "Median progression-free survival was 14.7 months, and the probability of overall survival at 24 months was 71.7%.",
        "In a Phase 1, open-label study to determine the maximum tolerated dose (MTD), pharmacokinetics, pharmacodynamics, clinical activity, and safety of duvelisib monotherapy in patients with advanced hematologic malignancies, duvelisib was administered at eight dose levels (8-100 mg BID) in a dose-escalation phase (n = 31 evaluable patients).",
        "No iNHL patients experienced Pneumocystis pneumonia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30094870": [
        "Duvelisib was administered twice daily (BID) in 28-day cycles at doses of 8-75 mg in RR patients (n = 55) and 25 mg in TN patients (n = 18.)",
        "The overall response rates were 56.4% for RR patients (1.8% CR, 54.5% PR) and 83.3% for TN patients (all PRs); median response duration was 21.0 months in RR patients but was not reached for TN patients.",
        "Diarrhea was the most common nonhematologic AE (TN 78%, RR 47%); transaminase elevations the most frequent lab-abnormality AE (TN 33.3%, RR 30.9%); and neutropenia the most common \u2265grade 3 AE (RR 44%, TN 33%).",
        "Based upon phase 1 efficacy, pharmacodynamics, and safety, duvelisib 25 mg BID was selected for further investigation in a phase 3 study in RR CLL/SLL.",
        "Duvelisib (IPI-145), an oral, dual inhibitor of phosphoinositide-3-kinase (PI3K)-\u03b4 and -\u03b3, was evaluated in a Phase 1 study in advanced hematologic malignancies, which included expansion cohorts in relapsed/refractory (RR) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and treatment-na\u00efve (TN) CLL.",
        "Per protocol, TN patients were at least 65 years old or had a del(17p)/TP53 mutation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28388280": [
        "Phase II and III trials of duvelisib alone or in combination with other agents are ongoing.",
        "Frontline chemotherapy is successful against chronic lymphocytic leukemia (CLL), but results in untoward toxicity.",
        "Further, prognostic factors, cytogenetic anomalies, and compensatory cellular signaling lead to therapy resistance or disease relapse.",
        "PI3K is a major player in the B-cell receptor (BCR) signaling axis, which is critical for the survival and maintenance of B cells.",
        "Therefore, for the past few years, development of targeted therapies is on the rise.",
        "Areas covered: Herein, we review PI3K isoforms and their inhibitors in general, and duvelisib in particular; examine literature on preclinical investigations, pharmacokinetics and clinical studies of duvelisib either as single agent or in combination, for patients with CLL and other lymphoid malignancies.",
        "Duvelisib, a PI3K \u03b4/\u03b3 dual isoform specific inhibitor that induces apoptosis and reduces cytokine and chemokine levels in vitro, holds promise for CLL.",
        "Expert opinion: Duvelisib targets the PI3K \u03b4 isoform, which is necessary for cell proliferation and survival, and \u03b3 isoform, which is critical for cytokine signaling and pro-inflammatory responses from the microenvironment.",
        "In phase I clinical trials, duvelisib as a single agent showed promise for CLL and other lymphoid malignancies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27174919": [
        "It generates phosphatidylinositol-3,4,5-triphosphate, which provides a membrane docking site for protein kinaseB activation.",
        "Pre-treatment of AML cells with IPI-145 inhibits both adhesion and migration of AML blasts to bone marrow stromal cells.",
        "The results show that PI3K\u03b4 and PI3K\u03b3 inhibition with IPI-145 has anti-proliferative activity in primary AML cells by inhibiting the activity of AKT and MAPK.",
        "Phosphoinositide-3-kinase (PI3K) is an enzyme group, known to regulate key survival pathways in acute myeloid leukaemia (AML).",
        "The results demonstrate that targeting both PI3K\u03b4 and PI3K\u03b3 to inhibit AML-BMSC interactions provides a biologic rationale for the pre-clinical evaluation of IPI-145 in AML.",
        "Using shRNA targeted to the individual isoforms we demonstrated that p110\u03b4-knockdown had a more significant anti-proliferative effect on AML cells, whereas targeting p110\u03b3-knockdown significantly inhibited AML migration.",
        "PI3K catalytic p110 subunits are divided into 4 isoforms; \u03b1,\u03b2,\u03b4 and \u03b3.",
        "The functions of these individual catalytic enzymes have not been fully resolved in AML, therefore using the PI3K p110\u03b4 and p110\u03b3-targeted inhibitor IPI-145 (duvelisib) and specific p110\u03b4 and p110\u03b3 shRNA, we analysed the role of these two p110 subunits in human AML blast survival.",
        "The PI3K\u03b4 isoform is always expressed in AML cells, whereas the frequency of PI3K\u03b3 expression is highly variable."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30067771": [
        "The combination of duvelisib with dexamethasone also significantly reduced p-4EBP1, which controls cap dependent translation initiation, leading to decreased levels of c-MYC 6 hours after treatment.",
        "Duvelisib is an orally active dual inhibitor of PI3K-\u03b4 and PI3K-\u03b3 in clinical development in hematologic malignancies (HM).",
        "These data provide a rationale for exploring multiple combinations in the clinic and suggest that suppression of mTOR-driven survival signaling may be one important mechanism for combination synergy.",
        "Combination with dexamethasone or ibrutinib, however, prevented this reactivation leading to durable inhibition of pAKT.",
        "Western blotting revealed that certain duvelisib-treated cell lines showed inhibition of phosphorylated (p) AKT at serine 473 only out to 12 hours, with mTORC2 dependent re-phosphorylation of pAKT evident at 24 hours.",
        "Synergy with duvelisib was prominent in lymphoma lines with approved and emerging drugs used to treat HM, including dexamethasone, ibrutinib, and the BCL-2 inhibitor venetoclax.",
        "To identify novel pairings for duvelisib in HM, it was evaluated alone and in combination with 35 compounds comprising a diverse panel of standard-of-care agents and emerging drugs in development for HM.",
        "In support of the in vitro studies, in vivo xenograft studies revealed that duvelisib in combination with the mTOR inhibitor everolimus led to greater tumor growth inhibition compared to single agent administration.",
        "Single agent activity was seen in fourteen cell lines, with a median GI50 of 0.59 \u03bcM.",
        "The combination treatments also inhibited downstream signaling effectors pPRAS40 and pS6.",
        "These compounds were tested in 20 cell lines including diffuse large B-cell, follicular, T-cell, and mantle cell lymphomas, and multiple myeloma.",
        "A scalar measure of the strength of synergistic drug interactions revealed a synergy hit rate of 19.3% across the matrix of drug combinations and cell lines."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28017967": [
        "In concert with induction of transcript levels, reverse phase protein arrays and immunoblots confirmed increase at the protein level.",
        "To characterize the molecular effect of duvelisib, we obtained samples from CLL patients on the duvelisib phase I trial.",
        "In vitro combination of duvelisib and venetoclax resulted in enhanced apoptosis even in CLL cells cultured under conditions that simulate the tumor microenvironment.",
        "These data provide a mechanistic rationale for testing the combination of duvelisib and venetoclax in the clinic.",
        "Duvelisib, an oral dual inhibitor of PI3K-\u03b4 and PI3K-\u03b3, is in phase III trials for the treatment of chronic lymphocytic leukemia (CLL) and indolent non-Hodgkin's lymphoma.",
        "Gene expression studies (RNAseq, Nanostring, Affymetrix array and real-time RT-PCR) demonstrated increased expression of BCL2 along with several BH3-only pro-apoptotic genes.",
        "Such combination regimen (<a href=\"http://clinicaltrials.gov/show/NCT02640833\" title=\"See in ClinicalTrials.gov\">NCT02640833</a>) is being evaluated for patients with B-cell malignancies including CLL.",
        "The BCL2 inhibitor venetoclax induced greater apoptosis in ex vivo-cultured CLL cells obtained from patients on duvelisib compared with pre-treatment CLL cells from the same patients.",
        "In CLL, duvelisib monotherapy is associated with high iwCLL (International Workshop on Chronic Lymphocytic Leukemia) and nodal response rates, but complete remissions are rare."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25912635": [
        "The concentrations leading to half-maximal reduction of the survival of CLL cells were more than ten-fold lower for copanlisib than for idelalisib and duvelisib.",
        "Pharmacological inhibition of phosphatiylinositide-3-kinase (PI3K)-mediated signaling holds great promise for treating chronic lymphocytic leukemia (CLL).",
        "Similarly copanlisib and duvelisib reduced the survival of CLL cells in co-cultures with the bone marrow stroma cell line HS-5 more strongly than idelalisib.",
        "In addition copanlisib and duvelisib impaired the migration of CLL cells towards CXCL12 to a greater extent than equimolar idelalisib.",
        "At concentrations reflecting the biological availability of the different inhibitors, high levels of apoptotic response among CLL samples were attained more consistently with copanlisib than with idelalisib.",
        "Copanlisib selectively reduced the survival of CLL cells compared to T cells and to B cells from healthy donors.",
        "Taken together, targeting the \u03b1- and \u03b4- p110 isoforms with copanlisib may be a useful strategy for the treatment of CLL and warrants further clinical investigation.",
        "Therefore we assessed three structurally related PI3K inhibitors targeting the PI3K-\u03b4 isoform for their ability to inhibit the survival of freshly isolated CLL cells.",
        "The purely PI3K-\u03b4-selective inhibitor idelalisib was compared to copanlisib (BAY 80-6946) and duvelisib (IPI-145), with isoform target profiles that additionally include PI3K-\u03b1 or PI3K-\u03b3, respectively.",
        "Survival inhibition by copanlisib and idelalisib was enhanced by the monoclonal CD20 antibodies rituximab and obinutuzumab (GA101), while antibody-dependent cellular cytotoxicity mediated by alemtuzumab and peripheral blood mononuclear cells was not substantially impaired by both PI3K inhibitors for the CLL-derived JVM-3 cell line as target cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29216772": [
        "In our work, the necessity of single-thread analysis of bulky data emerged during interpretation of HepG2 proteome profiling results for proteoforms searching.",
        "We selected combination of X!Tandem, MS-GF[Formula: see text] and OMMSA as the most time-efficient and productive combination of search.",
        "We also compared the results of our search combination with Mascot results using protein kit UPS2, containing 48 human proteins.",
        "We compared the contribution of each of the eight search engines (X!Tandem, MS-GF[Formula: see text], MS Amanda, MyriMatch, Comet, Tide, Andromeda, and OMSSA) integrated in an open-source graphical user interface SearchGUI ( http://searchgui.googlecode.com ) into total result of proteoforms identification and optimized set of engines working simultaneously.",
        "Proteomic challenges, stirred up by the advent of high-throughput technologies, produce large amount of MS data.",
        "These settings resulted in rise of the efficiency of our customized pipeline unobtainable by manual scouting: the analysis of 192 files searched against human proteome (42153 entries) downloaded from UniProt took 11[Formula: see text]h.",
        "We added homemade java-script to automatize pipeline from file picking to report generation.",
        "Nowadays, the routine manual search does not satisfy the \"speed\" of modern science any longer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29993281": [
        "In this work, we develop a free interactive web software platform, MixProTool, for processing multigroup proteomics data sets.",
        "This software is also highly compatible with the identification and quantification results of various frequently used search engines, such as MaxQuant, Proteome Discoverer, or Mascot.",
        "Deciphering and visualizing proteomics data are a big challenge for high-throughput proteomics research.",
        "MixProTool is deployed at the public shinyapps io server.",
        "This tool provides integrated data analysis workflow, including quality control assessment, normalization, soft independent modeling of class analogy, statistics, gene ontology enrichment, and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis.",
        "Moreover, all analyzed results can be visualized as vector graphs and tables for further analysis.",
        "MixProTool can be conveniently operated by users, even those without bioinformatics training, and it is extremely useful for mining the most relevant features among different samples."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27498275": [
        "Here, we evaluated five software tools for protein inference (PIA, ProteinProphet, Fido, ProteinLP, MSBayesPro) using three popular database search engines: Mascot, X!Tandem, and MS-GF+.",
        "We defined a set of quality control metrics to evaluate the performance of each combination of search engines, protein inference algorithm, and parameters on each dataset.",
        "Finally, merging the identifications of multiple search engines does not necessarily increase the number of reported proteins, but does increase the number of peptides per protein and thus can generally be recommended.",
        "However, most of the analytical methods are based on the identification of reliable peptides and not the direct identification of intact proteins.",
        "Furthermore, the robustness of reported proteins when using databases of differing complexities is strongly dependant on the applied inference algorithm.",
        "Thus, assembling peptides identified from tandem mass spectra into a list of proteins, referred to as protein inference, is a critical step in proteomics research.",
        "Currently, different protein inference algorithms and tools are available for the proteomics community.",
        "We show that the results for complex samples vary not only regarding the actual numbers of reported protein groups but also concerning the actual composition of groups.",
        "In mass spectrometry-based shotgun proteomics, protein identifications are usually the desired result.",
        "All the algorithms were evaluated using a highly customizable KNIME workflow using four different public datasets with varying complexities (different sample preparation, species and analytical instruments)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28960077": [
        "This workflow benefits from the complementarity of these search engines to increase the proteome coverage.",
        "Finally, we performed a combined analysis of the gene expression levels and the proteomic identifications from the common cell lines between the NCI60 and the CCLE project to suggest alternatives for further validation of missing protein observations.",
        "Moreover, 165 missing proteins were detected with only one unique peptide, and their functional analysis supported their participation in cellular pathways as was also proposed in other studies.",
        "The Human Proteome Project (HPP) aims deciphering the complete map of the human proteome.",
        "In this work, we used all the proteomic experiments from the NCI60 cell lines and applied an integrative approach based on the results obtained from Comet, Mascot, OMSSA, and X!Tandem.",
        "Five missing proteins C-HPP guidelines compliant were identified, although further validation is needed.",
        "In the past few years, significant efforts of the HPP teams have been dedicated to the experimental detection of the missing proteins, which lack reliable mass spectrometry evidence of their existence.",
        "In this endeavor, an in depth analysis of shotgun experiments might represent a valuable resource to select a biological matrix in design validation experiments."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29103968": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Avelumab has recently been approved by the Food and Drug Administration for the therapy of Merkel cell carcinoma and urothelial carcinoma.",
        "The rationale for a combined molecule is to block the PD-1/PD-L1 interaction between tumor cells and immune cell infiltrate and simultaneously reduce or eliminate TGF\u03b2 from the tumor microenvironment.",
        "In this study, we explored the effect of M7824 on invasive urothelial carcinoma cell lines.",
        "M7824 is a novel first-in-class bifunctional fusion protein comprising a monoclonal antibody against programmed death-ligand 1 (PD-L1, avelumab), fused to the extracellular domain of human transforming growth factor beta (TGF\u03b2) receptor 2, which functions as a TGF\u03b2 \"trap.\"",
        "Advanced urothelial tumors have been shown to express TGF\u03b2, which possesses immunosuppressive properties that promote cancer progression and metastasis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29606979": [
        "In addition, gemcitabine/cisplatin has been established as an alternative to methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC).",
        "However, the challenge in the age of precision medicine is to identify the patients who are most likely to benefit from CPIs, as the majority of patients do not respond to CPI.",
        "Vinflunine has been approved by the EMA (European Medicines Agency) with only limited improvement compared to best supportive care in second line treatment.",
        "The rapid acceptance in the treatment algorithm of UC is based on the impressive clinical efficacy of these agents in some patients, combined with their excellent safety profile.",
        "Five immune CPI have recently been approved for aUC/mUC by the US Food and Drug Administration (FDA) including atezolizumab, nivolumab, pembrolizumab, durvalumab and avelumab.",
        "The advent of checkpoint inhibitors (CPI) revolutionized the care of these patients, transforming a unanimously deadly disease into one with hope through sustained disease control.",
        "These new agents are indeed the most important advancement in UC care.",
        "Toward this goal, validation of clinical, molecular and imaging biomarkers that serve for prediction and monitoring of treatment response are of central necessity.",
        "Until recently, there were no true innovations in the management of locally advanced (aUC) and metastatic urothelial cancer (mUC) in the last three decades.",
        "All five CPI are FDA-approved as second-line therapy with atezolizumab and pembrolizumab also being approved for first-line therapy in cisplatin-ineligible patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29644490": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Advanced urothelial carcinoma (aUC) has long been treated preferably with cisplatin-based chemotherapy, but many patients are cisplatin-ineligible whereas for those who progress on a platinum-based regimen treatment options are limited.",
        "We review key recent data regarding immune checkpoint inhibitors that are changing this treatment landscape."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29540084": [
        "Metastatic urothelial carcinoma (UC) remains an aggressive disease associated with limited treatment options and a reduced survival.",
        "Its dual mechanism of action, blocking the interaction between PD-L1 and PD-1 and promoting antibody-dependent cell-mediated cytotoxicity could potentially be of great interest since it could produce synergistic clinical efficacy.",
        "For that matter, we undertook a literature review of all the studies assessing the pharmacology of avelumab and its efficacy within clinical trials.",
        "Similarly, before the advent of the immune checkpoint inhibitors, there were no FDA-approved drugs for second-line therapy.",
        "Avelumab, a PD-1 ligand (PD-L1) inhibitor, is currently being investigated for the treatment of UC.",
        "Expert commentary: Avelumab has shown promising antitumor activity and a manageable safety profile in patients with UC.",
        "Areas covered: This article will review the pharmacological characteristics of avelumab, the efficacy studies which led to its approval, its safety profile, as well as its place within the management of urothelial carcinoma with immunotherapy.",
        "In spite of this, the first-line treatment based on platinum-based combinations has remained virtually unchanged for the last 20-30 years.",
        "In the last few years, impressive signs of anti-tumor activity have been reported with several immunotherapy agents targeting the programmed cell death-1 (PD-1) pathway."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28214651": [
        "Research is ongoing to further categorize responses, define ideal patient populations, and investigate combinations of checkpoint inhibitors to address multiple pathways in immune system functioning.",
        "The checkpoint inhibitors offer an effective alternative for patients for whom previously there were few options for durable responses, including those who are ineligible for cisplatin-based regimens or who are at risk of significant toxicity.",
        "Atezolizumab is the only member of this class currently approved for the treatment of bladder cancer, but nivolumab, pembrolizumab, durvalumab, and avelumab all have positive results for this indication, and approvals are anticipated in the near future.",
        "Modern immunotherapy has focused on inhibitors of checkpoint proteins, which are molecules that impede immune function, thereby allowing tumor cells to grow and proliferate unregulated.",
        "The first immunotherapy was the live, attenuated bacterial Bacillus Calmette-Gu\u00e9rin vaccine, which has been the standard of care non-muscle-invasive bladder cancer since 1990.",
        "The treatment of bladder cancer has evolved over time to encompass not only the traditional modalities of chemotherapy and surgery, but has been particularly impacted by the use of immunotherapy.",
        "This review describes the most recent data on agents that inhibit PD-L1, found on the surface of tumor cells, and PD-1 found on activated T and B cells and macrophages.",
        "Several checkpoint targets (programmed death ligand-1 [PD-L1] programmed cell death protien-1 [PD-1], and cytotoxic T-lymphocyte associated protein 4 [CTLA4]) have received the most attention in the treatment of bladder cancer, and have inhibitor agents either approved or in late-stage development."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28982750": [
        "The complete version of the NCCN Guidelines for Bladder Cancer addresses additional aspects of the management of bladder cancer, including non-muscle-invasive urothelial bladder cancer and nonurothelial histologies, as well as staging, evaluation, and follow-up.",
        "This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer focuses on systemic therapy for muscle-invasive urothelial bladder cancer, as substantial revisions were made in the 2017 updates, such as new recommendations for nivolumab, pembrolizumab, atezolizumab, durvalumab, and avelumab."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28493171": [
        "Long-term survival remains stagnant around 12-14 months for patients with advanced disease who have progressed on or recurred after receiving first-line platinum-based chemotherapy.",
        "Atezolizumab, avelumab, durvalumab, nivolumab and pembrolizumab are promising PD-1/PD-L1 blockade drugs under investigation that will redefine the standard of care for bladder cancer.",
        "Atezolizumab, approved in May 2016, and nivolumab, approved in February 2017, are the first Food and Drug Administration (FDA)-approved immune-checkpoint inhibitors in bladder cancer for platinum-pretreated patients based on phase II data.",
        "Cytotoxic chemotherapy has been the only systemic treatment of locally advanced and metastatic urothelial carcinoma for decades.",
        "Research into biomarkers such as PD-L1 expression, messenger RNA subtype, mutational and neoantigen load and gene signature expression will be crucial to determining why some patients respond to immunotherapy and others do not.",
        "This review article describes the advances in immunotherapy since the development of BCG, presents results from clinical trials investigating immune-checkpoint inhibitors and discusses biomarkers and prognostic factors associated with response to these new drugs.",
        "Immune-checkpoint inhibitors targeting the programmed death 1/programmed death-ligand 1 (PD-1/PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) pathways have shown significant anti-tumor activity, tolerable safety profiles and durable, long-term responses in clinical trials.",
        "Improving clinical outcomes for patients with urothelial carcinoma in all disease settings requires the development of novel treatments, especially for patients who failed on first-line chemotherapy.",
        "On March 16, 2017, results from the phase III trial KEYNOTE-045 demonstrated that survival was significantly longer in patients treated with pembrolizumab when compared with the standard second-line chemotherapy.",
        "CTLA-4 inhibitors are also under investigation in this setting.",
        "Since the discovery of intravesical Bacillus-Calmette Guerin (BCG) in the 1970s for non-muscle invasive disease, there have not been any major breakthrough drugs that exploit the immune-sensitivity of bladder cancer until recently."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28864844": [
        "Risk factors are predominantly related to tobacco smoking, although infection with Schistosoma haematobium is another risk factor in selected populations (Antoni et al. in Eur Urol, 71:96-108, 2017).",
        "Thus, this approach is preferred for patients who can tolerate this treatment as first-line chemotherapy (Gupta et al. in Cancer, 9(15):1-14, 2017).",
        "This review outlines the systemic immunotherapies that have been approved or are currently being investigated.",
        "With further understanding of tumor immune evasion, systemic immunotherapy which utilizes the patient's own immune system directly to eradicate and target neoplastic cells, has now been approved for urothelial bladder cancer.",
        "Cisplatin-based systemic chemotherapy regimens remain the standard of care in both the neoadjuvant and metastatic setting for muscle-invasive bladder cancer (Gupta et al. in Cancer, 9(15):1-14, 2017; Von der Maase et al. in J Clin Oncol, 23:4602-4608, 2005; De Santis et al. in J Clin Oncol, 30:191-199, 2012; Bellmunt et al. in J Clin Oncol, 27: 4454-4461, 2009).",
        "The incidence rate for bladder cancer is higher in men compared to women.",
        "Bladder cancer is the most common malignancy involving the genitourinary system (Siegel et al. in CA Cancer J Clin, 66:7-30, 2016).",
        "Monoclonal antibodies that target programmed cell death protein 1 (PD-1), including Nivolumab and Pembrolizumab, and its ligand, PD-L1, including Atezolizumab, Durvalumab, Avelumab, have all been investigated and approved in the setting of metastatic refractory urothelial cancer (Gupta et al. in Cancer, 9(15):1-14, 2017; Von der Maase et al. in J Clin Oncol, 23:4602-4608, 2005; Zilchi et al. in BioMed Res Int, 2017, 2017, doi: 10.1155/2017/5618174 ).",
        "Atezolizumab and Pembrolizumab have also been approved as first-line therapy in the setting of cisplatin-ineligible metastatic bladder cancer (Gupta et al. in Cancer, 9(15):1-14, 2017; Zilchi et al. in BioMed Res Int, 2017, 2017, doi: 10.1155/2017/5618174 ).",
        "Those that target cytotoxic T-lymphocyte-associated protein 4, including Ipilimumab and Tremelimumab, have also been investigated and further studies are being performed (Gupta et al. in Cancer, 9(15):1-14, 2017; Zilchi et al. in BioMed Res Int, 2017, 2017, doi: 10.1155/2017/5618174 ).",
        "There is an estimated overall survival of 9-15 months in metastatic bladder cancer in those who receive the standard of care platinum-based chemotherapy (Von der Maase et al. in J Clin Oncol, 23:4602-4608, 2005; De Santis et al. in J Clin Oncol, 30:191-199, 2012).",
        "The median survival, however, is significantly reduced after relapse in patient treated with platinum chemotherapy to less than 7 months (Bellmunt et al. in J Clin Oncol, 27: 4454-4461, 2009).",
        "The mortality from bladder cancer is approximately 17,000 deaths each year (Siegel et al. in CA Cancer J Clin, 66:7-30, 2016).",
        "In the USA, it is the fifth most common cancer and approximately 79,000 new cases will be diagnosed in 2017 (Siegel et al. in CA Cancer J Clin, 66:7-30, 2016).",
        "Until recently, there were few treatment options for those patients with poor performance status who are ineligible to receive cisplatin including renal insufficiency and multiple comorbidities or had disease progression after receiving platinum-based chemotherapy (Gupta et al. in Cancer, 9(15):1-14, 2017)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29784744": [
        "After 30 years of minimal progress in the treatment of advanced-stage disease, recent advances in the genomic characterization of urothelial cancer and breakthroughs in bladder cancer therapeutics have rejuvenated the field.",
        "Urothelial carcinoma is the predominant histologic type of bladder cancer.",
        "Nivolumab, pembrolizumab, atezolizumab, durvalumab, and avelumab are among the exciting recent novel therapeutic advances gaining approvals by the FDA for treatment of advanced-stage urothelial carcinoma.",
        "Yet the challenge for clinicians is to determine the optimal choice of agents as first-line or second-line therapy and which offers the best chance for overall survival for the individual patient in this rapidly changing field."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29177435": [
        "We identify a burden of rare variants across PRKCD associated with SLE risk (P = 0.0028), and across DNMT3A associated with two severe disease prognosis sub-phenotypes (P = 0.0005 and P = 0.0033).",
        "We further characterise the TNF-dependent functions of the third candidate gene C1QTNF4 on NF-\u03baB activation and apoptosis, which are inhibited by the p.His198Gln DNM.",
        "In a follow-up cohort of 10, 995 individuals of matched European ancestry, we imputed genotype data to the density of the combined UK10K-1000 genomes Phase III reference panel across the 14 candidate genes.",
        "Here, using complementary whole-exome sequencing, high-density imputation, and in vitro cellular assays, we identify candidate core genes in the pathogenesis of systemic lupus erythematosus (SLE).",
        "Gene-level analyses indicate three functional candidates: DNMT3A, PRKCD, and C1QTNF4.",
        "Rare variant associations, expected to explain far less of the heritability, may be enriched in core disease genes and thus will be instrumental in the understanding of complex disease pathogenesis and their potential therapeutic targets.",
        "Our results identify three novel genes in SLE susceptibility and support extreme-phenotype sampling and DNM gene discovery to aid the search for core disease genes implicated through rare variation.",
        "The omnigenic model of complex disease stipulates that the majority of the heritability will be explained by the effects of common variation on genes in the periphery of core disease pathways.",
        "Using extreme-phenotype sampling, we sequenced the exomes of 30 SLE parent-affected-offspring trios and identified 14 genes with missense de novo mutations (DNM), none of which are within the &gt;80 SLE susceptibility loci implicated through genome-wide association studies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29985992": [
        "The transcription factor BCL11B is essential for development of the nervous and the immune system, and Bcl11b deficiency results in structural brain defects, reduced learning capacity, and impaired immune cell development in mice.",
        "Notably, all of them are affected by global developmental delay with speech impairment and intellectual disability; however, none displayed overt clinical signs of immune deficiency.",
        "Furthermore, the most C-terminally located premature termination codon mutation fails to rescue the progenitor cell proliferation defect in hippocampal slice cultures from Bcl11b-deficient mice.",
        "Unsupervised analysis of 102 T lymphocyte subpopulations showed that the patients clearly cluster apart from healthy children, further supporting the common aetiology of the disorder.",
        "A further frameshift mutation was transmitted from a similarly affected mother.",
        "Concerning the role of BCL11B in the immune system, extensive immune phenotyping of our patients revealed alterations in the T cell compartment and lack of peripheral type 2 innate lymphoid cells (ILC2s), consistent with the findings described in Bcl11b-deficient mice.",
        "Interestingly, the most severely affected patient harbours a missense mutation within a zinc-finger domain of BCL11B, probably affecting the DNA-binding structural interface, similar to the recently published patient.",
        "Using massively parallel sequencing we identified 13 patients bearing heterozygous germline alterations in BCL11B.",
        "Six frameshift mutations, two nonsense mutations, one missense mutation, and two chromosomal rearrangements resulting in diminished BCL11B expression, arose de novo.",
        "Taken together, we show here that mutations leading either to BCL11B haploinsufficiency or to a truncated BCL11B protein clinically cause a non-syndromic neurodevelopmental delay.",
        "However, the precise role of BCL11B in humans is largely unexplored, except for a single patient with a BCL11B missense mutation, affected by multisystem anomalies and profound immune deficiency.",
        "In addition, we suggest that missense mutations affecting specific sites within zinc-finger domains might result in distinct and more severe clinical outcomes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29345064": [
        "TLR8 agonists may synergize with cancer immunotherapeutic approaches to enhance the antitumor effects of the adaptive immune response.",
        "Myeloid-derived suppressor cells (MDSCs) accumulate in tumors and the peripheral blood of cancer patients and demonstrate cancer-promoting activity across multiple tumor types.",
        "A limited number of agents are known to impact MDSC activity.",
        "TLR8 was highly expressed in monocytic MDSC (mMDSC) but absent in granulocytic MDSC (gMDSC).",
        "The reduction of mMDSC was due to induced cell death by TLR8 ligation.",
        "There is increasing evidence that MDSCs contribute to the progression of cancer by inhibiting tumor-directed T cells.",
        "Motolimod did not impact levels of gMDSC.",
        "Treatment of human PBMC with motolimod reduced the levels of mMDSC in volunteers and cancer donors versus control (P &lt; 0.001).",
        "Pretreatment of PBMC with a FAS neutralizing antibody inhibited motolimod-induced reduction of mMDSC (P &lt; 0.001).",
        "Finally, we demonstrated that mMDSC impeded IL-2 secretion by CD3/CD28-activated T cells; IL-2 secretion was partially restored when cells were cocultured with motolimod (142 \u00b1 36 pg/ml vs. 59 \u00b1 13 pg/ml; P = 0.03).",
        "We investigated expression of TLR8 on MDSC and the effect of a TLR8 agonist, motolimod, on MDSC survival and function.",
        "TLR8 is expressed in myeloid cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29931076": [
        "<strong class=\"sub-title\">\n          Importance:\n        </strong>\n      \n      Immunotherapy for recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) is promising.",
        "The toll-like receptor 8 (TLR8) agonist motolimod may stimulate innate and adaptive immunity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27702821": [
        "Two subjects (15%) had complete responses and 7 subjects (53%) had disease stabilization.",
        "The NSG-HIS mouse helped elucidate the mechanism of action of the combination and revealed a positive interaction between the two drugs <i>in vivo</i> The combination produced no dose-limiting toxicities in patients with ovarian cancer.",
        "We sought to develop a rational combination of motolimod-a novel Toll-like receptor 8 (TLR8) agonist that stimulates robust innate immune responses in humans but diminished responses in mice-with pegylated liposomal doxorubicin (PLD), a chemotherapeutic that induces immunogenic cell death.<b>Experimental Design:</b> We followed an integrative pharmacologic approach including healthy human volunteers, non-human primates, NSG-HIS (\"humanized immune system\") mice reconstituted with human CD34<sup>+</sup> cells, and patients with cancer to test the effects of motolimod and to assess the combination of motolimod with PLD for the treatment of ovarian cancer.<b>Results:</b> The pharmacodynamic effects of motolimod monotherapy in NSG-HIS mice closely mimicked those in non-human primates and healthy human subjects, whereas the effects of the motolimod/PLD combination in tumor-bearing NSG-HIS mice closely mimicked those in patients with ovarian cancer treated in a phase Ib trial (<a href=\"http://clinicaltrials.gov/show/NCT01294293\" title=\"See in ClinicalTrials.gov\">NCT01294293</a>).",
        "A phase II study was consequently initiated.<b>Conclusions:</b> These results are the first to demonstrate the value of pharmacologic approaches integrating the NSG-HIS mouse, non-human primates, and patients with cancer for the development of novel immunomodulatory anticancer agents with human specificity. <i>Clin Cancer Res; 23(8); 1955-66. \u00a92016 AACR</i>.",
        "<b>Purpose:</b> Immunotherapy is an emerging paradigm for the treatment of cancer, but the potential efficacy of many drugs cannot be sufficiently tested in the mouse."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27810904": [
        "Five patients had disease stabilization equating to a disease control rate of 54%.",
        "Correlative biomarkers of immune activity were explored.<b>Experimental Design:</b> Thirteen patients with recurrent or metastatic SCCHN were enrolled in this open-label, dose-escalation study using a standard 3 + 3 design.",
        "Doses of motolimod (2.5, 3.0, or 3.5 mg/m<sup>2</sup>) were given on days 1, 8, and 15, in combination with fixed weekly doses of cetuximab in 28-day cycles.<b>Results:</b> There were no protocol-defined dose-limiting toxicities, drug-related deaths, or evidence of synergistic toxicities between motolimod and cetuximab.",
        "Motolimod (VTX-2337), a selective small-molecule agonist of TLR8, stimulates natural killer (NK) cells, dendritic cells, and monocytes.",
        "Statistically significant increases in plasma cytokines and in the frequency and activation of circulating NK cells were observed.<b>Conclusions:</b> Motolimod can be safely administered in combination with cetuximab with an acceptable toxicity profile.",
        "Encouraging antitumor activity and robust pharmacodynamic responses were observed.",
        "<b>Purpose:</b> As Toll-like receptors (TLR) are key mediators of immune responses, TLR agonists may be important for augmenting the efficacy of therapies for squamous cell carcinoma of the head and neck (SCCHN).",
        "Clinical tolerability at the 3.5 mg/m<sup>2</sup> dose level was not optimal for repeated dosing and 3.0 mg/m<sup>2</sup> was identified as the MTD.",
        "Motolimod is being further investigated in a phase II trial in patients with SCCHN (ClinicalTrials.gov ID: <a href=\"http://clinicaltrials.gov/show/NCT01836029\" title=\"See in ClinicalTrials.gov\">NCT01836029</a>). <i>Clin Cancer Res; 23(10); 2442-50. \u00a92016 AACR</i>.",
        "A phase Ib clinical trial assessed the safety and antitumor activity of motolimod in combination with cetuximab in patients with SCCHN.",
        "Two patients achieved partial responses for an overall response rate of 15%."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28453702": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      A phase 2, randomized, placebo-controlled trial was conducted in women with recurrent epithelial ovarian carcinoma to evaluate the efficacy and safety of motolimod-a Toll-like receptor 8 (TLR8) agonist that stimulates robust innate immune responses-combined with pegylated liposomal doxorubicin (PLD), a chemotherapeutic that induces immunogenic cell death."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27467937": [
        "Despite treatment with chemotherapeutic agents and advance disease, cancer patients remain sensitive to motolimod.",
        "A novel approach to immunotherapy is the activation of toll-like receptor 8 (TLR8).",
        "Motolimod, a selective TLR8 agonist can act in concert with approved immunotherapies to sensitize T cells and augment natural killer (NK) cell function."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26152744": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Immunotherapy as a treatment for cancer holds the promise of complete and durable tumor remission, yet the immunosuppressive environment created by many tumors, advanced patient age, and previous treatments with cytotoxic agents may limit the approach.",
        "The activity of motolimod (VTX-2337), a potent and selective Toll-like receptor 8 (TLR8) agonist, was therefore assessed in the context of advanced, late-stage cancer patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26928328": [
        "VTX-2337 (USAN: motolimod) is a selective toll-like receptor 8 (TLR8) agonist, which is in clinical development as an immunotherapy for multiple oncology indications, including squamous cell carcinoma of the head and neck (SCCHN).",
        "Inhibition of caspase-1 blocked VTX-2337-mediated NLRP3 inflammasome activation, but had little impact on production of other TLR8-induced mediators such as TNF\u03b1.",
        "Activation of TLR8 enhances natural killer cell activation, increases antibody-dependent cell-mediated cytotoxicity, and induces Th1 polarizing cytokines.",
        "These results are highly relevant to clinical studies of combination VTX-2337/cetuximab treatment.",
        "Cetuximab, a clinically approved, epidermal growth factor receptor-specific monoclonal antibody, activates NK cells through interactions with Fc\u03b3RIII and facilitates ADCC of tumor cells.",
        "Our preliminary findings from a Phase I open-label, dose-escalation, trial that enrolled 13 patients with recurrent or metastatic SCCHN show that patient NK cells become more responsive to stimulation by NKG2D or Fc\u03b3RIII following VTX-2337 treatment.",
        "NLRP3 activation in vivo was confirmed by a dose-related increase in plasma IL-1\u03b2 and IL-18 levels in cynomolgus monkeys administered VTX-2337.",
        "Together, these results indicate that TLR8 stimulation and inflammasome activation by VTX-2337 can complement Fc\u03b3RIII engagement and may augment clinical responses in SCCHN patients treated with cetuximab.",
        "Here, we show that VTX-2337 stimulates the release of mature IL-1\u03b2 and IL-18 from monocytic cells through coordinated actions on both TLR8 and the NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome complex.",
        "In vitro, VTX-2337 primed monocytic cells to produce pro-IL-1\u03b2, pro-IL-18, and caspase-1, and also activated the NLRP3 inflammasome, thereby mediating the release of mature IL-1\u03b2 family cytokines.",
        "IL-18 activated natural killer cells and complemented other stimulatory pathways, including Fc\u03b3RIII and NKG2D, resulting in IFN\u03b3 production and expression of CD107a."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28485332": [
        "Epidermal growth factor receptor inhibitors, including monoclonal antibodies and tyrosine kinase inhibitors, have achieved only a modest success in R/M HNSCC.",
        "Till date, the only systemic therapy regimen to demonstrate survival superiority over platinum-5-fluorouracil (5-FU) doublet is platinum, FU, and cetuximab.",
        "Immunotherapy represents an attractive treatment option for R/M HNSCC, with encouraging preliminary data from studies involving immune checkpoint inhibitors (e.g., pembrolizumab, nivolumab) and toll-like receptor agonists (e.g., motolimod).",
        "The median overall survival for patients with recurrent and/or metastatic (R/M) HNSCC remains &lt;1 year despite modern systemic chemotherapy and targeted agents.",
        "Head and neck squamous cell carcinoma (HNSCC) is now the seventh most common cancer worldwide.",
        "Palliative systemic therapy for patients with R/M HNSCC typically includes a platinum-based doublet, with an understanding that the increase in efficacy compared with single agents is primarily related to improved response rate, and not survival.",
        "Given the poor prognosis of R/M HNSCC, enrollment of patients into clinical trials to investigate novel systemic agents, is necessary for further improvement of oncologic outcomes in this patient population."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29352859": [
        "Furthermore, since 5-HT<sub>1F</sub> receptors are located on trigeminal fibers, they could modulate CGRP release.",
        "The gold standard for acute migraine treatment are the triptans, 5-HT<sub>1B/1D/(1F)</sub> receptor agonists.",
        "This review will be particularly focussed on the similarities and differences between the triptans and the ditans, their proposed sites of action, side effects and their cardiovascular risk profile.",
        "Their actions are thought to be mediated through activation of: (i) 5-HT<sub>1B</sub> receptors in cranial blood vessels with subsequent cranial vasoconstriction; (ii) prejunctional 5-HT<sub>1D</sub> receptors on trigeminal fibers that inhibit trigeminal CGRP release; and (iii) 5-HT<sub>1B/1D/1F</sub> receptors in central nervous system involved in (anti)nociceptive modulation.",
        "In addition, since migraineurs have an increased cardiovascular risk, it is important to develop antimigraine drugs devoid of vascular (side) effects.",
        "Admittedly, the exact site of action is still unknown, but lasmiditan possess a high lipophilicity, which suggests a direct action on the central descending antinociceptive pathways.",
        "Migraine is a neurovascular disorder that involves activation of the trigeminovascular system and cranial vasodilation mediated by release of calcitonin gene-related peptide (CGRP).",
        "Unfortunately, coronary arteries also express 5-HT<sub>1B</sub> receptors whose activation would produce coronary vasoconstriction; hence, triptans are contraindicated in patients with cardiovascular disease.",
        "Amongst the ditans, lasmiditan: (i) fails to constrict human coronary arteries; and (ii) is effective for the acute treatment of migraine in preliminary Phase III clinical trials.",
        "Ditans, here defined as selective 5-HT<sub>1F</sub> receptor agonists, were developed on the basis that most of the triptans activate trigeminal 5-HT<sub>1F</sub> receptors, which may explain part of the triptans' antimigraine action."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29488143": [
        "The advance in the development of 5-HT<sub>1</sub> receptor agonists for migraine, including 5-HT<sub>1B/D</sub> and 5-HT<sub>1F</sub> receptor agonists, has meant a major step forward towards the progression of a better treatment for migraine.",
        "Although ongoing phase III clinical trials are needed to confirm its efficacy and safety, lasmiditan might offer an alternative to treat acute migraine with no associated cardiovascular risk.",
        "Lasmiditan has much higher affinity for the 5-HT<sub>1F</sub> receptor than for the vasoconstrictor 5-HT<sub>1B</sub> receptor.",
        "Migraine is a common neurological disease characterised by the presence of attacks of unilateral, severe head pain accompanied by other symptoms.",
        "This review will focus on the characterisation of 5-HT<sub>1</sub> receptor agonists and their effects as migraine therapies.",
        "It is a well-tolerated compound that does not induce major adverse events.",
        "This has been confirmed in preclinical studies performed to date, where lasmiditan showed no effect on vasoconstriction, and in clinical trials, where healthy individuals and patients did not report cardiac events due to treatment with lasmiditan, although it should be confirmed in larger cohorts.",
        "Lasmiditan crosses the blood-brain barrier and may act both centrally and peripherally on 5-HT<sub>1F</sub> receptors expressed on trigeminal neurons.",
        "Triptans have a limited efficacy, and their effect on vasoconstriction makes them unsafe for patients with cardiovascular and/or cerebrovascular diseases.",
        "Therefore, novel effective antimigraine treatments without cardiovascular effects are required, such as selective 5-HT<sub>1F</sub> receptor agonists (ditans).",
        "Although it has been classified as the sixth most disabling disorder, the available therapeutic options to treat this condition have not progressed accordingly."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29563831": [
        "The cornerstone of pharmacological treatment is represented by the acute therapy.",
        "Since the introduction of triptans, no other acute drug class has passed all developmental stages.",
        "Lasmiditan is considered to be the first member of a new drug category, the neurally acting anti-migraine agent (NAAMA).",
        "The research for a new drug lacking vasoconstrictive effects led to the development of lasmiditan, a highly selective 5-HT1<sub>F</sub> receptor agonist with minimized interactions with other 5-HT receptor subtypes.",
        "The results of ongoing long-term Phase III trials will determine whether lasmiditan will become available in the market, and then active triptan comparator studies will assess patients' preference.",
        "Migraine is an important socioeconomic burden and is ranked the sixth cause of years of life lost because of disability in the general population and the third cause of years of life lost in people younger than 50 years.",
        "Future studies could then explore the safety during pregnancy and breastfeeding or the risk that overuse of lasmiditan leads to medication overuse headache.",
        "Phase II and III trials had shown superiority compared to placebo and absence of typical triptan-associated adverse events (AEs).",
        "Moreover, their mechanism of action based on vasoconstriction makes them unsuitable for patients with previous cardio- and cerebrovascular diseases and for those with uncontrolled hypertension.",
        "Most of the AEs were related to the central nervous system, depending on the high permeability through the blood-brain barrier and mild to moderate severity.",
        "The serotonin (5-hydroxytryptamine [5-HT]) receptor subtype 1<sub>B</sub>/1<sub>D</sub> agonists, called triptans, are nowadays the first-line acute therapy for patients who experience moderate-to-severe migraine attacks.",
        "Unfortunately, a high percentage of patients are not satisfied with this acute treatment, either for lack of response or side effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30323656": [
        "Preferential 5-HT<sub>1F</sub> agonists have shown promising results in in vitro and early proof-of-concept trials.",
        "Research to date suggests lasmiditan lacks vasoconstrictive properties and may be a safe and effective treatment option in patients refractory to current acute migraine medications or who have cardiovascular risk factors.",
        "Lasmiditan, a highly selective 5-HT<sub>1F</sub> agonist, has completed two Phase III randomized, double blind, placebo-controlled clinical trials, with a third - a long-term, open-label safety study - still underway.",
        "There is a large percentage of non-responders to current acute migraine treatments and the vasoconstriction associated with triptans limit their use in patients with pre-existing cardiovascular risk factors.",
        "Now that the vascular hypothesis of migraine is no longer the prevailing theory of migraine pathogenesis, there is interest in developing acute migraine treatments that act exclusively on non-vascular targets."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30446595": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess the efficacy and safety of lasmiditan in the acute treatment of migraine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22430431": [
        "For lasmiditan 400 mg, HR was 64 % and it was 25 % for placebo.",
        "Two RCTs in the phase II development of lasmiditan was reviewed.",
        "Larger studies including the parameters of patients' preferences are necessary to accurately position this new treatment principle in relation to the triptans.",
        "Adverse events (AEs) emerging from the treatment were reported by 22 % of the patients receiving placebo and by 65, 73, 87 and 87 % of patients receiving 50, 100, 200 and 400 mg, respectively.",
        "In the intravenous placebo-controlled RCT, lasmiditan doses of 2.5-45 mg were used, and there was a linear association between headache relief (HR) rates and dose levels (P &lt; 0.02).",
        "In the oral placebo-controlled RCT, lasmiditan doses of 50, 100, 200 and 400 mg were used.",
        "For HR, all doses of lasmiditan were superior to placebo (P &lt; 0.05).",
        "The majority of AEs after lasmiditan 100 and 400 mg were moderate or severe.",
        "If confirmed in larger studies in phase III, this might adversely limit the use of this highly specific non-vascular acute treatment of migraine.",
        "While lasmiditan most likely is effective in the treatment of migraine attacks it had, unfortunately, a high incidence of CNS related AEs in the oral RCT.",
        "For lasmiditan 20 mg, HR was 64 % and for placebo it was 45 % (NS).",
        "For the understanding of migraine pathophysiology, it is very important to note that a selective 5-HT(1F) receptor agonist like lasmiditan is effective in the acute treatment of migraine.",
        "Thus, migraine can be treated with a drug that has no vasoconstrictor ability.",
        "Lasmiditan is a novel selective 5-HT(1F) receptor agonist.",
        "It is both scientifically and clinically relevant to review whether a 5-HT(1F) receptor agonist is effective in the acute treatment of migraine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20855362": [
        "Preclinical and early clinical experiments predict acute antimigraine efficacy of COL-144 that is mediated through a non-vascular, primarily neural, mechanism.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Lasmiditan (COL-144; LY573144) is a novel, highly selective and potent agonist at 5-HT(1F) receptors that lacks vasoconstrictor activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22459549": [
        "We aimed to assess the efficacy and safety of oral lasmiditan for the acute treatment of migraine.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Lasmiditan (COL-144) is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28103158": [
        "The 5-HT<sub>1F</sub> receptor agonist lasmiditan, a drug acting through non-vasoconstrictive mechanisms, represents a promising safe, effective and tolerated acute migraine therapy also for patients at cardiovascular risk.",
        "Expert opinion: Data from our overview on investigational drugs in phase I and II clinical trials using the 5-HT<sub>1B/1D</sub> receptor agonist (sumatriptan TDS), 5-HT<sub>1D</sub> receptor agonist (PNU-142633), 5-HT<sub>1F</sub> receptor agonists (LY334370, lasmiditan) and a combined 5-HT<sub>1B/1D</sub> receptor agonist with nNOS inhibition (NOX-188) provided encouraging data for sumatriptan TDS and lasmiditan, disappointing results for PNU-142633, and promising findings for NOX-188.",
        "Research has focused on serotonin (5-HT) 5-HT<sub>1D</sub> and 5-HT<sub>1F</sub> receptors to develop drugs acting through non-vasoconstrictive mechanisms for treating acute migraine and those targeting 5-HT<sub>2B</sub> and 5-HT<sub>7</sub> receptors for preventing migraine.",
        "The negative results for the PNU-142633 trial prompt further studies using specific compounds more precisely targeting 5-HT<sub>1D</sub> receptors.",
        "Antagonism at 5-HT<sub>2B</sub> and 5-TH<sub>7</sub> receptors, a promising strategy to prevent migraine, is still limited to experimental migraine models.",
        "Areas covered: This paper reviews antimigraine drugs targeting 5-HT receptors in one phase I trial (sumatriptan iontophoretic transdermal system, TDS) and five phase II clinical trials (PNU-142633, LY334370, lasmiditan, NOX-188).",
        "Upcoming phase III trials should clarify the optimal lasmiditan dose and eventual clinical advantages over triptans."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29098075": [
        "Migraine remains one of the most disabling disorders worldwide.",
        "Within the past few years, new and promising drugs such as more specific 5-HT 1F receptor agonists (that is, lasmiditan) and monoclonal calcitonin gene-related peptide (CGRP) receptor antibodies entered advanced development phases while non-invasive neuromodulatory approaches were suggested to be potentially effective as non-pharmaceutical interventions for migraine.",
        "The introduction of specific anti-migraine treatment occurred over 20 years ago when the first triptan was approved by regulatory authorities (sumatriptan, 28 December 1992).",
        "The high prevalence in the general population and the often-delicate treatment of patients account for that.",
        "Triptan use is limited by side effects, time- and frequency-restricted application, and the risk of developing medication overuse headache.",
        "Therapeutic management of migraine relies mainly on non-specific medical treatment and is affected by low patient adherence to the treatment regimens applied."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29059031": [
        "We believe this is the first report of severe dolutegravir-related hepatotoxicity resulting in sub-acute liver failure and transplantation and highlights a potential need for closer monitoring after drug initiation.",
        "The patient was not a carrier of HLA-B5701, and abacavir hypersensitivity was unlikely.",
        "A patient with human immunodeficiency virus-1 infection presented with sub-acute liver failure, temporally related to commencement of an antiretroviral therapy regimen containing dolutegravir (Triumeq)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29105160": [
        "This review provides an overview of the clinical efficacy and safety data for these coformulated agents, highlighting the relative impact on comparative adverse events, assessing the potential for experiencing fewer drug-drug interactions, and discussing the clinical implications regarding adherence to treatment.",
        "Notably, the novel pharmacokinetic booster COBI, with its water soluble properties, has enabled the development and coformulation of a few of these STRs and FDCs.",
        "Recently approved FDCs, such as atazanavir (ATV)/COBI (Evotaz; Bristol-Myers Squibb, Princeton, NJ), darunavir (DRV)/COBI (Prezcobix; Janssen Products, Titusville NJ), and FTC/TAF (Descovy; Gilead), are also now available.",
        "The Department of Health and Human Services treatment guidelines for HIV recommend many of these integrase strand transfer inhibitor (INSTI) STRs as a preferred choice for initiation of treatment in both ART-naive and -experienced patients because they offer comparably faster rates of virologic suppression, reduced rates of resistance development (especially with DTG), and overall better adherence than protease inhibitors or NNRTIs.",
        "Further simplification regimens comprising dual ART therapies are currently being explored.",
        "Antiretroviral (ART) therapy for the treatment of human immunodeficiency virus (HIV) infection has undergone significant changes over the past 30 years.",
        "Many single-tablet regimens (STRs), including newer fixed-dose combination (FDC) tablets, are available, offering patients several options for choosing a treatment regimen that works best for them.",
        "Numerous phase 3 clinical trials support these recommendations including several switch or simplification clinical trials.",
        "Also, a newer tenofovir salt formulation, TAF, has an advantageous pharmacokinetic profile, contributing to better overall renal and bone tolerability compared with TDF.",
        "Given these changes, patients are more likely to adhere to treatment, achieve better clinical outcomes, and experience both fewer side effects and drug-drug interactions.",
        "Newer STRs include dolutegravir (DTG)/lamivudine (3TC)/abacavir (ABC) (Triumeq; Viiv Healthcare, Research Triangle Park, NC), rilpivirine (RPV)/emtricitabine (FTC)/tenofovir alafenamide (TAF) (Odefsey; Gilead, Foster City, CA), RPV/FTC/tenofovir disoproxil fumarate (TDF) (Complera; Gilead), elvitegravir (EVG)/cobicistat (COBI)/FTC/TDF (Stribild; Gilead), and EVG/COBI/FTC/TAF (Genvoya; Gilead)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29533918": [
        "An overdose of abacavir and lamivudine can cause mitochondrial toxicity and lactic acidosis.",
        "An intoxication with Triumeq can lead to several side effects.",
        "An intoxication with dolutegravir appears to be relatively harmless.",
        "Overdoses with Triumeq have not been reported previously.",
        "As Triumeq will be used on a regular basis as treatment for patients with HIV-1 infection, these intoxications are expected to be encountered more often.",
        "Triumeq is a single-tablet regimen for patients with HIV infection comprising dolutegravir, abacavir and lamivudine.",
        "We present a case of a 26-year-old man who presented to our hospital after intentionally ingesting 30 tablets of Triumeq."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29796595": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      If HIV patients are unconscious or cannot swallow tablets for other reasons, antiretroviral medication is crushed and dissolved prior to administration.",
        "Currently, there is no information about crushing of the branded fixed-dose combination of dolutegravir/abacavir/lamivudine (Triumeq\u00ae, referred to as TRI); therefore, crushing of TRI is not recommended.",
        "Crushing can alter drug exposure, possibly leading to treatment failure, development of resistance or toxicity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27530904": [
        "We report this case to highlight the possibility of a severe hypersensitivity reaction as an important potential consequence of couples, living with HIV, sharing anti-retroviral treatment.",
        "On the second occasion, re-introduction resulted in whole body rash 4 h post dose and was associated with fever, respiratory symptoms, headache and vomiting.",
        "This potentially could become an increasing problem with more couples, living with HIV, sharing medication.",
        "Re-challenge can result in a more rapid, severe and potentially life-threatening reaction.",
        "An HIV-1 positive and carrier of HLA-B*57:01 allele, treatment experienced man was commenced one pill Regimen Stribild (tenofovir, emtricitabine, elvitegravir and cobicistat) in July 2015.",
        "On running short of medication, he admitted to sharing his partner's treatment (Triumeq; abacavir, lamivudine and dolutegravir).",
        "On examination, he was pyrexic, tachyponeic, tachycardiac and hypotensive.",
        "Hypersensitivity to abacavir can cause significant morbidity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28748198": [
        "Drug-induced liver injury related to Triumeq (abacavir/lamivudine/dolutegravir) has not been reported in clinical trials.",
        "We report a case of hepatotoxicity related to Triumeq exposure in a human immunodeficiency virus-infected patient.",
        "Close monitoring is recommended.",
        "Clinicians should remain aware of the risk for acute and late-onset hepatitis with these agents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25395816": [
        "Naltrexone/bupropion (Contrave) for weight management; pembrolizumab (Keytruda) for melanoma; dolutegravir/abacavir/lamivudine (Triumeq) for HIV-1; and immune globulin infusion 10% (human) with recombinant human hyaluronidase (Hyqvia) for primary immunodeficiency."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27912079": [
        "Cessation of therapy resulted in viral rebound and CD4 T cell loss.",
        "Our results showed that hu-mice are susceptible to HIV-2 infection showing persistent viremia and CD4 T cell loss, key hallmarks of AIDS pathogenesis.",
        "These proof-of-concept studies establish the utility of hu-mice for evaluating HIV-2 pathogenesis in more detail in the future, testing novel therapies and providing pre-clinical efficacy data of a three drug combination to treat HIV-2 infections.",
        "While HIV-2 is a causative agent for AIDS in addition to the better studied HIV-1, there is currently no suitable animal model for experimental studies for HIV-2 infection and evaluating promising drugs in vivo.",
        "Here we evaluated humanized mice for their susceptibility to HIV-2 infection and tested a single-pill three drug formulation of anti-retrovirals (NRTIs abacavir and lamivudine, integrase inhibitor dolutegravir) (trade name, Triumeq<sup>R</sup>).",
        "Oral drug treatment led to full viral suppression and protection from CD4 T cell depletion."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29028902": [
        "Using the kernel matrices computed by the package, we can easily perform tasks such as classification, regression and clustering on graph-structured samples.",
        "Graph kernels have been proposed as a powerful and efficient approach to this problem of graph comparison.",
        "Here we provide graphkernels, the first R and Python graph kernel libraries including baseline kernels such as label histogram based kernels, classic graph kernels such as random walk based kernels, and the state-of-the-art Weisfeiler-Lehman graph kernel.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      Measuring the similarity of graphs is a fundamental step in the analysis of graph-structured data, which is omnipresent in computational biology.",
        "The core of all graph kernels is implemented in C ++ for efficiency."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28460612": [
        "Diagnostic modalities include liver biopsy, ultrasonography, CT scan, immunological tests like ELISA and IIFT.",
        "Clinical presentation mainly consists of fever, abdominal pain, hepatomegaly and eosinophilia.",
        "Spurious infection with unembryonated eggs cause gastrointestinal symptoms.",
        "Zoonotic infections are increasingly becoming public health menaces and are usually transmitted to humans due to unsuitable environmental conditions.",
        "Although its prevalence is very low, it can cause significant morbidity and mortality, with cases reported from all over the world.",
        "The study emphasizes the need for hepatic capillariasis to be considered as a differential diagnosis in cases of suspected hepatitis, leptospirosis, abdominal lymphadenopathy or other hepatic or parasitic infections prevalent in the region concerned; and meticulously assess the cases to facilitate early diagnosis and prompt treatment, thus reducing the distress faced by patients.",
        "The larvae mature and reproduce, and eventually form embryonated eggs, which cause chronic focal inflammation and septal hepatic fibrosis.",
        "The main infective form for humans is the embryonated egg of the parasite, which hatches in the intestine and ultimately colonize the liver.",
        "The infection can be treated mainly with a combination of benzimidazoles like thiabendazole, mebendazole and albendazole; with corticosteroids.",
        "One of them is hepatic capillariasis, caused by the parasite Capillaria hepatica, primarily a disease of rodents, with hepatic manifestations in humans."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25911041": [
        "Capillaria hepatica which accidentally infects humans is a zoonotic parasite of mammalian liver, primarily rodents and causes hepatic capillariasis.",
        "The diagnosis is difficult because of the non-specific nature of clinical symptoms, leading to misdiagnosis and can be confirmed only through liver biopsy or on autopsy results.",
        "This paper is written with an objective to report a new case of hepatic capillariasis as a rare differential for peripheral eosinophilia and an imaging dilemma for abdominal lymphadenopathy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20135717": [
        "This review mainly focuses on the biological characteristics and epidemiology of C. hepatica in China and histopathologic changes in the liver, with expectation of gaining a better understanding of the disease and seeking more effective treatment.",
        "Ecologic studies showed that the first hosts of C. hepatica were rodents, among which rats had relatively high infection rates, which explains why C. hepatica spreads globally.",
        "Capillaria hepatica (C. hepatica) is a parasitic nematode causing hepatic capillariasis in numerous mammals.",
        "Although C. hepatica might lead to serious liver disorders, relevant clinical reports were rare, because of the non-specific nature of clinical symptoms, leading to misdiagnosis.",
        "Anatomical studies showed that the liver was the principal site of colonization by these parasites and physical damage tended to occur."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29688815": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Recombinant human tripeptidyl peptidase 1 (cerliponase alfa) is an enzyme-replacement therapy that has been developed to treat neuronal ceroid lipofuscinosis type 2 (CLN2) disease, a rare lysosomal disorder that causes progressive dementia in children."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30205177": [
        "Therefore, the development of an ADA response to cerliponase alfa is not predictive of an adverse safety profile or poor treatment outcome.",
        "No events of anaphylaxis were reported.",
        "Treatment was associated with anti-drug antibody (ADA) production in the cerebrospinal fluid (CSF) of 6/24 (25%) and in the serum of 19/24 (79%) of clinical trial subjects, respectively, over a mean exposure of 96.4 weeks (range 0.1-129 weeks).",
        "Neutralizing antibodies (NAb) were not detected in the CSF of any of the subjects.",
        "Serum and CSF ADA titers did not correlate with change in ML score.",
        "Neither the presence of serum ADA nor drug-specific immunoglobulin E was associated with the incidence or severity of hypersensitivity adverse events.",
        "Treatment with intracerebroventricular (ICV)-delivered cerliponase alfa enzyme replacement therapy (ERT) in a Phase 1/2 study of 24 subjects with CLN2 disease resulted in a meaningful preservation of motor and language (ML) function and was well tolerated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28589525": [
        "This article summarizes the milestones in the development of cerliponase alfa leading to its first global approval in the USA for the treatment of motor function loss in paediatric patients \u22653 years of age with CLN2, and subsequent approval in the EU for CLN2 in all ages.",
        "Cerliponase alfa (Brineura\u2122) is a recombinant human tripeptidyl peptidase-1 (TPP1) being developed by BioMarin Pharmaceutical Inc. for use in patients with neuronal ceroid lipofuscinosis type 2 (CLN2), a paediatric neurodegenerative disease caused by a deficiency in TPP1.",
        "CLN2 is characterised by progressive impairment of motor function, language deficiencies, seizures, ataxia, blindness and early death, and intracerebroventricular infusion of cerliponase alfa has been shown to reduce the progression of functional decline."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28890641": [
        "Sarilumab (Kevzara) for moderately to severely active rheumatoid arthritis; valbenazine (Ingrezza), the first approval for tardive dyskinesia; and cerliponase alpha (Brineura) for late infantile neuronal ceroid lipofuscinosis type-2 disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28097393": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      This study aimed to assess the relative efficacy and safety of once-daily baricitinib 2 mg and 4 mg administration in patients with active rheumatoid arthritis (RA)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28440680": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      The objective of this study is to evaluate the efficacy and safety of long-term (64 weeks; 52-week extension of a 12-week study) baricitinib treatment in Japanese patients with active rheumatoid arthritis (RA) despite methotrexate therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28811354": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess the safety and efficacy of baricitinib in patients with rheumatoid arthritis (RA) up to 128 weeks in a phase IIb study (<a href=\"http://clinicaltrials.gov/show/NCT01185353\" title=\"See in ClinicalTrials.gov\">NCT01185353</a>)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29134891": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      To evaluate efficacy/safety of baricitinib for rheumatoid arthritis (RA) in Japanese subpopulations from four phase 3 studies, and assess whether results in these subpopulations are consistent with the overall study populations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29415145": [
        "We evaluated the effects of baseline characteristics, including prior bDMARD exposure, on baricitinib efficacy and safety.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      RA patients who have failed biologic DMARDs (bDMARDs) represent an unmet medical need."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30006916": [
        "Compared to placebo, 2 mg of baricitinib was more effective in achieving ACR20 [54 vs. 36.6%; OR 2.09; 95% CI 1.60-2.71; p &lt; 0.00001; I<sup>2</sup> 0%], ACR50 [31.6 vs. 10.3%; OR 2.3; 95% CI 1.68-3.15; p &lt; 0.00001; I<sup>2</sup> 0%], and ACR70 responses [18.7 vs. 5.1%; OR 4.05; 95% CI 2.54-6.44; p &lt; 0.00001; I<sup>2</sup> 0%].",
        "Baricitinib is an oral, selective JAK 1 and 2 inhibitor which has been shown to be effective in the treatment of RA in several clinical trials.",
        "We used RevMan 5.3 to perform meta-analysis between groups on baricitinib (2 and 4 mg daily) and placebo using random effect model calculating odds ratio (OR) as well as 95% confidence interval (CI).",
        "We excluded meeting abstracts without full text publication.",
        "Baricitinib 2 mg once daily did not increase any adverse events [65.3 vs. 62.4%; OR 1.03; 95% CI 0.80-1.34; p = 0.8; I<sup>2</sup> 0%], serious adverse events [3.5 vs. 5%; OR 0.68; 95% CI 0.37-1.27; p = 0.22; I<sup>2</sup> 0%], and herpes zoster [1.2 vs. 0.4%; OR 2.34; 95% CI 0.27-20.47; p = 0.44; I<sup>2</sup> 37%] as compared to placebo.",
        "Baricitinib is effective in treatment of RA, and did not appear to have significant safety concerns during the first 6 months of treatment.",
        "We searched PubMed, EMBASE, and Cochrane CENTRAL from inception through 09/24/17 with restriction to English language.",
        "Similarly, 4 mg of baricitinib did not increase the risk of serious adverse events but increased herpes zoster infection [OR 3.88; 95% CI 1.36-11.06; p = 0.01; I<sup>2</sup> 0%] when compared to placebo.",
        "Janus kinases (JAKs) play an important role in intracellular signaling for multiple cytokines in the pathogenesis of RA.",
        "This meta-analysis aims to aggregate currently available data to assess the overall efficacy and safety of baricitinib in RA.",
        "Similarly, 4 mg of baricitinib daily was more effective than placebo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30058112": [
        "This study was undertaken to analyze changes in lymphocyte cell subsets during baricitinib treatment and to correlate these changes with clinical outcomes.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Baricitinib is an orally administered inhibitor of JAK1 and JAK2 that has been shown to be effective in treating rheumatoid arthritis (RA)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24818516": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      The JAK kinases are a family of four tyrosine receptor kinases that play a pivotal role in cytokine receptor signalling pathways via their interaction with signal transducers and activators of transcription proteins.",
        "Selective inhibitors of JAK kinases are viewed as of considerable potential as disease-modifying anti-inflammatory drugs for the treatment of rheumatoid arthritis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30219772": [
        "We evaluated baricitinib's safety profile through 288 weeks (up to September 1, 2016) with an integrated database [8 phase III/II/Ib trials, 1 longterm extension (LTE)].",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Baricitinib is an oral, once-daily selective Janus kinase (JAK1/JAK2) inhibitor for adults with moderately to severely active rheumatoid arthritis (RA)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29500799": [
        "Concerns about baricitinib focus on clinical trial findings.",
        "There have been recent concerns about potential thromboembolic risks with these drugs.",
        "Observational studies suggest in the general population and non-RA controls there are one to four thromboembolic events per 1000 patient years.",
        "The impact of biologics and disease-modifying anti-rheumatic drugs (DMARDs) on disease risk appears minimal, and the number of thromboembolic events is between four and eight per 1000 patient years.",
        "Using all publically available data, we estimate thromboembolic risks are approximately five events per 1000 patient years with 4 mg baricitinib daily.",
        "Consequently, in the longer term, large observational studies are needed to accurately quantify thromboembolic risks attributable to JAK inhibitors and other drugs used to treat RA, and differentiate these from risks attributable to RA itself and its comorbidities.",
        "Two different Janus kinase (JAK) inhibitors-baricitinib and tofacitinib-are effective and licensed in active rheumatoid arthritis (RA).",
        "Concerns about tofacitinib have been raised by analyses of the Federal Drug Administration Adverse Event Reporting System (FAERs).",
        "These show some evidence of increased risks of pulmonary thrombosis, though not pulmonary embolism or venous thrombosis.",
        "As the numbers of thromboembolic events will be small and patients enrolled in trials are not representative of all RA patients who may receive JAK inhibitors, this information is unlikely to provide definitive answers.",
        "In RA, thromboembolic risks increase to three to seven per 1000 patient years.",
        "In the short term, full details of thromboembolic events in trials of JAK inhibitors need to be published."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27427830": [
        "There was a favorable response for clinical and functional parameters in studies with placebo, MTX and adalimumab as comparator.",
        "It is also reported that safety was tolerable within the limited study period.",
        "With the development of biological disease-modifying anti-rheumatic drugs (bDMARDs) and combination of conventional DMARDs, clinical remission is perceived as an appropriate and realistic goal in many patients.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Rheumatoid arthritis (RA) is characterized by systemic synovitis causing joint destruction.",
        "Under the circumstances, targeted synthetic DMARDs (tsDMARDs), which are orally available low-molecular weight products, have been emerging.",
        "Five phase 3 trials of Baricitinib, a JAK1 and JAK2 inhibitor, have been performed and showed high clinical efficacy in patients with active RA and na\u00efve to sDMARDs or an inadequate response to sDMARDs, MTX or bDMARDs.",
        "However, bDMARDs require intravenous or subcutaneous injection and some patients fail to respond to bDMARDs or lose their primary response."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30183607": [
        "In this narrative review we aimed to provide an overview of the real-world evidence for tofacitinib in RA.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Oral targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs), including the Janus kinase inhibitors tofacitinib and baricitinib, are the latest addition to the therapeutic options for rheumatoid arthritis (RA).",
        "Tofacitinib 5 mg, twice daily, is approved for treatment, with or without methotrexate, of moderate to severe active RA in adults not adequately responding to, or not tolerating one or more DMARDs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28290136": [
        "Regulatory approval to market baricitinib as a treatment for RA has also been sought in the USA and Japan.",
        "In February 2017, baricitinib was approved in the EU, as monotherapy or in combination with methotrexate, for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs).",
        "JAKs transduce intracellular signals from cell surface receptors for various cytokines and growth factors involved in inflammation and immune function, suggesting JAK inhibitors may be of therapeutic benefit in inflammatory conditions.",
        "This article summarizes the milestones in the development of baricitinib leading to this first global approval for the treatment for moderate to severe active RA in adult patients who have responded inadequately to, or are intolerant to one or more DMARDs.",
        "Baricitinib (Olumiant\u2122) is an orally-administered, small-molecule, janus-associated kinase (JAK) inhibitor developed by Eli Lilly and Incyte Corporation for the treatment of rheumatoid arthritis (RA), atopic dermatitis and systemic lupus erythematosus."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30191390": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      The relative efficacy and safety of tofacitinib and baricitinib were assessed in patients with rheumatoid arthritis (RA) with an inadequate response to disease-modifying anti-rheumatic drugs (DMARDs) or biologics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28199814": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Baricitinib is an oral, reversible inhibitor of the Janus kinases JAK1 and JAK2 that may have therapeutic value in patients with rheumatoid arthritis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29687421": [
        "This novel, small molecule is approved for use as monotherapy, or in combination with methotrexate, for the treatment of adults with moderate to severe active RA who responded inadequately to or were intolerant of \u2265 1 DMARD.",
        "The onset of these benefits was generally rapid and sustained over time.",
        "Baricitinib was generally well tolerated during up to 5.5 years' treatment; the most commonly reported adverse drug reactions were upper respiratory tract infections, increased LDL cholesterol, nausea and thrombocytosis.",
        "Thus, once-daily baricitinib, as monotherapy or in combination with methotrexate, is an effective and generally well tolerated emerging treatment for patients with moderate to severe active RA who have responded inadequately to or are intolerant of \u2265 1 DMARD, and extends the options available for this population.",
        "In pivotal multinational trials, once-daily baricitinib 4 mg, with/without methotrexate (\u00b1 another csDMARD), improved the signs and symptoms of RA, disease activity and physical function in DMARD-naive patients and in patients with an inadequate response to methotrexate, csDMARDs or TNF inhibitors; baricitinib treatment also slowed structural joint damage in DMARD-naive patients and in those with an inadequate response to methotrexate and csDMARDs.",
        "Baricitinib plus methotrexate was more effective than adalimumab plus methotrexate in patients with an inadequate response to methotrexate.",
        "Baricitinib (Olumiant<sup>\u00ae</sup>) is an oral, targeted synthetic DMARD that inhibits JAK1 and JAK2, which are implicated in the pathogenesis of rheumatoid arthritis (RA)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28930534": [
        "The poly(ADP-ribose) polymerases (PARPs) catalyze poly(ADP-ribosyl)ation, a post-translational modification of proteins.",
        "Hence, PARP1 inhibitors have become a promising therapeutic approach for human diseases including cancer.",
        "In this review, we describe the importance of PTMs to regulate the activity of PARP1, and the involvement of dysregulation of PTMs in human cancer.",
        "PARP1 is the most abundant and best-characterized member of the family of PARP enzymes.",
        "PARP1 plays key roles in DNA repair, as well as a wide variety of cellular processes, including transcriptional regulation, chromatin modulation, cellular signaling pathway, inflammation, cellular stress responses and so on.",
        "Recent studies indicate that post-translational modifications (PTMs) such as phosphorylation, acetylation, and methylation are crucial for the regulation of PARP1 activity, and dysregulation of modifications on PARP1 is observed in human cancer.",
        "This consists of the attachment of mono- or poly-<i><i>adenosine diphosphate</i></i> (ADP)-ribose units from nicotinamide adenine dinucleotide (NAD<sup>+</sup>) to specific polar residues of target proteins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22053002": [
        "Poly(ADP-ribose)polymerase-1 (PARP1) is a chromatin-associated enzyme that was described to affect chromatin compaction.",
        "Our results also reveal a PAR-dependent decrease in repressory histone marks (e.g. H3K9me3) and an increase in stimulatory marks (e.g. H3K4me3) at the PPAR\u03b32 promoter, suggesting that PARP1 may exert its regulatory function during adipogenesis by altering histone marks.",
        "Our results show that PARP1-dependent ADP-ribose polymer (PAR) formation increases during adipocyte development and, at late time points of adipogenesis, is involved in the sustained expression of PPAR\u03b32 and of PPAR\u03b32 target genes.",
        "Together, our study identifies PARP1 as a critical regulator of PPAR\u03b32-dependent gene expression with implications in adipocyte function and obesity-related disease models.",
        "Interestingly, activation of PARP1 enzymatic activity was prevented with a topoisomerase II inhibitor.",
        "During adipogenesis, PARP1 was recruited to PPAR\u03b32 target genes such as CD36 or aP2 in a PAR-dependent manner.",
        "These data hint at topoisomerase II-dependent, transient, site-specific double-strand DNA breaks as the cause for poly(ADP)-ribose formation, adipogenic gene expression, and adipocyte function.",
        "Previous reports suggested a dynamic modulation of the chromatin landscape during adipocyte differentiation.",
        "We thus hypothesized that PARP1 plays an important transcriptional role in adipogenesis and metabolism and therefore used adipocyte development and function as a model to elucidate the molecular action of PARP1 in obesity-related diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19622798": [
        "PARP1 functions as a transcriptional coactivator of nuclear factor kappaB (NF-kappaB) and hypoxia inducible factor 1 (HIF1).",
        "Here, we characterize PARP1 as a substrate for modification by SUMO1 and SUMO3, both in vitro and in vivo.",
        "PARP1 is sumoylated at the single lysine residue K486 within its automodification domain.",
        "Genetic complementation of PARP1-depleted cells with wild-type and sumoylation-deficient PARP1 revealed that SUMO modification of PARP1 restrains its transcriptional coactivator function and subsequently reduces gene expression of distinct PARP1-regulated target genes.",
        "At the cellular level, PARP1 has been implicated in a wide range of processes, such as maintenance of genome stability, cell death, and transcription.",
        "In proteomic studies, PARP1 was found to be modified by small ubiquitin-like modifiers (SUMOs).",
        "Poly(ADP-ribose) polymerase 1 (PARP1) is a chromatin-associated nuclear protein and functions as a molecular stress sensor.",
        "Interestingly, modification of PARP1 with SUMO does not affect its ADP-ribosylation activity but completely abrogates p300-mediated acetylation of PARP1, revealing an intriguing crosstalk of sumoylation and acetylation on PARP1."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24782312": [
        "In this work we identify a physical and functional poly(ADP-ribose)-mediated interaction of PARP1 with the E3 ubiquitin ligase UHRF1 (also known as NP95, ICBP90) that influences two UHRF1-regulated cellular processes.",
        "On the other hand, we showed that PARP1 controls the UHRF1-mediated ubiquitination of DNMT1 to timely regulate its abundance during S and G2 phase.",
        "On the one hand, we uncovered a cooperative interplay between PARP1 and UHRF1 in the accumulation of the heterochromatin repressive mark H4K20me3.",
        "The absence of PARP1 led to reduced accumulation of H4K20me3 onto pericentric heterochromatin that coincided with abnormally enhanced transcription.",
        "In contrast, although PARP1 also seemed to facilitate the association of UHRF1 with DNMT1, its absence did not impair the loading of DNMT1 onto heterochromatin or the methylation of pericentric regions, possibly owing to a compensating interaction of DNMT1 with PCNA.",
        "The loss of H4K20me3 was rescued by the additional depletion of UHRF1.",
        "Together, this report identifies PARP1 as a novel modulator of two UHRF1-regulated heterochromatin-associated events: the accumulation of H4K20me3 and the clearance of DNMT1.",
        "Poly(ADP-ribose) polymerase 1 (PARP1, also known as ARTD1) is an abundant nuclear enzyme that plays important roles in DNA repair, gene transcription, and differentiation through the modulation of chromatin structure and function."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29851986": [
        "In this study, we have employed genetic deletion and chemical inhibition approaches to determine the role of PARP1 in maintaining mtDNA dependent mitochondrial function in Chagas disease.",
        "We conclude that PARP1 overexpression is associated with a decline in Pol \u03b3-dependent maintenance of mtDNA content, mtDNA-encoded gene expression, and mitochondrial respiratory function, and subsequently contributes to an increase in mtROS and oxidative stress in chagasic myocardium.",
        "Our data show that expression of PARP1 and protein PARylation were increased by &gt;2-fold and &gt;16-fold, respectively, in the cytosolic, nuclear, and mitochondrial fractions of the human cardiac myocytes and the myocardium of wildtype (WT) mice chronically infected with T. cruzi.",
        "Chagasic cardiomyopathy is caused by Trypanosoma cruzi infection.",
        "However, PARP1 binding to Polymerase \u03b3 and mtDNA in mitochondria were increased, and associated with a loss in mtDNA content, mtDNA-encoded gene expression, and oxidative phosphorylation (OXPHOS) capacity, and an increase in mitochondrial ROS production in cells and heart of WT mice infected with T. cruzi.",
        "Genetic deletion of PARP1 or treatment with selective inhibitor of PARP1 (PJ34) improved the mtDNA content, mitochondrial function, and oxidant/antioxidant balance in human cardiomyocytes and chronically infected mice.",
        "Inhibition of mitochondrial PARP1/PAR offers a novel therapy in preserving the mitochondrial and LV function in chronic Chagas disease.",
        "The nuclear and cytosolic PARP1/PAR did not interfere with the transcription and translation of the components of the mtDNA replisome machinery in infected cardiomyocytes and chagasic murine myocardium.",
        "Further, PARP1 inhibition was beneficial in preserving the cardiac structure and left ventricular function in chagasic mice.",
        "Poly(ADP-ribose) polymerase 1 (PARP1) is known for its function in nuclear DNA repair.",
        "Subsequently, an increase in oxidative stress, and cardiac collagen deposition, and a decline in LV function was noted in chagasic mice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27440880": [
        "In this study, we detail the mechanisms that drive cellular PARylation during latent EBV infection and the effects of PARylation on host gene expression and cellular function.",
        "We identified a positive association between expression of the EBV genome-encoded latency membrane protein 1 (LMP1) and PAR levels that was dependent upon PARP1.",
        "Moreover, cellular PAR levels were up to 2-fold greater in type III than type I latently infected EBV B cells.",
        "PARP1 regulates gene expression by numerous mechanisms, including modifying chromatin structure and altering the function of chromatin-modifying enzymes.",
        "Inhibition of PARP1, or abrogation of PARP1 expression, also suppressed the expression of LMP1-activated genes and LMP1-mediated cellular transformation, demonstrating an essential role for PARP1 activity in LMP1-induced gene expression and cellular transformation associated with LMP1.",
        "The latent infection of Epstein-Barr virus (EBV) is associated with 1% of human cancer incidence.",
        "PARP1 inhibition resulted in the accumulation of the repressive histone mark H3K27me3 at a subset of LMP1-regulated genes.",
        "Poly(ADP-ribosyl)ation (PARylation) is a posttranslational modification catalyzed by poly(ADP-ribose) polymerases (PARPs) that mediate EBV replication during latency.",
        "Since LMP1 is essential in establishing EBV latency and promoting tumorigenesis, we explored the model that disruption in cellular PARylation, driven by LMP1 expression, subsequently promotes epigenetic alterations to elicit changes in host gene expression.",
        "EBV-infected B cells had higher PAR levels than EBV-negative B cells.",
        "In summary, we identified a novel mechanism by which LMP1 drives expression of host tumor-promoting genes by blocking generation of the inhibitory histone modification H3K27me3 through PARP1 activation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21543585": [
        "Accumulation of the pre-mutagenic 8-hydroxy-2'-deoxyguanosine and elevated PARP1 expression were found both in asbestos-exposed subjects and MM patients.",
        "We propose that exposure to asbestos inhibits the PARP1 activity possibly resulting in higher DNA instability, thus causing malignant transformation.",
        "To determine whether PARP1 is involved in asbestos-induced carcinogenesis, PARP1 expression and activity as well as DNA damage and repair were evaluated in circulating cells of asbestos-exposed subjects, MM patients and age-matched controls.",
        "PARP1 expression and activity were also evaluated in pleural biopsies of MM patients and compared with normal tissue.",
        "Although PARP1 was highly expressed, its activity was relatively low.",
        "Asbestos is known to induce malignant mesothelioma (MM) and other asbestos-related diseases.",
        "Low DNA repair efficiency was observed in lymphocytes from MM patients.",
        "Poly(ADP-ribose) polymerase-1 (PARP1) is a nuclear zinc-finger protein with a function as a DNA damage sensor.",
        "It is directly genotoxic by inducing DNA strand breaks and cytotoxic by promoting apoptosis in lung target cells.",
        "To mimic PARP1 dysfunction, PARP1 expression and activity were induced in immortalised mesothelial cells by their exposure to asbestos in the presence of a PARP1 inhibitor, which resulted in transformation of the cells.",
        "High expression of PARP1 associated with low PARP activity was also found in MM biopsies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26184161": [
        "In this review, the biological significance of Parp1 in transcription and the epigenetic modulation of Parp1 in pluripotent status, reprogramming process and cancer will be summarized.",
        "Furthermore, epigenetic modulation of Parp1 is explored for regulating wide variety of gene expression.",
        "Taken together, the proximity toward the understanding of the modulation of Parp1 including interaction and modification in different fields will provide new insight for future studies.",
        "Genetic and pharmaceutical disruption of Parp1 further confirmed the importance of Parp1 in cell growth, DNA repair, and reprogramming efficiency.",
        "Poly(ADP-ribos)ylation (PARylation) is the catalytic function of the Poly(ADP-ribose) polymerases (Parps) family for post-translational modification in cellular process.",
        "In addition, high expression level and activity of Parp1 are correlated with pluripotent status, reprogramming, and cancer.",
        "Being a major member of Parps, Parp1 is a crucial nuclear factor with biological significance in modulating DNA repair, DNA replication, transcription, DNA methylation and chromatin remodeling through PARylation of downstream proteins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28978478": [
        "Furthermore, semagacestat inhibits release of de novo intramembranous \u03b3-byproducts to the soluble space.",
        "Semagacestat increases intracellular byproduct peptides, produced along with A\u03b2 through serial \u03b3-cleavage of \u03b2APP, as well as intracellular long A\u03b2 species, in cell-based and in vivo studies of AD model mice.",
        "\u03b3-secretase inhibitors (GSI) are drugs developed to decrease amyloid-\u03b2 peptide (A\u03b2) production by inhibiting intramembranous cleavage of \u03b2-amyloid protein precursor (\u03b2APP).",
        "Other potential non-TSA GSIs, but not L685,458, a TSA GSI, have similar effects.",
        "Thus, semagacestat is a pseudo-GSI, and therefore, the semagacestat clinical trial did not truly test the A\u03b2 hypothesis.",
        "Here, we show that some semagacestat effects are clearly different from a phenotype caused by a loss of function of presenilins, core proteins in the \u03b3-secretase complex.",
        "However, a large phase 3 trial of semagacestat, a potential non-transition state analog (non-TSA) GSI, in patients with Alzheimer's disease (AD) was terminated due to unexpected aggravation of cognitive deficits and side effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27567808": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      In a recent report, 76 weeks' treatment with a gamma-secretase inhibitor (semagacestat) was associated with poorer cognitive outcomes in Alzheimer's disease (AD)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25292430": [
        "Evolving insights suggest that selective inhibition of one of these proteases, or more subtle modulation of \u03b3-secretases by stimulating their carboxypeptidase-like activity but sparing their endopeptidase activity, are potentially highly interesting approaches.",
        "\u03b3-Secretases are a group of widely expressed, intramembrane-cleaving proteases involved in many physiological processes.",
        "The rapidly growing knowledge of regulation, assembly, and specificity of these intriguing protein complexes and the potential advent of high-resolution structural information could dramatically change the perspective on safe and efficacious \u03b3-secretase inhibition in various disorders.",
        "Their clinical relevance comes from their involvement in Alzheimer's disease, cancer, and other disorders.",
        "A clinical trial with the wide-spectrum \u03b3-secretase inhibitor semagacestat has, however, demonstrated that global inhibition of all \u03b3-secretases causes serious toxicity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24983746": [
        "To assist in future development of \u03b3-secretase inhibitors, we report detailed safety findings from the IDENTITY study, with emphasis on those that might be mechanistically linked to \u03b3-secretase inhibition.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Semagacestat, a \u03b3-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23883379": [
        "Semagacestat is a small-molecule \u03b3-secretase inhibitor that was developed as a potential treatment for Alzheimer's disease.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Alzheimer's disease is characterized by the presence of cortical amyloid-beta (A\u03b2) protein plaques, which result from the sequential action of \u03b2-secretase and \u03b3-secretase on amyloid precursor protein."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23785331": [
        "In the present study the effects of the \u03b3-secretase inhibitor semagacestat was evaluated in preclinical in vivo electrophysiological models.",
        "Acute, subcutaneous administration of semagacestat (100 mg/kg) produced a similar effect on hippocampal activity.",
        "Field potentials were recorded across the hippocampal formation with NeuroNexus multi-site silicon probes in urethane anesthetized male C57BL/6 mice; hippocampal CA1 theta oscillation was elicited by electrical stimulation of the brainstem nucleus pontis oralis.",
        "Sub-chronic administration of semagacestat twice daily over 12 days at a dose known to reduce beta-amyloid peptide (A\u03b2) level [100 mg/kg, p.o. (per oral)] diminished power of elicited hippocampal theta oscillation.",
        "Neurological and psychiatric disorders are frequently associated with disruption of various cognitive functions, but development of effective drug treatments for these conditions has proven challenging.",
        "One of the main obstacles is the poor predictive validity of our preclinical animal models.",
        "As it has been expected, both acute and sub-chronic administrations of semagacestat significantly decreased A\u03b240 and A\u03b242 levels but the current findings do not reveal the mode of action of semagacestat in disrupting hippocampal oscillation.",
        "Recently disclosed Phase III findings on semagacestat indicated that Alzheimer's disease (AD) patients on this drug showed significantly worsened cognitive function compared to those treated with placebo.",
        "Since previous studies have shown that drugs impairing cognitive function (including scopolamine, NMDA (N-methyl-D-aspartate) receptor antagonists, and nociceptin receptor agonists) disrupt or decrease power of elicited theta oscillation in the hippocampus, we tested the effects of acute and sub-chronic administration of semagacestat in this assay.",
        "We propose that the disruptive effect of semagacestat on hippocampal function could be one of the contributing mechanisms to its worsening of cognition in patients with AD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21149978": [
        "Understanding the reasons of this setback may be important for the future research on effective treatments for this devastating disease.",
        "The recent failure of semagacestat in two large Phase III studies questions the value of \u03b3-secretase inhibitors in treating Alzheimer's disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23196551": [
        "In 2010, the development of semagacestat, a \u03b3-secretase inhibitor, was halted.",
        "Furthermore, semagacestat treatment was associated with an increased risk of skin cancer.",
        "Thus, drugs that regulate the brain A\u03b2 levels could provide effective disease-modifying therapy for AD.",
        "Thus, alternative compounds that indirectly modulate \u03b3-secretase activity without affecting Notch are attracting attention.",
        "To develop therapeutics with superior specificity and high potency for AD, we have been analyzing the mode of actions of known compounds, structure-and-function relationship of the \u03b3-secretase complex and possible rational design of \u03b3-secretase inhibitors and modulators using chemical biology.",
        "Preliminary results from Phase III studies showed that semagacestat failed to slow disease progression, and it was associated with worsening of clinical measures of cognition and the ability to perform activities of daily living.",
        "Several \u03b3-secretase inhibitors have been developed as AD therapeutics.",
        "Genetic and biological studies provide strong evidence that the deposition of amyloid-\u03b2 peptide (A\u03b2) contributes to the etiology of Alzheimer's disease (AD).",
        "However, molecular mechanism of these compounds still remains unclear.",
        "However, simple inhibition of \u03b3-secretase would have adverse consequences, as \u03b3-secretase is involved in several signaling pathways including Notch signaling.",
        "A\u03b2 is generated from amyloid-\u03b2 precursor protein (APP) by \u03b2- and \u03b3-secretases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30209701": [
        "The mutated form of the IDH1 enzyme produces a metabolite, 2-hydroxyglutarate (2-HG), which is thought to play a role in the formation and progression of acute myeloid leukaemia (AML), gliomas and other cancers.",
        "This article summarizes the milestones in the development of ivosidenib leading to this first approval in the USA for the treatment of patients with relapsed or refractory AML with a susceptible IDH1 mutation.",
        "Clinical development for AML, cholangiocarcinoma, glioma, myelodysplastic syndromes and solid tumours is ongoing worldwide.",
        "Ivosidenib targets the IDH1 metabolic pathway to prevent a build-up of the oncometabolite 2-HG.",
        "Elevated 2-HG levels interfere with cellular metabolism and epigenetic regulation, thereby contributing to oncogenesis.",
        "Ivosidenib (Tibsovo<sup>\u00ae</sup>) is a small molecule, orally available inhibitor of mutated cytosolic isocitrate dehydrogenase 1 (IDH1) that is being developed by Agios Pharmaceuticals for the treatment of cancer in patients with IDH1 mutations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16740622": [
        "Histopathological analysis showed that COG112 and COG133 attenuated demyelination and significantly diminished the number of peripheral cells infiltrating into the spinal cord.",
        "Most notably, fusion of COG133 to a protein transduction domain creates COG112, a modified apoE-mimetic peptide with significantly enhanced anti-inflammatory bioactivities in vitro, and improved therapeutic effects on EAE in vivo, which renders a nearly full remission from the disability.",
        "Apolipoprotein E (apoE), well known to play a role in lipid transport and cholesterol metabolism, also exerts anti-inflammatory and neuroprotective effects in the central nervous system.",
        "ApoE mimetics also interfered with several mechanisms relevant to the pathogenesis of EAE and multiple sclerosis, including activation of macrophages, subsequent production of nitric oxide and inflammatory cytokines, and lymphocyte proliferation.",
        "These data suggest that apoE mimetics represent a multidimensional therapeutic for multiple sclerosis capable of inhibiting the inflammatory cascade, modulating immune cell function, and reducing clinical signs, which may have novel utility for the treatment of inflammatory autoimmune diseases.",
        "Using a murine experimental autoimmune encephalomyelitis (EAE) model of human multiple sclerosis, we found that a peptidomimetic of apoE protein, COG133, substantially reduces the clinical symptoms of EAE and promotes remission from the disability when administered before or after onset of disease.",
        "Recent clinical and genetic studies display an association between apoE genotype (APOE) and the progression and severity of multiple sclerosis, raising the possibility that modulation of apoE may be a novel treatment for multiple sclerosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29449508": [
        "Rapid detection of nucleic acids is integral for clinical diagnostics and biotechnological applications.",
        "SHERLOCKv2 can detect Dengue or Zika virus single-stranded RNA as well as mutations in patient liquid biopsy samples via lateral flow, highlighting its potential as a multiplexable, portable, rapid, and quantitative detection platform of nucleic acids.",
        "Through characterization of CRISPR enzymology and application development, we report here four advances integrated into SHERLOCK version 2 (SHERLOCKv2) (i) four-channel single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar; (iii) 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme; and (iv) lateral-flow readout.",
        "We recently developed a platform termed SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) that combines isothermal preamplification with Cas13 to detect single molecules of RNA or DNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28855134": [
        "In the in vitro assays, AcAPS-2 showed superior scavenging activities on hydroxyl (82.98\u00b14.67%) and DPPH (64.47\u00b14.05%) radicals at the concentration of 1.0mg/mL than AcAPS and other polysaccharides fractions.",
        "This study was designed to investigate the antioxidant and anti-aging effects of D-galatose-induced (D-gal-induced) aging mice as well as monosaccharide compositions of acidic-extractable polysaccharides (AcAPS) and its major purified fractions (AcAPS-1, AcAPS-2 and AcAPS-3) from the fruiting body of Agaricus bisporus.",
        "For in vivo anti-aging analysis, AcAPS-2 showed superior effects on hepatic and nephric protection by improving serum enzyme activities, biochemical levels, lipid contents and antioxidant status, respectively.",
        "The results suggested that both AcAPS and its purified fractions might be suitable for functional foods and natural drugs in preventing the acute aging-associated diseases.",
        "The monosaccharide analysis showed that rhamnose (Rha) and glucose (Glu) may play vital roles in maintaining the antioxidant and anti-aging activities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22099844": [
        "Skin is the most voluminous organ of the body.",
        "Most well studied mechanisms of skin aging can be situated at the postgenetic level, both epigenetic and post-translational mechanisms being involved.",
        "This is the main reason its age-dependent modifications are in the forefront of dermatological research and of the \"anti-aging\" cosmetic industry.",
        "It assumes several important physiological functions and represents also a \"social interface\" between an individual and other members of society.",
        "Here we concentrate on some aspects only of skin aging, as far as the cellular and extracellular matrix components of skin are concerned.",
        "Some of these mechanisms will be reviewed as well as the capacity of fucose- and rhamnose-rich oligo- and polysaccharides (FROP and RROP) to counteract several of the mechanisms involved in skin aging."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30016770": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Non-alcoholic fatty liver disease (NAFLD) is the leading chronic hepatic condition worldwide and new approaches to management and treatment are limited."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29122694": [
        "Agents in later stages of development have shown fairly modest results in terms of reduction of hepatic steatosis, necroinflammation and fibrosis.",
        "Given the disease burden, there is an important unmet need for pharmacologic treatment options for this patient population.",
        "Although much progress has been made in enhancing our understanding of NAFLD pathogenesis, development of pharmacologic treatments has been hindered by challenges in clinical trial enrollment and complexities in clinical trial design.",
        "In broad strokes, drug development has focused on modulation of metabolic pathways, inflammatory cascades, and/or mechanisms impacting fibrosis.",
        "Non-alcoholic fatty liver disease (NAFLD) has become one of the most prominent forms of chronic liver disease worldwide, reflecting the epidemic of global obesity.",
        "However, there are currently no approved pharmacologic therapies for NASH.",
        "The compounds in phase IIa have provided promising results in terms of potential benefits on various aspects of histopathology.",
        "If longer term safety and efficacy are established among heterogeneous cohorts, these medications may help mitigate potential morbidity and mortality for this burgeoning patient population.",
        "Those with the progressive variant of NAFLD, non-alcoholic steatohepatitis (NASH), are at significantly increased risk of multisystem morbidity and mortality.",
        "The underlying pathophysiologic mechanisms that contribute to the development and progression of NAFLD and NASH are complex and reflected by the myriad of therapies, with different targets, currently under investigation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29247356": [
        "The first approach is targeting hepatic fat accumulation.",
        "A third target is intestinal microbiomes and metabolic endotoxemia.",
        "This class of drug includes apoptosis signaling kinase 1 (ASK1) inhibitor and emricasan (an irreversible caspase inhibitor).",
        "Antifibrotic agents are a cysteine-cysteine motif chemokine receptor-2/5 antagonist (cenicriviroc; CVC) and galectin 3 antagonist.",
        "The efficacy of vitamin E and pioglitazone has been established in nonalcoholic steatohepatitis (NASH), a progressive form of NAFLD.",
        "A second target is oxidative stress, inflammation, and apoptosis.",
        "Innovative NASH therapies include four main pathways.",
        "Several agents are in ongoing trials, including IMMe124, TLR4 antagonist, and solithromycin (macrolide antibiotics).",
        "Within the next few years, the availability of therapeutic options for NASH will hopefully curb the rising trend of NASH-related diseases.",
        "GLP-1RA and SGLT2 inhibitors, which are currently approved for use in diabetes, have shown early efficacy in NASH, and also have beneficial cardiovascular or renal effects.",
        "Among a variety of medications in development, four agents such as OCA, elafibranor, ASK1 inhibitor, and CVC are currently being evaluated in an international phase 3 trial for the treatment of NASH.",
        "Medications in this approach include modulation of peroxisome proliferator-activator receptors (e.g., pemafibrate, elafibranor), medications targeting farnesoid X receptor axis [obeticholic acid; OCA)], inhibitors of de novo lipogenesis (aramchol, ACC inhibitor), and fibroblast growth factor-21 analogues.",
        "Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and there is no approved pharmacotherapy.",
        "The final target is hepatic fibrosis, which is strongly associated with all-cause or liver-related mortality in NASH."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29448843": [
        "Simple steatosis and nonalcoholic steatohepatitis (NASH) can progress to liver fibrosis that is associated with mortality in NAFLD.",
        "However, open questions around CVC are the durability of antifibrotic responses, divergent effects on NASH versus fibrosis, potential long-term concerns and the expected path to approval.",
        "At present, no specific pharmacotherapy is approved for NAFLD.",
        "Nonalcoholic fatty liver disease (NAFLD) has an increasing prevalence worldwide.",
        "In animal models of liver diseases, CVC potently inhibits macrophage accumulation in the liver and ameliorates fibrosis.",
        "Expert opinion: Preclinical and clinical data support the development of CVC as a safe and potent antifibrotic agent.",
        "Areas covered: I summarize preclinical and clinical data on the efficacy and safety of the dual CCR2/CCR5 inhibitor cenicriviroc (CVC, also TBR-652 or TAK-652) for the treatment of NASH and fibrosis.",
        "In a phase 2b clinical trial (CENTAUR) on 289 patients with NASH and fibrosis, CVC consistently demonstrated liver fibrosis improvement after 1 year of therapy and had an excellent safety profile, leading to the implementation of a phase 3 trial (AURORA).",
        "The recruitment of inflammatory monocytes and macrophages via chemokine receptor CCR2 as well as of lymphocytes and hepatic stellate cells via CCR5 promote the progression of NASH to fibrosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29396065": [
        "We report the use of Pazopanib in a patient with VHL disease for treatment of RCC who also harbored multiple CNS HBs.",
        "Following initiation of treatment, a large cervical and a lumbar spinal HB regressed in size while the remaining CNS HBs exhibited stable or progressive disease.",
        "Von Hippel-Lindau (VHL) disease is a multisystem genetic disease, the cardinal manifestations of which include central nervous system hemangioblastomas (CNS HB), renal cell carcinomas (RCC), and pheochromocytoma.",
        "Treatment of RCCs with tyrosine kinase inhibitors (TKIs) such as Pazopanib is now first line therapy, but their effect on VHL-associated CNS HBs remains unknown.",
        "These findings highlight the multiplicity of factors contributing to hemangioblastoma development, even among tumors with a common germline mutation, and the potential limitations of TKIs, but additionally this report supports the conservative management of asymptomatic VHL patients with spinal HBs whereby tumor response to TKI treatment may alleviate or postpone the need for surgery.",
        "Tumorigenesis in VHL of both RCC and CNS HB occurs secondary to downstream effects of a mutated or absent VHL protein."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30236511": [
        "We aimed to assess the activity and safety of pazopanib in patients with von Hippel-Lindau disease.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      No approved systemic therapy exists for von Hippel-Lindau disease, an autosomal dominant disorder with pleiotropic organ manifestations that include clear cell renal cell carcinomas; retinal, cerebellar, and spinal haemangioblastomas; pheochromocytomas; pancreatic serous cystadenomas; and pancreatic neuroendocrine tumours."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26497655": [
        "Here, we report a 37-year-old woman's case with recurrent and rapidly progressive VHL-associated hemangioblastomas, causing severe disability.",
        "Inhibiting angiogenesis is a therapeutic option that may improve the quality of life and the autonomy of VHL patients disabled with multiple hemangioblastomas.",
        "She was treated 24 months with pazopanib, a multityrosine kinase inhibitor (TKI) targeting VEGF and PDGF-\u03b2 pathways.",
        "Surgery is the mainstay treatment, but management is challenging in case of recurrent and/or multiple tumors.",
        "It may arise sporadically in a solitary form, or associated with Von Hippel-Lindau (VHL) disease with multiple tumors.",
        "Despite moderate radiological changes, progressive improvement in her clinical condition persisting over 3 years was observed.",
        "Hemangioblastoma is a rare benign neoplasm, accounting for less than 2% of all primitive brain tumors.",
        "VHL protein is defective in both forms of hemangioblastoma, leading to the accumulation of hypoxia-inducible factor, stimulating angiogenesis via VEGF and PDGF mainly."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22374327": [
        "von Hippel-Lindau (VHL) disease is a genetically acquired multisystem tumor syndrome of the viscera and central nervous system (CNS).",
        "Treatment initiation with daily oral pazopanib (800 mg/day) resulted in significant neurologic improvement and radiologic tumor volume reduction.",
        "With mean age at diagnosis of 30 years, CNS hemangioblastomas are usually the first manifestation of the disease.",
        "Ongoing clinical and radiological surveillance is required, with symptomatic lesions necessitating treatment.",
        "The most common tumors associated with this disease are histologically benign, slow-growing CNS hemangioblastomas affecting the retina, cerebellum, brainstem, spinal cord or nerve roots.",
        "Here we provide the first report demonstrating clinical and radiological anti-tumor response using pazopanib, a small molecule multi-receptor tyrosine kinase inhibitor, in a patient with treatment-refractory VHL-associated CNS hemangioblastoma.",
        "As tumor growth is inevitable during the lifetime of most VHL patients, and the multiplicity of tumors may preclude surgical cure, the search for effective therapies is ongoing."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29358629": [
        "To this end, a number of approaches for estimating telomere length from whole-genome sequencing data have been proposed.",
        "Telomerecat also accounts for interstitial telomeric reads and presents a novel approach to dealing with sequencing errors.",
        "We also apply the method to a cancer cell data, uncovering an interesting relationship with the underlying telomerase genotype.",
        "Telomere length is a risk factor in disease and the dynamics of telomere length are crucial to our understanding of cell replication and vitality.",
        "We show that Telomerecat performs well at telomere length estimation when compared to leading experimental and computational methods.",
        "Here we present Telomerecat, a novel approach to the estimation of telomere length.",
        "Previous methods have been dependent on the number of telomeres present in a cell being known, which may be problematic when analysing aneuploid cancer data and non-human samples.",
        "The proliferation of whole genome sequencing represents an unprecedented opportunity to glean new insights into telomere biology on a previously unimaginable scale.",
        "Telomerecat is designed to be agnostic to the number of telomeres present, making it suited for the purpose of estimating telomere length in cancer studies.",
        "Furthermore, we show that it detects expected patterns in longitudinal data, repeated measurements, and cross-species comparisons."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27692431": [
        "Here we discuss these findings, as well as recent advances in microscopy and genomics that have revealed the importance of the higher-order spatial organization of the genome in defining and maintaining the senescent state.",
        "Senescent cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
        "Cellular senescence, an irreversible growth arrest triggered by a variety of stressors, plays important roles in normal physiology and tumor suppression, but accumulation of senescent cells with age contributes to the functional decline of tissues.",
        "These include the loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation of retrotransposons."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26581630": [
        "A few broad perspectives are presented regarding how continued work on these elements could provide important insights into the aging process, regardless of whether their mobility is ultimately found to significantly contribute to reduced lifespan and healthspan.",
        "Many questions remain to be addressed about the relationship between retrotransposons and aging, so it is unclear if changes in their activity will be found to contribute to aging or to be a consequence of aging.",
        "Since these mobile DNA elements can promote genome instability, this has raised the possibility that they can contribute to loss of cellular function with age.",
        "Retrotransposons are activated as organisms age, based on work from several model systems."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28101182": [
        "Furthermore, treatment with taraxasterol significantly suppressed tumor necrosis factor-\u03b1, interleukin (IL)-1\u03b2, IL-6 and nuclear factor-\u03baB protein expression levels compared with those in the rheumatoid arthritis model mice.",
        "Treatment with taraxasterol significantly increased the pain thresholds and reduced the clinical arthritic scores of the mice in the experimental group compared with those of the model group.",
        "In the experimental group, arthritic model mice were treated with 10 mg/kg taraxasterol once per day for 5 days.",
        "These observations indicate that the protective effect of taraxasterol against rheumatoid arthritis is mediated via the modulation of inflammatory responses in mice.",
        "The present study was performed to explore whether taraxasterol exhibits a protective effect against rheumatoid arthritis through the modulation of inflammatory responses in mice.",
        "Taraxasterol is an effective component of dandelion that has anti-inflammatory effects <i>in vivo</i> and <i>in vitro</i>.",
        "Taraxasterol treatment also significantly reduced nitric oxide, prostaglandin E2 and cyclooxygenase-2 levels compared with those in the rheumatoid arthritis model group.",
        "Eight-week-old CCR9-deficient mice were injected with a collagen II monoclonal antibody cocktail to create a rheumatoid arthritis model."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21303223": [
        "<strong class=\"sub-title\">\n          Context:\n        </strong>\n      \n      The axon guidance cues netrin-1 is a secreted protein overexpressed in many different cancer tissues."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24174661": [
        "Here we demonstrate a synaptogenic function of netrin-1 in rat and mouse cortical neurons and investigate the underlying mechanism.",
        "These findings identify netrin-1 as a synapse-enriched protein that promotes synaptogenesis between mammalian cortical neurons.",
        "At sites of contact, netrin-1 promotes adhesion, while locally enriching and reorganizing the underlying actin cytoskeleton through Src family kinase signaling and m-Tor-dependent protein translation to locally cluster presynaptic and postsynaptic proteins.",
        "Finally, we demonstrate using whole-cell patch-clamp electrophysiology that netrin-1 increases the frequency and amplitude of mEPSCs recorded from cortical pyramidal neurons.",
        "Netrin-1 is a secreted protein that directs long-range axon guidance during early stages of neural circuit formation and continues to be expressed in the mammalian forebrain during the postnatal period of peak synapse formation.",
        "Using gain and loss of function manipulations, we demonstrate that netrin-1 increases the number and strength of excitatory synapses made between developing cortical neurons.",
        "We show that netrin-1 increases the complexity of axon and dendrite arbors, thereby increasing the probability of contact.",
        "We detect DCC protein distributed along the axons and dendrites of cultured cortical neurons and provide evidence that newly translated netrin-1 is selectively transported to dendrites.",
        "We report that netrin-1 and its receptor DCC are widely expressed by neurons in the developing mammalian cortex during synapse formation and are enriched at synapses in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26039999": [
        "Yes-associated protein (YAP), a transcription coactivator, is the major downstream effector of the Hippo pathway, which plays a critical role in organ size control and cancer development.",
        "Inactivating netrin-1, deleted in colorectal cancer, or uncoordinated-5 homolog B (UNC5B) decreases YAP protein levels, abrogating cancer cell progression by netrin-1, whereas knockdown of mammalian STE20-like protein kinase 1/2 (MST1/2) or large tumor suppressor kinase 1/2 (Lats1/2), two sets of upstream core kinases of the Hippo pathway, has no effect in blocking netrin-1-induced up-regulation of YAP.",
        "Hence, our findings support that netrin-1 exerts oncogenic activity through YAP signaling, providing a mechanism coupling extracellular signals to the nuclear YAP oncogene.",
        "Netrin-1 stimulates phosphatase 1A to dephosphorylate YAP, which leads to decreased ubiquitination and degradation, enhancing YAP accumulation and signaling.",
        "Netrin-1, a laminin-related secreted protein, displays proto-oncogenic activity in cancers.",
        "However, how YAP is regulated by extracellular stimuli in tumorigenesis remains incompletely understood.",
        "Here we show that netrin-1 via its transmembrane receptors, deleted in colorectal cancer and uncoordinated-5 homolog, up-regulates YAP expression, escalating YAP levels in the nucleus and promoting cancer cell proliferation and migration.",
        "Nonetheless, the downstream signaling mediating its oncogenic effects is not well defined."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28174720": [
        "<strong class=\"sub-title\">\n          Background &amp; aims:\n        </strong>\n      \n      Netrin-1, a multifunctional secreted protein, is up-regulated in cancer and inflammation.",
        "Netrin-1's implication in cell survival on UPR in this context is unknown.",
        "Importantly, UPR is implicated in chronic liver conditions including hepatic oncogenesis.",
        "Netrin-1 blocks apoptosis induced by the prototypical dependence receptors deleted in colorectal carcinoma and uncoordinated phenotype-5.",
        "Although the unfolded protein response (UPR) triggers apoptosis on exposure to stress, it first attempts to restore endoplasmic reticulum homeostasis to foster cell survival."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22046354": [
        "However, the regulation of netrin-1 production is not unknown.",
        "Current study was carried out in mouse and mouse kidney cell line (TKPTS) to determine the signaling pathways that regulate netrin-1 production in response to injury.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Netrin-1 is a laminin-related secreted protein, is highly induced after tissue injury, and may serve as a marker of injury."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17174565": [
        "Interestingly, only the N-terminal domain (LNT) could bind to DCC and UNC5H1.",
        "Moreover, netrin-4 could also bind to CHO cells transfected with the plasmids expressing two known receptors for netrin-1, Deleted in Colorectal Cancer (DCC) and UNC5 homolog 1 (UNC5H1) respectively.",
        "The binding activity of the N-terminal domain of netrin-4 is about 3-fold higher than that for the C-terminal domain.",
        "To better understand the function and signal transduction pathway of netrin-4, the potential receptors for netrin-4 were studied in this paper.",
        "Axon guidance activity of netrin-4 was confirmed by using the cortical explants.",
        "The netrin-4 protein was prepared by introducing a eukaryotic expression vector with a secretable alkaline phosphatase tag (AP4) into COS7 cells to allow the expression of AP4-netrin4 fusion protein.",
        "In summary, our data here indicated that the two known receptors for netrin-1, DCC and UNC5H1, are also receptors for netrin-4, while only LNT but not EGFL and NCT is the key domain for specific binding.",
        "After incubation with cultured primary cortical neurons, the neurons were distinctly labeled by the AP4-coupled netrin-4 ligands.",
        "After competed by netrin-4, we confirmed that the binding of AP tagged netrin-4 domains to neurons were also netrin-4 dependent.",
        "Netrin-4 is a novel member of netrin family recently identified in the vertebrate with neuritis elongation promoting activity; however, the receptors for netrin-4 are still unknown.",
        "A further ligand-receptor binding analysis showed that both the N- and the C-terminal domain (NCT) but not the EGF-like (EGFL) domain of netrin-4 could bind to the surface of cultured primary neurons, indicating the existence of novel receptors for netrin-4.",
        "Netrins are a family of secreted protein related to laminin and act as tropic cues directing axon growth and cell migration during neural development.",
        "In addition, there are novel receptors for netrin-4, where both LNT and NCT but not EGFL are key domains for binding.",
        "In contrast, the binding activity of AP4-netrin4 to neurons could be completely competed by the exogenously expressed netrin-4 protein without AP4 tag, indicating specificity of netrin-4 binding to the potential receptors.",
        "As there are three domains in netrin-4, we further tried to narrow down the region containing binding sites with the receptors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28374935": [
        "Wolman's disease, also known as lysosomal acid lipase (LIPA) deficiency, is a rare autosomal-recessive disorder characterized by complete absence of the LIPA enzyme.",
        "No published case of Wolman's disease has described the prenatal sonographic findings.",
        "The diagnosis of Wolman's disease was made postnatally by biochemical testing, which indicated absence of LIPA enzyme activity and gene sequencing, which confirmed homozygosity for the G66V mutation within the LIPA gene. \u00a9 2017 Wiley Periodicals, Inc.",
        "We present a case in which a third-trimester sonographic examination demonstrated fetal hepatomegaly and bilateral adrenal echogenicity suggestive of diffuse calcification.",
        "J Clin Ultrasound 46:66-68, 2018."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29246491": [
        "Loss of SOAT2 function also dramatically curtailed EC entrapment in the small intestine of the LAL-deficient mice.",
        "Together, these data imply that SOAT2 inhibition, if applied concurrently with enzyme replacement therapy for LAL deficiency, may blunt the re-esterification of newly released unesterified cholesterol thereby improving clinical outcomes.",
        "The current studies represent a detailed exploration of our earlier findings in young male LAL-deficient mice also missing sterol O-acyltransferase 2 (SOAT2, also called ACAT2).",
        "Although only a small proportion of cholesterol in the body is esterified, in several diseases marked expansion of the esterified cholesterol (EC) pool occurs.",
        "Here we show that, even as they aged, male and female Lal<sup>-/-</sup>: Soat2<sup>- /-</sup> mice, compared to Lal<sup>-/-</sup>: Soat2<sup>+/+</sup> littermates, had appreciably less hepatomegaly as well as a marked reduction in the level of sequestration of EC, in liver transaminase activities, and in hepatic mRNA expression levels for markers of inflammation.",
        "The respective contributions that our three cholesterol esterifying enzymes make to EC production, especially in disorders like CESD, are not well defined.",
        "These include Wolman disease (WD) and Cholesteryl Ester Storage Disease (CESD) which both result from mutations in LIPA, the gene that encodes lysosomal acid lipase (LAL)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29339442": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Deficiency of lysosomal acid lipase (LAL) causes Wolman disease and cholesterol ester storage disease.",
        "With the recent introduction of enzyme replacement therapy to manage LAL deficiency comes the need for a reliable assay of LAL enzymatic activity that can be applied to dried blood spots (DBS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29374495": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Lysosomal acid lipase deficiency is an autosomal recessive metabolic disease with a wide range of severity from Wolman Disease to Cholesterol Ester Storage Disease.",
        "Furthermore, ezetimibe acts by blocking inflammasome activation which is the cause of liver fibrosis in steatohepatitis and in lysosomal storage diseases.",
        "Ezetimibe is an azetidine derivative which blocks Niemann Pick C1-Like 1 Protein; as its consequence, plasmatic concentration of low density lipoproteins and other apoB-containing lipoproteins, that are the substrate of lysosomal acid lipase, are decreased.",
        "Recently enzyme replacement therapy with sebelipase alpha has been approved by drug agencies for treatment of this lysosomal disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29547398": [
        "This review highlights the novel pathophysiological role of LAL, the functional genomic discoveries of LIPA as a risk locus for coronary heart diseases (CHD), and the clinical advance in therapies for LAL deficiency.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Lysosomal acid lipase (LAL), encoded by the LIPA gene, is an essential lysosomal enzyme that hydrolyzes cholesteryl ester and triglyceride delivered to the lysosome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24798600": [
        "Hepatic steatosis often leads to fibrosis and cirrhosis.",
        "Early diagnosis is particularly important for the enzyme replacement therapy.",
        "The diagnosis of LAL deficiency requires clinical experience and specialized laboratory tests.",
        "Hepatomegaly and/or elevation of liver transaminases are almost always present.",
        "Pilot screening projects using dried blood spot testing in 1) children with atypical fatty liver disease in the absence of overweight, 2) patients with dyslipidaemia and presence of hepatomegaly and/or elevated transaminases, 3) newborns/neonates with hepatomegaly and abdominal distension/failure to thrive/elevated transaminases are currently underway.",
        "Human lysosomal acid lipase is essential for the metabolism of cholesteryl esters and triglycerides.",
        "In infants, poor weight gain, massive hepatosplenomegaly, calcified adrenal glands (present about 2/3 of the time), vomiting, diarrhea and failure to thrive are indicative of Wolman disease.",
        "Cholesteryl ester storage disease (CESD, OMIM #278000) and Wolman disease (OMIM #278000) are autosomal recessive lysosomal storage disorders caused by a deficient activity of lysosomal acid lipase (cholesteryl ester hydrolase, LAL).",
        "The clinical picture is more variable in CESD.",
        "Human trials with recombinant LAL are currently ongoing, raising the prospect for specific correction of LAL deficiency in this progressive and often debilitating disorder.",
        "Other signs often include splenomegaly, high total cholesterol and LDL-cholesterol, elevated triglycerides, and low HDL-cholesterol.",
        "In Wolman disease, LAL activity is usually absent, whereas CESD usually presents some residual LAL activity.",
        "The diagnosis is based on finding deficient activity of acid lipase and/or molecular tests."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9925650": [
        "In order to elucidate the underlying molecular defects in Wolman disease, we have characterized the hLAL gene in two female Wolman patients of German and Turkish origin by SSCP and DNA sequence analysis.",
        "Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.",
        "These frameshift mutations lead to protein truncation at amino acid positions 24 and 116 and to complete loss of hydrolytic activity.",
        "Cholesteryl ester storage disease (CESD), in contrast, is characterized by very low levels of enzymic activity sufficient to allow survival of the affected patients into adulthood.",
        "Wolman disease, associated with deficient hLAL activity, leads to massive intracellular substrate accumulation and is always fatal in early infancy.",
        "Human lysosomal acid lipase/cholesteryl ester hydrolase (hLAL) is essential for the intralysosomal metabolism of cholesteryl esters and triglycerides taken up by receptor-mediated endocytosis of lipoprotein particles.",
        "The Turkish proband, in contrast, was homozygous for a G(1064)--&gt;T substitution in exon 10 of the hLAL gene which converts the completely conserved glycine (GGG) residue at position 321 of the mature enzyme to tryptophan (TGG).",
        "Our results demonstrate that the German proband was compound heterozygous for an 8-bp deletion in exon 3 and a 2-bp deletion in exon 4 of the hLAL gene.",
        "The mutations provide new insights into the molecular basis of Wolman disease which is apparently more heterogeneous at the genetic level than cholesteryl ester storage disease.-Lohse, P., S. Maas, P. Lohse, A. C. Sewell, O.",
        "P. van Diggelen, and D. Seidel.",
        "In vitro expression of the hLAL(Gly(321)--&gt;Trp) cDNA construct revealed that the amino acid replacement results in a more than 99% reduction of neutral lipid hydrolysis.",
        "The key role of the enzyme in intracellular lipid homeostasis is illustrated by two lysosomal storage diseases inherited as autosomal recessive traits."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8576647": [
        "Genomic Southern blot analysis disclosed a large deletion at the 3' end of the gene.",
        "The normal RLAL cDNA contains 3150 bp including an 1194 bp open reading frame and three poly A signals at the 3' end.",
        "The deduced amino acid sequence contained 397 amino acids, showed 79.9% homology with human LAL, and had the same functional domains at the same sites as human LAL.",
        "We cloned the RLAL gene from a cDNA library made from normal rat liver mRNA using the human LAL cDNA as a probe, subcloned the RLAL cDNA into pBlueScript vector, and sequenced it.",
        "Nucleotide sequence analysis showed that Wolman rat LAL cDNA had the same sequence as a RLAL cDNA from the 5'-untranslated region to nt 1101, followed by a 60 bp replacement from nt 1102 to nt 1161 with poly A signal and a 3' 1.8 kb deletion.",
        "The deduced amino acid sequence demonstrated the substitution of 367Ile to Asn, 368Pro to stop codon, and deletion of the C-terminal 29 amino acids.",
        "Lysosomal acid lipase (LAL) is a hydrolase essential for the intracellular degradation of cholesteryl esters and triglycerides.",
        "Northern blot analysis revealed that the RLAL mRNA from normal rat was 3.2 kb in length, while the RLAL mRNA from Wolman rat was only 1.4 kb.",
        "Next, we constructed a cDNA library from a Wolman rat liver, and used the RLAL cDNA as a probe to isolate the Wolman RLAL cDNA for comparison.",
        "We previously reported a rat model of Wolman's disease (Wolman rat) that is deficient for LAL activity.",
        "In this study, we cloned rat LAL (RLAL) cDNA and investigated abnormal LAL gene expression in the Wolman rat.",
        "These results identify the molecular defect in the Wolman RLAL, and suggest that the C-terminus of RLAL is essential for the activity and/or stability of the enzyme."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28659158": [
        "Fatality usually occurs within the first year of life.",
        "While an enzyme replacement therapy has recently become available, there is currently no small-molecule drug treatment for WD.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Wolman disease (WD) is a rare lysosomal storage disorder that is caused by mutations in the LIPA gene encoding lysosomal acid lipase (LAL).",
        "Deficiency in LAL function causes accumulation of cholesteryl esters and triglycerides in lysosomes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11019848": [
        "We report successful long-term bone marrow engraftment in a patient with Wolman disease resulting in continued normalization of peripheral leukocyte lysosomal acid lipase enzyme activity.",
        "All Wolman disease patients have adrenal gland calcification.",
        "Cholesterol and triglyceride levels are normal.",
        "Diarrhea is no longer present.",
        "Lysosomal acid lipase deficiency is the cause of the symptoms and signs.",
        "Now, at 4 years of age, this patient is gaining developmental milestones.",
        "Previous therapeutic attempts have failed to provide remission.",
        "This is the first long-term continued remission reported for Wolman disease.",
        "Liver function is normal.",
        "Wolman disease is characterized by severe diarrhea and malnutrition leading to death during infancy.",
        "It is inherited in an autosomal recessive manner."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8864960": [
        "A C--&gt;T transition leads to a nonsense codon and to a premature termination of the LAL protein at amino acid 277.",
        "Analysis of his LAL cDNA and genomic DNA revealed that he was homozygous for a mutation at position -3 of the exon 8 splice donor site.",
        "Due to this mutation, a shorter LAL mRNA species was also generated that lacked exon 8 and was deficient of the nonsense codon.",
        "We have determined the genetic defect in a 3-month-old boy of African origin affected by WD.",
        "As a consequence, the protein synthesis proceeded to the natural termination codon, but the enzyme generated had an internal deletion of 24 amino acids (254-277) and was also inactive.",
        "These findings, together with our previous observations when analyzing the mutations in WD and CESD patients lead to the conclusion that the more severe WD is due to mutations that absolutely abolish lysosomal acid lipase (LAL) enzyme activity and the cholesteryl ester storage disease phenotype is due to mutations that allow some residual LAL activity to be manifested.",
        "Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity and genetic defects of lysosomal acid lipase (LAL).",
        "Mutations at the exon 8/intron 8 transition of the LAL gene have been identified in several CESD and WD patients and are responsible for the manifestation of the disease.",
        "No enzymatic activity of the lysosomal acid lipase was detectable in white blood cells and cultured fibroblasts.",
        "The strikingly more severe course of WD is caused by genetic defects of LAL that leave no residual enzymatic activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8397511": [
        "In vitro degradation of PMLes indicated the existence of two PMLes-degrading enzymes in lymphoblastoid cell homogenates: one is the acid lipase which is involved in PMLes degradation in the lysosomal compartment (and is deficient in Wolman cells), while the second is a cytoplasmic enzyme (not deficient in Wolman cells).",
        "The intracellular degradation of PMLes was dependent on the mode of administration of the substrate into the cells, and occurred by two separate pathways involving lysosomal and extra-lysosomal hydrolases.",
        "Pyrenemethyl laurate (PMLes), a fluorogenic substrate for determining in vitro lipase activity [N\u00e8gre, Salvayre, Dagan and Gatt (1989) Biochim.",
        "Acta 1006, 84-88], has been administered to cultured lymphoblastoid cells from normal subjects and from a patient affected with Wolman disease, which is characterized by a deficiency of lysosomal acid lipase.",
        "When pyrenemethanol was administered directly to the cell culture, it was only poorly acylated and was rapidly released into the culture medium.",
        "These results and the fluorescence properties of PMLes ('monomeric' emission in a hydrophobic environment and 'excimeric' emission in a hydrophilic environment) and pyrenemethanol ('monomeric' emission in a hydrophilic environment) allowed us to design a 'direct reading' procedure by monitoring (without any lipid extraction) the fluorescence of intact living cells and that of the culture medium during pulse-chase experiments.",
        "In pulse-chase experiments with LDL-PMLes, the fluorescence of normal cells decreased relatively rapidly with time whereas the fluorescence of the culture medium increased concomitantly.",
        "In contrast, when PMLes dissolved in 2% dimethyl sulphoxide was added directly to the culture medium, its hydrolysis was similar in lymphoblastoid cells from controls and from patients affected with Wolman disease, neutral lipid storage disease or familial hypercholesterolaemia.",
        "This suggested that the administered PMLes was degraded by a non-lysosomal enzyme which is not deficient in Wolman cells.",
        "PMLes incorporated into LDL was taken up by normal lymphoblastoid cells through the apolipoprotein-B/E-receptor-mediated pathway and degraded in the lysosomal compartment, as suggested by the degradation block in Wolman cells.",
        "With Wolman cells, the cellular fluorescence decreased only very slightly, whereas that of the culture medium remained at the basal level; this demonstrates the catabolic block in intact living cells from patients with Wolman disease.",
        "This method allowed the direct evaluation of the time course of in situ degradation of PMLes.",
        "Biophys.",
        "This enzyme also differs from the neutral lipase system which is deficient in lymphoblastoid cells from patients with neutral lipid storage disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/179993": [
        "Previous studies have shown that cultured fibroblasts derived from patients with genetic defects in lysosomal acid lipase (i. e. the Wolman Syndrome and Cholesteryl Ester Storage Disease) are defective in their ability to hydrolyze the cholesteryl esters contained in plasma low density lipoprotein (LDL).",
        "Whereas pure monolayers of either the Familial Hypercholesterolemia cells (lacking cell surface LDL receptors) or the acid lipase-deficient cells (lacking cholesteryl ester hydrolase activity) responded poorly to LDL, the mixed monolayers developed lipoprotein responsiveness as measured by an enhancement of both LDL-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and LDL-mediated stimulation of cholesteryl ester formation.",
        "In the current studies, the Wolman Syndrome and Cholesteryl Ester Storage Disease cells were grown in the same Petri dish with mutant fibroblasts derived from a patient with the homozygous form of Familial Hypercholesterolemia.",
        "This effect was shown to result from the release of the lysosomal acid lipase from the Familial Hypercholesterolemia homozygote cells into the culture medium and its subsequent uptake by the acid lipase-deficient cells.",
        "These data emphasize the importance of the lysosomal acid lipase in the cellular metabolism of LDL cholesteryl esters and, in addition, demonstrate that delivery of this enzyme to genetically deficient cells can enhance the regulatory response to the lipoprotein.",
        "As a result, these mutant cells show a reduced responsiveness to the regulatory actions of LDL, as evidenced by a decreased LDL-mediated suppression of the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase and by a decreased LDL-mediated activation of cellular cholesteryl ester formation.",
        "The acquisition of this acid lipase activity enhanced the ability of the Wolman Syndrome and Cholesteryl Ester Storage Disease cells to respond to the lipoprotein by suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and activation of cellular cholesteryl ester formation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28780612": [
        "Approximately ~20% of the genome is found to be confined in regions with \"closed\" chromatin structure around gene promoters.",
        "In a recent work (Tsochatzidou et al., Nucleic Acids Res 45:5818-5828, 2017), we proposed the existence of a functional compartmentalization of the yeast genome according to which, genes occupying the chromosomal regions at the nuclear periphery have distinct structural, functional and evolutionary characteristics compared to their centromeric-proximal counterparts.",
        "Recent advances in our understanding of the three-dimensional organization of the eukaryotic nucleus have rendered the spatial distribution of genes increasingly relevant.",
        "Around the same time, it was also shown that the genome of Saccharomyces cerevisiae is organized in topologically associated domains (TADs), which are largely associated with the replication timing.",
        "Through the application of a simple boundary-calling criterion in genome-wide 3C data, we define ~100 TAD-like domains which can be clustered in six different classes with radically different nucleosomal organizations, significant variations in transcription factor binding and uneven chromosomal distribution.",
        "Most interestingly, we find both \"open\" and \"closed\" regions to be segregated, in the sense that they tend to avoid inter-chromosomal interactions.",
        "Our data further enforce the notion of a marked compartmentalization of the yeast genome in isolated territories, with implications in its function and evolution.",
        "In this work, we proceed to investigate whether such units of three-dimensional genomic organization can be linked to transcriptional activity as a driving force for the shaping of genomic architecture."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28348222": [
        "In contrast, herein we analyze Hi-C data for budding yeast and identify 200-kb scale TADs, whose boundaries are enriched for transcriptional activity.",
        "Thus, our work defines spatial organization within the budding yeast nucleus, demonstrates the conserved role of genome architecture in regulating DNA replication, and identifies a molecular mechanism specifically regulating interactions between pericentric origins.",
        "The genome of metazoan cells is organized into topologically associating domains (TADs) that have similar histone modifications, transcription level, and DNA replication timing.",
        "To investigate the molecular basis of TAD formation, we performed Hi-C experiments on cells depleted for the Forkhead transcription factors, Fkh1 and Fkh2, previously associated with replication timing.",
        "Although similar structures appear to be conserved in fission yeast, computational modeling and analysis of high-throughput chromosome conformation capture (Hi-C) data have been used to argue that the small, highly constrained budding yeast chromosomes could not have these structures.",
        "Forkhead factors do not regulate TAD formation, but do promote longer-range genomic interactions and control interactions between origins near the centromere.",
        "Furthermore, these boundaries separate regions of similarly timed replication origins connecting the long-known effect of genomic context on replication timing to genome architecture."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29266590": [
        "We examined the role of Mov10 in Xenopus laevis development and show a critical role for Mov10 in gastrulation and in the development of the central nervous system (CNS).",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Mov10 is an RNA helicase that modulates access of Argonaute 2 to microRNA recognition elements in mRNAs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21274438": [
        "Treatment of these cells simultaneously with GM1 and A\u03b21-40 caused a significant reduction of cell number, suggesting that A\u03b21-40 and GM1 cooperatively exert a cytotoxic effect on neuroepithelial cells.",
        "It has been suggested that A\u03b2 induces changes in neuronal membrane fluidity as a result of its interactions with membrane components such as cholesterol, phospholipids, and gangliosides.",
        "A complex of GM1 and A\u03b2, termed \"GA\u03b2\", has been identified in AD brains.",
        "GQ1b\u03b1 and GT1a\u03b1 exhibit high affinities to A\u03b2s.",
        "We evaluated the effects of GM1 and A\u03b21-40 on mouse neuroepithelial cells.",
        "Gangliosides are known to bind A\u03b2.",
        "Conversion of the soluble, nontoxic amyloid \u03b2-protein (A\u03b2) into an aggregated, toxic form rich in \u03b2-sheets is a key step in the onset of Alzheimer's disease (AD).",
        "We have reported an increase of Chol-1\u03b1 antigens, GQ1b\u03b1 and GT1a\u03b1, in the brain of transgenic mouse AD model.",
        "The presence of Chol-1\u03b1 gangliosides represents evidence for genesis of cholinergic neurons in AD brains.",
        "Abnormal ganglioside metabolism also may occur in AD brains.",
        "An understanding of the mechanism on the interaction of GM1 and A\u03b2s in AD may contribute to the development of new neuroregenerative therapies for this disorder."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/7997071": [
        "The highest ganglioside concentration of any organ is found in the mammalian brain, where the gangliosides are enriched in the neuronal membrane, particularly in the synapses.",
        "There are four major brain gangliosides with the same neutral tetrasaccharide core to which one to three sialic acids are linked--the simplest being the GM1-ganglioside.",
        "These gangliosides have been shown to have neuritogenic and neuronotrophic activity and to facilitate repair of neuronal tissue after mechanical, biochemical or toxic injuries.",
        "Beneficial effects of GM1 have been documented in the treatment of stroke and spinal cord injuries, particularly when the treatment has been initiated within a few hours of the acute event.",
        "Mixtures of native bovine brain gangliosides were adopted for pharmacological use in the treatment of peripheral nerve damage, and GM1-ganglioside has been applied for the treatment of CNS injuries and diseases.",
        "Gangliosides are glycosphingolipids localized to the outer leaflet of the plasma membrane of vertebrate cells.",
        "Continuous intraventricular infusion of GM1 has recently been shown to have a significant beneficial effect in Alzheimer disease of early onset (AD Type I)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28989060": [
        "We performed a competing-risk analysis to evaluate factors associated with survival of patients with HCC and developed a prognostic model based on features of HCC patients before liver transplantation.",
        "<strong class=\"sub-title\">\n          Background &amp; aims:\n        </strong>\n      \n      Outcomes of liver transplantation for hepatocellular carcinoma (HCC) are determined by cancer-related and non-related events.",
        "Treatments for hepatitis C virus infection have reduced non-cancer events among patients receiving liver transplants, so reducing HCC-related death might be an actionable end point."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28750141": [
        "Eligible patients were identified in the Danish Database for Hepatitis B and C, and data from national health registries and patient charts were obtained.",
        "The positive predictive value of an AFP \u2265 20 ng mL<sup>-1</sup> was 17%.",
        "Tumour stage was based on Barcelona-Clinic Liver Cancer stage, TNM classification and size and number of lesions combined into stages 0-3.",
        "Median survival after HCC for early-stage HCC disease was 30.1 months and 7.4 months for advanced HCC (stage 2/3).",
        "This study aimed to estimate changes in the HCC incidence rate (IR) over time, HCC stage and prognosis, and AFP and US performed in patients with hepatitis C and cirrhosis.",
        "Application of AFP and US was suboptimal, and most patients were diagnosed with advanced HCC with a poor prognosis.",
        "The HCC incidence rate increased from 0.8/100 PY [CI95% 0.4-1.5] in 2002-2003 to 2.9/100 PY [2.4-3.4] in 2012-2013.",
        "The incidence rate of HCC increased over time among patients with hepatitis C and cirrhosis in Denmark.",
        "We included 1075 patients with hepatitis C and cirrhosis, free of HCC and liver transplant at baseline.",
        "One-year cumulative incidence of at least one AFP or US was 53% among all patients.",
        "Cirrhosis in patients with chronic hepatitis C increases the risk of hepatocellular carcinoma (HCC), and surveillance with ultrasound (US) and alpha-fetoprotein (AFP) is recommended.",
        "During 4988 person years (PY), 115 HCC cases were diagnosed.",
        "Twenty-three (21%) patients were diagnosed with early-stage HCC (stage 0/1) and 84 (79%) with late stage."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29052791": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      To evaluate the diagnostic performance of the combination of tumor markers [alpha-fetoprotein (AFP) and carbohydrate antigen 19-9 (CA19-9)] and imaging features in differentiating combined hepatocellular-cholangiocarcinoma (CHC) from hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29707411": [
        "PPR in the first infant resolved by 4 months, but the second infant's PPR progressed, requiring photocoagulation followed by lens-sparing vitrectomy.",
        "The authors present the cases of four cousins with MDS who also carried a 16p13.3 microduplication (not associated with Rubinstein-Taybi syndrome).",
        "Retinopathy of prematurity-like proliferative peripheral retinopathy (PPR) was detected in two male first cousins, but was not detected in the female half-cousins.",
        "While ocular abnormalities are more prevalent and severe in other lissencephalopathies, the PPR in these MDS infants underscores the sight-saving potential of performing an ophthalmologic exam with early molecular testing for all lissencephaly infants.",
        "A complete ophthalmic examination is not routinely performed on infants with Miller-Dieker syndrome (MDS, chromosome 17p13.3 microdeletion)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29628935": [
        "These models are also crucial for the study of brain development at a mechanistic level since this cannot be accomplished in humans.",
        "Chromosome microdeletions within 17p13.3 can result in either isolated lissencephaly sequence (ILS) or Miller-Dieker syndrome (MDS).",
        "In contrast to microdeletions in 17p13.3, recent studies have attracted considerable attention to a condition known as a 17p13.3 microduplication syndrome.",
        "Individuals in class II always have microduplications of the <i>PAFAH1B1</i> gene, which may include <i>YWHAE</i> and other genetic microduplications.",
        "Chromosome 17p13.3 is a region of genomic instability that is linked to different rare neurodevelopmental genetic diseases, depending on whether a deletion or duplication of the region has occurred.",
        "We also focus on existing single and double knockout mouse models that have been used to study human phenotypes, since the highly limited number of patients makes a study of these conditions difficult in humans.",
        "Finally, we emphasize the usefulness of the CRISPR/Cas9 system and next generation sequencing in the study of neurodevelopmental diseases.",
        "Both conditions are associated with a smooth cerebral cortex, or lissencephaly, which leads to developmental delay, intellectual disability, and seizures.",
        "However, patients with MDS have larger deletions than patients with ILS, resulting in additional symptoms such as poor muscle tone, congenital anomalies, abnormal spasticity, and craniofacial dysmorphisms.",
        "Individuals in class I have microduplications of the <i>YWHAE</i> gene encoding 14-3-3\u03b5, as well as other genes in the region.",
        "Class I microduplications generally result in learning disabilities, autism, and developmental delays, among other disorders.",
        "Class II microduplications generally result in smaller body size, developmental delays, microcephaly, and other brain malformations.",
        "However, the <i>PAFAH1B1</i> gene encoding LIS1 is never duplicated in these patients.",
        "Here, we review the phenotypes associated with copy number variations (CNVs) of chromosome 17p13.3 and detail their developmental connection to particular microdeletions or microduplications.",
        "Depending on the genes involved in their microduplication, patients with 17p13.3 microduplication syndrome may be categorized into either class I or class II."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27644460": [
        "G banded chromosome analysis revealed 45,X,psu dic(17;Y)(p13;p11.32).ish dic (17;Y)(LIS1-,RARA+, SRY+, DYZ3+) by G-banding analysis using high resolution banding technique.",
        "Fetuses with lissencephaly have an abnormal smooth brain with fewer folds and grooves that will be detected by ultrasounds or fetal magnetic resonance imaging (MRI) after 30 weeks of gestation.",
        "Fetal delayed cortical development will be the findings to perform further investigations including fluorescence in situ hybridization analysis for MDS, a 17p13.3 microdeletion syndrome, pre/postnatally.",
        "Lissencephaly is one of the central nervous system anomalies of Miller-Dieker Syndrome (MDS).",
        "We report a fetus with lissencephaly diagnosed as Miller-Dieker Syndrome postnatally.",
        "This will be the first case of MDS with unbalanced translocation between deleted short arm of chromosome 17 and Y chromosome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29858378": [
        "This region has previously been reported in a collection of duplications with shared phenotype; our quadruplication suggests similarities in phenotype.",
        "Invasive testing performed after ultrasound abnormalities were seen revealed the quadruplication sequence as well as a short segment (850 kb) with x5 copy number variation.",
        "This region is well characterized for the deletion leading to Miller-Dieker syndrome but has an unclear replication phenotype.",
        "Prenatal genetic testing has advanced rapidly in the past decade.",
        "This raises the hypothesis of a potential spectrum or copy number variant-based phenotype.",
        "However, not all results, including variants, are well understood.",
        "We report the finding of a 2.5-Mb gene region quadruplication of Chromosome 17p13.3."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28186603": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To perform molecular cytogenetic study on two fetuses with abnormal ultrasound findings and analyze their genotype-phenotype correlation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28380362": [
        "Reinstalling active \u03b2-catenin signaling rescues division modes and ameliorates growth defects.",
        "Here, we used patient-specific forebrain-type organoids to investigate pathological changes associated with MDS.",
        "Patient-derived organoids are significantly reduced in size, a change accompanied by a switch from symmetric to asymmetric cell division of ventricular zone radial glia cells (vRGCs).",
        "Alterations in microtubule network organization in vRGCs and a disruption of cortical niche architecture, including altered expression of cell adhesion molecules, are also observed.",
        "Miller-Dieker syndrome (MDS) is caused by a heterozygous deletion of chromosome 17p13.3 involving the genes LIS1 and YWHAE (coding for 14.3.3\u03b5) and leads to malformations during cortical development.",
        "These phenotypic changes lead to a non-cell-autonomous disturbance of the N-cadherin/\u03b2-catenin signaling axis.",
        "Our data define the role of LIS1 and 14.3.3\u03b5 in maintaining the cortical niche and highlight the utility of organoid-based systems for modeling complex cell-cell interactions in vitro."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/3993677": [
        "We propose that essentially no loss of 17p material has occurred and confirm previous reports that the critical region for the production of the Miller-Dieker phenotype is located subterminally in the 17p13.3 region.",
        "We studied after death a 3-month-old girl whose karyotype was 45,XX,-15,-17,+der(17),t(15;17)(q13;p13.3) and thus combines abnormalities of chromosome 15 associated with the Prader-Willi syndrome and of chromosome 17 associated with the Miller-Dieker syndrome.",
        "This infant had several manifestations of the Prader-Willi syndrome in infancy but none of the Miller-Dieker syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/2903661": [
        "None of these loci were absent in one case of lissencephaly without MDS.",
        "Loci defined by two of the DNA probes, pYNZ22 and pYNH37.3, were deleted in all three patients.",
        "A minority of patients with the syndrome do not have a deletion detectable with current cytogenetic techniques.",
        "The most distal locus, defined by p144D6, was present in one MDS patient, possibly defining the distal limits of the MDS region in band 17p13.3.",
        "The Miller-Dieker syndrome (MDS), a syndrome with lissencephaly, distinctive craniofacial features, growth impairment, and profound developmental failure, has been associated with a deletion of the distal part of chromosome band 17p13.",
        "Using three highly polymorphic DNA probes (pYNZ22, pYNH37.3, and p144D6) we have detected microdeletions in three MDS patients, two of whom had no visible abnormalities of chromosome 17."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10787042": [
        "The neonatal period for a female infant born at 39 weeks gestation by emergency Caesarean section was complicated by frequent epileptic seizures as well as hypotonia.",
        "Neurofibromatosis type I (NF1) is an autosomal dominant condition associated with mutations in the long arm of chromosome 17, and characterised by neurofibromas, caf\u00e9-au-lait spots and axillary freckling.",
        "The child died at the age of 4 years and examination of the brain confirmed lissencephaly with a thickened cortex, deficient white matter, and grey matter heteropias.",
        "In addition, the mother's and maternal grandmother's genetic analysis showed identical mutations in the neurofibromatosis I gene on the long arm of chromosome 17, confirming the diagnosis of NF1.",
        "A computed tomography scan revealed evidence of lissencephaly, and chromosomal analysis showed a microdeletion on the short arm of chromosome 17 (17p13.3), confirming the diagnosis as Miller-Dieker syndrome.",
        "This case illustrates a rare neuronal migration disorder appearing in a child from a family with a history of NF1.",
        "The child did not possess the mutation.",
        "The mother had caf\u00e9-au-lait spots, and axillary freckling.",
        "The Miller-Dieker syndrome (type I lissencephaly) is a neuronal migration disorder which is associated with microdeletions in the short arm of chromosome 17."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18989166": [
        "Herein we review the literature regarding Miller-Dieker syndrome, with particular attention to the presence of several candidate tumor suppressor genes within the deleted material.",
        "This is, to our knowledge, the first report of acute leukemia in the setting of Miller-Dieker syndrome.",
        "A 15-month-old girl with Miller-Dieker syndrome, a contiguous gene deletion syndrome involving chromosome 17p13.3 and resulting in lissencephaly, was diagnosed with precursor B-cell acute lymphoblastic leukemia.",
        "Cytogenetic analysis identified both the previously detected 17p13.3 deletion and additional complex numerical and structural abnormalities, including loss of chromosome 9, isochromosome 9q and interstitial deletion of 20q."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/3963054": [
        "We report a new case of familial MDS in whom the mother carries a pericentric inversion of chromosome 17.",
        "The high frequency of familial MDS and its consistent association with balanced chromosomal rearrangements in one of the parents makes it important to do high-resolution chromosome analysis on all patients with MDS and possibly all patients with lissencephaly.",
        "She has had two children with MDS, one of whom was shown to carry a recombinant 17 consisting of dup(17q) and del(17p).",
        "Recently it has been shown that most cases of the Miller-Dieker syndrome (MDS) are caused by deletion 17p13.3.",
        "Finding a familial balanced rearrangement makes prenatal diagnosis of this condition feasible.",
        "All familial cases have been associated with a balanced reciprocal translocation in a carrier parent and unbalanced translocations in their affected offspring."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/1968707": [
        "The Miller-Dieker syndrome (MDS), a rare congenital disorder manifested by characteristic facial abnormalities and lissencephaly (smooth brain), is associated with microdeletions of the distal 17p region.",
        "RFLP analysis of a patient with MDS, and analysis of somatic cell hybrids containing partially deleted chromosomes 17 from patients with MDS, using the profilin gene probe, indicate that profilin is localized to chromosome subband 17p13.3.",
        "These results also indicate that profilin is the first identified cloned gene which is part of the genetic material deleted in some patients with MDS but that other patients have smaller deletions not affecting the profilin locus.",
        "Thus, single allelic deletion of the profilin locus may contribute to the clinical phenotype of the MDS in some patients but does not play a major role in the essential phenotype.",
        "Profilin is a conserved actin-monomer-binding protein which is found in all eukaryotes, including yeast.",
        "We therefore isolated human genomic clones to analyze these genetic loci in detail.",
        "The functional gene was localized to human chromosome band 17p13 by analysis of somatic cell hybrids and by in situ chromosomal localization.",
        "Four other isolated loci are all diverged, intronless pseudogenes and are likely to be nonfunctional.",
        "Only one of the cloned loci has typical features of a functional gene, including upstream transcriptional elements and typical exon-intron structure.",
        "Although amino acid sequence analysis and RNase protection analysis suggest a single profilin isoform in mammalian cells, Southern blot analysis of human and somatic cell hybrid DNA indicates several loci in the human genome which hybridize with the profilin cDNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/3189330": [
        "Using human chromosome 17-specific DNA probes, we have begun a molecular dissection of the critical region for MDS.",
        "In contrast, three highly polymorphic anonymous probes, YNZ22.1 (D17S5), YNH37.3 (D17S28), and 144-D6 (D17S34), were deleted in each of four patients with visible deletions, including one with a ring chromosome 17 that is deleted for a portion of the single telomeric prometaphase subband p13.3.",
        "In two MDS patients with normal chromosomes, a combination of somatic cell hybrid, RFLP, and densitometric studies demonstrated deletion for YNZ22.1 and YNH37.3 in the paternally derived 17's of both patients, one of whom is also deleted for 144-D6.",
        "To localize cloned DNA sequences to the MDS critical region, a human-rodent somatic cell hybrid panel was constructed which includes hybrids containing the abnormal chromosome 17 from three MDS patients with deletions of various sizes.",
        "Miller-Dieker syndrome (MDS), a disorder manifesting the severe brain malformation lissencephaly (\"smooth brain\"), is caused, in the majority of cases, by a chromosomal microdeletion of the distal short arm of chromosome 17.",
        "The results indicate that MDS can be caused by submicroscopic deletion and raises the possibility that all MDS patients will prove to have deletions at a molecular level.",
        "Three genes (myosin heavy chain 2, tumor antigen p53, and RNA polymerase II) previously mapped to 17p were excluded from the MDS deletion region and therefore are unlikely to play a role in its pathogenesis.",
        "The two probes lie within a critical region of less than 3,000 kb and constitute potential starting points in the isolation of genes implicated in the severe brain maldevelopment in MDS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/2740347": [
        "Cosmid clones containing both VNTR sequences were identified, and restriction mapping showed them to be less than 15 kb apart.",
        "A hypomethylated island and evolutionarily conserved sequences were identified within this 100-kb region, indications of the presence of one or more expressed sequences potentially involved in the pathophysiology of this disorder.",
        "The Miller-Dieker syndrome (MDS), composed of characteristic facial abnormalities and a severe neuronal migration disorder affecting the cerebral cortex, is caused by visible or submicroscopic deletions of chromosome band 17p13.",
        "By pulsed-field gel electrophoresis, YNZ22 and YNH37 were shown to be within 30 kilobases (kb) of each other.",
        "Three overlapping cosmids spanning greater than 100 kb were completely deleted in all patients, providing a minimum estimate of the size of the MDS critical region.",
        "Two highly polymorphic VNTR (variable number of tandem repeats) probes, YNZ22 and YNH37, are codeleted in all patients tested and make molecular diagnosis for this disorder feasible.",
        "All patients, including three with normal karyotypes, are deleted for a variable set of 5-12 markers.",
        "The conserved sequences were mapped to mouse chromosome 11 by using mouse-rat somatic cell hybrids, extending the remarkable homology between human chromosome 17 and mouse chromosome 11 by 30 centimorgans, into the 17p telomere region.",
        "Twelve anonymous DNA markers were tested against a panel of somatic cell hybrids containing 17p deletions from seven MDS patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19584063": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Deletions in the 17p13.3 region are associated with abnormal neuronal migration.",
        "The phenotypic consequences of YWHAE deletion without deletion of PAFAH1B1 have not been studied systematically.",
        "Point mutations or deletion copy number variants of the PAFAH1B1 gene in this genomic region cause lissencephaly, whereas extended deletions involving both PAFAH1B1 and YWHAE result in Miller-Dieker syndrome characterised by facial dysmorphisms and a more severe grade of lissencephaly."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10655551": [
        "HIC1 is a candidate tumor suppressor gene which is frequently hypermethylated in human tumors, and its location within the Miller-Dieker syndrome's critical deletion region at chromosome 17p13.3 makes it a candidate gene for involvement in this gene deletion syndrome.",
        "These animals die perinatally and exhibit varying combinations of gross developmental defects throughout the second half of development, including acrania, exencephaly, cleft palate, limb abnormalities and omphalocele.",
        "These findings demonstrate a role for Hic1 in the development of structures affected in the Miller-Dieker syndrome, and provide functional evidence to strengthen its candidacy as a gene involved in this disorder.",
        "To study the function of murine Hic1 in development, we have created Hic1 -deficient mice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8355785": [
        "Non-overlapping deletions involving either the 5' or 3' end of the gene were found in two patients, identifying LIS-1 as the disease gene.",
        "Here we report the cloning of a gene (LIS-1, lissencephaly-1) in 17p13.3 that is deleted in Miller-Dieker patients.",
        "6).",
        "Lissencephaly (agyria-pachygyria) is a human brain malformation manifested by a smooth cerebral surface and abnormal neuronal migration.",
        "These deletions are hemizygous, so haplo-insufficiency for a gene in this interval is implicated.",
        "The deduced amino-acid sequence shows significant homology to beta-subunits of heterotrimeric G proteins, suggesting that it could possibly be involved in a signal transduction pathway crucial for cerebral development.",
        "Identification of the gene(s) involved in this disorder would facilitate molecular dissection of normal events in brain development.",
        "Type 1 lissencephaly occurs either as an isolated abnormality or in association with dysmorphic facial appearance in patients with Miller-Dieker syndrome.",
        "About 15% of patients with isolated lissencephaly and more than 90% of patients with Miller-Dieker syndrome have microdeletions in a critical 350-kilobase region in chromosome 17p13.3 (ref."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11579431": [
        "Gene mutations associated with epilepsy are known, to date, only for two disorders: the lissencephaly 1 gene in Miller-Dieker syndrome and mutations in the UBE3A gene in Angelman syndrome.",
        "Its incidence, however, is very variable, and there are very few aberrations in which epilepsy is a constant finding.",
        "Similar observations can be made for congenital (major) malformations in chromosome aberrations.",
        "The situation is comparable to a polygenic model of inheritance.",
        "The common explanation is that in these instances epilepsy is not caused by the action of a single gene in single or triple dose, but is influenced by the combined action of a number of genes within and outside of the aneuploid segment.",
        "Even siblings and monozygotic twins with the same aberration are often discordant for seizure disorders.",
        "Chromosome aberrations in which epilepsy is a major and consistent finding include Angelman syndrome due to loss of the maternal 15q11.2-q12 segment, tetrasomy of the maternal segment 15pter-q13 due to an additional inv dup chromosome, Miller-Dieker syndrome due to deletion of the 17p13.3 segment including the lissencephaly1 gene, ring chromosome 20, and Wolf-Hirschhorn syndrome due to deletion of at least the 4p16.3 segment.",
        "Epilepsy is among the most frequent findings in many, especially autosomal, chromosome aberrations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/10406660": [
        "These findings and the phenotype of the proposita, strongly suggest that genes telomeric to LIS1 and locus D17S379 are involved in many clinical findings, including the minor facial anomalies of the Miller-Dieker syndrome.",
        "Trisomy 5p and Miller-Dieker syndromes frequently are the result of unbalanced segregations of reciprocal translocations of chromosomes 5 and 17 with other autosomes.",
        "The critical regions for the expression of the mentioned syndromes have been mapped to 5p13--&gt;pter, and 17p13.3--&gt;pter.",
        "In this report, we describe an 8-year-old girl with mental retardation, postnatal growth deficiency, generalized muscular hypotonia, seizures, microcephaly, cortical atrophy, partial agenesis of corpus callosum, cerebral ventriculomegaly, facial anomalies, patent ductus arteriosus, pectus excavatum, long fingers, and bilateral talipes equinovarus caused by the presence of a 46,XX,der(17)t(5;17)(p13.1;p13.3)mat chromosome complement.",
        "Cytogenetic studies of the family confirmed a balanced reciprocal translocation (5;17)(p13.1;p13.3) in her mother, maternal grandfather, maternal aunt, and a female first cousin.",
        "Fluorescence in situ hybridization studies on the mother and the proposita using three probes, which map to distal 17p, confirmed the reciprocal translocation in the mother and a terminal deletion in the patient, which resulted in the retention of LIS1 and D17S379 loci and deletion of the 17p telomere."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/7573359": [
        "Western blot analyses identified LIS-1 protein as a 45-kd, heparin-binding protein abundant in the cytosolic fraction.",
        "These results are consistent with the notion that a deficiency of LIS-1 protein is the direct cause of the brain malformation and that the protein plays a critical role in neuronal migration.",
        "The Miller-Dieker syndrome, a disorder of neuronal migration, is caused by deletions of chromosome 17p13.3.",
        "Immunostaining demonstrated the widespread distribution of LIS-1 protein in the brain and spinal cord of controls and a loss of immunoreactivity in individuals with Miller-Dieker syndrome.",
        "Here we immunochemically and immunohistochemically localized the gene product, LIS-1 protein, among control normal subjects and patients with Miller-Dieker syndrome, using specific antibodies raised against synthetic peptide fragments of LIS-1 protein.",
        "Recently, a gene on 17p13.3, named LIS-1, was identified as the causative gene for this cerebral anomaly.",
        "The protein was restricted to the central nervous system and detectable in brains of controls of all ages, from the early fetal to adult period."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23326253": [
        "Interestingly, the majority of patients who carry the deletion 10p have visual and auditory deficiencies that are attributed to loss of the GATA3 gene.",
        "Also, small deletions that affect chromosome region 10p14\u2192pter are rarely described in the literature.",
        "The girl was diagnosed by subtelomeric FISH and array-CGH, showing a 4.43-Mb heterozygous deletion on chromosome 10p that involved 14 genes and a 3.22-Mb single-copy gain on chromosome 17p, which includes the critical region of the Miller-Dieker syndrome and 61 genes.",
        "Because our patient exhibits a combination of 2 imbalances, she has phenotypic features of both chromosome abnormalities, which have been reported separately.",
        "To date, only a few cases have been reported with overlapping 17p13.3 duplications in this region.",
        "In this study, we describe, to our knowledge for the first time, a 5-year-old female patient with intellectual disability who has an unbalanced 10;17 translocation inherited from the father.",
        "However, our patient also presents severe hearing and visual problems even though GATA3 is present, suggesting the involvement of different genes that affect the development of the visual and auditory systems.",
        "Submicroscopic duplications in the Miller-Dieker critical region have been recently described as new genomic disorders.",
        "The patient's karyotype was established as 46,XX.arr 10p15.3p15.1(138,206-4,574,436)x1,17p13.3(87,009-3,312,600)x3."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9063734": [
        "It is associated with visible or submicroscopic deletions within chromosome band 17p13.3.",
        "Lissencephaly without facial dysmorphism has also been observed and is referred to as isolated lissencephaly sequence (ILS).",
        "However, the originally presumed 5' end of LIS1 was found to belong to the 14-33 epsilon gene residing more distally on 17p13.3.",
        "Therefore, LIS1 remains the strongest candidate gene for the lissencephaly phenotype in ILS and MDS.",
        "Our analyses also suggest that additional genes distal to LIS1 may be responsible for the facial dysmorphology and other abnormalities seen in MDS but not in ILS patients, supporting our original concept MDS as a contiguous gene deletion syndrome.",
        "We have now isolated the correct 5' end of LIS1, constructed a approximately 500 kb genomic contig encompassing LIS1, and estimated its gene to be approximately 80 kg.",
        "Miller-Dieker syndrome (MDS) is a multiple malformation syndrome characterized by classical lissencephaly and a characteristic facies.",
        "Apparently partial and non-overlapping deletions of the 5' or 3' end of a candidate gene LIS1 in one ILS and one MDS patient had suggested that MDS was a single gene disorder, and that LIS1 spans in excess of 400 kb.",
        "Fluorescence in situ hybridization analysis of an ILS patient with a de novo balanced translocation, as well as analysis of several other key MDS and ILS deletion patients, localizes the lissencephaly critical region within the LIS1 gene."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/6834189": [
        "A review of the literature revealed five additional patients in three families, who had Miller-Dieker syndrome and an abnormality of 17p.",
        "Miller-Dieker syndrome, which includes lissencephaly and a characteristic phenotypic appearance, has been reported to have an autosomal recessive pattern of inheritance.",
        "Thus, we propose that monosomy of distal 17p may be the cause of Miller-Dieker syndrome in some patients.",
        "However, we have found abnormalities of chromosome 17 in two of three unrelated patients with this syndrome, one with a ring chromosome 17 and the other with an unbalanced translocation resulting in partial monosomy of 17p13."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21239872": [
        "In this case, the submicroscopic cryptic deletion in the proband was initially elucidated by FISH, and karyotype analysis did not reveal additional chromosome abnormalities such as translocation.",
        "However, a family history of recurrent pregnancy abnormalities strongly suggested familial translocation.",
        "The proband presented with facial dysmorphism, arthrogryposis, and intrauterine growth retardation.",
        "When Miller-Dieker syndrome is caused by an unbalanced translocation, mild-to-severe phenotypes occur according to the extension of the involved partner chromosome.",
        "We report the case of a female infant with der(17)t(12;17)(q24.33;p13.3)pat caused by an unbalanced segregation of the parental balanced translocation of 17p with other chromosomes.",
        "Sequential G-banding and FISH analysis of the father's chromosomes showed that the segment of 17p13.3\u2192pter was attached to the 12qter.",
        "Most cases of Miller-Dieker syndrome have a de novo deletion involving 17p13.3.",
        "Miller-Dieker syndrome involves a severe type of lissencephaly, which is caused by defects in the lissencephaly gene (LIS1).",
        "Thus, we report a case that showed resemblance to the findings in cases of a nearly pure 17p deletion, derived from t(12;17), and delineated by whole genome array comparative genomic hybridization (CGH).",
        "However, a pure partial monosomy derived from a paternal balanced translocation is relatively rare.",
        "If such cases are incorrectly diagnosed as Miller-Dieker syndrome caused by de novo 17p13.3 deletion, the resultant improper genetic counseling may make it difficult to exactly predict the potential risk of recurrent lissencephaly for successive pregnancies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29540340": [
        "Radioulnar synostosis and B-cell deficiency were observed only in patients with mutations affecting a short region in the C-terminal zinc finger domain of EVI1.",
        "No single clinical manifestation was detected in all patients affected by <i>MECOM</i> mutations.",
        "The spectrum of phenotypes was much broader than initially reported for the first 3 patients; we found familial as well as sporadic cases, and the clinical spectrum ranged from isolated radioulnar synostosis with no or mild hematological involvement to severe bone marrow failure without obvious skeletal abnormality.",
        "The mutations affected different functional domains of the EVI1 protein.",
        "We propose the term MECOM-associated syndrome for this heterogeneous hereditary disease and inclusion of <i>MECOM</i> sequencing in the diagnostic workup of congenital bone marrow failure.",
        "Heterozygous mutations in <i>MECOM</i> (MDS1 and EVI1 complex locus) have been reported to be causative of a rare association of congenital amegakaryocytic thrombocytopenia and radioulnar synostosis.",
        "Here we report on 12 patients with congenital hypomegakaryocytic thrombocytopenia caused by <i>MECOM</i> mutations (including 10 novel mutations).",
        "The clinical picture included radioulnar synostosis, bone marrow failure, clinodactyly, cardiac and renal malformations, B-cell deficiency, and presenile hearing loss."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29315404": [
        "Moreover, the physiological relevance of MOV10-mediated L1 regulation in human disease has not yet been examined.",
        "Long interspersed nuclear element 1 is an autonomous non-long terminal repeat retrotransposon that comprises \u223c17% of the human genome.",
        "Moloney leukemia virus 10 homolog (MOV10), a putative RNA helicase, has been implicated in inhibiting L1 replication, although its underlying mechanism of action remains obscure.",
        "Using a proteomic approach, we identified RNASEH2 as a binding partner of MOV10.",
        "RNASEH2 and MOV10 co-localize in the nucleus, and RNASEH2 binds to L1 RNAs in a MOV10-dependent manner.",
        "Furthermore, we show that RNASEH2-MOV10-mediated L1 restriction downregulates expression of the rheumatoid arthritis-associated inflammatory cytokines and matrix-degrading proteinases in synovial cells, implicating a potential causal relationship between them and disease development in terms of disease predisposition.",
        "Its spontaneous retrotransposition and the accumulation of heritable L1 insertions can potentially result in genome instability and sporadic disorders.",
        "We show that MOV10 interacts with RNASEH2, and their interplay is crucial for restricting L1 retrotransposition.",
        "Small hairpin RNA-mediated depletion of either RNASEH2A or MOV10 results in an accumulation of L1-specific RNA-DNA hybrids, suggesting they contribute to prevent formation of vital L1 heteroduplexes during retrotransposition."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21931534": [
        "The novel role of CD28 as receptor for a class of microbial pathogens, the superantigen toxins, broadens the scope of pathogen recognition mechanisms.",
        "Mice were protected from lethal superantigen challenge by short peptide mimetics of the CD28 dimer interface and by peptides selected to compete with the superantigen for its binding site in CD28.",
        "Structural analysis showed that when a superantigen binds to the T cell receptor on the T cell and major histocompatibility class II molecule on the antigen-presenting cell, CD28 can be accommodated readily as third superantigen receptor in the quaternary complex, with the CD28 dimer interface oriented towards the \u03b2-strand/hinge/\u03b1-helix domain in the superantigen.",
        "Preventing access of the superantigen to CD28 suffices to block its lethality.",
        "Mutation of this superantigen domain abolished inflammatory cytokine gene induction and lethality.",
        "Superantigens use a conserved \u03b2-strand/hinge/\u03b1-helix domain of hitherto unknown function to engage CD28.",
        "CD28 is a homodimer expressed on T cells that functions as the principal costimulatory ligand in the immune response through an interaction with its B7 coligands, yet we show here that to elicit inflammatory cytokine gene expression and toxicity, superantigens must bind directly into the dimer interface of CD28.",
        "Our findings identify the CD28 homodimer interface as a critical receptor target for superantigens.",
        "Bacterial superantigens, a diverse family of toxins, induce an inflammatory cytokine storm that can lead to lethal shock."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24022021": [
        "Every adaptive immune response requires costimulation through the B7/CD28 axis, with CD28 on T-cells functioning as principal costimulatory receptor.",
        "We show that to elicit an inflammatory cytokine storm and lethality, superantigens must bind directly to CD28.",
        "Blocking access of the superantigen to its CD28 receptor with peptides mimicking the contact domains in either toxin or CD28 suffices to protect mice effectively from lethal shock.",
        "Our finding that CD28 is a direct receptor of superantigen toxins broadens the scope of microbial pathogen recognition mechanisms.",
        "Staphylococcal and streptococcal superantigen toxins hyperstimulate the T-cell-mediated immune response by orders of magnitude, inducing a lethal cytokine storm."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30404186": [
        "These host-oriented therapeutics target the human immune system itself, rendering pathogens less likely to become resistant.",
        "Acute toxic shock is induced by superantigen toxins, a diverse set of proteins secreted by Gram-positive staphylococcal and streptococcal bacterial strains that overstimulate the inflammatory response by orders of magnitude.",
        "Binding of the superantigen into the homodimer interfaces of these costimulatory receptors greatly enhances B7-2/CD28 engagement, leading to excessive pro-inflammatory signaling.",
        "The need to protect from superantigen toxins led to our discovery that in addition to the well-known MHC class II and T cell receptors, the principal costimulatory receptor, CD28, and its constitutively expressed coligand, B7-2 (CD86), previously thought to have only costimulatory function, are actually critical superantigen receptors.",
        "One such CD28 mimetic peptide is advancing in a Phase 3 clinical trial to protect from lethal wound infections by flesh-eating bacteria.",
        "During severe bacterial infections, death and disease are often caused by an overly strong immune response of the human host.",
        "It then turned out that such a peptide will protect also from Gram-negative bacterial infection and from polymicrobial sepsis.",
        "This finding led to the design of short receptor dimer interface mimetic peptides that block the binding of superantigen and thus protect from death."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28137564": [
        "We also mentioned some bioinformatics tools for extracting information such as toxin similarity search.",
        "This approach has been applied with great success to a variety of pathogens increasing the fundamental knowledge on pathogenicity.",
        "Exoproteomics aims at describing and quantifying the proteins found outside of the cells, thus takes advantage of the most recent methodologies of next-generation proteomics.",
        "Their pathogenicity relies on this arsenal of exoproteins and their orchestrated release upon changing environmental conditions.",
        "In this chapter, we describe how the exoproteome should be prepared and handled for high-throughput identification of exoproteins and their quantitation by label-free shotgun proteomics.",
        "Pathogens are known to release in their environment a large range of toxins and other virulence factors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29233035": [
        "This revealed a massive reduction in the number of staphylococcal exoproteins upon co-culturing with K. oxytoca or B. thuringiensis.",
        "Wound-colonizing microorganisms can form complex and dynamic polymicrobial communities where pathogens and commensals may co-exist, cooperate or compete with each other.",
        "Since the extracellular proteome of bacterial pathogens is a reservoir of virulence factors, the exoproteomes of the staphylococcal isolates in monoculture and co-culture with B. thuringiensis and K. oxytoca were characterized by Mass Spectrometry to explore the inherent relationships between these co-exisiting bacteria.",
        "Altogether, the observed exoproteome variations upon co-culturing are indicative of unprecedented adaptive mechanisms that set limits to the production of secreted staphylococcal virulence factors.",
        "Specifically, this involved two different isolates of the human pathogen Staphylococcus aureus, and isolates of Bacillus thuringiensis and Klebsiella oxytoca.",
        "Furthermore, our exoproteome analysis uncovered potential cooperativity between the two different S. aureus isolates.",
        "Particular focus was attributed to interactions of S. aureus with the two other species, because of the high staphylococcal prevalence among chronic wounds.",
        "Interestingly, this decrease was particularly evident for extracellular proteins with a predicted cytoplasmic localization, which were recently implicated in staphylococcal virulence and epidemiology.",
        "Intriguingly, upon co-cultivation, none of the wound isolates inhibited each other's growth.",
        "The present study was aimed at identifying possible interactions between different bacteria isolated from the same chronic wound of a patient with the genetic blistering disease epidermolysis bullosa (EB)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29419372": [
        "Consistent with a role of these enzymes in plant cell-wall degradation, pectin, cellulose, and xylan utilization were reduced in the VdSec22 or VdSso1 mutant strains along with a loss of exoproteome cytotoxic activity on cotton leaves.",
        "Comparative analyses of the secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
        "Comparisons with a pathogenicity-related exoproteome revealed that several known virulence factors were not regulated by VdSec22 or VdSso1, but some of the proteins regulated by VdSec22 or VdSso1 displayed different characteristics, including the lack of a typical signal peptide, suggesting that V. dahliae employs more than one secretory route to transport proteins to extracellular sites during infection.",
        "In this study, we identified vesicle-fusion components that included 22 soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), four Sec1/Munc18 (SM) family proteins, and 10 Rab GTPases encoded in the genome of the vascular wilt pathogen Verticillium dahliae Vd991.",
        "Targeted deletion of two SNARE-encoding genes in V. dahliae, VdSec22 and VdSso1, significantly reduced virulence of both mutants on cotton, relative to the wild-type Vd991 strain.",
        "Proteins that mediate cellular and subcellular membrane fusion are key factors in vesicular trafficking in all eukaryotic cells, including the secretion and transport of plant pathogen virulence factors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29255950": [
        "Triple A syndrome (TAS) or Allgrove syndrome (OMIM #231550) is a rare autosomal recessive disorder characterised by adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima, achalasia, and neurological and dermatological abnormalities.",
        "One novel mutation was detected: a homozygous 10-bp deletion (c.1264_1273del, p.Q422NfsX126) in exon 14 of the AAAS gene that caused a frameshift that introduced an aberrant stop codon after 126 amino acids.",
        "In all cases, genetic analysis revealed homozygous mutations in the AAAS gene.",
        "Between 2006 and 2017, we evaluated six patients with a clinical diagnosis of TAS, based on the presence of at least two symptoms, usually adrenal insufficiency and alacrima.",
        "A precise genotype-phenotype correlation was impossible to establish.",
        "Mutations in the AAAS gene on chromosome 12q13 encoding the nuclear pore protein ALADIN have been reported in these patients.",
        "This genetic variant is likely to be pathogenic because it caused a significant change in protein structure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29874194": [
        "Unlike other autosomal recessive disorders, triple A syndrome patients show a wide phenotypic variability both among different patients and family members harboring the same mutation(s).",
        "The clinical, biochemical and molecular testing data were collected and correlated.",
        "A significant gap between the onset of symptoms and confirmatory diagnosis was noted, suggesting that a high index of suspicion is required for diagnosing this disorder.",
        "A number of other features have been reported over time in this heterogeneous and multisystemic disorder.",
        "A gene-environment interaction has been thought to be a plausible cause.",
        "The results of treatment and follow-up and genetic counseling of the families were obtained wherever feasible.",
        "Results Our cohort consisted mostly of children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development.",
        "Sudden unexplained death was observed in siblings, and early diagnosis and treatment could help in preventing early mortality and improving the quality of life for these patients.",
        "It occurs due to biallelic mutations in the AAAS gene which codes for the nuclear pore protein ALADIN.",
        "Conclusion High index of suspicion for a potentially treatable disorder allows early appropriate intervention.",
        "Neurological and autonomic features were present in a few patients, suggesting requirement of prolonged follow-up for these patients.",
        "Background Triple A syndrome is characterized by achalasia, alacrima and adrenal insufficiency with neurological manifestations occurring later in the course of the disease.",
        "Methods A retrospective analysis of six families and seven patients presenting with triple A syndrome was carried out."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30069287": [
        "Generally, it's characterized by of adrenal insufficiency in consequence of adrenocorticotropic hormone (ACTH) resistance, besides of achalasia, and alacrimia.",
        "Allgrove or triple A syndrome (AS or AAA) is a rare autosomal recessive syndrome with variable phenotype due to mutations in <i>AAAS</i> gene which encodes a protein called ALADIN.",
        "Some cases of motor neuron disease, as ours, may be due to AAS.",
        "A few cases of Allgrove syndrome with motor neuron disease have been already described.",
        "The ENMG showed generalized denervation with normal conduction velocities.",
        "Our case presented a distal spinal amyotrophy with slow evolution and symptoms and signs of AS with a mutation in AAAS gen.",
        "Early diagnosis is extremely important for symptomatic treatment.",
        "He suffered later of orthostatic hypotension and erectile dysfunction.",
        "Genetic testing revealed 2 known pathogenic variants in the <i>AAAS</i> gene (c.938T&gt;C and c.1144_1147delTCTG).",
        "He presented distal amytrophy in four limbs, tongue myofasiculations, alacrimia, hoarseness and dysphagia due to achalasia.",
        "Neurologic features are varied and have been the subject of several case reports and reviews.",
        "A 25-year-old white man, at the age of four, presented slowly progressive distal amyotrophy and weakness, autonomic dysfunction, dysphagia and lack of tears."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27895694": [
        "Vitamin D and calcium supplements are usually prescribed for the prevention of osteoporosis.",
        "Alacrima is generally asymptomatic but can be detected by obtaining patient history.",
        "While very few such cases have been reported till date, one such case was presented to us as an edentulous child.",
        "Neurologic manifestations could be present in adults.",
        "The 3 features of this syndrome are achalasia, adrenal insufficiency, and alacrima.",
        "In some individuals with this disorder, genetic examination indicates mutations in both alleles of the <i>AAAS</i> gene, which encodes a special 546-amino-acid protein designated ALADIN, and in chromosome 12q13.",
        "The genetic cause of the triple A syndrome in some patients who do not have an identified mutation is unknown.",
        "Achalasia could be the first manifestation of the triple-A syndrome; however, its etiology is unclear.",
        "Triple-A syndrome, also known as Allgrove syndrome, is a rare autosomal recessive disorder.",
        "Although adrenal insufficiency could have manifestations such as asthenia, it might be wrongly diagnosed as muscle fatigue."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26354489": [
        "Alacrimia was the earliest feature evident at the age of 8 years.",
        "Our patient manifested adrenal insufficiency and achalasia in the second decade and manifested neurological dysfunction before adrenal dysfunction.",
        "Since its first description by Allgrove in 1978, approximately 100 cases have been reported in the literature.",
        "Here we report an 18-year-old boy diagnosed as having Allgrove syndrome, with ACTH resistant adrenal insufficiency, achalasia, alacrimia, and severe motor polyneuropathy.",
        "It is frequently associated with neurological manifestations like polyneuropathy.",
        "Allgrove (Triple A) syndrome is a rare autosomal recessive disorder characterized by cardinal features of adrenal insufficiency due to adrenocorticotropic hormone (ACTH) resistance, achalasia, and alacrimia.",
        "He presented with achalasia and adrenal insufficiency at 12 and 18 years respectively and developed neurological symptoms in the form of severe muscle wasting at the age of 15 years.",
        "Patients with Allgrove syndrome usually manifest adrenal insufficiency and achalasia during first decade of life."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22000320": [
        "We describe an 11-year-old boy with triple A syndrome who presented with progressive axonal motor neuropathy.",
        "Molecular analysis revealed compound heterozygous mutations in the AAAS gene, confirming the clinical diagnosis.",
        "Our patient manifested neurologic problems during early childhood, before other features of this condition were apparent.",
        "Most patients also develop some neurologic abnormalities.",
        "In the presence of complex axonal neuropathy, other features of this condition should be sought.",
        "\"Triple A\" syndrome is a rare, autosomal recessive condition whose main clinical features are alacrima, achalasia, and adrenal failure.",
        "The clinical presentation of patients with triple A syndrome is variable.",
        "We highlight the neurologic presentation of this multisystem disorder."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12752575": [
        "We therefore suggest that the diagnosis of triple A syndrome should be considered in patients who exhibit only one or two of the main symptoms (i.e. alacrima, achalasia or adrenal insufficiency).",
        "In one patient with isolated achalasia, the diagnosis of triple A syndrome could only be made on the basis of the molecular genetic analysis of the AAAS gene.",
        "These patients require careful neurological investigation, and mutation analysis of the AAAS gene should be performed.",
        "Associated features of the syndrome are neurological and dermatological abnormalities.",
        "The triple A or Allgrove syndrome is an autosomal-recessive disease (MIM*231550) characterized by the triad of achalasia, alacrima and adrenocorticotropic hormone (ACTH)-resistant adrenal insufficiency.",
        "Here we present the clinical and molecular genetic data which demonstrated the marked phenotypic variability in three unrelated patients with triple A syndrome.",
        "Until the discovery of the AAAS gene as the responsible gene in triple A syndrome, the diagnosis was based on characteristic clinical features.",
        "The final diagnosis of triple A syndrome was confirmed by molecular analysis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18551317": [
        "In addition, a large number of associated neurological and dermatological features were present in this patient.",
        "Triple A syndrome was confirmed by molecular analysis, revealing a nonsense mutation p.W84X in the AAAS gene.",
        "In most patients, neurological and dermatological abnormalities are associated features.",
        "The parents are both heterozygous carriers of the mutation.",
        "Further, triple A syndrome patients carrying the identical homozygous p.W84X mutation have to be studied to assess a genotype-phenotype relationship for this mutation.",
        "Moreover, he has dysmorphic facial features, which have not been previously described in triple A syndrome.",
        "Endocrine investigation confirmed primary adrenal insufficiency at the age of 5.8 years.",
        "We report on the first Bosnian patient with triple A syndrome.",
        "The affected twin brother unfortunately died from hypoglycaemic shock, despite a normal cortisol rise in an ACTH stimulation test.",
        "Two months later, achalasia was diagnosed, and in the presence of alacrima, the patient satisfies the diagnostic criteria of triple A syndrome.",
        "The triple A syndrome is a rare autosomal recessive disease that is characterised by the triad of adrenocorticotropin (ACTH)-resistant adrenal insufficiency, achalasia and alacrima."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11815731": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The triple A syndrome is characterized by the main features adrenal insufficiency, achalasia and alacrima.",
        "Other organ systems can be involved in a variable manner."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16970037": [
        "We present a 28 year-old woman with classical systemic features of triple A syndrome with prominent neurological dysfunctions/deficits, including distal muscular atrophy, progressive muscle weakness and wasting of both legs, sensibility dysfunction, hyperreflexia and autonomic dysfunction presented with excessive sweating.",
        "Allgrove syndrome (triple A syndrome) is a rare autosomal recessive disorder characterized by achalasia, alacrima, adrenal insufficiency, and--occasionally--autonomic instability.",
        "Disease causing mutations have been found in the AAAS gene on 12q13, but no strong phenotype-genotype correlation could be found.",
        "DNA sequencing of the AAAS gene revealed compound heterozygosity for previously reported mutations.",
        "A similar genotype was previously reported, but with a remarkably different phenotype."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12530689": [
        "With four WD repeats it belongs to the family of WD repeat-containing proteins which may exhibit a high degree of functional diversity.",
        "The triple A syndrome (MIM*231550) is a rare autosomal recessive disorder characterized by adrenocorticotropic hormone (ACTH) resistant adrenal failure, achalasia, alacrima and a variety of neurological and dermatological features.",
        "Adrenal insufficiency usually presents in the first decade of life, however in some patients it may occur later in life or may even lack completely.",
        "The subcellular localization of the protein and the determination of its putative binding partners will shed light on the role of the AAAS protein for the development and function of the adrenal gland and other neuroendocrine structures.",
        "Recently, we and others identified a novel gene on chromosome 12q13, designated AAAS (Achalasia-Addisonianism-Alacrima-Syndrome gene) which is mutated in patients with triple A syndrome.",
        "The AAAS protein function is unknown.",
        "Genotype/phenotype analyses revealed a highly variable occurrence, age of onset and severity of all clinical symptoms between patients with the same AAAS mutation.",
        "We investigated n=84 families including 111 patients with clinically suggested triple A syndrome and identified homozygous or compound heterozygous AAAS mutations in 78 families.",
        "The obvious lack of a genotype/phenotype relationship is suggestive of modifying genes/factors which need to be determined."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15666842": [
        "The lack of AAAS mutations in eight patients and negative linkage to chromosome 12q13 in three families are suggestive of genetic heterogeneity.",
        "The triple A syndrome is caused by mutations in the AAAS gene, which encodes a protein known as ALADIN (ALacrima Achalasia aDrenal Insufficiency Neurologic disorder).",
        "An investigation of 110 families with triple A syndrome disclosed mutation hot spots including Q15K (exon 1), and S293P (exon 8), which occur in 17 and 21 families from different geographical regions, respectively.",
        "To examine the cellular localization of ALADIN mutants causing triple A syndrome, we investigated nine different ALADIN-mutants: 2 nonsense (W84X, Q456X), 2 frameshift (F157fsX171, G397fsX414) and 5 point mutations (Q15K, L25P, H160R, S263P, L381R) by transfection experiments with green fluorescence protein.",
        "Mutants were predominantly localized in the cytoplasm, but also found in the nucleus indicating that ALADIN is essential for NPC targeting.",
        "Further studies have to investigate the role of ALADIN at NPCs and to identify interacting proteins.",
        "To investigate physiological functions of ALADIN in vivo, we generated and analysed Aaas-/- knockout mice by homologous recombination in embryonic stem cells.",
        "ALADIN is a new WD-repeat protein that has no significant homology to any previously identified WD-repeat protein.",
        "It has been shown that it colocalizes with nuclear pore complexes (NPCs), a finding that strongly suggests an involvement of ALADIN in nucleocytoplasmic transport.",
        "The variable phenotype of all patients cannot be correlated with the localization and the nature of the ALADIN mutations.",
        "Functional analyses of ALADIN may permit further understanding of its role for adrenocortical function and neurodevelopment.",
        "Thus, modifying genes/factors may be involved in the progression of this neurodegenerative disease.",
        "The triple A syndrome (MIM#231550) is a rare autosomal recessive disorder characterized by adrenocorticotropic hormone (ACTH) resistant adrenal failure, achalasia, alacrima, and a variety of neurological and dermatological features.",
        "Surprisingly, required animals lack any gross abnormality in adrenal and nervous system function."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23691407": [
        "Considering that the Triple A syndrome is a progressive disorder which can take years to develop the full-blown clinical picture, these patients require periodical medical controls.",
        "In sharp contrast with previous literature reports on frequent mild cognitive dysfunction in patients with Triple A syndrome, our child did not show any mental retardation.",
        "By contrast, he showed an average IQ at T0 with a slight improvement at T1.",
        "Many difficulties were observed in the motor domain, as well as in manual dexterity and static/dynamic balance domains of the motor task over time.",
        "Moreover, assessment of neuropsychological and psychopathological features should be performed in patients with this disease, in order to underline the variability of this syndrome.",
        "Triple A syndrome is an autosomal recessive disorder characterized by the triad of adrenocorticotropic hormone resistant adrenal insufficiency, achalasia, and alacrima.",
        "Our aim was to describe the neuropsychological characteristics and the cooccurring psychopathological and neurological disorders in an Italian male child suffering from Triple A syndrome at the time of admission (T0) and after one year of follow-up (T1).",
        "To our knowledge, this report is the first describing neuropsychological profile and co-occurring psychopathological problems in a child with Triple A syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11196451": [
        "The triple A syndrome or Allgrove syndrome (MIM*231550) is characterized by adrenocorticotropic hormone (ACTH) resistant Adrenal insufficiency, Achalasia of the cardia and Alacrima.",
        "There was no indication of genetic heterogeneity.",
        "The considerable intra- and interfamilial variability of the severity of the disorder implies a variable expression of an impaired pleiotropically acting gene.",
        "We initially performed a systematic genome linkage scan in eight triple A families and were able to map the syndrome to a 6 cM interval on human chromosome 12q13 near the type II keratin gene cluster.",
        "Dermatological abnormalities such as palmoplantar hyperkeratosis as well as other signs like short stature, microcephaly and osteoporosis point to the multisystemic character of the disorder.",
        "The molecular defect of the autosomal recessively inherited triple A syndrome is not known.",
        "A refinement of the triple A critical region was achieved by detailed haplotype analysis in a further 37 families from different ethnic backgrounds.",
        "The achalasia-alacrima (AA) syndrome which has been defined as a distinct clinical entity (MIM 200440) is most likely a variant of the triple A syndrome as shown by haplotype analysis in three AA families.",
        "In addition to the main features, patients frequently suffer from neurological disturbances.",
        "We constructed a high-resolution BAC/PAC-based transcript map of the region which will greatly facilitate the identification of the triple A syndrome gene."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12429595": [
        "We identified a spectrum of associated neurological abnormalities in these cases, including pupil and cranial nerve abnormalities, frequent optic atrophy, autonomic neuropathy and upper and lower motor neurone signs including distal motor neuropathy and amyotrophy with severe selective ulnar nerve involvement.",
        "The majority of mutations were homozygous.",
        "Mutations in the triple A gene are thus an important cause of this clinically heterogeneous syndrome, and sequencing represents an important diagnostic investigation.",
        "Affected individuals have between two and four of these relatively common clinical problems; hence the diagnosis is often difficult in all but the classical presentation.",
        "In these families, we have made genotype-phenotype correlations.",
        "Sequencing of the triple A gene revealed five families that had a total of nine compound heterozygous mutations, and one Portuguese family (previously published) had two homozygous mutations; these changes were spread throughout the triple A gene in exons 1, 2, 7, 8, 10, 11, 12, 13 and 16, and the poly(A) tract.",
        "Triple A (Allgrove) syndrome is characterized by achalasia, alacrima, adrenal abnormalities and a progressive neurological syndrome.",
        "Identifying further mutations and defining their phenotype along with functional protein analysis will help to characterize this neuroendocrine gene.",
        "Mutations in this gene were reported in families from North Africa and Europe.",
        "The inheritance is autosomal recessive, and most cases of triple A have no family history.",
        "We have identified 20 families with between two and four of the clinical features associated with the triple A syndrome.",
        "Those bearing mutations had the classical triple A syndrome of achalasia, alacrima, adrenal abnormalities and a progressive neurological syndrome.",
        "Using genetic linkage analysis in a small number of families, a locus on chromosome 12q13 was identified.",
        "The triple A gene was identified recently at this locus and called ALADIN (alacrima, achalasia, adrenal insufficiency neurologic disorder)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21656342": [
        "We then review the previous neurological reports of this disease, to improve the understanding of this rare condition.",
        "Diagnosis of late-onset Triple-A syndrome is difficult when the clinical picture is mainly neurological and when endocrine or gastrointestinal signs are minor.",
        "Other neurological features included cognitive deficits, pyramidal syndrome, cerebellar dysfunction, dysautonomia, neuro-ophthalmological signs and bulbar and facial symptoms.",
        "The characteristics of the peripheral neuropathy, among other neurological signs, can be of help.",
        "All patients were genetically confirmed and had a mutation in the ALADIN gene.",
        "Triple-A or Allgrove syndrome is a rare multisystem disease classically associated with esophageal achalasia, adrenal insufficiency and alacrima.",
        "However, all harbored a neurological picture characterized by a recognizable pattern of peripheral neuropathy.",
        "They all displayed a classical picture of Triple-A syndrome: all suffered from achalasia and alacrima and half of them from adrenal insufficiency.",
        "This neurological picture was prominent in all patients and misled the initial diagnosis in six of them, which had a late onset.",
        "Here, we describe the poorly understood neurological characteristics often associated with this condition, through the clinical and electrophysiological analysis of eight patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29270134": [
        "The aim of this study was to explore whether CID755673 and CRT0066101 block NF-\u03baB activation with <i>in vitro</i> and <i>in vivo</i> models of experimental pancreatitis and whether the small molecule PKD inhibitors have therapeutic effects when given before or after the initiation of experimental pancreatitis.",
        "For <i>in vivo</i> experimental pancreatitis, rats were treated with intraperitoneal injection of CID755673 or CRT0066101 prior to or after administering cerulein or saline.",
        "The effects of PKD inhibitors on pancreatitis responses were evaluated.",
        "Inhibition of PKD resulted in significantly attenuation of NF-\u03baB activation in both <i>in vitro</i> and <i>in vivo</i> models of experimental pancreatitis.",
        "Our results indicate that small chemical PKD inhibitors have significant potential as therapeutic interventions by suppressing NF-\u03baB activation.",
        "Freshly prepared pancreatic acini were incubated with CID755673 or CRT006101, followed by hyperstimulation with CCK or CCh.",
        "Our previous <i>in vitro</i> studies with molecular approaches on AR42J cell showed that protein kinase D (PKD/PKD1) activation was required in NF-\u03baB activation induced by cholecystokinin 8 (CCK) or carbachol (CCh) in pancreatic acinar cells.",
        "NF-\u03baB inhibition by CID755673 was associated with decreased inflammatory responses and attenuated severity of the disease, which were indicated by less inflammatory cell infiltration, reduced pancreatic interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1), decreased intrapancreatic trypsin activation, and alleviation in pancreatic necrosis, edema and vacuolization.",
        "PKD activation and NF-\u03baB-DNA binding activity in nuclear extracts from pancreatic acini and tissue were measured.",
        "Our results showed that both CID755673 or CRT0066101 selectively and specifically inhibited PKD without effects on related protein kinase Cs.",
        "Nuclear factor-kappa B (NF-\u03baB) activation is a key early signal regulating inflammatory and cell death responses in acute pancreatitis.",
        "Therapies for acute pancreatitis are limited.",
        "Furthermore, PKD inhibitor CID755673, given after the initiation of pancreatitis in experimental rat model, significantly attenuated the severity of acute pancreatitis.",
        "Recently developed small molecule PKD inhibitors, CID755673 and CRT0066101, provide potentially important pharmacological approaches to further investigate the effect of PKD in pancreatitis therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29071385": [
        "These novel findings suggest that CRT0066101 suppresses bladder cancer growth by inhibiting PKD2 through induction of G2/M cell cycle arrest, leading to the blockade of cell cycle progression.",
        "This notion was corroborated by demonstrating that the levels of phospho-PKD2 were markedly decreased in CRT0066101-treated bladder tumor explants.",
        "CRT0066101, an inhibitor of PKD, has antitumor activity in multiple types of carcinomas.",
        "Furthermore, our cell cycle analysis by flow cytometry revealed that CRT0066101 treatment or PKD2 silencing arrested bladder cancer cells at the G2/M phase, the arrest being accompanied by decreases in the levels of cyclin B1, CDK1 and phospho-CDK1 (Thr161) and increases in the levels of p27<sup>Kip1</sup> and phospho-CDK1 (Thr14/Tyr15).",
        "In the present study, we show that CRT0066101 suppressed the proliferation and migration of four bladder cancer cell lines in vitro.",
        "Moreover, CRT0066101 downregulated the expression of Cdc25C, which dephosphorylates/activates CDK1, but enhanced the activity of the checkpoint kinase Chk1, which inhibits CDK1 by phosphorylating/inactivating Cdc25C.",
        "Finally, CRT0066101 was found to elevate the levels of Myt1, Wee1, phospho-Cdc25C (Ser216), Gadd45\u03b1, and 14-3-3 proteins, all of which reduce the CDK1-cyclin B1 complex activity.",
        "We also demonstrate that CRT0066101 blocked tumor growth in a mouse flank xenograft model of bladder cancer.",
        "The protein kinase D (PKD) family of proteins are important regulators of tumor growth, development, and progression.",
        "However, the effect and mechanism of CRT0066101 in bladder cancer are not understood.",
        "To further assess the role of PKD in bladder carcinoma, we examined the three PKD isoforms and found that PKD2 was highly expressed in eight bladder cancer cell lines and in urothelial carcinoma tissues from the TCGA database, and that short hairpin RNA (shRNA)-mediated knockdown of PKD2 dramatically reduced bladder cancer growth and invasion in vitro and in vivo, suggesting that the effect of the compound in bladder cancer is mediated through inhibition of PKD2."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27030010": [
        "Irradiation of the Golgi region (405 nm) induced green-red photo-conversion of PAR2-Kaede.",
        "CRT0066101 also inhibited sustained protease signaling to colonocytes and nociceptive neurons that naturally express PAR2 and mediate protease-evoked inflammation and nociception.",
        "Inhibitors of PKD (CRT0066101) and G\u03b2\u03b3 (gallein) prevented PAR2-stimulated activation of PKD.",
        "We evaluated the contribution of protein kinase D (PKD) and G\u03b2\u03b3 to this process.",
        "CRT0066101, PKD1 siRNA, and gallein all inhibited recovery of PAR2-evoked Ca(2+) signaling.",
        "Trypsin depleted PAR2-Kaede from the Golgi apparatus and repleted PAR2-Kaede at the plasma membrane.",
        "PAR2 with a photoconvertible Kaede tag was expressed in KNRK cells to examine receptor translocation from the Golgi apparatus to the plasma membrane.",
        "Protease-activated receptor-2 (PAR2) traffics to lysosomes, and sustained protease signaling requires mobilization and plasma membrane trafficking of PAR2 from Golgi stores.",
        "CRT0066101 inhibited PAR2-Kaede translocation to the plasma membrane.",
        "Our results reveal a major role for PKD and G\u03b2\u03b3 in agonist-evoked mobilization of intracellular PAR2 stores that is required for sustained signaling by extracellular proteases.",
        "PAR2 activation induced translocation of G\u03b2\u03b3, a PKD activator, to the Golgi apparatus, determined by bioluminescence resonance energy transfer between G\u03b3-Venus and giantin-Rluc8.",
        "In HEK293 and KNRK cells, the PAR2 agonists trypsin and 2-furoyl-LIGRLO-NH2 activated PKD in the Golgi apparatus, where PKD regulates protein trafficking.",
        "Agonist-evoked endocytosis of G protein-coupled receptors has been extensively studied.",
        "The mechanisms by which agonists stimulate mobilization and plasma membrane translocation of G protein-coupled receptors from intracellular stores are unexplored."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25852060": [
        "Invasive ductal carcinomas (IDC) of the breast are associated with altered expression of hormone receptors (HR), amplification or overexpression of HER2, or a triple-negative phenotype.",
        "This identifies ER(-) breast cancers as ideal for treatment with the PKD inhibitor CRT0066101.",
        "The most aggressive cases of IDC are characterized by a high proliferation rate, a great propensity to metastasize, and their ability to resist to standard chemotherapy, hormone therapy, or HER2-targeted therapy.",
        "Our data strongly support the development of PKD inhibitors for clinical use for ER(-) breast cancers, including the triple-negative phenotype.",
        "Loss of ER results in upregulation of PKD3, leading to all hallmarks of aggressive IDC, including increased cell proliferation, migration, and invasion.",
        "We identify direct binding of the ER to the PRKD3 gene promoter as a mechanism of inhibition of PKD3 expression.",
        "Using progression tissue microarrays, we here demonstrate that the serine/threonine kinase protein kinase D3 (PKD3) is highly upregulated in estrogen receptor (ER)-negative (ER(-)) tumors.",
        "We show that similar to a knockdown of PKD3, treatment with this inhibitor targets all tumorigenic processes in vitro and decreases growth of primary tumors and metastasis in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20947701": [
        "Furthermore, PKD/PKD1 is a potential mediator of zymogen activation, amylase secretion, and NF-\u03baB activation induced by a range of secretagogues in pancreatic acinar cells.",
        "Protein kinase D (PKD/PKD1) is a convergent point of PKC \u03b4 and \u03b5 in the signaling pathways triggered through CCK or cholinergic receptors and has been shown to activate the transcription factor NF-\u03baB in acute pancreatitis.",
        "We pretreated isolated rat pancreatic acinar cells with CRT0066101 and a commercially available inhibitor G\u00f66976 (10 \u03bcM).",
        "CRT0066101 dose dependently inhibited secretagogue-induced PKD/PKD1 activation and autophosphorylation at Ser-916 with an IC(50) \u223c3.75-5 \u03bcM but had no effect on PKC-dependent phosphorylation of the PKD/PKD1 activation loop (Ser-744/748).",
        "Novel protein kinase C isoforms (PKC \u03b4 and \u03b5) mediate early events in acute pancreatitis.",
        "Neither inhibitor affected basal zymogen activation or secretion.",
        "This was followed by stimulation for 60 min with high concentrations of cholecystokinin (CCK, 0.1 \u03bcM), carbachol (CCh, 1 mM), or bombesin (10 \u03bcM) to induce initial events of pancreatitis.",
        "Furthermore, CRT0066101 reduced secretagogue-induced zymogen activation and amylase secretion.",
        "G\u00f66976 reduced zymogen activation but not amylase secretion.",
        "PKD/PKD1 phosphorylation and activity were measured as well as zymogen activation, amylase secretion, cell injury and NF-\u03baB activation.",
        "For the present study we hypothesized that a newly developed PKD/PKD1 inhibitor, CRT0066101, would prevent the initial events leading to pancreatitis.",
        "CRT0066101 did not affect secretagogue-induced cell injury or changes in cell morphology, but it reduced NF-\u03baB activation by 75% of maximal for CCK- and CCh-stimulated acinar cells.",
        "In conclusion, CRT0066101 is a potent and specific PKD family inhibitor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20442301": [
        "Initially, we showed that autophosphorylated PKD1 and PKD2 (activated PKD1/2) are significantly upregulated in pancreatic cancer and that PKD1/2 are expressed in multiple pancreatic cancer cell lines.",
        "Using Panc-1 as a model system, we showed that CRT0066101 reduced bromodeoxyuridine incorporation; increased apoptosis; blocked neurotensin-induced PKD1/2 activation; reduced neurotensin-induced, PKD-mediated Hsp27 phosphorylation; attenuated PKD1-mediated NF-kappaB activation; and abrogated the expression of NF-kappaB-dependent proliferative and prosurvival proteins.",
        "Activated PKD1/2 expression in the treated tumor explants was significantly inhibited with peak tumor concentration (12 micromol/L) of CRT0066101 achieved within 2 hours after oral administration.",
        "Our results show for the first time that a PKD-specific small-molecule inhibitor CRT0066101 blocks pancreatic cancer growth in vivo and show that PKD is a novel therapeutic target in pancreatic cancer.",
        "However, nothing is known about the effects of targeting PKD in pancreatic cancer.",
        "Protein kinase D (PKD) family members are increasingly implicated in multiple normal and abnormal biological functions, including signaling pathways that promote mitogenesis in pancreatic cancer.",
        "Further, we showed that CRT0066101 given orally (80 mg/kg/d) for 21 days in Panc-1 orthotopic model potently blocked tumor growth in vivo.",
        "The aim of our study was to determine the effects of CRT0066101 in pancreatic cancer.",
        "CRT0066101 significantly reduced Ki-67-positive proliferation index (P &lt; 0.01), increased terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive apoptotic cells (P &lt; 0.05), and abrogated the expression of NF-kappaB-dependent proteins including cyclin D1, survivin, and cIAP-1.",
        "Our PKD inhibitor discovery program identified CRT0066101 as a specific inhibitor of all PKD isoforms.",
        "We showed that CRT0066101 given orally (80 mg/kg/d) for 24 days significantly abrogated pancreatic cancer growth in Panc-1 subcutaneous xenograft model."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26797128": [
        "PMA treatment also caused impairments in insulin-signaling through Akt, which were prevented by PKD1 inhibition.",
        "Serine phosphorylation and inhibition of AMPK activity were partially prevented by the broad PKC inhibitor G\u00f66983 and fully prevented by the specific PKD1 inhibitor CRT0066101.",
        "Inhibition of previously identified kinases that phosphorylate AMPK at this site (Akt, S6K, and ERK) did not prevent these events.",
        "Diacylglycerol (DAG), which is also increased in muscle exposed to high glucose, activates a number of signaling molecules including protein kinase (PK)C and PKD1.",
        "C2C12 myotubes were treated with the PKC/D1 activator phorbol 12-myristate 13-acetate (PMA), which acts as a DAG mimetic.",
        "AMP-activated protein kinase (AMPK) is an energy-sensing enzyme whose activity is inhibited in settings of insulin resistance.",
        "Exposure to a high glucose concentration has recently been shown to increase phosphorylation of AMPK at Ser(485/491) of its \u03b11/\u03b12 subunit; however, the mechanism by which it does so is not known.",
        "We sought to determine whether PKC or PKD1 is involved in inhibition of AMPK by causing Ser(485/491) phosphorylation in skeletal muscle cells.",
        "Finally, recombinant PKD1 phosphorylated AMPK\u03b12 at Ser(491) in cell-free conditions.",
        "This caused dose- and time-dependent increases in AMPK Ser(485/491) phosphorylation, which was associated with a \u223c60% decrease in AMPK\u03b12 activity.",
        "These results identify PKD1 as a novel upstream kinase of AMPK\u03b12 Ser(491) that plays a negative role in insulin signaling in muscle cells.",
        "Expression of a phosphodefective AMPK\u03b12 mutant (S491A) prevented the PMA-induced reduction in AMPK activity.",
        "Genetic knockdown of PKD1 also prevented Ser(485/491) phosphorylation of AMPK."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26895471": [
        "One of the properties of human breast cancer cells is cancer stemness, which is characterized by self-renewal capability and drug resistance.",
        "Furthermore, we confirmed that the PRKD1 inhibitor CRT0066101 reduced phosphorylated PKD/PKC\u03bc, leading to suppression of breast cancer stemness through GSK3/\u03b2-catenin signaling.",
        "These results provide evidence that regulation of PRKD1, a novel miR-34a target, contributes to overcoming cancer stemness and drug resistance in human breast cancer.",
        "PRKD1 inhibition also influenced apoptosis initiation in MCF-7-ADR cells.",
        "We also found that reduction of PRKD1 by ectopic miR-34a expression or PRKD1 siRNA treatment resulted in suppressed self-renewal ability in breast cancer stem cells.",
        "Protein kinase D1 (PRKD1) functions as a key regulator of many cellular processes and is downregulated in invasive breast cancer cells.",
        "In this study, we found that PRKD1 was upregulated in MCF-7-ADR human breast cancer cells characterized by drug resistance.",
        "PRKD1 expression increased following performance of a tumorsphere formation assay in MCF-7-ADR cells.",
        "Tumors from nude mice treated with miR-34a or CRT0066101 showed suppressed tumor growth, proliferation, and induced apoptosis.",
        "Additionally, we discovered that PRKD1 expression was negatively regulated by miR-34a binding to the PRKD1 3'-UTR."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15899861": [
        "These results implicate Mtch2 as a mitochondrial target of tBID and raise the possibility that the Mtch2-resident complex participates in the mitochondrial apoptotic program.",
        "BID, a proapoptotic BCL-2 family member, plays an essential role in the tumor necrosis factor alpha (TNF-alpha)/Fas death receptor pathway in vivo.",
        "Mtch2 is a conserved protein that is similar to members of the mitochondrial carrier protein family.",
        "Our studies with mouse liver mitochondria indicate that Mtch2 is an integral membrane protein exposed on the surface of mitochondria.",
        "Using blue-native gel electrophoresis we revealed that in viable FL5.12 cells Mtch2 resides in a protein complex of ca. 185 kDa and that the addition of TNF-alpha to these cells leads to the recruitment of tBID and BAX to this complex.",
        "Activation of the TNF-R1 receptor results in the cleavage of BID into truncated BID (tBID), which translocates to the mitochondria and induces the activation of BAX or BAK.",
        "Here we describe the biochemical purification of this complex and the identification of mitochondrial carrier homolog 2 (Mtch2) as part of this complex.",
        "In TNF-alpha-activated FL5.12 cells, tBID becomes part of a 45-kDa cross-linkable mitochondrial complex.",
        "Importantly, this recruitment was partially inhibited in FL5.12 cells stably expressing BCL-X(L)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30401654": [
        "MTCH2 forebrain conditional KO (MTCH2 BKO) display a deficit in hippocampus-dependent cognitive functions.",
        "MTCH2 BKO exhibit impaired spatial but not motor learning and an impairment in long-term potentiation (LTP) in hippocampal slices.",
        "Mitochondrial Carrier Homolog 2 (MTCH2) acts as a receptor for the BH3 interacting-domain death agonist (BID) in the mitochondrial outer membrane.",
        "Loss of MTCH2 affects mitochondria energy metabolism and function.",
        "Moreover, MTCH2 BKO express an increase in activated microglia, in addition to a reduction in neuron density in the hippocampus, but do not express amyloid-\u03b2 plaques or neurofibrillary tangles.",
        "These results highlight the role of mitochondria in the normal hippocampus-dependent memory formation.",
        "Here we study age-related MTCH2 BKO behavioral and electrophysiological aspects of hippocampal functions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26794447": [
        "Using these cells, we found that CL was not required for either tBID-induced BAX activation, or for apoptosis in response to treatment with TRAIL.",
        "However, it is still unclear whether this process also relies on CL in the cell, or whether it is more dependent on MTCH2, a proposed receptor for tBID present in the MOM.",
        "In particular, cardiolipin (CL) has been shown to stimulate tBID-induced BAX activation in vitro.",
        "During apoptosis, proapoptotic BAX and BAK trigger mitochondrial outer membrane (MOM) permeabilization by a mechanism that is not yet fully understood.",
        "The CL-deficient cells were fully viable in glucose but displayed impaired oxidative phosphorylation and an inability to grow in galactose.",
        "BH3-only proteins such as tBID, together with lipids of the MOM, are thought to play a key role in BAX and BAK activation.",
        "Downregulation of MTCH2 in HCT116 cells also failed to prevent recruitment of tBID to mitochondria in apoptotic conditions.",
        "To address this issue, we deleted both alleles of cardiolipin synthase in human HCT116 cells by homologous recombination, which resulted in a complete absence of CL.",
        "However, when both CL and MTCH2 were depleted, a significant reduction in tBID recruitment was observed, suggesting that in HCT116 cells, CL and MTCH2 can have redundant functions in this process."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27320914": [
        "Acute activation of Fas signaling triggers massive apoptosis in liver.",
        "MOAP-1 is a Bax-binding protein enriched at the OMM.",
        "Upon Fas receptor stimulation, the BH3-only protein Bid is cleaved into the active form, tBid.",
        "MOAP-1 binds to MTCH2, and this interaction appears necessary for MTCH2 to engage tBid.",
        "Subsequent tBid recruitment to mitochondria, which is facilitated by its receptor MTCH2 at the outer mitochondrial membrane (OMM), is a critical step for commitment to apoptosis via the effector proteins Bax or Bak.",
        "Here, we show that MOAP-1-deficient mice are resistant to Fas-induced hepatocellular apoptosis and lethality.",
        "These findings reveal a role for MOAP-1 in Fas signaling in the liver by promoting MTCH2-mediated tBid recruitment to mitochondria.",
        "Fas apoptotic signaling regulates diverse physiological processes.",
        "In the absence of MOAP-1, mitochondrial accumulation of tBid is markedly impaired."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22326460": [
        "We review the experimental evidence for the role of MTCH2 in apoptosis and suggest that the original transport function of the ancestral MTCH2 mitochondrial carrier has been co-opted by the apoptotic machinery to provide a receptor and signaling mechanism.",
        "Recent studies report mitochondrial carrier homolog 2 (MTCH2) as a novel and uncharacterized protein that acts as a receptor-like protein for the truncated BH3-interacting domain death agonist (tBID) protein in the outer membrane of mitochondria.",
        "There are extensive differences between the protein sequences of MTCH2 and other mitochondrial carriers that may explain the ability of MTCH2 to associate with tBID and thus its role in apoptosis.",
        "These studies, using mouse embryonic stem cells and fibroblasts as well as mice with a conditional knockout of MTCH2 in the liver, showed that deletion of MTCH2 hindered recruitment of tBID to the mitochondria with subsequent reductions in the activation of pro-apoptotic proteins, mitochondrial outer membrane permeabilization and apoptosis.",
        "Sequence analysis shows that MTCH2 is present in all examined multicellular Metazoa as well as unicellular Choanoflagellata, and is a highly derived member of the mitochondrial carrier family.",
        "Mitochondrial carriers are monomeric transport proteins that are usually found in the inner mitochondrial membrane, where they exchange small substrates between the mitochondrial matrix and intermembrane space."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26251998": [
        "PhenomeCentral identifies similar patients in the database based on semantic similarity between clinical features, automatically prioritized genes from whole-exome data, and candidate genes entered by the users, enabling both hypothesis-free and hypothesis-driven matchmaking.",
        "Though the majority of these records have associated exome data, most lack a molecular diagnosis.",
        "The discovery of disease-causing mutations typically requires confirmation of the variant or gene in multiple unrelated individuals, and a large number of rare genetic diseases remain unsolved due to difficulty identifying second families.",
        "Users can then contact other submitters to follow up on promising matches.",
        "Each record includes a phenotypic description and relevant genetic information (exome or candidate genes).",
        "PhenomeCentral incorporates data for over 1,000 patients with rare genetic diseases, contributed by the FORGE and Care4Rare Canada projects, the US NIH Undiagnosed Diseases Program, the EU Neuromics and ANDDIrare projects, as well as numerous independent clinicians and scientists.",
        "PhenomeCentral has already been used to identify causative mutations for several patients, and its ability to find matching patients and diagnose these diseases will grow with each additional patient that is entered.",
        "To enable the secure sharing of case records by clinicians and rare disease scientists, we have developed the PhenomeCentral portal (https://phenomecentral.org)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28166691": [
        "Seven isolates of the genus Listeria were obtained, 6 of L. innocua and 1 of L. monocytogenes, which was found in the pasture where the bull grazed.",
        "Both isolates belonged to serotype 4b and were positive for internalins A, C, and J.",
        "In the brainstem, there was perivascular cuffing, multiple microabscesses, and positive immunostaining for L. monocytogenes.",
        "The source of infection was the pasture, implying that listeriosis should not be discounted in cases with compatible clinical signs but the absence of silage feeding.",
        "A pastured 2-y-old cross-breed bull developed brainstem encephalitis (rhombencephalitis); Listeria monocytogenes was isolated from the brain.",
        "According to the DNA fragment patterns of pulsed-field gel electrophoresis, the isolates were closely related.",
        "Samples of bovine feces, water, feedstuffs, milking parlor soil, and bulk tank milk were collected from the dairy farm."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30328643": [
        "N-Acetylaspartate (NAA), N-acetylaspartylglutamate, choline, myo-inositol and scyllo-inositol were decreased, and glycine, phosphocholine, taurine and lactate were increased, in the diseased group (n = 13) in comparison with the control group (n = 12).",
        "Little is known about the metabolic changes associated with neurolisteriosis in particular and infectious central nervous system (CNS) diseases in general.",
        "This may be an indicator of metabolic changes occurring in the early stages of the disease.",
        "In the thalamus, which showed no or only mild inflammatory changes in the majority of animals, no statistically significant metabolic changes were observed.",
        "The purpose of our study was to investigate the metabolic changes associated with listeria rhombencephalitis in small ruminants (goats and sheep) as a model for inflammatory CNS disease by <sup>1</sup> H high-resolution magic angle spinning nuclear magnetic resonance (<sup>1</sup> H HR-MAS NMR) spectroscopy of brain biopsies obtained from the brainstem and thalamus.",
        "Statistical analysis revealed distinct differences in the metabolic profile of brainstem biopsies, the primary location of listeria rhombencephalitis with moderate or severe inflammatory changes.",
        "Therefore, further research with a larger number of animals is needed to evaluate the presence of subtle metabolic changes associated with mild inflammatory changes in the thalamus.",
        "In conclusion, <sup>1</sup> H HR-MAS NMR investigation of listeria rhombencephalitis identified brain metabolite changes, offering new insights into the disease pathophysiology.",
        "However, trends for metabolic alterations were partly the same as those found in the brainstem, including NAA, choline and lactate.",
        "Listeria rhombencephalitis is caused by infection with Listeria monocytogenes and is associated with a high mortality rate in humans and ruminants."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28730571": [
        "The present clinical and radiological findings corroborate earlier data from animal experiments, indicating that L. monocytogenes may be capable of retrograde intra-axonal migration along the cranial nerves.",
        "Listeria monocytogenes is associated with rhombencephalitis.",
        "Prior to any other neurological symptoms, two patients complained of hypoesthesia and a tingling sensation in the ipsilateral half of the face, consistent with sensory trigeminal nerve dysfunction on that side.",
        "Three females (41, 64 and 70 years) with culture proven L. monocytogenes bacteremia and rhombencephalitis were investigated in the period of 2014-16.",
        "In addition, we identified another 120 cases of Listeria rhombencephalitis following a systematic review.",
        "We suggest that in a subset of patients with rhombencephalitis L. monocytogenes enters the cerebellopontine angle through the trigeminal nerve, invading the brainstem via the sensory trigeminal nuclei.",
        "Here, we demonstrate clinical and radiological data suggesting that Listeria may invade the brainstem via the trigeminal nerve.",
        "However, the exact mechanisms of brainstem invasion remains poorly understood.",
        "Cranial nerves VII, V, IX, and X, respectively, medulla oblongata, cerebellum and pons, were the most frequently involved brain structures.",
        "T2-weighted and contrast-enhanced T1-weighted MRI revealed a cerebellopontine abscess in all three patients, including the involvement of the trigeminal nerve root.",
        "In two patients, MRI also revealed selective contrast enhancement of the sensory trigeminal tract in the pons and medulla oblongata."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27818548": [
        "It usually has a biphasic time course with a flu-like syndrome, followed by brainstem dysfunction; 75% of patients have cerebrospinal fluid pleocytosis, and nearly 100% have an abnormal brain magnetic resonance imaging scan.",
        "However, other possible causes of rhombencephalitis must be borne in mind.",
        "Infection with bacteria of the genus <i>Listeria</i> is the most common cause of rhombencephalitis.",
        "This pictorial essay reviews the various causes of rhombencephalitis and the corresponding magnetic resonance imaging findings, by describing illustrative confirmed cases.",
        "Primary rhombencephalitis caused by infection with <i>Listeria</i> spp. occurs in healthy young adults.",
        "Some of the reported causes of rhombencephalitis are potentially severe and life threatening; therefore, an accurate initial diagnostic approach is important to establishing a proper early treatment regimen.",
        "In addition to the clinical aspects, the patterns seen in magnetic resonance imaging can be helpful in defining the possible cause.",
        "Rhombencephalitis has a wide variety of etiologies, including infections, autoimmune diseases, and paraneoplastic syndromes.",
        "The term rhombencephalitis refers to inflammatory diseases affecting the hindbrain (brainstem and cerebellum)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/3579687": [
        "Contrary to other listerioses, rhombencephalitis has been mainly observed in patients without predisposing conditions.",
        "In our case, however, findings of a detailed immunologic study, performed three months and one year, respectively, after clinical onset of Listeria rhombencephalitis manifestations, showed a transient cellular immunity defect, not associated with any other apparent disease.",
        "Listeria rhombencephalitis is a rare but well-defined clinical syndrome of lower brain-stem involvement caused by Listeria monocytogenes.",
        "We report a case of Listeria rhombencephalitis in a previously healthy 60-year-old man."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15765316": [
        "Preferred treatment is ampicillin in association with aminoglycosides.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Listeria monocytogenes is a gram-positive bacillus which causes sporadic infections in immunocompromised humans, with a special propensity for the central nervous system, in the form of acute, subacute or chronic meningitis, rhombencephalitis or abscesses in the brain or spinal cord.",
        "The final diagnosis is established by germ culture in blood or in cerebrospinal fluid (CSF)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24050079": [
        "We report here two brain abscess cases caused by L. monocytogenes in patients receiving immunosuppressive agents.",
        "MRS was useful in differentiating infectious processes from non-infectious causes.",
        "Listerial DNA was detected in the pus aspirated from the abscess in the first case.",
        "Listerial brain abscesses are rare.",
        "Listeria monocytogenes is a gram-positive bacillus that exhibits predilection to infect the central nervous system in immunocompromised individuals; the most common manifestations are meningitis and rhombencephalitis.",
        "Diagnosis was made with a positive blood culture in both cases.",
        "The first patient presented with left hemiparesis mimicking stroke and the second patient presented with neurological symptoms without fever, which was indistinguishable from brain tumor.",
        "In both cases, magnetic resonance spectroscopy (MRS) was performed to differentiate infectious processes from other causes.",
        "Both patients were successfully treated with intravenous ampicillin followed by oral amoxicillin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20204066": [
        "There is an urgent need to study the molecular mechanisms of neuropathogenesis, which are poorly understood.",
        "Listeriosis is an emerging zoonotic infection of humans and ruminants worldwide caused by Listeria monocytogenes (LM).",
        "In both host species, CNS disease accounts for the high mortality associated with listeriosis and includes rhombencephalitis, whose neuropathology is strikingly similar in humans and ruminants.",
        "Such studies will provide a basis for the development of new therapeutic strategies that aim to prevent LM from invading the brain and spread within the CNS.",
        "This review discusses the current knowledge about listeric encephalitis, and involved host and bacterial factors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9250779": [
        "This gerbil model of Listeria rhombencephalitis will be useful to study the molecular mechanisms allowing bacteria to cross the blood-brain barrier, and to evaluate the intracerebral efficacy of antibiotics.",
        "Rhombencephalitis due to Listeria monocytogenes is a frequent complication of human listeriosis, inducing a high mortality and severe neurological sequelae despite antibiotic therapy.",
        "Bacteria were detected by electronmicroscopy inside infectious foci, either free in necrotic material or inside inflammatory cells, mainly polymorphonuclear cells.",
        "Animals were inoculated in the middle ears with a low infective dose of L. monocytogenes, thus creating prolonged otitis media with persistent bacteremia.",
        "The histological lesions were mainly located in the brainstem, and consisted in coalescent, necrotic abscesses with perivascular sheaths, mimicking those observed in human rhombencephalitis.",
        "Gerbils developed a severe rhombencephalitis with circling syndrome, paresia, ataxia, rolling movements.",
        "The invasion of the central nervous system was visualized on living animals by resonance magnetic imaging and characterized by bacterial growth in the brain, reaching about 10(7) bacteria in the rhombencephalum by day 12 of infection.",
        "However, there is no animal model which consistently reproduces clinical rhombencephalitis.",
        "Here, we present a model of Listeria rhombencephalitis in gerbils."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30413440": [
        "A 46-year-old previously healthy man presented with 1 week of headache, nausea, vomiting and dizziness.",
        "This case highlights the importance of recognising <i>L. monocytogenes</i> infection as a cause of acute cranial nerve impairment with MRI findings suggestive of brainstem encephalitis.",
        "He was found to have cranial nerve deficits, his cerebrospinal fluid (CSF) demonstrated a lymphocytic pleocytosis and brain MRI suggested rhombencephalitis.",
        "Although Gram stains and cultures of his CSF did not identify a pathogen, <i>Listeria monocytogenes</i> DNA was detected by the FilmArray Meningitis/Encephalitis panel within 2 hours of performing a lumbar puncture.",
        "It also highlights the frequently atypical CSF profile and low yield of culture in <i>L. monocytogenes</i> rhombencephalitis and the value of multiplex PCR testing of CSF to rapidly identify this pathogen and permit targeted therapy.",
        "He was treated with ampicillin and gentamicin and had a near-complete recovery."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21956758": [
        "Rhombencephalitis (RE) is a syndrome of multiple causes and multiple outcomes.",
        "Treatment primarily is with ampicillin.",
        "Brain MRIs are usually normal; there is usually a CSF pleocytosis but the protein is usually normal.",
        "Mortality with acyclovir treatment was 22% versus those not on acyclovir 75%.",
        "The etiologic categories of RE include infections, autoimmune diseases, and paraneoplastic syndromes (PNS).",
        "Listeria RE primary occurs in healthy young adults.",
        "Prognosis is poor and treatment is only partially beneficial.",
        "Because Listeria and HSV are the most common treatable acute causes of RE, we recommend empiric therapy with ampicillin and acyclovir for all cases after samples have been obtained from CSF and blood for cultures and the polymerase chain reaction (PCR).",
        "Listeria is the most common cause of infectious RE.",
        "Most authors now use the terms \"rhombencephalitis\" and \"brainstem encephalitis\" interchangeably even though anatomically they are slightly different.",
        "Treatment is with corticosteroids and immunosuppressive agents, but only 25% have complete recovery.",
        "Positive CSF and blood cultures are the most specific for diagnosis.",
        "Paraneoplastic causes are the third category of RE.",
        "Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV6) have caused a few cases.",
        "Enterovirus 71 is probably the second most common infectious cause of RE; however, 95% of cases have occurred in the Asian-Pacific region and there is no specific treatment.",
        "The most common autoimmune etiology is Beh\u00e7et disease.",
        "Often anti-neuronal antibodies can be found.",
        "It usually occurs as a biphasic time course with a flu-like syndrome followed by brainstem dysfunction; 75% of patients have a cerebrospinal fluid (CSF) pleocytosis, and almost 100% have an abnormal brain MRI scan.",
        "Herpes simplex virus (HSV) is the third most common infectious cause of RE, and about 80% of cases are caused by HSV1 and 20% by HSV2.",
        "Antibiotics can be changed based upon MRI, culture results, PCR results, and antibody studies.",
        "Over 90% of those with Beh\u00e7et RE had abnormal MRI scans and 94% had a CSF pleocytosis.",
        "About 50% only had involvement of the brainstem whereas the other 50% also had supratentorial involvement of the temporal and frontal lobes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16126275": [
        "The treatment of choice is ampicillin.",
        "To the best of our knowledge, this is the first case in which linezolid was used to treat infection of the central nervous system caused by this organism.",
        "We describe in this report a case of rhombencephalitis caused by Listeria monocytogenes successfully treated with linezolid.",
        "Infection of the central nervous system due to Listeria monocytogenes is uncommon."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25794641": [
        "Therefore, in the present study, the expression of SIRT1, SIRT2, and SIRT7 during different stages of cervical cancer progression was analyzed.",
        "Specific inhibitors of SIRT1 (Ex527) and SIRT2 (AGK2) impaired the growth of the cervical cancer cells, SiHa, but not of the HaCaT cells.",
        "Sirtuins belong to the family of class III histone deacetylases; its role in neoplasia is controversial as both tumor-suppressive and promoting functions have been reported.",
        "A significant increase in SIRT1 expression was noted in the cytoplasm as well as in the nucleus of proliferative layers of cervical epithelium in squamous intraepithelial lesions (SIL); however, in the squamous cell carcinomas (SCC), a heterogeneous pattern of SIRT1 expression varying from low to high was noted.",
        "Further, a specific increase in the levels of SIRT1 in intraepithelial lesion makes it a promising candidate for identification of preneoplastic changes.",
        "A progressive increase in the expression of both SIRT2 and SIRT7 was noted during cancer progression in the following order: normal &lt; preneoplasia &lt; cancer.",
        "There are very few reports available, where expressions of sirtuin isoforms are comprehensively analyzed during neoplasia.",
        "SIRT1 inhibition caused cell death, while SIRT2 inhibition resulted in cell cycle arrest.",
        "In conclusion, we report the overexpression of SIRT2 and SIRT7 proteins in cervical cancer and suggest probable application of sirtuin inhibitors as therapeutic targets.",
        "The normal cervical epithelium showed feeble expression of sirtuin isoforms, SIRT1, SIRT2, and SIRT7.",
        "Cervical cancer cell lines, HeLa and SiHa, showed higher levels of SIRT1 and SIRT2 in comparison to the immortalized cell counterpart, HaCaT."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28776959": [
        "For one site in its N-terminal domain, namely K52, we reported earlier that acetylation completely switches off RhoGDI\u03b1 function.",
        "Recently, it was demonstrated by quantitative mass spectrometry that RhoGDI\u03b1 is heavily targeted by post-translational lysine acetylation.",
        "Herein we show that K52-acetylated RhoGDI\u03b1 is specifically deacetylated by the sirtuin deacetylase Sirt2.",
        "We show that acetylation at K52 decelerates cervical cancer cell proliferation, suggesting RhoGDI\u03b1 acetylation to be a promising therapeutic target.",
        "RhoGDI\u03b1 is a key regulator of Rho proteins, coordinating their GTP/GDP and membrane/cytosol cycle.",
        "Finally, we conclude that the potency of substrate-derived sirtuin inhibitors depends on structural features, the substrate-derived amino acid sequence as a determinant for selectivity, as well as the presence of an acetyl-lysine analogue to increase its potency.",
        "We demonstrate that treatment of cervical cancer cells with a RhoGDI\u03b1-derived K52-trifluoroacetylated, substrate-derived peptidic sirtuin inhibitor severely impairs cell proliferation.",
        "These data reveal a prospective therapeutic potential for novel substrate-derived sirtuin inhibitors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29406534": [
        "[This corrects the article on p. 2751 in vol.",
        "10, PMID: 29263689.]."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29263689": [
        "Global results so far obtained point to erenumab as a new promising candidate for the preventative treatment of episodic migraine.",
        "Erenumab is the only mAb that targets the CGRP receptor instead of the ligand, with high specificity and affinity of binding.",
        "Calcitonin-gene-related peptide (CGRP) plays a crucial role in migraine pathophysiology; agents aimed at blocking its activity have, therefore, been developed in recent years, among which are monoclonal antibodies (mAbs) against CGRP, to prevent migraine.",
        "Monthly subcutaneous administration (70 mg or 140 mg) of erenumab vs placebo for 3-6 months showed significantly higher efficacy in reducing the mean monthly number of migraine days and the use of migraine-specific medication, and in decreasing physical impairment and impact of migraine on everyday activities (<i>P</i>&lt;0.001).",
        "Licence applications for erenumab were recently submitted to the Food and Drug Administration in the USA and European Medicines Agency in Europe (May/June 2017).",
        "A favorable safety profile was demonstrated by the lack of significant differences in the occurrence of adverse events in erenumab-treated vs placebo-treated patients.",
        "Migraine is a highly disabling neurological condition, and preventative treatment still remains problematic, due to aspecificity of the majority of the currently available prophylactic drugs.",
        "This review will report on the most recent data on erenumab characteristics and on the results of clinical trials on its employment in the prevention of episodic migraine (4-14 monthly migraine days): one Phase II and two Phase III trials (completed) and one Phase III trial (ongoing)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28460892": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The calcitonin gene-related peptide (CGRP) pathway is important in migraine pathophysiology.",
        "We assessed the efficacy and safety of erenumab, a fully human monoclonal antibody against the CGRP receptor, in patients with chronic migraine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28644160": [
        "In this review, we will discuss the growing body of clinical trials studying CGRP-targeted therapies for migraine and cluster headache.",
        "Several other small-molecular CGRP receptor antagonists are in earlier stages of development for acute migraine treatment or prevention.",
        "Currently, 4 monoclonal antibodies targeting either the CGRP ligand or receptor are being studied for migraine prevention: ALD403 (eptinezumab), AMG 334 (erenumab), LY2951742 (galcanezumab), and TEV-48125 (fremanezumab).",
        "Meanwhile, 1 small-molecule CGRP receptor antagonist (ubrogepant, MK-1602) is currently in phase 3 studies for the acute treatment of migraine.",
        "There are a handful of CGRP-targeted therapies currently in phase 3 studies for migraine acute treatment or prevention.",
        "Calcitonin gene-related peptide (CGRP) is a signaling neuropeptide released from activated trigeminal sensory afferents in headache and facial pain disorders.",
        "Two of these anti-CGRP monoclonal antibodies are in clinical trials for cluster headache prevention as well."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29878340": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To determine the potential impact of erenumab, a human anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody, on total exercise time (TET), time to exercise-induced angina, and ST depression in a double-blind, placebo-controlled study in patients with stable angina due to documented coronary artery disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30409806": [
        "Half of this recessive burden is attributable to known genes.",
        "Our results suggest that recessive coding variants account for a small fraction of currently undiagnosed nonconsanguineous individuals, and that the role of noncoding variants, incomplete penetrance, and polygenic mechanisms need further exploration.",
        "It was higher (31%) in patients with Pakistani ancestry, owing to elevated autozygosity.",
        "We estimated the genome-wide contribution of recessive coding variation in 6040 families from the Deciphering Developmental Disorders study.",
        "The proportion of cases attributable to recessive coding variants was 3.6% in patients of European ancestry, compared with 50% explained by de novo coding mutations.",
        "We identified two genes not previously associated with recessive developmental disorders, <i>KDM5B</i> and <i>EIF3F</i>, and functionally validated them with mouse and cellular models."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26438538": [
        "We believe dbSUPER is a valuable resource for the biology and genetic research communities.",
        "We developed dbSUPER (http://bioinfo.au.tsinghua.edu.cn/dbsuper/), the first integrated and interactive database of super-enhancers, with the primary goal of providing a resource for assistance in further studies related to transcriptional control of cell identity and disease. dbSUPER provides a responsive and user-friendly web interface to facilitate efficient and comprehensive search and browsing.",
        "Current studies have identified super-enhancers in more than 100 cell types and demonstrated their functional importance.",
        "Super-enhancers are clusters of transcriptional enhancers that drive cell-type-specific gene expression and are crucial to cell identity.",
        "The data can be downloaded and exported in variety of formats.",
        "Many disease-associated sequence variations are enriched in super-enhancer regions of disease-relevant cell types.",
        "Thus, super-enhancers can be used as potential biomarkers for disease diagnosis and therapeutics.",
        "Furthermore, dbSUPER lists genes associated with super-enhancers and also links to external databases such as GeneCards, UniProt and Entrez. dbSUPER also provides an overlap analysis tool to annotate user-defined regions.",
        "The data can be easily sent to Galaxy instances, GREAT and Cistrome web-servers for downstream analysis, and can also be visualized in the UCSC genome browser where custom tracks can be added automatically.",
        "However, a centralized resource to integrate all these findings is not currently available."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29235227": [
        "With an effective sirtuin activity assay in hand, it is demonstrated that iron chelation by Sirtinol, a commonly employed sirtuin inhibitor, results in an enhancement in the inhibitory activity of the compound that may affect its performance in vivo.",
        "In addition to acetyl groups, deacetylases can remove other acyl modifications on lysines, the roles and regulation of which are far less understood.",
        "A peptide-based fluorescent probe for single-reagent, real-time detection of deacetylase activity that can be readily adapted for probing broader lysine deacylation, including decrotonylation, is reported.",
        "Histone deacetylases regulate the acetylation levels of numerous proteins and play key roles in physiological processes and disease states.",
        "Following cleavage of the lysine modification, the probe undergoes rapid intramolecular imine formation that results in marked optical changes, thus enabling convenient detection of deacylase activity with good statistical Z' factors for both absorption and fluorescence modalities.",
        "The peptide-based design offers broader isozyme scope than that of small-molecule analogues, and is suitable for probing both metal- and nicotinamide adenine dinucleotide (NAD<sup>+</sup> )-dependent deacetylases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29330215": [
        "The mitochondrial deacetylase sirtuin 3 (SIRT3) plays a pivotal role in the maintenance of mitochondrial function through regulating the mitochondrial acetylome.",
        "It is interesting to note that unique cardiac and systemic microRNAs have been shown to play an important role in cardiac remodeling by modulating key signaling elements in the myocardium.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Heart failure leads to mitochondrial dysfunction and metabolic abnormalities of the failing myocardium coupled with an energy-depleted state and cardiac remodeling."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29659581": [
        "The evolutionarily-conserved sirtuin family of histone deacetylases regulates a multitude of DNA-associated processes.",
        "A recent genome-wide screen conducted in the yeast Saccharomyces cerevisiae identified Yku70/80, which regulate nonhomologous end-joining (NHEJ) and telomere structure, as being essential for cell proliferation in the presence of the pan-sirtuin inhibitor nicotinamide (NAM).",
        "Our results reveal a novel interplay between sirtuin-mediated regulation of chromatin structure and telomere-regulating factors in promoting timely completion of S phase upon replicative stress.",
        "Finally, we show that reducing H4K16ac in yku70\u0394 cells limits activation of the DNA damage checkpoint kinase Rad53 in response to replicative stress, which promotes usage of translesion synthesis and S phase progression.",
        "Our data further suggest that early firing of replication origins at short telomeres compromises the cellular response to NAM- and genotoxin-induced replicative stress.",
        "Here, we show that sirtuin-dependent deacetylation of both histone H3 lysine 56 and H4 lysine 16 promotes growth of yku70\u0394 and yku80\u0394 cells, and that the NAM sensitivity of these mutants is not caused by defects in DNA double-strand break repair by NHEJ, but rather by their inability to maintain normal telomere length.",
        "Indeed, our results indicate that in the absence of sirtuin activity, cells with abnormally short telomeres, e.g., yku70/80\u0394 or est1/2\u0394 mutants, present striking defects in S phase progression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30066578": [
        "<strong class=\"sub-title\">\n          Aim:\n        </strong>\n      \n      This study aims to investigate the mode of action of a novel sirtuin inhibitor (BZD9L1) and its associated molecular pathways in colorectal cancer (CRC) cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28254776": [
        "Most methods employ a comparison of chemically acetylated peptides to native acetylated peptides, however, the potentially large differences in abundance between these peptides presents a challenge for accurate quantification.",
        "Manipulations that cause increased nonenzymatic acetylation by acetyl-phosphate (AcP), such as stationary-phase arrest and deletion of <i>ackA</i>, resulted in globally increased acetylation stoichiometry.",
        "We measured acetylation stoichiometry at 3,669 unique sites and found that the vast majority of acetylation occurred at a low stoichiometry.",
        "Here we show that serial dilution of SILAC-labeled peptides (SD-SILAC) can be used to identify accurately quantified peptides and to estimate the quantification error rate.",
        "To further analyze CobB-regulated sites under conditions of globally increased or decreased acetylation, we measured stoichiometry in phophotransacetylase (<i>pta</i>\u0394) and acetate kinase (<i>ackA</i>\u0394) mutant strains in the presence and absence of the Sirtuin inhibitor nicotinamide.",
        "Similar to Sirtuin deacetylase 3 (SIRT3) in mitochondria, CobB suppressed acetylation to lower than median stoichiometry in WT, <i>pta</i>\u0394, and <i>ackA</i>\u0394 cells.",
        "Stable isotope labeling by amino acids in cell culture (SILAC)-based mass spectrometry (MS) is one of the most widely used quantitative proteomic methods.",
        "Together, our results provide a detailed view of acetylation stoichiometry in <i>E. coli</i> and suggest an evolutionarily conserved function of Sirtuin deacetylases in suppressing low stoichiometry acetylation.",
        "Accurate measurement of acetylation stoichiometry on a proteome-wide scale remains challenging.",
        "We applied SD-SILAC to determine absolute acetylation stoichiometry in exponentially-growing and stationary-phase wild-type and Sirtuin deacetylase CobB-deficient cells.",
        "Comparison to relative quantification under the same conditions validated our stoichiometry estimates at hundreds of sites, demonstrating the accuracy of our method.",
        "Lysine acetylation is a protein posttranslational modification (PTM) that occurs on thousands of lysine residues in diverse organisms from bacteria to humans."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26722027": [
        "This study developed a novel sirtuin-3 (SIRT3) inhibitor (LC-0296) and examined its role in altering HNSCC tumorigenesis.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The survival rate of patients with head and neck squamous cell carcinoma (HNSCC) stands at approximately 50% and this has not improved in decades."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28231809": [
        "The NLM Medical Text Indexer (MTI) is the main product of this project and has been providing automated indexing recommendations since 2002.",
        "This cross-library team's mission is to explore indexing methodologies for ensuring quality and currency of NLM document collections.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Facing a growing workload and dwindling resources, the US National Library of Medicine (NLM) created the Indexing Initiative project in 1996.",
        "After all of this time, the questions arise whether MTI is still useful and relevant."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29625577": [
        "Furthermore, for extended monitoring of Strimvelis, the young age of children treated, small patient numbers, and broad geographic distribution of patients all increase the risk of loss to follow-up before sufficient data have been collected.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Strimvelis (autologous CD34+ cells transduced to express adenosine deaminase [ADA]) is the first ex vivo stem cell gene therapy approved by the European Medicines Agency (EMA), indicated as a single treatment for patients with ADA-severe combined immunodeficiency (ADA-SCID) who lack a suitable matched related bone marrow donor.",
        "Establishing individual investigator sites would be impractical and uneconomical owing to the small number of patients from each location receiving Strimvelis.",
        "Existing primary immunodeficiency registries are tailored to transplantation outcomes and do not capture the breadth of safety and efficacy endpoints required by the EMA for the long-term monitoring of gene therapies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27601193": [
        "Fidaxomicin has recently been introduced as a new antibiotic that has been shown to significantly reduce the recurrence of this infection.",
        "Despite this superiority, its high cost has led to very restrictive policies in its use, as such that many institutions only use it in patients with multiple recurrences.",
        "While waiting for new predictive clinical tools, we propose the development of scoring systems that allow the more high-risk patients to be treated earlier.",
        "Recurrences of Clostridium difficile infections lead to hospital readmissions and high costs, in addition to the suffering and frustration for the patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28009682": [
        "Given limited clinical experience with fidaxomicin, we assessed outcomes in a diverse cohort of patients with CDI treated with fidaxomicin.",
        "<strong class=\"sub-title\">\n          Background and goals:\n        </strong>\n      \n      Fidaxomicin is a new antibiotic used to treat Clostridium difficile infection (CDI)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16445657": [
        "Using p16(INK4a) as a bio marker of HPV oncogenic activity, we demonstrate that the level of pRb dysfunction by high-risk HPV varied from subtypes and was getting more frequent from CIN2.",
        "As for CIN1 cases, p16(INK4a) overexpression was observed more frequently in HPV16 and HPV52 than in HPV51 and HPV35.",
        "We investigated overexpression of p16(INK4a) and HPV infection in cervical squamous neoplasia to evaluate the oncogenic potential among various HPV subtypes.",
        "Overexpression of p16(INK4a) has been observed when retinoblastoma protein is inactivated by high-risk human papillomavirus (HPV) oncoprotein E7.",
        "In high-risk HPV positive cases, 32.4% (12/37) of CIN1, 82.1% (32/39) of CIN2, 93.2% (41/44) of CIN3, and all (16/16) SCC showed p16(INK4a) overexpression.",
        "The high-risk HPV was detected by PCR in 69.8% (37/53), 97.5% (39/40), 91.7% (44/48), and 100% (16/16) of cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, and squamous cell carcinoma (SCC), respectively.",
        "The p16(INK4a) overexpression was investigated immunohistochemically using a p16(INK4a)-specific monoclonal antibody (clone E6H4).",
        "The incidence of p16(INK4a) overexpression was significantly different between CIN1 and CIN2, suggesting that the disorder of cell cycle regulation by HPV frequently occurred from CIN2."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25708613": [
        "Human papillomavirus (HPV) oncogenic activity is the result of viral oncogene E6 and E7 expression in infected cells.",
        "We compared the diagnostic accuracy of several methods commonly employed for HPV characterization in OPSCC with the results of the newly available HPV E6/E7 mRNA in situ hybridization (ISH) on formalin-fixed, paraffin-embedded biopsy samples, in order to establish if the latter should be introduced in the diagnostic routine to increase accuracy when fresh tissue is not available. p16 immunostain, DNA ISH for high-risk HPV genotypes, SPF LiPA amplification and genotyping, and HPV16 E6 amplification were performed on 41 consecutive OPSCC samples.",
        "While no stand-alone test was sufficiently accurate for classifying HPV-associated OPSCC, the high sensitivity and specificity of the established combination of p16 immunostain, DNA ISH, and HPV16 DNA amplification suggests that the introduction of labour- and cost-intensive mRNA ISH, is not necessary in the diagnostic routine of oropharyngeal tumors.",
        "Oncogene expression analysis is, however, not part of the routine diagnostic evaluation of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) since it requires fresh tumor tissue.",
        "Twenty (48.7%) cases were positive by mRNA ISH; sensitivity and specificity were 100% and 90% for p16, 90% and 100% for DNA ISH, 70% and 76% for SPF10 LiPA, 90% and 76% for E6 amplification.",
        "A diagnostic algorithm considering p16 immunostain as first step followed by either high-risk HPV DNA ISH or HPV16 E6 amplification in p16-positive cases correctly characterized 90% of mRNA-positive and all mRNA-negative cases; combining the 3 tests correctly identified all cases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27739439": [
        "Patients diagnosed with HSIL/CIN2 colposcopy-directed biopsy, were recruited prospectively between December 2011 and October 2013. p16 staining was performed in all HSIL/CIN2 diagnostic biopsies.",
        "p16<sup>INK4a</sup> (p16) tumor-suppressor protein is a biomarker of human papillomavirus (HPV) oncogenic activity that has revealed a high rate of positivity in histological high-gade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 2 (HSIL/CIN2) lesions.",
        "In conclusion, patients with p16 negative HSIL/CIN2 biopsy had a high rate of regression during first 12 months of follow-up.",
        "Complete regression, partial regression, persistence, and progression rates of HSIL/CIN2 were defined as a final outcome.",
        "The aim of this study was to evaluate the outcome of HSIL/CIN2 patients followed up without treatment for 12 months according to p16 immunohistochemical staining.",
        "Status of p16 staining could be considered for HSIL/CIN2 management.",
        "However, there is a paucity of data regarding p16 status as a surrogate marker of HSIL/CIN2 evolution.",
        "A total of 96 patients were included in the analysis.",
        "The rate of spontaneous regression was 64%, while 28% had persistent disease, and 8% progressed at 12 months of follow-up. p16 was positive in 81 (84%) initial HSIL/CIN2 biopsies.",
        "Regression was observed in all 15 p16 negative cases and in 46 of 81 (57%) p16 positive cases (P=0.001).",
        "Follow-up was conducted every 4 months by cytology, colposcopy and biopsy if suspicion of progression and once the 12 months of follow-up completed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28850302": [
        "The New Mexico Department of Health school-based health centers (SBHCs) universally administer a validated screen, the CRAFFT (Car, Relax, Alone, Forget, Friends, Trouble), for adolescent substance use concerns; however, quality assurance efforts revealed that SBHC providers needed more information at the point of screening to initiate brief interventions for students with positive CRAFFT screens.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Adolescent substance use is an important public health problem in New Mexico and the United States.",
        "This paper describes the development and initial reliability and validity of data obtained using the CHISPA instrument.",
        "The CHISPA (Cocaine, Heroin, IV drugs, Synthetic pot, Pot, Alcohol) was developed to gather specific information on recent substance use experience to guide brief interventions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29282234": [
        "Substance-related disorders (SRD) are common psychiatric morbidities among adolescents within youth correctional systems.",
        "The CRAFFT instrument has good internal consistency (Cronbach's \u03b1 = 0.85) and 2-week test reliability (Spearman correlation = 0.979; <i>p</i> &lt; .001).",
        "We present the results of the reliability and concurrent validity of the CRAFFT (acronym for Car, Relax, Alone, Forget, Friends, and Trouble) substance abuse screening instrument among residents of youth correctional facilities in Lagos, Nigeria.",
        "As validated, the CRAFFT is a reliable instrument for screening for SRDs in incarcerated youth.",
        "At a cutoff point of &gt;1.00, CRAFFT had the best sensitivity and specificity (area under the curve = 0.889; 95% confidence interval 0.765-1.000) among the participants.",
        "Adolescents who screened positive on CRAFFT were further assessed with the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) to determine whether they met diagnostic criteria for SRDs.",
        "Identification and treatment of SRDs is critical for successful reformation and reintegration.",
        "Lack of simple, structured, valid, brief screening instruments that can be easily administered and scored by lay workers militates against screening for SRDs.",
        "A total of 23 (12.9%) had CRAFFT scores of &gt;1.00.",
        "The mean CRAFFT scores for all the adolescents (<i>n</i> = 178) was 0.66 (SD \u00b1 1.45)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25727823": [
        "The Problem Oriented Screening Instrument for Teenagers (POSIT) and the Car, Relax, Alone, Forget, Family/Friends, Trouble questionnaire (CRAFFT) are used to this end.",
        "The screening for problematic alcohol and substance use, abuse and dependence should be part of the case-taking process for adolescents.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Substance use and abuse and their consequences are a major problem among adolescents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23183686": [
        "The aim of this study was to compare the performance of the Alcohol Use Disorders Identification Test (AUDIT), its short form AUDIT-C, the Substance Module of the Problem Oriented Screening Instrument for Teenagers (POSIT), and CRAFFT (acronym for car, relax, alone, forget, family, and friends).",
        "<strong class=\"sub-title\">\n          Background/aims:\n        </strong>\n      \n      Only rather few data on the validity of screening questionnaires to detect problem drinking in adolescents exist."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21466499": [
        "The CRAFFT (Car, Relax, Alone, Forget, Friends, Trouble, 1999) was developed as a brief screening instrument for adolescents to measure AUD and SUD.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Alcohol (AUD) and other substance use disorders (SUD) are common among adolescents.",
        "This systematic review examines the psychometric properties of the CRAFFT."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29069318": [
        "However, the computational pipelines for bar-seq clustering are not well developed.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Barcode sequencing (bar-seq) is a high-throughput, and cost effective method to assay large numbers of cell lineages or genotypes in complex cell pools.",
        "Because of its advantages, applications for bar-seq are quickly growing-from using neutral random barcodes to study the evolution of microbes or cancer, to using pseudo-barcodes, such as shRNAs or sgRNAs to simultaneously screen large numbers of cell perturbations.",
        "Here, we developed Bartender, an accurate clustering algorithm to detect barcodes and their abundances from raw next-generation sequencing data.",
        "Available methods often yield a high frequency of under-clustering artifacts that result in spurious barcodes, or over-clustering artifacts that group distinct barcodes together."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28284702": [
        "A good understanding of the natural history of rare genetic lipid disorders is a pre-requisite for successful patient management.",
        "Lipoprotein Lipase Deficiency (LPLD) is a rare, autosomal-recessive lipid disorder characterized by severe hypertriglyceridemia and a very high risk for recurrent acute pancreatitis, however, only limited data are available on its natural course.",
        "A total of 11 relevant initiatives/registries were identified (homozygous Familial Hypercholesterolemia (hoFH) [n = 5]; LPLD [n = 1]; Lysosomal Acid Lipase Deficiency [LALD, n = 1], detection of mutations in genetic lipid disorders [n = 4]).",
        "GENIALL is the first global prospective registry in LPLD that will collect physician and patient generated data on the natural course of LPLD, as well as long-term outcomes of gene therapy.",
        "Disease registries have been helpful in this regard.",
        "Besides one product registry in hoFH and the LALD registry, all other initiatives are local or country-specific.",
        "The aim of this publication is to introduce the GENIALL Registry within a structured literature review of registries in rare genetic lipid disorders.",
        "Alipogene tiparvovec (Glybera<sup>\u00ae</sup>) is the first gene therapy to receive Marketing Authorization in the European Union; GENIALL (GENetherapy In the MAnagement of Lipoprotein Lipase Deficiency), a 15-year registry focusing on LPLD was launched in 2014 as part of its Risk Management Plan."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28916862": [
        "The rats were divided into three groups (n = 10/group): control, non-treated, and BCG-treated groups.",
        "Intravesical Bacillus Calmette-Guerin (BCG) is the best treatment modality for progression of non-muscle invasive bladder cancer.",
        "We aimed to monitor changes at the proteome level to identify putative protein biomarkers associated with the response of urothelial precancerous lesions to intravesical BCG treatment.",
        "Greater than twofold changes occurred in the expression of a number of proteins.",
        "Among them, Rab-GDI\u03b2, aldehyde dehydrogenase 2 (ALDH2) and 14-3-3 zeta/delta were important since they were previously reported to be associated with cancer and their expression levels were found to be lower in BCG-treated group in comparison to the non-treated group.",
        "The down-regulation of these proteins and Rab-GDI\u03b2 was achieved with BCG; this result indicates that they may be used as putative biomarkers for monitoring changes in bladder carcinogenesis in response to BCG immunotherapy.",
        "Precancerous lesions of bladder cancer were more common in non-treated group (77.8%) than in BCG-treated group (50%) and the control group (0%).",
        "The non-treated and BCG-treated groups received N-methyl-N-nitrosourea intravesically.",
        "ALDH2 and 14-3-3 zeta/delta were also found to be highly expressed in the non-treated group compared to the control group.",
        "Differentially expressed proteins were validated by Western blot analysis.",
        "At the endpoint of experiment, all surviving rat bladders were collected and equally divided into two portions vertically from dome to neck.",
        "BCG Tice-strain was instilled into bladder in BCG-treated group.",
        "Half of each bladder was assessed immunohistopathologically and the other half was used for 2D-based comparative proteomic analysis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29362915": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      The identification of factors predicting the outcome of stage T1 high-grade bladder cancer (BC) is a major clinical issue."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29673806": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      To evaluate the efficacy and safety of a tailored endovesical immunotherapy protocol with biweekly BCG for elderly Patients with high risk non muscle invasive bladder cancer (HG-NMIBC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12031870": [
        "In most series BCG is more effective than intravesical chemotherapy, although it is more toxic.",
        "BCG (Bacillus of Calmette Guerin) has been used for more than 20 years and is currently the most active agent for superficial bladder cancer therapy.",
        "A review of the current information on BCG therapy of high-risk superficial bladder cancer is reported.",
        "There is some evidence that BCG therapy improves survival and progression rates of patients with high-risk superficial bladder cancer decreasing the proportion who require radical cystectomy.",
        "Intravesical BCG therapy is effective in prophylaxis after transurethral resection of papillary tumours and in the treatment of carcinoma in situ (cis)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21541499": [
        "Following treatment using ELISA this cytokine was detected in the urine of all patients examined confirming that intravesical BCG therapy does not induce in bladder cancer patients solely a T(H)1 response but rather T(H)1/2 or T(H)0 like response.",
        "The aim of this work was to determine if this treatment resulted in the production of IL-5, a classical T(H)2 cytokine.",
        "Among the many immunological events associated with successful intravesical bacillus Calmette Guerin (BCG) immunotherapy of bladder cancer is the induction of a wide range of cytokines including the T helper 2 (T(H)2) designated cytokines Interleukin-6 (IL-6) and IL-10, but not IL-4, in the urine of the patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/1732628": [
        "Intravesical Bacillus Calmette-Guerin is used to treat patients with superficial bladder cancer.",
        "The urothelium remains mucin deficient at two hours, but by 24 hours the mucin layer has been regenerated.",
        "The proposed mechanism of action of Bacillus Calmette-Guerin is adherence to the urothelium with induction of an immunologic and/or inflammatory response.",
        "Two hours following intravesical 3H-labeled Escherichia coli administration, bacterial adherence was 29-fold greater in mucin deficient than mucin intact rabbits (p = 0.05).",
        "Two hours following intravesical administration of 3H-labeled Bacillus Calmette Guerin, mucosal adherence was 21-fold greater in mucin deficient compared to mucin intact rabbits (p = 0.002).",
        "The current study was designed to determine if rabbit bladder mucin removal results in increased Bacillus Calmette-Guerin urothelial adherence.",
        "The significant increase in Bacillus Calmette Guerin adherence after mucin removal may be clinically exploitable.",
        "After mucin removal, Bacillus Calmette Guerin urothelial adherence was significantly increased.",
        "PAS and colloidal iron stains were used to demonstrate that intravesical instillation of 50% acetone renders rabbit bladder urothelium mucin deficient.",
        "By 12 hours, the difference in adherence was not significant.",
        "It has been established that the urothelial mucin layer functions as a bacterial anti-adherence factor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11989131": [
        "Recent literature is reviewed for this rare complication.",
        "Local immunotherapy with bacillus Calmette-Guerin (BCG) is an effective and frequently used treatment for superficial bladder cancer.",
        "We describe a 53 year- old man with a disseminated bacillus Calmette-Guerin (BCG) infection after intravescical instillation for bladder carcinoma.",
        "Serious side effects are infrequent but can affect every organ system."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16813873": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      We assessed the safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19758621": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Bacillus Calmette-Guerin is the most effective therapy for nonmuscle invasive bladder cancer.",
        "We developed a risk stratification model to provide accurate estimates of recurrence and progression probability after bacillus Calmette-Guerin.",
        "However, in that series only 171 patients were treated with bacillus Calmette-Guerin.",
        "Recently to calculate the risks of recurrence and progression based on data from 7 European Organisation for Research and Treatment of Cancer trials a scoring system was reported."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19918272": [
        "To the best of our knowledge, we report the first case of disseminated bacillus Calmette-Guerin infection causing multiple abscesses affecting the pancreatic head and right psoas muscle, diagnosed 5 years after intravesical treatment with bacillus Calmette-Guerin therapy for bladder cancer.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used to treat urothelial carcinoma since 1976, and has been reported to eradicate disease in more than 70% of patients with in situ and stage I disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/2231917": [
        "Intravesical administration of bacillus Calmette-Guerin has been shown to be highly effective treatment of superficial bladder cancer.",
        "Two men who had equally progressive sepsis with intravesical bacillus Calmette-Guerin survived with the use of cycloserine for the first 72 hours of treatment.",
        "Triple antituberculous antibiotics, including cycloserine, may be lifesaving.",
        "One man with severe debility and the organic brain syndrome died acutely with a fever of 40 C. Two men had frank sepsis that progressed to multiorgan failure and death.",
        "Complications from bacillus Calmette-Guerin therapy are usually minor but serious and even fatal reactions can occur.",
        "Sepsis progressed despite the use of isoniazid, rifampin and streptomycin.",
        "Sepsis resulted from intravenous absorption through inflamed or disrupted urothelium.",
        "Five recent cases illustrate the gravity of bacillus Calmette-Guerin sepsis.",
        "Bacillus Calmette-Guerin treatment should not be administered in the presence of severe cystitis or after grossly traumatic catheterization."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/3892051": [
        "We treated 40 patients with superficial bladder cancer via intravesical bacillus Calmette-Guerin for 1) prophylaxis against tumor recurrence, 2) residual carcinoma or 3) flat carcinoma in situ.",
        "Most patients who failed initial therapy with a low viability lot of bacillus Calmette-Guerin responded favorably to re-treatment with a higher viability lot.",
        "Of 17 patients receiving a single course of bacillus Calmette-Guerin for prophylaxis 11 remained free of tumor during short-term followup.",
        "Marked variability in viability of bacillus Calmette-Guerin organisms was observed among different lots of bacillus Calmette-Guerin, and a direct relationship was observed between bacillus Calmette-Guerin vaccine viability and therapeutic efficacy.",
        "Favorable results occurred more frequently among patients who exhibited a granulomatous inflammatory response in the bladder and delayed hypersensitivity skin test response to purified protein derivative.",
        "The results suggest that the level of viability of each lot of bacillus Calmette-Guerin vaccine should be verified before clinical use.",
        "A second course of therapy was administered to failures in each treatment category, which resulted in favorable responses in 5 of 6 patients treated for prophylaxis, 2 of 5 treated for residual tumor and 3 of 6 treated for carcinoma in situ.",
        "Over-all complete responses were achieved in 16 of 17 patients (94 per cent) treated for prophylaxis, 8 of 11 (73 per cent) for residual carcinoma and 8 of 12 (66 per cent) for carcinoma in situ, with a mean followup from the final treatment of 9.3, 12.3 and 7.9 months, respectively.",
        "A single course of intravesical bacillus Calmette-Guerin therapy was successful in 6 of 11 patients (55 per cent) treated for residual carcinoma and 6 of 12 (50 per cent) treated for carcinoma in situ."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17945285": [
        "We tested the hypothesis that tumor expression of natural cytotoxicity receptor ligands can serve as a predictive factor for the response to intravesical bacillus Calmette-Guerin in patients with nonmuscle invasive, high grade bladder cancer.",
        "The recently discovered natural cytotoxicity receptors are linked to the host response to viral infection and to cancer.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Up to 90% of patients with high grade superficial bladder tumors experience tumor recurrence and up to 50% have progression despite bacillus Calmette-Guerin treatment.",
        "Natural killer cells have a major role in the mechanism of the response to bacillus Calmette-Guerin but the exact mechanisms are still elusive."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/3892050": [
        "Seven recurrences (33 per cent) developed in 21 patients whose skin tests remained negative (p equals 0.015) and 5 recurrences (29 per cent) developed in 17 patients whose tests previously were positive (p equals 0.068, Fisher's test, not significant).",
        "Side effects of bacillus Calmette-Guerin are observed to increase with increasing frequency and duration of treatment.",
        "Skin test reactivity to purified protein derivative is particularly useful in predicting response to bacillus Calmette-Guerin immunotherapy.",
        "Currently, 60 patients have been randomized to receive bacillus Calmette-Guerin immunotherapy and only 1 of 22 patients (4.5 per cent) in whom the purified protein derivative skin test results converted from negative to positive has had recurrent tumor, compared to 12 recurrences (32 per cent) in patients whose skin tests were positive before treatment or failed to convert following treatment (p equals 0.014, chi-square).",
        "The benefit of percutaneous bacillus Calmette-Guerin is suggested by the observations that the recurrence rate in patients treated with intravesical bacillus Calmette-Guerin alone is 40 per cent, and all 7 patients whose purified protein derivative skin tests were negative continued to have negative results when percutaneous bacillus Calmette-Guerin was omitted (p equals 0.003).",
        "While the optimal protocol for bacillus Calmette-Guerin remains to be determined, experience with 92 randomized and 30 nonrandomized (high risk) patients followed for up to 5 years provides information that may improve future protocols.",
        "Among high risk patients a marked decrease in or complete prevention of recurrent tumor was observed in 82 per cent of 22 patients treated previously with chemotherapy and 11 of 14 (78 per cent) with carcinoma in situ have had a complete response.",
        "Bacillus Calmette-Guerin immunotherapy has been found by a number of investigators to be effective in the treatment and prevention of superficial bladder cancer.",
        "The protection from tumor recurrence has persisted: only 6 of 30 patients (20 per cent) treated with bacillus Calmette-Guerin have had recurrent tumor compared to 14 of 27 controls (52 per cent, p equals 0.008, chi-square test), and mean time to recurrence increased from 24 to 48 months (p less than 0.005, Savage)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/2359181": [
        "In some probes activated mononuclear cells invaded the urothelium, emanating from suburothelial granulomas.",
        "This phenomenon persisted even in biopsies 1 year after initial treatment.",
        "It is tempting to assume that these changes within the local immunocompetent cells are related to the therapeutic effect of bacillus Calmette-Guerin against bladder cancer.",
        "To characterize further the local cellular response in the bladder wall of patients receiving intravesical bacillus Calmette-Guerin bladder biopsies were examined before and immediately after a 6-week course of bacillus Calmette-Guerin and for up to 1 year at 3-month intervals thereafter.",
        "The results showed a marked infiltration after bacillus Calmette-Guerin therapy predominantly of the suburothelial tissue with mononuclear cells, which expressed activation markers and accumulated to follicle-like granulomatous structures.",
        "With regard to T lymphocyte subsets the ratio of T helper-to-T suppressor cells in the bladder wall increased from 0.5 to nearly 2.",
        "The antitumoral effects of intravesical bacillus Calmette-Guerin against recurrent superficial urothelial bladder cancer seem to be linked to immunological effector mechanisms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/6381762": [
        "All 3 groups of survivors had less tumor growth (p less than 0.01) than nonsurviving controls.",
        "Effective immunotherapy may lower that risk.",
        "Our results suggest that intralesional bacillus Calmette-Guerin immunotherapy can afford long term protection from transplanted bladder cancer, and that live bacillus Calmette-Guerin is superior to levamisole and P3 + Re-glycolipid + bacillus Calmette-Guerin cell walls in the treatment of bladder cancer.",
        "Even among survivors, additional bacillus Calmette-Guerin immunization, but not levamisole treatment, significantly inhibited tumor growth (p less than 0.01).",
        "Despite effective treatment of existing tumors, patients with bladder cancer remain at risk of developing new tumors.",
        "To test this hypothesis, mice that had survived transitional cell carcinoma (MBT2) transplantation with the aid of bacillus Calmette-Guerin immunotherapy were randomized and tested for long term protective immunity against bladder carcinoma.",
        "Both bacillus Calmette-Guerin and saline-treated groups had significantly less tumor growth (p less than 0.001) than nonsurviving controls.",
        "Footpad response to purified protein derivative did not correlate with tumor growth in these mice.",
        "Animals treated with P3-Re-glycolipid (with or without preimmunization with cell wall) did not differ from nonsurviving control.",
        "Fifty-one tumor-free mice that had survived tumor challenge 10 to 15 months previously were randomized into 3 groups to receive intradermal tumor .noculation and intraperitoneal levamisole, intralesional Tice strain bacillus Calmette-Guerin, or intralesional saline.",
        "Cell wall-preimmunized mice were divided into matching groups according to footpad response to purified protein derivative.",
        "Fifteen previously unchallenged animals also received tumor and intralesional saline.",
        "The cell-wall preimmunized and nonimmune mice received the immunostimulant P3+Re-glycolipid or the carrier solution alone.",
        "The group of survivors received either intralesional saline or live bacillus Calmette-Guerin.",
        "A 2nd experiment compared 22 nonimmune mice, 21 mice preimmunized intravenously with 300 micrograms of bacillus Calmette-Guerin cell walls, and 18 mice that had survived MBT2 by 8 months after live bacillus Calmette-Guerin treatment.",
        "Nonimmune and survivor groups were randomly subdivided into saline or treatment groups."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/6757467": [
        "In addition, 9 patients at high risk for tumor recurrence were treated with bacillus Calmette-Guerin produced a self-limited cystitis and 1 complication (hydronephrosis) of immunotherapy was observed.",
        "The interval free of disease was prolonged significantly with bacillus Calmette-Guerin treatment (p equals 0.014, generalized Wilcoxon test).",
        "Of 5 patients with carcinoma in situ 3 remain free of tumor after bacillus Calmette-Guerin treatment and 5 of 6 who had multiple recurrences after intravesical chemotherapy responded favorably to bacillus Calmette-Guerin immunotherapy.",
        "A randomized controlled prospective evaluation of intravesical and percutaneous bacillus Calmette-Guerin immunotherapy was done in 57 patients with transitional cell carcinoma of the bladder.",
        "Of the 57 randomized patients 54 were followed for 3 to 30 months.",
        "Tumor recurrence was documented in 13 of 26 controls (50 per cent) and only 6 of 28 patients (21 per cent) treated with bacillus Calmette-Guerin (p equals 0.027, chi-square).",
        "Only 1 of 17 treated patients (6 per cent) whose purified protein derivative test converted from negative to positive had tumor recurrence compared to 5 recurrences (38 per cent) among the 13 patients whose test remained negative or had been positive before treatment (p equals 0.022, chi-square).",
        "Importantly, a simple purified protein derivative skin test distinguished those patients who responded to bacillus Calmette-Guerin immunotherapy from those who did not.",
        "Bacillus Calmette-Guerin was given to 10 patients with stage B transitional cell carcinoma who were not candidates for cystectomy and 7 are free of disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17997439": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      We review how the bacillus Calmette-Guerin vaccine evolved to become standard therapy for superficial bladder cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29466232": [
        "We compared AQUIOS CL to a dual-platform analysis and evaluated analytical performance.",
        "AQUIOS CL (Beckman Coulter) is a fully automated system that performs an onboard volumetric cell count, automatically processes the sample (staining, lysing and fixation) and analyzes the results.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Quantitation of lymphocyte subsets (B cells, T cells, CD4 and CD8 T cells and NK cells) classically relies on quantitation of lymphocytes and immunophenotyping by flow cytometry."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29516957": [
        "<strong class=\"sub-title\">\n          Aims:\n        </strong>\n      \n      Thermal ablation can evoke an immune response, which may have effects on the prognosis of patients with hepatocellular carcinoma (HCC).",
        "Our aim is to investigate the changes of circulating T-cell subsets after microwave ablation (MWA) and to explore the risk factors of tumor recurrence in patients with hepatitis B virus (HBV)-related HCC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29935030": [
        "This article is protected by copyright.",
        "Total T, T4 cells and T4:T8 ratio were significantly higher in girls, while T8, NK and DN cells - in boys; significantly higher relative and absolute B cell counts in boys appeared in adolescence.",
        "All rights reserved.",
        "Absolute counts of T, B, T4 cells dropped from neonates to adolescents, decrease of T8 and NK cells was milder; relative count of T cells increased with age and that of B cells decreased; T4:T8 ratio went down and T:B ratio grew.",
        "The study revealed significant age and gender-related changes in all subsets.",
        "Age and gender-related variability of main lymphocyte subsets (T, B and NK cell absolute counts and percentages from Ly; T4, T8 and DN cell absolute counts and percentages from lymphocytes and from T cells; T4:T8 and T:B ratios) was studied in a large cohort of pediatric patients (2 days - 17 years) at yearly intervals.",
        "Advantages of using patient cohort instead of healthy children as reference, possibilities for adjusting age and gender-specific reference ranges and potential international data pooling are discussed.",
        "We compared our results with reference values for healthy children (Tosato et al., 2015), there was a good concordance, except for DN cells.",
        "4128 6-color TBNK tests performed on BD FACSCanto II flow cytometer were assessed; patients with immune deficiencies and tumors were not included."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29547597": [
        "Therefore, new strategies that improve adherence are needed.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Prevention of chemotherapy-induced nausea and vomiting (CINV) can be improved with guideline-consistent use of antiemetics.",
        "However, adherence to antiemetic guidelines remains often insufficient."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27473611": [
        "Intracellular Ca<sup>2+</sup> signaling is triggered by activation of diverse emetic receptors (including tachykininergic NK<sub>1</sub>, serotonergic 5-HT<sub>3</sub>, dopaminergic D<sub>2</sub>, cholinergic M<sub>1</sub>, or histaminergic H<sub>1</sub>)<sub>,</sub> whose activation in vomit-competent species can evoke emesis.",
        "Other emetogens such as cisplatin, rotavirus NSP4 protein and bacterial toxins can also induce intracellular Ca<sup>2+</sup> elevation.",
        "Cisplatin-like chemotherapeutics cause vomiting via calcium (Ca<sup>2+</sup>)-dependent release of multiple neurotransmitters (dopamine, serotonin, substance P, etc.) from the gastrointestinal enterochromaffin cells and/or the brainstem.",
        "Netupitant is a highly selective neurokinin NK<sub>1</sub> receptor (NK<sub>1</sub>R) antagonist and palonosetron is a selective second-generation serotonin 5-HT<sub>3</sub> receptor (5-HT<sub>3</sub>R) antagonist with a distinct pharmacological profile.",
        "On the other hand, blockade of LTCCs by corresponding antagonists (nifedipine or amlodipine) not only provide broad-spectrum antiemetic efficacy against diverse agents that specifically activate emetogenic receptors such as 5-HT<sub>3</sub>, NK<sub>1</sub>, D<sub>2</sub>, and M<sub>1</sub> receptors, but can also potentiate the antiemetic efficacy of palonosetron against the non-specific emetogen, cisplatin.",
        "In this review, we will provide an overview of Ca<sup>2+</sup> involvement in the emetic process; discuss the relationship between Ca<sup>2+</sup> signaling and the prevailing therapeutics in control of vomiting; highlight the evidence for Ca<sup>2+</sup>-signaling blockers/inhibitors in suppressing emetic behavior in the least shrew model of emesis as well as in the clinical setting; and also draw attention to the clinical benefits of Ca<sup>2+</sup>-signaling blockers/inhibitors in the treatment of nausea and vomiting.",
        "An oral fixed combination of netupitant/palonosetron (NEPA; Akynzeo(\u00ae)) with &gt;85% antiemetic efficacy is available for use in the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV).",
        "Cannabinoid CB<sub>1</sub> receptor agonists possess broad-spectrum antiemetic activity since they prevent vomiting caused by a variety of emetic stimuli including the chemotherapeutic agent cisplatin, 5-HT<sub>3</sub>R agonists, and D<sub>2</sub>R agonists.",
        "Our findings demonstrate that application of the L-type Ca<sup>2+</sup> channel (LTCC) agonist FPL 64176 and the intracellular Ca<sup>2+</sup> mobilizing agent thapsigargin (a sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase inhibitor) cause vomiting in the least shrew."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26613606": [
        "The convenience of administering netupitant/palonosetron as a single dose in a fixed combination has the potential to improve adherence to CINV prevention guidelines.",
        "Complete response rates during the delayed, acute and overall phases were significantly higher with single-dose netupitant 300 mg plus palonosetron 0.5 mg than with single-dose palonosetron 0.5 mg in cycle 1 of cisplatin-based highly emetogenic chemotherapy (HEC) in a phase II trial and with single-dose netupitant/palonosetron 300/0.5 mg than with single-dose palonosetron 0.5 mg in cycle 1 of anthracycline-cyclophosphamide (AC) moderately emetogenic chemotherapy (MEC) in a phase III trial; the greater efficacy of netupitant/palonosetron was maintained over repeated cycles of AC MEC in the phase III trial.",
        "An oral fixed combination of netupitant/palonosetron (NEPA; Akynzeo(\u00ae)) is available for use in the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV).",
        "In conclusion, netupitant/palonosetron is an important option to consider in the prevention of acute and delayed CINV in patients receiving MEC or HEC.",
        "Netupitant is a highly selective neurokinin-1 receptor antagonist and palonosetron is a serotonin 5-HT3 receptor antagonist with a distinct pharmacological profile.",
        "Netupitant/palonosetron was well tolerated, with no cardiac safety concerns.",
        "In another phase III trial, netupitant/palonosetron 300/0.5 mg was effective over repeated cycles of non-AC MEC or HEC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25516691": [
        "Ledipasvir/sofosbuvir (Harvoni) for hepatitis C virus genotype 1 infection; dulaglutide (Trulicity) for glycemic control in type-2 diabetes; netupitant/palonosetron (Akynzeo) for prevention of nausea and vomiting related to chemotherapy; and naloxegol (Movantik) for opioid-induced constipation in patients with chronic noncancer pain."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29092025": [
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Targeted sequencing using capture probes has become increasingly popular in clinical applications due to its scalability and cost-effectiveness.",
        "However, because of the dynamics of the hybridization process, it is difficult to evaluate the efficiency of the probe design prior to the experiments which are time consuming and costly.",
        "The approach also allows for higher sequencing coverage of the targeted regions resulting in better analysis statistical power."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27762892": [
        "\"Evaluating the Past and Present of Regenerative Medicine (RM)\" was the first part of an Industry Symposium dedicated to the subject during the 2015 TERMIS World Congress in Boston.",
        "This should be achieved by wisely leveraging all possible synergies of the different stakeholders, for example, patients, clinicians, reimbursement and health technology assessment (HTA) agencies, regulatory authorities, public/private investors, academia, and companies.",
        "This working session presented a critical review of the current RM landscape in Europe and North America with possible projections for the future.",
        "Benefiting from past and present experience, the RM burgeoning industry is expected to accelerate the market release of cost-effective RM products with real curative potential for specific clinical indications with high unmet needs.",
        "Interestingly, the RM development cycle seems to obey the Gartner hype cycle, now at the enlightenment phase, after past exaggerated expectations and discouragements, as suggested by increasing numbers of clinical trials and recent market approvals of RM solutions in both Europe (Glybera and Holoclar<sup>\u00ae</sup> from Chiesi Pharma and Strimvelis<sup>\u00ae</sup> from GSK) and Japan (Remestemcel-L from Mesoblast<sup>\u00ae</sup>).",
        "The successful commercial translation of RM research is governed by five major drivers: (i) fully validated manufacturing capability for autologous or allogeneic products, (ii) reimbursement for targeted clinical indications with high and demonstrable medico-economic benefits versus standard of care, (iii) implication of regulatory bodies in the design and development plan of any RM solution, which should be well characterized, robust, with proven consistent efficacy and an acceptable and controlled positive benefit/risk ratio, (iv) collaborations facilitated by multicompetence hubs/consortia of excellence, (v) well-thought-out clinical development plans for reducing the risk of failure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15667975": [
        "Tetrocarcin A (TC-A) and bcl-2 antisense oligonucleotides exhibit antitumor activity by inhibiting Bcl-2 function and transcription, respectively.",
        "Therefore, inhibiting Bcl-2 function may enhance the radiosensitivity of tumor cells.",
        "We investigated whether these antitumor agents would enhance the cytotoxic effects of radiation in tumor cells overexpressing Bcl-2.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Bcl-2, an inhibitor of apoptosis frequently shows elevated expression in human tumors, thus resulting in resistance to radiation therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17350598": [
        "A survival kinase, Akt, is a downstream factor in the phosphatidylinositide-3'-kinase-dependent pathway, which mediates many biological responses including glucose uptake, protein synthesis and the regulation of proliferation and apoptosis, which is assumed to contribute to acquisition of malignant properties of human cancers.",
        "Tetrocarcin A affected neither expression of Akt, PDK1, or PTEN, nor did it affect the expression of Bcl family members including Bcl-2, Bcl-X(L), and Bax.",
        "The apoptosis is accompanied by the activation of a proteolytic cascade of caspases including caspase-3 and -9, and concomitantly decreases phosphorylation of Akt, PDK1, and PTEN, a tumor suppressor that regulates the activity of Akt through the dephosphorylation of polyphosphoinositides.",
        "Here we find that an anti-tumor antibiotic, tetrocarcin A, directly induces apoptosis of human breast cancer cells.",
        "These results suggest that tetrocarcin A could be a potent chemotherapeutic agent for human breast cancer targeting the phosphatidylinositide-3'-kinase/Akt signaling pathway."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12560233": [
        "In this study, we analyzed the direct proapoptotic effect of TC-A in the B-chronic lymphocytic leukemia (B-CLL) model.",
        "The expression levels of known effector molecules mediating mitochondrial signaling, such as Bax and Bid, and the antagonistic molecule Bcl-2 did not influence sensitivity of B-CLL cells to TC-A. Furthermore, the molecular chaperone and sensor of ER stress, HSP70, though significantly up-regulated in B-CLL cells undergoing TC-A-triggered apoptosis, was ineffective to exert its anti-apoptotic function described in multiple cell death pathways.",
        "Tetrocarcin-A (TC-A), an antibiotic agent isolated from actinomycetes, has recently been described to antagonize Bcl-2 functions, thereby sensitizing tumor cells to cell death signals under control of Bcl-2.",
        "We focused on the signal cascade triggered by TC-A in B-CLL cells and identified activated mitochondrial as well as endoplasmatic reticulum (ER) stress signals.",
        "From our data showing that TC-A induced a cell death pathway via ER stress preferentially in B cells and that it acted independently of important markers of drug sensitivity and of clinical markers, we conclude that TC-A might represent an attractive candidate drug for further evaluation in preclinical trials.",
        "Furthermore, sensitivity of B-CLL cells to TC-A treatment in vitro was dependent neither on the expression levels of CD38-a prognostic factor for survival of B-CLL patients as well as for their response to therapy-nor on the clinical stage or pretreatment status of patients.",
        "Autologous T cells of B-CLL patients were significantly less sensitive to TC-A as were also T cells from healthy donors when compared with their normal B-cell fraction."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30312728": [
        "This was accompanied by Tetrocarcin-A-induced caspase-dependent apoptosis.",
        "Screening of a natural compound library identified the antibiotic Tetrocarcin-A as a novel downregulator of JAM-A and human epidermal growth factor receptor-2 (HER2) protein expression in breast cancer cells.",
        "Tetrocarcin-A treatment or JAM-A silencing reduced AKT and ERK phosphorylation, inhibited c-FOS phosphorylation at Threonine-232 (its transcriptional regulation site), inhibited nuclear localization of c-FOS, and downregulated expression of the inhibitor of apoptosis proteins (IAP).",
        "To begin evaluating the potential clinical relevance of our findings, we extended our studies to other models.",
        "Overexpression of the tight junction protein Junctional Adhesion Molecule-A (JAM-A) has been linked to aggressive disease in breast and other cancers, but JAM-targeting drugs remain elusive.",
        "Taken together, our data suggest that Tetrocarcin-A warrants future evaluation as a novel cancer therapeutic by virtue of its ability to downregulate JAM-A expression, reduce tumorigenic signaling and induce apoptosis.",
        "Lysosomal inhibition partially rescued the downregulation of JAM-A and HER2 caused by Tetrocarcin-A, and attenuated its cytotoxic activity.",
        "Encouragingly, Tetrocarcin-A downregulated JAM-A expression and caused cytotoxicity in primary breast cells and lung cancer stem cells, and inhibited the growth of xenografts in a semi-in vivo model involving invasion across the chicken egg chorioallantoic membrane."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26598580": [
        "Gut microorganisms are capable of producing and delivering neuroactive substances such as serotonin and gamma-aminobutyric acid, which act on the gut-brain axis.",
        "Preclinical research in rodents suggested that certain probiotics have antidepressant and anxiolytic activities.",
        "In the past few years, neuroscientific research has shown the importance of the microbiota in the development of brain systems.",
        "Based on evidence, the gut microbiota is associated with metabolic disorders such as obesity, diabetes mellitus and neuropsychiatric disorders such as schizophrenia, autistic disorders, anxiety disorders and major depressive disorders.",
        "Herein, we present the latest literature examining the effects of the gut microbiota on depression.",
        "The gut microbiota is essential to human health and the immune system and plays a major role in the bidirectional communication between the gut and the brain.",
        "Effects may be mediated via the immune system or neuroendocrine systems.",
        "Recent studies showed that the microbiota could activate the immune and central nervous systems, including commensal and pathogenic microorganisms in the gastrointestinal tract."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27571098": [
        "This review examined the effects of prebiotics on bone strength, neural and cognitive processes, immune functioning, skin, and serum lipid profile.",
        "As the types of prebiotics available diversify, so too will our understanding of the range of microbes able to degrade them, and the extent to which body sites can be impacted by their consumption.",
        "This has given the ability to maintain and restore microbial homeostasis a new significance.",
        "The mode of action is in part affected by intestinal permeability and by fermentation products reaching target cells.",
        "Saccharides such as inulin and other fructo-oligosaccharides, galactooligosaccharides, and polydextrose have been widely used to improve gastrointestinal outcomes, but they appear to also influence distant sites.",
        "Prebiotic compounds are appealing for this purpose as they are generally food-grade substances only degraded by microbes, such as bifidobacteria and lactobacilli, from which beneficial short-chain fatty acids are produced.",
        "The gut microbiome is being more widely recognized for its association with positive health outcomes, including those distant to the gastrointestinal system."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29748506": [
        "Moreover, gut microbiota are considerable sources of NTs.",
        "Some of these substances are the neurotransmitters (NTs) acetylcholine (ACh), the modified amino acids glutamate and \u03b3-aminobutyric acid (GABA), and the biogenic amines dopamine, serotonin (5-HT), and histamine.",
        "These substances can either be naturally present, as part of essential metabolic processes and ecological interactions, or derive from controlled/uncontrolled food technology processes.",
        "Relevant books and literature from PubMed and Scopus databases were searched for data on food sources of Ach, glutamate, GABA, dopamine, 5-HT, and histamine.",
        "Foods are natural sources of substances that may exert crucial effects on the nervous system in humans.",
        "However, the significance of dietary NTs intake needs to be further investigated as there are no significant data on their bioavailability, neuronal/non neuronal effects, or clinical implications.",
        "In neuropsychiatry, progressive integration of dietary approaches in clinical routine made it necessary to discern the more about some of these dietary NTs.",
        "Ripening time, methods of preservation and cooking, and microbial activity further contributes to NTs.",
        "Different animal foods, fruits, edible plants, roots, and botanicals were reported to contain NTs.",
        "Evidence-based interventions studies should be encouraged."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29167350": [
        "We conclude that safinamide inhibits in vivo Glu release from stimulated nerve terminals, likely via blockade of sodium channels at subpopulations of neurons with specific firing patterns.",
        "This dose attenuated veratridine-stimulated Glu (but not GABA) release in subthalamic nucleus, globus pallidus, and substantia nigra reticulata, but not in striatum.",
        "These data are consistent with the anticonvulsant and antiparkinsonian actions of safinamide and provide support for the nondopaminergic mechanism of its action.",
        "Since this property might contribute to the therapeutic action of the drug, we undertook the present study to investigate whether safinamide inhibits Glu release also in vivo and whether this effect is consistent across different brain areas and is selective for glutamatergic neurons.",
        "To this aim, in vivo microdialysis was used to monitor the spontaneous and veratridine-induced Glu and GABA release in the hippocampus and basal ganglia of naive, awake rats.",
        "To shed light on the mechanisms underlying the effect of safinamide, sodium currents were measured by patch-clamp recording in rat cortical neurons.",
        "In addition to inhibiting monoamine oxidase type B, it blocks sodium channels and modulates glutamate (Glu) release in vitro.",
        "Safinamide was ineffective on spontaneous neurotransmitter release.",
        "Brain levels of safinamide were measured as well.",
        "Safinamide has been recently approved as an add-on to levodopa therapy for Parkinson disease.",
        "In vitro, safinamide inhibited sodium channels, showing a greater affinity at depolarized (IC<sub>50</sub> = 8 <i>\u00b5</i>M) than at resting (IC<sub>50</sub> = 262 <i>\u00b5</i>M) potentials.",
        "Safinamide maximally inhibited the veratridine-induced Glu and GABA release in hippocampus at 15 mg/kg, which reached free brain concentrations of 1.89-1.37 <i>\u00b5</i>M."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29339106": [
        "In addition, nondopaminergic actions (neuroprotective effects) have been reported, with safinamide inhibiting glutamate release and sodium/calcium channels, reducing the excitotoxic input to dopaminergic neuronal death.",
        "Recently licensed by the European Medicine Agency (EMA) and US Food and Drug Administration (FDA), safinamide [a monoamine oxidase B (MOA-B) inhibitor] is an alternative to L-DOPA; as we discuss here, it enhances dopaminergic transmission with decreased secondary effects compared with L-DOPA.",
        "Effects of safinamide have been correlated with the amelioration of non-motor symptoms (NMS), although these remain under discussion.",
        "The loss of dopaminergic neurons (DAn) and reduced dopamine (DA) production underlies the reasoning behind the gold standard treatment for Parkinson's disease (PD) using levodopa (L-DOPA).",
        "Overall, safinamide can be considered to have potential antidyskinetic and neuroprotective effects and future trials and/or studies should be performed to provide further evidence for its potential as an anti-PD drug."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29441484": [
        "Eight patients withdrew safinamide within the first month for minor side effects.",
        "Evaluations were based on the Unified Parkinson's Disease Scale part III (UPDRS III), Hoehn &amp; Yahr (HY), Unified Dyskinesia Rating Scale (UDysRS) walking and balance item 9 score, daily time spent in OFF and in ON with disabling dyskinesias (1 week diary), mean daily dose of levodopa (LD), dopamine-agonists (DA), catechol-O-methyl transferase inhibitor (COMT-I), monoamine oxidase B inhibitor (MAOB-I), and their LD equivalent dose (LEDD).",
        "At the follow-up evaluation, after a mean time with safinamide of 7.5 months \u00b1 3.4, all patients showed a significant improvement of all the scale scores, except for HY, and of the daily dosages of the drugs and the LEDD.",
        "Ninety-one PD patients were evaluated during the first year of commercialization of the drug, both prior to starting safinamide and at the last available follow-up.",
        "PD patients with safinamide 100 mg and patients who started safinamide switching from a previous MAOBI significantly improved in time spent in OFF and LEDD.",
        "The same results were shown by PD patients treated with safinamide 50 mg and patients who started safinamide without switching from a previous MAOBI.",
        "In conclusion, safinamide is safe and effective in improving motor complications in patients with idiopathic PD and can be considered a useful levodopa sparing strategy.",
        "In this retrospective study, we evaluated both efficacy and effectiveness of safinamide 50 and 100 mg in the treatment of motor fluctuations and disabling dyskinesias in a cohort of patients with idiopathic Parkinson's disease (PD)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29670409": [
        "Intervals, characterized by reappearance of motor and associated certain nonmotor symptoms, determine the end of good tolerability and efficacy of oral levodopa therapy.",
        "It will probably cause less nausea and edema than a dopamine agonist/levodopa regimen.",
        "Safinamide reversibly inhibits mono-amine oxidase B and declines abnormal glutamate release by modulation of potassium- and sodium ion channels.",
        "An ideal candidate for combination with safinamide is opicapone.",
        "It will reduce adherence issues and may complement levodopa treatment.",
        "Safinamide provided beneficial effects on \"OFF\" symptoms in pivotal trials with doses of 50 or 100 mg once daily.",
        "This inhibitor of peripheral catechol-O-methyltransferase supports continuous brain delivery of levodopa and, thus, the continuous dopaminergic stimulation concept.",
        "Thus, a promising, future option will be combination of safinamide and opicapone in one formulation.",
        "Both compounds with their once-daily application and good tolerability may complement each other by reduction of necessary oral levodopa intakes and \"OFF\" times.",
        "This review discusses safinamide as an add-on therapeutic agent in orally levodopa-treated patients with \"OFF\" phenomena.",
        "Heterogeneous expression of neurotransmitter deficits results from onset and progression of Parkinson's disease.",
        "These \"OFF\" states result from levodopa pharmacokinetics and disease progression-related deterioration of the central buffering capacity for fluctuations of dopamine levels."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29760163": [
        "\u25bc Safinamide (Xadago - Zambon S.p.A) is a monoamine-oxidase B (MAO-B) inhibitor licensed as add-on therapy for people with idiopathic Parkinson's disease who are experiencing motor fluctuations with levodopa.<sup>1</sup> Currently there is no cure for Parkinson's disease and drugs are used to reduce motor symptoms and improve daily activities.<sup>2,3</sup> Here, we review the evidence for this MAO-B inhibitor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28110399": [
        "Furthermore, in an 18-month extension of one study, although dyskinesia (primary endpoint) was not significantly improved with safinamide relative to placebo, treatment benefits in other outcomes were generally sustained over 24 months of treatment.",
        "Other outcomes, including motor function, overall clinical status and health-related quality of life, were also generally improved with safinamide.",
        "Safinamide (Xadago<sup>\u00ae</sup>) is an orally active, selective, reversible monoamine oxidase-B inhibitor with both dopaminergic and non-dopaminergic (glutamatergic) properties.",
        "Safinamide 50-100 mg/day administered as a fixed or flexible dose significantly increased daily 'on' time without dyskinesia (primary endpoint) in patients with mid- to late-stage PD with motor fluctuations in 24-week, placebo-controlled clinical trials.",
        "Although further studies are needed, including comparative and long-term studies, current evidence indicates that safinamide extends the treatment options available for use as add-on therapy to levodopa and other PD medications in patients with mid- to late-stage PD experiencing motor fluctuations.",
        "Safinamide was generally well tolerated in clinical trials; dyskinesia was the most common adverse event.",
        "In the EU, safinamide is approved for the treatment of mid- to late-stage fluctuating Parkinson's disease (PD) as add-on therapy to a stable dose of levodopa alone or in combination with other PD medications."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30142650": [
        "<strong class=\"sub-title\">\n          Aim:\n        </strong>\n      \n      Safinamide (Xadago<sup>\u00ae</sup>) is a newly approved selective MAO-B inhibitor for the treatment of Parkinson's Disease (PD).",
        "The X-TRA study investigated the efficacy and tolerability of the substance under clinical practice conditions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27802242": [
        "Safinamide is a new drug with dopaminergic and non-dopaminergic properties, approved in Europe as adjunct therapy to levodopa for the treatment of fluctuating PD patients.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Pain, a frequent non-motor symptom in Parkinson's Disease (PD), significantly impacts on quality of life.",
        "Results from two 24-month, double-blind, placebo-controlled studies demonstrated that safinamide has positive effects on both motor functions and quality of life in PD patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30271159": [
        "It works through multiple mechanisms, namely as a reversible selective monoamine oxidase-B inhibitor and through modulation of glutamate release.",
        "In large clinical trials of patients with early PD on a single dopamine agonist, safinamide administered orally at a dose of 100 mg daily improved overall motor function as measured by UPDRS part III total score; however, some of the results reported were exploratory.",
        "Safinamide is extensively metabolized via oxidation to several inactive metabolites that are excreted primarily through the urine.",
        "Safinamide (Xadago<sup>\u00ae</sup>) is a novel medication with both dopaminergic and non-dopaminergic effects, approved first by the European Commission and more recently by the US Food and Drug Administration (FDA) as an adjunctive treatment to carbidopa/levodopa in patients with mid- to late-stage Parkinson's disease (PD) and motor fluctuations.",
        "Evidence suggests that safinamide is a good option for add-on therapy to carbidopa/levodopa in patients with advanced PD with motor complications, but there is still insufficient evidence to recommend it as monotherapy or add-on therapy in patients with early PD.",
        "Several large Phase III clinical trials of patients with advanced PD with motor fluctuations have shown that safinamide, administered orally at doses of 50-100 mg daily, increased ON time with no or non-troublesome dyskinesia, decreased daily OFF time, improved overall motor function (as measured by Unified Parkinson's Disease Rating Scale [UPDRS] part III total score), and quality of life (as measured by Clinical Global Impression-Change and 39-item Parkinson's Disease Questionnaire).",
        "Safinamide does not cause new or worsening dyskinesia and may be able to reduce this symptom in patients reporting it at baseline.",
        "Safinamide is generally well-tolerated and safe, with few to no treatment-related adverse events."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30291173": [
        "The present study investigated the effects of safinamide on the development of LID in 6-hydroxydopamine (6-OHDA)-lesioned rats, evaluating behavioral, molecular, and neurochemical parameters associated with LID appearance.",
        "Abnormal involuntary movements, motor performance, molecular composition of the striatal glutamatergic synapse, glutamate, and GABA release were analyzed.",
        "6-OHDA-lesioned rats were treated with saline, levodopa (6 mg/kg), or levodopa plus safinamide (15 mg/kg) for 21 days.",
        "In addition to its selective and reversible monoamine oxidase B inhibition, safinamide through use-dependent sodium channel blockade reduces overactive glutamatergic transmission in basal ganglia, which is believed to contribute to motor symptoms and complications including levodopa-induced dyskinesia (LID).",
        "In the striatum, safinamide prevented the rearrangement of the subunit composition of <i>N</i>-methyl-d-aspartate receptors and the levodopa-induced increase of glutamate release associated with dyskinesia without affecting the levodopa-stimulated motor performance and dyskinesia.",
        "Overall, these findings suggest that the striatal glutamate-modulating component of safinamide's activity may contribute to its clinical effects, where its long-term use as levodopa add-on therapy significantly improves motor function and \"on\" time without troublesome dyskinesia.",
        "Safinamide (Xadago) is a novel dual-mechanism drug that has been approved in the European Union and United States as add-on treatment to levodopa in Parkinson's disease therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25851099": [
        "The drug has both dopaminergic properties (highly selective and reversible inhibition of monoamine oxidase-B) and non-dopaminergic properties (selective sodium channel blockade and calcium channel modulation, with consequent inhibition of excessive glutamate release).",
        "Safinamide is approved in the EU, Iceland, Lichtenstein and Norway, as an add-on therapy to stable-dose levodopa, alone or in combination with other PD therapies in mid- to late-stage fluctuating PD patients; regulatory submissions have also been filed in the USA and Switzerland for its use in this indication.",
        "Safinamide has also undergone phase II investigation in PD patients with drug-induced dyskinesia (France, Germany, Austria, Canada and South Africa) or cognitive impairment (USA and Spain).",
        "Additional submissions have been made in the USA, Iceland, Lichtenstein, Norway and Switzerland for early-stage PD.",
        "Safinamide (Xadago(\u00ae)) is an oral \u03b1-aminoamide derivative developed by Newron for the treatment of Parkinson's disease (PD).",
        "This article summarizes the milestones in the development of safinamide leading to its first approval for PD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26587996": [
        "A meta-analysis of the most frequent adverse events among Phase III trials has been also performed.",
        "In 2014, safinamide was approved in the European Economic Area, as \"an add-on therapy to stable dose levodopa, alone or in combination with other PD therapies in mid- to late-stage-fluctuating PD patients.\"",
        "This article summarizes the pharmacological properties, development program, clinical indications for PD treatment, stratified according to several disease's stages and the safety profile of safinamide.",
        "Safinamide (Xadago\u2122) is an oral \u03b1-aminoamide derivative marketed for the treatment of Parkinson's disease (PD).",
        "The drug has both dopaminergic properties, namely highly selective and reversible inhibition of monoamine oxidase B, and nondopamimetic properties, namely selective sodium channel blockade and calcium channel modulation, with consequent inhibition of excessive glutamate release.",
        "In addition, evidence has been provided for safinamide in the treatment of motor symptoms in early PD patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23677804": [
        "Apixaban recipients also had a significantly lower risk of intracranial haemorrhage than warfarin recipients.",
        "In the AVERROES (Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients who have Failed or are Unsuitable for Vitamin K Antagonist Therapy) trial in patients with AF and at least one additional risk factor for stroke for whom vitamin K antagonist therapy was unsuitable, apixaban was associated with a significantly lower risk of stroke or systemic embolism than aspirin, without an increase in the risk of major bleeding.",
        "In the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial in patients with AF and at least one additional risk factor for stroke, apixaban recipients were significantly less likely than warfarin recipients to experience stroke or systemic embolism, major bleeding or death; the beneficial effects of treatment with apixaban versus warfarin were generally maintained across various patient subgroups.",
        "This article reviews the efficacy and tolerability of oral apixaban to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF).",
        "The direct factor Xa inhibitor apixaban (Eliquis(\u00ae)) has predictable pharmacodynamics and pharmacokinetics and does not require routine anticoagulation monitoring.",
        "In conclusion, although longer-term efficacy and safety data are needed, apixaban is an important new option for use in patients with nonvalvular AF to reduce the risk of stroke or systemic embolism."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29040384": [
        "In many applications concerning Systems and Synthetic Biology such as the reverse engineering and the de novo design of genetic circuits, stochastic effects (yet potentially crucial) are often neglected due to the high computational cost of stochastic simulations.",
        "With advances in these fields there is an increasing need of tools providing accurate approximations of the stochastic dynamics of gene regulatory networks (GRNs) with reduced computational effort.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Gene regulation is inherently stochastic."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29266249": [
        "Current MG therapies do not target complement directly.",
        "Generalized myasthenia gravis (gMG) is a rare autoimmune disorder characterized by skeletal muscle weakness caused by disrupted neurotransmission at the neuromuscular junction (NMJ).",
        "Complement plays an important role in innate and antibody-mediated immunity, and activation and amplification of complement results in the formation of membrane attack complexes (MACs), lipophilic proteins that damage cell membranes.",
        "Approximately 74-88% of patients with gMG have acetylcholine receptor (AChR) autoantibodies.",
        "Eculizumab is a humanized monoclonal antibody that inhibits cleavage of complement protein C5, preventing MAC formation.",
        "Damaged NMJs are associated with more severe disease, fewer AChRs, and MACs in synaptic debris.",
        "Studies in animals lacking specific complement proteins have confirmed that MAC formation is required to induce experimental autoimmune MG (EAMG) and NMJ damage.",
        "Eculizumab treatment improved symptoms compared with placebo in a phase II study in patients with refractory gMG.",
        "The role of complement in gMG has been demonstrated in animal models and patients.",
        "Complement inhibition in EAMG models can prevent disease induction and reverse its progression.",
        "Patients with anti-AChR<sup>+</sup> MG have autoantibodies and MACs present at NMJs.",
        "Direct complement inhibition could preserve NMJ physiology and muscle function in patients with anti-AChR<sup>+</sup> gMG."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29337452": [
        "Ocrelizumab (Ocrevus), an anti-CD20 monoclonal antibody, has been approved for the treatment of multiple sclerosis.",
        "The criteria for Lewy body dementia have been revised.",
        "A form of gene therapy, patisiran, has shown positive results in transthyretin familial amyloidosis.",
        "In the treatment of headaches, particularly migraines, non-pharmacological approaches have shown some interesting results.",
        "Eculizumab (Soliris) has been approved in several countries for refractory forms of generalized seropositive severe myasthenia gravis.",
        "Generic use of lamotrigine does not result in recrudescence of epileptic seizures or adverse effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29435915": [
        "Eculizumab was generally well tolerated in these studies, with a tolerability profile similar to that reported previously in other indications.",
        "Although several questions remain, such as duration of treatment, cost effectiveness and long-term efficacy and tolerability, current evidence indicates that eculizumab is a valuable emerging therapy for patients with refractory gMG.",
        "Overall, patients receiving eculizumab experienced significant improvements in the ADL, muscle strength and health-related quality of life (HR-QOL) parameters relative to patients receiving placebo.",
        "The humanized monoclonal antibody eculizumab (Soliris<sup>\u00ae</sup>) is a complement inhibitor indicated for use in anti-acetylcholine receptor (AChR) antibody-positive adults with generalized myasthenia gravis (gMG) in the USA, refractory gMG in the EU, or gMG with symptoms that are difficult to control with high-dose IVIg therapy or PLEX in Japan.",
        "Moreover, an ongoing extension of REGAIN showed that treatment benefits with eculizumab were sustained during continued therapy for at least 52 weeks.",
        "In the well-designed, 26-week REGAIN study in patients with anti-AChR-positive refractory gMG, although a statistically significant benefit of eculizumab over placebo in the prespecified primary endpoint analysis (change from baseline in MG-activities of daily living (ADL) score assessed by worst-rank ANCOVA) was not formally demonstrated, preplanned and post hoc sensitivity analyses of this outcome, as well as other secondary outcomes supported the efficacy of eculizumab.",
        "It is the first complement inhibitor to be approved for use in these patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29655452": [
        "This article reviews the evidence base and provides a framework for the treatment of myasthenia gravis, highlighting recent additions to the literature.",
        "The 2 exceptions are acetylcholinesterase inhibitors and complement inhibition with eculizumab, which was recently approved by the US Food and Drug Administration for myasthenia gravis.",
        "Nearly all of the drugs used for MG are considered \"off-label.\"",
        "The mainstays of treatment are acetylcholinesterase inhibitors, and immunosuppressive and immunomodulatory therapies.",
        "There is good evidence thymectomy is beneficial in thymomatous and nonthymomatous disease.",
        "With specialized care, patients with myasthenia gravis can have very good outcomes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28010051": [
        "Correlations were then analyzed between these assessments.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      A phase 2 study of eculizumab for treating myasthenia gravis (MG) used the quantitative myasthenia gravis score (QMG) and myasthenia gravis activities of daily living profile (MG-ADL) to evaluate baseline disease severity and treatment response."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23945282": [
        "We review recent findings on risk factors, pathogenesis and treatment of autoimmune myasthenia gravis.",
        "Their pathogenesis is diverse, including genetic and autoimmune mechanisms.",
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Myasthenic disorders are a well characterized group of diseases of the neuromuscular junction."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29066163": [
        "Results from a phase 2 study suggested that eculizumab, a terminal complement inhibitor, produced clinically meaningful improvements in patients with anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis.",
        "We further assessed the efficacy and safety of eculizumab in this patient population in a phase 3 trial.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Complement is likely to have a role in refractory generalised myasthenia gravis, but no approved therapies specifically target this system."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23512355": [
        "Eculizumab, a humanized monoclonal antibody, blocks the formation of terminal complement complex by specifically preventing the enzymatic cleavage of complement 5 (C5).",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Complement activation at the neuromuscular junction is a primary cause of acetylcholine receptor loss and failure of neuromuscular transmission in myasthenia gravis (MG)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29700266": [
        "Finally, we report the rapid (&lt;1 week) design and testing of instrument-free assays to detect clinically relevant viral single-nucleotide polymorphisms.",
        "We further demonstrate that SHERLOCK can distinguish the four DENV serotypes, as well as region-specific strains of ZIKV from the 2015-2016 pandemic.",
        "We developed HUDSON (heating unextracted diagnostic samples to obliterate nucleases), a protocol that pairs with SHERLOCK for viral detection directly from bodily fluids, enabling instrument-free DENV detection directly from patient samples in &lt;2 hours.",
        "In this study, we demonstrate that the Cas13-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) platform can detect Zika virus (ZIKV) and dengue virus (DENV) in patient samples at concentrations as low as 1 copy per microliter.",
        "Mitigating global infectious disease requires diagnostic tools that are sensitive, specific, and rapidly field deployable."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29449511": [
        "CRISPR-Cas12a (Cpf1) proteins are RNA-guided enzymes that bind and cut DNA as components of bacterial adaptive immune systems.",
        "By combining Cas12a ssDNase activation with isothermal amplification, we create a method termed DNA endonuclease-targeted CRISPR trans reporter (DETECTR), which achieves attomolar sensitivity for DNA detection.",
        "Here we show that RNA-guided DNA binding unleashes indiscriminate single-stranded DNA (ssDNA) cleavage activity by Cas12a that completely degrades ssDNA molecules.",
        "Like CRISPR-Cas9, Cas12a has been harnessed for genome editing on the basis of its ability to generate targeted, double-stranded DNA breaks.",
        "We find that target-activated, nonspecific single-stranded deoxyribonuclease (ssDNase) cleavage is also a property of other type V CRISPR-Cas12 enzymes.",
        "DETECTR enables rapid and specific detection of human papillomavirus in patient samples, thereby providing a simple platform for molecular diagnostics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27653758": [
        "Thus, apixaban is useful therapeutic alternative for the management of adults with VTE.",
        "Similarly, in Japanese adults with acute VTE (AMPLIFY-J), apixaban was associated with a significantly lower risk of major or CRNM bleeding than unfractionated heparin plus warfarin, and no cases of recurrent VTE or VTE-related death over 24 weeks.",
        "Like other direct oral anticoagulants (DOACs), apixaban has generally predictable pharmacological properties and does not require routine anticoagulation monitoring.",
        "Apixaban was generally well tolerated in these trials; the risks of major bleeding and the composite endpoint of major or clinically relevant nonmajor (CRNM) bleeding with apixaban were significantly lower than enoxaparin/warfarin in AMPLIFY and not significantly different from that of placebo in AMPLIFY-EXT.",
        "In large phase III trials, oral apixaban was noninferior to subcutaneous enoxaparin sodium overlapped with and followed by oral warfarin (enoxaparin/warfarin) in the treatment of adults with acute VTE over 6 months with regard to the incidence of recurrent VTE or VTE-related death (AMPLIFY), and was significantly more effective than placebo in the prevention of recurrent VTE or all-cause mortality over 12 months in patients who had completed 6-12 months' anticoagulation treatment for VTE (AMPLIFY-EXT).",
        "Apixaban (Eliquis<sup>\u00ae</sup>) is an oral, direct factor Xa inhibitor that is available for use in the treatment and secondary prevention of venous thromboembolism (VTE)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29999590": [
        "This novel approach would provide an unlimited source of stem cells with cardiac differentiation potential.",
        "Therefore, there is an emerging interest in generating cardiosphere-like stem cells from somatic cells via somatic reprogramming.",
        "Unfortunately, their therapeutic application is limited by low yield of cell harvesting, declining quality and quantity during the aging process, and the need for highly invasive heart biopsy.",
        "Here we provide the detailed protocol for generating induced cardiospheres (iCS) for cardiac regeneration by somatic reprogramming of mouse fibroblasts using a panel of pluripotent transcription factors and cardiotrophic growth factors. \u00a9 2018 by John Wiley &amp; Sons, Inc.",
        "Cardiospheres represent a more effective cell-based therapy for treatment of myocardial infarction than stem cells of non-cardiac origin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26333423": [
        "Here, we report a male patient with partial PSS phenotypes including global developmental delay, craniofacial anomalies, minor limb anomalies, and micropenis.",
        "In Potocki-Shaffer syndrome (PSS), the full phenotypic spectrum is manifested when deletions are at least 2.1 Mb in size at 11p11.2.",
        "Additionally, we also discuss the phenotypes observed in our patient with respect to those of published cases of microdeletions across the Potocki-Shaffer interval.",
        "The PSS-associated genes EXT2 and ALX4, together with PHF21A, all map to this region flanked by markers D11S1393 and D11S1319.",
        "Being proximal to EXT2 and ALX4, a 1.1 Mb region containing 12 annotated genes had been identified by deletion mapping to explain PSS phenotypes except multiple exostoses and parietal foramina.",
        "Using microarray, qPCR, RT-qPCR, and Western blot analyses, we refined the candidate gene region, which harbors five genes, by excluding two genes, SLC35C1 and CRY2, which resulted in a corroborating role of PHF21A in developmental delay and craniofacial anomalies.",
        "This microdeletion contains the least number of genes at 11p11.2 reported to date."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25653495": [
        "Potocki-Shaffer syndrome (PSS, OMIM #601224) is a rare contiguous gene deletion syndrome caused by haploinsufficiency of genes located on the 11p11.2p12.",
        "Affected individuals have a number of characteristic features including multiple exostoses, biparietal foramina, abnormalities of genitourinary system, hypotonia, developmental delay, and intellectual disability.",
        "Based on the clinical and radiological features, PSS was highly suspected.",
        "We report here on the first Korean case of an 8-yr-old boy with PSS diagnosed by high resolution microarray.",
        "Coronal craniosynostosis and enlarged parietal foramina were found on skull radiographs.",
        "The patient continued rehabilitation therapy for profound developmental delay.",
        "Initial evaluation was done at age 6 months because of a history of developmental delay, hypotonia, and dysmorphic face.",
        "This case confirms and extends data on the genetic basis of PSS.",
        "At age 6 yr, he had severe global developmental delay.",
        "The progression of multiple exostosis has being monitored.",
        "In clinical and radiologic aspect, a patient with multiple exostoses accompanying with syndromic features, including craniofacial abnormalities and mental retardation, the diagnosis of PSS should be considered.",
        "Multiple exostoses of long bones were detected during a radiological check-up.",
        "Subsequently, chromosomal microarray analysis identified an 8.6 Mb deletion at 11p11.2 [arr 11p12p11.2 (Chr11:39,204,770-47,791,278)\u00d71]."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15852040": [
        "Yet one subject with parietal foramina whose deletion does not include ALX4 indicates that ALX4 in this subject may be rendered functionally haploinsufficient by a position effect.",
        "We constructed a natural panel of 11p11.2-p13 deletions using cell lines from 10 affected individuals, fluorescence in situ hybridization (FISH), microsatellite analyses, and array-based comparative genomic hybridization (array CGH).",
        "Based on comparative deletion mapping of eight individuals with the full PSS syndrome including mental retardation and two PSS families with no mental retardation, at least one gene related to mental retardation is likely located between D11S554 and D11S1385/D11S1319, 45.6-46.7 Mb from the 11p terminus.",
        "Potocki-Shaffer syndrome (PSS) is a contiguous gene deletion syndrome that results from haploinsufficiency of at least two genes within the short arm of chromosome 11[del(11)(p11.2p12)].",
        "The clinical features of PSS can include developmental delay, mental retardation, multiple exostoses, parietal foramina, enlarged anterior fontanel, minor craniofacial anomalies, ophthalmologic anomalies, and genital abnormalities in males.",
        "The full spectrum of PSS manifests when deletions are at least 2.1 Mb in size, spanning from D11S1393 to D11S1385/D11S1319 (44.6-46.7 Mb from the 11p terminus) and encompassing EXT2, responsible for multiple exostoses, and ALX4, causing parietal foramina.",
        "We then compared the deletion sizes and clinical features between affected individuals."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20140962": [
        "Our data highlight the characteristic facial features, biparietal foramina, moderate-to-severe developmental delay and intellectual disability, myopia and strabismus, and multiple exostoses seen with this disorder.",
        "Finally, we provide recommendations for the health maintenance of patients with Potocki-Shaffer syndrome.",
        "Diagnostic studies included skeletal survey, magnetic resonance imaging of the brain, renal ultrasound, complete blood count, comprehensive metabolic panel, thyroid studies, and urinalysis.",
        "Potocki-Shaffer syndrome is a rare contiguous gene deletion syndrome due to haploinsufficiency of the 11p11.2p12 region and is characterized by craniofacial abnormalities, developmental delay, intellectual disability, multiple exostoses, and biparietal foramina.",
        "In this study, six patients with the Potocki-Shaffer syndrome were identified and evaluated using a multidisciplinary protocol that included assessments by a geneticist, ophthalmologist, otolaryngologist, orthopedist, nephrologist, audiologist, and neuropsychologist.",
        "We also identify for the first time an association of Potocki-Shaffer syndrome with sensorineural hearing loss and autistic behaviors.",
        "Using array comparative genomic hybridization, we further characterized the deletion in five of these patients.",
        "The results of these evaluations were combined with a comprehensive review of reported cases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15666301": [
        "The deleted region in our case-11p11.12p11.2-is a newly reported site of constitutional neocentromere formation.",
        "The patient inherited a maternal deleted chromosome 11 but not the marker chromosome, thus resulting in an unbalanced karyotype along with the phenotype of Potocki-Shaffer syndrome.",
        "The phenotypically normal mother has an interstitial deletion of 11(p11.12p11.2) with neocentric marker chromosome formation.",
        "We report a family with inherited Potocki-Shaffer syndrome.",
        "The marker chromosome contains the deleted material on 11p11.2 and is likely a ring.",
        "This is also the first report describing deletion of 11p11.12-p11.2 and neocentromere formation resulting in inherited Potocki-Shaffer syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28571721": [
        "However, the molecular consequences of reduced PHF21A expression remain elusive.",
        "The patient cells displayed down-regulation of key pathways relevant to learning and memory, including Cyclic Adenosine Monophosphate (cAMP)-signaling pathway genes.",
        "We found that PHF21A is required for full induction of a luciferase reporter carrying cAMP-responsive elements (CRE) following stimulation by the cAMP analog, forskolin.",
        "In this study, we analyzed by RNA-Sequencing (RNA-Seq) two patient-derived cell lines with heterozygous loss of PHF21A compared to unaffected individuals and identified 1,885 genes that were commonly misregulated.",
        "Finally, PHF21A-deficient patient-derived cells exhibited a delayed induction of immediate early genes following forskolin stimulation.",
        "These results suggest that an impaired response to cAMP signaling might be involved in the pathology of PHF21A deficiency.",
        "This article is part of a Special Issue entitled: [SI: Molecules &amp; Cognition].",
        "Genetic evidence has implicated haploinsufficiency of PHF21A, a gene that encodes a histone-binding protein, as the likely cause of intellectual disability and craniofacial abnormalities in Potocki-Shaffer Syndrome.",
        "Potocki-Shaffer Syndrome is a rare neurodevelopmental syndrome associated with microdeletion of a region of Chromosome 11p11.2."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28127865": [
        "We report a patient with multiple exostoses, biparietal foramina, and history of mild developmental delay.",
        "Cognitive and behavioral testing supported formal diagnoses of anxiety, verbal dyspraxia, articulation disorder, and coordination disorder, without intellectual disability.",
        "His facial features, though distinctive, were not typical of those observed in PSS.",
        "Potocki-Shaffer syndrome is a contiguous gene deletion syndrome involving 11p11.2p12 and characterized by multiple exostoses, biparietal foramina, genitourinary anomalies in males, central nervous system abnormalities, intellectual disability, and craniofacial abnormalities.",
        "Current literature implicates haploinsufficiency of three genes (ALX4, EXT2, and PHF21A) in causing some of the cardinal features of PSS.",
        "As the chromosomal deletion does not encompass PHF21A, this case lends further support that haploinsufficiency of PHF21A contributes to the intellectual disability and craniofacial abnormalities in PSS and that there are other genes in the region which likely contribute to the behavioral phenotype in this syndrome. \u00a9 2017 Wiley Periodicals, Inc."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23239541": [
        "Classic features include biparietal foramina, multiple exostoses, profound hypotonia, dysmorphic features, and developmental delay/intellectual disability.",
        "This deletion results in haploinsufficiency for all or portions of six OMIM genes: SLC35C1, CRY2, MAPK8IP1, PEX16, GYLTL1B, and PHF21A.",
        "Fewer than 40 individuals with PSS have been reported, with variable clinical presentations due in part to disparity in deletion sizes.",
        "Recently, translocations interrupting PHF21A have been associated with intellectual disability and craniofacial anomalies similar to those seen in PSS.",
        "The identification of this small deletion in a child with developmental delay and hypotonia provides further evidence for the genetic basis of developmental disability and identifies a critical region sufficient to cause hypotonia in this syndrome.",
        "Additionally, this case illustrates the utility of high resolution genomic approaches in correlating clinical phenotypes with specific genes in contiguous gene deletion syndromes.",
        "We report on a boy who presented for initial evaluation at age 13 months because of a history of developmental delay, hypotonia, subtle dysmorphic features, and neurobehavioral abnormalities.",
        "Potocki-Shaffer syndrome (PSS) is a rare disorder caused by haploinsufficiency of genes located on the proximal short arm of chromosome 11 (11p11.2p12).",
        "SNP microarray analysis identified a 137 kb deletion at 11p11.2, which maps within the classically defined PSS interval."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19222835": [
        "As PAX6 was intact the cataract observed cannot be explained by a deletion of this gene.",
        "Seizures have been described in Potocki-Shaffer syndrome while mental retardation has been described in both WAGR and Potocki-Shaffer syndrome.",
        "Cytogenetic analysis showed a deletion on 11p that was further characterized using FISH and MLPA analyses.",
        "Deletion of WT1 explains the genital abnormalities observed.",
        "Characterization of this patient contributes further to elucidate the function of the genes in the 11p14-p12 chromosome region.",
        "The deletion (11p13-p12) located in the area between the deletions associated with the WAGR and Potocki-Shaffer syndromes had a maximum size of 8.5 Mb and encompasses 44 genes.",
        "WAGR syndrome (Wilms' tumor, aniridia, genitourinary abnormalities and mental retardation) and Potocki-Shaffer syndrome are rare contiguous gene deletion syndromes caused by deletions of the 11p14-p12 chromosome region.We present a patient with mental retardation, unilateral cataract, bilateral ptosis, genital abnormalities, seizures and a dysmorphic face."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22822387": [
        "PSS is a rare contiguous gene deletion syndrome, mainly characterized by multiple exostoses and bilateral parietal foramina.",
        "Mental retardation and craniofacial dysmorphisms have often been reported, too.",
        "Although the patient showed many signs of PSS since early childhood, the diagnosis was suggested only when we examined her at adult age.",
        "This case highlights how frequently rare diseases remain undiagnosed till adulthood and is an excellent example of the need for a timely and correct diagnosis.",
        "We describe the case of an adult patient affected by multiple exostoses, severe mental retardation, epilepsy and facial dysmorphisms with a deletion of \u223c2.3 Mb on chromosome 11p11.21, correlated to Potocki-Shaffer syndrome (PSS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28707191": [
        "<strong class=\"sub-title\">\n          Purpose of the review:\n        </strong>\n      \n      Review tests available for detection of Clostridium difficile (C. Diff) induced disease, including when such tests should be done in children and how they should be interpreted."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28366569": [
        "Clostridium difficile is a gram-positive intestine bacterium that causes a severe diarrhea and could eventually be lethal.",
        "Recent C. difficile-associated disease (CDAD) outbreaks have been caused by hypervirulent strains which secrete an additional binary toxin (CDTa/CDTb).",
        "Vaccination against these toxins is considered the best way to combat the CDAD.",
        "Furthermore, the developed method was utilized for monitoring the stability of the tetravalent C. difficile vaccine in final container.",
        "A sequential weak cation exchange (carboxyl group) and weak anion exchange (tertiary amine group) columns were employed.",
        "The standard analytical parameters such as LOD, LOQ, linearity, accuracy, precision and repeatability were evaluated for this method and it was deemed acceptable as a quantitative assay for vaccine release.",
        "The main virulence factor is related to the release of two major exotoxins, toxin A (TcdA) and toxin B (TcdB).",
        "Recently, a novel tetravalent C. difficile vaccine candidate containing all four toxins produced from a baculovirus expression system has been developed.",
        "A dose assay to release this tetravalent C. difficile vaccine was developed using tandem ion-exchange HPLC chromatography.",
        "The four C. difficile vaccine antigen pIs range from 4.4 to 8.6.",
        "The final optimized separation employs salt gradient elution at two different pHs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28232034": [
        "Using a combination of approaches including a number of biophysical techniques, we show that there are two distinct actoxumab binding sites within the CROP domain of TcdA centered on identical amino acid sequences at residues 2162-2189 and 2410-2437.",
        "Comparisons of the putative TcdA epitope sequences across several C. difficile ribotypes and homologous repeat sequences within TcdA suggest a structural basis for observed differences in actoxumab binding and/or neutralization potency.",
        "The antitoxin antibodies actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively.",
        "This mechanism of neutralization is similar to that observed with bezlotoxumab and TcdB.",
        "These data provide a mechanistic basis for the protective effects of the antibody in vitro and in vivo, including in various preclinical models of CDI.",
        "The exotoxins toxin A (TcdA) and toxin B (TcdB) are produced by the bacterial pathogen Clostridium difficile and are responsible for the pathology associated with C. difficile infection (CDI).",
        "In this study, we characterize the binding of actoxumab to TcdA and examine its mechanism of toxin neutralization.",
        "Actoxumab binding caused the aggregation of TcdA especially at higher antibody:toxin concentration ratios.",
        "We have previously shown that a single molecule of bezlotoxumab binds to two distinct epitopes within the TcdB combined repetitive oligopeptide (CROP) domain, preventing toxin binding to host cells.",
        "Bezlotoxumab was recently approved by the FDA for reducing the recurrence of CDI.",
        "Actoxumab prevented the association of TcdA with target cells demonstrating that actoxumab neutralizes toxin activity by inhibiting the first step of the intoxication cascade."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12825250": [
        "C. difficile infection presents with a wide range of clinical manifestations, from asymptomatic carriers to life-threatening pseudomembranous colitis.",
        "This article reviews causes, pathogenesis, diagnosis, prevention, and treatment.",
        "The pathogenic organism, Clostridium difficile, produces two enterotoxins, toxin A and toxin B, that cause colonic mucosal inflammation.",
        "The incidence of antibiotic-associated colitis is increasing worldwide as a consequence of widespread use of broad-spectrum antibiotics for various illnesses.",
        "Acute gastroenteritis is a common cause of emergency and office visits."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/2115017": [
        "The complex expression or interaction of the toxins produced by Cl difficile may explain the broad spectrum of disease (diarrhoea, colitis, and pseudomembranous colitis) associated with this micro-organism.",
        "All three caused fluid accumulation in the small intestine, maximal secretion being induced by 1 micrograms of toxin A, 20 micrograms of B, and 15 micrograms of C. Both toxins A and C caused shedding of epithelial cells from the villi without visible damage to crypt cells; toxin A caused further extensive necrosis and bleeding.",
        "The action of toxins A, B, and C from Clostridium difficile was studied in the small intestine and colon of rats.",
        "In the colon, toxin A caused secretion and shedding of surface epithelial cells without damage to crypt cells, toxin C caused only a weak secretion, and toxin B had no effect at all.",
        "In terms of immunohistochemistry, it was found that toxin A bound to the enterocytes at the tips of the villi but not to goblet and crypt cells.",
        "Toxin B caused secretion without visible damage to the epithelial cells, though this activity was unstable and decreased significantly after one week of storage."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28756250": [
        "Here, we used vaspin treated 3T3-L1 murine adipocytes as well as 3T3-L1 cells with stable vaspin expression to investigate the effect of exogenous and endogenous vaspin on inflammatory processes and insulin signaling in adipocytes.",
        "Moreover, endogenous vaspin positively affected insulin signaling by increasing insulin-stimulated phosphorylation of the key mediator protein kinase B (AKT).",
        "Our stably transfected cells secreted significant amounts of vaspin which was in the physiological range of \u223c0.5 ng/ml in cell supernatants.",
        "Treatment of 3T3-L1 cells with exogenous vaspin resulted in reduced cytokine-induced activation of the intracellular and pro-inflammatory NF\u03baB signaling cascades (IKK\u03b1/\u03b2, I\u03baB and NF\u03baB).",
        "The results provide evidence for potent anti-inflammatory action of vaspin not only in vascular cells but also in adipose tissue.",
        "Together, we demonstrate anti-inflammatory effects of vaspin in 3T3-L1 adipocytes as well as increased insulin signaling by endogenous expression or exogenous treatment.",
        "Multiple studies have also demonstrated strong anti-inflammatory effects in vascular and skin cells.",
        "Vaspin expression is increased in white adipose tissue (WAT) of diet-induced obese mice and rats and is supposed to compensate HFD-induced inflammatory processes and insulin resistance in adipose tissue by counteracting pro-inflammatory gene expression in obesity.",
        "We found that IL-1\u03b2 induced expression and secretion of pro-inflammatory cytokines, such as IL-6, MCP1 and TNF\u03b1 was significantly blunted in vaspin expressing 3T3-L1 cells.",
        "Adipocyte differentiation was not affected by vaspin as expression of adipogenic marker genes as well as lipid accumulation after full differentiation was similar to control cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29734265": [
        "This study was designed to investigate the impact of vaspin on autophagy in tumor necrosis factor (TNF)-\u03b1-induced injury in cardiomyocytes and its cardioprotective effects in the pathogenesis of diabetic cardiomyopathy (DCM).",
        "Tumor necrosis factor-\u03b1 treatment inhibited autophagy and promoted apoptosis in H9C2 cells after stimulating for 24 hours.",
        "In DCM rats, upregulation of vaspin reversed cardiac dysfunction, as identified by increased left ventricular ejection fractions and fractional shortening levels, a higher Em/Am ratio, and lower levels of TNF-\u03b1, lactate dehydrogenase, creatine kinase, and creatine kinase-myocardial isoenzyme.",
        "Visceral adipose tissue-derived serine protease inhibitor (Vaspin) is an adipocytokine that has been shown to exert anti-inflammatory effects and inhibits apoptosis under diabetic conditions.",
        "Furthermore, the AKT agonist IGF-1 significantly reversed the effect of vaspin on autophagy.",
        "In vivo DCM model was also developed by treating rats with streptozotocin followed by intraperitoneal injection with vaspin.",
        "H9C2 cells were treated with TNF-\u03b1 with or without vaspin in vitro.",
        "In conclusion, vaspin attenuated the TNF-\u03b1-induced apoptosis by promoting autophagy probably through inhibiting the PI3K/AKT/mTOR pathway and further ameliorated the cardiac dysfunction in DCM rats.",
        "Pretreatment with vaspin significantly mitigated apoptosis induced by TNF-\u03b1 partly because of augment effects of vaspin on autophagy as demonstrated by a higher ratio of LC3-II/LC3-I, higher expression of Beclin-1, and increased autophagosomes formation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27629594": [
        "Blood was collected after an overnight fast and plasma glucose, insulin, serum lipids, 25(OH)D and adipokines (adiponectin and leptin) concentrations were determined at baseline in all participants.",
        "However in our study the interlink between leptin level and 25(OH)D was found only in females.",
        "Vitamin D insufficiency and deficiency were found in 314 (72.2%) subjects.",
        "Mean (95% CI) age, body mass index (BMI) and serum 25(OH)D for the cohort were 47.6\u00b111.3years; 28.7\u00b10.2kg/m<sup>2</sup> and 62.5\u00b124.3nmol/l respectively.",
        "Further investigations are required to study the relationship between serum 25(OH)D level, obesity and serum adipokine levels.",
        "We included 435 residents (132 males) from St. Petersburg, Russia into this study.",
        "Abdominal obesity was diagnosed in 310 (71.3%) subjects (251 females and 59 males).",
        "Our study showed a high prevalence of abdominal obesity, vitamin D deficiency and insufficiency in residents from North-West region of Russia, close association between adipokine (leptin, adiponectin) concentrations as well as vitamin D status and body composition (WC, BMI).",
        "We found correlation between leptin and serum 25(OH)D level (r=-0.15, p=0.01) but this finding was a characteristic seen only in women.",
        "WC was positively correlated with leptin and negatively correlated with adiponectin.",
        "Abdominal obesity is a risk factor for cardiovascular disease and diabetes mellitus and has been associated with vitamin D deficiency.",
        "Some studies have suggested an association between obesity and adipokine levels as well as low serum 25-hydroxyvitamin D (25(OH)D) level but the underlying mechanisms of the interlink between vitamin D status and serum leptin and adiponectin concentrations are still disputed.",
        "Serum 25(OH)D level inversely correlated with body weight, waist circumference (WC) and BMI in females but not in males, was lower in diabetic than non-diabetic subjects, and was not significantly different in subjects with and without MetS.",
        "All subjects had physical examination and demographics noted."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28393393": [
        "Many resistin gene polymorphisms were described and their implication in obesity was controversial.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Adipose tissue is an important endocrine organ that secretes a number of adipokines, like Resistin (RETN); it's an adipocytes-secreted cytokine and has been proposed as a link between obesity and diabetes.",
        "This study was to investigate the prevalence of single nucleotide polymorphisms (SNPs) in RETN gene 420C/G; 44G/A; 62G/A; 394C/G and 299 G/A and their association with Resistin level and obesity in Tunisian volunteers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28857629": [
        "Leptin decreased 5 min after exercise (23.6 \u00b1 13.2 vs. baseline 27.8 \u00b1 14.4 ng/ml; p &lt; .01) and remained depressed following 90 min (p &lt; .01).",
        "Plasma adipokine levels were measured before exercise, and at 5 and 90 min after exercise on the first and the last training days.",
        "Adiponectin was higher at 5 min than 90 min post-exercise (11.7 \u00b1 7.3 and 10.5 \u00b1 5.8 ng/ml; p = .01) in the first exercise day.",
        "The aim of this study was to investigate the plasma adipokine responses to high-intensity interval training (HIT) in overweight/obese women.",
        "Twelve women (age 21.7 \u00b1 3.8 years) completed a 19 days of HIT comprising six session of 4-6 repeats of a Wingate test (0.065 kg load/kg).",
        "No consistent effect was found on resistin concentration.",
        "Future studies are required to disclose the functional consequences of these alterations in plasma adipokine levels.",
        "The changes in adiponectin and leptin concentrations were similar on the first and last exercise days."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28877872": [
        "The current study used this cohort of adult rats to evaluate insulin resistance [homeostatic model assessment of insulin resistance (HOMA-IR)], plasma adipokines (reflecting insulin resistance states), and testosterone.",
        "The major findings were that daily maternal-neonatal separation led to an increase in body weight and HOMA-IR in adult male and female rats and increased plasma leptin in adult male rats only; neither prior neonatal hypoxia (without or with body temperature control) nor neonatal hypothermia altered subsequent adult HOMA-IR or plasma adiponectin.",
        "Care of premature infants often requires parental and caregiver separation, particularly during hypoxic and hypothermic episodes.",
        "Adult male-female differences in plasma leptin were lost with prior exposure to neonatal hypoxia or hypothermia; male-female differences in resistin were lost in the adults that were exposed to hypoxia and spontaneous hypothermia as neonates.",
        "We conclude that neonatal stressors result in subsequent adult sex-dependent increases in insulin resistance and adipokines and that our rat model of prematurity with hypoxia without hypothermia alters adult testosterone dynamics.",
        "Exposure of neonates to daily hypoxia without spontaneous hypothermia led to a decrease in plasma testosterone in adult male rats.",
        "We have established a neonatal rat model of human prematurity involving maternal-neonatal separation and hypoxia with spontaneous hypothermia prevented by external heat.",
        "Adults previously exposed to these neonatal stressors show a sex difference in the insulin and glucose response to arginine stimulation suggesting a state of insulin resistance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21743113": [
        "DOOR syndrome is a rare multisystem genetic disorder, consisting of deafness (sensorineural), onychodystrophy, osteodystrophy, and mental retardation.",
        "Seizures reported frequently in this condition are often refractory to treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19830001": [
        "For the first short examination sedoanalgesia was employed and the second, longer, procedure was performed under general anaesthesia.",
        "The potential anaesthetic implications of Deafness, Onycho-Osteodystrophy and mental Retardation syndrome are highlighted.",
        "We report the anaesthetic management of a 48-year-old male patient with Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy and cerebral palsy who had two dental procedures under anaesthetic care.",
        "His airway management was moderately difficult and the postoperative period was complicated by partial seizures involving the upper extremity and a short period of decreased oxygen saturation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18263975": [
        "The diagnosis was based on characteristic abnormalities, including congenital deafness, nail and bone abnormalities, and mild mental retardation.",
        "We present the case of a 9-year-old boy with DOOR syndrome recognized in the first year of his life because of a delayed development of speech."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17994565": [
        "In this report, we present a newborn with manifestations consistent with DOOR syndrome and a progressive clinical course.",
        "A comprehensive literature review reveals 32 patients with DOOR syndrome.",
        "DOOR syndrome (deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature.",
        "The purpose of our communication is to report on an additional patient with DOOR syndrome, delineate common as well as less frequent manifestations of DOOR syndrome, bring attention to the under appreciated facial features in DOOR syndrome, document the natural history of this disorder, and propose a suggested workup of those suspected of DOOR syndrome.",
        "The hallmarks of the syndrome, represented in the DOOR acronym, include sensorineural hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalanges of the hands and feet, and mental retardation.",
        "The majority of patients with DOOR syndrome have elevated levels of 2-oxoglutarate in the urine and plasma.",
        "In conclusion, DOOR syndrome is a neurometabolic disorder with recognizable facial features and a progressive natural history.",
        "The natural history is one of a deteriorative course, with progressive neurological manifestations including sensorineural deafness, seizures from infancy, optic atrophy, and a peripheral polyneuropathy.",
        "DOOR syndrome is associated with characteristic, coarse facial features with large nose with wide nasal bridge, bulbous tip and anteverted nares, a long prominent philtrum and downturned corners of the mouth."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15279406": [
        "The awareness and appropriate weighing of the importance of vestigial nails (onychodystrophy) was crucial for the correct diagnosis.",
        "Although, prenatal diagnosis is not possible at present, knowledge of the enzyme defect and detection of the reduced activity of the 2-oxoglutarate dehydrogenase E1 component may provide an opportunity.",
        "If parents opt to have another child, a 25% risk is to be taken into account.",
        "Based on the normal level of 2-oxoglutarate excretion, the patient can be categorized as type 2.",
        "Authors highlight the difficulties of syndrome identification through reporting the first case of DOOR syndrome in Hungary (the 28th case worldwide).",
        "This is associated with better survival, which does not mean a substantial difference in quality of life."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12457410": [
        "Four patients from three families with the clinical features of DOOR syndrome (onycho-osteodystrophy, dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate) are the subjects of this report.",
        "Our report deals with the autosomal recessive form of the disease, wherein the activity of 2-oxoglutarate decarboxylase (E1(0)) in fibroblasts and white blood cells of the patients is decreased.",
        "This study demonstrates for the first time that E1(0) deficiency is an important biochemical marker for the autosomal recessive form of DOOR syndrome.",
        "The activity of E1(0) in all patients' fibroblasts and white blood cells was significantly lower compared to the controls."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/7808978": [
        "We present two sisters who died in early infancy with the clinical features of DOOR syndrome, both of whom in addition had cardiac defects and urinary tract abnormalities.",
        "Both infants had the classical clinical features of sensorineural deafness, seizures, hypoplastic nails, finger-like thumbs, and the characteristic facies of the syndrome.",
        "The first child had left-sided hydronephrosis and hydroureter, and the second sibling had bilateral hydronephrosis, hydroureter, and dilatation of the bladder.",
        "Congenital heart disease and renal abnormalities have not to our knowledge been previously described in association with the DOOR syndrome.",
        "To date, 16 cases of the syndrome have been documented in the literature.",
        "Autopsy in each case revealed the additional findings of a membranous ventricular septal defect and a septum secundum atrial septal defect.",
        "The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness, osteodystrophy, onychodystrophy, and mental retardation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8256819": [
        "The parents were Guatemalan and not known to be consanguineous.",
        "This observation may be useful in discussing the prognosis for newly identified cases.",
        "We report the seventeenth case of the recessive form of the DOOR syndrome.",
        "The patient was among a subset of DOOR syndrome patients without seizures in infancy.",
        "Urinary 2-oxoglutarate excretion was normal.",
        "The patient had developmental delay, severe sensorineural deafness, and abnormal nails and phalanges in the hands and feet."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29095980": [
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      The collection, management and visualization of clinical pedigree (family history) data is a core activity in clinical genetics centres.",
        "However, clinical pedigree datasets can be difficult to manage, as they are time consuming to capture, and can be difficult to build, manipulate and visualize graphically.",
        "Several standalone graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical pedigree editors that can be easily configured and incorporated into web applications."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17488757": [
        "For complex pedigrees, we use a hybrid algorithm in which consanguinous loops are drawn as cyclic graphs whenever possible, but we resort to acyclic graphs when matings can no longer be connected without line crossings.",
        "A similar hybrid approach is used to avoid line crossings for matings between distant descendants of different founding groups.",
        "The program is designed to handle large and complex pedigrees with an emphasis on readability and aesthetics.",
        "Written in object-oriented C++ and released under the GNU General Public License (GPL), Madeline 2.0 PDE reads input files specified on the command line and generates pedigree drawings without user interaction.",
        "We provide an easy-to-use public web service, which is experimental and still under development.",
        "The Madeline 2.0 Pedigree Drawing Engine (PDE) is a pedigree drawing program for use in linkage and family-based association studies.",
        "Pedigree output in scalable vector graphics (SVG) format can be viewed in browsers with native SVG rendering support or in vector graphics editors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29891587": [
        "Clinical and preclinical data suggest that the wake-promoting effects of solriamfetol differ from medications such as modafinil and amphetamine.",
        "Moreover, the wake-promoting effects of solriamfetol are probably owing to activity at DA and NE transporters rather than other neurotransmitter systems, such as histamine or orexin.",
        "Excessive sleepiness (ES) is associated with several sleep disorders, including narcolepsy and obstructive sleep apnea (OSA).",
        "Solriamfetol (JZP-110) is a wake-promoting agent that is currently being evaluated to treat ES in patients with narcolepsy or OSA.",
        "Taken together, these data suggest that solriamfetol may offer an important advancement in the treatment of ES in patients with narcolepsy or OSA.",
        "The dual activity of solriamfetol at DA and NE transporters and the lack of significant monoamine-releasing properties of solriamfetol might explain the differences in the in vivo effects of solriamfetol compared with modafinil or amphetamine.",
        "Results indicate that solriamfetol has dual reuptake inhibition activity at dopamine (DA; IC<sub>50</sub> = 2.9 <i>\u03bc</i>M) and norepinephrine (NE; IC<sub>50</sub> = 4.4 <i>\u03bc</i>M) transporters, and this activity is associated in vivo with increased extracellular concentration of DA and NE as measured by microdialysis.",
        "The goal of the current studies was to characterize the mechanism of action of solriamfetol at monoamine transporters using in vitro and in vivo assays.",
        "A role for monoaminergic systems in treating these conditions is highlighted by the clinical use of US Food and Drug Administration-approved drugs that act on these systems, such as dextroamphetamine, methylphenidate, modafinil, and armodafinil.",
        "Solriamfetol has negligible functional activity at the serotonin transporter (IC<sub>50</sub> &gt; 100 <i>\u03bc</i>M)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30269642": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      This study evaluated the human abuse potential of solriamfetol (formerly JZP-110), a selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30365900": [
        "Current pharmacotherapy is ineffective in correcting sleep-disordered breathing and is used adjunctively to address residual sleepiness.",
        "A new drug, solriamfetol, a selective norepinephrine-dopamine reuptake inhibitor, is the first drug of its class that is being considered by the US Food and Drug Administration (FDA) to treat excessive sleepiness in OSA and narcolepsy patients. <b>Areas covered</b>: This review covers drug chemistry, pharmacodynamics, pharmacokinetics, and metabolism of solriamfetol.",
        "Published abstracts/articles and a 2017 Jazz Investor Presentation provided data.",
        "Unlike stimulants like methylphenidate or dextroamphetamine, it does not have cardiac effects, rebound hypersomnia, or withdrawal effects.",
        "Databases searched included PubMed, Google Scholar, Lexi-Comp, Scopus, Science, and Ovid. <b>Expert commentary</b>: Solriamfetol shows promise as adjunctive therapy in OSA.",
        "Results of three Phase 3 trials, Treatment of OSA and Narcolepsy Excessive Sleepiness (TONES 3, 4, 5), relevant to OSA patients are summarized.",
        "It is well tolerated and effective in reducing sleepiness and is an alternative to modafinil or armodafinil.",
        "<b>Introduction</b>: Obstructive sleep apnea (OSA) is highly prevalent and constitutes a major health hazard."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30521757": [
        "Adverse events were reported in 47.9% of placebo- and 67.9% of solriamfetol-treated participants; five participants experienced serious adverse events (two [1.7%] placebo, three [0.8%] solriamfetol); none were deemed related to study drug.",
        "The most common adverse events with solriamfetol were headache (10.1%), nausea (7.9%), decreased appetite (7.6%), anxiety (7.0%), and nasopharyngitis (5.1%). <b>Conclusions:</b> Solriamfetol significantly increased wakefulness and reduced sleepiness in participants with obstructive sleep apnea and excessive sleepiness; most adverse events were mild or moderate in severity.",
        "Furthermore, effectiveness of sleep apnea treatment is limited by poor adherence.",
        "All doses except 37.5 mg resulted in higher percentages of participants reporting improvement on Patient Global Impression of Change (key secondary endpoint; <i>P</i> &lt; 0.05).",
        "Currently available pharmacologic options for the treatment of sleepiness in this population are limited. <b>Objectives:</b> To evaluate the efficacy and safety of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects, for the treatment of excessive sleepiness in participants with obstructive sleep apnea with current or prior sleep apnea treatment. <b>Methods:</b> This was a double-blind, randomized, placebo-controlled, parallel-group, 12-week trial comparing solriamfetol, 37.5, 75, 150, and 300 mg, with placebo. <b>Measurements and Main Results:</b> Of 476 randomized participants, 459 were included in the prespecified efficacy analyses.",
        "<b>Rationale:</b> Primary treatment of obstructive sleep apnea can be accompanied by a persistence of excessive sleepiness despite adherence.",
        "Coprimary endpoints (Maintenance of Wakefulness Test sleep latency and Epworth Sleepiness Scale score) were met at all solriamfetol doses (<i>P</i> &lt; 0.05), with dose-dependent effects observed at Week 1 maintained over the study duration.",
        "Clinical trial registered with www.clinicaltrials.gov (<a href=\"http://clinicaltrials.gov/show/NCT02348606\" title=\"See in ClinicalTrials.gov\">NCT02348606</a>) and www.eudract.ema.europa.eu (EudraCT 2014-005514-31)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29575326": [
        "Recent results show that the system is also applicable for combating viral infection in plants.",
        "Recently, with the discovery of the nuclease Cas13a (previously called C2c2), molecular biologists have obtained a system that enables sequence-specific cleavage of single-stranded RNA molecules.",
        "The first application of Cas13a for post-transcriptional regulation of gene expression in plants has been reported.",
        "As single-stranded RNA viruses are by far the most abundant class of viruses in plants, the application of this system is of special promise for crops.",
        "Moreover, by combining DNA- and RNA-directed systems, the most complex of changes in plant metabolism might be achievable.",
        "Application of the bacterial CRISPR/Cas systems to eukaryotes is revolutionizing biology.",
        "More interesting applications are imminent for plant biologists, with nuclease dead versions of Cas13 enabling the ability to visualize RNA molecules in vivo, as well as to edit different kinds of RNA molecules at specific bases by deamination or to modify them by conjugation.",
        "The latest experiments with this and also the alternative Cas13b system demonstrate that these proteins can be used in a similar manner in eukaryotes for RNA manipulation as Cas9 and Cas12 for DNA manipulations.",
        "Moreover, histone modifications, as well as cytosine methylation or base editing, were achieved with these systems in plants.",
        "Cas9 and Cas12 (previously called Cpf1) are widely used as DNA nucleases for inducing site-specific DNA breaks for different kinds of genome engineering applications, and in their mutated forms as DNA-binding proteins to modify gene expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28946360": [
        "The aim of this study was to determine the structure dependant antioxidant capacity of phlorotannins from Icelandic brown algae, Fucus vesiculosus.",
        "Brown algae are rich in polyphenolic compounds, phlorotannins, which have been found to possess high in vitro antioxidant capacity, especially DPPH radical scavenging activity, due to the high number of hydroxyl groups.",
        "Whereas, the overall antioxidant capacity of brown algae extracts has been widely studied, the antioxidant capacity of individual phlorotannins has been rarely explored.",
        "On-line determination of antioxidant capacity of the individual phlorotannins generally showed that low molecular phlorotannins exhibited higher antioxidant capacity and that the capacity decreased with polymerisation.",
        "Tentative structural elucidation of 13 phlorotannin isomers from EAF was obtained by LC-DAD-QTOFMS, ranging from 374 to 870Da.",
        "The antioxidant capacity of individual phlorotannins was determined by an on-line method using liquid chromatography and an electrochemical detector followed by quadrupole Time of Flight mass spectrometry (UHPLC-DAD-ECD-QTOFMS)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29342865": [
        "Related to this are observations of modulation of post-prandial glycemic response in mice and increased insulin sensitivity in humans when supplemented with seaweed extract.",
        "Computerized measures of episodic memory, attention and subjective state were completed at baseline and 5 times at 40 min intervals over a 3 h period following lunch, with either seaweed or placebo consumed 30 min prior to lunch.",
        "In order to explore the mechanism underlying these effects, future research should examine effects on cognition in parallel with blood glucose and insulin responses.",
        "Seaweed led to significant improvements to accuracy on digit vigilance (<i>p</i> = 0.035) and choice reaction time (<i>p</i> = 0.043) tasks.",
        "Analysis was conducted with linear mixed models controlling for baseline.",
        "(Poly)phenols and, specifically, phlorotannins present in brown seaweeds have previously been shown to inhibit \u03b1-amylase and \u03b1-glucosidase, key enzymes involved in the breakdown and intestinal absorption of carbohydrates.",
        "However, no studies to date have explored the effect of seaweed extract on cognition.",
        "The current randomized, placebo-controlled, double-blind, parallel groups study examined the impact of a brown seaweed extract on cognitive function post-prandially in 60 healthy adults (<i>N</i> = 30 per group).",
        "These findings provide the first evidence for modulation of cognition with seaweed extract."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29344826": [
        "Phytochemical determinations showed considerable differences in total phenolic content (TPC) and phlorotannin content (PHT).",
        "Furthermore, the pharmacological screening of the anti-inflammatory potential of these fractions using in vivo models, in comparison to reference drugs, established a remarkable activity of PHT-SED at the dose of 100 mg/kg; the inhibition percentages of ear edema in mice model and paw edema in rats model were of 82.55 and 81.08%, respectively.",
        "The content of malondialdehyde (MDA) in liver tissues has been quantified, and PHT-SED was found to remarkably increase the lipid peroxidation in rat liver tissues.",
        "In addition, in two pain mice models, PHT-SED displayed a profound antinociceptive activity at 100 mg/kg and has proved a better analgesic activity when used in combination with the opioid drug, tramadol.",
        "Phlorotannins, phenolic compounds produced exclusively by seaweeds, have been reported to possess various pharmacological properties.",
        "However, there have been few works on these compounds from Mediterranean seaweeds.",
        "In this study, we investigated the phytochemical analysis and pharmacological potential of phlorotannin-rich fractions from three brown seaweeds collected along the Tunisia coast: Cystoseira sedoides (PHT-SED), Cladostephus spongeosis (PHT-CLAD), and Padina pavonica (PHT-PAD).",
        "The highest TPC level (26.45 mg PGE/g dry material (Dm)) and PHT level (873.14 \u03bcg PGE/g Dm) were observed in C. sedoides.",
        "The antioxidant properties of these three fractions assessed by three different methods indicated that C. sedoides displayed the highest total antioxidant activity among the three species (71.30 mg GAE/g Dm), as well as the free radical scavenging activity with the lowest IC<sub>50</sub> value in both DPPH (27.7 \u03bcg/mL) and ABTS (19.1 \u03bcg/mL) assays."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30072652": [
        "Phlorotannins show potential for use in functional foods or drugs.",
        "In this study, six purified phlorotannins (eckol; 6,6'-bieckol; 6,8'-bieckol; 8,8'-bieckol; phlorofucofuroeckol (PFF)-A and PFF-B) from <i>Eisenia arborea</i>, orally administered to mice, were examined for their suppression effects on ear swelling.",
        "Results showed that the phlorotnannins exhibited suppression effects in all experiments, with 6,8'-bieckol, 8,8'-bieckol and PFF-A showing the strongest of these effects.",
        "Since the incidence of allergies is currently increasing in the world, there is a focus on phlorotannins having anti-allergic and anti-inflammatory effects.",
        "Phlorotannin is the collective term for polyphenols derived from brown algae belonging to the genera <i>Ascopyllum</i>, <i>Ecklonia</i>, <i>Eisenia</i>, <i>Fucus</i> and <i>Sargassum</i> etc.",
        "In considering the suppression, we also examined whether the phlorotannins suppressed release of chemical mediators (histamine, leukotriene B\u2084 and prostaglandin E\u2082), and mRNA expression and/or the activity of cyclooxygenase-2 (COX-2), using RBL-2H3 cells, a cultured mast cell model.",
        "In conclusion, orally administered phlorotannins suppress mouse ear swelling, and this mechanism apparently involves suppression of chemical mediator release and COX-2 mRNA expression or activity.",
        "This is the first report of the anti-allergic effects of the orally administered purified phlorotannins in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29608860": [
        "Furthermore, eckmaxol showed favorable interaction in the ATP binding site of glycogen synthase kinase 3\u03b2 and mitogen activated protein kinase.",
        "Moreover, both glycogen synthase kinase 3\u03b2 and mitogen activated protein kinase inhibitors produced neuroprotective effects in SH-SY5Y cells.",
        "These results suggested that eckmaxol might produce neuroprotective effects via concurrent inhibition of glycogen synthase kinase 3\u03b2 and extracellular signal-regulated kinase pathways, possibly via directly acting on glycogen synthase kinase 3\u03b2 and mitogen activated protein kinase.",
        "Alzheimer's disease is a progressive neurodegenerative disorder that mainly affects the elderly.",
        "Here we report that eckmaxol, a phlorotannin extracted from the brown alga Ecklonia maxima, could produce neuroprotective effects in SH-SY5Y cells.",
        "Based on the central role that \u03b2-amyloid oligomers play in the pathogenesis of Alzheimer's disease and the high annual production of Ecklonia maxima for alginate and other nutritional ingredients, this report represents a new candidate for the treatment of Alzheimer's disease, and also expands the potential application of Ecklonia maxima and its constituents in the field of pharmacology.",
        "Eckmaxol also significantly reversed the decreased expression of phospho-Ser9-glycogen synthase kinase 3\u03b2 and increased expression of phospho-extracellular signal-regulated kinase, which was induced by A\u03b2 oligomer.",
        "Eckmaxol effectively prevented but did not rescue \u03b2-amyloid oligomer-induced neuronal apoptosis and increase of intracellular reactive oxygen species.",
        "Soluble \u03b2-amyloid oligomer, which can induce neurotoxicity, is generally regarded as the main neurotoxin in Alzheimer's disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22612266": [
        "The antioxidant activity of F. vesiculosus extract/fractions was assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, reducing power, and ferrous ion-chelating assays.",
        "Sephadex subfractions LH-2 and LH-3 with high total phlorotannin content exhibited strong DPPH quenching activity, comparable to those of ascorbic acid and butylated hydroxytoluene and significantly higher than that of \u03b1-tocopherol.",
        "This fraction was further fractionated by Sephadex LH-20 column chromatography or ultrafiltration.",
        "Among the crude extract and different polarity fractions, the phlorotannin-enriched ethyl acetate fraction possessed the highest DPPH scavenging activity and reducing power.",
        "A process for the effective extraction and fractionation of phlorotannins from Fucus vesiculosus with high antioxidant potentials was investigated.",
        "Further characterization of the phlorotannin compounds was performed on six Sephadex subfractions.",
        "Several phlorotannin oligomers were tentatively identified on the basis of HPLC-ESI-MS(n) analyses.",
        "All the subfractions separated by Sephadex LH-20 column chromatography and ultrafiltration showed a high ability to scavenge reactive oxygen species generated by mononuclear cells.",
        "There were no clear relationships between the degree of polymerization, molecular size, and antioxidant activity.",
        "The antioxidant properties were evaluated by both the above chemical antioxidant tests and a mononuclear cell-based bioassay.",
        "Polyphenols in F. vesiculosus were found to consist mainly of high molecular weight phlorotannin polymers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28735901": [
        "Panx1 is the most studied and best-characterized isoform of this gene family.",
        "Pannexins are a family of integral membrane proteins with distinct post-translational modifications, sub-cellular localization and tissue distribution.",
        "While many investigations revolve around Panx1 functions in health and disease, more recently, details started emerging about mechanisms that control Panx1 channel activity.",
        "Here, we review recent progress in our understanding of Panx1 at the center of these pathways, highlighting its modulation in a context specific manner.",
        "These advancements in Panx1 biology have revealed that beyond its classical role as an unopposed plasma membrane channel, it participates in alternative pathways involving multiple intracellular compartments, protein complexes and a myriad of extracellular participants.",
        "The ubiquitous expression, as well as its function as a major ATP release and nucleotide permeation channel, makes Panx1 a primary candidate for participating in the pathophysiology of CNS disorders.",
        "This article is part of a Special Issue entitled: Gap Junction Proteins edited by Jean Claude Herve."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29932112": [
        "Our objectives were to validate the predicted N-glycosylation site of Panx2 and to study the effects of Panx2 glycosylation on localization and its capacity to interact with Panx1.",
        "Panx2 and the N86Q mutant are predominantly localized to the endoplasmic reticulum (ER) and cis-Golgi matrix with limited cell surface localization was seen only in the presence of Panx1.",
        "Panx1 and Panx2 intermixing can regulate channel properties, and both pannexins have been implicated in neuronal cell death after ischemia.",
        "Pannexins (Panx1, 2, 3) are channel-forming glycoproteins expressed in mammalian tissues.",
        "Our study indicates that N-glycosylation may be important for folding and trafficking of Panx2.",
        "The Panx2 N86Q mutant is glycosylation-deficient and tends to aggregate in the ER reducing its cell surface trafficking but it can still interact with Panx1.",
        "We previously reported that N-glycosylation acts as a regulator of the localization and intermixing of Panx1 and Panx3, but its effects on Panx2 are currently unknown.",
        "We found that the un-glycosylated forms of Panx1 and 2 can readily interact, regulating their localization and potentially their channel function in cells where they are co-expressed.",
        "We used site-directed mutagenesis, enzymatic de-glycosylation, cell-surface biotinylation, co-immunoprecipitation, and confocal microscopy.",
        "Our results showed that N86 is the only N-glycosylation site of Panx2."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26386583": [
        "The identification of Panx1 channels as large particles within the plasma membrane provides the knowledge required to enable recognition of Panx1 channels in tissues in future studies.",
        "Panx1 channels are generally of major importance in a large number of system and cellular processes and their function has been thoroughly characterized.",
        "The fact that no counterparts were identified on apposing cells, which would have been indicative of intercellular signaling, supported the idea of Panx1 channels within one membrane.",
        "Pannexins (Panx) are proteins with a similar membrane topology to connexins, the integral membrane protein of gap junctions.",
        "We therefore determine the subcellular localization of Panx1 channels in cultured cells and aim at the identification of channel morphology in vitro.",
        "Control cells (transfected with EYFP only, non-transfected) were devoid of both particles and immunogold labeling.",
        "Thus, these results open up new avenues for the detailed analysis of the subcellular localization of Panx1 and of its nearest neighbors such as purinergic receptors in vivo.",
        "In contrast, little is known about channel structure and subcellular distribution.",
        "Using freeze-fracture replica immunolabeling on EYFP-Panx1-overexpressing HEK 293 cells, large particles were identified in plasma membranes, which were immunogold-labeled using either GFP or Panx1 antibodies.",
        "Altogether, this study provides the first demonstration of Panx1 channel morphology and assembly in intact cells.",
        "The assembly of particles was irregular, this being in contrast to the regular pattern of gap junctions.",
        "There was no labeling or particles in the nuclear membranes of these cells, pointing to plasma membrane localization of Panx1-EYFP channels."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24300303": [
        "These single membrane large-pore channels exhibit a variety of tissue, cell type, and subcellular distributions.",
        "Pannexins (Panxs) are a multifaceted family of ion and metabolite channels that play key roles in a number of physiological and pathophysiological settings.",
        "We examine several intrinsic features of Panxs including specific post-translational modifications, the divergent C-termini, and oligomerization, all of which contribute to Panx anterograde transport pathways.",
        "The lifecycles of Panxs are complex, yet must be understood to accurately target these proteins for future therapeutic use.",
        "Further, we examine the potential influence of extrinsic factors, such as protein-protein interactions, on Panx trafficking.",
        "Finally, we highlight what is currently known with respect to Panx internalization and retrograde transport, and present new data illustrating Panx1 internalization following an activating stimulus.",
        "Here we review the basics of Panx function and localization, and then analyze the recent advances in knowledge regarding Panx trafficking."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25505382": [
        "Furthermore, our results indicate that Panx2 transcriptional activity is a poor predictor of Panx2 protein abundance and does not correlate with Panx2 protein levels.",
        "In this study, we characterized novel commercial monoclonal antibodies and surveyed Panx2 expression and distribution at the mRNA and protein level by real-time qPCR, Western blotting and immunofluorescence.",
        "Three distinct Panx paralogs (Panx1, Panx2 and Panx3) have been identified in vertebrates but previous reports on Panx expression and functionality focused primarily on Panx1 and Panx3 proteins.",
        "Despite showing disproportionately high transcript levels, the CNS expressed less Panx2 protein than any other tissues analyzed.",
        "Overall, our results demonstrate that the endogenous expression of Panx2 protein is not restricted to the CNS and is more ubiquitous than initially predicted.",
        "Panx2 protein levels were readily detected in every tissue examined, even when transcriptional analysis predicted very low Panx2 protein expression.",
        "Additionally, we showed that Panx2 protein does not localize at the plasma membrane like other gap junction proteins but remains confined within cytoplasmic compartments.",
        "Pannexins (Panx) are proteins homologous to the invertebrate gap junction proteins called innexins (Inx) and are traditionally described as transmembrane channels connecting the intracellular and extracellular compartments.",
        "However, the lack of suitable antibodies prevented the creation of a comprehensive map of Panx2 protein expression and Panx2 protein localization profile is currently mostly inferred from the distribution of its transcript.",
        "Several gene expression studies reported that Panx2 transcript is largely restricted to the central nervous system (CNS) hence suggesting that Panx2 might serve an important role in the CNS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29559781": [
        "Further, two new formulations of long-acting injections of second-generation antipsychotics (aripiprazole lauroxil and 3-month paliperidone palmitate) were introduced into clinical practice.",
        "New treatment options not yet available include cannabidiol, glutamate modulators, and nicotine receptors agonists.",
        "Optimization of treatment includes not only practical tools such as therapeutic drug monitoring but also implementation of general trends in the clinical practice.",
        "Two new partial dopamine agonists, brexpiprazole and cariprazine, are now available in addition to aripiprazole.",
        "In medicine, there are two main methods of improving the health care provided: seeking new treatment procedures and perfecting (optimizing) the existing ones.",
        "Although the mechanisms of action are similar, the two agents differ in terms of their pharmacodynamic profiles.",
        "In depression, treatment resistance to antidepressive pharmacotherapy represents one of the most important clinical challenges.",
        "In spite of tremendous development in central nervous system research, current treatment is suboptimal, especially in severe mental disorders.",
        "Novel approaches being studied include ketamine and opioids.",
        "Antipsychotics are still the cornerstone of the current treatment of schizophrenia.",
        "Switching to monotherapy with new multimodal/multifunctional antidepressants and augmentation with new atypical antipsychotics (aripiprazole and brexpiprazole) may be promising options.",
        "New pharmacological options include new more sophisticated forms of monoaminergic drugs, old drugs rediscovered on the base of a better understanding of pathophysiology of mental illnesses, and drugs aimed at new treatment targets.",
        "Recent advances in technology and emerging knowledge about dysfunctional brain circuits and neuroplasticity have led to the development of different new neuromodulation techniques usually used as add-on therapy.",
        "Further, current evidence supports utility and safety of adjunctive treatment of nutraceuticals."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29729086": [
        "This study used in vivo electrophysiological techniques in anesthetized rats to determine cariprazine's effect on dopaminergic cell activity in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc).",
        "<strong class=\"sub-title\">\n          Aim:\n        </strong>\n      \n      Cariprazine, a dopamine D<sub>3</sub> -preferring D<sub>3</sub> /D<sub>2</sub> receptor partial agonist, is FDA approved for the treatment of schizophrenia and acute manic or mixed episodes of bipolar disorder."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29722587": [
        "Expert opinion: Cariprazine shows highest affinity toward D<sub>3</sub> receptors, followed by D<sub>2</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>1A</sub> receptors.",
        "Long-term administration of cariprazine altered the abundance of dopamine, serotonin, and glutamate receptor subtypes in different brain regions.",
        "Cariprazine is approved in the United States and Europe for the treatment of manic or mixed episodes associated with bipolar I disorder and for the treatment of schizophrenia in adult patients.",
        "All these mechanisms of cariprazine may contribute toward its unique preclinical profile and its clinically observed benefits in the treatment of schizophrenia, bipolar mania, and possibly other psychiatric disorders.",
        "It has a half-life of 2 - 4 days with an active metabolite that has a terminal half-life of 2 - 3 weeks.",
        "Areas covered: This review article focuses on the preclinical discovery of cariprazine providing details regarding its pharmacological, behavioral, and neurochemical mechanisms and its contribution to clinical therapeutic benefits.",
        "It also shows moderate affinity toward \u03c3<sub>1</sub>, 5-HT<sub>2A</sub>, and histamine H<sub>1</sub> receptors.",
        "It is typically administered orally once a day (a dose range 1.5 - 6 mg/day), does require titration, and may be given with or without food.",
        "This article is based on the available literature with respect to the preclinical and clinical findings and product labels of cariprazine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28531264": [
        "Thus, in this study we examined whether the effects of cariprazine are mediated by dopamine D3 receptors.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Cariprazine, a D3-preferring dopamine D2/D3 receptor partial agonist, is a new antipsychotic drug recently approved in the United States for the treatment of schizophrenia and bipolar mania.",
        "We recently demonstrated that cariprazine also has significant antianhedonic-like effects in rats subjected to chronic stress; however, the exact mechanism of action for cariprazine's antidepressant-like properties is not known."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23138433": [
        "Based on preclinical efficacy, dopamine D\u2082 and D\u2083 receptor partial agonists and antagonists are assumed to have relapse-preventing potential in human cocaine addiction.",
        "Substance abuse is a frequent comorbidity of both disorders and is associated with serious health issues.",
        "<strong class=\"sub-title\">\n          Rationale:\n        </strong>\n      \n      Cariprazine (RGH-188) is a D\u2083-preferring dopamine D\u2083/D\u2082 receptor partial agonist antipsychotic candidate for the treatment of schizophrenia and bipolar mania."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26586950": [
        "Cariprazine induces extrapyramidal symptoms less often than risperidone and can cause acute akathisia.",
        "As a consequence of its improved adverse effects, cariprazine improves patients' quality of life to a greater extent than other second-generation antipsychotic drugs.",
        "In these patients, its long-term therapeutic effect and its action in comparison with other second-generation antipsychotic drugs, above all aripiprazole, remain to be tested in clinical trials.",
        "It is a prolactin-sparing antipsychotic drug and has a favorable metabolic profile.",
        "Cariprazine is a recently developed antipsychotic drug with a partial agonism for the D2 and D3 receptors.",
        "Cariprazine is a promising antipsychotic drug in the treatment of schizophrenia, acute mania in bipolar disorder, and in schizophrenia with mania.",
        "In clinical trials, its therapeutic effect has been tested in patients with an acute exacerbation of schizophrenia and in patients with acute mania in bipolar disorder.",
        "In acute mania in bipolar disorder, it treats manic symptoms significantly better than placebo.",
        "Like risperidone, cariprazine improves positive and negative schizophrenic symptoms, and ameliorates cognitive functions.",
        "It shows a tenfold greater affinity for the D3 receptor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26723167": [
        "In adult male rats, cariprazine (0.03-0.3 mg/kg i.p.), and the atypical antipsychotic aripiprazole (1-3 mg/kg i.p.) caused dose-dependent reversal of a delay-induced impairment in novel object recognition (NOR).",
        "One promising therapeutic development is to design new molecules that balance actions on dopamine D2 and D3 receptors to maximise benefits and limit adverse effects.",
        "This study used two rodent paradigms to investigate the action of the dopamine D3-preferring D3/D2 receptor partial agonist cariprazine.",
        "These findings support recent clinical studies demonstrating the efficacy of cariprazine in treatment of negative symptoms and functional impairment in schizophrenia patients.",
        "Treating neonatal rat pups with phencyclidine (PCP) and subsequent social isolation produced a syndrome of behavioural alterations in adulthood including hyperactivity in a novel arena, deficits in NOR and fear motivated learning and memory, and a reduction and change in pattern of social interaction accompanied by increased ultrasonic vocalisations (USVs).",
        "Results suggest that in the behavioural tests investigated cariprazine is at least as effective as aripiprazole and in some paradigms it showed additional beneficial features further supporting the advantage of combined dopamine D3/D2 receptor targeting.",
        "Current antipsychotic medication is largely ineffective against the negative and cognitive symptoms of schizophrenia.",
        "Acute administration of cariprazine (0.1 and 0.3 mg/kg) and aripiprazole (3 mg/kg) to resultant adult rats reduced neonatal PCP-social isolation induced locomotor hyperactivity and reversed NOR deficits.",
        "Cariprazine (0.3 mg/kg) caused a limited reversal of the social interaction deficit but neither drug affected the change in USVs or the deficit in fear motivated learning and memory."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30322874": [
        "The study objective was to determine whether cariprazine leads to functional alterations of monoamine systems in vivo via electrophysiological recordings from anesthetized rats.",
        "In the LC, cariprazine reversed the inhibitory effect of the preferential 5-HT<sub>2A</sub> receptor agonist, 2,5-dimethoxy-4-iodoamphetamine, on norepinephrine (NE) neurons (ED<sub>50</sub> = 66 <i>\u00b5</i>g/kg) but did not block the inhibitory effect of the <i>\u03b1</i> <sub>2</sub>-adrenergic receptor agonist, clonidine.",
        "These results indicate that, in vivo, cariprazine acted as a 5-HT<sub>1A</sub> autoreceptor agonist in the DRN, a 5-HT<sub>2A</sub> receptor antagonist in modulating the firing activity of LC NE neurons, and a full agonist at 5-HT<sub>1A</sub> receptors mediating the electrophysiological effect of 5-HT on pyramidal neurons.",
        "Dorsal raphe nucleus (DRN), locus coeruleus (LC), and hippocampus pyramidal neurons were recorded, and cariprazine was administered systemically or locally through iontophoresis.",
        "Cariprazine, iontophorized into the hippocampus, diminished pyramidal neuronal firing through activation of 5-HT<sub>1A</sub> receptors, while its concomitant administration did not dampen the suppressant effect of 5-HT.",
        "In the DRN, cariprazine completely inhibited the firing activity of 5-HT neurons, which was fully reversed by the 5-HT<sub>1A</sub> receptor antagonist, WAY100635.",
        "The modulatory actions of cariprazine on these monoaminergic systems may contribute to its therapeutic effectiveness in patients with depressive episodes.",
        "Cariprazine also displays partial agonism at serotonin [5-hydroxytryptamine (5-HT)] 5-HT<sub>1A</sub> receptors and antagonism at 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors in vitro.",
        "Cariprazine, an orally active and potent dopamine D<sub>3</sub>-preferring D<sub>3</sub>/D<sub>2</sub> receptor partial agonist, is approved to treat adults with schizophrenia (in the United States and Europe) and manic or mixed episodes associated with bipolar I disorder (in the United States)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27440212": [
        "Three positive, 6-week, Phase 2/3, randomized controlled trials in acute schizophrenia demonstrated superiority of cariprazine over placebo.",
        "In a 26-72 week, randomized withdrawal study, significantly fewer patients relapsed in the cariprazine group compared with placebo (24.8% vs. 47.5%), resulting in an NNT of 5.",
        "Clinical trials are ongoing in patients with acute bipolar I depression and as adjunctive treatment to antidepressant therapy in patients with major depressive disorder.",
        "Cariprazine is administered once daily and is primarily metabolized in the liver through the CYP3A4 enzyme system and, to a lesser extent, by CYP2D6.",
        "There are two active metabolites of note, desmethyl-cariprazine and didesmethyl-cariprazine; the latter's half-life is substantially longer than that for cariprazine and systemic exposure to didesmethyl-cariprazine is several times higher than that for cariprazine.",
        "Pooled responder rates were 31% for cariprazine 1.5-6 mg/d vs. 21% for placebo, resulting in a number needed to treat (NNT) of 10.",
        "Short-term weight gain appears small (approximately 8% of patients receiving cariprazine 1.5-6 mg/d gained \u22657% body weight from baseline, compared with 5% for those randomized to placebo, resulting in an NNH of 34).",
        "The recommended dose range of cariprazine for the treatment of schizophrenia is 1.5-6 mg/d; the starting dose of 1.5 mg/d is potentially therapeutic.",
        "Cariprazine is also approved for the acute treatment of manic or mixed episodes associated with bipolar I disorder.",
        "Cariprazine is associated with no clinically meaningful alterations in metabolic variables, prolactin, or the ECG QT interval.",
        "The most commonly encountered adverse events (incidence \u22655% and at least twice the rate of placebo) are extrapyramidal symptoms (number needed to harm [NNH] 15 for cariprazine 1.5-3 mg/d vs. placebo and NNH 10 for 4.5-6 mg/d vs. placebo) and akathisia (NNH 20 for 1.5-3 mg/d vs. placebo and NNH 12 for 4.5-6 mg/d vs. placebo).",
        "Cariprazine is also a partial agonist at the serotonin 5-HT1A receptor and acts as an antagonist at 5-HT2B and 5-HT2A receptors.",
        "Cariprazine is a dopamine D3 and D2 receptor partial agonist, with a preference for the D3 receptor.",
        "Cariprazine is an antipsychotic medication and received approval by the U.S. Food and Drug Administration for the treatment of schizophrenia in September 2015."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25083572": [
        "For the last 5 weeks of the CMS procedure, rats were injected once daily with vehicle, imipramine (10 mg/kg), aripiprazole (1 and 5 mg/kg), or cariprazine (0.01, 0.03, 0.065, 0.25, and 1.0 mg/kg).",
        "Imipramine, and both doses of aripiprazole and cariprazine 0.03, 0.065, and 0.25 mg/kg significantly attenuated CMS-induced reductions in sucrose intake; the lowest and highest cariprazine doses (0.01 and 1 mg/kg) did not have this effect.",
        "Cariprazine showed greater potency (ED50=0.052) relative to aripiprazole (ED50=4.4) in this model.",
        "The aim of this study was to evaluate whether chronic treatment with cariprazine, a dopamine D2 and D3 receptor partial agonist with preferential binding to D3 receptors, shows antidepressant-like effects in the chronic mild stress (CMS)-induced anhedonia model.",
        "CMS significantly reduced sucrose intake.",
        "Male Wistar rats were subjected to the CMS procedure for 7 weeks; nonstressed animals served as controls.",
        "Thus, in the rat CMS model, cariprazine showed antidepressant-like action with greater potency than aripiprazole.",
        "These results suggest that cariprazine may have clinical utility in the treatment of depression and the negative symptoms of schizophrenia.",
        "Activity in reversing CMS-induced decreases in consumption of 1% solution of sucrose was measured."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23320989": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Cariprazine is an atypical antipsychotic in clinical development for the treatment of schizophrenia and bipolar mania/mixed episodes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30131592": [
        "At the D<sub>3</sub> receptor, aripiprazole exhibits a slow monophasic dissociation, while cariprazine displays a rapid biphasic behaviour.",
        "The dissociation behaviours of aripiprazole and cariprazine at the human D<sub>2</sub> and D<sub>3</sub> receptor are evaluated.",
        "The binding kinetics of four ligands were indirectly evaluated.",
        "With these findings novel agents may be developed that display rapid, biphasic dissociation from the D<sub>3</sub>R to further investigate this effect on in vivo profiles.",
        "Functional \u00df-arrestin assays and molecular dynamics simulations at the D<sub>3</sub> receptor confirm a biphasic binding behaviour of cariprazine.",
        "A potential correlation between kinetics and in vivo profiles, especially cariprazine's action on negative symptoms in schizophrenia, is investigated.",
        "After the receptor preparations were pre-incubated with the unlabelled ligands, the dissociation was initiated with an excess of [<sup>3</sup>H]spiperone.",
        "This may influence its in vivo action, as the partial agonist could react rapidly to variations in the dopamine levels of schizophrenic patients and the ligand will not quantitatively dissociate from the receptor in one single step.",
        "Slow dissociation kinetics characterizes aripiprazole and cariprazine at the D<sub>2</sub> receptor."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29659705": [
        "These tools can provide a deeper insight into the genomic structure of the organism.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Genome plotting is performed using a wide range of visualizations tools each with emphasis on a different informative dimension of the genome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19674480": [
        "The realisation that many of these toxins may have pharmaceutical and insecticidal potential due to their remarkable potency and selectivity against target receptors has led to an explosion in the number of new toxins being discovered and characterised.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Venomous animals incapacitate their prey using complex venoms that can contain hundreds of unique protein toxins.",
        "From an evolutionary perspective, spiders are the most successful venomous animals and they maintain by far the largest pool of toxic peptides.",
        "However, at present, there are no databases dedicated to spider toxins and hence it is difficult to realise their full potential as drugs, insecticides, and pharmacological probes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21036864": [
        "These proteins are of interest to a wide range of biologists due to their diverse applications in medicine, neuroscience, pharmacology, drug discovery and agriculture.",
        "ArachnoServer (www.arachnoserver.org) is a manually curated database providing information on the sequence, structure and biological activity of protein toxins from spider venoms.",
        "The following significant improvements have been implemented in version 2.0: (i) the average and monoisotopic molecular masses of both the reduced and oxidized form of each mature toxin are provided; (ii) the advanced search feature now enables searches on the basis of toxin mass, external database accession numbers and publication date in ArachnoServer; (iii) toxins can now be browsed on the basis of their phyletic specificity; (iv) rapid BLAST searches based on the mature toxin sequence can be performed directly from the toxin card; (v) private silos can be requested from research groups engaged in venoms-based research, enabling them to easily manage and securely store data during the process of toxin discovery; and (vi) a detailed user manual is now available.",
        "Key features of ArachnoServer include a molecular target ontology designed specifically for venom toxins, current and historic taxonomic information and a powerful advanced search interface.",
        "ArachnoServer currently manages 1078 protein sequences, 759 nucleic acid sequences and 56 protein structures."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29069336": [
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      ArachnoServer is a manually curated database that consolidates information on the sequence, structure, function and pharmacology of spider-venom toxins.",
        "Although spider venoms are complex chemical arsenals, the primary constituents are small disulfide-bridged peptides that target neuronal ion channels and receptors.",
        "A new version of ArachnoServer (v3.0) has been developed that includes a bioinformatics pipeline for automated detection and analysis of peptide toxin transcripts in assembled venom-gland transcriptomes.",
        "ArachnoServer v3.0 was updated with the latest sequence, structure and functional data, the search-by-mass feature has been enhanced, and toxin cards provide additional information about each mature toxin.",
        "Due to their high potency and selectivity, these peptides have been developed as pharmacological tools, bioinsecticides and drug leads."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29189942": [
        "With regard to recent developments in utilizing the CRISPR-Cpf1 system in genome editing of various organisms, it can be concluded with confidence that this system is a reliable molecular toolbox of genome editing approaches.",
        "CRISPR-Cas systems are classified into two main classes and six types.",
        "In the present review, we attempt to highlight most recent advances in CRISPR-Cpf1 (CRISPR-Cas12a) system in particular, considering ground expeditions of the nature and the biology of this system, introducing novel Cpf1 variants that have broadened the versatility and feasibility of CRISPR-Cpf1 system, and lastly the great impact of the CRISPR-Cpf1 system on the manipulation of the genome of prokaryotic, mammalian, and plant models is summarized.",
        "Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas) is a microbial adaptive immune system.",
        "Cpf1 is a putative type V (class II) CRISPR effector, which has revolutionized the genome editing approaches through multiple distinct features such as using T-rich protospacer-adjacent motif, applying a short guide RNA lacking trans-activating crRNA, introducing a staggered double-strand break, and possessing RNA processing activity in addition to DNA nuclease activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27757389": [
        "MK-3415A treatment resulted in lower <i>Enterobacter</i> levels and restoration of <i>Blautia, Akkermansia</i>, and <i>Lactobacillus</i> which were the core components of the original microbiota.",
        "Here, we showed that <i>C. difficile</i> infection resulted in the prevalence of <i>Enterobacter</i> species.",
        "Sixty percent of mice in the vehicle group died after 2 days and their microbiome was almost exclusively formed by <i>Enterobacter</i>.",
        "Human monoclonal antibodies MK-3415A (actoxumab-bezlotoxumab) to <i>C. difficile</i> toxin A and toxin B, as an emerging non-antibiotic approach, significantly reduced the recurrence of CDI in animal models and human clinical trials.",
        "Using a CDI murine model, we compared the bacterial diversity of the gut microbiome of mice under different treatments including MK-3415A, vancomycin, or vancomycin combined with MK-3415A, sampled longitudinally.",
        "Vancomycin treatment led to significantly lower survival rate than the combo treatment of MK-3415A and vancomycin.",
        "Antibiotics have significant and long-lasting impacts on the intestinal microbiota and consequently reduce colonization resistance against <i>Clostridium difficile</i> infection (CDI).",
        "Vancomycin treatment decreased bacterial diversity with predominant <i>Enterobacter</i> and <i>Akkermansia</i>, while <i>Staphylococcus</i> expanded after vancomycin treatment was terminated.",
        "However, these animals were able to recover their initial <i>Blautia</i> and <i>Lactobacillus</i> proportions, even though episodes of <i>Staphylococcus</i> overgrowth were detected by the end of the experiments.",
        "It remains to be examined whether or not the prevention of recurrent CDI by the antitoxin antibodies observed in clinical trials occurs through modulation of microbiota.",
        "Standard therapy using antibiotics is associated with a high rate of disease recurrence, highlighting the need for novel treatment strategies that target toxins, the major virulence factors, rather than the organism itself.",
        "In conclusion, MK-3415A (actoxumab-bezlotoxumab) treatment facilitates normalization of the gut microbiota in CDI mice.",
        "Although the main mechanism of protection is through direct neutralization of the toxins, the impact of MK-3415A on gut microbiota and its restoration has not been examined.",
        "In contrast, mice treated by vancomycin combined with MK-3415A also experienced decreased bacterial diversity during vancomycin treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25486992": [
        "These data provide a mechanistic basis for the prevention of recurrent disease observed in CDI patients in clinical trials.",
        "A combination of human monoclonal antibodies, actoxumab and bezlotoxumab, directed against TcdA and TcdB, respectively, has been shown to decrease the rate of recurrence in patients treated with standard-of-care antibiotics.",
        "Disease symptoms are caused by the two homologous exotoxins, TcdA and TcdB.",
        "In this study, we show that the antitoxin antibodies are protective in multiple murine models of CDI, including systemic and local (gut) toxin challenge models, as well as primary and recurrent models of infection in mice.",
        "Clostridium difficile infection (CDI) represents the most prevalent cause of antibiotic-associated gastrointestinal infections in health care facilities in the developed world.",
        "Furthermore, mutant antibodies (N297Q) that do not bind to Fc\u03b3 receptors provide a level of protection similar to that of wild-type antibodies, demonstrating that the mechanism of protection is through direct neutralization of the toxins and does not involve host effector functions.",
        "Standard therapy for CDI involves administration of antibiotics that are associated with a high rate of disease recurrence, highlighting the need for novel treatment paradigms that target the toxins rather than the organism itself.",
        "Systemically administered actoxumab-bezlotoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile in these models, including in mice challenged with a strain of the hypervirulent ribotype 027.",
        "However, the exact mechanism of antibody-mediated protection is poorly understood."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28636484": [
        "The current knowledge about the immune response to C. difficile toxins and how this knowledge led to the development and the clinical use of bezlotoxumab is described.",
        "The unmet needs in CDI care were ascertained with emphasis in rCDI, including the epidemiology, pathophysiology and current management.",
        "Current and potential future competitors to the drug were examined.",
        "The first passive immunotherapy drug targeting C.difficile toxin B (bezlotoxumab) has been approved recently by the FDA and EMA for prevention of rCDI.",
        "Expert commentary: A single 10 mg/kg intravenous infusion of bezlotoxumab has been shown to decrease rCDI by ~40% (absolute reduction ~10%) in patients being treated for primary CDI or rCDI with SOC antibiotics.",
        "Clostridium difficile infection (CDI) is the most common nosocomial infection in the U.S. 25% of CDI patients go on to develop recurrent CDI (rCDI) following current standard of care (SOC) therapy, leading to morbidity, mortality and economic loss.",
        "Targeting C.difficile toxins by passive immunotherapy is a novel mechanism for prevention of C.difficile infection.",
        "Bezlotoxumab will be a valuable adjunctive therapy to reduce the burden of CDI.",
        "Areas covered: A body of key studies was selected and reviewed by the authors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27905086": [
        "This article summarizes the milestones in the development of bezlotoxumab leading to this first approval for use in patients receiving antibacterial drug treatment for C. difficile infection who are at high risk for recurrence of C. difficile infection.",
        "Bezlotoxumab (Zinplava\u2122) is a human monoclonal antibody against Clostridium difficile toxin B developed by Merck &amp; Co.",
        "In October 2016 it was approved in the USA for reducing the recurrence of C. difficile infection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28865041": [
        "It is the first agent approved for recurrence prevention and is administered as a single intravenous infusion in conjunction with standard-of-care (SoC) antibacterial treatment for CDI.",
        "Bezlotoxumab has low immunogenicity and is generally well tolerated, although the potential for heart failure in some patients requires consideration; cost-effectiveness data for bezlotoxumab are awaited with interest.",
        "Bezlotoxumab (Zinplava\u2122) is a fully human monoclonal antibody against Clostridium difficile toxin B indicated for the prevention of C. difficile infection (CDI) recurrence in patients with a high recurrence risk.",
        "In well-designed, placebo-controlled, phase 3 trials (MODIFY 1 and 2), a single infusion of bezlotoxumab, given in combination with SoC antibacterial therapy for CDI in adults, was effective in reducing CDI recurrence in the 12 weeks post-treatment, with this benefit being seen mainly in the patients at high recurrence risk.",
        "Bezlotoxumab did not impact the efficacy of the antibacterials being used to treat the CDI and, consistent with its benefits on CDI recurrence, appeared to reduce the need for subsequent antibacterials, thus minimizing further gut microbiota disruption.",
        "Longer term, there were no further CDI recurrences over 12 months' follow-up among patients who had received bezlotoxumab in MODIFY 2 and entered an extension substudy.",
        "Thus, a single intravenous infusion of bezlotoxumab during SoC antibacterial treatment for CDI is an emerging option for reducing CDI recurrence in adults at high risk of recurrence."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29756573": [
        "Notably, it has been used as an adjuvant therapy for some intestinal diseases.",
        "It is now used in nutraceuticalsupplemented infant formula and other food products.",
        "This article reviews the content, distribution, physiologic functions and current applications of Lf, and aims to shed light on future prospects for additional applications of Lf.",
        "Lactoferrin (lactotransferrin; Lf) is an iron-binding glycoprotein and one of the most important bioactivators in milk and other external secretions.",
        "Lf regulates the quantity of iron absorbed in the intestine via its role in iron transport and can also chelate iron, directly or indirectly.",
        "It has numerous biological roles, including the regulation of iron absorption and modulation of immune responses, and has anti-microbial, anti-viral, antioxidant, anti-cancer, and anti-inflammatory activities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26137081": [
        "Dysregulated activation of numerous genes, including zinc finger, DHHC-type containing 14; caspase-associated recruitment domain-containing protein; and Ras association domain family member 10, have been implicated in GC.",
        "In advanced and metastatic GC, conventional chemotherapy results in limited efficacy and the average survival rate is currently approximately 10 months.",
        "A similar trend in LTF protein expression was observed by western blot analysis.",
        "The present study demonstrates that LTF expression is downregulated in GC tissues and that LTF may serve an important role in the dysregulation of the MAPK signaling pathway.",
        "Furthermore, the present study demonstrated that the mitogen-activated protein kinase (MAPK) signaling pathway intermediates p38, <i>c</i>-Jun N-terminal kinase (JNK) and <i>c</i>-Jun were highly expressed in GC tissue samples, and indicated that LTF downregulation may be associated with the dysregulation of the MAPK signaling pathway in GC tissues.",
        "Gastric cancer (GC) is the second leading cause of cancer-associated mortality worldwide.",
        "In addition, the present study indicated that LTF overexpression reduced the expression of p38, JNK2 and <i>c</i>-Jun in the GC cell line, SGC7901.",
        "In the present study, the expression levels of LTF in patient GC tissue samples were investigated using reverse transcription-quantitative polymerase chain reaction, and it was demonstrated that the LTF mRNA expression level in GC tissue samples was reduced by ~20-fold compared with the adjacent non-cancerous tissues (t=4.56, P&lt;0.01).",
        "However, the mechanism of the tumor suppressor function of LTF in GC remains unclear.",
        "The tumor suppressor function of lactotransferrin (LTF) has been reported in a variety of tumors, including GC, nasopharyngeal carcinoma (NPC) and prostate cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25535701": [
        "Due to its large use worldwide, the small percentage of implant loss becomes significant in number of cases.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Dental implants have been widely used to replace missing teeth, accomplishing aesthetics and function.",
        "Recently, a few studies have been investigating genetic aspects underlying dental implant failure.",
        "Lactotransferrin (LTF) is a pleiotropic protein, expressed in various body tissues and fluids, which modulates the host immune-inflammatory response and bone metabolism, and might be involved in dental implant osseointegration."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25647781": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Axitinib is a potent and selective inhibitor of vascular endothelial growth factor receptors 1-3.",
        "This analysis compared efficacy and safety of axitinib plus gemcitabine in patients with advanced pancreatic cancer from Japan, North America and the European Union, enrolled in a randomized Phase III study."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21306953": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Axitinib is a potent, selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3.",
        "A randomised phase 2 trial of gemcitabine with or without axitinib in advanced pancreatic cancer suggested increased overall survival in axitinib-treated patients.",
        "On the basis of these results, we aimed to assess the effect of treatment with gemcitabine plus axitinib on overall survival in a phase 3 trial."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24328549": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Advanced understanding of the pathogenesis of renal cell carcinoma (RCC) has led to development and approval of several molecularly targeted therapies since 2005.",
        "In the randomized Phase III AXIS trial, axitinib significantly prolonged progression-free survival compared with sorafenib, respectively (6.7 vs 4.7 months; p &lt; 0.0001), and improved objective response rate (19 vs 9%; p = 0.0001), resulting in its approval for advanced or metastatic RCC after failure of one systemic therapy.",
        "However, overall survival was similar with axitinib and sorafenib.",
        "Axitinib is a potent and selective inhibitor of vascular endothelial growth factor receptors 1, 2 and 3.",
        "Common adverse events associated with axitinib include diarrhea, hypertension and fatigue."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29608663": [
        "In addition to release of the software, we benchmark its key parameters and provide a compact cancer reference network that increases the significance of tumor stratification using the NBS algorithm.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      We present pyNBS: a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm for stratifying tumor somatic mutation profiles into molecularly and clinically relevant subtypes.",
        "The structure of the code exposes key steps of the algorithm to foster further collaborative development."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19752190": [
        "The MLP/CFL2 complex is stronger in moderately acidic (pH 6.8) environments and upon CFL2 phosphorylation, while it is independent of Ca(2+) levels.",
        "The interaction involves the inter-LIM domain, amino acids 94 to 105, of MLP and the amino-terminal domain, amino acids 1 to 105, of CFL2, which includes part of the actin depolymerization domain.",
        "This interaction has direct implications in actin cytoskeleton dynamics in regulating CFL2-dependent F-actin depolymerization, with maximal depolymerization enhancement at an MLP/CFL2 molecular ratio of 2:1.",
        "We have shown for the first time, using a range of biochemical and immunohistochemical methods, that MLP binds directly to CFL2 in human cardiac and skeletal muscles.",
        "The muscle LIM protein (MLP) and cofilin 2 (CFL2) are important regulators of striated myocyte function.",
        "Herein, we have investigated whether MLP and CFL2 are involved in common molecular mechanisms, which would promote our understanding of disease pathogenesis.",
        "Mutations in the corresponding genes have been directly associated with severe human cardiac and skeletal myopathies, and aberrant expression patterns have often been observed in affected muscles.",
        "Deregulation of this interaction by intracellular pH variations, CFL2 phosphorylation, MLP or CFL2 gene mutations, or expression changes, as observed in a range of cardiac and skeletal myopathies, could impair F-actin depolymerization, leading to sarcomere dysfunction and disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25200592": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Most studies on suicide exclude subjects with autism spectrum disorders, yet there is a risk group.",
        "The purpose of this article is to present the data in the literature regarding the clinical and epidemiological characteristics of suicidality in subjects with autism spectrum disorders and to identify the factors that promote the transition to action."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17885828": [
        "The present exploratory study examined the level of peer victimization, depressive symptomatology, anxiety symptomatology, and level of suicidal ideation among adolescents and young adults diagnosed with Asperger's Syndrome (AS).",
        "The study included two samples.",
        "Of the sample, 20 percent met criteria for a diagnosis of Major Depressive Disorder, 30 percent met criteria for Generalized Anxiety Disorder and 50 percent had clinically significant level of suicidal ideation.",
        "The second sample consisted of a volunteer sample of parents who accessed Web sites for parents and individuals diagnosed with Autism Spectrum Disorder.",
        "The high proportion of respondents with scores above the cutoff point on the overt victimization and relational victimization scales suggests that these adolescents and young adults experienced high levels of victimization.",
        "The first sample used snowball sampling, beginning with parents of adolescents and young adults diagnosed with AS who participated in a qualitative study conducted in 2002.",
        "A total sample of 10 adolescents and young adults diagnosed with AS was obtained.",
        "This cross-sectional study used a self-administrated mail questionnaire and a Web-based questionnaire."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28872268": [
        "However, whether ASD independently increases the risk of attempted suicide regardless of depression has not been determined.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Previous studies reported a high prevalence of depression among patients with autism spectrum disorder (ASD) and suggested a relationship between ASD and suicidality."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23666287": [
        "The intimidation and the lack of socio-professional integration were also reported as environnemental risk factors.",
        "The suicidal behaviors are frequently observed in the adolescents and adults with an ASD without intellectual deficience.",
        "Among the individual risk factors of the suicidal behavior in ASD patients, mood and anxiety disorders are found as well as a familial affective disorder history.",
        "However, the clinical research on the topic is limited and the diagnosis not assessed in the emergency units.",
        "Laters tudies taking into account the cognitive characteristics would permit to investigate the suicidal phenomenology in ASD patients.",
        "The Autistic Spectrum Disorders (ASD) are characterized by an atypical sociability, alterations in communication, restricted interests and stereotypies, with adding affective and adaptative disabilities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24201088": [
        "Four primary research studies were identified for this review following a comprehensive literature search.",
        "The purpose of this review is to synthesise primary research on suicidal behaviour among adolescents and young adults with autism spectrum disorders in order to estimate prevalence and to identify and critically evaluate risk factors for suicidal behaviour in this population.",
        "However we have very little understanding of suicidal behaviour among individuals with autism spectrum disorders.",
        "Suicide is a major problem in Western society.",
        "The available research provides little empirical evidence for the processes underlying suicidal behaviour in adolescents and young adults with autism."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27956832": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Considering that suicide is one of the most common reasons of adolescent death worldwide, there is a lack of clinical awareness on suicidal behaviors of children and adolescents with autism spectrum disorder (ASD).",
        "The present study aims to assess the rate of suicidality (suicidal ideation, behaviors and attempts) and associated risk factors for suicidality in high functioning ASD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29854129": [
        "We present a systematic approach to 1) adapt Natural Language Processing (NLP) solutions to screen with high sensitivity for reference to suicidal constructs in a large clinical ASD EHR corpus (230,465 documents), and 2) evaluate within a screened subset of 500 patients, the performance of an NLP classification tool for positive and negated suicidal mentions within clinical text.",
        "When evaluated, the NLP classification tool showed high system performance for positive suicidality with precision, recall, and F1 scores all &gt; 0.85 at a document and patient level.",
        "However systems to accurately extract suicidality-related concepts need to be developed so that putative models of suicide risk in ASD can be explored.",
        "Electronic health records (EHRs) can be used to create retrospective clinical cohort data for large samples of children with ASD.",
        "Over 15% of young people with autism spectrum disorders (ASD) will contemplate or attempt suicide during adolescence.",
        "The application therefore provides accurate output for epidemiological research into the factors contributing to the onset and recurrence of suicidality, and potential utility within clinical settings as an automated surveillance or risk prediction tool for specialist ASD services.",
        "Yet, there is limited evidence concerning risk factors for suicidality in childhood ASD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29706156": [
        "Retrospectively, the lack of focus on suicidality in ASD seems surprising when self-injurious behavior has long been a focus of attention in ASD.<sup>2</sup> The emerging studies indicate that the increased risk of self-injurious behavior in younger and less cognitively able children with ASD<sup>3,4</sup> is matched by an increased risk of suicidality in those at a more advanced developmental level.",
        "A cluster of recent articles, including an article by Culpin et al.<sup>1</sup> in this issue, has highlighted not only that suicidal thoughts and suicide attempts can occur in adolescents and young adults with ASD, but also that suicidality is likely more common in ASD than in the general population.",
        "Until recently, suicidality in autism spectrum disorder (ASD) was rarely discussed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25084822": [
        "This article presents the characteristics of the suicidal behaviors and the process for preventing a suicide reattempt associated with an adolescent with ASD who attempted suicide.",
        "Although the suicide risk of autism spectrum disorder (ASD) has been suggested to be higher than previously recognized, there are few case reports focusing on the process for preventing suicide reattempts.",
        "We reported that a 17-year-old male who had attempted suicide by jumping was admitted to our emergency department and hospitalized for lumbar spine fracture.",
        "In addition to the diagnosis of adjustment disorder, he was diagnosed as ASD according to his life history."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23479198": [
        "Furthermore, miR-214 expression level was up-regulated in NPC especially in metastasis-prone NPC tumor tissues compared with normal nasopharyngeal epithelial tissues, while the LTF expression level was negatively correlated with miR-214, suggesting that miR-214 targeting is partly responsible for LTF down-regulation in NPC specimens.",
        "The pro-tumor function of miR-214 was depended on LTF suppression since LTF re-expression can reverse it. miR-214 can also activate AKT signaling by suppressing LTF expression.",
        "We previously reported that LTF is significantly down-regulated in nasopharyngeal carcinoma (NPC) and acts as a tumor suppressor by suppressing AKT signaling.",
        "However, the exact mechanism of the down-regulation of LTF in NPC has not been revealed.",
        "In the current study, we screened and identified LTF is a bona fide target of miR-214 in NPC cells. miR-214 mimics significantly suppressed LTF mRNA and protein expression levels in NPC cells. miR-214 not only can promote NPC cell proliferation and invasion abilities in vitro, but also can accelerate tumor formation and lung metastasis in a mouse xenograft model.",
        "LTF (lactotransferrin, or lactoferrin) plays important role in innate immunity, and its anti-tumor function has also been reported in multiple cancers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25370482": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Lactotransferrin (LTF) has been confirmed to act as a tumor suppressor in multiple cancers; however, its roles in oral squamous cell carcinoma (OSCC), one of malignant head and neck carcinomas, has not been explored."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23069661": [
        "In the current study, we revealed that LTF can suppress 3-phosphoinositide-dependent protein kinase 1 expression via the mitogen-activated protein kinase/c-Jun pathway and thus repress AKT signaling.",
        "However, the mechanism underlying this remains unclear.",
        "LTF (lactotransferrin, also known as lactoferrin) is a key component of innate immune defense.",
        "It suggests that both LTF and AKT signaling merit further study in the field of NPC research.",
        "We also showed that LTF interacts with keratin 18 (K18) and so blocks the formation of the K18-14-3-3 complex, leading to downregulation of K18-mediated AKT activation.",
        "It has recently been found to have anti-tumor and anti-metastatic activity in different cancers.",
        "This is the first report on the tumor suppressive effects of LTF through repression of AKT signaling in NPC.",
        "Thus, LTF suppresses AKT signaling by two separate mechanisms, leading to inhibition of NPC tumorigenesis.",
        "We previously reported LTF to be the most significantly downregulated gene in nasopharyngeal carcinoma (NPC) specimens relative to normal nasopharyngeal epithelial tissues, and it was also negatively associated with the progression and metastasis of NPC."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18697201": [
        "Therefore, our findings provide new insights in understanding the mechanism(s) underlying the action of LTF in regulating the development of human NPC.",
        "Similarly, 41.58% of NPC with local lymph node metastasis displayed LTF expression, a value significantly lower than the 46.36% in primary tumors (p &lt; 0.05).",
        "Loss of LTF expression was observed in a significantly higher frequency of NPC tissues compared to that in nontumor nasopharyngeal epithelial tissues.",
        "The aim of our study was to investigate whether LTF could regulate the development of NPC by characterizing the pattern of LTF expression in human NPC tissues using cDNA and tissue microarrays.",
        "However, little is known about the role of LTF in regulating the development of human nasopharyngeal carcinoma (NPC).",
        "Thus LTF is likely to be a candidate tumor suppressor and downregulates the development of NPC by inhibiting NPC proliferation through induction of cell cycle arrest and modulation of the MAPK signaling pathway.",
        "Furthermore, overexpression of or treatment with LTF inhibited the proliferation of NPC cells and promoted cell cycle arrest at the G(0)/G(1) phase in vitro.",
        "While LTF treatment downregulated expression of cyclin D1 and phosphorylation of retinoblastoma protein (Rb), expression of p21 and p27 in 5-8F NPC cells was enhanced.",
        "While 61.25% of NPC tissues at the T1/T2 stage were positive for LTF expression, only 40.82% of NPC at the T3/T4 stage were stained by anti-LTF.",
        "Moreover, LTF treatment modulated the mitogen-activated protein kinase (MAPK) pathway, but did not affect p53 and STAT3 expression in 5-8F NPC cells.",
        "These findings suggest that LTF may negatively regulate the development and metastasis of NPC in vivo.",
        "Lactotransferrin (LTF) has been shown to regulate tumorogenesis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28494719": [
        "However, long-term levodopa (LD) treatment is frequently associated with fluctuations in motor response with serious impact on patient quality of life.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Ever since the pioneering reports in the 60s, L-3,4-Dioxyphenylalanine (levodopa) has represented the gold standard for the treatment of Parkinson's Disease (PD).",
        "The pharmacokinetic and pharmacodynamic properties of LD are pivotal to such motor fluctuations: discontinuous drug delivery, short half-life, poor bioavailability, and narrow therapeutic window are all crucial for such fluctuations.",
        "During the last 60 years, several attempts have been made to improve LD treatment and avoid long-term complications."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29161531": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      CVT-301, an inhaled levodopa (LD) formulation, is under development for relief of OFF periods in Parkinson's disease (PD).",
        "In this study, we evaluate pulmonary function in patients treated with a single dose of CVT-301 or placebo for 3 hours, or received multiple doses/day for 4 weeks.",
        "Previously, we reported that CVT-301 improved OFF symptoms relative to placebo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30479171": [
        "Areas covered: CVT-301 is a self-administered dry powder aerosol inhaled formulation of LD that is being developed as a self-administered treatment for OFF periods.",
        "Despite the many medical treatment options available, unpredictable OFF episodes can still occur and be severe and disabling.",
        "Levodopa (LD), in combination with a decarboxylase inhibitor, is a mainstay and the most effective therapeutic agent in the treatment of Parkinson's disease (PD).",
        "Unfortunately, during chronic treatment with this agent, ON-OFF phenomena and dyskinesia appear.",
        "The PK profile of CVT-301, the efficacy, and the safety highlighted in randomized clinical trials will be reviewed.",
        "A rescue therapy that provides a rapid and predictable ON response for patients with OFF periods would be of great value for such patients.",
        "Expert opinion: CVT-301 may offer several potential advantages including increased systemic bioavailability through pulmonary absorption, rapid onset of action, avoidance of first-pass drug metabolism and less plasma-level variability.",
        "List of Abbreviations: PD: Parkinson's disease; LD: Levodopa; CD: Carbidopa; AADC: aromatic L-amino acid decarboxylase; IR: immediate-release; FPD: fine particle dose; GI: gastrointestinal; PK: pharmacokinetic; CVs: coefficient of variation; UPDRS: Unified Parkinson's Disease Rating Scale; AEs: adverse events; FEV: forced expiratory volume; FVC: forced vital capacity; DL<sub>CO</sub>: diffuse lung CO ; t<sub>max</sub>: time to maximum concentration."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27345931": [
        "To assess ON- versus OFF-state pulmonary function, the quality of its spirometric evaluation, and the quality of longitudinal spirometric findings in a large sample of PD patients with motor fluctuations.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Spirometry patterns suggesting restrictive and obstructive pulmonary dysfunction have been reported in Parkinson's disease (PD).",
        "However, the patterns' precise relation to PD pathophysiology remains unclear.",
        "Purpose/Aim."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27743318": [
        "Levodopa-carbidopa intestinal gel (LCIG) is an approved therapy consisting of a suspension of levodopa and carbidopa infused directly into the proximal jejunum via a percutaneous endoscopic gastrojejunostomy (PEG-J) tube through a portable infusion pump.",
        "IPX066 is a novel levodopa-carbidopa (LD/CD) oral formulation combining immediate-release (IR) and extended-release (ER) LD/CD recently approved in the USA and the EU.",
        "Efforts have been made recently to improve levodopa bioavailability either by developing more effective oral formulations or by innovating routes of administration (intestinal infusion, transcutaneous or inhaled levodopa).",
        "The current review aims to summarize the pharmacokinetic aspects, clinical efficacy, and potential adverse events of novel levodopa formulations currently available or under development.",
        "Other novel formulations have been discontinued, including DM-1992, which is a bilayer formulation containing an IR LD/CD layer and an ER LD/CD layer with gastroretentive properties, and XP21279, a novel oral levodopa prodrug that is absorbed from the small and large intestine by high-capacity nutrient transporters expressed throughout the gastrointestinal system.",
        "Levodopa remains the most effective treatment for Parkinson's disease and is considered the gold standard therapy.",
        "ND0612 is a proprietary liquid formulation of LD/CD that enables subcutaneous administration via a small patch-pump device, and CVT-301 is a levodopa inhalation powder with rapid onset of action; both are currently in active studies.",
        "Ongoing studies are evaluating the 'accordion pill' (AP09004), an ER LD/CD formulation with gastroretentive properties.",
        "However, disease progression and changes in the gastrointestinal tract result in a declining window of treatment response in a majority of patients.",
        "ODM-101 is a new oral formulation of levodopa/carbidopa/entacapone that contains a higher amount of carbidopa (65 or 105 mg), but no active studies are underway."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27733560": [
        "The most common adverse event was cough; all cough events were mild to moderate, occurred at the time of inhalation, resolved rapidly, and became less frequent after initial dosing.",
        "We present preclinical, phase 1, and phase 2 results for CVT-301.",
        "These results support further development of CVT-301 for better management of PD.",
        "In 18 healthy persons, comparisons between inhaled CVT-301 and oral carbidopa/levodopa showed analogous differences in pharmacokinetics.",
        "For average and best change, the improvements were statistically significant compared to placebo.",
        "Among 24 PD patients inhaling CVT-301 as a single 50-mg dose during an OFF episode, 77% showed an increase in plasma levodopa (&gt;400 ng/ml) within 10 min versus 27% for oral dosing with carbidopa/levodopa at a 25-mg/100-mg dose.",
        "CVT-301 is a powder formulation of levodopa delivered by a breath-actuated inhaler that has been developed for treating OFF episodes (motor fluctuations between doses of standard oral levodopa) in patients with Parkinson's disease (PD).",
        "Improvements in timed finger tapping and overall motor function (Part III of the Unified Parkinson's Disease Rating Scale) were seen 5 and 15 min after administration, the earliest assessment time points.",
        "Inhaled drugs offer advantages, such as rapid onset of action, but require formulations and delivery systems that reproducibly and conveniently administer the drug.",
        "In dogs insufflated with a levodopa powder, plasma levodopa peaked in all animals 2.5 min after administration; in contrast, in dogs dosed orally with levodopa plus carbidopa, plasma levodopa was not detected until 30 min after administration."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27090868": [
        "CVT-301 is a levodopa inhalation powder with the potential for rapid onset of action.",
        "The objective of this study was to evaluate CVT-301 self-administered by PD patients to relieve OFF episodes.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Although levodopa is the most effective oral PD therapy, many patients experience motor fluctuations, including sudden loss of dose effect and delayed benefit."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29547981": [
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28389707": [
        "The attention of pharmaceutical industry rapidly turned to RNAi, as an opportunity to explore new drug targets.",
        "Changes in the chemical structure of synthetic oligonucleotides make them more stable and specific, and new delivery strategies became progressively available.",
        "Although some issues are still matters of concern (delivery, toxicity, cost, and biological barriers), RNAi definitively opens a wide avenue for drug development.",
        "Regarding miRNAs, their content can be down- or up-regulated, by using miRNA inhibitors (AntimiRs) or miRNA mimics.",
        "This review addresses nine small-interfering RNAs (siRNAs) and one unique microRNA (miRNA) inhibitor, which entered the phase 2-3 clinical trials.",
        "Miravirsen is an AntimiR-122 for hepatitis C virus infection.",
        "Ten years after Fire and Melo's Nobel Prize for discovery of gene silencing by double-stranded RNA, a remarkable progress was achieved in RNA interference (RNAi).",
        "The flexibility of RNAi technology is easily understood taking into account: (i) the different drug targets (i.e. p53, caspase 2, PKN3, \u03b22-adrenergic receptor, mutated KRAS, microRNAs); (ii) therapeutic conditions, including ophthalmic diseases, kidney injury, amyloidosis, pancreatic cancer, viral hepatitis; and (iii) routes of administration (ocular, intravenous, subcutaneous, intratumoral).",
        "The siRNAs in focus are PF-04523655, TKM-080301, Atu027, SYL040012, SYL1001, siG12D-LODER (phase 2), QPI-1002, QPI-1007, and patisiran (phase 3)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18634911": [
        "Relevant FABP2 promoter polymorphisms c.-80_-79insT, c.-136_-132delAGTAG, c.-168_-166delAAGinsT, c.-260G&gt;A, c.-471G&gt;A, and c.-778G&gt;T result in two haplotypes A and B. Activation of haplotypes by rosiglitazone stimulated PPARgamma/RXRalpha leads to 2-fold higher activity of haplotype B than A. As shown by chimeric FABP2 promoter constructs, the higher responsiveness of FABP2 haplotype B is mainly but not solely determined by polymorphism c.-471G&gt;A. As shown by EMSA and promoter-reporter assays, Oct-1 interacts with the -471 region of FABP2 promoters, induces the activities of both FABP2 promoter haplotypes and abolishes the different activities of haplotypes induced by rosiglitazone activated PPARgamma/RXRalpha.",
        "In conclusion, our findings suggest a functional role of PPARgamma/RXRalpha and Oct-1 in the regulation of the FABP2 gene.",
        "Variants of the human intestinal fatty acid binding protein 2 gene (FABP2) are associated with traits of the metabolic syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18440731": [
        "In electromobility shift and supershift assays we show the presence of two adjacent HNF-1alpha binding sites within the FABP2 promoter regions -185 to -165 and -169 to -149.",
        "Thus, our data suggest a major role of HNF-1alpha in control of FABP2 expression in intestine via a functional HNF-1alpha recognition element within FABP2 promoter region -185 to -165.",
        "Here we investigate transcriptional regulation of FABP2 by the endodermal hepatic nuclear factor 1 alpha (HNF-1alpha).",
        "Mutational analysis of HNF-1alpha elements resulted in about 50% reduction of basal and HNF-1alpha induced activity of FABP2 promoter constructs, predominantly caused by deletion of the -185 to -165 site.",
        "The human fatty acid binding protein (FABP2) is involved in intestinal absorption and intracellular trafficking of long-chain fatty acids.",
        "HNF-1alpha activates an FABP2 promoter luciferase construct by 3.5 and 20-fold in Caco-2 and Hela cells, respectively."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17960769": [
        "Studies with knockout mice and association analysis of polymorphisms revealed that FABP2 is a susceptibility gene for type 2 diabetes (noninsulin dependent diabetes mellitus [NIDDM]) and related traits.",
        "This provides the molecular basis for the variant specific transcriptional regulation of the diabetes type 2-associated FABP2 gene.",
        "In accordance, in electrophoretic mobility shift assays (EMSAs), transcriptional factors GATA-5 and -6 bind with higher binding affinities to the FABP2 promoter region containing the -80A allele compared to B. As functional consequence, haplotype A is twice as much more activated by GATA factors than haplotype B in liver Huh7 cells.",
        "The human intestinal fatty acid binding protein 2 (FABP2) mediates fat absorption by binding and intracellular trafficking of long-chain free fatty acids.",
        "Additionally, a construct bearing the -80B allele in the background of haplotype A reversed the activity from A to B. Thus, the GATA mediated differential activation of FABP2 haplotypes depends on polymorphism c.-80_-79insT.",
        "Relevant FABP2 promoter polymorphisms c.-80_-79insT (rs5861422), c.-136_-132delAGTAG (rs5861423), c.-168_-166delAAGinsT (rs1973598), c.-260G&gt;A (rs6857641), c.-471G&gt;A (rs2282688), and c.-778G&gt;T (rs10034579) result in two haplotypes A and B, whereby B possesses two- to three-fold lower transcriptional activity than A. We show in luciferase reporter gene assays by a series of chimeric FABP2 promoter constructs in intestinal Caco-2 cells that polymorphism c.-80_-79insT essentially determines different activities of the FABP2 promoter."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20670215": [
        "The GFP-positive cells (i.e. Msi1-positive cells) were sorted by FACS and were hypodermically engrafted into the backs of NOD/SCID (non-obese diabetic/severe combined immunodeficient) mice.",
        "The pMsi1-GFP vector can be used to sort Msi1-positive cells from a cell population derived from mouse embryonic stem cells.",
        "Msi1 (Musashi 1) is regarded as a marker for neural and intestinal epithelial stem cells.",
        "The grafts from the Msi1-negative cells contained more mesodermal-like tissues than those from the Msi1-positive cells.",
        "However, it is still unclear whether Msi1-positive cells derived from mouse embryonic stem cells have the ability to differentiate into neural or intestinal epithelial cells.",
        "The Msi1-positive cells can differentiate into neural and intestinal epithelial-like cells in vivo.",
        "The markers for neural cells (Nestin and Tubulin \u03b2 III) and intestinal epithelial cells [FABP2 (fatty acid binding protein 2), Lyz (lysozyme) and ChA (chromogranin A)] were more highly expressed in the grafts from Msi1-positive cells than those from Msi1-negative cells (P&lt;0.05).",
        "The presence of neural and intestinal epithelial cells in the grafts was detected.",
        "Msi1 was highly expressed in the GFP-positive cells, but not in the GFP-negative cells.",
        "A pMsi1-GFP (green fluorescent protein) reporter plasmid was constructed in order to sort Msi1-positive cells out of the differentiated cell population."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29032508": [
        "Therefore, the current study focused on the development and characterization of buffalo IEC culture, as cattle slaughter is banned in India.",
        "Therefore, future studies are needed to understand the role of FABP2, IP and ZO1 in differentiation of buffalo IEC.",
        "The buffalo jejunum fragments were washed consecutively several times in saline, warm phosphate buffered saline (PBS), PBS with 5 mM dithiothreitol, digesting solution and 2% sorbitol in PBS.",
        "However, 50% of the successful cultures could not show epithelial phenotype on 10% FBS culture conditions even on collagen coated plates.",
        "Interestingly, undifferentiated IEC showed an increasing expression of FABP2, IP and ZO1 transcripts compared to differentiated intestinal cells with 10% FBS on collagen plates.",
        "The cells were differentiated into typical epithelial cobblestone morphology from day 5 onwards in 50% successful cultures.",
        "The cells were cultured on 17 \u00b5g/cm<sup>2</sup> collagen coated plates and transwell plates with serum (2% Fetal bovine serum (FBS) and 10% FBS) and serum-free culture conditions.",
        "Small intestinal epithelial cells (IEC) play a major role in the absorption of nutrients and toxins.",
        "The cultured IEC were characterized by gene expression of epithelial cell markers, cytokeratin and vimentin, and enterocyte markers like villin, zonula occluden (ZO1), fatty acid binding protein 2 (FABP2) and small intestinal peptidase (IP).",
        "Based on the morphology and gene expression profile, 10% FBS has been recommended for culturing primary buffalo IEC on collagen coated plates for 10 days.",
        "Due to the similarity of genome-wide single copy protein orthologues between cattle and human, establishment of ruminant's primary small IEC culture could be a valuable tool for toxicity studies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29574468": [
        "CASE REPORT We illustrate the phenotypic variability of 5 patients with WSS due to the previously reported homozygous single nucleotide deletion c.436delC in the DCAF17 gene, identified in 2008.",
        "Since its original description, approximately 50 cases have been reported with various clinical signs and symptoms.",
        "CONCLUSIONS The phenotypic variability of WSS due to c.436delC founder mutation may have a wider range than previously recognized.",
        "BACKGROUND Woodhouse-Sakati syndrome (WSS) is a rare autosomal recessive genetic condition that was first described in 1983.",
        "Despite identical genetic alteration, our 5 patients had various clinical features among them and compared with previously reported cases with the same pathogenic mutation.",
        "Clinical presentation is variable, and a subset of patients may have additional features, such as premature aging, alopecia, distinctive facial features, cognitive impairment, or deafness.",
        "Characteristics include progressive neurologic deterioration with extrapyramidal involvement and polyendocrinopathy most notable for hypogonadism starting in early adolescence."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30409855": [
        "The disease is caused by biallelic pathogenic variants in the <i>DCAF17</i> gene.",
        "<strong class=\"sub-title\">\n          Background and purpose:\n        </strong>\n      \n      Woodhouse-Sakati syndrome is a rare autosomal recessive disorder characterized by hypogonadism, alopecia, diabetes mellitus, and progressive extrapyramidal signs.",
        "The purpose of this study was to describe the spectrum of brain MR imaging abnormalities in Woodhouse-Sakati syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26612766": [
        "Considerable phenotypic heterogeneity exists in WSS with regard to severity, organs involvement and age of onset, both in inter-familial and intra-familial cases.",
        "Exome sequencing identified a novel single base deletion variant (c.270delA; K90Nfs8*) in third exon of the gene DCAF17 (RefSeq; NM_025000), resulting in a truncated protein.",
        "Sequence variants in the gene DCAF17, encoding nucleolar substrate receptor, were identified as the underlying cause of inherited WSS.",
        "Taken together, the data confirmed the single base pair deletion as the underlying cause of this second report of WSS from Pakistan.",
        "Structural analysis of truncated DCAF17 revealed absence of amino acid residues crucial for interaction with DDB1.",
        "Woodhouse Sakati syndrome (WSS, MIM 241080) is a rare autosomal recessive genetic condition characterized by alopecia, hypogonadism, hearing impairment, diabetes mellitus, learning disabilities and extrapydamidal manifestations.",
        "This signifies the vital yet unexplored role of DCAF17 both in development and maintenance of adult tissues homeostasis.",
        "In this study, the genetic characterization of a consanguineous pedigree showing mild features of WSS was performed, followed by structural analysis of truncated protein."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26664771": [
        "Sequencing of the coding exons and flanking intronic regions of DCAF17 in the proband revealed homozygosity for a previously described founder mutation (c.436delC).",
        "This family illustrates the utility of SNP array testing in consanguineous families to efficiently and inexpensively identify regions of genomic homozygosity in which genetic candidates for recessive conditions can be identified.",
        "DCAF17 mutations are associated with Woodhouse-Sakati syndrome, a rare disorder characterized by alopecia, hypogonadotropic hypogonadism, sensorineural hearing loss, diabetes mellitus, and extrapyramidal movements.",
        "Our patients shared multiple homozygous genomic regions; ten shared regions were &gt;1 Mb in length and constituted 0.99% of the genome.",
        "Both required hormone treatment to produce secondary sex characteristics and pubertal development beyond Tanner 1.",
        "Targeted DCAF17 sequencing of his affected sibling revealed the same homozygous mutation.",
        "DCAF17, encoding a transmembrane nuclear protein of uncertain function, was the only gene identified in a homozygous region known to cause hypogonadotropic hypogonadism.",
        "Two consanguineous Qatari siblings presented for evaluation: a 17-4/12-year-old male with hypogonadotropic hypogonadism, alopecia, intellectual disability, and microcephaly and his 19-year-old sister with primary amenorrhea, alopecia, and normal cognition.",
        "SNP array analysis of both probands was performed to detect shared regions of homozygosity which may harbor homozygous mutations in a gene causing their common features of abnormal pubertal development, alopecia, and variable cognitive delay."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24464444": [
        "WSS was invariably associated with hypogonadism, decreased IGF1 and frontotemporal alopecia starting in childhood.",
        "Phenotypic description of three patients (two females, one male) with WSS followed in the Endocrinology Department of the University Hospital of Nancy, France, and exhaustive review of the literature using the PUBMED database were performed.",
        "In addition to this triad, some patients exhibited intellectual disabilities of varying severity (87 %), bilateral deafness (76 %), cervicofacial dystonia and limb pain (42 % of cases, rising to 89 % after 25 years) and diabetes (66 %, rising to 96 % after 25 years).",
        "The responsible gene, DCAF17 located on chromosome 2q31.1, was discovered in 2008 and to date nine mutations have been reported in the literature.",
        "First described in 1983, Woodhouse-Sakati syndrome (WSS) is a rare autosomal recessive genetic disorder that leads to a spectrum of hypogonadal symptoms in adolescence.",
        "The pathophysiology of WSS remains unclear.",
        "Of 72 patients from 29 families with documented WSS who were identified, 39 had undergone genetic testing.",
        "The aim of the study was to review WSS descriptively in the light of new case reports with focus on endocrine features."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30052912": [
        "Furthermore, the tools are unable to integrate the analysis of shortening/lengthening events with APA site detection.",
        "Moreover, correlation between diseases and the shortening (or lengthening) of 3' UTRs has been reported in the literature.",
        "These tools consider either up to only two APA sites in a gene or only APA sites that occur in the last exon of a gene, although a gene may generally have more than two APA sites and an APA site may sometimes occur before the last exon.",
        "This length is largely determined by the polyadenylation cleavage site in the mRNA.",
        "As alternative polyadenylation (APA) sites are common in mammalian genes, several tools have been published recently for detecting APA sites from RNA-Seq data or performing shortening/lengthening analysis.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      The length of the 3' untranslated region (3' UTR) of an mRNA is essential for many biological activities such as mRNA stability, sub-cellular localization, protein translation, protein binding and translation efficiency."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27446120": [
        "Increasing numbers of poly(A) sites collected in various plant species demand new methods and tools to access and mine these data.",
        "Particularly, through PlantAPA, users can analyze poly(A) sites in extended 3' UTR regions, intergenic regions, and ambiguous regions owing to alternative transcription or RNA processing.",
        "PlantAPA provides various interactive and dynamic graphics and seamlessly integrates a genome browser that can profile heterogeneous cleavage sites and quantify expression patterns of poly(A) sites across different conditions.",
        "As a user-friendly web service, PlantAPA will be a valuable addition to the community of biologists studying APA mechanisms and gene expression regulation in plants.",
        "In addition, it also provides tools for analyzing poly(A) site selections, 3' UTR lengthening or shortening, non-canonical APA site switching, and differential gene expression between conditions, making it more powerful for the study of APA-mediated gene expression regulation.",
        "We have created an open-access web service called PlantAPA (http://bmi.xmu.edu.cn/plantapa) to visualize and analyze genome-wide poly(A) sites in plants.",
        "Alternative polyadenylation (APA) is an important layer of gene regulation that produces mRNAs that have different 3' ends and/or encode diverse protein isoforms.",
        "To date, PlantAPA hosts the largest database of APA sites in plants, including Oryza sativa, Arabidopsis thaliana, Medicago truncatula, and Chlamydomonas reinhardtii.",
        "Up to 70% of annotated genes in plants undergo APA.",
        "More importantly, PlantAPA offers a bioinformatics pipeline that allows users to upload their own short reads or ESTs for poly(A) site extraction, enabling users to further explore poly(A) site selection using stored PlantAPA poly(A) sites together with their own poly(A) site datasets."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29733382": [
        "Taken together, we present IntMAP as a new bioinformatics algorithm for APA analysis by which we expand our understanding of the physiological role of mTOR-coordinated APA events to ER stress response.",
        "The prevention of APA in Cebpg using the CRISPR/cas9-mediated genome editing tool showed that mTOR-driven 3'-UTR shortening in Cebpg is critical in protecting cells from endoplasmic reticulum (ER) stress.",
        "Here, we developed a novel bioinformatics algorithm, IntMAP, which integrates RNA-Seq and PolyA Site (PAS)-Seq data for a comprehensive characterization of APA events.",
        "Several transcription factors including Cebpg (CCAAT/enhancer binding protein gamma) were among the newly discovered APA transcripts, indicating that diverse transcriptional networks may be regulated by mTOR-coordinated APA.",
        "By applying IntMAP to the datasets from cells with hyper-activated mTOR, we identified novel APA events that could otherwise not be identified by either profiling method alone.",
        "In our recent RNA-seq experiments using cells with hyper-activated mammalian target of rapamycin (mTOR), we found that cellular mTOR activation leads to transcriptome-wide alternative polyadenylation (APA), resulting in the activation of multiple cellular pathways.",
        "3'-untranslated regions (UTRs) can vary through the use of alternative polyadenylation sites during pre-mRNA processing.",
        "IntMAP toolbox is available at http://compbio.cs.umn.edu/IntMAP/.",
        "Multiple publically available pipelines combining high profiling technologies and bioinformatics tools have been developed to catalog changes in 3'-UTR lengths."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25506822": [
        "VAAPA will be a valuable addition to the community for the comprehensive study of APA, not only by making the high quality poly(A) site data more accessible, but also by providing users with numerous valuable functions for poly(A) site analysis and visualization.",
        "This platform can visualize the distribution of poly(A) sites and poly(A) clusters of a gene or a section of a chromosome.",
        "Here, a web platform for visualization and analysis of alternative polyadenylation (VAAPA) was developed.",
        "It can also highlight genes with switched APA sites among different conditions.",
        "Alternative polyadenylation (APA) as an important layer of gene expression regulation has been increasingly recognized in various species.",
        "VAAPA is an easy-to-use web-based tool that provides functions of poly(A) site query, data uploading, downloading, and APA sites visualization.",
        "Polyadenylation [poly(A)] is an essential process during the maturation of most mRNAs in eukaryotes.",
        "It was designed in a multi-tier architecture and developed based on Smart GWT (Google Web Toolkit) using Java as the development language."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30251172": [
        "Patisiran has been developed by Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR) in adults and subsequently approved in the EU for the treatment of hATTR in adults with stage 1 or 2 polyneuropathy.",
        "The recommended dosage, administered as a single intravenous infusion over approximately 80 min, is 0.3 mg/kg once every 3 weeks for patients weighing &lt; 100 kg and 30 mg once every 3 weeks for patients weighing \u2265 100 kg.",
        "This article summarizes the milestones in the development of patisiran leading to these approvals.",
        "Patisiran (ONPATTRO\u2122) is a double-stranded small interfering RNA encapsulated in a lipid nanoparticle for delivery to hepatocytes.",
        "By specifically binding to a genetically conserved sequence in the 3' untranslated region of mutant and wild-type transthyretin (TTR) messenger RNA, patisiran causes its degradation (via RNA interference) and subsequently a reduction in serum TTR protein levels and tissue TTR protein deposits."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29355908": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Epilepsy is a common neurologic disorder, affecting approximately 50 million people worldwide; nearly a third of these people have epilepsy that is not well controlled by a single antiepileptic drug (AED) and they usually require treatment with a combination of two or more AEDs.",
        "This is an update of a Cochrane review first published in 2012 (Cochrane Database of Systematic Reviews 2012, Issue 6) and updated in 2015.",
        "In recent years, many newer AEDs have been investigated as add-on therapy for focal epilepsy; losigamone is one of these drugs and is the focus of this systematic review."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26661741": [
        "This is an update of a Cochrane review first published in 2012 (Cochrane Database of Systematic Reviews 2012, Issue 6).",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Epilepsy is a common neurologic disorder, affecting approximately 50 million people worldwide; nearly a third of these people are not well controlled by a single antiepileptic drug (AED) and usually require treatment with a combination of two or more AEDs.",
        "In recent years, many newer AEDs have been investigated as add-on therapy for partial epilepsy; losigamone is one of these drugs and is the focus of this systematic review."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23683707": [
        "GABAAR efficacy is also affected by the transmembrane chloride gradient, which changes during development and in chronic epilepsy.",
        "For topiramate, felbamate, retigabine, losigamone and stiripentol, GABAAR modulation is one of several possible antiseizure mechanisms.",
        "For the benzodiazepines, barbiturates, and loreclezole, actions at the GABAAR are the primary or only known mechanism of antiseizure action.",
        "A variety of agents that act at GABAARs s are used to terminate or prevent seizures.",
        "Other agents modulate GABAergic \"tone\" by regulating the synthesis, transport or breakdown of GABA.",
        "This may provide an additional target for \"GABAergic\" ASDs.",
        "GABAAR subunit changes occur both acutely during status epilepticus and in chronic epilepsy, which alter both intrinsic GABAAR function and the response to GABAAR-acting ASDs.",
        "Many act at distinct receptor sites determined by the subunit composition of the holoreceptor.",
        "The GABAA receptor (GABAAR) is a major target of antiseizure drugs (ASDs).",
        "Manipulation of subunit expression patterns or novel ASDs targeting the altered receptors may provide a novel approach for seizure prevention.",
        "Allopregnanolone, a progesterone metabolite that enhances GABAAR function, led to the development of ganaxolone."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22696384": [
        "In recent years, many newer antiepileptic drugs have been investigated as add-on therapy for partial epilepsy; losigamone is one of these drugs and is the focus of this systematic review.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Epilepsy is a common neurologic disorder, affecting approximately 50 million people worldwide; nearly a third of these people are not well controlled by a single antiepileptic drug and usually require treatment with a combination of two or more antiepileptic drugs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21549021": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      About 3% of people will be diagnosed with epilepsy during their lifetime, but about 70% of people with epilepsy eventually go into remission."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21429248": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      About 3% of people will be diagnosed with epilepsy during their lifetime, but about 70% of people with epilepsy eventually go into remission."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15638775": [
        "We also briefly discuss the urgent need for new drugs in this arena and the potential of combinatorial methods and recombinant screening to identify leads.",
        "Epilepsy is one of the most prevalent neurological syndromes in the world today.",
        "In this review we focus on elements that are crucial to determining the intrinsic excitability of neurons in the CNS, the voltage gated ion channels (VGICs).",
        "Many drugs routinely used in the clinical setting, as well as several novel experimental drugs, have shown interactions with VGICs that underpin, at least in part, their anticonvulsant action.",
        "We review the physiological roles of voltage gated ion channels that are selective for sodium, potassium and calcium conductance and attempt to highlight their role in the pathology of epilepsy.",
        "The excitability of neurons is governed by the input they receive from their neighbours and the intrinsic excitability of the neuron.",
        "VGICs as well as being important for physiological function are critical in producing hyperexcitability such as that associated with seizure discharges.",
        "Seizures result from the abnormal discharge of groups of neurons within the brain, usually within a focal point, that can result in the recruitment of large brain regions into epileptiform activity.",
        "This is supplemented by the mechanisms of drug action at these important anticonvulsant targets for classical and clinically relevant compounds (e.g. phenytoin, ethosuximide) as well as some important second generation drugs (e.g. gabapentin, levetiracetam) and novel experimental agents (e.g. retigabine, losigamone, safinamide).",
        "Although the range of explanations for the development of seizures can be as varied as genetic composition to acute head trauma, the net result is often similar.",
        "Epilepsy describes a group of brain disorders whose symptoms and causes are diverse and complicated, but all share a common behavioural manifestation: the seizure."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15112861": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      The influence of the new antiepileptic drug losigamone (CAS 112856-44-7/123783-52-8) on the pharmacokinetics of a combined oral contraceptive containing ethinylestradiol (CAS 57-63-6) and levonorgestrel (CAS 797-63-7) was investigated in 16 healthy women."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12972172": [
        "Adverse events during treatment were reported by 58.8% of the patients for placebo, by 62.1% for LSG 1200 mg/day and by 76.1% for LSG 1500 mg/day.",
        "Based on the study's results, LSG is an effective and safe add-on drug for refractory partial epilepsy in adults.",
        "In the intention-to-treat population of 264 patients, the relative median reduction of partial seizure frequency was 3.3% for placebo, 19.7% for LSG 1200 mg/day, and 25.3% for LSG 1500 mg/day.",
        "The objective of the study was to investigate the efficacy and safety of two different dosages of Losigamone (LSG) in add-on treatment of partial seizures.",
        "In a multi-center, double-blind, randomized clinical trial, patients received one of three 12-week treatments: placebo, LSG 1200 mg/day, or 1500 mg/day, in addition to up to three standard anticonvulsants after a prospective period of 12 weeks to assess baseline seizure frequency.",
        "In the responder analysis, 11.8% of the patients in the placebo group, 17.2% in the LSG 1200 mg/day group, and 29.3% in the LSG 1500 mg/day group showed a seizure reduction versus baseline of at least 50%.",
        "Most events in the LSG groups occurred during the first 4 weeks of double-blind (during or immediately after up-titration) and subsided quickly.",
        "Over the last 4 weeks of treatment, the incidence of adverse events in the LSG groups was close to the placebo level.",
        "The differences of both LSG groups versus placebo were significant (P&lt;0.01, two-tailed).",
        "The primary efficacy measure was the relative reduction of seizure frequency per 4 weeks in the double-blind phase as compared to baseline.",
        "A positive association between dosage and response was observed (P=0.003)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20650103": [
        "The results show distinct, concentration-dependent patterns of biochemical changes for the different drugs.",
        "Phenytoin, carbamazepine, losigamone and diazepam greatly reduced GAD, ChAT and AChE activities, indicating a relatively high neuron-specific toxic potential.",
        "Five drugs (carbamazepine, diazepam, phenobarbital, phenytoin and valproate), currently used in the treatment of epileptic patients, were tested together with losigamone, a recently developed anticonvulsant.",
        "Phenobarbital and valproate slightly but significantly increased the activities of several enzymes.",
        "The patterns of concentration-dependent effects observed in this three-dimensional cell culture system are in good agreement with the presumed neurotoxic and/or teratogenic potential of these drugs.",
        "Diazepam produced a more general pattern of toxicity and, in contrast to the anticonvulsants, showed higher toxicity in less-differentiated cultures.",
        "As an extension of a previous validation study, the concentration-dependent effects of a series of anticonvulsant drugs were examined in aggregating cell cultures of foetal rat telencephalon.",
        "Cultures were treated either at an early (day 5 to day 14) or at an advanced (day 20 to day 28) developmental stage, and assayed for changes in the activities of the cell type-specific enzymes choline acetyltransferase (ChAT), acetylcholinesterase (AChE), glutamic acid decarboxylase (GAD), glutamine synthetase (GS) and 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNP)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9421300": [
        "Losigamone is a novel anticonvulsant the mechanism of action of which is not known.",
        "2.",
        "5.",
        "NMDA antagonism and inhibition of excitatory amino acid release may contribute to the anticonvulsant effect of losigamone.",
        "Cortical wedges exhibit spontaneous depolarizations in magnesium-free medium and losigamone was effective in significantly reducing these spontaneous depolarizations at concentrations of 100 microM and above.",
        "Veratridine (20 microM) and potassium (60 mM) were used to stimulate the release of amino acids from mouse cortex.",
        "NMDA-induced depolarizations were significantly reduced by losigamone at concentrations of 25 microM and above.",
        "Losigamone had no effect on AMPA-induced depolarizations.",
        "This study investigated the effect of losigamone on spontaneous, NMDA- and AMPA-induced depolarizations in the cortical wedge preparation of the DBA/2 mouse (which are susceptible to sound-induced seizures) and on endogenous amino acid release from BALB/c mouse cortical slices.",
        "1.",
        "3.",
        "4.",
        "Veratridine-stimulated release of glutamate was significantly reduced by losigamone at concentrations of 100 microM and above, while potassium-stimulated release was significantly reduced by losigamone at 200 microM."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/14704462": [
        "Toxicity studies do not indicate any teratogenic risk of the drug, at least in animals.",
        "Losigamone is a new antiepileptic drug with an unknown mechanism of action.",
        "In vitro, losigamone exerts anticonvulsant activity in the picrotoxin model in CA1 and CA3 hippocampal areas, the low Ca(2+) model in CA1 area and the low Mg(2+) model in the entorhinal cortex and hippocampus.",
        "Potency of losigamone varies with the respective seizure test, animal species used in experiments and route of drug administration.",
        "The drug is eliminated by oxidation.",
        "The experimental data can be helpful for predicting effective drug combinations in patients with refractory epilepsy.",
        "These patients require more than one antiepileptic drug.",
        "Cytochrome CYP2A6 appears to be the main isoenzyme responsible for the metabolism of losigamone.",
        "The enantiomer AO-242 seems to be more potent than AO-294 or racemate.",
        "In vivo, the drug exhibits significant efficacy against maximal electroshock-induced seizures in rodents and pentetrazole-induced clonic convulsions in mice.",
        "In clinical trial, losigamone proved to have satisfactory effectiveness and good tolerance in the treatment of partial and secondary generalized seizures.",
        "Patients with drug resistant epilepsy represent about 40% of the whole population of epileptic patients.",
        "In animal models of epilepsy, it is possible to determine which combinations produce supra-additive anticonvulsive effects with minimal or even no adverse reactions.",
        "The drug belongs to the group of beta-methoxy-butenolides, and exists as a racemic mixture of two enantiomers (AO-242 and AO-294)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29069466": [
        "10 model organisms are currently represented: Homo sapiens, Mus musculus, Danio rerio, Drosophila melanogaster, Apis mellifera, Caenorhabditis elegans, Arabidopsis thaliana, Zea mays, Saccharomyces cerevisiae and Schizosaccharomyces pombe.",
        "As of today, the resource contains over 24 000 samples.",
        "In conjunction with other tools developed by our group (the ChIP-Seq and SSA servers), it allows users to carry out a great variety of analysis task with MGA samples, such as making aggregation plots and heat maps for selected genomic regions, finding peak regions, generating custom tracks for visualizing genomic features in a UCSC genome browser window, or downloading chromatin data in a table format suitable for local processing with more advanced statistical analysis software such as R. Home page: http://ccg.vital-it.ch/mga/.",
        "Each sample has undergone local processing in order the meet the strict MGA format requirements.",
        "The original data source, the reformatting procedure and the biological characteristics of the samples are described in an accompanying documentation file manually edited by data curators.",
        "The Mass Genome Annotation (MGA) repository is a resource designed to store published next generation sequencing data and other genome annotation data (such as gene start sites, SNPs, etc.) in a completely standardised format."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27789702": [
        "To overcome this challenge, we built the Cistrome database, a collection of ChIP-seq and chromatin accessibility data (DNase-seq and ATAC-seq) published before January 1, 2016, including 13 366 human and 9953 mouse samples.",
        "Although rapidly accumulating publicly available ChIP-seq, DNase-seq and ATAC-seq data are a valuable resource for the systematic investigation of gene regulation processes, a lack of standardized curation, quality control and analysis procedures have hindered extensive reuse of these data.",
        "All the data have been carefully curated and processed with a streamlined analysis pipeline and evaluated with comprehensive quality control metrics.",
        "Chromatin immunoprecipitation, DNase I hypersensitivity and transposase-accessibility assays combined with high-throughput sequencing enable the genome-wide study of chromatin dynamics, transcription factor binding and gene regulation.",
        "The resulting Cistrome DB (Cistrome Data Browser), available online at http://cistrome.org/db, is expected to become a valuable resource for transcriptional and epigenetic regulation studies.",
        "We have also created a user-friendly web server for data query, exploration and visualization."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24253304": [
        "Within this database, we collected all publicly available ChIP-Seq data on CRs in human and mouse and categorized the data into four cohorts: the reader, writer, eraser and remodeler cohorts, together with curated introductions and ChIP-Seq data analysis results.",
        "However, no specific resource for the integration of CR ChIP-Seq data or CR-HM ChIP-Seq linkage pairs is currently available.",
        "Chromatin regulators (CRs), which are indispensable in epigenetics, can mediate HMs to adjust chromatin structures and functions.",
        "Diversified histone modifications (HMs) are essential epigenetic features.",
        "For the HM readers, writers and erasers, we provided further ChIP-Seq analysis data for the targeted HMs and schematized the relationships between them.",
        "Therefore, we constructed the CR Cistrome database, available online at http://compbio.tongji.edu.cn/cr and http://cistrome.org/cr/, to further elucidate CR functions and CR-HM linkages.",
        "With the development of ChIP-Seq technology, there is an opportunity to study CR and HM profiles at the whole-genome scale.",
        "They play important roles in fundamental biological processes including transcription, DNA repair and DNA replication.",
        "We believe CR Cistrome is a valuable resource for the epigenetics community."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24174536": [
        "GeneProf Data (http://www.geneprof.org) is an open web resource for analysed functional genomics experiments.",
        "We have built up a large collection of completely processed RNA-seq and ChIP-seq studies by carefully and transparently reanalysing and annotating high-profile public data sets.",
        "GeneProf makes these data instantly accessible in an easily interpretable, searchable and reusable manner and thus opens up the path to the advantages and insights gained from genome-scale experiments to a broader scientific audience.",
        "Moreover, GeneProf supports programmatic access to these data via web services to further facilitate the reuse of experimental data across tools and laboratories."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29254998": [
        "We discuss strategies and challenges associated with characterizing catalytic and noncatalytic outputs in cells, and describe successes and new frontiers that will support more comprehensive cancer-targeting and therapeutic evaluation in the future. <i>Cancer Res; 78(1); 15-29. \u00a92017 AACR</i>.",
        "While a major research focus of the last 30 years has been cancer-associated Tyr and Ser/Thr kinases, over 85% of the kinome has been identified to be dysregulated in at least one disease or developmental disorder.",
        "The human protein kinome comprises 535 proteins that, with the exception of approximately 50 pseudokinases, control intracellular signaling networks by catalyzing the phosphorylation of multiple protein substrates.",
        "Despite this remarkable statistic, for the majority of protein kinases and pseudokinases, there are currently no inhibitors progressing toward the clinic, and in most cases, details of their physiologic and pathologic mechanisms remain at least partially obscure.",
        "By curating and annotating data from the literature and major public databases of phosphorylation sites, kinases, and disease associations, we generate an unbiased resource that highlights areas of unmet need within the kinome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28736830": [
        "PCSK9 mAbs, administered once or twice monthly, reduce LDL cholesterol levels by 50% to 70%, and appear to be safe and acceptable to patients over at least 2 years of treatment; however, treatment-emergent adverse effects are not always identified in clinical trials, as well-evidenced by statin myopathy.",
        "PCSK9 mAbs are already in limited clinical use and are the subject of major cardiovascular outcomes trials, which, if universally positive, could see much wider clinical application of these agents.",
        "Patients with familial hypercholesterolaemia are the most obvious candidates for these drugs, but other patients with elevated cardiovascular risk, statin intolerance or hyperlipoproteinaemia(a) may also benefit.",
        "The cost-effectiveness and long-term safety of therapies targeted at inhibiting PCSK9 remain to be demonstrated if they are to be used widely in coronary prevention.",
        "The identification of the critical role of proprotein convertase subtilisin/kexin type 9 (PCSK9) has rapidly led to the development of PCSK9 inhibition with monoclonal antibodies (mAbs).",
        "Inclisiran is a promising RNA-based therapy that promotes the degradation of PCSK9 mRNA transcripts and has similar efficacy to mAbs, but with a much longer duration of action."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29424317": [
        "Nevertheless, residual CV risk and unmet goals in hypolipidaemic treatment make novel options necessary.",
        "Thus, many novel hypolipidaemic drugs targeting different aspects of lipid metabolism are being investigated, although they need to be assessed in large trials to prove their CV benefit and safety.",
        "Among others, gene therapy substituting the loss of essential enzymes is already used for Lipoprotein Lipase (LPL) deficiency in autosomal chylomicronaemia and is expected to eliminate the lack of Low- Density Lipoprotein (LDL) receptors in patients with homozygous familial hypercholesterolaemia.",
        "Recently marketed monoclonal antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9) have shown the way towards innovation, while other ways of PCSK9 inhibition like small interfering RNA (Inclisiran) are already being tested.",
        "Over the last 3 decades, hypolipidaemic treatment has significantly reduced both Cardiovascular (CV) risk and events, with statins being the cornerstone of this achievement.",
        "Additionally, other novel hypolipidaemic drugs are in early phase clinical trials, such as the inhibitors of apolipoprotein C-III, which is located on triglyceride (TG)-rich lipoproteins, or the inhibitors of angiopoietin-like 3 (ANGPTL3), which plays a key role in lipid metabolism, aiming to beneficial effects on TG levels and glucose metabolism.",
        "Experimental data of High-Density Lipoprotein (HDL) mimetics infusion therapy have shown a beneficial effect on atherosclerotic plaques.",
        "Other effective and well tolerated drugs affect known paths of lipid synthesis and metabolism, such as bempedoic acid blocking acetyl-coenzyme A synthesis at a different level than statins, pemafibrate selectively acting on peroxisome proliferator-activated receptor (PPAR)- alpha receptors and oligonucleotides against apolipoprotein (a)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29451410": [
        "Inclisiran targets intracellular PCSK9 synthesis specifically, resulting in a dose-dependent, long-term, significant reduction in LDL-C. Inclisiran has been well tolerated and safe, without severe adverse events so far.",
        "Expert opinion: Plasma PCSK9 enhances the degradation of LDL receptor, resulting in accumulation of LDL-C in the circulation.",
        "Inclisiran inhibits translation of PCSK9 mRNA and thus switches off PCSK9 production and provides advantages over monoclonal antibodies with an infrequent dosing interval of twice a year to reduce LDL-C by over 50%.",
        "Dyslipidemia is one of the most important risk factors for cardiovascular disease.",
        "Insufficient reduction in LDL-C from existing therapies in patients at high risk of atherogenic cardiovascular disease is an unmet clinical need.",
        "Current approaches with monoclonal antibodies sequester circulating PCSK9 but require frequent injections.",
        "Ongoing studies will establish the long-term safety of inclisiran in patients with high cardiovascular risk and an elevated LDL-C.",
        "This review discusses current PCSK9 inhibitors and the results of phase I and II clinical trials of inclisiran.",
        "Circulating PCSK9 causes hypercholesterolemia by reducing LDL receptors in hepatocytes.",
        "Areas covered: PCSK9 inhibition has emerged as a promising new therapeutic strategy to reduce LDL-C. Inclisiran, a novel, synthetic, siRNA molecule, inhibits PCSK9 synthesis in hepatocytes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29516321": [
        "Inclisiran was evaluated in large clinical trials but did not receive government approval.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      To our knowledge, inclisiran was the first agent composed of small interfering RNAs (siRNAs) to be preliminarily used to reduce proatherogenic lipoprotein cholesterol levels.",
        "The ability of inclisiran to reduce low-density lipoprotein cholesterol (LDL-C) greatly improved its chances of becoming a novel therapeutic option for patients with hyperlipidemia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29735484": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The ORION-1 trial (Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol [LDL-C]) demonstrated that inclisiran, an siRNA therapeutic that targets protease proprotein convertase subtilisin/kexin type 9 mRNA within hepatocytes, produces significant low-density lipoprotein cholesterol reduction.",
        "The effects of inclisiran on other lipids are less well described."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29850255": [
        "After thorough literature search in the PubMed, Embase, Scopus, and Google Scholar, we present this article to provide a brief overview of the safety and efficacy of lowering LDL below the current goal.",
        "Moreover, various studies aiming to lower the CV risk and mortality by lowering LDL levels have demonstrated encouraging results.",
        "The development of inclisiran, siRNA silencer targeting PCSK9 gene, is a one step forward in these endeavors.",
        "The risk of cardiovascular disease has been reported to have a linear relationship with LDL levels.",
        "Previous attempts to maximally lower the LDL levels with statin monotherapy have met dejection due to the increased side effects associated with the treatment.",
        "Additionally, the currently recommended LDL target goal of 70 mg/dl does not diminish the CV risk entirely leaving behind some residual risk.",
        "Nevertheless, with the new advancements in clinical medicine, it has now become possible to bring down the LDL levels to as low as 15 mg/dl using PCSK9 monoclonal antibodies alone or in combination with statins.",
        "The current challenge is to explore this arena to redefine the target LDL levels, if required, to avoid any suboptimal treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30011788": [
        "Initially, the therapeutic approaches to reduce circulating levels of PCSK9 were focused on the use of monoclonal antibodies.",
        "The discovery of proprotein convertase subtilisin-kexin type 9 (PCSK9), a serine protease which binds to the low-density lipoprotein (LDL) receptors and targets the receptors for lysosomal degradation, offered an additional route through which plasma LDL-cholesterol (LDL-C) levels can be controlled.",
        "This review aims to present and discuss the current clinical and scientific evidence pertaining to inclisiran, which is a new promising agent in the management of hypercholesterolemia.",
        "The small interfering RNA (siRNA) molecules have been used recently to target the hepatic production of PCSK9. siRNA interferes with the expression of specific genes with complementary nucleotide sequences by affecting the degradation of mRNA post-transcription, thus preventing translation.",
        "To that effect, evolocumab and alirocumab, two human monoclonal antibodies directed against PCSK9, given on a background of statin therapy, have been shown to markedly decrease LDL-C levels and significantly reduce cardiovascular risk.",
        "Inclisiran is a long-acting, synthetic siRNA directed against PCSK9 and it has been shown to significantly decrease hepatic production of PCSK9 and cause a marked reduction in LDL-C levels."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30375244": [
        "Phase I and II data show that inclisiran lowers low-density lipoprotein cholesterol levels on average by &gt;50% with a duration of effect that enables twice-yearly dosing.",
        "In addition, the ORION-4 trial will assess the impact of inclisiran on cardiovascular outcomes in approximately 15,000 ASCVD subjects.",
        "The ongoing ORION program includes Phase III trials that will provide robust evidence of inclisiran's safety and efficacy in individuals at high risk of atherosclerotic cardiovascular disease (ASCVD), including established ASCVD and familial hypercholesterolemia.",
        "Inclisiran is a novel drug that inhibits PCSK9 synthesis specifically in the liver, harnessing the natural mechanism of RNAi.",
        "Phases I, II and emerging Phase III data support inclisiran's safety, tolerability and risk-benefit profile."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27959715": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Inclisiran (ALN-PCSsc) is a long-acting RNA interference (RNAi) therapeutic agent that inhibits the synthesis of proprotein convertase subtilisin-kexin type 9 (PCSK9), a target for the lowering of low-density lipoprotein (LDL) cholesterol."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30487231": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To evaluate the efficacy and safety of inclisiran by diabetes status."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28306389": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      In a previous study, a single injection of inclisiran, a chemically synthesized small interfering RNA designed to target PCSK9 messenger RNA, was found to produce sustained reductions in low-density lipoprotein (LDL) cholesterol levels over the course of 84 days in healthy volunteers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29335563": [
        "We present the Protein Contacts Atlas, an interactive resource of non-covalent contacts from over 100,000 PDB crystal structures.",
        "In contrast, non-covalent contacts between atoms, which govern normal physiology, pathogenesis, and drug action, are seldom visualized.",
        "The Protein Contacts Atlas is available at http://www.mrc-lmb.cam.ac.uk/pca/ and also through PDBe.",
        "Typical visualizations (such as ball and stick) primarily depict covalent bonds.",
        "The Protein Contacts Atlas enables researchers from different disciplines to investigate diverse questions in the framework of non-covalent contacts, including the interpretation of allostery, disease mutations and polymorphisms, by exploring individual subunits, interfaces, and protein-ligand contacts and by mapping external information.",
        "Visualizations of biomolecular structures empower us to gain insights into biological functions, generate testable hypotheses, and communicate biological concepts.",
        "We developed multiple representations for visualization and analysis of non-covalent contacts at different scales of organization: atoms, residues, secondary structure, subunits, and entire complexes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28087644": [
        "On December 22, 2014, the FDA granted accelerated approval to nivolumab (OPDIVO; Bristol-Myers Squibb) for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor.",
        "Approval was based on a clinically meaningful, durable objective response rate (ORR) in a non-comparative analysis of 120 patients who received 3 mg/kg of nivolumab intravenously every 2 weeks with at least 6-month follow-up in an ongoing, randomized, open-label, active-controlled clinical trial.",
        "In 13 patients, the response duration was 6 months or longer.",
        "The risks of nivolumab, including clinically significant immune-mediated adverse reactions (imARs), were assessed in 268 patients who received at least one dose of nivolumab.",
        "The FDA review considered whether the ORR and durations of responses were reasonably likely to predict clinical benefit, the adequacy of the safety database, and systematic approaches to the identification, description, and patient management for imARs in product labeling. <i>Clin Cancer Res; 23(14); 3484-8. \u00a92017 AACR</i>.",
        "Ongoing responses were observed in 87% of responding patients, ranging from 2.6+ to 10+ months.",
        "The ORR as assessed by a blinded independent review committee per RECIST v1.1 was 31.7% (95% confidence interval, 23.5-40.8)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29136946": [
        "The AD was induced in animals by intracerebroventricular injection of STZ (icv-STZ) unilaterally.",
        "Alzheimer disease (AD) is a progressive dementia affecting a large proportion of the aging population.",
        "Animals were treated with the Hst and nano-Hst (10, 20 mg/kg body weight), then after three successive weeks, recognition memory was examined (passive avoidance test and novel object recognition test) and antioxidant parameters were evaluated.",
        "Hesperetin (Hst) is a natural flavonoid, which has been reported to exert various biological activities such as antioxidant and anti-inflammatory effect.",
        "There is evidence that brain tissue in patients with AD is exposed to oxidative stress during the course of the disease.",
        "The present study aimed to investigate the effects of hesperetin and nano-hesperetin on neurobehavioral activity and superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GRx) and catalase (CAT) enzymes activity, malondialdehyde (MDA) and glutathione (GSH) levels in hippocampal area of rats in an experimental model of AD.",
        "These results suggested that Hst and nano-Hst may inhibit STZ-induced oxidative stress, and that it may possess therapeutic potential for the treatment of AD.",
        "Furthermore the Hst and nano-Hst increased the activity of antioxidant enzymes (SOD, glutathione GPx, GRx and CAT) and GSH levels and decreased MDA in the hippocampal area.",
        "In our study behavioral testes showed improvement on memory retrieval and recognition memory consolidation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30352242": [
        "The purpose of this study was to explore the influence of hesperidin on depression-related symptoms in a mouse model of mTBI, and that what mechanisms are primarily involved in the antidepressant effects of this bioflavonoid.",
        "<strong class=\"sub-title\">\n          Aims:\n        </strong>\n      \n      There is increasing evidence showing that mild traumatic brain injury (mTBI) is associated with increased depression-related disorders in humans.",
        "However, the exact mechanisms by which hesperidin indicates its neuroprotective effects are not fully understood.",
        "Recent studies suggest that dietary intake or supplementation of natural flavonoids like hesperidin can be used for therapy of patients with brain injury and depression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30448580": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      We examined the protective effects of hesperidin on cerebral vasospasm by establishing an experimental rat model of subarachnoid hemorrhage and performing biochemical, pathologic, and histomorphometric analysis on these data."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28761134": [
        "Thus, we found that hesperidin suppressed a number of cytotoxic factors associated with NMDA-induced cell death signaling, such as oxidative stress, over-activation of calpain, and inflammation, thereby protecting the RGCs in mice.",
        "Therefore, hesperidin may have potential as a therapeutic supplement for protecting the retina against the damage associated with excitotoxic injury, such as occurs in glaucoma and diabetic retinopathy.",
        "Finally, hesperidin treatment improved electrophysiological function, measured with visual evoked potential, and visual function, measured with optomotry.",
        "We found that hesperidin, a plant-derived bioflavonoid, may be a candidate agent for neuroprotective treatment in the retina, after screening 41 materials for anti-oxidative properties in a primary retinal cell culture under oxidative stress.",
        "We found that the intravitreal injection of hesperidin in mice prevented reductions in markers of the retinal ganglion cells (RGCs) and RGC death after N-methyl-D-aspartate (NMDA)-induced excitotoxicity.",
        "Hesperidin treatment also reduced calpain activation, reactive oxygen species generation and TNF-\u03b1 gene expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22850463": [
        "Immunohistochemical staining of cortices, striata and hippocampi showed patches of iNOS positive cells.",
        "Electron microscopic ultrastructural examination showed marked mitochondrial swelling, perivascular edema and shrunken nerve cells.",
        "The implications of nitric oxide in a variety of neurodegenerative diseases attract attention to study the possible role of flavonoids in interaction with nitric oxide pathways involved in HD.",
        "Pretreatment with hesperidin (100 mg/kg) ahead of 3-NP prevented any changes of locomotor activity or PPI response, slightly increased cortical, striatal and hippocampal MDA levels by 10% and reduced respective catalase activity by 22%, 20% and 5%.",
        "Only few iNOS positive cells were detected in sections from rats pretreated with hesperidin which also reduced cellular abnormalities induced by 3-NP.",
        "This study suggests a potential neuroprotective role of hesperidin against 3-NP-induced Huntington's disease-like manifestations.",
        "Systemic administration of 3-NP to rats for 5 days (20 mg/kg) caused reduction of locomotor activity by days 2 and 5, 55% deficit of PPI response, elevation of cortical, striatal and hippocampal malondialdehyde (MDA) levels by 63%, 41% and 56%, reduction of respective catalase activity by 50%.",
        "Such neuroprotection can be referred to its antioxidant and anti-inflammatory activities.",
        "The present study investigates the potential effect of hesperidin, a flavanone group member, on 3-NP-induced behavioral, neurochemical, histopathological and cellular changes.",
        "The mitochondrial toxin 3-nitropropionic acid (3-NP) effectively induces specific behavioral changes, primarily manifested as prepulse inhibition (PPI) deficit of acoustic startle stimuli, and selective striatal lesions in rats and primates mimicking those in HD.",
        "Huntington's disease (HD) is a progressive neurodegenerative disorder with a spectrum of cognitive, behavioral, and motor abnormalities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24987179": [
        "<strong class=\"sub-title\">\n          Aim:\n        </strong>\n      \n      Epilepsy is a chronic neurological disorder with complex pathophysiology.",
        "Thus, this study was undertaken to evaluate the possible neuroprotective mechanism of Hesp against pentylenetetrazole (PTZ)-induced convulsions in mice.",
        "Several evidences suggest a role of oxidative stress and mitochondrial dysfunction in pathophysiology of epilepsy.",
        "Hesperidin (Hesp) acts as a powerful anti-oxidant agent against superoxide, singlet oxygen, and hydroxyl radicals."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29687202": [
        "Hesperidin, a flavanoglycone abundantly present in citrus fruits, is reported to have antioxidant, anti-inflammatory, and neuroprotective properties.",
        "Our results imply that treatment with hesperidin might be a potent option for treating the symptoms of cognitive impairment in Alzheimer's disease by targeting its most prominent hallmarks.",
        "Previous reports from our laboratory indicated the neuroprotective effect of hesperidin against aluminum chloride (AlCl<sub>3</sub>)-induced memory loss, acetylcholine esterase hyperactivity, oxidative stress, and enhanced expression of amyloid \u03b2 protein biosynthesis-related markers.",
        "However, their role on AlCl<sub>3</sub>-induced inflammation, caspase activation, Tau pathology, altered Akt/GSK 3\u03b2 signaling pathway, and A\u03b2 clearance marker has not yet been fully elucidated.",
        "Intraperitonial injection of AlCl<sub>3</sub> (100 mg/kg body weight) for 60 days significantly elevated the expressions of insulin-degrading enzyme (IDE), cyclin-dependent kinase 5 (CDK 5), and phosphoTau (pTau); inflammatory markers such as glial fibrillary acidic protein (GFAP), ionized calcium-binding adapter molecule 1 (Iba-1), NF-kB, cyclooxygenase-2 (COX-2), interleukin (IL)-1\u03b2, IL-4, IL-6, tumor necrosis factor-alpha (TNF-\u03b1), inducible nitric oxide synthase (iNOS); and apoptotic markers including cytosolic cytochrome c (cyto c), caspase-3, caspase-8, and caspase-9, and lowered expressions of mitochondrial cyto c, phospho-Akt (pAkt) and phospho-glycogen synthase kinase-3\u03b2 (pGSK-3\u03b2) in the hippocampus and cortex.",
        "Co-administration of hesperidin to AlCl<sub>3</sub> rats for 60 days significantly ameliorated the aluminum-induced pathological changes.",
        "The behavioral studies also supported the above findings."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25860498": [
        "The mechanisms underlying hesperidin-induced growth arrest and apoptosis are, however, not well understood.",
        "Here, we aimed to investigate the anti-proliferative and apoptotic effects of hesperidin on non-small cell lung cancer (NSCLC) cells and to investigate the mechanisms involved.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Hesperidin, a glycoside flavonoid, is thought to act as an anti-cancer agent, since it has been found to exhibit both pro-apoptotic and anti-proliferative effects in several cancer cell types."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26381129": [
        "Flavonoids are one of the most important ingredients in vegetables and fruits, especially in the genus Citrus.",
        "Hence, screening and testing of more effective compounds with minimum side effects for the prevention and treatment of cancers started a few decades ago.",
        "In the present review, we attempt to provide an overview and summarize the scientific literature about the cancer chemoprotective effects of hesperidin with an emphasis on its relation to the protection roles against oxidative stress.",
        "Cancer is the third cause of death worldwide, with complex etiology, and is defined as an uncontrolled growth of cells.",
        "Regarding this, much attention has been paid to natural antioxidants as a novel prevention and treatment strategy for cancer.",
        "Hesperidin is a flavonone glycoside, belonging to the flavonoid family, which is widely found in Citrus species and acts as a potent antioxidant and anticancer agent.",
        "A high proportion of cancer incidence and deaths are due to different environmental and genetic factors such as high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, alcohol consumption, exposure to radiation, chronic infections, and heredity also.",
        "In addition, oxidative stress plays a crucial role in the pathophysiology of different types of cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21445621": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Hesperidin, a flavanone present in citrus fruits, has been identified as a potent anticancer agent because of its proapoptotic and antiproliferative characteristics in some tumor cells.",
        "However, the precise mechanisms of action are not entirely understood."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24205431": [
        "The apoptosis in rotenone-induced SK-N-SH cells was accompanied by the loss of mitochondrial membrane potential, increased ROS generation, the depletion of GSH, enhanced activities of enzymatic antioxidants, upregulation of Bax, cyt c, and caspases 3 and 9, and downregulation of Bcl-2, which were attenuated in the presence of hesperidin.",
        "Our data suggests that hesperidin exerts its neuroprotective effect against rotenone due to its antioxidant, maintenance of mitochondrial function, and antiapoptotic properties in a neuroblastoma cell line.",
        "The current study was carried out to investigate the neuroprotective effects of hesperidin, a citrus fruit flavanol, against rotenone-induced apoptosis in human neuroblastoma SK-N-SH cells.",
        "We assessed cell death, mitochondrial membrane potential, ROS generation, ATP levels, thiobarbituric acid reactive substances, reduced glutathione (GSH) levels, and the activity of catalase, superoxide dismutase (SOD) and glutathione peroxidase (GPx) using well established assays.",
        "Apoptosis was determined in normal, rotenone, and hesperidin treated cells, by measuring the protein expression of cytochrome c (cyt c), caspases 3 and 9, Bax, and Bcl-2 using the standard western blotting technique.",
        "Studies have shown that the neurotoxicity of rotenone may be related to its ability to generate reactive oxygen species (ROS), leading to neuronal apoptosis.",
        "Rotenone a widely used pesticide that inhibits mitochondrial complex I has been used to investigate the pathobiology of PD both in vitro and in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16964766": [
        "When the excitotoxicity was induced by the glutamate receptor subtype-selective ligands, only the N-methyl-D-aspartic acid-induced toxicity was selectively and markedly inhibited by hesperetin.",
        "Hesperidin, however, exerted minimal or no protective effects on the neuronal damage tested in this study.",
        "While hesperidin was inactive, hesperetin was found to be a potent antioxidant, inhibiting lipid peroxidation initiated in rat brain homogenates by Fe2+ and L-ascorbic acid.",
        "Taken together, these results demonstrate potent antioxidant and neuroprotective effects of hesperetin, implying its potential role in protecting neurons against various types of insults associated with many neurodegenerative diseases.",
        "Furthermore, hesperetin protected cultured cells against the A(beta(25-35))-induced neuronal damage.",
        "Both hesperidin and hesperetin exhibited similar patterns of 1,1-diphenyl-2-picrylhydrazyl radical scavenging activities.",
        "The present study evaluated antioxidant and neuroprotective activities of hesperidin, a flavanone mainly isolated from citrus fruits, and its aglycone hesperetin using cell-free bioassay system and primary cultured rat cortical cells.",
        "In consistence with these findings, hesperetin protected primary cultured cortical cells against the oxidative neuronal damage induced by H2O2 or xanthine and xanthine oxidase.",
        "In addition, it was shown to attenuate the excitotoxic neuronal damage induced by excess glutamate in the cortical cultures."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22383310": [
        "<strong class=\"sub-title\">\n          Scope:\n        </strong>\n      \n      This study investigated whether flavonoids, such as hesperetin and hesperidin, inhibited amyloid \u03b2 (A\u03b2)-impaired glucose utilization through regulating cellular autophagy in insulin-stimulated neuronal cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26342684": [
        "These KA-induced alterations were attenuated by pretreatment with hesperidin (10 or 50 mg/kg, i.p.) before administering the KA.",
        "The citrus flavonoid hesperidin exerts neuroprotective effects and could cross the blood-brain barrier.",
        "In rat hippocampal nerve terminals (synaptosomes), hesperidin inhibited the release of glutamate and elevation of cytosolic free Ca(2+) concentration evoked by 4-aminopyridine (4-AP), but did not alter 4-AP-mediated depolarization.",
        "In hippocampal slice preparations, whole-cell patch clamp experiments showed that hesperidin reduced the frequency of spontaneous excitatory postsynaptic currents without affecting their amplitude, indicating the involvement of a presynaptic mechanism.",
        "Given the involvement of glutamate neurotoxicity in the pathogenesis of neurodegenerative disorders, this study was conducted to evaluate the potential role of hesperidin in glutamate release and glutamate neurotoxicity in the hippocampus of rats.",
        "Our findings indicate that hesperidin may be a promising candidate for preventing or treating glutamate excitotoxicity related brain disorders such as neurodegenerative diseases.",
        "These results demonstrate that hesperidin inhibits evoked glutamate release in vitro and attenuates in vivo KA-induced neuronal death in the hippocampus.",
        "In addition, intraperitoneal (i.p.) injection of kainic acid (KA, 15 mg/kg) elevated the extracellular glutamate levels and caused considerable neuronal loss in the hippocampal CA3 area.",
        "The inhibitory effect of hesperidin on evoked glutamate release was prevented by chelating the extracellular Ca(2+) ions and blocking the activity of Cav2.2 (N-type) and Cav2.1 (P/Q-type) channels or protein kinase C."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24211676": [
        "Taken altogether, the results of the present study suggest a possible interplay of microglial modulation and anti-oxidant effect in neuroprotective potential of hesperidin against QA induced HD like symptoms in rats.",
        "Unilateral intrastriatal administration of QA (300 nmol/4 \u00b5l) significantly reduced body weight, impaired behavior (locomotor activity, beam balance and memory performance), caused oxidative damage (increased lipid peroxidation, nitrite concentration, depleted super oxide dismutase and reduced glutathione), demonstrated mitochondrial dysfunction (decreased Complex-I, II, III, and IV activities), increased striatal lesion volume and altered the levels of TNF-\u03b1, caspase-3 as well as BDNF expression, as compared to sham group.",
        "Besides its anti-oxidant properties, the other probable mechanisms which underpin its neuroprotective potential are still not clear.",
        "Meanwhile, chronic hesperidin (100mg/kg, p.o.) and minocycline (25mg/kg, p.o.) treatment for 21 days significantly attenuated the behavioral, biochemical and cellular alterations as compared to QA treated (control) animals, whereas hesperidin (50mg/kg, p.o.) treatment was found to be non-significant.",
        "In light of emerging role of flavonoids in modulating oxidative stress and neuro-inflammation, the study has been designed to explore the possible neuroprotective effect of hesperidin and its combination with minocycline (microglial inhibitor), against quinolinic acid (QA) induced Huntington's disease (HD) like symptoms in rats.",
        "Emerging evidences indicate hesperidin, a citrus flavanone, attenuates neurodegenerative processes and related complications.",
        "However, treatment of hesperidin (50mg/kg) in combination with minocycline (25mg/kg) potentiated their neuroprotective effect, which was significant as compared to their effects per se in QA treated animals."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28721824": [
        "Citrus fruits and juices are a rich source of vitamin C and flavonoids, with a potential effect on the inflammatory response.",
        "Dietary polyphenols constitute a large family of bioactive substances with potential beneficial effects against a broad group of diseases.",
        "Inflammation plays an important role in the pathogenesis of numerous diseases such as arthritis, allergies or neurodegenerative disorders.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The benefits of the Mediterranean diet for protecting against many diseases are usually attributed to high consumption of certain foods, characterized by the presence of bioactive substances such as polyphenols."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22965147": [
        "However, the effects of apoE-mimetic treatment on AICD-mediated AD-like pathologies remain to be elucidated.",
        "Our previous work showed that the APP intracellular domain (AICD), which is produced simultaneously with A\u03b2, also contributes to the development of AD-like features.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Amyloid-\u03b2 (A\u03b2) peptides derive from the amyloid precursor protein (APP) and play a pivotal role in Alzheimer's disease (AD) pathogenesis.",
        "Studies show that administration of apolipoprotein E (apoE) and apoE-derived small peptide mimetics protect AD mouse models against these AD-like features."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29199013": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      To evaluate the efficacy and ocular and systemic safety of netarsudil 0.02% ophthalmic solution, a rho-kinase inhibitor and norepinephrine transporter inhibitor, in patients with open-angle glaucoma and ocular hypertension."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29453668": [
        "Phase III development in the EU and phase II development in Japan are underway for this indication.",
        "It has been developed by Aerie Pharmaceuticals and was recently approved in the USA for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension.",
        "The recommended dosage is one drop in the affected eye(s) once daily in the evening.",
        "Netarsudil ophthalmic solution 0.02% (hereafter referred to as netarsudil 0.02%) [Rhopressa<sup>\u00ae</sup>] is a Rho-associated protein kinase inhibitor that is thought to lower intraocular pressure (IOP) by increasing aqueous humour outflow through the trabecular meshwork.",
        "This article summarizes the milestones in the development of netarsudil 0.02% leading to this first approval for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29469601": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Netarsudil, an inhibitor of Rho kinase and a norepinephrine transporter, has been shown to lower elevated intraocular pressure (IOP) in controlled studies of patients with open-angle glaucoma and ocular hypertension, and in healthy volunteers.",
        "The mechanism of this ocular hypotensive effect in humans is unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29622939": [
        "Netarsudil ophthalmic solution (Rhopressa) for the reduction of elevated intraocular pressure; ertugliflozin (Steglatro) for adults with type-2 diabetes; and lutetium lu 177 dotatate (Lutathera) for certain gastroenteropancreatic neuroendocrine tumors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30028313": [
        "However, retinal vascular abnormalities and a high sensitivity of RGCs and optic nerve head components to neurotoxic, inflammatory, oxidative and mechanical insults also contribute to vision loss in POAG/GON.",
        "Current treatment modalities for POAG and NTG involve lowering IOP using topical ocular drugs, combination drug products, and surgical interventions.",
        "These complex and heterogeneous diseases are characterized by extensive death of retinal ganglion cells (RGCs) accompanied by retraction and severance of their axonal connections to the brain and thus damage to and thinning of the optic nerve.",
        "Elevated intraocular pressure (IOP), low cerebrospinal and/or low intracranial fluid pressure, advancing age, and ethnicity are major risk factors associated with POAG.",
        "Peripheral vision loss followed by \"tunnel vision\" and eventual irreversible blindness is the fate of patients afflicted by various forms of glaucoma including primary open-angle glaucoma (POAG) and normotensive glaucoma (NTG).",
        "Two recently approved multi-pharmacophoric drugs (e.g., rho kinase inhibitor, Netarsudil; a drug conjugate, Latanoprostene Bunod) and novel aqueous humor drainage devices (iStent and CyPass) are also gaining acceptance for treating POAG/ NTG.",
        "The latter techniques and approaches hope to rejuvenate RGCs and repair the optic nerve structures, thereby providing a gain of function of the visual system for the glaucoma patients.",
        "Since patients suffering from this glaucomatous optic neuropathy (GON) first notice visual impairment when they have lost &gt; 40% of their RGCs, early diagnosis is the key to retard the progression of glaucoma.",
        "Neuroprotective and regenerative agents, coupled with electroceutical, mechanical support systems, stem cell transplantation and gene therapy are emerging therapeutics on the horizon to help combat GON."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30007591": [
        "The neuroprotective and vasoactive properties of Rho kinase inhibitors, as well as the antifibrotic properties, of these agents are reviewed in the context of their possible role in the medical and surgical treatment of glaucoma.",
        "The development of Rho kinase inhibitors as a class of medications to lower IOP in patients with glaucoma and ocular hypertension represents a triumph in translational research.",
        "Ultimately, a search for Rho kinase inhibitors led to the discovery of several molecules of therapeutic interest, leaving us today with 2 new ocular hypotensive agents approved for clinical use: ripasudil in Japan and netarsudil in the United States.",
        "The objectives of this review are to describe the basic science underlying the development of Rho kinase inhibitors as a therapy to lower IOP and to summarize the results of the clinical studies reported to date.",
        "They also offer the possibility of neuroprotective activity, a favorable impact on ocular blood flow, and even an antifibrotic effect that may prove useful in conventional glaucoma surgery.",
        "These represent members of the first new class of clinically useful ocular hypotensive agents since the US Food and Drug Administration approval of latanoprost in 1996.",
        "The critical discovery that pharmacologic manipulation of the cytoskeleton of outflow pathway cells decreased outflow resistance placed a spotlight on the Rho kinase pathway that was known to regulate the cytoskeleton.",
        "In an elegant example of bench-to-bedside research, a hypothesis that cells in the outflow pathway actively regulate conventional outflow resistance was proposed in the 1990s and systematically pursued, exposing novel cellular and molecular mechanisms of intraocular pressure (IOP) regulation.",
        "Local adverse effects, however, including conjunctival hyperemia, subconjunctival hemorrhages, and cornea verticillata, are common.",
        "Development of Rho kinase inhibitors targeted to the cells of the outflow pathway and the retina may allow these agents to have even greater clinical impact.",
        "Rho kinase inhibitors are effective alone or when combined with other known ocular hypotensive medications."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30209441": [
        "In three phase III trials of patients with elevated IOP, the ocular hypotensive efficacy of once-daily netarsudil 0.02% met the criteria for noninferiority to twice-daily timolol 0.5% at all time points over 3 months in patients with baseline IOP less than 25 mmHg.",
        "This report summarizes the available preclinical and clinical data on netarsudil.",
        "Netarsudil, a Rho kinase (ROCK) inhibitor that lowers IOP primarily by increasing trabecular outflow, produces statistically and clinically significant reductions in mean IOP from baseline, with comparable effects on nocturnal and diurnal IOP.",
        "The most frequent adverse event (AE) was generally mild conjunctival hyperemia, the severity of which did not increase with continued dosing.",
        "Netarsudil was associated with minimal treatment-related serious or systemic AEs, likely due to the lack of systemic exposure.",
        "Once-daily (p.m.) netarsudil ophthalmic solution 0.02% (Rhopressa) is approved in the United States for lowering elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28609185": [
        "The preclinical characterization of netarsudil, a new ROCK/norepinephrine transporter (NET) inhibitor currently in clinical development, is presented herein.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Rho-associated protein kinase (ROCK) inhibitors lower intraocular pressure (IOP) by increasing aqueous outflow through the trabecular meshwork (TM)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30323550": [
        "The most common local adverse effects relate to conjunctival hyperemia.",
        "The efficacy of netarsudil has been shown in animal studies and human clinical trials.",
        "Further studies of a combination of netarsudil and latanoprost agents are currently underway.",
        "Importantly, netarsudil has been shown to reduce IOP to the same degree, regardless of baseline levels.",
        "It has been shown to be noninferior to the therapy with topical timolol in individuals with baseline IOP &lt;25 mmHg.",
        "There are no known systemic safety issues associated with netarsudil.",
        "Netarsudil ophthalmic solution is a novel topical intraocular pressure (IOP)-lowering agent that has recently been approved by the US Food and Drug Administration (FDA) for the treatment of ocular hypertension and open-angle glaucoma.",
        "The once-daily dosing schedule is advantageous for individuals who have difficulties with medication adherence.",
        "Its unique pharmacology allows for IOP lowering as a result of direct reduction in trabecular outflow resistance in addition to a decrease in episcleral venous pressure and aqueous humor production."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27072905": [
        "From these studies, netarsudil (a.k.a. AR-13324) was discovered and is currently in clinical trials for the treatment of glaucoma and ocular hypertension.",
        "Compounds that provided a longer duration of intraocular pressure reduction in Dutch Belted rabbits also inhibited norepinephrine transporter.",
        "Inhibition of Rho kinase (ROCK) to improve fluid outflow through the trabecular meshwork and lower intraocular pressure is a strategy for the development of new anti-glaucoma agents.",
        "Ester 60 improved bioavailability of its parent ROCK inhibitor, 29 (Ki=0.2nM) and demonstrated an effective and sustained IOP reduction for 24h after dosing.",
        "Alpha-aryl-beta-amino isoquinoline analogs were identified as potent ROCK inhibitors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30298407": [
        "We describe this predictor, explain how to run the web server, and show how to interpret the results it generates.",
        "MoRFpred is implemented as a user-friendly web server that is freely available at http://biomine.cs.vcu.edu/servers/MoRFpred/ .",
        "A popular computational tool, MoRFpred, accurately predicts MoRFs in protein sequences.",
        "MoRFs facilitate translation, transport, signaling, and regulatory processes and are found across all domains of life.",
        "Molecular recognition features (MoRFs) are segments of intrinsically disordered regions that bind to partner proteins, where binding is concomitant with a transition to a structured conformation.",
        "Intrinsically disordered proteins and regions are involved in a wide range of cellular functions, and they often facilitate protein-protein interactions.",
        "We also demonstrate the utility of this web server based on two case studies, focusing on the relevance of evolutionary conservation of MoRF regions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29042212": [
        "Upon interaction they undergo a disorder-to-order transition as a result of which their functionality arises.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Intrinsically Disordered Proteins (IDPs) lack stable tertiary structure and they actively participate in performing various biological functions.",
        "These IDPs expose short binding regions called Molecular Recognition Features (MoRFs) that permit interaction with structured protein regions.",
        "Predicting these MoRFs in disordered protein sequences is a challenging task."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29360926": [
        "The scores are processed and combined using common averaging method.",
        "In this study, we present a new MoRF predictor, OPAL, to identify MoRFs in disordered protein sequences.",
        "OPAL utilizes two independent sources of information computed using different component predictors.",
        "The first score is computed using a component MoRF predictor which utilizes composition and sequence similarity of MoRF and non-MoRF regions to detect MoRFs.",
        "Key to their biological function are the molecular recognition features (MoRFs) located within long disordered regions.",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Intrinsically disordered proteins lack stable 3-dimensional structure and play a crucial role in performing various biological functions.",
        "The second score is calculated using half-sphere exposure (HSE), solvent accessible surface area (ASA) and backbone angle information of the disordered protein sequence, using information from the amino acid properties of flanks surrounding the MoRFs to distinguish MoRF and non-MoRF residues.",
        "Computationally identifying these MoRFs from disordered protein sequences is a challenging task."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30324701": [
        "OPAL+ is available for download at https://github.com/roneshsharma/OPAL-plus/wiki/OPAL-plus-Download.",
        "These intrinsically disordered regions (IDRs) participate in binding events through regions called molecular recognition features (MoRFs).",
        "This performance improvement comes at the expense of increased run time as a result of the requirement of HMM profiles.",
        "OPAL+ uses separate models to predict MoRFs of varying lengths along with incorporating the hidden Markov model (HMM) profiles and physicochemical properties of MoRFs and their flanking regions.",
        "In this study, OPAL+, a novel MoRF predictor, is presented.",
        "Intrinsically disordered proteins (IDPs) contain long unstructured regions, which play an important role in their function.",
        "Computational prediction of MoRFs helps identify the potentially functional regions in IDRs.",
        "Together, these features help OPAL+ achieve a marginal performance improvement of 0.4-0.7% over its predecessor for diverse MoRF test sets."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26517836": [
        "In this work, we introduce MoRFCHiBi_Web, which predicts MoRF locations in protein sequences with higher accuracy compared to current MoRF predictors.",
        "Key to their regulatory function is often the binding to globular protein domains via sequence elements known as molecular recognition features (MoRFs).",
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Intrinsically disordered regions of proteins play an essential role in the regulation of various biological processes.",
        "Development of computational tools for the identification of candidate MoRF locations in amino acid sequences is an important task and an area of growing interest.",
        "Given the relative sparseness of MoRFs in protein sequences, the accuracy of the available MoRF predictors is often inadequate for practical usage, which leaves a significant need and room for improvement."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25637562": [
        "<strong class=\"sub-title\">\n          Motivation:\n        </strong>\n      \n      Intrinsically disordered regions of proteins play an essential role in the regulation of various biological processes.",
        "Predicting the location of MoRFs in protein sequences with high accuracy remains an important computational challenge.",
        "Key to their regulatory function is the binding of molecular recognition features (MoRFs) to globular protein domains in a process known as a disorder-to-order transition."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29209918": [
        "Therefore, indications of Keytruda significantly expanded.",
        "Several types of malignancies are disclosed by MSI-H status due to dMMR and characterized by increased neoantigen load, which elicits intense host immune response in tumor microenvironment, including portions of colorectal and gastric carcinomas.",
        "Taking gastric cancer as an example, its molecular classification is built on genome abnormalities, but it lacks acceptable clinical characteristics.",
        "Pathologists are expected to act as \"genetic interpreters\" or \"genetic translators\" and build a link between molecular subtypes with tumor histological features.",
        "Subsequently, by using their findings, oncologists will carry out targeted therapy based on molecular classification.",
        "Pathologists play important roles in evaluating histology and biomarker results and establishing detection methods.",
        "FDA previously approved Keytruda for treatment of several types of malignancies, such as metastatic melanoma, metastatic non-small-cell lung cancer, recurrent or metastatic head and neck cancer, refractory Hodgkin lymphoma, and urothelial carcinoma, all of which carry positive programmed death-1/programmed death-ligand 1 biomarkers.",
        "On May 23, 2017, the US Food and Drug Administration (FDA) approved a treatment for cancer patients with positive microsatellite instability-high (MSI-H) markers or mismatch repair deficient (dMMR) markers.",
        "This approach is the first approved tumor treatment using a common biomarker rather than specified tumor locations in the body.",
        "Currently, biomarker-based patient selection remains a challenge."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26242768": [
        "PCV13 has a well established immunogenicity and tolerability profile in adults, particularly those \u226550 years of age.",
        "The 13-valent pneumococcal conjugate vaccine (Prevenar 13(\u00ae), Prevnar 13(\u00ae)) [PCV13] consists of 13 serotype-specific polysaccharides of Streptococcus pneumoniae (pneumococcus), each covalently conjugated to a non-toxic immunogenic carrier protein.",
        "PCV13 also has a role in preventing pneumococcal disease (pneumonia and IPD) in younger adults with immunocompromising conditions and potentially in those with other underlying medical conditions that increase the risk of pneumococcal disease.",
        "These findings, along with changes in pneumococcal serotype distribution and epidemiology of pneumococcal disease, prompted the US Advisory Committee on Immunization Practices (ACIP) to recommend PCV13 in series with 23-valent pneumococcal polysaccharide vaccine (PPVS23) for all adults aged \u226565 years.",
        "Results of CAPiTA, a randomized, double-blind, placebo-controlled trial in &gt;84,000 older adults aged \u226565 years, showed that PCV13 was effective in preventing vaccine-type pneumococcal community-acquired pneumonia (CAP), vaccine-type pneumococcal nonbacteraemic (noninvasive) CAP and vaccine-type invasive pneumococcal disease (IPD)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26059840": [
        "POI is heterogeneous with only a few causative genes having been discovered so far.",
        "Primary ovarian insufficiency (POI) is a distressing cause of infertility in young women.",
        "Exome sequencing combined with linkage analyses offers a powerful tool to efficiently find novel genetic causes of rare, heterogeneous disorders, even in small single families.",
        "Linkage analysis identified a locus on chromosome 7 where exome sequencing successfully identified a homozygous two base pair duplication (c.1947_48dupCT), leading to a truncated protein p.(Y650Sfs*22) in the STAG3 gene, confirming it as the cause of POI in this family.",
        "This is only the second report of a STAG3 variant; the first STAG3 variant was recently described in a phenotypically similar family with extreme POI.",
        "Our objective was to determine the genetic cause of POI in a consanguineous Lebanese family with two affected sisters presenting with primary amenorrhoea and an absence of any pubertal development.",
        "Multipoint parametric linkage analysis was performed.",
        "Identification of an additional family highlights the importance of STAG3 in POI pathogenesis and suggests it should be evaluated in families affected with POI.",
        "Whole-exome sequencing was done on the proband."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30006057": [
        "Here, we performed a targeted massively parallel sequencing to identify the genetic diagnosis of primary ovarian insufficiency (POI) in a Brazilian patient.",
        "<strong class=\"sub-title\">\n          Background/aim:\n        </strong>\n      \n      Primary ovarian insufficiency (POI) is characterized by primary or secondary amenorrhea, infertility, low estradiol levels, and increased gonadotropin levels.",
        "Most cases of POI remain unsolved even after exhaustive investigation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27836978": [
        "<strong class=\"sub-title\">\n          Study question:\n        </strong>\n      \n      Does a novel homozygous NOBOX truncating variant, identified in whole exome sequencing (WES) of patients with primary ovarian insufficiency (POI), cause defective transcriptional activation of multiple oocyte-related genes?"
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29186450": [
        "Some of these approaches are implemented in the user-friendly SplitsTree software package.",
        "<strong class=\"sub-title\">\n          Summary:\n        </strong>\n      \n      Split-networks are a generalization of phylogenetic trees that have proven to be a powerful tool in phylogenetics.",
        "SPECTRE also supports the use of longer running algorithms by providing command line interfaces, which can be executed on servers or in High Performance Computing environments.",
        "Here, we present SPECTRE, a readily available, open-source library of data structures written in Java, that comes complete with new implementations of several pre-published algorithms and a basic interactive graphical interface for visualizing planar split networks.",
        "However, to give the user the option to adjust and extend these approaches and to facilitate their integration into analysis pipelines, there is a need for robust, open-source implementations of associated data structures and algorithms.",
        "Various ways have been developed for computing such networks, including split-decomposition, NeighborNet, QNet and FlatNJ."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24436254": [
        "We illustrate the application of FlatNJ by applying it to whole HIV genome sequences, where recombination has taken place, fluorescent proteins in corals, where ancestral sequences are present, and mitochondrial DNA sequences from gall wasps, where biogeographical relationships are of interest.",
        "We present a new method for constructing such networks called FlatNetJoining (FlatNJ).",
        "Split networks are a type of phylogenetic network that allow visualization of conflict in evolutionary data.",
        "For complex data sets that involve, for example, non-neutral molecular markers, this can allow additional detail to be visualized as compared to previous methods such as split decomposition and NeighborNet.",
        "We find that the networks generated by FlatNJ can facilitate the study of genetic variation in the underlying molecular sequence data and, in particular, may help to investigate processes such as intra-locus recombination.",
        "A key feature of FlatNJ is that it produces networks that can be drawn in the plane in which labels may appear inside of the network.",
        "FlatNJ has been implemented in Java and is freely available at www.uea.ac.uk/computing/software/flatnj."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17119010": [
        "QNet can be viewed as a quartet analogue of the distance-based Neighbor-Net (NNet) method for network construction.",
        "To illustrate the applicability of QNet, we apply it to a previously published Salmonella data set.",
        "We present QNet, a method for constructing split networks from weighted quartet trees.",
        "QNet is freely available for download.",
        "Moreover, it can be used as an aid for determining when a quartet-based tree-building method may or may not be appropriate for a given data set.",
        "Just as NNet, QNet works by agglomeratively computing a collection of circular weighted splits of the taxa set which is subsequently represented by a planar split network.",
        "We conclude that QNet can provide a useful alternative to NNet if distance data are not available or a character-based approach is preferred."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22149316": [
        "It has anti-atherogenic and anti-inflammatory properties.",
        "This peptide consists of residues 141-150, the putative receptor-binding region of human apoE, covalently linked to a well characterized class A amphipathic helix, 18A, which has no sequence homology to any other exchangeable apolipoprotein sequences.",
        "Toward this end, we describe the design and studies of a dual-domain apoE mimetic peptide, Ac-hE18A-NH(2).",
        "Therefore, this and similar peptides may be useful in the treatment of dyslipidemic disorders such as familial hyperlipidemia and atherosclerosis.",
        "It demonstrates dramatic effects in reducing plasma cholesterol levels in dyslipidemic mouse and rabbit models.",
        "Apolipoprotein E (apoE) is a ligand for clearance of lipoprotein remnants such as chylomicrons and very low-density lipoproteins.",
        "ApoE mimetics such as Ac-hE18A-NH(2) may therefore restore or replace ligands in genetically induced hyperlipidemias to enable reduction in atherogenic lipoproteins via HSPG even in the absence of functional low-density lipoprotein receptors.",
        "We discuss the scientific rationale and review the literature for the design and efficacy of the peptide.",
        "A number of synthetic peptides that encompass different regions of apoE have been studied for inhibiting inflammatory states, including Alzheimer disease.",
        "Analogous to apoE, this peptide bypasses the low-density lipoprotein receptor for the hepatic uptake of atherogenic lipoproteins via heparan sulfate proteoglycan (HSPG).",
        "Therefore, there is extensive ongoing research to create peptides that can mimic properties of apoE.",
        "However, peptides that clear atherogenic lipoproteins, analogous to apoE, via enhanced hepatic uptake have not been previously reviewed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30299483": [
        "While it is known that host sex affects HIV-1 viremia and influences the severity of HIV-1-associated neurocognitive disease, a cellular or molecular basis for these findings remains elusive.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Macrophages are major targets for HIV-1, contribute to viral propagation in vivo, and are instrumental in the pathogenesis of HAND."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23332752": [
        "Once unveiled, many of these enhancers did not return to a latent state when stimulation ceased; instead, they persisted and mediated a faster and stronger response upon restimulation.",
        "We suggest that stimulus-specific expansion of the cis-regulatory repertoire provides an epigenomic memory of the exposure to environmental agents.",
        "According to current models, once the cell has reached terminal differentiation, the enhancer repertoire is completely established and maintained by cooperatively acting lineage-specific transcription factors (TFs).",
        "Macrophage stimulation caused sequential binding of stimulus-activated and lineage-determining TFs to these regions, enabling deposition of enhancer marks.",
        "TFs activated by extracellular stimuli operate within this predetermined repertoire, landing close to where master regulators are constitutively bound.",
        "Here, we describe latent enhancers, defined as regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers but acquire these features in response to stimulation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15734119": [
        "The diagnosis of this syndrome can be done with the prenatal diagnosis, with fetal pathology or with a child alive.",
        "This acronym doesn't recapitulate the full spectrum of the symptoms.",
        "The deletion of chromosome 22q11.2 is involved in the majority of DiGeorge or velo-cardiofacial syndrome.",
        "The phenotypic variability was noted in the \"CATCH 22\" acronym."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16617304": [
        "Overall the majority of rearrangements were interchromosomal, so arising from unequal meiotic exchange, and there were approximately equal numbers of maternal and paternal deletions.",
        "The proportion arising from interchromosomal exchanges varied among deletions with 22q11 the highest and 15q11-q13 the lowest.",
        "To look for locus-specific differences, we have used microsatellites to determine the parental and chromosomal origins of a large series of patients with de novo deletions of chromosome 7q11.23 (Williams syndrome), 15q11-q13 (Angelman syndrome, Prader-Willi syndrome) and 22q11 (Di George syndrome) and duplications of 15q11-q13.",
        "Several factors are likely to be involved in the formation of recurrent rearrangements and the relative importance of these appear to be locus-specific.",
        "Non-allelic homologous recombination between chromosome-specific LCRs is the most common mechanism leading to recurrent microdeletions and duplications.",
        "However, parental and chromosomal origins were not always independent.",
        "For 15q11-q13, maternal deletions tended to be interchromosomal while paternal deletions tended to be intrachromosomal; for 22q11 there was a possible excess of maternal cases among intrachromosomal deletions.",
        "Duplications and deletions of 15q11-q13 appear to be reciprocal products that arise by the same mechanisms."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9674897": [
        "Haplotype analysis demonstrates that the deletion in the affected sibs has occurred on the same maternal chromosome 22.",
        "Furthermore, an unaffected sib was found to have inherited the same maternal haplotype at 22q11 in an undeleted form.",
        "This is the first molecular demonstration of germ line mosaicism for a microdeletion at chromosome 22q11 and highlights the need for caution in estimation of recurrence risks, even when constitutional deletions have been excluded on parental analysis.",
        "Submicroscopic deletions of chromosome 22q11 have been reported in a multiple anomaly syndrome variously labelled as velocardiofacial syndrome, conotruncal anomaly face syndrome, and Di George syndrome.",
        "We describe two affected sibs with confirmed 22q11 deletions from unaffected parents who are not deleted.",
        "Most 22q11 microdeletions occur sporadically, although in some cases the deletion may be transmitted."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26605035": [
        "The 22q11.2 deletion syndrome (di George syndrome) is one of the most prevalent genetic disorders.",
        "We describe the case of an 18-year old patient suffering from 22q11.2 deletion syndrome.",
        "Antipsychotic medications either accelerate or reveal dystonic symptoms.",
        "Since adolescence, he presented with behavioral disorders, recommended treatment with 2 mg aloperidin and he presented cervical dystonia and emergence of torticollis and trunk dystonia.",
        "The clinical features of the syndrome are distinct facial appearance, velopharyngeal insufficiency, conotruncal heart disease, parathyroid and immune dysfunction; however, little is known about possible neurodegenerative diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/8998528": [
        "The phenotypic expression of this chromosomal abnormality is highly variable.",
        "Most of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within chromosome 22q11."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25523123": [
        "A small percentage of affected individuals have shorter deletions in the same region (contiguous gene deletion syndrome).",
        "Most people with 22q11.2DS are missing a sequence of about 3 million DNA building blocks (base pairs) on one copy of chromosome 22 in each cell.",
        "Characteristic symptoms may include congenital heart disease, defects in the palate, neuromuscular problems, velo-pharyngeal insufficiency, hypoparathyroidism, craniofacial features and problems with the immune system T-cell mediated response (caused by hypoplasia of the thymus).",
        "22q11.2DS has several presentations including Di George's syndrome, velo-cardio-facial syndrome or Shprintzen's syndrome and it is the most frequent microdeletion syndrome in the general population (prevalence estimated at 1/4000 births, de novo: 90%).",
        "The general features of 22q11.2DS vary widely (more than 180 phenotypic presentations) and the syndrome is under diagnosed.",
        "The inheritance of the syndrome (10%) is autosomal dominant.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      The 22q11.2 deletion syndrome (22q11.2DS) is caused by hemizygous microdeletions on chromosome 22."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12238021": [
        "1) Variability of clinical features depends on the size and pathogenetic mechanism of underlying deletion; 2) Dysmorphic face features are of a characteristic type and can be somatoscopically recognized; 3) Heart defects and mental retardation are common features of microdeletion syndromes; 4) New mutations represent the most common etiology of microdeletions; only 1 to 10% of mutations are transmitted from the parental gonadal mosaics, from the balanced translocation or from the same microdeletion in parents; 5) Recurrence risk is low, but it may be as high as 50% in individual cases of inherited mutation; 6) Genetic heterogeneity is high and the responsible genes can be located at different chromosomes (e.g. Di George syndrome due to mutation on 22q or 10q) and can also result from microdeletion or point mutation (in the Shprintzen syndrome 70% represent microdeletion and 30% point mutation at 22q11, in Rubinstein-Taybi syndrome 10% cases result from microdeletions and 90% from point mutations); 7) Population incidence of microdeletions is high (1:4000 to 1:30,000) because their etiologic mechanism is related to the common unequal crossing over; 8) Imprinting plays a role in some cases, e.g. Prader-Willi syndrome results from nullisomy of paternal 15q12 chromosome, Angelman syndrome is related to that of maternal 15q12 chromosome; 9) Prenatal prevention of the high risk familial chromosomal rearrangements is feasible since the 12th gestation week.",
        "A loss of contiguous genes shows a high phenotypical variability and at the same time it is significant for genetic prognosis.",
        "New high-resolution cytogenetical technique identified an increased number of terminal, interstitial and subtelomeric microdeletion as the etiology of many syndromes of multiple congenital anomalies, mental retardation and facial dysmorphy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25689697": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To provide an overview of the literature describing the role of asporin, a small leucine-rich proteoglycan (SLRP), in osteoarthritis (OA)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27409832": [
        "Besides other investigations, large scale analysis of aspartic acid repeat polymorphism will be needed for clarification of the asporin dual role in progression of breast cancer.",
        "In line with other studies, we have confirmed asporin expression by RNA scope in situ hybridization in cancer associated fibroblasts.",
        "We have also found asporin expression in the Hs578T breast cancer cell line which we confirmed by quantitative RT-PCR and western blotting.",
        "Asporin has been reported as a tumor suppressor in breast cancer, while asporin-activated invasion has been described in gastric cancer.",
        "Invasion of asporin-negative MDA-MB-231 and BT549 breast cancer cells through collagen type I was enhanced by recombinant asporin.",
        "According to our in silico search, high asporin expresion associates with significantly better relapse free survival (RFS) in patients with low-grade tumors but RFS is significantly worse in patients with grade 3 tumors.",
        "Downregulation by shRNA inhibited invasion of Hs578T as well as of CAFs and T47D cells.",
        "From multiple testing, we found that asporin can be downregulated by bone morphogenetic protein 4 while upregulation may be facilited by serum-free cultivation or by three dimensional growth in stiff Alvetex scaffold."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27705916": [
        "The portal vein injection models suggested that asporin overexpression stimulated the liver metastasis of HT29 cell line, while asporin knockdown inhibited the liver metastasis of RKO cell line.",
        "With clinical samples, we found that asporin was highly expressed in CRC tissues compared to adjacent normal tissues and the asporin expression levels were significantly associated with lymph node metastasis status and TNM stage of the patients.",
        "In addition, asporin was found to augment the phosphorylation of EGFR/src/cortactin signaling pathway, which might be contributed to the biological functions of asporin in CRC metastasis.",
        "These results suggested that asporin promoted the tumor growth and metastasis of CRC, and it could be a potential therapeutic target for CRC patients in future.",
        "Further more, with the human umbilical vein endothelial cells (HUVECs) tube formation assays and the xenograft model, we found that asporin promoted the tumor growth through stimulating the VEGF signaling pathway.",
        "Asporin has been implicated as an oncogene in various types of human cancers; however, the roles of asporin in the development and progression of colorectal cancer (CRC) have not yet been determined.",
        "Through knockdown of asporin in CRC cell lines RKO and SW620 or overexpression of asporin in cell lines HT-29 and LoVo, we found that asporin could enhance wound healing, migration and invasion abilities of the CRC cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28152543": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Prostate cancer shows considerable heterogeneity in disease progression and we propose that markers expressed in tumour stroma may be reliable predictors of aggressive tumour subtypes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29990539": [
        "In this review, we discuss new insights into how the structural features of the 3D genome hierarchy are established and maintained, how this hierarchy undergoes dynamic rearrangement during normal development and how its perturbation will lead to human disease, highlighting the accumulating evidence that links the diverse 3D genome architecture components to a multitude of human diseases and the emerging mechanisms by which 3D genome derangement causes disease phenotypes.",
        "It is now clear that the hierarchical organization of the eukaryotic genome critically impacts nuclear activities such as transcription, replication, as well as cellular and developmental events such as cell cycle, cell fate decision and embryonic development.",
        "Recent burst of new technologies that allow for quantitatively delineating chromatin structure has greatly expanded our understanding of how the genome is organized in the three-dimensional (3D) space of the nucleus."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30241613": [
        "The findings have important implications for TAD function and mechanisms underlying diseases such as fragile X syndrome and Huntington's disease.",
        "In this issue, Sun et al. show that disease-associated tandem repeats are located to TAD boundaries and affect their insulation.",
        "TAD boundaries are insulators of genomic neighborhoods."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28408976": [
        "TADs are demarcated by boundary regions bound by architectural proteins, such as CTCF and cohesin, although much remains to be discovered about the structure and function of these domains.",
        "Chromatin in the interphase nucleus is organised as a hierarchical series of structural domains, including self-interacting domains called topologically associating domains (TADs).",
        "Further insights into chromatin organisation, in parallel with accumulating whole genome sequence data for disease cohorts, are likely to yield additional valuable insights into the roles of noncoding sequence variation in human disease.",
        "Similar boundary disruptions in certain cancers can result in oncogene overexpression, and CTCF binding sites at boundaries appear to be hyper-mutated across cancers.",
        "Recent studies of TAD boundaries disrupted in engineered mouse models show that boundary mutations can recapitulate human developmental disorders as a result of aberrant promoter-enhancer interactions in the affected TADs.",
        "This arrangement is thought to bring enhancers into closer physical proximity with their target genes, which often are located hundreds of kilobases away in linear genomic distance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26862051": [
        "We discuss how the disruption of these structures by genomic rearrangements can result in gene misexpression and disease.",
        "Spatial organization is an inherent property of the vertebrate genome to accommodate the roughly 2m of DNA in the nucleus of a cell.",
        "In this review we summarize the most recent findings about TADs and the boundary regions separating them.",
        "In this nonrandom organization, topologically associating domains (TADs) emerge as a fundamental structural unit that is thought to guide regulatory elements to their cognate promoters."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27111891": [
        "One mechanism locally disrupts domains by deleting or mutating a TAD boundary leading to fusion of the two adjacent TADs.",
        "The other mechanism involves genomic rearrangements that break up TADs and creates new ones without directly affecting TAD boundaries.",
        "Recent studies have shown that TAD disruption is often found in cancer cells and contributes to oncogenesis through two mechanisms.",
        "Disruption of TAD boundaries results in aberrant gene expression by exposing genes to inappropriate regulatory elements.",
        "Understanding the mechanisms by which TADs form and control long-range chromatin interactions will therefore not only provide insights into the mechanism of gene regulation in general, but will also reveal how genomic rearrangements and mutations in cancer genomes can lead to misregulation of oncogenes and tumor suppressors.",
        "Topologically Associating Domains (TADs) are conserved during evolution and play roles in guiding and constraining long-range regulation of gene expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30086749": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The human genome is highly organized in the three-dimensional nucleus.",
        "However, it is not clear to which extent TAD regions are conserved in evolution and whether disruption of TADs by evolutionary rearrangements can alter gene expression.",
        "Disruption of TADs can result in altered gene expression and is associated to genetic diseases and cancers.",
        "TADs contribute to gene regulation by restricting chromatin interactions of regulatory sequences, such as enhancers, with their target genes.",
        "Chromosomes fold locally into topologically associating domains (TADs) defined by increased intra-domain chromatin contacts."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30374058": [
        "This fetus carries a de novo deletion next to the IHH gene, encompassing a TAD boundary.",
        "The organization of mammalian genomes into sub-megabase sized Topologically Associated Domains (TADs) has recently been revealed by techniques derived from Chromosome Conformation Capture (3 C), such as High Chromosome Contact map (Hi-C).",
        "We hypothesize that the deletion harbored by this fetus results in the same pathophysiological mechanisms as those of the Dbf model.",
        "Disruption of this organization by structural variations can lead to ectopic interactions between enhancers and promoters, and to alteration of genes expression patterns.",
        "The description of this case expands the spectrum of the disruption of chromatin architecture of WNT6/IHH/EPHA4/PAX3 locus, and could help to understand the mechanisms of chromatin interactions at this locus.",
        "This mechanism has already been described as the main pathophysiological mechanism in several syndromes with congenital malformations.",
        "Such an IHH TAD boundary deletion has already been described in the Dbf mouse model, which shows a quite similar, but less severe phenotype.",
        "We describe here the case of a fetus with a severe multiple congenital anomalies syndrome, including extensive polydactyly of the four limbs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25959774": [
        "This rewiring occurred only if the variant disrupted a CTCF-associated boundary domain.",
        "Using CRISPR/Cas genome editing, we generated mice with corresponding rearrangements.",
        "We demonstrate that disruption of TADs can rewire long-range regulatory architecture and result in pathogenic phenotypes.",
        "Our results demonstrate the functional importance of TADs for orchestrating gene expression via genome architecture and indicate criteria for predicting the pathogenicity of human structural variants, particularly in non-coding regions of the human genome.",
        "We show that distinct human limb malformations are caused by deletions, inversions, or duplications altering the structure of the TAD-spanning WNT6/IHH/EPHA4/PAX3 locus.",
        "Mammalian genomes are organized into megabase-scale topologically associated domains (TADs).",
        "Both in mouse limb tissue and patient-derived fibroblasts, disease-relevant structural changes cause ectopic interactions between promoters and non-coding DNA, and a cluster of limb enhancers normally associated with Epha4 is misplaced relative to TAD boundaries and drives ectopic limb expression of another gene in the locus."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22495304": [
        "TADs align with, but do not rely on, several domain-wide features of the epigenome, such as H3K27me3 or H3K9me2 blocks and lamina-associated domains.",
        "We discover a series of discrete 200-kilobase to 1 Mb topologically associating domains (TADs), present both before and after cell differentiation and on the active and inactive X.",
        "The extent of Xic sequences required for the proper regulation of Xist remains unknown.",
        "Disruption of a TAD boundary causes ectopic chromosomal contacts and long-range transcriptional misregulation.",
        "The Xist/Tsix sense/antisense unit illustrates how TADs enable the spatial segregation of oppositely regulated chromosomal neighbourhoods, with the respective promoters of Xist and Tsix lying in adjacent TADs, each containing their known positive regulators.",
        "In addition to uncovering a new principle of cis-regulatory architecture of mammalian chromosomes, our study sets the stage for the full genetic dissection of the X-inactivation centre.",
        "TADs also align with coordinately regulated gene clusters.",
        "In eukaryotes transcriptional regulation often involves multiple long-range elements and is influenced by the genomic environment.",
        "We identify a novel distal regulatory region of Tsix within its TAD, which produces a long intervening RNA, Linx.",
        "Here we use chromosome conformation capture carbon-copy (5C) and super-resolution microscopy to analyse the spatial organization of a 4.5-megabases (Mb) region including Xist.",
        "A prime example of this concerns the mouse X-inactivation centre (Xic), which orchestrates the initiation of X-chromosome inactivation (XCI) by controlling the expression of the non-protein-coding Xist transcript."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29245934": [
        "The results show that L-4F substantially reduced the tumorigenicity of H7 cells.",
        "These results suggest that L-4F exhibits an effective therapeutic effect on pancreatic cancer progression by inhibiting tumor-associated macrophages and inflammation.",
        "The cytotoxicity of L-4F toward H7 cells was assessed <i>in vitro</i>.",
        "Pancreatic cancer is an aggressive malignancy that is unresponsive to conventional radiation and chemotherapy.",
        "However, L-4F could not directly attenuate H7 cell invasion or proliferation and did not induce apoptosis.",
        "Furthermore, we investigated the effects of L-4F on macrophage polarization by analyzing the polarization and genes of mouse bone marrow-derived macrophages <i>in vitro</i>.",
        "Notably, L-4F also decreased the percentage of macrophages in tumor tissues, especially M2 macrophages (CD11b<sup>+</sup>F4/80<sup>+</sup>CD206<sup>+</sup>), which was also confirmed <i>in vitro</i>.",
        "Additionally, the expression of the M2 marker genes <i>Arg1</i>, <i>MRC1</i>, and <i>CCL22</i> and the inflammatory genes <i>IL-6</i>, <i>iNOS</i>, and <i>IL-12</i> was decreased by L-4F, indicating that L-4F prevents M2 type macrophage polarization.",
        "In addition, L-4F potently down-regulated STAT3, JNK and ERK signaling pathways but not affects the phosphorylation of p38 in RAW 264.7 cells.",
        "In this work, H7 cells were orthotopically implanted in C57BL/6 mice and treated with L-4F.",
        "Therefore, development of novel immune therapeutic strategies is urgently needed.",
        "L-4F, an Apolipoprotein A-I (ApoA-I) mimetic peptide, is engineered to mimic the anti-inflammatory and anti-oxidative functionalities of ApoA-I.",
        "L-4F inhibited inflammation by reducing the accumulation of inflammatory cells, such as IL-17A-, IL-4-, GM-CSF-, IL-1\u03b2-, and IL-6-producing cells and Th1 and Th17.",
        "Then, pancreatic cancer progression and the inflammatory microenvironment were investigated <i>in vivo</i>."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24561791": [
        "Lactotransferrin-reporter(-) bone marrow cells retain lymphoid, erythroid and long-term repopulating potential, while lactotransferrin-reporter(+) bone marrow cells confer only myeloid, but not lymphoid potential.",
        "We show that lactotransferrin mRNA is expressed by Gr-1(+)/CD11b(+) cells in the bone marrow, as opposed to hematopoietic stem cells or any peripheral cell population.",
        "We conclude that lactotransferrin represents a late stage differentiation marker of neutrophils, macrophages and distinct subtypes of dendritic cells.",
        "Here, we describe a myeloid-specific marker that is not shared by any other lineage.",
        "Considerable effort has been expended to identify genes that account for myeloid lineage commitment and development.",
        "We found that lactotransferrin-reporter labels a majority of neutrophils, monocytes, macrophages and distinct subtypes of dendritic cells, while excluding T, B, natural killer cells, interferon-producing killer dendritic cells, plasmacytoid dendritic cells, erythrocytes and eosinophils.",
        "However, currently available non-invasive mouse models utilize myeloid-specific reporters that are significantly expressed in hematopoietic stem cells as well as lymphoid compartments.",
        "To follow the progeny of lactotransferrin-expressing bone marrow cells, we generated a mouse model in which a reporter gene is irreversibly activated from the lactotransferrin-promoter."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29099642": [
        "Therefore, olive leaf extract (OLE) is considered as a natural supplement.",
        "Olive leaves are rich in polyphenolic compounds that are known to have antioxidant, antimicrobial, and anti-inflammatory activities.",
        "Polymorphonuclear cells (PMNCs) were isolated from the whole blood using Histopaque solution and cultured in RPMI-enriched medium.",
        "We found a significant decrease in TNF\u03b1 secretion level in PMNCs culture treated with OLE.",
        "Downregulation of TNF\u03b1 secretion in PMNCs culture in response to OLE treatment indicates that this polyphenol-rich extract has an anti-inflammatory effect, and oleuropein is the major OLE component responsible for this effect.",
        "The antibacterial activity of OLE was determined by well diffusion assay.",
        "In this study we evaluated the antibacterial and the anti-inflammatory effect of OLE and its individual phenolic components in vitro.",
        "Furthermore, OLE exhibited antibacterial activity against some gram positive bacterial strains; however, gram negative bacterial strains were resistant to OLE.",
        "Tumor necrosis factor \u03b1 (TNF\u03b1) level was determined by ELISA after 24 h of lipopolysaccharide stimulation.",
        "Oleuropein is the only OLE component that has shown anti-inflammatory effects at a concentration of 20 \u03bcg/mL.",
        "The antibacterial activity of OLE is limited to gram positive bacteria."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29059618": [
        "Accurate determination of bioactivity is crucial for the safety and efficacy of therapeutic antibodies.",
        "After careful optimization, we demonstrate the excellent specificity, precision, accuracy and linearity of the established RGA.",
        "Since IL-5 plays an important role in the maturation, survival and migration of eosinophils, hence the pathogenesis of eosinophilic asthma, biotherapeutics targeting IL-5/IL-5R\u03b1 have been developed and/or marketed, including Mepolizumab, Reslizumab, and Benralizumab.",
        "Our study also proves that the assay is superior on precision, sensitivity and assay simplicity to the anti-proliferation assay.",
        "The established RGA is also applicable to another anti-IL-5R\u03b1 mAb.",
        "The current mode of action (MOA) based method used in the quality control and stability tests for anti-IL-5 mAbs is anti-proliferation assay, which is tedious with long duration and high variation.",
        "Eosinophilic asthma is characterized by the eosinophilic inflammation with the allergen independent activation of Th2 lymphocytes.",
        "These results show for the first time that this novel RGA, based on the IL-5-IL-5R-STAT5 pathway, can be a valuable supplement to the anti-proliferation assay and employed in the bioactivity determination of anti-IL-5/anti-IL-5R\u03b1 biotherapeutics.",
        "We describe here the development and validation of a reporter gene assay (RGA), based on an IL-5-dependent TF-1 cell line variant we established that stably expresses the luciferase reporter under the control of STAT5 response elements."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29486600": [
        "Expert opinion: Large pivotal and supportive trials reinforce the view that reslizumab is well tolerated, with an acceptable safety profile in patients exposed for longer than 2 years.",
        "However, no or few data concerning safety in special populations such as smokers, those with immune- and cellular senescence, patients with comorbidities and those receiving multi-drug treatments are available as yet.",
        "Based on efficacy and safety data from pivotal RCTs, reslizumab had been approved for use as an add-on maintenance treatment of severe asthma with an eosinophilic phenotype in adults who have a history of exacerbations despite receiving their current asthma medicines.",
        "Areas covered: Current literature on reslizumab has been reviewed with a specific focus on its safety profile in the treatment of severe asthma.",
        "Furthermore, we need to fully elucidate some fundamental issues such as the risk of anaphylaxis and the long-term risk-benefit ratio of the impact of depletion of eosinophils and the potential risk of malignancies induced by a treatment with this anti-IL-5 agent.",
        "Reslizumab, a humanized mAb against IL-5, reduces the number of eosinophils in the blood and lungs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29554826": [
        "This short review discusses recent studies of the effectiveness of the anti-IL-5 reslizumab in relation to the use of simple reproducible biomarkers in eosinophilic asthma.",
        "Such asthma phenotypes have been identified by reproducible and straightforward discriminatory biomarkers.",
        "A marked heterogeneity is exhibited by asthma both clinically and at the molecular level with different phenotypes driven by diverse mechanistic pathways that require specifically targeted treatments.",
        "Importantly, it is now widely accepted that biologic-based therapies give significant clinical improvements in those patient populations where asthma phenotypes are taken into account.",
        "Biologics aimed at IL-4/13, IL-5 or IgE are proven or potentially effective treatments for patients with difficult to treat eosinophilic asthma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28683596": [
        "Eosinophils have long been implicated as playing a central role in the pathophysiology of asthma in many patients, and eosinophilic asthma is now recognized as an important asthma endotype.",
        "Reslizumab is a humanized monoclonal (immunoglobulin G4/\u03ba) antibody that binds with high affinity to circulating human IL-5 and downregulates the IL-5 signaling pathway, potentially disrupting the maturation and survival of eosinophils.",
        "Reslizumab also demonstrated a favorable tolerability profile similar to that of placebo, with reported adverse events being mostly mild to moderate in severity.",
        "The efficacy of reslizumab as add-on intravenous therapy has been reported in several phase III studies in patients with inadequately controlled moderate-to-severe asthma and elevated blood eosinophil counts (\u2a7e400 cells/\u00b5l).",
        "Eosinophil differentiation, maturation, migration, and survival are primarily under the control of interleukin-5 (IL-5).",
        "Compared with placebo, reslizumab was associated with significant improvements in clinical exacerbation rate, forced expiratory volume in 1 s, asthma symptoms and quality of life, and significant reductions in blood eosinophil counts.",
        "Ongoing studies are focusing on the evaluation of a subcutaneous formulation of reslizumab in patients with asthma and elevated eosinophil levels.",
        "In 2016, an intravenous formulation of reslizumab was approved in the USA, Canada, and Europe as add-on maintenance treatment for patients aged \u2a7e18 years with severe asthma and with an eosinophilic phenotype.",
        "This review discusses the preclinical and clinical trial data available on reslizumab, potential opportunities for predicting an early response to reslizumab, and future directions in the field of anti-IL-5 antibody therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28421429": [
        "Reslizumab (Cinqaero<sup>\u00ae</sup>; Cinqair<sup>\u00ae</sup>) is a humanized monoclonal antibody against interleukin-5 (IL-5), a cytokine mediator of eosinophilic airway inflammation.",
        "Thus, intravenous reslizumab extends the valuable add-on treatment options for adults with severe eosinophilic asthma inadequately controlled with standard therapies.",
        "Reslizumab was generally well tolerated, with very few recipients experiencing severe or serious treatment-related adverse events.",
        "Pooled data from the two trials of 52 weeks' duration indicated similar benefits with reslizumab across various patient subgroups, including patients with severe eosinophilic asthma.",
        "Moreover, in an open-label extension study, continued use of reslizumab for up to 2 years was associated with durable lung function benefit, without any new tolerability concerns.",
        "In three double-blind BREATH studies of up to 52 weeks' duration, adding intravenous reslizumab (3 mg/kg, once every 4 weeks) to the current asthma therapy of patients (aged 12-75 years) with eosinophilic asthma inadequately controlled with inhaled corticosteroids resulted in significant reductions in clinical asthma exacerbation frequency and significant improvements in lung function, asthma control and health-related quality of life relative to adding placebo.",
        "Reslizumab is indicated as an add-on treatment for severe eosinophilic asthma in adults, on the basis of data from the BREATH phase III clinical trial programme."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30346831": [
        "<strong class=\"sub-title\">\n          Rationale:\n        </strong>\n      \n      Reslizumab is a humanized anti-IL-5 monoclonal antibody used as add-on maintenance treatment for patients with uncontrolled eosinophilic asthma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27445482": [
        "These important therapeutic effects of reslizumab, demonstrated by several controlled clinical trials, have led to the recent approval by US Food and Drug Administration of its use, together with other antiasthma medications, for the maintenance treatment of patients suffering from severe uncontrolled asthma.",
        "In particular, reslizumab is a humanized anti-IL-5 monoclonal antibody that has been found to be an effective and safe add-on therapy, capable of decreasing asthma exacerbations and significantly improving disease control and lung function in patients experiencing persistent allergic or nonallergic eosinophilic asthma, despite the regular use of moderate-to-high doses of inhaled corticosteroids.",
        "Within the context of the heterogeneous phenotypic stratification of asthmatic population, many patients are characterized by moderate-to-severe eosinophilic asthma, not adequately controlled by relatively high dosages of inhaled and even oral corticosteroids.",
        "Therefore, these subjects can obtain significant therapeutic benefits by additional biologic treatments targeting interleukin-5 (IL-5), given the key pathogenic role played by this cytokine in maturation, activation, proliferation, and survival of eosinophils."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23326187": [
        "Interleukin-5 is central to eosinophil maturation, release from the bone marrow, and subsequent accumulation, activation, and persistence in the tissues.",
        "Reslizumab (Cinquil\u2122) is a humanized monoclonal antibody with potent interleukin-5 neutralizing effects, which represents a potential treatment for poorly controlled eosinophilic asthma.",
        "This review will consider the current status of the clinical development of reslizumab for asthma and in other inflammatory diseases with a marked eosinophilic component.",
        "Eosinophils are important proinflammatory cells that make a major contribution to the inflammation seen in allergic diseases including asthma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27458609": [
        "Interleukin-5 (IL-5) in particular is an important factor in some forms of severe asthma.",
        "However, initial studies of this antibody in patients with asthma were unsuccessful.",
        "A rat antibody to IL-5 (39D10) was humanized producing the product now know as reslizumab.",
        "Studies of the pathophysiology of eosinophils revealed that they produce many bioactive compounds that contribute to the pathophysiology of a number of diseases including asthma.",
        "These studies have determined that reslizumab is a valuable drug for the management of such patients provided that they have an eosinophil count of &gt; 400 cells/mcL.",
        "The starting point for this drug was the growing realization that eosinophils appeared to be associated with a severe form of asthma in which patients were subject to exacerbations of their condition that could not be adequately managed using inhaled and/or oral corticosteroids.",
        "It was only when the importance of the eosinophilic asthma endotype was recognized that reslizumab was found to indeed reduce the severity and exacerbations of asthma in patients who were inadequately treated by inhaled and/ or oral corticosteroids.",
        "Because a very small percentage of patients receiving reslizumab may experience anaphylaxis, reslizumab must be only given in a facility with adequate facilities and by a health professional trained in the management of anaphylaxis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29581357": [
        "Therefore, this study might contribute to a further understanding of B cell-related pathologies.",
        "Cation homeostasis, in relation to various immune-suppressive diseases, is a novel field of investigation.",
        "Using <i>Magt1</i>-knockout mice (<i>Magt1<sup>-/y</sup></i> ), we show that Mg<sup>2+</sup> homeostasis was impaired in <i>Magt1<sup>-/y</sup></i> B cells and Ca<sup>2+</sup> influx was increased after BCR stimulation, whereas T and NK cell function was unaffected.",
        "Altogether, our study demonstrates for the first time, to our knowledge, that abolished MAGT1 function causes imbalanced cation homeostasis and developmental responses in B cells.",
        "Recently, patients with a loss-of-function mutation in magnesium transporter 1 (MAGT1) were reported to present a dysregulated Mg<sup>2+</sup> homeostasis in T lymphocytes.",
        "Consequently, mutant B cells displayed an increased phosphorylation of BCR-related proteins differentially affecting protein kinase C activation.",
        "These in vitro findings translated into increased frequencies of CD19<sup>+</sup> B cells and marginal zone B cells and decreased frequencies of plasma cells among CD45<sup>+</sup> splenocytes in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30385806": [
        "These results underpin the contribution of magnesium, TRPM7 and MagT1 to autophagy and osteoblastogenesis.",
        "Mesenchymal stem cells are fundamental for bone formation and repair since they respond to microenvironmental stimuli by undergoing osteogenic differentiation.",
        "TRPM7 and MagT1 are upregulated in osteogenic differentiation and silencing either one accelerates osteogenic differentiation, partly through the activation of autophagy.",
        "We show that the kinase and cation channel TRPM7 and the magnesium transporter MagT1 have a role in harmonizing the osteogenic differentiation of human mesenchymal stem cells.",
        "Intriguingly, similar results were obtained when the cells were cultured under magnesium deficient conditions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29051561": [
        "Our data illustrate that [Mg<sup>2+</sup>]i plays a key role in control of HBV infection.",
        "Here, we identified the effects of MAGT1-mediated disturbance of Mg<sup>2+</sup> homeostasis on chronic hepatitis B virus (HBV)-infected natural killer (NK) and CD8<sup>+</sup> T cells.",
        "The expression of MAGT1 was gradually decreased with the increase of infected time in CD8<sup>+</sup> T cells, but not with that in NK cells, of the patients.",
        "Decreased level of intracellular free Mg<sup>2+</sup> ([Mg<sup>2+</sup>]i) leads to defective expression of programmed cell death 1 (PD-1) and the NK activating receptor (NKG2D) in NK and CD8<sup>+</sup> T cells.",
        "The magnesium transporter 1 (MAGT1) is a critical regulator of basal intracellular free magnesium ([Mg<sup>2+</sup>]i) levels.",
        "It has been shown that MAGT1 was involved in the disorder in Mg<sup>2+</sup> homeostasis after Epstein-Barr virus (EBV) infection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29571746": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Many data highlight the benefits of the Mediterranean diet and its main lipid component, extra-virgin olive oil (EVOO).",
        "EVOO contains many phenolic compounds that have been found effective against several aging- and lifestyle-related diseases, including neurodegeneration.",
        "Oleuropein, a phenolic secoiroid glycoside, is the main polyphenol in the olive oil.",
        "It has been reported that the aglycone form of Oleuropein (OleA) interferes in vitro and in vivo with amyloid aggregation of a number of proteins/peptides involved in amyloid, particularly neurodegenerative, diseases avoiding the growth of toxic oligomers and displaying protection against cognitive deterioration."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30323286": [
        "The transcriptional co-activator p300 is a histone acetyltransferase (HAT) that is typically recruited to transcriptional enhancers and regulates gene expression by acetylating chromatin.",
        "Our data explain how cellular signalling and the activation and dimerization of transcription factors control the activation of p300, and therefore explain why gene transcription is associated with chromatin acetylation.",
        "Substrate access to the active site involves the rearrangement of an autoinhibitory RING domain.",
        "Here we show that the activation of p300 directly depends on the activation and oligomerization status of transcription factor ligands.",
        "We describe a crystal structure of p300 in which the autoinhibitory loop invades the active site of a neighbouring HAT domain, revealing a snapshot of a trans-autoacetylation reaction intermediate.",
        "Using two model transcription factors, IRF3 and STAT1, we demonstrate that transcription factor dimerization enables the trans-autoacetylation of p300 in a highly conserved and intrinsically disordered autoinhibitory lysine-rich loop, resulting in p300 activation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23211718": [
        "p300, a transcriptional co-activator with histone acetyl transferase (HAT) activity, plays an essential role in the pathogenesis of cardiomyocyte hypertrophy in response to multiple pro-hypertrophic stimuli including hyperglycemia.",
        "Similar alterations were observed in neonatal rat cardiomyocytes that had been exposed to high levels of glucose. miR-150 mimics inhibited p300 3'-UTR luciferase reporter activity, as well as endogenous p300 expression.",
        "These data demonstrated a novel upstream role for miR-150 in p300-mediated cardiomyocyte hypertrophy and revealed a previously uncharacterized miRNAs and HATs cross-talk mechanism for the hypertrophic phenotype induced by high glucose.",
        "Co-transfection with a p300 expression vector and miR-150 mimics reversed the protective effect of miR-150 on cardiomyocyte hypertrophy.",
        "We observed that the expression of miR-150 was significantly reduced, whereas the expression of p300 was strongly elevated, concomitant with cardiomyocyte hypertrophy, in the hearts of diabetic rats compared with normal controls.",
        "However, the precise mechanisms by which p300 expression is regulated remain unclear.",
        "The purpose of this study was to investigate the role of miR-150, a potential p300-targeting microRNA (miRNA), in the post-transcriptional control of p300 expression and cardiomyocyte hypertrophy induced by high glucose.",
        "In addition, miR-150 mimics prevented glucose-induced cardiomyocyte hypertrophy.",
        "We further showed that the high glucose-mediated activation of PKC\u03b2(2) in turn mediated the down-regulation of miR-150 expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22274814": [
        "It also appears that induction of oxidative stress might be involved in its cytotoxicity, since B16 and HL-60 cells increased their ROS production in response to treatment with diethyl ether extract.",
        "Compared to the effect of the positive control, the anti-inflammatory drug indomethacine (4 mg/kg), which produced a 50 % decrease in inflammation, diethyl ether and N-butanol extracts exhibited about the same effect in doses of 200 and 100 mg/kg (53.6 and 48.7 %; 48.4 and 49.9 %, respectively).",
        "Oral administration of the investigated extracts caused a dose-dependent anti-inflammatory effect in a model of carrageenan-induced rat paw edema.",
        "Apoptotic and necrotic cell death were analyzed by double staining with fluoresceinisothiocyanate (FITC)-conjugated annexin V and PI.",
        "These results demonstrated the potent anti-inflammatory and gastroprotective activities, as well as the promising cytotoxicity.",
        "Gastroprotective activity of the extracts was investigated using an ethanol-induced acute stress ulcer in rats.",
        "Neither of the tested extracts nor any phenolic compounds showed significant cytotoxic effect to human PBMC.",
        "It seems that phenolic compounds (apigenin, luteolin, and their corresponding glycosides) are responsible for the diethyl ether extract cytotoxic effect.",
        "This study aimed to evaluate its gastroprotective and anti-inflammatory activities.",
        "The diethyl ether extract showed significant dose-dependent cytotoxicity on B16 cells and HL-60 cells, decreasing cell growth to 51.3 % and 77.5 % of control, respectively, when used at 100 \u00b5g/mL.",
        "Sideritis scardica Griseb. (ironwort, mountain tea), an endemic plant of the Balkan Peninsula, has been used in traditional medicine in the treatment of gastrointestinal complaints, inflammation, and rheumatic disorders.",
        "All investigated extracts produced dose-dependent gastroprotective activity with the efficacy comparable to that of the reference drug ranitidine.",
        "The developed HPLC method enabled qualitative fingerprint analysis of phenolic compounds in the investigated extracts.",
        "The cytotoxic activity of plant extracts was assessed on PBMC, B16, and HL-60 cells and compared to the cytotoxicity of phenolic compounds identified in extracts.",
        "Besides, continuously increasing interest in assessing the role of the plant active constituents preventing the risk of cancer was a reason to make a detailed examination of the investigated ethanol, diethyl ether, ethyl acetate, and N-butanol extracts regarding cytotoxicity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28956265": [
        "The purpose of the present study is to determine the quantitative biodistribution of GVs, which is critical for their development as imaging agents.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Contrast-enhanced ultrasound plays an expanding role in oncology, but its applicability to molecular imaging is hindered by a lack of nanoscale contrast agents that can reach targets outside the vasculature.",
        "Gas vesicles (GVs)-a unique class of gas-filled protein nanostructures-have recently been introduced as a promising new class of ultrasound contrast agents that can potentially access the extravascular space and be modified for molecular targeting."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29483636": [
        "Non-invasive biological imaging requires materials capable of interacting with deeply penetrant forms of energy such as magnetic fields and sound waves.",
        "Here, we show that gas vesicles (GVs), a unique class of gas-filled protein nanostructures with differential magnetic susceptibility relative to water, can produce robust contrast in magnetic resonance imaging (MRI) at sub-nanomolar concentrations, and that this contrast can be inactivated with ultrasound in situ to enable background-free imaging.",
        "Additionally, clustering-induced changes in MRI contrast enable the design of dynamic molecular sensors.",
        "By coupling the complementary physics of MRI and ultrasound, this nanomaterial gives rise to a distinct modality for molecular imaging with unique advantages and capabilities.",
        "Genetic variants of GVs, differing in their magnetic or mechanical phenotypes, allow multiplexed imaging using parametric MRI and differential acoustic sensitivity.",
        "We demonstrate this capability in vitro, in cells expressing these nanostructures as genetically encoded reporters, and in three model in vivo scenarios."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28880278": [
        "GVs can then be imaged with ultrasound in vitro and in vivo using pulse sequences optimized for their detection versus background.",
        "They can also be imaged with hyperpolarized xenon MRI using chemical exchange saturation transfer between GV-bound and dissolved xenon-a technique currently implemented in vitro.",
        "Pressurized absorbance spectroscopy is used to characterize their mechanical properties, whereas dynamic light scattering (DLS)and transmission electron microscopy (TEM) are used to determine nanoparticle size and morphology, respectively.",
        "Here we provide a protocol for isolating GVs from native and heterologous host organisms, functionalizing these nanostructures with moieties for targeting and fluorescence, characterizing their biophysical properties and imaging them using ultrasound and MRI.",
        "Taking 3-8 d to prepare, these genetically encodable nanostructures enable multimodal, noninvasive biological imaging with high sensitivity and potential for molecular targeting.",
        "GVs can be isolated from natural cyanobacterial and haloarchaeal host organisms or from Escherichia coli expressing a heterologous GV gene cluster and purified using buoyancy-assisted techniques.",
        "Gas vesicles (GVs) are a unique class of gas-filled protein nanostructures that are detectable at subnanomolar concentrations and whose physical properties allow them to serve as highly sensitive imaging agents for ultrasound and MRI.",
        "They can then be modified by replacing surface-bound proteins with engineered, heterologously expressed variants or through chemical conjugation, resulting in altered mechanical, surface and targeting properties."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27351374": [
        "Ultrasound is among the most widely used biomedical imaging modalities, but has limited ability to image specific molecular targets due to the lack of suitable nanoscale contrast agents.",
        "Furthermore, as a genetically encoded material, gas vesicles present the possibility that the nanoscale mechanical, acoustic, and targeting properties of an imaging agent can be engineered at the level of its constituent proteins.",
        "Their unique physical properties give gas vesicles significant advantages over conventional microbubble contrast agents, including nanoscale dimensions and inherent physical stability.",
        "Gas vesicles-genetically encoded protein nanostructures isolated from buoyant photosynthetic microbes-have recently been identified as nanoscale reporters for ultrasound.",
        "Here, we demonstrate that genetic engineering of gas vesicles results in nanostructures with new mechanical, acoustic, surface, and functional properties to enable harmonic, multiplexed, and multimodal ultrasound imaging as well as cell-specific molecular targeting.",
        "These results establish a biomolecular platform for the engineering of acoustic nanomaterials."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30111043": [
        "Taking cinobufagin as an internal reference substance, QAMS was verified for the determination of five bufagenins (gamabufotalin, bufotalin, bufalin, cinobufagin, resibufogenin) in toad venom samples.",
        "The characteristic chromatogram and QAMS established in this study could effectively control the quality of toad venom and provide scientific evidence for the improvement of the quality standard of the toad venom to be described in Chinese Pharmacopoeia (2020 edition).",
        "So, it is urgent to establish a scientific and perfect quality control method to improve the quality of toad venom and guarantee its safety and effectiveness in clinical application.",
        "Up to now, much attention shall be paid to the poor quality of commercial toad venom because of the adulteration.",
        "RCFs of cinobufagin to gamabufotalin, bufotalin, bufalin and resibufogenin were determined as 1.05, 0.895, 1.09 and 0.913, respectively.",
        "The durability and applicability of the relative correction factor (RCF) were also studied systematically.",
        "Toad venom (Chansu) is prepared from the dried secretion of parotid gland and skin gland from Bufo bufo gargarizans or B. melanostictus.",
        "As a result, the reference characteristic chromatogram was established, displaying serotonin, gamabufotalin, arenobufagin, hellebrigenin, telocinobufagin, bufotalin, cinobufotalin, bufalin, cinobufagin and resibufogenin as characteristic peaks.",
        "The different batches of toad venom samples were assayed by high performance liquid chromatography (HPLC) and the quantitative analysis of multi-components by single marker (QAMS) was used to detect the contents of five bufagenins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28631214": [
        "Compounds were detected both after inducing skin gland secretions and in constitutive mucosal rinses from toads.",
        "The maximum Bd inhibition produced by arenobufagin, gamabufotalin, and telocinobufagin were approximately 50%, in contrast to the complete Bd inhibition shown by antimicrobial skin peptides produced by some amphibian species.",
        "Further studies investigating bufadienolide expression across toad populations, their regulation, and interactions with other components of the skin mucosome will contribute to understanding the complexities of amphibian immune defense.",
        "Amphibian granular glands provide a wide range of compounds on the skin that defend against pathogens and predators.",
        "Overall, our results suggest that bufadienolides can function in antifungal defense on amphibian skin and their production is a potentially convergent trait similar to antimicrobial peptide defenses found on the skin of other species.",
        "All three bufadienolides were found to inhibit Bd growth at similar levels.",
        "We identified three bufadienolides-the steroid-like compounds arenobufagin, gamabufotalin, and telocinobufagin-from the boreal toad, Anaxyrus boreas, through liquid chromatography mass spectrometry (LC/MS).",
        "Here, we localized skin bacteria within the mucus layer and granular glands of toads with fluorescent in situ hybridization.",
        "Bufadienolides also appeared to enhance growth of the anti-Bd bacterium Janthinobacterium lividum, and thus may be involved in regulation of the skin microbiome.",
        "In addition, skin mucus samples significantly reduced Bd viability, and bufadienolides were detected in 15 of 62 samples.",
        "We described the antimicrobial properties of each bufadienolide against Batrachochytrium dendrobatidis (Bd), an amphibian fungal pathogen linked with boreal toad population declines."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26894970": [
        "In the current study, gamabufotalin (GBT) was isolated from toad venom, and its tumor-specific cytotoxicity was investigated in human MM cells.",
        "Further analysis showed that GBT especially evoked the ubiquitination and degradation of c-Myc protein, thereby globally repressing the expression of c-Myc target genes.",
        "We found GBT inhibited cell growth and induced apoptosis with the IC50 values &lt;50 nM.",
        "The antitumor effect of GBT was validated in a xenograft mouse model and the suppression of MM-induced osteolysis was verified in a SCID-hu model in vivo.",
        "Deciding appropriate therapy for multiple myeloma (MM) is challenging because of the occurrence of multiple chromosomal changes and the fatal nature of the disease.",
        "Taken together, our study identified the potential of GBT as a promising therapeutic agent in the treatment of MM.",
        "Mechanistic studies using functional approaches identified GBT as an inhibitor of c-Myc.",
        "GBT treatment inhibited ERK and AKT signals, while stimulating the activation of JNK cascade.",
        "An E3 ubiquitin-protein ligase, WWP2, was upregulated following JNK activation and played an important role in c-Myc ubiquitination and degradation through direct protein-protein interaction."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25175164": [
        "However, the underlying mechanism of CS-6 involved in anti-tumor activity remains poorly understood.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Gamabufotalin (CS-6), a major bufadienolide of Chansu, has been used for cancer therapy due to its desirable metabolic stability and less adverse effect."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29754476": [
        "Here, I provide a comprehensive description of the optimal approach for identifying functional units of super-enhancers and their unique chromatin features in normal development and in diseases, including cancers.",
        "With the recent progress in genome-wide technologies, the genomic landscapes of enhancers have been broadly explored in mammalian genomes, which led to the discovery of novel specific subsets of enhancers, termed super-enhancers.",
        "This review will provide perspectives on using super-enhancers as biomarkers to develop novel disease diagnostic tools and establish new directions in clinical therapeutic strategies.",
        "I also review the recent updated knowledge on novel approaches of targeting super-enhancers for the treatment of specific diseases, such as small-molecule inhibitors and potential gene therapy.",
        "The transcriptional regulation of genes determines the fate of animal cell differentiation and subsequent organ development.",
        "Super-enhancers are large clusters of enhancers covering the long region of regulatory DNA and are densely occupied by transcription factors, active histone marks, and co-activators.",
        "Accumulating evidence points to the critical role that super-enhancers play in cell type-specific development and differentiation, as well as in the development of various diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25914650": [
        "This has broadened its range of action and apelin now appears clearly as a new player in energy metabolism in addition to leptin and adiponectin.",
        "Apelin, a ubiquitously expressed peptide was known to exert different physiological effects mainly on the cardiovascular system and the regulation of fluid homeostasis prior to its characterization as an adipokine.",
        "The advances concerning the role of apelin in metabolic diseases in relation with the recent reports on apelin concentrations in obese and/or diabetic subjects will also be discussed.",
        "Moreover, different studies in both animals and humans have shown that plasma apelin concentrations are usually increased during obesity and type 2 diabetes.",
        "This mini-review will focus on the various systemic apelin effects on energy metabolism by addressing its mechanisms of action.",
        "Apelin has been shown to act on glucose and lipid metabolism but also to modulate insulin secretion.",
        "A wide range of adipokines identified over the past years has allowed considering the white adipose tissue as a secretory organ closely integrated into overall physiological and metabolic control."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29229313": [
        "Hence, the present review summarizes the regulatory roles of adipocytokines in diabetes linked with obesity.",
        "Thus, it can be considered 1 of the candidate genes for obesity and type 2 diabetes.",
        "All these adipocytokines play significant roles in the regulation of energy metabolism, glucose and lipid metabolism, reproduction, cardiovascular function and immunity.",
        "Adipocytokines are significantly regulated by nutritional status and can directly influence other organ systems, including brain, liver and skeletal muscle.",
        "Ghrelin, the circulating peptide, has been found to stimulate appetite and regulate energy balance.",
        "Adipose tissue is an enormously active endocrine organ, secreting various hormones, such as adiponectin, leptin, resistin and visfatin, together with classical cytokines, such as tumor necrosis factor-alpha (TNF-\u03b1) and interleukin-6 (IL-6).",
        "Upregulated expression of resistin, vaspin, apelin and TNF-\u03b1 plays a significant role in induction of insulin resistance linked with obesity and type 2 diabetes.",
        "Adiponectin plays a key role as an anti-inflammatory hormone.",
        "Omentin is a novel adipokine produced by visceral adipose tissue.",
        "Circulating levels of omentin are decreased in insulin-resistant states, for example, in obesity and diabetes.",
        "IL-6 plays a vital role in regulating the accumulation of lipids intramyocardially.",
        "Based on the biologic relevance of these adipocytokines, they can no longer be considered as energy storage sites alone but must also be considered in metabolic control."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19756893": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The physiological role of apelin in obesity and diabetes remains unclear.",
        "Although apelin has been studied in persons with different conditions, no studies have yet examined the joint influence of obesity and diabetes on apelin levels.",
        "We measured the changes in apelin levels in morbidly obese subjects, with and without diabetes, and in the inverse situation of improvement in carbohydrate metabolism as a result of bariatric surgery."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24721640": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Apelin regulates insulin sensitivity and secretion in animals.",
        "However, whether plasma apelin predicts incident diabetes in humans remains unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30265292": [
        "We suggest that the peculiar GiTim17 sequence reflects adaptation to the unusual, detergent resistant, inner mitosomal membrane.",
        "Mitochondria have evolved diverse forms across eukaryotic diversity in adaptation to anoxia.",
        "Transport of proteins via TIM complexes, composed of three proteins of the Tim17 protein family (Tim17/22/23), is one of the key unifying aspects of mitochondria and mitochondria-derived organelles.",
        "Analysis of TIM complexes across eukaryote diversity suggests that a \"single Tim\" translocase is a convergent adaptation of mitosomes in anaerobic protists, with Tim22 and Tim17 (but not Tim23), providing the protein backbone.",
        "Mitosomes are the simplest and the least well-studied type of anaerobic mitochondria.",
        "Here, we present the identification of a single G. intestinalis Tim17 protein (GiTim17), made possible only by the implementation of a metamonad-specific hidden Markov model.",
        "Specific pull-down experiments indicate interaction of GiTim17 with mitosomal Tim44, the tethering component of the import motor complex.",
        "While very divergent in primary sequence and in predicted membrane topology, experimental data suggest that GiTim17 is an inner membrane mitosomal protein, forming a disulphide-linked dimer.",
        "However, multiple experimental and bioinformatic attempts have so far failed to identify the nature of TIM in mitosomes of the anaerobic metamonad protist, Giardia intestinalis, one of the few experimental models for mitosome biology."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28372543": [
        "Here, we investigated the dynamics of the mitosomes, the simplest forms of mitochondria, in the anaerobic protist parasite Giardia intestinalis, a member of the Excavata supergroup of eukaryotes.",
        "The mitosomes have abandoned typical mitochondrial traits such as the mitochondrial genome and aerobic respiration and their single role known to date is the formation of iron-sulfur clusters.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Mitochondria of opisthokonts undergo permanent fission and fusion throughout the cell cycle."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21984067": [
        "The apicomplexan parasite Cryptosporidium parvum possesses a mitosome, a relict mitochondrion with a greatly reduced metabolic capability.",
        "The small Tim protein family is a case in point.",
        "The genomes of C. parvum and related species of Cryptosporidium each encode just one small Tim protein, CpTimS.",
        "We show that the atypical CpTimS exists as a relatively unstable homohexamer, shedding light both on the early evolution of the small Tim protein family and on small Tim hexamer formation in contemporary eukaryotes.",
        "This observation challenged the tenet that small Tim proteins are always found in pairs as \u03b13\u03b23 hexamers.",
        "This mitosome houses a mitochondrial-type protein import apparatus, but elements of the protein import pathway have been reduced, and even lost, through evolution."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20382757": [
        "All truncated PNTs failed to reach vesicles/vacuoles and were retained in the endoplasmic reticulum.",
        "These data indicate that the putative targeting signal is not sufficient for the trafficking of PNT to the vesicular/vacuolar compartments and that full-length PNT is necessary for correct transport.",
        "Pyridine nucleotide transhydrogenase (PNT) catalyzes the direct transfer of a hydride-ion equivalent between NAD(H) and NADP(H) in bacteria and the mitochondria of eukaryotes.",
        "PNT displayed a smear of &gt;120 kDa on SDS-PAGE gels.",
        "The domain(s) required for the trafficking of PNT to vesicles/vacuoles was examined by using amoeba transformants expressing a series of carboxyl-terminally truncated PNTs fused with green fluorescent protein or a hemagglutinin tag.",
        "PNT was previously postulated to be localized to the highly divergent mitochondrion-related organelle, the mitosome, in the anaerobic/microaerophilic protozoan parasite Entamoeba histolytica based on the potential mitochondrion-targeting signal.",
        "An immunofluorescence assay using anti-E. histolytica PNT (EhPNT) antibody raised against the NADH-binding domain showed a distribution to the membrane of numerous vesicles/vacuoles, including lysosomes and phagosomes.",
        "PNGase F and tunicamycin treatment, chemical degradation of carbohydrates, and heat treatment of PNT suggested that the apparent aberrant mobility of PNT is likely attributable to its hydrophobic nature.",
        "PNT that is compartmentalized to the acidic compartments is unprecedented in eukaryotes and may possess a unique physiological role in E. histolytica.",
        "However, our previous proteomic study of isolated phagosomes suggested that PNT is localized to organelles other than mitosomes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29764166": [
        "Chimeric antigen receptor (CAR) T cells represent a medical and scientific breakthrough that may represent a paradigm for the future of personalized medicine in the age of cancer immunotherapy.",
        "At the time of the writing of this article, there are two CAR T cells available, Kymriah, produced by Novrtis with a price tag of US$475,000 and Yescarta produced by Gilead Pharmaceuticals with a price tag of US$373,000, neither price including the required hospital admission in order to administer the agent in addition to potential treatment of side effects.",
        "While only approved for less than a year, there are thoughts about how to bring the price down with more approved CAR T cells and more center with the ability to administer this therapy, however results may be years away before they are realized.",
        "There are several issues that are imperative to recognize when understanding the high cost, however the two more pertinent issues are low availability of the agent and no billing code.",
        "Regardless, its high price tag highlights moral issues underlying value-based payments and whether the treatment is worth the cost while evaluating the juxtaposition of life years and monetary values.",
        "As CAR T cells expand the boundaries of immunotherapy with extraordinary results, the need for a lower price in combination for more availability of CAR T cells will grow until some of these fundamental issues are addressed.",
        "As with many new cancer agents, such novel and incredible results come with a high price.",
        "In the short term, insurance companies are grappling over how to pay for CAR T therapy, with one of the biggest voids concerning the absence of a billing code for CAR T cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30145372": [
        "A reliable QSAR model based on molecular descriptors was obtained (R<sup>2</sup>: 0.83; Q<sup>2</sup><sub>CV</sub>: 0.69 and Q<sup>2</sup><sub>EXT/F2</sub>: 0.66) indicating that stronger inhibition requires a balanced distribution of the hydrophobic regions across the molecular surface, as well as higher width and lower hydrophobicity of the molecules.",
        "Focused on contributing to the development of new therapeutic alternatives for NDs, in this study, for the first time, a screening of 57 natural products for in vitro inhibition of Leishmania major DHODH (LmDHODH) was carried out, including cross validation against the human DHODH (HsDHODH).",
        "Additionally, thermostability studies by differential scanning fluorimetry (DSF) were performed to determine whether the STLs are effectively or not binding to the enzyme.",
        "These data indicated for the first time that natural products can actually inhibit LmDHODH and highlighted some metabolites as potentially interesting starting points for the discovery of more potent LmDHODH inhibitors, ultimately aiming at new effective therapeutic alternatives for leishmaniasis and, possibly, other NDs caused by trypanosomatids.",
        "DSF assays confirmed binding of STLs to LmDHODH; moreover, it is suggested that such inhibitors might act in a different site other than the active site.",
        "The IC<sub>50</sub> values against LmDHODH varied from 27 to 1200 \u03bcM; only irrelevant inhibition was obtained on HsDHODH.",
        "A subset of natural products consisting of 21 sesquiterpene lactones (STLs) was submitted to QSAR studies.",
        "Thus, this enzyme stands out as a new key molecular target for parasites causing Neglected Diseases (NDs).",
        "A pharmacophore-based 3D-QSAR approach also afforded a useful model (R<sup>2</sup>: 0.72; Q<sup>2</sup><sub>CV</sub>: 0.50 and Q<sup>2</sup><sub>EXT/F2</sub>: 0.62), which confirmed the importance of proper orientation of the ligands, molecular surface features and shape for stronger inhibition, reflecting properties of a putative common binding site.",
        "The flavoenzyme dihydroorotate dehydrogenase (DHODH) catalyzes the fourth reaction of the de novo pyrimidine biosynthetic pathway, which exerts vital functions in the cells, especially within DNA and RNA biosynthesis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30233375": [
        "In addition, the cytotoxicities of <b>1</b> and its potent derivatives <b>7</b>, <b>8</b>, and <b>9</b> were studied using human cultured cancer cells.",
        "The selectivity ratio of <b>8</b> under this microenvironment show the most potent inhibition which was over 1000-fold higher compared to that under normal culture condition.",
        "We conducted a structure-activity relationship study and have identified functional groups of <b>1</b> that are essential for the inhibition of HsDHODH enzymatic activity.",
        "Our studies suggest that under microenvironment conditions, cancer cells heavily depend on the pyrimidine <i>de novo</i> biosynthesis pathway.",
        "We also provide the first evidence that <b>1</b> and its derivatives are potential lead candidates for drug development which target the HsDHODH of cancer cells living under a tumor microenvironment.",
        "We have discovered ascofuranone (<b>1</b>), a natural compound produced by <i>Acremonium sclerotigenum</i>, and its derivatives are a potent class of HsDHODH inhibitors.",
        "Interestingly, they showed selective and strong cytotoxicity to cancer cells cultured under microenvironment (hypoxia and nutrient-deprived) conditions.",
        "Furthermore, the binding mode of <b>1</b> and its derivatives to HsDHODH was demonstrated by co-crystallographic analysis and we show that these inhibitors bind at the ubiquinone binding site.",
        "Human dihydroorotate dehydrogenase (HsDHODH) is a key enzyme of pyrimidine <i>de novo</i> biosynthesis pathway.",
        "It is located on the mitochondrial inner membrane and contributes to the respiratory chain by shuttling electrons to the ubiquinone pool."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27481247": [
        "In Toxoplasma gondii, disruption of the first, fifth, or sixth step of de novo pyrimidine biosynthesis induced uracil auxotrophy.",
        "Dihydroorotate dehydrogenase (DHODH) mediates the fourth step of de novo pyrimidine biosynthesis and is a proven drug target for inducing immunosuppression in therapy of human disease as well as a rapidly emerging drug target for treatment of malaria.",
        "Replacement of the endogenous DHODH gene with catalytically deficient DHODH gene alleles induced uracil auxotrophy.",
        "Catalytically deficient TgDHODH localized to the mitochondria, and parasites retained mitochondrial membrane potential.",
        "To further address the essentiality of TgDHODH, mutant gene alleles deficient in TgDHODH activity were designed to ablate the enzyme activity.",
        "However, previous attempts to generate uracil auxotrophy by genetically deleting the mitochondrion-associated DHODH of T. gondii (TgDHODH) failed.",
        "These results show that TgDHODH is essential for the synthesis of pyrimidines and suggest that TgDHODH is required for a second essential function independent of its role in pyrimidine biosynthesis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20334617": [
        "While there are a number of drugs approved for its treatment, drug resistance has compromised most of them, making the development of new drugs for the treatment and prevention of malaria essential.",
        "The pyrimidine biosynthetic pathway illustrates one of the best examples of successful identification of anti-malarial drug targets.",
        "Potent activity against parasites in whole cell models with good correlation between activity on the enzyme and the parasite have also been observed for a number of the identified series.",
        "The challenge remains to identify compounds with the necessary combination of potency and metabolic stability to allow identification of a clinical candidate.",
        "Lead optimization of a triazolopyrimidine-based series has identified an analog with prolonged plasma exposure, that is orally bioavailable, and which shows good efficacy against the in vivo mouse model of the disease.",
        "The completion of the Plasmodium falciparum genome and a growing understanding of parasite biology are fueling the search for novel drug targets.",
        "These data provide strong evidence that PfDHODH is a validated target for the identification of new antimalarial chemotherapy.",
        "Several chemical scaffolds have been identified by high throughput screening as potent inhibitors of PfDHODH and these show strong selectivity for the malarial enzyme over that from the human host.",
        "Malaria remains a globally prevalent infectious disease that leads to significant morbidity and mortality.",
        "This review focuses on recent studies to exploit the fourth enzyme in the de novo pyrimidine biosynthetic pathway of P. falciparum, dihydroorotate dehydrogenase (PfDHODH), as a new target for drug discovery.",
        "Despite this, few targets have been chemically validated in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28666740": [
        "It also attempts to describe the latest advances in medicinal chemistry for therapeutic development based on the selective inhibition of DHODH, including an overview of the experimental techniques used for ligand screening during the process of drug discovery.",
        "Through a chronological narrative, this review summarizes the efforts of the scientific community to achieve our current understanding of structural and biochemical properties of DHODHs.",
        "Inhibition of pyrimidine metabolism by selectively targeting DHODHs has been exploited in the development of new therapies against cancer, immunological disorders, bacterial and viral infections, and parasitic diseases.",
        "The flavoenzyme dihydroorotate dehydrogenase catalyzes the stereoselective oxidation of (S)-dihydroorotate to orotate in the fourth of the six conserved enzymatic reactions involved in the de novo pyrimidine biosynthetic pathway."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17228860": [
        "Pyrimidine biosynthesis presents an attractive drug target in malaria parasites due to the absence of a pyrimidine salvage pathway.",
        "PfDHODH-specific inhibitors with low nanomolar binding affinities were identified that bind in the N-terminal hydrophobic channel of dihydroorotate dehydrogenase, the presumed site of ubiquinone binding during oxidation of dihydroorotate to orotate.",
        "These results further highlight PfDHODH as a promising new target for chemotherapeutic intervention in prevention of malaria and provide better understanding of the factors that determine specificity over human dihydroorotate dehydrogenase.",
        "Models that suggest the mode of inhibitor binding is based on shape complementarity, matching hydrophobic regions of inhibitor and enzyme, and interaction of inhibitors with amino acid residues F188, H185, and R265 are supported by mutagenesis data.",
        "These compounds also prevented growth of cultured parasites at low micromolar concentrations.",
        "A set of compounds designed to inhibit the Plasmodium falciparum pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (PfDHODH) was synthesized."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16172019": [
        "T. cruzi and human DHOD have different biochemical properties, including the electron acceptor capacities and cellular localization, suggesting that T. cruzi DHOD may be a potential chemotherapeutic target against Chagas' disease.",
        "Here, we report nucleotide sequence polymorphisms of T. cruzi DHOD genes and the kinetic properties of the recombinant enzymes.",
        "Our findings facilitate further exploitation of T. cruzi DHOD inhibitors, as chemotherapeutic agents against Chagas' disease.",
        "These results suggest that, despite their genetic variations, kinetic properties of the three T. cruziDHODs are conserved.",
        "In contrast, all residues critical for constituting the active site are conserved among the three proteins.",
        "In contrast, DHOD3 had a higher Vmax and Km for both substrates.",
        "T. cruzi Tulahuen strain possesses three DHODgenes: DHOD1 and DHOD2, involved in the pyrimidine biosynthetic (pyr) gene cluster on an 800 and a 1000 kb chromosomal DNA, respectively, and DHOD3, located on an 800 kb DNA.",
        "The three DHOD genes differ by 26 nucleotides, resulting in replacement of 8 amino acid residues.",
        "Dihydroorotate dehydrogenase (DHOD) is the fourth enzyme in the de novo pyrimidine biosynthetic pathway and is essential in Trypanosoma cruzi, the parasitic protist causing Chagas' disease.",
        "Recombinant T. cruzi DHOD1 and DHOD2 expressed in E. coli possess similar enzymatic properties, including optimal pH, optimal temperature, Vmax, and Km for dihydroorotate and fumarate.",
        "Orotate competitively inhibited all three DHOD enzymes to a comparable level.",
        "The open reading frames of all three DHOD genes are comprised of 942 bp, and encode proteins of 314 amino acids."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18312275": [
        "Nucleotide biosynthesis pathways have been reported to be essential in some protozoan pathogens.",
        "We also show that this trypanosomal enzyme is inhibited by known inhibitors of bacterial Class 1A DHODH, in distinction to the sensitivity of DHODH from human and other higher eukaryotes.",
        "This selectivity is supported by the crystal structure of the T. brucei enzyme, which is reported here at a resolution of 1.95 A. Additional research, guided by the crystal structure described herein, is needed to identify potent inhibitors of T. brucei DHODH.",
        "Specifically, a combination therapy including a T. brucei-specific DHODH inhibitor plus 5-FU may prove to be an effective therapeutic strategy.",
        "RNAi knockdown of DHODH expression in bloodstream form T. brucei did not inhibit growth in normal medium, but profoundly retarded growth in pyrimidine-depleted media or in the presence of the known pyrimidine uptake antagonist 5-fluorouracil (5-FU).",
        "These results have significant implications for the development of therapeutics to combat T. brucei infection.",
        "Hence, we evaluated the essentiality of one enzyme in the pyrimidine biosynthetic pathway, dihydroorotate dehydrogenase (DHODH) from the eukaryotic parasite Trypanosoma brucei through gene knockdown studies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19351152": [
        "Pyrimidine biosynthesis is an attractive drug target in a variety of organisms, including humans and the malaria parasite Plasmodium falciparum.",
        "In this study, we have applied SPROUT-LeadOpt, a software package for structure-based drug discovery and lead optimization, to improve the binding of the active metabolite of the anti-inflammatory drug leflunomide to the target cavities of the P. falciparum and human dihydroorotate dehydrogenases.",
        "Dihydroorotate dehydrogenase, an enzyme catalyzing the only redox reaction of the pyrimidine biosynthesis pathway, is a well-characterized target for chemotherapeutical intervention.",
        "Furthermore, cocrystal structures of five of these SPROUT-designed inhibitors bound in the ubiquinone binding cavity of the human dihydroorotate dehydrogenase are also analyzed.",
        "Following synthesis of a library of compounds based upon the SPROUT-optimized molecular scaffolds, a series of inhibitors generally showing good inhibitory activity was obtained, in keeping with the SPROUT-LeadOpt predictions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24900364": [
        "We report herein the synthesis and structure-activity relationship of a series of 5-(2-methylbenzimidazol-1-yl)-N-alkylthiophene-2-carboxamides that are potent inhibitors against PfDHODH but do not inhibit the human enzyme.",
        "On the basis of efficacy observed in three mouse models of malaria, acceptable safety pharmacology risk assessment and safety toxicology profile in rodents, lack of potential drug-drug interactions, acceptable ADME/pharmacokinetic profile, and projected human dose, 5-(4-cyano-2-methyl-1H-benzo[d]imidazol-1-yl)-N-cyclopropylthiophene-2-carboxamide 2q was identified as a potential drug development candidate.",
        "Inhibition of dihydroorotate dehydrogenase (DHODH) for P. falciparum potentially represents a new treatment option for malaria, since DHODH catalyzes the rate-limiting step in the pyrimidine biosynthetic pathway and P. falciparum is unable to salvage pyrimidines and must rely on de novo biosynthesis for survival."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27744189": [
        "The trifluoromethyl group at the 2- or 5-positions of the pyrazolo[1,5-a]pyrimidine ring led to increased drug activity.",
        "Four compounds showed the highest selective index (SI), which is a ratio between cytotoxicity and activity in vitro.",
        "The compounds were tested against Plasmodium falciparum, as antimalarials in mice with P. berghei, and as inhibitors of PfDHODH.",
        "Malaria remains one of the most serious global infectious diseases.",
        "The docking results agreed with the values obtained from enzymatic assays.",
        "In this study, we have designed and synthesized fifteen 7-arylpyrazolo[1,5-a]pyrimidine derivatives using ring bioisosteric replacement and molecular hybridization of functional groups based on the highly active 5-methyl-N-(naphthalen-2-yl)-2-(trifluoromethyl)- [1,2,4]triazolo[1,5-a]pyrimidin-7-amine.",
        "Thirteen compounds were found to be active against P. falciparum, with IC<sub>50</sub> values ranging from 1.2 \u00b1 0.3 to 92 \u00b1 26 \u03bcM in the anti-HRP2 and hypoxanthine assays.",
        "An important target for antimalarial chemotherapy is the enzyme dihydroorotate dehydrogenase from Plasmodium falciparum (PfDHODH), which is responsible for the conversion of dihydroorotate to orotate in the de novo pyrimidine biosynthetic pathway.",
        "The inhibition of PfDHODH showed that compound 30 (R<sub>2</sub> = CH<sub>3</sub>; R<sub>5</sub> = CF<sub>3</sub>; Ar = 7-\u03b2-naphthyl) displayed higher and selective inhibitory activity, with IC<sub>50</sub> = 0.16 \u00b1 0.01 \u03bcM, followed by 25 (R<sub>2</sub> = CH<sub>3</sub>; R<sub>5</sub> = CH<sub>3</sub>; Ar = 7-\u03b2-Naphthyl) and 19 (R<sub>2</sub> = CF<sub>3</sub>; R<sub>5</sub> = CF<sub>3</sub>; Ar = 7-\u03b2-naphthyl), with IC<sub>50</sub> = 4 \u00b1 1 \u03bcM and 6 \u00b1 1 \u03bcM, respectively."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26088338": [
        "Dihydroorotate dehydrogenase (DHODH) is an enzyme in the pyrimidine biosynthetic pathway which is an important target for anti-hyperproliferative and anti-inflammatory drug design.",
        "Since these enzymes share a common role in the DNA replication and repair mechanisms, it may be beneficial to target both PARP-1 and DHODH in attempts to design new anti-cancer agents.",
        "Benzimidazole derivatives have shown a wide variety of pharmacological activities including PARP and DHODH inhibition.",
        "Amongst these polymerases is PARP-1 which is the key DNA damage-sensing enzyme that acts as an initiator for the DNA repair mechanism.",
        "We hereby report the design, synthesis and bioactivities of a series of benzimidazole derivatives as inhibitors of both the PARP-1 and DHODH enzymes.",
        "Poly (ADP-ribose) polymerases (PARPs) play diverse roles in various cellular processes that involve DNA repair and programmed cell death."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22542640": [
        "This is the first structural evidence of a relationship between the dimeric form and the catalytic mechanism.",
        "In this study, we report the crystal structures of DHODH from Leishmania major, the species of Leishmania associated with zoonotic cutaneous leishmaniasis, in its apo form and in complex with orotate and fumarate molecules.",
        "Analysis of LmDHODH structures reveals that rearrangements in the conformation of the catalytic loop have direct influence on the dimeric interface.",
        "Dihydroorotate dehydrogenase (DHODH) is the fourth enzyme in the de novo pyrimidine biosynthetic pathway and has been exploited as the target for therapy against proliferative and parasitic diseases.",
        "Both orotate and fumarate were found to bind to the same active site and exploit similar interactions, consistent with a ping-pong mechanism described for class 1A DHODHs.",
        "According to our analysis, the high sequence and structural similarity observed among trypanosomatid DHODH suggest that a single strategy of structure-based inhibitor design can be used to validate DHODH as a druggable target against multiple neglected tropical diseases such as Leishmaniasis, Sleeping sickness and Chagas' diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20702404": [
        "Compounds from this series demonstrated in vitro potency against the 3D7 and Dd2 strains of P. falciparum, good tolerability and oral exposure in the mouse, and ED(50) values in the 4-day murine P. berghei efficacy model of 13-21 mg/kg/day with oral twice-daily dosing.",
        "A high throughput screen and subsequent medicinal chemistry program identified a series of N-alkyl-5-(1H-benzimidazol-1-yl)thiophene-2-carboxamides with low nanomolar in vitro potency against DHODH from P. falciparum, P. vivax, and P. berghei.",
        "The compounds were selective for the parasite enzymes over human DHODH, and x-ray structural data on the analog Genz-667348, demonstrated that species selectivity could be attributed to amino acid differences in the inhibitor-binding site.",
        "Plasmodium falciparum, the causative agent of the most deadly form of human malaria, is unable to salvage pyrimidines and must rely on de novo biosynthesis for survival.",
        "In particular, treatment with Genz-667348 at 100 mg/kg/day resulted in sterile cure.",
        "Dihydroorotate dehydrogenase (DHODH) catalyzes the rate-limiting step in the pyrimidine biosynthetic pathway and represents a potential target for anti-malarial therapy.",
        "Two recent analogs of Genz-667348 are currently undergoing pilot toxicity testing to determine suitability as clinical development candidates."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25945707": [
        "The relevance of nucleotide-biosynthetic pathways for cell metabolism together with structural and functional differences from the respective host enzyme suggests that inhibition of LbDHODH could be exploited for antileishmanicidal drug development.",
        "(V.) braziliensis is the species responsible for the mucosal form of leishmaniasis, a neglected disease for which no cure or effective therapy is available.",
        "Analyses of sequence, structural and kinetic features classify LbDHODH as a member of the class 1A DHODHs and reveal a very high degree of structural conservation with the previously reported structures of orthologous trypanosomatid enzymes.",
        "The enzyme dihydroorotate dehydrogenase (DHODH) is a flavoenzyme that catalyses the oxidation of dihydroorotate to orotate in the de novo pyrimidine-biosynthesis pathway.",
        "In this study, a reproducible protocol for the heterologous expression of active dihydroorotate dehydrogenase from Leishmania (Viannia) braziliensis (LbDHODH) was developed and its crystal structure was determined at 2.12 \u00c5 resolution.",
        "The present work provides the framework for further integrated in vitro, in silico and in vivo studies as a new tool to evaluate DHODH as a drug target against trypanosomatid-related diseases.",
        "L."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/1348618": [
        "The order of effectiveness as inhibitors on pyrimidine ring cleavage reaction for dihydroorotase was 5-fluoro orotate greater than 5-amino orotate, 5-methyl orotate greater than orotate greater than 5-bromo orotate greater than 5-iodo orotate with Ki values of 65, 142, 166, 860, 2200 and greater than 3500 microM, respectively.",
        "Orotate and a series of 5-substituted derivatives were found to inhibit competitively the purified enzymes from the malaria parasite.",
        "The infected mice treated with 5-fluoro orotate at a lower dose of 2.5 mg/kg had a 95% reduction in parasitemia.",
        "5-Fluoro orotate and orotate were the most effective inhibitors for dihydroorotate dehydrogenase.",
        "In mice infected with P. berghei, these two orotate analogs at a dose of 25 mg/kg body weight eliminated parasitemia after a 4-day treatment, an effect comparable to that of the same dose of chloroquine.",
        "The effects of the more potent compounds tested in combination with inhibitors of other enzymes of this pathway on P. falciparum in vitro and P. berghei in vivo are currently under investigation.",
        "These results suggest that the pyrimidine biosynthetic pathway in the malarial parasite may be a target for the design of antimalarial drugs.",
        "In vitro, 5-fluoro orotate and 5-amino orotate caused 50% inhibition of the growth of P. falciparum at concentrations of 10 nM and 1 microM, respectively.",
        "Dihydroorotase and dihydroorotate dehydrogenase, two enzymes of the pyrimidine biosynthetic pathway, were purified from Plasmodium berghei to apparent homogeneity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18842591": [
        "The primary antimalarial mechanism of action of these compounds was confirmed to be inhibition of pfDHOD through a secondary assay with transgenic malaria parasites, and the structural basis for enzyme inhibition was explored through in silico structure-based docking and site-directed mutagenesis.",
        "Using a target-based high throughput screen, we have identified a series of potent, species-specific inhibitors of P. falciparum DHOD (pfDHOD) that are also efficacious against three cultured strains (3D7, HB3, and Dd2) of P. falciparum.",
        "Compound-mediated cytotoxicity was not observed with human dermal fibroblasts or renal epithelial cells.",
        "Dihydroorotate dehydrogenase (DHOD), a mitochondrially localized flavoenzyme, catalyzes the rate-limiting step of this pathway and is therefore an attractive antimalarial chemotherapeutic target.",
        "Plasmodium falciparum causes the most deadly form of malaria and accounts for over one million deaths annually.",
        "These data validate pfDHOD as an antimalarial drug target and provide chemical scaffolds with which to begin medicinal chemistry efforts.",
        "The malaria parasite is unable to salvage pyrimidines and relies on de novo biosynthesis for survival."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22580100": [
        "We constructed C-terminally c-myc tagged TgDHODs to examine subcellular localization of TgDHOD in transgenic parasites expressing the tagged protein.",
        "TgDHOD exhibits a lengthy 157-residue N-terminal extension, consistent with a potential organellar targeting signal.",
        "The pyrimidine biosynthesis pathway in the protozoan pathogen Toxoplasma gondii is essential for parasite growth during infection.",
        "The IC(50)s determined for A77-1726, the active derivative of the human DHOD inhibitor leflunomide, and related compounds MD249 and MD209 were, 91\u03bcM, 96\u03bcM, and 60\u03bcM, respectively.",
        "Using both exogenous and endogenous expression strategies, anti-myc fluorescence signal colocalized with antibodies against the mitochondrial marker ATPase.",
        "These findings demonstrate that TgDHOD is associated with the parasite's mitochondrion, revealing this organelle as the site of orotate production in T. gondii.",
        "To investigate the properties of dihydroorotate dehydrogenase (TgDHOD), the fourth enzyme in the T. gondii pyrimidine pathway, we expressed and purified recombinant TgDHOD.",
        "TgDHOD exhibited a specific activity of 84U/mg, a k(cat) of 89s(-1), a K(m)=60\u03bcM for l-dihydroorotate, and a K(m)=29\u03bcM for decylubiquinone (Q(D)).",
        "Quinones lacking or having short isoprenoid side chains yielded lower k(cat)s than Q(D).",
        "As expected, fumarate was a poor electron acceptor for this family 2 DHOD.",
        "DSM190, a known inhibitor of Plasmodium falciparum DHOD, was a poor inhibitor of TgDHOD.",
        "Collectively, our study suggests that TgDHOD is an excellent target for the development of anti-Toxoplasma drugs.",
        "The enzyme was not significantly affected by brequinar or TTFA, known inhibitors of human DHOD, or by atovaquone.",
        "The TgDHOD gene appears to be essential because while gene tagging was successful at the TgDHOD gene locus, attempts to delete the TgDHOD gene were not successful in the KU80 background."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/1617622": [
        "Brequinar sodium inhibits the activity of this enzyme isolated from mammalian sources only but not those forms isolated from yeast or bacteria, which also use ubiquinone as the cofactor.",
        "Brequinar sodium also does not inhibit the activity of a soluble Zymobacterium oroticum dihydroorotate dehydrogenase which uses NAD+ as a cofactor.",
        "This binding site appears to be unique to the mammalian enzyme, because brequinar sodium does not inhibit the yeast, Escherichia coli, or Z. oroticum forms of the enzyme.",
        "Our results suggest that brequinar sodium inhibits dihydroorotate dehydrogenase by binding to the enzyme at a unique site that is distinct from the dihydroorotate or the ubiquinone-binding site.",
        "Brequinar sodium inhibits L1210 dihydroorotate dehydrogenase with mixed inhibition kinetics with respect to either the substrate (dihydroorotate) or the cofactor (ubiquinone Q6) with Ki' values in the 5-8 nM range.",
        "The novel anticancer drug candidate brequinar sodium (DuP 785, NSC 368390, 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinoline- carboxylic acid sodium salt) was shown previously to be an inhibitor of dihydroorotate dehydrogenase, the fourth enzyme of the de novo pyrimidine biosynthetic pathway."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30200251": [
        "Similarly, DHODH inhibitor (leflunomide) also reduced cell growth and proliferation, with a significant decrease of <i>cyclin B</i> and <i>cdk2</i>.",
        "Dihydroorotate dehydrogenase (DHODH), in the de novo pyrimidine biosynthetic pathway, is the fourth enzyme of pyrimidine synthesis and is used to oxidize dihydroorotate and hence to orotat.",
        "We cloned and characterized here the <i>dhod</i> of silkworms, <i>Bombyx mori</i>.",
        "The full-length cDNA sequence of <i>dhod</i> is 1339 bp, including an open reading frame (ORF) of 1173 bp that encoded a 390 amino acid protein.",
        "And two domains were involved in the Dihydroorotate dehydrogenase amino acid sequence of silkworms, <i>Bombyx mori</i> (BmDHODH), namely a DHO_dh domain and a transmembrane domain in N-termina.",
        "DHODH is the fourth enzyme of pyrimidine synthesis, so we also found that leflunomide can inhibit, at least in part, the endomitotic DNA replication in silk glands cells.",
        "The silkworm <i>dhod</i> is expressed throughout development and in nine tissues.",
        "Moreover, knockdown of the silkworm <i>dhod</i> gene reduced cell growth and proliferation through G2/M phase cell cycle arrest.",
        "These findings demonstrate that downregulation of BmDHODH inhibits cell growth and proliferation in silkworm cells, and the endomitotic DNA replication in silk gland cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/2386542": [
        "These results will be useful in the elucidation of the precise nature of the interaction between brequinar sodium and dihydroorotate dehydrogenase.",
        "The three principal regions are: (i) the C(2) position where bulky hydrophobic substituents are necessary, (ii) the C(4) position which has a strict requirement for the carboxylic acid and its corresponding salts, and (iii) the benzo portion of the quinoline ring with appropriate substitutions.",
        "The novel anticancer drug candidate brequinar sodium [DuP 785, NSC 368390, 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinoline carboxylic acid sodium salt] inhibits dihydroorotate dehydrogenase, the fourth enzyme in the de novo pyrimidine biosynthetic pathway leading to the formation of UMP.",
        "Sixty-nine quinoline 4-carboxylic acid analogs were analyzed as inhibitors of L1210 dihydroorotate dehydrogenase.",
        "This structure-activity relationship study identified three critical regions of brequinar sodium and its analogs, where specific substitutions are required for the inhibition of the activity of dihydroorotate dehydrogenase."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20942817": [
        "Mutations in voltage gated transient receptor potential (TRPV) channels are known from genetic pain research and may modulate the effects of analgesics under development targeting TRPV1 or TRPV3.",
        "For most of these genes, functional variants have been associated with neuro-psychiatric disorders and not yet with analgesia.",
        "To this add ligand-gated ion channels including nicotinic acetylcholine receptors, ionotropic glutamate-gated receptors and ATP-gated purinergic P2X receptors with most important subunits coded by CHRNA4, GRIN2B and P2RX7.",
        "This addresses voltage-gated sodium, calcium and potassium channels, for which SCN9A, CACNA1B, KCNQ2 and KCNQ3, respectively, are primary gene candidates because they code for the subunits of the respective channels targeted by analgesics currently in clinical development.",
        "Among G protein coupled receptors, \u03b4-opioid receptors (coded by OPRD1), cannabinoid receptors (CNR1 and CNR2), metabotropic glutamate receptors (mGluR5 coded by GRM5), bradykinin B(1) (BDKRB1) and 5-HT(1A) (HTR1A) receptors are targeted by new analgesic substances.",
        "Patient phenotypes in pharmacological pain treatment varies between individuals, which could be partly assigned to their genotypes regarding the targets of classical analgesics (OPRM1, PTGS2) or associated signalling pathways (KCNJ6).",
        "Finally, nerve growth factor (NGFB), its tyrosine kinase receptor (NTRK1) and the fatty acid amide hydrolase (FAAH) have become targets of interest.",
        "However, research on the genetic modulation of pain has already identified variants in these genes, relative to pain, which may facilitate the pharmacogenetic assessments of new analgesics.",
        "The increased number of candidate pharmacogenetic modulators of analgesic actions may open opportunities for the broader clinical implementation of genotyping information.",
        "Translational and genetic research have identified new targets, for which new analgesics are being developed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19474215": [
        "Production and evaluation of bivalent ligands is an emerging field in drug design and for anaesthesia, analgesics that are designed not to be highly selective morphine-like (MOP) ligands represents a new avenue for the production of useful drugs for chronic (and in particular cancer) pain.",
        "For example linking the MOP agonist oxymorphone to the DOP antagonist naltrindole produces a MOP/DOP bivalent ligand that should produce analgesia with reduced tolerance.",
        "There is now good laboratory evidence to suggest that blocking DOP while activating MOP produces analgesia (or antinociception) without the development of tolerance.",
        "Morphine is the current gold standard analgesic acting at MOP receptors but produces a range of variably troublesome side-effects, in particular tolerance.",
        "Simultaneous targeting of MOP and DOP can be accomplished by: (i) co-administering two selective drugs, (ii) administering one non-selective drug, or (iii) designing a single drug that specifically targets both receptors; a bivalent ligand.",
        "Bivalent ligands generally contain two active centres or pharmacophores that are variably separated by a chemical spacer and there are several interesting examples in the literature.",
        "Opioid receptors are currently classified as mu (mu: mOP), delta (delta: dOP), kappa (kappa: kOP) with a fourth related non-classical opioid receptor for nociceptin/orphainin FQ, NOP.",
        "The type of response/selectivity produced depends on the pharmacophore combination (e.g. oxymorphone and naltrindole as above) and the space between them."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29568381": [
        "These data suggest that DSBs in transcriptionally active euchromatin in G<sub>0</sub>/G<sub>1</sub>-phase cells are repaired through a mechanism that requires contact formation between homologous chromosomes and that this mechanism is mediated by HDR proteins and nuclear myosin/actin motors.",
        "We recently showed that DNA double strand breaks (DSBs) induced by \u03b3-rays or endonucleases cause ATM-dependent contact formation between homologous chromosomes at damaged sites of transcriptionally active chromatin in G<sub>0</sub>/G<sub>1</sub>-phase cells.",
        "Here, we report that the mechanism of contact generation between homologous chromosomes also requires homology-directed repair proteins, including BRCA1, RAD51 and RAD52, and nuclear myosin/actin-motors.",
        "We provide evidence for a mechanism of DNA repair that requires nuclear myosin/actin-dependent contact between homologous chromosomes to prevent formation of chromosomal rearrangement in human cells.",
        "Moreover, inhibition of ATM kinase or deficiency in nuclear actin polymerization causes carcinogenic <i>RET/PTC</i> chromosome rearrangements after DSBs induction in human cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29925947": [
        "DNA double-strand breaks repaired by non-homologous end joining display limited DNA end-processing and chromosomal mobility.",
        "We demonstrate that nuclear actin polymerization is required for the migration of a subset of double-strand breaks into discrete sub-nuclear clusters.",
        "The molecular basis of this movement is unknown.",
        "Here, using Xenopus laevis cell-free extracts and mammalian cells, we establish that nuclear actin, WASP, and the actin-nucleating ARP2/3 complex are recruited to damaged chromatin undergoing homology-directed repair.",
        "By contrast, double-strand breaks undergoing homology-directed repair exhibit extensive processing and enhanced motion.",
        "Actin-driven movements specifically affect double-strand breaks repaired by homology-directed repair in G2 cell cycle phase; inhibition of actin nucleation impairs DNA end-processing and homology-directed repair.",
        "By contrast, ARP2/3 is not enriched at double-strand breaks repaired by non-homologous end joining and does not regulate non-homologous end joining.",
        "Our findings establish that nuclear actin-based mobility shapes chromatin organization by generating repair domains that are essential for homology-directed repair in eukaryotic cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30019087": [
        "We conclude that both ancient and eukaryotic features of the actin world can be detected in the nucleus today, which supports the idea that the cytoskeleton attained significant eukaryotic innovations before the tandem evolution of the cytoskeleton and nucleus occurred.",
        "The discovery of nuclear actin opened new perspective on the field, suggesting that the nuclear activities of actin reflect the functions of primordial actin-like proteins.",
        "In this paper, we review the recent literature to explore the evolutionary origin of nuclear actin.",
        "As a result, the idea has taken shape that the appearance of actin occurred in the very first cell; therefore, the emergence of microfilaments precedes that of the eukaryotic cytoskeleton.",
        "Until recently it was widely accepted that the dynamic cytoskeletal matrix is exclusive to the cytoplasm of eukaryotes, evolving before the emergence of the cell nucleus to enable phagocytosis, cell motility and the sophisticated functioning of the endomembrane system within the cytosol.",
        "The discovery of the existence of a prokaryotic cytoskeleton has changed this picture significantly."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30312531": [
        "Furthermore, even within a given structure, distinct pools of nuclear actin that can be differentially labeled have been identified.",
        "While the structures of nuclear actin remain unclear, it can function as monomers, polymers, and even rods.",
        "Further, nuclear actin mediates chromatin movement and organization.",
        "Subsequently, it was established that the nuclear import and export of actin is highly regulated.",
        "These studies provided the first hints that actin has a nuclear function.",
        "The structure and integrity of the nuclear envelope and sub-nuclear compartments are also regulated by nuclear actin.",
        "It has roles in meiosis and mitosis, and these functions may be functionally conserved from ancient bacterial actin homologs.",
        "It regulates the activity of RNA polymerases, as well as specific transcription factors.",
        "Furthermore, nuclear actin contributes to human diseases like cancer, neurodegeneration, and myopathies.",
        "While actin was discovered in the nucleus over 50 years ago, research lagged for decades due to strong skepticism.",
        "Numerous mechanistic studies have uncovered an array of functions for nuclear actin.",
        "Anat Rec, 301:1999-2013, 2018. \u00a9 2018 Wiley Periodicals, Inc.",
        "Here, we explore the early discovery of actin in the nucleus and discuss the forms and functions of nuclear actin in both normal and disease contexts.",
        "Actin also modulates the activity of several chromatin remodeling complexes and histone deacetylases, to ultimately impinge on transcriptional programing and DNA damage repair.",
        "The revitalization of research into nuclear actin occurred after it was found that cellular stresses induce the nuclear localization and alter the structure of actin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30193156": [
        "While it is long known that actin is part of the nuclear proteome, its properties and functions as regulated, functional and dynamically assembled actin filaments are only recently emerging.",
        "Here, we summarize recent studies on actin filament polymerization and turnover within the nuclear compartment of mammalian cells.",
        "Thus, newly uncovered roles for intranuclear actin filaments are opening new perspectives on how the nucleus and its genomic content may be organized in particular with regard to a given stage of the cell cycle.",
        "We emphasize and discuss novel findings, in which transient and dynamic nuclear actin filaments have been visualized in physiological contexts, and focus on aspects of signalling mechanisms, chromatin reorganization and DNA repair.",
        "Further, a better understanding of the spatiotemporal control of nuclear actin-regulating factors in mammalian cells will ultimately provide a more detailed view on how the nuclear F-actin cytoskeleton contributes to genome organization and nuclear architecture."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29501911": [
        "Their dramatic efficacy in the short term has been highlighted by many media reports.",
        "Kymriah\u2122 is for the treatment of pediatric patients and young adults with refractory or relapse (R/R) B cell precursor acute lymphoblastic leukemia and Yescarta\u2122 is for the treatment of adult patients with R/R large B cell lymphoma.",
        "Two autologous chimeric antigen receptor (CAR) T cell therapies (Kymriah\u2122 and Yescarta\u2122) were recently approved by the FDA.",
        "By contrast, their glaring safety gaps behind the miracles remain much less addressed.",
        "In common, both are CD19-specific CAR T cell therapies lysing CD19-positive targets.",
        "Here, we focus on addressing the crucial challenges in relation to the gaps."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30290178": [
        "Altogether, these findings provide integrated insights into the genetic and epigenetic mechanisms steering the trajectory of astrogliogenesis.",
        "We report molecularly distinct phases of astrogliogenesis that exhibit stage- and lineage-specific transcriptomic and epigenetic signatures with unique primed and active chromatin regions, thereby revealing regulatory elements and transcriptional programs underlying astrocyte generation and maturation.",
        "A broad molecular framework of how neural stem cells are specified toward astrocyte fate during brain development has proven elusive.",
        "Here we perform comprehensive and integrated transcriptomic and epigenomic analyses to delineate gene regulatory programs that drive the developmental trajectory from mouse embryonic stem cells to astrocytes.",
        "These transcription factors facilitate stage-specific gene expression programs by switching the chromatin state of their target regulatory elements from primed to active.",
        "By searching for transcription factors that function at these elements, we identified NFIA and ATF3 as drivers of astrocyte differentiation from neural precursor cells while RUNX2 promotes astrocyte maturation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24729685": [
        "Treatment of RA has improved over the past decade.",
        "The aim of this review is to discuss the role of IL-6 in RA, and to provide an overview of the mode of action, pharmacokinetics, and safety of TCZ.",
        "There have been several important clinical trials evaluating the efficacy and safety of TCZ in RA patients; this review summarizes this data from 14 key trials with emphasis on Phase III trials.",
        "Furthermore, efficacy studies of TCZ as both monotherapy and combination therapy will be evaluated.",
        "Review of these trials provides strong evidence that its use, both as monotherapy and in combination with methotrexate or other DMARDs, is an effective treatment in reducing the signs and symptoms of RA.",
        "Additionally, given the efficacy of TCZ in the treatment of RA, this review discusses how TCZ may be beneficial in the treatment of other autoimmune diseases, spinal disease, cardiovascular disease, organ transplantation, and malignancies where elevated levels of IL-6 may play a role in the pathogenesis of these diseases.",
        "Tocilizumab (TCZ) is a recombinant humanized monoclonal antibody against the IL-6 receptor and has been approved in many countries, including the United States, for the treatment of moderate to severe RA in patients who have not adequately responded to one or more disease-modifying antirheumatic drugs (DMARDs) or cannot tolerate other approved drug classes for RA.",
        "Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by joint pain, swelling, stiffness, and progressive destruction of the small joints of the hands and feet.",
        "TCZ showed tolerable safety but care is required for its use since there are some important safety concerns including elevated liver enzymes, elevated low-density lipoprotein, infections, and gastrointestinal perforations.",
        "With multiple cytokines well-known now to play a role in the pathogenesis of RA, including tumor necrosis factor alpha, interleukin (IL)-1\u03b2, and IL-6, many targeted biological treatments against these cytokines have emerged, changing the treatment of this disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27790001": [
        "Interleukin (IL)-6 has a variety of biological functions.",
        "Several clinical studies have demonstrated that a humanized anti-IL-6 receptor antibody, tocilizumab, improves clinical symptoms in rheumatoid arthritis.",
        "IL-6 also acts on lymphocytes, not only on B cells to stimulate autoantibody production, but also on na\u00efve T helper cells to promote T<sub>h</sub>17 cell differentiation.",
        "Tocilizumab prevented radiographic progression of joint destruction by inhibiting cartilage/bone resorption.",
        "Tocilizumab also improved hematological abnormalities, including hypergammaglobulinemia, high levels of autoantibodies, and elevation of erythrocyte sedimentation rate and acute-phase proteins.",
        "Many patients treated with tocilizumab achieved clinical remission associated with decreased serum IL-6, suggesting that IL-6 enhances autoimmunity.",
        "These findings have confirmed that hyperproduction of IL-6 is responsible for the above clinical symptoms, including joint destruction.",
        "Tocilizumab is a new therapeutic option for rheumatoid arthritis.",
        "Thus, an imbalance between T cell subsets possibly contributes to development of rheumatoid arthritis.",
        "For example, it stimulates the production of acute-phase reactants (C-reactive protein and serum amyloid A) and hepcidin which interferes with iron recycling and absorption, causing iron-deficient anemia, and augments expression of vascular endothelial growth factor and receptor activator of nuclear factor-\u03baB ligand in synovial cells, leading to neovascularization and osteoclast formation.",
        "Importantly, tocilizumab improved quality of life by reducing systemic symptoms, including fatigue, anemia, anorexia, and fever."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22101760": [
        "The neutrophil counts were described as a direct function of unbound sIL-6R concentrations.",
        "Thus, the observed changes in sIL-6R, neutrophil, and platelet data are consistent with the tocilizumab mechanism of action and can be fully explained by tocilizumab binding to sIL-6R and mIL-6R.",
        "Following tocilizumab administration, concentrations of total sIL-6R increased, while neutrophil and platelet counts declined.",
        "Tocilizumab concentrations were described by a two compartment model with parallel linear and Michaelis-Menten elimination.",
        "These changes were transient, with counts returning to their respective baseline levels soon after tocilizumab is eliminated from the body.",
        "The quasi-steady-state target-mediated drug disposition model described tocilizumab relationships to total sIL-6R, which allowed computation of unobserved unbound sIL-6R concentrations.",
        "Tocilizumab is a recombinant humanized antihuman interleukin-6 receptor monoclonal antibody, which inhibits binding of IL-6 to its soluble (sIL-6R) and membrane-expressed (mIL-6R) receptors.",
        "The platelet counts were described by the transit-compartment life-span model with inhibition of production that depended on the unbound sIL-6R concentrations.",
        "A population approach was applied to describe the relationship between tocilizumab and sIL-6R concentrations and subsequent changes in neutrophil and platelet counts.",
        "Patients received 4 or 8 mg/kg tocilizumab intravenous infusions every 4 weeks for a total of 6 doses.",
        "Tocilizumab and total sIL-6R concentrations, neutrophil and platelet counts from 4 phase 3 studies in rheumatoid arthritis patients were available.",
        "The work investigated whether the observed decline in peripheral neutrophil and platelet counts after tocilizumab administration can be directly explained by tocilizumab IL-6R blockade, thus demonstrating the mechanism of tocilizumab action."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28748416": [
        "The RSV-induced AMPK activation decreased the level of DNA fragmentation in comparison with the control (21.18 \u00b1 0.92 vs. 22.50 \u00b1 0.40; p &lt; 0.01).",
        "In conclusion, these results demonstrated the cryoprotective effect of the RSV-induced increase in AMPK activity on DNA integrity and key paternal transcripts of cryopreserved human spermatozoa.",
        "These findings are of great importance for improving the available cryopreservation protocols in terms of the number of lesions that produced over key genes and the dramatic effects on sperm DNA fragmentation.",
        "The relative mRNA expression levels of protamines (1 and 2) and ADD1 in RSV pretreated frozen-thawed human spermatozoa were also improved significantly compared to the control (p &lt; 0.05).",
        "The study populations was drawn from 22 normozoospermic healthy volunteers which were incubated with or without AMPK activator (resveratrol [RSV], 15 \u00b5M) or inhibitor (Compound C [CC], 30 \u00b5M) for 1 h and were then cryopreserved.",
        "Untreated frozen-thawed spermatozoa served as controls.",
        "Conversely, the inhibitory effect of CC on AMPK activity deteriorated the deleterious effects of cryopreservation on these parameters (p &lt; 0.01).",
        "This work aimed at investigating the effect of resveratrol on (1) DNA integrity and (2) fertilizing capacity of sperm by quantifying the presence of key paternal transcripts considered as markers for male fertility (protamine 1 [PRM1] and protamine 2 [PRM2]) and pregnancy success (adducin 1 alpha [ADD1]) in cryopreserved human spermatozoa through modulation of AMP-activated protein kinase (AMPK)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28666211": [
        "Furthermore, we also found that OCTN2 overexpression dramatically increased the levels of biomarkers associated with spermatogenesis, including azoospermia-like (DAZL), phosphoglycerate kinase 2 (PGK2), and protamine 2 (PRM2).",
        "We found that cultured epididymal epithelial cells isolated from rat epididymides expressed high levels of CK-19 but barely expressed vimentin.",
        "These results demonstrate that OCTN2 plays a positive role in epididymal epithelial cells, and might be useful in the clinical treatment of male infertility by serving as a key regulatory factor.",
        "Carnitine/organic cation transporter 2 (OCTN2) is localized at the basolateral membrane of epididymal epithelial cells, and mainly serves to reabsorb carnitine as an essential factor for sperm maturation; however, its functional features in epididymal epithelial cells have remained unclear.",
        "Moreover, forced expression of OCTN2 inhibited the cell apoptosis process, and at the same time increased expression of the pro-apoptosis factor BAX, and decreased expression of the anti-apoptosis factors BCL-2 and Survivin.",
        "Gain-of-function assays, which included the CCK-8 assay and EdU flow cytometry assay, indicated that overexpression of OCTN2 significantly promoted epididymal epithelial cell growth and proliferation.",
        "We isolated primary epididymal epithelial cells from rat epididymides and verified their phenotype by detecting the presence of cytokeratin-19 (CK-19, an epithelial cell marker) and the absence vimentin (an interstitial cell marker)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26801756": [
        "We focused on possible differences in selective constraints between these two clades and on the two functional domains of PRM2 (cleaved- and mature-PRM2).",
        "Previous studies showed that sexual selection affects protamine coding sequence and expression in rodents.",
        "Here we analyze selective constraints and post-copulatory sexual selection acting on protamine 2 (Prm2) gene sequences of 53 species of primates and rodents.",
        "We also assessed if and how changes in Prm2 coding sequence may affect sperm head dimensions.",
        "Their function is strongly linked to sperm head morphology and male fertility.",
        "Protamines appear to be affected by a complex pattern of selective constraints.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Protamines are sperm nuclear proteins with a crucial role in chromatin condensation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25516990": [
        "Interestingly, seminal vesicle weight and serum testosterone level were restored in autografted mice by 8 weeks post grafting.",
        "Elevated expression of PDGFRA, LIF, DHH and NEFH in autografts indicated de novo regeneration of LC populations.",
        "The expression of Leydig cell-specific proteins such as CYP11A1, HSD3B2 and LHCGR showed revival of Leydig cell (LC) populations in autografts over time since grafting.",
        "In this study, we examined the fate of various testicular cells in adult mouse testes following ectopic autografting at 1, 2, 4 and 8 weeks post grafting.",
        "Ectopic autografting of testis tissue is a promising approach for studying testicular development, male germline preservation and restoration of male fertility.",
        "Autografted adult testis can be used as a model for investigating Leydig cell regeneration, steroidogenesis and regulation of the intrinsic factors involved in Leydig cell development.",
        "The presence of Sertoli and peritubular myoid cells, as indicated by expression of WT1 and ACTA2 proteins, respectively, was evident in the autografts until 8 weeks.",
        "Expression of germ cell-specific proteins such as POU5F1, DAZL, TNP1, TNP2, PRM1 and PRM2 revealed that, although proliferating and differentiating spermatogenic germ cells such as spermatogonia, spermatocytes and spermatids could survive in autografts until 4 weeks, only terminally differentiated germ cells such as sperm persisted in autografts until 8 weeks.",
        "The success of this rodent model can have therapeutic applications for adult human males undergoing sterilizing cancer therapy.",
        "Histological examination showed no evidence of re-establishment of spermatogenesis in autografts, and progressive degeneration of seminiferous tubules was detected."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24869677": [
        "Indeed, an increase in rare imprinting disorders has been observed in children conceived via in vitro fertilisation (IVF).",
        "Human sperm express two types of protamine: protamine 1 (P1) and the family of protamine 2 (P2) proteins, with P1 and P2 normally existing in a ratio of approximately 1:1.",
        "Consequently, it is imperative that Assisted Reproductive Technologies (ARTs) endeavour to utilise sperm devoid of protamine abnormalities, especially because retained histones are present in imprinted gene clusters.",
        "Both the elevation and reduction of this ratio have been linked with male infertility suggesting that abnormalities in protamine expression, processing and replacement may be responsible for effects on semen parameters observed in infertile males affected by deficient protamination, along with abnormalities in associated regulatory processes.",
        "This review examines the links between male infertility, abnormal protamine expression and replacement, the implications of abnormal sperm DNA packaging on fertility treatments and the potential iatrogenic effects of ART procedures on sperm function.",
        "Abnormal protamination may result in insufficient condensation in the sperm nucleus, thus rendering paternal DNA susceptible to damage, which could have detrimental consequences upon embryogenesis.",
        "Emerging evidence indicates that abnormalities in protamine content may influence epigenetic signals transmitted via paternal DNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30070328": [
        "The role of miR-122 in glioma tumorigenesis has been poorly defined.",
        "The current study is designed to investigate whether and how miR-122 affects proliferation and apoptosis of human glioma cells.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Accumulating evidence has suggested that microRNAs play critical roles in the development and progression of human glioma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28401573": [
        "Hence, little is known to guide management of patients with UCD, refractory to surgical resection and combination chemotherapy.",
        "Castleman disease is a rare lymphoproliferative disorder with 2 distinctly defined clinical forms.",
        "He had severe paraneoplastic pemphigus and was treated with tocilizumab, an anti-interleukin-6 receptor monoclonal antibody that has demonstrated good response rates in multicentric Castleman disease but demonstrated no clinical response despite 2 months of treatment.",
        "Our report is the first to describe a lack of response to tocilizumab in the rare setting of refractory UCD and discuss potential for distinct disease biology.",
        "We present a case of a patient, negative for HIV and HHV-8, who had an unsuccessful surgical intervention and no response to radiotherapy and chemotherapy.",
        "While multicentric Castleman disease (UCD) poses a potential therapeutic challenge, unicentric variant has historically been considered curable with surgical resection."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29495891": [
        "Of particular interest is the demonstration of its effectiveness in monotherapy in comparison with other bDMARDs.",
        "Therapeutic strategies, including biological disease-modifying antirheumatic drugs (bDMARDs) have improved the prognosis and quality of life of RA patients.",
        "RA management guidelines and recommendations consider TCZ as one of the bDMARDS indicated after methotrexate or other conventional synthetic DMARDs and/or TNF inhibitors failure in adult RA.",
        "Recent observational studies have shown good results for the safety profile of TCZ with no new alert signals.",
        "Tocilizumab (TCZ) is a humanized monoclonal antibody against IL-6 receptor licensed in 2009 that has demonstrated clinical efficacy in various adult RA populations.",
        "Rheumatoid arthritis (RA) is the most prevalent immune-mediated chronic rheumatic disease and is associated with joint destruction and disability."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19368420": [
        "It may also be administered as monotherapy in patients intolerant of methotrexate or in whom methotrexate therapy is inappropriate.",
        "Notably, tocilizumab-based therapy was effective in patients with long-standing disease in whom anti-TNF therapy had previously failed.",
        "Tocilizumab-based therapy was consistently more effective than placebo, methotrexate or other DMARDs in reducing disease activity, and some trials also showed significant benefits with tocilizumab in terms of reducing structural joint damage and improving health-related quality of life (HR-QOL).",
        "Tocilizumab is also approved in Japan for the treatment of polyarticular-course juvenile idiopathic arthritis, systemic-onset juvenile idiopathic arthritis and Castleman's disease.",
        "However, the present data suggest that tocilizumab is an important emerging treatment option in adult patients with moderate to severe rheumatoid arthritis.",
        "Tocilizumab (RoActemra or Actemra) is a recombinant humanized monoclonal antibody that acts as an interleukin (IL)-6 receptor antagonist.",
        "Intravenous tocilizumab 8 mg/kg (and no less than 4.8 mg), in combination with methotrexate, is approved in the EU for the treatment of moderate to severe active rheumatoid arthritis in adult patients with inadequate response to, or who are intolerant of, prior disease-modifying anti-rheumatic drug (DMARD) or tumour necrosis factor (TNF) antagonist therapy.",
        "More data are required to determine the comparative efficacy and safety of tocilizumab versus other biological agents and to establish their relative cost effectiveness.",
        "Intravenous tocilizumab was effective and generally well tolerated when administered either as monotherapy or in combination with conventional DMARDs in several well designed clinical studies in adult patients with moderate to severe rheumatoid arthritis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24286116": [
        "In this study, we evaluated and compared the effects of IL-6 and TNF-\u03b1 blocking therapies on anemia, disease activity, and iron-related parameters including serum hepcidin in RA patients.",
        "Upregulation of hepcidin by inflammatory cytokines has been implicated in AI.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Anemia of inflammation (AI) is a common complication of rheumatoid arthritis (RA) and has a negative impact on RA symptoms and quality of life."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26751942": [
        "Evidence in the literature indicates that patients treated with anti-TNF-\u03b1 agents and tocilizumab are at increased risk for bacterial infections.",
        "Both under-diagnosis and over-diagnosis of hypersensitivity reactions to biological agents are potential problems.",
        "The recent development of biological agents, namely, anti-tumour necrosis factor alpha (TNF-\u03b1) agents (infliximab, adalimumab and etanercept), anti- CD20 monoclonal antibody (rituximab) and anti-interleukin 6 receptor (IL-6R) monoclonal antibody (tocilizumab), represents a major breakthrough for the treatment of immune-mediated disorders.",
        "This article reviews the general aspects of adverse events during biologic treatment, focusing on IgE-mediated hypersensitivity reactions to anti-TNF-\u03b1 agents, rituximab and tocilizumab, and on the tools for the diagnosis of these life-threatening reactions.",
        "Thus, it is important to identify these reactions and to adopt the right approach to manage them.",
        "However, an increased therapeutic use of these biological agents has disclosed other side-effects, including immediate hypersensitivity reactions, such as anaphylaxis and urticaria.",
        "Given their structural and functional differences, distinct safety profiles can be expected for each of these agents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21949922": [
        "Several monoclonal antibodies targeting different components of the immune systems have been licensed for treatment of RA.",
        "Inflammatory cytokines such as interleukin-6 (IL-6) are found abundantly in the blood and the joints.",
        "The biologic effect of IL-6 on leukocyte, osteoclast, hepatocytes and bone marrow may mediate the articular and systemic inflammation in RA.",
        "It improves symptoms and signs as well as reducing joint damage.",
        "Tocilizumab monotherapy has been shown to be superior to methotrexate.",
        "Recently, an anti-IL-6 receptor monoclonal antibody, tocilizumab, has been licensed for the treatment as monotherapy or in combination with methotrexate of moderate to severe RA, when disease modifying anti-rheumatic drugs or anti-tumour necrosis factors (TNF) have failed.",
        "Overall, tocilizumab has a well-defined and manageable safety profile that supports a favourable benefit/risk ratio for patients with RA.",
        "Its side-effects include infections, decrease in neutrophils, and increases in lipid and liver transaminases.",
        "Rheumatoid arthritis (RA) is a chronic inflammatory arthritis with many systemic manifestations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22431927": [
        "The safety was good with no adverse events and maintenance, during a six-month followup, of normal liver enzymes.",
        "We report on safety and efficacy of tocilizumab in a 71-year-old female with rheumatoid arthritis and chronic hepatitis C. Monotherapy with tocilizumab (8 mg/kg every 4 weeks, i.v.) was prescribed after the discontinuation, determined by clinical inefficacy, of anti-TNF-alfa agents (adalimumab and, subsequently, etanercept).",
        "The safety of tocilizumab in HCV patients is an open question.",
        "Tocilizumab is a monoclonal humanized anti-IL-6-receptor antibody used for the treatment of rheumatoid arthritis.",
        "We have registered an optimal and rapid clinical response to tocilizumab with early remission (SDAI &lt;3.3 since 4 weeks).",
        "These data suggest a good safety profile of tocilizumab in patients with rheumatoid arthritis and chronic hepatitis C virus pathology."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24741293": [
        "Although bDMARDs have elicited to a paradigm shift in the treatment of RA due to the prominent efficacy that had not been previously achieved by sDMARDs, a substantial percentage of patients failed primary or secondary responses to bDMARD therapy.",
        "Because cytokines such as tumor necrosis factor (TNF)-\u03b1 and interleukin (IL)-6 play a major role in the development of RA, their targeting could constitute a reasonable novel therapeutic strategy for treating RA.",
        "Indeed, worldwide clinical trials of TNF inhibiting biologic disease modifying antirheumatic drugs (bDMARDs) including infliximab, adalimumab, golimumab, certolizumab pegol, and etanercept as well as the humanized anti-human IL-6 receptor antibody, tocilizumab, have demonstrated outstanding clinical efficacy and tolerable safety profiles, resulting in worldwide approval for using these bDMARDs to treat moderate to severe active RA in patients with an inadequate response to synthetic disease modifying antirheumatic drugs (sDMARDs).",
        "Because RA is a heterogeneous disease in which TNF-\u03b1 and IL-6 play overlapping but distinct pathological roles, further studies are required to determine the best use of TNF inhibitors and tocilizumab in individual RA patients.",
        "Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by persistent joint inflammation, systemic inflammation, and immunological abnormalities."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20979549": [
        "Tocilizumab in combination with methotrexate after 24 weeks of treatment could induce disease remission in 30% of patients with rheumatoid arthritis refractory to anti-TNF antagonist therapy.",
        "Several Phase III clinical trials demonstrate the clinical efficacy of tocilizumab as monotherapy or with disease-modifying anti-rheumatic drugs for adult patients with moderately to severely active rheumatoid arthritis.",
        "Serious adverse reactions include infections, gastrointestinal perforations and hypersensitivity reactions, including anaphylaxis.",
        "The clinical efficacy and safety of tocilizumab has led to the approval of this innovative drug for the treatment of rheumatoid arthritis in more than 70 countries worldwide.",
        "Tocilizumab is a humanized anti-IL-6 receptor monoclonal antibody, which binds to circulating soluble IL-6 receptor and membrane-expressed IL-6 receptor, inhibiting IL-6 binding to both forms of IL-6 receptor.",
        "The most common adverse reactions reported in clinical studies are upper respiratory tract infection, nasopharyngitis, headache, hypertension and mild, reversible increases in alanine aminotransferase enzymes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19882783": [
        "(1) First-line disease-modifying treatment for rheumatoid arthritis is based on \"slow-acting\" antirheumatic agents, generally methotrexate.",
        "It carries a risk of serious infections, haematological disorders (neutropenia, thrombocytopenia), gastrointestinal bleeding, hepatic disorders, and systemic and local reactions during the infusion; (5) the adverse effects of long-term tocilizumab therapy are unknown, particularly the risk of cancer; (6) Tocilizumab carries a risk of interactions with drugs that are metabolised by cytochrome P450 isoenzymes.",
        "Subsequent options include a TNF-alpha antagonist, followed by rituximab or possibly abatacept; (2) Tocilizumab, a monoclonal antibody, inhibits interleukin-6 receptors.",
        "It is licensed in the European Union for patients with rheumatoid arthritis in whom other drugs have failed; (3) Clinical evaluation includes 4 placebo-controlled trials of the methotrexate-tocilizumab combination, after failure of a slow-acting antirheumatic drug (3 trials) or failure of a slow-acting antirheumatic drug and a TNF-alpha antagonist (1 trial).",
        "An indirect comparison suggests that tocilizumab is no more effective than rituximab in patients with multiple treatment failure; (4) Tocilizumab, like TNF-alpha antagonists, is an immunosuppressant.",
        "It is therefore better to continue to use rituximab, or possibly abatacept.",
        "Clinical consequences cannot be ruled out when co-administered drugs have a narrow therapeutic margin; (7) Tocilizumab is administered intravenously every 4 weeks, making it slightly more convenient that rituximab at the beginning of treatment; (8) In patients with rheumatoid arthritis and multiple treatment failure, it remains to be shown whether tocilizumab has a better risk-benefit balance than rituximab, a drug with which we have more experience."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21234291": [
        "This report summarises the key efficacy and toxicity findings from the major clinical trials.",
        "TCZ works quickly and effectively in rheumatoid arthritis either as monotherapy or in combination with other agents in early disease, DMARD inadequate responders, seronegative disease and after anti-TNF failure.",
        "In summary, there is sufficient evidence to make TCZ a first line biologic therapy for rheumatoid arthritis especially for those who are unable to take methotrexate or who fail anti-TNF therapy.",
        "Tocilizumab (TCZ) is a monoclonal antibody which inhibits the interleukin-6 receptor.",
        "The toxicity profile is manageable but includes infections (most notably skin and soft tissue), increases in serum cholesterol, transient decreases in neutrophil count and abnormal liver function tests (especially in combination with methotrexate).",
        "After initial studies in Japan, it has been extensively studied in five multicentre clinical trials.",
        "Recent years have seen many exciting developments in the treatment of rheumatoid arthritis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26154623": [
        "In this study, we have addressed both challenges by carrying-out mass spectrometry (MS) analyses of plasma-derived vesicles, in the size range of exosomes, from healthy donors obtained by 2 alternative methodologies: size-exclusion chromatography (SEC) on sepharose columns and Exo-Spin\u2122.",
        "Plasma-derived vesicles hold a promising potential for use in biomedical applications.",
        "No exosome markers, as opposed to the most abundant plasma proteins, were detected by Exo-Spin\u2122.",
        "Independent of the isolation method, however, we consistently identified 2 proteins, CD5 antigen-like (CD5L) and galectin-3-binding protein (LGALS3BP), whose presence was validated by a bead-exosome FACS assay.",
        "Noticeably, after a cross-comparative analysis of all published studies using MS to characterize plasma-derived exosomes from healthy individuals, we also observed a paucity of \"classical exosome markers.\"",
        "Altogether, our results support the use of SEC as a stand-alone methodology to obtain preparations of extracellular vesicles, in the size range of exosomes, from plasma and suggest the use of CD5L and LGALS3BP as more suitable markers of plasma-derived vesicles in MS.",
        "In contrast, exosomal markers were present in the early fractions of SEC where the most abundant plasma proteins have been largely excluded.",
        "Two major challenges, however, hinder their implementation into translational tools: (a) the incomplete characterization of the protein composition of plasma-derived vesicles, in the size range of exosomes, as mass spectrometric analysis of plasma sub-components is recognizably troublesome and (b) the limited reach of vesicle-based studies in settings where the infrastructural demand of ultracentrifugation, the most widely used isolation/purification methodology, is not available."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26598503": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Exosomes, via heat shock protein 70 (HSP70) expressed in their membrane, are able to interact with the toll-like receptor 2 (TLR2) on myeloid-derived suppressive cells (MDSCs), thereby activating them."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30290833": [
        "Melanoma is highly influenced in its aggressive phenotype by the changes it determinates in its microenvironment, such as pH decrease, in turn influencing cancer cell invasiveness, progression and tissue remodelling through an abundant secretion of exosomes, dictating cancer strategy to the whole host.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Microenvironment cues involved in melanoma progression are largely unknown.",
        "A role of exosomes in driving melanoma progression under microenvironmental acidity was never described."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29783743": [
        "Moreover, Me665 cells treated with CT-containing exosomes showed an increase in Adenosine 3',5'-Cyclic Monophosphate (cAMP) level, reaching levels comparable to those seen in cells exposed directly to CT.",
        "Our results prompt the idea that CT can exploit an exosome-mediated cell communication pathway to extend its pathophysiological action beyond an initial host cell, into a multitude of cells.",
        "Confocal microscopy showed direct internalization of CT containing fluorescent exo into CHO cells coupled with morphological changes in the recipient cells that are characteristic of CT action.",
        "To follow the CT intracellular route towards exosome secretion, we used a novel strategy for generating metabolically-labeled fluorescent exosomes that can be counted by flow cytometry assay (FACS) and characterized.",
        "The first evidence for long-term transmission of CT's toxic effect via extracellular vesicles was obtained in Chinese hamster ovary (CHO) cells.",
        "This finding could have implications for cholera disease pathogenesis and epidemiology.",
        "In this study, we report how the cholera toxin (CT) A subunit (CTA), the enzyme moiety responsible for signaling alteration in host cells, enters the exosomal pathway, secretes extracellularly, transmits itself to a cell population.",
        "Our results clearly show the association of CT with exosomes, together with the heat shock protein 90 (HSP90) and Protein Disulfide Isomerase (PDI) molecules, proteins required for translocation of CTA across the ER membrane into the cytoplasm."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30293207": [
        "Two ongoing, phase I/II, single-arm studies for nivolumab were identified, but no studies directly compared nivolumab with any specified comparator.",
        "As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer (Bristol-Myers Squibb) of nivolumab (Opdivo<sup>\u00ae</sup>) to submit evidence of its clinical and cost effectiveness for metastatic or unresectable urothelial cancer.",
        "The use of a treatment stopping rule to cap treatment cost left treatment effectiveness unaltered.",
        "The use of time-dependent hazard ratios produced overfitting and was not represented in the probabilistic sensitivity analysis.",
        "Nivolumab was compared with docetaxel, paclitaxel, best supportive care and retreatment with platinum-based chemotherapy (cisplatin plus gemcitabine, but only for patients whose disease has had an adequate response in first-line treatment).",
        "Multiple limitations in the STC were identified and remained.",
        "The ERG's concerns regarding the economic analysis included the use of a non-established response-based survival analysis method, which introduced additional uncertainty.",
        "Substantial uncertainties about the relative treatment effectiveness comparing nivolumab against all comparators remained.",
        "A simulated treatment comparison (STC) analysis was used in an attempt to reduce the bias induced by na\u00efve comparison, but there was no clear evidence that risk of bias was reduced.",
        "The effect of an analysis based on different combinations of covariates in the prediction model remains unknown.",
        "The revised ERG deterministic base-case incremental cost-effectiveness ratios based on the company's Appraisal Consultation Document response were \u00a358,791, \u00a378,869 and \u00a362,352 per quality-adjusted life-year gained versus paclitaxel, docetaxel and best supportive care, respectively.",
        "Evidence from directly examining the single arms of the trial data indicated little difference between the outcomes measured from the nivolumab and comparator studies.",
        "A relevant comparator was excluded from the base-case analysis.",
        "Kleijnen Systematic Reviews Ltd, in collaboration with Maastricht University Medical Centre+, was commissioned to act as the independent Evidence Review Group (ERG), which produced a detailed review of the evidence for the clinical and cost effectiveness of the technology, based on the company's submission to NICE.",
        "NICE did not recommend nivolumab, within its marketing authorisation, as an option for treating locally advanced, unresectable or metastatic urothelial carcinoma in adults who have had platinum-containing therapy, and considered that nivolumab was not suitable for use within the Cancer Drugs Fund.",
        "Nivolumab was dominated by cisplatin plus gemcitabine in the ERG base case."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27538766": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To determine the utility of ultrasonography in guiding modification of disease-modifying anti-rheumatic drug (DMARD) and steroid therapy for inflammatory arthritis (IA) in routine clinical practice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27604908": [
        "Therapies with known benefits include disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, as well as more recent biologic agents, such as tumor necrosis factor inhibitors (anti-TNF therapy).",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Rheumatoid arthritis (RA) is the most common chronic inflammatory disorder and is associated with progressive destruction of synovial joints and physical disability."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28324149": [
        "This study investigated rheumatological care on a population basis, using claims data from a nationwide statutory health insurance fund (BARMER GEK) in combination with patient-reported outcomes from a questionnaire survey of insured persons with RA.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Healthcare of patients with rheumatoid arthritis (RA) in Germany has mainly been evaluated in the past in RA cohorts from specialized arthritis centers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23961667": [
        "Understanding these characteristics is very important in treating RA.",
        "It is necessary to select DMARDs and follow up patients with recognition of the pattern of ADRs.",
        "This chapter deals with some major DMARDs in Japan, including methotrexate, which is indispensable in current RA treatment; salazosulfapyridine and bucillamine; tacrolimus, which is recently increasing in use; and iguratimod, which became available in 2012.",
        "Individual DMARDs have common characteristics.",
        "DMARDs can be indicated for all RA patients and early use of DMARDs after diagnosis of RA is recommended.",
        "As for safety, the pattern of adverse reactions (ADRs) associated with DMARDs has been generally understood.",
        "Regular monitoring is also essential to ensure the safety of DMARDs.",
        "Disease-modifying antirheumatic drugs (DMARDs) have largely contributed to recent paradigm shift of rheumatoid arthritis (RA) treatment strategy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28679392": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Biologic disease-modifying antirheumatic drugs (DMARDs) are increasingly used for rheumatoid arthritis (RA) treatment.",
        "However, little is known based on contemporary data about the factors associated with DMARDs and patterns of use of biologic DMARDs for initial and subsequent RA treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25630309": [
        "Patients initiating treatment with TCZ generally had more severe disease and longer disease duration compared with the corresponding TNFi group.",
        "Significantly more patients achieved remission (DAS28 ESR &lt;2.6) in the TCZ groups compared with corresponding TNFi groups (DMARD-IR, TCZ 44.0 % vs. TNFi 29.6 %; monotherapy, TCZ 37.2 % vs. TNFi 30.2 %; TNF-IR, TCZ 41.3 % vs. TNFi 19.2 %; p &lt; 0.001 for all comparisons).",
        "Patient-reported outcomes showed greater improvements in TCZ compared with TNFi groups.",
        "This retrospective analysis assessed the efficacy of TCZ and TNFi, alone or in combination with DMARDs, in 1603 patients with IR to previous treatment with either DMARDs (DMARD-IR) and/or TNFi (TNFi-IR), initiating treatment with TCZ or a TNFi, managed in routine clinical practice.",
        "Patients were grouped according to treatment history and treatment initiated: DMARD-IR patients initiating treatment with TCZ + DMARD (DMARD-IR TCZ) or TNFi + DMARD (DMARD-IR TNFi), DMARD-IR and/or TNFi-IR patients initiating treatment with TCZ monotherapy (TCZ mono) or TNFi monotherapy (TNFi mono), and TNFi-IR patients initiating treatment with TCZ + DMARD (TNFi-IR TCZ) or TNFi + DMARD (TNFi-IR TNFi).",
        "More patients achieved moderate-good responses (EULAR criteria) in the TCZ treatment groups (79-85 %) compared with TNFi treatment groups (65-81 %).",
        "Tocilizumab (TCZ) and tumour necrosis factor inhibitors (TNFi) are recommended for the treatment of rheumatoid arthritis (RA) in patients with inadequate response (IR) to prior disease-modifying antirheumatic drugs (DMARDs).",
        "In patients with inadequate response to DMARDs and/or TNFi treated in routine clinical practice, TCZ in combination with DMARDs or as monotherapy resulted in significantly more patients achieving remission and more marked improvements in patient-reported outcomes compared with TNF inhibitors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25943001": [
        "Few studies have examined the factors associated with the transition from nonbiologic DMARDs, the first-line therapy for RA, to biologic DMARDs in RA patients.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Rheumatoid arthritis (RA) is a progressive autoimmune disorder of joints that is associated with high health care costs, yet guidance is lacking on how early to initiate biologic disease-modifying antirheumatic drugs (DMARDs), a class of medications that is the major cost driver in RA management."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12468815": [
        "This study aimed to reveal treatment patterns with traditional DMARDs and their changes during the two decades before the recent introduction of new DMARDs.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Therapy of rheumatoid arthritis (RA) is typically characterized by the sequential use of disease-modifying anti-rheumatic drugs (DMARDs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/7732491": [
        "In this paper we emphasized (1) that this rate 46% of adverse reaction against multiple DMARDs was elevated and (2) that the rate of frequency of adverse reactions against two drugs was elevated.",
        "It is important to select an appropriate DMARD for the patient.",
        "There are only six DMARDs (disease modifying anti-rheumatic drugs) available in the clinical practice, such as gold sodium thiomalate, D-penicillamine, bucillamine, auranofin, salazosulphapyridine, and lobenzarit disodium.",
        "However, 57 of the 171 patients showed an adverse reaction toward one DMARD and 26 (46%) of these 57 patients showed undesirable reactions to other DMARDs.",
        "The ranking orders of the frequency of the adverse reactions of the switching of one DMARD to another are as follows; 1. gold sodium thiomalate to D-penicillamine, 2. gold sodium thiomalate to bucillamine, 3.",
        "Therefore, a special attention for switching DMARDs should be paid to the patient who has already shown an adverse reaction to one DMARD, and we should lower the dose of DMARDs administered to the patient.",
        "D-penicillamine to bucillamine.",
        "In addition, steroid was found not to decrease the rates of the adverse reaction against DMARDs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23716132": [
        "Selective inhibition of JAKs by tofacitinib potentially modulates inflammatory processes and provides a novel approach for the treatment of RA.",
        "Direct head-to-head trials and/or further clinical experience (including long-term safety data), along with robust pharmacoeconomic studies, are required to more definitively position tofacitinib relative to other currently available DMARDs.",
        "Oral tofacitinib is indicated for the treatment of adult patients with active RA who have had an inadequate response to methotrexate and/or other DMARDs.",
        "Tofacitinib (Xeljanz(\u00ae)) is the first approved drug in a new class of disease modifying antirheumatic drugs (DMARDs), the Janus kinase (JAK) inhibitors.",
        "JAKs have a pivotal role in triggering cytokine-induced signal transduction pathways that influence normal and pathological cellular processes of haematopoiesis and immune cell function, including pathogenic mechanisms involved in rheumatoid arthritis (RA).",
        "In the meantime, tofacitinib (alone or in combination with nonbiological DMARDs) is an emerging option for the treatment of DMARD-experienced adult patients with moderately to severely active RA who have had an inadequate response to or are intolerant of methotrexate or other DMARDs.",
        "In several large well designed trials, tofacitinib, in combination with methotrexate or other nonbiological DMARDs or as monotherapy, was an effective and generally well tolerated DMARD for the treatment of adult patients with moderately to severely active RA who had had an inadequate response to previous DMARDs, including tumour necrosis factor-\u03b1 inhibitors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24470443": [
        "We examined predictors of starting and stopping DMARDs among a longitudinal cohort of patients with RA.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Disease-modifying antirheumatic drugs (DMARDs) are the standard of care for rheumatoid arthritis (RA); however, studies have found that many patients do not receive them."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23959574": [
        "Older age, female, higher comorbidity score, number of medical visits pre-diagnosis, care by other specialists, and the use of acetaminophen were inversely associated with DMARD initiation.",
        "A total of 37,399 subjects were included (65.8 % \u226565 years; 70.5 % female).",
        "We examined trends in use of traditional and biologic DMARDs, and non-DMARD treatments, among overall RA patients, and factors associated with DMARD initiation in the newly diagnosed RA.",
        "Care by an internist, increasing calendar year, use of NSAIDs, corticosteroids, or opioids, and a history of hospitalization increased the likelihood of DMARD initiation.",
        "Despite the clinical practice guideline recommendations for earlier aggressive RA management, DMARD use appears to be suboptimal in Quebec.",
        "Among newly diagnosed RA, being followed by a rheumatologist was the strongest predictor of DMARD initiation (odds ratio 4.31; 95 % CI 3.73-4.97).",
        "For a subgroup of newly diagnosed subjects, we used multivariable logistic regressions to identify predictors of DMARD initiation within 12 months of diagnosis and survival analyses to appraise time to DMARD initiation.",
        "Disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of rheumatoid arthritis (RA) pharmacotherapy and should be initiated promptly after RA diagnosis.",
        "DMARD use was characterized on November 1 of each year using cross-sectional analyses.",
        "The percentage of subjects using any DMARDs increased over the study period from 41.4 % [95 % confidence interval (CI) 40.8-42.0] to 43.3 % (95 % CI 42.7-43.9).",
        "The probability of any DMARD initiation at 12 months was 38.5 %.",
        "RA subjects identified with the Quebec administrative databases were followed between January 1, 2002, and December 31, 2008."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24129128": [
        "This review addresses this question by summarising the clinical evidence about DMARD withdrawal.",
        "It includes an assessment of predictive factors for sustained DMARD-free remissions.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      When rheumatoid arthritis (RA) patients have achieved sustained good clinical responses can their disease-modifying anti-rheumatic drugs (DMARDs) be reduced or discontinued?"
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25943002": [
        "Biologics are usually combined with traditional DMARDs, primarily methotrexate (MTX), but some biologics and tofacitinib (together referred to in this article as novel DMARDs) have been shown to be efficacious as monotherapy as well.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Given the availability of a number of alternative biologic treatment options and other novel disease-modifying antirheumatic drugs (DMARDs) for the treatment of patients with rheumatoid arthritis (RA), clinicians are faced with an increasingly challenging choice regarding optimal treatment.",
        "Limited data, however, are available analyzing the effectiveness of monotherapy compared with combination therapy across novel DMARDs.",
        "In real-world practice, approximately one-third of RA patients receiving biologics are on monotherapy, primarily because of intolerance of, or noncompliance with, MTX."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22420649": [
        "The purpose of this systematic review was to evaluate the comparative effectiveness and safety of DMARDs versus conventional therapy and versus other DMARDs.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Treatment of juvenile idiopathic arthritis (JIA) with disease-modifying antirheumatic drugs (DMARDs) may improve outcomes compared to conventional therapy (e.g., non-steroidal anti-inflammatory drugs, intra-articular corticosteroids)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25244345": [
        "DMARDs act by different mechanisms against inflammation like inhibition of tumor necrosis factor, suppression of IL-1 and TNF-\u03b1, induction of apoptosis of inflammatory cells, by increasing chemotactic factors, inhibition of purine synthesis, pyrimidine metabolism or purine embolism.",
        "DMARDs have important applications in diseases like rheumatoid arthritis, Crohn's disease, juvenile idiopathic arthritis, psoriatic arthritis and myasthenia gravis.",
        "About 83% of population worldwide uses DMARDs.",
        "Withdrawal of COX-2 inhibitors because of cardiovascular side effects and short-term action associated with glucocorticoids provided a motivation for development of newer DMARDs.",
        "Disease modifying antirheumatic drugs (DMARDs) is a category of drugs which is used as medication in various arthritic conditions to arrest the progression of disease along with relief from pain.",
        "Present review mainly focuses on DMARDs and their clinical applications giving an overview of their mechanism of action, pharmacokinetic properties, advantages over conventional therapies, shortcomings and recent trends.",
        "Biological DMARDs like toclizumab, adalimumab, infliximab, golimumab and abatacept have shown more efficacy and lesser side effects as compared to non- biological DMARDs but their access to patient is less because of higher cost.",
        "Currently non- biological DMARDs like methotrexate, sulfasalazine, hydroxychloroquine and azathioprine serve the purpose of relieving pain and inhibiting the progression of disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22298075": [
        "All DMARDs are expected to prevent the progression of bone and cartilage destruction of RA patients from the results of in vitro research, and prevention of joint destruction is confirmed in vivo in all biologic DMARDs, but not in all non-biologic DMARDs.",
        "In this chapter, we would like to review the results of basic researches and clinical studies to demonstrate the prevention of joint destruction by non-biologic DMARDs that have been frequently used I daily practice.",
        "For this purpose, all patients with the diagnosis of RA should be treated by disease-modifying antirheumatic drugs (DMARDs) including biologic DMARDs and non-biologic DMARDs.",
        "The primary goal in the treatment of rheumatoid arthritis (RA) is to maintain good quality of life by preventing joint destruction and avoiding disability."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30448932": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      This is a demand-based infodemiology study using the Google Trends and AdWords tools to illustrate infodemiology's potential use in rheumatology.",
        "The study investigates three questions in North American countries: (1) What terms associated with \"rheumatology\" and \"arthritis\" do people search for on Google?",
        "(2) What is the search volume for disease-modifying antirheumatic drugs (DMARDs)? and (3) What is the search volume for the term \"arthritis\" compared with for \"hepatitis C\" and \"breast cancer\"?"
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18824833": [
        "The objective of this study was to identify the considerations that are most important to patients and rheumatologists when deciding to initiate BRM therapy for RA.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Patients and rheumatologists have a number of options to consider for the treatment of rheumatoid arthritis (RA), including biologic response modifier (BRM) therapy and diseasemodifying antirheumatic drugs (DMARDs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25504789": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To explore what considerations patients have when deciding about disease-modifying antirheumatic drugs (DMARDs) and what information patients need to participate in the decision-making process."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9608316": [
        "Combination studies have focused on use of rapidly decreasing high-dose steroids as a part of the combination and emphasize the importance of using patients with early rheumatoid arthritis.",
        "Adverse reactions to DMARDs continue to concern clinicians, although evaluation of the frequency of these events has led to a reappraisal of previously accepted monitoring strategies in some cases.",
        "Data on combination therapy have highlighted the difficulties in performing these studies and the large number of patients required to produce meaningful results.",
        "For example, it may not be cost-effective to subject patients on antimalarials to regular review by an ophthalmologist because of the low frequency of serious eye defects.",
        "Even with relatively aggressive use of DMARDs, the majority of patients develop erosions.",
        "Disease-modifying antirheumatic drug (DMARD) therapy is now clearly accepted as the primary treatment for rheumatoid arthritis, with an increasing emphasis on use of combination therapy.",
        "Studies have also identified risk factors for the development of pulmonary toxicity in association with methotrexate.",
        "That DMARDs are effective in treating rheumatoid arthritis is beyond question-just how effective they are and what combinations of DMARDs will show improved efficacy will provide data for the next annual review."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20681888": [
        "<strong class=\"sub-title\">\n          Importance of the field:\n        </strong>\n      \n      The efficacy of the biologic disease-modifying antirheumatic drugs (DMARDs) shown in clinical trials may be jeopardized due to prevalent poor patient adherence."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25603037": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Dramatic improvement seen in the prognosis of rheumatoid arthritis has been driven by higher expectations, led by newer drugs and more intensive use of the older drugs.",
        "We have tried to critically summarize the findings of some landmark trials that compare these two approaches.",
        "Although methotrexate has retained its place as the first-line agent, there has been great interest in comparing biologicals to conventional Disease Modifying Anti Rheumatic Drugs (DMARDs) over the past few years with the updated guidelines from both the American College of Rheumatology and European League Against Rheumatism."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28287607": [
        "The use of mitochondria donor and target cells with distinct haplotypes (SNPs) also allows detection of the transferred mitochondria based on the concentration of their circular mitochondrial DNA (mtDNA) in the target cells.",
        "The MitoCeption protocol described here allows the transfer of the mitochondria isolated beforehand from the donor cells to the target cells, using MSC mitochondria and glioblastoma stem cells (GSC) as a model system.",
        "Interestingly, mitochondria have recently been shown to display the capacity to be transferred between cell types, notably from human mesenchymal stem cells (MSC) to cancer cells in coculture conditions, with metabolic and functional consequences for the mitochondria recipient cells, further enhancing the current interest for the biological properties of these organelles.",
        "Evaluating the effects of the transferred MSC mitochondria in the target cells is of primary importance to understand the biological outcome of such cell-cell interactions.",
        "Once the protocol has been validated with these criteria, the cells harboring the transferred mitochondria can be further analyzed to determine the effects of the exogenous mitochondria on biological properties such as cell metabolism, plasticity, proliferation and response to therapy.",
        "This mitochondria transfer protocol is adapted here for GSCs that present the specific particularity of growing as neurospheres in vitro.",
        "Mitochondria play a central role for cell metabolism, energy production and control of apoptosis.",
        "The transfer of the isolated mitochondria can be followed by fluorescence-activated cell sorting (FACS) and confocal imaging using mitochondria vital dyes.",
        "Inadequate mitochondrial function has been found responsible for very diverse diseases, ranging from neurological pathologies to cancer.",
        "This protocol has previously been used to transfer mitochondria, isolated from MSCs, to adherent MDA-MB-231 cancer cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25766410": [
        "The essential role of mitochondria, added to their recently documented capacity to transfer from cell to cell, obviously contributes to their current interest.",
        "Mitochondria dysfunction constitutes a hallmark of many genetic diseases and plays a key role in tumor progression.",
        "However, determining the proper role of mitochondria in defined biological contexts was hampered by the lack of suitable experimental tools.",
        "The MitoCeption technique, which can be applied to different cell systems, will therefore be a method of choice to analyze the metabolic modifications induced by exogenous mitochondria in host cells.",
        "We designed a protocol (MitoCeption) to directly and quantitatively transfer mitochondria, isolated from cell type A, to recipient cell type B. We validated and quantified the effective mitochondria transfer by imaging, fluorescence-activated cell sorting (FACS) and mitochondrial DNA analysis.",
        "Mitochondrial activity is central to tissue homeostasis.",
        "We show that the transfer of minute amounts of mesenchymal stem/stromal cell (MSC) mitochondria to cancer cells, a process otherwise occurring naturally in coculture, results in cancer cell enhanced oxidative phosphorylation (OXPHOS) activity and favors cancer cell proliferation and invasion."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22045904": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To review the immunogenicity, efficacy, and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) for use in pediatric patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28976302": [
        "Secukinumab (SEC; COSENTYX<sup>\u00ae</sup>, Novartis International AG, Basel, Switzerland) and certolizumab pegol (CZP; CIMZIA<sup>\u00ae</sup>, UCB Pharma, Brussels, Belgium) have not previously been appraised by NICE.",
        "NICE does not specifically recommend switching from one biologic to another, and only ustekinumab (UST; STELARA<sup>\u00ae</sup>, Janssen Pharmaceuticals, Inc., Horsham, PA, USA) is recommended after anti-tumour necrosis factor failure.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Several biologic therapies are approved by the National Institute for Health and Care Excellence (NICE) for psoriatic arthritis (PsA) patients who have had an inadequate response to two or more synthetic disease-modifying antirheumatic drugs (DMARDs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28536935": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      In the treatment of poly- and dermatomyositis, only a limited number of treatment modalities are established."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29797711": [
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Off-label use of rituximab to treat MS patients in Sweden is high, and the need for long-term safety data may not be met.",
        "Our objectives were to assess the rate of rituximab prescription in patients with multiple sclerosis in Sweden and, in addition, to evaluate the safety of rituximab in a single centre for patients with multiple sclerosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28742259": [
        "There has not previously been an audit of off-label rituximab use in the Northern Territory, where the majority of patients are Aboriginal.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Rituximab, an anti-CD20 B-cell depleting monoclonal antibody, is increasingly prescribed off-label for a range of autoimmune diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29574922": [
        "This situation leads to suboptimal approaches, including prolonged exposure to treatments that are not intended for long-term use (eg, corticosteroids) and overuse of off-label therapies (eg, rituximab) while approved, more efficacious options exist.",
        "A better understanding of available second-line treatments may ensure best use of therapeutic options and thereby optimize patient outcomes.",
        "These approaches may not only fail to address symptoms and burden of disease, but may also worsen health-related quality of life.",
        "In patients with immune thrombocytopenia who do not adequately respond to first-line therapy, there is no clear consensus on which second-line therapy to initiate and when."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30185361": [
        "Off-label use of rituximab (RTX) has shown significant promise in this patient group; however, data are still controversial.",
        "We aimed to analyze the outcomes of RTX therapy in refractory lupus using a meta-analysis approach.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Conventional treatment of systemic lupus erythematosus (SLE) and lupus nephritis (LN) is associated with damage accrual, hence increased morbidity rate."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18270863": [
        "Rituximab is increasingly used off label for difficult-to-treat auto-immune diseases.",
        "Double-blind randomised controlled trials and phase IV studies are mandatory in most clinical settings to confirm the overall favourable perception of rituximab benefit to risk ratio.",
        "In warm agglutinin auto-immune anaemia, its efficacy has essentially been reported in chronic lymphocytic leukemia (CLL) patients and in children.",
        "A substantial infectious risk has been reported in pemphigus patients and in post-renal transplant cryoglobulinemia.",
        "In CLL patients, lethal adverse events occurred in patients also receiving cyclophosphamide.",
        "A single 375 mg/m2 infusion may be as efficacious as the classical four infusions cycle.",
        "Refractory immune thrombocytopenic purpura was the main indication.",
        "Efficacy and safety data in lupus are difficult to interpret.",
        "Rituximab seems to have an interesting benefit-to-risk ratio in Wegener granulomatosis (excepted in granulomatous lesions), HCV-associated symptomatic cryoglobulinemia in patients unresponsive to anti-viral therapy, pemphigus and thrombotic thrombocytopenic purpura.",
        "Rituximab is the best treatment for cold agglutinin disease.",
        "We reviewed the main case series or clinical studies to identify the best indications of rituximab and the situations at substantial risks for adverse events.",
        "Serum sickness disease is not exceptional in immune thrombocytopenic purpura (ITP), lupus and sicca syndrome patients.",
        "However, the long term benefit-to-risk ratio of rituximab treatment before or after splenectomy is unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29362447": [
        "Meanwhile, treatment with microtubule polymerisation inhibitors nocodazole or colcemid in cell culture decreased mitochondrial velocity, and knockdown of the microtubule motor protein kinesin family member 5B (KIF5B) led to a similar effect, indicating that mitochondrial movement was dependent on microtubules and the motor protein KIF5B.",
        "In conclusion, as a novel means of intercellular communication, MNTs rescue distressed CMs from apoptosis by transporting mitochondria along microtubules via KIF5B.",
        "Our previous work reported on the transfer of mitochondria via MNTs between cardiomyocytes (CMs) and cardiac myofibroblasts (MFs); however, the elucidation of the underlying mechanism and pathophysiological significance of this transfer requires additional study.",
        "Membrane nanotubes (MNTs) act as \"highways\" between cells to facilitate the transfer of multiple signals and play an important role in many diseases.",
        "In this study, we determined that the mean movement velocity of mitochondria in MNTs between CMs and MFs was approximately 17.5 \u00b1 2.1 nm/s.",
        "Furthermore, we showed that hypoxia/reoxygenation-induced CM apoptosis was attenuated by coculture with intact or hypoxia/reoxygenation-treated MFs, which transferred mitochondria to CMs.",
        "This rescue was prevented either by separating the cells using Transwell culture or by impairing mitochondrial transfer with nocodazole or colcemid treatment."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29335691": [
        "It is shown that the membrane undergoes a discontinuous shape transition as the size of the pulling region and the membrane tension increase.",
        "During the membrane extraction, lipids in the upper and lower leaflets exhibit different behaviors of structural rearrangements.",
        "A formula characterizing the nonlinear relationship between the maximum static pulling force and pulling size is identified.",
        "Moreover, our computational simulations indicate that the steady state pulling force increases linearly with the pulling velocity as well as the size of the pulling region.",
        "Membrane nanotubes play important functional roles in numerous cell activities such as cellular transport and communication.",
        "By exerting an external pulling force over a finite region in a membrane patch, here we investigate the size dependence of the membrane nanotube formation under the continuum and atomistic modeling frameworks."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29130162": [
        "The radiolabeled SAM is then incorporated into AHL signal by an AHL synthase enzyme.",
        "Many Proteobacteria synthesize acyl-homoserine lactone (AHL) molecules for use as signals in cell density-dependent gene regulation known as quorum sensing (QS) and response.",
        "AHL detection protocols are essential to QS researchers and several techniques are available, including a <sup>14</sup>C-AHL radiolabel assay.",
        "Here we describe a methodology to perform the AHL radiolabel assay, which is unbiased, relatively fast, and very sensitive compared to other AHL detection protocols.",
        "This assay is based on the uptake of radiolabeled methionine by living cells and conversion of the radiolabel into S-adenosylmethionine (SAM)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29130160": [
        "Chromobacterium violaceum, commonly found in soil and water, produces the characteristic purple pigment violacein, regulated by AHL-mediated QS.",
        "At least one signal, distinct from traditional QS, has been identified and there are a variety of other environmental factors that also trigger dispersion.",
        "We describe a microtiter-based experimental strategy whereby potential biofilm dispersion compounds can be screened.",
        "In another commonly used bioassay organism, Agrobacterium tumefaciens, QS can be detected by the use of a reporter gene such as lacZ.",
        "Based on this readily observed pigmentation phenotype, C. violaceum strains can be used to detect various aspects of AHL-mediated QS activity.",
        "Consequently, there is considerable interest in understanding, detecting, and inhibiting QS.",
        "N-acylated homoserine lactones (AHLs) are used as extracellular QS signals by a variety of Gram-negative bacteria.",
        "Here, we describe several commonly used approaches incorporating C. violaceum and A. tumefaciens that can be used to detect AHL and QS inhibitors.",
        "Due to the inherent low susceptibility of biofilm bacteria to antimicrobial agents, biofilm dispersion, whereby bacteria reenter the planktonic community, is another increasingly important area of research.",
        "In most bacteria, a global level of regulation, termed quorum sensing (QS), exists involving intercellular communication via the production and response to cell density-dependent signal molecules.",
        "QS has been associated with a number of important features in bacteria including virulence regulation and biofilm formation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29095463": [
        "In many pathogenic microorganisms, communication systems, collectively termed quorum sensing (QS), have been observed to control a number of bacterial behaviours including expression of virulence factors and the development of biofilms.",
        "The emergence of antibiotic resistance coupled with the lack of investment by pharmaceutical companies necessitates a new look at how we tackle bacterial infections.",
        "Herein we review recent developments towards the interference of Pseudomonas aeruginosa QS using signalling molecules and their mimetics.",
        "This non-biocidal approach would circumvent the evolutionary pressure on bacteria to mutate and develop resistance.",
        "QS signalling molecules and their biomimetics, therefore, represent a rational target for the disruption of cooperative behaviour and thus the development of novel antimicrobial strategies.",
        "An intriguing tactic is the interruption of bacterial communication systems."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27688408": [
        "It is known that they use it for regulation of biofilm formation, iron uptake, stress response and virulence factor expression.",
        "A better understanding of bacterial communication mechanisms will allow the targeting of quorum sensing with quorum sensing inhibitors to prevent and control disease.",
        "Canonical LuxI/R-type/acyl homoserine lactone mediated quorum sensing system is the best studied quorum sensing circuit and is described in Gram-negative bacteria which employ it for inter-species communication mostly.",
        "Bacteria can communicate within their own species (intra-species) but also between species (inter-species), for which they employ an autoinducer-2 quorum sensing system which is called the universal language of the bacteria.",
        "Once the concentration of the stimulatory threshold is reached, alteration in gene expression occurs.",
        "Gram-positive and Gram-negative bacteria possess different types of quorum sensing systems.",
        "Bacteria produce and secrete small molecules, named autoinducers, into the intercellular space.",
        "Gram-positive bacteria possess a peptide-mediated quorum sensing system.",
        "Periodontal pathogenic bacteria possess AI-2 quorum sensing systems.",
        "The term 'quorum sensing' describes intercellular bacterial communication which regulates bacterial gene expression according to population cell density.",
        "The concentration of these molecules increases as a function of population cell density."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15151251": [
        "Quorum sensing is a mechanism of cell-to-cell communication and is mediated by extracellular chemical signals generated by the bacteria when specific cell densities are reached.",
        "It is important that food microbiologists have an awareness and an understanding of the mechanisms involved in bacterial quorum sensing, since strategies targeting quorum sensing may offer a means to control the growth of undesirable bacteria in foods.",
        "Quorum sensing is a signaling mechanism through which bacteria modulate a number of cellular functions (genes), including sporulation, biofilm formation, bacteriocin production, virulence responses, as well as others.",
        "A number of compounds have been isolated or synthesized that antagonize quorum sensors, and application of these antagonists may potentially be useful in inhibiting the growth or virulence mechanisms of bacteria in different environments, including food.",
        "The physiological and clinical aspects of quorum sensing have received considerable attention and have been studied at the molecular level.",
        "When the concentration of the signal (and cell population) is sufficiently high, the target gene or genes are either activated or repressed.",
        "Quorum sensing increases the ability of the bacteria to have access to nutrients or to more favorable environmental niches and enhances bacterial defenses against eukaryotic hosts, competing bacteria, and environmental stresses.",
        "Little is known, however, on the role of quorum sensing in food spoilage or in the growth and/or toxin production of pathogens present in food."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22825856": [
        "Crystal structures of LuxI-type AHL synthases provide insights into acyl-substrate specificity, but the current knowledge is still greatly limited.",
        "In this review we focus on the AHL-dependent quorum sensing system and highlight recent progress on structural and mechanistic studies of AHL synthases and the corresponding receptors.",
        "Structural studies of AHL receptors have facilitated a more thorough understanding of signal perception and established the molecular framework for the development of quorum sensing inhibitors.",
        "The best-studied autoinducers are acyl homoserine lactone (AHL) molecules, which are the primary quorum sensing signals used by Gram-negative bacteria.",
        "Quorum sensing is used by a large variety of bacteria to regulate gene expression in a cell-density-dependent manner.",
        "Quorum sensing plays critical roles in regulating diverse cellular functions in bacteria, including bioluminescence, virulence gene expression, biofilm formation, and antibiotic resistance.",
        "Bacteria can synchronize population behavior using small molecules called autoinducers that are produced by cognate synthases and recognized by specific receptors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27634359": [
        "Quorum quenching molecules (QQ) can inhibit the growth of such bacteria.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Quorum sensing or the bacterial information flow in an orchestrated manner is an essential feature of many pathogenic bacteria."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22269240": [
        "<strong class=\"sub-title\">\n          Aim:\n        </strong>\n      \n      This review intends to provide a brief overview regarding quorum sensing among bacteria in biofilms and also attempts to throw light on the new research focusing on interference with the quorum sensing."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23125205": [
        "Quorum sensing is a process of cell-cell communication that allows bacteria to share information about cell density and adjust gene expression accordingly.",
        "We outline these canonical quorum-sensing mechanisms and how each uniquely controls virulence factor production.",
        "Here we review the quorum-sensing circuits of Staphylococcus aureus, Bacillus cereus, Pseudomonas aeruginosa, and Vibrio cholerae.",
        "Among the many traits controlled by quorum sensing is the expression of virulence factors by pathogenic bacteria.",
        "Additionally, we examine recent efforts to inhibit quorum sensing in these pathogens with the goal of designing novel antimicrobial therapeutics.",
        "This process enables bacteria to express energetically expensive processes as a collective only when the impact of those processes on the environment or on a host will be maximized."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20819164": [
        "Bassler and others have highlighted the surprising observation that quorum sensing seems to repress Vibrio cholerae virulence factor expression (e.g. cholera toxin), in contrast to what has been observed for virulence gene expression in other bacteria.",
        "Further research is needed to understand the role of cholera toxin in the environmental existence of V. cholerae.",
        "Here, I present a novel insight that may clarify the way V. cholerae quorum-sensing signals regulate its genes.",
        "Chironomids (Diptera; Chironomidae), which occur worldwide and are frequently the insect found most abundantly in fresh water bodies, are natural reservoirs of V. cholerae.",
        "Indeed, in a survey carried out over the course of a year, V. cholerae and chironomids showed a pattern that mirrored the dynamics of predator-prey populations.",
        "Quorum sensing is the phenomenon, whereby bacteria use signal molecules to communicate with each other.",
        "HAP, therefore, is a virulence factor against chironomids.",
        "Globally, the numbers of chironomids are much larger than those of humans, so quorum-sensing signals of V. cholerae and HAP gene regulation should be understood with regard to their role in chironomids rather than humans.",
        "For example, to establish a successful infection, pathogenic bacteria become virulent only when they reach a certain local concentration in their host.",
        "Quorum-sensing signals in V. cholerae up-regulate the production of an extracellular enzyme, haemagglutinin protease (HAP), which degrades chironomid egg masses and prevents the eggs from hatching."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28598007": [
        "We found the late-onset form of KD present in 82% of the patients in our study, which was more prevalent than in patients from other populations.",
        "Next generation sequencing, applied at the final step, revealed 2 missense mutant alleles missed using Sanger sequencing.",
        "Krabbe disease (KD) is a rare disease caused by the deficiency of \u03b2-galactocerebrosidase.",
        "This study investigated 22 unrelated Chinese patients, including their clinical presentations, plasma psychosine levels and \u03b2-galactocerebrosidase gene mutations.",
        "The most common mutation in Chinese population is p.P154H, which accounts for 20.5% of alleles.",
        "Plasma psychosine levels were elevated in KD, which were correlated with the severity of clinical presentations.",
        "Sanger sequencing identified 8 novel mutations, including 7 missense mutations, p.H253Y, p.S259L, p.P318L, p.F350V, p.T428A, p.L530P, p.G586D, and 1 splicing mutation, c.1251+1G&gt;A. Quantitative real-time polymerase chain reaction (PCR) and multiplex ligation-dependent probe amplification identified a novel exon 12 and 14 deletion, separately.",
        "This work was the first large-scale study of Chinese KD patients describing their clinical, biochemical and genetic characteristics, which furthered our understanding of this classical neurological lysosomal storage disease.",
        "Consistent with the higher prevalence of the late-onset form of KD, missense mutations predominated in our study, different with the common mutation types in Europe and Japan."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29316812": [
        "Combination of intravenous and intracerebroventricular AAV gene therapy had a clear dose response and resulted in delayed onset of clinical signs, extended life-span, correction of biochemical defects, and attenuation of neuropathology.",
        "Most commonly, deficits of galactosylceramidase result in widespread central and peripheral nervous system demyelination and death in affected infants typically by 2 years of age.",
        "Adapted from studies in twitcher mice, GLD dogs were treated by combination intravenous and intracerebroventricular injections of AAVrh10 to target both the peripheral and central nervous systems.",
        "For the first time, therapeutic effect has been established in the canine model of GLD by targeting both peripheral and central nervous system impairments with potential clinical implications for GLD patients.",
        "Herein, the first adeno-associated virus (AAV) gene therapy experiments are presented in a naturally occurring canine model of GLD that closely recapitulates the clinical disease progression, neuropathological alterations, and biochemical abnormalities observed in human patients.",
        "However, disease correction is incomplete.",
        "Globoid cell leukodystrophy (GLD), or Krabbe disease, is an inherited, neurologic disorder that results from deficiency of a lysosomal enzyme, galactosylceramidase.",
        "Hematopoietic stem-cell transplantation is the current standard of care in children diagnosed prior to symptom onset."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29391017": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Krabbe disease is a rare neurodegenerative genetic disorder caused by deficiency of galactocerebrosidase.",
        "To ensure that those identified with infantile disease received timely treatment, New York public health and medical systems took steps to accurately diagnose and rapidly refer infants for human stem cell transplantation within the first few weeks of life.",
        "After 11 years of active screening in New York and the introduction of Krabbe disease newborn screening in other states, new information has been gained which can inform the design of newborn screening programs to improve infantile Krabbe disease outcomes.",
        "Patients with the infantile form of Krabbe disease can be treated at a presymptomatic stage with human stem cell transplantation which improves survival and clinical outcomes.",
        "In 2006, New York began screening newborns for Krabbe disease to identify presymptomatic cases.",
        "However, without a family history, most cases of infantile Krabbe disease present after onset of symptoms and are ineligible for transplantation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22560515": [
        "CFL2 encodes the protein cofilin-2, which plays an important role in regulation of sarcomeric actin filaments.",
        "Nemaline myopathy and myofibrillar myopathy are heterogeneous myopathies that both comprise early-onset forms.",
        "Muscle biopsies showed features of both nemaline myopathy and myofibrillar myopathy.",
        "We performed homozygosity mapping in both siblings using an Affymetrix 250K Nspl SNP array.",
        "Given the clinical variability and the multitude of histological features of congenital myopathies, CFL2 sequence analysis should be considered in patients presenting with an autosomal recessive form of congenital myopathy.",
        "One of the overlapping homozygous regions harbored the gene CFL2.",
        "We present two sisters from a consanguineous Iraqi Kurdish family with predominant axial and limb girdle weakness.",
        "Because a mutation in CFL2 was identified in a family with nemaline myopathy, we performed sequence analysis of the gene and a novel homozygous missense mutation in exon 2 (c.19G&gt;A, p.Val7Met) of CFL2 was identified in both siblings.",
        "To our knowledge, this is the second family in which a mutation in CFL2 causes an autosomal recessive form of congenital myopathy with features of both nemaline and myofibrillar myopathy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28866747": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      The objective of this study was to explore the prognostic value of cancer stem cell markers, namely CD133, NANOG, and NOTCH1, in early stage oral squamous cell carcinoma (OSCC)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29177763": [
        "The successful development from a single-cell zygote into a complex multicellular organism requires precise coordination of multiple cell-fate decisions.",
        "Here, we review the current understanding of key transcriptional control mechanisms and genes responsible for these distinct differences during the first cell lineage specification.",
        "The very first of these is lineage specification into the inner cell mass (ICM) and trophectoderm (TE) during mammalian preimplantation development.",
        "Conversely, TFs such as Cdx2 and Eomes become highly upregulated in TE, which contribute to the placenta.",
        "In particular, we highlight recent insights gained through advances in genome manipulation, live imaging, single-cell transcriptomics, and loss-of-function studies.",
        "In mouse embryos, transcription factors (TFs) such as Oct4, Sox2, and Nanog are enriched in cells of ICM, which gives rise to the fetus and yolk sac."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29243835": [
        "These novel findings could provide new insights into the molecular mechanisms of breast CSCs regulation as well as its target intervention and might provide new strategies for preventing and treating breast cancers.",
        "Taken together, our results illustrated that DATS suppressed breast CSCs through inhibiting Wnt/\u03b2-catenin pathway activation.",
        "Furthermore, we showed that DATS downregulated the activity of Wnt/\u03b2-catenin pathway, while LiCl-triggered Wnt/\u03b2-catenin activation diminished DATS inhibition on breast CSCs.",
        "However, the role of DATS in regulating breast CSCs activity and the underlying molecular mechanisms remain obscure.",
        "The canonical Wnt/\u03b2-catenin signal pathway is critical for maintaining CSCs characteristics.",
        "In the present study, we reported that DATS efficiently inhibited the viability of breast CSCs as evidenced by reducing turmorspheres formation, decreasing the expression of breast CSCs markers (CD44, ALDH1A1, Nanog, and Oct4), as well as inhibiting proliferation and inducing apoptosis.",
        "Diallyl trisulfide (DATS), a natural organosulfur compound from the garlic, exhibits effective antitumor properties.",
        "Cancer stem cells (CSCs) play a central role in the development of breast cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29204746": [
        "All WJMSCs were highly proliferative, positively expressed CD90, CD105, CD73 and vimentin, while not expressing CD34, CD45, CD14, CD19 or HLA-DR, differentiated into adipocytes, osteocytes and chondrocytes and expressed pluripotency markers OCT-4, SOX-2 and NANOG at gene and protein levels.",
        "WJMSCs from all three parts were maintained in normal growth conditions (10% ADMEM) and analyzed for mesenchymal markers, pluripotent genes, proliferation rate and tri-lineage differentiation potential.",
        "Easy isolation, lack of ethical issues, high proliferation, multi-lineage differentiation potential and immunomodulatory properties of umbilical cord (UC)-derived mesenchymal stem cells (MSCs) make them a valuable tool in stem cell research.",
        "For this purpose, using an explant attachment method, WJMSCs were isolated from three different parts of the UC, mainly present towards the placenta (mother part), the center of the whole cord (central part) and the part attached to the fetus (baby part).",
        "Finally, we conclude that WJMSCs derived from all the parts are valuable sources and can be efficiently used in various fields of regenerative medicine.",
        "Furthermore, MSCs derived from all the parts were shown to have potency towards hepatocyte-like cell differentiation.",
        "There may be varied MSCs present in different parts of WJ throughout the length of the UC.",
        "Recently, Wharton's jelly (WJ) was proven as the best MSC source among various compartments of UC.",
        "Human bone marrow-derived MSCs were used as a positive control.",
        "However, it is still unclear whether or not Wharton's jelly-derived MSCs (WJMSCs) from different parts of the whole cord exhibit the same characteristics."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29414604": [
        "And the iPSC line was demonstrated to have the three germ layers differentiation capacity in vivo by teratoma assay.",
        "Human fibroblasts were isolated from foreskin of a clinically diagnosed 40-year old patient with idiopathic infertility.",
        "This patient-specific iPSC line can be used to explore the mechanism for idiopathic male infertility.",
        "The fibroblasts were reprogrammed with the Yamanaka KOSM transcriptional factors using the retroviral vectors.",
        "The iPSC line also showed normal karyotype.",
        "The obtained induced pluripotent stem cell (iPSC) line showed pluripotency verified by the expression of pluripotency markers, NANOG, SOX2, OCT4, TRA-1-60, and SSEA-4."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26339994": [
        "We found that targeted inhibition of Nanog could suppress proliferation and colony formation in breast cancer cells.",
        "Nanog is one of the transcription factors that are essential for stem cellular physiology process.",
        "We report here that Nanog was highly expressed in CSCs-enriched population from the breast cancer cells, as well as stemness-associated genes.",
        "Further studies showed that targeted inhibition of Nanog resulted in a decrease of BCSCs activities, including mammosphere formation, CD44 + CD24- proportion and expressions of stemness-associated genes.",
        "In this study, CD44 + CD24- fraction sorting with Fluorescence Activated Cell Sorter and mammosphere culture were used for enriching BCSCs.",
        "However, expression feature of Nanog in breast cancer stem cells (BCSCs) enriched population and its biological function in BCSCs is poorly understood.",
        "Previous studies reported that Nanog was detected in breast cancer and other solid tumors and indicated that it has oncogenic characteristics.",
        "Emerging evidences suggest that cancer stem cells (CSCs) are responsible for tumor growth, metastasis and treatment resistance.",
        "In addition, we employed the lentivirus-mediated shRNA targeting Nanog to investigate function of Nanog in BCSCs.",
        "These data therefore suggest that Nanog possesses important function in BCSCs and targeted inhibition of Nanog may provide a novel means of targeting and eliminating BCSCs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29486740": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Heterogeneous gene expressions of cells are widely observed in self-renewing pluripotent stem cells, suggesting possible coexistence of multiple cellular states with distinct characteristics.",
        "Though the elements regulating cellular states have been identified, the underlying dynamic mechanisms and the significance of such cellular heterogeneity remain elusive."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24487281": [
        "<strong class=\"sub-title\">\n          Ethnopharmacological relevance:\n        </strong>\n      \n      Sideritis scardica Griseb. is an endemic species in the Balkan Peninsula.",
        "It is used in traditional medicine as a loosening agent in bronchitis and bronchial asthma; against the common cold and lung emphysema; in the treatment of inflammation, gastrointestinal disorders and coughs; and as an active constituent of dietary supplements for the prevention of anemia.",
        "This review aims to provide a comprehensive overview of the traditional use, phytochemistry, biological activity, cultivation, and extraction of Sideritis scardica and to highlight the gaps in our knowledge which deserves further research."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28144274": [
        "Noonan syndrome diagnosis is primarily based on clinical features, but molecular testing should be performed to confirm it in patients.",
        "Patients with NS also have higher risk for leukemia and specific solid tumors.",
        "Germline mutations in the RAS-MAPK (mitogen-activated protein kinase) signal transduction pathway are responsible for NS and other related disorders.",
        "Various symptoms have been reported for this abnormality such as short stature, unusual facial characteristics, congenital heart abnormalities, developmental complications, and an elevated tumor incidence rate.",
        "Noonan syndrome (NS) is an autosomal dominant disorder with vast heterogeneity in clinical and genetic features.",
        "Noonan syndrome shares clinical features with other rare conditions, including LEOPARD syndrome, cardio-facio-cutaneous syndrome, Noonan-like syndrome with loose anagen hair, and Costello syndrome.",
        "Age-specific guidelines for the management of NS are available.",
        "Due to the high number of genes associated with NS and other RASopathy disorders, next-generation sequencing is the best choice for diagnostic testing."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29084544": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Noonan syndrome (NS) and Noonan syndrome with multiple lentigines (NSML) are autosomal dominant developmental disorders.",
        "NS and NSML are caused by abnormalities in genes that encode proteins related to the RAS-MAPK pathway, including PTPN11, RAF1, BRAF, and MAP2K.",
        "In this study, we diagnosed ten NS or NSML patients via targeted sequencing or whole exome sequencing (TS/WES)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24447602": [
        "We describe the case of a male patient diagnosed with Noonan's syndrome and peripheral spondyloarthritis, a previously undescribed association in the literature.",
        "Noonan's syndrome is an autosomal dominant genetic disorder with high phenotypic variability, characterized mainly by facial dysmorphism, congenital heart disease and short stature."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20882035": [
        "In order to understand the contribution of SHOC2 mutations to the clinical manifestations of Noonan syndrome and related disorders, we analyzed SHOC2 in 92 patients with Noonan syndrome and related disorders who did not exhibit PTPN11, KRAS, HRAS, BRAF, MAP2K1/2, SOS1 or RAF1 mutations.",
        "It shows phenotypic overlap with Costello syndrome and cardio-facio-cutaneous (CFC) syndrome.",
        "We found the previously identified p.S2G mutation in eight of our patients.",
        "No SHOC2 mutations were identified in leukemia cells from 82 leukemia patients.",
        "Six of the mutation-positive patients showed severe mental retardation and easily pluckable hair, and one showed leukocytosis.",
        "Recently, a gain-of-function mutation in SHOC2, p.S2G, has been identified as causative for a type of Noonan-like syndrome characterized by the presence of loose anagen hair.",
        "These results suggest that clinical manifestations in SHOC2 mutation-positive patients partially overlap with those in patients with typical Noonan or CFC syndrome and show that easily pluckable/loose anagen hair is distinctive in SHOC2 mutation-positive patients.",
        "Noonan syndrome and related disorders are caused by germline mutations in genes encoding molecules in the RAS/MAPK pathway.",
        "Noonan syndrome is an autosomal dominant disease characterized by dysmorphic features, webbed neck, cardiac anomalies, short stature and cryptorchidism.",
        "All the patients with the p.S2G mutation showed short stature, sparse hair and atopic skin.",
        "We developed a rapid detection system to identify the p.S2G mutation using melting curve analysis, which will be a useful tool to screen for the apparently common mutation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12439898": [
        "The family history is suggestive of a new autosomal dominant mutation in the father.",
        "Alternatively, this family may have a previously undescribed genetic condition.",
        "This is a report on a father and his two children with an apparent autosomal dominant condition characterized by craniofacial anomalies, coarctation of the aorta, hypertrophic cardiomyopathy, and other structural heart abnormalities with normal psychomotor development.",
        "Some clinical features are reminiscent of Noonan syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29797354": [
        "Therefore, it is more than likely that correct protamine expression represents a kind of chromatin checkpoint during sperm development rendering protamines as suitable biomarkers for the estimation of sperm quality.",
        "Protamines are nuclear proteins which are specifically expressed in haploid male germ cells.",
        "This review presents an overview of our current knowledge on protamines comparing gene and protein structures between different mammalian species with particular consideration given to man, mouse and stallion.",
        "Mammalian sperm contain two types of protamines: PRM1 and PRM2.",
        "At last, recent insights into the possible role of inherited sperm histones for early embryo development are provided.",
        "While the proportion of the two protamines is highly variable between different species, abnormal ratios within a species are known to be associated with male subfertility.",
        "Their replacement of histones and binding to DNA is followed by chromatin hypercondensation that protects DNA from negative influences by environmental factors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28471166": [
        "Crocus sativus, commonly known as saffron or Kesar, is used in Ayurveda and other folk medicines for various purposes as an aphrodisiac, antispasmodic, and expectorant.",
        "Reduced A\u03b2 load could be explained, at least in part, by Crocus sativus extract effect to enhance A\u03b2 clearance pathways including BBB clearance, enzymatic degradation and ApoE clearance pathway.",
        "Crocin (10 mg/kg/day) was able to reduce A\u03b2 load but to a lesser extent when compared to Crocus sativus extract.",
        "The effect of Crocus sativus extract on A\u03b2 load and related toxicity was evaluated.",
        "Crocin, a major active constituent of Crocus sativus and known for its antioxidant and anti-inflammatory effect, was also tested separately in vivo in 5XFAD mice.",
        "Collectively, findings from this study support the positive effect of Crocus sativus against AD by reducing A\u03b2 pathological manifestations.",
        "In vitro results showed that Crocus sativus extract increases the tightness of a cell-based blood-brain barrier (BBB) model and enhances transport of A\u03b2.",
        "Further in vivo studies confirmed the effect of Crocus sativus extract (50 mg/kg/day, added to mice diet) on the BBB tightness and function that was associated with reduced A\u03b2 load and related pathological changes in 5XFAD mice used as an AD model.",
        "The aim of this study was to in vitro and in vivo investigate the mechanism(s) by which Crocus sativus exerts its positive effect against AD.",
        "Furthermore, Crocus sativus extract upregulated synaptic proteins and reduced neuroinflammation associated with A\u03b2 pathology in the brains of 5XFAD mice.",
        "Previous evidence suggested that Crocus sativus is linked to improving cognitive function in Alzheimer's disease (AD) patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29217417": [
        "This is the first reported study of that kind in Hong Kong, and further work is required to expand the survey of companion animals in the geographical region.",
        "Fleas are commonly recorded on stray as well as domestic dogs and cats in Hong Kong.",
        "DNA sequencing confirmed the presence of R. felis, B. clarridgeiae and Bartonella henselae.",
        "A multiplex Bartonella and Rickettsia real-time PCR of DNA from 20 C. felis found Bartonella and Rickettsia DNA in three (15%) and ten (50%) C. felis, respectively.",
        "The most common haplotype was HK-h1 with 17 specimens (17/20, 85%).",
        "HK-h1 was identical to cox1 sequences of fleas in Thailand and Fiji.",
        "Fleas can be a major cause of pruritus in dogs and cats and also vectors of potentially zoonotic bacteria in the genera Rickettsia and Bartonella.",
        "Morphological examination of 174 fleas from dogs and cats living in Hong Kong revealed only cat fleas (Ctenocephalides felis).",
        "HK-h3 forms a new Clade 6.",
        "The sampling of fleas on domestic cats and dogs in Hong Kong revealed them to be exclusively infested by the cat flea and to be harbouring pathogens of zoonotic potential.",
        "HK-h1 and HK-h2 form a distinct cat flea cox1 clade previously recognized as the Clade 3.",
        "Cytochrome c oxidase subunit 1 gene (cox1) genotyping of 20 randomly selected specimens, revealed three cox1 haplotypes (HK-h1 to HK-h3)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24149035": [
        "Rickettsia felis was first recognised two decades ago and has now been described as endemic to all continents except Antarctica.",
        "Few bacterial pathogens of humans have been found associated with such a diverse range of invertebrates.",
        "With the projected increase in global temperature over the next century, there is concern that changes to the ecology and distribution of R. felis vectors may adversely impact public health.",
        "The large number of arthropod species found to harbour R. felis and that may act as potential vectors support the view that it is a pan-global microbe.",
        "The main arthropod reservoir and vector is the cat flea, Ctenocephalides felis, yet more than 20 other species of fleas, ticks, and mites species have been reported to harbour R. felis.",
        "The rickettsiosis caused by R. felis is known as flea-borne spotted fever or cat-flea typhus."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19645274": [
        "Recent advances toward further understanding the ecology of R. felis have been facilitated by stable R. felis-infected cat flea colonies, several primary flea isolates and sustained maintenance of R. felis in cell culture systems, and highly sensitive quantitative molecular assays.",
        "Here, we provide a synopsis of R. felis including the known distribution and arthropods infected; transmission mechanisms; current understanding of vertebrate infection and human disease; and the tools available to further examine R. felis.",
        "It has been two decades since the first description of Rickettsia felis, and although a nearly cosmopolitan distribution is now apparent, much of the ecology of this unique microorganism remains unresolved.",
        "The cat flea, Ctenocephalides felis, is currently the only known biological vector of R. felis; however, molecular evidence of R. felis in other species of fleas as well as in ticks and mites suggests a variety of arthropod hosts.",
        "Likewise, serological and molecular tools have been used to detect R. felis in a number of vertebrate hosts, including humans, in the absence of a clear mechanism of horizontal transmission.",
        "Considered an emerging flea-borne rickettsiosis, clinical manifestation of R. felis infection in humans, including, fever, rash, and headache is similar to other rickettsial diseases.",
        "Studies examining the transmission of R. felis using colonized cat fleas have shown stable vertical transmission but not horizontal transmission."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21722253": [
        "Recently, two studies respectively conducted in Senegal and Kenya, have challenged the importance of R. felis infection in patients with unexplained fever in sub-Saharan Africa.",
        "Within the last 20 years, there have been a growing number of reports implicating R. felis as a human pathogen, parallel to the fast-growing reports of the worldwide detection of R. felis in arthropod hosts, mainly the cat flea Ctenocephalides felis felis.",
        "Rickettsia felis is a spotted fever group rickettsia that has been definitely described in 2002.",
        "More studies are needed, including the study of other arthropod vectors, but it can be speculated that R. felis infection might be an important neglected agent of fever in sub-Saharan Africa.",
        "We focus here on the epidemiological and clinical aspects of R. felis infection.",
        "R. felis is now known as the agent of the so-called flea-borne spotted fever, with more than 70 cases documented in the literature."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26824189": [
        "Two R. felis-like genotypes were also detected in fleas from Los Angeles County; Genotype 1 was detected in 1 flea pool and Genotype 2 was found in 10 flea pools.",
        "Genotype 1 was also detected in a single flea pool from Sacramento County.",
        "The objective of this study is to assess the presence and infection rate of Rickettsia species in cat fleas from selected endemic and nonendemic regions of California.",
        "Results from this study show that R. felis is widespread in cat flea populations in both flea-borne rickettsioses endemic and nonendemic regions of California, suggesting that a high prevalence of this bacterium in cat fleas does not predispose to increased risk of human infection.",
        "Cat fleas were collected from cats in Los Angeles County (endemic region) and Sacramento and Contra Costa counties (nonendemic region).",
        "In California, more than 90% of locally acquired human cases are reported from suburban communities within Los Angeles and Orange counties despite the almost ubiquitous presence of cat fleas and their hosts throughout the state.",
        "Another rickettsia, Rickettsia felis, found in cat fleas, Ctenocephalides felis, has also been implicated as a potential human pathogen.",
        "R. typhi was not detected in any flea pools.",
        "Further studies are needed to elucidate the role of R. felis and the two R. felis-like organisms as etiologic agents of human flea-borne rickettsioses in California.",
        "Rickettsia typhi, transmitted by rat fleas, causes most human flea-borne rickettsioses worldwide.",
        "Sequencing of 17 amplicons confirmed the presence of R. felis in both the endemic and non-endemic regions with a calculated maximum likelihood estimation of 131 and 234 per 1000 fleas, respectively.",
        "In the continental United States, human cases of flea-borne rickettsioses are reported primarily from the southern regions of Texas and California where the cat flea is considered the principal vector."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26697860": [
        "In the present study, we overexpressed I1PP2A by intracerebroventricular injection with adeno-associated virus vector-1-I1PP2A in Wistar rats.",
        "An endogenous inhibitor of protein phosphatase-2A, inhibitor-1, I1PP2A, which inhibits the phosphatase activity by interacting with its catalytic subunit protein phosphatase-2Ac, is known to be upregulated in Alzheimer's disease brain.",
        "The I1PP2A rats showed a decrease in brain protein phosphatase-2A activity, abnormal hyperphosphorylation of tau, neurodegeneration, an increase in the level of activated glycogen synthase kinase-3beta, enhanced expression of intraneuronal amyloid-beta and spatial reference memory deficit; littermates treated identically but with vector only, i.e., adeno-associated virus vector-1-enhanced GFP, served as a control.",
        "Treatment with memantine, a noncompetitive NMDA receptor antagonist which is an approved drug for treatment of Alzheimer's disease, rescued protein phosphatase-2A activity by decreasing its demethylation at Leu309 selectively and attenuated Alzheimer's disease-like pathology and cognitive impairment in adeno-associated virus vector-1-I1PP2A rats.",
        "Deficiency of protein phosphatase-2A is a key event in Alzheimer's disease.",
        "These findings provide new clues into the possible mechanism of the beneficial therapeutic effect of memantine in Alzheimer's disease patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29607687": [
        "Pharmacological treatment accounts for 10-20% of direct costs; no new drugs have been approved during the past 15 years; and the available medications are not cost-effective.",
        "The most prevalent pharmacological categories included neurotransmitter enhancers (11.38%), multi-target drugs (2.45%), anti-Amyloid agents (13.30%), anti-Tau agents (2.03%), natural products and derivatives (25.58%), novel drugs (8.13%), novel targets (5.66%), other (old) drugs (11.77%), anti-inflammatory drugs (1.20%), neuroprotective peptides (1.25%), stem cell therapy (1.85%), nanocarriers/nanotherapeutics (1.52%), and others (&lt;1% each).",
        "Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.",
        "Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion.",
        "Recommendations for the future are as follows: (i) the reconsideration of dominant pathogenic theories, (ii) the identification of reliable biomarkers, (iii) the redefinition of diagnostic criteria, (iv) new guidelines for disease management, (v) the reorientation of drug discovery programs, (vi) the updating of regulatory requirements, (vii) the introduction of pharmacogenomics in drug development and personalized treatments, and (viii) the implementation of preventive programs.",
        "Areas covered: A massive scrutiny of AD-related PubMed publications (ps)(2013-2017) identified 42,053ps of which 8,380 (19.60%) were associated with AD treatments."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20234994": [
        "Artificial oxygen carriers (AOC) use either the molecular oxygen bondage to hemoglobin: HBOC- \"hemoglobin based oxygen carriers\" or the physical dissolution of oxygen in the blood plasma compartment by hyperbaric pressure in perfluorocarbon emulsions (PFC).",
        "A research driven by the army requested an oxygen carrier that does not need cross typing and cooled storage.",
        "In this article, a short overview about the current situation on artificial blood products is given.",
        "However, some ventures currently are trying to use the knowledge gained so far and are investigating third and fourth generation products of artificial blood components.",
        "Artificial platelets are in clinical phase IIa, recombinant albumin in phase III.",
        "Other products, just prior to filing for FDA approval, did not achieve convincing study results and research and production was stopped.",
        "Decades of preclinical and clinical research did pass but the results were disappointing- in Russia, a not well designed PFC is available locally and the only approved HBOC in South Africa is not being used much.",
        "These imitate the cellular structure of red cells as micells, nanocapsules, (ABC- artificial blood cells) or gas bubbles (microbubbles), admixture of volume substitutes such as starches, gelatin or albumin or use hyperbaric oxygenation [38].",
        "The critical point for the break through for artificial blood products did not come yet but could be ahead-",
        "Formerly developed resuscitation fluids solely imitated the main function of the blood -oxygen transport.",
        "Some trials have been stopped by the FDA for safety reasons, half of trials with the primary endpoint reduction of allogeneic transfusion requirement were unsuccessful or offset by an increased blood requirement later."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28406466": [
        "Intravenous injections of Hb-Vs caused the dilatation of microvessels, and dye laser treatment with Hb-Vs destroyed the vessel wall effectively.",
        "These attributes of Hb-Vs will potentially contribute to enhancing the efficacy of dye laser treatment for port-wine stains.",
        "Small sized Hb-Vs (250 nm) distribute in the plasma phase in blood and tend to flow in the marginal zone of microvessels.",
        "Thus, our proposed treatment may have aspects of photodynamic therapy using porphyrin that leads to a cytotoxicity effect by active oxygen.",
        "This extra Hb tended to flow near the endothelial cells, which were the target of the laser treatment.",
        "Following the intravenous injection of Hb-Vs, the microvessels contained more Hb that absorbed laser photons and produced heat.",
        "We suggest a novel method that uses artificial blood cells (hemoglobin vesicles, Hb-Vs) as photosensitizers in dye laser treatment (at 595-nm wavelength) for port-wine stains (i.e., capillary malformations presenting as red birthmarks) based on the results of animal experiments.",
        "As compared with human red blood cells, Hb-Vs have the same absorbance of 595 nm wavelength light and produce the same level of heat following dye laser irradiation.",
        "Hemoglobin is a type of porphyrin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25157031": [
        "Reduced levels of HDL cholesterol (HDL-C) are a strong independent predictor of coronary artery disease (CAD) risk.",
        "One of these (AEM-28) has recently been given orphan drug status and is undergoing clinical trials.",
        "Agents including cholestyramine, fibrates, niacin, and statins significantly lower LDL cholesterol (LDL-C) and induce modest increases in HDL-C, but tolerance issues and undesirable side effects are common.",
        "This response is highly dependent on apoA-I and apoE, protein components of HDL.",
        "Randomized clinical trials have assessed effects of several classes of drugs on plasma cholesterol levels in CAD patients.",
        "The major anti-atherogenic function of HDL is to mediate reverse cholesterol transport.",
        "Additionally, residual risk may be present in patients with persistently low HDL-C and other complications despite a reduction in LDL-C.",
        "These include apoA-I mimetic peptides that have undergone initial clinical assessment.",
        "The goal of this review is to discuss the therapeutic potential of synthetic apolipoprotein mimetic peptides.",
        "We also discuss newer apoE mimetics that mediate the clearance of atherogenic lipids from the circulation and possess anti-inflammatory properties.",
        "These observations have fueled interest in the development of new pharmacotherapies that positively impact circulating lipoproteins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29733009": [
        "Human infection occurs by the accidental ingestion of embryonated eggs present in the soil, vegetables or on other contaminated surfaces, as well as via consumption of uncooked paratenic hosts, such as bird meat and giblets.",
        "Based on the flotation results of the 150 soil samples, six (4%) were found to be positive for Toxocara spp. eggs, whereas nested-PCR showed 24 samples to be positive (16%).",
        "The results showed a higher number of soil samples to be positive for Toxocara by the molecular method than microscopy, and higher T. cati infection in soil samples, which could have an important role in human infection with toxocariasis in this region.",
        "The objective of this study was to evaluate the contamination of soil in public parks and playgrounds in Shiraz using microscopy and molecular methods.",
        "To differentiate T. canis and T. cati eggs from each other, PCR restriction fragment length polymorphism (RFLP) of the internal transcribed spacer (ITS)-rDNA region by SalI endonuclease enzyme was used.",
        "Human toxocariasis, a worldwide parasitic disease, is caused by the larval stage of intestinal nematodes of dogs and cats, namely Toxocara canis and Toxocara cati.",
        "PCR-sequencing was performed to confirm the results of the PCR-RFLP method.",
        "A total of 150 soil samples were collected from public parks and playgrounds in various areas of Shiraz, southern Iran.",
        "The samples were treated with saturated zinc sulphate solution, and Toxocara spp. eggs were detected by microscopic observation followed by nested polymerase chain reaction (PCR).",
        "Based on the PCR-RFLP method and the sequence of the ITS-rDNA region, a total of 23 out of 24 isolates were confirmed as T. cati and one out of 24 as T. canis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25910623": [
        "An alternative to producing large amounts of Toxocara TES and improved diagnosis for toxocariasis is through the development of highly specific recombinant antigens such as the T. canis second stage larva excretory-secretory 30 kDa protein (recTES-30).",
        "The prevalence for toxocariasis in this population using both ELISA and RDT was 27.1% (36/133) and the K-concordance test suggested good agreement of the two tests with a Cohen's kappa of 0.722, P&lt;0.01.",
        "The overall prevalence rates by ELISA and RDT were 29.3% and 33.1%, respectively, with more positive cases detected in males than females.",
        "In conclusion, the RDT kit was faster and easier to use than an ELISA and is useful for the laboratory diagnosis of hospitalized cases of toxocariasis.",
        "A total of 133 subjects were included in the study.",
        "Human toxocariasis which is caused mainly by the larvae of Toxocara canis and Toxocara cati, is a worldwide zoonotic disease that can be a potentially serious human infection.",
        "The enzyme-linked immunosorbent assay (ELISA) using T. canis excretory-secretory (TES) antigens harvested from T. canis larvae is currently the serological test for confirming toxocariasis.",
        "The percentage sensitivity, specificity, positive predictive value and negative predictive value of RDT were 85.7%, 90.1%, 80% and 93.2%, respectively.",
        "However, no association was found between toxocariasis and gender or age.",
        "In addition, the followed-up Spearman rank correlation showed a moderately high correlation at R=0.704 and P&lt;0.01.",
        "The aim of this study was to evaluate the sensitivity and specificity of a rapid diagnostic kit (RDT, named as iToxocara kit) in comparison to recTES-30 ELISA in Serendah Orang Asli village in Selangor, Malaysia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28761463": [
        "However, how these paratenic hosts response to these worms and whether any common biomarker can be applied for diagnosis are still unclear.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Toxocariasis is a prevalent zoonosis disease caused by the closely related nematode species <i>Toxocara canis</i> and <i>Toxocara cati</i> which parasitise Canidae and Felidae respectively.",
        "In paratenic hosts, larvae of these worms cause multiple organ damage."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18179629": [
        "Our study showed that 94.2% of positive sera collected from patients reporting infection &gt; 6 months ago had high IgG avidity values, confirming distant toxocariasis, whereas 25.9% of positive sera taken &lt; 6 months after infection showed low indices of IgG avidity.",
        "The method can be used effectively to rule out (because of high avidity) a recently acquired infection.",
        "Human toxocariasis is a zoonosis caused by infection with larvae of the ascarid nematode Toxocara canis and, less frequently, T. cati.",
        "The avidity of specific antibodies increases with time after antigen challenge and assessment of the degree of avidity can be used to discriminate between recent and distant infections.",
        "Our study developed a method for distinguishing distant from recent human toxocariasis by assessing the avidity of the IgG antibodies.",
        "Low avidity is less reliable in discriminating between recent and distant infections.",
        "Our results suggest that measurement of the specific IgG avidity may assist in discriminating between recent and distant toxocariasis.",
        "The relative avidity was measured in 150 sera from children with visceral toxocariasis and in 46 sera from children with ocular toxocariasis.",
        "The probable time of infection was estimated on the basis of the medical history and clinical syndrome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24808249": [
        "In addition, risk factors for acquiring infection need to be better defined, and research needs to be conducted to better understand the pathophysiology and clinical course of toxocariasis.",
        "Humans become infected when they accidently ingest infectious Toxocara eggs commonly found in contaminated soil; children are most often affected.",
        "Toxocariasis is a preventable parasitic disease that is caused by the dog and cat roundworms Toxocara cani and T. cati, respectively.",
        "Although infection with Toxocara can cause devastating disease, the burden of toxocariasis in the United States population remains unknown.",
        "Clinical manifestations of Toxocara infection in humans include ocular toxocariasis and visceral toxocariasis.",
        "Development of diagnostic tests would enable clinicians to detect active infection, and determination of optimal drug regiments would ensure patients were appropriately treated.",
        "Addressing these public health gaps is necessary to understand and address the impact of toxocariasis in the United States."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30050644": [
        "It is mostly a benign condition.",
        "Human toxocariasis is a cosmopolitan parasitic zoonosis caused by Toxocara canis and Toxocara cati which are roundworms of dogs and cats.",
        "We here report a case of acute pancreatitis secondary to toxocariasis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25777539": [
        "The results indicated that LPS-induced loss of nigral DA neurons was inhibited by SST and the observed effects of SST on neuroprotection were associated with suppression of microglial activation and the NF-\u03baB pathway, ensuing decreases of neuroinflammation and oxidative stress.",
        "In the present study, a model of PD was generated by injecting lipopolysaccharide (LPS) into the substantia nigra (SN) of rats in order to investigate the effects of SST on LPS-induced degeneration of DA in vivo.",
        "The present study therefore suggested that SST is beneficial for treating neurodegenerative diseases, such as PD, through inhibiting the activation of microglia.",
        "Somatostatin (SST) is a neuromodulator which is abundant throughout the central nervous system (CNS) and has a crucial role in neurodegenerative disorders.",
        "Intramural injection of LPS resulted in a significant loss of DA neurons, while reduction of neuronal death by SST pretreatment was confirmed using immunohistochemical staining for tyrosine hydroxylase and Nissl.",
        "ELISA revealed a decreased production of pro-inflammatory mediators, including tumor necrosis factor-\u03b1, interleukin-1\u03b2 and prostaglandin E2 when SST was administered prior to LPS treatment.",
        "Western blot analysis showed that LPS-induced expression of inducible nitric oxide synthase, cyclooxygenase-2 and nuclear factor \u03baB (NF-\u03baB) p-p65 was attenuated by administration of SST prior to LPS application.",
        "In parallel, immunohistochemical detection of OX-42 and hydroethidine staining were employed to determine the activation of microglia and production of reactive oxygen species (ROS), respectively.",
        "However, little is known about the effects and mechanisms of SST in dopaminergic (DA) neurons in the context of Parkinson's disease (PD).",
        "It was found that SST inhibited the LPS-induced microglial activity and ROS production."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24627166": [
        "Since topical administration of SST has been effective in preventing retinal neurodegeneration in STZ-induced diabetic rats, it seems reasonable to test this new approach in humans.",
        "However, clinical trials will be needed to establish the exact position of targeting SST in the treatment of this disabling complication of diabetes.",
        "In this article, we give an overview of the mechanisms by which this deficit of SST participates in the main pathogenic mechanisms involved in diabetic retinopathy (DR): neurodegeneration, neovascularization, and vascular leakage.",
        "Somatostatin (SST) is abundantly produced by the human retina, and the main source is the retinal pigment epithelium (RPE).",
        "This could be implemented by intravitreous injections of SST analogs or gene therapy, but this is an aggressive route for the early stages of DR.",
        "SST exerts relevant functions in the retina (neuromodulation, angiostatic, and anti-permeability actions) by interacting with SST receptors (SSTR) that are also expressed in the retina.",
        "In conclusion, SST is a natural neuroprotective and antiangiogenic factor synthesized by the retina which is downregulated in the diabetic eye and, therefore, its replacement seems a rational approach for treating DR.",
        "In the diabetic retina, a downregulation of SST production does exist.",
        "In view of the relevant SST functions in the retina and the reduction of SST production in the diabetic eye, SST replacement has been proposed as a new target for treatment of DR.",
        "In this regard, the results of the ongoing clinical trial EUROCONDOR will provide useful information."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23894587": [
        "However, the temporal profile by which OB somatostatin-expressing (Som+) interneurons are produced and the molecular mechanisms controlling this profile are totally unknown.",
        "In the present study, we found that all the Som+ interneurons in the mouse external plexiform layer (EPL) and the rat glomerular layer (GL) express the transcription factor Sp8.Using the 5-bromo-2'-deoxyuridine (BrdU) birth dating method, combined with immunostaining, we showed that the generation of Som+ interneurons in the mouse and rat OB is confined to the later embryonic and earlier postnatal stages.",
        "Interestingly, genetic ablation of Sp8 by cre/loxP-based recombination severely reduces the number of Som+ interneurons in the EPL of the mouse OB.",
        "Somatostatin (Som), one of the most concentrated neuropeptides in the brain, is highly expressed in the olfactory bulb (OB).",
        "Taken together, these results suggest that Sp8 is required for the normal production of Som+ interneurons in the EPL of the mouse OB.",
        "Within the mouse OB, the production of Som+ interneurons is maximal during late embryogenesis and decreases after birth, whereas the generation of Som+ interneurons is low during embryogenesis and increases gradually after birth in the rat OB."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23370538": [
        "However, demonstration and quantification of functional IP in HF cells are required.",
        "The data identify SST as a secretory factor potentially contributing to the HF IP repertoire.",
        "It is noteworthy that somatostatin (SST) was significantly upregulated relative to epidermis.",
        "PBMCs, cultured with stimulatory allogeneic epidermal cells and SST, secreted significantly less IFN\u03b3 than controls.",
        "Immune privilege (IP) is believed to exist in the anagen hair follicle (HF).",
        "Studies have shown that downregulation of major histocompatibility complex Class I occurs and immunosuppressive factors are expressed in the HF bulb and bulge.",
        "By qPCR, we found significant downregulation of Class I and Class II HLA alleles in both the bulb and sheath, and upregulation of multiple immunoregulatory genes.",
        "We found that HF cells, relative to non-follicular epidermal cells, failed to promote allogeneic PBMC proliferation and CD4(+) and CD8(+) IFN\u03b3 production.",
        "By immunohistochemistry, SST was most strongly expressed in the HF outer root sheath, and, by ELISA, cultured sheath cells secreted SST.",
        "We examined the middle (sheath) and lower (bulb) portions of the human HF using quantitative real-time RT-PCR (qPCR), immunohistology, ELISA, in vitro coculture with peripheral blood mononuclear cells (PBMCs), and flow cytometry.",
        "Addition of SST antagonists to PBMCs cocultured with allogeneic HF cells increased IFN\u03b3 secretion."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19819962": [
        "There was a subsequent drop of glucagon release concomitant with the appearance of a pronounced pulse of insulin and a slightly delayed pulse of somatostatin.",
        "Glucose caused pronounced stimulation of average insulin and somatostatin release.",
        "Increase of glucose from 3 to 20 mm resulted in a brief pulse of glucagon coinciding with suppression of basal insulin and somatostatin release.",
        "Batches of 10-15 islets were perifused and the hormones measured with RIA in 30-sec fractions.",
        "The kinetics of insulin, glucagon and somatostatin release was studied in human pancreatic islets.",
        "The resulting greater than 20-fold variations of the insulin to glucagon ratio might be essential for minute-to-minute regulation of the hepatic glucose production.",
        "Continued exposure to 20 mm glucose generated pulsatile release of the three hormones with 7- to 8-min periods accounting for 60-70% of the secreted amounts.",
        "However, the nadirs between the glucagon pulses were lower than the secretion at 3 mm glucose, resulting in 18% suppression of average release.",
        "The repetitive glucagon pulses were antisynchronous to coincident pulses of insulin and somatostatin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29435292": [
        "Chronic myeloid leukemia (CML) is a hematologic malignancy associated with increased circulating myeloid cells and platelets in the peripheral blood, with accompanying bone marrow hyperplasia.",
        "Cytogenetic analysis by G-banding revealed the presence of a three-way translocation involving the long arms of chromosomes 9, 22 and 17.",
        "Fluorescence <i>is situ</i> hybridization utilizing a dual-color fusion probe confirmed the presence of the Bcr-Abl fusion gene.",
        "The Philadelphia chromosome, t(9;22)(q34;q11), is present in 95% of CML patients, resulting in constitutive tyrosine kinase activity; however, ~5% of CML patients possess a Philadelphia variant.",
        "A novel three-way Philadelphia translocation variant, t(9;22;17)(q34;q11.2;q11.2), was identified in a 54-year old man who presented with leukocytosis, anemia and thrombocytosis that was diagnosed with chronic myeloid leukemia, chronic phase."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29633730": [
        "However, variant cytogenetic still happens in 5-10 % of cases, the importance of which is controversial as well as its response to therapy, prognosis and progression to acute leukemias.",
        "Chronic Myeloid Leukemia (CML) is myeloproliferative neoplasm characterized by Philadelphia chromosome which is a balanced translocation between chromosome 9 and 22 in 90% of cases.",
        "Here we report a male patient with CML and variant cytogenetic who responded to low dose of Dasatinib (50 mg daily)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29046997": [
        "Previously, we reported two novel cell-penetrating peptides (CPPs), namely, cationic IR15 and anionic SR11 present in tryptic digest of Abrus agglutinin.",
        "Both IR15 and SR11 significantly reduce the viability of CML cells in the presence of imatinib by increasing the intracellular accumulation of the drug.",
        "The use of first- and second-generation tyrosine kinase inhibitors has been successful to an extent.",
        "Fluorescent correlation spectroscopy and lifetime imaging were employed to map membrane fluidity and lipid raft distribution following peptide-drug co-administration.",
        "Chronic myeloid leukemia is a stem cell disease with the presence of Philadelphia chromosome generated through reciprocal translocation of chromosome 9 and 22.",
        "In addition, intracellular accumulation of drug critically depends on cell membrane fluidity and lipid raft dynamics.",
        "Apart from several drug-resistant mechanisms, drug influx/efflux ratio appears to be one of the key determinants of therapeutic outcomes.",
        "Results show that IR15 and SR11 are the two CPPs which can modulate membrane fluidity and lipid raft distribution in K562 cells.",
        "Here, the potential of IR15 and SR11 to influence intracellular concentration of imatinib has been evaluated.",
        "However, resistance against such drugs is an emerging problem."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28586632": [
        "The authors focused on immunoregulatory components of colostrum (antidietary antibodies and TGF-\u03b22) in the neonatal gut.",
        "Research aim: This work has two main aims: evaluate the antibody profile of colostrum and study the quantitative variations in the antibodies' level and specific reactivity after undergoing Holder pasteurization.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      When feeding preterm infants, donor milk is preferred if the mother's own milk is unavailable.",
        "Pasteurization may have detrimental effects on bioactivity, but more information is needed about its effects on the immunological compounds."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28836271": [
        "Key elements required for causality inferences linking epigenetic changes to exposure and cancer are discussed and how these alterations can be incorporated in carcinogen evaluation and in understanding mechanisms underlying epigenome deregulation by the environment.",
        "There is also growing evidence that epigenetic changes may be risk factor-specific (\"fingerprints\") that should prove instrumental in the discovery of new biomarkers in cancer.",
        "Recent evidence has highlighted the key role of epigenetic mechanisms in mediating gene-environment interactions and translating exposures into tumorigenesis.",
        "The interaction between the (epi)genetic makeup of an individual and his/her environmental exposure record (exposome) is accepted as a determinant factor for a significant proportion of human malignancies.",
        "Here, we review the state of the science of epigenetics associated with environmental stimuli and cancer risk, highlighting key developments in the field.",
        "Critical knowledge gaps and research needs are discussed and advances in epigenomics that may help in understanding the functional relevance of epigenetic alterations."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28494612": [
        "As population studies are essential for establishing these environment-organism interactions, biomarkers of OS or inflammation are critical in formulating mechanistic hypotheses.",
        "<strong class=\"sub-title\">\n          Significance:\n        </strong>\n      \n      The environment can elicit biological responses such as oxidative stress (OS) and inflammation as a consequence of chemical, physical, or psychological changes.",
        "We discuss the difference between biomarkers that are the result of a chemical reaction (such as lipid peroxides or oxidized proteins that are a result of the reaction of molecules with reactive oxygen species) and those that represent the biological response to stress, such as the transcription factor NRF2 or inflammation and inflammatory cytokines.",
        "Recent Advances: By using examples of stress induced by various mechanisms, we focus on the biomarkers that have been used to assess OS and inflammation in these conditions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29169635": [
        "Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect almost any organ in the human body.",
        "Experimental data strongly suggests a complex interaction between the exposome (or environmental influences) and genome (genetic material) to produce epigenetic changes (epigenome) that can alter the expression of genetic material and lead to development of disease in the susceptible individual.",
        "In this review, we focus on the available literature to explore the role of environmental factors in SLE disease onset and progression and to better understand the role of exposome-epigenome-genome interactions in this dreaded disease.",
        "Low concordance rates among monozygotic twins with SLE (as low as 24%), clustering of disease prevalence around polluted regions and an urban-rural difference in prevalence all highlight the importance of environmental influences in SLE.",
        "Despite significant advancements in our understanding of SLE over the recent years, its exact mode of onset and disease progression remains elusive."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29377341": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Acne vulgaris is one of the main reasons for dermatological consultations.",
        "Severity and response to treatment may be impacted by various external factors or exposome."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28961712": [
        "We aimed to assess the presence of vedolizumab in breast milk of nursing inflammatory bowel disease [IBD] patients.",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      There are no data on the transfer of vedolizumab in breast milk of nursing mothers."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30373828": [
        "SURFY was used to predict a human surfaceome of 2,886 proteins with an accuracy of 93.5%, which shows excellent overlap with known cell-surface protein classes (i.e., receptors).",
        "As a training set, we used experimentally verified high-confidence cell-surface proteins from the Cell Surface Protein Atlas (CSPA) and trained a random forest classifier on 131 features per protein and, specifically, per topological domain.",
        "To make the predicted surfaceome readily accessible to the research community, we provide visualization tools for intuitive interrogation (wlab.ethz.ch/surfaceome).",
        "The in silico surfaceome enables the filtering of data generated by multiomics screens and supports the elucidation of the surfaceome nanoscale organization.",
        "Thus, the surfaceome diversity depends on cell type and appears to be more dynamic than the nonsurface proteome.",
        "Despite this biomedical relevance, there has been no comprehensive assessment of the human surfaceome, and only a fraction of the predicted 5,000 human transmembrane proteins have been shown to be located at the plasma membrane.",
        "To enable analysis of the human surfaceome, we developed the surfaceome predictor SURFY, based on machine learning.",
        "In deposited mRNA data, we found that between 543 and 1,100 surfaceome genes were expressed in cancer cell lines and maximally 1,700 surfaceome genes were expressed in embryonic stem cells and derivative lines.",
        "Cell-surface proteins are of great biomedical importance, as demonstrated by the fact that 66% of approved human drugs listed in the DrugBank database target a cell-surface protein."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30089698": [
        "Our results suggest that targeted mutation of a greater breadth of neutralizing epitopes will be required to evade the repertoire of neutralizing antibodies responsible for blocking viral vector transduction.",
        "Capsid mutagenesis demonstrated that even a single amino acid substitution within this epitope markedly reduced binding and neutralization by PAV9.1.",
        "In particular, exposure to the AAV capsid can generate an immune response of neutralizing antibodies.",
        "Recent clinical trials have demonstrated the potential of adeno-associated virus (AAV)-based vectors for treating rare diseases.",
        "We then mapped its epitope to the 3-fold axis of symmetry on the capsid, specifically to residues 496-NNN-498 and 588-QAQAQT-592.",
        "One approach to overcome this response is to map the AAV-specific neutralizing epitopes and rationally design an AAV capsid able to evade neutralization.",
        "However, we observed minimal changes in binding and neutralizing titer when we tested these mutant vectors for evasion of polyclonal sera from mice, macaques, or humans previously exposed to AAV.",
        "However, significant barriers remain for the translation of these vectors into widely available therapies.",
        "Epitope-based mutations in the capsid interfered with the binding and neutralizing ability of the antibody but not when tested against polyclonal samples from various sources.",
        "To accomplish this, we isolated a monoclonal antibody against AAV9 following immunization of BALB/c mice and hybridoma screening.",
        "In addition, <i>in vivo</i> studies showed that mutations in the PAV9.1 epitope conferred a \"liver-detargeting\" phenotype to the mutant vectors, unlike AAV9, indicating that the residues involved in PAV9.1 interactions are also responsible for AAV9 tropism.",
        "One challenge is the immune response to viral infection or vector administration, precluding patients from receiving an initial or readministered dose of vector, respectively.",
        "Here, we mapped the epitope of a novel neutralizing antibody generated in response to this viral vector to design a next-generation capsid to evade immune responses.",
        "We used cryo-electron microscopy to reconstruct PAV9.1 in complex with AAV9.",
        "However, application of this approach to other tissues faces significant barriers.",
        "This antibody, PAV9.1, is specific for intact AAV9 capsids and has a high neutralizing titer of &gt;1:160,000.",
        "Taken together, these studies demonstrate the complexity of incorporating mapped neutralizing epitopes and previously identified functional motifs into the design of novel capsids able to evade immune response.<b>IMPORTANCE</b> Gene therapy utilizing viral vectors has experienced recent success, culminating in U.S. Food and Drug Administration approval of the first adeno-associated virus vector gene therapy product in the United States: Luxturna for inherited retinal dystrophy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21576357": [
        "In this paper, we show that loss of Mir140 in mice causes growth defects of endochondral bones, resulting in dwarfism and craniofacial deformities.",
        "As expected, Dnpep expression was increased in Mir140-null chondrocytes.",
        "These results demonstrate that Mir140 is essential for normal endochondral bone development and suggest that the reduced BMP signaling caused by Dnpep upregulation plays a causal role in the skeletal defects of Mir140-null mice.",
        "In the mouse skeletal system, a global reduction of miRNAs in chondrocytes causes a lethal skeletal dysplasia.",
        "However, little is known about the physiological roles of individual miRNAs in chondrocytes.",
        "Comparison of profiles of RNA associated with Argonaute 2 (Ago2) between wild-type and Mir140-null chondrocytes identified Dnpep as a Mir140 target.",
        "Dnpep overexpression showed a mild antagonistic effect on bone morphogenetic protein (BMP) signaling at a position downstream of Smad activation.",
        "MicroRNAs (miRNAs) play critical roles in a variety of biological processes in diverse organisms, including mammals.",
        "Endochondral bone development is mildly advanced due to accelerated hypertrophic differentiation of chondrocytes in Mir140-null mice.",
        "Mir140-null chondrocytes showed lower-than-normal basal BMP signaling, which was reversed by Dnpep knockdown.",
        "The miRNA-encoding gene, Mir140, is evolutionarily conserved among vertebrates and is abundantly and almost exclusively expressed in chondrocytes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24973690": [
        "However, by the end stages of fracture healing, double mutant animals diverged from the Runx2(+/-) mice, showing smaller calluses and increased torsional strength indicative of more rapid end stage bone formation as seen in the Axin2(-/-) mice.",
        "Runx2 and Axin2 regulate skeletal development.",
        "Transcripts associated with cartilage development (e.g., Acan, miR140) were expressed at higher levels, whereas blood vessel morphogenesis transcripts (e.g., Slit2) were suppressed in Axin2(-/-):Runx2(+/-) calvaria.",
        "We recently determined that Axin2 and Runx2 molecularly interact in differentiating osteoblasts to regulate intramembranous bone formation, but the relationship between these factors in endochondral bone formation was unresolved.",
        "Cartilage maturation was impaired, as primary chondrocytes from double mutant mice demonstrated delayed differentiation and produced less calcified matrix in vitro.",
        "Axin2 deficiency unexpectedly exacerbated calvarial components of the CCD phenotype in the Runx2(+/-) mice; the endocranial layer of the frontal suture, which develops by endochondral bone formation, failed to mineralize in Axin2(-/-):Runx2(+/-) mice, resulting in a cartilaginous, fibrotic and larger fontanel than observed in Runx2(+/-) mice.",
        "To address this, we examined the effects of Axin2 deficiency on the cleidocranial dysplasia (CCD) phenotype of Runx2(+/-) mice, focusing on skeletal defects attributed to improper endochondral bone formation.",
        "Taken together, our data demonstrate a dominant role for Runx2 in chondrocyte maturation, but implicate Axin2 as an important modulator of the terminal stages of endochondral bone formation.",
        "The genetic dominance of Runx2 was also reflected during endochondral fracture repair, as both Runx2(+/-) and double mutant Axin2(-/-):Runx2(+/-) mice had enlarged fracture calluses at early stages of healing."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28928081": [
        "Simultaneously, miR-140-5p decreased lactate dehydrogenase (LDH) leakage and improved cell vitality in HK2 cells under Cisplatin-induced oxidative stress.",
        "Recent studies had reported the protective role of specific microRNAs (miRNAs) against oxidative stress.",
        "In vitro study, Enforced expression of miR-140-5p in HK2 cells significantly attenuated oxidative stress by decreasing ROS level and increasing the expression of manganese superoxide dismutase (MnSOD).",
        "Our findings showed the novel transcriptional role of miR140-5p in the expression of Nrf2 and miR-140-5p protected against Cisplatin induced oxidative stress by activating Nrf2-dependent antioxidant pathway, providing a potentially therapeutic target in acute kidney injury.",
        "These results indicated that miR-140-5p might exert its anti-oxidative stress function via targeting Nrf2.",
        "Oxidative stress was predominantly involved in the pathogenesis of acute kidney injury (AKI).",
        "Bioinformatics analysis revealed nuclear factor erythroid 2-related factor (Nrf2) was a potential target of miR-140-5p, We demonstrated that miR-140-5p did not affect Kelch-like ECH-associated protein 1 (Keap1) level but directly targeted the 3'-UTR of Nrf2 mRNA and played a positive role in the regulation of Nrf2 expression which was confirmed by luciferase activity assay and western blot.",
        "We found that miR-140-5p expression was markedly increased in mice kidney.",
        "A mice Cisplatin induced-AKI model was established.",
        "What was more, consistent with miR140-5p expression, the mRNA and protein levels of Nrf2, as well as antioxidant response element (ARE)-driven genes Heme Oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase l (NQO1) were significantly increased in mice kidney tissues.",
        "However, HK2 cells transfected with a siRNA targeting Nrf2 abrogated the protective effects of miR-140-5p against oxidative stress.",
        "Hence, we investigated the levels of miR140-5p and its functional role in the pathogenesis of Cisplatin induced AKI."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30408721": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Stress activates the central nervous, the autonomic nervous, and the endocrine system.",
        "This study aimed to (1) test the usability of salivary cortisone in a standardized psychosocial stressor, (2) create a comprehensive profile of hormonal responses to determine laboratory parameters with high discriminatory power, and (3) analyze their association with psychometric and autonomic stress measures."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29455296": [
        "Fifteen studies involving 684 subjects were included.",
        "PubMed/Medline, Embase, and Cochrane Library were searched for relevant articles in English or Italian about studies involving healthy and sub-healthy subjects or patients with a diagnosed disease about effects of balneotherapy, mud/peloid therapy, and spa therapy on serum and salivary cortisol levels.",
        "Two of them reported significant changes of cortisol levels in healthy participants.",
        "Ten studies investigated biological effects of spa therapy with or without included mud/peloid therapy, and in all but two studies, significant variations of cortisol levels were reported.",
        "Our main findings suggest that balneotherapy may have the potential to influence cortisol levels in healthy subjects, in such a way as to improve stress resilience.",
        "Spa therapy with or without included mud/peloid therapy demonstrated the same potential to influence cortisol levels also in sub-healthy subjects and in patients with a diagnosed disease.",
        "Further investigation is needed because of limited available data.",
        "No studies investigated biological effects of mud/peloid therapy alone.",
        "Secondarily, it aims at understanding if these interventions may improve stress resilience.",
        "The other three studies reported no significant variations in patients with rheumatic conditions.",
        "Five studies investigated biological effects of balneotherapy alone.",
        "This systematic review primarily aims at assessing if balneotherapy, mud/peloid therapy, and spa therapy may influence cortisol levels.",
        "Therefore, balneotherapy and spa therapy may be considered as useful interventions for the management of stress conditions.",
        "Balneotherapy and spa therapy are well-known practices, even though limited evidence has been produced about their biological effects."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23971022": [
        "The salivary cortisol level was significantly correlated with the SCORAD index (r = 0.42, P &lt; 0.05) while the serum TARC and LDH levels were positively correlated with the SCORAD index.",
        "These results suggest that the saliva cortisol level is therefore a useful biomarker to evaluate the stress in AD patients.",
        "The serum levels of TARC, total IgE, and lactate dehydrogenase (LDH) and peripheral blood eosinophil counts were measured by laboratory tests.",
        "The results showed that the saliva cortisol level was significantly higher in AD patients compared to healthy subjects (P &lt; 0.01).",
        "The Skindex-16 was used as a skin disease-specific, quality of life measure, instrument.",
        "AD patients were also evaluated for general disease severity using the Scoring Atopic Dermatitis (SCORAD) index.",
        "The symptoms of atopic dermatitis (AD) are often aggravated by stress, and AD can also lead to psychological stress due to social isolation and discrimination.",
        "The salivary cortisol level reflects psychological stress, and it is a good index to assess chronic stress.",
        "However, no statistically significant correlations were observed between the salivary cortisol level and Skindex-16.",
        "In this study, we measured the salivary cortisol levels in patients with AD (n = 30) and compared them with those of healthy control subjects (n = 42)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28375882": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      A resurgence of interest in salivary biomarkers has generated evidence for their value in assessing adrenal function.",
        "The advantages of salivary measurements include only free hormone is detected, samples can be collected during normal daily routines and stress-induced cortisol release is less likely to occur than during venepuncture.",
        "We review the use of salivary biomarkers to diagnose and monitor patients for conditions of cortisol excess and deficiency and discuss the value of measuring salivary cortisone versus salivary cortisol."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19095358": [
        "Salivary cortisol is frequently used as a biomarker of psychological stress.",
        "However, psychobiological mechanisms, which trigger the hypothalamus-pituitary-adrenal axis (HPAA) can only indirectly be assessed by salivary cortisol measures.",
        "The different instances that control HPAA reactivity (hippocampus, hypothalamus, pituitary, adrenals) and their respective modulators, receptors, or binding proteins, may all affect salivary cortisol measures.",
        "The present paper addresses several psychological and biological variables, which may account for such dissociations, and aims to help researchers to rate the validity and psychobiological significance of salivary cortisol as an HPAA biomarker of stress in their experiments.",
        "Thus, a linear relationship with measures of plasma ACTH and cortisol in blood or urine does not necessarily exist.",
        "This is particularly true under response conditions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23969030": [
        "The area under the diurnal variation curves (AUC) over the 24h time course and relative diurnal variation (VAR) were calculated.",
        "Increasing evidence has suggested that hypothalamic-pituitary-adrenal (HPA) axis and pro-inflammatory cytokines may play a key role in the pathophysiology of depression as well as cancer.",
        "Receiver operating characteristic (ROC) analysis was performed.",
        "Depression is common among lung cancer patients.",
        "These findings suggested that higher 24h overall levels of sputum IL-6, TNF-\u03b1 and flattened diurnal salivary cortisol slopes were associated with depression in lung cancer patients.",
        "Patients with co-morbid depression and lung cancer showed highest level of sputum IL-6 AUC, sputum TNF-\u03b1 AUC and lowest level of cortisol VAR (P&lt;0.001).",
        "As a biomarker for depression, salivary cortisol VAR demonstrated an optimal cutoff point at 77.8% (AUC=0.94; 95% CI, 0.85-0.98), which is associated with a sensitivity of 82.1% and a specificity of 96.0%.",
        "Sputum IL-6 AUC and salivary cortisol VAR performed best as biomarkers in the diagnosis of depression in lung cancer patients.",
        "The diurnal rhythms of sputum IL-6, sputum TNF-\u03b1 and salivary cortisol were measured in lung cancer patients with and without depression as well as depressed controls and healthy controls.",
        "This pilot study investigated the efficacy of sputum interleukin (IL)-6, tumor necrosis factor (TNF)-\u03b1 and salivary cortisol as new markers to support the diagnosis of depression in lung cancer patients.",
        "Sputum IL-6 AUC demonstrated a sensitivity of 74.4% and a specificity of 92.0% (AUC=0.81; 95% CI, 0.69-0.90)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27686043": [
        "However, cortisol is highly variable and sensitive to a wide range of factors, creating a challenge for reliable salivary cortisol collection in the community setting.",
        "The purpose of this integrative review was to investigate current evidence on the acceptability and feasibility of salivary cortisol collection in community samples of children.",
        "Furthermore, the acceptability of salivary cortisol collection in community samples of children is largely unknown.",
        "Further research is required to fully understand the factors that influence acceptability and feasibility of salivary cortisol collection in community samples of children.",
        "Understanding individual, family, and community perceptions of biobehavioral research will lead to more culturally sensitive and feasible community-based research methods. \u00a9 2016 Wiley Periodicals, Inc.",
        "Salivary cortisol is considered to be a safe and noninvasive measure of hypothalamic-pituitary-adrenal axis functioning, and is a commonly measured biomarker of the human stress response in pediatric research.",
        "In an analysis framed by the Theory of Planned Behavior, data extracted from 31 studies revealed six categories of psychosocial influences on acceptability and feasibility: uncertainty and misconceptions, cultural and ethnic values, family rules and values, difficulty following protocols and procedures, burden of multiple samples, and child refusal or resistance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29747642": [
        "In addition, the possible relationship between both biomarkers, the score in Equine Acute Abdominal Pain scales version 1 (EAAPS-1 scale), Heart Rate (HR) and Respiratory Rate (RR), plasma lactate, the systemic inflammatory response syndrome (SIRS) score and serum amyloid A (SAA) concentration was assessed by a Spearman correlation test.",
        "Therefore, a prospective observational study was performed in which both biomarkers were analyzed in a group of horses with acute abdomen syndrome, and compared with a group of healthy control horses by an unpaired Student's t-test.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      The aim of this study was to evaluate salivary alpha-amylase (sAA), considered a non-invasive biomarker for sympathetic nervous system (SNS) activity, and salivary cortisol as possible pain-induced stress biomarker, in horses with acute abdominal disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23017499": [
        "AnxA1 protein is detectable in whole human saliva, as detected by Western blot analysis and ELISA.",
        "The presence of salivary AnxA1 protein was confirmed by Western blotting.",
        "Salivary cortisol is commonly used as a clinical biomarker of endocrine status and also as a marker of psychosocial stress.",
        "Salivary cortisol and AnxA1 protein were sampled at between 3 and 6 time points over 24h and measured for cortisol and AnxA1 protein using specific ELISA's.",
        "AnxA1 protein did not exhibit an awakening response (P&gt;0.05), whereas salivary cortisol was significantly elevated between time 0 and 30 min post waking (P&lt;0.001).",
        "Saliva was collected using salivette tubes.",
        "Annexin-A1 (AnxA1) is an anti-inflammatory protein whose expression is modulated by glucocorticoids.",
        "A total of 37 healthy participants (male and female) were used in the study.",
        "A diurnal rhythm was evident in both salivary cortisol (P&lt;0.01) and AnxA1 (P&lt;0.01) and was defined as a significant difference in time 0 (waking) samples compared to 'bed' (2300 h) samples.",
        "AnxA1 protein correlates positively with salivary cortisol, indicating that cortisol is most likely a regulator of AnxA1 in human saliva.",
        "Our principal objectives were to (i) detect the presence of and (ii) measure AnxA1 protein in whole human saliva and to (iii) investigate whether salivary cortisol and AnxA1 are correlated in healthy humans."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27014891": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To investigate the influence of occupational stress on salivary cortisol concentration in employees."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25773457": [
        "Salivary cortisol is often used as a noninvasive sampling method that possesses important health implications.",
        "The present study was designed to address this critical barrier through creation of a lateral flow test (LFT) cortisol device capable of measuring salivary cortisol within minutes of sample collection.",
        "The present study extends the LFT into the research domain by presenting performance characteristics of a quantitative LFT that measures salivary cortisol within 20 minutes of sample collection.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Cortisol is frequently assayed as a stress-responsive biomarker which changes over the course of minutes to meet the demands of a person's social context.",
        "A critical barrier to psychobiological research that involves salivary cortisol is a time delay of days to months before cortisol results are obtained via immunoassay, long after the person is no longer proximate to the social context in which they provided the sample.",
        "The LFT is frequently used within commercial point-of-care settings to obtain rapid answers to the presence/absence of a biomarker."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23332247": [
        "This study examines whether children's dietary pattern is indeed related to salivary cortisol levels.",
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Psychological stress has been suggested to result in hormonal effects (e.g. changes in cortisol pattern) that may change food selection in unhealthy ways."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21838298": [
        "Second, a circularly permutated (CP) variant of Simgr4 was formulated.",
        "This study is the first to investigate the contribution of the HLBD of a nuclear receptor and multiple ON-OFF switches for molecular probes and salivary cortisols.",
        "Furthermore, a circularly permutated (CP) variant of Simgr4 exerted a 10\u00d7 enhanced detection limit to cortisol and a long dynamic range from 10(-9) to 10(-6) M cortisol, covering all of the normal clinical ranges of serum, urine, and saliva.",
        "Cortisol is a classical biomarker for the stress levels of human beings.",
        "Gaussia princeps luciferase (GLuc) was dissected into two fragments, between which an N-terminal-extended ligand binding domain of glucocorticoid receptor (GR HLBD), named Simgr4, was inserted.",
        "First, this unique single-chain probe was then situated downstream of a glucocorticoid response element (GRE) promoter in a reporter-gene system for constructing two ON-OFF switches for cortisol.",
        "We fabricated highly sensitive bioluminescent probes for salivary cortisol.",
        "The reporter-gene system exerted an improved signal-to-background (S/B) ratio of 8.5 to cortisol.",
        "This optimized probe successfully determined daily fluctuations of salivary cortisol and the correlations with those by ELISA.",
        "The following strategies were contrived in the molecular design."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22812714": [
        "The interpretation of salivary cortisol levels relies on rigorous standardization of sampling equipment, sampling protocols and assay technology with establishment of a local reference range.",
        "The utility of measuring salivary cortisol has become increasingly appreciated since the early 1980s.",
        "The analytical sensitivity varies between these assay methods, as does the potential for cross-reactivity with other steroids.",
        "Several assay techniques have been used to measure salivary cortisol, including radioimmunoassay and more recently liquid chromatography-tandem mass spectrometry.",
        "Clinically, the commonest use for salivary cortisol is measuring late-night salivary cortisol as a screening test for Cushing's syndrome.",
        "There are emerging roles for the use of salivary cortisol in diagnosing adrenal insufficiency, particularly in conditions associated with low cortisol-binding globulin levels, and in the monitoring of glucocorticoid replacement.",
        "Salivary cortisol is a measure of active free cortisol and follows the diurnal rhythm of serum or plasma cortisol.",
        "Several studies have shown diagnostic sensitivities and specificities of over 90%, which compares very favourably with other screening tests for Cushing's syndrome such as the 24-h urinary-free cortisol and the 1-mg overnight dexamethasone suppression test.",
        "The saliva sample may be collected by drooling or through the use of absorbent swabs which are placed into the mouth until saturated.",
        "Salivary cortisol is therefore convenient for patients and research participants to collect noninvasively on an outpatient basis.",
        "Finally, salivary cortisol has been used extensively as a biomarker of stress in a research setting, especially in studies examining psychological stress with repeated measurements."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29169058": [
        "Cyclic di-AMP (c-di-AMP) is a bacterial signaling nucleotide synthesized by several human pathogens.",
        "During their long-standing interaction, host and pathogens have co-evolved to control c-di-AMP activation of innate immunity.",
        "On the bacterial side, the quantity of c-di-AMP released inside cells allows to manipulate the host response to exacerbate infection by avoiding immune recognition or, at the opposite, by overloading the STING-cGAS pathway.",
        "This widespread and specific bacterial product is recognized by infected host cells to trigger an innate immune response.",
        "Detection of c-di-AMP in the host cytosol leads primarily to the induction of type I interferon via the STING-cGAS signaling axis, while being also entangled in the activation of the NF-\u03baB pathway."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30395807": [
        "Using systems biology approaches, we formulated a mathematical model to describe the dynamics of this pathway and examine the resulting system-level emergent properties.",
        "Lastly, we demonstrate that the model recapitulates interferon expression data resulting from small molecule inhibition of cGAS.",
        "An in-silico knock-down of TREX1 found that the interferon response is highly robust, showing that complete inhibition is necessary to induce chemical conditions consistent with chronic inflammation.",
        "Overall, the importance of this model is exhibited in its capacity to identify sensitive components of the cGAS pathway, generate testable hypotheses, and confirm experimental observations.",
        "A local sensitivity analysis demonstrated that parameter sensitivity trends across model ensembles were independent of the select parameterization.",
        "The cGAS pathway is vital in the recognition of DNA encoded viruses as well as self-DNA leaked from the nucleus of damaged cells.",
        "Currently, the dynamics regulating the cGAS pathway are poorly understood; limiting our knowledge of how DNA-induced immune responses are regulated.",
        "Unknown model parameters were fit to data compiled from literature using a Parallel Tempering Markov Chain Monte Carlo (PT-MCMC) approach, resulting in an ensemble of parameterized models.",
        "Cyclic GMP-AMP synthase (cGAS) has recently been identified as the primary protein that detects cytosolic double stranded DNA to invoke a type I interferon response."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28137885": [
        "Here we show that cGAS is indispensable for the antitumor effect of immune checkpoint blockade in mice.",
        "cGMP-AMP (cGAMP) synthase (cGAS) is a cytosolic DNA sensor that activates innate immune responses. cGAS catalyzes the synthesis of cGAMP, which functions as a second messenger that binds and activates the adaptor protein STING to induce type I interferons (IFNs) and other immune modulatory molecules.",
        "These results indicate that activation of the cGAS pathway is important for intrinsic antitumor immunity and that cGAMP may be used directly for cancer immunotherapy.",
        "Wild-type, but not cGAS-deficient, mice exhibited slower growth of B16 melanomas in response to a PD-L1 antibody treatment.",
        "Consistently, intramuscular delivery of cGAMP inhibited melanoma growth and prolonged the survival of the tumor-bearing mice.",
        "The combination of cGAMP and PD-L1 antibody exerted stronger antitumor effects than did either treatment alone. cGAMP treatment activated dendritic cells and enhanced cross-presentation of tumor-associated antigens to CD8 T cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28801534": [
        "Cytosolic DNA stimulates innate immune responses, including type I interferons (IFN), which have antiviral and immunomodulatory activities.",
        "Importantly, <i>in vitro</i> studies reveal that long DNA activates recombinant human cGAS more efficiently than short DNA, showing that length-dependent DNA recognition is an intrinsic property of cGAS independent of accessory proteins.",
        "This is observed over a wide length-span of DNA, ranging from the minimal stimulatory length to several kilobases, and is fully dependent on cGAS irrespective of DNA length.",
        "Collectively, this work identifies long DNA as the molecular entity stimulating the cGAS pathway upon cytosolic DNA challenge such as viral infections.",
        "Despite the importance of DNA in innate immunity, the nature of the DNA that stimulates IFN production is not well described.",
        "Cyclic GMP-AMP synthase (cGAS) recognizes cytoplasmic DNA and signals via STING to induce IFN production.",
        "Using low DNA concentrations, we show that dsDNA induces IFN in a length-dependent manner."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28920955": [
        "Mechanistically, miR-25/93 targets NCOA3, an epigenetic factor that maintains basal levels of cGAS expression, leading to repression of cGAS during hypoxia.",
        "This allows hypoxic tumour cells to escape immunological responses induced by damage-associated molecular pattern molecules, specifically the release of mitochondrial DNA.",
        "Moreover, restoring cGAS expression results in an anti-tumour immune response.",
        "Clinically, decreased levels of cGAS are associated with poor prognosis for patients with breast cancer harbouring high levels of miR-25/93.",
        "Together, these data suggest that inactivation of the cGAS pathway plays a critical role in tumour progression, and reveal a direct link between hypoxia-responsive miRNAs and adaptive immune responses to the hypoxic tumour microenvironment, thus unveiling potential new therapeutic strategies.",
        "The mechanisms by which hypoxic tumours evade immunological pressure and anti-tumour immunity remain elusive.",
        "Here, we report that two hypoxia-responsive microRNAs, miR-25 and miR-93, are important for establishing an immunosuppressive tumour microenvironment by downregulating expression of the DNA sensor cGAS."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28940468": [
        "Cyclic GMP-AMP synthase (cGAS) is activated by ds-DNA binding to produce the secondary messenger 2',3'-cGAMP. cGAS is an important control point in the innate immune response; dysregulation of the cGAS pathway is linked to autoimmune diseases while targeted stimulation may be of benefit in immunoncology.",
        "Mechanistic studies of cGAS provide the first kinetic constants for 2',3'-cGAMP formation, and interestingly, describe a catalytic mechanism where 2',3'-cGAMP may be a minor product of cGAS compared with linear nucleotides.",
        "Our structural work supports the understanding of how ds-DNA activates cGAS, suggesting a site for small molecule binders that may cause cGAS activation at physiological ATP concentrations, and an apparent hotspot for inhibitor binding.",
        "We report here the structure of cGAS with dinucleotides and small molecule inhibitors, and kinetic studies of the cGAS mechanism."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27648547": [
        "Here we review the recent advances in understanding of the cGAS-STING pathway, focusing on the regulatory mechanisms and roles of this pathway in heath and disease.",
        "The cGAS-STING pathway not only mediates protective immune defense against infection by a large variety of DNA-containing pathogens but also detects tumor-derived DNA and generates intrinsic antitumor immunity.",
        "The recognition of microbial nucleic acids is a major mechanism by which the immune system detects pathogens.",
        "Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a cytosolic DNA sensor that activates innate immune responses through production of the second messenger cGAMP, which activates the adaptor STING.",
        "However, aberrant activation of the cGAS pathway by self DNA can also lead to autoimmune and inflammatory disease.",
        "Thus, the cGAS pathway must be properly regulated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27902332": [
        "Hepatitis B virus (HBV) is a small DNA virus, and the cGAS-STING pathway may inhibit HBV RNA synthesis and viral assembly in cell culture, but the exact roles of the cGAS pathway in the restriction of HBV replication in infection systems remain to be elucidated.",
        "Collectively, our data indicate that the cGAS-STING pathway plays a role in the surveillance of HBV infection and may be exploited for development of novel anti-HBV strategies.",
        "In contrast, the presence of enzymatically inactive cGAS mutant did not influence HBV replication.",
        "In this study, replication of HBV was significantly inhibited both in cell culture and in vivo in a mouse model when the cGAS-STING pathway was activated by dsDNA or cGAMP.",
        "Cyclic GMP-AMP (cGAMP) synthase (cGAS) senses cytosolic DNA and catalyses synthesis of the second messenger cGAMP, which activates the downstream signalling adaptor protein STING, leading to the expression of type I interferons.",
        "Moreover, knockdown of cGAS in human peripheral blood monocytes led to a higher level of intracellular HBV DNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27546532": [
        "Moreover, little is known about how cell-fate determinants are regulated in functionally important subnetworks in large gene-regulatory networks (i.e., GRN motifs).",
        "Thus, the presented GRN-based model of stem cell differentiation and computational method can guide differentiation experiments in stem cell research and regenerative medicine.",
        "The method was able to recapitulate experimentally validated cell-fate determinants, and validation of two predicted cell-fate determinants confirmed that overexpression of ESR1 and RUNX2 in mouse neural stem cells induces neuronal and astrocyte differentiation, respectively.",
        "Here we propose a model of stem cell differentiation in which cell-fate determinants work synergistically to determine different cellular identities, and reside in a class of GRN motifs known as feedback loops.",
        "Based on this model, we develop a computational method that can systematically predict cell-fate determinants and their GRN motifs.",
        "Identification of cell-fate determinants for directing stem cell differentiation remains a challenge."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29531424": [
        "Via building computational (typically mathematical and computer simulation) models, human performance modeling (HPM) quantifies, predicts, and maximizes human performance, human-machine system productivity and safety.",
        "Recent and classic HPM findings are addressed in the five questions to provide new thinking in HPM's motivations, expectations, procedures, system integration and future directions.",
        "This paper describes and summarizes the five key questions of human performance modeling: 1) Why we build models of human performance; 2) What the expectations of a good human performance model are; 3) What the procedures and requirements in building and verifying a human performance model are; 4) How we integrate a human performance model with system design; and 5) What the possible future directions of human performance modeling research are."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22005615": [
        "We conducted a systematic review of the literature to address 5 key questions specific to this population: 1) What are the current national clinical practice recommendations and guidelines for depression screening; 2) What are the prevalence and predictors of screening; 3) How well do screening tools detect depression; 4) Does screening lead to diagnosis, treatment, and improved outcomes; and 5) What are the most effective treatment methods?",
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Whether routine screening for depression among nonpregnant women of reproductive age improves identification and treatment of the disorder remains unclear."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30232455": [
        "They are composed of three subunits, TcA, TcB and TcC.",
        "The presence of the toxic enzyme inside the cocoon is essential for its subnanomolar binding affinity for the TcA subunit.",
        "Binding of the cocoon to the channel triggers opening of the cocoon and translocation of the toxic enzyme into the channel.",
        "The enzyme passes through a narrow negatively charged constriction site inside the cocoon, probably acting as an extruder that releases the unfolded protein with its C terminus first into the translocation channel.",
        "TcA forms the translocation channel and the TcB-TcC heterodimer functions as a cocoon that shields the toxic enzyme.",
        "Here we show in atomic detail how the assembly of the three components activates the toxin.",
        "Tc toxins secrete toxic enzymes into host cells using a unique syringe-like injection mechanism.",
        "We find that part of the cocoon completely unfolds and refolds into an alternative conformation upon binding."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/11286884": [
        "Although Photorhabdus luminescens is symbiotic with nematodes that kill insects, tc genes have recently been described from other insect-associated bacteria such as Serratia entomophila, an insect pathogen, and Yersinia pestis, the causative agent of bubonic plague, which has a flea vector.",
        "Here, recent advances in our understanding of the tc gene family are reviewed in view of their potential development as insect-control agents.",
        "The toxin complex (tc) genes of Photorhabdus encode insecticidal, high molecular weight Tc toxins.",
        "These toxins have been suggested as useful alternatives to those derived from Bacillus thuringiensis for expression in insect-resistant transgenic plants."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15679840": [
        "They also show that both toxin genes and their potentiator pairs will need to be expressed to reconstitute full activity in insect-resistant transgenic plants.",
        "Moreover, they suggest that the same potentiator pair will be able to cross-potentiate more than one toxin in a single plant.",
        "Several domains produced abnormal cellular morphologies leading to cell death, while others showed specific phenotypes such as nuclear translocation.",
        "Our results prove that the Tc toxins are complex proteins with multiple functional domains.",
        "Here we show that increased activity of the toxin TcdA1 requires potentiation by either of two pairs of gene products, TcdB1 and TccC1 or TcdB2 and TccC3.",
        "The toxin complex (tc) genes of bacteria comprise a large and growing family whose mode of action remains obscure.",
        "These toxins therefore represent alternatives to toxins from Bacillus thuringiensis (Bt) for deployment in transgenic crops.",
        "In the insect pathogen Photorhabdus, tc genes encode high molecular weight insecticidal toxins with oral activity against caterpillar pests.",
        "To elucidate the likely functional domains present in these large proteins, we expressed fragments of each 'toxin' or 'potentiator' gene within mammalian cells.",
        "Moreover, these same pairs of proteins can also cross-potentiate a second toxin, TcaA1B1.",
        "Levels of TcdA expression in transgenic plants were, however, low and the full toxicity associated with the native toxin was not reconstituted.",
        "One protein, TcdA, has recently been expressed in transgenic plants and shown to confer insect resistance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23870259": [
        "TcdA1 was able to increase the specific conductance of artificial lipid bilayer membranes by the formation of ion-permeable channels.",
        "A combination of biologically active components (TccC3) and a possible chaperone (TcdB2) blocked the TcdA1-mediated conductance efficiently in a dose-dependent manner when they were added to the cis side of the membrane.",
        "The toxins are composed of different components that form oligomers for biological activity.",
        "The half-saturation constant for binding of TcdB2-TccC3 to TcdA1 is in the low nanomolar range.",
        "The channels had on average a single-channel conductance of 125 pS in 150 mM KCl and were found to be cation selective.",
        "Tc toxins are widely distributed among different gram-negative and gram-positive bacteria, where they act as pathogenicity factors.",
        "Experiments to study the voltage dependence of the TcdA1 channel demonstrated that it is reconstituted in a fully oriented way when it is added to only one side of the lipid bilayer membrane.",
        "Lipid bilayer experiments were performed with the TcdA1 component of the Tc toxin from Photorhabdus luminescens, which preferentially kills insects by actin polymerization.",
        "The single-channel conductance of the TcdA1-channels was only moderately dependent on the bulk aqueous KCl concentration, which indicated point-charge effects on the channel properties."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24572368": [
        "Here we report the first, to our knowledge, high-resolution structures of a TcA subunit in its prepore and pore state and of a complete 1.7 megadalton Tc complex.",
        "Tripartite Tc toxin complexes of bacterial pathogens perforate the host membrane and translocate toxic enzymes into the host cell, including in humans.",
        "The underlying mechanism is complex but poorly understood.",
        "Binding of TcB/TcC to TcA opens a gate formed by a six-bladed \u03b2-propeller and results in a continuous protein translocation channel, whose architecture and properties suggest a novel mode of protein unfolding and translocation.",
        "The structures reveal that, in addition to a translocation channel, TcA forms four receptor-binding sites and a neuraminidase-like region, which are important for its host specificity. pH-induced opening of the shell releases an entropic spring that drives the injection of the TcA channel into the membrane.",
        "Our results allow us to understand key steps of infections involving Tc toxins at the molecular level."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27571177": [
        "Using electron cryomicroscopy, we determined the structure of TcdA1 from Photorhabdus luminescens embedded in lipid nanodiscs.",
        "However, the helices do not span the complete membrane; instead, the loops connecting the helices form the rim of the funnel.",
        "Lipid head groups reach into the space between the loops and consequently stabilize the pore conformation.",
        "The molecular mechanism of this unusual injection system is poorly understood.",
        "In our structure, compared with the previous structure of TcdA1 in the prepore state, the transmembrane helices rearrange in the membrane and open the initially closed pore.",
        "The linker domain is folded and packed into a pocket formed by the other domains of the toxin, thereby considerably contributing to stabilization of the pore state.",
        "Tc toxins from pathogenic bacteria use a special syringe-like mechanism to perforate the host cell membrane and inject a deadly enzyme into the host cytosol."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28233068": [
        "While TcA is involved in receptor binding and toxin translocation, TcC possesses the specific toxin enzyme activity and TcB is a linker between components TcA and TcC.",
        "These large tripartite toxins with molecular masses &gt;1.4 megadaltons consist of three components termed A, B, and C (or TcA, TcB, and TcC).",
        "Here, a structure function analysis of the toxins is described and the application of Tc toxins as potential insecticides is discussed.",
        "Recently, the Toxin complexes (Tc's) of Photorhabdus and Xenorhabdus species have become an increased focus of current research.",
        "Various bacterial toxins have potent insecticidal activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19121369": [
        "In pluripotent P19 progenitor cells, Runx2 mRNA expression was drastically increased along with mRNA expression of an astrocytic marker, but not with neuronal marker mRNA expression.",
        "We have previously shown functional expression by osteoblasts of signaling machineries required for neurotransmission in the brain.",
        "In embryonic and adult mouse brains, mRNA expression was invariably seen for the master regulator of osteoblastic differentiation Runt related factor-2 (Runx2), in addition to the partner protein core binding factor-beta and their targets such as osteopontin (OPN) and matrix metalloproteinase-13 (MMP13), but not for collagen-I or osteocalcin.",
        "Moreover, transient overexpression of Runx2 significantly increased luciferase activity in C6 glioma cells transfected with the reporter plasmid linked to a wild-type Runx2 binding element in the MMP13 promoter, but not in cells with a mutated element.",
        "In C6 glioma cells, transient overexpression of Runx2 significantly increased mRNA expression of MMP13, but not of OPN.",
        "Both mRNA and corresponding protein were detected for Runx2 in cultured rat neocortical astrocytes and astrocytic C6 glioma cells.",
        "These results suggest that Runx2 signal input may lead to transactivation of MMP13 gene without affecting OPN expression in astrocytes.",
        "In this study, we have evaluated possible functional expression of different osseous genes in the brain."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29413774": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Dislocated metatarsophalangeal joints from clawed or hammer toes can be a disabling consequence of several conditions.",
        "We present a retrospective, three surgeon case series of 215 toes in 126 patients.",
        "The Cobb-Stainsby forefoot arthroplasty combines partial phalangectomy (Stainsby) with extensor tendon transfer to the metatarsal head (Cobb)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30053394": [
        "Their cytotoxicity and the underlying mechanistic signaling axes have been extensively documented, but only a few anti-viral activities of cardenolides and the associated signaling pathways have been reported.",
        "Previously, we reported that a variety of cardenolides impart anti-transmissible gastroenteritis coronavirus (TGEV) activity in swine testicular (ST) cells, through targeting of the cell membrane sodium/potassium pump, Na<sup>+</sup>/K<sup>+</sup>-ATPase.",
        "Ouabain, a representative cardenolide, was found to potently diminish TGEV titers and inhibit the TGEV-induced production of IL-6 in a dose dependent manner, with 50% inhibitory concentrations of 37 nM and 23 nM respectively.",
        "Cardenolides are plant-derived toxic substances.",
        "Herein, we further explore the potential signaling cascades associated with this anti-TGEV activity in ST cells.",
        "This finding is the first report of a PI3K_PDK1 signaling axis further induced by ouabain and implicated in the suppression of TGEV activity and replication; greatly illuminates the underlying mechanism of cardenolide toxicity; and is expected to result in one or more anti-viral applications for the cardenolides in the future.",
        "Finally, inhibition of PI3K by LY294002 or PDK1 by BX795 antagonized the anti-viral activity of ouabain and restored the TGEV virus titer and yields.",
        "By pharmacological inhibition and gene silencing, we demonstrated that PI3K_PDK1_RSK2 signaling was induced in TGEV-infected ST cells, and ouabain imparted a degree of anti-TGEV activity via further augmentation of this existing PI3K_PDK1 axis signaling, in a manner dependent upon its association with the Na<sup>+</sup>/K<sup>+</sup>-ATPase."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29683473": [
        "We tested hypotheses about the mode of action and macroevolution of toxicity in this group.",
        "<strong class=\"sub-title\">\n          Premise of the study:\n        </strong>\n      \n      Pachypodium (Apocynaceae) is a genus of iconic stem-succulent and poisonous plants endemic to Madagascar and southern Africa.",
        "We further hypothesized that while monarch butterflies are highly resistant to cardenolide toxins (a type of cardiac glycoside) from American Asclepias, they may be negatively affected by Pachypodium defenses, which evolved independently."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30372816": [
        "In this context, the use of liposomes represents a promising strategy to deliver GEVPG, thus allowing its intravenous administration.",
        "Therefore, the results of the present work indicate the potential applicability of SpHL-GEVPG as a new anticancer formulation.",
        "SpHL-GEVPG presented adequate properties, including a mean diameter of 182.2 \u00b1 2.7 nm, a polydispersity index equal to 0.36 \u00b1 0.03, a zeta potential of -2.37 \u00b1 0.31 mV, and a GEVPG entrapment of 0.38 \u00b1 0.04 mg/mL.",
        "Moreover, this formulation showed a good stability after having been stored for 30 days at 4 \u00b0C.",
        "The cytotoxic studies against breast (MDA-MB-231, MCF-7, and SKBR-3) and lung (A549) cancer cell lines demonstrated that SpHL-GEVPG treatment significantly reduced the cell viability.",
        "Cardenolides have shown significant antitumor activity due to their ability to inhibit the Na<sup>+</sup>K<sup>+</sup>ATPase enzyme, and the expression of this enzyme is increased in tumor cells.",
        "Cancer is an important public health problem, being one of the leading causes of death worldwide.",
        "In this study, long-circulating and fusogenic liposomes containing GEVPG (SpHL-GEVPG) were developed, and their chemical and physicochemical properties were evaluated.",
        "The evaluation of the therapeutic efficacy of the treatment with SpHL-GEVPG showed a potent anticancer effect in an A549 human lung cancer xenograft model.",
        "SpHL-GEVPG administered at doses of 1.0 and 2.0 mg/kg (i.v.) induced antitumor effect comparable to paclitaxel given at dose of 10 mg/kg (i.v.) to mice.",
        "Glucoevatromonoside containing peracetylated glucose hydroxyl groups (GEVPG) is a cardenolide derivative that has low solubility in aqueous media, which constitutes a barrier to its potential biological applications.",
        "In addition, the SpHL-GEVPG formulation presented a good selectivity toward these cancer cells.",
        "Most antineoplastic agents cause severe toxic effects and some types of cancer do not respond or are resistant to the existing pharmacotherapy, necessitating the research and development of new therapeutic strategies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22726826": [
        "Lowering mutant Huntingtin is a consensus therapeutic strategy for Huntington's disease.",
        "In this issue of Neuron, Kordasiewicz et al. (2012) show the benefit of transient antisense oligonucleotide (ASO) therapy to degrade Huntingtin mRNA and elicit sustained therapeutic benefit in HD mice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29300010": [
        "The mammalian microbiome has many important roles in health and disease, and genetic engineering is enabling the development of microbial therapeutics and diagnostics.",
        "Heterologous expression of engineered gene clusters encoding gas vesicles allows Escherichia coli and Salmonella typhimurium to be imaged noninvasively at volumetric densities below 0.01% with a resolution of less than 100 \u03bcm.",
        "We demonstrate the imaging of engineered cells in vivo in proof-of-concept models of gastrointestinal and tumour localization, and develop acoustically distinct reporters that enable multiplexed imaging of cellular populations.",
        "These constructs are based on gas vesicles, a unique class of gas-filled protein nanostructures that are expressed primarily in water-dwelling photosynthetic organisms as a means to regulate buoyancy.",
        "However, existing methods for imaging cellular location and function, primarily based on optical reporter genes, have limited deep tissue performance owing to light scattering or require radioactive tracers.",
        "Here we introduce acoustic reporter genes, which are genetic constructs that allow bacterial gene expression to be visualized in vivo using ultrasound, a widely available inexpensive technique with deep tissue penetration and high spatial resolution.",
        "A key determinant of the activity of both natural and engineered microorganisms in vivo is their location within the host organism.",
        "This technology equips microbial cells with a means to be visualized deep inside mammalian hosts, facilitating the study of the mammalian microbiome and the development of diagnostic and therapeutic cellular agents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30028636": [
        "E., Weihl, C.",
        "Additionally, lipin 1-deficient mice had abundant, but abnormal, mitochondria likely because of impaired autophagy.",
        "Finally, these mice exhibited increased plasma creatine kinase following exhaustive exercise when unfed.",
        "S., Pittman, S.",
        "M., Harris, T.",
        "Mutations in human lipin 1 are a common cause of recurrent rhabdomyolysis in children.",
        "Mice with constitutive whole-body lipin 1 deficiency have been used to examine mechanisms connecting lipin 1 deficiency to myocyte injury.",
        "L., Chen, Z., McCommis, K.",
        "K., Yoshino, J., Matkovich, S.",
        "C., Finck, B. N. Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice.",
        "G., Collier, S.",
        "Herein, 2 muscle-specific mouse models were studied: 1) Lpin1 exon 3 and 4 deletion, resulting in a hypomorphic protein without PAP activity, but which preserved transcriptional coregulatory function; and 2) Lpin1 exon 7 deletion, resulting in total protein loss.",
        "However, that mouse model is confounded by lipodystrophy not phenocopied in people.",
        "These data suggest that mice lacking lipin 1-mediated PAP activity in skeletal muscle may serve as a model for determining the mechanisms by which lipin 1 deficiency leads to myocyte injury and for testing potential therapeutic approaches.-Schweitzer, G.",
        "J., Hsu, F.-F., Chrast, R., Eaton, J.",
        "In both models, skeletal muscles exhibited a chronic myopathy with ongoing muscle fiber necrosis and regeneration and accumulation of phosphatidic acid and, paradoxically, diacylglycerol.",
        "Lipin 1 regulates glycerolipid homeostasis by acting as a phosphatidic acid phosphohydrolase (PAP) enzyme in the triglyceride-synthesis pathway and by regulating transcription factor activity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30092116": [
        "Our proteomic analysis implicated lipin1 in novel roles in various cellular processes. \u00a9 2018 IUBMB Life, 70(8):753-762, 2018.",
        "Pull-down assay on the Ni<sup>2+</sup> -chelating column was used to isolate lipin1 complexes from 293T cells transfected with 6-His tagged lipin1.",
        "The lipin1 complexes were analyzed on Q Exactive mass spectrometer.",
        "In fact, it is also involved in many other cell processes.",
        "As a lipin family founding member, lipin1 exerts dual functions as a phosphatidate phosphatase enzyme and/or a co-transcriptional regulator in lipid metabolism.",
        "Lipin1 also interacted with HIST1H2BK, which was confirmed in SMMC7721 cells by protein immunoprecipitation.",
        "The physical interaction between lipin1 and eEF1A1 was further affirmed in 293T cells transfected with 6-His tagged lipin1 and hepatocyte SMMC7721 cells by protein immunoprecipitation and immunofluorescence microscopy.",
        "In this study, we utilized pull down assay coupled with mass spectrometry (MS) to unravel protein-protein interaction networks of lipin1 in 293T human embryonic kidney cells.",
        "A total of 30 proteins were identified from label free quantitation of the MS data by Proteome Discoverer platform."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29457836": [
        "Furthermore, hepatocyte-specific deletion of SIRT1 disrupted DEPTOR function, enhanced mTORC1 activity, and exacerbated alcoholic fatty liver, inflammation, and liver injury in mice.",
        "However, how chronic alcohol consumption causes hepatic lipid accumulation remains elusive.",
        "Alcoholic liver disease (ALD) is characterized by lipid accumulation and liver injury.",
        "Conversely, adenoviral overexpression of hepatic DEPTOR suppressed mTORC1 signaling and ameliorated alcoholic hepatosteatosis, inflammation, and acute-on-chronic liver injury.",
        "Chronic-plus-binge ethanol feeding led to activation of SREBP-1 and lipin 1 through S6K1-dependent and independent mechanisms.",
        "DEPTOR-dependent inhibition of mTORC1 also attenuated alcohol-induced cytoplasmic accumulation of the lipogenic regulator lipin 1 and prevented alcohol-mediated inhibition of fatty acid oxidation.",
        "Aberrant activation of mTORC1 was likely attributed to the defects of the DEP domain-containing mTOR-interacting protein (DEPTOR) and the nicotinamide adenine dinucleotide-dependent deacetylase sirtuin 1 (SIRT1) in the liver of chronic-plus-binge ethanol-fed mice and in the liver of patients with ALD.",
        "Chronic-plus-binge ethanol feeding led to hyperactivation of mTORC1, as evidenced by increased phosphorylation of mTOR and its downstream kinase S6 kinase 1 (S6K1) in hepatocytes.",
        "Mechanistically, the lipid-lowering effect of hepatic DEPTOR was attributable to decreased proteolytic processing, nuclear translocation, and transcriptional activity of the lipogenic transcription factor sterol regulatory element-binding protein-1 (SREBP-1).",
        "Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes.",
        "The present study demonstrates that activation of the mechanistic target of rapamycin complex 1 (mTORC1) plays a causal role in alcoholic steatosis, inflammation, and liver injury."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25065756": [
        "These data define a requirement for early endocytosis in shaping seamless tube lumens.",
        "Importantly, apical proteins Crumbs and phospho-Moesin accumulate to aberrantly high levels in braided terminal cells.",
        "Indeed, mutations in Moesin dominantly suppressed seamless tube cyst formation and restored terminal branching.",
        "Conversely, the braided seamless tube cyst phenotype was suppressed by mutations in crumbs or Moesin.",
        "Most tubes have seams (intercellular or autocellular junctions that seal membranes together into a tube), but \"seamless\" tubes also exist.",
        "We propose that early endocytosis maintains normal steady-state levels of Crumbs, which recruits apical phosphorylated (active) Moe, which in turn regulates seamless tube shape through modulation of cortical actin filaments.",
        "In Drosophila, stellate-shaped tracheal terminal cells make seamless tubes, with single branches running through each of dozens of cellular extensions.",
        "We show that braided encodes Syntaxin7 and that cysts also form in cells deficient for other genes required either for membrane scission (shibire) or for early endosome formation (Rab5, Vps45, and Rabenosyn-5).",
        "Overexpression of either Crumbs or phosphomimetic Moesin induced lumenal cysts and decreased terminal branching.",
        "We find that mutations in braided impair terminal cell branching and cause formation of seamless tube cysts."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21172808": [
        "How their epithelial features, such as apicobasal polarity or adhesion, are maintained and remodelled and how adhesion and polarity proteins contribute to morphogenesis are two important questions in development.",
        "Many epithelial tissues undergo extensive remodelling during morphogenesis.",
        "This hypothesis is supported by the phenotype of lethal giant larvae (lgl); crb double mutants.",
        "Crb accumulates differentially throughout tracheal development and is required for different tracheal events.",
        "Here, we approach these issues by investigating the role of the apical determinant protein Crumbs (Crb) during the morphogenesis of the embryonic Drosophila tracheal system.",
        "The earliest requirement for Crb is for tracheal invagination, which is preceded by an enhanced accumulation of Crb in the invagination domain.",
        "These results unveil a link between Crb and the organisation of the actin cytoskeleton during morphogenesis.",
        "There, Crb, acting in parallel with the epidermal growth factor receptor (Egfr) pathway, is required for tracheal cell apical constriction and for organising an actomyosin complex, which we propose is mediated by Crb recruitment of moesin (Moe).",
        "The ability of a Crb isoform unable to rescue polarity in crb mutants to otherwise rescue their invagination phenotype, and the converse inability of a FERM-binding domain mutant Crb to rescue faulty invagination, support our hypothesis that it is the absence of Crb-dependent Moe enrichment, and not the polarity defect, that mainly underlies the crb invagination phenotype."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27384346": [
        "The collagen matrix of human articular cartilage is an essentially permanent structure that has no significant turnover in adults, even with the occurrence of disease.",
        "The (14)C levels observed in cartilage collagen showed that, virtually, no replacement of the collagen matrix happened after skeletal maturity and that neither OA nor tissue damage, per se, influenced collagen turnover.",
        "However, the collagen turnover rate during life is not clear, and it is debated whether osteoarthritis (OA) can influence it.",
        "Using the carbon-14 ((14)C) bomb-pulse method, life-long replacement rates of collagen were measured in tibial plateau cartilage from 23 persons born between 1935 and1997 (15 and 8 persons with OA and healthy cartilage, respectively).",
        "Regional differences in (14)C content across the joint surface showed that cartilage collagen located centrally on the joint surface is formed several years earlier than collagen located peripherally.",
        "The poor regenerative capacity of articular cartilage presents a major clinical challenge and may relate to a limited turnover of the cartilage collagen matrix."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18991091": [
        "Type IX collagen epitopes were evident throughout the matrix in all cartilage samples up to 19 years of age.",
        "However, this study provides evidence that even in old age, the chondrocyte attempts to maintain its pericellular environment and hence its mechanical role.",
        "Type IX collagen fragments were extracted from young tissue, supporting the hypothesis that young cartilage is continually remodelled, while mature cartilage maintains relatively low levels of collagen turnover.",
        "Recent studies have identified a range of interactions between type IX collagen and other cartilage matrix components.",
        "To determine the extent to which these interactions are important in maintaining the integrity of ageing articular cartilage, we analyzed an age range of normal healthy articular cartilage samples by Western blotting, immunohistochemical, and PCR analyses.",
        "Type IX collagen expression at the transcriptional level is maintained at all ages.",
        "Clearly the age changes we observed may have significant effects on the integrity of the tissue as the chondrocytes in ageing articular cartilage have limited capacity to turnover the interterritorial matrix.",
        "Therefore, the potential of type IX collagen to interact with other matrix components continues to be of importance in the territorial environment, and these interactions may have significant roles in mechanotransduction.",
        "Reduced levels of type IX collagen were detected in post adolescence cartilage.",
        "Post adolescence, however, the pattern of immunoreactivity revealed territorial staining only."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20488735": [
        "This is the first part of a two-part review and describes the need for accurate, reliable information regarding collagen turnover, the processes by which the biomarker epitopes are generated, their application to the study of both healthy and diseased cartilage and the results of currently published studies, with particular reference to the veterinary species.",
        "The second part of the review considers the non-collagenous biomarkers of cartilage matrix turnover.",
        "Several biomarker assays have been developed which can be used to measure the synthesis and degradation of collagen, and therefore provide information regarding cartilage turnover.",
        "Type II collagen is a major component of articular cartilage and its breakdown is a key feature of osteoarthritis.",
        "Products of cartilage collagen metabolism can be detected in the blood, synovial fluid and urine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29164954": [
        "<strong class=\"sub-title\">\n          Aim:\n        </strong>\n      \n      Ustekinumab, a human monoclonal IgG1 antibody targeting the p40-subunit shared by interleukin (IL)12 and IL-23, represents a potential treatment for atopic dermatitis (AD).",
        "We evaluated the efficacy and safety of ustekinumab in the treatment of AD."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29392854": [
        "We hypothesized that vagal signals are not required for the (i) preprandial increase or (ii) postprandial suppression of ghrelin levels.",
        "Further, we wanted to investigate the hypothesis that (iii) glucagon-like peptide-1 might be implicated in the postprandial decline in ghrelin levels.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Ghrelin, an orexigenic peptide, is secreted from endocrine cells in the gastric mucosa.",
        "Circulating levels rise in the preprandial phase, suggesting an anticipatory or cephalic phase of release, and decline in the postprandial phase, suggesting either the loss of a stimulatory factor or inhibition by factors released when nutrients enter the intestine."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15648018": [
        "Increased plasma ghrelin concentration was also reported during diet-induced weight loss and in malnourished states.",
        "The known metabolic effects of ghrelin and the potential implications of hyperghrelinemia in kidney disease will be discussed in this article.",
        "Ghrelin is a recently described hormone secreted by the stomach.",
        "Plasma ghrelin concentration was shown to be increased in advanced renal failure and hemodialysis patients.",
        "Ghrelin administration in ad-libitum-fed rodents was shown to increase appetite as well as body weight and body fat content, showing metabolic effects of ghrelin in vivo and suggesting its involvement in the pathogenesis of obesity.",
        "These findings suggest that circulating ghrelin is regulated by nutritional state and body fat with a feedback mechanism opposing changes in body composition, with a potential key adaptive role during calorie restriction.",
        "However, plasma ghrelin concentration was shown to be inversely correlated with body weight and body fat in people and rodents."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22231739": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Ghrelin is secreted mainly in the stomach and plays a role in food intake regulation.",
        "Ghrelin cell distribution and expression were determined in three areas of resected stomach specimens from MO patients subjected to SG.",
        "Morbidly obese (MO) individuals report a decline in appetite after sleeve gastrectomy (SG), presumably due, in part, to ghrelin cell removal."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17096064": [
        "However, the effect of H. pylori eradication on plasma ghrelin levels and its relation to body weight change after H. pylori cure are still uncertain.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Ghrelin is a body weight-regulating peptide produced and secreted primarily by the gastric mucosa.",
        "Helicobacter pylori infection impairs gastric ghrelin production, leading to a lower plasma ghrelin concentration.",
        "We examined the association of plasma ghrelin levels with gastric ghrelin production and body weight change before and after H. pylori eradication."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12176667": [
        "Intracerebroventricular treatment with the anti-ghrelin antiserum against the N-terminal region twice a day for 5 days decreased significantly both daily food intake and body weight.",
        "The former antibody recognizes specifically ghrelin with n- octanoylated Ser 3 (acyl ghrelin), and does not recognize des-acyl ghrelin.",
        "Ghrelin, a 28-amino-acid peptide, has recently been isolated from the rat stomach as an endogenous ligand for the GH secretagogue receptor.",
        "The ghrelin levels exhibited a diurnal pattern, with the bimodal peaks occurring before dark and light periods.",
        "We have reported previously that central or peripheral administration of ghrelin stimulates food intake, and the secretion of GH and gastric acid in rats.",
        "These results suggest that (1) endogenous centrally released ghrelin participates in the regulation of food intake and body weight, (2) acyl ghrelin is secreted from the stomach, (3) intestinal hormones stimulate ghrelin release from the stomach, and (4) regulation of the diurnal rhythm of ghrelin is complex, since ghrelin secretion is augmented under conditions of both gastric emptying and filling.",
        "Either fasting for 12 h, administration of gastrin or cholecystokinin resulted in increase of both acyl and des-acyl ghrelin levels.",
        "The latter also recognizes des-acyl ghrelin (i.e. total ghrelin).",
        "Des-acyl ghrelin levels were significantly higher in the gastric vein than in the trunk.",
        "These two peaks were consistent with maximum and minimum volumes of gastric content respectively.",
        "In the present study, we investigated how much endogenous centrally released ghrelin is involved in the control of food intake and body weight gain.",
        "We also examined the profile of ghrelin secretion from the stomach by RIA using two kinds of anti-ghrelin antiserum, one raised against the N-terminal ([Cys(12)]-ghrelin[1-11]) region and one raised against the C-terminal ([Cys(0)]-ghrelin [13-28]) region of the peptide."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19129426": [
        "Accordingly, different approaches to antagonize ghrelin/GHS-R1a signaling have been pursued for the treatment of obesity.",
        "The lack of long-term effects on body weight control by 33A suggests that compensatory mechanisms may contribute to the regulation of energy balance.",
        "Our results indicate that peripheral neutralization of ghrelin can suppress appetite stimulated by a transient surge in ghrelin levels.",
        "In the present study, we generated and characterized high-affinity anti-acyl ghrelin-specific monoclonal antibodies (mAbs).",
        "In vitro, the lead mAb (33A) displayed specific binding to acyl-ghrelin, with an estimated K(d) value &lt; 100 pM.",
        "Ghrelin is a 28-amino acid peptide secreted mainly by the stomach.",
        "In recombinant receptor cell-based assays, 33A dose-dependently inhibited the ghrelin-mediated calcium signal, with an IC(50) of approximately 3.5 nM.",
        "Acyl-ghrelin, which binds to and activates the growth hormone secretagogue receptor type 1a (GHS-R1a), is considered to be the active form for its orexigenic effects.",
        "In vivo, ghrelin dose-dependently stimulated food intake in mice, and this effect was fully blocked by a single injection of 33A.",
        "In a 4-week chronic study, 33A was shown to effectively bind to endogenous acyl-ghrelin; however, long-term administration of 33A did not affect food intake or body weight gain in a mouse model of diet-induced obesity.",
        "It has been demonstrated that peripheral administration of ghrelin stimulates food intake and adiposity in rodents and humans."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19009647": [
        "Helicobacter pylori (H pylori) infection is involved in the pathogenesis of gastritis, gastric and duodenal ulcer, gastric carcinoma, and mucosa-associated lymphoid tissue lymphoma.",
        "Ghrelin is primarily secreted from the stomach and has been implicated in the coordination of eating behavior and weight regulation.",
        "Impaired gastric ghrelin production in association with atrophic gastritis induced by H pylori infection accounts for the decrease in plasma ghrelin concentration.",
        "However, changes in plasma ghrelin concentrations before and after H pylori cure are not associated with the gastric ghrelin production.",
        "Plasma ghrelin changes are inversely correlated with both body weight change and initial plasma ghrelin levels.",
        "Thus, it is important to clarify which diseases primarily influence changes in plasma ghrelin concentrations.",
        "However, the ratio of plasma acylated ghrelin to total ghrelin levels is higher in patients with chronic atrophic gastritis than in healthy subjects.",
        "After H pylori eradication, gastric preproghrelin mRNA expression is increased nearly 4-fold in most cases.",
        "Plasma ghrelin concentration decreases with the progression of gastric atrophy.",
        "Ghrelin also plays an essential role in the mechanism of gastric mucosal defense.",
        "H pylori eradication is related to body weight change.",
        "This may result from the compensatory increase in plasma active ghrelin concentration in response to gastric atrophy.",
        "Compared, H pylori infected and negative subjects with normal body mass index, plasma ghrelin concentration, gastric ghrelin mRNA, and the number of ghrelin producing cells in gastric mucosa are significantly lower in H pylori infected subjects than in H pylori-negative controls."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18350524": [
        "Identification of ghrelin started with the discovery of growth hormone secretagogues, continued with the description of ghrelin receptors and ended with the elucidation of the chemical structure of ghrelin.",
        "Current data support the hypothesis that the stomach, in addition to its important role in digestion, not only influences pituitary hormone secretion but, via ghrelin production, it also sends orexigenic (appetite increasing) signals to hypothalamic nuclei involved in the regulation of energy homeostasis.",
        "However, several issues concerning the role of ghrelin in physiological and pathophysiological processes are still under investigation.",
        "In addition to these main effects, ghrelin influences insulin secretion and glucose metabolism and it may exert potentially important effects on cardiovascular and gastrointestinal functions.",
        "Because of its effects on a large number of physiological functions, ghrelin may be involved in the pathomechanism of several human disorders, including disturbances of appetite, energy homeostasis and glucose metabolism.",
        "Ghrelin stimulates growth hormone secretion via growth hormone secretagogue receptors.",
        "Ghrelin secretion in the stomach depends on both acute and chronic changes in nutritional status and energy balance.",
        "Further research might lead to a better understanding of the pathophysiology of ghrelin and might provide more effective therapy for the above disorders.",
        "Most of the ghrelin produced in the body is secreted in the stomach, but it is also expressed in the hypothalamus, pituitary, pancreas, intestine, kidney, heart and gonads."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16254526": [
        "There are few studies on this hormone in healthy infants during the first year of life.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Ghrelin, a recently discovered hormone mainly secreted by the stomach, has several metabolic functions including regulation of food intake, energy homeostasis and body weight.",
        "The aim of this study was to examine the correlations between ghrelin and weight gain in healthy term infants in the first year of life."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26019019": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      Ghrelin is mainly secreted from the stomach and plays a role in appetite, weight gain, and the promotion of a positive energy balance.",
        "We herein investigated the effect of the administration of synthetic ghrelin to treat postoperative severe weight loss in a prospective, one-arm clinical trial to develop new strategies for weight gain.",
        "The levels of ghrelin decrease immediately after gastrectomy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17251274": [
        "In addition, following OVX, there was an increase in plasma ghrelin that was temporally associated with increased food intake, body weight, and hypothalamic neuropeptide Y and Agouti-related protein mRNA expression.",
        "To investigate sex differences in the action of ghrelin, we assessed the effects of exogenous ghrelin in intact male and female rats, the effects of exogenous ghrelin in ovariectomized (OVX) and estradiol (E2)-treated female rats, as well as the effects of OVX on plasma ghrelin and hypothalamic orexigneic neuropeptide expression in rats and on food intake and weight gain in transgenic mice lacking the ghrelin receptor (Ghsr(-/-) mice).",
        "Collectively, these data suggest that estradiol inhibits the orexigenic action of ghrelin in females, that weight gain associated with OVX is ghrelin mediated, and that this endocrine interaction may account for an important sex differences in food intake and the regulation of body weight.",
        "Furthermore, OVX increased food intake and body weight in wild-type mice, but not in Ghsr(-/-) mice, suggesting that OVX increases food intake by releasing ghrelin from a tonic inhibitory effect of estradiol.",
        "Male and OVX female rats were significantly more sensitive than intact female rats to the orexigenic effects of both centrally (intra-third ventricular, i3vt, 0.01, 0.1, and 1.0 nmol) and systemically (ip, 3, 6, and 9 nmol) administered ghrelin.",
        "This difference is likely to be estradiol dependent because E2 attenuated the orexigenic action of ghrelin in OVX female and male rats.",
        "Ghrelin, the only known orexigenic gut hormone, is secreted mainly from the stomach, increases with fasting and before meal initiation in humans and rats, and increases food intake after central or peripheral administration."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21035199": [
        "Furthermore, I discuss how the recently demonstrated role of ghrelin in promoting survival during periods of caloric restriction could contribute to its inherent neuroprotective and neuromodulatory properties.",
        "However, GHSR1a is also expressed in numerous extra-hypothalamic neuronal populations, suggesting that ghrelin has physiological functions besides those involved in metabolic functions.",
        "Numerous studies over the past decade demonstrate its importance in food intake, body-weight regulation and glucose homeostasis.",
        "In this review, I focus on increasing evidence that ghrelin has important roles in extra-hypothalamic functions, including learning and memory, reward and motivation, anxiety and depression, and neuroprotection.",
        "Ghrelin is a peptide hormone produced and secreted in the stomach.",
        "These effects are driven largely by the high expression of the ghrelin receptor (GHSR1a) in the hypothalamus."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17983856": [
        "In a lean state and anorexia nervosa, plasma ghrelin levels are increased, whereas in obesity, except in Prader-Willi syndrome, plasma ghrelin levels are decreased and the feeding- and sleeping-induced decline in plasma ghrelin levels is disrupted.",
        "The efferent vagus nerve contributes to the fasting-induced increase in ghrelin secretion.",
        "Thus, a dysfunction of the ghrelin feedback systems might contribute to the pathophysiology of obesity and eating disorders.",
        "Hyperphagia and obesity are likely to decrease plasma des-acyl ghrelin, but not n-octanoyl-modified ghrelin levels.",
        "There are two forms of ghrelin: active n-octanoyl-modified ghrelin and des-acyl ghrelin.",
        "Moreover, body mass index modulates plasma ghrelin levels.",
        "Hypothalamic serum and glucocorticoid-inducible kinase-1 and serotonin 5-HT2C/1B receptor gene expression levels are likely to be proportional to plasma des-acyl ghrelin levels during fasting, whereas they are likely to be inversely proportional to plasma des-acyl ghrelin levels in an increased energy storage state such as obesity.",
        "Ghrelin is produced primarily in the stomach in response to hunger, and circulates in the blood.",
        "Fasting increases both ghrelin types compared with the fed state.",
        "These findings indicate that the vagal circuit between the central nervous system and stomach has a crucial role in regulating plasma ghrelin levels.",
        "GH inhibits stomach ghrelin secretion.",
        "Plasma ghrelin levels increase during fasting and decrease after ingesting glucose and lipid, but not protein.",
        "Ghrelin also stimulates pituitary gland secretion of growth hormone (GH) via the afferent vagus nerve.",
        "Ghrelin secreted by the stomach stimulates the afferent vagus nerve and promotes food intake."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17101319": [
        "The aim of this study was to compare effects of exogenous ghrelin (at a dose that stimulates growth hormone [GH] release in the physiologic range) versus placebo on gastric emptying, gastric volume, and postprandial symptoms and determine whether body mass (ranging from normal weight to obesity) influences responses to ghrelin.",
        "Obese individuals have lower fasting plasma ghrelin levels but increased appetite, suggesting greater responses to endogenous ghrelin in obesity.",
        "<strong class=\"sub-title\">\n          Background &amp; aims:\n        </strong>\n      \n      Ghrelin is secreted by the stomach and stimulates food intake."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27376422": [
        "In humans, there is a preprandial rise and a postprandial fall in plasma ghrelin levels, which strongly suggest that the peptide plays a physiological role in meal initiation and may be employed in determining the amount and quality of ingested food.",
        "Ghrelin, the endogenous ligand for the GH secretagogue receptor, is the only peripheral orexigenic hormone that activates the receptors to be found especially in the appetite center (hypothalamus and pituitary gland).",
        "Ghrelin is a gut peptide composed of 28 amino acids mostly secreted in the gastric fundus mucosa.",
        "Thus, in the human body ghrelin induces a positive energy balance, an increased adiposity gain, as well as an increase in caloric storage, seen as an adaptive mechanism to caloric restriction conditions.",
        "As a consequence, the hypothesis that ghrelin is involved in the current obesity epidemic has been embraced by many scholars and researchers.",
        "The literature even mentions an extremely complex ghrelin/GOAT/GHSR system involved in the regulation of human energy, metabolism and adaptation of energy homeostasis to environmental changes.",
        "In the current world context, when we are witnessing an increasing availability of food and a reduction of energy expenditure to a minimum level, these mechanisms have become pathogenic.",
        "Besides the stimulation of food intake, ghrelin determines a decrease in energy expenditure and promotes the storage of fatty acids in adipocytes.",
        "It was isolated and described in 1999 by Kojima et al. and only three years later its specific receptor, GHSR1a, was also identified.",
        "Ghrelin is present in human plasma in two forms: an inactive form known as deacylated ghrelin, and an active form called acylated ghrelin synthesized under the action of ghrelin O-acyltransferase enzyme (GOAT)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24806082": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      A wide variety of functions has been attributed to ghrelin, a peptide hormone secreted in the stomach.",
        "The objective of the study was to assess the association of ghrelin concentrations with body composition among Iranian children."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17646723": [
        "The main objective of the present study was to examine the effect of age on ghrelin levels in non-institutionalized elderly people.",
        "Endocrine factors are among the causes of anorexia in elderly people.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Ghrelin is a hormone secreted mainly in the stomach which stimulates appetite and food intake."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12352514": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Ghrelin is secreted by the stomach, the hypothalamus, and the placenta in humans and has growth hormone-secreting and orexigenic properties.",
        "Leptin is secreted mainly by the adipocyte, plays a major role in energy balance, and reflects fat mass in infants as well as adults.",
        "Leptin and ghrelin central effects are mediated, at least partly, through the neuropeptide Y/Y1 receptor pathway in the hypothalamus."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29329782": [
        "Among the LPAR subtypes expressed in these cells, LPA<sub>1</sub> and LPA<sub>2</sub>, but not LPA<sub>3</sub>, induced phosphorylation of ERM proteins at their C-termini.",
        "The activated ERM proteins mediated cytoskeletal reorganization and formation of membrane protrusions in OVCAR-3 cells.",
        "Here, we explored the cellular signaling pathway via which LPA induces migration of ovarian cancer cells.",
        "Importantly, LPA-induced migration of OVCAR-3 cells was completely abolished not only by gene silencing of LPA<sub>1</sub> or LPA<sub>2</sub>, but also by overexpression of a dominant negative ezrin mutant (ezrin-T567A).",
        "Lysophosphatidic acid (LPA) has been implicated in the pathology of human ovarian cancer.",
        "This phosphorylation was dependent on the G\u03b1<sub>12/13</sub>/RhoA pathway, but not on the G\u03b1<sub>q</sub>/Ca<sup>2+</sup>/PKC or G\u03b1<sub>s</sub>/adenylate cyclase/PKA pathway.",
        "LPA induced robust phosphorylation of ezrin/radixin/moesin (ERM) proteins, which are membrane-cytoskeleton linkers, in the ovarian cancer cell line OVCAR-3.",
        "Taken together, this study demonstrates that the LPA<sub>1</sub>/LPA<sub>2</sub>/ERM pathway mediates LPA-induced migration of ovarian cancer cells.",
        "These findings may provide a potential therapeutic target to prevent metastatic progression of ovarian cancer.",
        "This phospholipid elicits a wide range of cancer cell responses, such as proliferation, trans-differentiation, migration, and invasion, via various G-protein-coupled LPA receptors (LPARs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29311472": [
        "This review deals with recent advances in studies on P-glycoprotein (P-gp) and its expression regulators, focusing especially on our own research.",
        "Thirdly, we review evidence that P-gp activity is enhanced in the process of epithelial-to-mesenchymal transition (EMT), which is associated with cancer progression, without any increase in expression of P-gp mRNA.",
        "Secondly, we discuss the post-translational regulation of P-gp localization and function by the scaffold proteins ezrin, radixin and moesin (ERM proteins), together with recent reports indicating that tissue-specific differences in regulation by ERM proteins in normal tissues might be retained in corresponding cancerous tissues.",
        "Firstly, we describe findings demonstrating that the distribution of P-gp along the small intestine is heterogeneous, which explains why orally administered P-gp substrate drugs often show bimodal changes of plasma concentration.",
        "Finally, we describe two examples in which P-gp critically influences the brain distribution of drugs, i.e., oseltamivir, where low levels of P-gp associated with early development allow oseltamivir to enter the brain, potentially resulting in neuropsychiatric side effects in children, and cilnidipine, where impairment of P-gp function in ischemia allows cilnidipine to enter the ischemic brain, where it exerts a neuroprotective action."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29777033": [
        "In contrast, a non-cleavable L-selectin mutant binds selectively to ezrin, driving multi-pseudopodial extensions.",
        "The spatio-temporal organisation of ERM proteins with their targets, and their individual contribution to protrusion during TEM, has never been explored.",
        "Here, we show that blocking binding of moesin to phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>) reduces its C-terminal phosphorylation during monocyte TEM, and that on-off cycling of ERM activity is essential for pseudopod protrusion into the subendothelial space.",
        "Reactivation of ERM proteins within transmigrated pseudopods re-establishes their binding to targets, such as L-selectin.",
        "Taken together, these results show that ezrin and moesin play mutually exclusive roles in modulating L-selectin signalling and shedding to control protrusion dynamics and polarity during monocyte TEM.",
        "Leukocyte transendothelial migration (TEM) is absolutely fundamental to the inflammatory response, and involves initial pseudopod protrusion and subsequent polarised migration across inflamed endothelium.",
        "Ezrin binds preferentially to L-selectin in resting cells and during early TEM.",
        "The moesin-L-selectin interaction increases within transmigrated pseudopods as TEM proceeds, facilitating localised L-selectin ectodomain shedding.",
        "Knockdown of ezrin, but not moesin, severely impaired the recruitment of monocytes to activated endothelial monolayers under flow, suggesting that this protein plays a unique role in the early recruitment process.",
        "Ezrin/radixin/moesin (ERM) proteins are expressed in leukocytes and mediate cell shape changes and polarity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29671387": [
        "The outcome of this intense research field is the discovery that development, ageing, and stem-cell dependent regeneration but also several diseases including cancer are largely controlled by the epigenetic state of cells.",
        "However, bases in DNA and RNA can be chemically modified.",
        "Triplets of these four letters jointly encode 20 different amino acids out of which proteins of all organisms are built.",
        "Here we provide a perspective on necessary and expected developments in the fast expanding area of RNA modifications, termed epitranscriptomics.",
        "The genetic alphabet consists of the four letters: C, A, G, and T in DNA and C,A,G, and U in RNA.",
        "In DNA, around 10 different modifications are known, and those have been studied intensively over the past 20 years.",
        "In recent years, the ~150 modifications found in RNA have come to the focus of intense research.",
        "Scientific studies on DNA modifications and proteins that recognize them gave rise to the large field of epigenetic and epigenomic research.",
        "Consequently, this research has already led to the first FDA approved drugs that exploit the gained knowledge to combat disease.",
        "This system is universal and is found in all kingdoms of life."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29278852": [
        "These adipokines have been proposed as potential prognostic biomarkers of cardiovascular mortality/morbidity and therapeutic targets in patients with cardiometabolic diseases.",
        "Leptin, adiponectin, and resistin are the most studied adipokines which play important roles in the regulation of cardiovascular homeostasis.",
        "Adipose tissue is now described as an endocrine organ secreting a number of adipokines contributing to the development of inflammation and metabolic imbalance, but also endothelial dysfunction, vascular remodeling, atherosclerosis, and ischemic stroke.",
        "Leptin and adiponectin have been linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of ischemic stroke.",
        "Resistin, a pro-inflammatory cytokine, is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke.",
        "Leptin and adiponectin mediate both proatherogenic and antiatherogenic responses.",
        "The changes in serum levels of novel adipokines apelin, visfatin are also associated with acute ischemic stroke.",
        "In this article, we summarize the biologic role of the adipokines and discuss the link between dysfunctional adipose tissue and metabolic/inflammation imbalance, consequently endothelial damage, progression of atherosclerotic disease, and the occurrence of ischemic stroke."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12660880": [
        "Thiazolidinedione treatment did not influence resistin plasma levels.",
        "Resistin treatment impaired glucose tolerance and insulin action.",
        "Therefore, resistin could play a critical role in the development of obesity and type 2 diabetes.",
        "They were not statistically different in individuals with a broad BMI range.",
        "Resistin is a recently discovered hormone that is exclusively expressed in adipose tissue.",
        "Immunoneutralization of resistin improved insulin sensitivity, while thiazolidinedione treatment reduced resistin expression.",
        "Resistin plasma levels in type 2 diabetes were 38.7 ng/ml, and 39.4 ng/ml in type 1 diabetes.",
        "Plasma levels of resistin in healthy controls were 38.78 ng/ml.",
        "We conclude from our data: 1. resistin can be detected in human plasma, 2. plasma resistin levels are not different in type 1 and type 2 diabetes.",
        "Its expression in rodents was reported to be elevated or suppressed in genetic and diet-induced obesity, respectively.",
        "In this study were determined resistin plasma levels in humans suffering from type 1 and type 2 diabetes and in healthy controls."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/14644422": [
        "Resistin is a secreted adipose tissue hormone that belongs to the resistin-like molecule family.",
        "Both cDNAs, resistin and S-resistin, were carboxy-tagged with FLAG epitope and transiently expressed in cultured cell lines.",
        "While the resistin-FLAG construct gives the expected pattern for a secretion protein, the S-resistin-FLAG construct yielded a predominant nuclear staining.",
        "We report here a new alternatively spliced isoform of the rat resistin gene, named S-resistin (short resistin), detected in adipose tissue by reverse transcription-polymerase chain reaction (RT-PCR).",
        "A comparison of this cDNA variant and genomic sequences indicates the lack of the second exon containing the secretory consensus signal.",
        "These results indicate that this splicing event regulates the fate and probably the function of the mature protein."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18417718": [
        "The concentration of octylphenol that increased resistin mRNA levels by 50% was approximately 100 nM within 6 h of treatment.",
        "These results imply that ERalpha and ERK are necessary for the octylphenol stimulation of resistin mRNA expression.",
        "These data suggest that the way octylphenol signaling increases resistin protein levels is similar to that by which it increases resistin mRNA levels; it is likely mediated through an ERK-dependent pathway.",
        "It can be regulated by sexual hormones.",
        "In addition, octylphenol stimulated resistin protein expression and release.",
        "The basal half-life of resistin protein induced by cycloheximide was lengthened by octylphenol treatment, suggesting that octylphenol decreases the rate of resistin protein degradation.",
        "In vivo, octylphenol increased adipose resistin mRNA expression and serum resistin and glucose levels, supporting its in vitro effect.",
        "While octylphenol was shown to increase activities of the estrogen receptor (ER) and MEK1, signaling was demonstrated to be blocked by pretreatment with either ICI-182780 (an ERalpha antagonist) or U-0126 (a MEK1 inhibitor), in which both inhibitors prevented octylphenol-stimulated phosphorylation of ERK.",
        "Moreover, U-0126 antagonized the octylphenol-increased resistin protein expression and release.",
        "Whether environmental estrogens regulate the production of resistin is still not clear.",
        "Using 3T3-L1 adipocytes, we found that octylphenol upregulated resistin mRNA expression in dose- and time-dependent manners.",
        "Resistin is known as an adipocyte-specific secretory hormone that can cause insulin resistance and decrease adipocyte differentiation.",
        "The basal half-life of resistin mRNA induced by actinomycin D was lengthened by octylphenol treatment, suggesting that octylphenol decreases the rate of resistin mRNA degradation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24780007": [
        "Following knee injury, elevated levels of resistin have been found in synovial fluid (SF) while very little is known about the role of resistin in osteoarthritis (OA).",
        "The aim of the present study was to investigate resistin levels in OA joints and to determine if it is associated with inflammatory and catabolic factors in the joints.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Resistin is an adipocytokine that has been related to inflammation and insulin resistance."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26729407": [
        "Resistin increased intracellular calcium concentration, and chelation of intracellular calcium blocked resistin-mediated activation of Src.",
        "However, the molecular mechanism by which resistin acts is not fully understood.",
        "In addition, resistin increased phosphorylation of PKC\u03b1.",
        "Additionally, ezrin interacted with PKC\u03b1, and resistin promoted co-localization of ezrin and PKC\u03b1.",
        "Resistin also increased phosphorylation of ezrin, radixin, and moesin (ERM).",
        "Knock-down of ezrin abrogated resistin-induced vimentin expression.",
        "Either inhibition of c-Src and PKC\u03b1 or knock-down of ezrin blocked resistin-induced breast cancer cells invasion.",
        "Here, we report that resistin stimulated invasion and migration of breast cancer cells as well as phosphorylation of c-Src.",
        "These results suggest that resistin play as a critical regulator of breast cancer metastasis.",
        "Resistin also induced phosphorylation of protein phosphatase 2A (PP2A).",
        "Inhibition of c-Src blocked resistin-mediated PP2A phosphorylation.",
        "The aim of this study was to investigate whether resistin could stimulate invasion and migration of breast cancer cells.",
        "Inhibition of PP2A enhanced resistin-induced PKC\u03b1 phosphorylation, demonstrating that PP2A activity is critical for PKC\u03b1 phosphorylation.",
        "Moreover, resistin increased expression of vimentin, a key molecule for cancer cell invasion.",
        "Inhibition of c-Src blocked resistin-induced breast cancer cell invasion.",
        "Resistin, an adipocyte-secreted factor, is known to be elevated in breast cancer patients."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/18191042": [
        "Resistin single nucleotide polymorphism (SNP) -420 was typed.",
        "Multiple regression analysis adjusted for age, sex, and body mass index revealed that the reductions in serum resistin were dependent on baseline resistin levels.",
        "Resistin is an adipokine that induces insulin resistance in mice; serum concentrations are decreased by fasting and increased by feeding.",
        "Therefore, in young, lean, nondiabetic humans, serum resistin was reduced by glucose and meal loading; the reduction in resistin was greater in subjects with higher fasting resistin.",
        "Serum total and HMW adiponectin was unchanged.",
        "Fasting resistin was correlated with SNP -420 and white blood cell count.",
        "The aims of this study were to determine the effects of glucose and meal loading on serum resistin and total and high-molecular weight (HMW) adiponectin in humans and to explore potential determinants of fasting serum resistin and of changes in resistin.",
        "Serum resistin and total and HMW adiponectin were measured by enzyme-linked immunosorbent assay in young, lean, nondiabetic subjects during 75-g oral glucose tolerance test (OGTT) and meal tolerance test (MTT).",
        "Subjects with greater baseline concentrations of resistin experienced more pronounced declines in resistin (OGTT, unstandardized regression coefficient (beta) = -0.19, P = .0005; MTT, beta = -0.63, P &lt; .0001).",
        "Serum resistin was also reduced at 240 minutes during MTT (n = 33, 1-way repeated measures analysis of variance, P &lt; .0001; Scheffe, P = .0002).",
        "Fasting serum resistin was positively correlated with the G allele number of SNP -420 (beta = 7.70, P = .01) and white blood cell count (beta = 0.007, P = .0001) adjusted for age, sex, and body mass index.",
        "Adiponectin, another adipokine, improves insulin sensitivity.",
        "Serum resistin was decreased at 60 and 120 minutes during OGTT compared with baseline (n = 36, 1-way repeated-measures analysis of variance, P &lt; .0001; Scheffe, P = .0457 and P &lt; .0001, respectively)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/14962997": [
        "However, the regulation of resistin expression by physiological conditions, hormones, or agents known to modulate insulin sensitivity does not always support the association between resistin and obesity-induced insulin resistance.",
        "The lack of effect of leptin on resistin in db/db mice indicated that the leptin inhibitory action on resistin expression requires the long leptin receptor isoform.",
        "We show that the expression of resistin mRNA and protein in adipose tissue is lower in ob/ob than in wild-type control mice, in agreement with the reduced adipocyte resistin mRNA level reported in several models of obesity.",
        "Resistin is an adipose-derived hormone that has been proposed as a link among obesity, insulin resistance, and diabetes.",
        "In addition, we demonstrated that the effect of leptin on resistin expression was centrally mediated.",
        "In the present study we investigated the effects of leptin administration on adipose resistin expression in insulin-resistant and obese ob/ob mice.",
        "In conclusion, our results demonstrate that leptin decreases resistin expression and suggest that resistin may influence glucose homeostasis.",
        "Leptin administration in ob/ob mice resulted in improvement of insulin sensitivity concomitant with a decrease in resistin gene expression.",
        "Interestingly, in both ob/ob and high fat-fed mice we obtained a striking positive correlation between glycemia and resistin gene expression.",
        "In agreement with a role of resistin in insulin resistance, the administration of recombinant resistin led to glucose intolerance in mice and impaired insulin action in rat liver.",
        "High-fat feeding in C57BL/6J wild-type mice, which is known to induce the development of obesity and insulin resistance, produced an increase in resistin expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30353146": [
        "We demonstrate that restoration of Ca<sup>2+</sup> homeostasis in diabetic hearts, through normalization of Serca2a function genetically and pharmacologically, suppressed resistin expression via inhibition of NFATc.",
        "We have previously reported that diabetic hearts express high levels of resistin while overexpression of resistin in adult rat hearts gives rise to a phenotype resembling diabetic cardiomyopathy.",
        "This study investigated the mechanism of resistin upregulation and the role of Serca2a in its transcriptional suppression.",
        "Interestingly, activation of Serca2a by a novel agonist, CDN1163, mirrored the effects of AAV9-Serca2a gene transfer on resistin expression and its promoter activity and AMPK signaling in diabetic mice.",
        "Interestingly, overexpression of Serca2a or VIVIT mitigated glucose-stimulated resistin and NFATc expression and enhanced AMPK activity, a downstream target of resistin signaling.",
        "H9c2 myocytes stimulated with high-glucose concentration or Ca<sup>2+</sup> time-dependently increased NFATc and resistin expression while addition of the Ca<sup>2+</sup> chelator BAPTA-AM attenuated this effect.",
        "The transcriptional regulation of resistin in diabetic cardiac tissue is currently unknown.",
        "The adipokine resistin has been proposed to link obesity, insulin resistance and diabetes.",
        "NFATc direct activation of resistin was verified by resistin promoter luciferase activity and chromatin-immunoprecipitation analysis.",
        "These findings parse a role for Ca<sup>2+</sup> in resistin transactivation and provide support that manipulation of Serca2a-NFATc-Resistin axis might be useful in hyper-resistinemic conditions.",
        "NFATc expression was enhanced in hearts from ob/ob diabetic and from cardiac-specific Serca2a<sup>-/-</sup> mice.",
        "Similarly, NFATc increased resistin expression in myocytes cultured in low glucose while the NFATc inhibitor VIVIT blocked glucose-induced resistin expression, suggesting that hyperglycemia/diabetes induces resistin expression possibly through NFATc activation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19095472": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Resistin is a secreted factor that is elevated in rheumatoid arthritis (RA) and believed to drive joint inflammation in vivo.",
        "This study was undertaken to determine if resistin is present in the joint following joint injury and to elucidate the role of resistin in cartilage degradation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23981771": [
        "Recent clinical studies have connected elevated resistin levels with the development and severity of heart failure.",
        "Remarkably, doxorubicin (25mg/kg ip) led to a 4-fold induction of serum resistin levels in Hum-Retn mice.",
        "Hum-Retn mice showed increased cardiac mRNA levels of inflammatory and cell adhesion genes compared with Retn(-/-) mice.",
        "Macrophages, but not cardiomyocytes, from Hum-Retn mice treated with doxorubicin in vitro showed dramatic induction of hRetn (human resistin) mRNA and protein expression.",
        "Further, elevation in resistin correlated with decline in ejection fraction in these women.",
        "These results suggest that elevated resistin is a biomarker of anthracycline-induced cardiotoxicity and may contribute in the development of heart failure via its direct effects on macrophages.",
        "Resistin is a circulating mediator of insulin resistance mainly expressed in human monocytes and responsive to inflammatory stimuli.",
        "To further our understanding of the role of human resistin in heart failure, we studied a humanized mouse model lacking murine resistin but transgenic for the human Retn gene (Hum-Retn mice), which exhibits basal and inflammation-stimulated resistin levels similar to humans.",
        "We also examined resistin levels in anthracycline-treated breast cancer patients with and without cardiotoxicity.",
        "Intriguingly, serum resistin levels in women undergoing anthracycline-containing chemotherapy increased significantly at 3 months and remained elevated at 6 months in those with subsequent cardiotoxicity.",
        "These results further implicate resistin as a link between inflammation, metabolism, and heart disease.",
        "Moreover, doxorubicin-induced cardiotoxicity was greater in the Hum-Retn mice than in littermate controls not expressing human resistin (Retn(-/-)).",
        "Specifically, we explored whether resistin underlies acute anthracycline-induced cardiotoxicity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29937317": [
        "Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders.",
        "A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils.",
        "Here we assessed the relationship of resistin to CF lung disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15103228": [
        "In the present study we compared the ontogeny of resistin gene expression in the pituitary of male and female mice using semi-quantitative RT-PCR analysis.",
        "Since resistin expression in adipose tissue is also influenced by obesity, we evaluated resistin expression in fat, brain and pituitary of the obese ob/ob mouse.",
        "However, significant gender differences were evident (male &gt; female at postnatal day 28 and 42) and this was not modified by neonatal treatment of female pups with testosterone.",
        "In conclusion, pituitary resistin expression is age- and gender-dependent.",
        "In ob/ob mice, and in fasted mice, resistin is regulated in a tissue-specific manner.",
        "Moreover, resistin expression in female mouse pituitary is developmentally regulated and maximal expression occurs peripubertally.",
        "Resistin is a new adipocytokine which is expressed in rat, mouse and possibly human adipose tissue.",
        "Its putative role as a mediator of insulin resistance is controversial.",
        "Resistin mRNA was significantly increased in both visceral and subcutaneous adipose depots in postnatal day 28 ob/ob mice compared to controls, but pituitary resistin expression was significantly reduced.",
        "Thus in visceral fat obesity increases but starvation decreases resistin mRNA.",
        "Resistin gene expression was severely down-regulated by a 24-hour fast in adipose and pituitary tissue but not in hypothalamus.",
        "We show that resistin expression is developmentally regulated in the pituitary of male and female CD1 mice.",
        "In contrast, pituitary levels are decreased in the presence of both high (ob/ob) and low (fasting) adipose stores.",
        "Further studies are required to define the unexpected hormonal regulation of resistin gene expression in the pituitary.",
        "In contrast to the prepubertal levels, and in agreement with other reports, adipose resistin expression was reduced in adult ob/ob mice.",
        "Although the role of endogenous resistin in mouse brain and pituitary has not been determined, our data suggest that resistin could be important in the postnatal maturation of the hypothalamic-pituitary system.",
        "We hypothesized that resistin, like leptin, would have multiple roles in non-adipose tissues and we reported that resistin is expressed in mouse brain and pituitary.",
        "In a third set of experiments we examined the influence of food deprivation on pituitary and fat resistin mRNA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19024936": [
        "Leptin and resistin impair insulin sensitivity, whereas adiponectin enhances it.",
        "Leptin belongs to the adipokine family, which also contains adiponectin and resistin.",
        "Leptin is a potent stimulator of central GnRH and gonadotropin secretion, and, paradoxically, a potent inhibitor of ovarian steroidogenesis.",
        "In 1996, it was claimed that leptin might be the \"missing link\" between fat and reproduction.",
        "Its role in female reproduction will provide an exciting field of research in coming years.",
        "The central roles of adiponectin and resistin are less clear.",
        "In the ovary, adiponectin stimulates steroidogenesis by granulosa cells.",
        "The body mass index, and especially the lean/fat tissue ratio, are determinants of female fertility.",
        "Recent data point to the existence of a distinct lipid metabolism in the ovary."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29399171": [
        "PIM-1 expression levels were significantly associated with tumor size, lymph node involvement, nerve invasion, distant metastasis and weakly associated with tumor node metastasis stage.",
        "The present study investigated the clinical significance of the PIM-1 protein, apoptosis status and apoptosis-associated proteins, including forkhead box O3a (FOXO3a), B cell lymphoma-2 (BCL-2) and BCL-2-associted agonist of cell death (BAD), were investigated in salivary gland adenoid cystic carcinoma (ACC) tissues.",
        "IHC staining results demonstrated high expression ratios of PIM-1, FOXO3a, BCL-2 and BAD [33.33% (20/60), 51.67% (31/60), 51.67% (31/60) and 55% (33/60)], respectively, and significant correlations between the expression of PIM-1 and FOXO3a and BCL-2 (P&lt;0.05).",
        "Kaplan-Meier survival curves revealed that PIM-1 expression level was significantly associated with disease-free survival of patients with ACC (P=0.009).",
        "Apoptotic rates were significantly associated with PIM-1, FOXO3a, BCL-2 and BAD expression levels (P&lt;0.05).",
        "PIM-1 expression levels in 4 pairs of ACC tissues and corresponding normal salivary gland tissues were determined by western blot analysis.",
        "PIM-1, FOXO3a, BAD and BCL-2 expression levels in 60 ACC tissues were evaluated by immunohistochemistry (IHC).",
        "Cox regression multivariate analysis results revealed that histotype, distant metastasis and apoptotic rate were independent prognosis factors for ACC.",
        "PIM-1 was revealed to be highly expressed in ACC tissues compared with adjacent normal tissues.",
        "Assessment of PIM-1 may be useful in investigating the malignant behaviors of ACC and predicting the outcome of patients with ACC.",
        "A terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling assay was performed to detect the apoptosis status of ACC tissues.",
        "Pim-1 proto-oncogene, serine/threonine kinase (PIM-1) phosphorylates a series of substrates to exert its oncogenic function in numerous malignancies."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29355758": [
        "However, little is known about the role of Pim1 in invertebrate immunity.",
        "Sequence and phylogenetic analysis revealed that LvPim1 shared a close evolutionary relationship with Pim1 from vertebrates.",
        "Moreover, knockdown of LvPim1 resulted in increased hemocytes apoptosis; shown by high caspase3/7 activity, coupled with increase in pro-apoptotic LvCaspase3 and LvCytochrome C, and decrease in pro-survival LvBcl2, LvIAP1, and LvIAP2 mRNA expression in hemocytes.",
        "In this study, we identified and characterized for the first time, a Pim1 (LvPim1) gene in Litopenaeus vannamei, with a full-length cDNA of 2352 bp and a 1119 bp open reading frame (ORF) encoding a putative protein of 372 amino acids, which contains a typical serine/threonine kinase domain.",
        "The Pim1 serine/threonine kinase is associated with multiple cellular functions including proliferation, survival, differentiation, apoptosis, tumorigenesis, immune regulation and inflammation in vertebrates.",
        "Taken together, our present data strongly suggest that LvPim1 is involved in modulating shrimp resistance to pathogen infection, promote hemocytes survival, and therefore plays a role in shrimp immune response.",
        "Finally, LvPim1 knockdown renders shrimps more susceptible to V. parahaemolyticus infection.",
        "Real-time qPCR analysis showed that LvPim1 was widely expressed in all tissues tested; with its transcript level induced in hepatopancreas and hemocytes upon challenge with Vibrio parahaemolyticus, Streptoccocus iniae, lipopolysaccharide (LPS), and white spot syndrome virus (WSSV), thus, suggesting its probable involvement in shrimp immune response."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28886070": [
        "Furthermore, expression of miR-301a contrastingly regulated Cfl2 expression levels in neonatal rat ventricular cardiomyocytes (NRVCM).",
        "Mechanistically, we found that Cfl2 activated serum response factor response element (SRF-RE) driven luciferase activity in neonatal rat cardiomyocytes and in C2C12 cells.",
        "Cofilin-2 (Cfl2) was identified as one of the potential targets of miR-301a using prediction databases, which we validated by luciferase assay and mutation of predicted binding sites.",
        "Interestingly, the expression of SRF and its target genes was strikingly increased in Cs1-ko suggesting a possible in vivo correlation between expression levels of Cfl2/miR-301a and SRF activation, which needs to be independently validated.",
        "Our findings provide an additional and important layer of Cfl2 regulation, which we believe has an extended role in cardiac signal transduction and dilated cardiomyopathy presumably due to the reported involvement of Cfl2 in these mechanisms.",
        "In summary, our data demonstrates that miR-301a regulates Cofilin-2 in vitro in NRVCM, and in vivo in Cs1-ko mice.",
        "Here we performed a microRNA microarray to identify the molecular causes of this cardiac phenotype that revealed the dysregulation of several microRNAs including miR-301a, which was highly downregulated in Cs1-ko mice compared to the wild-type littermates.",
        "Similarly, knockdown of miR301a activated, whereas, its overexpression inhibited the SRF-RE driven luciferase activity, further strengthening physiological interaction between miR-301a and Cfl2.",
        "Calsarcin-1 deficient mice develop dilated cardiomyopathy (DCM) phenotype in pure C57BL/6 genetic background (Cs1-ko) despite severe contractile dysfunction and robust activation of fetal gene program.",
        "Along these lines, Cfl2 was significantly upregulated in Cs1-ko mice, indicating the physiological association between miR-301a and Cfl2 in vivo."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25373779": [
        "The results suggest that cofilin-2 evolved specific biochemical and cellular properties that allow it to control actin dynamics in sarcomeres, where filament pointed ends may contain a mixture of ADP- and ATP/ADP-Pi-actin subunits.",
        "Mammals express several ADF/cofilin isoforms, but their specific biochemical activities and cellular functions have not been studied in detail.",
        "Our findings also offer a rationale for why cofilin-2 mutations in humans lead to myopathies.",
        "In contrast to other isoforms, cofilin-2 efficiently binds and disassembles both ADP- and ATP/ADP-Pi-actin filaments.",
        "Here, we demonstrate that the muscle-specific isoform cofilin-2 promotes actin filament disassembly in sarcomeres to control the precise length of thin filaments in the contractile apparatus.",
        "ADF/cofilins drive cytoskeletal dynamics by promoting the disassembly of \"aged\" ADP-actin filaments.",
        "We mapped surface-exposed cofilin-2-specific residues required for ATP-actin binding and propose that these residues function as an \"actin nucleotide-state sensor\" among ADF/cofilins."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28898511": [
        "We discuss our results in respect to the GvpA structure and data available from solid-state NMR.",
        "An in-silico 3D-model of GvpA of the predicted coil-\u03b11-\u03b21-\u03b22-\u03b12-coil structure is available and implies that the two \u03b2-chains constitute the hydrophobic interior surface of the gas vesicle wall.",
        "Gas vesicles are proteinaceous, gas-filled nanostructures produced by some bacteria and archaea.",
        "A replacement of residues near the \u03b2-turn altered the spindle-shape to a cylindrical morphology of the gas vesicles.",
        "To test the importance of individual amino acids in GvpA we performed 85 single substitutions and analyzed these variants in Haloferax volcanii \u0394A + A<sub>mut</sub> transformants for their ability to form gas vesicles (Vac<sup>+</sup> phenotype).",
        "In helix \u03b12, only the alanine substitution of His53 or Tyr54, led to Vac<sup>-</sup> transformants, whereas most other substitutions had no effect.",
        "Vac<sup>-</sup> transformants were also obtained with alanine substitutions of charged residues of helix \u03b11 suggesting that these amino acids form salt-bridges with another GvpA monomer.",
        "The hydrophobic major structural protein GvpA forms the ribbed gas vesicle wall.",
        "In most cases, an alanine substitution of a non-polar residue did not abolish gas vesicle formation, but the replacement of single non-polar by charged residues in \u03b21 or \u03b22 resulted in Vac<sup>-</sup> transformants."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25648404": [
        "The applications of gas vesicles include their use as an antigen presenter for viral or pathogen proteins, but also as a stable ultrasonic reporter for biomedical purposes.",
        "Halophilic Archaea (Haloarchaea) thrive in salterns containing sodium chloride concentrations up to saturation.",
        "Except for GvpI and GvpH, all of these are required to form the gas permeable wall.",
        "The gas vesicle wall is solely formed of proteins with the two major components, GvpA and GvpC, and seven additional accessory proteins are also involved.",
        "Their synthesis depends on environmental factors, such as light, oxygen supply, temperature and salt concentration.",
        "Fourteen gas vesicle protein (gvp) genes are involved in their formation, and regulation of gvp gene expression occurs at the level of transcription, including the two regulatory proteins, GvpD and GvpE, but also at the level of translation.",
        "Gas vesicles increase the buoyancy of cells and enable them to migrate vertically in the water body to regions with optimal conditions.",
        "Many Haloarchaea possess genes encoding gas vesicles, but only a few species, such as Halobacterium salinarum and Haloferax mediterranei, produce these gas-filled, proteinaceous nanocompartments."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22941504": [
        "The wall of these gas vesicles is freely permeable to gas molecules and is composed of a small hydrophobic protein, GvpA, which forms a single-layer wall.",
        "A range of bacteria and archaea produce intracellular gas-filled proteinaceous structures that function as flotation devices in order to maintain a suitable depth in the aqueous environment.",
        "I also discuss the function of these vesicles and the initial attempts to exploit them for biotechnological purposes.",
        "In different organisms, 8-14 genes encoding gas vesicle proteins have been identified, and their expression has been shown to be regulated by environmental factors.",
        "In this Review, I describe the basic properties of gas vesicles, the genes that encode them and how their production is regulated.",
        "In addition, several minor structural, accessory or regulatory proteins are required for gas vesicle formation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9094221": [
        "The formation of halobacterial gas vesicles occurs along a complex pathway involving 14 different gvp genes that are clustered in a genomic region termed the \"vac region\".",
        "Various vac regions found in Halobacterium salinarum (p-vac and c-vac), Haloferax mediterranei (mc-vac), and Natronobacterium vacuolatum (nv-vac) have been investigated.",
        "Single gvp genes have been mutated to study the effect on gas vesicle synthesis in transformants and to determine their possible function.",
        "Gas vesicles are intracellular, microbial flotation devices that consist of mainly one protein, GvpA.",
        "Except for the latter vac region, the arrangement of the gvp genes is identical.",
        "Each vac region exhibits a characteristic transcription pattern, and regulatory steps have been observed at the DNA, RNA, and protein level, indicating a complex regulatory network acting during gas vesicle gene expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22580065": [
        "The highest ranked predictions exhibited an \u03b1-\u03b2-\u03b2-\u03b1 secondary structure in agreement with earlier experimental findings, as well as with our own secondary structure predictions.",
        "PCC 7601, was also predicted, which reproduced the major features of our GvpA model, supporting the expectation that homologous GvpA sequences synthesized by different organisms should exhibit similar structures.",
        "Thus, alternate approaches were used to model its tertiary structure.",
        "NRC-1, we performed ab initio modeling and threading to acquire a multitude of structure decoys, which were equilibrated and ranked using molecular dynamics and mechanics, respectively.",
        "Moreover, GvpA has extremely low similarity with any known protein structure, which renders homology modeling methods ineffective.",
        "Finally, the GvpA structure for two representative organisms, Anabaena flos-aquae and Calothrix sp.",
        "Elucidating this protein's structure has been challenging due to its adherent and aggregative nature, which has so far precluded in-depth biochemical analyses.",
        "This work combines state-of-the-art computational methods to develop a model for the major gas vesicle protein, GvpA, and explore its structure within the assembled vesicle.",
        "The structure and assembly process of gas vesicles have received significant attention in recent decades, although relatively little is still known.",
        "Afterwards, GvpA subunits were docked in a quasi-periodic arrangement to investigate the assembly of the vesicle wall and to conduct simulations of contact-mode atomic force microscopy imaging, which allowed us to reconcile the structure predictions with the available experimental data.",
        "Starting with the sequence from haloarchaeon Halobacterium sp."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/1282192": [
        "A series of deletions introduced into the gvp gene cluster of Haloferax mediterranei, comprising 14 genes involved in gas vesicle synthesis (mc-vac-region), was investigated by transformation experiments.",
        "None of these transformants containing deletion constructs assembled the GvpA protein into gas vesicles.",
        "In contrast, transformants containing a construct carrying a 918 bp deletion internal to gvpD exhibited a tremendous gas vesicle overproduction, suggesting a regulatory role for the gvpD gene or its product.",
        "This is the first assignment of a functional role for one of the 13 halobacterial gvp genes found in addition to gvpA that are involved in the synthesis of this unique structure.",
        "Whereas transformants containing the entire mc-vac-region produced gas vesicles (Vac+), various deletions in the region 5' to gvpA (encompassing gvpD-gvpM) or 3' to gvpA (containing gvpC, gvpN and gvpO) revealed Vac- transformants.",
        "All these transformants expressed gvpA and contained the 8 kDa GvpA protein as shown by Western analysis.",
        "However, transformants containing the gvpA gene by itself indicated a lower level of GvpA than observed with each of the other transformants.",
        "Gas vesicle production and the expression of the gvpA gene encoding the major gas vesicle protein, GvpA, was monitored in each Haloferax volcanii transformant."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/7683649": [
        "These genes are transcribed from a common promoter located upstream of gvpA.",
        "The majority of the mRNA formed terminates 64 base pairs downstream of gvpA at the cytosine of the sequence 5' TTTTTC 3'.",
        "In samples containing isolated gas vesicles, mainly partially disaggregated gas vesicle fragments hybridize, but a minor amount of monomeric GvpA is also seen.",
        "By Western analysis, GvpC is also detectable in samples containing isolated gas vesicles demonstrating that GvpC is a second, but minor, gas vesicle structural protein.",
        "The expression of part of this region, encompassing the genes gvpA, gvpC, gvpN, and gvpO was investigated.",
        "For the detection of the GvpC protein, two versions of the gvpC gene (full length and gvp delta C lacking the 3' part encoding the acidic C terminus) were expressed in E. coli, and the resulting proteins were purified.",
        "Gas vesicle synthesis in Haloferax mediterranei involves several gene products encoded by a 9.4-kilobase pair DNA region (mc-vac region) that contains 13 genes in addition to gvpA encoding the major structural gas vesicle protein.",
        "An antiserum raised against isolated gas vesicles of Hf. mediterranei detects, in addition to gas vesicle fragments, the GvpA protein of the M(r) of approximately 8,000 in lysates derived from different halobacteria or from Escherichia coli expressing gvpA.",
        "The synthesis of the GvpA and GvpC proteins was investigated by Western analyses.",
        "Transcripts of 0.34 (gvpA only), 1.8 (gvpA/C), 2.4 (gvpA/C/N) and 3 kilobases (gvpA/C/N/O) were observed, with the gvpA transcript being the predominant mRNA species.",
        "The two antisera raised against these GvpC versions indicate the expression of gvpC in different halobacteria."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29075937": [
        "The purpose of the present study was to determine to what extent it is possible to improve the effectiveness of operation of sensorimotor rhythm-based brain-computer interfaces (SMR-BCI) by supplementing user training with elements modifying the characteristics of visual feedback.",
        "The use of neurofeedback training is a popular method of improving the effectiveness BCI operation.",
        "In Group 1 a schematic image a face, placed on the controlled object, showed various emotions, depending on the accuracy of control.",
        "Training consisted of a series of trials where the subjects directed a ball into a basket located to the right or left side of the screen.",
        "The challenges of research into brain-computer interfaces (BCI) include significant individual differences in learning pace and in the effective operation of BCI devices.",
        "SMR activity during the task was recorded before and after the training.",
        "In Group 3 there was a significant improvement in SMR control, compared to subjects in Group 2 and 4 (control).",
        "Subjects with the greatest improvement in SMR control showed a significantly lower difference in the accuracy of rightward and leftward movement than others.",
        "This means that relatively small changes in the training procedure may significantly impact the effectiveness of BCI control.",
        "Both modifications were also used simultaneously in Group 3.",
        "In Group 2, the cue and targets were flashed with different frequency (4 Hz) than the remaining elements visible on the monitor.",
        "Four experimental groups had training designed to reinforce BCI control by: visual feedback in the form of dummy faces expressing emotions (Group 1); flashing the principal elements of visual feedback (Group 2) and giving both visual feedbacks in one condition (Group 3).",
        "Differences between subjects in Groups 1, 2 and 4 (control) were insignificant.",
        "Analysis of behavioural data acquired from all participants at training showed greater effectiveness in directing the object towards the right side of the screen.",
        "The fourth group participated in training with no modifications (Group 4)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30063219": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Brain-computer interface (BCI) technology is attracting increasing interest as a tool for enhancing recovery of motor function after stroke, yet the optimal way to apply this technology is unknown.",
        "Here, we studied the immediate and therapeutic effects of BCI-based training to control pre-movement sensorimotor rhythm (SMR) amplitude on robot-assisted finger extension in people with stroke."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26891350": [
        "Finally, we propose valid developments to move a step forward to the applicability of the promising co-adaptive methods.",
        "Anyway, we still found about 22% of users with performance significantly lower than the threshold of efficient BCI control at the end of the session.",
        "BCI performances could be significantly predicted by the neurophysiological indicator, consolidating the validity of the model previously developed.",
        "In this study we evaluated for the first time a fully automatic co-adaptive BCI system on a large scale.",
        "In the last years Brain Computer Interface (BCI) technology has benefited from the development of sophisticated machine leaning methods that let the user operate the BCI after a few trials of calibration.",
        "Different psychological interventions were performed prior the BCI session in order to investigate how motor coordination training and relaxation could influence BCI performance.",
        "Results show that high accuracies in operating the BCI could be reached by the majority of the participants before the end of the session.",
        "Being the inter-subject variability still the major problem of BCI technology, we pointed out crucial issues for those who did not achieve sufficient control.",
        "Especially for BCIs based on the modulation of the Sensorimotor Rhythm (SMR) these improvements are essential, since a not negligible percentage of users is unable to operate SMR-BCIs efficiently.",
        "One remarkable example is the recent development of co-adaptive techniques that proved to extend the use of BCIs also to people not able to achieve successful control with the standard BCI procedure.",
        "A pool of 168 participants naive to BCIs operated the co-adaptive SMR-BCI in one single session.",
        "A neurophysiological indicator based on the Power Spectral Density (PSD) was extracted by the recording of few minutes of resting state brain activity and tested as predictor of BCI performances."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30414824": [
        "Third, the main findings regarding BCI/neurofeedback efficiency in patients with hypokinetic activities (in particular, motor deficit following stroke) as well as in patients with hyperkinetic activities (in particular, Attention Deficit Hyperactivity Disorder, ADHD) will be introduced.",
        "Due to a range of limitations, a clear association between SMR BCI/neurofeedback training and enhanced motor skills has yet to be established.",
        "Many Brain Computer Interface (BCI) and neurofeedback studies have investigated the impact of sensorimotor rhythm (SMR) self-regulation training procedures on motor skills enhancement in healthy subjects and patients with motor disabilities.",
        "This critical review aims first to introduce the different definitions of SMR EEG target in BCI/Neurofeedback studies and to summarize the background from neurophysiological and neuroplasticity studies that led to SMR being considered as reliable and valid EEG targets to improve motor skills through BCI/neurofeedback procedures.",
        "The second objective of this review is to introduce the main findings regarding SMR BCI/neurofeedback in healthy subjects.",
        "However, SMR BCI/neurofeedback appears promising, and highlights many important challenges for clinical neurophysiology with regards to therapeutic approaches using BCI/neurofeedback."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25147518": [
        "In more than 50% of the participants, the prediction error was smaller than 10%.",
        "The purpose of the current study was to replicate these results thereby validating these predictors within a neurofeedback based SMR-BCI that involved no machine learning.Thirty-three healthy BCI novices participated in a calibration session and three further neurofeedback training sessions.",
        "Modulation of sensorimotor rhythms (SMR) was suggested as a control signal for brain-computer interfaces (BCI).",
        "Nevertheless, on the basis of our prior regression model for sensorimotor control ability we could predict current SMR-BCI performance with an average prediction error of M = 12.07%.",
        "Hence, psychological variables played a moderate role in predicting SMR-BCI performance in a neurofeedback approach that involved no machine learning.",
        "Yet, there is a population of users estimated between 10 to 50% not able to achieve reliable control and only about 20% of users achieve high (80-100%) performance.",
        "In a linear regression they accounted for almost 20% in variance of SMR-BCI performance, but predictor (1) failed significance.",
        "Future studies are needed to further consolidate (or reject) the present predictors.",
        "In a recent study, we predicted SMR-BCI performance from psychological variables that were assessed prior to the BCI sessions and BCI control was supported with machine-learning techniques.",
        "Two variables were related with mean SMR-BCI performance: (1) a measure for the accuracy of fine motor skills, i.e., a trade for a person's visuo-motor control ability; and (2) subject's \"attentional impulsivity\".",
        "We described two significant psychological predictors, namely the visuo-motor coordination ability and the ability to concentrate on the task.",
        "Predicting performance prior to BCI use would facilitate selection of the most feasible system for an individual, thus constitute a practical benefit for the user, and increase our knowledge about the correlates of BCI control."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26736445": [
        "To maximize SMR discrimination, the method of filter-bank common spatial patterns (fbCSP) and Random Forest (RF) classifier were combined.",
        "We recently introduced a two class motor imagery BCI system which continuously adapted with increasing run-time to the brain patterns of the user.",
        "This can be exhausting and fatiguing for the user as data collection may be monotonous and typically without any feedback for user motivation.",
        "Therefore, we consider this system the next step towards fully auto-calibrating motor imagery BCIs.",
        "The aim of the current work was to improve user-specific online adaptation, which was expected to lead to higher performances.",
        "Hence new ways to reduce user training and improve performance are needed.",
        "In a supporting online study, all volunteers performed significantly better than chance.",
        "Overall peak accuracy of 88.6 \u00b1 6.1 (SD) % was reached, which significantly exceeded the performance of our previous system by 13%.",
        "Sensorimotor rhythm (SMR) based Brain-Computer Interfaces (BCI) typically require lengthy user training.",
        "The system was designed to provide visual feedback to the user after just five minutes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/21436515": [
        "Here, we use a similar approach and investigate to what extent co-adaptive learning enables significant BCI control for completely novice users, as well as for those who could not achieve control with a conventional SMR-based BCI.",
        "All brain-computer interface (BCI) groups that have published results of studies involving a large number of users performing BCI control based on the voluntary modulation of sensorimotor rhythms (SMR) report that BCI control could not be achieved by a non-negligible number of subjects (estimated 20% to 25%).",
        "This failure of the BCI system to read the intention of the user is one of the greatest problems and challenges in BCI research.",
        "Previously, we introduced the concept of machine learning based co-adaptive calibration, which provided substantially improved performance for a variety of users.",
        "There are two main causes for this problem in SMR-based BCI systems: either no idle SMR is observed over motor areas of the user, or this idle rhythm is not modulated during motor imagery, resulting in a classification performance lower than 70% (criterion level) that renders the control of a BCI application (like a speller) difficult or impossible."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24080080": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Connect-Four, a new sensorimotor rhythm (SMR) based brain-computer interface (BCI) gaming application, was evaluated by four severely motor restricted end-users; two were in the locked-in state and had unreliable eye-movement."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24835634": [
        "Nevertheless, the effect of this training procedure on the cortical activity related to the mental imagery ability still requires investigation to be fully elucidated.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      It is well known that to acquire sensorimotor (SMR)-based brain-computer interface (BCI) control requires a training period before users can achieve their best possible performances.",
        "The aim of this study was to gain insights into the effects of SMR-based BCI training on the cortical spectral activity associated with the performance of different mental imagery tasks."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27532209": [
        "The results suggest metabolic coordination between Myc and RhoA/SRF in sustaining cancer cell viability and indicate RhoA/SRF as a potential vulnerability in cancer cells for therapeutic targeting.",
        "Interestingy, loss of RhoA is synthetic lethal with oncogenic Myc, a master transcription factor that turns on anabolic metabolism to promote cell growth in many cancers.",
        "We show evidence indicating that the synthetic lethal interaction between RhoA loss and Myc arises from deficiency in glutamine utilization, resulting from impaired co-regulation of glutaminase expression and anaplerosis by Myc and RhoA - serum response factor (SRF) pathway.",
        "RhoA regulates actin cytoskeleton but recent evidence suggest a role for this conserved Rho GTPase also in other cellular processes, including transcriptional control of cell proliferation and survival."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27880072": [
        "The complex signaling network engaged by oncogenic KRAS and its modulation by EGFR signaling, remains incompletely understood.",
        "In order to study early signaling events activated by oncogenic KRAS in the pancreas, we recently developed a novel model system based on murine primary pancreatic epithelial cells enabling the time-specific expression of mutant Kras<sup>G12D</sup> from its endogenous promoter.",
        "Here, we discuss our findings of a Kras<sup>G12D</sup>-induced autocrine EGFR loop, how this loop is integrated by the MYC oncogene, and point to possible translational implications.",
        "EGFR signaling has a critical role in oncogenic KRAS-driven tumorigenesis of the pancreas, whereas it is dispensable in other organs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28430012": [
        "The ERG expression was suppressed by miR-96 which was increased by GM-CSF through the phosphoinositide-3 kinase (PI3K)/Akt pathway.",
        "We previously reported that in Alzheimer's disease patients, a high level of GM-CSF in the brain parenchyma downregulated expression of ZO-1, a blood-brain barrier tight junction protein, and facilitated the infiltration of peripheral monocytes across the blood-brain barrier.",
        "Inhibition of miR-96 prevented ZO-1 down-regulation induced by GM-CSF both in vitro and in vivo.",
        "Our results revealed the mechanism of ZO-1 expression reduced by GM-CSF, and provided a potential target, miR-96, which could block ZO-1 down-regulation caused by GM-CSF in BMECs.",
        "However, the molecular mechanism underlying regulation of ZO-1 expression by GM-CSF is unclear.",
        "The level of granulocyte-macrophage colony-stimulating factor (GM-CSF) increases in some disorders such as vascular dementia, Alzheimer's disease, and multiple sclerosis.",
        "Herein, we found that the erythroblast transformation-specific (ETS) transcription factor ERG cooperated with the proto-oncogene protein c-MYC in regulation of ZO-1 transcription in brain microvascular endothelial cells (BMECs)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28833404": [
        "Ascochlorin promoted the G1 arrest, upregulated p53 and p21<sup>WAF1/CIP1</sup> , and downregulated c-Myc in HCT116 cells.",
        "The ERK inhibitor PD98059 and siRNA-mediated ERK silencing induced G1 arrest and p21<sup>WAF1/CIP1</sup> expression by downregulating c-Myc in p53-deficient cells.",
        "Numerous anti-cancer agents inhibit cell cycle progression via a p53-dependent mechanism; however, other genes such as the proto-oncogene c-Myc are promising targets for anticancer therapy.",
        "In the present study, we provide evidence that ascochlorin, an isoprenoid antibiotic, is a non-toxic anti-cancer agent that induces G1 cell cycle arrest and p21<sup>WAF1/CIP1</sup> expression by downregulating of c-Myc protein expression.",
        "Small interfering RNA (siRNA) mediated c-Myc silencing indicated that the transcriptional repression of c-Myc was related to ascochlorin-mediated modulation of p21<sup>WAF1/CIP1</sup> expression.",
        "Thus, we reveal a role for ascochlorin in inhibiting tumor growth via G1 arrest, and identify a novel regulatory mechanism for ERK/c-Myc.",
        "In p53-deficient cells, ascochlorin enhanced the expression of G1 arrest-related genes except p53.",
        "These results indicated that ascochlorin-induced G1 arrest is associated with the repression of ERK phosphorylation and c-Myc expression.",
        "Ascochlorin suppressed the stabilization of the c-Myc protein by inhibiting ERK and P70S6K/4EBP1 phosphorylation, whereas it had no effect on c-Myc degradation mediated by PI3K/Akt/GSK3\u03b2."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29583030": [
        "We outline open questions regarding the biology of SAMHD1 whose answers will be important for understanding its function as a regulator of cell cycle progression, genomic integrity, and in autoimmunity.",
        "Its emerging role as an effector of innate immunity is affirmed by mutations in the SAMHD1 gene that cause the severe autoimmune disease, Aicardi-Goutieres syndrome (AGS) and that are linked to cancer.",
        "Sterile alpha motif and histidine-aspartic acid domain-containing protein 1 (SAMHD1) is a deoxynucleotide triphosphate (dNTP) hydrolase that plays an important role in the homeostatic balance of cellular dNTPs.",
        "Here, we review the current biochemical and biological properties of the enzyme including its structure, activity, and regulation by post-translational modifications in the context of its cellular function.",
        "Additionally, SAMHD1 functions as a restriction factor for retroviruses, such as HIV."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29187402": [
        "The RING domain of RING1 was required for its E3 Ub ligase activity.",
        "However, the contributions of RING1 to cancer etiology or development are unknown.",
        "In this study, we report that RING1 is a critical negative regulator of p53 homeostasis in human hepatocellular and colorectal carcinomas.",
        "Its growth inhibitory effect was partially rescued by p53 silencing, suggesting an important role for the RING1-p53 complex in human cancer.",
        "Collectively, our results elucidate a novel PRC1-independent function of RING1 and provide a mechanistic rationale for its candidacy as a new prognostic marker and/or therapeutic target in human cancer.<b>Significance:</b> These results elucidate a novel PRC1-independent function of RING1 and provide a mechanistic rationale for its candidacy as a new prognostic marker and/or therapeutic target in human cancer. <i>Cancer Res; 78(2); 359-71. \u00a92017 AACR</i>.",
        "In clinical specimens of hepatocellular carcinoma, RING1 upregulation was evident in association with poor clinical outcomes.",
        "RING1 acts as an E3 ubiquitin (Ub) ligase to directly interact with and ubiquitinate p53, resulting in its proteasome-dependent degradation.",
        "RING1 depletion inhibited the proliferation and survival of the p53 wild-type cancer cells by inducing cell-cycle arrest, apoptosis, and senescence, with only modest effects on p53-deficient cells.",
        "As a component of the transcriptional repression complex 1 (PRC1), the ring finger protein RING1 participates in the epigenetic regulation in cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29107100": [
        "Taken together, these results indicate that the TRIM49 protein plays a role in autophagic protein degradation independently of an ubiquitin E3 ligase activity.",
        "Autophagy is the process of degradation of intracellular proteins through the lysosome.",
        "Members of the tripartite motif (TRIM) proteins have shown to directly recognize autophagic cargo and also to act as a hub for the phagophore nucleation complex.",
        "Although regarded as ubiquitin E3 ligases, this activity has been shown only for a minor set of the 79 human TRIM proteins.",
        "However, cells transfected with the wild-type or mutant protein showed increased levels of lower mass polyubiquitinated proteins and both proteins copurified with polyubiquitinated proteins.",
        "The TRIM proteins are classically characterized by the presence of an amino-terminal RING domain and a B-box domain followed by a coiled coil domain.",
        "Wild-type and mutant constructs of tagged TRIM49 were expressed in E. coli or mammalian cells, and the autoubiquitination activity of the purified protein was assessed.",
        "We investigated the role of the SPRY and RING domains of the human TRIM49 protein in its E3 ubiquitin ligase activity.",
        "The purified TRIM49 showed no ubiquitin E3 ligase activity in vitro.",
        "Additionally, the role of each domain in the E3 ligase activity is unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29432170": [
        "Tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) plays a vital role in immune signal transduction pathways by acting as a ubiquitin ligase (E3) for Lys63-linked polyubiquitin chain synthesis.",
        "In particular, we reveal the importance of the C-terminal extension of the TRAF6 RING domain that mediates <i>trans</i>-interactions with the donor-Ub.",
        "Through structural modeling and biochemical analysis, we here show that the TRAF6 RING dimer employs a concerted allosteric mechanism using both subunits of the TRAF6 dimer to promote ubiquitin (Ub) transfer.",
        "By analyzing structures and models of E3s in complex with Ub-loaded ubiquitin-conjugating enzymes (E2s), we further highlight the roles of N-terminal and C-terminal extensions beyond the bona fide RING domains in promoting Ub transfer through engagement with a donor-Ub in <i>cis</i> and <i>in trans</i>, respectively.",
        "However, the detailed mechanism by which the TRAF6 RING dimer promotes ubiquitin transfer was unknown."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29324855": [
        "Here we describe a new family of E3 ligases that encodes a RING-H2 domain related in sequence to the ATL and BTL RING-H2 domains.",
        "Basal animal and vertebrate, as well as fungi species, encode a single CTL gene that constraints the number of paralogs observed in vertebrates.",
        "Our analysis describes key structural features of a novel family of E3 ubiquitin ligases as an integral component of the set of core eukaryotic genes.",
        "E3 ubiquitin ligase BIG BROTHER is a plant CTL that regulates organ size, and SUMO-targeted ubiquitin E3 ligase RNF111/ARKADIA is a vertebrate CTL.",
        "Conversely, as previously described in ATL and BTL families in plants, CTL genes range from a single copy in green algae and 3 to 5 copies in basal species to 9 to 35 copies in angiosperms.",
        "RING ubiquitin E3 ligases enclose a RING domain for ubiquitin ligase activity and associated domains and/or conserved motifs outside the RING domain that collectively facilitate their classification and usually reveal some of key information related to mechanism of action.",
        "This family, named CTL, encodes a motif designed as YEELL that expands 21 amino acids next to the RING-H2 domain that is present across most eukaryotic lineages."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29471350": [
        "We provide evidence that UHRF1 N-terminal ubiquitin-like domain (UBL) also binds directly to DNMT1.",
        "UHRF1 plays multiple roles in regulating DNMT1-mediated DNA methylation maintenance during DNA replication.",
        "Collectively, our study adds another layer of complexity to the regulatory mechanism of DNMT1 activation by UHRF1 and supports that individual domains of UHRF1 participate and act in concert to maintain DNA methylation patterns.",
        "The UHRF1 C-terminal RING finger functions as an ubiquitin E3 ligase to establish histone H3 ubiquitination at Lys18 and/or Lys23, which is subsequently recognized by DNMT1 to promote its localization onto replication foci.",
        "We further show that the UHRF1 UBL-mediated interaction between UHRF1 and DNMT1, and the binding of DNMT1 to ubiquitinated histone H3 that is catalyzed by UHRF1 RING domain are critical for the proper subnuclear localization of DNMT1 and maintenance of DNA methylation.",
        "Despite sharing a high degree of structural similarity, UHRF1 UBL and ubiquitin bind to DNMT1 in a very distinct fashion and exert different impacts on DNMT1 enzymatic activity.",
        "Here, we present the crystal structure of DNMT1 RFTS domain in complex with ubiquitin and highlight a unique ubiquitin binding mode for the RFTS domain."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29295817": [
        "The tumor suppressor p53 plays a prominent role in the protection against cancer.",
        "Here, we show that MARCH7, a RING domain-containing ubiquitin E3 ligase, physically interacts with Mdm2 and is essential for maintaining the stability of Mdm2.",
        "MARCH7 catalyzes Lys<sup>63</sup>-linked polyubiquitination of Mdm2, which impedes Mdm2 autoubiquitination and degradation, thereby leading to the stabilization of Mdm2.",
        "MARCH7 also promotes Mdm2-dependent polyubiquitination and degradation of p53.",
        "The activity of p53 is mainly controlled by the ubiquitin E3 ligase Mdm2, which targets p53 for proteasomal degradation.",
        "Furthermore, MARCH7 is able to regulate cell proliferation, DNA damage-induced apoptosis, and tumorigenesis via a p53-dependent mechanism.",
        "However, the regulation of Mdm2 remains not well understood.",
        "These findings uncover a novel mechanism for the regulation of Mdm2 and reveal MARCH7 as an important regulator of the Mdm2-p53 pathway."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29320607": [
        "In tomato (Solanum lycopersicum), the SINA gene family has six members, and we characterize in this study all tomato SINA (SlSINA) genes and the gene products.",
        "Seven in absentia (SINA) protein is one subgroup of ubiquitin ligases possessing an N-terminal cysteine-rich really interesting new gene (RING) domain, two zinc-finger motifs, and a C-terminal domain responsible for substrate-binding and dimerization.",
        "Moreover, all SlSINAs can interact with each other for homo- or hetero-dimerization.",
        "The functionality of SlSINA proteins has been investigated.",
        "SlSINA4 plays a positive role in defense signalling, as manifested by elicitation of E3-dependent hypersensitive response-like cell death; the other SlSINAs are negative regulator and capable to suppress hypersensitive response cell death.",
        "SlSINA1/3/4/5/6 are localized in both cytoplasm and nucleus, whereas SlSINA2 is exclusively localized in the nucleus.",
        "Transgenic tomato plants overexpressing SlSINA2 exhibit pale-green leaf phenotype, suggesting SlSINA2 regulates chlorophyll level in plant cells, whereas transgenic tomato plants overexpressing SlSINA5 have altered floral structure with exserted stigma, implicating SlSINA5 plays a role in flower development.",
        "Our results show that SlSINA genes are differentially regulated in leaf, bud, stem, flower, and root.",
        "All SlSINA proteins possess RING-dependent E3 ubiquitin ligase activity, exhibiting similar specificity towards the E2 ubiquitin-conjugating enzyme."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29367421": [
        "Each of these mutant BARD1 proteins retained the ability to form heterodimeric complexes with BRCA1 to make an active ubiquitin ligase, but the mutant BRCA1/BARD1 complexes were deficient in binding to nucleosomes and in ubiquitylating histone H2A.",
        "The function of the BARD1 RING domain is unknown.",
        "These results indicate that an intact BARD1 RING domain is critical to BRCA1/BARD1 binding to nucleosomes and hence to ubiquitylation of histone H2A and also critical to transcriptional repression of BRCA1-regulated genes active in estrogen metabolism.",
        "The BARD1 mutations also caused loss of transcriptional repression of BRCA1-regulated estrogen metabolism genes <i>CYP1A1</i> and <i>CYP3A4</i>; breast epithelial cells edited to create heterozygous loss of <i>BARD1</i> showed significantly higher expression of <i>CYP1A1</i> and <i>CYP3A4</i> Reintroduction of wild-type <i>BARD1</i> into these cells restored <i>CYP1A1</i> and <i>CYP3A4</i> transcription to normal levels, but introduction of the cancer-predisposing <i>BARD1</i> RING mutants failed to do so.",
        "In families severely affected with breast cancer, we identified inherited BARD1 missense mutations Cys53Trp, Cys71Tyr, and Cys83Arg that alter three zinc-binding residues of the BARD1 RING domain.",
        "The BRCA1 RING domain is a ubiquitin ligase, whose structure and function rely critically on forming a heterodimer with BARD1, which also harbors a RING domain.",
        "Missense mutations that disrupt the RING domain of the tumor suppressor gene <i>BRCA1</i> lead to increased risk of breast and ovarian cancer."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22442717": [
        "Human FAAH gene mutations are associated with increased body weight and obesity.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      FAAH (fatty acid amide hydrolase), primarily expressed in the liver, hydrolyzes the endocannabinoids fatty acid ethanolamides (FAA).",
        "In our present study, using targeted metabolite and lipid profiling, and new global acetylome profiling methodologies, we examined the role of the liver on fuel and energy homeostasis in whole body FAAH(-/-) mice."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22912404": [
        "Infusion of NAEs (anandamide and palmitoylethanolamide) recapitulated increases in PPAR\u03b3-mediated decreases in EE.",
        "Fatty acid amide hydrolase (FAAH) knockout mice are prone to excess energy storage and adiposity, whereas mutations in FAAH are associated with obesity in humans.",
        "Our data indicate that FAAH deletion, and the resulting increases in NAEs, predispose mice to ectopic lipid storage and hepatic insulin resistance by promoting centrally mediated hypothyroidism.",
        "However, the molecular mechanism by which FAAH affects energy expenditure (EE) remains unknown.",
        "FAAH(-/-) mice were also prone to diet-induced hepatic insulin resistance, which could be attributed to increased hepatic diacylglycerol content and protein kinase C\u03b5 activation.",
        "Here we show that reduced energy expenditure in FAAH(-/-) mice could be attributed to decreased circulating triiodothyronine and thyroxine concentrations secondary to reduced mRNA expression of both pituitary thyroid-stimulating hormone and hypothalamic thyrotropin-releasing hormone.",
        "These reductions in the hypothalamic-pituitary-thyroid axis were associated with activation of hypothalamic peroxisome proliferating-activated receptor \u03b3 (PPAR\u03b3), and increased hypothalamic deiodinase 2 expression."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12060782": [
        "Nonetheless, the precise identities of human genes that confer vulnerability to problem drug use remain mostly unknown.",
        "Here, we describe a natural single nucleotide polymorphism in the human gene that encodes the principal endocannabinoid-inactivating enzyme, fatty acid amide hydrolase (FAAH), that in homozygous form is strongly associated with both street drug use and problem drug/alcohol use.",
        "Collectively, these results suggest that genetic mutations in FAAH may constitute important risk factors for problem drug use and support a potential link between functional abnormalities in the endogenous cannabinoid system and drug abuse and dependence.",
        "This single nucleotide polymorphism results in a missense mutation (385C--&gt;A) that converts a conserved proline residue to threonine (Pro129--&gt;Thr), producing a FAAH variant that displays normal catalytic properties but an enhanced sensitivity to proteolytic degradation.",
        "Although environmental factors contribute to drug abuse and addiction, genetic factors also play a significant role estimated at 40-60% of the total risk.",
        "Problem drug use and dependence are neurobehavioral disorders of complex origin."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20098695": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Obesity is a worldwide epidemic, and severe obesity is a risk factor for many diseases, including diabetes, heart disease, stroke, and some cancers.",
        "Endocannabinoid system (ECS) signaling in the brain and peripheral tissues is activated in obesity and plays a role in the regulation of body weight.",
        "The main research question here was whether quantitative measurement of plasma endocannabinoids, anandamide, and related N-acylethanolamines (NAEs), combined with genotyping for mutations in fatty acid amide hydrolase (FAAH) would identify circulating biomarkers of ECS activation in severe obesity."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29150834": [
        "Here we show that the level of anti-IL17A autoantibodies that develop in aged Aire-deficient mice is not sufficient for conferring susceptibility to oropharyngeal candidiasis.",
        "Nevertheless, the lack of macroscopically evident infectious pathology on the oral mucosa of infected mice suggests that additional susceptibility factors are needed to precipitate a clinical disease.",
        "Moreover, autoantibodies neutralizing Th17 cytokines have been related to chronic candidiasis in a rare inherited disorder called autoimmune polyendocriopathy candidiasis ectodermal dystrophy (APECED) caused by mutations in autoimmune regulator (AIRE) gene.",
        "However, the direct pathogenicity of these autoantibodies has not yet been addressed.",
        "Protection against mucocutaneous candidiasis depends on the T helper (Th)17 pathway, as gene defects affecting its integrity result in inability to clear Candida albicans infection on body surfaces.",
        "However, patient-derived monoclonal antibodies that cross-react with murine IL-22 increase the fungal burden on C. albicans infected mucosa."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29427825": [
        "The autoimmune regulator gene (AIRE) is a transcription factor expressed both in the thymus, by medullary thymic epithelial cells, and in secondary lymphoid organs.",
        "Thereafter, several studies found evidences indicating that AIRE impairment might be pathogenically involved in several autoimmune diseases and in tumorigenesis.",
        "AIRE controls the local transcription of organ- specific proteins typically expressed in peripheral tissues, thus allowing the negative selection of self- reactive T cells.",
        "In particular, we address the following issues: 1) AIRE function and mTECs biology, 2) the impact of AIRE gene mutations in autoimmune diseases, and 3) the role of AIRE gene in anti-tumor immune response.",
        "The crucial role played by AIRE in central immune tolerance emerged in the studies on the pathogenesis of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, a rare inherited polyendocrine/autoimmune disease.",
        "In this review, we focus on recent advances relative to AIRE's effect on T cell development in physiology and disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29437776": [
        "Rapid trio whole-genome sequencing revealed compound heterozygous variants in <i>AIRE</i> in the proband, with a paternally inherited, pathogenic, frameshift variant (c.1265delC; p.Pro422LeufsTer58) and a novel, likely pathogenic, maternally inherited missense variant (c.268T&gt;C; p.Tyr90His).",
        "APS-1 is classically characterized by a triad of chronic mucocutaneous candidiasis, autoimmune hypoparathyroidism, and autoimmune adrenocortical insufficiency.",
        "We report a 5-yr-old female who presented with symptoms of tetany due to hypocalcemia and was subsequently found to be secondary to hypoparathyroidism.",
        "Autoimmune polyendocrine syndrome type 1 (APS-1; OMIM #240300), also referred to as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), is a rare monogenic autoimmune disorder caused by mutations in the autoimmune regulator (<i>AIRE)</i> gene."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29666621": [
        "AIRE co-localized with Dectin-2 and Syk at the FS upon hyphal stimulation of macrophage-like THP-1 cells.",
        "Autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a primary immunodeficiency caused by mutations in the autoimmune regulator gene (<i>AIRE</i>).",
        "We previously demonstrated that cytoplasmic AIRE regulates the Syk-dependent Dectin-1 pathway.",
        "Our results suggest that AIRE modulates the FS formation and hyphal recognition and help to orchestrate an effective immune response against <i>C. albicans</i>.",
        "Furthermore, IL-1\u03b2, IL-6, or TNF-\u03b1 secretion by AIRE-knockdown macrophage-like THP-1 cells and AIRE-deficient patient macrophages was decreased compared to control cells.",
        "AIRE-knockdown macrophage-like THP-1 cells exhibited less Dectin-1 and Dectin-2 receptors accumulation, decreased signaling pathway activity at the FS, lower <i>C. albicans</i> phagocytosis, and less lysosome formation.",
        "In this study, we further evaluated direct contact with fungal elements, synapse formation, and the response of macrophage-like THP-1 cells to <i>C. albicans</i> hyphae to determine the role of AIRE upon Dectin receptors function and signaling.",
        "Patients with AIRE mutations are susceptible to <i>Candida albicans</i> infection and present with autoimmune disorders.",
        "We examined the fungal synapse (FS) formation in wild-type and AIRE-knockdown THP-1 cells differentiated to macrophages, as well as monocyte-derived macrophages from APECED patients.",
        "We evaluated Dectin-2 receptor signaling, phagocytosis, and cytokine secretion upon hyphal stimulation."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28770472": [
        "Despite the marked increase in exosome production, the profiles of selected miRNA cargoes carried by the exosomes were generally similar in cells treated with the compounds.",
        "In this study we assessed the effects of MOPIPP, a novel indole-based chalcone, and vacuolin-1, a distinct triazine-based compound, on exosome production in cultured glioblastoma and 293T cells.",
        "Insofar as MOPIPP and vacuolin-1 seem able to increase the overall yield of exosomes from cultured cells, they might be useful for efforts to develop exosome-based therapeutics.",
        "Both compounds promote vacuolization of late endosome compartments and interfere with trafficking of late endosomes to lysosomes, without significant cytotoxicity.",
        "Exosomes are produced from mammalian cells when multivesicular endosomes fuse with the plasma membrane, releasing their intralumenal vesicles.",
        "The results show that vacuolated cells treated with these compounds release exosomes with morphologies similar to untreated controls.",
        "However, both compounds trigger multi-fold increases in release of exosome marker proteins (e.g., CD63, Alix) in exosome fractions collected from equivalent numbers of cells."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28819811": [
        "Trunk blood was collected 1 and 18 h after the last exercise session, and circulating EVs were obtained.",
        "In addition, the quantification of amyloid-\u03b2 (A\u03b2) levels and the oxidative status parameters, specifically reactive species content, superoxide dismutase (SOD) activity, and SOD1 content were evaluated.",
        "CD63 levels and acetylcholinesterase (AChE) activity were used as markers of exosome, a subtype of EVs.",
        "Delayed exercise effects were observed on peripheral EVs, since CD63, reactive species content, and AChE activity were altered 18 h after the last exercise session.",
        "The exercise protocol consisted in a daily moderate treadmill exercise (20 min daily during 2 weeks).",
        "Male Wistar rats of 3-, 21-, and 26-month old were allocated into exercised and sedentary groups.",
        "Aged rats showed reduced CD63 levels and increased AChE activity in circulating exosomes compared to young ones.",
        "Moreover, higher reactive species levels were found in circulating EVs of aged rats.",
        "Our results suggest that the healthy aging process can modify circulating EVs profile, and exercise-induced beneficial effects may be related to its modulation on EVs.",
        "Our aim was to investigate transitory and delayed exercise effects on serum extracellular vesicles (EVs) in aging process."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28346015": [
        "In this study, Exosomes were isolated from cerebrospinal fluid of SCI and normal, and incubated neuron in vitro respectively to research its biological function in cell proliferation.",
        "Our research showed exosomes derived from cerebrospinal fluid of SCI, they can influence neuron cell proliferation in vitro, we did not observe these characters in exosome derived from normal cerebrospinal fluid.",
        "Exosomes contain cytosolic content, including proteins, mRNAs and non-cording RNAs, and play a role in important biological function.",
        "Exosomes is a key component of cell paracrine secretion and can exert important effects in various disease models.",
        "The results demonstrated these exosomes all expressed CD9, CD63, CD81, Alix and Tsg101; however, only exosomes derived from cerebrospinal fluid of SCI could promote proliferation of neuron via ERK signaling pathway, and decrease cell apoptosis.",
        "However, the role of exosomes in neuron repair of spinal cord injury (SCI) has rarely been reported."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29404826": [
        "<strong class=\"sub-title\">\n          Purpose of review:\n        </strong>\n      \n      Acute and chronic sinusitis can give rise to a wide array of intracranial and orbital complications.",
        "Despite numerous medical advances, these complications carry a risk of mortality and significant morbidity.",
        "These complications include brain abscess, subdural empyema, epidural abscess, meningitis, venous sinus thrombosis, frontal bone osteomyelitis, and orbital cellulitis and abscess."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29682134": [
        "A computed tomography scan showed bilateral paranasal sinus disease, and magnetic resonance imaging showed a right frontal abscess and subdural empyema.",
        "He was subsequently discharged for acute rehabilitation.",
        "Neurosurgery took the patient to the operating room, performed a craniotomy, and drained a large amount of purulent fluid.",
        "A 49-year-old male was brought to the Emergency Department after being found unresponsive.",
        "The patient had multiple seizures and was intubated in the prehospital setting.",
        "Clinicians should consider complicated frontal sinusitis, especially in the undifferentiated patient presenting with neurologic deficits and signs or symptoms of sinus disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30014307": [
        "In older children, sinusitis and otitis media are usually the source for subdural empyema.",
        "It can mimic as well as complicate meningitis and aheightened clinical awareness is therefore paramount.",
        "In infants, the most common cause is bacterialmeningitis.",
        "Theclinical symptomatology is varied and has a wide range including prolonged or recurrent fever, seizures,meningeal irritation, and raised intracranial pressure.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Subdural empyema denotes the collection of purulent material in the subdural spaceand is commonly seen in infants and older children."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16777239": [
        "We undertook a review of our cases of subdural empyema and other intracranial complications of sinusitis over the past 8 years at a busy inner city hospital.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Sinusitis is a rare cause of intracranial infection in children.",
        "Our intent was to identify factors that may predispose children to these serious complications.",
        "While intracranial complications of sinusitis are rare, the morbidity and mortality remain high.",
        "Subdural empyema is recognized as the most common sinogenic intracranial complication."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29131135": [
        "Daily supervision at the primary health care center with continuous antibiotic treatment was recommended to the patient.",
        "We report the case of a 17-year-old boy who presented in a state of somnolence due to interhemispheric and infratentorial subdural empyema with preseptal cellulitis secondary to pansinusitis.",
        "Intracranial complications of paranasal sinusitis have become rare due to the use of antibiotics nowadays.",
        "Subdural empyema is a rare but potentially life-threatening complication following paranasal sinusitis and should be considered as a neurological emergency.",
        "The case was managed using a multidisciplinary approach including the ENT, eye, and nutrition departments.",
        "Early diagnosis and aggressive antibiotic treatment combined with neurosurgical operation were mandatorily implemented.",
        "The boy achieved clinical improvement, with impairment of eye movement as the only persistent symptom before discharge.",
        "Once the infection spreads over the cranial structure, it could infect the orbits, underlying bones, meninges, adjacent veins, and brain.",
        "However, several cases have been reported due the ability of paranasal sinusitis to cause serious complications.",
        "The location where subdural empyema may appear is a challenge in diagnosis and treatment.",
        "Pertinent literature with controversies in the management of subdural empyema will be briefly discussed in this case report."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9951090": [
        "Although clinical suspicion is fundamental, computed tomography and magnetic resonance imaging are essential for discovering these complications.",
        "Streptococcus milleri was isolated in one of them.",
        "Furthermore, subdural empyema usually is related to sinus infections, particularly those caused by Streptococcus milleri, an anaerobic organism.",
        "Intracranial complications of sinusitis now are unusual and subdural empyema is even more infrequent.",
        "We report two cases of subdural empyema secondary to sinusitis in persons without impaired immunity.",
        "These studies enable early diagnosis and prompt treatment, thus reducing the high mortality of this disease.",
        "A review of the literature disclosed that this is the most frequently involved organism, so the empirical selection of antibiotics targeted this organism."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12172943": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      Subdural empyema is an uncommon but serious complication of sinusitis.",
        "Despite the use of advanced imaging facilities, modern antibiotic therapy and aggressive neurosurgical protocols, this condition still carries significant morbidity and mortality."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12521560": [
        "Spinal subdural empyemas are almost invariably caused by streptococci or by S. aureus.",
        "The most common organisms in intracranial subdural empyema are anaerobic and microaerophilic streptococci, in particular those of the Streptococcus milleri group (S. milleri and Streptococcus anginosus).",
        "Conversely, occasion spinal subdural empyemas may be detected by CT myelography where MRI is negative.",
        "Because intracranial subdural empyemas may contain multiple organisms, provisional antibiotic therapy of intracranial subdural empyema, where the organism is unknown, should be directed against S. aureus, microaerophilic and anaerobic streptococci, and Gram-negative organisms.",
        "Spinal subdural empyema is rare and may result from hematogenous infection or spread of infection from osteomyelitis.",
        "Staphylococcus aureus is present in a minority of cases, and multiple additional organisms, including Gram-negative organisms, such as Escherichia coli, and anaerobic organisms, such as Bacteroides, may be present.",
        "Subdural empyema--whether it occurs in the skull or the spinal canal--may cause rapid compression of the brain or spinal cord, and represents an extreme medical and neurosurgical emergency.",
        "Subdural empyema represents loculated infection between the outermost layer of the meninges, the dura, and the arachnoid.",
        "Provisional antibiotic therapy of spinal subdural empyemas should be directed against S. aureus and streptococci, and should include nafcillin, oxacillin, or vancomycin.",
        "Both conditions should, thus, be treated with great urgency.",
        "Pseudomonas aeruginosa or Staphylococcus epidermidis may be present in cases related to neurosurgical procedures, and Salmonella species have been detected in patients with advanced AIDS; multiple organisms may be present simultaneously.",
        "The empyema may develop intracranially or in the spinal canal.",
        "Computed tomography scan may miss intracranial subdural empyemas detectable by MRI.",
        "The diagnostic procedure of choice for intracranial and spinal subdural empyema is MRI with gadolinium enhancement.",
        "Treatment in virtually all cases of intracranial or spinal subdural empyema requires prompt surgical drainage and antibiotic therapy.",
        "Antibiotics should include 1) nafcillin, oxacillin, or vancomycin; plus 2) a third generation cephalosporin; plus 3) metronidazole.",
        "Morbidity and mortality in intracranial and spinal subdural empyema relate directly to the delay in institution of therapy.",
        "Intracranial subdural empyema is most frequently a complication of sinusitis or, less frequently, otitis or neurosurgical procedures.",
        "Pus from the empyema should always be sent for anaerobic, as well as aerobic, culture."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12402493": [
        "The problem was resolved successfully using endoscopic surgery and an external approach of the sinus.",
        "Afterwards it was completed with a subdural drainage through craniotomy.",
        "We present a case of frontal sinusitis complicated with a subdural empyema, in which the identified microorganism was Gemella morbillorum, a frequent host of the aerodigestive tract and occasionally related to infections.",
        "We want to emphasize the importance of early diagnosis of intracranial complications, the need of a detailed microbiology test the method used to obtain samples, and the convenience of a combined approach by the otolaryngologists and the neurosurgeons for its complete drainage.",
        "Subdural empyema is a rare complication of sinusitis although very severe."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16462969": [
        "We report the clinical and radiological course of an adolescent with a subdural empyema secondary to sinusitis.",
        "Subdural empyema is a rare complication of sinusitis in children.",
        "Clinical and radiological features, laboratory findings and outcome of this condition are discussed based in a review of previously reported cases.",
        "Its clinical presentation represents a neurosurgical emergency and as a scarcely recognized entity a delayed diagnosis rapidly increases its fatal prognosis."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/9217340": [
        "This case illustrates the necessity of early surgical intervention to remove displaced roots in the maxillary antrum in order to prevent the serious complications of paranasal sinusitis.",
        "Subdural empyema is a rare but serious complication of paranasal sinusitis which may result in death or permanent disability in a significant proportion of cases.",
        "A case is presented in which displacement of a premolar root in the maxillary sinus led to a subdural empyema and a resultant left-sided hemiplegia."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22030191": [
        "Early and accurate diagnosis of subdural empyema will lead to prompt treatment and a favorable outcome for the patient.",
        "Intracranial complications of pediatric sinusitis are rare but potentially life threatening.",
        "Children with these complications may experience significant morbidity from their infection.",
        "Emergency physicians, pediatricians, and otolaryngologists should maintain a high index of suspicion for this complication of disease when treating patients with sinusitis in the emergency department or outpatient clinic.",
        "These complications include cavernous sinus thrombosis, orbital infection, meningitis, and subdural empyema.",
        "In such cases, delay in diagnosis and treatment may lead to severe brain damage or death.",
        "We report a case of subdural empyema secondary to frontal sinusitis in an otherwise healthy immunocompetent adolescent boy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28806018": [
        "We hope that this article will raise awareness among colleagues who can educate parents on high-alert symptoms to watch out for if the patient is discharged home after initial presentation.",
        "We report a case of a 12-year-old male patient who originally presented with clinically insignificant symptoms and later developed intracranial abscess requiring aggressive neurosurgical intervention.",
        "The intent of this paper is to raise awareness to primary care and pediatric colleagues of how a clinically insignificant appearing condition like sinusitis can lead to a major complication.",
        "Subdural empyema is a rare but life-threatening complication of paranasal sinusitis, otitis media, or mastoid disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25437686": [
        "<strong class=\"sub-title\">\n          Introduction:\n        </strong>\n      \n      We present the first case of a subdural empyema caused by Streptococcus pluranimalium, in a healthy adolescent male as a possible complication of subclinical frontal sinusitis.",
        "Clinical features, diagnostic approach and management of subdural empyema are discussed."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/17182345": [
        "We present a patient with subdural empyema in whom the diagnosis was delayed, followed by a discussion of suppurative complications of sinusitis.",
        "Suppurative intracranial infection, including meningitis, intracranial abscess, subdural empyema, epidural abscess, cavernous sinus thrombosis, and thrombosis of other dural sinuses, are uncommon sequelae of paranasal sinusitis.",
        "A high index of suspicion is necessary to identify these serious complications.",
        "The case shows the rapid progression of subdural empyema, which represents a true neurosurgical emergency requiring prompt diagnosis and management."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/7810468": [
        "Despite the availability of new broad-spectrum antibiotics, sinusitis occasionally causes significant morbidity and mortality.",
        "Before magnetic resonance imaging became available, computed tomography was used for rapid diagnosis of this infection.",
        "The symptoms of subdural empyema may be mild and may be the same as those associated with sinusitis, or the infection may result in alteration of the level of consciousness and focal neurologic deficits.",
        "Magnetic resonance imaging, however, is now becoming the diagnostic tool of choice.",
        "Rapid recognition and treatment of subdural empyema is extremely important.",
        "Neurosurgical intervention and high doses of intravenously administered antibiotics are the mainstays of treatment.",
        "If treatment is initiated as soon as the diagnosis of subdural empyema is made, the patient has a good chance of recovering with no, or only slight, neurologic defects.",
        "One serious complication of paranasal sinusitis is subdural empyema, a fulminating intracranial disease that is invariably fatal if not treated."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26999324": [
        "One participant showed significant improvement on the training task, another showed a tendency for improvement, and both of them improved significantly in spoken sentence comprehension.",
        "Aphasia, the language disorder following brain damage, is frequently accompanied by deficits of working memory (WM) and executive functions (EFs).",
        "We used a pre-post-test case control design.",
        "Three individuals with chronic aphasia practised an adaptive training task (a modified n-back task) three to four times a week for a month.",
        "The third participant did not improve on the training task, however, she showed improvement on one measure of spoken sentence comprehension.",
        "Their performance was assessed before and after the training on outcome measures related to WM and spoken sentence comprehension.",
        "Our aim was to investigate whether a combined WM and EF training improves the understanding of spoken sentences in IWA.",
        "Compared to controls, two individuals improved at least in one condition of the WM outcome measures.",
        "Recent studies suggest that WM, together with certain EFs, can play a role in sentence comprehension in individuals with aphasia (IWA), and that WM can be enhanced with intensive practice.",
        "Thus, our results suggest that a combined WM and EF training can be beneficial for IWA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28691196": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      People with aphasia (PWA) use pantomime, gesture in absence of speech, differently from non-brain-damaged people (NBDP)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29398602": [
        "Six species and five types of strains genetically related are currently assigned to the genus Anaplasma including Anaplasma marginale, A. centrale, A. bovis, A. phagocytophilum, A. ovis and A. platys as classified species, and \"A. capra\", A. odocolei sp. nov., A. phagocytophilum-like 1 (Anaplasma sp.-Japan), A. phagocytophilum-like 2 (Anaplasma sp.-China) and A. platys-like (also named Candidatus Anaplasma camelii) as unclassified strains.",
        "The aim of this review is to summarize the current knowledge about molecular epidemiology, associated risk factors and genetic diversity of Anaplasma species and related strains infecting animals and/or their incriminated tick vectors in North Africa.",
        "The genus Anaplasma belonging to the Anaplasmataceae family (order Rickettsiales) comprises obligate intracellular Gram-negative bacteria of veterinary and public health importance.",
        "All these data should be considered when establishing of common management and control programs for anaplasmosis infecting humans and different animal species in North African countries.",
        "Most of these Anaplasma species and strains have been molecularly identified in several animal and/or tick species in the north of Africa."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30217516": [
        "Hereby, we identified novel immunoreactive proteins and delineated a specific epitope of A. phagocytophilum, which might be employed for HGA diagnosis.",
        "Human granulocytic anaplasmosis (HGA), an increasingly recognized febrile tick-borne illness, is caused by a gram-negative obligate intracellular bacterium Anaplasma phagocytophilum.",
        "Here we in silico screened A. phagocytophilum genome for encoding proteins which bear features of type IV secretion system substrates.",
        "Because of nonspecific clinical manifestations, diagnosis of HGA highly depends on laboratory tests.",
        "Previous studies indicated that secreted proteins of A. phagocytophilum and other bacteria can be immunoreactive antigens.",
        "Among seventy seven predicted proteins, fourteen proteins were determined for antigenicity and nine proteins were showed to be immunoreactive antigens.",
        "In addition, an APH1384 peptide harboring a B cell epitope predicted by bioinformatics was found specifically reacting with anti-A. phagocytophilum sera.",
        "In this study, we identified novel immunoreactive proteins of A. phagocytophilum.",
        "Identification of immunoreactive proteins is prerequisite for development of specific and sensitive immunoassays for HGA."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30352386": [
        "We also study the stability of the interaction to find key structural characteristics that explain the antagonist activities of this set of ligands.",
        "This information is relevant for the rational modification or design of molecules and their identification as powerful LasR modulators.",
        "The carbonyl groups belonging to the lactone ring and the amide group of the acyl chain are oriented towards the amino acids forming hydrogen bond like interactions.",
        "The analysis of molecular docking simulations shows that the 28 analogues have a similar binding mode compared to the native ligand.",
        "Additionally, we carried out molecular dynamics simulations to understand the conformational changes in the ligand-receptor interaction and the stability of each complex.",
        "The present work combines molecular docking calculations, 3D-QSAR, molecular dynamics simulations and free binding energy calculations (MM/PBSA and MM/GBSA) in a set of 28 structural analogues of acyl homoserine lactones with Quorum Sensing antagonist activity.",
        "The difference in antagonist activity is due to location and orientation of the LasR side chains within the hydrophobic pocket in its binding site.",
        "Results show a direct relationship among the interaction energies of the ligands and the activities as an antagonist of the LasR receptor.",
        "The aim of this work is to understand how ligand binds and is affected by the molecular microenvironment in the active site of the LasR receptor for pseudomonas aeruginosa."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29130184": [
        "A panel of AHL compounds conjugated to carrier proteins are used for sheep immunization and a phage display antibody library is constructed using the immune repertoire of sheep as a source of antibody genes.",
        "A number of bacteria use a class of chemical compounds called acyl-homoserine lactones (AHLs) as quorum sensing (QS) signals to coordinate their behavior at the population level, including pathogens like Pseudomonas aeruginosa.",
        "High sensitivity single chain antibody fragments (scFv) are isolated from the library using \"smart selection strategies\" and reformatted into single chain antibodies (scAbs).",
        "Here the methods involved in the generation of high sensitivity anti-QS monoclonal antibodies from an immunized sheep phage display antibody library are described.",
        "The resultant monoclonal antibodies: (1) recognize HSL compounds at low nanomolar concentrations; (2) have the potential to reduce virulence gene expression in P. aeruginosa; and (3) offer protection in a nematode model of infection.",
        "Blocking QS using antibodies is an attractive strategy for infection control as this process takes a central role in P. aeruginosa infections."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27896412": [
        "Certain acyl-homoserine lactones can modulate mammalian cell function and are thought to contribute to bacterial pathogenicity.",
        "Given the role of mast cells in host defense, we investigated the ability of acyl-homoserine lactones to modulate mast cell function.",
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      Bacterial colonization relies on communication between bacteria via so-called \"quorum-sensing molecules\", which include the acyl-homoserine lactone group."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/26989738": [
        "The purpose of this investigation was to biochemically detect and characterize AHL activity in biofilm-forming uropathogenic E. coli (UPEC) isolated from urine samples of the patients with urinary tract infections (UTIs) in Kerman, Iran.",
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      N-Acyl homoserine lactone (AHL) is found to be the main component of quorum sensing (QS) in Gram-negative bacteria and plays an important role in biofilm formation.",
        "Little information is available regarding the role of AHL in biofilm formation in Escherichia coli (E. coli)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/19464950": [
        "We suspect that through apoptosis an anti-inflammatory response is triggered.",
        "It becomes more and more evident, that bacteria communicate not only with each other but also with their host.",
        "In this paper, we investigated the role of 7 different AHLs on apoptosis of human Jurkat T lymphocytes.",
        "We found, that among all homoserine lactones tested, only OdDHL rapidly induced apoptosis which was accompanied by the breakdown of the mitochondrial transmembrane potential (DeltaPsi(m)).",
        "The reason that bacteria induce apoptosis is largely unknown.",
        "Since overexpression of anti-apoptotic Bcl-2 completely abrogated the apoptotic effect, we presume that OdDHL induces apoptosis by activation of the intrinsic mitochondrial apoptosis pathway.",
        "The AHL quorum sensing molecule N-3-(oxododecanoyl)-L-homoserine lactone (OdDHL) from Pseudomonas aeruginosa has been shown to influence the immune system of the host.",
        "Diverse Gram-negative bacteria communicate with each other by using diffusible N-acyl-homoserine lactone (AHL) signaling molecules to coordinate gene expression with cell population density.",
        "This mechanism termed 'quorum sensing' is involved in the regulation of physiological functions as well as multiple virulence determinants.",
        "Up to now, little is known about this interkingdom communication.",
        "The role and potential influence of other AHL molecules from other bacteria have so far not been determined."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28887424": [
        "The genomes of many nitrifying bacteria contain genes associated with bacterial cell-cell signaling or quorum sensing (QS).",
        "The genomes of many bacteria that participate in nitrogen cycling through the process of nitrification contain putative genes associated with acyl-homoserine lactone (AHL) quorum sensing (QS).",
        "QS is a method of bacterial communication and gene regulation that is well studied in bacterial pathogens, but less is known about QS in environmental systems.",
        "Our work lays the foundation for future experiments investigating communication between nitrifying bacteria, the purpose of QS in these microorganisms, and the manipulation of QS during nitrification.",
        "Here, we carried out a broad survey of AHL production in nitrifying bacteria in three steps.",
        "Our survey expands the list of AHL-producing nitrifiers to include a representative of <i>Nitrospira</i> lineage II and suggests that AHL production is widespread in nitrifying bacteria.<b>IMPORTANCE</b> Nitrification, the aerobic oxidation of ammonia to nitrate via nitrite by nitrifying microorganisms, plays an important role in environmental nitrogen cycling from agricultural fertilization to wastewater treatment.",
        "Our results suggest that an AHL synthase gene is required for, but does not guarantee, cell density-dependent AHL production under the conditions tested.",
        "Our previous work suggested that QS might be involved in the regulation of nitrogen oxide gas production during nitrite metabolism.",
        "Finally, we utilized mass spectrometry to identify the AHLs produced by the AOB <i>Nitrosospira multiformis</i> and <i>Nitrosospira briensis</i> and the NOB <i>Nitrobacter vulgaris</i> and <i>Nitrospira moscoviensis</i> as <i>N</i>-decanoyl-l-homoserine lactone (C<sub>10</sub>-HSL), <i>N</i>-3-hydroxy-tetradecanoyl-l-homoserine lactone (3-OH-C<sub>14</sub>-HSL), a monounsaturated AHL (C<sub>10:1</sub>-HSL), and <i>N</i>-octanoyl-l-homoserine lactone (C<sub>8</sub>-HSL), respectively.",
        "First, we analyzed the evolutionary history of AHL synthase and AHL receptor homologs in sequenced genomes and metagenomes of nitrifying bacteria to identify AHL synthase homologs in ammonia-oxidizing bacteria (AOB) of the genus <i>Nitrosospira</i> and nitrite-oxidizing bacteria (NOB) of the genera <i>Nitrococcus</i>, <i>Nitrobacter</i>, and <i>Nitrospira</i> Next, we screened cultures of both AOB and NOB with uncharacterized AHL synthase genes and AHL synthase-negative nitrifiers by a bioassay.",
        "This study characterized putative QS signals produced by different genera and species of nitrifiers.",
        "AHL QS or bacterial cell-cell signaling is a method of bacterial communication and gene regulation and may be involved in nitrogen oxide fluxes or other important phenotypes in nitrifying bacteria."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/12426339": [
        "Many proteobacteria use acyl-homoserine lactones as quorum-sensing signals.",
        "A mutation in this gene, which we named gtaI, resulted in decreased production of the R. capsulatus gene transfer agent, and gene transfer agent production was restored by exogenous addition of N-hexadecanoyl-homoserine lactone.",
        "The long-chain acyl-homoserine lactones were concentrated in cells but were also found in the culture fluid.",
        "These long-chain acyl-homoserine lactones are not readily detected by standard bioassays.",
        "Traditionally, biological detection systems have been used to identify bacteria that produce acyl-homoserine lactones, although the specificities of these detection systems can limit discovery.",
        "An R. capsulatus gene responsible for long-chain acyl-homoserine lactone synthesis was identified.",
        "We used a sensitive approach that did not require a bioassay to detect production of long-acyl-chain homoserine lactone production by Rhodobacter capsulatus and Paracoccus denitrificans.",
        "Thus, long-chain acyl-homoserine lactones serve as quorum-sensing signals to enhance genetic exchange in R. capsulatus.",
        "The most abundant acyl-homoserine lactone was N-hexadecanoyl-homoserine lactone."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29606668": [
        "<strong class=\"sub-title\">\n          Objective:\n        </strong>\n      \n      To assess clinical outcomes including imaging findings on computed tomography (CT), pulmonary function testing (PFT), and glucocorticoid (GC) use in patients with the antisynthetase syndrome (AS) and interstitial lung disease (ILD) treated with rituximab (RTX)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30358861": [
        "The aim of this study was to describe RTX use and outcomes among children with JIA.",
        "<strong class=\"sub-title\">\n          Objectives:\n        </strong>\n      \n      Rituximab (RTX) may be a treatment option for children and young people with JIA, although it is not licensed for this indication."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28185174": [
        "The use of kinase inhibitors is already well established in recurrent/refractory disease.",
        "A new indication for ibrutinib was recently approved for older patients with comorbidities, as an alternative to the already existing indication for chlorambucil with obinutuzumab.",
        "Immunochemotherapy with fludarabine, cyclophosphamide, rituximab (FCR) remains a major first-line option for many CLL patients without the TP53 gene deletion/mutation, and who have no significant comorbidities or history of infections, and is particularly effective in patients with favorable features including mutated IGHV status.",
        "A number of new treatment options have recently emerged for chronic lymphocytic leukemia (CLL) patients, including the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, phosphatidylinositol-3-kinase (PI3K) delta isoform inhibitor idelalisib combined with rituximab, the Bcl-2 antagonist venetoclax, and the new anti-CD20 antibodies obinutuzumab and ofatumumab.",
        "There are a number of issues regarding novel therapies for CLL that need further investigation such as optimum duration of treatment with kinase inhibitors, appropriate sequencing of novel agents, mechanisms of resistance to inhibitors and response to class switching after treatment failure, along with the potential role of combinations of targeted agents.",
        "Ibrutinib was proven as a primary choice for patients with the TP53 gene deletion/mutation, who otherwise have no active treatment available.",
        "Idelalisib with rituximab is also an active therapy, but due to increased risk of serious infections, its use in first-line treatment is limited to patients for whom ibrutinib is not an option.",
        "Most of these agents are already included into treatment algorithms defined by international practice guidelines, but more clinical investigations are needed to answer still remaining questions."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28633733": [
        "As PF is restricted to the superficial epidermis, it is considered more benign than other pemphigus diseases.",
        "Although rituximab's efficacy has been well-documented in adults with refractory PF, little data is available on its role in adolescents.PurposeWe describe a patient with juvenile PF treated with rituximab and review the literature for similar cases.MethodsPubMed was searched for the terms: antibody, B cells, blistering, CD20, foliaceus, juvenile, pemphigus, rituximab, immunosuppression.",
        "The indication for rituximab in most cases was refractory PF unresponsive to systemic glucocorticoids and non-steroidal adjuvant therapies.",
        "As the first reported case of rituximab treated pemphigus was in 2001, only cases from 2001 and after were included.",
        "BackgroundPemphigus foliaceus (PF) is a blistering disorder most commonly presenting in middle age.",
        "However, progression to severe disease is not uncommon.",
        "Juvenile PF was defined as disease diagnosis between ages 12-17.ResultsFive cases have been reported.",
        "All cases demonstrated significant improvement or complete remission and most experienced no adverse events.ConclusionsRituximab appears to be both well tolerated and efficacious for refractory juvenile PF.",
        "Therefore, it may be considered for severe cases of PF to avoid side effects associated with conventional glucocorticoid therapy."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23735074": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Rituximab is a chimeric, anti-CD20 monoclonal antibody registered for the treatment of B-cell malignancies and refractory rheumatoid arthritis in Australia.",
        "In addition to these approved indications, there has been growing interest in the use of off-label rituximab in the management of a variety of diseases."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/27603326": [
        "Rituximab is an anti-CD20 monoclonal antibody with considerable potential in dermatology due to an increase in off-label indications.",
        "Currently, rituximab is only FDA-approved for treatment of follicular and diffuse large B-cell non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis (formerly Wegener's granulomatosis) and microscopic polyangiitis.",
        "It is a generally safe alternative that should be considered when traditional therapy with corticosteroids or immunosuppressants has failed or caused significant intolerance.",
        "Herein, off-label uses of rituximab and its efficacy in the treatment of cutaneous diseases are reviewed.",
        "Chronic graft-versus-host disease and pemphigus vulgaris are two of the most promising indications for off-label use of rituximab."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23700188": [
        "<strong class=\"sub-title\">\n          Purpose:\n        </strong>\n      \n      To analyze the therapeutic indications for off-label use of rituximab, the available evidence for its use, the outcomes, and the cost."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/16227208": [
        "Pim kinases are emerging as important mediators of cytokine signaling pathways in hematopoietic cells, and they contribute to the progression of certain leukemias and solid tumors.",
        "We have solved the crystal structure of Pim-1 bound to a high affinity peptide substrate in complexes with either the ATP analog AMP-PNP or the bisindolylmaleimide kinase inhibitor 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide HCl.",
        "Here, we have conducted peptide library screens to exhaustively determine the sequence specificity of active site-mediated phosphorylation by Pim-1 and Pim-3.",
        "Recent crystallographic studies of Pim-1 have identified unique structural features but have not provided insight into how the kinase recognizes its target substrates.",
        "The Pim kinases are a family of three vertebrate protein serine/threonine kinases (Pim-1, -2, and -3) belonging to the CAMK (calmodulin-dependent protein kinase-related) group.",
        "The structures provide a rationale for the unusually high affinity of Pim kinases for peptide substrates and suggest a general mode for substrate binding to members of the CAMK group.",
        "These structures reveal an unanticipated mode of recognition for basic residues upstream of the phosphorylation site, distinct from that of other kinases with similar substrate specificity.",
        "We have identified the major site of Pim-1 autophosphorylation and find surprisingly that it maps to a novel site that diverges from its consensus phosphorylation motif.",
        "A number of cytoplasmic and nuclear proteins are phosphorylated by Pim kinases and may act as their effectors in normal physiology and in disease."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/30033129": [
        "HS56 represents a significant step in the development of molecularly targeted antihypertensive medications.",
        "In vivo, HS56 decreased blood pressure in spontaneously hypertensive mice in a dose-dependent manner without affecting heart rate.",
        "These findings suggest including Pim kinase inhibition within a multi-target engagement strategy for hypertension management.",
        "In vitro and ex vivo studies indicated that Pim kinases directly phosphorylate smooth muscle targets and that Pim/DAPK3 inhibition, unlike selective DAPK3 inhibition, significantly reduces contractility.",
        "Sustained vascular smooth muscle hypercontractility promotes hypertension and cardiovascular disease.",
        "Here we report that Pim kinases, in combination with DAPK3, regulate contractility and control hypertension.",
        "Using a co-crystal structure of lead molecule (HS38) in complex with DAPK3, a dual Pim/DAPK3 inhibitor (HS56) and selective DAPK3 inhibitors (HS94 and HS148) were developed to provide mechanistic insight into the polypharmacology of hypertension.",
        "The etiology of hypercontractility is not completely understood.",
        "New therapeutic targets remain vitally important for drug discovery."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/25575657": [
        "We show the SAR suggesting the importance of having a hydrogen bond donor in this pocket for inhibiting PIM2; however, this interaction is not important for inhibiting PIM1 or PIM3.",
        "In addition, we report the discovery of a new class of PIM inhibitors by using computational de novo design tool implemented in MOE software (Chemical Computing Group).",
        "These inhibitors have a different interaction profile.",
        "The crystal structure of this compound with PIM1 confirmed the predicted binding mode and protein-ligand interactions except those in the acidic ribose pocket.",
        "We have identified a low-nanomolar pan-PIM inhibitor (PIM1/2/3 potency 5:14:2nM) using structure based modeling.",
        "PIM kinases are implicated in variety of cancers by promoting cell survival and proliferation and are targets of interest for therapeutic intervention."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22926267": [
        "We employ ensemble docking simulations to characterize the interactions of two enantiomeric forms of a Ru-complex compound (1-R and 1-S) with three protein kinases, namely PIM1, GSK-3\u03b2, and CDK2/cyclin A. We show that our ensemble docking computational protocol adequately models the structural features of these interactions and discriminates between competing conformational clusters of ligand-bound protein structures.",
        "Using the determined X-ray crystal structure of PIM1 complexed to the compound 1-R as a control, we discuss the importance of including the protein flexibility inherent in the ensemble docking protocol, for the accuracy of the structure prediction of the bound state.",
        "The top scoring conformation of the inhibitor bound to CDK2 is not present among the top-scoring conformations of the inhibitor bound to either PIM1 or GSK-3\u03b2 and vice-versa.",
        "A comparison of our ensemble docking results suggests that PIM1 and GSK-3\u03b2 bind the two enantiomers in similar fashion, through two primary binding modes: conformation I, which is very similar to the conformation presented in the existing PIM1/compound 1-R crystal structure; conformation II, which represents a 180\u00b0 flip about an axis through the NH group of the pyridocarbazole moiety, relative to conformation I.",
        "Collectively, our results help provide atomic-level insights into inhibitor selectivity among the three kinases.",
        "In contrast, the binding of the enantiomers to CDK2 is found to have a different structural profile including a suggested bound conformation, which lacks the conserved hydrogen bond between the kinase and the ligand (i.e., ATP, staurosporine, Ru-complex compound)."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/23936194": [
        "Human Pim1 kinase is a serine/threonine protein kinase that plays important biological roles in cell survival, apoptosis, proliferation, and differentiation.",
        "The interactions between SKI-O-068 and the Pim1 active site pocket residue are different from those of other scaffold inhibitor-bound structures.",
        "Here, we describe the crystal structure of Pim1 in complex with a newly developed pyrido[4,3-d]pyrimidine-derivative inhibitor (SKI-O-068).",
        "Our inhibitor exhibits a half maximum inhibitory concentration (IC50) of 123 (\u00b114) nM and has an unusual binding mode in complex with Pim1 kinase.",
        "Thus, Pim1 is an attractive target for cancer therapeutics, and there has been growing interest in developing small molecule inhibitors for Pim1.",
        "The binding mode analysis suggests that the SKI-O-068 inhibitor can be improved by introducing functional groups that facilitate direct interaction with Lys67, which aid in the design of an optimized inhibitor.",
        "Moreover, Pim1 is up-regulated in various hematopoietic malignancies and solid tumors."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/22339127": [
        "These investigations highlight that fragments that do not fill their binding pocket can exhibit promiscuous hydrophobic interactions due to the lack of steric constraints imposed on them by the boundaries of said pocket.",
        "As a result, docking modes that disagree with an observed crystal structure but maintain key crystallographically observed hydrogen bonds still have potential value in ligand design and optimization.",
        "This observation runs counter to the lore in fragment-based drug design that all fragment elaboration must be based on the parent crystal structure alone.",
        "Crystallographic and docking data analyses have been undertaken using inhibitor complexes derived from an in-house surface plasmon resonance (SPR) fragment screen, a virtual needle screen, and a de novo designed fragment inhibitor hybrid.",
        "We have studied the subtleties of fragment docking and binding using data generated in a Pim-1 kinase inhibitor program."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/15808862": [
        "The crystal structures of Pim1 in apo form and bound with AMPPNP have been solved and several unique features of Pim1 were identified, including the presence of an extra beta-hairpin in the N-terminal lobe and an unusual conformation of the hinge connecting the two lobes of the enzyme.",
        "One crystal structure reported here shows that changing P123 to methionine, a common residue that offers the backbone hydrogen bond to ATP, does not restore the ATP binding pocket of Pim1 to that of a typical kinase.",
        "Pim1, a serine/threonine kinase, is involved in several biological functions including cell survival, proliferation, and differentiation.",
        "Pim1 is unique among protein kinases due to the presence of a proline residue at position 123 that precludes the formation of the canonical second hydrogen bond between the hinge backbone and the adenine moiety of ATP.",
        "In each case, the observed effects on kinase activity are consistent with the predicted consequences of the mutation on the Pim1 structure.",
        "These unique structural features in Pim1 result in novel binding modes of AMP and a known kinase inhibitor scaffold, as shown by co-crystallography.",
        "In addition, the kinase activities of five Pim1 mutants identified in DLCL patients have been determined.",
        "Finally, 70 co-crystal structures of low molecular mass, low-affinity compounds with Pim1 have been solved in order to identify novel chemical classes as potential Pim1 inhibitors.",
        "While the apo Pim1 structure is nearly identical with that reported recently, the structure of AMPPNP bound to Pim1 is significantly different.",
        "Based on the structural information, opportunities for optimization of one specific example are discussed.",
        "While pim1 has been shown to be involved in several hematopoietic cancers, it was also recently identified as a target of aberrant somatic hypermutation in diffuse large cell lymphoma (DLCL), the most common form of non-Hodgkin's lymphoma."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/28767130": [
        "Increasing evidence suggests that tumour-associated macrophages/microglia (TAMs) facilitate tumour progression by acquiring a M2-like phenotype.",
        "<strong class=\"sub-title\">\n          Aims:\n        </strong>\n      \n      Glioblastomas are highly aggressive and treatment resistant.",
        "Our objective was to investigate the prognostic value of TAMs in gliomas using automated quantitative double immunofluorescence."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/24089530": [
        "CCL4 is associated with cellular neovascularization, whereas FGF2 and IL6 induction led to better cellular survival and decreased apoptotic activity of the stellate cells.",
        "The identified direct effects of individual cytokines on human pancreatic stellate cells provide new insights about their contribution to pancreatic cancer promotion.",
        "Further analysis showed that TNF-\u03b1 is the prime factor responsible for the activation of pancreatic stellate cells.",
        "Variations were detected by means of a microarray of 810 antibodies targeting relevant proteins.",
        "Pancreatic stellate cells are key mediators in chronic pancreatitis and play a central role in the development of pancreatic fibrosis, stromal formation, and progression of pancreatic cancer.",
        "This study was aimed at investigating molecular changes at the level of the proteome that are associated with the activation of pancreatic stellate cells by proinflammatory factors, namely TNF-\u03b1, FGF2, IL6, and chemokine (C-C motif) ligand 4 (CCL4).",
        "All tested factors triggered increased proliferation and migration.",
        "They were added individually to cells growing in serum-free medium next to controls in medium supplemented with serum, thus containing a mixture of them all, or in serum-free medium alone."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/20689058": [
        "PSCs were isolated from human and rat pancreas tissues.",
        "Recombinant IL-33 did not stimulate key cell functions of PSCs.",
        "PSCs expressed soluble ST2, ST2L, and IL-1RAcP, but the expression level of ST2L was relatively low.",
        "The expression of IL-33 was examined by Western blotting, PCR, ELISA, and immunostaining.",
        "In conclusion, activated PSCs expressed IL-33 in the nucleus.",
        "Nuclear IL-33 expression was also observed in the pancreatic acinar and ductal cells.",
        "Activated PSCs expressed IL-33 in the nucleus, and the expression was increased by IL-1\u03b2, TNF-\u03b1, PDGF-BB, and IFN-\u03b3, but not TGF-\u03b21.",
        "Decreased IL-33 expression by small interfering RNA resulted in decreased proliferation in response to PDGF-BB.",
        "Recent studies have suggested a role of IL-33, a newly identified IL-1 family member, in fibrosis.",
        "The roles of IL-33 in the regulation of PSC functions were examined by using recombinant IL-33 and small interfering RNA.",
        "Activated pancreatic stellate cells (PSCs) play a pivotal role in pancreatic fibrosis in chronic pancreatitis and pancreatic cancer.",
        "We here examined the expression of IL-33 and the IL-33-mediated regulation of cell functions in PSCs.",
        "IL-1\u03b2 induced IL-33 expression mainly through the activation of NF-\u03baB and ERK pathways and partially through that of p38 MAP kinase, whereas PDGF-BB induced IL-33 expression mainly through the activation of ERK pathway.",
        "IL-33 might regulate the PDGF-induced proliferation in PSCs."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29158129": [
        "Genetic approaches that use mitochondrial DNA polymorphisms have also been used in some in vitro studies and in tumor models and are particularly useful where mtDNA is damaged or deleted.",
        "Interest in the recently discovered phenomenon of mitochondrial transfer between mammalian cells has gained momentum since it was first described in cell culture systems more than a decade ago.",
        "As research on intercellular mitochondrial transfer moves from cell culture into animal models and human diseases it will be important to understand the limitations of the various techniques in order to apply appropriate methodologies to address physiological and pathophysiological conditions.",
        "These approaches can also be used to study the long-term consequences of mitochondrial transfer such as in bone marrow and organ transplantation and in tumour biology where inherent mitochondrial damage is often a key feature.",
        "Mitochondria-targeting fluorescent dyes have been repurposed and are now widely used in these studies and in acute disease models, sometimes without due consideration of their limitations, while vectors containing mitochondrially-imported fluorescent proteins have complemented the use of mitochondria-targeting dyes."
    ],
    "http://www.ncbi.nlm.nih.gov/pubmed/29357914": [
        "<strong class=\"sub-title\">\n          Background:\n        </strong>\n      \n      Despite the high cure rate of T cell acute lymphoblastic leukemia (T-ALL), drug resistance to chemotherapy remains a significant clinical problem.",
        "In this study, we aimed to uncover the mechanism of MSC-induced chemoresistance in T-ALL cells, thus providing a promising clinical therapy target.",
        "Bone marrow mesenchymal stem cells (MSCs) protect leukemic cells from chemotherapy, but the underlying mechanisms are poorly understood."
    ]
}